>AAS90606.1|FEATURES|farme|aminoglycoside|AAC(6')-Iai|antibiotic inactivation|1
MNIFSLTRDNEHLIHQAAQLLMDAFHEHWPDAWPTFEEGWKEVHEMLEAERICRAAVDDN
GNLLGLIGGIAGYDGNVWELHPLAVQPHLQGQGIGRALVEDFEEQVRLRGGLTITLGSDD
EDDMTSLSDVDLHENPWEKIQKIRNFKGHPFTFYQKMGYVITGVVPDANGRGKPDILMSK
RVG
>ACH59003.1|FEATURES|farme|beta_lactam|mrdA|antibiotic inactivation|0
MTTHSPVPDVDEMTIQTRPGNAVQSSSGQVAHADRQRSDPSQVHQYSIQRTRIAERLETL
IPWLSVAWFFGVLGLTARVTGGMIYTQRLIRCHTQLFGSYWTERLKHVSKRLRLSRSVRL
LESSVVKVPTTIGWWRPVILVPGSVLSGLTPQQLELILAHELAHIRRHDYLINLFQVLVE
TLLFYHPAVWWISKQVRNERELVCDDMAVSVGGDPITYARALAKIERLRRETPVWALAAD
GGRLSKRIVRLIDSTQDSPRLPSMVVGFIMIGALFISIAVVQNVLSITKRSAQVAVAGAT
SVHQQLTPQSVQELIALDDTTGEDSEVRRISLAALGKREGAVIVMDPRTGRVYTIVNQEW
AVRQSWQPASIIKLVTAAAALGEKVIQPSQPLRVSAKSRPLDLTEALALSSNPYFAFVGN
GVGPDQIIKYAREFGLGERTGINYSQEGAGIIPGFSENLDVRFGATGEGVEATPIQLATL
VSAVANGGQLVTPYVPHSSAESSETQPPVRRRIAIPPANLGLLMAGMIAAVDHGSGTGAS
DTSQIVAGKTGTFRDKTTNVGLFASYAPANDPRFVVVVVTRGQNESGPEAANVAGTIFRG
LRNRS
>ACN18097.1|FEATURES|farme|beta_lactam|acc-3a|antibiotic inactivation|0
MSRIVLPVRVMLLVAFCVPVTSIAQRMPTGAAIDTEVGKIMTRTNAKGMAVAVIDRGQIS
YVHAYGIRNAKGDPLTTDTVMYGASLTKTVFAYTVMQLVDQRKLTLDTPLKDLLDKPLPN
YGPDPVFPDKYGPYKDLADDSRWEKITPRMCLTHSTGFANFWFIEPDQKLRIHFEPGMRY
AYSGEGLILLQFVIEHGRKAQGLGLDVGDLTKANFDRLHMTRTSLVWRDDFAANLADGWN
DQGEPQEHDQRSKVRAAGSMDTTISDLAKFTAALVRGDGLSAASRAAMTKPQLHIGSAHQ
FPPFVPELPLKDQRKDLYAGLGVVVFDGPQGHGFYKGGHDGQTANTMICLEASQRCVVIL
SNDVRSEAGFKDLVGLILGDIGVPYDWEYGDRAGKS
>ACN58946.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic target protection|1
MAEPVLSVKDLDIRFTTPDGNVHAVKKVSFDIAPGECLGVVGESGSGKSQLFMACIGLLA
GNGKATGSVTYRGQELLGQPAAKLNAIRGAKITMIFQDPLTSLTPHMRIGDQIVESLRTH
SKLSKGEAEKRAIQALELVRIPEAKRRMRQYPHELSGGMRQRVMIAMATACGPDLLIADE
PTTALDVTVQAQILDIMRDLRKELGTSIALISHDMGVIASICDRVQVMRYGEFVETGPAD
DIFYHPQHPYTRMLLEAMPRIDQPVREGRAALKPLAPQEARTTLLEVDNVKVHFPIQMGG
VFFGKYKPLRAVDGVSFTLHQGETIGIVGESGCGKSTLARAVLELLPKTTGGVVWMGRDL
GALPPAELRRARKDFQIVFQDPLASLDPRMTIGQSIAEPLQSLEPELSKHEVQSRVRAIM
EKVGLDPDWINRYPHEFSGGQNQRVGIARAMILKPKLIVCDEAVSALDVSIQAQIVDLIL
SLQAEFGMSIIFISHDLSVVRQVSHRVMVLYLGRVVELASRDAIYEDARHPYTKALISAV
TVPDPRAERLKKRRELPGELPSPLDTRSALMFLKSKRIDDPDAEQYVPKLIEVAPGHFVA
EHDPFEVVEMTG
>ACN58863.1|FEATURES|farme|multidrug|ceoB|antibiotic efflux|1
MTSRGYPSRRRRPAPRLWPKAEERRMDISRFFIDRPRFATVLSIFIFMVGLLAIFQLPIS
EYPEVAPPQIVVRAQFPGANPRVISETVAAPLEEQINGLEHMLYFESQATADGSMTLTVT
FKIGTVPEQAETAVQNRINRALPRLPDIVRQIGVTTEKQSPNLTMVVHMVSPDNSHDALY
LRNYANLNVRDDLLRISGMGSVLLFGSGDYAMRIWLNPRQLAARNMTAGDVVTAIREQNA
QVAAGVVGSPPAPNDTDFQLQVNARGRLIKEEDFADIIVRGDPATGALVRIKDIGRVEIS
ANSYSLRSLLNNKEAAAIGIFQAPGSNALKLSNDVRATMENAKKSFPKGVDYDIVYDPTR
FVQTSIEKVVHTLIEAVLLVVLVVIIFLQTWRASVIPLLAVPVSIIGTFAMLLLLGYSIN
TLTLFGLVLAIGIVVDDAIVVVENVERNIADGLTPHDATVRAMREVSGPIVAIALVLCAV
FIPLTFVPGLSGQFYKQFAATIAISTVISAFNSLTLSPALAALLLRPHDAPKDKIMVVMD
KLFGRFFHWFNCMFQRRSKAYGRGVTGLLHRKSLALVVYGVLLLCTGLLFTRIPSGFVPA
PDKQYLIGIAQLPAGSSLARTEKVIREMSDIALKVPGIVDSIAFPGLSIAGFSSSPNEGI
VFFGLAPFEERTTRALSKDAILGKVNGAIQAIQGARMFVVPPPAVDGLGNAGGFKLQVQD
RGGQGEQALYGAVWGGILGPIYGNPKSSIGTPYSNYDINVPQLFADVDRTKAKQMGLPLQ
EIYDTLQINLGSLYVNDFTRFGKTYQVVVQADAPFRSRADSITNLETRNSAGQMVPLGSV
MQVSPTFGPTRVTRYNGFPSADINGAAKPGFSSGQAEAEIERIVKQLPRGMSYEWTDLTY
QDRLTRDITLPGINVKIPTLAAVLFLSVVLVALVLTAQYESWSLPLAIIMIVPMCILSAL
FGVWMSHFPPFSQGGDLNLFTQVALVVLVGLACKNAILIVEFAKELEEQGQPMMDAIVNA
CHLRLRPILMTSIAFCAGVIPLILGSGAGSEMRRAMGIAVFSGMVGVTSFGIFLTPVFYS
LLRKSTEKSRAHSAELRHQIEAAAHPFHPGIDDADPPRKGEV
>ACH58976.1|FEATURES|farme|multidrug|OpmD|antibiotic inactivation|0
MRRSLRHLASEGTDIGGYGLPFGHMALRMATAEALSEQQIVVEAAQVLLTQGSSQALDLV
ARRLLKPGDSVLVDDPGYPNLMFMLRFLGVEIIGVPRIPSGYDMPALEALLAVHRPKAFF
TQPRLQSPTCSMASLPQLVQLLQLAQAHDFTLVENDIYAEMDASMRPSLASLGQLRHVVY
VSSYSKTISPNIRVGFVVAQPELLEDLAQLKMVSGLTSSDITERLAFGTVTDGRWRKHLK
SLRDRLAQAQGSVARRLDALGFELFHEAAAGMYLWARHPDIADSAELSRRAAVEGIMLGP
GQLFLVNPHPTGWLRFNVAFSEDERLWRFLERSIAQQSHELAAEGDG
>ACH58996.1|FEATURES|farme|beta_lactam|RPSI07_mp0046|antibiotic inactivation|1
MDLLLVRFLLASMASMAVGLAVWSLCAVLRRLLPALASQRMGWLLAQLTVAAVFLLTLAP
QPQRQRLVPPVDIEAVDAAVTRYLAPAVRTPAIPAPVSAGAARQDITASWLVACAQGWLL
FYLLGLGWQIGKFWRAQRLLAGLAAGGVPLGAGEAGGRFNAVAPTGTVAGMCAGVPVIEV
DAPVPPMLLGPYKPRLLLPRHLRAFDPLQQRLIVEHELTHWRRRDLHWMLAGVVLQTLLW
FNPFMRWLRASLLWAQELGCDRDVLRGRPVQERKAYAAALVAQLKWQCHPGATTTSAALA
FGGVSTETVKARIGLIRAPANPATTMRVRCAAIAVLAVAAGGGYALQPALAWQGAGAPSG
LVQCLALTDAATGQPLLRQGQCDARVTPASTFNIVVSLMGYDSGMLKDEATPRLPFRAGY
PDWNDAWRATTGPAEWIRNSTLWYAQQVALQVGAPAFQRYLDRFDYGNRDAAGDAGASNG
LTMSWVNSSLKISADEQLAFLRRLVNRDLGLAPQAYDMTSRLLKVRTLPNGWVVYGKTGT
GSPVGTDGKDDRDHAYGWFVGWAVKGDRTVVFARLNQDRQAHEDAAGPRARDALLRELPA
QLDAL
>ACH58997.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MLKRIRLPQLALALAALFPLAAYAAPDAAALRQAVDAAVGPVMAQFDVPGMAVAVTVDGQ
PHFFNYGVAARDSKQPVTEATIFELGSNSKTFTATLAAYAQAQGKLALDDHPGKYVPQLQ
GSALDGATLLHLGTYTAGGFPLQIPDNLKTREQLFSYFQHWKPDAAPGKQRNYSNPSIGL
FGHIAGLALGGGFADAAERDLFPQLGLQHTYIRVPQSAMAHYAWGYSKDQAVRVQPDLFD
SEAYGVKSTAADMIRYVQLQIDPSRLAAPMRRAVQATHTGYFKAGPMTQGLGWESYPYPV
SLEQLLQGNSTDMAWKPQPVQAIQPVQTAAPALYNKTGSTRGFGSYVAFVPSQKIGIVLL
ANRAYPNDARIKLAYAILNQLAPAAN
>ACN58854.1|FEATURES|farme|glycopeptide|vanRM|antibiotic inactivation|0
MDVPDFDLQPALENDLLLLRPLREEDFDALYGVASDPLLWEQHPARDRYKKNVFEALFRD
AMLSKGAFAIVDKKTRQIIGSTRFHRIPEVQNAVEIGWTFLAREYWGGFYNRSMKLLMME
YAFNYVDHVLFYIGEGNIRSQKAVEKIGGVRIISLEGQILDTRPTAAIVYNITKQAWEIK
LKENSCRQAAD
>ACN58776.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MGNLPRPTLSPSLSGIRPTMNRETTTRVDSSTPAARLGMRVPSTSRAALVGVAALVVILG
GWYGIKRWRAHVASEGQYIFAAIQKGDIEDLVTATGSLQPRDYVDVGAQVSGQLDKILVE
VGSDVKEGDLLAEIDADVAAARVDASRAQLRSQQAQLVQQQANLTKAERDLTRQQNLMKE
DATTAEQVQNAETTLDTTKAQINALKAQMEQLRASMRVDESNLNYTKILAPMSGTVVSIS
AKQGQTLNTNQQAPTILRIADLSTMTVQTQVSEADVSKLRSGMQAYFTTLGSAGKRWYGQ
LKKIEPTPTVTNNVVLYNALFEVPNDNKQLLPQMTAQVFFVAAAAHDVLVVPMSAVSLQR
TPPGGIPNAAAAQAAGARGAGAQGAGAQGAQGASAQGAGAQSGQGGQGAAALTPEQIARR
EARRQQRMQSNGGSATGGAIEGGPPRGGFGASMAARGPRHATVRVQAADGKIEERQITIG
VTNRVHAEVLSGLKEGERVVAGTKEPEKAPATAGGQQGAGGQRNNIGGFPGGGLGGGFGR
>ACN58740.1|FEATURES|NCBI|pleuromutilin|TaeA|antibiotic efflux|1
MRQAVMQGVGDAFKKLVRFNEISEKFAEPMSDDEMNALLEEQAKLQDAIDAANGWELERK
LDIAADALRLPDWDAIIGKLSGGEKRRVALCQLLLSAPDMLLLDEPTNHLDAESVAWLER
YLEEYPSTVIAVTHDRYFLDNVAEWILELDRGHGIPWQGNYSSWLEQKDKRLEQEERSQE
GLRKMLERELEWVRSNPKARQSKSKARMQRFEELSSQEFQKRNETNEIYIPPGERLGDVV
IEVKNLTKGFGDRLLIDNFSFSLPRGGIVGIIGPNGAGKTTLFRMLTDQEKPDSGEIRIG
PSVKLAYVDQSRQQLNDKNSVFQEISGGQEIIKVGNYETSSRGYVGRFNFKGTQQQQLIG
ELSGGERNRVHLAKVLKTGGNLLLLDEPTNDLDIETLRALEEALVAFPGCAVVISHDRWF
LDRIATHILAFEGDSQVVFFEGNYQEYAADYERRHGDSQPHRIKYKKLTR
>ACS83734.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MAQAIPYRSSGKLIIKVSHHCDIPFSVFLMNKAYIVLPVSLLSSPNNVKIALAHEGQHHR
NGDCLWAYFIEVIRIIFFCNPGVTRWKKVLSDLQEFSCDEVLIGHSKISPHDYGHCLVRV
VQAASQSSLPTNPKFACAVGMALDKQNEDCTFIIRRISMLSAYPLKTSRPLIIGIAFVGF
SIVAPLCMAYSAAGTLTSPKLKEMDTSHLNPKIQDIAQKEIALAVKEYHAKSGVIAIVDS
KNGTIIAFAESSRNLENSWKSRVFSPGSTIKPFIAAAAIDSGTSYETKNYDCRSPYNIEG
KTFTNYDSKVKSASLADAIAKSINVCLIKVSQEAGAPVVRKKLSEFGFDLNSGWQSSQSD
DLQLAQASLGENIPVTIESLAKSYAILAHQGRSFEEPSKAVVSEKTLSSVNRMLENAVAN
GTGRRAAIPGISVAGKTGTVIENKVKPLALFAGYAPANNPNYVLLVVIEDGYLSKNGATM
TSGGELAAPVFHNVAKNILK
>ACS83735.1|FEATURES|farme|beta_lactam|cft1|antibiotic inactivation|1
MKKIIVFLIIELLSCSTSWAQNTCFLVKENQTILKQEGNECTKRYAPESTFKIALSLMGF
DSGLLKDETHPEWPYKKEYELYLNVWKSPHNPRTWIRDSCVWYSQVLTKQLGMARFKGYV
DAFDYGNQDTSGDKGKNNGLTNAWLSSSLVISPTEQIQFLQKIVDKNIPVSSKAVNMTKK
VLYIQELPGGWKLYGKTGTGRQLAKDGTTKLPLQHGWFVGWIEKEGRAITFANHIADSKE
NTVFASFRAKNDALIKLFYLINELEK
>ACS83724.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MKTLASLVMAAFAAVAPAHADDWSDPQKPFTIYGNTHYVGTAGISAVLITSPQGHVLIDG
ATAAGAKVIAANIAAMGYRLEDVKYILSSHSHEDHAGGISALQKLSGATVLAGAANVEAL
RSGVSPKEDPQFGNLSNFQGVAKVRAVKDGEVLKQGPLAITAHATPGHTVGGVSWTWQSC
EMGKCKAMVFGDSLTAVSADSYRFSEHPEVVATFKASFSKVEALPCDVMITAHPGVNALF
ERQKREAAEGKAAYVDAGACKAVAGKGRELLASRLADEGKKK
>ACS83726.1|FEATURES|farme|beta_lactam|cft11|antibiotic inactivation|1
MARTESMADLIHMNKLKTLAACMAMLATGPCIAADPIETAVNAAVQPVMQAQNIAGMAVA
VTVNGKPQYFNYGVASTETGKPVSENTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQ
VWPALRGSAFDRISVLQLGTYSAGGLPLQFPPEADSADTMLGYYQQWKPLYPAGTHRLYS
NPSLGLFGYLAAHSIGQPFDDAMEKTLLPKLGLKHTYVNVPQDQMSLYAQGYNKDDKPVR
VGPGALDSEAYGVKTSAADLLMYVQANMKPASLAKPLQQAIALTHTGYYTVGDMTQGLGW
ELYAYPVSLDRLLEGNSTPMAMQAHKVQWLNPPQPQPSNVLINKTGSTGGFGAYVAFVPS
KDIGIVILANKNFPIAERVKIAHQVLSAL
>ACT97627.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANSDD
QYPLMSVFQFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYG
DLINYMVSQSDNNACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMEQDIRKSYNNW
STPLSVTQLLRKVYTEKVLSDEHFAFLEKAMLASASGKDKFRAGLPKEVEVGHKTGMSYR
TPEGIRMCDADVGVIYMPGGEKCYLAVLVKDSKETDAANAKIMADIAKKVYSHYTENAGK
NSAPAK
>ACT97597.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MQNFGKVAVLMGGFSSEREVSLDSGAAILAALKSKGVDAHAFDPKETPLSELKTQGFQTA
FNILHGTFGEDGAVQGALELMGIPYTGSGVAASALGMDKYRCKLIWQAVGLPVPEFAVLH
DDSDFDAVEEKLGLPMFVKPAAEGSSVGVVKVKEKGRLKSVYEELKHLQGEIIAERFIGG
GEYSCPVLNGKGLPSIHIIPATEFYDYEAKYNRDDTVYQCPSEDLSEDEENLMRELAVRG
AQAIGADGCSRVDFLKDTDGKLYLLEINTLPGMTSHSLVPKSAAHTGVDFADLCIEILKT
AHVG
>ACT97590.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKDKQIIVLMGGPSEEAEVSRRTGAAIAEALVSKGYKAQTLELNPRTVLKDIDSLGGEVV
FNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTARSESYN
GNLESAEAIIDHIRKEFTIPVVVKSATQGSSIGVTIVREESQLEAAVTEALKYDPILVVE
QFLDGREFTVAVLDGKALSVIEIRPHSGEYDYKSKYTVGATEYLVPAPISDEMTAEMQRI
GELVYREVQGSGVIRVDIMTDHADKMYVLEYNTVPGMTVTSLVPKAANEMGIDFPTLCEK
ILLTASIGKF
>ACT97588.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MTEKKTVALLCGGRSSEHPISLITAAGVLGAIDRTAYEVITIGITRDGRWYLTDEQQLAE
LTAGTRGTAEFPEGTQQVFLPMGTGDSRLTLVDAEGIVTRTAPVDVVFPLLHGPFGEDGT
VQGLLEMADLHYVGCGVTASAVGMDKHFMKVAFESAGLEVGPYEVVTNREWEHEDREQIL
ERVLKLGFPLFVKPTRAGSSFGITKVDSVEELVPAIEEARRHDPKIIIEAGIVGREIECA
VLDGHHGEMPRASYPGEIEVVDQDHGFYDFEAKYVSESSAVTVCPANLPQDVQERLRELA
VKAFLALDGEGLSRADFFYTEDGRLVINEVNTMPGFTPISMYKTMWENTGISYTDLISEL
LTLAMERPLGLR
>ACT97560.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKPSLGGSSFGVTKVTAKEQIQP
AITKAFAEAQEVVVEAFMDGTEITCGCYKTKDRSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARKKDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>ACT97551.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKVLVLMGGFSAEREVSLTTGKCVCAALKKAGYEVVSHDLQNGFELVETLKKEKPDVV
FNALHGNWGEDGEIQGFLDVLQVPYTHSGLKASVLGMDKSLTKELASENGIKVPQGEKMT
FRKFKAEGTFLKMPYVVKPVSDGSSVGVYIIRKKEDAEAVRYEDDREILIEEFIDGKELT
CMVLGSQAHVVTELRASDEFYDYHAKYTAGATQHILPAEIPEEAANRCKLYAEHMHNILG
CRSVSRCDFRYNPEDGVVLLEINTAPGMTDLSLVPEQAKYIGIGYERLCSYLVENASCRK
I
>ACT97462.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQ
SISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAG
GIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKE
LKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRK
YYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>ACT97536.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELPVSLRSAQGIYSFIDKERYNLYIVEMEGHRWEVILPDGTKTPID
RNDFGFMENGEKKLFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAITFNKFTC
NQYLKGFGIRVSESLILRKGFEITDQEVISKIGLPCFIKPNAGGSSFGVTKVKTEEEIQP
AIEKAFHESDEVMIEAYMKGTEVTCGCYKTKDKEVVFPITEVVTDNEFFDYDAKYNGQVQ
EITPARLPEDTAERVRLLTSAIYDILGCSGIIRIDYIITEGDKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIEN
>ACT97457.1|FEATURES|farme|multidrug|mexf|antibiotic efflux|1
MGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEM
VPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPVFSSGEGIRQMESLIKEHLGDEFGY
EWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCY
VMGTPVSIYTQIGIILLVALSAKTVF
>ACT97453.1|FEATURES|farme|beta_lactam|BACSTE_01456|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNKVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLQQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQK
AYANWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEEDAAIIAHISRIVYDEMK
>ACT97451.1|FEATURES|farme|beta_lactam|CfxA6|antibiotic inactivation|1
MLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNY
TSPLGAAMLMNRLFTESLISNEKQKFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSG
NVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFV
>ACT97378.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSLLKDKKATVGVAVLANDETVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYSPLRDKFPDQDITI
SLGELLKYSISQSDNNACDILIEYAGGIDQVNEYVKSLGIKDCNLVATEDLMHTSGDAYL
NWSTPEEVVRLLNIADKHPLFGTQYKDFLQAIMQETSTGKDKLKGQLPADVIVGHKTGSS
DRTPEGIKIADNDAGFVILPNGQKYYIAVFVMESQENDADNAAIIASISKIVYDTLNSDI
Q
>ADI87852.1|FEATURES|farme|chloramphenicol|FMAG_00636|antibiotic target protection|0
MSHRKHIVWAIDAFAEKSLQIKGIKILKLVSEAFGLEVEPVYVLSSGQVQVQSELYPKWS
LDYEKASENLLDDLIRLANLSKVSKPTVLIESTGSLRGATEELVKFSQNKHAKFIFVNSH
ANEGLPRFFLGSFTETLLLQSKIPVIVTNPTTEMRGKISHILFPTDFYNDARKGFEDAVQ
LAVKLQAKLTLYHKEITPLYLTFPEAPFYSIYIEDIHKQIKKNAADWLAWAKNQGAKCEL
VMDNSVENGVLGKHLIAYGEKNNVDLICLITKSSALGAALLGSTARYVTRHAHCPVWVEH
A
>ADI87862.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGESGCGKTTLARTILRFYEPTEGKIFFQNQDLSLLSASEMRKMRREMQMVFQDPVSSLN
PRMTIGSILSEPFLIHSVKAKKEIPDIIISLLEKVGLKKEALNLYPHEFSGGQRQRICIA
RALALNPKFIVCDEPVSALDVSIRAQILNLLVSLRNEYKLAYLFISHDLAVIEHISDRVA
VMYLGKIVELASNENLFARPAHPYTKALMDAIPRANFDTREKHLIKNAKLIPGDVPSPFQ
PPSGCHFHPRCPLATEKCRKEIPELRNIGSEQNPHWVSCHYA
>CBI71204.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPRLVIIAAVSRNGVIGRDGDMPWRLSTDLKRFKALTLGKPVIVGRKTFDSFGGRPLP
GRPHVVVTRNPDFHYEGVDVAASLDEALKIAGRRAEEAGADEIFVLGGGEIYAQAIRIAD
MLRVTHVETDISDGDTVFPAIDAAVFEKIDEVAVPVGEKDSYPTRFATYARRTATN
>CBI71207.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTIRIAMIAGVAENGVIGSHQTIPWRIPSDFAYFKRTTLGKPIVMGRKQYETVGKPLPGR
TNIVITRQQGYQPDGVLVFTDVEEAMKKAADIARADGVDEIMVIGGGDLYRQLMDRADRL
YISHIDLAPEGDVLFPPIDPLEWAVVDLPEVEPSPKDEATYRVKVYERRKASAH
>CBI71177.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MNRKISLAESEQSIIDCYLVMSELRPHIKRSEFVSTVKRLGEVAGYRLAYLADGGVKAVA
GFRISEWLAGGRYLEIEDLVSISGERSKGYGGELFDWLVRHAEENGCNQIRLVSRVTRLD
AHRFYLNKRMIIEAYYFSRQLK
>CBI71180.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
ILNRDELAILELRGGTHLVLFRAEGKPEAGPVSVFDFMVEDIEAAHAGMQKAGLHVTAIC
EDNLAGHLWFEVTDPDGYVLKVFSSHTGGRPV
>AET35504.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MERKTAAVIFGGQSSEHEVSCMSAANVIDRINKEKYDLLLIGITMDGHWIKTDSVDDIRS
GEWRNGKVSAAILPDATKKCAILMDGDKVTEVKLDLVFPVLHGLHGEDGTIQGLLELARI
PYVGCGVLASAVGMDKLYTKIIVNNLGIRQADYEPVMSEQLADMDAVIARVEKHFSYPVF
IKPSNAGSSKGVSKAENREELENGLKEAANHDRKILVEEMIVGREIECAVFGGGKEEVKA
SGVGEILAAADFYDFDAKYYNAESKTVTDPELPGNAAEEVRKAAAAIFKAVDGYGLSRVD
FFVKEDGEIVFNEINTMPGFTAISMYPMLWEARGINKEELVDKLMSHALERF
>AET35483.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
AWLPVDTLQRALQTAGRRLDARGQSYSLPPGRADLRRKIAARAAQWGALFGADDLIITAG
ATQALRLALRAVCQPGDAVAIEQPAYFGTLLLLEDLGLKALQIPTDPVEGLLLAPLEEAL
QRHRPAAVLASPTVQNPLGASMPVARKRDLVALLAGMGIPLIEDDVYGDLAGDAQRPPAC
KAFDRCGNVIYCSSLSKTLAPGWRIGWIAAGRYHSTVLQARMAGEWAGAPLIEAAASELL
ASGDYDRHLRQLKLRIAQGMQAIIAQVETSFPPGTRVAAPEAGFSDLGKASVKDRCAGGT
SSRTRPWHWRQSGTVVFPGGGRTAKLPALERCQ
>AET35514.2|FEATURES|farme|aminoglycoside|AAC(6')-Iih|antibiotic inactivation|1
MENRAVRIVRLTGEDREKLLECAKLLFVCFEHAWNTMEEAEEDMLRILEAGPVLAAVEEE
LVVGFIGTRATYEPYGWELHPLAVEERSRKKGIGSLLIKEIEKEAVNRGAIVMYLGTDDE
DGATSLSEGDLFIDTFQKIKNIKNKKNHPYEFYEKNGYQIVGVLPDVNGYGRPDIYMAKR
LCEKLGGKSMNDVKAVKVFTAQDNLQAEMVLDTLKQNQIPAYKKDVDESGFMNIYAGNSM
CGEEIYVAQKDEEKTMEILREMGLEPEKAPGEEE
>AET35519.1|FEATURES|farme|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>AET35512.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKE
KAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKR
DIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNA
TTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTN
FGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD
>AET35525.1|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
TSFCWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMD
IPTIIFINKIDQNGIDLRRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPQKKASYTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEG
VRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGR
SVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM
>AFQ60599.1|FEATURES|farme|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLGRMDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLT
FPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCP
EAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLR
AAFRSRYAA
>AFQ60589.1|FEATURES|farme|beta_lactam|CARB-3|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLAILWSLMLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQD
VKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNS
TVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLR
QIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVN
NQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAER
NDAIVKIGHSIFDVYTSQSR
>ACI02045.1|FEATURES|farme|beta_lactam|PEDO-2|antibiotic inactivation|1
MSIKIGSMTIGYVQTNCYFVYDDEKKEAIVFDPAADGVGIYNALLKNEIKVSAIMLTHGH
FDHIMGANELREKAGVKIYASELEKDLLASSELNVSNQIGRNYTVEADVYLKDNEKVTIN
GIEIKMISTPGHTAGSCCYLIEGEKLLIAGDTLFAGSCGRTDLPTGSGGMLDRSLKEKLM
RLDDEIKVYPGHGESTTIGYERKHNPFC
>ACI02050.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEYPMSYADTVFINMVRDILDNGCSTEGEKVRPHWEDGTSAYTIKKFGVVNRYDLRKECP
IITLRKTALKSATDELLWIWQKKSNNVNELSSHIWDEWADETGSIGKAYGYQMGVKHQYK
EGMMDQVDRVIFDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQRKGEDKLTL
HAILNQRSQDVLTANNWNVVQYAVLVHMLAQCCDMYVGEFMHVIADAHIYDRHIPLVEEL
IKRPVFDAPKFFMNPDIKDFYKFTKDDVWVEGYQYGEQISIPVAI
>AFH53887.1|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MEFRLIDLKRWKRKAYFTHYFESVPCTYSMTVKLDITTIKTGKAKLYPTLLYAVSTVVNR
HEEFRMAVDDEGQIGIFSEMMPCYTIFHKDTEMFSNIWTKYIGDYTEFCKQYEKDMQQYG
ENKGMMAKPNPPVNTFPVSMIPWTTFEGFNLNLQKGYGYLLPIFTFGRYYEENGKYWIPL
SIQVHHAVCDGFHTCRFINELQEVFKSLPNHGVTKMSEEHGLTPYETREXFFYKTENESA
GGNLLFRNSWLTQQMLNCRVQKPPFSY
>AFH53886.1|FEATURES|farme|aminoglycoside|ANT(9)-Ia|antibiotic inactivation|1
MNINEFPQQVNQVISIAETILQGQILGIYLYGSATMNGLRPDSDIDILIITKQELSNSIR
ADLTKQLLKISGSVGCIEKRPLEVTIINQSDIVPLQFPPKCQYMYGEWLRGEMEAGEYPQ
ACNDPDIMILLWQAEKIAYFEGAESKELIPAIPFHEIKKAIRFSLPGLISSFKGDERNVL
LTLSRMWFTLVTEEITTKDVAAKWVILKLPERFPPLLTTAKEAYLGNLSDEWETVEKEAM
ALVEYMKKQIEELLRTE
>AFH53882.1|FEATURES|farme|beta_lactam|bla-TEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGARW
>AGC09621.1|FEATURES|farme|macrolide-lincosamide-streptogramin|AAX16_03865|antibiotic efflux|1
MAIVEIDDLHKSFGPLEVLKGIHLEVMQREVVTIIGRSGSGKSTLLRCINFLEQPTHGRI
TVDGLSVLVEQHKLTKEQRQTVHEIRLRTGMVFQEFNLFPHLSVIENLIEAPVTVKRMKK
REATEIAEQYLDKVGMSDKRNEFPNRLSGGQKQRVAIARALTMQPKVMLFDEPTSALDPE
LIGEVLEVMRQLAEEGMTMLVVSHEMSFAHDVSHRVVFMEEGIIAEEGPPEQLFDNPQNP
KTRMFLQRIIGEKEEAEG
>AGC09669.1|FEATURES|farme|aminoglycoside|AAC(6')-IIb|antibiotic inactivation|1
MLAAWLAEPHWAEWWDEGLEASLAGIREAMESIETEPLIVELDGRPIAYLQSYDPHLEDG
HPYQDQPFGTLGMDISIGPPDLVGKGHGSAIVRQFVDMLFEEGAPRVVIDPHPDNRRAIR
AYEKAGFRAFDTRTTVFGPALMMARDAE
>AGC09623.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MLWPNLTGGEVIDLLGRLRGGLDSRRKSHLLERFDLDPTKKGRTYSKGNRQKVALVAALS
SDVELLILDEPTAGLDPLMEAQFRACIEEDRGRGRTVLLASHILAEVEALCDRVSIVRQG
RTVESGTLTELRHLTRTTIQVELDADPSAITSLAGVHDVRLHDHRAEFEVDSDRLSEVIS
TLGPLGVRSLVSHPPTLEELFLRHYEEELERE
>AHN92782.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTAIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>AHN92781.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLK
ITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTAI
APKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLE
TVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLN
QSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKE
SGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYR
TDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>AHN92761.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MTQKAKKQDARVLAELACKLWPDNTLEEMRSAFSDLLSQTNAALFLAYDGATAVGFAQCQ
LRQDYVEGTDTSPVGYLEGIYVEPEYRKQGIARKLLSACENWAKTKGCTEFASDCELTNT
QSLEFHLNVGFTEANRIICFTKKL
>AHN92760.1|FEATURES|farme|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MEIIAKSARLSIRKMEACDADFEQHLKWMRDPEVLKYWDGDYDEASIREMYYDHLKVGVT
PCFIELCGRPIGYVQFDRIPDAEGYECPEEDWVRFFKPGEIIYGVDMFIADVSCRNRGIG
TEMLTILGDAIFEKYGADALVVDPKTHNARAIACYRKCGFKDC
>AHN92756.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MTIRKATPADSTVLGELASRMWDHDPSELAAEFAVLTASDEAACFLAFDGVTPIGFAQCQ
LRHDYVEGCETSPVGFLEGIFVVEGYRLTGTGRALLAACEAWAKSVGCTEFASDCELDNT
VSLAWHLKNVFTEMGRTIWFAKKL
>AHN92749.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
CRSRGIAKALLKACEDWAKDQGCTEFASDCELDNVGSLHFHLNVGFQEVNRIICFTKKL
>AHN92742.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MLKASMDNLKDLVNLALELWPHHSAKELKAEFEEIVAKEDAVFFLEYDGSLPVGFAQCQL
RYDYVEGTSASPVGYLEGIFVSEPYRKKGIARQLLTACEGWAKEKGCTEFASDCELTNTQ
SLRFHQSTGFEEANRIICFVKKL
>AHN92734.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKREGERNMAIQTPNTNLRKRMFNVMLFFTALLVILALYILKIHIFDGEKYRTGAIEQQT
RDYQVSSARGTIYDRNGKTLAVSSSAETISVNPEEIKKAEYAIDELANKLAEILDLDPEE
LKPKLTKNAKDVEIKRKVESEVADEVRALNLKGIYFKEDTKRYYPYGTFASHVIGFTGRD
NQGLGGIEMVYDDELSGVPGRVVTLKNARGTDMPFQEERHIDSENGLNVVLTIDETIQHF
AEKHLTDVYNQTEAAEGVATIVMDVNTAEVLAMATMPNFDLNTPNELVDEVTLRRLEEIE
DEEEYDKAVVDAKNKMWRNKAVVDSYEPGSCFKIMTMSMALEEGVVTPEDNFFCPGFKIV
EDRTIHCAEESGHGPETFKDGVKNSCNPVFIEVGQRVGIEKFKQYYKAFGFNDKTGFDLP
GEASGVFFSDEQFNIVELATASFGQGQKVTPLQLISAVSAIANGGTLMKPYLVKELTNEE
GTVVKKYEPTVVRQIVSEETSKTVRALLENAVNTGSGQNAYIKGYRVAGKTGTSEKIPRG
QGKYIASFVGFAPANDPQIACLVVVDEPHLGSYYGGAVAAPVVGKIMEDTLKYLGVEPQY
TTEEKTAIDVAVPDVVGLDLSIAKTKIEDMGLKYTIVGGGDTVTAQMPSFGAAVNAGSVV
VLYTEGTEETATVTVPDVTGKTLSEVRTILTAQGLNLSIVGAGATGEDNDRTIAESQKPA
AGSAIARGEVVEVEFRFLDVEGTVEQ
>AHN92726.1|FEATURES|farme|chloramphenicol|cat7|antibiotic inactivation|1
MAFRLIDIENWERKEFYQHFISQVVCTYSVVVNLDITNLKKHRLYPAMIWLLTKTVNDMP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKDYEIDAEKYGTST
CYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKYFERKGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKYIDHFG
>AHN92723.1|FEATURES|farme|chloramphenicol|cat2|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHRLYPAMIWLLTKTVNDIP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKNYEFDAEKYSTST
CYTPKDGTPSNSFNISMVPWLEFTGFNINVFNDGHFLLPIFTMGKYFDREGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKHIDHFG
>AHN92717.1|FEATURES|farme|chloramphenicol|cat14|antibiotic inactivation|1
MTFRLIDIDNWKRKEFYEHFISQVVCTYSVVVNLDITNLKNQRLYPAMIWLLTKTVNDMP
EFRTSLTAEGLGIYDDMHPMYTVFNKDNKNFSGIWSYFSEDYDTFLKSYEIDAEKYSTST
RYAPKDGTPANSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKFFEKNGKRMLPLAIQ
AHHAVCDGNHVRLFVKKLQSYIEPLQVRRKPDSPHAPRLALPPKM
>AHN92715.1|FEATURES|farme|chloramphenicol|cat27|antibiotic inactivation|1
MAFHLIDMENWDRREFYEHFINEVVCSYSVTVNLDITNLRDARLYPAMIWLLTKTVNEMP
EFRTSLTKDGLGVYDSMHPMYTVFNKENKNFSGIWSYYSENYIDFLKNYDEDVRVYSKST
RYAPKDGTPENSFNISMVPWLEFTSCNLNVYDDGKFLLPIFTMGKYFERDGKRLLPLAIQ
VHHAVCDGYHVGLFVEKLQTNIIRFSAK
>AHN92706.1|FEATURES|farme|chloramphenicol|cat18|antibiotic inactivation|1
MAFKLIDIENWERKEFYEHFIGEVVCTYSVSVNLDITNLKGQKLYPAMIWLLTKTVNDMP
EFRTSLTSEGLGIYDDMHPMYTVFNKENKNFSGIWSYFSEDYDTFLRSYEEDAAIYSTST
RYAPKDGTPVNSFNISMVPWLEFTGFNINVYDEGKFLLPIFTMGKYFERDGKRMLPLAIQ
VHHAVCDGYHVGMFVERLQGYIDNFSV
>AHN92701.1|FEATURES|farme|chloramphenicol|cat1|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVICTYSVVVNLDITNLKNQRLYPAMIWLLTKTVNDMP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKNYEVDAEKYSTST
CYTPKDGTPSNSFNISMVPWLEFTGFNINVFDDGHFLLPIFTMGKYFEREGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKHIDHFG
>AFQ60590.1|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGVLNTTPSIIQLTLSLYMV
MLGVGQVIFGPLSDRVGRRPILLVGATAFVAASLGAACSSTALAFVAFRLVQAVGASAML
VATFATVRDVYANRPEGAVIYGLFSSMLAFVPALGPIAGALIGEFWGWQAIFITLAALAS
LALLNASFRWHETRPLDQARTQRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAGYSEIGFSLAFATVALVMVTTTRFAKSFVAKWGIAGCVARGMALLVSGAILLGIGQL
FGSPSFFSFILPMWVVAVGIVFTVSVTANGALAQFDDIAGSAVAFYFCIQSLIVSIVGTL
AVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV
>AIA18797.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MTDVTFNFQSRPTNLWTQVMVFARRNAEHIRQVPEKLLDVTLQPLMFTVLFAYVFGGAIG
VGGDVNYHEFLIGGILIQSLGFGMMGPGTAIATDLADGVVSRFRTMPTTGTAYLLGHYVA
ELLGQILSIAILLGAGLIVGWTPHTDVFHFLAALLLLVLFSSAMIWLGTLIGLIVRSADA
VQGIAFVAIFPLTFMSSAFVPVSTLPNVLQWFATYNPFSLMTNAVRELFGNPTGPIAKDV
WVVHHAVASGFAITVVILAICIPLAAHRFAVRNRD
>AIA17944.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MMISHIAACSQNRVIGKDNHLPWKIPEDWKFFKDKTSGHILIMGRKTFESLGKPLPNRLN
VVITRDPTYQAPGAVVLPSVEAALEFAQTKFKDYPDEVFIGGGGEIYKQTLAIADRVYLT
VIHKDFEGDAFYPTLPEGEFQEVEKRDRTDPIPFTFFTYDRVKFKA
>AIA17945.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
REGTQKTDRTGTGTLSVFGHQMRFDLSRGFPLVTTKKLHLKSIVYELLWFLKGDTNVRWL
QENKVSIWNEWADENGDLGPVYGAQWRNWKSADGNTIDQISWVIDEIKKNPDSRRLIVNA
WNVGELHKMALPPCHAFFQFYVADGRLSCQLYQRSADVFLGVPFNIAGYSLLTMMVAEVT
NLKLGEFVHTLGDAHLYSNHMEQAKLQLTRTPLALPQMRFKRKVSNIFDFQYEDFELVEY
NPHPSIKAEVAV
>AIA17870.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MIISLVAAMSENRVIGIDNKLPWNIPVDMKRFRDITRGHVVVMGRKTFESLGKPLPQRTN
IVITRNRDWTAEGATVVHSLEEALAPYKNSDEEVFVIGGGEIYDRAIEIADRIYLTVVHK
NFQGDAYFPEFDSAKFDVFHEEKHNEPIPFTFIDYQRKNDRTKT
>AIA16632.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTLFVGRPLDLFGNKVMNAQIVKAAVVLGLLSVIGPLAIDMYLPALPAIGADLNAGVAAV
QQSLMAYMAAIAVCQLAYGPLSDMFGRKPPIYFGIVLYIVASLGAAWAPSIEWLVLFRFL
QGVGACASMSLPRAIVRDGYTGAEAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMF
YVMAVVGVLSLLLLVFGLKETRPKEARLESSLGGAFRAYWQLLRDWRFIGLSLIGAFGMA
SFMAFLGNSSFVYIEHYGLTPTLYSLAFSVNAVSFFAVSQATGYLVGRFGLPRVVRVAVG
GYVTAMLALLALFLLGIDSIWALAVLMFIAFGFLGLVLPSTGVLAMEEQGEIAGSASALM
GTLQMVIASVVMGIVGAFGDGTAMPMVIGFAGCALAALVITLVTLRGSAQSEPVAAPAE
>AIA15986.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNANINQLGKVGVLYGGRSAEREVSLMSGSGVLKALKDKGIDAHGFDPSVNSIAELAAQK
FDRVFIALHGRYGEDGTLQGALEQLGIPYTGSGVMASAIAMDKIMTKRVWLSHGLPTPRF
IVLDAKATSAAQLRDVPDQLGLPLMLKAPHEGSTIGISKVMGYSEMQAGFDNCAKYDEVV
LAEEFVTGREFTVPVLGEGRSARALPIVEIRAPEGNYDYQHKYFSDDTKYLCPAPLDAAL
TQKMQTIAVQAFNALGCAGWGRVDFMLRATDNEPFLLEINTSPGMTGHSLVPMSAKAAGV
SYEDLCVDILKTASLEIQADWKTT
>AIA13613.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRAGDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13096.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELVFEKKSKIMQWINDSLLMIARSSRHIIRHTDQLLGTFFQPIMFIILFSAVFGGAI
SLALPPGIGYLDFLMAGIIVQTVAFGSTTTAVAITSDLQKGIVDRFRSLPMSDIAVLNGH
VVSDLFRNAFSTIVMLVVGVIIGFRSSASVIDWLAITGILVLFTLAFSGLMAIVGVLAKS
VEAVQWLSFVLIFPLTFASSAFVPTEGMGKYLKAFAENQPVTQVIEAVRALMLGTPIGNH
AWLAVIWCVGALIVAIPVATWLFKRRTSN
>AIA12303.1|FEATURES|farme|aminoglycoside|AAT_like|antibiotic inactivation|0
AGATLSPVTAPRLLKLAEQSGLTIIEDDIFADFEHEPAPRLAAFDGLDRVIHIGSFSKTL
SAATRCGFIAARRDWTDGLIDLKIATSFGGSPIAAELVLGILRDGTYRKHINGLRDRLSR
AMAETAARLKVMGIEPWIEPRSGMFLWCTLPEGLDAADIARQALAENIVLAPGDAFSLAQ
SAIGFLRFNVAQSSDPRIFTALERAMRG
>AIA10807.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKSDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTMDQISRLIEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLTREPRAASADEDQSIGQIHI
>AIA10578.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDMKRFRQLTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRNESIAFEGCFIAHSVSDAISLARERGESELFICGGAEIYAQSFGAADRMYLTLVH
ADCDADIFFPEWDRDEWIEVESEHHAADEKNQYSFTFKVLARKSRV
>AIA19226.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MSTSSPANPRRAWVMLIALTMLTVIGMTAVFPVMPFIVKQYLPAGDDNLALWVGVLEGVN
AFCAFLAAPFLGALSDRIGRRPVIIIASFGAVVGYVVFGIGGALWVLLLGRVIQGITAGD
MPALFAYVADITPPEKRAQRFGMLGALNGISFMIGPAVGGLLAAVDIRLPVFVTAGAALT
VALLSIFLLPESLAPANRKTSISLDEMHPIKVISGAFRRVELRGLLIAFTLLGIPFAFFT
SNYSVLAIDTVQWNATQVGLLLAVIGVIDIAVQGGLLALLLPRIGERPVILIGIIGQGVA
CASLVVLATVLAQPWVLIFGVLLFGATQGLTQAPLDGLMSSAVGDDEQGQVAGAIQSVGS
AIQMLAPLVAGLLYSAITHSAPYILGVALIIGSAVAFARVKLPARREADSVEAPAPADA
>AIA16810.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSLNSPTSTRTARRAWVMLVVLTLLTVIGMTVVLPVLPFVVLQYVSNEKDLAVWVGILE
AVNGLCAFLVAPFLGRLSDRFGRRPVIIVAAFGAAFAMTLFGIGGAIWVLLLARVIQGLT
AGDMPALFAYLADITPPERRAKRFGMLGALSGIGMMIGPALGGLLAAVSIQLPVFITAGV
SLTVAILSIFLLPESHKRENRITAITLRDVQPFGVFTEAFGRKELRGLLIGFGLLALPFG
FFVNNFSVMAYDSIQWGPTAVGLLTAAVGIVDILIQGVLLGILLPRMGERGVIVSGIVAQ
TIGLIALALVASIFAQPWLFIVGALVLAAGQGAAQAAMDGAMSNAVGDDEQGWLGGATQS
LNAAMSTVAPLIAAALYATVSHAAPYWLGAAIMVVAAIVVGRAHIADAAKKPADAAPVEL
SDAVS
>AIA15439.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTPTTTSPIRTYSSLRAAWIPLTALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTGLQWV
TGAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAAFGLISLCVVAVSTVGELIGLRALLGV
TAAAMAPITNSLVFRLFNDQALRMRAMTVMIVVGMSGFILGPLLGGTALAHVRWEWLLVV
NAPIALIAFIGVRLGVPADHPDDLTHDALDLPGALLSIAAIGLACFSLTSGVEHGWLSAL
TLASILGAVAAGIVFVRHERRTASPMLDLALFSNGTVRGAAIAQIATSIAMAAVMFGLIL
HFQYAYGWSPVRAGLANLPLIVTMILATPVSEWLARRFGHRIACLVGAGFLAGALAGLAW
GVSHGYLAIAIAMVVMTVGLRTVMTICAVALVSAMPDNRTSIGTALNDTAQEVGSSIGTA
VVGTMIAVLVTAQLPAGTWSSELVASFFHGERITYAVLAAAVGLIGVLGARTLTDSRAVE
EH
>AIA15428.1|FEATURES|farme|multidrug|mexW|antibiotic inactivation|0
MPRSRYKSLVDAFAADIRSGRLLPGTRLPTHRQLATAEGLALVTASRVYAELEAMGLVSG
ETGRGTFVRETSLPPGQGIDQKVVATGMIDLNFNYPSLPGQAELLRTALRQLALAGDLES
LLRYQPHAGRPHERASVARHLRARGLTVDAEQVLMVSGAQHGLAVTLMALLQPGDVIAAD
ALTYSGFDG
>AIA15373.1|FEATURES|NCBI|tetracycline|tcr3|antibiotic efflux|1
MEPIKSKEIISFSSYQKLVIALLAIMQFTVVLDFMVLSPLGDILMKSMDITPSRFGLVVS
SYAFSAGISGIFAAGFADKFDRKKLLLFFYSGFILGTFCCAMADSFAVLLAARIVTGLFG
GVIGSISMAIITDLFTINQRGRVMGFVQMAFAASQVLGIPTGLFFADIWGWHSSFLMIVI
LALTTALTIYWKLRPVNAHLQLQTDKAPLLHLWHTLTNKHYQIGFVATAFLSVGGFILMP
FGSSFLINNIGIHQEQLKLVFMLTGVSSVIIMPIVGKLSDKFDKFVLFTCGSVISIIMII
IYTNLSTIPLWEVVGINMLLFMGIMSRMVPAMALASAVPEMKDRGAFMSVNSSLQQMAGG
FAALVAGMIVVQKTKTSPLEHYDTLGLVVSGVAVVCLFFVYRVSELVKKKTAERELAGIN
QALALKNQLPAEESILQ
>AIA15128.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHEHDLAIWVGVLEAVNGLCAFLVAPFLGRLS
DRFGRRPVIIGAAFGGAFAMALFGIGGALWVLVLARVIQGLTAGDMPALFAYLADITPPE
KRAQRFGLLGALSGIGMMIGPAVGGLLAAVSLQLPVFLTAAVGLTIAILSIFLLPESLQP
QNRAKAITLRQVQPFAVFKDAFGRKELRALMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAGVGIIDILIQGVLLAILLPRIGERGVIVSGIVTQMIGLAGLAIVASVFAQPW
VFIVGALLLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLQAAMSTVAPLVAAALYT
TISHAAPYWLGVVIMVVAAIIVARAHIPNSAKDLEVG
>AIA15069.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTTPASPSPQVDQSAPSDASVEPQPIPTGSRVYPSLRAAWIPLAALCLAFFVEMVDNTLL
TIALPTIGRDLQGTTTSLQWITGAYSLTFGGLLLTAGSIADRFGRRRVLQVGLAAFGLMS
LAVLAVTSTGELIALRAGLGIAAAAMAPITNSLVFRLFDDQALRMRAMTVMIVVGMSGFI
LGPLIGGTALAHVSWEWLLLANAPIALIAFVGVRFGVAKDRPEDLTADVLDIPGAALTIL
GIGLACYTLTSGVEHGWTSLPTLLSAAGAVVAIVGFVLRERSAAFPMLDLRLLRNRTVRG
ATLAQIGTSIAMAGVMFSLILHFQYAYGWSPIRAGLANLPFIVTMLAASPLTERLVTRFG
RRMACLAGAVALTVGLGWLSWAVDQGYLAIAIGMVVMTIGLRTVMTICAVGLIDAMPSNR
TSLGAALNDAAQEVGTSVGTALIGTLIAALVVTALPSGAWSPALVTSYFHGEHVAYLVLT
VLVGVVAVLGALTLDDSRSTDEHHEEQAG
>AIA14794.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSPNLSIRSAKRAWIMLIVLTMLTVIGMTVVLPVLPFVVLQYVSEEKDLAIWVGVLEAV
NGLCAFLIAPFLGRLSDRFGRRPVIIAAAFGAAFSMALFGIGGALWVLVLARVIQGLTAG
DLPALFAYLADITPPEKRAQRFGLLGALSGIGMMIGPAIGGLLAAISIQLPVFLTAAVAL
TIAILSIFLLPESLKPENRIGAIALRDVQPFAVFKNAFGRRELRGLMIGFGLLALPFGFF
VNNFSVLALDSIQWGPTQIGLMTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQMI
GLIGLAVVASIFAQPWLFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLN
AAMGTVAPLIAGALYVTVSHAAPYWLRAALMVVAVIVVGRAHIANTAKRSLSDAPTEEHV
AAVG
>AIA14664.1|FEATURES|farme|multidrug|CynX|antibiotic efflux|0
MKGRVGALLGILLLALSLRAAVVSVPPLLARIQNDIQFTEFTIGLLATLAPIVFAVFGLL
TPRLIRGFGLELTLMLSIALAIVGQVARIFMPEVYSFLGMSIVALAGYGVGNVVLPPLVK
KYFPDRIGTVTSGYVTMLAIGTWMAPQFSVPLANVTDWQISIGSWAVLSTIVLIPWLLQL
IADRNVDRPDQPLNAAGTVHPTVKINPWKSKVAWGLAIFLAGNSAQTYVYFTWLPPYLQA
RGLDELTSGNMLALFAILGLPVSLLVPLWVPRLKNPIIAVLVFTVFWVTGHLGIYLSPTN
GTAFWVAMAGLGQGTFAIALLMMNLRSRTTYGSGVLSGFAQGLGYAGAGIVPMLFGVVQK
ATDSWGVAFSMLGICVVVMLIGAVIINPPRTIEDTAPGAEDAGKLERIN
>AIA19282.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSSLLYQRSADMFLGVPFNIGSYALLTQIIAHLAGYEAGEFVHTFGDAHIYSNHMEQVNE
QLKREPRPFPRLIIDPAIKSLDDVKAEYITLEGYDPHTALKGELTVAGGFDEKDRKNEYQ
K
>AIA19279.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKAGIPPCHLLFQFFVADGKLSCQMYQRSADTFLGVPFNIASYSLLTMMIARVTGLKPG
DFVHTFGDTHLYVNHLEQVDEQLARKPKKLPTMKINPKVKNIDDFKFEDFELINYDPYPA
IYAPIAV
>AIA19269.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MIIAGRQCRPINLKKERFMNAQLIRAAIVLGLLSVIGPLAIDMYLPALPAIGQDLNASVG
AVQQSLMAFMLAFAVGQLVYGPLSDMFGRKPPLYAGIGIFLAGTIGAAFAPSIEWLVFFR
FVQGLGACAPMSLPRAIVRDEYTGAPAAQLISLLMLVFSISPILAPLAGSAVIAFGDWRL
LFWAMAMGGVLCLLLAAFALRETRPKAARLNSGLGNAVSAYWTLLRDGRFMGLSLIGTFG
MSAFMAFLGNSSFVYIQHYGLTPTEYSIAFSVNAVSFFAVSQATGFLVGQFGLNRVVRMA
VGGFVASMMALLAVYLGGIDSVWVLGGFMFIAFGFLGLVLPSTSVLAMEEQGAIAGSASA
LMGTVQMIVASVVMGIVGACSDGTARPMVIAFALCSIAAFVITQMTLGKGDGSRMIEVPA
E
>AIA19255.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MILSIIVAAAENGVIGKDGKMPWRLPAESAYFRGTTLGHPVITGRKNYEGMGRPLPDRLN
VVITRQPDYKVPPGVIVVHTLADALGLPQVRDQAEVFIIGGSQIYDEAMPMTDKLYLTKI
HADIEGDTFFRYDPDEWELEWSEHHPADAENKYAFTLQRLVRK
>AIA19252.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLCHHYTIANKAKKRYSLNAFIRRGYFMKESNKIRVAVLYGGRSAEHEISLQSATNVMQY
LDPNRFEIVPIGIDKKGKWLLGNDIFKNSIAHQEVKALTDKTETWFTPEWIGQAVVTKQT
ESSAKTPTQFDVVFPAVHGTFCEDGTLQGLLELADMPYVGCGVLASAIGMDKDIAKRLSI
LAGIPVGPYLVIKQAEWAFKKEAVIDQIEAEIGLPVFVKPANTGSSIGITKAKTIDELKA
AIPLAFEFDTKIVIEKALNVIELEVAVLESLEDIDPIVSVVGEIRSSHEFYSYDAKYLDE
HGAELFIPAPIPESEQKKAQAMAKKIFTTLECSGMARVDLFLDKDSGQLYFNEINTLPGF
TAISMYPKLMAASGISYPALLTHLVELAIKNHQIKSHLKRSYTD
>AIA19211.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNKPLISLIAALSENRVIGNKGEIPWKIPGEQKRFKDITTPHPVIMGRKTFESIGRLLPN
RPNIIITGDTSYSVSDATITHSLPEAIKKATELDREEIFVIGGGKVFEEAISSAGRLYLT
IVHTEVEGDAFFPEYSDFRNVVYQEDGETGGYRFTYITLER
>AIA19181.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNSSLKHPEYQYLDLVQEILDHGERKVDRGTDIVLYSLFGRQTRYDLSQGFPLLTTKRVY
WKGVLHELYWFMSGQTNIKYLAENNVHIWDDYPYKMYAKRADAKEVPAFTKDEFVQKVIE
DKKFAEKYGNLPRIYGEMWRHWPTRKKGRTVDQLAWVLQEMKDDPDAKNLIVNSWNPEYL
YTMATLEDASRFPICHNMYQISNRNGKLSLQLYQRSADIFLGVPFNIASYALLTIILAKI
TGLEPGEFIHTFGDVHIYENHMEQAKEQLKRKPREFPTVTLDKSVTSLETFKPEHVTLEG
YDPYPMLKAELTVAGGLYDPKTGKMAA
>AIA19036.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAAKHPEYQYLGLLKEVLDTGIKNVDRGTGAVSYSLFGRQTRYDLSQGFPLLTTKKVYWK
GVLAELYWFFSGNSNIKYLVDNNVHIWDDYPYKIYNWKREANKKLPELTKEEFVQKIASN
ATFAKKWGELPRIYGEMWRRWPTRTKRTVDQLAWVVKELKEDPDARNLIVTSWNPEYLYT
MARYEDASRFPICHNTYQISQKDGKLSLQLYQRSADLFLGVPFNIASYALLTIILARITG
YEPGEFVHTFGDLHIYENHIEQVKEQLKRKPKPFPTITLDKKLKKIEDFVPELVTLENYD
PYPLLKGELTVAGGLYEGKKKK
>AIA19018.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSSSKHPEYQYLDLLQDIMDTGFEKHEFNTGIALKSVFGRMMRFDLSQGLPLLTTKKVFI
KGIIHELVWFLRGETNIKYLVDNDVHIWDEWAYKEYSKAAKSGKVPELDEKAFAAQIKAD
AEFAKQWGELGPVYGRQWRRWKASDGREIDQLSWAIEKVRKYPDRKHTVVSAWNPEFIYE
MAAPGTSMAIPPCHTMYQLNVIDGKLSLALFQRSADMFLGVPFNIASYSLLTMVVAQIAG
YEPGDFVHMIGDAHIYSNHYDQVREQVAREPRAFPTIRINPNLQSIDDVTFEDFTVEGYD
PHPPIKAPITVVGGFKEEDRKVMVKSSTKKKR
>AIA18994.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKQINQLRCSAIVAMTKNRVIGQNNHLPWHLPKDLQRFKALTTGHPIIMGRKTYESIGKP
LPNRTNIILTRDQDFTASGCLIANSIKQAMHYAGEVDSEVFIIGGADIYQQFLPQITRLY
LTIVETELTGDAYFPVFDAAKWQEVFREPHLADEKHAYPFQFLVLEKKQAKEN
>AIA18962.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIVAMDEKRGIGKAGKLPWRLSSDLKTFRELTMGHHVIVGRKTFESIGKLLPGRQM
IVVSRDRGFKPEGCLVAGSVQDALNIAQEHGETELFVIGGAEIYSQTLQAADRLYLTQVH
AEVDADTFFPELNFEEWNPADSSFQLADEKNEYAFTFTVLIRKRH
>AIA18952.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|0
MIRPFIIAALSADGYIAKDEKHPAFWTSTEDKKRFVELTRRAGVVVMGANTFTTLPRALK
ERTNIVYSHTKKFEGAETTQKDPIDLLNELESRGFREVAICGGSKIYTMFMKAGVIDRLY
LTIEPIIFGKGIRLFEEDMLYHMTLENAFQAQNGGLLLEYRVDYRGTLKR
>AIA18938.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
ALNALAIDIMLPGLQQIGASLGVENENHRQYVITAYLIGFGFAQLIYGPLSDRLGRRIPL
LGGLVIYVLAGFAIVVTPSFGMLLALRVIQGMGSAAMRVITVSIVRDIFGGRQMAEAMSL
IMMVFMIAPVVAPATGQAVMLFGNWHLIFLFISVVAILNGIWAYLRLPETLDPKDVRSLR
IGTILGGFRIVLTNRLALCYTLASTFIFGALFGFINSAQQVYVGIYGLGLWFPLAFAGVA
AFMSLSSFMNSRLVGRFGMRKLSHGALVGFMTVTGIWLLCQIFWDGPMPFPLFITLFALA
MFQFGWIGSNFNTLAMEPLGHVAGTASSVLGFMGTVGGALIGATIGQAFDGTALPMIGGF
FLVSLMGLVFVPIAEKGRLFQPHNKAV
>AIA18877.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MASSMSPKISLIVAMGENRVIGNKGQIPWQLPSDQKRFRALTLGHPVIMGRKTYESIGRL
LPKRSNIIVTRDTNYAVEGAIVCHSLNEAFDEAKKVEKEEIFVIGGGQIYHEAIALADKL
YLTIVKGTFEGDATFPEYGDFKKVIFEEKGTENGHEYKFIDVVKFLHD
>AIA18815.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTIISLIAAMSQNRVIGANNKLPWYIPEELQHFKSVTMGKPLIMGRKTFDSIGRRLLPGR
KTIILSRDKDLQGEGFTVVHSVQDALRAAGNVAEIMIVGGAGIYQEFLPLAQRIYLTVIP
QDYAGDAYFPQLDETKWHLREEQQNEKFTVKILER
>AIA18748.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKYLVVAYDMNRGIGADNDLLWQRNLPADLKRFKQLTTGQSIVMGRKTFESIGRPLPDRQ
NIVVSRSLPEIQGVTVVGSLAAAYAAAERDIYIIGGGTIYEQALPDADVVYATEVAADFP
NATVFFPELGSGWRETAREHHEADERNLFNCDFVTYERHH
>AIA18743.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAVKQNHSENQYLDLLQEVLDDGIKKVDRGTDIELRSLFGKQIRFDLSKGFPLLTTKKVY
WSGVLHELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYSKKAEEEKVPVLTKDEFVGKVKD
DKKFATKFGNLPRIYGEMWRHWPTRTTRTIDQLAWVMQEMKDDPDAKNLIVNSWNPEYLY
TMATNKDASRFPICHNMYQISNRNGKLSLQLYQRSADLFLGVPFNIASYSLLAIILANIA
GLEPGEFVHTFGDVHIYGNHIEQVKEQLSRKPRPFPTVKIKRNLKSIDDFKTDDVVLENY
DPYPAVKAELTVAGGLFDKKTGKMAG
>AIA18745.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAIDEKRGLGKNNDLLFKIPGDMQRLRTLTTGHPLVMGRKTFASLGRLLPNRTHI
VITRDPESLKNLSYQPEVVVSSLEEALEKAKEVSLRGGTTKQSQEHDRDRHAALAMTEEN
EEVFIFGGGQIFTEAIEKGLVDRLYLTIVKGEYEADTFFPDYSMFTKVVSKEDHEEEGYT
YTFLDLEK
>AIA18702.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDARGVPFSIVVAADAARGIGKGNALPWKLPKEMAYFKRLTSEAKPGFGNAVVMGRKTYE
SIPSKFRPLKDRLNVVLSRDPRFVADGARACGSLDQALAVLAGEANLDQVFVIGGGSLYA
EALEHPRCARVYLTRVHRTFDCDTFLSAFEPNFHLLTSDGPHRDGDVEFTFEVYERSRRS
APSGA
>AIA18704.1|FEATURES|farme|beta_lactam|AWI28_19250|antibiotic target alteration|0
MKQYLELVERVLTDGERREDRTGTGTLSIFGAQTRYDLREGFPLLTTKKVLWTGVVRELL
WFLRGSTNVRQDLSQHTPIWDAWADPNGELGPGVRSPMATVGRSVCPARTGQERHRG
>AIA18624.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MISFIAAITKNHVMAKNGGLPWELKTDKEYYHAKVRGHIAIVGSTTFPQLNEGLTDREII
VLAHDLDYHPAGATVVHSVDEALKYTHTTEEIMVLGGGQVFKGMMPYADRMYLTEIDIEL
DGDVFFPEFDRSEWIETSREHHEKDKDNEYDFDFVVYDRRSKETA
>AIA18506.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ADVNQMPLPPCHSLFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVCGLQ
YGDFIHTFGDAHLYNNHLEQTKLQLSREPRPLPTMKINPDVKDIFSFTFEDFTLGNYDPW
PHIKGEVAV
>AIA18502.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKLSIIVAADENNVIGGHNTLLWHLPADFKRMKELTMGHPLIMGRKTHESIGRALPGRRN
IVITHQAVMYPGCEVVSSLDEALAAVQDDPPGEVFIFGGGEIYRQAMSKADRIYLTRVHG
KFDGDVTFPEISPAQWKEISREDHAADAENPYSFSFITYERKK
>AIA18377.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GIKEFTERIKKDADFAKWHGELGPVYGYQWRKWPTPDGRHIDQIKSAIETIKTNPDSRRI
IVSAWNAAEVEEMAISGLPPCHLLFQFYVSNGKLSCQMYQRSADTFLGVPFNIASYSLLT
MMIAQVTGLKPGEFVHTFGDTHLYVNHMKQVNEQLKRKPRPLPIMKINPAVKNIDDFKFE
DFELINYNPHPAIWAPIAV
>AIA18353.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MGHHIIVGRKTFESIGRALPGRETIIITHKENYNPEGCFIVHSLEEAIELARSRGETEAF
ICGGAEIYAQSIDLADRFYLTLVHTVTDADTFFPEWNQGEWIEKESSDHPSDEKNQYSTT
FKVLHKR
>AIA18332.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LNKGFPLLTTKKVFIRGIIHELIWFLQGSTNIKYLVDNDVHIWDDWPYKAYLMKQGKKIP
EPNSEDWNKGIKQFTERIKKDDDFARWHGELGPVYGYQWRSWPTPDGRHIDQIKQAIQTI
KNNPDSRRIIVSAWNVADIEEMAISGLPPCHLLFQFYVADGRLSCQMYQRSADTFLGVPF
NIASYSLLTMMVAQVTGLKLGEFVHTFGDTHLYSNHLNQVNEQLSRKPRALPVMKLNPAV
KSISDFTIDDFELTGYDPHPAIYAPIAV
>AIA18291.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLIRDILENGKPDNNQVRPDRTGVGTYSVFGRQLRFNLDEGFPLLTTKKVHLRSI
IVELLWFLKGETNIKYLKDNKVTIWDEWADKNGELGSVYGKQWRRWEAPNGKKVDQISNV
LAQIKKNPMSRRHLVVSYNPGDLPEVAPPACHTLFQFYVSGDRLSLQLYQRSADLMLGVP
FNIASYSLFLMMVAQECGLRAHEFVHTFGDVHIYSNHVEGAQLQLSREPRKLPKMLLNPG
KKNIFDFEYEDFTLVDYTPHDPIKFEIAV
>AIA18252.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MKVFIIAALTADGFIAKDANHPAMWTSKADKKRFVELTKKAGVIVMGSTTYKTIGRPLKD
RINIVYSKTQKFEGAETTQDSPQELLKNLEARGYNEVAICGGSHIYSMFMKAGVVDTLYL
TVEPIIFGKGISLFNEDMLYHLKLKSAQSSETGGSLLLEYSVDYTGTPKLA
>AIA18239.1|FEATURES|farme|beta_lactam|VMC_16480|antibiotic target alteration|0
MRQYLDLMQHVLSHGTPKSDRTGTGTLSVFGAQLRFDLNAGFPLLTTKKVHLKSIIHELL
WFLKGETNIRYLKDNGVGIWDEWADERGDLGPVYGYQWRSWPAADGRHIDQISLVLD
>AIA18238.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDHGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIEYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQIIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPGDFVHTLGDAHLYSNHLEQARLQLAREPRPLPQMSINPSVKSIF
EFDYSDFELPGYEPHPHIKAEVAV
>AIA18235.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MSRLRVALLFGGKSGEHEVSIASALSIYSALDKSKYEVTLIGIDKSGQWLLPDQTKILAQ
AKNPAAVNLNDHHQQLVTLIPYPHEENLLLLDSSAASAGARAGAGAGAGASESASASGGA
AGGAEAAGAAAKPSDARKFDVFLPILHGPYGEDGTIQGLLDLAQVPYVGSGVLGSAVGMD
KQMAKKIMQAEGIPVVPFLTVRRHEFTKNPEQFLEEAEKRFGLPYFVKPANMGSSVGVNK
VKTRAEARAKFEDAFLHDTKVLVEKFIKARELEVAILGNHLPEASIIGEIVPHHEFYSYE
AKYIDENGAELLIPAPNLSDARMSEIKQLAIKAFQALECSGMARVDFFYDEAAGKVYINE
INTIPGFTKISMYPKLWAATGLPYPKLLDKLIDLALE
>AIA18150.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLLAAMDEARGIGWNGRIPWRLSSDMKRFRELTMGHHIIVGRKTFESIGRPLPGRQT
IIITRNPEFRAEGCFIVRSVEKALDLAKARGESEVFICGGSQIYAETIGEAHRFYLTLVH
ARVESDAFFPEWDESAWTRKSSTNHEADDKDEYSSTFSLLIRDGRPG
>AIA18120.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MNTSAPSFSAIAAMSLNRVIGDGKKIPWHLPEDFKWFKQTTMSHVIVMGRTTFESIGKPL
PGRETIILSRSGFEYPGVRTVHGLQEISAIAGDRKVFICGGAQVYAQALPMCSDLYLTLV
KREVTGDILFPSFEDRFTLVAELRDTPEFKILHYRQG
>AIA18081.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKSNSMKQKIRVAVLFGGRSGEHEVSLRSAANVIQNLDRDLFEVVPVGISKQGSWFLGE
DVGMLTENLLELPEDADRMLFAPNLIGHLRQMDSAGEVVHRLKQKGSLFDVIFPVIHGTL
CEDGTVQGLLELAEVPYVGCGVLSSAVGMDKDVSKRLALNAGLNVPPFLVINQGQWEKKK
TFFCDQVCSKLKFPLFVKPANTGSSVGVQKIKEPQELVPAIENAFTYDTKILVEEGINAR
EIELSVLESLDYGCEPIVSMAGEICPQNGHEFYSYASKYLDEDGAKIIIPAPVSETLQQE
LQAVAKTIFAALDCEGMARVDLFVEKDTQRIYFNEINTIPGFTEISMYPKLLMASGISYS
KLLTHLIDLAIDRHTRKSHLSREYLA
>AIA18062.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSRSAAKHTGLFSIERTKREAVMKQYQDLLSHVLDKGVRKSNRTGIDTISTFGYQMRFD
LSEGFPLVTTKKVHMKSIVHELLWFLKGDTNIKYLKENGVRIWDEWAEENGDLGPVYGQQ
WRAWKTADGRTIDQISDVIHQIKTNPDSRRMLVVAFNPGDIANTPKAPPPCHSFFHFYVS
EGKLSCQLYQRSADVFLGVPFNIASYALLTMMIAQVTGLKPGEFVHSFGDVHIYTNHLEQ
VNLQLSRQPLPLPRMELNPYVKDIFGFKYEDFELLNYQHHEAIKGQVAV
>AIA18031.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTMISLVAALSANRVIGKDNAMPWHIPEELQLFKSITMGKPIIMGRKTFDAIGRRLLPGR
STIVLTQDQNLHGAGFEIAHSVEEALRLAGDVPEVMVVGGAGIYAQFLPLAHRMYLSFIP
QQYDGDAFFPEFAAEEWRKVSEQEHGKFTAVVLEHIQ
>AIA17960.1|FEATURES|farme|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MTTKEDLVGDFGRLGICDGDTIMVHASLKAIGPVDGGPAMIVEALVDAVGQRGNLLAYVS
WDRSPYEDTLNGRRLSDAEREAWPAFDPATAGTYRGFGVLNDFICGYPGAWRSAHPDASM
AAIGPRASELVRPHRLGDAYGPGSPLERFVSMRGRVLMLGAPLDAVTVLHYAEALADIPD
KRLVTYEMPLLDSSGKKVWRTAKEFDSNGILDCFAVEGQPDAVEQIATDFVRLGRYRQGR
VANADCFLFDAVQLVDFGVRWLERRFGATRQGSRAG
>AIA17922.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
RWLMSRDAAAMLPQAVMDSKSHRQVAIIGDPTKKGLTQLDNKDRSLANQQLDAVFPVLHG
TYGEDGTIQGLLEMAGVPYVGCGVLASATGMDKVTMKQLFAHAGLTIIEYEWFLRSSWEE
DHAAVIKRIARVLGFPVFVKPANLGSSVGISKAANKTELRDAIDDAARYDRKVVVERAIN
GREIEVSVLGNEHPMASLPGEIITGHEFYDYEDKYVDSASRTEVPAKLSQKITARLQRDA
LTAFQAIDGAGLARVDFFVEHKTNRVIINEINTMPGFTSISMYPKLWEASGISYSELIDR
LIQLAIERHSDKSRNLTSYQPRTTG
>AIA17901.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKDAPKQPKKIRVAVLFGGQSQEHAVSLASAQSVMRALDPARYDVVPVGITREGRWLAGG
NPMQQLRGGPSEDAAETEGPEESIALAPAPGGPTAIVEGAGHAIGGVDVVFPVLHGPFGE
DGTIQGMLELAGIPYVGSGVLGSALGMDKIAMKAVFESYGLPVGPYIAVSRHEWEHNPSA
VLRRAELALHYPMFAKPANLGSSVGISKIHGPDEFTAAVDRAAAYDRRILIEEGIVGREI
ECSVLGNDDPRASVCGEIVAKREFYDFAAKYLEDSSELHIPAEVSPEVSDRIRALAVAAF
QAVDAAGLARVDFFLRRSDGAVFLNEINTLPGFTSISMYPKLWEASGLSYSDLVSRLIDL
ALERAADRQRRPPPDEGTSVNV
>AIA17873.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSIVVAYDLNRGIGANNDLLWQRDLPADLAHFKQITSGGTVLMGLNTYESIGRALPGRQ
NIVVSHKPIDIPGVTVVNSLEDAYKAAKGEIFIIGGGSIYAQTIDDADKIYATEVQLTFP
QATVFFPAMTGDWREISREHNQSDDKNKYAYDFVIYERS
>AIA17850.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNNKVSLIAALTHEYVIGKDNDLPWPRLEGDLQNFKQLTTGHTVLMGKNTYASILARLKK
PLPNRRNVVISKTLPEQQGIIVYSNLDEALEKELGEIFVIGGQQIYEQTIDRADKMYLSW
VKRNYEGDAYFPRFNSDEWDITIKEFPDFEFVTYERKK
>AIA17847.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLGLLEDILENGVDRGDRTGTGTRGVFARQLRFNLSEGFPLVTTKKIHFKAVVYELL
WMLGGHTNVKWLQERGITIWDEWADENGELGPVYGAQWRKWLAFRKVADGDQHGLNGSFL
WEPKAIDQIAKVVRDIRENPNSRRLMVTAWNPADVDKMALPPCHCLFQFYVADAKLSCQL
YQRSADTFLGVPFNIASYALLTMMVAQVTGLKPGDFVHTFGDLHLYSNHLDQAHEQLTRE
PRLLPKMKLNPKVKHIDRFKFEDFELVGYDPYPSIKAPIAV
>AIA17740.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRNTILFGGTNKERLVSVATAQALCEALPDADLWFWHVADTVHAVTPAQLLGHKRPFEDE
FQPDSRGVPLAQALDSAKAEGRVLVLALHGGRAENGELQTMCEIRGVPFTGSGSASSHLA
SDKTAAKRFAALGGVPSPAGIDLSNLDEAFAEYGKLIAKPVKDGSSYGLIYVVAKQDLVA
VRNAAKAEEYLIEPFISGGEATCGVLEQSDGKMFTLPPIEIVAAEGRFDYTAKYLLKSTQ
EICPGRFTPEVTAQLQDLAVKAHRALSCSGYSRSDFIISPKGPIYLETNTLPGLTKASLY
PKMLNAEGIGFSDFLQDQVALAIKRTQR
>AIA17566.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVSAIAAMGKNRVIGKDNQLLWKLPLELKYFKETTMGHHLILGRKTFESRPPLPNRTSI
IVTRNKKYNPPAGCFVVHSIESAIELAHKRGEEEVFISGGEEIYHLSMPHIQKLYLTEVD
FSAEGDAYFPVLVPNQWNLESENFMPVSEKNPLAWTARIYVRK
>AIA17567.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WFLKGETNIAYLKEHDVKIWDAWADKDGNLGPVYGSQWRSWKGADGKTTDQISALIEQIK
KNPDSRRLIVSAWNVGEIPNMALPPCHAFFQFYVANKKLSCQLYQRSADIFLGVPFNIAS
YSLLTMMVAQVCDLGLGDFVHTLGDAHLYSNHFDQAKEQLSRKPFPLPNMSINPKVKNIF
EFTFDDFKLENYQAHPHIKGAVAV
>AIA17550.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKLRVGVIFGGRSGEHEIAIRSARTVIEQIDKSKYEVVPLAISQDGRWLSPSEAVALLPD
ERRSSLGSDTTHNEAEPIALVGDTTRRGLTVFKDGGSDSLPLDVIFPVLHGTFGEDGTIQ
GLLEMADIPYVGCGVLASSCGMDKAVMKILFRDAGLPICKHIWFLRNEFETNPAVVTAEV
GKQLGYPCFVKPANLGSSVGVSRATDVSSLKDAIALAAQYDRKIIVEEALEMREIECAVL
GNDDPKASLPGEYLIRDQSKAFLDYTEKYSGTGNNEFVVPAPISPELTAKIQKMAVAAFK
AVDGSGLARVDFFLRNDTGELLVNEINTMPGLTDASGYPKMWAGTGKEFSAVIDELINLA
IERHEDKSRNKTSR
>AIA17504.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIQYLNLLRHVMEHGTDKSDRTGTGTKSVFGYQMRFNLGEGFPLLTTKKVHTKSIIHELL
WFLKGETNIKYLKENGVSIWDEWADENGNLGPVYGSQWRSWQTADGRTVDQITQVIDQIK
KNPDSRRLIVSAWNVGEIDKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLEPGDFVHTLGDAHIYSNHFEQVALQLSRAPKPLPTMKLNRDVKNIF
NFRFEDFTLENYDPYPAIKAPVAV
>AIA17487.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MTAVLSDTRFVWQREMLTILRDPFSLIFSLIQPLIFLGLFGPLLNGVAGSGAAGAFGGSS
LQWFLPGVVVMITMFGTSMTGSNLQYEIMTGAFERILATPLSRPALLIGRALKEMTPLVV
QALIITLIAAPFGFHLYPAHIVVGLVILGVFGVGVGALSYALAIAARKTEWIFWAVQQTL
LFPLLILSGMMLPLETGPGWMQVLSKFNPLTYIVEAERTLFAGDLGMSVLWGAVAAAISA
GVGLFVGVRSVTKTVF
>AIA17460.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNMNILKSALVLGLLSVIGPVAIDMYLPALPEIGGQLGTTDAQVQLSLMAFMAAVAVCQL
FYGPISDMIGRKPPLYFGIGLFVAGSIACALAPSIEWLIAARFIQGVGACASMSLPRAIV
RDNYTGAEAAQLFSLLMLVFSISPILAPLSGSIVIAFGDWRLLFWVMTAVGVLGLVLAVV
GLKETRPKHLRTESSIGGAIRGYGTLLLDLNFVGLSLIGAFGMSSFMSFLGNSSFVYIDH
YGLNPTQYSLAFSVNAVSFFAVSQSTGYMVKRFGLQRVVRWAVTGFASCMLLLAAIFYAG
VDSMWVMSGLMFVAFGFLGLVLPTTGVLAMEEHGEFAGTASALMGTIQMVLAAGIMGVVG
AFQDGTAMPMVTAFAICAIAAFVLTQLTIRTTATPVVGAPAE
>AIA17404.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLREIRTTGTRKAQRAALRSDGRRPEVLSVFGRQIRFDLAAGFPMVTTKRMPWN
AVVHELLWFLSGSTNVGYLREHKVSIWDEWATSEGELGPVYGKQWRCWEGPQGKVDQIAN
LIAGIRKVIENPHASEARRLILSAWNPADMPDPKVPTGCHTLVQFNVTEGRLSSQLYQRS
ADMFLGVPFNIASYALLTLMVAQVCDLQPGEFIHTFGDAHLYLNHLEQARLQLTRAPLPL
PQMKLNPTVKDIFAFTYDDFELVNYQFHPHIKAAVAV
>AIA17326.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVLEQGAKKEDRTGTGTLSIFGYQMRFDLQQGFPLVTTKRLHLKSIIYELL
WFLRGETNVRYLREHGVTIWDEWADANGELGEGIYGSQWRAWPNPDGTHIDQISQVIEQI
KRNPNSRRLLVMAYNPSFADKTPLPPCHSFFQFYVANGKLSCQMYQRSADIFLGVPFNIA
SYALLTMMIAQVCDLQPGDFVHIFGDAHLYLNHLEQARLQLAREPHPLPQMKLNQAVKDI
FAFKYEDFELVNYQFHPHIKAAVAV
>AIA17314.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTISLVVAVSENGVIGKDNRLLWRLSDDLKRFKEITGGHHILMGRKTFESIGKPLPNRIH
LIISGNYKTEHDNCFVFTSIPEAIQFAESREESELFIIGGGEIFKQTMQLADCIHLTIVH
TEIEGDTFFEYDDSSWKVTQKEFVQADPKNEYNSTYLKLERQ
>AIA17306.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIRVSAIVAVADNGVIGRSGSTNLGLPWHIKSEFQYFKNTTLGHPVIHGRKSFEALGKPL
PKRPNIVVTRDPNYKAENVTIAHTVEEAIDVAKNLARQDGKGEIFICGGAEIYRLAMPVT
DRLYYTEIHLKPEGDTFFPDFDRKEWQEVKREFHKAEPGEDADYTITVLDRK
>AIA17307.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMQHVLDNGVLKKNRTGIDTISTFGYQARYDLSKRFPLVTTKKIHTKSIIHELL
WFLKGDTNIGYLKDNKVRIWDEWADERGDLGPVYGHQWRSWPTQDGGTIDQISQLVHDIK
TNPDSRRLIVTAWNPADLPKMALAPCHCLFQFYVAEGKLSCQLYQRSADVFLGVPFNIAS
YALLTLMIAQVTGLKPGDFVHSFGDLHIYTNHLEQVKLQLTRAPLSLPRMELNPYVKDIF
SFKFEDFELLNYQHHAAIKGEVAV
>AIA17262.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILLHGKEHQDRTGVGTISHFGFQTRFDLRKGFPIVTTKKIPFRWVAEELF
WFLSGDTNEANLRARGVDIWAEWADEAHTKRFARKPGDLGPVYGYLWRSFGGHYPEHDGV
DQIARLVGEIKNNPHSRRLIVTGWDPREADSVDLPPCHTLFQFKVENGSVLHCQLYQRSA
DAFLGVPFNISSYALLLRMVAHVCELAVGEFVYTLGDYHIYKNHLDQVNELLSREPLPLP
SLEIVDPTKRLRGLQGLLDLRYEDLNLSGYQSHGKIAAAVAV
>AIA17103.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTCEGNEKSLEAKNNHPENQYLGLMRDILQSDDDRAMHIPGDQGIRCVKGVLHKYNLQEG
FPLLTTKDVFWKGVKHELLWLMRGDTNIKYLVENGVNIWTDDAYRKYQRAAGEGKAPTLE
KQEYSDRVKNDPDFANWGDLGPVYGAQWRRWKNPDGGEVDQLQQLVDQLRNPIQRYRKSL
MVSAWNPSYLPGNAPTEAEEMALPPCHVSFQADVDERDRLSLTLYQRSADVFLGVPFNIA
SYALMTHMLAQASGLEAHQFIHVMNNAHLYHRHFGAVQEQLKREPYPFPKLVLNPDVTEI
DGFKYEDIKLEGYQHHPRLKAEMVAVGGRIDNPVQLKPTKS
>AIA17073.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIVAMDRRRGIGIGNRLPWRLPADLKRFRELTMGHHLIVGRKTYESIGKPLPGRRM
VIITRDPNYRADGCIVAHSVEEALDRARAQGESEAFIGGGAEIYAQTLPRADRIYLTVVE
ADVEADVFLPKWNDEEWIEQESIHHPPDEKNALPFTFKLLERIEQS
>AIA17071.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTISIIVAVSENNVIGRNNDLPWHLPVDMKYFKDTTMGHCVVMGRKNYESIPDKYRPLQG
RTNIVITRQLDYHPPGTHVVHAIGEAISLAKEKNETECFITGGGEIFAQSIKYCDRLYIT
RIHQIIEGDVYFPEVDMNEWKEVSRRDVTPDEKNKYPFSFLVYERVK
>AIA17068.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GRSGEHEVSLRSAESIIKALDPERYEIRPFFISKEGRWDPGPIVPEPGANPGIDVVFPVL
HGTFGEDGTMQGLLELADLPYVGPGVLGSSASMDKEVTKRLCVQAGLPVVDFTVVRGGVY
DVAELESRFGYPMFVKPANLGSSVGISKAKDRAGLDASIRDAAQYDTKVIVERTIVGQEI
ECAVLGNDDPQASTPCEVLPFKDFYDYEDKYILDKTEFRLPAAVTPDRMAEIRRLAVQCF
QALGCQGMSRVDFLIESSTGEIFINEINTIPGFTSISMYPKMWDHDGLPYPKLLDRLIEL
AMERHAARRKLKFTR
>AIA16983.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTASFFRMALVLGLLSAIGPFAIDMYLPALPSIGADLGSDNSVTQLSLLSFFISFALAQL
LYGPLSDMWGRKLPLYLGIGIFTIASVGCALAQNIETLIAFRFIQGIGGAAGMVVPRAVV
RDMHTGVQAARLMSLLMLVFSISPILAPLAGSAVIEFYGWRGVFWAVMVAAFIGLLLLAT
QLDETRPEKDRKGSSLGSAMSAYRFLLRDKNFLTLTFIGGLGISSFLVYLANSPFVLIQH
YGLTPTQYSFAFSINAVSFFAVSQATGWLGERFGLVRVMRTAVTAFSLVMVVMAVVMATG
LNKLPVMAAFLFAGYGFLGLVIPTSAVLALEDHGESAGTASSLMGTLHFVIAAVAMVVSS
LFADGTALPMAAGIAICALFAFIVTQVALGRRATAAPAE
>AIA16957.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MLLEIKDLHAGIEGKEILKGLNLTVNKGEVHAIMGPNGSGKSTLSKVLAGHPSYEVISGE
VFYEGKNLLELEPDERAREGIFLAFQYPVEVPGVSNSQFLRLAYNEKMKHHGEEELHPLE
FNDYLR
>AIA16920.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPEIIGIAAVAINGVIGADNDIPWRIPADWQRFKALTMGNVLIMGRKTYDSIGRPLLGRT
TFVITRDRMWRVDGVRALPSLDEAFEQALLLDPEIVFVAGGGEIYQAAWNRLTRLEITEV
DRAPVGEVRFPKIDPGEWIETGRESYDGYSFVSYRRRSQRESAS
>AIA16917.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MMLISMIAAMTQKGVIGKNNALPWHLPDDLKHFKEVTLNKVVVMGRRTYLSIGRPLPKRE
NIILSQDDNFKAQNCLVAHSIQEALKIAQTLKAPELVVMGGAEIYQAFLPFAHILYLSFV
HKEVEGDTYFPSIAWNE
>AIA16904.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGKGHDVTPMDPARGVISAAEERELSTGKVGA
EPPSLEALSKFAEGTFLSNLIAMKEIKGADVVFLALHGGQGEDGTLQALLDMAHVKYTGS
GHLSSALAMDKDLSKKLFRMEDVKTADWLMAPATTEQVEGILGLPVIVKPSKQGSTVGLS
LVKKREDLAPAIAEASKYDDEVMVEKFIPGRELTVGILGDVALPVGEIFPKHEIYDYECK
YTAGMASEEFPAKLSKEATEKVQQQALLAFKALKLRGYARIDFRLTTEGEFYCLEANTLP
GMTELSLIPQGAAAMGIGFPELCERIVRLALG
>AIA16876.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAQLVRAAIVLGLLSVIGPLAIDMYLPALPAIAGDLNASAAAVQQSLMAFMLAFAVGQL
VYGPLSDMFGRKPPLYAGIGIFLAGTVGAALAPSVEWLVFFRFVQGMGACAPMSLPRAIV
RDNYTGAPAAQLMSLIMLVFSVSPILAPLSGSFVIQFGDWRTLFYVMAATGLLGLLLVAF
VLKETRPKEARTGSTLSSALGAYWQLLRDWKFMGLTLIGTFGMSSFMAFLGNSSFIYINH
YGLTPTQYSIAFSVNAVSFFAVSQATGTLVGRFGLNRVVRIAVGGYVASMIALLAVYLSG
IDSVWVLGGFMFVAFGFLGLVLPSTSVLAMEEQGEIAGSASALMGTVQMVVASVVMGIVG
AFSDGTARPMVIAFAACALAALAITLATLRGGNSERMLEVPAE
>AIA16846.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQAYLDLLRHIFDHGSDKSDRTGTGTRSVFGYQMRFNLQEGFPLLTTKKLHTRSIFHELL
WILKGETNIRYLKENGVTIWDEWADEHGDLGPVYGSQWRSWPAADGRTIDQVSRVVEQIK
TNPDSRRLIVSAWNVGEIDRMKLPPCHTFFQFYVHPMQDGESKRRLSCQLYQRSADVFLG
VPFNIASYAAFTMMMAQACDLLPGEFVHTFGDVHLYANHFEQARLQLTRQPRPLPILRLN
PEVRNIFDFKYEDLVIEQYDPHPAIKAPVAV
>AIA16832.1|FEATURES|farme|polymyxin|eptA|antibiotic target alteration|0
SPEYFPIAVDRYNESGRTGAQTGGASRAGRGDGHGRGERNAEDTPEPPLYSFLRNSSGSD
LHRTGDMPKVQRGIDFLRSRLPDDPPFMLYLPLSIPHPPYHAPEPFHSMYDPDKLPPLRP
HGLAGKPDFYRLIRDYRHLDEEPERLMRQIQAVYLGAISYSDWMLGQLLEVLEQAGLADN
TTVIFAADHGDWAGDYGLVEKWPSGLDDTLTHVPLIVRTPGNTAGHIVPEQVELFDIMAT
VLDLAGLKAEHSHFARSLTPQLNGAPGDDERAVFAEGGYDVREPHCFEGSPTRGSTNTRN
TNHVYWPKGLQQQEQPLSVCRATMIRTLTHKLVRRVDGVSELYDLQVDPQELNNVYGDPD
YTEVRSNLESRMLEWYIRTSDVTPFHEDPARIPGGCRMRSYLNLLQDILDHGVEKGDRTG
TGTISVFGRMLRFDLSQGFPLLTTKKMHLPSIVHELLWFISGEDEHSLLAGKQRADLERV
GG
>AIA16764.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPEIIGIAAVAINGVIGADNDIPWRIPADWQRFKALTMGNVLIMGRKTYDSIGRPLLGRT
TFVITRDRMWRVDGVRALPSLDEAFEQALLLDPEIVFVAGGGEIYQAAWNRLTRLEITEV
DRAPVGEVRFPKIDPGEWIETGRESYDGYRLRQLSPPIAEGVGFLSVSVWRRPKR
>AIA16757.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AFAAEYGVLPRIYGELWRHWPTSTPGQTIDQLKWIVDEIKADPDAHNAIVNSWNPEYLYT
MAKPENASLFPICHNMYQIDQIDGKLHLQLYQRSADIFLGVPFNIASYALLTIILARITG
YEPGEFVHTFGDVHIYEKHLEQGKEQLSREPLAFPTIKLDPAVKNLDD
>AIA16678.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAIAKNGIIGGDNDLPWYFPEDLKHFKEITLGQTVLMGRKTFDSIIKRLGKPLP
GRVNVVITRQENFIVPPGVLVFHSIDQALDALKDTEVYVIGGAQIFSATADRAEKMYITH
IHNEYKGDVYFPKIDWNKWEKIEEQPHEEYTFATYILKK
>AIA16654.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEEAATELETPAQPSQPQQEERPRLEMSSRRRWIVIIGVMTGMFLAALEATVVGTAMPTV
IASLGGLNHYSWVFSAYLITSTVTVPVWGKLSDLYGRRLFYQIGIAVFLFGSVLSGVASS
MEQLIVFRAVQGLGAGALVPLGMTIIGDIFTVTERARMQALFSGVWGFSSVIGPIVGGFI
TDQLSWRWVFYINLPVGLAAAVIIGIALKEPKVHQRPAIDYAGAGLLMAAITLLMLGLVE
GGTGIAALLSPHNLQLFAGAVALLAAFVWVEKRAVDPIIPFRLFRNRTVAVSVYAGFLAG
AAMFGAISYVPLYAQSALGSTATEAGSLLTPLMLSWVSMSIVGGHLLLRVGYSLISIVGF
CFLTAGFVFISIFERETPRFWLYFDLVLIGAGLGLTMLTLLIAVQQAVARTELGVATSLN
QFVRSIGGAVGVAIMGAVLSAGLASELNRAAQSERSVITPAQAEAFAANPNALIEPQARA
GLSPATLDVLQSAMSSAIHRVFWLGSVLAALALLVAFFLPRAGKSATANANASSPNDSLD
ESDGGQMLMAEFTTIDAEHEPKYRARDER
>AIA16609.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MEKLRVAVLFGGTSSERDVSIASGSQVVKALRAAGHDVIAVDTATGVLGPAQEQQLLTAG
VAPAPPEESALEALSGGGANLLQSGELNSVDVVFLALHGGSGENGTLQALLDLTGLPYIG
SGVLGSAVAMDKDIAKRLMLVSGVPTPRWLMAPADPNAVGEEIGWPAIVKPNKQGSTVGL
TIVREPAGLQPAIELAYKHDDEVIIEEFIPGRELTVPILGDEPLPVGEIIVEREIFDYET
KYQPGMAQEIFPADLTGAQVVEVQRLALATHRALKLGGYSRIDFRMAQDGRFWCLEANTL
PGMTAASLFPKGAAAAGMTFPQVVDRICRLAIEEHQRRRRV
>AIA16514.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNLGKGTGERPVIALVVAIGENGAIGRGGELPWRLSSDMRYFRKVTMGKPVIMGRRTFKS
LPRVLDGRLNIVLTRDQGFIAPDAVMAHSLDEGLAAARDSAALTDAGEIMVIGGEDVFRE
VLPQAHRIYLTEVHASPEADTWFPDFDKRDWREVFRERHEAGPRDEHAFSFVVLERTDGP
>AIA16476.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKFAEGAFLPNLTSMKEVKDADVAFLALHGGQGEDGTIQALLDMANVKYTGSGHLSSAL
AMDKDLSKKLFRSEDVKTADWLMAPVTTEQVEGMLGLPVVVKPSKQGSTVGLSLVKKREG
LAKAIEEASKYDDEVMVESFVPGRELTVGILGDIALPVGEILPKHEIYDYECKYTAGMAT
EEFPAKLSPEATEKVQQQALAAFRALKLRGYARIDFRLTSEGEFYCLEANTLPGMTELSL
IPQGAAAMGISFPELCERIVRLALG
>AIA16474.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TLSVFGAQLRFDLNAGFPLLTTKKVHLKSIIHELLWFLKGDTNIKYLRDNGVRIWDEWAD
EQGNLGPVYGAQWRSWPAADGTHIDQIKLVLAQLRTNPDSRRMIVSAWNVGELDKMALMP
CHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTLMVAQVCGLKPGDFVHTFGD
THLYLNHPEQAREQLSRQPRKLPTMRLNPSAKDLFEFKYEDFTLEGYDPHPAIKAAVAV
>AIA16432.1|FEATURES|farme|aminoglycoside|AAC(6')-Iaa|antibiotic inactivation|0
MTEVVYTKGEFSISTDRSRIDLDLVHSFLSNSYWARNIPREVVRRSVENSLCFGVYEGVA
QVGFARVLPDIATFAYLADVFILESHRGRGLSKWLVESILGHPDLQGLRRWMLATRDAHG
LYSKSGFVPLKGVEKWMEIHNPDVYR
>AIA16389.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLETGAPKQDRTGTGTASVFGYQMRFNLGEGFPLLTTKKLHVKSIIYELL
WFLRGETNVGYLREHGVNIWNEWAREDGELGPVYGAQWRSWKAADGRSIDQISQVIDQIK
TNPDSRRLIVSAWNVGEISKMALPPCHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMVAQACDLEPGEFVLTLGDAHLYSNHFEQARLQLSREPLKLPTMKINPSVQSIF
DFDYGDFELVGYAPHPHIKAEVAV
>AIA16367.1|FEATURES|farme|macrolide-lincosamide-streptogramin|lmrD|antibiotic efflux|1
MLLEVKDLHAAIDGKEILKGLNLQINKGEVHAIMGPNGSGKSTLSKVLAGHPSYEVTSGE
VLYEGKNLLELEPDERAREGVFMAFQYPVEVPGVSNSQFLRLAYNEKMKHHGKEELDPLE
FNDYLKEKAKVVDMSPEFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAILDETDSGLDID
ALRIVAGGVNVLRSSENAIILVTHYQRLLNYIEPDFVHVLAGGKIVKEGGKELALELEAK
GYDWVKSAAK
>AIA16343.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLNPTDQQYPDLLRHIMENGSGKEDRTGTGTRSVFGYQMRFDLAKGFPLITTKKVHLKSI
IYELLWFLKGDTNVKWLNDRGVTIWDEWADENGELGPIYGKQWTAWEAKDGTKINQIANA
VDLIKNNPTTRRIIVSGWNVGDLQTLIRGQKSAPPPCHTMFQFYVVDNKLSCQLYQRSGD
VFLGVPFNIASYALLTMMMAQVTGKELGDFVHTFGDVHIYNNHVDQVNLQLTRDSRPMPT
MKINPEVKDIFGFKFEDFTLEGYDPHPGIKAPIAI
>AIA16322.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAAIAKNYTIGKNNDLPWKLPDDTKFFMNTTKGHYVIMGRKNYESLHEKFRPLPN
RTNIVVTRQQSFSAPGCLVTHQINDAIAIAKKGSETEAFIIGGAEIYKLSLPTADRLYLT
EIDAEVEGDTFFPAFNKNEWKETSRTHHAADEKHKYAFDFVIYDRMK
>AIA16148.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYHQLLKTVLTNGQRKDDRTGTGTLSVFGHQMRFDLSKGFPLLTTKKLSMRSIIHELF
WFLKGETTIDYLREHKVTIWDEWATAEQCARFGRQEGNFGPIYGHQWRNFGATQLPDGTY
AKDGKDQIMWLLNEIQRNPNSRRLIVTGWNPKEADQVALPPCHTLFQFYVSNGKLSCQLY
QRSADVFLGVPFNIASYSLLTHMIAQVSGLEVGEYVHTLGNAHLYLNHLNQAEEQLTRDF
RPLPVLKLNPTIKNLWDFTIEDIAIENYDPHPSIKAPIAV
>AIA16139.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGKLNARISLIVAMAKNRVIGANNAIPWHLPAELKMFKAITMGHHIIMGRKTWESIGRLL
PGRTTVVVTRQHGYSVPGAIVADSLDSALAACKGDDEIFVIGGAELFAAALPRATRIYLT
IVDADVAG
>AIA16140.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YLRDNGVRIWDEWADEQGNLGPVYGAQWRSWPAADGTHIDQIKLVLAQLRTNPDSRRMIV
SAWNVGELDKMALMPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTLMVAQ
VCGLKPGDFVHTFGDTHLYLNHLEQAREQLSRQPRKLPTMRLNPSAKDLFEFKYEDFTLE
GYDPHPAIKAAVAV
>AIA16084.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTIVLIAGVAQNNVIGQQGALPWYISEDLKRFKELTTGHPVVMGRKTYESIVQRLGKPLP
HRKNIVVTSNTSYQAHPEVLLCSSVQEALMKAQQSSEKVFVIGGQQIYEQTLPLAHELEI
THVHKAFEGDAYFPEIKKEEWKEVKREERTGDMHYSFVSYQRSKKGLFIVFEGIDGCGKT
TQLKRLVEYLFAKSKYNHLVVTREPYQETKIRNLLHAETDPHSQAEQIAQLFIADRKNHA
EHLITPSIQKGMHIISDRYKLSTIAYQHAQGLPLQRLIDMHYGLPIPDITFVIDLPAKVA
AQRMSKESSRKAHKFEANLEFLEQVRMNFHKAKEALPQEKIFILDGQRAPEVIAAEIKES
IDASS
>AIA16020.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VDLPPCHTLFQFKVENGSVLHCQLYQRSADAFLGVPFNISSYALLLRMVAHVCELAVGEF
VYTLGDYHIYKNHLDQVNELLSREPLPLPRLEIVDPTKRLRGLQGLLDMRYEDLNLSGYQ
SHGKIAAAVAV
>AIA15975.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MNIKTENIKPVAEDKPNVLLSLNRRRAVTAGIMLGSFLAAMETTVVGTAMPTVISSLGGL
NVYSWVVSAYILTSTVTVPVWGRLSDLLGRRTLYTLAVIIFLIGSVLSGAATSIWGLIIF
RAVQGLGAGGIIPLGMTVNGDIYTLRERAKVQGLFSLMWGLASIVGPLAGGFITQHWSWR
WVFYINVPFGLAAALVVWLALKEPAKTQKPVIDYAGASWLFLSITLLLIVLSESRDMRAW
QHPLMIAAVIGIVVFSFLFIRTERAAVEPIMPLTIFRNRIVAVGSLVGFLVGTAMFGALT
FIPLFVQGTLGGSATEAGVILTPLLLGWVILAIIGGRLMLRIGYRPTILIGLAFVLASFI
VLSRITQFTPRWVLLSDIGLMGSGMGLVMLTLVLATQNSVERSQLGIATSLTQFSRSIGG
AIGVAVMGTMMSIGLASQQAQIQQASGLPEAEVAAIVHNPNALIETTARAELPPALLHSM
EGALAKSLHNVFIVGAVFAAFALVAGFLLPASDG
>AIA15894.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKTPFSIVVAVDANFGIGRGGLLPWHLPGDMKHFKEVTLEGSSEAHRNVVIMGRKTWDSI
PDKFRPLPGRRNIVLTRDITPTFPSGVERAFDFEDALLKAAQSVPSKIFVIGGGEIFKIA
IGHPSCQRLFLTHIETTFDCDRFFPSLPSSFKPIFKSPLLQDGKTKYFFCTYERC
>AIA15890.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MQLTQDIPVRKIRRSKIGKVDFSSLEFGKYISDHMLVCDYYDGEWQTPQILPFANLSLSP
ATLALHYGQSVFEGMKAFRMKDGSINIFHIDNYDRLVKSLQRMCMQVPPKEIFAEGLTEL
VKLDKAWVPDGNGSSLYIRPFVFASEAKFGVKVADEYRFIIFSGPVGPYYAKPLRVKVER
EFIRAARGGTGYAKCAGNYGGAFYPTQLAREKGFDQVLWTDAGENKFIEESGTMNVMFVI
NGKLITPGLSDSILDGVTRDSLIQLAKDKGVAVEERRICTDELITAFRDNTITEAFGAGT
AAVVAPINLIHIDGVDYKLPFYTVNNLMNQLKQQLEDIRTGRVSDIYNWNHII
>AIA15858.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIRGPVTLIVARATNGVIGRDGTLPWRISADLKRFKALTMGTAMIMGRRTFDSLPGILPG
RRHIVLTRDLDWSANGAEVAHSVEEALSLAGDEPVSVIGGAEIFELFLPHADRFELTEVI
GNIEGDTRMPDPRNTGDWREVAREDHTAEGDTPAFRFITLKRA
>AIA15842.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSRKIRIGLIYGGKSGEHDVSLQTALAVMKAVDFTKYEITPFYISKNGEWRSGTPLLGPA
ESKEVLTFRTGDAGAPASNPLAPIFGGIQTKGDVAVSSITSPGAEDIGLDVVFPLLHGTF
GEDGTIQGLLEMANIPYVGAGVLASAVGMDKVMMKKVFAQEGLPQCVFRHFTRTEWEKNR
DYHLMEMETAIGYPCFVKPANLGSSVGISKARNQEELIAAVAFAFQYDRKVIIEENIDAR
EIEVAVLGNDEPIASVVGEIVSSNEFYDYKAKYLDGKSAMIIPAEISQEISDEVRELALR
AFLAVDGSGLSRVDFFLGKTDQKIYINEINTMPGFTPFSMYPLLWQETGKPYKELLDDLI
RLALERHAAKQNIQYSFDAE
>AIA15833.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|0
MTVLETDRLILRQLTPDDAPFILELLNQPSFLRFIGDKNVRSREDAVRYLETGPLASYER
FGFGLYRVELKDTGTPIGMCGLLKRDTLPDADIGFAFSPEYWSAGYGFEAADAVMNYGRG
LGLKRIVAITSLDNDASIKLLGKIGMQFEGVIKLADDQPEVKLFGKSLAA
>AIA15819.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MHISLIVAATENGVIGKDGKMPWRLPAESAYFRNTTLGHPVITGRKNYEAMGRPLPDRLN
VVITRSADYRVPSGVAVVHSLDEALDLPEVKSQSEVFIIGGAQIYDEAMPRADKLYLTTI
HTTMDGDTYFRYNPSEWRQEWSEHHAADAENKYAFTLKRLARQ
>AIA15803.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNIVLVAAVTADGFIARNAGHAADWTSKDDKRHFVEVTKRLGTMVMGSTTFETIGRALPG
RRMIVLTNRPDDFRIEGVETFSGPVESLVAALEKEGVAGLAVVGGAHVYGQFLEAGLVDR
LELTVEPHLFGKGITVAGTELDLKLRLLGLERLGEQAVLITYEVER
>AIA15801.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTLGLIWAQTLAGVIGMDGTIPWRVPEDSAHFRSVTGTSSVVMGRRTWDSLPDRFRPLPE
RRNIVVTRQPGWHADGAVVADSVEAALAAAGSDAWIIGGSELYAATIDRADVLEVTEIDT
DAPGDTFAPSIDDGWAARLREPSDGSWRQSRTGIRYRFIRYERISRDTVT
>AIA15746.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPSLPPCHSLFQFNVANGKLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKQGEF
VHTLADAHIYLNHFDQVDEQLSREPRALPTLWLNPEVKSIDDFTFEDIRLEGYDPYPPIK
APIAV
>AIA15699.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MIRVFVIAAVSADGFIARTQTELADWTSKEDKKIFVELTKKAGVMVMGSNTFKTIGRALP
GRRNIVYSHTPIEVEGIETTEETPQELVTRLEAEGCAELAVCGGRAIYDMFLRAGVVDEV
YLTLEPVLFGTGITLAGSPLTTSLKLLETRPLNEDVMLMHYGVRK
>AIA15700.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
EQVWFISGARKPEIFLRDFTRIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGMLVNLLQKD
PSSRHGVVVTWDPASDGLGGASKGNVPCPYSFTVNIIGGRLNMMNVVRSNDMILGFPHDV
AGFALLQLILAQKLGVKPGVYTHTIANAHVYDIHYDAAQMMIDRPAKQKKINLSLPEDAY
DRAEKKDVALVEELNEQVQAQYEPGEPIKGLRIVL
>AIA15611.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
MLMKIRLALVAAVAAGAFAGMAGAAGPSPADLAKFNAPVEPFKIFGNTYYVGTQGLSSVL
ITSDFGHVLIDGGLPTTAPLIEENIRKLGFKVEDIKAILQSHAHPDHVGGIAQLQKDSGA
AVYARRPADEVMRTGKLPPEDPQYDRRMAKIPTVQTAWVVHGDQLLGVGSVRLRVYATPG
HTPGGTSWTWESCEEKTCLQIVYADSLSPVSRDKYRFSDHPEVLAQFEESFKTLEGAKCD
VILTPHPEMSSLFERLQNAGGKPDKVKDSDGCKKYVAASRQKLADRLEMEKASGHK
>AIA15608.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKAYLQLCEHILSNGIRKEDRTGTGTISVFGYQMRFDLGQGFPLVTTKKLHLRSIIHELL
WFLKGETNIRYLKENGVRIWDEWADDNGDLGPVYGKQWRSWTGADGRTVDQISEVIETIK
HNPNSRRMIVSAWNVAELPDMALAPCHCLFQFYVADGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCGLQPGDFVHTLGDAHIYNNHIEQVHLQLSREPRALPKMAINPEISSIF
DFTYSDFALEGYDPHPHIKGEVSV
>AIA15593.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKTRIGVIFGGRSGEHEVSIRSARSVIEAIDKERYEIVPMAIAKNGKWLSPAESALLFP
AETRQLLAEQNSVKETRAVALIGDPTYQGLTLLEKSDERAQPLDVVFPVLHGTYGEDGTI
QGLFEMAGIPYIGCGVLASSCGMDKVAMKVLFRDAGLPMCRYTWFLRRDFEAAPEAAIER
IKNEIGFPVFVKPANLGSSVGISRADDDESLRKAIELAAHFDRKIIVEEGLDAREIEVAV
IGNDEPQASLPGEYIIFDENAKFLDYEEKYKGTGHNEFTVPAPLEREIIEQIRALACVAF
KAVDGSGLSRVDFFLRRDNNQLLINEINTLPGLTDVSGFPKMWAATGKPFSQVIDELVAL
AFERFKDKSRNQTSI
>AIA15500.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNVMTNKPLISLIVAIDENKAIGKDNQLLWHLPNDLKFFKKTTSGHTVIMGRKTYDSIGK
PLPNRRNIVISRNKDLKIEGVEAYTSLAAALENSVSEEEVFIIGGAEIYKQALPLTDKIY
LTQVYHKFDADTYLENL
>AIA15477.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSNATKFGKVAVLFGGKSAERAVSLDSGQAVLDALLRSGVQAEAFDPQDRSVTELVSYDR
AFIVLHGRGGEDGQIQGVLEWLNLPYTGTGVQGSAIGMDKVKTKQIWQGSDLPTAPYRII
TKETDLDAVIAELGLPVIIKPVHEGSSVGMSKVEKAEDFAAAIEKATQHDAVVMAEKWIT
GREFTISFLNGQPLPVIRLQPPADVAFYDYEAKYERNDVEYGIPCGLSEAEEKSLQALCL
RAFQAVGAEGWGRIDAMQDEQGNFWLLEVNTVPGMTSHSLVPKAAQAVGYSFDELCVAIL
EQTLEGTA
>AIA15417.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKMNLLLIFGGESAEHEVSIRSARNVFDALDKQKYDIDIELCYIDRNGKWWLVSAVIEN
PQKLGALLPVLGAGKFWIDEPNHAITPDVLFPVLHGPNGEDGSVQGLAQLLHIPIVGCGI
IGSAVCMDKEITKRLLTRAGITVAPGVVHHREDATPVYAEALEKLGGDALFVKPANLGSS
VGVSKVTDQASLSKALEEAHRYDRKVLIERAVKGRELECAVLGNEHPEASVVGEIMPGDE
FYSYDEKYAETSNTKTSTRAPLPKETSAKIRAVALAAYKVLECRGLARVDFFLADDGTVY
LNEVNTLPGFTSISMYPQLWKASGLDYSSLLDRLVALSRQ
>AIA15280.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTVRIAMIVGVAENGVIGSDQTIPWRVPSDMAFFKRTTMGKPIVMGRKQFETVGKPLPGR
TNIVITRQQNYQPEGVLVFNDIDAALQRAREIARADGVDEIMIIGGGELYAQLMGRADRL
YITHIDLHPAGDVVFPAIAPEQWTVVDLPEVTPSPKDEATYRVKVYERRRDAAH
>AIA15211.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MLIIIAAIAANWVIGKDNDLPWYYPEDLEHFKNITTGHPIIMGWNTYVSILSRVHKRTGK
AKPLPKRMHFVLTSKKAAVIKIELQKLFPGFDQESFSDQVIFCSSFGEAVQRAEVLDKEV
YVIGGEKVFETAIRDANAMEITEIDAEYDGDAFFPKFDKSLWNREVRKRDGFSFVRYTRK
KLDA
>AIA15212.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TMFQRSADFFLGVPFNISSYALLTCMIAFVMGMKPRKFTHNFGDAHIYSNHLTPGEGQDQ
SPVDQLLSREPLELPILQFKNADHLVGKGLDGLLEFKWENIDLVGYKNHGKISAPVAV
>AIA15135.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKPRSIYAVDFVYRAIMSRERCDRLHDWLVATTRLYYLALSAATVKVKRGFMAQEQDKYV
VEAKNLTKSYGSNKVLQGIDLRLERGTMLALLGPNGAGKTTTVRILSTLLAFDGGSVTVE
GHDVTTEPDKVRGVIGLTGQSAAIDDLLTGRENLVMMGRLYQLTADSARARAQELLEEFD
LVEPADRPAKTYSGGMRRRLDLAVSLIAAPPVIFLDEPTTGLDPRSRLAMWEIIRNLMAA
GTSILLTTQYLEEADQLADRIVVIDGGKVIAEGTATELKSKVGKDRLELTLKDSQALARA
VKILGKDIINTDEKDYTITVVIKDTSTDIRKTLDMLAEEKITIQSMAIHKPTLDDVFLSL
TGKQKKAKKEDKQ
>AIA15081.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGKAKGDNKNGRPLRITVLIGGASSERDVSFASGTRVAAALREKGHTVTAFDPAGDVMTR
EEETRYLSGAVKTAPPTPEYLATLRIPGTLGDHPAVRGADVVFLALHGGQGEDGTVQALL
DLAGITYTGSGHLASALAMDKDLSKLLFRAGGVRTADWLMAPAADDEIVSALGLPVVVKP
SKQGSTVGLSVVKRREDLAAAIELAYKHDDEVMIEAFVPGRELTVGILGDEALAVGEIIP
KHEIYDYECKYTAGMAIEEFPAKLDRAQTGAVQQQAVAAFRALKLGGYARIDFRMSPEGH
FYCLEANTLPGMTETSLIPQSAQACGISFADLCERVVRLALEKRRPIAGAGV
>AIA15033.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRAMIVAYDNNRVIGNHGDIPWQGKMRTDSRYFRDMTLGHPVIMGSKTYLAMNRLLPNRP
NIILTRDKLSVEGAVVVHTLEEAFRVAEKLDELVFVIGGGHVYEAALNMVDAIYATEIDA
SNEGDALFPQLDPLKWVETKRDHHEADEKNTYNYDFVTYKRKG
>AIA15035.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDILENGHEKGDRTGTGTKSVFGRQVRYNLADGFPAVTTKKLYFNSVVHELL
WFLQGTGNIEYLAQNNVHIWDEWPYKAYLQKNNLPVPASDSDEWKTGIKEFIASIANDHE
FAHKWGDLGPVYGVQWRKWPDGKGGVIDQIANVIETINTNPNSRRIIVSAWNVAEIDEIV
AMGGLPPCHSLFQFNVHDGVLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKQGE
FVHTLADTHIYLNHFDQVNEQLSREPKALPTLWLNPEVKSIDDFTFADIRLEGYDPYPPI
KAPIAV
>AIA15026.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DTSKSFAENVANGKAALPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALFTM
MVAQVVGLQPGDFIHTFGDAHIYNNHMEQLELQLSRDPKPLPKMVLNPNVKNIFDFTFDD
FTLEGYEPHPHIKGAVAI
>AIA14931.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKTRIGVIFGGRSGEHEVSIRSARSVIEAIDKERYEIVPMAIAKNGKWLSPAESALLFP
AETRQLLAEQNSVKETRAVALIGDPTYQGLTLLEKSDERAQPLDVVFPVLHGTYGEDGTI
QGLFEMAGIPYIGCGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWERDGATVAEH
VKAKLGFPCFVKPANLGSSVGVSQATDEESLQRAIALAAEYDRKIIIEEGLDMREIECAV
IGNDEPQASLPGEYIVHDESKKFLDYTEKYSRTGNNEFIVPAMISDELTHKIQDLAVRAF
KAIDGAGLARVDFFLRNDTGALLVNEINTLPGMTDSSGFPKMWAGSGMEFSQVVDLLVTF
AMERYRDKAKNKTVK
>AIA14885.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTVTLIAAAAENNALGKDNQMIWRLPDDFKRFKQLTTGHHIIMGRKTLESMNGPLPNRTN
VVITRQNNYAHEGCLIVNSLEEALAASPQDEEVFIIGGGEIYSQSIAKADKIELTRVLGI
SPDADAFFPDINPDDWQLAESVFHGKDEKHAYEFVFETWVRK
>AIA14859.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKIDPQAFGKVAVLLGGTSAEREVSLQSGALVLAALRARGVDAFAFDPAERSIFALKEE
RVERVFNVMHGGYGENGALQGALDLLGIRYPGAGVLGSALCMDKVRSKLIWQQIGIPTPA
FEVVMRVDDYAVRASEIMAKLGFPLFVKPASEGSSVATARVTSPTSLVAAIAEAARYDSA
VLVEQSIESGSEYTLALVDGLDLPTIRIVPAGEFYDYHAKYVADDTQYFIPCGLPAQVEQ
QIKVLAAQQQIKVLAAQAAAALGCHGWGRIDFMTDAQGQVYFLEINTVPGMTTHSLVPKA
AQAIGVDYESLIMHALSLTLN
>AIA14843.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MDSSKFPKHIAVLKGGPGSEREVSLATAAGVSNALRSLGVQVTDVDVRDETFELPHDVDL
AFIAIHGTFGEDGQVQQILEQRGVPYTGENVEGSRIAFDKISSKEKFDAAGVPTPEWERI
AAGARPTLSVPLVIKAPRQGSTVGVYIVKTEAELESSLKEAAQYDDHLLVEKFIPARELT
IGVLGDQALPIIEIIAKEGFYDFAEKYPFLNPNAAPGGGAQHVCPAHLPEDQTRELQELA
LRAHRSLGLRVYSRVDVMLPENGKPTVLELNTIPGMTPTSLLPEAAAAAGISYPQLCARI
IELSVAARGRKQA
>AIA14729.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MDKDFTKRLLRDAGLNVAPWVSVTQAQRAQLDASAVIARFGLPLFIKPANQGSSVGVSKV
DSIEEFDAALALAFSFDRKVLIEQGIKGREIECAVLGNDAPEASPCGEVVVHDAFYSYDT
KYISESGAQTVVPAAISPETSDAIREVAIKAFTALECFGMARVDVFLTADGEIIVNEVNT
LPGFTNISMCPKLWQAAGLSYQDLISRLIDLAIERHQQASTLKSSVS
>AIA14726.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNPRVSIIVAIDEKRGIGKNNDLLVKIPEDFKRMKELTSGHPIILGRRTYESIGRLLPNR
TSIIVTRDSSFAVDGAVVANSLEDSLEKAKSASGAEEVFIFGGGQIFKEALEKGLVDRLY
LTIIKGDYGADTFFPDYEICGFTKIIEKVERDADGYQYSFVTLEK
>AIA14598.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
TKRAGVMVMGRTTFATIGRALPGRKTIVYSHQAVDIDGVEVTDEAPANLIQQLHRQGYNE
VAICGGSAIYTQFMLAGVVDELYLTVEPVLFGNGVPLFAGQLQERLLLLETRQLNDNAIL
LHYEVQK
>AIA14589.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
RASQVLITTGSQQALDLLGKVLVCPESPVLVETPTYLGALQSFSMYEPRYVQVPTDDNGL
IPEALTPELTKGARLLYAQPNFQNPTGRRLPIERRRALAEFAKSAPFPVIEDDPYGALDY
RGEPLPTMLSMSPDHIVHLGSFSKVLAPGLRIGYIIAPEELHFKLVQAKQATDLHTPSFT
QRIVHEVVKDGFLDTHVPKIRALYRDQCEAMLGSLERSNATCPKA
>AIA14583.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKSDFLKNAITLGLITAVGPFAIDMYLPALPTIAADLGASTAATQMTLMVFFITFGVAQI
AFGPISDMVGLKPPLYFGLVVFAIGGIGAGFSPTIEWLIFFRFVQGIGAAACMVIPRAVI
RDLHTGIAATRLMSTIMLVFSVSPILAPLIGSAVIVPFGWRAVFVAVTIVAIIGFALVAF
ALPETLKPENRIRVSVGSVLSGFGTLFRDARFLGLTFIGGLGLASFFAFLATSSFVYIDH
YGLTPTQYSLAFSVNAIGFIGASQFAAKLAGRYGFSRVIMAAVSGYAAIILVLFAVTAAG
VDDLLTLMVGLFTAFAFLGLVIPSTMVLSLEDHGPIAGMASALGGTLQFLAGAVVISVAS
VFFDGTSLPMVAIIAACAMGAFVLAVLTLRRRPQPAPAPAE
>AIA14482.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EIKNMALPPCHALFQFYVQPQPHGPAKLSCQLYQRSADMFLGVPFNIASYALLTRMMADQ
AGLEPGDFVWVGGDCHIYNNHVEQVTEQLSREAYEFPRLDIAKRGSLFDYAYEDFKLLEY
KYHPALKAPVAV
>AIA14475.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YELLWFLNGDTNIKYLNDNGVRIWDDWADENGNLGPVYGKQWRRWEGPRGERIDQIQRAV
DTIKKSPNSRRILVVAYNPADLPEVAPPACHTLFQFYVSGNRLSLQLYQRSADLMLGVPF
NIASYSLLLMMVAQVTVLKPYEFVHTFGDVHIYSNHIQGAELQLTREPRPLPKMILNP
>AIA14452.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAELVFTKKPKALLVINDSLIMIKRSSTHIIRNTDQLLGTFFQPIMFLLLFSAVFGGAIG
LALPNGVSYLSYLMAGIIIQTAAFGSTTTALAVANDLQRGIIDRFRSSPMSSSALLMGHV
VSDVFKNAISTIIMLLVGLLIGFRTSASLIDWLTIAVILILFSLAFSWLAAIMGVVAKSV
EAVQWLTFVIIFPLTFASSAFTPTSVLNNAVLKAFAENQPITHVINAVRALLLGTPTGNS
VWLAIVWSLGTLIVAIPLASWIFRNKTSH
>AIA14401.1|FEATURES|farme|beta_lactam|CARB-10|antibiotic inactivation|1
MKELNLHSLIKTVLLAAAGAIAAASAQAAPGDRIVAAAQATEKALGARVGVAVIDMADGA
SWTYKARERFPMASTFKGLACGALLAAGADVKARSVVIQKQELVPYSPVTETLVGKEVAA
VDLCKATLRTSDNTAANKVLDILGGPAKVTAFLRESGDDITRLDRREPELNEGKPGDDRD
TTTPLAVATTMRNLILGDILKESDRAQLTEWLVANEVGGPLLRAGVPSDWRIADRTGGGG
FGTRGVVAVMWPAQGEPIVAAVYITETTATMDERNKAIAEIGRAIATEANEYRSN
>AIA14396.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MDLIADHISHRFGALEVLDDVSFTVGAGEVVAIVGPSGCGKSTLLSILGGLLQPSGGAAE
WRGAAPPGSLNPLTFVFQDFALLPWCTVEGNVEFPLLHTSLTPAERRASIDDALRRTGLT
DFRNAYPKQLSGGMRQRVGIARALAVRPAILLMDEPLSALDSQTRELLLEDFIRLLTDGV
MGAVYVTHNLEEAVRIADRIVVLSRRPGKVRETVAIAMTRAERGAIEARGKLLTLQNELW
SLIREQAIDAEREVQHA
>AIA14382.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELEFEKRPRFIQNVVDSMIMIKRSSTHIIRNTDQLLGTFFQPIMFIILFSAVFGGAI
GRSLPPGVKYIDFLMAGIIVQTLAFGSTTTAVAICNDLQKGIVDRFRSLPMSNLAVLNGH
TISDLFRNGISTVIMILVGLVLGFRSHASFLDWLAIAGILLLFTFMFSWLAAIVGVFAKS
IEAVQWLSFIIVFPLTFASTAFVPAEGMNKYLKAFAENQPITQVIEAVRALILGTPVGNH
IWLAVIWCVGILIVAVPLSAWLFKRKTT
>AIA14312.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTTKKPRVSMIAAVAETDRAIGYKNELLWHIPEDLAHFKKTTFGHPVIMGRNTYLSLGRP
LPGRKNIVLTLDKEEVFEGVEMAYDIPTALARAAESDQEEIFIIGGATIYELLLSYADRL
YITLVPGSYQADTYFPPYEAFTKVIAKEECTTAAGTIQFLTLEKE
>AIA14285.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SWRFWPDGKGGHIDQIATLIDGLKKKPFSRRHLFHAWNVAYLPDETKKPWENAAEGKMAL
PPCHLLYQFNVVQNKLSCLLYIRSNDLFLGNPYNTASVAFLTHMIAEQCGYEPGEVILSM
GDLHLYKNHLEQARLQLTREPRPLPKLVIKRKPDSIFDYRFEDFEILGYDPHPHIAAPIA
I
>AIA14271.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MMTQWHNKRVGVLFGGLSAEREISHLSGTAICTILRERGYAVTPVELGASGTWMVQVRDT
DVVFIALHGKLGEDGTVQGTLELLGVPYTGSGVLASALEINKPMAKRVWQVYGLPTPAWQ
VIEKAHPAAMTLPYPVVVKPSTEGSSVGVTIVQSAETLAPALAEAWRFDPQALVETYIPG
KEVTVGILGEQALGAMEVIAKGEFHSYDVKYTAGREEFLLPAPLLPAVYDRVMQIALAAH
SALECRGYSRVDTRITEQGDVFLLEVNSLPGFTGLSYLPRIAAHAGLDYGDLVEAILQRA
TLHIHRSTR
>AIA14221.1|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MRVGVIFGGRSGEHEVSLRSAESVINAMDKSRYQIVPIGITQEGKWLVSGDAKTMLPKTV
MASNNHQQVAIIGDPTRQGLTRLDAGTSEQLDVVIPVLHGTYGEDGTIQGLLEMAGVPYV
GCGVLASATGMDKIVMKQLFTQAGLTVIDYEWFLRSSWEENPAGDNKTDQPKARLSCLRQ
TRQSGFERRHLEGKEQSRIARIHKRCGTL
>AIA14212.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISVIVAMDEERGIGKAGTLPWRLSDDLKRFRELTMGHHLIVGRKTYDSIGRPLPGRHI
IVVTRNKSYKPDNVVTVHSLQEALSLAEDAGESEVFIGGGAEIYKEALPLADRMYVTRVE
ADAQADTFFPELDPSDWMVKQIGEHPADDRNQYPFSVWVMERRG
>AIA14201.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELKFEHKPRLIQNLSDAMIMIGRSSRHIVRNTDQLLGTFFQPIMFLVLFSAVYANAL
SSVLPPGVSYLQFLMAGLIVQTVAFGSTTTALAVANDLQKGIIDRFRSLPMSNLAVLTGH
VISDLFRNMLSTVVLVVAGLALGFRSNANFLEWLLIAGVILLFTLAFSWLAAIMGVVSKS
VEGVQWLSFVLVFPLTFASSAFVPAEGMNRFLKAFAENQPITHVVDTVRGLMLGTPIGDS
AYWAIGWCLGTLLVAVPLASYLFKRKATQ
>AIA14166.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MATALEFTKRPKVISLLNDSLLMIKRSSTHIIRNTDQLIGTFFQPIMFLILFTAVFNVVG
TSLPPGVTFINFLMAGIIIQTVSFGSTTTAIAVCNDLQKGIIDRFRSLPMSNIAVLNGHV
VSDVFRNGISTAVIVLAGLLSGFRSNASLIDWLAIAGIIVLFTLAFSWLAAIMGVLAKSV
EGVQWMSFVVVFPLTFASSAFVPADSMVSWLRPFAENQPLTHIIEAIRALMIGAPIGNHG
WLAFAWCVGILIVSIPLASYLFRRKTTS
>AIA14106.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
IEVKGLTKSYGSNDVLRGIDIQVEEGTMLALLGPNGAGKTTTVRILSTLLKHDSGTVRVA
GYDVAEDADKVRTVIGLTGQSAAVDELLTGRENLVMMGRLYRLTKASAQARANELLQEFD
LQKAADRPTKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWDIIKKLMAA
GTTVLLTTQYLEEADQLADQIVVIDGGKVIAQGTASELKSKVGKDRLELVFQDTSTLKAA
RKALGASAVDIANNSLALSMTIEDIN
>AIA14097.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGRPLPGREMIVVTRNES
FAPEGCFIARSVEDAIQFAKERGESELFICGGAEIYAQTLDRADRIYLTLVHADCGADTF
FPEWNNDEWIEQEGEPHAADEKNQYSFTFKALARKYKA
>AIA14079.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|0
MLLEIKHLHAGIEGKEILKGLNLQVNKGEVHAIMGPNGSGKSTLAKVLAGHPSYEVTQGE
VLYEGKNLLELEPDERAKEGIFLAFQYPVEVPGVSNSQFLRLAYNEKMKYLGEEELDPLE
FNDYLKEKAKVVEMSSDFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDID
ALRIVATV
>AIA14059.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MENSFSLVVAMDRRRGVGKNGGLPWTLPPDLKHFKEITTDLRIPGQKNAVIMGRKTWESL
PERFRPLPGRTNVVLSHSLVKTPPDVILAKSFDDAFAQLERQKFSGQIFVIGGGQIFSES
LADRRCVKIYATHLDDDLNCDVFFPPLNADWTESKRCASSVYEGIRYAFVEYLRQPVS
>AIA14028.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLKERGVNIWNEWADERGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPLMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA14031.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AENDEIVETGGLPPCHTLFQFNVRDDKLDLHLYQRSADIFLGVPFNIASYALLTMMIAQV
CDLNPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIFEFDYSDFELSD
YEPHPHIRAEVAV
>AIA14008.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MSDKRSAALGFIFLTVLIDCIGIGIIIPVIPDLIRQLTGKGLSEASEIGGWLLVAYASMQ
FVFSPILGGLSDKYGRRPILLISLLGLGIDYLFLTFAPDMFWLFIGRFIAGICGASFTTA
SAYIADISTHEKRSQNFGLIGAAFGLGFIIGPIIAGLTGDLGVRASLCDRCWFIVS
>AIA13969.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLKERGVNIWNEWADESGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLNPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYDPHPHIKAEVAV
>AIA13883.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGKPLPGRQMIIVTHSES
FAPEGCFSVHSISDAISFARERGESELFVCGGAEIYAQMFGVADRMYLTLVHADSEADTF
FPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA13884.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLWFLRGDTSIKYLQEHGVNIWNKWADEHGDLGPVYGAQWRAWRADNGRTIDQISQVIEQ
IKSDPDSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNI
ASYALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKS
IFEFDYSDFELSDYEPHPHIRAEVAV
>AIA13879.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELMQHVLEHGTPKDDRTGTGTLSVFRYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGETNIKYLKERGVNIWNEWADERGDLGPVYGAQWRAWRAGDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELQRCGLRPVICSFNSMSQTDISLASFIKGRLIFFWACRSTSHP
TRC
>AIA13862.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKLPHISMSCAMTECGVIGNKGKMPWRRLGRDLRRFRELTENTAVVMGPKTYASLPEKYR
PLPRRLNIILTTNQNYKAPEGVLIAHDPRQVLELAAIEGYVELFVIGGAMIYTSFLPIAE
HLFITYVKSRAKGDTHFPHWEKSRWREVWVESAYRKDKGDSYPTRFAEYRRMQKPLPQCN
QVSWRHPDDARFEAALAKKKRNRKKQKRPRAK
>AIA13782.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKNIIVAYGQNREIGKDGDLLWQRDLPADLQHFKQLTTGNAIIMGRVTFTDDLKKRILPN
RQTIVVTRQPDEFDGATVTHSMQEAYNSVEAGRETFVIGGAQIYEQALNDADRVYATEVD
VLLSADKYFPELDESVWREVSREHHEADEKDKYAYDFVIFDRVRD
>AIA13772.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHIKSIIYELL
WFLRGDTNIRYLKEKGVNIWNEWADERGDLGPVYGAQWRGWRAADGRVIDQISQVVEQIK
SNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMMAQVCGLKPGDFVHTLGDAHLYSNHLEQARLQLAREPRPLPQMKINPSVKSIF
EFDYSDFELSGYDPHPHIKAEVAV
>AIA13715.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MQSQTTTPEVIEHEKHLVQQQLGLDTTDAIIFIDAGWDSRVYMINDGYSFFKFPRSDKIR
QRYQYEIAALKLAATVNPAVQVPEVSWGHPSNEYFGYHGVPGTVLAEMIPTLTGNTKQTI
GSIIGTFLKQLHELSLPGARMIPVDREIKQFQEWYQPAVPVIQQMFSESEQRQLRTLVED
TWPAQLLSLGSDTVLCHGDLGFRNCLYQDETTIGIIDFGDVGYYDRSKDFINLTDPEIFE
AALQAYGDSPELRQKIAIRQTVLQIIKLTASIGKQDEQGVHQAITQLGEVLRQNKTT
>AIA13708.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLDLPADLKRFKELTTGNAVIMGRKTFDSIGRPLPHRQNIVITRQALEIEGAIVVDSLEK
AYQAVDSDKEAFVIGGGEIYKLALDTVNRIYATEVQETFTADVFFPVLEKSTWRETFREH
HPADEKNKYSFDFVTYERV
>AIA13617.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTFVIAALTADGFIGRDAGHLADWTGQADKKVFTELTKEAGVMVMGSRTFETIGRALPG
RRTIVYTKRPEAIAVAGIETTSEDPAQLVARLRADGANGIAICGGASIYSLFMTAGLVDE
LYITVVGKLFGSGVPLFGERLDVDLDLLEMEHLDEQTVLLHYRVKK
>AIA13587.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKNVVLLQGGLGAERDVSLVTGKGFEEALKELGYPYQVIDCKEDFLERITAAKKDFKA
DVALLALHGKYAEDGIVQSICEYIKLPYSGSGVMGSALCMDKIFFKEVMANHDVPTPDAQ
IVEKAQIKGLKLTLDFPVVVKPSREGSSVGVSIVKDASTFNKALEYAAQYDNYILIEKYI
PGMELTIAILDGKVLTPIEIQPKVDFYDYKNKYTAGRTEYHLPARLEPKALSRAKDIALK
AFHLCRLRTYGRVDFRVDPQGNPFVMEINTLPGCTPTSLLPKAAKDCGISFPQLIETLVE
KAGLDYAGVK
>AIA13552.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSALPKRIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFEVPQNIDVAF
LTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRTAFDKIESKKKFEAAGVTTPRWQIIGS
NERPTLPLPFVVKAPRQGSTVGIYIIRSADQLETGLAEARKFDRRLLVEEFVPGRELTVG
ILGDQALPIIEIIPKSGFYDFTNKYPFLNPQAGGGAEHVCPAKIEEKLTRQIQDLALRAY
RSIGLRVYSRVDVLLPENAAPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLQIIELS
RVRRGSGK
>AIA13389.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPRLVIIAAVSRNGVIGRDGDMPWRLSTDLKRFKALTLGKPVIVGRRTFDSFGGRPLP
GRPHVVVTRNPDFHYDGVDIAASLAEAIEIAGAKAQETGSDEIFVLGGGEIYAQAIGIAD
MLRITHVETEISDGDTVFPAIDPDVFYKAEEIAVPAGEKDSYPTRFATYVRRTATN
>AIA13383.1|FEATURES|farme|multidrug|farB|antibiotic efflux|1
YRLDTSIANVSIPAIAGDLGVSQSQGTWVITSFAVANAISVPLTGWMARRIGTVKLFVGS
VLMFTIASWLCGLSPSIEMLIFFRVIQGLVAGPMIPLSQTLLMGSYPKAKVGLALALWSM
TTLVAPVMGPLLGGWITDNMSWPWIFYINVPVGIFSAGLTWSIYRKRDSGAHRIPLDYVG
LTLLVVWVGAMQIMLDKGKELDWFNSGFIVSLAVIAVVGFLFFLAWELTERNPIVDLKLF
ASRNFTFGVIALSVAYGLFFGNLVLLPLWLQQIVGYPATQAGIALAPVGILAIFLSPWVG
KNAGKIDPRIFASVSFLTFAVVLWLRSRFNVQADFVTIVIPTIIQGAALAFLFFFIPLLS
IVMSNLHPSRIPAAAGLSNFVRITAGAVGTSLFQTAYEDRAAMHHAHLVDSINNGSSTAT
QALQQLGNTGYDQQQALSVVNRLIDQQAFTLSVTDLFWLSAVLFLLLIPIVWLTKRFKPA
GGVDAGGAH
>AIA13366.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQAYLNLLKTVLENGVDRSDRTGTGTKSLFGHQLRFDLGQGFPMLTTKKVHLKSIVHELL
WFLQGDTNVKYLQENGVSIWNEWADEAGNLGRVYGAQWRSWQTPDGKSIDQIQEVLANIR
RDPYSRRHLVVAYNPGEISQMALPPCHAFFQFYVAEGKLSCQLYQRSADIFLGVPFNVAS
YALLTMMMAQVLDLRPGDFVHTFGDLHLYNNHIEQAKLQLSRETRPLPQMKINPAVRDLF
EFKFEDFTLEGYDPHPAIKAPVAV
>AIA13360.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
HSGEGIRAEDAVVLSDAIDLSSSPEVLRAKELGLPLFRRSQVLGWLLRGKKVIAVTGTHG
KTTTTGMVGAALRSAGLDPTIVVGAGVPEFGGAVVDGHGDWAVVEACEAYDSFHDLDPHL
VLLTNLELDHVDFHGSYENLLASVCRFVDRLPAGGQLVYCEEDAGARDVALRFEGSKLGY
GLRDGLDMALPGRHNALNASGALVAATLVGAPTDAALAGVTEFRGAERRLQVLREGPITV
VDDYAHHPAEVVASLSALRERYEGRRLVVVYQPHLYSRTAGLIDEFAEALSLADKVVLTD
IYPAREAPIPGISSSRIAEGVSVPVEYVPSRHLLPRLVARHALPGDVIVGMGAGSIGDFA
PALVKELDRPSGRKVAVVYGGDSAEREVSLLSGRCIHDALVAKGYDARLYDVTELLLSRG
EVGDFVGNNRPDVAFLAVHGTNAEDGAIQGLFELLHIPYTGSGIQASALAMDKRLTKQIL
SVEGLPVPRGVMLTSRSESVPDWLKAPLIVKPNAQGSTVGLSFVERDEELGSAIERAFQY
DSAVLVEDWVDGVEISVPVLGDRALLPVEIAPVGGRYDFAAKYTPGATEEIVPARLSELQ
TRLAQEYALRAHMALGCAGATRTDMIVCKDEIVVLEVNTLPGMTGTSLLPNSALGMGISF
EELADWIVQDALIRYAAKT
>AIA13345.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MIRLQAIAAMSLNRVIGAGNQIPWHLPEDFKWFKEMTTGHVIVMGRRTFESIGKPLPNRE
TFVLSRSQFSYPGVKTIARLDELPALTGKREVFICGGAQVYAEALPLCSDLYLTLVKRTF
EGDTFFPPFEDQFELAEEIRDTPEFKILHYRSRQSKV
>AIA13337.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFVAAMTKNRVIGVNNALPWNKLKTDMRRFQKITTGHPVIYGSSTFLASPQNGRALP
NRTNIVLTRDTDKAYEGCIMAHSLAEAIRTAEKHEGNDEIFIIGGSHIFEQALPLANRIY
LTEVDTELQGDAYFPELDQIRWKAEDEGAFDADEDNQYAGKFVRYTRTGEYPIVEPYNAR
TEEFKKYLNEIIDEGKCPFCPGGATHRNQEMIYQNDHWWVINTLQPLANTLHHFMIVPFR
HIVTMDELTAAEWEGFSKMLTWANGQFKANGLAYYWRQGEPMVTGASVSHLHVQAIAPAG
LVQVNFGPYPKEK
>AIA13315.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAVSLARKRGESELFICGGAEIYAQTFGVADRMYLTVVH
ADSEADTFFPEWDRDEWVELESEHRTADEKNQYPFTFKVLEKKSKI
>AIA13273.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGRGHKVIALDPARGVLSAKEEQELSTGKVGT
KPPSLEDLTKVAEGAFLPNLTSMKEVTEADVAFLALHGGQGEDGTIQALLDMAKVKYTGS
GHLSSALAMDKDLSKKLFRSDDVKTADWLMAPASTEQIEGILGLPVIVKPSKQGSTVGLT
LVKKRQDLVPAIEEAFKYDDEVMIERFVPGRELTVGVLGDVALPVGEIISKHEIYDYECK
YTAGMAREEFPAKLTPEATERVQNQALAAFRSLKLKGYARIDFRLTTEGEFYCLEANTLP
GMTELSLIPQGAAAMGIDFPELCERIVKLALE
>AIA13267.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LDLLRHVMETGTDRGDRTGKGTRSVFGYQMRFDLGEGFPLLTTKKLHTRSIIGELLWFIQ
GSTNVKWLWLHEQGITIWDEWADPDGELGPIYGYQWRSWPTAAGGHIDQLAGVINTIKTV
PDSRRHIVSAWNVGDLADMALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPSNIASYA
LLTALVAQVCDLEVGDFVHTLG
>AIA13252.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|1
MALFLNRDLGVDKHLELWSGVAFGISFLAAALISPFWGSLADKYGRKPMMLRSGFSLAFI
YALTYFVTNPYELIGLRVLQGLLAGFVPASIALVATNTPEKQVGYALSIISTAGAAGSIV
GPLVGGFTSRYFGYRESYLCSALVVLIAALVALIGARETNFNRQAKRSGVREDLKVARKN
RKFTRLVTLTMIIATSVMVLEPLLTIYVLKLGASHDTASLSAGFIFSAVGISTVLAAPFW
GKIGGKIGYQNTLLIGLLGGGIGNVLQFFVHNLVAFGVLRFVYGLFFAAVYPSINALIVK
TTPSDFRGRAFSLNQSANQIGTMAGPMAGGALGGWISIPAVFIMNGIALITTALTFVPRR
KQSGTAEEGHEGPSASG
>AIA13254.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MKPGAKARLKNHVSFGQSIRNSLTMAYRGILKIRRTPEQLFDVTLQPIIFTLMFTYIFGG
AISGDVVSYLPVIIPGILVQTVVTTSIVTGVQLREDMDKGVFDRFKSLPIARIAPLAGAL
LADTIRYTIATVLTFSMGFIMGYRPEGGLGNVVLAALLVIFCSWAISWIFAFFGVIARTA
SSVQGISMLVLFPLTFLSNAFVPVETMPNWLQFFVKINPISHLVSAVRQLANSGTVGWDL
SISLIGSAVIVAIFAPITVRAYMRRT
>AIA13211.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYHELLKSILEKGTEHQDRTGVGTISHFGHQTRFDLREGFPIVTTKRIPFRWVAEELF
WFLSGDTNEANLRSRGVDIWAEWADEEHTKRFGREAGDLGPIYGYLWRSFGGHYPKLDGV
DQIARLMRPNSRRLIVTGWDPSQCDNVDLPPCHTLFQFKVENQKVLHCQLYQRSADAFLG
VPFNISSYALLTHMIAHASGLEAGEFIYTLGDYHIYKNHLSQVEELLSRTPLKLPHLEIH
SETGGPSGLEGLLKMRFEDLKLVGYESHGKIAAPVAV
>AIA13197.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGARKDDRTGTGTLSIFGHQMRFDLSEGFPLLTTKKLHVKSIIYELL
WFLRGDTNIRYLKEKGVNIWNEWADERGDLGPVYGAQWREWRTADGRAIDQISHAVEQIK
SNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMVAQVCGLQPGDFVHTLGDA
>AIA13196.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
ENGATRFEYVYGESLRVPVTLRFSGKHNVLNAAAALTTAVILGANDTETLGKMAQGLSEF
GGAERRQELLSDTDGVRIIDDYAHHPTEIRATMDAVRTAYPNRRLIAVFQPHLYSRTRDF
LTEFAAELSRADILIVTDIYAARELPIAGVSAEQIVALAQSNNPELNAVYLQKREEIPAR
LNTMLESGDIVVIMGAGDIREQGEQLAMMRKETKRFHVAVLMGGKSSERPVSLSTGRMIL
DALDKNRYTVTAIDTSELITPEGLSYLLAERPDVAFIALHGKGGEDGSLQGMLDLLDIPY
TGSGVLSSALAMDKVMSKRMFRCAGLPVVDDVIVPQGMELSGLPQFLNQRLGGYPVFVKP
NAEGSTFGCTLVTSESELEAAVQTALKYDSLAIIERYIEGMEITAGILGNAGEELIRLPL
IEIVPKSQFYDYESKYADGGSEHIIPARLSEELTLRAQEFAQQCHLLLGCRGMSRTDFMV
KNGELFILETNTIPGMTPTSLLPQAAAEAGITFPQLLDRLIHSALN
>AIA13184.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSNEDLEKTFGKVGVLFGGRSAEREVSLMSGSGVLKALQSKGVDAHAFDPAERSIAELAA
QKFDRVFIALHGRYGEDGTLQGTLEQLGIPYTGSGVMASAIGMDKVMTKRIWINHGLPTP
RFIVLDAKGATKEELRTVPDELGLPLMLKAPHEGSTIGISKVVGYSDMQTGFALCAKYDD
VVLAEEFITGRELTVPVLGEGRNARALPIVEIRAPQGNYDYQNKYFSDDTQYLCPAPLDE
ELTKRIQSIAVRAFNAIGCSGWGRVDFMLRASDNEPFLLEVNTSPGMTGHSLVPMAAKAA
GVSYEDLCVEILRGADLEMKPSQDWKPA
>AIA13158.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIRYLKEHGVNIWNEWADERGDLGPVYGAQWRAWRAGDGQTIDQISQVIGQIK
SDPDSRRLIVNAWNAGELSKMRLAPCHLLFQFYVAEGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMTAQVCDLKPAEFVHTLGDAHLYSNHLEQARLATHARAARASADEDQSSGQIHI
>AIA13078.1|FEATURES|farme|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
MGRSAKLSNLARAIYVVWTLLSFALYVYLDSKGWLGGGKQGRETRLRRQAARLRGRLIAL
GPTFIKMGQMLATRADLLPLEYIDELSALQDRVPAFPDEQAFRIIESELNRPLEDVFAQV
GERPIASASLGQVYHARLVTGEDVAVKVQRPRLDEHIRFDLELLRRVGRFLDRYPKLFPG
AEWLGAVEEFDRVIHEELDYRREAANAEEFRRNFASWPAIHVPRMFGGYSTGRVLVMEFI
SGTKVTDLDGLRAAGHDARRINELIYRAYFKQLLEDGFFHADPHPGNLLVMADGRLAVFD
FGMVGRISEELQRRMIEAFFHLYNRDVDAIVNDLVGLGFLEPEADVAAFRVIVADVFKRK
LNLKLGEVRFRDLTYDLAPIVYEHPITTPARFTYLIRALMTLEGISIVMNPDFNF
>AIA13015.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIKPKISLIVALAENKVIGNKGQLPWHIPEDMKRFRELTTGNVVIMGRKTYDSLPDKYRP
LPNRVNIVITRNKNFPDKGIIICDSVNEALTEAKNYNKEIFIIGGAQIFEQSIRYADKLY
LTVIKGKFEGDVFFPDYSEFKRVVA
>AIA12839.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKIRVGVVFGGRSGEHEVSIRSAKTVIEQINKDKYEVIPIAITKAGNWLNPMESLSLMP
SSIQNLLMAEIGKYPRNAIALIGDTQYRGLTKLETTVGEDRTTPFDVVFPVLHGTYGEDG
TIQGLFEMAGIPYVGCGVLASACGMDKVVMKVLFRDAGLPMCKYVWFLRSEWEKASETVI
EQVKTKLGFPCFVKPANLGSSVGVTMANDEISLRQGIELAAEFDRKIIVEEGLNMREIEC
AVLGNEEPRASLPGEYIIKDEAKAFLDYTEKYAGTGNNEFVVPALVSEELSKKIQQMAIQ
AFKAVDGSGLARVDFFLRNDTGALLINEINTLPGLTDASGYPKMWAGSELHFSQVIDTLI
TLAMERFDDKARNKTSFS
>AIA12826.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEAANTENNLAAQIDRPHVILSSRRRWAVTAGVLLGMFLAALEATVVGAAMPTIIASLGG
MDRYSWVVSAYLLTATVTVPIWGKLSDIYGRRPLYLAGIATFLLGSALSGASQTMTQLIT
FRAVQGLGAGALVPLSLTINGDIFTPQERTRIQGLFSGMWGLASIIGPLAGGFITDNFSW
HWVFYINIPFGLAAAIIVGLALVEPKRAEPPVVDYAGAAWLTFSITALLIGLIESAHPEM
WTSPLMIISGISFILFGILFIRAEKRAIEPIVPLSLFRNRMVAVGSITSFLTGTAMFGSI
TFVPLLVQGVWGGTATEAGSALTPFLLGWVGMAIVGGKLMLKVGYRSTVLTGLAIMAVSF
VILSSFDIHTPRWLLLANLGLMGSGMGMVMLALLITIQSSVERQVLGVATSLQQFSRSIG
GAVGVAIMGAVLTISLMSHRQDIQRETHLPEAEVEKIVHNISDLMRPETRAKMPPEALGP
LAEGLSDALQNAFIVGAFFAGLGLLSGFWLPSFRATASSKAVKEAAEMASSSKECERMLM
AEMTTIDAENEPAAIEPKADANRRG
>AIA12811.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MGFAEFVAMVAALMALNALAIDIMLPALQEIGAAFHVLEPNRRQAILSSYLVAFGIGQLL
VGSVSDRFGRRPVLLGGLALYVLASALCAAAASFEALLIARFMLGLASAAPRVITTAIVR
DSYSGRRMASVMSLAMTAFIAVPVLAPSIGQLVLLFAPWRAIFGLLTAYGVFMAVWISLR
LPETLPVERRQSVAPKRLLGALYRVITTRQTLGYALAGGMMFGANFGFLVSAQQVFTEIF
GLGVYFPLAFAAVALTMSMSSFINSRLVGRLGMRVISHGAVACFTGLAAVMAIMARLDAL
SFLPFMILLAGLMFLLGMVFSNFNSLAMEPQGEIAGTASSLFGSITTVMAAVLGYLVGQA
YDGTLVPLTTAYLALGATTVVIIAVTERGRFLR
>AIA12807.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSVQLEFEHKSRIMQSVTDSLLMIKRSSTHIVRHTDQLLGTFFQPVMFLVLFSAVFGGAI
SKALPEGVSYLNFLMAGIIIQTLAFGSTTTAVAVCNDLQKGIIDRFKSLPMSNVAVLNGH
VISDLARNGISTAVMLAVGFVMGFRTHADLQGWLMIIGLLVLFTLTFSWLAVIVGVKAKS
IEAVQWLSFIIVFPLTFASSAFVPTEGMNKFLKAFAENQPITHIIEAVRALMLGTPTGNH
VWLSVAWCIALLLVSIPLSIYFYRKKAS
>AIA12575.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVIIGPVAIAKNGIIGGDNDLPWYIPEDLKHFKKITLGKTVLMGRKTYESIVARLHKPLP
GRKSVVITRDVNFAQRNDVPPEVLVFHDLNSALDALNNEDIYVIGGAQIFTAAMPRAEKM
FITHIHEAYDGDVYFPEVDYNQWNKIEEEPHEDFTYAVYAKK
>AIA12510.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRNESISFEGCFIAHSVSDAISLARERGESELFVCGGAEIYAQMLGAADRMYLTLVH
ADCDADTFFPEWDRDEWIEVESEHHAADEKNQYSFTFKVLARKSRA
>AIA12480.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RLIINAWNVGELSKMRLAPCHLLFQFYVVDGHLSCQLYQRSADIFLGVPFNIASYALLTM
MIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLAREPRALPQMKINPSVKSIFEFDYSD
FELSGYEPHPHIKAEVAV
>AIA12361.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAATSENNVIGKDGKIPWHLPAEWKYMRAVTMGKPAIMGRKTYNSIQAIGRAPLP
GRRNIVITRNKDLQFEGADIVSTIEEAIELAKKDPADEAFIFGGEEIYKLSLPYADRIYL
TRVHTTIEGGEAFFPEIDWSEWNEVSKKEHPADSENAIPFTMLIFERK
>AIA12358.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTTVHMIWAEARDGVIGAEGGIPWRIPGEQATFKQRTIGSTVVMGRGTWESLPERVRPLP
GRRNVVITRAALDGVETARGVDEVLRKYDDFWVIGGGAVYAAFLPYATHLVRTEVDLKIE
GDTFAPALNDWPGIPGEWQITDTGVRWRVVEHLRAEAPRIG
>AIA12328.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HFKSVVHELLWFLRGSTNIGYLQERGVSIWDEWASPSGDLGPVYGVQWRSWPTPSGEHID
QISAALQLLRSDPDSRRNIVSAWNVGEIPQMALPPCHAFFQFYVAGGRLSCQLYQRSADL
FLGVPFNIASYALLTHMMAAQAGLEVGEFVWTGGDCHIYDNHVGQVTEQLSREPRPYPEL
VLAPRDSIFDYTYEDIVIKNYDPHPAIKAPVAV
>AIA12306.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNSIDQETPMKQYLDLMRHVLEHGTPKDDRTGTGTLSVFGYQMRFDLQEGFPLLTTKKLH
TRSIIGELLWFIQGSTNVKWLHEQGVTIWDEWADADGELGPIYGYQWRSWPTPAGAHVDQ
LAGVINSIKAAPDSRRHIVSAWNVADLADMALPPCHTLFQFYVAQGRLSCQLYQRSADIF
LGVPFNIASYALLTHLVAQVCDLEVGDFVHTLGDAHLYLNHLDQARLQLGREPRALPKLL
LNTGVSSIDDFTFDDVAIEGYDPHPGIRAPIAV
>AIA12226.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIINMVVAAADNNVIGKDNRLLWHLPNDMAFFKNTTWGMPVIMGRKTFESLGKPLKGRTN
IVITTNKNFSPGGAVIIANSFDEAVREAGSVGARECYIIGGGEIYKQAMHKANRIYMTRV
HTSPHGDTFFPSINDNDWLKTSSDTFNADEKHAYSYTFEIWQRK
>AIA12153.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPTIGESFAADIGAVQLSLTLFFVSFGAFQL
IFGPISDMYGRKLPLYLGLVLFAIGGIGCAFAPDIATLAPLTGSLVITLAGWRAVFWVVT
AAAVVGLVMIATLLPETRPRNLRAGSGIASALAGYRLLLGDANFLALSFIGGFGIASFFV
YLANSPFVLIEHFGLTPSVYSVFFSINAVAFIGMSQLTGMLSERFGLKRVVWVAVTGYAT
TMVALFAVMATGVDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLH
FATGAVAIAVIGLFADGTVLPMVAGIGTCALITFILAQVTLRQRQAIEVPAE
>AIA12152.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
LRGSNQNSKKATIMSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMS
LLIFFLSMGFGQIVVGPISDMVGRKLPLYGGLALFMVGGIGSAMAPTIEWLIAFRFLQGL
GASAGMAVPRAIVRDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTV
TGAALLATILLATSLKETRPAEERVGSSFGTALAGYRFLMGDRNFLGLVAIAGFGIASFF
VYLSSSSFILIDHYGLSPSVYSVFFSINAVAFIGMSQLTGMLSERFGLKRVVWVAVTGYA
TTMVALFAVMATGVDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTL
HFAIGALAMGVAGIFFDGTPLPMVAGITLCAVISFTLAKLTLGRTREAVEAPAE
>AIA12149.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSAMAPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLATILLAT
SLKETRPAEERVGSSFGTALAGYRFLMGDRNFLGLVAIAGFGIASFFVYLSSSSFILIDH
YGLSPSVYSVFFSINAVAFIGMSQLTGMLSERFGLKRVVWVAVTGYATTMVALFAVMATG
VDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFATGAVAIAVIG
LFADGTVLPMVAGIGTCALITFILAQVTLRQRQAIEVPAE
>AIA12147.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTVQRSKRQNFLLVLMLGVLYTLTPISIDMYLPAFPLIAADFHTQISNVALSVSTYFLGF
SIGQIVYGPLLDRFGRKKPMYFGLTLYILATIGCAASGSIGALLILRFIQAIGGCVAAVA
AMAMVRDFFPADQSAKIISLLILILGVSPLLAPTIGGFIVTMLNWRWVFILLAIIVFIVL
LVVVFLLPEGHQPDTTISLKPRPIINGFKEILTRRQFIIFALAGTFSFAGLFVYVAGSPA
IFMDTFHVSPKVYGGIFALLSIGFISCSQLNHLFTRSYSSERILKTTVMIQSIVGLIYFT
GALNGWYGIVENLVFLFILLACCGLTFPNAAAVALAPFSKNAGSASALLGFIQIGVGGLI
SSGVGMMKIPGSLPTAMIMAFSSLTAWIILLAGRVHITDEMREEIKLAGKSEMI
>AIA12093.1|FEATURES|farme|fusidic_acid|fusB|antibiotic efflux|0
MIGKRYLHAKRSLYVLWTLVSFALYVYLDSKGWFGKSQEKREMRLRRQAARLRARLIRLG
PTFIKMGQMLATRADLLPLDYIKELSALQDQVPPFSDKQAIEIIETELGRSVKDIFAGIS
EQPIASASLGQVYRATLASGEVVAVKVQRPGLSEKIRFDLDLLRWIGHLLDRYPKLFPGA
EWMGAIDEFDRVIHEE
>AIA12052.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|1
MLLEIKNLHAGIDGKEILKGLNLQINKGEVHAIMGPNGSGKSTLAKVLAGHPSYEVLQGE
VLYEGKNLLELEPDERAKEGIFLAFQYPVEVPGVSNSQFLRLAYNEKMKHLGQEELDPLE
FNDYLKEKAKIVEMSSDFFKRSVNEGFSGGEKKRNEILQMAVLDPKLAVLDETDSGLDID
ALRIVAGGVNTLRDANKAIILVTHYQRLLNYIEPDFVHVLANGKIVKQGGKELALELEEK
GYDWVKSANAK
>AIA12008.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRSSDGRTIDQISQLIEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMID
>AIA11996.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LTMGAPMIMGRKTFESLPSLLPGRRHIVLTRSPEWRAEGADVAQDVPEALALAGEPRVSI
IGGADIFRLFLPVANRIELTEVHDSPEGDTFLPPFNPADWRETGRETHAAADGRPAFSFV
TLVRAGG
>AIA11892.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTRKDDRTGTGTLSTFGYQMRFDLGEGFPLLTTKKLHIKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIK
SNPDSRRLIVSAWNAGELDRMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTLMMAQVTGYEPGEFIHTFGDAHIYGNHVEQVKEQLKREPRPFPTLAISDELQDLD
SAKAEHFSLENYDPHDTIKAELTVAGGFQEKDRRDFAKPSKS
>AIA11888.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DQIESNPNSRRLIVTGWDPHQADNVDLPPCHTLFQFKVEQSGLLHLQLYQRSADAFLGVP
FNISSYALLLHMVAHVTGLKAGEFVYTLGDYHIYKNHLQQVRELLRREPLHLPRLEIVDE
GKRFRGLAGLLAITYDNLKLVGYQSHGKIAAPVAV
>AIA11839.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLGHVLEHGADKSDRTGTGTRSVFGWQMRFDLSEGFPLVTTKKLHLRSIVHELL
WFLQGDTNIAYLKDNKVSIWDEWADADGELGPVYGKQWRRWAGADGIEIDQIRWVVDEIK
RNPDSRRLIVSAWNVADLPRMALMPCHTMFQFYVANGKLSCQLYQRSGDIFLGVPFNIAS
YALLTHMVAQVCGLGVGDFVHTLGDAHLYSNHFEQAREQLSRTPRALPQLRLNPDVKDIF
GFTFDDIAIEHYDPLPAIKAPVAV
>AIA11791.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIEYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPGDFVHTLGDAHLYSNHLEQARLQLAREPRPLPQMSINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA11788.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MADTTPVLVDKQLQIKSGWQWALSDSWIMTKRSVLHIIRSLDQVMSLVLFPIMFMLLNRY
VLGGAINTGEVSYVNYLFAGIFVQTLAFGANYTTINLAVDLKEGIVDRFKSLPMASGSLL
VGHITADLVRNVISGMVIIAVGFLVGFRPSATMEDWLVVVGLAVLFTLSISWLSAILGLM
VKSLEAAQWIGFVVIFPLTFISSAFVPTDTMPSALQVFAENQPLTQTIDAMRSLLVGTPM
DNAALYSVIWSVGIIAVSAPLAVWMFKNRITQNK
>AIA11772.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIEYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA11673.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLSLLRHVLDHGVDHPDRTGVGRKSVFGYQMRFNLQEGFPLMTTKKLHTRSIFHELL
WFLSGDTNVRALQQNKVTIWDEWATAEQTAKFGRPEGELGPVYGHQWRNFGATLKQDGTY
EKDGIDQITRLINGLKKNPHGTRHIVTGWNPKEADQVELPPCHTLFQFYVAPGVPGARPA
LSCQLYQRSADIFLGVPFNIASYALLTHMIAQVCDMDVGDFV
>AIA11650.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLLVAMDENRGIGKGNHLPWRLSADLKRFRELTLGHHILVGRKTFQSIGKPLPGRQT
IVVTRDKGFEPEGCLTAHSVEDGIRLARQRGESELFICGGAEIYAQSLRVADRMYLTLVH
TVTDADTFFPEWETDEWVEEEISRKEADAKNEFSFTFKMLTKKDAGC
>AIA11472.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RPDRTGVGTYSVFGRQVRFDLRDGFPLVTTKKVHMRSIIHELLWFLRGETNVRSLHENKV
TIWDEWADADGELGPVYGKQWRSWEGPGGRKVDQIQRALDTLRANPTSRRIVVVSFNPAD
LPEVAPPACHTLFQFYVSGQDLSLQLYQRSADLMLGVPFNIASYALFLMMVAQVTGFRPK
EFVHTFGDVHIYANHIEGAKRQLEREPRALPTMRLNPDVNDLFAFRFEDFTLEGYAPWEH
IKFDIAV
>AIA11154.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPRDID
LAFLAIHGTFGEDGQLQQILENRGVPYTGDGVKESWTAFDKIESKKKFEAAGVTTPRWQV
IGANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLETALAEARKFDRQLLVEEFVPGREL
TIGILGDQALPVIEMIPKSGFYDFTNKYPFLNPQAGGGAEHVCPAKIEAKLTRKIQDLAL
RAYHSIGLQVYSRVDVLLPENAEPSVLEVNTIPGMTEASLLPEAAAAAGIKYDELCLRII
ELSRVRREGAK
>AIA11143.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTKLKVGLLFGGCSGEHEVSISSARSIAQALTAEANAQKYELVPFYIQKDGQWQAPDVAQ
QVLASGKAIPVSDEKINLWQFPAEAATIEVWFPILHGPNGEDGTVQGLLKLMRVPFVGSE
VLGSAAGMDKIAMKMVFAQAGLPQVKYVAVNRSEVWSNACVFPKLCDRIEDELGYPCFVK
PANLGSSVGISKVRTRAELEAALDSAASYDRRIIVEAGVVAREVECAVLGNDQPKASVVG
EITFQSDFYDYETKYTAGEADLFIPAKLPPEVASEIQERAIEAFTALDCAGLARVDFFYV
ESTGEILINEINTLPGFTATSMYPQLWEASGVPYPELVDRLIQLAIERHTK
>AIA11127.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIIGIAAVDRKGAIGKGGKLPWHYSADMKFFRETTSGHAVVMGRKTWLTIGKPLKNRLNI
VLSRDTDIGPQDSLIVFSDMESVLSFNKSLSTDLFVIGGAQIYEAFREHIEKWIITEVPL
TVQGADAFMPKGYLEGFEVVESKSLDDDLVVKFWERG
>AIA11078.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTKSIIYELL
WFLRGDTNVKYLQEHGVNIWNEWADERGDLGPVYGAQWRDWRAADGRTIDQISQLVEQIK
SAPDSRRLIVNAWNVGELSKMRLAPCHLPLSILCRRRSALLPALSKVG
>AIA11014.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MATDQSLPKKTAVLMGGPGSERDVSLATGRGVSKALRSLGAEVIDVDVRGENFELPKDVD
LAFITIHGTFGEDGQLQQILEERGVPYTGDGVEPSRAAFDKILSKEKFREHNVVTPEWEV
IEVGQRPTISVPLVVKPARQGSTVGVVIVKNASELDSAMAEAGKYDQKLLIEKFVSGREL
TIGVLGDQALPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPAKIDPNKTKQIQEQAL
RAFRALGLLVYGRVDILLPDSGEPFVLEVNTIPGMTEASLLPEAAAAAGINYVDLCARII
ALSRARAERSRR
>AIA10928.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MTELVFDKRPKVVLAFIDSLLMIKRSSIHIVRNRDQLLGTFFQPIMFLVLFASVFGGAIA
PSLPQGVNYLNFLMAGIIVQTLAFGSTTTAIAVCNDMQKGIIDRFRSLPMSNLAVLNGHT
ISDLFRNGISTVVMLLTGLLIGFRSSASFTDWLLIAFIILLFTLAFSWLSAIVGVYSKSV
EGVQWLTFIIVFPLTFASTAFVPGDSMNPVLKAFAENQPITHVVEAVRSLMLGLPVGNHV
WLAIVWSLGILAVAVPVSAWLFRRKTTS
>AIA10843.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MAQERVKIQLADDVFIEKLEPGVWRHVSYKTLPNLGPVPSNGGIITVGSDILLIDSAWNN
EQTKLILDWSEKELRAAPSIAVITHAHEDRIGGIHELHRRGIRTVSSKLTAELAKQQGLE
VPQQTFEGRRNLSLGGRSIEVYYPGPGHTKDNVVVWIPDKHILFGGCLIKAAQAQNLGNI
KEADLEQWPKTVETLAHEFKEVRLVVPGHGDPSGSEAMTHTLELLEKAVPLKPPVKGSTS
H
>AIA10796.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTFGAKKEDRTGTGTLSTFGYQMRFNLGQGFPLLTTKKLHTKSIVAELV
WFLRGETNVKWLQDQGVSIWNEWADEDGELGPIYGYQWRSWPSPDDQHIDQIAQVIEAIK
TNPNSRRHLVSAWNVSDLEQMALPPCHTMFQFYVAEGRLSCQLYQRSADIFLGVPFNIAS
YALLTHLVAQVCGLEVGDFVHTLGDAHLYLNHVEQAKLQLQRDPRPLPRLTLNPTVGDID
GFTLADIAVEAY
>AIA10712.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MRVGVIFGGRSGEHEVSLRSAESVINAIDKSKYEVVPIGISREGRWIVSGNATAMLPQAV
MSSDHQEQVAIIGDPTRQGLTLLDAGVSEPLDVVVPVLHGTYGEDGTIQGLLEMAGVPYV
GCGVLASATGMDKVVMKQLFQHAGLSVTEYEWFPRSLWEESPGSVIERVGAGIGLPAFVK
PANLGSSVGISKAGDEKELREAINDAARYDRRIIVERAVNGREIEVSILGNEHPMASLPG
EIITGHKFYDYEDKYMDSASRTEVPADLPQATVEQVQRDAIKAFQAIDGAGLARVDFFIE
RDTGRIIINEINTMPGFTSISMYAKLWEASGISYTELIDRLIALALERHRDRSRNLTSYK
PR
>AIA10695.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MPNFFRFPEKSAKNLFWFPIFLLLYSFTGNVSNDIYMPSMPILVHVFNTNDHWVQLTLAV
WFLGAAAPQLLMGPVADRYGRRALLFCGGAVFLLSTLVCAVSAHIGWLIVARFFQGVGVC
SLTIISFVVVHELFSGHHSVRLLALLNVCNSVAPLLGPLLGGYIFLLLGWRANFFIVFFL
ALIGLIGLWRCLPESKIPLDYQALAPKMLFSNYLALLKNRLFMTHLIGYGLSFSGMIAYL
SGAPFVIINLLEIPAQHFGLTQLAVFGAFILTSLLVGKLVQRYGSHKIIWLGAIIIVLSS
VAMVCFSIILPHSLYGFVGSMMGYAAGFGLAGSPLAKEALSANPQAGGFAAAMLGFSMTG
FSSLASILVSAIYNQTIISVAAIILIISLLTLFIIFWIPGKKLRGTCYRK
>AIA10676.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIVAMDRRRGIGIENRLPWRLPADLKRFRELTMGHHLIVGRKTYESIGRPLPGRRM
VIVTRDPNYRAEDCLVAHSVEEALARARAQGEPEAFIGGGAEIYAQSLPYANRIYLTVVE
AEVEADVFLPRWPEEEWIEEENVYHPPDEKNALPSTFKLLVRRGSQTGRLRPSLKT
>AIA10619.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDEPLEQPYLDLMKYVLAHGARKDDRTGTGTLSIFGHQMRFDLERGFPLLTTKKLHLKSI
IYELLWFLRGETNVKYLRDHNVTIWDEWADPEGELGPVYGAQWRSWRGADGRTIDQISEL
IEQIRRHPDSRRLIVSAWNVGEIERMALPPCHAFMQFYVVDKKLSCQLYQRSADIFLGVP
FNIASYALLTMMIAQVCDLAPGHFVHTLGDAHIYLNHLEQAQLQLAREPYSAPQMRINPA
VKSIFEFNYEDFELVGYEAHPHIKAKVAV
>AIA10620.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIVAMDRRRGIGIENRLPWRLPADLKRFRELTMGHHLIVGRKTYESIGKPLPGRQM
VIITRDRNYRVDGCVVAHSVEEALALARAQGESEVFIGGGAEIYAQTLPHADRIYLTVVE
AEVEVDVFLPEWPEEGDEEWIEQESIHHPPDEKNALPFTFKLLVRRKD
>AIA10605.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDEPLEQPYLDLMKYVLAHGARKDDRTGTGTLSIFGHQMRFNLQAGFPILTTKRLPLKAI
VHELLWFLKGDTNIKYLKDHGVSIWDEWADANGDLGPVYGSQWRSWPAPDGRSIDQIANV
VDMIRKNPDSRRLIVSAWNPAEVDKMALPPCHCLFQFYVANGKLSCQLYQRSGDVFLGVP
FNIASYALLTMMVAQVTGLKPGDFVHSLGDAHLYSNHLEQARLQLTRPTRQLPVMKINPD
VKDIFSFRYEDFVLEGYDPHPHIKAEVAV
>AIA10568.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKQQHPEYQYLNLVQEILDSGIKNVDRGTGAVSYSLFGRQTRYDLSQGFPLLTTKKVYW
KGVLHELYWFMSGNANIKYLVDNNVHIWDDYPYKIYLEKSGKGKGERILTKDEFIEKIKN
DDKFAKEWGELRRIYGEMWRRWPTRTERTVDQLKWVLQELKDDPDARNLIVNSWNPEYLY
TMATFEDASRFPICHNMYQVSQKGGKLYLHLYQRSADSFLGVPFNIASYALLTIILAHLS
GYEPGEFIHSFGDVHIYENHIEQMKEQLKRKPKPFPSITIDPSVKSLDDFRPEHVTLENY
DPHPALKGELTVAGGLFIDTKKKQGKK
>AIA10562.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
GVPYVGCGVLASATGMDKVVMKQLFQHAGLSVTEYEWFPRSLWEESPGSVIERVGAGIGL
PAFVKPANLGSSVGISKAGDEKELREAINDAARYDRRIIVERAVNGREIEVSILGNEHPM
ASLPGEIITGHKFYDYEDKYMDSASRTEVPADLPQATVEQVQRDAIKAFQAIDGAGLARV
DFFIERDTGRIIINEINTMPGFTSISMYAKLWEASGISYTELIDRLIALALERHRDKARN
LTTYQPREVKK
>AIA10494.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIRAIAAIDEKRGLARDGDIPWKIPEDVKYYRDKTEHSTIIMGRDTYEGFAKPLVNRRNV
VISRTLQTVREGFELVHDVDAFLVQATEDIWNIGGAGIFESTLGYCDELYLTHVAGDFNC
DRFFPEYDDYKLVTRSPDREQNGHRFYYAVYAKNR
>AIA10490.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVSAIAALSQNRVIGKNNDLPWKLPDDMKFFMETTKGHHVVMGRKNYDSLKGKFKPLPD
RTNIVITRQSELDAPGCIVLHNIPEALLVANKNAEQECFIIGGSDIYKLAMPHTNRLYLT
EIQATIEGDTFFPEFNKKEWHEVSRKHHPADERHAYAFDFVIYEKN
>AIA19293.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKPEIVFVVARAENGVIGRDGALPWRLPEDMKRFKALTMSAPMIMGRKTFESLPKLLPGR
RHIVLTRSDSQAEGAEVAHTVEEALALVNGPRVSVIGGAEIYRLFLPVADRIELTEVHGR
PEGDTVMPPFTGWRESAREDHEGYSFVTLVR
>AIA19286.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLKDIKQNGVIKEDRTGVGTLSVFGRQMRCDLSQGFPLLTTKKVPIKAVIIELL
WFLRGDTNIKFLVDNDVKIWNEWAYQVYLEENGLDKKLERYSDAWKAEMDNFIDQMKNDD
EFAKRWGELGPIYGKQWVRWQAADGTEINQIENVIDLIKNDPTSRRIIVSGWNVGEIQEL
IRNHHHAPPSCHTMFQFMVIDGKLSCQLYQRSADTFLGVPFNIASYALLTMMIAQVTGLE
VGEFVHTFGDLHLYRNHMEQVELQLSRKPKKLPTMNLNPQVKNIFDFKLEDFTLEGYDPD
PAIRAPIAV
>AIA19276.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTEMNSSKKHGEYQYLDLLDEILKNGERKVDRGTDVVLYSLFGRQTRYDLSEGFPLLTTK
KVYWKGVLHELYWFMSGQTNIKYLVDNNVHIWDDYPFKIYNWKRESDKKLPELTKEEFVE
KIHTDAAFAEKWGELPRIYGEMWRHWPTRSGRTIDQLKWILQEMKDDPDAKNLIVNSWNP
EYLYTMATYEDASRFPICHNMYQISNRNGKLSLQLYQRSADIFLGVPFNIASYALLTIIL
AQISGLEPGEFVHTFGDVHVYENHIEQAKEQLSRKPRPFPTVTIDPAVKNLDDFRPEHVM
LENYDPYPVLKGKLTVAGGFYEKKK
>AIA19265.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGAKTWRSIGKALPGRQSI
VLSRSEIEELPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDKGLIVETFDWRT
>AIA19241.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKPEIVFVVARAENGVIGRDGALPWRLPEDMKRFKALTMGAPMIMGRKTFESLPKLLPGR
RHIVLTRSDSQAEGAEVAHTVEEALALVNGPRVSVIGGAEIYRLFLPVADRIELTEVHGR
>AIA19228.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
GVVLLVSFVLIERRVSHPIVPLRLFKSAARSTSYLTMLLVVGTMFGMFFFLTQYLQGVLA
LSPLSAGLAFLPMTGLLFTASRVVPRLVARIDGAKLMLAGSTLVVLGTVWLTRLDAHSTY
LHDVVGPLLLFGGGAGMIFIPLVGRAISGVAPQDSGAASGMLNVVQQVGGALGLGILVTI
FGTASRNSTAVVPREVLVDGVHAAFIGALVYAGLSLTMIVISVRPWNWFRTEPAPVESLT
QMEAAPSTTST
>AIA19222.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
MARERGEVGALFKRAGVRGTFVMYDAAAGRLAGHDRARADTRFIPASTFKIPNSLIGLST
GAVKNVDEVLPYGGKPQLFKQWEQDMGLRDAIRVSNVPVYQELARRIGINRMRDSVAKLG
FGNAEIGAVVDNFWLEGPLKISAIEQTQFLARLARGQLPFPQDVQGKVREIVRLEQGDGW
ALYGKTGWATTDEPAIGWWVGWVQKRERYYSFALNIDMPQATDAAKRIELGKASLKALGV
L
>AIA19187.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLSQYQNLLKTILDNGVRTHTQQETDAITYIAPPPLRYKLSEGFPLITERSIKSFWKQAV
AEIIGFMNGARTQEELEKYGCRWWHPWVTEAKTKKRGLETGDLGPGSYGAAFHDFPTAEG
ESFNQFAAVIQQIKERPHLRTHFISPWIPQYNFRIEGRTQKVVVCPCHGWLHLRILDGKL
TLHMFQRSADVPVGVPANMVQYAALLMMIRPRHGI
>AIA19184.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EAKTKKRGLEVGDLGPGSYGGAFHDFPTAEGESFNQFAAVIQQIKERPHLRTHFISPWIP
QYQFRIDGRTQKVVVCPCHGWIHLRILDGKLTLHMFQRSADVPVGVPANMVQYAALLMMI
AHVTGYEPYEYVHSFSDAHIYVDQIPRVKEIIAREARPFPTVKMVNTHDNIFDFRKDDFE
LFDYHPHPAIKDIPVAI
>AIA19098.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MSDELPSPKRNAALETMSIPEFRSFVLGRFCFVMAIRMTATVIGWMIYQVTKNPLALGIV
GLAEVIPALSLALYAGHVIDKSEKRSLVLKTMSTYVLCELALLCITAPWIMERANTSHFV
EYAVYGIIFCTGILRAFVGPAMSSMISQIVPRERLGNAVTISQGTYLSASVVGHASSGFL
IAHFSYTVVFSVIAGFMLIAIVFMSRLKKKPILYTPKENQRTWGSVKEGLRFVFKSKEVL
GALSLDMFAVLFGGAVALIPIYASDILKVGPVGFGWLNAAADIGSISIILFMTFFPMKRN
QGRILLYSVFGFGICIIVFGLSKLFILSFFALLISGMLDGVSVVVRGTIVQLKTPEELKG
RVLSVSSMFINSSNELGQFESGLAAKVMGTVRATVFGGCMTLLVVMATWFKAPSLRKMEY
>AIA19077.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISAIVAMSTNRVIGRDGGLPWHLPRDMKYFQRTTVGHHVIMGRESFASMDYRPLKGRT
NIVLTRDPFFISSSAIVLHSIEEGINYAYEAGEKEVFILGGGKIFAQSMHLIEKIYLTVV
ISEVVGDIYFPEIDMSEWQVASSEYFEADAKNEFPMRFEILLRK
>AIA19067.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MNKKNVLILIIALLNAIGLTIVIPLFPFLISQYVPAEKVAFYLGILISIYAGCKFFMAPI
MGALSDYFGRKPILFFSLFATAIGYFTLGIGGALWVLFLGRIIVGISAGDISALYAYVAD
STQGRERTKLYGYLGAANGIGYMIGPAIGGLLGIKYLSLPFYIAGVISFITALFIYIFLP
ETLVEEKREKSITINALNPFFHFKDIFSLKEARKVFILGAFFFIGLLFYQSNISVYLKDI
FAWGPTQIGVLFALIGLCDIFSRAILLPKLLIFSEKSIISGGLILMITGFASIVLSGYLG
MSNLLWMSIVLITIGEGLFDPSYNNILSHSVSENQQGQLQGVNQSLHASYEIFVPFAAGV
LYLYNPLVIYIIVILLMIATLLFFFKNLRAFKLTRSG
>AIA19068.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MPKINKILVVGAGISGLAVCYWLRRFGFSPVLIEKFSNLRKEGQALDFRGASIDLLKKMN
IYEKICNMRTRLKLGRYVDAEGNVLHEEKGERFGFRQGEDVEIARGDVAEILMNAIEGIP
CHFNQLIDSIEQNDRDVKVQFKDGRVEHYDLVIGADGIHSTTRDMVFDKNEYKLVKLGMC
FSVFSIPNYLNLSHIEVQCEVNQKLISITSDKNPNIAEVAVMFRMRNDG
>AIA19065.1|FEATURES|farme|beta_lactam|KPC-2|antibiotic inactivation|1
MIRFPSLLIFAALNLSIAHAASEARQKKTIEQRLNEIATQVAPAKLGVAVFDFQTGKQIG
LHADERFPMQSVFKAPLAAAVFSLAEQGKLSLDQKVTLEEKDLSAPIGIPESINEQWPGN
REYTILELIEKAVAISDNTAADLLLSRVSGPEGVDQYLEKHGIHGMHLDRSERELQPQVH
GMGKFQTSWARGDQFKLALQAIPEEIRRKSITNYLSDPRDTTTPQAALTFLKKLESGELL
SKDHTQQLLKMMSSNRYGTHRLKAGIPADAIFAHKTGTARVDLGICPAVNDIGIITLANG
KKYAIASFLSGTTLNDVEREAIHSEVARSVFAICW
>AIA19064.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|0
MHEKQGLQSHKIVAISLWLITLSVNIAMPLFRIYAFEAGMNNVETTLVLATYIMGMLPCY
VFLGGISDRLGRKPIILLSLICAFLSTVIITIFPNVYALIASRLLHGIALGISMGCGTAY
ISELLGNSEQAATKAANIASLSTSLGFGGGALATTTVLIFQFSLLPITYYLLIAITIIGI
SLAVSLPRLPPIGGSLIRLPYFPKGSLPINIAIAICWAANGVVIAIIPAQLAKYGLTIYA
GFCLVLMNWSGAFLQPFIRKMNPLSSVRVGFVLVPLGFGLVVIGCYADQLWLILVGSFIM
GLAAYGFSYMGGLAIITNLGGVQKARAVSGYMFWGYIGFGIPAIFLGYLADRFGVVSSLL
SFEIVMIVLSVYLFAKSKVERNYEL
>AIA19058.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPTPRYKHLVDKLAADIRSGRLAPGTRLPTHRKLAAKEGLALVTATRVYAELGAMGLVSG
ETGRGTFVKEALLPRAHGIDQVSVAADMVDLNFNYPALPGQADLLRTALRQLSQAGDLEA
LLRYQPHGGRKHERASVARHLARRGLCVTEDQVMLVDGTQHGLATTVMAFLQPGDVVAVD
ALTYPGFKLLAQAHRLELVPLPAAGDGPDLDALEALCKRRRVRAIYTMPTLHNPLGWVMK
TGRRRTLASIARTHGLLIIEDGAYAFLAEDAPPPLAALAPELTVYVSGFSKNVATGLRVG
YVAAPLEYVPKIERAIRVTTWNTPSVMTSIACGWLDDGTVDRLEDEKRQDAKARQAIAVA
ALGRLKRISHPASYFVWLPLPGETRADRIAKALLEEQVSVSTAEPFATTAQAPHAIRLAL
GSVGLDTLQAALERVRRVIAHHTY
>AIA19045.1|FEATURES|farme|aminoglycoside|APH(2'')-Ig|antibiotic inactivation|0
RPGKTIPWEAYTMEHIKNLGAAQSDMHGLLKKLPQEDLPFVIDECRTLLKRMEKYFAEDG
VHDALAGKLGLSVPDISAFRPALTAAIDLPAQTLHMDFVRGNILFSENEKATVTGVLDFE
KTAWGPPVFDIARTLAFLLVDCKYKEEAKVRKYFLHSGYNKRGHSSFIPDRLLETLVNFF
>AIA19030.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic target alteration|0
MKQYLDLLQHVLDKGVKKDDRTGTGTLSVFGYQMRFDLNAGFPLLTTKKLHTRSIFHELL
WFLKGETNIKYLKNNGVSIWDEWADKDGNLGPVYGSQWRSLPGSGWENVRSDYECHRDDQ
KKSQFASVDR
>AIA18996.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLIRTVLADGEKREDRTGTGTISLFGTQAKYDLRQGFPLLTTKKVNFGAVVRELL
WFLKGSTNINDDLHEHTNIWDAWADENGELGPIYGYQWRSWPAYDLDEKTGLYKKRHIDQ
IQNAIDLIKTNPDSRRIIVTAWNVADVPKMALPPCHMMFQFYVINGRLDCQLYQRSADLA
VGVPFNISSYSLLMIMMAKECGLTPGIFTHTIGDAHIYQNHLEGLQKQLDRKPGSLPEVE
IPNKSLFDLKFEDFTLKNYDHQGFIKFPVAV
>AIA18967.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIAQNGVIGNNGLIPWHISDDMKRFKALTLGHTVVMGRKTWDSLPRKPLPGR
INVVVTRQTDWQAEGAVVANSLGQATAGTSGTVMVIGGAEIYERALPLASRIERTEIHKD
FDGDARFVLDRTGWHETLREEHVTPDGLRYSYVTLTR
>AIA18940.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MLALLGPNGAGKTTTVKILSTLLGFDEGTVTIEKYDVKTQSDKVRSVIGLTGQSAAVDEL
LTGRENLIMMGRLYHLTKQSALGRAQELLEEFDLVDAAERPVKTYSGGMRRRLDLAVSLI
ATPPIIFLDEPTTGLDPRSRIAMWEIIQGLKKKGSTILLTTQYLEEADQLADCIVVIDGG
KVIAEGTANELKAKVGKDRLELTFEEASSYKKALTIIDGEGEDRDGADFTITMTIDDTNK
DVAKVLNDLTAAKIKIASMAVHKPTLDDVFLSLTGKVKKTQEEK
>AIA18915.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MLARAINGVIGKDNDLPWHIPGDLKRFKQLTMGSAMIMGRKTFDSLPGILPGRRHIVMTR
DADWKVEGVEVVHDVESAIAAAGDEPISVIGGAAIFELFEPIADKIELTEVIAEVDGDVS
MPDLRSSERWREVAYEDHLPTADTPAWRTVTLVRA
>AIA18892.1|FEATURES|farme|beta_lactam|PER-1|antibiotic inactivation|1
MDSVKSVADGRLGKAEVVAAQPNTVRLQERLNNLDLSSAQGNVGIGVLDLDTGERWFRNG
KQRFPMQSVFKLPVGIVVLKLVDEGKLSLNQTVTITREQFAPAWSPILKEIKGDRGQFTV
QYLLQRAVGDSDNTAADALVRLVGGPEQVTAILGRMSLRNIRVDRLEQQLQPDTVGLTNF
RPELVDKQKYEEAVQQIPDAVKKAAMERYLTDPRDTATPEGMIDLLVKLQSRQLLSEDST
ALLLKIMTDSPTGQKRLKAGLPQGWSIAHKTGTGEDVVGIGIATNDVGLISSPTGKHIAV
AVFIAGSKAPLEQRESVMSAVASAVIQAMQ
>AIA18822.1|FEATURES|farme|multidrug|ABC-2_transporter|antibiotic efflux|0
PRGYSNTSFAFFQSKFFARSIDEILVSPTPPWLLIAGYISGGIVRGVLIGFIVLIVSVLF
TGLHLAIHNLFIIFGFAVLTALVFSLAGLVNGVYAKSIDGINIVPTFVLTPMVYLGGVFY
SVQSLPEIARYVTYINPVFYLINGFRYGFLGIADISIWVSLAVLFSMVAVLVGINWYLIR
TGLGLKQ
>AIA18798.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MPSLRPICAVTLFVGRPLDLFGNKVMNAQIVKAAVVLGLLSVIGPLAIDMYLPALPAIGA
DLNAGVAAVQQSLMAYMAAIAVCQLAYGPLSDMFGRKPPIYFGIVLYIVASLGAAWAPSI
EWLVLFRFLQGVGACASMSLPRAIVRDGYTGAEAAQLMSLLMLVFSISPILAPLSGSIVL
QFGDWRVMFYVMAVVGVLSLLLLVFGLKETRPKEARLESSLGGAFRAYWQLLRDWRFIGL
SLIGAFGMASFMAFLGNSSFVYIEHYGLTPTLYSLAFSVNAVSFFAVSQATGYLVGRFGL
PRVVRVAVGGYVTAMLALLALFLLGIDSIWALAVLMFIAFGFLGLVLPSTGVLAMEEQGE
IAGSASALMGTLQMVIASVVMGIVGAFADGTAMPMVIGFAGCALAALVITLVTLRGSAQS
EPVAAPAE
>AIA18793.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MFNMTPRQSSVRFIFATILLDALGIGLIIPILPDVIRRFGAEANFVNHYFGYFISVYALM
QFVASPVLGSLSDRFGRRPILLVSLLGAGLDYVLMALAPNLWILFFGRVIAGLTGASMTV
ASSYMADISDDSNRSSNFGMIGAGWGLGFIAGPMLGGLLGSFGSHYPFYAAAVLNLLNFA
FGYFILPESLPTSQRRKIDIKRLNPLRSLLKVFVPSSTVVLIYVYTLVYLAGHAHPSIWT
LFTQFKFGWSAFQVGLSLSVVGISIAIVQGGLTRVVIPKLGEPKALSVGLWFNVVGFALF
AFATQGWMMYAILAVSSLSGIAGPALQSLISKDIPPSEQGELQGSLISIGSLTAIVGPLI
YTNAFATFTKPDAVYFFPGVPYLLAAVISFAGWALLVIAQRQHKHKNRHERQIVG
>AIA18774.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|0
MNNKVARTAMTPGAPGTHYPFVTRLVMELVAQDLLPNIATVQIEPMFGHVGRLVYRDGRV
RFFRNTSLGINNLGASEISRDKGYTKYFLELLGYSTPRGKVFLFRDFLRILKGKLSRYGV
EELADADAAPEWVQSIIGYPCYVKRNDSSQGRGVERCGSVDELVEALARLRAQGLQKVLI
EESIALPDYRVVVLGEEVISCYRRLPLTVVGNGVSSIERLMAQKQELFCEAGRDTVIDCA
DSRISRKLKRHGLSMETVLGEDVSFELHDISNLSAGGEAEDVLERMHASWRELCVSVTAR
MGLFLCGVDLFCEDISKPDKKYSILELNAAPGLDNYAASGTCQAEVVRSLYRKVLNSG
>AIA18763.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAAVSQNNAIGKGGKLPWHYSADMKFFRETTTSHAVVMGRKTWLTLGKPLKNRLNIVLSR
DSNIEPEESLVVLRDIESVLSFSKSLSTDLFVIGGAQIYKEFLPHIERWVITEVPLTVNG
ADAFMPEGYLEGFKRAETKKLGDELRVVTYERE
>AIA18755.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLAIKVGSPGLFKGEQKRLKEITLGSPLIMGRKTHESVGRTLPGRLNIVISRNPKYTVN
EGSVLVSSLEKALSLDKVKSAKQAFIFGGEKIFAESMPLLKRIYLTRVHTTLEGDSFFRY
NPKEWKIISEEKHKKDLSLGRPYDFDYIVLERKQS
>AIA18733.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGKALPGRTNIVVTRDLQFRADNTLVAHDIDSALRCADEIAQRDGAGEIMVIGGADIYRQ
TLPVAHTLYYTDVKMDADGDAYFRDIDWAQWRCVQQQDFAASDTATPAYSLKIFNRQ
>AIA18723.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVGYANGYVIGKDNDLPWHLRADLQRFTALTTDHTVIMGRKTFESIVARLGHPLPN
RTNIVISSKLDPGEGYEVARSLEQALENIPNEEEAFILGGAQVFSQALPKVVKLYVTEID
ADIDGDTHFPELDLSAWKVESKEKHPADEQNDYPYTFVNLVRKNG
>AIA18690.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKDKLLWCIPEDLKRFRELTRGHPVIMGRKTFESIVGYRGKPLPDRTNIVVTRDAKYHAK
LEEQGFTEVLVAGSVEEAIEIAKKQPGADVICVIGGAQIYEQSLPYLDKLCLTLIDDSAP
ADAFFPEYEKEFTEKTFQENREWNGIKYTWMDLERATA
>AIA18688.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIIGIVAVDQNGAIGKGGKLPWHYPADMKFFKETTIGNACVMGYKTWLTLKKPLVDRLNI
VLSRSRDVEPQESVMVCRDVESVLELLKTLNTDLFVIGGEQVYRSFLPHIDKWLVTEVPL
IVEGADTFMPQNYLEGFDLTESKRLDDELWVSVYQRK
>AIA18636.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
SRNGVIGKDGRVPWDIPEDLKHFRRVTTGHAIIMGRRTWDEVKKPLPNRRNLVVSRKEGL
TLPGAEVASTLEEAIALARTTDPEPRVIGGAEIYRLALPLATKIYLTEVDRDVEGDTFFT
VDRSGFRETERRPGEEPGVTFLTLER
>AIA18562.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MGLRTVMTICAVALVEAMPANRTSIGTALNDTAQEVGTSVGTAVVGTMVAVLVTKVLPSG
TWGADLLETFFRGERITYLVLALIVGVVATWGASTLTNSRAVDEHGTEPRSAEEATEELV
TSADPAR
>AIA18561.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTTTNPATAPRTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGGSTTALQW
VTGAYSLTFGGLLLTAGSTADRLGRRRVLLVGLTAFGVISLGVVAVTTSGELIALRALLG
IAAAAMAPITNSLVFRLFDEQV
>AIA18492.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|0
MKVFILAALTADGYIARDSSHLSTTWTTRTDKILFTRLTKQAGVAVMGYSSFATVGTALP
GRRTIVYTRQDRPAVEGVEFTAEDPAKLLQQLEADGVKGVAICGGLHIYNLFMATGLVTE
FYLTVQPVLFGQGIKMFDLPLDTKLELIDSAASAEDGTITLHYRVAS
>AIA18472.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MPITVATKDSISTLVSLLNSAYRGEESKKGWTTEADLLLGELRTDATTLNILMDTPGAFF
LQYKEDNELLGCVFLQKKDQRLYLGMLSVSPAAQAKGIGKELMLAAEAYARKQNCTSIFM
KVISIRHELIAWYERKGFIKTGETEPFPDDHKFGVPTQELEFLILEKTF
>AIA18463.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISAIVAVANKGVIGKEGDLPWYLPSELARFKAITMGHPIVMGRKTHESIGRALPGRTNI
IITRDKKFKAEDCVVCNSLDEALEAAAKSPGSEEIFVIGGESVYSEALPKVGKLYLTKVA
ASVNGDKFFRYNKSEWNQLSSEAHKADEKNQYAYEFKVLERR
>AIA18401.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|0
GQQRTLYSLMYDMIILSSNLATNLVIERVGAVNVTATMRELGAKDIEVLRGVEDDKAFEK
GLNNSITAYDQMLIMKKIAQGEAVSADASVAMMNILFDQRFRDIIPAKLPTDVRVAHKTG
WIVGLAHDCAIVELPDGRRYILILLSRKLTNHEKGIEAMANVSRIVYDHIMHK
>AIA18380.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GETLKQYLNLLEDVLKNGIEKEDRTGTGTLSVFGRQVRYDLNEGFPLVTTKKLHIRSILH
ELLWFLKGETNIKYLKENKVSIWDEWATPEGELGPVYGYQWRFWPDGKGGSIDQIAQLIE
GIKRNPSSRRHLFHAWNVAYLPDESKKPWENAAEGKMALPPCHLLYQFNVAKNKLSCLLY
IRSNDLFLGNPYNTASVAFLTHMVAQQCGLEVGEVILSIGDLHLYRNHIEQAKLQLTREP
RPLPKLVIKRNPVSIFDYKFEDFEIVGYDPHPHIPAPIAV
>AIA18382.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MDQIQEDLPSVEEYCHLRKLCGMAPRTAEAARIGLPRSLYSVTVRQNGKLIGMGRVIGDL
GCHVQITDIAVHPDYQRQGISHQIMKKIMFFIEREVPSCAFVNLFADVHFLYQKYGFMEG
TVTKGMYLKRNQTVARESSDELFSFRLGDS
>AIA18376.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLRKVRNRGAKKGDRTNTGTLSIFGHQMRFDLADGFPLVTTKKLHVKSIVHELL
WFLQGSTNVRYLNEHGVTIWDEWADERGDLGPIYGRQWRSWPTPDGGHIDQIAKVVEGLK
REPDSRRHIVSAWNVGELDQMELLPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTQMMAQVTGFESGEFVHSFGDAHLYLTHLDQADEQLKRSPRALPRMEINPDVRSLF
DFAYEDFKLVGYDPHPAISAKVAV
>AIA18360.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|0
TVPAPRGALRVTFLDVGQGDAALVELPSGAVWLIDAGGDPSAHDLAVASGTGRTIERTLA
VYGKHAIDLAIVSHPHPDHYLGLAALTVPVHELWFADRGDSTSRASLARVVAGLAARGTR
IATPPLGTLREGGVELTLWAPRYQSVAGAREVLAPDPVRSINDNSLVVSLRFGGRSMLFT
GDVEAEGEALLVEAGIGEADVVKVAHHGSRTSSSPAFVAATRPELVVISCGVANGFGFPA
PGVVERWREVGARVERTDLAGAISVTVTADGDLDVSRFVRAKP
>AIA18324.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MPWRLPGELAHFKKLTSQNDSGKRNAVIMGRKTWQSLPAKSRPLKDRLNIVVTSDKKYEV
PEGVHTASSLDEALAIAQKETTEHCFVIGGAQLYEQAMQHPGLRNLYITEIEHDFDCDCF
FPEYASALHDVSSPSCDVHAEKGFKYRFKVFERQGARANK
>AIA18215.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|0
MHEQQGLQSHKIVAISLWLITLSVNIAMPLFRIYAFEAGMNNVETTLVLATYIMGMLPCY
VFLGGISDRLGRKPIILLSLICAFLSTVIITIFPNVYALIASRLLHGIALGISMGCGTAY
ISELLGNSEQAATKAANIASLSTSLGFGGGALATTTVLIFQFSLLPITYYLLIAITIIGI
SLAVSLPRLPPIGGSLIRLPYFPKGSLPINIAIAICWAANGVVIAIIPAQLAKYGLTIYA
GFCLVLMNWSGAFLQPFIRKMNPLSSVRVGFVLVPLGFGLVVIGCYADQLWLILVGSFIM
GLAAYGFSYMGGLAIITNLGGVQKARAVSGYMFWGYIGFGIPAIFLGYLADRFGVVSSLL
VFEIVITVLSVY
>AIA18179.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MIEQTPEAIFIGATFKKEISMRSTVALIVIVVVTGAAVLACSGFSARNRGSNVETKSSTT
PSSTGLSQNNSATDEKLAERLRSMIEAAGGDVGLTVIHVESGRTVSIHGDIQLPLYSVFK
LPLAVAVLKDVEEKRLQLDHKVVTSPTEIVPGSQENTDLWRKPIERTVAELLELSISRSD
NTSADKLLKLVGGPEAVTNRMRSLGFPNFMIHSSVSEYVKDRSKVNTGTASELGRLLVEL
QQGHVLQKPQLSVLLGFMERATTGNHRLRGLLPAGTLVADKTGTGEAGVATNDVGLITLP
NGGGHLAIAVLIKASKLAPTEQEKLIAELARVSYEAHLSTGESATQ
>AIA18162.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VVAASANNAIGKDNQLLWHLPNDLKFLKNKTWAMPVLMGRKSFESLGNKPLNGRINIVLT
SSKFFKKEGIVLVNNLKNAYFFAAQNDYNEIMILGGAHVYEQTINECDNIYITRVHHVFE
DADAFFPVIDENKWKLVFNEDRYKDEKHVYDYSFQQWIRR
>AIA18130.1|FEATURES|farme|trimethoprim|dfrA8|antibiotic target replacement|0
MDNDSQKPLYAAYIAMTMDGRLGVDSHHMSTDWTSAEDKAFFRAELCTCDVMLLGRNTYE
TAKSRLSKRNCIVLTTKVAGTLKEADNLLWVNPAHESVAKIIEDAGYKKVAVLGGAQTYD
YCLRNNLLDDLYLTMEPIVFGLGIPFVVSKDFDPIKFKLIDSKSLNEQGTLLLHYRPMNK
>AIA18097.1|FEATURES|farme|beta_lactam|OCH-8|antibiotic inactivation|1
MTKLGSIVGAFLLCAANTYAAESGGQNFLEQAVNDAIKPTMRENNIPGVAVAVTIEGKRY
FFNYGVASKESGQKVAEDTIFEIGSISKTFTATLASYAQLRGTLSFSDNASKHLPALAGS
SFDKISLLDLATYTAGGLPLQFPDDVTDQKTTIGYYRDWRPIYPTGTHRLYSNPSIGLFG
YLAARSMGKPFDDLMEQTLFPALRLAHTYIKVPRDQMGDYAYGYSKNGKPVRVTPGAFDS
EAYGVKTSAADMIRFVEANIDGSKLDETLQRAITSTHTGYYKVGDMTQGLGWEMYAYPTD
LDRLLAGNSPEMALKPNKATKLVPPVEPQDDVLINKTGSTNGFGAYVSFVPAKRIGIVIL
ANRNYPISARVKAGYQILMALDGQSGSSTAR
>AIA18087.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRDVLENGRSEEGVARTDRTGVGTYSVFGRQLRFNLAHGFPLVTTKKVHLRSI
IHELLWFLNGETNIRYLKDNKVGIWDEWAAPDGELGPVYGKQWRRWEGRDGERIDQIQRA
VQLIRTNPTSRRILVVSYNPGDLPEVAPPACHTLFQFYVSGKKLSLQLYQRSADLMLGVP
FNIASYALLLMMVAQVTDLEPHEFVHTFGDVHIYANHLAGARLQVEREPRRLPRMNLNSE
DHVDADL
>AIA18058.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
PSEKTTGKKIDSFANENLFQPLGIIRFEWAKYPGTELPAAASGLRLRSRDLLNFAFLYDK
KGKWNDKQLIPEKWIEESFQPQVQRPDGGAYGYQFWMWDEKLGDRTIPVVTCVGNGDQRI
FFDKANDLLVVMTAGNYNKWDIKNNTSALLRDYIYPALFNGR
>AIA17966.1|FEATURES|farme|tetracycline|tetG|antibiotic efflux|1
MIRRDIARPIALAVVTLDAIGLGLIMPVLPSLLRAFLPSSQVTTHFGILLSLYALMQAFF
SPVLGWLSDRYGRRPVILMSLAGAAIDYAVMATAPFLWVLYIGRIISGIAGATGAVANSI
LADKTQEKSRARWFGYLGTCYGIGMIAGPAIGGVLESFSLHAPFIAASILNGTGFLLAFF
FLSETRPVSNEKKISEVTHSFAILRMKGLFWSLFPLLSLYFLIQLLGQLPATLWVIYGED
QFHWSASQVGISLAGYGLAHALFQAFVTGPLATRLGEKRTLLLGMVADAIGFLAMAFITR
GWMVPPVLLFLAAGGIGMPALQAMLSNTTKTDQQGTLQGILTSLTNFSSVAGPICFSMLY
TASAGTWRGGVWLFGFVLYGVGLLIFCKRELSQRDQLCSR
>AIA17950.1|FEATURES|farme|tetracycline|tetA(P)|antibiotic efflux|1
MKKMDAYRVYLSMEGGMSLFFSAIVTANMIYQVTTVGLNPLQLVLVGTVLEATAFLCEVP
TGVIADVYSRRLSIIIGYIMIGLGFMLEGLVPRFEAILLAQVLWGMGYTFTSGATEAWIA
DEIGERNSGAAFMRSAQVGQLTAVAGAVLGILLGSLQLNLPVVAGCIGTSMIGLCLILVM
PETGFKPRPRGDRNTFQHMLQTARDGAGMVRRRPALLTILAIGAVYGVFSEGFDRLSTAH
MLDNFTFPDFGGFQPIVWLGAIRILMMLLSAGVIEGLRKRIDTNNHHVVARALFFFYAIL
GSAVVAFGLAGSFWLAVVASMVASLARRISDPIYTAWVNQRIDPQVRATVISLSSQANAL
GQIVGGPAVGEIGLAISIRAALVTAGLLLSPVLGLIRYTARSHEQVVEGAVVAPEA
>AIA17946.1|FEATURES|farme|multidrug|MdtK|antibiotic efflux|0
MPKVFALAFSPLEYLMSSQNNAVYGASVKDVVTIAWPVMLSMASHTIMDVTDTLMVGWIG
TKERAAIGIATTVLFLLMSFFMGLFEGVKILGSQHMGAGRLDHAWSIGINGLFLVMPCAL
VVVAIGFFSETIFALFGGPKEIQELAVVYFNIRVFAPIFWFITLALTQFFQGLGDTKTPM
RINVLVCLLNIAINPFLIFGLGPIPALGVAGSALATVLSTAIGSLIFLWIFFKKAPVKKS
FDIKIFTRISQLGWPSGIRWFCDISGYTVFTALVARLGEVELAANQICIKIVCLSILPIW
GVAEATCILTGYHFGGGRYDKIKQSFYSGLKVSCALMVILGVVFIVGRSMIVGIFEPEPA
VFMLSMNVMLVVVVFQFFESFQNTCSLALYGTGDTRFPMLTSLCGSWFIMLPLAYGLGFF
GGLGLVGMWIAATIHLSILSVAVFWRFMRAGYMTRKFDADTTKTDHRAEHSPRSEEPLSE
AL
>AIA17932.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAIAENGVIGSNNDLPWHLPEDLKHFKELTLGKTVLMGRKTFDSIFKRLGKPLP
GRKNVVITRQTDLAMPAGVLVFHDLDKALEALREDEVCVIGGAQIFEQALPHAQIMQITH
VHGNYEGDVYFPEIDWDQWEKTAEQKQDKFTFAEYRRKHLAS
>AIA17765.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTVVLIAAISSNGVIGNKGKLPWHLPVDMEHFKQLTIPHPVVMGRKTYESIPAKFRPLPE
RPNIVVTRNPAFTADKGVLVTHSVELAIDLAQRTEDTVFVIGGGEIYQQALPLATHIYLT
RVETIVEGDTYFPNFPLLQWRRIEEKQHLRDERNKFDLTWEVYERIDERRDEELRKSLWG
PA
>AIA17753.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
GGCESTLVKIEGLTKAFAGHSIFSELSIEFPRGELSAVMGPSGCGKSTLLRCINFLEMFD
SGRITIGDASVAWNAGEVAVLSEEKKTALHRLRLKTGMVFQSFNLFPHLTVLENVTLAPI
LVKRVEQSHAIDLGRAILDRVGLGDKTDRYPSTLSGGQQQRVAIARSLAMQPEVMLYDEP
TSQLDPRLVDEVFQVMRELANEKMTQIVVTHHEQFAREAAGRALVLENGRAEWRDL
>AIA17749.1|FEATURES|farme|glycopeptide|VanA|antibiotic target alteration|1
MRAKPANLPKKIAVLMGGPSAEREVSLATGRGISRALRSLGADVVDVDVRDAKFELPSDV
EFAFIALHGTFGEDGQVQQILEERGVAYTGEGVEGSQLAFNKIRSKEKFRKHGVRTPEWE
TIGSHQRPGMQLPIVVKAPRQGSTVGVYIVKKKEELEPAIADAAKYDDELLIEKFVPGRE
LTIGILGEQALPILEIIPKGGSY
>AIA17730.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRITILFGGTNKERLVSVASAQALHRALPEADLWFWDVADTVHEVTSQKLLSHTRPFEDE
FKPGNRGLPLEAALDKARAEDRVLVLGLHGGRAENGELQAMCELRGIPFTGSGSASSNLA
FDKVAAKRFAAYAGVAAPAGVALENLDAAFAEYGRLIAKPARDGSSYGLFFVNAKQDLVA
VRDAARAEEYLIEPFVAGVEATCGVLERPDGEVLSLPPIEIVPGEGTFDYTAKYLLKSTQ
ALRAHRALSCSGYSRTDFIVSANGPIYLETNTLPGLTAASLYPKALKAQGIEFTDFLREQ
VV
>AIA17705.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIAQNGVIGNSGLIPWHISDDMKRFKALTLGHTIVMGRKTWDSLPRKPLPGR
INVVVTRQKDWQADGAVVAHSLDEAIAGTSGAVMVIGGAEIYERALPLASRIELTEIHQD
FDGDARFVLDRTGWHETLRQEHVTPDGLRYSYVTLTR
>AIA17686.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGIIGKNNDLPWRLPDDMKYFMTTTRGHHAIMGRKNYDSLPEAYRPLPN
RTNIVVTRQDEFHAPGCIVVHSIDRALEIANKNSETEAFVIGGAEIYALAMAHADRLYLT
EIDADISGDTYFPSFDTTHWREVSRKHHDADARHAYAFDFVIYERSPKQKSIDKEVI
>AIA17671.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MTKFDTIYQGMLSDIMDRGVREVNGRTKHETASLPGLHFSIDIEKDGFPLLTLRKIPIKL
MVAEQVWFIMGSRKPADFLRDYTRIWDDFTNPGDVVTVAYGYRWRNHFGRDQLGQLVSHL
QEDNSSRHGVVVTWDPSADGLGGVSKKNVPCPYTFTVNIIGGRPISTTSYAQMI
>AIA17661.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MEIRLATADDSEAISSLIHEAFSPFKAEYTDGAFEYTTPSADVIRERFAEGTIWVAMDGD
LIVGTVSGRPEDHRFYIRSMAVRPGVQRGGTGQQLLESLETYAREAGFERLYLYTTFVLP
GAKRLYEKNGFYTLRETAPEEWFDMGGLEMEKILD
>AIA17627.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRLCEKHFIFADLIFMPPTRKAAIGFIFITLLIDVMGWGLIIPVMPTLISQLKGIPVNEA
SPYGAWLVAAYAITQFVCGPIMGNLSDKYGRRPVILFSLFGFAIDYIFMALAPTYSLLFV
GRIIAGITGASITTAAAYIADISTKETRAKNFGMIGAAFGIGFIAGPALGGVLAEWGVRA
PFYAAAALCLLNATYGYFVLPESLSLEHRRDFHWKKINPFGGIVFLKKHKAIIGLAGCYF
LLYLGAQSVMANWSYFTMYQFGWGEGMVGLSLTVVGLLVAGVQAGLTRLVNPRLGNEKSI
YLGLCLYITGLVLFGIATQGWMIFVFLVPYCLGGLAGPALQSSLTSHIPPNEQGALQGSL
SSLMSITTIFGPLIMNNLFEYFTTDKAPFHFPGMPFMLGAALILVALVIVYNFFQKERAS
IVNRQS
>AIA17596.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MLLVHTSFRAVRPVEGGPLGLIRALREALGAQGTLVMPTMTDGESVYDPRSTPSEGMGIV
AELFWRKEGVLRSDHPGGSFAAEGPLAARICATQPLSPPHGQDSPVGRVYELGGQVLLLG
VTHSEDTTLHLAEAIARVPYSVSHPTVVVEEGVVKTVLVAETDHCCRRFRLADEWLRAKG
LQREGKVGSATARLADAKHIVAVAVERLAADPIVFLCPPSEACEECDLARASIK
>AIA17588.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKKRYFRFTLAAICFILFTFTSVAQNKPPQEINKREADLLELVKLDKTIKLDIRYARTDN
FVGKKVYSQARAFLQRPAAEAVTRVHKELKKQGLGIVIFDGYRPWSITKLFWEVTPDEKR
KYVANPKTGSKHNRGCAVDLSIYDLKTGKLVPMPSDFDEFTERASPDYKGGTEEETRNRE
LLRKLMETEGFTVNPNEWWHFDYKDWQSYAIYDISFDDAGSLDKKPKKPKIEEKKEFKKF
FDDAGVSGGIYIYDLNKNKYTIYDRRRMDTGFVPASTSKIIHSLIFLDSGAIRDENEILK
WDGVKRSVEAWNKDHNLRTALPTSAVWFYTEVSKRVGQERMQKYYDAVGYGNRDTNGFGA
DYWNNGKLRVTPREQIEFLVKFHQNRLPFSPQVIAIVKEIMTEEKTDKFTLRAKTGWSDA
FEPQVGWWVGYVERGKDVYFFATEIDIKKGRGRGKAQGNYAQCFEESEDYRINSF
>AIA17591.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|reduced permeability to antibiotic|0
ARQELLAYQVRELRALDLKEGEVESLERERLLLANASRIGAGLQKALDRLYDAEELSAND
AIGASLREIAALSPLDPRLEPAVAALELSRIQLQEAADEIRRRLGAVEHDPARHDAVELR
LVAAVDLARKHRAPPERLWALTRDFEQQLDDITASDSRLESISREVDRLRASMRAATEAL
HAARITAARSLGSEVNANLQSLGMVGCSFLVNVDALPVAEAGPDGADQVEFLISTSPGLA
AGPIARIASGGELSRLSLAIQVVAMTANGAPTLIFDEVDAGIGGGVAEIVGQCLQRLSSQ
RQVLCVTHLPQVASQADHHYAVSKAIDETKTCTSVREISGASRVDEIARMLGGIRITART
RDHAREMLKGARPRRAG
>AIA17579.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TLRRTAIKSCTDELLWIWQKKSNDIHELHSHIWDSWADEDGLIGKAYGYQMGVKHKYKEG
MFDQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEQRSDRLTLNG
ILNQRSNDVLAANNWNVCQYAVLLHMLAQVCDMQVGEFVHVIADAHIYDRHVPMIEELIK
REPLPAPKFWLNPEIKDFYQF
>AIA17574.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIILGPVAVADNLVIGKGNDLPWHLPEDLKHFKEMTLGKTVLMGRKTYESIVARLNKPLP
GRKNIVITRQKDFKVPEGVLVFPDLPSAFQKLSSEDIYVIGGAEIYKQALPASEIMYITH
VHGNYLGDAFFPVVDWSQWEKLEEEKHEKFTFSKYKKRA
>AIA17560.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAIAKNGIIGGDNDLPWYLPEDLKHFKKITTGRTVLMGRKTYDSIVKRLGKPLP
DRVNVVITRQTEFPVPPSVLVFHDLDQALDALRHDDVYIIGGAQIFAAALPRAEKMYITH
VHKAYPGDVYFPVVDWKAWKMTEEKEHEEYTFATYLKNT
>AIA17499.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKFELVVAADEARGIGRAGGLPWRLPGDMAFFKRVTSEAPAGRHNAVLMGRKTYASISPK
FRPLRGRLNVVLSRQAALTVDEGVLVFGSLEAALARLAAFTDLAHTFVIGGGELYAEAIA
HPGLARVHLTRVHATFDCDTFLAPFEDRFRLVTQDGPHHDDGVHYTFETYERA
>AIA17474.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MQAEHKIVAVVAIGKNRELGLGDKLLWHIPDDLKRFRMLTRGHPIIMGRKTFESILSYRG
KPLPDRTNIVITRDQNYDKTLTERGFKGVLVAGNVEEAIWLAKRQPGADEIHIGGGAQIY
EQALPHIDKLCLTLIEDSKPADTFFPDYTPFFKKKVFEESHEHDGLKYTWVDLER
>AIA17432.1|FEATURES|NCBI|elfamycin|facT|antibiotic efflux|1
MAQTTHLSAQEHAAGFTHRARTIALIIVALAFIMDLLDNTIVNIAIPSIQSNLGASYATI
QWLIAGYALTFATLLITGGRMGDVYGYKKVFMAGVGGFTLASLLCGVSWNSHVLIAARLL
QGAFAALMVPQVMSLMQVMFKPHERGGIMGIFGALAGVAATLGPVIGGILIHFNIAGLDW
RPIFLINIPVGLFALFAGAKYLPDGKSPHPLKLDVFGTVLITAALFLLVFPLIQGRELGW
PTWSFVLMALAIPILPFICMVAANKRA
>AIA17419.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGKNRELGKGNTLLWHIPEDLKRFRTITNGHPCIMGRKTFESIVAILGKPLPNRTNIVVT
RDKNWTAEGAPSVQSMEDAIQLAKRKPGGEEVFIIGGGEIYALGISYADKLYLTLIDDSK
EADSFFPEYAAAFKKKVYEEEKVHEGLKYSWVDLER
>AIA17398.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAALTADGFIGRDSGHTADWTGKEDKKVFTRLTKEAGTIVMGSRTFATIGRALPE
RRNIVYTSRPSEINVEGVETTSEAPAELIARLEKEGATAVAICGGAAIYHLFMSAGVVDE
LYITYVPVLFGKGVGLFSDELDVQLELQESEALGDGALLVHYIVKK
>AIA17391.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MLSTSKEVRGKKLKVNFSEMIISAIAAMSSNRVIGRDGDLPWHLPKDMRFFMNTTKHHHV
IMGRNNFASMNYIPLKNRVNIVLTRDPFFITSSAVVLHSIEEALHFAYQAGEEEAFIIGG
G
>AIA17352.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNYLPFDQRTADTQYRDRLRLILNEGEMVKETQQGVGALTYMAPPPMRFRLENGVPLITE
RKAPFWRGAVGELLAFINGARRTEELEAFGCKWWSSWLTEEKCRKRGLEPGDNGPGSYGA
AFHDFPTAEGPAFNQFEEIVKQIKEEPQLRSHIITPWIPQYTIRVKSRQQKVVVAPCHGW
IHLRVLDNKLTLHMFQRSGDVPVGVPSNMVQYGALLMMLAHATGTEPYENIPTISDAHIF
VDQVPAVELMLS
>AIA17342.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MRDFSIVVAADEELGIGLAGGLPWKLPGDMAYFKRLTIGAPEGLRNAVIMGRKTYESIPE
RFRPLSDRLNVILTRTGAEPPAPGVLVAGSIDQALALIDAEPAIHHMFVIGGGDVYRQAL
LHERCSTLYVTRVHGQFGCDTHFPSFTETFRLVTETAVQHDNGIDYRFEVYERA
>AIA17320.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVAASTNNVIGKNNQLVWHLPRDMKFFMNTTKGHHVIMGRNNFASMNYIPLKNRVNIVLT
RDPFFITSTAIVLHSIEEAINFAYEAGEEEAFIIGGGEIYTQALHLTEKIYLTEVITELP
GDTYFPELDMREWEVVSSEYVEPDAKNEFPMRFDVLLRKE
>AIA17303.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKTFIIAAITADGFIGRTSSHHADWTGKADKKLFVEKTKEAGVMVMGSRTFATIGRALPG
RRTIVYTSKPETITVDGVEATNEPPTQLISRLASEGASGVAICGGATIYSLFMEAGVVDE
LYLTVIPTVFGQGVPLFANPVEQHLELLENRDLGDGAILLHYKTA
>AIA17286.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
LTLIMLQISERGHLMPPSPIRKLVPFAEAAKKKGIKVYHLNIGQPDIETPPAIIDAVKKA
DIKVLEYSHSAGNESYRRKLVEYYKRVGIDVNHNNIIITAGGSEAIIFGFMSCLNPGDEV
IIPEPFYANYNGFAVMAGIKVVPIRSDIETGFALPPIDDFEKVITSRTKGIVVCSPNNPT
GYLYSRDEMEHLKAICLKHNLYLFSDEAYREFCYAGDYVSAMHLDGLEEHVVLMDTISKR
YSACGARIGAFVTKNNAIYNVAMKFAQARLSPPGLAQILGEAAVDLPENYFDKPKAEYMA
RRDLLVKRLNNMPGVYCPKPGGAFYAMARLPIDDSDRFCQWLLESFSHNNQTVMLAPATG
FYGTPGLGKNEVRLAYVLNLDAINGAMDCLEAALKEYPGNTSVQRSKAEQLIG
>AIA17202.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
GRFDTTLFCKLLDITKAEFVTRMTKDWRSLRFSKSIPFNFMEHITADKYQYIQEYMHLFP
GFYGELRSARGYFDSHSPHILGYMSEVDQKKIDDSDGIYAPGDYHGMTGVESYYEDVLRG
AKGSKYVLKDNLGREIESLDGGRHDSAAISGDNLILTLDHVLQEYGEQLLKNKRGSIVAI
EPSTGEILCMLSSPGYDPNILSISRERGQAFASLEQDTLKPLFDRSVQAMYPPGSIFKPL
LSLIAMQQGILDENRTIYCGGAYYSGTLRRGCHNHPTPHNVAAAIQYSCNTYFFTVYKEV
IDQAGYTLPEIGLRKLNDNLSEFGLGHSISVDLPNEKSGNLPTPDYFTKIYKGEWRSPYI
LSMGIGQGELQLTTLQMAHAAAIIANEGTYTDPHIVRSRVTPGGKTISEYFPRRRVSIDY
RHFEPVIEGMSGAVRAGTATLAYNPLFEVCGKTGTSENPHGEDHSVFFGFAPRDQPKIAI
AVYIENAGWGGSYATPIGGLMMEKYLRGEIMESRKWLEERMMLADMIHPKKS
>AIA17167.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MIRAIAAIDDKRGIAAGGKIPWRIPEDTRYYKEKTEHSTVVMGWATYEEFAEPLPNRRNL
VVSRTDQPIRPGFELVTDVDSYLQHATEDIWIIGGAGLFSTTLQYCEELYLTHVAGDFNC
DRIFPVYEDAFTLAESSPEQVSGPYHFRYNVYRRT
>AIA17120.1|FEATURES|farme|beta_lactam|SHD_1818|antibiotic inactivation|1
MCCGVNFIGSQPIGTALPIQILFLMKLSSRIFLSLFACLFVCTPIQAQDLSKFFKNTTGA
FVLYDLKNDRYLRHNPTRCRQRFSPYSTFKIPNSLIGLDTKVIADADYLIRWDQQIYPAQ
SGWIDPPFVYWKQDHTLRSAIKYSVVWYYRELAKRVGEQQMKKYVSAFSYGNQDISGGLS
SPNLFEAFWLNSSLRISADEQIEFLKRFYTGKLPVAERSTNIVKDILVLEKTDRYTLSGK
TGGGSLRNGKSLGWFVGYVETNGNVYFFATNIEGANYAAIRDRRIDLTKQILRELGYLPK
Q
>AIA17099.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNYLPFDQRTADTQYRDRLRLILNEGEMVKETQQGVGALTYMAPPPMRFRLENGVPLITE
RKAPFWRGAVGELLAFINGARRTEELEAFGCKWWSSWLTEEKCRKRGLEPGDNGPGSYGA
AFHDFPTAEGPAFNQFEEIVKQIKEEPQLRSHIITPWIPQYTIRVKSRQQKVVVTPCHGW
IQLRIIKSKLTLHMIQMKADMPVGVPSNMIQYAALTLALAHVTGYAPYEFIHSFSDAHIY
EDQIADVEEMLKREPRRLPTMTMNKVPNNIFDVRPEDFDITDYDPHPPIKGIPVAV
>AIA17055.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIVSAWNVAEVEQMALPPCHMLFQFYVAKGYLSCQLYQRSAGVFLGVPFNIASYALLTMM
IAQVTGLKPGEFIHTLGDAHLYMNHLEQADEQLGRTPYPLPQMQLNPAVHDILDFKYEDF
KLLNYRSHPAIKAPIAV
>AIA17030.1|FEATURES|farme|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MIGLDQLVDHLQRLGVQAGDTIMIHASLKAIGPVVGGASSVVAALVEAVGNAGTILAYAS
WDRSPYEETLNGAELPDTERRAWPAFDPATAGTYRGFGLLNEYLRKWPGALRSGHPDASM
LAIGAQAEYLISPHALGQAFGPGSPLERFVKLRGKVLLLGAPPDAVTVLHHAEAIAQIPN
KRRVTYLMPVLEAGQKEWRRAEDFYSNGILDCFAVDGEKGRR
>AIA17028.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
RSVTLFKLLWRKLFAGTYSLLTALLIYGTQPLDNQNLTSSVDETAAILSLIAMKHFKAIA
AMSLNRVIGAGNKIPWHLPEDFKWFKQLTTGNVVVMGRKTFESIGRPLPNRETIILSRSQ
FAYPGVRTISDLGQIELAHEAREVFICGGAQVYAQALPLCSDLYLTRVKREVEGDAFFPA
FENRFELAEELRDTPDFKILHYRQMS
>AIA17017.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MEAKRRVETMVEAAAKRREGFRFFKENAILLRQCKYREYFMRGLLLSLSLALLSCSTLSQ
SRSDPFLNQFTVQEVAPKTYVATDRSYHNSNVMVAVMPDQTVFIASSPFETEGADALLQW
IQAEFKPQKVIAVNTHFHADGTGGNEAYKKHGVEIWASDLTRKLQRERGESQKVKEAAGF
ESQPELKKRLEKRQIVIADHEYKIQDGKTFEFGGEKVDVIYPGPAHSTDNVAVYLPQRKV
LFGGCMVRPVKTLGYVGDADVKSWADSVSHLRALAPQVVIAGHEAVGGVELIDNTVETAR
QAGLQDDARRQSR
>AIA17013.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKKFQVVVAVDQDRCIGKDGRLPWHLPGELKHFRSLTTKTADDAKKNAVVMGRKTWEPI
PETRRPLAGRHNIVVSRTLKSVDGAQVARSLDDALQLADKLNADRCFVIGGGEIYQSAIA
HDNCDLLHLTQIEQRFECDTYFPDYARFFEKVEESELIEENGLYYRYCTFKRKG
>AIA17006.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MKTFYHLLANTLLASVINFTVWFAITFYVYLQTRSVFATSIISGIYLVLTAISGFWFGSL
VDHHKKKNVMLFSSVVSLLLYIVCFVIYIIAGQGAFKDPASVTLWVFVILLMIGVIFGNI
RTIALATTVTILIEEKKRDKANGLVGTASGVSFLVTSVISGLLVGLSGMFHVLLLAIFVT
GATILHLLPIVIPEKHIVHTGEKPKKVDIRGTLVAVGAIPGLFALILFNTFNNFLGGVFM
ALMDAYGLSLVSVQAWGLLWGFLSTGFIIGGLVVAKWGLGKNPLRTMFLANILIWIVSSV
FTLHSSIILLTVGMFIYLCVIPAIEASEQTIIQKVVPHERQGRVFGFAQSMEQSASPLTA
FLIGPIAQFIAIPFMTTGAGVDLIGSWFGTGADRGIALVFTVTGIIGLVVTIIAMNSKYY
ALLSRRYVMGK
>AIA16993.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
AAINDSLLMIKRSSTHILRNTDQLLGAFFQPIMFLVLFATVFGGAISKALPEGVTYLNFL
MAGIIVQTVAFGSTTTAIAVCNDLQKGIVDRFRSLPMSNLAVLNGHVISDLFRNSISTIV
MLVTGLIIGFRSHASVVEWLYIAGLLLLFTLAFSWLAAIVGVYAKSVEAVQWLTFIIIFP
LTFASTAFVPAEGMNSVLKVFALNQPITHIVEAVRALILGTPMGDHGWLAIVWCVGILIF
AVPFASLLFKRKTSQ
>AIA16990.1|FEATURES|farme|chloramphenicol|catB3|antibiotic inactivation|1
YAEMKNFFESPFKGKIIKDHIANPNIVAGNHSYYSGYYHGHSFDDCARYLFPDRNDVDKL
IIGSYCSIGSGVSFIMAGNQGHRHDWISSFPFHYMPEVETFSGANDGFANAGDTLVGNDV
WIGSEAMVMPGITIGDGAVIGSRALVTKNVEPYAIIGGNPARVIKKRFSDSQIEMLLEMS
WWNWDNVRLSAAIPILCSGNVALLYAYYHNSME
>AIA16979.1|FEATURES|farme|multidrug|cynX|antibiotic efflux|0
MINTSRSTIQTVWLIIGILLIAANLRASITAIGPLIGHIRAATGISNTWAGFLTTLPLLG
FAFFSPIAPIIARRFGLERTIGLSLAAIATGICIRLIPSIIALFVGTALLGAAIGVVNVL
LPGLIKRDYPERIGMLTGAYSVAMGVFAGLAAGISIPLADDAGLGWRGTLFVWLFLAVPA
ILVWLPQYKNSLLPLRNAALTGGNIWRSRLAWQISLFMGLQSFLFYVAIAWLPQILVDRG
SDPETAGWMLFLMQLAGLPATFLVPVWAGKLADQRGVVAVVIAFSAAGWIGLLLDQKAQW
AWLWVIFIGIALGAFISLALAFMGLRTHSASQAAQLSGMAQSVGYLLAAIGPTLAGLVHD
LTHSWQLPLIALLFVNLLLLLFGLGAGRNVLMAEERPSHNQLSQSKYSG
>AIA16956.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKKIRIGLVYGGRSGEHDVSLQTALAVMKAIDYSKYEIKPVYITQQGDWRHGPSGVERL
QSKEQLTLGESADARISAVDPISARALSKTGVTGLSEEHAVDVVFPLLHGTYGEDGTIQG
LLEMAGIPYVGAGVLASAVGMDKVMMKKIFAHEGLPQCMFRHFTKSHWKQEQTFHVMEIE
VSLGYPCFVKPANLGSSVGISKVHNRQELLEAIEYAFRFDRKVIVEESIDAREIEVGVLG
NDRPITSVPGEVVSNHEFYDYKAKYIDGNSAMLIPADLEEDVKLKLQEMAIRAFQAIDAA
GLSRVDFFIKRGDGQILINEINTMPGFTPFSMYPLLWRESGKTYPELLNELIMLALERHK
GKEDIQYTF
>AIA16922.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIIGIVAISENYAIGRNGKLPWHYSADLTHFKETTMGGTLVMGSSTWQSIGKALPGRQSI
VMSRAETLELPEGVLLCHSVKQVLERAERFDGDVFIIGGAGVFESFQDEIQRWIVTRVPE
TIDDADVFMPVQFLDDFELTDKKEIGDGLVVETFDRRR
>AIA16885.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MTDTISKKSPDLSAPFRGTGGKGGIVLSLLVAADEGNVIGKNNQLPWHLPNDLKYFKNLT
WGLPIVMGRKTYESIGKPLPGRTNIVITRNKDYAAEGIVVVHTIEEALNVAQEKGAREIF
VIGGAEIFNSVFESANRIYLTRIHHRFEGDVFFPELNEDWRLVKKHQYNADEKNAYAHTF
QVWERSL
>AIA16861.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
ILEGCGIAYTGEGVAGSEIAFDKIRTKEKFQEHGVTTPPWEVIHAGQRPSIPLPIVVKAP
RQGSTVGVVIVKNEPDIDSAIAEATKYGRELLIEKFVSGRELTIGILGDQVLPILEIIPK
GGVYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQELALRAFRSAGLQVYARVDAIL
SDDGQPYILEINTIPG
>AIA16848.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MYNTYNHKHPIHPENPGSKPIIAFITGGYSTEAVISYKSAITIENNIDREKFTVYKIDIR
PDGWFCEIPGNGVTTIDRNDFTLLDHGRKVRFDAVLVGIHGTPGEDGKLQGYFDLLNIPY
TSCNAATSALTFNKRYTVAVAAFAGIHVARSMHLFRQQKPDLKLITEQLKLPYFVKPNNG
GSSIGMSKVSRSQDLEAAIEKAFKEDDQVLVEEFISGREFTIGVFRNKGEIMTLPITEVK
SKKEFFDFEAKYTAGLSEETTPAQVDESVAEKVRAAARKVYQIFNCRGVVRIDFIYNEEA
GAPYMLEINTVPGQSEASIVPQQVKAMGWTLKDFYSALIEDVLAHK
>AIA16817.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRIYAVAALTVDGFIGRYSGHFADWTGEEDKKVFVRLTKEAGTMVMGSNTFATIGRALPE
RRNIVMTSKPDKIKVEGVEATNETPEALVKRLEKEGVETLAVLGGAGIYTAFMQAGLMDE
LYITYVPVVFGGGITMFKGELDAKLEMREQTTLPDGSILVRYIVKKS
>AIA16734.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MITGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGAKTWRSIGKALPGRQSI
VLSRTEIEDLPDDVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDKGLIVETFDRRT
>AIA16694.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILSSVIAALFVAGMATAAMAGQPAAWTRPAKPFKILDNIYYVGTEGLASYLIVSDQG
AILLDGTLAENAGHIEKNIRALGFKLSDVKISLNSHAHFDHAAGIAQLKQDTDAKVMARE
ADRSALENGKQEGDTNYGGASFPAVKVDRALKDGDVVELGKVKMVAIATPGHTKGCTTWQ
TTATDNGISRRVVFPCSITVAGNILVGNKGYPGIVEDFRRTFEKMASLEADVVLPAHPEF
ADVFQREAKQEAGDKDAYVDTQLLPRLVKKSKIAFEKELKAAQK
>AIA16660.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MQEIASVTKGPVGAAAMIVETGEKASISGSEHFPMQSVYKLPIAMAVLKRIDNNTLTFDD
KIAVKPKDFVSRREFSIAIKYPKGADLSIRELLDYMISESDGTACDALMRMLGGPEAVTK
NLREWGVNDIVLATYEQDMFKTPAVSFQNWSTPDAMVQLLRLLQTEKVLSAERRDILLSL
MIKSRPGQQRIKGLLPPGTTVAHKTGTSGTIDGVTTATNDVGIVTLPNGRHLAIAVFVSS
TTADQETREGVIAKIARAASDCWFEH
>AIA16655.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNTKILKTALVLGLLSVIGPVAIDMYLPALPEIGGQLGTTDAQVQLSLMAFMAGVAVCQL
FYGPISDMIGRKPPLYFGIGLFVAGSIACALAPSIEWLIAARFVQGVGACASMSLPRAIV
RDNYTGAEAAQLFSLLMLVFSISPILAPLSGSIVIAFGDWRLLFWVMTAVGVLGF
>AIA16646.1|FEATURES|farme|beta_lactam|TLA-2|antibiotic inactivation|1
MSKSKSLLLVLALVTLMFACVKPAANQSAPPQNNASPAATVPAQSTRDLQARIEQLVDFA
KGRVGVAAELLETRAAVSVNAREQFPMQSVYKLPISMAVMKQVDAGKLKLDQKVQITKAD
YIGPNAHSPIREKYPNGAELSLTELIRFALSESDGTASDILMRLAGGAEAVQAYLTELGI
NKMDLVVLDPEMALAKDPSVQYRNYARPAAAIELLRSLHEKRGLSDSAQALILKCMVEST
PGAKRLKGLLPAGTVVAHKTGTSGTEKGITAATNDIGIITLPDGRHLAIAVFVSESPADL
DTRERVIAEIAKAAYEKFASN
>AIA16615.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTITNTQFKISKATRIGVLYGGLSSEREVSLISGKNCFEALKRLGYENAILIDVGHDIAK
KLIDEKVEIAYIALHGKYGEDGCLQGLLELLGVPYTGCRVAASALTMNKALTKSVLKDAG
LPVIRSVVVKSGTVNGKPLDLNVQYPVMVKPINEGSSIGMSKVDKPEDLKEALKTAFKYA
DEVMVEEYVKGKSLTVGVVEVDGEPKVTPILELRPTKSEWYDLEAKYTEGGTEFILPADL
PQDVTEAIQEATLNAHIAAGCRGMSRIDFVTNDSDNKFYILEINTIPGMTPLSDLPAQAK
AMGISYEQLVECILKTAVQ
>AIA16597.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
GNTSERAVSLKSSAEVKTALETAGYEAELFDLQDGFEALKEESEGFDAFFPVLHGKEGED
GTLYEFLDTLNKPYVGNDCKGTAQAFNKITSKNYFEENGIPTGSWREVKNKEEVEQFGFP
SVLKAASGGSSREVVLLHSEKDLESKAVDELLRLDDQFLVEKFLKGDEITVPVLGKEVLD
VIAIVPPDGKWFDYENKYSGETQEIVNPDFVPEELKKHAQEIALKIHKDLELGPYSRTDM
IVVNGKPYVLEVNGPCGVGFTSQSLFPKAAKKIGLDFPALCKLLVERSISLIPPGPR
>AIA16556.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MHVIMLAAVTIDGKLARNSAHFVDWTSHEDKKLFFSMSKRAGVLILGHNTYKTFPAPLPG
RLHVVMTYDTKGKESVPGEVEYTSASPAEIPQSLVARGYSEAALGGGSQINTLFLEAGLV
DEIWLTVEPLIFGLGVDLLRGVQFDIHAKLTHIEQLNDRGAVHLRYSLR
>AIA16543.1|FEATURES|farme|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLVKQPISEKLIIDCLNTNYNIKVIRLTFLPLGADMNASVYKVEAHDQSSYFVKIKLGSH
HDIGIAVVGLLHDAGIQQIIPPVKTTHSQPTQYIDDFTIIVYPFIEGQNGFSRPLTDEQW
LTFGKVLRQVHEIDVPSSIQQEVRREAYSPKWREIVRSLYTHIEAEPIGDEIALQLLAFM
RENTLTIHHLVDRSEQLAKILQNESSKFVLCHSDIHGGNILIGNNNTIYIVDWDDPIMAP
KERDLMFIGGGVANVWNKPHEEALFYKGYGKTEINMTILAYYRHERIVEDIASYGQALLL
TMTGGENRLEMYKHFLAMFEKNGVVDIATRDF
>AIA16537.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQEYLDLVRLVLDRGIRKPSRTGVDTISYFGAFYRVDLGRGFPLLTTKKVNYTACLHELL
WYLSGEDHIRNLKKVTKIWDAWADEKGDLETAYGRYWRRFPHPVQKSHAPVSETGETASP
VQEIDQIQYVINEIRRNPYSRRLVVTAWEPGNAETSKLPPCHYTFAFNVSPDERGEPRRL
NCHLTQRSGDIALGIPFNLACYATLTQMLAQEVGLEVGHFAHTIIDAHIYCADAGSPMAA
YDHVSGLKEQLKREPRPLSKLVIAKKPFAELKFEDFRLEGYDPHPGIQFKVAV
>AIA16530.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MIGNVYYVGTDGLASYLITSPQGHILVDTVMPEATSQIKANIEKLGFKVADIKYLLNTHA
HIDHTGGLAEMKQASGAQLVAGEADKPLLEGGYYPGAREETALNFPPVKVDRTVREGDTV
TIADVTLTARETPGHSPGCTSWEFSVKDGDATRSALIFCSGTVALNRLVTNPTYPGIVTD
YKKTFARAQDMKPDVLLAPHPEMYKMAEKRAKLAEGGPNPFVNPGEFNAYAATLEKAFED
ALAKQTAAAQEKKG
>AIA16494.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIKIVVAYGRDNRVIGEDGKLPWDRIPADMKHFQMTTKGCPIIMGRKTWESMNECPLRNR
WNVILTNSSSLPVIPGYDNYIYVRTIEDALISAINKRDDIFVIGGEQVFKQFLDRGLIDE
IIATEIKQHYDGDTFFPSLVGNWQKEVIEENDVFDIVKYKRGLSDGID
>AIA16483.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKDGKLPWHYSADMKFFKETTIGNACVMGYTTWLTLKKPLVDRLNI
VLSRTRDVEPHESVVVYRDVESVLEKAKTLDGDLFVMGGEQVYRSFLPHIEKWFVTEVPL
SVEGADTFMPTNYLDGFDLTASKMLDEELFVSVYEKK
>AIA16426.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MPEKILKLNLNAKICLNFDENATKFCEIQPIMLSLEIVEESNIHMNESHKGTNIEIVNFS
SELRTHFERLNRGWIERQFEMEPLDYLLLQNPETEIIEKGGAVLFAVASRGEVVGTAALK
NEGEGVYELSKMAVDEESRGLGIGKALGLAALDRVRKMGAVKVILYTNSALEPAINLYRK
LGFIDVPVTEKGYTRADVKMEIEFKVN
>AIA16417.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLEDIKTNGVKKSDRTGTGTVSVFGRQMRFDLSEGFPLLTTKKVFLRGIIHELI
WFLQGSSNLKYLVDNDVHIWDEWPYKHYLQEQGKKVPASDSDEWKAGIKEFTEKIKADAK
FAKKWGELGPVYGYQWRNWPTPDGKHIDQIAQIIETIKTNPDSRRMIVSAWNVADIDEMA
KAGLPPCHLLFQFYVADGKLSCQMYQRSADTFLGVPFNIASYSLLTMMIAQVCGLKPGDF
VHTLGDTHLYLNHLEQVDEQLKRKPRKLPTMKINPKVKDISQFTIDDFELVGYDPHPAIW
APIAV
>AIA16415.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRFHWIYILLLFYVLASACTKTANTAEVKQSPAPVAAAQNVDHELEQRLKTISDGSQGTV
GLSVVHIESGKTVSINGSSQLPLYSVYKLPLAVTVLKDVEEKRLRLDQKIHVTPQNVVQG
TTANSALWQKPVDYTVEQLLEFSISRSDNTSSDKLVELVGGPLQVTERMRSLGFQNLDIH
ISSGEFAKTRQNPNTGSADDLVQLLVQLHRGKILQPDQVNLLRGFMQRATTGLHRLRGDL
PRGTVVADKTGSGEADAVTKVAKVTNDVGIITLPRGRGHLAMAVLVNGSK
>AIA16348.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MRSLTSIVAVNRDGVIGRQNGLPWRLRSDMKFFREQTLDNVVIMGRKTFDSFGRGALPRR
YNIVISSHFGLFPEGSDCQTATGVEDALFRATLAPRIYKESFVIGGATIYEQFAPFVDRY
LITLVEKDVPDGDTFFNQEPLGDPDAWEIRPLISCPASEADEADFTTFEVLARNPELFRE
RRELAIERARIAASEGRAARTRSRGPKAAGGDASPTLF
>AIA16331.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
GVWYVQEPLSALPHQQPATLTITSHINDMVSLIPGQNHALIMGLMTKEQLSAIDVIFPIM
HGPYGEDGTIQGLLRLANVPFVGPDVLSSAICMDKDVMKRLAREAGIPIPAFVTVYRREM
ATLDTAKILKTVGLPCFVKPANMGSSIGISKVKKKEELLAAIEKAMIYDHKIIIEQGV
>AIA16282.1|FEATURES|farme|beta_lactam|S70_09140|antibiotic inactivation|1
MLARKIPSISVAVARKGDIIWEEAFGFADKENGIPANQDTMYYVASVTKSFTATAVAMLA
ERKQLDLDRPINEYIKPMKVWSPIWNPQEATVRKVATHMGGLTTFGRNCWADQDNCHISA
DETIARYGIIFWRPGDHFDYSNLGYGILGEAIRGASGKSYAEFLRDELFLPLGMTRASVG
IASGFEKYAAIRYSSVNGRRPIAYSASPAASGIYCNAHGLALFGMFHLKSHLANQKAILS
DKSIEMMQNSTVSTGGSSRYGMGWWVTEDLNGYRSLLGQGGTDDAMAFLRLIPSEEIAVV
MLTNTGDEFPPKIVDEILSTLLPKYRLRSQNVPINSAQPPSTQIKTFSSFEGDWVT
>AIA16273.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MNMKLILLVGMCLTLAGCSGSSSPAATTATSVNSPKTIDVQAVDAELTKRLATLAKSIGD
DVGVTVIHVETGRTITVDGAKKLQLYSVFKVPLAIAVLKAVEEKKISLEQKLHVTPSDVA
PGSQINTDLWRRPVDKNVAELLEFSIVRSDNTSSDKLMQLIGGPAVVTERMRALGYSNID
IVTTVRDFAAKGENPNVGTPADLARLLTQLQKGELLQPANASLLLGYMERARTGGERRLR
ANLPAGTQVAEKTGSGTAATNDIGLITLPDGKGHLAIAVLINGTKSKTDAQEKLIAETAR
AAYDAFVASTETTAKP
>AIA16257.1|FEATURES|farme|beta_lactam|XBI1_1260030|antibiotic inactivation|0
MQDATLTRVLEAFGLRAAGVLPSQKGYRNESHPVRLSNGCVVNVILYKQEPDMAATIHRV
HAVSTFLHNQGFPVRTPLDRRRLQIRNRDAVRYLAVYNYLSGHTLSWDTYTQKHLKLLGK
TMSDLHAALAQYPTDDLPNVADQYHEIYRRMQRYFGDNAVVLALRAKLNLAVDDTQLTV
>AIA16226.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRTEIEDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVEDADVYMPLQFLDDFELVDSKEIDEGLIVETFDWRT
>AIA16217.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MGKDKGLLWHLPKDMEFFKKVTYGHHVLMGRKSYESIPEQYRPLKGRVNIIITRQQEFKA
EGCKIVTSAEEGIGFAKDNGEEELMILGGGQIYKQLLGQTDKIYLTRVHHSFPEADTFFP
ELDLNEWKLLRNEKHAADEKHLYSFEFIELERKESAKN
>AIA16210.1|FEATURES|farme|beta_lactam|OXA-320|antibiotic inactivation|1
MKKALLIILLALFMPPVLANALSICDHFTGKSGCFLLFDQNQSSLLTQYNPARCAQRLSP
NSTFKIPLSLMAFDQKLISQKSIFKWDNKDKGLAVWNQHQTPRTWLENSTVWVSQDLVTK
LGQNNIKNYLGKFNYGNQDNKLPNFWLDSSLTISAEEQLTFMKALVANKLPVSKEAMLNT
KENMYLETSPHGWKLYGKTGSGKQQGWFVGFIEKANQVYVFVLNFSDIQAPTTSDAAGPR
AKEITKALLTKMDLF
>AIA16205.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MLDFSLQHPETIMKKIFAAASLFALSLPAFAGWDDPQEPFQLFGNSYYVGPKGVSSVLIT
SPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGSIAELQRASGAVV
GGQRIERGRHEDRRSEQG
>AIA16151.1|FEATURES|farme|tetracycline|tap|antibiotic efflux|1
MLLDLSPLKVSRDYRLLFFGQLVSFFGSMMTFIVVPWQMYQLTQSSAMVGYIYLAEFVPM
VALAFVGGALADYLDKRKMLRITEIGQTSVTAILLLNSLLPQPRVSILFLSVALHAGLAA
LQRPAFESFIQKVIPPEMMSSVMALNSIRYSVGAIVSPAVAGIIATQLSSSVAYSIDLVT
FLASLTAVFMLRHVPRPENAERPSWEGIKKAWRYAFSRQELLGTYFIDIAAMFFAMPQAL
YPALAVIYGDKYVGFFPASIAAGALVASLTSGWTKKIQRHGLMVTIAATLWGVAIIFFGL
VDSLALALFFLAAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMMSYLTGPMLGSAKM
GIVAEKFGVKTALVSGGVLCVLSVVGAAFFLPKFLRYDGREGVKEREREEAARGELMRVS
ESEF
>AIA16144.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MPTNKKAAITFIFFTLLIDVMGFGLIIPVMADLIAQLKHIPMNIASNYGAILLSVFAITQ
FLFSPVIGNLSDRFGRRPVLLCSLLGFGVDYIVLAIAPAYGWLFIGRVVAGITGASFTTA
TAYIADVSTNETDRAKNFGLIGAAFGIGFVLGPALGGFLAHWGIRAPFYAAAALCLLNCL
YGYFFLPESLDAQHRRPFDWKRANPFGSLRFLTRHPEIGGLAIGFFLIYLGAQSIQGNWN
FFTIYRFGWSEKMIGISLALVGVLVGGVQAGLTRVINPKIGNENSIYLGLSLYTFGLLLF
AFANQSWMMFAFLVPYCLGGICGPSLQSVISGHVPVNQQGELQGALTSLMSLTTIIGPPL
MSLTFSYFTTDKAPFYFPGMQFLIGAVCMLLSVIIIYKVLNKEKKEHPELRTVIESDHKN
V
>AIA16124.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPFKTMRVELEFFIKGLTDKQWLQDRRCMIWNEWANPKKAPYGHDEESKKRMMEERDLGP
VYGFQWRHFDATYQNYDTEYTGTGIDQLANVIETLKKNPNDRRMIVMAWNPKALPEQALP
PCHYGFQVTVINGKLNLLWNQRSVDTMLGLPFNIASYALLLHLLAKESGLQEGKLIGFLA
DTHIYVNHIDGAKEQLAREPRALPKITTDPFTSIFDWTGEHTTLEGYDPQDKIDFPIAV
>AIA16059.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQKARLSIIAALGKNRELGKGNELIWRISPDLKRVKTLTTGHPIIMGRKTFESIGKPLPN
RTNIVITRSNMCIDGVLIFDSLDKAILAARAVDEEEIFIFGGSSVYAEALPNVDRLYITR
IDATDNTADVFFPDYSAFTKEIFREEHPEHNPPFTWITLER
>AIA16024.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QDRTGTGTASVFGYQMRFNLGEGFPLLTTKKLHVKSIIYELLWFLRGETNVGYLREHGVN
IWNEWAREDGELGPVYGAQWRSWKAADGRSIDQISQVIDQIKTNPDSRRLIVSAWNVGEI
SKMALPPCHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIASYSLLTMMVAQACDLEPGE
FVLTLGDAHLYSNHFEQARLQLSREPLKLPTMKINPSVQSIFDFDYGDFELVGYAPHPHI
KAEVAV
>AIA16008.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKQLLIIILFVIIVSAVAATKHVDNLQKPAPDLSPFFKDTTGAFVLYDLKNDRYIRYNEQ
RCRERFSPKSTFKIPNSLIGLESGVIRDADFVIPWNRQKYPPQDNWNQEPFSHWGQDHTL
RSAIKYSVVWYYRELALRVGESRMKKLVSAFRYGNEYVSGEIDDFWLNGTLKISADEQVE
FLKAFYAERLPVSKRSVDIVKDILVLEKTPAYTLRGKTGGGSIAEGKYIGWFVGYLETNS
DVYFFATNIEGSNFNAIRDKRIELTRQILLQLGYLTN
>AIA16005.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKAFTLTAIFMLSLTPCVFSQRDVLHKRIKELAATVDGQAGVAIMDLSSKDTLLYNVHGR
FAMQSVYKFQLGLAVLNEIDKEALSLDKKIRLTKENLLPNTYSPMRDKYPGGNVELPLRD
VLKYLVTNSDNNACDILFKELGGTKRVNRYVHDLGVNEMEIAATEDEMHQGYDVQFTNWS
TPRATLQLLEMFYDKKLLKPASQELMWKMMVETTTGPKRLKGLLPEGVEAAHRTGLGDRD
TDGRLGAVNDVGIVKLPNGKYYAIVVYIGRAKGELPDLEKVIAEISLAAYKSQWLNK
>AIA16001.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TGVGTISVFGRQIRFDLSKGFPAVTTKKLFMRGIIHELLWFLQGSTNIKYLVDNDVHIWD
EWPFKAYLMKQGKPIPKPNSDAWNTGIKEFTERIKKDSDFARWHGELGPVYGYQWRSWPT
PDGRHIDQIKQAIDTIKTNPDSRRIIVSAWNAAEVEDMAISGLPPCHLLFQFYVADSKLS
CQMYQRSADTFLGVPFNIASYSLLTMMMAQVTGLMPGDFVHTFGDTHLYLNHFKQVSEQL
KRRPRPLPKMKLNPAVKNIDDFKFEDFELVGYNPHPSIWAPIAV
>AIA16000.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILLHGKEHEDRTGVGTISHFGFQTRFDLRKGFPIVTTKKIPFRWVAEELF
WFLSGDTNEANLRARGGDIWAEWADEAHTKRFARKPGDLGPVYGYLWRSFGGHYPEHDGL
DQIARLVGEIKNNPHSRRLIVTGWEPREADNVDLPPCHTLFQFKVENGSVLHCKLYQRSA
DAFLGVPFNISSYALLLRMVAHVCELAVGEFVYTLGDYHIYKNHLDQVNELLSREPLPLP
RLEIVDPTKRLRGLQGLLDMRYEDLNLSGYQSHGKIAAAVAV
>AIA15993.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIIGIVAISENYAIGRNGKLPWHYSADLTHFKETTMGGTLVMGSSTWRSIGKALPGRQSI
VMSRAETLELPEGVLLCHSVKQVLERAERFDGDVFIIGGAGVFESFQDEIQRWIVTRVPE
AIDDADVFMPVQFLDDFELTDRKEIGDGLVVETFDRRR
>AIA15977.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MPAPTYRSLRAAALPLLALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQWVTGAYSL
TFGGILLTAGSTADRLGRRRVLLAGLAAFGVLSLGVIFVSTSGELIALRAALGVAAAAMA
PVTMSLIFRLFDEERLRMRAITVVMVVGMSGFVLGPILGGTVLAHLSWEWLLVVNAPIAL
IAWIGVRLGVPADRPEDLTADPVDLPGTVLSIAGIGLACYTLTSGVEHGWLSGFTLACAL
GAAVAVFAFIRHERSTESPMLDLRLFSSGPARGAAITQMGASITMAGVMFGLILHFQYAY
GWSPMRAGLANLPLIITMIAATPLSEWLAERHGHRIACLIGTALLVVSLLGMAWGVDHGY
LAIAVSMVVLTLGLRTIMTICAVALVAAMPENRTSIGAALNDTAQEIGTSVGTAVVGTMI
AALVTTGLPPGIWSTELVQSLFHGERVTFLVLAAIVGLVATFGSLSLTDSRSTEEH
>AIA15966.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MIIGIVAISENYAIGRNGKLPWHYSADLTHFKETTMGGTLVMGSSTWRSIGKALPGRQSI
VMSRAETLELPEGVLLCHSVKQVLERAERFDGDVFIIGGAGVFESFQDEIQRWIVTRVPE
TIDDADVFMPVQFLDDFELTDRKEIGDGLVVETFDRRR
>AIA15934.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
KKWRMPVKKIAVALVALISLTAAVEAQTPKDLLAAMLAKWNKPTEPFKMIGNVYYVGTDG
LASYLITSPQGHILDDTVMPEATSQIKANIEKLGFKVTDIKYLLNTHAHIDHTGGLAEMK
QASGAQLVAGEADKPLLEGGYYPGAQEETALNFPPVKVDRTVREGDKVTVGDVTLTARET
PGHSPGCTSWEFSVKDGDATRSVLIFCSGTVALNRLIGNPTYSGIVADYRKTFARAKDMK
VDVLLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFDDALAKQTAAAQEK
KG
>AIA15864.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKISIVVAAADDNAIGKDKGLLWHLPKDMEFFKKVTYGHHVLMGRKSYESIPEQYRPLKG
RVNIIITRQQEFKAEGCKIVTSAEEGIGFAKDNGEEELMILGGGQIYKQLLGQTDKIYLT
RVHHSFPEADTFFPELDLNEWKLLRNEKHAADEKHLYSFEFIELERKESAKN
>AIA15851.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MLDFSLQHPETIMKKIFAAASLFALSLPAFAGWDDPQEPFQLFGNSYYVGPKGVSSVLIT
SPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGSIAELAARQRRSG
GGQRIERGRHEDRRSEQG
>AIA15785.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
SMTLSLIVAAAQNGVIGKDGKMPWRLPDESTYFRQTTLGHPVITGRKNYEAMGRPLPDRL
NVVITRQPDYKVPDGVVVVHNLQEALQLSQVKSAPEVFIIGGAQIYNEAMPFADKLYLTD
IDAKIEGDTFFRYDPSQWQLEWSKHHPADEVNKYAFTMKRFKRK
>AIA15783.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MQLSIVVAVAEDRAIGRNGVLPWRLPSDLQYFKEQTMGKPVIMGRRTWEERKGKPLKGRL
NIVLSRTLKEVPEGMLICHDLHDALTAAEMRDFGQAAVIGGASLFAEAVPKADILHITRV
HTRVPDADTFFPEIDLSPFELAWEERHQADERNEHDYTFQRWERKKG
>AIA15739.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRVFIIAAVTADGFIARHTDHLSDWTSVEDKKLFVALTKEAGVMVMGSRTFATIGRALPG
RRTIVYTTHPERITAAGVETSNEDPKVLIKRLEQEGATGLAVCGGGEIYSLFMSAGVIAE
LYLTIEPILFGQGIPLFKKELDSTLLLNEVRALNNHTMLLHYKVA
>AIA15718.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|0
MIERLNIVLLAAVTADGKMARNSAQLSNWTSHEDKKIFVAESRRAGVIILGNSTYKTLPA
PLPGRLHIVLTTNTADKTNIPGVVEFTSASPEEIAASLQARGYKSAVLAGGSQINSLFLA
HNMVDEIWLTFEPLVFGIGVHVFEGVQFDMRLRLLSLEQINKDAFIAKYSTRPAEV
>AIA15680.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MQISVENIGKKFVREWIFRNASFELEAGQKYTFVGPNGSGKSTLLQLLTGIFPASEGTIR
YIDKGGKEIEVDEWYKHLVIAAPYMELVEEFTLKEMVEFHARFKPLKNKMEVAEFEDFIK
LSHASHKLIRHFSSGMKQRLKLGLAFMSDVPVIFLDEPTTNLDAQGFQWYIDNVTLHTEN
QMLLLGSNVKQEYEFCENIISVSAFK
>AIA15674.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKVKTLRRILLPALFVLPNLLFAQKSDFKSQLESITKQIDGIAGVAVKDLEGKETLILNA
DHKFPMLSSFKFPIAMAVLDQVDKGKLALDQKYHLTKEDIQLKTYSPLRDKFPDGNVDLT
IADLLASMVSLSDNIACDILFKLAGGTKPVQDYVHSLGVKDIAIVANEEQMGQDWNVQYT
NWCKPGAMLQLLDIFYKGKNLSKSSHDFLSKIMIDGPTGMNRIKGQLPKEAVVAHKTGTS
GTNHKGVMAVVNDVGIVKMANGKSFAIVLFMSNSTAELKAIESVMAQVSKAAYEHYAAK
>AIA15650.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MFKRIYWAFFDCWILIQRSLKHIFKNPDQLLGVTTQPIMFMLLFRYVFGGAISTGSTSYV
NFLVAGILIQSAAFGALTTSLSVATDLHKGIIDRIKSLPIAGWGVLVGHVVADMVRNVIQ
SVILIAVAFLVGFRPHASAGAWLEITAIVLLFTLAFSWMAAIMGLLAKTIEATQWMGFFL
IFPLTFASAAFVPTDSMAKGLRAFAQNQPVTHVIEAIRALMNGAPVGNHVWLAVVWCLGI
IAVSVPTAAILFRRYSGK
>AIA15642.1|FEATURES|farme|beta_lactam|VIM-29|antibiotic inactivation|1
MKKGSWTVGMAMMGIVACAPAEAPPPAPARTVAVAGTPVIATAKADTLGDDIVVRHLAGR
VWLHVTLSPDANRIPSNGLLVDEGDGVLLIDTAWDDEQTGRLAEWSLRRLGKPIRRSIST
HFHDDRLGGIDTLKALGVDARALDLTVSKAAAKGKTTLPTIYMAAAQRARRDDAGFEVFY
PGPGHSPDNIVVWFPAEGVLFGGCFVKGAESRDLGNLSDADVRAWPASVASVLDRYPRAS
IVIPGHGAPGGLNLLTHTTALLAAAPARNGGG
>AIA15636.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNPKISIIVAMDEKRGIGKENTLMWKIPGELKRFKEITTGHPIIMGRKTFDSIGRVLPGR
TNIIITRDIHYVVDGAVVVHSLEEALKKAKGIDAEEIFVIGGGQIFQQALPQVDRLYLTL
VQGDFSADTFFPDYSAFTKKISEEQKEAENYKFTFLTLDK
>AIA15577.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TGGYSGEAQISYQSAKTIEKNIDPEKFDHYKIDITPNGWFFDNNGERSEVDKNDFSISVN
GQKILFDAVLIGIHGTPGEDGKLQGYFDVLGLPYTSCDCAISALTFNKRYTVAVAAFSGI
KVANSVLLFKNNYQSPDELVSNLQFPVFVKPNNGGSSIGMSKVNSPSEELGAAIEKAFR
>AIA15507.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MLIALTMLTVIGMTTVFPVMPFIVKQYLPVGDDNLALWVGILEGVNALCAFLAAPFLGAL
SDRIGRRPVIIIASFGAVVGYVVFGIGGAIWVLLLGRVIQGITAGDMPALFAYVADITPP
EKRAQRFGMLGALNGISFMIGPAVGGLLAAIDIRLPVFVTAGAALTVALLSIFLLPESLA
PANRKTSISLDEMHPIKVIVGAFRRVELRGLLIAFTLLGIPFAFFTSNYSVLAIDTVQWN
ATQVGLLLAVIGVIDIAVQGGLLALLLPRIGERPVILIGIIGQGVACASLVVLATVLAQP
WVLIFGVLLFGATQGLTQAPLDGLMSSAVGDDEQGQVAGAIQSVGSAIQMLAPLIAGLLY
SAITHSAPYILGVALIIGSAIAFARVRLPAKRAADVVETPAPADV
>AIA15493.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIGEDISTKTKGDATGEEFVSARINSVPPSGIRKFFDIVATMKDVISLGIGEPDFVTPE
PILNAGIESLRAGHTAYTSNSGILELRQLIAAQLKHHYNVKYDPETELLVTVGVSEALLL
ALMAVLEPGSEVIVPEPCFVAYQPTVIFAGGVPVAVPTHVSQNFQVTVEDLEKARTTQTR
AILLGYPNNPTGAVLDRSRLIEIATWAQQNDLLVISDEIYDRLVYGTEHTCFSALPGMWK
RTILLGGFSKSYAMTGWRIGYAAAPPAILSAMRKIHQYVIMSAPTTGQEAAIEALKSGEP
YVESMRQEYDRRRRLIVDGFNRLGLTCFEPRGAFYAFPSIESTGLNEEEFCERLLAEEKV
ALIPGSAFGTSGKGHVRASYANSYSNLQEALVRIERFLDKLK
>AIA15491.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIRFIVAIDDKNGLADDHGIPWPKPPSDLRLFRDSTKHTIVMMGYKTYQEFDHPLSDRRN
LVATHTAGPLQAGFEAVNDVRKFLQRSTEDIWVIGGAGLFATTLDLADELLITYIKGDYN
CTKFFPDYKDIFELAAKTETQTEKGVEFYFTTWKRKSLPKQR
>AIA15475.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDNNHVKKVRVAVLYGGRSGEHEVSLMSAANVIENLDKDQFEVVPIGIDKEGAWHVGDAV
FRRGLSDTSRLPRLNAQPNQLLFDPSAIGKSLSISAEGGSHNVFDVIFPVIHGPLCEDGT
VQGFLELTGLPYVGCGVLASALGMDKDVSKRLVVHAGIATPAYVALSRSAWHRHTERCLE
QVEAALTYPVFVKPANTGSSVGISKAKTRKQLLDAVEAAFQYDHKIVIEQGLNAREIEVA
VLESLEYGADPIVSIPGEVRPTARYEFYSYASKYLDEAGADLIIPATLSDETVARIQAIA
KDIFQVLGCEGMARVDLFLDDATGNIYFNEINSLPGFTSISMYPKLMMASGLSYQDLLTH
LVQLAMDRNIRKSQLSRDYVEKTTTTV
>AIA15453.1|FEATURES|farme|beta_lactam|OXA-60|antibiotic inactivation|1
PHRGQPYKKGNDMNRLLLLTFSVLTILISSCTPNNVIVDNSLEKIFNESGVKGTFGIYDN
GQNNFTIYDLGRFKDSAYLPASTFKIVNSLIGIETGKIIDEKMVIKWDGVQRSVPEWNKD
LTMAEAFKVSAVPYYQEVARRIGKDTMQHWLDSMGYASRYNKAVINKIDTFWLDNSIKIT
ADEQLGLAKKLYFNQLPFQKRTMRIVKEVMLQEKNSNYALSYKTGWGTAENGNAIGWVVG
WIEENQHPYIFALNVEGSHDADMRTIRINILNQILDQLGFKKGKK
>AIA15450.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|1
MTKQLAIILATVALAATGIGLTMPVLPDLPRDVGRSGDLGWQYGSFLALYALMQFLFAPL
LGALSDRFGRRPLLLLALAGATVDYLFMAFAPTLPLLFLGRAISGITGAGSAVAAPYITD
ITSEPERARRFG
>AIA15430.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSAIVSLVIARAANGVIGQRGQIPWRIPADMKHFKAVTMGKPCIMGRKTWHSLPKKPLPG
RTNIVLTREMGFHAEGAVLAHSFDDALVRAEAESPEEIAVIGGADIYRVALPRAVRIYLT
DVHGVFEGDVHMPEFNPLEWKQVAREDHAANETGVAFSFVTLERR
>AIA15431.1|FEATURES|farme|aminoglycoside|O206_06725|antibiotic inactivation|0
MGIAIRGARSEDAPLLCAFIRELAEYERLLPECVATPETVAATLFAPSPRAFCNIAEAHG
EPAGFALWFYSYSTFQAKPGIYLEDLYVRPRFRSRGVGKALLIHLARRAVHENCGRFEWS
VLDWNTPSIAFYEALGAKPVSGWTRYRLDGETLAGLADR
>AIA15415.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTAPIALVVARAADGTIGHEGKIPWRIPADMLHFKAVTLGKPCVMGRKTWESLPKKPLPR
RTNIVVTRDRAFAAEGTAIVHSFAEAIARAEAEHPSEIAIIGGADLYREALPQADRVYLT
EVQGTFDGDVRLPPFDPNDWQEAAREDHPAEQGIPAFSFVTLERRAK
>AIA15413.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MAAMTLDGKIARDESHFVDWSSKEDKRLFYSTSKRARVLIMGNNTYKTLPAPLPNRLHIV
LTTNTADKASKLGEVEFTSASPADIISDLEGRGYTEAVLTGGAQVNSLFLKAGMVSEIWV
TVEPLIFGVGIDLFRGSPFDVRVTLTSVEKLNDGGSVLLKYSVGGGNEAVDASVAPHAAP
TS
>AIA15412.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
METTTNKLRVILLAAITADGKMARNTSHLSDWTSPEDKRVFVAESKRAGVVILGNNTFKT
LPRPLPGRLHIVLTTSTADKTDIPGVVEYTSNPPGAIVADLAARGYSSAVLAGGAQINTL
FLAHNMVDEIWLTVEPIVFGTGVHVFEGAAFDQRLRLISLEQLNQNTFLAKYSTRVEEAA
GTSNLTQPAPINHG
>AIA15385.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTTILFGGNSRERLVSVASAQALCRALPDADLWFWDNDDTVHAASAEALLAHQRPFEIA
FKADGARIGALTEALDRAQVEARVLVLGLHGGAPENGEFQVLCEVRGVPFTGSGSASSNL
AFDKVQAKKFAAAAGVASPAGLSLAEADEALGHYGKLVAKPSQDGSSMGLIFVHTTQDLE
AVRRAAAAMPYVIEPFITGQESTCGVLEQADGSLIALPPVEIITASGSFDYESKYLASTT
QEICPARFAPEVNAELQRRAILAHKALSCRGYSRSDFIISDKGPVYLETNTLPGLTAASL
YPKSLKAQGIAFADFLQGQIDLAIQRARG
>AIA15376.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPRPLTRIESVIQAVRTRINARVDGPGSRLPSVRAQAAAMAVSVSTVVEAYERLAAEGLI
TARAGSGFYVSGPAAPLALAKMEPRLDRAVDPLWVSRQSLETPPGHLKPGCGWMPSDWLY
HDGVRRGLRRLARADAMHLADYAGPLGLPALRQLLQRRSATLGIDASMEQILLTESGTHA
VDLICRFLLKPGDCVLVDDPSYFNYHALLKAHQVQAVGVPYTPTGPDLEAFERALQAHSP
RLYITNSGLHNPTGAVLSASTAHRLLGLAERSELIIVEDDIFADFELQPAPRLAALDGLS
RVIHVGGFSKTLSAASRCGYIAARHDWIEALTDLKLATSFGGGHLAAQLMHIALTDSGYR
RHMQSVRSRLADARRHTLRKLHTLGITPWLQPEARLFLWCQLPDGRDSAVLARQCLREGI
VLAPGNAFSQSQRAADYLRFNVSQCQDARIWQVLARELR
>AIA15355.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VHEVSSALLLGHARPFEDEFKPGDRGIALEAALDKAAAEDRVLVLGLHGGRAENGELQAM
CELRGIPFTGSGSASSNLAFDKVAAKRFAAIAGVLAPDGIELANLDAAFAEHGRLIAKPA
RDGSSYGLIFVNAKQDLVAVRNAAKSEEYVIEPFVAGVEATCGVLERSDGEVFSLPPIEI
VPGEGAFDYTAKYLLESTQEICPGRFSPEISAALMDHAMRAHRALSCGGYSRTDFIISEN
GPVYLETNTLPGLTAASLYPKALKAQGIEFADFLRDQIVLAERRVRPSA
>AIA15323.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MTQETQQRPVLSQRVQAIPPSGIRRFFDIVATMQDVVSLGIGEPDFVTPDPIRDAGIASI
QSGFTAYTSNSGMQELREELAAHLDRLYGVRYNPNDELLITVGVSEAMQNAMLALIDPGD
EVIIPEPCFVAYGPSVVLAGGTAVPVATYVENAFQVTGAEIEAAVTPRTKAILIGYPNNP
TGAVMSRERLLEVADVARRHDLLVISDEIYDRLVYGVQHICFASLPDMRDRTILLGGFSK
AYAMTGWRLGYVAARPDIAAAIRKIHQYAIMSAPTMSQFAALEALRSCEEEVEEMRRDYD
RRRQFFVKGLNEIGLATFEPQGAFYAFPQVGHLGLSSEEFAEQLLEAERVAVVPGNAFGA
SGSGFVRACYAVSTEKLEIALERIERFVRRLS
>AIA15296.1|FEATURES|farme|chloramphenicol|catA5|antibiotic inactivation|1
MRQDETMNEKHAIDLGSWPRRETFEHFRSRVPCTYSVTVELDATRFVAAIAQSGRKTYPA
QVWAIAAVVNRHEEFRISVDGSGAPSVWSVVHPYFTVFNPERETFAGVWAEYDDDFGRFH
SRAVETLAEYRSTASFAPQGDPPANVFDVSSLPWASFTGFNLNIQQGYGHYLPIFTLGKY
VERDGRMLLPFALQIHHAAADGFHAARLFTELQELFDTAESWL
>AIA15288.1|FEATURES|farme|beta_lactam|VEB-7|antibiotic inactivation|1
MRKLACILVAAVCAHFTASAQDTALVTRLSKLLGPLQPKVGVSVKLAGKQQTSGWNESAH
LPMQSVFKFPIAVVVLSEVDKGNLSLDQEIDIQKKDLPANTWSPIRDDHPSGAKLTLAEI
LQYTVSQSDNIGCDLLLKLLGGLEKVQHYFATHGFTEISVEVTEDDMHRDWNAQFKNWCT
PREITRIIEATYENTDRLLSESSHAFLWKIMTETNTGQKRLKALLPADAIVSHKTGSSGA
FEGITAGTNDVGVIQLPNGRAVYISVFVTDSKESDEVNERIIAEIGKLVWDYYVK
>AIA15249.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|0
MKYFADLSIFRRNPNFTFLFIGQFVSFFGSMITSVALPYQIYVETHSILMVGLLSLVQLL
PILVTALIGGVFADRYHRRMLLLVSEFAMGVGSFLLAYNTSLATPHIWLLFIVAAFMSAF
NGLHRPALESIVQQIVERKDFPTVSSLGSIKYSVGMIVGPAIGGLLVAHAGLIMTYFVDA
ASFAISLIAILLMRHIPKPENPSDEPVLRSLQTGLRYALSRQELVGTYVIDFVAMIFGMP
NALFPAIAQSFGGAQALGMLYSAPAVGALAISLLSGWASSIKRHGAAIAISAAIWGVAII
GFSLAPHFWLALIFLGIAGAADAVSGIFRGIMWNQTIPNHLRGRMAGIEMISYLSGPRLG
DTEASMVAAAFGITASIVSGGVLCVAGVAICCVLLPKFWRYHSDHL
>AIA15232.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAAVAKNGVIGNHDGLPWYLPADLRHFKQLTVGQTVIVGRTTHESIVTRLGHPLPDRRT
IMVTRQMDYVPEGVEVAHSLDEAIAMADGNAVIIGGGEIYRQGLPRADRLEITEVATEPE
GDVTFPEIDESWQEIARDRHVHDDKNPYDYDFVSYIRQR
>AIA15183.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|0
MKTIVLAAVTIDGKLARNPSHFVDWTSREDKKLFYQLTKRSGVMVIGDNTFKTFPGPLPG
RLHVVLTYTPAGKENVPGVVEYTAAPPEAILSDLEARGYEEVVIGGGSQTNALFLEHDLV
DEIWLTIEPLLFGIGVELFHGGTIGRPARLIHMERLNEAGSVHLRYSLRV
>AIA15181.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MLVKMLQKDPSSRHGVVITWDPSSDGLGGASKANVPCPYTFTVNIMGGRLNMMNVVRSND
VILGLPHDVAGFCLLQLILAQKLGVRPGVYTHVIANAHVYDIHYDAAKEMISRPADHPKV
TLQLPDGTFGRAEAKDIGLVDDINGSLLAQYRPGEAIKGLRIVL
>AIA15112.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
NDLKYFKNLTWGMPILMGRKTFDSIGKALPGRKSIVITRNQEWQHEGVDVVHSIEEAVKK
AESYGAKEIFVIGGAEIFKTSLSAANRVYVTRIHHQFEGDVFFPEISEKEWQLKASRYCE
ADEKNHYNHTYQVWNRK
>AIA15104.1|FEATURES|farme|aminoglycoside|WS68_05870|antibiotic inactivation|0
MSLSIRPAQVQDAAVIVGFIRDLAAYEKLSHEAKATEGDILRDLFGSAPKVFCEIAEWGG
KPVGFALWFYTYSTFQGRHGIWLEDLFVDPSMRGRGIGKSLLVQLAQRCVAEALGRLEWW
VLDWNAPSIEFYISQGGVMQDEWTKVRVDGEALQRLGAS
>AIA15092.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
NMKKPRLSIVVSMAENRGIGKDGDLPWNIPEDRKRFKNLTMGHPVIMGRTTFESILHYIR
KPLPGRTNIILTRDKAYSYPGTIVVHSLADALKKAAELDNEEIHIGGGANVYEQIISLVD
KLYLTIVKGEFNTDAFFPDYSEFKKVLHKEEGESNGYKYIYMELER
>AIA15048.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MKTTVLARLTCSLTFLSLATILPAQSPSPSASETPSAMVKSWLAPAEPLHIAGPINFVGT
QGLGVYLITTPAGHILLGGGMPGSAATIETSIRKLGYKPEDIKILLSNHAHFDHVGTLAD
LKKLTRATVAAMDRDVDLLASAGKIDYLFAKNPRFRFPPVTVDRVLKEGDVVELGNVKLT
ARLTAGHTPGCATFTTTLEERGRSYNVVFPDGTSVNEGTRFLNNPSYPGILEDYRRTFTT
LESLKPDIFLTYHVDEFDLAAKRTRAATEGVRAFVDPEGYKRFIAERKAKFEKLVTEEKS
STANESLPTPAQ
>AIA15045.1|FEATURES|farme|beta_lactam|blaA|antibiotic inactivation|1
MKFLSFILILVCAQHIFANKYPSARKQLNKLEHSLDGKIGIFAMNTANQQTIHYRSKERF
PIQSTFKLMVVAAILKKSATDPELLQKKIFYTKNDLVTWSPITEKRIDSGMSILELCDAT
MKYSDNTATNLLMKQVGGPAVITDFAHSLGDSVFNVLHYEAELNSNPNSTDDTSTPENMG
INLKKIAFNPILPSSYIHLLLNWMKENTTGDAQIRAGVPKEWVVADKTGSSSFGTSNDIG
IIWPTGCDPIIIAIYTVQNKEDATKRNDILKDATRTVINEFARADLCIKQALKNEKA
>AIA15000.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MKNFYQILLNTLIANVTTSYLWFGLTFWVYIETQSVLATGIIGGAYMLLVAIFSIIFGTI
VDRNKKKNVMVFSSVFTLLFFALGGLVYLLFDKGQLLDWTGPVFWLFAGLILIGGVVENM
RNIALSTTVTLLVPKEGRDKANGMVGTVQGVAFMVTSVFSGLSIGLLGMGWTLAIAIAFT
AVAAVHILFVKIPEKTIAHDPELAGKKIDLKGSLAAIRVVPGLIWLIVFSTFNNLVGGVF
MTLMDPYGLTLFPVEIWGIVLGITSTGFIVGGIIVAKKGLGKNPLRTMLLVNIGVAVLGG
LFTIRELWPLYVVGIFLFMCLMPAAEAAEQTIIQRVVPLKRQGRVFGLAQAIESASSPLT
AFLIAPLAQFAIIPYMNSDA
>AIA14994.1|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|0
MPAQTANASSGAPQIRDATEADLPAIQTIYAHHVLTGVASFEETPPSVEDLRARLASVRA
HGLPYMVAEIDGEIAGYCYATPYRPRAAYRTTIEDSIYMSDAYRGRGLGRMLLQALIERC
ETGPWRQMVAVIADGGSGGSLSLHRQAGFELTGTFKAVGFKHGRWLDTTLMQRRLGRGDS
ALPDDVARDATTIAARSDD
>AIA14963.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MIQTSIVATVSADGFIARDHNELADWSSKADKKLFVELTKRSGVMVMGSATYKTIGRALP
GRRNIVYTHGTIDQEGIETTSETPTDLLKRLEQEGCTEVSICGGATIYGMFLRAGLVTDI
YLTVSPLLFGTGISLLASTLDVQLALKDSRLLDENSMLLHYKVEQ
>AIA14953.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSMIVAASENGVIGKDGTMPWRLPAESAYFREVTLGHPVITGRKNYEAMGRPLPGRLN
IVITRQTDYEVPKGVIVVHSLAEALKLPQVQSEQEVFIIGGAEIYQQAMPLADKLYLTTV
HAQIDGNTFFKYDPGQWQLEWSQHHPADAENKYSFTLQRFQRIQ
>AIA14947.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MSKVDKAEDLKEALTTAFKYADEVMVEQYVKGKSLTVGVVEVNGQPKVTPILELRPTKSE
WYDLEAKYTEGGTEFIMPAELPDTVTTVIQDATLRAHLAAGCRGMSRIDFVTGRKTNFTF
WKSTPFRA
>AIA14935.1|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MKIAVMFGGTSEERDVSIASGSQVVKALRSKGHDVVAVDTATGVLDADTEAKLMSSDVRT
APPGSEDLDVLRTGDATSILRAPEMQGVEVIFLALHGGAGEGGTLQALLELTNIPFTGSG
MLGSAVAMDKDISKRLFMTAGVPTPEWLMAPA
>AIA14910.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MAQSTYVIEAKNLQKSYGTNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLGFD
GGSVTVEGYDVIKQADKVRGVIGLTGQSAAVDELLTGRENLIMMGRLYRLTTESAKTRAQ
ELLEEFDLVKAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSR
>AIA14872.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKYIDFAKRTPDSQYHDVLQSILDKGQWSDTRQGPRAKTLMGIQMHFNLANGFPVITDRS
IKSFWQKPIGELCAFINGARTREQLAAFGCTWWDAWTTEEKTKKRGLEPGDIGPGSYGAA
FHDFPTADGGTFDQFKHLVEQIKELPELRTHFITPWIPQYIVRGKGKQQKVTIAPCHGWV
HVRIFGGDKLHLHMYQRSGDMPIGVPSNMIQYAALALMLEHLTGYEAVEYVHTVSDAHIY
EDQIEHLLPMMKREALRLPTVKLTAEGKKVTDIHDFRGEHFELSDYEPHPSIPKIPVAT
>AIA14867.1|FEATURES|farme|aminoglycoside|APH(6)-Id|antibiotic inactivation|0
DLEVVEVGDGNLNYVYFVTNAKAPGRSVVVKQAPPFLRLVGKTWPLSCQRMEHEVAALRR
FGALCPRHVPKVYHADSKRFLVVMQHLASHRILRQGLMDGAMYPRLADHLSTYLAHTLFY
GSDLFLAPDIKKQAASAAVNAELCKITEDLVFTFPFEDHPSNVYSPALPKAAIERLRTHA
PLRIAAADMKWAFMNHAETLLHGDLHTGSIMVNEEDTFVIDPEFAFYGPMGFDVGAVIAN
LLLAYFSRDWHGRIDGRDPVAYQEWLHAAAAGRYARLRGLQDDSPHRRHGEGRGSHAHSG
CASAGEYRSALPALRGSVTRRARHARRYRTSGGARARHSARYRDDVTGDLMASQPLFTTL
PPTIEWRDGDLLLLDQTRLPHEIVVENIADVKAVWRAIRELRVRGAPAIGVAAA
>AIA14857.1|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MESRMNRKTILVLFGGESSEHDVSIMSARNVYAAINREKYEPVLIYIDRVGRWWLLDDWQ
ENLENHNGAEVALLPGEGSLIVLGEDKKLYIDIAFPVMHGENGHEDGAIQGFLRMAHIPV
VGCGIGASAVCWDKIYTKQILERNSIKTTPYVYHRGGTQMPDYDRIAGEGADLFVKPATA
GSSVGVSKVRNKDEFEQA
>AIA14856.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSLNPSPSTRVSRRAWVMLVVLTMLTVIGMTVVLPVLPFVVLQYVGNENDLAIWVGVLE
AINGLCAFLVAPFLGRLSDRFGRRPVIIVAAFGAAFAMTLFGIGGAIWVLVLARAIQGVT
AGDLPALFAYLADITPPEERAKRFGILGALSGIGMMIGPAVGGLLAGVSLQLPVFITAGI
SLLVAVLSIFLLPESLKAENRIRTISIRDVQPFSVFKAAFGRKELRGLLIGFGLLALSFG
FFVNNFSVLALDSINWGPTEIGLMTASIGIIDILI
>AIA14806.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKSLEPYGQQTMNKEGFPSMSSVQTPVKLSSQTRIGVLYGGLSSERKVSLISGQNCFDAL
KRLGYENAELIDVNHHIAQTLAEKRIEVAYIALHGKFGEDGCIQGLLELMGIPYTGCRVA
ASALTMNKATTKSVLKDAGLPVIDSVVIKAGTVNGKAVRYRAELPGDGQTHQRGLQHRHE
QGGQGRGPERGPHHGL
>AIA14767.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MELSLIVAMTRGGVIGRDGGLPWRLSADLQRFKTLTMGHAILMGRKTWESLGRVLPGRTM
IVVSRRGGFVVPEGVIIVPDLEAAIAAAGNDGEPFVIGGGQLFEPAMGLCSRMYVTWVEG
EVAGDVYFPAVNWGEWREVSRESHSADTKNDYDTTYCVYDRVSKTPAPVAAG
>AIA14764.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MASAATMTTLPKNIAVLMGGPGSEREVSLATGRGVANALRSLGATVTEVDVRGPDFVLPE
GVELAFISLHGTFGEDGQVQKILEERGVAYTGEGVEESRLAFDKIESKNRFRAAQVATPY
WQIILAKQRPTIPPPFVVKAPRQGSTVGIYIVHSDREIEAAITSASQYDEQLLIEKFVSG
RELTVGVLGDLALPVLEIIPKGGVYDFTNKYPFLNPGAGGGAQHVCPAAISEEQTATIQK
LALQAHRALGLQVYSRVDILLPEEEEPTVLEVNTIPGMTEASLLPEAAAEAGIPYPELCA
RIIELSAKARPSKG
>AIA14748.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MTTTAFARPGLAPLVAEATFIKRSLIHTLRTPDALIMAIALPVVLMLLFTFVFGGAIDGE
GQYVNYVVPGIILLCAGFGAASVANDVANDMTTGIIDRFRTMPLRATAVITGHVVASLLR
NLVATVVVIGVALAVGFRPNASPLEWQAMLGLVALYILAITYLFAAIGLAASSPEAAGLA
ASSPEAAGGYGFILMFLPYLSSAFVPVDTMPEWLRWISNNQPLTPIIETIRGLLLGTDIG
SSGWLALMWCGIILAVAVVWASILFRVKAGRR
>AIA14746.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MKNFYQILLNTLIANVTTSYLWFGLTFWVYIETQSVLATGIIGGAYMLLVAIFSIIFGTI
VDHNKKKNVMVFSSVFTLLFFALGGLVYLLFDKGQLLDWTGPVFWLFAGLILIGGVVENM
RNIALSTTVTLLVPKEGRDKANGMVGTVQGVAFMVTSVFSGLSIGLLGMGWTLAIAIAFT
AVAAVHILFVKIPEKTIAHDPELAGKKIDLKGSLAAIRVVPGLIWLIVFSTFNNLVVGVL
MTLMDPYGLTLFPVEIWGIVLGITSTGFIVGGIIVAKKGLGKNPLRTMLLVNIGVAVLGG
LFTIRELWPLYVVGIFLFMCLMPAAEAAEQTIIQRVVPLKRQGRVFGLAQAIESASSPLT
AFLIAPLAQFAIIPYM
>AIA14743.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSFFRDTWSIFSRSMRLSLRQPLWVAIGLLQPILYLTLFGPLLQNIAATSGFKGDAWQVF
VPGLLVQLGIFGGLFVGFGIIAEWRSGVIERQLVTPASRNAIITGRSLRDVVVIVVQAAV
LVGCAFLLGLRVPVGALLIGLVLVALLGAAFSFISNAIGIATKSEDALAPMVNTLALPIL
LLSGILLPMSIAPQWLQIVSNFNPFKHIVEALRAVFLGDFGNPIVWIGLLL
>AIA14733.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRITLLFGGTSRERLVSVASAQALTQALPEADLWFWDLDGTVFEASQGALLGHDKPFEVP
FKADGARLGTIAEALDKAAVEDRILVLGLHGGTAENGQFQVLAEARGVPFTGSGSAASHL
AFDKTAAKLFAGLAGVYSPSTVTIDEADEALSHYGRLIAKPASEGSSYGLIYVNSSQDIA
AVRRESASMAYLIEPFITGPEATCGVLEQVDGSVIALPPVEIVPGDGAFDYAGKYLKSTT
QEICPARFDPAINAELQRLAVKAHKAMSCRGYSRSDFIISDKGPVYLETNTLPGLTKASL
YPKSLKAQGIEFIDFLNGQIDLAIRKAGR
>AIA14720.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKTFIIAAISADGFIARRTNELADWTSKEDKRIFVELTKRAGVMVMGNTTFQTIGRALPG
RRNIVYSYGTVDVESVEVTDEAPAVLLQRLEAEGCTEVAICGGSAIYTMFMQAGVVDELY
LTVEPCVFGTGVPLFSGALQTQLTLLEPRSLNDNVLLLHYEVQK
>AIA14717.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MVNSKLKSLFVGNSVFIFGGSLLVPIYALFTEDIGATVQMTGLLFAAKFVATALADIVIM
RIPHKFNNAVAVYQWSMFVRALAWLYIGVAPSITSLLIVQIVTGLAEGFGTPAFSTLMTN
ALDKKRQMQQWALWDLIKNPVLAASGIAGGFIANQYGFSVLFYAMGILALAGTLVPVGNK
GLKRRKAKQYAKLSYEYLFSR
>AIA14703.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
MTIKRRIGFVFYSVFTMSCFGSFGVHAAETVKCTVILDAKSGEALHRNGECDKAFAPQSS
FKLPLAIMGYDAGILKDETTPRWDYKAAWKRPKREQQPTDPTIWERDSIVWYSQEITRRL
GKEKFADYVRRFDYGNADVRGVKGQTDGLTESWLMSSLKISGDQQVDFLRRFLSRKLPVS
NVAYDKTMAIIPKFPAADGWQVQGKTGSGRMRTKAGKYDGDSWLGWFVGWADKGDRRVVF
ATLNIQDWKNDEPISFATRDTLIADLPKLVKQV
>AIA14647.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQKSLLNAVVAIGRNRELGKDNQLLWRIPDDLKRFKALTMGHPLVMGRKTYESIGRPLPG
RTNIVVTRDPNWRADGIEIFHSLEEALARARELDQEEIFLGGGSEIYRQAFPQIDRLYLT
LIDDEKDADTFFPKYEKEFTSKTFEEAHEWEGLRYRWINLERA
>AIA14643.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MITHVKNSQPVEAPLSAVVAMAKNRVIGKNNQLPWHLPADLKHFKALTSGGVVIMGRKTF
TSIGKKLPNRVNIIVTRDKNFFADDCLIAHSVQDAIALAREQDNEHLFVIGGNEIYEQAM
PYLEKIYLTTVEQAFSGDTYFPLLDPLVWQETSREEHHADEKNPYDYAFTILERV
>AIA14636.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MMTEDLKKEFGKVGVLFGGRSAEREVSLMSGKGVFAALQSKGVDAHPFDPAERSLAELAA
EKFDRVFIALHGRFGEDGTLQGALEQLGIPYTGPGVMASSIAMDKVMTKRIWLACGLPTP
KFLVLDSHSSTVEQLREVPDELGLPLMLKAPHEGSTIGIAKVAGYSDMQDGFALCAKYDE
VVLAEQFVAGRELTVPVLAEGRNARALPGD
>AIA14623.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
EIPDMRKILASLTALVATLSLFAPAMAGQPAAWSQPTKPFQILDNIYYVGTKGLASYLIV
SNGKAILLDGTLAENAGYIEANIKALGFRLEDVKIILNSHAHYDHAAGIAKLRQDTGAQV
MAMEEDRSALEHGKQEGDTNYGGARFPAVKVDRALHDGDVVALGDVRMTAVLTPGHTKGC
TTWTVMSADNGAPRQVVFPCSITVAGNILVGNKSYPGIVEDFRDSFERLGSMEADVVLTA
HPEFADVFQRKARRDAGDKDAFVDKDLLHRMVEKARTAFDRNLKAAQE
>AIA14607.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
PVDGGSSVDTFIVRDVATADMEAMQASCEKNSRMLIEELIEGTEITVGVLGNESLPVIEI
IPPADGEFDYENKYNGKSQELCPPQSVAADVQTAAQELALRVHTLSGCRDFSRTDMIITA
DNSLYVLETNTIPGMTDQSLLPKAAAVAGLSMPELVDRLVNLAAARA
>AIA14584.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EVPTAGSLRDAVEAALNDGNGALVEELVEGIEVTASVIGDGATTRALPLIEIEPQSDVEF
FDYKTKYTPGAARHITPPRISEELQKRIADDTLRAYQVLGCRDVARADFIVRPDGTACFL
EINTLPGMTETSLVPDAARAAGLSFEELIESFIQGALNRK
>AIA14572.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MMTISILCGFVPTFILSPIAGVWADRYNRKMLIMLADSLIAISTLILAILFLIGYDDLWL
LFVMSAVRAVGTGIQTPAVGAILPQIVPEDQLTKVNGANGSIQAMIMLIAPIISAALLTT
ASLETIFFIDVVTAAIAVSILLFFLKISVHEKALQKQTTSYFSDMQKGFIYIKNHDFLKK
FFLFFAFFFVLSAPAAFLTPLQVTRSFGDDVWRLTAIEITFSIGMIIGGIAISSWGGFKN
KIHTMTLAALIFGACTFALGVIPVFWLYLIFMGIIGVAMPMFNTPSTVLLQEKVEPDYLG
RVFGVLGMISTSMMPLGMLVFGPLSDYVEIEWLLIGTGIVMFIQGFFLLGSKVLVAAGKP
NLEESK
>AIA14542.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLARLRQHGHEKGDRTGTGALSLFGAQMRFDLTQGFPLLTTKKLHVKSIIHELL
WFLQGSTNVRHLNEHGVSIWDEWADASGELGPVYGRQWRSWPTPDGGHIDQIAKVVAGLK
RDPDSRRHIVSAWNVGELDR
>AIA14513.1|FEATURES|farme|glycopeptide|glyoxalase|antibiotic inactivation|0
MSTTNVGSNDASVKDVDLKLEAVVIPVSDVDRAKEFYGSLGWRLDADFAFDNGFRVVQFT
PPGSGCSVQFGTDITPSAPGSAHGLYLVVSDISAARDGLAARGVDVSEVFHAGTPGAQFQ
PDGSGRVSEPAPDHASYGSFATFSDPDGNGWLVQEITTRLPGRIDAADTAFASVADLASA
LRRAEAAHGEHEKRTGQPDENWPDWYAEYMVAERAGTELPT
>AIA14483.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILATVTIDAIGGGLIFPILPGLLAEVAGSGDIAWLFGAMLAAYAIMQFVASPV
LGALSDRFGRRPVLLLSLAGAAIDYLIMAFAPELWMLVLGRAISGITSANMAVATAYITD
ISTEEERAGRFGLFHAMFGIGFIIGPVLGGVLGDFWVRAPFIAAALLNAVNFALALFVLP
ESRKGTSGARFSWDTLNPFKPLKWALTFRALIPLMAIFVIMNFVGTMYGTIWAMFGEDSF
QWNGLMIGLSLGAFGVFHAGAQAFLTGPAVARLGERWALIVGMACELTALVIVGLATQGW
ILFALAPLFALGGIGMPALQSVTTQQVDGDKQGQLQGVLASLVSLASIFGPVFFSFMYFA
VSDTWPGLIWIVGAGIYLLALPLMLGIRRGATPATAAGE
>AIA14466.1|FEATURES|farme|beta_lactam|blaA|antibiotic inactivation|1
MEFLSFILILVCAQHIFANKYPSARKQLNKLEHSLDGKIGIFAMNTANQQTIHYRSKERF
PIQSTFKLMVVAAILKKSATDPELLQKKIFYTKNDLVTWSPITEKRIDSGMSILELCDAT
MKYSDNTATNLLMKQVGGPAVITDFAHSLGDSVFNVLHYEAELNSNPNSTDDTSTPENMG
INLKKIAFNPILPSSYIHLLLNWMKENTTGDAQIRAGVPKEWVVADKTGSSSFGTSNDIG
IIWPTGCDPIIIAIYTVQNKEDATKRNDILKDATRTVINEFARADLCIKQALKNEKA
>AIA14464.1|FEATURES|farme|multidrug|MdtH|antibiotic efflux|0
MQLSGRKMKPSLRRSTAALLASSLLLTIGRGATLPFMTIYLTRVYNMSVENIGYALTVAL
TIGVVFSLGFGILADKFDKNRYMLIAITAVALGFLAIPLVDNVVLVVLAFSLINCAYSIF
STVLKAWFADVLNPAEKARVFSLNYSFLNIGWTIGPPLSTLLVMYSLQLPFWVAAFCAAL
PLVLIQRYVQKGVAADSEHVPVPWQPSVLLRDRALFWYTLSGLLASYVGGSFASCISQYV
LAADYDSDFAQNVVAVVLPVNAAMVVSLQYIIGRKLSARNIRPLMTLGTLFFVLGLAGFM
VSGENLIYWGLAAAVFTIGEIIYAPGEYMLIDNIAPPGMKASYFSAQALGWLGAAFNPMI
TGLILTHLPHWSLFVIMMVAIVLAWMMILRGMRVKAWVELPRVA
>AIA14434.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
AIMGRKNYDSLPEVFKPLPNRTNIVVTRQPEFHAPGCIVVHSLEHALRIARENGESEAFV
IGGAEIYALAMSQANRLYLTEIDAVVEGDTYFPSFDKTQWRELSRRHHEVDEKHEYAFDY
VIYERLP
>AIA14405.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTRCARISVLILLFPILAFAQQAKLKSEIETISKQAKGIVGVGIMDLKTQETLLINQDHK
FPMQSTFKFPLAIAVLDLVDKGKYKLDQTIHVTKAQIDTETHSPMRDKRPNQDFDITLAE
LLSYSVSESDNNACDILFELAGGTKKVNDYIHSLGVKDIAIVATEREMKAGWDVQYTNYS
RPSAYLQLLQIAYERKKLSKASHDFLWKTLVEGPTGLKRIKGQLPKGTEVAHKTGTSGTS
DKGIVAATNDVGIVKLPNGKDIAVVVFVSDAAADIDTRELVIARIAKAVWDYYGGK
>AIA14394.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MQLTIAIYFTPILMIKKSCTLFLFIVACCAASVVSAQSLKSENLIIEKVKDHVYQHITYL
QTQSFGRVPCNGMIVFDKGEAIIFDTPVSDSTSNAVIDWVEANLKCKVKAVIATHFHEDC
VAGLDAFHKRGIPSYATNKTIASAKNAKFKVPQKGFDDKLELTVGDRKVITEFNGEGHTR
DNVIGYFPSEKAMFGGCLIKELDATKGNLADANVKDWSTTVTKIKQKYPDTQVVIPGHGD
VGNTALLDYTIALFEMKK
>AIA14368.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|0
DWTSKEDKKLFVELTKQAGVIVVGRNTYETIGKALPGRLNIVYTSKPLDNSDIQTTQEPP
KELVNRLEKEGYDQLALCGGRSIYDLFLKEGLVDEIYLTIEPKLFGSGITLSKLPLELDL
ELIESKKLNNDTLNLHYKVLKRDVGTNQ
>AIA14352.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
AIVLGLLSAVGPFAIDMYLPALPTIASDLNASIAATQMTLMSFFIAFGVCQIAYGPISDM
VGRKPPLYFGLVLFTIGSIGCGLAPSIEWLIFCRFVQGVGAASVMVIPRAIIRDLHTGVE
ATRLMALCMLVLSVSPILAPLTGSALIVPFGWRAVFVAVTIVAILGLLLTAFSLRETHPP
KNRMRVSAGDVLSSFGTLLRHGRFLGLTFIGGLGMASFFTFLASSSFLYIEHFGLTPTQF
SFAFSINAVGFIGASQFAAHLGERFGMARMVMTAVSIYAAFLAILFGLTLAGVDDLAVLM
ALLFFGFASMGVVIPSTMVLALDDHGPIAGMASALGGTLQMLTGGAMIVIVSFFFNGTPM
PMVATMTACALGAFLLSIVTLGGRKRALQPAE
>AIA14349.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MDRPWVTRRLRRQPDSKEAFIMSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGADLHA
GTAAVQMSLLIFFLSMGFGQIVVGPISDMVGRKLPLYGGLALFMIGGIGSAMAPTIEWLI
AFRFLQGLGASAGMAVPRAIVRDLHTGN
>AIA14347.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGQDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSAMSPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVF
>AIA14348.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MPASSLKETRPAEERVGSSFGTALAGYRFLMGDRNFLGLVAIAGFGIASFFVYLSSSSFI
LIDHYGLSPSVYSVFFSINAVAFIGMSQLTGLLSERFGLKRVVWVAVTGYASTMVVLFAV
MATGIDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFAIGAVAM
GVAGIFFDGTPLPMVAGITLCAVISFTLAKFTLGRTREAVEAPAE
>AIA14334.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
RIIGRENKIPWRLLDDLVSLRKLTKDHAVILGRKTYESMLFYYERSGKQMPGKVYVVVTR
NTEYQPARDDAVAVYSVDEALAVARKFDDTVMVIGGATIYEAMLPHTDRIYMTEVQTQAE
GDVYFPQLDTAVCTRLPANTTTKTTATNTITTRSSSKSATNSSRR
>AIA14313.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISSIAAVSQNHVIGRNNDLPWNLPDDMRFFMQTTKGHHCVMGRKNYDSIPDKFRPLPN
RTNIVVTRQADFKAPGCIVVNSIERAVSIATSNGETELFIIGGADIYRSAMPVTQRMYLT
EIQAQIQGDVFFPTLDKAEWKETKRTHHQADERHAYAFDFVVYDKIT
>AIA14296.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVIMVVAAAENNALGKDNDLLWHLPDDFKRFRQITTGHPIIMGRKTFESLPKMLPNRTHV
IITRQKDYKPEGCIVVDSLEKALALYPKNEDVFIIGGGEIFKIAMPLTDVVELTRVHANF
DADTFFPELNPDEWQLSGSEFHPKDERHAYDFT
>AIA14291.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNKPRISIIVAMSENSVIGNKGEIPWNIPGEQKRVKEITTPHPLIMGRKTHEAIGRVLPG
RLNIIVTSDKAYQVEGGVVVHSLQEAIAKATEQDSQEIFIFGGGKIYEEAMPLVDRLYLT
IVHIEVEGDAFFPDYSAFT
>AIA14239.1|FEATURES|farme|multidrug|emra|antibiotic efflux|0
DIAKLAELAAVHKPRFYVINSVLHNPTSTSLSAAKAFQILKIAEQHDFTIVEDDIYCDLH
PGSAVQPATRIASLDQLNRVIYLGGFSKTLAANLRVGFIATSEDMAKRLSDRKMLSTLTT
SDIGERIVYKILSEGHYRKHVDRLRSKLDTVRDKTVKQLERVGLTIDITTPAGMFVWADT
GRDTHVLTEKALEHGILLAPGSLFSPSQLPSTRMRVNVASASDVSVLRFLERELGKP
>AIA14191.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILANGNEHEDRTGVGTISHFGYQTRFDLRQGFPIVTTKKVPFRWIAEELF
WFLSGDTNEANLRARGVDIWAEWADEEHTRRFDRQAGDLGPVYGYLWRSFGGHYPRRNGV
DQIANLISEIGSNPNSRRLIVTGWDPRQANRVDLPPCHTLFQFKVENGTVLHCQLYQRSA
DAFLGVPFNISSYALLMHMVAHVCGLEVGDFVYTLGDYHIYKNHLEQVEELLAREPFPLP
RLEIVDHDKRLRGLESLLGMRYEHLNLVGYQSHGKIAASVAV
>AIA14182.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
YAGATWLTAAVTLLLVALVESGEPRVWARPLMWLLIIGTVMFSYLFIRAERRAKEPIVPF
SLFQNRVIAVGSLISFLIGAAMFGAITFIPLFVQGTLGGTATQAGVLLTPFLLGWVVMSV
VGGRLIFRIGYRTTILSGLLLLVASSAALTSFGQGTPRAALMIDVAAMGCGMGLVMFTLI
VTTQNAVDRSRLGIATSLTQFARSIGQTLGVAAMGMVMTISLTAHLADIQRTSGRPPEEV
AQVVHNPSSLIDP
>AIA14139.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKVLLIAAMTADGYIAKDKDHLATDWTNPEDKYLFTHFVKDLGGNMVMGLNTFVTIAKKF
PTVFNKAIPGRRLLVYTYNPEDVVPYPNVEAVTEPPEKLVRRLAKEGLKNLTVCGGAQIY
TMFMQAGVVDELYIDMQATVFGGGVTIFNGPIDATISLQEIKRLGDNNVLLQYKVEK
>AIA14136.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTREGVIGRDNAMPWKLPDDLKRFKALTMGKPMLMGRKTFLSIGKPLPGRTTLVLTRDPA
WQAEGVIAVRSVEEAFQKMGDAPELCVVGGAEIFALTLPVTDVIYLTRIHADIPGDTHFP
PFDTSEWRETERVEHPADERHAYAMTFSTLERRPA
>AIA14115.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GSNKERLVSVATAQALNAALPDADLWFWDADDTVHETQTAVLQGHARPFEEPFKPRPHSL
GRIDEALDRAKLENRLLVLGLHGGIAENGELQAMCELRGIPFTGSGSASSHLAFDKVAAK
HFAAIAGVKAASGVPLDEAERALAQYGKLIAKPSRDGSSYGLIFVNAKQDLVAVRDAART
EDYLLEPFISGVEATCGVLEQSDGSVFSLPPVEIIPAEGGFDYTAKYLAKTTQEICPGRF
APEVSAAIMDQALRAHKALSCRGYSRSDFIVTDNGPVFLETNTLPGLTKASLYPKALKAQ
GITFVDFLNDQIALAMKHTQK
>AIA14104.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
MASNRKAALGFIFITILIDVTGWGIIIPVVPTLIKELINGDISAAARWGGLLTFAYAGMQ
FLCAPIIGNLSDRFGRRPVLLFSLFGFAIDYVVVAFAPTIWWLFAGRLVAGITGASITTA
MAYIADISSPEDRAKNFGLVGVAFGAGFVLGPAIGGLLGELGSRVPFMFAAGLTLLNWLY
GYFVLPESLAAQNRRKFEWKRANPVGSLMLFKRYPGIWGLVCSLALVYIAAHAVQSTWNF
FTVERFGWSEKMIGLSLAVVGVLVGLVQGVLIRYVNPRLGNEKSIYTGLVMYAIGLFLFA
FASQSWMMFVFLIPYCLGGIAGPALQAIITNHVPGNEQGELQGGLTSVMSLTTIIGPLVM
TNLFAFFTRKDAPVHFSGAPFLLGSLLMLASAITAYVILKKEKHHAPAQVAK
>AIA14067.1|FEATURES|farme|beta_lactam|SHD_1818|antibiotic inactivation|1
MNIRLGFLLLSLFIVGLNSAPVEAQDLSPYFKNTNGAFVLYDLKENHYIRYNEQRCRERF
SPKSTFKIPNSLIGLDTGVIRDADFTIAWNRQKYPPQDNWNQEPFIHWAQDHTLRSAIKY
SVVWYYRELALRVGKQKMMKYITAFNYGNKTISKDIDNFWLDNSLKISADEQVEFLKEFY
AGRLPVSKLATETVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFA
TNIEGASFAEIREKRVELSKEILAALGYLTK
>AIA14055.1|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
MALATPTSNVDAQPPRGLFMRGADLVVSYVRMHPLPFAVSVAGSLVFAVASILLTQALAR
ATDEVLGPVFEGEAVNARQVWLSVVALMVFACGRALGIMVRRYYSGVAGERVMQSLRTRV
AERYRELQLQFHRETPTGELLAHMEADVKAAVDVFWPVPFATGVIALTLLAMWELLRADL
WLAAIGLLLFPSLALMNQVFAKRMEGPAQRAQEDIGDVSAVAHESIDGALVVKTLGREDA
ETGRLEAKAESLRHDRVTGGYIRATFEAALDALPTLATALLLAVGSWRVSVGAITVGDLI
GFVALFGLLSWPMRFIGWILAELPRAVVGYARLEDVFRQQVTVAPPASPVALPTGPLGLS
ARAVRHVFDGQAVLNGVTFDVEPMESVAIVGPTGVGKSTLAQLLVRLADPEAGHIFVGSV
DVRDADPVALRRDVSIVFQESFLFATSVRDNISLDAEVSEADVVRAAMIASADRFIRELP
KGYETVVGERGYTLSGGQRQRVALARALVRAPRILILDDATSSVDPTIEADILAALRREL
STTLIVVAYRLSTIRLADRVIFLEDGVVKATGPHDELLRRERGYAQIIHAYERGER
>AIA14050.1|FEATURES|farme|beta_lactam|VEB-7|antibiotic inactivation|1
SGQINKIESTKRQQDTPSKKVENLQKENDRKSDLTGQIKQIAKTVGLGRVGVAATILETG
ETVSLNAKDRYPMQSVYKLPIGMTVLSQIDAGQLNLSERLRIEKENVLKTSRILPKEKFP
DGTEQTIEELLRLMVSESDNTASDALLRLVGGPEAVMKFLNKNEIFGIEIANYEKEFAAD
WRVQYKNRAAPKAAIELLRALHESRGLSAQSQALLLKYMTDSPTGPRRLKGLLPEDAQVA
HKTGTSGTRDGITAATNDIGIVTLPDGRHLAIAVFVSDSPADETIREETIARIARAVWDY
WSKK
>AIA14034.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MANKNAALGFIFVTLLIDVIGFGIIIPVVPTLISELGHVSIPEAASYGGWLIAAFSVMQF
FFSPVLGNLSDQYGRRPILLISLFGFGVDYLLTAFAPTIAWLFVGRIIAGIMGASFTTAS
AYIADVSTAENRAQNFGMIGAAFGLGFIIGPALGGVIATFGLRAPFIAAAILTLINWLYG
YFVVPESLKLENRRKFDWKRANPLGSLKFFLRYKVILGLVASIVLIYVAGHAVQSTWSFY
TIEKYKWNAAMVGYSLAFVGLMVAFVQGWLIRFIIPKLGQERSVYVGLTLYAIGFLLFGI
ATQGWMMFAFLIPYCLGGIAGPSLQGIMSGQVPANQQGELQGALTSLISLTSIVGPLLMT
SLFYYFSEPSADIYFPGAAMIAGSILTIMSAFLARLSLKKNIVKASNA
>AIA14015.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSRISFVVAVSHNGVIGRVGGLPWHISTDLRRFKAITMGKPLIMGRKTWESLPKKPLPGR
PNIVITRQKNYRADGAIVVSDIPSALAAAGQVEEVCVIGGGEIFDMFLAQTDRIYLTEID
LQVDGDTFFPSIDPAQWTETGREIHPRGPNDSAGFVLRVLDRNA
>AIA14016.1|FEATURES|farme|aminoglycoside|N184_17645|antibiotic inactivation|0
MITVRPMQRGDGAALLSMVVALAESHNLLHTVLATPEMYEAAMFADRPIVGTLMAEYDGR
LAGCAVWHRSFSTNRGAEVMYLEDLSVLPEFRRRGVARALLKAVARLALAKNYPSVYWLM
MDWNKEASALYKSIGAEIEPGTTFCRIRDDALRALAT
>AIA13945.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVSIIAAVTADGFIAKASDHMADWTSPEDKKRFVALTREAGVMIMGSSTFDTIGRPLPG
RKTVVYTTNPSKYAGVDILTTKDDPKVLLEKLEAEGYSQVAICGGAHIYDLFIQSGFVTD
IYLTVEPVLFGQGLTLFTNPTEYKLELVAHEKLNDNTVATHYRVLA
>AIA13928.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAHARYKQLVDALAAEIRAGRLPPGTRLRTHRQLAAKEGLALVTATRVYAELEAMGLVSG
ETGRGTFVRETSLPRGLGIDQHAAAADIVDLNFNYPSLPGQAELLRAALRQLAASGDLEA
LLRYQPHGGREHERATVARHLACRGLTVTADRVLIVDGAQHGLATTVMALLNPGDVVAAD
ALTYPGFRLLAESHRLELAPIPTAGHGPDLDALERLCKKRRVRATYMMPTLNNPLGWVMS
ASRRRHLVSIARRHGLLIIEDAAYAFLVEDPPAPLAALAPETTVYVSGFSKSVATGLRVG
FVAAPVAWVPKIKRAIRATTWNTPGVTTAIACGWLDDGTVARLESEKRQDARTRQAIAAG
ILGRLHRVCHPASYFVWLPLAEEVRADQVAMALMRNRISVSTAEPFATSAQVPHAIRLAL
GSVELDTLREALETVKSVIAC
>AIA13914.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFVIAAITLDGFIGRDASQVSIYWTSPEDSKMYRRITKEAGVTIYGSRTFDTIMRGLP
GRKTIVVTSHPDTYANIENVEATSDSPAEIIQRLESEGQAQVAVCGGSTIYYQFLEAGLV
DELYITVEPLLFGTGVPLISDKLETKLQLLEVKHLNDNTLQLFYKVLK
>AIA13903.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKTTLSRNLHLFLLIIICLSVDSGCNKVKTENPVNAPAQAATPDIKNTTGSTLQKRIEEI
AAGAQGKVGVAAVVLETGEAFGFNENEHFPMQSVYKFPIAMAVLKQIEQGNLKLEQNIRI
EKSDLVPPQLRSPIRDRFPQGTEMTLNDILKYSVSDSDGTACDVLLKTIGGADAVTKYLR
DTGVKDIVVATTERAMSQDESVQYQNWASPQATNDLLRLLHSGGVLAESNRALLLQWMTE
TPTSAKRIKGLLPAGTVVAHKTGTSNTSEGLTRATNDVGLVTLPDGKHLAISVFVSDSKA
DETTREEVIAKITRAIWDEFVKAN
>AIA13898.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MTIKSIIVVIDENNAIGKNNGLLCHLPNDLKHFKAITEGHTVIMGRKTFDSLPKGALPNR
RNIVVSRNADLQYAGCEMCGSVQEAFDLCKDEDEVFVIGGGSIYRETIGMADVLYVTRIH
HEFEDADTFFPSIEPSVWKEAGRERHDADEKNKYKHSFIKFEKIKP
>AIA13846.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MQKTSLLRHRLTKLLPVVLLFLPSIAKAQSNETDRDWNRPVEPFRIAGNIYYVGATEVSS
FLITTPEGHILLDSGLAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELT
GAKLMTSKADAVLLANGGKGDFRWGDDLSYKPVKVDRLLRDNDKVELGGVTLTARLTPGH
TKGSTTWTMKVKESGRQLDVIFAGSTSAPGYKLVDNQKYPGIIEDYAHTFQLLKSLPCDV
FLAPHGSIFSMLEKAGQLKQDEKHNPFIDPKGYRNFIERTEKAYLQQLEKERQATKT
>AIA13845.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MSKTLILLAAAIISLNCSRAVSNTQQEAPKVLTSTTPSPAASSNNQRETSKLAAQVEKIA
GEARGRVGAAVMLIETGEAIVSLNADQRFPMQSVYKLPIALVVLRRVDRGALALEQRVRV
EQSDFISARQHSPIRDKNPRGVEMSLRDLLRFAISESDGTASDVLMRLAGGADVITRELR
ELGVSGVMVVNTEKELGENQSLQHQNWATPESMLVLLRALQEGRGLSVQSRILLLQLMAE
STPGPRRLKGRLPPGTVVAHKTGTSGTEKGMTAATNDVGLITLPDGRHLAIAVFVSDSPA
DESVREGVIARIARAAWDWSTQARWVPFTSQG
>AIA13842.1|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MAVSKKTFTTVDDDKLHQLLGKFVTDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELA
ERTGTNERYVREWLNSQAAGGYVEYDTDTGRYFLTAEQAFTLADETSPAYMPGAFLLAIS
ALRAVPKITERFRTGDGLGWHEHDSGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLKD
GAKVADVGCGLGASTILMAQAYPNSTFTGFDYHDASIEMAKERAREAGVSDRVNFEVAKA
KDYPGTGYHLVTFFDCLHDMGDPVGASAHVLESLAPDGAWMIVEPFAEDNVEGNINPIGR
AFYGASTLLCTPASLSQEVGLALGAQAGEARIREVVTEGGFTRFRRATQTPFNLVYEAKP
>AIA13800.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
RNLTMGHHIIVGRKTFESIGRPLPGREMIVVTRNESFAPEGCFIARSVEEAVGLARERGE
SELFICGGAEIYAETLGAADRLYLTLVHADSEADTFFPEWNSSEWIEVESEHRTADEKNQ
YSFTFKVLARRSQV
>AIA13694.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALSKNRVIGKNNDLPWKLPDDMKFFMEKTKGHHTIMGRKNYDSIPLKFKPLPQ
RTNIVVTRQKNFQAPGCIVVDSLENGLAIAQDNDEPETFIIGGAEIYKLGLPHANRLYLT
EIDAEIDGDTFFPAVDRNQWKEISRLHHATDSRHAFAFDFVIYEKK
>AIA13681.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
GTALALGAPAWQTALIETAPVEQRSSVVLLGGLAVSISRGVGPLLAGLVLSAAGGSTLSF
ALCAVGFSIAFLLVLAWPATASTAPRLSAEGIFEAIRAGVRFARNEPAMQVALRRVFVFV
LAGAAYWSVVPLVGRRVIGFDALGFGLWMMAFGLGSVTGAYLMSRILAVLSLNKIVAVST
VAMAVGVAAISLYPTPYVAYPVMFGIGLVWTMAISSFVVSVQSNVPSWVRSRAMAIYGMV
FEGTIALAAAMWGFVAERLGVRVELLIGAAALL
>AIA13671.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGGWSAEREVSLNSGKACADALDTLNAYKITRVDVTRDIAATLKALKPDVALNVLHGRPG
EDGTLQGMLEILGIPYSHSGVLASAVAMQKDLSKSILKAAGVPVPGGMIAARTDAAKQHL
LETPYVIKPIAEGSSVGVFIVQKDHAHPPQELTRPDWAYGEKVMVEPFIPGKELTCAVIG
DQATGVIEITTALKFYDYEAKYAPGGSQHILPAPVSAEVYEECRRLALLSHQALGCRGVT
RADFRYDDSQPGVSGVFCLEVNTQPGMTGTSLVPEMAAHAGMSFPELCRWMVEDASLDR
>AIA13649.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MSRELWLNLPVREPERSKAFYTQLGFRLNEQYASQDGSFSLIVGDNQVVLMLFPESAFRG
FAGNAVADSWQSTEVLFSLGANSRDEVDEFALKAERAGGTVFSKAGEKGGWMYGCGFADP
DGHRWNALYMDMSKVPQG
>AIA13631.1|FEATURES|farme|beta_lactam|LRA-19|antibiotic inactivation|1
MGIFLFLLTVIGAGGFTPAAAQDLAPDNPWVKPAEAFKILGPIHYVGTEDLAVYLIATPE
GHIVIDGGVKGSIPAIEGSIRALGFKPEDIKILLTTQAHYDHVASMAYFQRLSKARVEVM
AGDAKLLETGGEADYLGAEWGAKARFEPVKATRILKDGDKVTLGGVTLTARHTPGHTPGC
TTFIMDVPAGGRTYNVVFPGSMTINSGTRLVGKESYPGIARDYARSLDFLESLKPDITLM
AHASAFDLPAKRDRLKKDPSSNPFGDVAGYRAWIAANRANLQKQIKEQEASR
>AIA13589.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MQTRFIRNAVILGLLSAIGPFAIDMYLPALPTIGQSLNADIRSVQLSLMLFFVSFGAFQL
IFGPISDMFGRKLPLYIGLILFAIGGIGCALAPDITTLNFFRFIQGIGACAGMVIPRAVV
RDLHTGIDAARMMSLLMLVFSISPILAPVTGSLVISLADWRAVFWVVTVAALLGFVMIAT
MLPETRPKALRVASGVGTALAGYRFLLGDLNFLALSFIGGFGIASFFAYLANSPFVLIGH
FGLSPTLYSVFFSINAVSFFTVAQFTGKLADRFGLRRIVRFAVIGYFAAMAVLFALTASG
VDRLDVLAACLFVGYGCLGLVIPTTAVLAMEEHGEIAGTASALMGTLHFVTGALAVAIIG
FFADGTVLPMVTGIAACALITFILAQTTLRQRQAVEVPAE
>AIA13591.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
LTSIFRNPDIEIYRLFRDETVAGLLELDFTGPGECELSFFGLVPQEIGKGAGRFLMNEAI
RRAWARPIKRFWVHTCTFDHPAAIGFYKRSGFTPYDMRVEVHPDPRLTGHLPREAAPHVA
IIAR
>AIA13574.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MSIIGIVAIDRNKAIGKGGKLPWHYSSDMKFFKQQTIGNACVMGHRTWLSLPKPLPDRLN
IVLSRTSEIEHQPAMITLRDKSAVLSLNSYLKCDLYVIGGAQVYRTFLDDIDEWVVTEVP
LSVDGADAFMPEGFLRGFEPYEVRDLDELIKVTFYRRSVRS
>AIA13557.1|FEATURES|farme|beta_lactam|OXA-347|antibiotic inactivation|1
MKRHVAAFAYGNEDISGGIDNFWLNGGLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDI
LILEKTPEYTLSAKTGGGSIAEGTYIGWFVGYVETKGNVYFFATNIEGASYPAIREKRID
VTKLILAELGVLPK
>AIA13531.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKITVALVALMSLAGTVQAQTVKDLLETLKVKWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPEATSQIKANIEKLGFKVTDIKYLVNTHAHIDHTGGLAEMKQASG
AQMVAGEADKPLLEGGYYPGAQEDTALAFPPVKVDRTVREGDTVTVGDVTLTAHETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLVANPTYSGIVTDYRKTFARAKDMKVDVL
LAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA13519.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MHTTKKSAIGFIFITLLIDVMGWGLIIPVMADLIAQLKHIPVNEASPYGALLLSVFAITQ
FVFAPVVGNLSDKFGRRPVLLFSLLGFGIDYIILALAPTYGWLFVGRVIAGVTGASFTTA
TAYIADVSTDETTRAKNFGMIGAAFGLGFVLGPALGAFLATWGIRAPFYAAAALCLLNCL
YGFFLLPESLSKENRRPFEWKRANPLGSLKFLTQHPEIGGLAISFFLIYLGSQSVQGNWN
FFTIYRFNWSEKMVGISLAVVGVLVGAVQAGLTRVIIPKIGNEKSIYLGLSLYTVGLVLF
AFATQGWMMFAFLIPYCLGGICGPSLQSVISVHVPPNQQGELQGALTSLMSLTTIIGPLI
MNTTFSYFTTDKAPFHFPGIHFLIGAVCMLLSVIITNKVLTREKRERPELKNAIAEGNLT
DVPMH
>AIA13512.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MTLACFLLILAALAWGQQQGAPQSSSCDNCPEWNKPQQPFRIYGNTYYVGPHGLSSILIT
SKAGHILIDSALPESVPQVVANIRALGFRIEDVKLIVNSHVHFDHGGGISELQRLSGAKV
AASPWSVEVLTKSGVGKGDPQFGSIPPVALIPKATTLRDGQTLRVGNIKLTTHFTPGHTP
GGTSWTWKSCEGKRCLSLVYADSLTPVSAEGFRFSDSREYPNAVKDFEKSFAFLRAARCD
ILLTSHPDASGLWQRLEGRERGVRPDPLVSPQGCKELSERASEQLRRRLASEKSQ
>AIA13496.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSHGPITMIVARATNGVIGRDGSLPWRISADLKRFKALTMGTAMVMGRRTFNSLPRVLPG
RRHIVLTRDRNWTADGAEVAHSIEEALSLAADEPVSVIGGAEIFELFLSRADRFELTEVV
GDIEGDTRMPDPRSTGEWREVAREEHQADGDAPAFRFITLERV
>AIA13453.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSDTITNFGKVGVLFGGRSAERDVSIMSGTGVLQALKSRGIDAHGFDPAERSLAELAAEN
FDCVFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIIWLSKNIPTPRY
ATVAPGDDLDAIVLDLGLPLIVKPPLEGSTIGITKVEAAEQFEAAVALALGFDETVLAEE
FVTGREFTVAVLGTGKHARAADRRDRGPARQLRLPEQVFYGRHQIPLPGAARRGIERRDP
EACGRRLPCARLRGLGPGRRAGARERHASVPAGGEHLAGHDQPLAGADGGARGRDQLRRT
VRRDPAFGALQDGEGARLRHVA
>AIA13444.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIISMIAAVSKNRVIGKNNDLPWKLPDDMKFFMEKTKGHHAIMGRKNYESIPHKFKPLPN
RTNIVVTRQNNFNAPGCIVVDSLEKGLAIAKDNQEPEAFIIGGAEIYKLGMSYANQLYLT
EINAEIKGDTFFPEYDRAQWRETSRLHHDKDDRHAYEFDFVIYNKK
>AIA13419.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSPARRAGEAPIIALVVAIGENGAIGKGGGLPWRLSSDMRYFRKITMGKPVIMGRRTFKS
LPRLLDGRLNIVLTRDRSFAAPDAVMAHSLAEGLAAARASAQRTGAQEIMVIGGEDVFRE
VLPQAARIYLTEVHASPEADTWFPDFDKRGWHEVFREAHEAGPKDNHAFSLVV
>AIA13407.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTIIVLAGGISTEREVSLRSGQAVAEALESKGYRTILHDPIHGIDNLPEADAVFLALHG
EGGEDGSLQADLETQGRVYVGADAAASALCFNKQAYKKLLTERDFPLANGEVVTKETIWQ
SPLTSQPFVLKPVDGGSSIDAHIIRDTANVPKAAIEKTLETYGDMLLEELIEGIELTVGI
LGDTPLQVIEIIPPAGGEFDFDNKYNGTSLELCPPEHLDQETQRQAQELSLQVHVLVGAR
DLSRTDMIATPDGRLVVLETNTLPGMTAESLYPKAAAASGIDMADLVDQLVKMALERKS
>AIA13399.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MRNTILAAALLGLSSGYASAQAPRDWNAPFPAHRVIDNVYFVGTEALGTFLITTPNGHFL
INSDFETTVPLIRASVESLGFKFEDIEIILGSHAHGDHMEADALVKELTGADVMVMQEDV
EGLRALRPHGKEHPIDRILHDGEEVALGGTTLIAHRTPGHTKGCTSWCLVAEEAGKAYDV
LIACSFGANDNYVLVNNPDYPQIAEDYAAMYAKARTLPVDVFLGSHGFFYDLAGKYEKLL
HRQPGDANPFVDRAGYLSHIATQEQRFRAMLQTQQAAAR
>AIA13382.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|0
VIEMDLITGIKVTELDRLRAAGHSPRRINELIYRAYFKQLLEDGFFHADPHPGNLLVMKD
GRLAVFDFGMVGRISDELQRQMINAFFHLYNRDVKAIVGDLVGLGFLAPEADVAAIGTIV
AEVFERKLNLKLGEVRFKDLTYDLAPIVYEHPITTPARFTYLIRAIMTLEGISIVMNPEF
NFFDVARPYVKEFLFRRESSHLRQMALQSLRDARTGRFSWDRLWSMAKMAYSLYIGD
>AIA13370.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKGKNKTPKTVLSPCHGTIHVRVMDGKLHMHMLQRSGDVPIGIPSNMVQYGAVLLMLEQL
TNYEASTFYHTISDAHIYVNQTDNINELLAREPRRLPTVHLNEAGKRVTDIHDFRAEHFE
LSDYDPHPPIRGIAVQV
>AIA13286.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKITVALVALMSLTAAAQAQTPKDLLAALLVKWNKPTEPFKMIDNVYYVGTDGLASY
LITSPQGHILVNAVMPEATSQIKANIEKLGFKVTDIKYLLNTHAHIDHTGGLAEMKAASG
AQLVAGEADKPLLEGGYYPGAREETALNFPPVKVDRTVREGDKVTVGDVTLIARETPGHS
PGCTSWEFSVKDGDATRSALTFCSGTVALNRLVTNPTHPGIVTDYRKTFARAKDMKVDVL
LAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFDDALAKQTAAAQAKKG
>AIA13223.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSMDLKRFRNLTMGHHIIVGRKTFESIGRPLPGRQT
IILTRNESFRPEGCLIARSVEDALRLAEDRGEGEAFICGGAEIYAQSLDKADRIYLTLVH
ADSGADTFSPAYNGGQWVERESEHHSADEKNQYPFT
>AIA13217.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTIALIYAVSENHIIGKGNALPWHLPADFKHFKEITTGHPVIMGRLTFEDIGRPLPGRQ
NIVLSRDPDYEPHGVDVARSIDDAIAKAKDDTVFIIGGAKVFEEALPLATRVYETRVHAV
IEGDTLFDPNLSHWLEESEEIHKADERNKYDYTFINYVRQ
>AIA13177.1|FEATURES|farme|aminoglycoside|N182_21955|antibiotic inactivation|0
MITVRPMKPGEGGALLSMIKALAHSHNLMHTVLATPEMYEAAMFSGQPIVGTLMAEYNGV
LAGCAVWHRSFSTNRGAEVMYLEDLSVLPEFRRRGVARALLKGVARLALEKNYPSVYWLM
MDWNKEANALYESVGAEIEAGATFCRIRDDALKALAS
>AIA13128.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKVFLIAATTADGKIGLAKDHHADWTSKEDKQLFVKLTKESGVMIMGMNTFKTIGRGLPG
RKTIVYSYDSKVIEGVEGDVEVTSDEPEKLLQELSDQGHKSVAICGGAQIYSLFLSKGLV
DELYLTVEPVLFGDGISLAEGVSLTNLQLIETRQLNENTVLLHYSVKR
>AIA13116.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
MLAAGYAGVAANAQDLSPFFKDTKGAFVLYDQKNDRYTRYNEARCRERFSPKSTFKIPNS
LIGLDTGVIQDADFVISWNREKYPPQDNWDQEPFKHWGQDQTLRSAIKYSVVWYYQELAL
LVGEKRMKKYVTALNYGNQNVSGGITQFWLNGGLKISADEEVEFLKALYANRLPVSKRST
GIVKDILVLEKAPTYTLSGKTGGGSIAAGTYIGWFVGYLETNGNVYFFATNIEGPSFAAV
REKRIEVTRQVLSHLGYLPK
>AIA13052.1|FEATURES|farme|beta_lactam|LRA-19|antibiotic inactivation|1
MLLPVVLLFLPSIAKAQADETSRSWNRPVEPFRIIGNIYYVGATEVSSFLITTPEGHILL
DSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMTSEADAA
LLANGGKGDFRWGDSLSYKPVKTDRLLRDNDKVELGGITMTFRLTPGHTKGSTTWMMKVK
EG
>AIA13044.1|FEATURES|farme|streptothricin|sat-1|antibiotic inactivation|0
MLKKRLALHSSRQYNTPLEIVESRNKNLLVPILHDADEDDVRIASAIVDMANISYAAYIG
DECVGAAMMHWQLDESEILYIAIRAADRGKGYGRELIAAIVNMARERSTQALVVGTASTS
VDNILFYQKCGFRMDSVRKDFFNYKPTPVYEHGIQLRDMVMLRYELGG
>AIA13032.1|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|0
MSTSKKTLTTVNEDKLHQLLGKFVSDFGAAFHAGMVVIGMELGLYKDMAGEGPMLPSELA
ERTGTNERYVREWLNSQAAGGYVEYDADTGRYSLNAEQAFTLADENSPAYMPGAFLLATS
ALKAVPKLIERFRTGEGLGWHEHDTGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLNN
GAKVADVGCGLGASTILMAQAYPNSAFTGFDYHDGSIEMAKERAKEAGISDRVNFEIAKA
KDYPGTGYDLVTFFDCLHDMGDPVGASG
>AIA13012.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIIGIVAVDRNLAIGKGGKLPWHYSADMKFFKQTTMGNAVVMGRRTWSTLKGPLPNRQNI
VLTRNGDMTVPAGVNAMNDADGVLSLTETLNTHLFVIGGATIYKAFLPHIDRWIVTEVPL
SVAEADTFMPANFLDGFEMYEMLELDEGLCVKFYERRGTDFSL
>AIA12960.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRDVLDNGVKKEDRTGTGTLSVFGRQMRFDLAQGFPMVTTKKLHLKSIIHELI
WFLAGDTNIKYLSDNGVRIWDEWADENGNLGPVYGHQWRSWPTADGRAIDQISNVIERIK
ANPDDRRLIVSAWNVGEIGKMALPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTLMVAQVTGLKPGEFVHTFGDAHLYSNHIEQAQLQLSRDPKPLPEMHLNPHVKNIF
DFKFEDFELVGYDAHPHIKGAVAV
>AIA12924.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MERPRLDVAWRRQPDLKEAFIMSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGADLHA
GTAAVQMSLLIFFLSMGFGQIVVGPISDMVGRKLPLYGGLALFMVGGIGSAMAPTIEWLI
AFRFLQGLGASAGMAVPRAIVRDLHTGNEAAKLMSLLMLVFSVSPILAPLTGSVIIENFG
CRAVFWTVSGAALLATILLATSLKETRPVEDRAGSSFGTALSAYRFLMGDRNFLGLTAIA
GFGIASFFVYLSSSSFILIDHYGLSPSVYSVFFSINAVAFIGMSQMTGLLAERFGLRRVV
RVAVTGYATTMVVLFAVMATGIDRLDVMAALLFVGYGFLGLVIPTTSVLAMEEHGEIAGT
ASALMGTLHFAIGALAMGVAGVFFDGTPLPMVAGITLCAVISFTLAKVTLGRSREAVEAP
AE
>AIA12908.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
MNRISRAIAVILIVFGCITSVLVQTPQSALTVPPPVQESPLRGGDVAETINFGRHFQELG
VEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILNSLISLETGVISDEIAVLTWDGTQ
RQIPAWNRDLNMREAIKLSAVWFYQVLARRVGHEQMKKWVAKVGYGNQKIGNKDDIDKFW
LEGELRITPNEQIQFLRRLYKNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANFGEQ
TKPQIGWYVGYLEKDKNVYFFATNIDIRNKNDSSARIELTRRCFKDLALL
>AIA12882.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKKLRVGVIFGGRSGEHEVSVRSARAVIDALDARRYEVVPIAITKEGKWLSPARATRLLP
EETKKRVADKVASEERQPSALIGDPSSNGLVARESSGEDDALAPLQPLDVVFPVLHGTFG
EDGTIQGWLEMVGMPYVGCGVLASSCGMDKVAMKALFKEAGLPICRYTWLLRKDWDEDRG
AILRRVVREIGFPSFVKPANLGSSVGISKASDKSSLERAIDLAARYDRKVIIEEGLDARE
>AIA12856.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAVAKNGIIGGDNDLPWYFPEDLKHFKEITMGKTVLMGRKTYESILKRLGKPLP
GRKNIVITTNATYEVPEGVAVYPDIETAVSKNQNDDLYFIGGASIFKKGLELAQYMYLTH
VHDEYPGDVYFPEVDWNLWEKVREAPHEHYTYAEYQKRHGENQAETR
>AIA12824.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|1
MGLGLVIPILNQLIFEPNSASLAGYHFSPVMHNFIYGLIIGIFMICWFFGAAVLGDLSDQ
IGRKRSLIICLIGAFLSYVLSAFAVLYDSLALLILGRIIAGFTAGSQPIAQAAIIDLSTP
ETKAKNIGYILLALSLGFIFGPLFGGILADND
>AIA12797.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MNKALVVILAAVTLDAVGIGLIFPILPALLRDVGHISEVATLLGLMLALYSACQFLFSPI
LGVLSDRFGRRPVLLVSLAGAAIDYLIMAFAPELWILVLGRAISGITSANMAVATAYITD
ISTEEERAGRFGLFHAMFGIGFIIGPVLGGVLGDFWVRAPFIAAALLNGVNFALALFVLP
ESRKGTAGARFTWDTLNPFKPLKWALTFRALIPLMAIFVIMNFVGTMYGTIWAMFGEDSF
QWNGLMIGLSLGAFGVFHAGAQAFLTGPAVARLGERWSLVVGMACELTALVIVGFATQGW
ILFALAPLFALGGIGMPALQSLTTQQVESDKQGQLQGVLASLVSLASIFGPVFFSFMYFG
VSDSWPGLIWIIGAAIYLLALPLMLGIRRSAMPAPAAGE
>AIA12696.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MTALRAATIEFDIVVAADLGDGIGAGGSVPWHLPSDMAHLKRLTSETEIAGMHNSVIMGR
VTWETIPDQFRPLPGRLNIVISRNVSLALPEGVVRAPNLARALEQSRSRADVAGIFVLGG
GEIYKQAILLPGCRRMYLTRVMKRYQCDTFFPPIPSGFRRASLLSEGADGEGAERLGYRI
ELWSRTVRS
>AIA12691.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MKVALINQTMADQLWPNQNPIGKRIRFPDSDQNPLRWRTIVGVVSDVSQYALDQKPPMQM
YMPHEQFPTSFNTIVVKTGSKPEEMFSAVRSAILSVDGEQAVYNVATLEELQSNSIVLRS
FFMVLLITFAVLALMLAVVGIYGVMSYAVTQRTQEIGIRMALGAGAGDVLKLILRNGLAL
T
>AIA12687.1|FEATURES|farme|beta_lactam|SHD_1818|antibiotic inactivation|1
MNTRIGFLLLSLFIVALYSAPAEAQDLSPHFKNTNGAFVLYDLKENHYIRYNEQRCRERF
SPKSTFKIPNSLIGLDTGVIRDADFPIAWNRQKYPPQDNWNQEPFVHWAQDHTLRSAIKY
SVVWYYRELALRVGKQKMMKYITAFNYGNKTISKDIDNFWLDNSLKISADEQVEFLKEFY
AGRLPVSKLAIETVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFA
TNIEGASFAEIREKRVGLSKEILAALGYLPK
>AIA12673.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MSKRDEFRDKVQEFQEQKIEDQELADLTALIEKTAGPAKGRVGVFAVVLETGDSVSLDPD
GRYPMQSVYKFPISMVVLRQVEEGKLKLDQKVRVEKEEYVRKGMRSPLRDKNPNGADVTV
QELIRLSIVESDGSASDALMRLAGGAAAIQEYLTGINVGEVIVANPEKEIGQDWETQYRN
WATPEGAASLLRALYEKRGISDQHQKLLLKFMTESVPGAKRLRGMLPPGTAVAHKTGTSG
TNPAGVTAATNDIGIITLPNGNHLAIAVFVSDSPADETTRESVIAGIAKAAWDTWSK
>AIA12600.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGADLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSAMAPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGNEAAKLMSLLMLVFSVSPILAPLTVGCGAAGHNPLGDFAQGDAAGGRPRRLLLR
HRAVGLPLPDG
>AIA12589.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRRFIKHSIIVLFTLALASLIFGKERNASIAHLPVMPDAFTSDALAQSSLERAIKRLADN
SGGVVGVSAIHVETGRRVALNGAMRFPMASVYKLPIALQLLHKVDRGELRLSDSVTLSEQ
DFRPGHSPIAEFANHKPLTLSIERLLELMLGESDNSASDKLLALAGGPAAVTARMRALDI
TGLDISRPEGRLALDFWGVREPPPESEWTLAFFERMSESGTPAAREAAAAAFADDPRDTS
TPDAMAQLLVRVERREVLEPASMERLLQITTATQTGPLRLKGLLPAGTPVAHKTGTMGAT
TNDVGIITLPDGAGHVALAVFVKGSTLDVPSRERVIAEIARTIYDYYLLVG
>AIA12579.1|FEATURES|farme|beta_lactam|LRA-8|antibiotic inactivation|1
MGSGLFYNVAADKNSGSDMSKMSLKSLVLLPLVAVIAVPSLAARKDKAAAKAPPCEQCAA
WNADQEPFKIWGNTYYVGVKGLSSVLVTSDWGHVLLDGGLPESAPKIAANIEKLGFKLTD
VKAILSSHVHVDHAGGIAELQRRSGAKVYQRRPSDQVLRTGKPDPADPQFARARPIPPVE
NVWVVHDEELLGLGPTRFTVVATPGHTPGGTTWAWESCEGAQCVKMVYADSLNAVSAEGF
RFTASTSYPNVLQDLEQSFKRVESLPCDVIVSVHPEQSDFFPRMAKRVDGKPDSIKDPEG
CKRYVAAARERLAQRVASEKQGS
>AIA12540.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLKHQWRYKMRISFIVAKSENNVIGRNNDLPWRLKEDLQNFKKITLGHHILMGRKTFESI
GKPLPGRMSLVVSSEPRANAENVFWFTSIFRAIKQAERTGETELFIIGGEKIFKAALPLV
DRIYLTQVQANVEGDVYFPQLSMKNWKLVSEQPFQKNEGNDFNFVFQVLDRR
>AIA12534.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|1
MATNRKAAIGFIFITLLIDVMGWGLIIPVMPELIAKLKGISVNEASSYGAWLISVYALVQ
FVCAPLIGNLSDRYGRRPVILFSLLGFGIDYLFLALAPTYGLLFIGRIIAGMTGASFTTA
AAYIADISTAETRAKNFGMIGAAFGLGFIIGPALGGLLARLGYTCAILRRRHSLFIKLPV
WIFCFARIFIKRKPQEV
>AIA12448.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSVQLEFEHKSRIMQSVTDSLLMIKRSSTHIVRHTDQLLGTFFQPVMFLVLFSAVFGGAI
SKALPEGVSYLNFLMAGIIIQTLAFGSTTTAVAVCNDLQKGIIDRFKSLPMSNVAVLNGH
VISDLARNGISTAVMLAVGFVMGFRTHADLQGWLMIIGLLVLFTLTFSWLAVIVGVKAKS
IEAVQWLSFIIVFPLTFASSAFVPTEGMNKFLKAFAENQPITHIIEAVRALMLGTPTGNH
>AIA12408.1|FEATURES|farme|multidrug|MexD|antibiotic efflux|0
LALALRGMPFSISAGVGFIALFGVAVLNGVVMVSYINHLRDEGKSLEEAVGEGAETRLRP
VLMTALVASLGFIPMAIATSAGAEVQRPLATVVIGGLITSTLLTLLILPTLYRWFERDKV
EY
>AIA12378.1|FEATURES|farme|multidrug|CynX|antibiotic efflux|0
MTAGTETGKPAFRTPAFIALLLFALTLRGPFVVVSTVTGELSTELGMSATAIGLLTTLPV
LCFGLAAPGASAVIARLGVERSVLVSLLGTLLGVLIRSVGGIPGALLGTLVMGLAITIGN
VVSPVIIGRDFQGRSATVTGSYTAALNVGTMITLSATGPLVTQFGWQIALASWAVLPVIA
AAAWVPLSRRRAERVAKAKVESAASAEPPKAAHSARLSTVLRRPTTWMLTIAFAGQAFAY
YGLTAWLPTLLATEQGMTRDQAGAASSIFQICALIGAFGTPVIIGRLGGPLTAFLVAGVL
WCGLPLGLLFAPDLWAVWSALSGVAQGAGFVAVFTVVVWRSKTLRENRQLSAIVQTGGYT
VACLGPVVLGGLHDSTGGWTAPLLASFIAVLALMIMGALASRGLRR
>AIA12324.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAIIGIVAVDRNGAIGKNGSIPWHYSADVKFFRQQTIGHACVMGYKTWLSLKKPLKERLN
IVLSRKSEVKPQPNVIVLRDTLSILSLKKFLACDLFIIGGEQVYRSFLPHMDRWIVTQIP
VAVEGADTFMPEGYLKNFSPYDSQQLEENLKVTFYE
>AIA12311.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MAEKSTTTNAATPQAAGLRGLLKNRNFRFLWLGQIISDFGDSLTMLTLLVLVNALTGSTA
ALATMFIVLTVPQITFGLVAGVYVDRLDRKKIMVLSDLARGALVLGFIFVDSADKLWMLY
LLGFVQATVGTLFTPARSALIPSIVPRSDLMSANSIAQVSRIIAGLLGTAGAGVMVGIFG
SFWPAFVLDALTFFVSVLFVSRIAAPARENVPDSTGGIKAVLGQFVDGMRIIRHTSALAG
TLVAAGVMMLGIGAVNVLLVPMIMNDLKVPVTWFAGIEFSQTSAMILSGSFVAVIAAKLK
PTNIVSATLLGIGVAVAGLSLVTEVWHLIPIMFVVGWMVTPLQGAIATLVQTSVSDSVRG
RISSALNTIISTASLVSMGLAGVLGTLMGVRNVFLLSGAIVVTAGVVSAWVFRIGGKPAR
AAEDVPASRMSLSSGVME
>AIA12291.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MLGVVTSLSLAGHVNAAAIDCSYCETWNKPQAPFQIYGNTYYVGPHGLSAVLITSPQGHI
LIDGALPQSAPMIAKHVEQLGFKMTDVKVILNSHTHYDHAGGIAELQKLSGAKVIASDKA
APVLRSGRVGPDDPQVGHLLPFPGVSNVEALGRRQSIEVGTLQLNVIHTPGHSPGGTSWR
WQSCEADRCLNMMYSDSLNAVADSTFKYSGDPRYPAAAKDLTSSMEAIAAAPCDILVTAH
PELSGLWATIDERGNGDRAKLNDPAACQRYVATTKQRLDQRLASEKADKK
>AIA12287.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MLLLSALLLALAALASGQSGGTPASSCSNCPVWNEKQEPFRIYGNTYYVGPHGLTSILLT
SKKGHILLDGALPESATQIAANIRSLGFRVEDVKLIVNSHVHFDHGGGIAELQRLSGARV
AASPWSAEVLTKSGVGKGDPQFGGIPPVALVPRAETLRDGQTLRVGDIKLTAHFTPGHTP
GGTSWTWKSCEGKRCLSLVYSDSMTPVSSDSFRFTDSREYPNAVQDFEKSFAFLRATPCD
ILLTSHPDASGLWQRLEGRQKGVKPDPLVSPNACKELAGRASEQLRVRLESEKGR
>AIA12253.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MRKLVIALAALLPLTGAAQAQTLKDRLATLLVKWNEPTEPFKMIGNVYYVGTNGLSSYLI
TSPQGHILVGTVMPEATSQIKGNSEKLGFKVTDIKYVLNTHAHIDHTGGLAEMKQASGAQ
LIAGEADKPLLEGGYYPGAREETVLNFPPVKVDRTVREGDTITLGDVKITARETPGHSPG
CTSWEFSVKDGDATRSVLIFCSGTVALNRLVTNPTYPGIVADYRKTFARAKDMKVDVLLA
PHPEMYKMQEKRAKLADGAPNPFVNPGEFNTYAATLEKAFEEGLAKQTAAAQEKKG
>AIA12239.1|FEATURES|farme|aminoglycoside|rmtH|antibiotic target alteration|1
MVKTKKQKMAYKKSKLKKRGKVAPHIKRMTKSKAPRPDRFDHTKPLPKVAIPATITADIL
DKKDLLVAPDFANHIILRYLRKNPALIEKLHEPHVLRSAEYEKMKKWVRQELRVLVGMFV
FDSGLKGLATADTEKILTAHRSTIERQMHYPGLYDDLFGSKKPEVILDLCAGLNPCAYEY
LGCTPVYYAIDVSPQLMAFVQQFFDDHAIVGKAWAEDITTMKEFPDADTILIFKGMDVLE
RVKYGYGEQLLNVFLERRIIVSFATATISGGREISTTKRTWVERWAANNNKSVRIHDIPG
ERFYIIE
>AIA12183.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIIIIVAYDLNRLIGADNTLIWHIPEDLKRFKVLTMGGICIMGRNTWESLPEKVRPLPGR
KNIVITHNPDYKVPNGVVLASSWEDAKTIAQDPEQMKEYHGKNIYVCGGAQIYTLSLPDA
DQVQVTEVAKIFSVENLRNPKYFPELPLDMVPTLLKSNQKTEGGLFYDYIQYDKLP
>AIA12090.1|FEATURES|farme|beta_lactam|SHD_1818|antibiotic inactivation|1
MLYYDWFENHVRKILMYRIKQVPLAIAIASLVALLTISGFFGTAANSQPPQPTSEITTTQ
GIDLGRSFRELGIEGSIVVYDQNKNQFYEHNAPRNSTAFFPASTFKIFNALVALETGVIR
DEVTVLTWDGIQRNIPAWNRDTNLRQGFKDSTVWFYQVLARKIGHERMQKFINQVGYGNR
QIGTSEQIDRFWLDGPLKITPKQEIEFLQRLYRNDLPFSQRSLDLVKDIMVREQTPDYVL
RGKTGWTDSTTPGNGWFVGYLEQNKNVYFFATNMDMRNDNDGVNRIEITRRSLQALGLL
>AIA12071.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTSTVNALEFHGVKKSFKKKRGEFVYALKGIDLTIGRGEVVGILGPNGSGKSTLVRAIST
LLTPDEGTVEIFGIDAIAHPKVVQRMMNRVSVEASFFKKLSAYENLIYGSKLYGLPTSEA
KPKISAILESIGFSMKRANEPMEHLSRGMQQKIALARALLTSPMLMLLDEPTTGLDPRSK
KDVQAVIWDIRRNHDSSILLCTHDMGEAEELCDRIGIIVDGQIIAMDTADGLKRKYQTGI
ELPTLEEVFMAATGVALGDAAFEPEEELVEA
>AIA12065.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MKKHFLRFTVCVFCFILFSSCAATAQVAPPKEENKREADLLELVKLDKTIKLDIRYARTD
NFVGKVVYPEARAFLQRPAAEAVLRVHEKLKKQGLGLVIFDGYRPWSITKLFWEVVREDQ
RKFVANPANGSKHNRGCAVDLSIYDLQTGKLTEMPSDFDEFTERASPDYAGGTDKERANR
DLLRRLMEAEGFTVNANEWWHFDYKDWQEYAIYDIPFSAIGDFKARFADAKIEENKDWKK
FFDAEKAKGGIVVYDLRQNKFTVYDRERMNKGFVPASTSKIIHSLIFLDSGAVKDETEVF
KWDGVKRFSPDWNKDHNLRTAFQTSAAWFYVEASKRLGREKMQKYYDAVGYGNRKTDGFG
EAYWVNGDLRITPREQVELLVRLYENSLPFAQRSIELVKEIMIAEKTDKYVLRAKTGWSD
TFKPQVGWWVGYVEREQNAYFFALEMDMKNFADAEKRKTVTKNILKSLQIIE
>AIA12058.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRILLSLAFVCIPLITICACNAGSTAGTKKTQATETQKDELQKQIERIAASAKGRVGVA
AEVLETGESISLNPQDHFPMQSVYKLPIGMAVLAHVDTQKLSLDQRVRVEKSDYVRLGQH
SPIRDKNPKGVELTFKELLRFAVSESDGTASDVLLKLAGVEAVAKYLNELGISEIVVANS
EKEIGKDWETQYRNWASPQGALQLLRGLHEKRGLTEQSQQLLLKLMTETPTGPKRLKGLL
PQTVVVAHKTGTSGTSDAGISAATNDIGLITLPSGRHLAIAVFVSDSPADLPTRERVIAE
IAKAIYDAYSHG
>AIA12045.1|FEATURES|farme|beta_lactam|SPM-1|antibiotic inactivation|1
MKNTLFIAALILASCAHDHGIQPSLSQNDAKEISSSASAAIPIDENLSATQLKPDVWLVQ
DKSFYDTNVLLAKMPDRAVVIASSFIDTPKTAKLIAWINQTLKPKEIRAINTHFHFDGTG
GNEAYHQEGVQTWSTQQTLSLYKARADSMRSSLADSLNDKQHGKDLRATNNTLADHIFNA
ADGLEWDFQGEKLIVYYPGPAHSPDNLVVYLPSKRILFGGCMVRALDYDLGNTADADLKN
YYKSALSLKRFPAEIVIPGHGQKGGMDLIDHTITLASKASQRP
>AIA12037.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
LLLAALVSGQTGAPQSSSSSCADCPEWNKPQRPFRIYGNTYYVGPHGLSSILITSSAGHV
LIDSALPESVPQVVANIRALGFRVEAVQFIVNSHVHFDHAGGISELQRLSGAEVAASPWS
VEVLTKSGVGPGDPQFGSIPPVALIQRATTLRDGQTLSVGDIKLTAHFTPGHTP
>AIA12036.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MNQPVEPFKIIDNIYYVGASDVTVFLITTPQGHILIDAGFEETVPQIKANVAKLGFKMED
IKILLVNHAHYDHCGGLAEIKKLTGARLFASPADATVLEDGGASDFRFGGDKAFSFAPAK
LTERLKNGQEIRLGGTVLKTHFTPGHTKGATSWTMDAKDGGKKYKVVFMSSATTLDYTFV
NNAKYPQIAEDYTRTYATFKSIKADVFLASHGQFFDLLGKAEKVRAGTKTNPFIDPQGYR
QFVNRITRQFEEKLKTERAAKK
>AIA11953.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SGEHIDQISAALQLLRSDPDSRRNIVSAWNVGEIPQMALPPCHAFFQFYVAGGRLSCQLY
QRSADLFLGVPFNIASYALLTHMMAAQAGLEVGEFVWTGGDCHIYDNHVGQVNEQLSRDP
RPYPELILAPRDSLFDYTYEDVVIKNYEPHPAIKAPVAI
>AIA11922.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MRTTFAVLLAALTFTSYAQAQTLRELLKTTIENWNKPTEPFKIIGNIYYVGTNGLSSFLV
TSPQGHVLIDTTMPETASQIEANIQKLGFKLTDVKYLVNTHAHMDHTGGFAQLKKSTGAQ
MFSGEKDKPLLEGGYYPGNDDEALKFPPVTVDRVVRDGDKITVGDVTITANSTPGHSPGC
TSWSMTVKDGNTDRSVLVFCSATVALNRLVTNPTHAGIVEDYRKTFAWSKNVHPDVLLAP
HPEMFDLPAKRAKIADGAPNPFVKPGEFDAFAAKLEKDFDEGLAKQKAAAEAKK
>AIA11901.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MNILRPWAAGAAFVLAATGYSLVSQQVTINREWTAPIDPVRIFENVYYVGTEDLASYLIT
TPQGHVLVDSGVAQNAASIIKGIQQLGFKPADVKYLLTTQAHFDHVAAHAELQRLTGAQV
VASVGDAELMETGGKTDYHFGAPYNFPPVKVNRRVKDGDTVTIGDAVLTAHLTPGHTQGT
TTWVMPVTSGGVPTNVVFVGSTSVNPGVKLVGNTKYPQIAEDFAATFERLKRIKVDVFLT
AHLSANGGLEKIAKLRTGGTPNPFVDPSGYAAYLERSKKAFETELARQRGEQR
>AIA11886.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPEIIESEIVKPEIIGIAAVAANGVIGASNDIPWRIPADWQRFKALTMGNVLIMGRKTYD
SIGRPLPGRTTFVITRDRMWRGDGVRAVPSVEEAIDQAMLLDPKIIFVAGGGEVYRAAWD
RLTGLEITEVDQHPQGRVTFPEIDPNEWIQTSREARDGYTFVSYRRRAREESH
>AIA11880.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSDETSTGDRPEVVGIAAVARNGVIGAGNDIPWRIREDWARFKAITMGHVLIMGRKTYDS
IGRPLPGRTTIVVTRDPAWRTDGVVVATDLDDAFDLAYALTPTKVFVAGGGQIYAAAWDR
LDTLEITEVYADPAGDVRFPVIGADWHETDRDEREGFAFITFRRHSE
>AIA11871.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKGGKLPWHYSADMKFFKETTTGNAVVMGHNTWRSLKKPLPNRLNI
VLSRQSEIEPKESLLVLQTIESVLSIAKKLETDLYVIGGEQVYQSFLPYIDKWIVTEVPL
TIERADAFVPENYLEGFRVVGSRELEPNLIARFYERSRR
>AIA11853.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKGGKLPWHYSADLKFFKATTTGNAIVMGHNTWKTLKKPLPNRLNI
ILSRQAEIPSQESVLVVRDGESVLTLEKDLKTDLFVIGGAQIYSAFLPFIEKWIVTEVPL
SVEGADTFMPANYLEGFQLIETKQLDAELRVSIYGERTIIRATNLQETH
>AIA11851.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISYIFAMDENRGIGVDNKLPWRLPADLARFKKLTLNHTILMGRKTFDSIGRKPLPKRRN
VVLTRDLSFAAEGCEVVHSIDEVVERYAGTAEDELFVIGGTEVFVLLMPYVDKMYITEIA
GQFPADTWFPEVDPSEWKAVLREKGVKNEENPYDYEFVDYVRVRE
>AIA11760.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIMVGRKTFESIGKGCFIAHS
ISDAISFARERGESELFVCGGAEIYAQTLSAADRLYLTLVHADCDADTFFTEWNSDDWIE
MESEHRTS
>AIA11679.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAIIGIVAVDKNNAIGKGGQLPWHYSSDMKFFRGQTMGHACVMGYKTWRTLKKPLPGRLN
LVLSRRSEITPQASVVVMRDKLDVLSLLPFLSCDLFIIGGRQIYDAFLGEIDRWLVTEVP
LVIDGADTFMPANFLEGFDVTQTLPLEEGLSVKFYDRNRGATASNVHP
>AIA11647.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKVFLIAAITADGFIGRGAYHTADWTSPEDKKLFVRLTKEAGVMVFGSRTFETIGRALPG
RRTIVYTSQPSKITAEGVEATSESPTDLVKRLEAEGAAGLAVCGGASIYSLFMHAGVVEE
LYITVEPLLFGQGLPLFGDKLETTLRLLDTSKLNDNAVLLHYAVEKP
>AIA11632.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKIILMAAVTIDGKIARHEHHFVDWSSKEDKKLFMQTSKRGGVVILGNNTYETFPSPLPG
RLHIVLTTKVSDKPHKPGEIEFTDRSPAEIVAGLEARGYTEAVLTGGAQINALFLAANVV
DEIWLTMEPHIFGVGLDLFRGVPFDRRATLLEVRQLNEGGSVLLRYGLDRSSETED
>AIA11578.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
PSHHQGAGRGVNGRPIISVIAAVARNGVIGDGSAMPWRLPEDARHFKAATLGFPVVMGRR
TWDSLPATFRPLPGRRNLVVTRNPQWQASGAEAVPSLDAALARAADASKVFVIGGGELYA
QALARADELVLTEIDRDFDGRTLFPQWDRNAFIESQRERYHAGPPNDFDYAFVTYQRKT
>AIA11548.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMNSFLFGKKIAVLCGGPSSEREVSLRSGSGVANALRLLGVDAFEIDVRDDKFRLPVGTE
LAFNALHGAFGEDGAIQAILEEKGIPFTGEGEIGSRLAFDKIESKKRFIECGVPTAPYVT
VCKGEIPALSLPYVVKVPCQGSSVGVYLVKTMNERDAALEKAFALADTILVEAFVSGREL
TVGVLGENVLPIIEIRPRGGFYSYENKYTWTNRGGAAEHECPARLNRNEKAMVEAAALAA
HRALDLEIYSRVDVILDADRGPQVLEVNTIPGMTETSLLPEAAAAAGISMAQLCEFIVQL
SLERRLASKR
>AIA11536.1|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|1
MTAWEMVEYFGRLYGMDEERLQQRIDELFNTLQMQDFRDTLGSKMSTGMRQKVSIARTIV
HDPPVMIFDEPTSGLDVLVARALLKAIESLKDQGKCIIFSTHIMREVEKLCDRIAIIHRR
>AIA11491.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MEKHFVRNAVMLGLVTAIGPLAIDMYLPALTLIGRNLGADHTAVQLSLIVFFLSLGICQL
IYGPVSDMTGRKLPLYFGLVLFSAASIGCALAPDIETLIVLRFLQGVGACAGMVVPRAIV
RDLHTGIDATRMMSLLMLVFSVSPILAPLFGSVVIATLGWRWVFWIVLVAGLLALAMIWA
YLPETRPRAARLDSSIGSALRAYGLLLRDWNFLGLTFIGSFAIASFFAYLANSPFVLIEH
YGLSPAIYSLFFSVNAVSFFSVSQASSWLAKRFGLVPVVRVAVIGFAASMSLLFV
>AIA11480.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIIGIVAVDRRGAIGKDGKLPWHYSSDMKFFKHTTIGNAVVMGYKTWLTLKRPLPDRLNI
VLSRQSEIEPQDSVIVMRNVEEVLSSATNFEGDLFVIGGEQVYRSFLPHIDKWLVTEVPL
TVEGADAFVPENYLEGSSAYRHQEA
>AIA11438.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MGKGDPQFGGLVPVALIPRADTLRDGQTLRVGDIKLTAHFTPGHTPGGTSWTWESCEGGR
CLNLVYSDSMTPVSAEGFRFTDSREYPTAVQDFEKSFAFLRSTPCDILLTSHPDASGLWQ
RLEGRQQGVKPDPVVSPNACKELAGRAAQQLRHRLEGEKGQ
>AIA11433.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MTRSTPSLSCAASIGKISATTHKGVLKMKKKHICLTAIVLAASLVTARAADWYAPQEPFA
IYGNTYYVGTGGISAVLVTSPAGHILIDVGAPMSPPQIVASIRQLGFKVEDIRYILNSHA
HHDHAGGIAELQKLSGATVVASPASAELISSGQPDKTDPQLPDLVAMPPVGKIRVIHDGE
VLELGPLALTAHFTPGHTKGGTSWTWQSTENGRVANMVFADSLFAMSGAGVRFSDNPGYP
NAKADLDRSITTVESLKCDVLVAGHPELGGLWERKAKQPVRGNAAFIDRDACRNYGRKAR
ARLAETLAGDVTAAAAAQATRLKH
>AIA11417.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
RSGRPMPGKTYIVVTRSEDYKPARDNARVAHSIAQAIELANSLGEEEILAIGGGGIFSEI
LPFTDRIYLSEIQAEVEGDSYFPKLNKKEWHETSRTHYEKDEKNEYDFDLIVLERS
>AIA11381.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HDLLRHIRENGTRKTDRTGTGTISCFGYQMRFDLAEGFPLLTTKKLHVKSIIHELLWFLK
GDTNIKYLQENGVKIWDEWADVNGNLGPVYGYQWRSWATPDGRTIDQISELVTMIKKNPD
SRRLIVSAWNPADVPNMALPPCHCLFQFYVADGKLSCQLYQRSADTFLGVPFNIASYALL
TLMVAQVCGLRPGEFIHTFGDVHLYIDHLEQAKLQLTREPRALPTMEIDPSVTDLFAFRF
EHFTLKDYDPHPHIKAAVSV
>AIA11382.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSAIAAVAENGTIGRDGDLPWHLPDDMAYFQRTTSGHHVITGRKNYQSIPPKYRPLKG
RVNMVVSSDAGYQAPGAIVLTSMEAAIANARAAGETETFVIGGGEIYREAFRLNLVDRVH
LTRVHAEVPGDTHFPTLDPAHWREVSRTEHPADDRHAHAFTILVLDRI
>AIA11374.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|0
MKVFIIATLTADGFIAVDDSHLATTWTTKADKIFFTRKTKEAGATVFGRKTFDTFTRALK
DRRTIVMTSEPHLITLEGVEPTNESPADLVARLGREGVSALAVCGGASIYAQFLQADLVD
EIYVNMQPVVFGTGVTLFNTPVHRPLELLDVQNIGDDTVALHYKVTK
>AIA11336.1|FEATURES|farme|beta_lactam|OXA-60|antibiotic inactivation|1
MFSRWSKTFAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIR
LSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGHVYAFA
LNIDMPREGDMAKRIPLGKQLMRALEVWPAP
>AIA11317.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKPMKTFIIAAITADGFIGQSAHHLSTRWTSRADKVFFTETTKNAGVVVMGRSTFDTIGR
ALPGRRTIVLTTRPLDVEGVETTQESPKELVERLAKEGHAKLAVCGGASVYAQFINAGGV
DELYLTVHPTLFGAGVPLLDKPLTRQLQLIETKNIGDDTVLLHYSL
>AIA11281.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MHTFAVVVAADEQRGIGRDGMLPWRLPGDMAYFKRVTSEAAPGKANAVIMGRKTYESIPE
RFRPLPDRINVVLTRSVTNTEHAGEVLRCATLEAALEELDARADIDQRFVIGGGQVYEQA
LAHPRCDRVHVTRVHRSFACDTFLPHFEANFQLVRSDGPHQDGDASYTFELYERAVDARG
SARE
>AIA11268.1|FEATURES|farme|beta_lactam|OXA-55|antibiotic inactivation|1
GATPVQAQDLSPFFKDINGAFVLYDLKNDHYIRYNEARCRERFSPFSTFKIPNSLIGLES
GVIKDADFIIPWDRRKYPPDDWTIEPFIHWGRDHTLRSAIKYSVVWYYRELAGRVGERAM
KEYVSKLHYGNQDISGGVDRFWLNSTLKISADEQVAFLKALYKEELPVSSRSMKILKDIL
VLEETPQYKLSGKTGGGPNNGKGLGWFVGYVETKGNVYFFATNIEGADYLAIRDKRIALT
KRILAELGHLPKS
>AIA11265.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MFKFAIPVLHVTSSIAAEEFYCDRLGFTQTFAYRPFGGADPCYMGLTRDDVELHVSSFSG
DGVAGGVVFVGVEDVDALHEQLKATGIVIDLEPTDQSWGNREMYVHDPDGNSIRFVHDG
>AIA11237.1|FEATURES|farme|aminoglycoside|ASE98_04520|antibiotic inactivation|0
MQPYEITSDKSRMSVEAAHAFLSQAYWARGVPISTVRKAFDNSICFATLAGSEQIGFARV
VTDKATFAYLSDVYVLPAHRGKGVAKRMVEAIQRHPELQGLRRFMLATRDAHELYAKFGF
APLSAPGMFMELHNPDAYAQD
>AIA11179.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MLSSSESSVVKTANNSFWSILREAVAGSNRDFTQGSIGLAIFILSIPMIIEMLGESLFAI
VDIFFVAKLGADAVAIVGLTESMMALIYAVAFGLAIGATATVARRVGEKDAKGAAKSAAH
VLYLGVIVSVVMSAIGITFAPNILALLGAKPHIIEQGTTFMQIMLGGNAVVVFIFLLNAI
FRGAGDAAIAMRVLWLANILNIILAPCFIFGVSFFPELGVTGAAVGTTIGRGCGVLFAAW
HLFRPGGRIHVHRESWRLDVGLLWKIIKLSSNAVFQFLIATASWSALVVIIAGFGEEAVA
GYVIALRVVMFALLPALGLSNAAATLVGQNLGAGKPERSEKSVWKAASFNAAFYFAIGLI
FLFFSHPIIGIFTAEPTVLSYGASCLHIVAYGFAFYGLGMVLETAFNGAGDTWTPTYLNL
FIFWLFEIPLAYLLAYYFGMGPQGVFWAITIAFSVLAVASALLFRRGKWKEKKV
>AIA11177.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MQKPMKSAMGFIFITLLIDVMGWGLIIPVMAELIAQLKGIPVNEASPYGALLLSVFAIAQ
FAFAPVVGNLSDKYGRRPILLISLLGFGIDYIILALAPTYSWLFIGRIIAGMTGASFTTA
TAYIADVSPDEKSRAKNFGLIGAAFGLGFVLGPALGAFLATWGIRAPFYAAAALCLLNCI
YGYFLLPESLSKENRRPFEWKRANPFGSLKFLTSHREISGLALSFFLIYLGAQSVQGNWN
FFTIYRFNWSEKMVGISLAVVGVLVGAVQGGLTRVVVPKMGNEKSIYLGLGLYTLGLVLF
AFATEGWMMFAFLVPYCLGGICGPSLQSVISVHVPPNQQGELQGALTSLMSLTTIFGPLI
MNSTFAFFTTDKAPFHFPGIHFMIGAVCMLFSLIIIWKVLTREKKDKPELAKAIETKHKL
SDTPVH
>AIA11172.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MNKKLWLILIIGLLNAVGLTIVFPLFPFLISLYVPAEKVALYLGILISIYAVCKFFMAPI
MGALSDYFGRKPILFFSLLATAVGYFTLGIGGALWVLFLGRVIAGISAGDISALYAYVAD
STQGKERTKLYGYLGAANGIGFMIGPAIGGVLGIEYISLPFYIAGGISIITALFIYLSLP
ETLIEGKRKKNITVNAFNPFSHFKDILSLKEARKVFILGAYFFIALLSYQSNISVYLKDV
FAWGPARIGVLFALIGLCDIVSRAILLPKLLIFSEKSIIFGGLILMIAGFASIVLSGYLG
IASLLWISIVFITVGEGLFDPSYNNMLSQSVSGNKQGQLQGVNQGLHSLYEIFGPFAAGL
IYLYNPLAIYILAALLMMTTLLYFCKNSRVLVN
>AIA11163.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKVFIIAAITADGYIARDADHLADWTTREDKRLFVKLTKEAGVIVMGSKTFATIGRALPE
RRMVVYTRHPEEVAVEGVETTTESPQQLVSRLETEGAKGVAICGGAAIYSLFMAAGVVDE
LYVSVEPLVFGKGITMLDTPLEQNLSLKDVSKLNDHTVLLHYTTR
>AIA11124.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVALAENGVIGRDNHLLWRIKTDLGRFRSLTIGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDAGFAAEGVHVVHAWEEAVAQGAELAAGMGAKSVAVVGGAEIYALALPHVQSI
FLTKVHASPEGDAVFPDFDGSLFRETRREDHPKGPDDEHPFTFIDLERRP
>AIA11115.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
MRRKLMLALFIMPLLCAMSRAAEFRERPEWTRYFTDAGTQGTFVLYDLQHDRYQVSDRQR
ADTRFIPASTFKIPNSLIALDTGVVTDEHHVFPWDKMKREDASWNRDHTLRTALKYSVVP
IYQGIARQVGVQRMQEYVTKFHYGNTDISGGIEQFWLDGGLRISPVEQVQFLVKLYGNAL
PVQERSQRIVKDILLTEATAAYILRAKTGYGVRFTPSIGWWVGWVEREDNTYVFALNMDI
TSKEQLGERIAIAKAILRAEGILPHSS
>AIA11099.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MQDKSMINPLRIILLAAVTVDGKMARDTAHLSNWTSPEDKKIFVAESKRAGVLIVGNTTF
KTLLKPLPGRLHIVMTRTTADKTNIPGVVEYTSAPPAEIVAGLAARGYTSAVLAGGSQIN
SLFLAQGMVDEVWLTVEPLVFGTGVHVFEGVSFDLRLRLLSLEQINKDAYIAKYSTRPEG
G
>AIA11087.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNMRITILFGGSNRERLVSVASAQALHQALPEADLWWWDVEDKVHVVQSKQLLEHARPFE
DEFKPGTSGIPLGQALDQAKTEGRVLVLGLHGGRAENGELQVMCEARGVPFTGSGSASSH
LAFDKIAAKHFAALGGVTPPANVALDKIDEAFAEYGRLIAKPARDGSSYGLIFVNARQDL
VAVRNAAKHEDYVIEPYIAGVEATCGVLERPDGSIISLPPIEIIPGEGNFDYAAKYLLKS
TQEICPGRFSPEITAALKEQAMLAHRAMSCTGYSRSDFIVSDRGLIYLETNTLPGLTKSS
LYPKALKAEGIEFVDFLRGLVQLAERRVRK
>AIA11012.1|FEATURES|farme|aminoglycoside|SEI61121_11461|antibiotic inactivation|0
MTVLQTERLALRRLSPDDAEFILDLLNQPSFLRYIGDKGVRNTEEAINYIQTGPVASYEE
HGFGLYLVQLKETGASIGICGLLKRETLPDVDIGFAFLPAYWSRGYALEAAEAMMKYGRE
LFGLQRIVAITSLENESSIKLLEKLGMKFEGLIKLGDDEREVRLFGTSAGSAGILPAAT
>AIA11006.1|FEATURES|farme|beta_lactam|LRA-19|antibiotic inactivation|1
GIGVAIALGAGLGASIAAQSPAAQPASSVAKNGTDNDEWTRTFPPFRIIGNVYWVGGYDL
STYLITTPQGHILINTGVGDTAKQIAASVTQLGFKMSDVKILTATHGHIDHVAGLAELKR
MTGAPVVIAEPDKELLETGGRADYLLGKQPSMQFEPVKVDRTVRDGETIALGGTELTAHL
TAGHTKGATSFSFTVQDSGKDYRVVIANMPSINGGTKLTGMPGYPGIGKDYAQAFLTLKD
MKIDVFLASHASQFRLHEKYTPGAAYDPARFVDPAGFLRSVNQLEKAYLDQLEKERSGK
>AIA10996.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MHTFAVVVAADEQRGIGRDGMLPWRLPGDMADFKRVTSEAAPGKANAVIMGRKTYESIPE
RFRPLPDRINVVLTRSVTNTEHAGEVLRCATLEAALEELDARADIDQRFVIGGGQVYEQA
LAHPRCDRVHVTRVHRSFACDTFLPHFEANFQLVRSDGPHQDGDASYTFELYERAVDARG
SARE
>AIA10993.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNALVVAVAENGVIGGDNRLLWHLPLDLKHFKQLTQGHPIVMGRRTFESIGKPLPNRTNI
VVTRQAGWQADGCEVAYSVPQALEMARSIEENIFVIGGGEIYRQALPAADVVYLTEVHHA
FEGDVTFPSLNPDEWR
>AIA10951.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLHIRQAAPGDEQLVFNYICKLADYESLRHEVEATVADICESLFGSAPRAYCDLAFWSG
EPAGFALWFYNYSTFRGRAGIYLEDLFVDDAMRGKGIGKALLRHLAQRCVSEGLPRLQWW
VLDWNAPSIEFYKSLGAVPQDEWTVFRVSGDALEKLAAK
>AIA10916.1|FEATURES|farme|beta_lactam|RW26_17670|antibiotic inactivation|1
MKWSAMSVPTLAPAPAPVRTRLIAAAMFTMFTMLPTLAIMLCQAADATAATTCTLIVDAV
TGATQVRIGARCDERQTPASTFKVPLAVIGFDSRILQDGDHPAWPYREEYAAWDELWKRT
TTPTSWLRDSVVWYSQELTRRLGAAHFKEYVDRLDYGNRDVSGHPGRNDGLTTAWLSSSL
RISATEQVAFVRRLVRQELKVSPAAIERTMAVMPTREVDGWRISGKTGTGNRRNADGSND
RNRQVGWFVGWATRDGKTLVFARLIEDDKPEKVRGGWRARDTLFADWPALMAQAKVPAQA
HDG
>AIA10905.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALVALMSLTTAVEAQTPKDLIAALKAKWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTAMPEATSQIRASIEKLGFKVTDIKYLLNTHAHIDHTGGLAELKKASG
GRLVAGEADKSLLEGGYYPGAEEDTALAFPPVNVDRTVREGDTVTVGDMTLTARETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLGGADPTYFGIVSDYRKTFARAKDMKVDV
LLAPHPEMYRMQDKRAMLSDGAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA10897.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKVFIIAAMTADGHIGQAKDHLATTWTNPEDKYLFKHFVKEANNMVMGLKTFLTTAKVTP
TVFNKSMPGRRLFVYTHHPEAIAAYENIEVVTESPQELVARLEREGLDSVVICGGSQIYT
MFMQSGVVTDLYIDMQATLFGEGVPLFNAPIDAVISLKEIKRLGDNNVLLHYQVAK
>AIA10882.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
HEVSLVTAREVATALRESGYEVIELELDEHLPEKLLQTQPATVFPAVHGAPGEDGSLQGM
LEIMGISYVGSDVLASALAMHKATAKQLFQMAGLPITGSHLMREGDDLEATVAAIKDKLG
EPPYMVKPNTEGSALGATRVFDAGELRPAIERAVSPGKEVLIEEFIEGREMTVGILEEDD
GYRTFPLIEILSKKDWYDYEARYTPGMSEHICPAEVPPEVAAELARISLEAHKVLGCRDL
SRADLILTSSNEAYLLEVNTLPGMTPTSLFPDAAKVAGISFNSLMDHLIKRALRRRQS
>AIA10870.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAIIGIVAVDQNGAIGKNGSIPWHYSADVKFFRQQTIGHACVMGYTTWLSLKKPLKERLN
IVLSRKSEIKPQPSVIVLKDMLSVLSLKKFLACDLFVIGGERVYRSFLPHIDRWIVTQIP
LAVEGADTFMPEGYLQEFAPYDSQQLEENLKVTFYS
>AIA10855.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MQKSEELQIRLAVPEDSEAIAKVLYEAFAPFESGYTAQAFAATIISAEAIRKRFEEEGVI
WVALKTGEIVGTVSIVPEGQRLYMRSMAVMPSAQGGVGRELLKTVIDFATEKGFEELFLY
TVPFLDRAINLYEQNGFVRGDG
>AIA10826.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTEIVGIAAVGRNGVIGSENDIPWRIPEDWQRFKAITMGHVLIMGRKTFASIGRPLPGRT
TIVVTRDRMWSGDGVLVAPTLEEAFGQARALSPELLFVAGGGEIYRSSWDRLDRLEITEV
DLEPDGDVTFPVIEPEEWDETERDDRDGFSFVRYHRKQPQY
>AIA10794.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIMSEIIESKIIRPEIVRPEIIGIAAVAANGVIGARNDIPWRIPADWQRFKALTMGNVLI
MGRKTYDSIGRPLPGRTTFVITRDRMWRCNGVRAVPSVEEAIDQAILLDSQKIFVAGGGE
IYRAAWNRLNGLEITEVDQYPQGDVRFPDISPDDWIETRRERHEGYSFVSYSRRSRREST
L
>AIA10784.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAQARYKQLVDALAAEIRAGRLPPGTRLPTHRRLASQEGLALVTATRVYAELEAMGLVSG
EPGRGTFVRETALPRGLGIDQDAAASGMVDLNFNYPSLPGQAELLREGLRQLAASGDLEA
LLRYQPHGGRRHERATVARHLAARRLTVSADQVMIVNGAQQGLATTVIALLQPGDVVATD
GLTYPGFKVLAQALRLELAPIPADGNGPDLDTLERLCKRRRVRAVYAMPTLHNPLGWVMS
ASRRRQLVGIARRHGLLIIEDAAYAFLAEDPPDPLAALAPETTVYVSGLSKSVATGLRVG
FVAAPAEWVPKFQRAIRATTWNTPGVITAIACGWLDDGTVTRLESEKRRDATIRQAIAGD
ILAGLRCVRHPASYFVWLPLAEEVRADQVAMALMRDRIAVSTAEPFATSTHVPHAIRLAL
GSVELDTLRDALEKVKRAIDELAY
>AIA10768.1|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|0
MRSNDKPVKPNSAIVVARFKAADLCPIQTPHYFKKEIFMSTSKKTVTTINEDNLNQLLGK
FVSDFGAAFHAGMVVIGMELGLYKNMAGEEPTLPSELAERTGTNERYVREWLNSQAAGGY
VEYDADTGRYFLSAEQAFTLADENSPAYMPGAFLVATSALKAVPKLIERFRTGEGFGWHE
HDTGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLNNGAKVADVGCGLGASTILMAQAY
PNSAFTGFDYHDGSIE
>AIA10744.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKGGKLPWHYSADMKFFKETTTGNAVVMGHKTWLTLKKPLPNRLNI
VLSRQAEIEPAESVVILRDVDSVLAMNKDLKGDLFVIGGAQVYQAFLPYIDKWIVTEVPL
TVEDADTFVPPNYLEGFKQIGSKDLGDGLTVSFYER
>AIA10739.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
CADRGVKTEMEEERKIAVLNNVLETSLRFIAIAAMTPHRVIGLHKDIPWHLPEDLKFFKK
ITGGHPILMGRKTWESLPGSLPNRRNLVLSRKLNTAPGAEILRNPEQIDKLGLQGTVYVI
GGGEIYRLLMPRTSEILLTIVESAAEGDTLFPPFEEEFELAEVLDRMPGVAEWRRYVRRG
A
>AIA10700.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MIIGIAAVDRKGAIGKGGKLPWHYSADMKFFRETTTGNAVVMGRKTWLTIGKPLKNRLNI
VLSRDATIEPQESLLVLSDIDSVLSFNQSLTTDLYVIGGAQIYKAFLPHIEQWIITEVPL
TVQGADAFMPGGYLDEFEVADTKPLGEELVVKFYNRG
>AIA10639.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MADSAFEINTVKPAKHSRLYWGLSDSLTLIGRSMRHITRSMDQLLSVAFQPIMFMLLFRY
VFGGAIDTGGPSYVNYLVAGILVQSAAFGATTTAIGVCNDLQRGIVDRLKSLPMLSSAVL
TGHVVADLARNVASSVIMILVGLLVGFRPNANFMEWLGIFGILLLFTLAISWLSAMLGML
AKSIEGVQWFSFVVIFPLTFASSAFVRPETMPGVLRAFAENQPVSHVVDAIRALLIGTPI
GNHGWMAVAWCVGILVVSLPLAGWLFRRHTSK
>AIA10611.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGPLPGRTNIVVTRDAAWRAAGAVVTHSFTDAKAIATGDALRRFATEIAVIGGAEIYVQW
MDSADRLEITEVHARPDGDTHFPAVDPAAWEEVARVRNPAGSQDSVDFSYVTYRRRKPR
>AIA10593.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
MMKLLAITFLLLVSITETVAQAQDLSPFFKDTKGAFVLYDLKNNRYLRFNVARCRERFSP
KSTFKIPNSLIGLDTGVIQDADFVIAWNREKYPPQDNWDQEPFKHWGQDQTLRSAIKYSV
VWYYQELALRVGEKRMKKYVTALNYGNQNVSGGITQFWLNGGLKISADEEVEFLKALYAN
RLPVSKRSTYIVKDILVLEKAPTYTLSGKTGGGSIAAGTYIGWFVGYLETNGNVYFFATN
IEGPSFAAVREKRIDVTRQVLSYLGYLPK
>AIA10573.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISLIVAASKNNVIGEEGTIPWHISEDLIRMKKLTEGHPIIMGRKTHESISGFKNFEGWK
HNEKFEHKLLPNRTNIIVTRQTDYEVPGGIVTHSLEEAIQAANKSEGSDEIFIIGGESLF
KEGLSIAKRVYLTVIDREGMVIHFFQN
>AIA10532.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAKVHISAIAAVAKNNVIGRDNKLIWHIPEDMRHFKATTMGKPIVMGRKSYESLGKPLPG
RVNIVISRSGGKVVNENGPFFFTSIDEALADANKRAEKSGAGEIMIIGGGEIYKQTLPIT
DRIYLTRVEKDYEGDTFFPDLNPHEWHTVSKEHHDGDPPFTFYLLERK
>AIA10504.1|FEATURES|farme|beta_lactam|OXA-48|antibiotic inactivation|1
MKLLKLSFVCLVFICGTRAAVGRAQDLSPFFQNTTGAFVLYDSKNDRYVRYNDERCRRRF
SPKSTFKIPNSLIGLETGVIKDAAFVIPWDRRKYPPQDNWNTEPFIHWAQDHTLRSAIKY
SVVWYYRELALRVGPQRMKKYLGDFKYGDRRMGGRVDEFWLDNSLKISADEQVEFLKAFY
AGKLPVSKRSTDIVKDILLLEQTPTYRLSAKTGGGSIAEGKIIGWFVGYVETGGNVYFFA
TNIEGPNYAAIRDRRIDITKQILASLGYLPNQ
>AIA10502.1|FEATURES|farme|beta_lactam|RW26_17670|antibiotic inactivation|1
MKWSAMSVPTLAPAPAPVRTRLIAAAMFTMFTMLPTLAIMLCQAADATAATTCTLIVDAV
TGATQVRIGARCDERQTPASTFKVPLAVIGFDSRILQDGDHPAWPYREEYAAWDELWKRT
TTPTSWLRDSVVWYSQELTRRLGAAHFKEYVDRLDYGNRDVSGHPGRNDGLTTAWLSSSL
RISATEQVAFVRRLVRQELKVSPAAIERTMAVMPTREVDGWRISGKTGTGNRRNADGSND
RNRQVGWFVGWATRDGKTLVFARLIEDDKPEK
>AIA10458.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSAELEFSKRPKWLSALNDSLIMIKRSSTHIIRNTDQLIGTFFQPIMFLVLFTAVFGGAV
GMALPEGISYINFLMAGIIIQTVAFGSTTTAIAVANDLQRGIIDRFRSLPMSSIAVLNGH
VVSDVFRNAISTTVMLVAGLVFGFRASASFVDWLLIAGIIVLFTLAFSWLAAIMGVLAKS
VEGVQWMTSIIIFPLTFASSAFVPTQSMVPWLKTFAENQPITQIIEAIRALMLGLPVGDH
AWKSVVWCVGILIVAIPLASILFRRKTTN
>AIA10455.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MSERTEAEPGNAQASTEKVTFFTILRNRNFRNLWLGQIISQMGDYFAFLAILVVVGTFAQ
DVNETTQQVSVVMIAATLPRLLFGVLAGVFVDRWDRRLTMLASDLIRPALTLAMIPAFMS
KNLWLMCILAFAMSAVGTFFNPAKGALIPKMVPTEHLTAANSLSQTSMMAAFVLGPALSG
AIFFLAGAGNEWIAFVLDAVSY
>AIA10444.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MGFKLIEVSKWSRKEYFDHYLNQVTCTYSMTLNLDLTDLIKEIRRADVKLYPTMIYLLSR
IVNKHEEFRTSIDSNKQVGVFDLLHPSYTIFQKDSETFTNIWTEHSPSFSEFYERYLLDI
KSYGEIKSFIAKPNMPENVFNISSIPWVSFTGFNLNLPKVTDYLLPIFTTGKYFEQTGKT
WLPVAVQVHHAVCDGFHIAKFINELQEAMNTLKIKLREKKL
>AIA10438.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
LMLVFSVSPILAPLAGSLMVQFGDWRTIFWTIAVIGVLGLLLIAFFLKETRPASERLESS
VGSAMRGYALLLKDRNFIGLSLIGAFGMSSFMAYLANSSFILIDHYHLTPTLYSVMFSIN
AVSFIGVSQLTGILTRRFGLNTVVRTSVSGFIVVMVALAALFLAGIDQLAVLAVLLFIGY
GFLGLVVPTTAVLALENHGTIAGTASALMGTLQMVTA
>AMJ38575.1|FEATURES|farme|multidrug|hp1181|antibiotic efflux|0
MKPSIRRSTAALLASSLLLTIGRGATLPFMTIYLTRVYDMSVENIGYALTVALAIGVVFS
LGFGILADKFDKKRYMLIAIVAFIAGFVATV
>AMJ38557.1|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
DTIANNIALGCPTATQDQIEHVARLASVHEDILRLPQGYDTEVGERGVMLSGGQKQRISI
ARALLLDAEILIL
>AMJ38548.1|FEATURES|NCBI|multidrug|mdtG|antibiotic efflux|0
MTGEKTMTQQSDGEAEPERYWRRNLWVCMAGSFTTLIAMTLLLPFLPLYVAELGVSEPAA
VARWSGVAYGATFFTAALTAPLWGRLGDRYGRKLMLIRASLGMAIAMSLIGMASAPWQLV
ALRLLAGLLGGYASGATIFIAAQTPKAHTGWALGMLSSGVMAGNVVGPLIGGLLPPLIGI
RATFWLAGGVIFLAFLATSLLLKEAPRPAPQQRQRETAALSLRQGMLPVMLLSGMLLIFA
NMSVEPIITLYVAQFVHQPHQVTLMAGVTMSAAALGSILSAAWLGRRY
>AMJ38521.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIVLVIAGLLEVVWAIGLKYTHGFTRLTPSVITIAAMIVSIVMLSWAMRTLPVGTAYA
VWTGIGAVGAAITGILLLGESASLARIASLALIVAGIIGLKLSTH
>AMJ38505.1|FEATURES|farme|quinolone|oqxB|antibiotic efflux|1
LLLLCAAGVMFKAVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVD
YAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILP
PPILGLGQGSGYSLYIQDRAGLGYG
>AMJ38504.1|FEATURES|farme|beta_lactam|CMY-48|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AMJ38494.1|FEATURES|farme|beta_lactam|ACT-17|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEK
QLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ
>AMJ38489.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTITDVFEPGSTVKPMVVMTALQRGV
VRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSNVGVSKLALAMPSSALVDTYSR
FGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYGLMVTPLQLARVYATIGSYGIYR
PLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGGGVKAAIKGYRIAIKTGTAKKVG
PDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKYYGGAVSAPVFGAIMGGVLRTMN
IEPDALTTGDKNEFVINQGEGTGGRS
>AMJ38407.1|FEATURES|farme|multidrug|mdfA|antibiotic efflux|1
MAAYTPVSRLTFRHLMFPLSLVLFEFATYIAHDMIQPGMLLVTSEFHVGAEWVSTSLTAY
LIGGILLQWLLGPLSDKYGRRPVMLAGVLFFIVCCAMTHWVASIEQFVALRFFQGASLCF
IGAVGYAAIQEAFDEARSVRIMALMANVALLAPLAGPLAGAAFLTVGDWRTMFWLFALLA
AVALIGLWRAMPETAGDRSVSISLKSLGRAYLALARDRQVMSGSLAIGLVFIPILAWVAL
SPVILIHDEGLTRMDYALLQLPVFLAMIAGNLTLSRLASRLPIEGPLRFGAWPILAGLML
ATLTSIIDRHSYLWLTAGLSIYAWGAGMVNAGLYRLTLFSSTAGKGSVAAMLGMVSILAF
ALGIELSKYGYFHGGAAWFSLINLASGLLWLVLVTAFLRERKRRSKIDPA
>AMJ38377.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MQLAGKRILIDPVLSSYAAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATI
KALLPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVHISDALTVHVLPARHFSGRGI
KRNQTLWGSFMFVTPERKVYYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDWKYIHM
HPAETAQASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVR
VSDTTQQFREWWE
>AMJ38326.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIVLLVAGLLEVVWAIGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYA
IWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIVGLKLSTH
>AMJ38292.1|FEATURES|farme|beta_lactam|CFE-1|antibiotic inactivation|1
MLRFYQNWQPQWALGAKRLYANSSIGLFGALAVKPSAMRYEEAMTRRVLQPLKLTHTWIT
VPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSLVDMTRWVQTNMDASQVQEKTLRQ
GIEIAQARYWRIGDMYQGLGWEMLNWPVNPNSIINGSDSKVALAALPAVEVNPPAPAVKA
SWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>AMJ38287.1|FEATURES|farme|beta_lactam|ACT-17|antibiotic inactivation|1
MPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQ
GIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKA
SWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHILEALQ
>AMJ38255.1|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
MKHNKIIISILTIFIILLSVGCSNKQENIPDSNENVNADYDSLFQELEEKYDATLGIYAL
DTETNKEISYNADERFAYCSTYKALAAGAILEKYSIEELDNVIYFEEEDVLSYAPVAKDK
VDTGMTIREICDAAVRQSDNTAGNLQFTLLDGPNGFKQSLSKIGDTVSEPSRIETELNDA
VPGDIRDTSTPKQLAFNLKEYVTGDILSDDKKEIFIDWMSNNATGDELIRAGVPSDWIVA
DKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDAEYDNKLIADATKIIFDLIS
>AMJ38221.1|FEATURES|farme|macrolide-lincosamide-streptogramin|LmrB|antibiotic efflux|0
MRFTEACLLKTENNMTTLSEPLVTPKYGKWRQLVLGLICMAAISSPQYVWTLLTKPLAAK
LGVGLPELQVTFSLLIILQTFFSPFQGRLVEKFGPRRLIAIGTVMAGMSWVLSAQVNGLA
TLWLVYGCMGGLGTGIVYIGVVGLMVKWFPQQRGFAAGAVAAGYGMGAIITTFPISLSLI
TNGLEHTLTTFGILFALVGFLASQGLKLPPPAVSQPVSQTVAQSSRSFTSREMLRQPLFW
LMFAMMAMMSTSGLMVTSQMAVFAEDFGISQAVVFGMAALPLALTIDRFTNGLTRPLFGF
ISDRFGREQTMFIAFALEGVAMMLWLACREDPLLFVLLSGVVFFGWGEIFSLFPSTLTDT
FGSEHAASNYGWLYISQGIGSIFGGPLAALLYQYTHGWHVVFSCAIGLDFVTAALALWVL
KPWRARFIRQHS
>AMJ38208.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
IDQLIVMRFFHGLAAAAASVVINALMRDVYPKEEFSRMMSFVMLVTTIAPLVAPMVGGAV
LVWFSWHAIFWILAIAALLASVMIFVFIDETLPVERRQKFHVRTTLGNFASLFRHKRVLS
YMLASGFSFAGMFSFLSAGPFVYIELNHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVG
ALNMFRAGLWIQFVMAIWLVLSALLGVGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPH
MAGTASSLAGTFRFGIGAIVGALLSTATFNTAWPMLWAIALCATCSILFYLYASRPRKTA
HK
>AMJ38206.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
LDVTVQAQILQLLRELRDELNMSLLFITHNLSIVKKLADAVAVMQNGRCVEQNRASALLS
APQHPYTQRLLDSEPAGDPVPLNADSAPLLRVERLSVSFPIRKGILRRVVDHNHVLKDMS
FALRPGESLGLVGESGSGKSTTGLALLRLIASQGSIVFDGMPLQNLNRRMMLPVRPRMQV
VFQDPNSSLNPRLSVLQIIEEGLRVHQPTMTAQQREIDVMRVMAEVGLDPETRHRYPAEF
SGGQRQRIAIARALILKPELIVLDEPTSSLDRTVQAQILALLKGLQEKHRLAYIFISHDL
QVVRALCHQVVVLRQGEVVEQGECQRVFTAPTQDYTRQLLSAD
>AMJ38176.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
YAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIKALLPKVKRVV
>AMJ38151.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|0
DYATIRALLPKIKRVITPLGVGSHLRYWGMDGALITEADWQQAIPVNDELTVHVLPARHF
SGRGLKRNQTLWASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDW
KYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQ
GEPVWVADKTQSFNAWWR
>AMJ38123.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLRQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AMJ38059.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLVSLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ37940.1|FEATURES|farme|tetracycline|tetA(P)|antibiotic efflux|1
MVNKLSAYKTYLLFSAITAMCFSLVATVMIVYHIEIVHLNPLQLILVGTTLELACFIFEI
PTGIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWI
AEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLY
MPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNA
HFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINIL
YISSMLIFALTRNFSLMLIAYLATNTFRIINEPIFSAWLNGHIDDNSRATVLSINGQMNS
LGQILGGPIIGIIATNISVSIGIVCTSLLVAPVLVLYIISMIMDKKIS
>AMJ37929.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
MIYKNYNCNIGGFILKRLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKS
GQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AMJ37901.1|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AMJ37776.1|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
ESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSLK
ISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIV
>AMJ37770.1|FEATURES|farme|beta_lactam|OXY-6-2|antibiotic inactivation|1
MLKSSWRKSALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ37723.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTVATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37691.1|FEATURES|farme|triclosan|TriC|antibiotic efflux|0
TIVSRNGEHFRLADIAQIEEGYQTPPANQMRINGSPAVGIAISTVPTGNVVDMAEDIKMR
IGELSQSIPDGYELISIYDQGYESAVANQGFILNLIISVITVVAILLFFIGFKNGLLIGS
GLVFSIFATLIVMMACDIALQRMSLAAIIIAMGMLVDNAIVVSDSALINMERGMRKRVAI
MRACSSTALPLLAATVIAILTFL
>AMJ37632.1|FEATURES|NCBI|multidrug|acrB|antibiotic efflux|1
MFSRFFVRRPVFAWVIAILIMLAGVLAIRTLPVGQYPDVAPPAVKISATYTGASAETLEN
SVTQVIEQQLTGLDHLLYFSSTSSSDGSVSITVTFEQGTDPDTAQVQVQNKVQQAESRLP
SEVQQSGVTVEKSQSSFLLILAVYDKTNRATSSDISDWLVSNMQDPLARVEGVGSLQVFG
AEYAMRVWMDPTKLASYSLMPSDVQSAIEAQNVQVSAGKIGALPSSNAQQLTATVRAQSR
LQTPDQFKAIIVKSQADGSVVRLSDVARVEMGSEDYTATANLNGHPAAGIAVMMAPGANA
LDTATLVKSKIAEFQRQMPQGYDIAYPKDSTEFIKISVEDVIQTLFEAIILVVCVMYLFL
QNFRATLIPAVAVPVVLLGTFGVLALFGYSINTLTLFAMVLAIGLLVDDAIVVVENVERI
MRDEGLPAREATEKSMGEISGALVAIALVLSAVFLPMAFFGGSTGVIYRQFSVTIISAMM
LSVVVALTLTPALCGALLSHSKPHTKGFFGAFNRLWGRTEAGYQRRVLGGLRRGAVMMGA
YALICGAMALAMWKLPGSFLPVEDQGEIMVQYTLPAGATAVRTAEVRRQVTDWFLTKEKA
NTDVIFTVDG
>AMJ37631.1|FEATURES|farme|multidrug|smeD|antibiotic efflux|0
RPALVVDAANKVEQRTVETGDTYGDKWLVLSGLKAGDKLIVEGTSKVAPGQTVKAVAVNN
NGGNA
>AMJ37564.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MIPTLRRSTAALLASSLLLTIGRGATLPFMTIYLTRQYQLEVDKIGYALSSALIVGVLFS
MGFGILADKFDKKRYMTLAVLAFIGGFIAIPLVNSVALVVFFFALINCAYSVFSTVLKAW
FADVLSPEKKAQIFSLNYTFLNIGWTVGPPIGTLLVMHSINLPFWLAAGCAALPLVFIQL
FVQRTSAAVAQDNAVQWSPSVLLRDRALLWFTLSGLLASFVGGSFASCISQYVLVVADSD
FAEKVVAVVLPVNAAVVVALQYAVGRRLTARNIRPLMTFGTVCFVIGLGGFVISDNSLLL
WGVSAAIFTLGEVIYAPGEYMLIDNIAPPG
>AMJ37438.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
MRETPEVSGDDNANARAAVHSANKPGAAYAAAVANGESERAWIRRVALLLVGQAFSLLGS
SIVQYAIWWWIVLQTRTGSAMLLATLFGVVPQAVVSIFGGSWADRHSRKLLIMLPDMVIA
VVTVVLSLSFAMGWASLTMIFVVLFIRSAGGGVQTPAVQSFIPDVVPSGKLLRVNSIYGV
INSANTIVAPAVAAVLINTVPLWSILLVDVTTAIIGVGFVALIKAPKKSTEHVARRMAEA
ENSGQPTLEPMSDANADRSLIASVRRVFADLKDGFSYTWRRANLRNVVLGGALVCFVSVA
PMNLTLLLMTREYEGIDLNLGFINLTTASDKLAANELGWSIGMLLGGALMSTIGAKLIRN
NMRVVAFGIALVGVSVVGLGVVHNLLAYLLIDVVNGLASAICTGPMRTIIQTEADEKMVG
RVFGLDTTLSALGMPLGMLIFAPLADVIPISLVFIIGGVLTPPIGIYLFGQARRNVSVQV
TRTAA
>AMJ37379.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
NKKVEIHFLSGKNAISHISFAGRPANASFTGDGPIVLEPDMSWIVLLIAGLLEVVWAIGL
KYTHGFTRLTPSIITIVAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLGE
SASPARLLSLGLIVAGIIGLKLSTH
>AMJ37375.1|FEATURES|farme|beta_lactam|blaCMY|antibiotic inactivation|1
MKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AMJ37339.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
THGFSRLTPSVITVTAMIVSMALLAGAMKSLPVGTAYAVWTGIGAVGAAITGILLLGESA
SPARLLSLGLIVAGIIGLKLSTH
>AMJ37292.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
TGQKNMLAAWWEFLVAKRENARPAQPLPLVNTDLASLPLGQDAMVWLGHSSWYLQLAGQR
ILIDPVFSRYAAPFSFINKAFAGDYPWHAEGMPEIDLLIISHDHYDHLDYATIKALMPKV
KRVVTPLGVGSHLRYWGMESAIISEADWNQAVPVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPEETAQ
AADDVRARAVLPGHAGRFVLAKHTWDDPYIRLAEASTGRPWRLLTPMLGEPVWVADKTQS
FNAWWR
>AMJ37218.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGVTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37059.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAKLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ37056.1|FEATURES|farme|beta_lactam|MIR-12|antibiotic inactivation|1
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAGAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEVHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLEAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AMJ37035.1|FEATURES|farme|beta_lactam|CMY-85|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISPLHLAPYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPLHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQLGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AMJ36998.1|FEATURES|farme|beta_lactam|MIR-16|antibiotic inactivation|1
QAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKTNVKDMA
SWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDVKTVVGGSDNKV
ALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKNYPNPARVT
AAWQILNTLQ
>AMJ36992.1|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
MSWDHKHYPFDAWNKEQNLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSY
KSYWMEDSLKISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGI
VNGKYNNGWFVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>AMJ36942.1|FEATURES|farme|chloramphenicol|cmx|antibiotic efflux|1
IQATDRRYVVILFAVLLTLSCLLVSFANSFSLLLIGRACLGLALGGFWAMSASLTMRLVP
PRTVPKALSVIFGAVSIALVIAAPLGSFLGELIGWRNVFNAAAVMGVLCIFWIIKSLPSL
PGEPSHQKQNTFRLLQRPGVMAGMIAIFMSFAGQFAFFTYIRPVYMNLAGFGVDGLTLVL
LSFGIASFVGTSLSSFILKRSVKLALAGAPFVLALSALVLTLWGSDKIVATGVAIIWGLT
FALIPVGWSTWITRSLADQAEKAGSIQVAVIQLANTCGAAIGGYALDNIGLTSPLMLSGT
LMLLTALLVTAKVKMKKS
>AMJ36940.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MLNRSSSGSRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVAQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHMAPWEGMFVLFAVL
AAIAFFGLHRAMPETATRIGEKLSLKELGRDYKEVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEKLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLI
LAAVATVASSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYAMGGNGLFSLFNLANGVLWVGLMVVFLKDKRVGNALQP
>AMJ36864.1|FEATURES|farme|macrolide-lincosamide-streptogramin|LmrB|antibiotic efflux|1
MNIHQGKLVKETTHPRPTNAIPPVLWMQAAIITLGAFSTMLSSTMLSAALPAMAIGLGVP
DSAIQWIATAYLMALAAGVPLSAWAVRRFGATQLWLYGLILFAIFSAVCALSPRFEVLLA
ARMLQGLAGGLLVPAGQTILGLVVGRERLGRVIGTIGVAIVIAPLLGTSLGALLVESCGW
RGLFWITVPFCLCAYLTGWKLLPRPAIKNDRPLSLDWLGLALVFCSLPMLMEGMKELSLN
NGKYGWNVIMLSVGALFTCLFIYRSLRIESPLLHLGLFKHRGFTLSAVLMTIGGAVN
>AMJ36835.1|FEATURES|farme|beta_lactam|LEN-2|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AMJ36823.1|FEATURES|farme|multidrug|cmeA|antibiotic efflux|1
MNKQFIITNFAAFALMLFLPTGCRQADGKQDAVQSYRVIKVAASPVEISESYSAAIRGRQ
DVDILPQISGRIIRLKVKEGERVKTGQVLAVIDQVPYRAALRTAQANVSAAQAKVETARI
ELRGKQALFDEKVISDYELSLARNQLAVACAELEQAKAQESDARNNLSYTEIKSPSNGVV
GTLPYRIGALVGPNMAQPFTVVSDNAEMYAYFSISENMLRRYSARYGSIDSMIAGTPEVG
LQLNDGSLYKAKGRIETVSGVVDPVTGTVQIKALFPNPDRELLSGSIGNVILQNPKTEAV
TIPMTATVELQDKITAYR
>AMJ36814.1|FEATURES|farme|beta_lactam|C273_11191|antibiotic inactivation|1
IANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPK
GQSEPIVLVIFTNKDNKSDKPNDKLISETAKSV
>AMJ36788.1|FEATURES|farme|beta_lactam|MIR-9|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQSIRMLDLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGA
LAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEA
YGVKSTIEDMARWVQSNLKPLDITEKTLQARDTTGTISLLANRRYVSGPGLGNAGLAGKS
>AMJ36747.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
AYAVWTGIGAVGAAITGILLLGESASLARIASLALIVAGIIGLKLSTH
>AMJ36744.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILTDPVFSDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPMQGEPLWVADKTQS
FNAWWR
>AMJ36694.1|FEATURES|farme|multidrug|mdtL|antibiotic efflux|1
MQKFLFLLLSLVLLGPLGIDLYLPTIPAIALGLNSSEALIQSTISLFILVLGLGQIIAGP
LVDNYGRKPVALAGIVIYMIGAAMAALATTPTVFVASRLLQGVAVCCTAVVAFSGVRDRM
NGDDAARAFGFLNGTLNIIPALAPLLGGLLAEAFGWRAPFWFLVCYALAVLVLIALRLPE
TRPADTVRVKGLPVRQYARILKDRRFLSFAVVNSGAMGMALTYVSLAPNVLMGTAGLTPL
QFSLVFGANGFWIMLVSFFANRIIHKVGRPVCLATGGILMGIGCVGLLLGVTWLSGSAQT
HWLAYMLPVASACAGLAFVMGPATSYALEPYSNEAGVASALVGFVQMAGGAGLGLLAMAL
PLQPKLSLALVMLVGCLLALHARQRSKQIKGQLKKIA
>AMJ36541.1|FEATURES|farme|aminoglycoside|SG34_20990|antibiotic inactivation|0
VAAGMSPRPLEGARAGLPHSCYGVHILWQETPIAMGRIVGDGAINFDIVDVAVDPAHQGK
GLGRLVMEKLIAWLDANAFDGAYVTLVADVPALYAKFGFESVRP
>AMJ36426.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MLMPLAIDMYLPSMPVIAEQFGVPSGDVQMTLSAYTLGFAFGQMIYGPMADSIGRKPVIM
YGTLFFALAGAACAMAQSVDQLIVMRLIHGLAAAAASVVINALMRDMFTKDDFARMMSFV
VLVMTIAPLLAPIMGGALLIWFSWHAIFWAMAGAALLGTILVAIFIKETLPKEKRQKFRL
RTTLGNFASLFRHKRVLCYMLASGFSFAGMFSFLSAGPFVYIDLNGVSPQHFGYYFALNI
VFLFIMTLINSRNVRRFGAINMLRFGLLVQFVMGIWLVITAALGLGFWSLVIGVAAYVGC
IAMITSNAMAVILDDFPHMAGTASSLAGTLRFSLGAVVGTLLALASARSEWPMVSSMFLC
IFAAMMLFLYASRPSKSSRVEPV
>AMJ36416.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSGYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ36402.1|FEATURES|farme|glycopeptide|AANH_like|antibiotic target alteration|0
NTMAYKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHV
>AMJ36331.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ36263.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MSLKNKIRRFMEKKNLNPMNNRKKVGIILFATSIGLFFLFAVRFSYIVIGGHVAGTSLAE
KTKQLYQGSEVVKAKRGTIYDRNGVALAEDASSYSIKAILSKTYTSGDKKLYVEEKNFDK
IAEILHKNLSIDKKDALNILEDGAKKELYQVEFGSYGKNISQETKQNIEADMKKEGVAGL
YFVDHQARMYPNGVFSSHFIGYAVPDKDENGLVGKLGLESAYNDILSGKDGKIIYQKDNF
QNPLPGTVAEEEKAVDGQDIYTTLDSRLQSYLETLMDQVNEEYQPEELTVVLMKAKTGEI
LAMGQRPTFNPETMEGLTGEDAIWRNFLVQDSYEPGSTMKVFTTAAAIEEGEFNENETFQ
SGKIQVEDATINDHDFGEKGVLTMRQALSWSSNVGMVILEQRLGGRWYNYLQKLGFGQST
YSGLDDEVNGALPTSNIVDRAMSAYGQAVGVTNFQMMKAFTSIANNGTMIQPRYISKVVD
PQTGEERTTQTEVLGQPFSKETTEKVREYMRDVVESENYGSAYGVYSVPGYNVSAKTGTA
QIASDTGGYQTGDTAYLYSIVEMVPSEDPDYVLYLTMKHPKTYDRMALAKIANPLMKRAM
DFKETEEDTDTETKTEKVSVADYRNLEADVAAADAQKSGL
>AMJ36207.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYTVPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ36071.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGS
YVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AMJ36005.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
TFTGVLGGDAIARGEISLDDPVTRYWPQLT
>AMJ36000.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
FWAMSASLTMRLVPPRTVPKALSVIFGAVSIALVIAAPLGSFLGELIGWRNVFNAAAA
>AMJ35989.1|FEATURES|farme|beta_lactam|CMY-85|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYGGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELRSPM
TLRIKPNYCAFIKTGNHNGLRALSVFMLTPALVCLVRWW
>AMJ35965.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNALLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQRDGAAAAQPGAA
>AMJ35953.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKTDLATLPLGQDVMVWLGHSSWYLQLAGKRILIDPVLGNYAAPFSFLNKAFAGEYPWRA
EIMPAIDLLIISHDHYDHLDYATIRALLPKVKRVVTPLGVGSHLRYWGMKPEIIDERDWN
QSVRISDALTVHVLPARHFSGRGIKRDRTLWGSFMFVTPEQKVYYSGDSGYGPHFRAIGE
QFGEVDVAIMENGQYDQDWKYIHMLPEETAQASADLNAKAVVPGHNGRFVLAKHAWNDPL
IQLAKASQDKNYRLLTPELGEPVRVSDTAQTFRAWWE
>AMJ35950.1|FEATURES|farme|quinolone|oqxA|antibiotic efflux|1
MALSQPGQRKWRGFSRCVLPGGYIYRNKNNEPAKNLGKHSPDRARRDDALLLLVGCDDSV
AQNAAPPAPTVSAAKVLVKSISQWDSFNGRIEAVESVQLRPRVSGYIDKVNYTDGQEVKK
GQVLFTIDDRTYRAALEQAQAALARAKTQASLAQSEANRTDKLVHTNLVSREEWEQRRSA
AVQAQADIRAAQAAVDAAQLNLDFTKVTAPIDGRASRALITSGNLVTAGDTASVLTTLVS
QKTVYVYFDVDESTYLHYQNLARRGQGASSDNQALPVEIGLVGEEGYPHQGKVDFLDNQL
TPSTGTIRMRALLDNSQRLFTPGLFARVRLPGSAEFKATLIDDKAVLTDQDRKYVYIVDK
DGKAQRRDITPGRLADGLRIVQKGLNPGDSVIVDGLQKVFMPGMPVNAKTVAMTSSATLN
>AMJ35917.1|FEATURES|farme|beta_lactam|CMY-51|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAV
>AMJ35764.1|FEATURES|farme|beta_lactam|ACT-14|antibiotic inactivation|1
MFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLP
LQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYERAMTTRV
LKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANM
APEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPV
AEVNPPAPPVKASWVHKTGSTGGVWGYGGLFS
>AMJ35570.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQSIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAAL
AAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIILGGWPIAAGLI
IAAVATVASSHAYLWMTAGLSVYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYAFGGNGLFSLFNLANGVLWVGLMVVFLKDKRVGNALQP
>AMJ35560.1|FEATURES|farme|quinolone|qacH|antibiotic efflux|0
MQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAIGLKYTHGFTRLTPSVITIAAM
IVSIVMLSWAMRTLP
>AMJ35555.1|FEATURES|farme|beta_lactam|MIR-14|antibiotic inactivation|1
TTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVTDNAALLRF
>AMJ35522.1|FEATURES|farme|beta_lactam|ACT-14|antibiotic inactivation|1
LATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPFRH
GL
>AMJ35494.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
MFRLEEEKNSRGTVMSGSAIRGRQGSERFFTLPAVTLIASSFVLGMSDFVVVGILPDIAH
GLRVLEVTVGNLASRFATHLTLIGVFLAGNILCALAPNYAVLPHYRHMAKVGFLPQFRMR
AGNGRLSALRLRTIPGR
>AMJ35462.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
YWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVKSSSDLLR
>AMJ35432.1|FEATURES|farme|beta_lactam|ACT-14|antibiotic inactivation|1
YYFTWDNAHIAKKQPVAQQTLFELGSVSKTFTGVLGGDAIARGEISLDDPVTRYWPRLTG
KQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLF
GALAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDA
QAYGVKTNVQDMANWVMANMAPE
>AMJ35409.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGAAGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ35338.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIAALSLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQGLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLPAFLRQMGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ35271.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
DTVINISARRKHIHAGCLINNAWEADNADQHIQSLNIKTPGPEQLIMNLSGGNQQKAILG
RWLSEEMKVILLDEPTRGIDVGAKHEIYNVIYGLAAAGVAVVFASSDLPEVLGVADRIVV
MREGQVAGELLHEEANEQQALSLAMPKVSQAVA
>AMJ35249.1|FEATURES|farme|quinolone|oqxB|antibiotic efflux|1
SIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSL
FGLVLAIGIVVDDAIVVVENVERNIEEGLGPLAAAHQAMREVSGPIIAIALVLCAVFVPM
AFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFG
WIFRPFNRFFLRSSNGYQGLVSKTLGRRGAVFVVYLLLLCAAGVMFKVVPGGFIPTQDKL
YLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFG
LKPFDQRKHSAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYG
ALQSAVNAMSGTIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYL
GSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPD
PVIRYNGYPAADLIGDADPRVLSSSQAMTLLDAMSKQVLPNGMNIEWTDLSFQQATQGNT
ALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLV
VLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGH
GAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRSKPVQEDLPA
>AMJ35217.1|FEATURES|farme|multidrug|mexC|antibiotic efflux|0
MIKTFRFALLASALASSALTATAAPAVPVRVATAELAPHAEERAIPGRVEAIRAVDIRAR
TEGVIVQRHFQDGQYVTEGDLLFTLDDAQPRAALALAQAELKSAEASLRQSQQLLTRYER
LINNHSISRNDVDTARMQRDVAAAAVQQAKARVEAQQIVLSYTRIAAPVTGRVGHSAFHV
GTLINPSSGVLVDIVQLDPVRVSFALDEAAFFSKTGQHADIHALKQAWLAQID
>AMJ35162.1|FEATURES|farme|multidrug|MFS_1|antibiotic efflux|0
IIEGLPAVLLGIAAFFILRDRPHQAGWLTERQKTWLENTLQAERQQQTQIGHTTTWQLLK
HRQIWLMALIYAGASSAGTTLSVWSPQLLKSFHLDNLTTGLLNAIPYGLASVLMIVWGRS
SDRNNERRWHTALALFMIAAGVFAAFINLSLPATIMILSTILIGAYAAKGPFWALASGWM
SSTSAAAGLAAIGAIANLIGGAVMVNAYGIISERTGSYTLAMLPLAALCLAGG
>AMJ35156.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISRIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ35141.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTAKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQFNVPDGSAQMTLSTYILGFAL
GQLLYGPMADSMGRKPVILGGTLVFAAAAVACALSQTIDMLITMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTVAPLVAPMVGGAVLVWFSWHAIFWILAVAALLASAM
IAFFISETLPPERRQKFHIRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
ININHVSPQHFGYYFALNVVFLFVMTMINSRFVRRVGALNMFRAGLWIQ
>AMJ35124.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGY
TGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQR
ILIDPVFSNYAAPLSFLNKAFVGDYPWSAQTMPEIDLLILSHDHYDHLDPATIKALMPKI
KRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLW
ASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQ
AAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYNYRLLTPMLGEPVILSEPDQL
FTAWWQQVTQ
>AMJ35052.1|FEATURES|farme|beta_lactam|OXY-1-2|antibiotic inactivation|1
ALINTADDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSP
ITEKHLQSGMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEP
ALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPA
SWVVGDKTGGGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEG
L
>AMJ35046.1|FEATURES|farme|beta_lactam|TEM-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFFAQHGGSCNSP
>AMJ35024.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MRNRTITDVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLT
GVLQKSSNVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERA
TFSFGYGLMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMES
VALPGGGGVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVIN
DRRRVNTTAAPFPRRSLVPSWAAYCVP
>AMJ34864.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFGDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ34816.1|FEATURES|farme|beta_lactam|BSONL12_02412|antibiotic inactivation|1
MKKFCFLFLIICGLMVFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDT
RFSYCSTHKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSAS
LRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQM
VKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAETPQGWKVIDKSGSGDYGARNDI
AVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF
>AMJ34754.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYIRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ34672.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
LGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQV
PDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYERAMTTRVLKP
LKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPE
KVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEV
NPPAPPVKASWVHKTGSTGGVGRYL
>AMJ34666.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFN
>AMJ34581.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNAPLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQRDGAAAAQPGAAPWSPSVLLRDRALLWFTCSGLLASFVGGAFASCLSQYVL
VVASSDF
>AMJ34544.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVL
AAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLI
LSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG
>AMJ34467.1|FEATURES|farme|tetracycline|tetA(60)|antibiotic efflux|1
MVLIAVVVYLLRYVWRVLLFGASYQLAVELREDYYRQLSRQHPEFYLRHRTGDLMARATN
DVDRVVFAAGEGVLTLVDSLVMGCAVLIMMSTQISWQLTLFALLPMPVMAIMIKRNGDAL
HERFKLAQAAFSSLNDRTQESLTSIRMIKAFGLEDRQSALFAADAEDTGKKNMRVARIDA
RFDPTIYIAIGMANLLAIGGGSWMVVQGSLTLGQLTSFMMYLGLMIWPMLALAWMFNIVE
RGSAAYSRIRAMLAEAPVVNDGSEPVPEGRGELDVNIRQFTYPQTDHPALENVNFALKPG
QMLGICGPTGSGKSTLLSLIQRHFDVSEGNIRFHDIPLTQLQLDSWRSRLAVVSQTPFLF
SDTVANNIALGCPNATQQEIEHVARLASVHDDILRLPQGYDTEVGERGVMLSGGQKQRIS
IARALLVNAEILILDDALSAVDGRTEHQILHNLRQWGQGRTVIISAHRLSALTEASEIIV
MQHGHIAQRGNHDELAQQSGWYRDMYRYQQLEAALDDAPEIREEAVDA
>AMJ34449.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNALLVVIFFALINCAYSVFS
TVL
>AMJ34434.1|FEATURES|farme|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>AMJ34432.1|FEATURES|farme|beta_lactam|TEM-183|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSGPSGWLVYC
>AMJ34359.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MGWLTHEVGWSHVFFFMGGLGIVISFVWLKVIHDPNNHPGVNQKELDYIAEGGALINMDQ
KSSAQKVPFSVKMGQIKQLIGSRMMIGIYIGQYCINALTYFFITWFPVYLVQARGMSILK
AGFVASIPAVCGFVGGVLGGVISDWLMRRTGSLNIARKTPIVLGMLLSMTMLMCNYVNVE
WMVIGFMAMAFFGKGIGALGWAVMADTAPKEISGLSGGLFNMFGNISGIVTPIAIGYIVG
TTGSFNGALIYVGIHALVAVLSYLVLVGNIKRIELKPVAGR
>AMJ34346.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGY
TGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQR
ILIDPVFSNYAAPLSFLNKAFVGDYPWSAQTMPEIDLLILSHDHYDHLDLATMKALMPKI
KRVITPPGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLW
ASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQ
AAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYNYRLLTPMLGEPVILSEPDQL
FTAWWQQVTQ
>AMJ34321.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ34299.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVVFS
LGFGILADKFDKKRYMLLAITAFACGFIAIPLVNNVTLVVLFFALINCAYSVFATVLKAW
FADNLSSTSKTKIFSINYTMLNIGWTIGPPLGTLLVMQSINLPFWLAAICSAFPMLFIQI
WVKRSEKIIATETASAWSPKVLLQDKALLWFTCSGFLASFVSGAFASCISQY
>AMJ34272.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMAAGLSLYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>AMJ34230.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLTTASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHRTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>AMJ34192.1|FEATURES|farme|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWASMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>AMJ34190.1|FEATURES|farme|beta_lactam|OXY-2-7|antibiotic inactivation|1
SGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAA
VLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLII
GYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGDAL
GEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPEDHAPLVL
VTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AMJ34074.1|FEATURES|farme|beta_lactam|blaOXY|antibiotic inactivation|1
MISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGN
ALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYG
>AMJ34072.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIILFIAGLLEVVWAIGLKYTHGFTRLTPSVITVTAMIVSIVLLSWAMRSLPVGTAYA
VWTGIGAVGAAITGILLLGESASLARIASLALIVAGIIGLKLSTH
>AMJ34043.1|FEATURES|farme|beta_lactam|MIR-10|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVTRYWPELTGKQ
RQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGIKTNVKDMASWVMANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVETAYRILDALQ
>AMJ33970.1|FEATURES|farme|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGNAIARGEISLGDPVTRYWHELTGKQ
WQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGIKTNVKDMASWVMANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVETAYRILDALQ
>AMJ33965.1|FEATURES|farme|beta_lactam|MOX-7|antibiotic inactivation|1
MGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSLELDDKASLFAP
WLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPS
IGLFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTP
GMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYA
YPVSEQTLLAGNSPAMIYNANPAAPAPAATGHPVLFNKTGSTNGFGAYVAFVPAKGIGIV
MLANRNYPNEARIKAAHAILTQLAR
>AMJ33909.1|FEATURES|farme|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|0
VGGVVAAILGPLLTIVARDVPGLPRFAGVYLVVAALGILSALNLALFFGHAKKYSPTPDT
AAPSERSPTSRELMKRPDYRAAWFHLVVGSLVMLFLMTAAPLSVTHHHSMNDGALVIQLH
LLGMYVPSLFTGLLIRKVGLTVLLYSGIALNMSAIVVNLTGETMLAYSLSLLLVGVGWNF
MFVGGSTLLSLSYRDHERKKAQGLAETSRFIFSAIATSGAGVMLALLGWKLLGLMMLPVL
LICLVSTWQYDQAIRKARRTASRTAEDGS
>AMJ33844.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAPKTLKPKRQEEQASFISWRFALLCGCILIALGFLLGRVAWLQVISPDMLVRQGDMR
SLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDNRWKALADTLNMP
LDQLASRINTNPRMRFIYLARQVNPDMADYIKKLKLPGIHMREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVSTGEVLAMANSPSYNPNNFSGTAKDIMRNRAIT
DVFEPGSTVKPMVVMTALQRGIVNENTVLNTIPYRINGHEIKDVARYSELTLTGVLQKSS
NVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYG
LMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPEPLVRTVVHMMESVALPGGG
GVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASHPRFALVVVINDPQAGKY
YGGAVSAPVFGAIMGGVLRTMNIEPDALATGEKSEFVINQGEGTGGRS
>AMJ33833.1|FEATURES|farme|multidrug|mepB|antibiotic target alteration|0
MAAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYK
ELLEQIAELLHILGSADRLMEVIREELEAMREKFGDARRTEITANTADINIEDLINQEDV
VVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRL
YWMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTA
LTEFSRPRSAGIIAVNLNEGDELIGVDLTNGNDEAMLFSAAGKVVRFKESAVRAMGRTAT
GVRGIKLAGDDKVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTER
NGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRV
AEPVDDEELDAIDGSVAEGDDEIAPETDADADDDAVEDEE
>AMJ33832.1|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
TEVINGCLAYIDDENISVEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKIYIRARAE
VETDAKTGRETIIVHEIPYQVNKARLIEKIAELVKDKRVEGISALRDESDKDGMRIVIEV
KRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDILSAFVRHRREVVTRRTI
FELRKARDRAHILEALAIALANIDRIYPPCADACGSESWPDRASMGSGQRGGDAGTCR
>AMJ33807.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
SAEDKMVTAAYVISSFAMLFTVGRFIGGFINLKLGDRKTLILFSLFSLIAIIASRYFASQ
FVYLFMVFGFAMSVLFPTA
>AMJ33679.1|FEATURES|farme|beta_lactam|CMY-85|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFY
>AMJ33667.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
TPGFTGQQNMLVAWWQFLTRKTENARPAQPLPLVKTDLASLSPEQDTLVWLGHSSWYMQL
AGKRILIDPVLSSYAAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIKAL
LPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVHISDALTVHVLPARHFSGRGIKRN
QTLWGSFMFVTPERKVYYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDWKYIHMHPA
ETAQASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSD
TTQQFREWWE
>AMJ33665.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKT
>AMJ33662.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
AIGLKYTHGFTRLTPSVITIAAMIVSIVMLSWAMRTLPVGTAYAVWTGIGAVGAAITGIL
LLGESASLARIASLALIVAGIIGLKLSTH
>AMJ33657.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIAALALAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ33620.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVWLGHSSWYLQLAGKRILIDPVLSSYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHD
HYDHLDYATIRALLPKIKRVITPLGVGSHLRYWGMDGALITEAGLAAGGTGQRRAHRPRA
AGAALFRPWAEA
>AMJ33606.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSAYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAIPVNDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ33550.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLEVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAACAAFP
LVFIQLFLQRDGAAAAQPGAAVWTPSVLVRDRAAAVVYLFRAAGLLRRRRFRLLYLAVRT
GGRQQRLRRKSGGRGAAG
>AMJ33519.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
EIDLLIISHDHYDHLDYATIKALMPKVKRVVTPLGVGSHLRYWGMESAIISEADWNQAVP
VSDELTVHVLPARHFSGRGLKRNQTLWASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGA
VDLAIMENGQYDQDWKYIHMMPEETAQAADDVRARAVLPGHAGRFVLAKHTWDDPYIRLA
EASTGRPWRLLTPMLGEPVWVADKTQSFNAWWR
>AMJ33505.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLVGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVL
AAISFVGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTSRRTVRSLIIMGGWPILFGLL
LSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG
>AMJ33439.1|FEATURES|farme|multidrug|cfr|antibiotic target alteration|0
MKWTIHNTLVCPHSGVAFSSISSLRFLKFILWYEADILLLPGESIKLYSSSVLINEQYHA
VKVYNITRYDEAQWEKLRERPSCPYHSTATTADSCRYQALCAIKRCPNDFPRAVPGLPSG
QHDLGQQIR
>AMJ33433.1|FEATURES|farme|tetracycline|tetB(60)|antibiotic efflux|1
MIFPVVLVVMVIYQRYSTPIVRRVRAYLADINDGFNEIINGMSVIQQFRQQARFGERMGE
ASRSHYMARMQTLRLDGFLLRPLLSLFSSLILCGLLMLFGFSASGTIEVGVLYAFISYLG
RLNEPLIELTTQQAMLQQAVVAGERVFELMDGPRQQYGNDDRPLQSGTIEVDNVSFAYRD
DNLVLKNINLSVPSRNFVALVGHTGSGKSTLASLLMGYYPLTEGEIRLDGRPLSSLSHSA
LRQGVAMVQQDPVVLADTFLANVTLGRDISEERVWQALETVQLAEL
>AMJ33420.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MIPTLRRSTAALLASSLLLTIGRGATLPFMTIYLTRQYQLEVDKIGYALSSALIVGVLFS
MGFGILADKFDKKRYMTLAVLAFIGGFIAIPLVNSVALVVFFFALINCAYSVFSTVLKAW
FADVLSPEKKAQIFSLNYTFLNIGWTVGPPIGTLLVMYSINLPFWLAAGCAALPLVFIQL
FVQRTSAAIAEDNAVQWSPSVLLRDRALLWFTLSGLLASFVGGSFASCISQYVLVVADSD
FAEKVVAVVLPVNAAVVVALQYAVGLRLTARNIRPLMTFGTVCFVLGLGGFVISDNSL
>AMJ33418.1|FEATURES|farme|tetracycline|tetA(60)|antibiotic efflux|1
VLIAVVVYLLRYVWRVLLFGASYQLAVELREDYYRQLSRQHPEFYLRHRTGDLMARATND
VDRVVFAAGEGVLTLVDSLVMGCAVLIMMSTQISWQLTLFALLPMPVMAIMIKRNGDALH
ERFKLAQAAFSSLNDRTQESLTSIRMIKAFGLEDRQSALFAADAEDTGKKNMRVARIDAR
FDPTIYIAIGMANLLAIGGGSWMVVQGSLTLGQLTSFMMYLGLMIWPMLALAWMFNIVER
GSAAYSRIRAMLAEAPVVNDGSEPVPEGRGELDVNIRQFTYPQTDHPALENVNFALKPGQ
MLGICGPTGSGKSTLLSLIQRHFDVSEGNIRFHDIPLTQLQLDSWRSRLAVVSQTPFLFS
DTVANNIALGCPNATQQEIEHVARLASVHDDILRLPQGYDTEVGERGVMLSGGQKQRISI
ARALLVNAEILILDDALSAVDGRTEHQILHNLRQWGQGRTVIISAHRLSALTEASEIIVM
QHGHIAQRGNHDELAQQSGWYRDMYRYQQLEAALDDA
>AMJ33274.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNRLSSGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRVGRRPVMLTGVLWFIVTCLATLLAQNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAISFFGLQRAMPETATRLGEKLSIKELGKDYKLVLRNVRFVAGALALGFVSLPLLAWIA
QSPIIIISGEHLSSYEYGLLQVPIFGALIAGNLVLARLTSRKTVRSLIIMGGWPIAVGLI
IAAAATVVSSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYLLGGNGLFSLFNLASGVLWLILMVIFLKDKRVGDSREG
>AMJ33259.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVVFS
LGFGILADKFDKKRYMLLAITAFA
>AMJ33133.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AMJ33089.1|FEATURES|farme|macrolide-lincosamide-streptogramin|Rahaq2_0060|antibiotic efflux|0
VHTLSDGERQKVMIAKALAQETPVIFLDEPTAFLDFPSKVEMMQLLHRLSRQTNKTIFLS
THDLELALQIADKIWLMDKMNGVTIGTPEDLSLSGKLSSFFACKGIVFDLETGLFRVDNE
YTS
>AMJ33060.1|FEATURES|farme|beta_lactam|UM93_16900|antibiotic inactivation|1
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
SRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIY
TTGSQATMDERNRQIAEIGASLIKHW
>AMJ33034.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKNCTGSTPRKSDYAPNSCSTRIMGT
>AMJ32958.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
SGRGIKRNQTLWGSFMFVSPEQKVYYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDW
KYIHMHPAETAQASADLNARAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPEL
GEPVRVSDTTQQFREWWE
>AMJ32925.1|FEATURES|NCBI|quinolone|oqxB|antibiotic efflux|1
PDDMKWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVV
GTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREV
SGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLK
PHGAPKDFPTRLIDILSSVRLDFPPV
>AMJ32883.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
VPASDELTVHVLPARHFSGRGLKRNQTLWASFLFVTRQQKIYYSGDSGYGPHFKAIGNEF
GPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQR
LAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ32855.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MIIASAASLPFVLNAGFGQPPQGAQLSEVEASPHYRDGQFHNTLPTPGFTGQQNMLVAWW
QFLTRKTENARPAQPLPLVKTDLASLSPEQDTLVWLGHSSWYMQLAGKRILIDPVLSSYA
APFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGS
HLRYWGMNPEIIDERDWNQSVHISDTLTVHVLPARHFSGRGIKRNQTLWGSFMFVTPERK
VYYSGDSGYGSHFKAIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETAQASADLNAKAVV
PGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQQFREWWE
>AMJ32847.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
IPFGAAEVAINVEGAAVEQAMNKTVLPMMHGFYSLGTLAGAGIGMALTALGIAANVHILL
AALVCIIPILTGIRAIPAGTGQNASDEQKSAAKGLPFYRDFQLMLIGVVVLAMAFAEGSA
NDWLPLLMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRVAVVRASALLGGLG
IAMIIFVDVDWIAGVSVILWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVG
PPLLGFLGEHYGLRSAMLVVLGLVIIAALVARAVAKPEAETTSMEKGYER
>AMJ32845.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MINRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAAL
AAISFFGLHRAMPETATRLGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQLSSYEYGLLQVPIFGALIIGNLVLARLTSRRTVRSLIIMGGWPIAAGLI
IAAVATVASSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYAFGGNGLFSLFNLANGVLWIALMVVFLKDKRVGNALQP
>AMJ32843.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVL
AAISFFGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTARRTVRSLIIMGGWPIMFGLI
LSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG
>AMJ32841.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRP
>AMJ32763.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
HNTLPTPGFTGQQNMLVAWWQFLTRKTENARPAQPLPLVKTDLASLSPEQDTLVWLGHSS
WYMQLAGKRILIDPVLSSYAAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYA
TIKALLPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVHISDALTVHVLPARHFSGR
GIKRNQTLWGSFMFVTPERKVYYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDWKYI
HMHPAETAQASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEP
VRVSDTTQQFREWWE
>AMJ32740.1|FEATURES|farme|beta_lactam|CMY-50|antibiotic inactivation|1
GMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLS
DPVTKYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGT
TRLYA
>AMJ32735.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
MLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEML
NWPVEANTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQI
GIVMLANTSYPNPARVEAAYHILEALQ
>AMJ32620.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>AMJ32565.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
PQTLFELGSISKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAG
GLPLQVPDEVKSSSDLLRFYQNWQPQWKPGTTRLYANASIGL
>AMJ32525.1|FEATURES|farme|beta_lactam|TEM-214|antibiotic inactivation|1
MMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAI
TMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMA
TTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIA
ALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ32493.1|FEATURES|farme|beta_lactam|ACT-17|antibiotic inactivation|1
KAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGI
ALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASW
VHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEA
>AMJ32490.1|FEATURES|farme|beta_lactam|MIR-9|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQSIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYHILDALQ
>AMJ32474.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
HYDHLDYATIRALLPKVKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVRISDALTVHVL
PARHFSGRGIKRDRTLWGSFMFVTPEQKVYYSGDSGYGPHFRAIGEQFGEVDVAIMENGQ
YDQDWKYIHMLPEETAQASADLNAKAVVPGHNGRFVLAKHAWNDPLIQLAKASQDKNYRL
LTPELGEPVRVSDTAQTFRAWWE
>AMJ32394.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAIVLDNITYTYGVGTPFEKTALRGVSLTIENGEFLGVIGHTGSGKSTFVQHLNGLLHPT
TGTVTVNGVDISASTEEAKKMRHKVGMVFQYPEHQLFEETIAQDIAFGPKNLGLSADDVD
ERVRDAMKFVGLDYDTYAERSPFHLSGGQMRRVAIAGVVAMDPDFLVLDEPSAGLDPFGR
EEIFEEIIRLHKEKGITVILVSHNMEDISRMASRLVVLDKGRIVLDGEPMDIFNNHRDEL
QAVGVDVPPVSVTMEYLREQGFDVSNR
>AMJ32290.1|FEATURES|farme|tetracycline|tetD|antibiotic efflux|1
ITGATGAVAASVVADSTAVSERTAWFGRPGAAFGAGLIAGPAIGGLAGDISPHLPFVIAA
ILNACTFLMVFFIFKPAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIP
ATVWVLFTESRFAWDSAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADAT
AFLLMSAITSGWMVYPVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGV
AGPLLFAFIFSQTQQSADGTVWLIGTALYGLLLAICVLIRKPAPVAATC
>AMJ32281.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
NASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDHTWINV
>JX009347.1_1037|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
ANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTEGNNAGMIMNGA
PATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFPNDDRVAATYRI
VQALDKR
>JX009347.1_1038|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
NPAMMARIVSVAHPGPMVNAVHTSVINIGLGGGSYLGGMAIASGYGLRSALWIGMALAVL
ALLSILPYLRRGQQGWR
>JX009345.1_1040|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
VKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>JX009331.1_1050|FEATURES|farme|beta_lactam|AV650_28380|antibiotic inactivation|1
AGGLPLQVPDSVTDDASLLNFYQNWQPQWKPGTMRLYANASIGLFGHLAVKPSSMTFEQT
ISQRVFQPLQLTHTWINVPKSAEKEYAWGYSNGQPVRVSLGMLGAESYGVKSTIEDMTVW
LKANMTPQHLNDSTLKQGILLAQSRYWRVGNMYQGLGWEMLNWPV
>JX009233.1_1132|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
VPMNPAMMARIVSVAHPGPMVNAVHTSVINIGLGGGSYLGGMAIASGYGLRSALWIGMAL
AVLALLSILPYLRRGQQGWR
>JX009229.1_1140|FEATURES|farme|beta_lactam|AK972_2544|antibiotic inactivation|1
MNRHVQKILISALLMGAGTCMAAPDLRKVVDSSVEPLMQQQGIAGLSIAVVSKGQVQYFN
YGVASRETQKPVTEGTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRGDKFD
HISLLNLGTYTAGGLPLQFPEESDNTGKMISYYQHWKPDFAPGTQRLYSNPSIGLFGHLA
AQSLGQPFDRLMEQTLLPKLGLKHTFITVPKAQMNLYAQGYDKAGKPVRVGPGALDAEAY
GIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPITLDA
LTEGNSAQMAFQPHKVSWLTPPQAPHADTLVNKTGATGGFGAYVAYVPSKGLGVVILANK
NYPNAERVKVAHAIFSALDQ
>JX009223.1_1144|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
TQPGNVMFNKTGSTGGFGAYVAYVPGKDIGVVILANKNYPIADRVTAAHGILSAMDQ
>JX009209.1_1153|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MTKINRLAAALFAALILPAGHAADKADIDAIIQPLMQKYAVPGMAIAVSVEGKQQFYHYG
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLSALRGSAFDHV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKS
LNQPFAQAMEQRLFPALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVK
SNAQDLIRYLEANMQVAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVALARLTE
GNNAGMIMNGTPATAITPPQREQGAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFP
NDDRVAATYRIVQALEKP
>JX009362.1_1169|FEATURES|farme|beta_lactam|blaRAHN-2|antibiotic inactivation|1
EKHLDTGMTVGELAAAALQYSDNTAMNKLIEQLG
>JX009356.1_1172|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
LTPPQAPHADTLVNKTGATGGFGAYVAYVPSKGLGVVILANKNYPNAERVKVAHAILSA
>JX009354.1_1173|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
GNSTEMAMQPHKVNWLTPAQPQPANVLYNKTGSTGGFGGYVAYVPSKDMGVVILANRNYP
NAERVKLA
>JX009352.1_1174|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
ANKDSQQPVTENTLFEIGSGSKTFTATLAGYALANGKLKLSDPASQYLPALRHLHCGWLA
AAIPRRVR
>JX009334.1_1190|FEATURES|farme|beta_lactam|AV650_28380|antibiotic inactivation|1
MKKNFNKVLAITSLMVSMAPFAAQKSLTAEQISQIVNGTVKPLLEAQSIPGMAVAVIYQG
QPYYFTYGQADIKKNLPVTKKTIFELGSVSKTFT
>JX009326.1_1198|FEATURES|farme|beta_lactam|OA39_00246|antibiotic inactivation|1
MPSAYAINLHEKVKQYERDGWKVGVSVLFSDKKSVSINGSQRFPLNSTVKAISCANVLSK
VDNGSLSLNREMKVTEKNIESYSPVAKDYIGRPFSLSQACKAATEYSDNTGANFSISSGG
GPKGLTNFMRSIGDDITRSDRYEPDLTVNPESDLRDTTTPDAMSASIKKLLTGNVLSDKS
KTQLKEWMIDNKVADNMLRASLPPGWKIADRSGASDYGIRGITSMVWSDNHEPVFISIYV
RKKDTSLDERSEVIRVLGAHIFSEYLTK
>JX009304.1_1215|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
FEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHVSLLNLATHTSGLPLF
VPDEVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKSLNQPFAQAMEQRLFP
ALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVKSNAQDLIRYLEANMQ
VAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVALARLTEGNNAGMIMNGTPATA
ITPPQREQGAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFPNDDRVAATYRIVQAL
EKP
>JX009302.1_1216|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPHKIQFAVRHITTLGFFLTAGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVVKDGKT
QYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DKFDHISLLNLGTYTAGGLPLQFPDESDNAGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMAQTLLPKLGLKHTFITVPKAQMNLYAQGYDKAGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTV
>JX009298.1_1221|FEATURES|farme|beta_lactam|L580_0134|antibiotic inactivation|1
MLKKSLSCVLLLATSGSVFAVPQTEKQIADIVNRTVAPLMKEQAIPGMAVAVIYQGQPYY
FTWGLADVAGKQPITQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPASKYWSALSGKQ
WQGITLLHLATYTAGGLPLQIPDNVTDEASLQNYYQTWQPQWAPGTTRLYSNASIGLFGA
LMIKPSGMSFEQAMTKRVFQPLKLSHTWINVPQQEDKHYAWGYSDGKAVRVSPGMFDAEA
YGVKSSIEDMASWVQANMAPANVEDASLQKGITLAQARYWHVGDMYQGLGWEMLNWPVKA
KTVVDGSDNKNALAPLSATKITPPAPLSSASWVHKTGSTGGFGSYVAFIPQKDLGIVMLA
NKNYPNPVRVEAAYRILEALQQDLEGGR
>JX009294.1_1228|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
MTKINRLAAALFAALILPAGHAADKADIDAIIQPLMQKYAVPGMAIAVSVEGKQQFYHYG
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLPALRGSAFDHV
TLLNLATHTSGLPLFVPDNVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQPFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTE
GNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQALDKR
>JX009264.1|FEATURES|farme|aminoglycoside|PLP-dependent_aminotransferase|antibiotic inactivation|0
FPSLQGLDPARVIYLGTFSKVLFPSLRLGYAIVPQPLVNAFCGARVLMDRHPPSADQYVL
ASFMAQGHLDRHIRKMRGVYAEKRRVLTDAINAQVSAELATLHPSDQGMHMLLWLKADLD
DRQVARKAAEAGIAVGALSPMYSPGSGKNGLILGLGGYTEQQIHQAAQKLNRVLATLATG
>JX009224.1_1289|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
LVAIRIVTGILCAGCLSLSLATSMALVPIQHRPRAASIVIGGFMVSNVFGV
>JX009208.1_1300|FEATURES|farme|beta_lactam|PMI39_02504|antibiotic inactivation|1
VKLISQTLIATALTSACSLAFAETADVQATVDQAIKPLMQQQAIPGMAVAVVVKGQPHYF
TWGMADVKQQRPVTQDTLFELGSVSKTFTGVLGGVAVNKGEIALSDPARKYWPALNTPQW
RDITLLQLATYTAGGLPLQVPDAVTDEKALANFYQQWQPQWAPGNTRQYANSSIGSACLA
GWRRNPAG
>JX009202.1_1310|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MYTSLFPTVRNTAIFALLLGAGNCMAATDIRQVVDSTVEPLMQQQDIAGLSVAVIQNGKA
QYFNYGVASKDSQQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DTFDHISLLNLGTYTAGGLPLQFPDESDNAGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMAQTLLPKLGLKHTFITVPKAQMNLYAQGYDKAGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPI
TLDALTEGNSAQMAFQPHKVSWLTPPQAPHADTLVNKTGATGGFGAYVAYVPSKGLGVVI
LANKNYPNAERVKVAHAILSAMDK
>KF630358.1_11322|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKN
IPIAV
>KF630356.1_11328|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|0
RDPAFAPEGAEVFRSLEALRAAAPADSFVIGGESVYAALLDWCDTAYITKIGQAWEGADA
FFPDLGAGPDWEMAEEGEPQEHAGIPFRYVTYRRRKPHVCG
>KF630350.1_11345|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLREKGHQAFLLDVFFGLPYDTDKLDEVFDLPGG
GLEIAEGIKTTVPDLEALKKQRPDQSDCLIGPNVLELCKMADITFMGLHGSIGEDGKLQA
MFDILDIHYTGPNALSCTLSMNKLVSKQIFKMSGVPTPRGTSLTPKTKDTPLSELGYYLP
LVLKPCSGGSSIGVFIVHTEEEYKEAVHQSFDINHEEKVVVEPYIKGQEFACGILAGKAL
PLVEIVPKAGLFDYANKYQAGGAQEICPPVSINEELQEKMKRAGEAAFEALHMDVYARAD
FIVDESDGEIYCFEVNALPGMTSASLYPKAAKAYGLDYGDLCERIIEESKKARYH
>KF630345.1_11355|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKDRKIIVLMGGPSKEAEVSRRTGAAIAEALESKGYNAQTLELNPRTVLKDIESLGGEIV
FNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTATSESFN
GNLESAEAIIGHIRKQFTIPVVVKSATQGSSIGVTIVRDEAQLEAAVTEALKYDPILVVE
QFLDGREFTVSVLDGKALSVIEIRPHSGEYDYTSKYTVGATEYLVPAPISEEMTAEMQRI
GELVYREVRGSGVIRVDIMTDHADNMYVLEYNTVPGMTATSLVPKAAKEMGIDFPTLCEK
ILLTASIGKF
>KF630338.1_11369|FEATURES|farme|multidrug|cdeA|antibiotic efflux|0
VAKKSTAIDVTQGVIWQQLLSLCVPIFFSSFFQQAYTLIGTYIVGQFGGKLALGGIQATM
VLTELCIGFCVGVGAGCAVITGQYFGQHEDERLSRSVHTAMTLALVGGIAFSILGIVFVE
PMLVLMNTPHELLAEGVAYARCYFAAMVAALLLNMGTALLRAVGDTRGPAVIIA
>KF630336.1_11380|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
EVDFSMGNPDGATPPHIVEKLCTVAQRPDTHGYSTSRGIPRLRRAISRWYQERYNVEIDP
ESEAIVTIGSKEGLAHLMLATLDHGDTVLVPNPSYPIHIYGAVIAGAQVRSVPLVEGVDF
FNELERAIRESYPKPKMMILGFPSNPTAQCVELEFFEKVVALAKRYDVLVVHDLAYADIV
YDGWKAPSIMEVPGARDVAVEFFTLSKSYNMAGWRIGFMVGNKTLVNALARIKSYHDYGT
FTPLQVAAIAALEGDQQCVHDIAAQYKRRRDVLVKGLHEAGWMVDMPKASMYVWAKIPEQ
YAHMGSLEFAKKMLQDAKVCVSPGIGFGDYGDTHVRFALIENRDRIRQAIRGIKAMFRAD
GLLPSEGKSAG
>KF630330.1_11394|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIE
DGDTFFPEFDINDFEVLIGETLGEEVKYTRTFYVRKNELSRFWI
>KF630320.1_11419|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNPEEAAEAARALDAAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEDAFTIESVVDGIVDEKNQYPHRFVTYRRKAAK
>KF630317.1_11428|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSKTIVTIQPSGIRKFFDIVNEMEDAISLGVGEPDFDTPWHIRDEGIYSLEKGRTF
YTSNAGLKELKIEIAKYLFRNYDLQYDYQHEIVVTVGGSEAIDIAMRAMLDPGDEVLIPM
PSYVSYLPCAVLANGVPVPINLKAENDFRLTAEELEAAITPKTKLLVMPFPNNPTGAIME
KKDLEAVAEVVKKHDLFVISDEIYSALTYTEKHISIASLPGMKERTIVINGFSKSHAMTG
WRLGYACGPRIILDQMLKIHQYAIMCAPTTSQYAAVDALRAGDEDVQRMREEYNGRRRYL
MHRFEEMGLECFEPYGAFYCFPCIKEFGMTSEEFATNLLKTEKVAVVPGTAFGDCGEGFI
RISYAYSLDNLKEALDRMERYITGLRGGNNGEA
>KF630301.1_11470|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKQRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQW
>KF630299.1_11473|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRNPLSRKIVEIQPSGIRKFFDVANEMEDAISLGVGEPDFDTPWRIREEGMFSLEKGRTF
YTSNAGLKELRKEICNYLERKIHVKYDAVHETLVTVGGSEAIDVGLRCMLDPGDEVLIPQ
PSYVSYLPCTVMADGVPVIIPLQEKNEFKLTAEELEKYTTPKTKVLVLPFPNNPTGAIMT
REDLEPIAKFVEEHDLYVMSDEIYSELTYKEEHVSIASLPGMRERTLVINGFSKGFAMTG
WRLGYCCGPEVIISQMTKLHQFAIMCAPTNSQYAAVQGLRNCGDEVEEMRKSYNQRRRFL
MHEFKKMGLECFEPFGAFYVFPSIKQFGMTSEEFATRLLNEEKVAVVPGTAFGECGEGFL
RISYAYSLEDLKEAIGRLERFIGRLRNERK
>KF630265.1_11554|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSVVNVINHMNREKYDLLLIGITEEGHWIKVESVEAIESGSWREGTVNAVISPDATKQCV
ILTEGDRVEFVKADVVFPVLHGLYGEDGTVQGLLELARIPYVGCGVLASAVSMDKLYTKI
VVDDLGVRQAAYVPVMRSDLNDMASVVGRVEAKFSYPVFVKPSNAGSSKGVARADGREEL
EAALREAANHDRKILVEEMIKGREIECAVFGGGLIPVEASGVGEILAAAEFYDFDAKYYN
SDSRTVVNPDLPGDAVNQVREAAKAIFQAVDGYGLARVDFFVKDDGTVVFNEINTLPGFT
AISMYPMLWEAAGVTKDQLVDRLTEHAFDRCRL
>KF630260.1_11564|FEATURES|farme|multidrug|emrB|antibiotic efflux|0
SMTASHMSQGVKSATASGIAFSYLLCAAISLVALIICIFTVTSRAKEKAARNAKASEAQA
SAEVAAETTEGQPAEHHYAGAYVAPAASLFKQAQEQSIGGIMDDQPYSCLDSDDITHVVR
EFIRLNVSSLPVVNGDGRLVGFVSDGDVMKSIATYESRTVSTGTGSTMVVFDDETVASKV
QALSGKKVMDIATRKVVAATPDQHVGEVARILAKKQFKKLPVVDGDGRLVGVIRRKSVME
HAFDALFPKDDR
>KF630238.1_11604|FEATURES|farme|chloramphenicol|catB3|antibiotic inactivation|1
SAKMINFFESPFKGKIIKDHITNPNIIAGKYSYYSGYYHGHSFDDCARYLMPDRNDIDKL
IIGSFCSIGSGVSFIMAGNQGHRHSWISSFPFFYMPEVEIFNKAIDGFENAGDTVVGNDV
WIGTEAIIMSGVKIGDGAVIGSRSVVTKDVAPYTIIGGNPSKTIKSRFSEQHIKMLLEIK
WWDWDEEKLSEAIPIICSDNIELLYEFYHNHIVQ
>KF630235.1_11608|FEATURES|farme|aminoglycoside|APH(2'')-Ig|antibiotic inactivation|1
MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQ
QREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDM
AIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYE
HIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDD
FGKD
>KF630193.1_11714|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGCGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>KF630176.1_11748|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELCSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF630170.1_11766|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
KVLEYSPSAGYRSYREKLVGYYAKYNINLTADDIIITSGGSEAVLFSFLACLNPGDEIIV
PEPAYANYMAFAISAGAKIRTIATTIEEGFSLPKVEKFEELINERTRAILICNPNNPTGY
LYTRREMNQIRDLVKKYDLFLFSDEVYREFIYTGSPYISACHLEGIENNVVLIDSVSKRY
SECGIRIGALITKNKEIRDAVMKFCQARLSPPLIGQIAAEASLDADEDYLRDTYDEYVER
RKCLIDGLNRIPGVYSPIPMGAFYTVAKLPVDDSDKFCAWCLSEFEYEGQTVFMAPASGF
YTTSGSGRNEVRIAYVLKK
>KF630158.1_11800|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|0
ELAFKALKLDIYSRADFLLDENNDIYCLEVNSLPGMTAASLLPKEARAAGIEYGDLCKLI
IEKSLARYNV
>KF630148.1_11825|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLGRQEATPDDGLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHADADTYAPDV
KSLVESGAWKVLEEGVWQNTRKGSGDIAGFRFMTYAKNREE
>KF630141.1_11844|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLPNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF630137.1_11855|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLSQQEAI
>KF630136.1_11858|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGIKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKK
SGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELVHVIADAHIYDR
HIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF630132.1_11872|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNTVSKQLIAIWAEAHNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFDCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMRAFKEVSRDRVPKDDKNAYDFSISRYEKEG
D
>KF630131.1_11877|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADTQYLGIIENILDHGIYGQNRTGIATYKLPQQIMQFNLQEEFPILTTKFVAFKTAV
KELLWIWQMQSNDVRKLQEMNVHVWDEWMREDGTIGKAYGYQIAKYKQLDKLIKTIKEDA
DSRRMIVTLWNIEDLDDMALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAA
LQCMIAQVTGLKPGKFTHVINNAHIYENHVDALREQLARRNQALPAPKIIVNPEVKDFYD
FTPEDVTLDGYEHLGKLSMTVAV
>KF630129.1_11885|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADQNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCLGGDSIYEQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITAESDEQTYFDLEYQFVKYERKDR
>KF630106.1_11936|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKPWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLARQEA
>KF630105.1_11937|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KELGFPCFIKASRSGSSVGCYRCDHKEDLMTKLIEASKYDRHIVVEECVDCIELETAVLG
NDDPIVSRVGQIMPHGEFYTFESKYEDEESKTCIPALVDQEIQDKIREYALRVFKAVDGH
GLSRVDFFLDKKSNQIYLNEINTLPGFTKISMYPQLMNDFGISYSELLDRVIQ
>KF630100.1_11951|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
TLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADI
AKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLH
LATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGL
SFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIE
DMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSD
NKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPA
RVTAAWQILNTLQ
>KF630094.1_11964|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HPRGHQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLTL
NAILNQRSQDILAANNWNVCQYSILLMMIAQVCDMEAGELVHVIADCHIYDRHVPVIKEL
ISRTPYPAPTVKLNPEIRDFYKFTTDDLIVENYETWPQIKNIPIAI
>KF630079.1_11996|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
LRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVDRNDFSFMNGTEKVVFDFAY
ITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFACNQYLKAFGVRIAESLLLRQ
GQSVSDEDVLEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFGEAEEVLVEAFME
GTELTCGCYKTKEKSVVFPPTE
>KF630077.1_12001|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
MKENKNWKKQIALFLISQNLSMFGSSVVGFSIVWYITVTTESGFWITLSTLATLIPQVLV
SLWAGVFADRYNKKTIIMLADGFTALATLLAFVAFHYGFANLSFLIFIACLRSVGGGFQA
PAVNALYPEIVPREHLLRINGINQMANNVLLLLSPAAGGAILGMFGMQWTFLVDLLTAVI
AIAIMFRLKIVTRAADRSDSSVLKELREGVRYTWSQPLLRVMLVCYAVTFVLITPAAFLS
PLMVVRSFGSEVWKLTANEMLWSLGALLGGAFVAWKGEFKNKITMIAVSLAVFGCTFALM
GLSRVFWVYLIFDCICGMFVPVLIASETVLIQTNTEKGYMGRVFALLQFVSQGMMPIAIL
GFGPLSDLVRIESIMIGCGLLLICWSLYFKKAAGRALCSI
>KF630074.1_12007|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNIIAAVDKNWAIGKNNELLVRIPMDQKFFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTHNPAYQVKDAIVVHSMEELHRELEKYDTNDVYVIGGQKIYEQLLDECDVAHITKID
YAYDADAYFPNLDEKPEWKITADSEEQTYFDLEFYFYKYERVQK
>KF630073.1_12009|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GTSAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVDEMLWIWQKKSNNIHDLNSHIWDS
WADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMN
LYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKV
GEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHP
QIKNIPIAV
>KF630073.1_12010|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVLGGESIYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF630068.1_12024|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTNIVLTGNKDYNVKDAIIVHTV
EELLEEIKKYPSEEVYCIGGDSVYKQLLPYCDTAHVTKIDFAYEADSYFPNLDEMPEWKV
TAESDEQTYFDLEYSFMKYERIK
>KF630063.1_12034|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKMFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNRAYSVPEGVYVFHTVKELLSALPEGENFIIGGEKMYEAMFPYADKMYITEIEKE
YDGDAVFPSFRKEEWKETESVMGK
>KF630063.1_12035|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PDVHDFYDFKPEDIVLENYKHHEKIAMEVSV
>KF630040.1_12093|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITGESDEQTYFNLEYQFVKYERKK
>KF630038.1_12100|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WDYEAFEETAGLQPCAFQTMFDVRRVGEDIYLDATLTQRSNDMLVAHHINAMQYVALQMM
IAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPRLVLNIPDGTNFFDIKPE
DFELVDYDPVKPQLKFDLAI
>KF630030.1_12120|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPVFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDKGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTER
>KF630021.1_12142|FEATURES|farme|macrolide-lincosamide-streptogramin|VgbA|antibiotic target replacement|0
MGWNTSHQVVTELSPQEWVYNKFTTYVLTHKECNSSQQIHFTSENPVLLLERLKQEAGKD
IWICGGANLVQQLVSKNMIDKYYIS
>KF630019.1_12152|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKAPVGIAVCTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF630018.1_12155|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VRRIYPGKPGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAEVVFIALHGKYGEDGTI
QSILELSRIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKPYYLKNGIDTVAESIEK
NFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILAEAYLDGKEFTIAVLNG
KALPIIQICPHSGQYDFHSKYTSGATDYIVPAPLPGAAADEMTRMAILGYEAAECSGVVR
FDFRTDKRGTPFLLEANSIPGMTETSLVPKAAAAIGMDFPSLCENILLKAGVGKV
>KF630013.1_12166|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MHIGMIWAQAAHRVIGDGRGMLWHVPADFKHFKATTMGSPIIMGRRSFEALGKKPLPGRL
NIVLTSQENYQAKGASLAFSLSEALTIAKDSGAERCWITGGARLYAEGMEIADELVVTYL
DLDVGDSEDFAHAPLISPAIWKKNSLRSDSEFRPISGDCRWQVTYYERAENPSD
>KF630007.1_12179|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPSTSMMMAQQAGLKPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPTIEIRKADSLFD
YQYEDFKVVGYQHHPTIKAPVAV
>KF630007.1_12180|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAEALPFADKAYVTDLAATVDADSYAPD
MASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF629998.1_12202|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
THLEVRRILTSLYNFADLHEMALYPCAYSMTFNVSGNRLNAILNQRSQDMLTANNWNVVQ
YAVLVHMLAQVSGLVAGELVHVIADCHIYDRHIPLVEQMLELEPYPAPEFRLDPAVTDFY
AFTPDSVQVENYRYHPFSARIPVAI
>KF629997.1_12205|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MISLIAAAGEKNEIGKNGRMPWNLPGDLRHFKDLTLGKTMLMGRKTFQSLPGVLPKRQHI
IVTRDADFCNSHPRVQVISDLTGALLRYEAAEEEIFVIGGGQIYEAAMPYASVIYLTRIH
KNYDADAFFPEISPEQWMIADRGPSMEEQDTRYEFITYRRRELPVKGGERFR
>KF629995.1_12213|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICNTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDGKALPP
IEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKSLTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF629991.1_12229|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MKMIASADNNWAIGYKGSLLAHVSADMKFFKSKTVGNVVILGRKTLMTFPNGKPLKDRKN
IIITTDESFKVEGAEIVHSTDELLETVEKYDDDSLY
>KF629986.1_12241|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MSTISIIAAIADKSAIGKNQQLLCHMPSDMKRFKELTTGHAVIMGRKTFESLPVAPLPNR
KNVVLTTMPEAGFVNCFACESMGAALDLCEKEDEIFIIGGALVYRQALRIADKMYITRIH
HEFPDATSFFPVVNWDLWEETEREEYPADEKNPYPYTYITYVRKK
>KF629981.1_12254|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NLYPCAYSVTFNVTEKPGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDME
PGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAG
EQIKDIPIAI
>KF629975.1_12275|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSSEHEVSRVSAGTFVDQLDRQRYELLTIGITKEGRWLYTEADSAQMADGSWEELPGNMP
CVLSPDRADHGLILFTPAGQVEKVHVDVVIPVLHGLWGEDGTVQGLLELAGIPYVGCGVL
ASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESDPDGVCDGVIAKLGWPVFVKPANAG
SSVGITKAHDRDELKAAIRLAL
>KF629968.1_12294|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|0
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKPTLSLSLVISSKHKNLQKNQV
ITRSS
>KF629967.1_12298|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVIADAHIYDRHVPMIEELISREPLPAPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKN
IPIAV
>KF629958.1_12320|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
CHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALY
PCAFLTMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVI
NNAHVYKNHVDAMKTQLARLPKAYDAPVLKLNPDVHNFYDFKPEDIVLENYKHHEKIAME
VSV
>KF629951.1_12341|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF629931.1_12407|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLRNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAAFAGAECFPSLEIALSHCKEEEEIFIIGGASLYKEAMHIARQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF629930.1_12410|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNIIVAADKNWGIGRNNELLVSIPADMKMFREETTGKVVVMGRKTLESFPNGLPLKNRTN
IVITGNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAH
>KF629930.1_12411|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAAN
NWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNP
EIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF629929.1_12412|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPSRSSHVWDEWADETGSIGKAYGYQMGVKHKYKEGMFDQVDRVIYDLKNNPFSRRIMTN
IYVHQDLSEMHLYPCAYSMTFNVTQKKGDDKLTLNAILNQRSQDILAANNWNVCQYAVLM
HMLAQVCDMRVGELVHVIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRN
DVRLDNYVTGPQIQDIPIAI
>KF629923.1_12428|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAVHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF629921.1_12433|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MAMSTISIVAAISDNNAIGKNLGLLWHMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLP
NRKNVVLTTMPEAGFINCFACESMHDALYICEKEENIFIIGGSLVYRQGLGIADKMYLTR
IHGEFPDADAFFPVVNWDLWEEVERQEFPADEKNPYPYTFLTYVRKK
>KF629916.1_12446|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
GILYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTMTRDNLEKDIAKHGLEFPVVVKT
SCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYIKGREFSVAVVDDKAYPIIEIAP
IQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVKAAKALGLTGYSRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIRISLKKYE
>KF629912.1_12457|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
LGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEE
QLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQ
AGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQ
IGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPL
LFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629911.1_12463|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VQKKEEMNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNG
LPLKKRTNIVLTGNPNYHVKDAVIVHTTEELLEELRQYNDEDIYVIGGESIYRMMLPYCS
KVYVTKIDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF629904.1_12488|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSEKMCVVLLFGGMSSEHEVSRVSVGNFVNNIDREKYETLAVGITKEGRWLYTEATAAQ
MADGSWEELAGNMPCVISPDRADHGMILFTPEGHVEKVYVDVVIPVLHGLWGEDGTVQGL
LELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTRWLAADRWEIESDLEGVCDDVEK
KLGWPVFVKPANAGSSVGISKVSSRDELKKAIDLALENDRKVVFEAFVDGQEVECAVIGS
DPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCEG
LARCDFFVEKGTGRVLINEINTFPGFTSISMYPKLMEHEGLPVPQLIDRLIALALERKEK
QHG
>KF629895.1_12516|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAIARNGVIGNGNALIWHIAEDLRRFKALTTGHPVIMGRKTYESIGCPLPNRTNV
VVTRRKDYRPEGCLVAGSLEQAVGLFDPSEEIFIIGGAQIYAQAMPMADRLYLTEIDSDY
EGDTRFPEWKREEWTLLSEERHERGERYDRPFAFRNYIRTKE
>KF629891.1_12530|FEATURES|farme|quinolone|oqxB|antibiotic inactivation|0
LFYKFIKKDDHMKRIILVVLRCIFKLPYWWFYKLKQYQNKEKYPTIDEGYQFIHNVADEI
VKKARVDLKCYGLENLPKENGYLIAPNHQGLFDIVALFKTD
>KF629866.1_12604|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
IVAADNNWGIGYQNRLLVSIPSDMKFFRQKTTGNVVVMGRKTLESFPNGLPLKNRVNIVL
TKNKNYQVKDAVIVHSEEELLEELKKYPSEKVYVIGGESIYKMMLPYCDTVYVTKIDREF
QADTYFPNLDQMEDWKMTEEGEEQTCFDLEFAFTKYERC
>KF629861.1_12613|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
MEKKNIDWSSLGFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEG
MKAYTTEDGHIVTFRPDLNAERMANSAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGS
GATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGT
GHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKS
NSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGK
EICFPSGMEKMGPVIQKLYDTLIGIQVGRIQAPEGWLKVIE
>KF629853.1_12636|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSVSDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVIVEAFMDGTELTCGCYKTKEKSVIFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIITAGEKLNLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF629844.1_12662|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MQSEKMCVVLLFGGMSSEHEVSRVSVGNFVNNIDREKYEVLTVGITKEGRWLYTEATAAQ
MADGSWEELAGNMACVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQGL
LELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTRWLAADRWEIESDLEGVCEGVEK
KLGWPVFVKPANAGSSVGISKVSSRDELKKAIDLALENDRKVVFEAFVDGQEVECAVIGS
DPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCEG
LARCDFFVEKGTGRVLINEINTFPGFTSISMYPKLMEHEGLPVPQLIDRLIALALERKEK
QHG
>KF629835.1_12685|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQAAFDLMGIRYTGTGYLSSAMAMDKRITKEVFLMNNVPTPGGFTM
TRDNLEKDIAKYNLQFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIR
ISLKKYE
>KF629831.1_12692|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
DEQQLAELTAGTRGTAEFPEGTQQVFLPMGAGDSRLTLVDAEGNVTRTAPVDVVFPLLHG
PFGEDGTVQGLLEMADLRYVGCGVTASAVGMDKHFMKVAFESAGLEVGPYEVVTNRQWEH
EDREQILERVLKLGFPMFVKPTRAGSSFGITKVDSVEELVPAIEEARRHDPKIIIEAGIV
>KF629825.1_12712|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAVAENGVIGDNNRLLWHISEDLRRFKRITTGHPVVMGRKTWESLGRPLPGRENV
VVTRRELSFDGARTVHSLDEAYALFPPEEEVFVIGGAQIYGEALPAADRFYLTRVHRAYE
GDTRFPEWDAAEWRLVGSESFPCGERYEYPFTFETYERKR
>KF629822.1_12718|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PTSRSKVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITLRKTALRTCTEEMLWIWQRKS
NNIHDLNSTVWDEWADADGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPFSRRIM
TNIYVHADLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVCQYAV
LMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNPDIKDFYQFT
TDDIKITDYVTGEQIKDIPIAV
>KF629821.1_12723|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRIWNEWADDTGDLGHIYGYQWRSWPTYNGGFIDQISEAVDAIK
HNPDSRRIIVSAWNVGDLDHMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLQAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIF
DFQFEDFELVNYDPHPHIAGKVAV
>KF629820.1_12725|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
VVAREIEVGILGNTTVKTTDPGEVVKDVAFYDYQAKYIDNKITMDIPAHVPAEVMTQMRA
YAAKAFRALGGCGLARCDFFLTEDGAIYLNELNTMPGFTQWSMYPLLWENMGLSYSDLIK
ELVALGQEMFDKRESHLI
>KF629810.1_12757|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLGGGISTERDVSLSSSRMIYEALKKKGHQAILLDVYLGYEGDYEDIFEKNIDWAE
NIGGITESNPDISSIKALRKDGGKSFFGPGVIPVCQMADVVFLGLHGEDGENGKVQAAFD
LLGIRYTGTDYVSSALAMDKSLAKELFAFHSIPTPAGTHLKKGEESTQRVPFPCVVKACR
GGSSVGVCIAHDDKEYQAALKEAFLYDEEAVIEQYIQGREFSCAVIDGKALPVIEIAPLT
GFYDYKNKYQAGSTIETCPADLPKEKAEEMQAISEKVFSALRLKQYARMDFMMDGDGKLY
CLEANTLPGMTPTSLIPQEAQAMGVSFEDLCEWIMELALKEGE
>KF629809.1_12760|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDRISVAVLFGGVSSEHEISCISAASVLNHIDRDRYDISTIGITKEGNWFLTGSPVANI
GDGSWEKDDSNRRAFIAPDRSVGGIMAETGDGRFEILKVDVVLPMLHGRNGEDGTIQGLF
QIAGIPFVGSGTAASAASMDKVMTKAIINQSGVVAQAGCCVSYRNVYESDRPAETERIRE
FFKNTFPLFVKPANAGSSVGITKVKEEENLPAALELAFGEDDKVLVEEAIKGREIEVAVL
GNESPQASCIGEIFAANEFYDYNAKYENSMSRTAIVRDLPPEKEEEIRSKAVKVYETMGC
AGMARIDFFLEESGRVVLNELNTLPGFTSISMYPKLWEESGLPYDKLIDELITLALEKGD
R
>KF629798.1_12790|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MAKEIRMIAAVASDLGIGKDGKLLFHIKEDMAWFRSHTLHNVVVMGRKTLESFPGGRPLP
ERTHIVLSHKKHENTENVIWVTSVEEALAKMEKLPGEVYVTGGEQVYREFLPLASKLYLT
EVAQKCDADAYFPDFLSDGEWEKMEENKRDGFSFVTYERNRYLFRRGNL
>KF629792.1_12803|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKIRVAVIFGGKSNEHDVSVVSATHVIKSIPKDKYDVICIGITKKGHWMKYIGDVDDIA
SNKWEQHPDNVPCVLSPDPLHKGFIALGENGEYQNVKVDVIFPVLHGKNGEDGTIQGLFQ
LAEIPFVGCDCISSANCMDKGLTHTVLDANGIKTAKWVGIITSELSHLDKKCDEMESKLG
YPMFVKPANCGSSVGVSKAKNRDELKFAHDSKVIVEETIVGMECECAVMGNDEPFASTVG
EVCSANDEFYDFDAKYNDAASKTLIPARMSEESIEEIRKTAVKAYRAMGCSGLSRVDFFL
MKDGTVILNEINTLPGHTPISMYPQLMQYEGMTPAQQEDKLIKLALDKAEVDYE
>KF629785.1_12826|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IDEKGYWNATQMLPDENGNLVKTEVHKFFGKEWAHTIGTAYGYIVNKFQMTQNLIDKIKN
HPEDRRMVMTLWQNDYLDTAVLPSCVWSSEWDVTNGKLNCWVHQRSCDVPLGLPFNVTQY
ATLLCMLAQVCGLKPGTIDWSIKDAHIYVNQIDGIKEQLKRFDEQGDLPAPKLWLNPEVD
DFFKFDSSRDCKDVKLIDYKHLGKISFPISQ
>KF629769.1_12872|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNR
HSEFRTAINQDGELGIYDEMIPSYTIFHNDTEAFSSLWTECKSDFKSFLADYESDTQRYG
NNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDNKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>KF629764.1_12884|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PTSRSKVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITLRKTALRTCTEEMLWIWQRKS
NNIHDLNSTVWDEWADADGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPFSRRIM
TNIYVHADLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVCQYAV
LMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNPDVKDFYQFT
TKDITIEDYVTGPQIKNIPIAV
>KF629754.1_12914|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF629748.1_12933|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWSDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF629743.1_12952|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNTVSKQLIAIWAEAHNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFDCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMTAFKEVSRDRVAKDDKNAYDFSISRYEKEG
D
>KF629739.1_12959|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFKMDEGFPCLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYKGGTIDQISEAVETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMVAQVTGLKAGDFVHTLGDAHIYLNHLEQVKLQLSREPRALPQMKINPDVKDIF
DFKYEDFELINYNPHPHIAGKVAV
>KF629736.1_12969|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASIYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREVHPADEKHLCSYAFVDYVRGID
>KF629734.1_12973|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWPNVTVVHPLDEIPIQDTTEDEIFIMGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWKIANSQEMPADEKHAYPYTFVTYTRRRIENRESSDK
>KF629710.1_13051|FEATURES|farme|aminoglycoside|APH(2'')-Ig|antibiotic inactivation|1
VPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYEHIGQNQELFNY
AACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDELWERFRAKGFK
ALWPSESTISRKKSRNQ
>KF629710.1_13052|FEATURES|farme|aminoglycoside|APH(2'')-Ig|antibiotic inactivation|1
MTMCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRV
TQQREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALAS
DMAIFLRRLQWYIGAAFRETVL
>KF629705.1_13061|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MRAIVCADKNWGIGYKNRLLVSIPSDMKFFRETTTGKVIVMGRKTLESFPGGRPLKNRVN
IVITKKEDYKVDGAVVVHSVEEAVKEASKYDENDVFVIGGGSIYKAMLPYCNTAYVTYIN
QAYSADTFIPNLDKEVDWVLADESDENTYFDIEYFFRTYKRK
>KF629702.1_13067|FEATURES|farme|beta_lactam|OI25_4698|antibiotic target alteration|0
IVTFRPDLNGERMEHSAARLEMPVFPKDRFVDAVVQTIKANAAYVPPYGSGATLYVRPYM
FGSDAVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYA
MSLTCNRRCSQERIR
>KF629693.1_13097|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNFIVSVDQHWGIGKQNDLLFSIREDMRFFKNTTMGGTVVMGDKTLLSLPGAKPLPGREN
LVLSLDPAFSAEGITLFSSIETLFDRLRGTDTSRVFVIGGATIYNLLMDYCETAYITKVE
ADGGAEVFLRDIDAQQNWELVACSGQHRQGSLAYRFCTYRNRNVKPM
>KF629692.1_13100|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTINEMPE
FRTALTEKGLGYFSEMHPAYTIFNQGQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHIGRFIELLQEKINDFDSSFNSTSYEISATAKERMYEMTDKAPWVFSDMSGN
CSNTTSLCEATKEDAPFIASVYNQAILAGNCTCDTKTVTSEMREKWICQHAADGYPVYLC
LENGMPVGYGYLTAYRQGREAVNHVAEVSYYLDFSAHGRHIGTHLLAALEQQAKKQGIKV
LIAILVGSNRPSVGLLEKNGYVEWGRLPQIVHFGNRHTDHLIYGKYL
>KF629687.1_13115|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNCKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF629674.1_13147|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
IINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTS
IIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQIP
TIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEHKEFVCN
HDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFILP
PASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIYQG
REINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERSKV
ISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYK
ERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGI
RMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLC
FELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVS
>KF629673.1_13150|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
EELLEEIKKYPSEEVYCIGGDSVYKQLLPYCDTAHVTKIDFAYEADSYFPNLDEMPEWKV
TAESDEQTYFDLEYSFMKYERIK
>KF629671.1_13154|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFEVSLRSAQGIYSFIDKERYTLYIVEMRGTDWHVQLPDGTKTLVD
RNDFSFRLDGAKVVFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAAALTYDKFAC
NQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVKVKEQIQP
AIAKAFAEAKEVLVEAFMDGMEITCGCYKTKEKSVVFPITEVVSHNEYFDYEAKYNGESD
EITPARIPDELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTPPGMTATSF
IPQQVRAANLDIKDVMTDIIENQF
>KF629669.1_13158|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAAVDRRMAIGYQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSTQKDLICPGAEVFPSLETALQSCKEDEHVYIIGGASVYQQALPFADELCLTEID
STAPEADAFFPEVSPAVWHEKSREAHPADEKHLCSYAFVDYVKA
>KF629638.1_13226|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEAGDEVDIDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGVAC
>KF629634.1_13235|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFEVSLRSAQGIYSFIDKERYTLYIVEMRGTDWHVQLPDGTKTLVD
RNDFSFRLDGAKVVFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAAALTYDKFAC
NQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVKVKEQIQP
AIAKAFAEAKEVLVEAFMDGMEITCGCYKTKEKSVVFPITEVVSHNEYFDYEAKYNGESD
EITPARIPDELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTTPGMTATS
>KF629624.1_13259|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
SREADISRKTGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAEVVFIALHGKYGEDGT
IQSILELSKIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKPYYLKNGIDTVAESIE
KNFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILAEAYLDGKEFTIAVLN
GKALPIIQICPHSGQYDFHSKYTSGATDYIVPAPLPGAAADEMTRMAILGYEAAECSGVV
RFDFRTDKRGTPFLLEANSIPGMTETSLVPKAAAAIGMDFPSLCENILLKAGVGKV
>KF629621.1_13266|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSLKYRPLPNRDNIVVSHDSSYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLFHEAMPFADKAYVTQISMHVDADTYAPDI
KGLVESGAWKVAEEGVWQGTRKGSDDIAGFRFITFERNHEE
>KF629614.1_13287|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIRGREFSVAVVDGKAYPIIEIAP
KQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF629600.1_13321|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIIVLAGGLSTERDVSLSSGAGICRTLREKGHDAFLLDPFLGLPDAGDNLEAAFTRPDA
GLSLASGIRSTEPDLEAVKASREDKSDCFFGANVIELCRLADIVFMGLHGDVGENGKLQA
AFDVLGIRYTGSGSLGCALSMDKEITKVIFEANHIPTPKGTWMKRSTADHSLASTGLPLP
LVVKPCSGGSSIGVYITQTEEEFDKAVKESFRYEDEIIIEEYIKGRE
>KF629599.1_13323|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
MPQQRHTRHFTLKAMHESTFFLTRAVLHTASRQTTLPGMTPTSLLPQEAAVEGISYPDLC
EKIIEISLAKYPKEKSDF
>KF629599.1_13324|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIVVLAGGLSTEREVSISSGTLVAEALRSKGHEVVLLDVFMGYEENICDIDALFKQNYS
FTDGNSIGDDVENTITNIKEAKENRLDKTSRYIGRNVIEICAEADITFLALHGGEGENGQ
LQATLDLFGIKYTGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWSMFPC
IVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPI
EIAPKSGMYDYAAKYQAGATVETCPADIDEETDQKAP
>KF629598.1_13326|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNLIVAVDKNWAIGNKGELLVRIPADHKMFRQETTGKVVVLGRKTMDTFPGGQPLKNRDN
IILSRNEAYQQKDAQVVHSVEELLEAVKGYDTKEVYVIGGSSVYEQLLPYCDTAHVTKID
HAYEADAWFPNLDEDPDWEITADSDEQYYFDLTYHFLKYERKKG
>KF629597.1_13332|FEATURES|farme|multidrug|ABC_transporter|antibiotic efflux|1
MALIKCDGISIAYEGQTVVRDLSFWIEQGDYLCIVGENGSGKSTLVKSLLGLKPPFKGQI
LLGDGLKQDEIGYLPQQTVVQKDFPASVYEVVLSGRLNSRGWRPFYSAADKKAARENMEL
LGIRETSSG
>KF629592.1_13352|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
PDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASRHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFASKYMAAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF629583.1_13368|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDVRLLQQWNCHVWD
EWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALYPCAFL
TMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVINNAHV
YKNHVDAMKTQLARLPKAYDAPVLKLNPDVHDFYDFKPEDIVLENYKHYEKIAMEVSV
>KF629575.1_13383|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEVKKYPSEDVYCIGGDSVYTQMLPYCDVAHVTKID
FVYEADSHFPDLDEDEEWEITAESDEQTYFDLEYQFVKYERKK
>KF629557.1_13438|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
AELFLKNPKKYFEGFLIGASRISRVWGRHSPTRFPQGQNERKANFGTAVESCSP
>KF629555.1_13451|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKIFVNMCRDILDNGTDTKGEKVRAKWDDGSFAYTIKKFGVVNRYDLKKEFPALTL
RKTGFKNCVDELLWIWQKKSNNVNDLNSHIWDAWADETGSIGKAYGYQMSVKHHYPEGDM
DQVDRVLYDLKNNPYSRRIMTNIYVHQDLSEMNLYPCAYSMTFNVTKNKETGKLILNGIL
NQRSQDVLTANNWNVCQYAALLHMFAQVNDMEVGEFVHVIADAHIYDKHVDLVEELITRK
QYPAPKLWINPEIKNFYDFTVDDIKLLDYEHGEQIKIPVAV
>KF629542.1_13487|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTIEMIFYIIDKEVNEMKQYLDMCQYILENGQDRDDRTGTGTRSVFGYQTRYDLTDGFPL
LTTKKMFLRPIAEELLWFIKGDTNIKYLVDRNVKIWNEWPYEAFKKSEDFHGETLEEFVA
KIKELPADDPFVVKYGELGPVYGRQWRNFNNEGVDQVAKLVDSLKNNPLSRRHIICAWNP
AEVDEMALPPCHAFLQFYVSNDKKYLSCQLYQRSADTFLGVPFNIASYALFTAMLAQVCG
YKPKEFVHTIGDAHIYKDHFDVVKEQISRTPYPKCQLVLNPEVKSIFDFTIDDIKIENYQ
SHGRLVGKVSV
>KF629536.1_13498|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPQGQMRFNLDDGFPCLTTKKLHLKSIIYELLWFLQGDTNVKYLQEHGVRIWNEWADENG
DLGHVYGYQWRSWPDYNGGFIDQISEVVETLKHNPDSRRIIVSAWNVADLNNMNLPPCHA
FFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFVHTFGDAHI
YLNHLEQVKLQLSREPRPLPQMKINPDVKTSSILNLRTSN
>KF629528.1_13524|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
PNGSKQSLSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLALNLKEYATGDILSDDKK
EIFIDWMSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSK
KAEQDAEYDNKLIADATKIIFDLIS
>KF629519.1_13551|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target alteration|0
LSYADKVFIEMCRDIIDNGTSTEGEKVRPVWEDGASAYTIKKFGVVNRYDLRKEFPALTL
RKTALKSAMDEILWIWQQKSNNIHDLHSHIWDSWADEKGSIGKAYGYQLGVKHQ
>KF629498.1_13617|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITGESDEQTYFDLEYQFVKYERKK
>KF629497.1_13619|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GNKDLSIFEKSEKEYDVMAERDHIRSLSSKVKEEEKIRKSFFGENVLGICAKADIVFLAL
HGKNGEDGKCQATLDLHGIKYTGSGALASAIGMDKAVTKQIFIAKGVPTAKSVWIKKGED
TSLEAHGMKAPVVVKACNGGSSVGVVLVKEASEYDSAVEECFKYDNQILVEDFIEGREFS
IGVVDGMAYPIVEIIPNEGWYDYENKYKEGATTHVCPAKLDEELTKKMQKVAEGACAAIG
CEAYSRADVMMDKDGNMFCLEVNTLPGMTATSLIPDEARAIGIDYPTLCDNLINISLKKY
Q
>KF629496.1_13621|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
RGGIVMEKKNIDWSSIGFAYMPTDYRYVSNFKDGKWDEGTLSTDPNIVLNECAGVLQYSQ
SVFEGLKAYTTEDGHIVTFRPDLNAERMAASAARLEMPVFPKERFIDAVEQVVKANAAWV
PPYGSGATLYLRPYMFGSNAVIGVKPADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRA
APCGTGNIKAGLNYAMSLHAIVDAHKQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKV
VTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKI
NDHGKEICFPSGMEKMGPVIQKLYDTLTGTQMGRIQAPEGWLKVIE
>KF629488.1_13645|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
LLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKKRTNIVLTSDQNYKVKDAVVVN
SVEALLEELRQYNDEDIYVIGGESIYRQLLPYCKVAHITKIDHAYEADTYFPNLDEMPEW
KITGISEEQTYFNLEYEFVKYERIG
>KF629486.1_13649|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
PVYEVQTDYRYVSTFKDCAWDAGELTTDPNVTLNECAGVFQYAQTVFEGMKAYTTEDGHI
VTFRPDLNAERMAHTAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGSGATLYVRPYMM
GTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAM
SLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRS
LIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKM
GPVIQKLYDTLTGIQMGRIEAPKGWIHVIE
>KF629460.1_13719|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MHKLRDGRDAMGDIMKRFPEEETALREMERVFHSHVDKKEQPDEAFYINAASMIKTLKRQ
FPERFPRHFQLIAAVDRNWGIGNKGQMLTVIPADQKLFRQETMGKIIVMGYKTFLTFPAQ
RPLDGRINLILTKKKALSVKGAEICHSVEEALVRIDELKQEKHLTDVDVVIIGGESVYRQ
FLPFCDTAQITWIDFSYVADTHMVDLEKE
>KF629458.1_13723|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MHFGSQREGSEQLQADNESGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDM
KFFRQETMGKVVVMGRKNLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEEL
KKYDDDDEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFPNLDEDPEWEITAASDE
QTYFDLEYTFVKYERK
>KF629454.1_13736|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVNVDNNWAIGYRNSLLVRIPSDMKFFRQETTGKVIVMGRKTLESFPGGQPLKNRIN
IVLTTDPAYQVKGAVIVHDLEELKEALKPYDSENIYVIGGESIYRQLLPYCDTAHVTRVC
NTYQADTWFPNLDELPDWELTGESEEQTYFDLEYYFLRYERKKK
>KF629450.1_13747|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLKNAPANLEDVFTLPGA
GLEIAKNISTKEPDLEALKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF629446.1_13755|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLRR
>KF629436.1_13780|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGKIPWKIKGEQKQFKELTTGNVVIMGRNSYDEIGRPLPNRETI
VISNTKKYIGENLHTASSVKEAIEFAKGKDVYIAGGYGVYKEAIPLVDVMYITEININVE
QGDVFFPEFDDNNFNISIVETSENNEQFIRKIYRRKNKQ
>KF629430.1_13797|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAVDRHMGIGYENKLLFWLPNDLKRFKTLTTGNTIIMGRKTFESLPKGALPNRRN
IVLSTRPDTQCPGAEVFPSLEEALKNCAQDEQVYIIGGASVYHQALPLADALCLTEIDAE
APHADAYFPEVDLKIWQEKSRDSHPIDEKHPCAYAFVDYIRR
>KF629429.1_13800|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTLESFPGGLPLKNRTN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCFGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQTYFDLEYKFVRYERNK
>KF629429.1_13801|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNIYVHEDLHEMNLYPCAYSMTFNVTKEPGKDKLTLNAILNQRSQDILAANNWNVCQYS
LLLMMIAQCCDVEAGELVHVIEDCHIYDRHVPVIKELISRTPYPAPTVKLNPNVKNFYDF
TTDDLIVENYQTWPQIKNIPIAI
>KF629420.1_13825|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
PRGPNFKDGKWDEGTLSTDPNIVLNECAGVLQYSQSVFEGLKAYTTEDGHIVTFRPDLNA
ERIAASAARLEMPVFPKERFIDAVEQVVKANAAWVPPYGSGATLYLRPYMFGSNAVIGVK
PADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRAAPCGTGNIKAGLNYAMSLHAIVDAH
KQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYL
GLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQKLYD
TLTGIQMGRIEAPKGWIHVIE
>KF629420.1_13826|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNIIVAADKNWGIGRNNELLVSIPADMKMFREETTGKVVVMGRKTLESFPNGLPLKNRTN
IVITSNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
FAYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF629419.1_13828|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDRSSWKRNEYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYWVPIFTMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>KF629412.1_13845|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|0
MIREVRPEDTGSITAIYNEYVAHSVITFETEPVREEEMRSRITGIVSHFPYFVYETEGKI
AGYCYAHAWKERAAYRHTLETTVYLASEYQGKGIGKQLMQTLINECRHRGYHALIACITE
GNEASNSLHQKLGFKQVSHFEKVGLKFDRWLDVFDYELILTPESPQN
>KF629412.1_13846|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSFLKDKKATVGVAVLANDEIVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKDHIGLRQPYRSEVFSTEA
>KF629407.1_13861|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVI
KELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF629397.1_13893|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
VRETPEVSGDDNANARAAVHSANKPGAAYAAAVANGESERAWIRRVVLLLTGQAFSLLGS
NIVQYAIWWWIVLQTKTGSAMLLATLFGVVPQAIVSICGGSWADRHSRKLLIMLPDMVIA
VVTVVLSLSFAMGWASLTMIFVVLFIRSAGGGVQTPAVQSFIPDVVPSGKLLRVNSIYGV
INSANMIVAPAVAAVLINTVPLWSILLVDVTTAIIGVGFVALIKAPKKSAEHVARRMAEA
ENSGQPTLEPMSDANADRSLIASVRRVFADLKDGFSYTWRRANLRNVVLGGALVCFVAVA
PMNLTLLLMTREYEGIDLNLGFINLTTASDKLAANELGWSIGMLLGGALMSTIGAKLIRN
NMRVVAFGIALVGVSVVGLGVVHNLLAYLLIDVVNGLASAICTGPMRTIIQTEADEKMVG
RVFGLDTTLSTLGMPLGMLIFAPLADVIPISLVFIIGGVLTLPIGIYLFGQARRNVSAQV
TRTAA
>KF629385.1_13924|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIACGGDTSEFEVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGTKTPVD
RNDFSFRLGGEKVVFDFVYITIHGTPGEDGRLQGYLDMLHIPYSCCGVLAAALTYDKFAC
NQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVKTREEIQP
AIEKAFKEAREVLVEAFMQGTEITCGCYKTKEKSVVFPITEVVSHNEYFDYKAKYNGESD
EITPARIPDELRDRVQKLTSAIYDILGAAGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAANLDIKDVMTDIIENQF
>KF629381.1_13934|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MRAIVCADKNWGIGYKNRLLVSIPSDMKFFRETTTGKVIVMGRKTLESFPNGMPLKNRIN
IVLTRDRNYEAKGAVIVHDEEELMNELGKYDTEQIYIIGGESVYKMMLSYCDKIYVTKVD
RAFQADTYFPNLDEMSEWKMTQESEEQTCFDLEFCFTTYERC
>KF629365.1_13983|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNQFDNEVSSTLKEIAERVETPPYLKDRIDKELLRRCPEYRKKIAVIFGGCSPEYSVSLQ
SAYAVISHMDTEVYTPVLIGISQSGDWFLYEGDIEKIVSDTWCGGKDCTPVVVSPNRTSH
NLLLLENGKVKKLHIDAAFPVLHGRNGEDGTIQGLFEMAGIPVVGCGVLSSALCMDKDRA
HKLVHTAGISVPASFVLGKSASVATALQQAEKIGYPLFVKPVKAGSSFGITKVSSSNELP
AALELAFEYDKRVIVEECISGFEVGCAILGDEDLTVGEVDEIELSGGFFNFTEKYTLKTS
AIHVPARIPQNTAEQIKQAAKTIYRTLDCQGFARVDLFLTPSGEIVFNEVNTIPGFTTHS
RYPNMMKAAGFTFEQIVSVLIEQAVRE
>KF629360.1_13998|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIKKRIAIIFGGNSTEYEVSLQSASAVFENINTKKFDIVPIGITRNGDWYHYTGKKEKIA
NNTWFEDNENLYSVAVSQNRSVKGFIEFKEEKFYIIKVDLIFPVLHGKNGEDGTLQGLFE
LAGIPVVGCDTLSSALCMDKDKAHKLVSLAGISVPKSVTFKFSGKKAALKKIEKELSYPL
FVKPVRAGSSFGITKVTKQQELENAIQLAFEHDAEVIVEETINGFEVGCAVLGIDELIVG
RVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQETAVTIYKALGCSGFSRVDM
FYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFAQMLDKLIGLYVE
>KF629353.1_14019|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFTETPS
DDEKLMTNDTVVASQVIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKHILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENEAELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPAHVPAEVMTQMRTYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDLIKELVALGQEMFEKRESHLI
>KF629336.1_14072|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKRFGVVNRYDLSKEFPALTLRRTAIKSCVD
ELLWIWQKKSNNVNELKSHIWDSWADETGSIGKAYGYQMGVKHQYKEGRMDQTDRVIFDL
KNNPYSRRIMTNIYVHNDLHEMHLYPCAYSMTFNVTKEKDSEKLTLNAILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISREPLPAPKFWLN
PEVKDFYDFTPDDVKLEGYETHPQIKNIPIAV
>KF629334.1_14080|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSKISIIAAVDRRMGIGYQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNIVLSTNPATNFPGTEVFPSLEAALQSCHEKEHVYIIGGETVYRQAIELAMNSALQR
>KF629331.1_14091|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLEEKRVSFRPMSEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRV
IIEYDTIPIGYAQIYRIQGELFDEYDYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVC
QYLRTEMDANAVILDPRKNNPRAVRAYQKAGFEIIKELPEHELHEGKKEDCVLMEWRA
>KF629326.1_14109|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
NPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSL
HAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLI
YVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGP
VIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF629324.1_14115|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDINSWTRHEYFEHYFTNIPCTYSMTVNLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQVGELGIYDEMIPSYTVFHKDTETFSNLWTEYMPNIEEFSRAYENDIQRYG
SNHGMTGKPDVPENVSTVSMIPWSTFESFNLNLQKGYRYLIPIFTLGKYYMEDGRIMLPL
AIQVHHAVCDGFHICRFVNELQELINS
>KF629305.1_14166|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQGTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629293.1_14198|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MAMSTISIVAAISDNNAIGKNLGLLWHMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLP
NRKNVVLTTMPEAGFINCFACESMHDALGICEKEENIFIIGGSLVYRQGLGIADKMYLTR
IHGEFPDADAFFPVVNWDLWEEVERQEFPADEKNPYPYTFLTYVRKK
>KF629286.1_14220|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFS
>KF629283.1_14228|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDL
>KF629282.1_14231|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGTMIAHALRGLGHQAALVDMYFGLEAYTGPVADYFDAPLT
DQWKQVDPKAPDLAEIRAARKWQSPSQFGQGVLELCQMADIVFLALHGTCGEDGRVQAAF
DLMGIPYTGAGYLGSGLAMDKDLTKRLIAHLGVHTPQWQRVSYTEQEVEDLAAATQVPCV
VKPVASGSSIGVSIAHTRQELHGALMEGLRFGGQCVLEQYVAGREIQVAILAGQALPSIE
IIPKEGFYDYENKYQPGAAEEVCPAPIPPAWEQRVGQAALTVYHALGLSVYSRADFIVDQ
EGTPWFLEINTLPGMTPTSLVPQEAAAVGIDYASLCQRIIEESLRVRKG
>KF629274.1_14249|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFRKAATGAIPNVPFELLAQKMRTCKTKLDFQ
KAFCYGILWKIAEEHTNGLTLDHNALPNKKKAYTYISNHRDIILDSGFLSILLVDQGMDT
VEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLEASTRMSRYMHYTIAEKNQSIWI
AQREGRAKDSNDRTQDSVL
>KF629269.1_14262|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVCGGDTSEFEVSLRSAQGIYSFIDKERYTLYIVEMRGTDWHVQLPDGTKTPVD
RNDFSFRLDGAKVVFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAAALTYDKFAC
NQYLKAFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVNVKEQIQP
AIAKAFAEAKEVLVEAFMDGMEITCGCYKTKEKSVVFPITEVVSHNEYFDYKAKYNGESD
EITPARIPGELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAANLDIKDVMTDIIENQF
>KF629261.1_14281|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
VIDYNNFINKKISTVKPSGIRKFFDIANEMDDVISLSIGEPDFQTPWHIREEGINSLKKG
KTWYSPNRGFAELREEIAAYYKRRFGIEYDAKKQTLVTVGGSEAIDLVFRTLLDPGDEVI
IPEPSFVCYEPLTVMADGVPVIINTKNEDNFRLKASDLRAAITPKTKLLVLPFPNNPTGA
IMEREDLEEIAEVIKEHDIFILSDEIYCELTYGNKNHVSIAEIDGMYERTIVVNGFSKSY
AMTGWRLGYALGPVPVIAQMTKLHQYGIMSAPTTAQYAAIEALRNGDRDVEMMRGEYDMR
RRLVVDSFNAMGLTCFEPLGAFYVFPCIKSTGLTSEEFCTRLIVDKHVAVVPGTAFGESG
EGFVRVSYSYSIKNLKIALERIKEFLDELKKG
>KF629252.1_14305|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNMEFDEIRPYHDEELPQIYEELIADPAFQQVASAVFPEVPFEALAQKMRACKTKLEFQK
AFCYVILRKFSRDTTQGVTLDHTAQPEHESAYTYISNHRDIILDSGFLSVELIDKGMDTV
EIAIGDNLLIYPWIKKFVRVNKSFIVQRTLTMRQMLESSGRMSRYMHHTIKDKNQSIWIA
QREGRAKDSNDRTQESVLKMLAMGGEGDIIDRLTEMNIVPLAISYEYDPCDYLKAQEFQL
KRDIPDYKKTQADDLKNMQTGLFGAKGHVHFQVAPCINGELAKLTVATSG
>KF629247.1_14320|FEATURES|farme|multidrug|MexB|antibiotic efflux|1
ILIVEFARDFRVQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIAL
GAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629246.1_14321|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
IDTEKYNVVKVGITHDGKFYLYEGENSLIPENKWLAEGKCTPLSLDLEKGCFTAGEREIR
PDAVLPMIHGKNCEDGTLQGMLTLMKIPVAGCGCTSSAVCMDKAFTKAIINSETGINQAK
AVVIRAEDYTPDTAVSFREKCEKQLGYPVFVKPANAGSSVGVTKVKSAEDFDKAVKTALN
EDEKVLVEEFILGKEIEVAVLEEHGKYYAAHPAEIDHGSAEFYDYETKYISDASSFYIPA
RIPEKEQENVRAQALEVFKALGCRGFSRVDFFYSEERGFVFNEINTLPGFTPISMYPKMM
VNDGISYKELISRLIEAAR
>KF629233.1_14352|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MLSIIVAINQNRGIGHENKLLYWLPNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRRN
IVLSRSCREFEGAECFHTLEEALKACANEEEVFIIGGASLYAEALPLADRLYVTEVEDRL
AEADAFFPALDPAQWQEKSRECHSQDEKHLYSYTFIDYDRIRPASAGNGNV
>KF629232.1_14354|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MEIIVAVDENYGIGKDGDLLAHLSPDLKRLKAMTVGNIIVMGSKTYMSFPKRPLPDRENL
IITHHPENYPGIKCFTGVDEFLEYSKTADKPIFVLGGGSVYEQLLPYCEKAHITKILHSF
EADTFFPNLDNNPDWEKESEEEIVTGEKYPFRYVTYVRRKK
>KF629226.1_14369|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
YDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGDMYCL
EANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPTQDFTL
>KF629221.1_14380|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFPSLETALQSCKEDEHVYIIGGASVYQQALPFADELCLTEID
STAPEADAFFPEVSPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>KF629219.1_14386|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LQKKSNNIHDLRGNIWDSWADESGSIGKAYGYQLGVKHQYPEGEMDQVDRVLYDLKHNPA
SRRILTNLYNFQDLHEMALSPCAYSMTFNVSGDTLNAILNQRSQDMLTANNWNVVQYSVL
VHMMAQVSGLKAGELVHVIADAHIYDRHVPAVKAMLELDGYPTPTFRMDESITDFYAFTK
DSFSMENYQFHPFNFEIPMAI
>KF629216.1_14395|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKITLGVLFGGVSSEHDISTVSAKGILSAIDKEKYNLVLLGITKEGRWFLFDDDIDLLP
EDRWLTSPSLVPAWISPDRSVHGVVTAKGDTIRLDAVFPVLHGKNGEDGTVQGLLQLAGI
PFVGCDATASGVCMDKAVTNAVADAVGIAQAKWCAYTRFAYDSDREGCLQAAEEKLGYPI
FVKPANAGSSVGITKATDRESLVRGMEVAFAEDKKAVLEACIVGHEVECAVMGNDTPIAA
QVGEIVAAADFYDFDAKYNNPQSELHIPADLSPEKLEEVRAAALRAYGAMGCEGLSRVDF
FVTYDGEQVLLNEINTIPGQTPISMYPKLFEAVGVPYSELIDRLVAYALERGAV
>KF629213.1_14400|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAIAAADRNWAIGNKGSLLCHIPGDLKYFKEKTIGKTVVMGRKTLESLPGGRPLPGRQT
IVLSRSLEAGEGFTVCRSVEEVIEACKDKDTFICGGEEIYREFEPYCDTLYITRINEEFE
ADAYFPEPGEDMEIVWQSEVFCEKGHEYQFLEYRRKK
>KF629211.1_14406|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKIAVLCGGLSPERNVSISSGTKIAGALQESGHQVVLLDMFFGLEDYTGDIAHVFDDPPA
LGGTRIDESAPDLEAVRAQRKLQSPSLFGEHVLEVCAMADIVFLALHGRTGEDGRVQATL
DLLGIPYTGSGYLGSAIAMDKDLTKRVVAPLGVKTPAWMLVESDGMDIDAVCAQAKLPCV
VKPDDSGSSIGVSIANDEAELRAALKAAANEGSRILIEQYICGREVQIGILGDKALPSIE
IIPAEGFYDYRNKYQPGAAREITPAEIPAETEQRLADAALTVFHALNLSAYSRADFILDA
EGELWFLEINTLPGMTPTSLVPQEAAAVGISYSELCEQIIAAALHK
>KF629210.1_14410|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MLSIIVAINQNRGIGHENKLLYWLPNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRRN
IVLSRSCREFEGAECFHTLEEALKACANEEEVFIIGGASLYAEALPLADRLYVTEVEDRL
AEADAFFPALDPAQWQEKSRECHSQDEKHLYSYTFIDYDRIRPATAGNGNV
>KF629209.1_14414|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VLKLCEAADIVFLGLHGANGEDGKVQATFDLMGIKYTGTGYLSSALAMDKGITKQMFLMN
NVPTPRGVSMVKEEMTTDLKALGMEFPVVVKTCCGGSSVGVYIVNDQAEYEQALKDAYSY
ENEVVVEEYIKGREFSVAVVDGKALSDHRNCSASGIL
>KF629205.1_14427|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPGTYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIVTSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>KF629197.1_14446|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
GRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
>KF629191.1_14462|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHVYGYQWRSWPDYNGGFIDQISEVVETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF629186.1_14478|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKIFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNRAYSVPEGVYVFHTVKELLSALPEGENFIIGGEKMYEAMFPYADKMYITEIEKE
YDGDAVFPSFRKEEWKETESVMGKGDPVHCFVTYKRVRG
>KF629183.1_14490|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MQSANKMCVALLFGGMSSEHEVSCVSVGNFVRNIDRSKYEVLTVGITKEGRWLYTEATAE
QMADGSWEELPGNMACVISPDRSDHGMILFTPDGRVEKMHLDVVIPVLHGLWGEDGTVQG
LLELA
>KF629182.1_14492|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSTERQVALTSGTGVCRALRERGHQAILVDMFLGLESYEGRLEDIFDAPDG
LCGDNRVTEEAPDLEAVRRSRKDQGPSLLGKDVLAVCAMADIVFLALHGSCGEDGRIQAT
LDLLGVPYTGSGYLGSGMAMDKSVTKRFLESEGIRTAPWRDVHYTASDIPRLVEELEVPC
AVKIVNGGSSIGVELPDTKEQLREALAKLLTYGDHVVVEKKIKGREIQIAVLGDTYLPAV
EIIPRGEYFDYVSKYQKGGAQEICPAPITEEEWHQIGEMALKLHRGLGLSVYSRSDFLLD
EEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYGDLCQRIVDESLALRKGGRA
>KF629173.1_14516|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MMRNPLSKKITGIEPSGIRKFFDLVSEMPDAISLGVGEPDFDTPWRIREEGIYTLEQGKT
FYTSNAGLKDLKIEISKYLERKIHVEYDPDHEIMVTVGGSEGIDVALRAMLDQGDEVLIP
QPSYVSYVPCTILADGNPVVIPLQQKNEFKLTAEELEAAITPKTKMLVMPFPNNPTGSIM
TKEDLEPIAEVVKRHDLYVLSDEIYSELTYKTEHVSISSLPGMKERTLVINGFSKGFAMT
GWRLGYICGPSVIIEQMLKIHQFAIMCAPTNSQYAAIEGLRHCEDEVQQMRNAYNQRRRY
LVNEFAKMKLECFEPFGAFYIFPSIKEFGMTSEEFAMRFLEEEKVAVVPGSAFGESGEGF
LRVSYAYSLEDLKEAIGRLSRFVERLRSQK
>KF629157.1_14556|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MQSEDKLCVVVLFGGMSSEHEVSRVSAGTFVDHIDRTRYELMTIGITKEGRWLYTEASSA
QMADGSWEELDSNMPCVLSPDRADHGMILFTPAGQVEKIHVDVVIPVLHGLWGEDGTVQG
LLELAGIPYVGCGVLASAVCMDKAVANALFDANSIPHTKWLSATRWEIESDPEGVCDGVI
AKLGWPVFVKPANAGSSVGITKATNREQLKEGHPAGPRQ
>KF629156.1_14558|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKKNLAVIFGGRSSEHEVSCVSVVTIAKAVDLEKYNMFLIGITKDGEWKLVEDIAGIEDG
SWKESPVSAIISPDTKGGLIISQDDMMKVQPIDVIFPVLHGMYGEDGTIQGLFEMADIPY
VGCGVFASAASMDKFYTKLVVDTLGIRQAVYVPVLAEQLDDIDEVTARVEAKLSYPVFVK
PSKAGSSKGVSKADDRAALVVALKEAAKHDYKILVEETIVGREIECAVLGYGKNTKASRV
GEILAAAEFYDFDAKYNNAESKTVIGADLPDGKEAEVQKDAVAIFNALDGFGLSRVDFFL
>KF629154.1_14565|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSTERQVSLTSGTGVCRALRQRGHQAILVDMFLGLESYTGRLADVFDAPDG
LCGDNQVLSTEPDLEAVRRSRRDQGPSLLGKDVLAVCAMADLVFLALHGSCGEDGRIQAT
LDLLGVPYTGSGYLGSGMAMDKSVTKRIMDAAGIPTAPWHDVRYTREDIPRLAQELPVPC
AVKIINGGSSIGVELPDTREELAQTLERMLAYGDHVIVEQKIRGREIQVAVLGDGYLPAV
EIIPKGAYFDYFCKYQKDGAQELCPAPITDEQWHTVGELALRLHRALGLGVYSRADFILD
EEGRFWCLEINTLPGMTPTSLVPQEAAQVGLSYGDLCQRIVDESLALRKGGRA
>KF629146.1_14582|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YHVEKAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAF
DLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPAGKAMKKKDRVETPQELGMDFPVV
VKTCCGGSSIGVYIVDNQEDYTKALDGAFTYENEVVVEEFVEGVEYTVAVVDGKAYPVVQ
IVPVQGFYDYENKYKPGAVKETCPAPISEELTKRLQEAAVDGYHALEMESYARLDFIVTK
DEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIKVSQKKYA
>KF629143.1_14586|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MIRLGILFGGRSEEHEVSRLSAVSVIGAIDRSKYDIIMIGITKQGEWMLYDGDVDKIATG
EWEETARQKLFDDPENYAFSLLGTGGRSLREIVDFVLPVVHGTYCEDGTLQGLLEMIDIP
YGGCGVTASAVAMDKIIAKDVFVRAGLPVCGYVATSAEEISA
>KF629142.1_14590|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKAIVCADINWGIGKGTGMLFHIPADLKFLKEKTMGSTVIMGRTTFLSLPGQKALPGRKN
IVLTRDENWSAENVTVCHGIDELADIIENGENVFLMGGEEVYNELIDSCDEAYVTRVNAD
GKAEKFFPDLDRRAGWKLVERSAAQESNGYVFTFDRYVKK
>KF629141.1_14593|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
IVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTNIVL
THDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDKAYVTRTDFAY
DADTYFPNLDEMPEWKLVKESEEETYFDIEYQFVVYGK
>KF629137.1_14604|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDVRLLQQWNCHVWDE
WMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALYPCAFLT
MWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVINNAHVY
RNHVDAMKTQLARLPKAYDAPVLKLNPDVHNFYDFKPEDIVLENYKHHEKIAMEVSV
>KF629128.1_14630|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRSHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGIL
NQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKRE
PLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF629121.1_14646|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDANWAIGYKNKLLVSIPDDMKFFRQTTTGKVVVMGRKTLESFPNGQPLKNRVN
IVLTSDKNYKVKDAIVVHDLDELHKELEQYNSEDVYVIGGESIYRQLLDECDVAHITKID
YAYDADAYFPNLDEKEEWQITEDSDEQTYFDL
>KF629115.1_14655|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
DSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQAADIVFMGLHGSNGEDGKVQATFDLL
GIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIHDLGMEFPVVVKT
CCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYINGREFSVAVVDGKAYPIIEIAP
KQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF629107.1_14669|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTILVLFGGCSTEYEVSLHSAYAVLSHMDPARYTPLAVGITREGQWLCYTGDLSRLEDG
TWQQAADCIPCTPLVEREAHALLLLDGSGRRLLFDAVFPVLHGKNGEDGTVQGLFELAGV
PVIGCGTLSSALCMDKDRAHQLAALAGIRVPRSHVFHSSDDFSRIAQAAEELGYPVFVKP
VRAGSSFGITKVSGPEELPAAMEEAFRHDSAVILEETIPGFEVGCAVMGNEELTVGLVDE
IALSEGFFNYEEKYTLKTSAIHCPARIPPEKAAEIQAAAKTIYRALDCRVFARVDLFLTP
DGEIVFNEVNTIPGFTAHSRYPSMMQGIGISFGELVTRLIELGVVG
>KF629103.1_14683|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRIIAIVAGGDSSEHGVSMKSAEGIYSFIDQQKYNLYIVELTHKSWEAILPDGTRAAID
KNDFSFEENGKRIKPDFAYITIHGTPGENGILQGYFELIGMPYSTCDVLVSALTFSKFLL
NQYLKRVWYPRSRILTGEEKERYHRRTGRGNHRTSLLHQAECQRFQFRSYQSKDQRADSA
CPGSSVQGIRRCDD
>KF629098.1_14698|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
EDLERLKALTTGNTIIMGRKTFESLPKGALPNRRNIVLSTRPDTLCPGAEIFPSLEEALK
HCEQDEQIYIIGGASVYRQALPLADALCLTEIDAEAPQADAYFPEVSPEIWQEKSRESHP
IDEKHPCPYAFVNYIRR
>KF629096.1_14701|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRKIAIIFGGHSTEYEVSLQSAAAVFENINTEEFEVFPIGITKAGDWYHYTGELSKIAAG
TWCNDASHLNKVAFSQDRSVGGFLELLDGRYTVQKIDLAFPVLHGKNGEDGTVQGLLELA
GVPIVGCGTLASALCMDKDRAHKLVSLEGISVPKSVAFKKSEINDAVQKIKDSLSFPIFV
KPVRAGSSFGVTKVSEPEKLENAIHLAFENDSEVIAEEAIDGFEVGCAVLGVEKLMVGRV
DEIELSGGFFDYTEKYTLKTSKIHMPARIDAATELRIQEAAKTIFKALDCSGFARVDMFL
TPAGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSDMLDKLLGLYTKECAKSL
>KF629094.1_14706|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVF
FGKEGADPATAFDGDYDVDAEAAYISSFNAQVKDAVASGREFFGPGVIELCKAADVVFMA
LHGANGEDGRVQAYFDLCGIPYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGK
DSMNLADYNMELPVVVKTCCGGSSVGVYITKTPEEYEEALKGAFSYEDEVVVEEYIEGRE
FSVGVVDGKAYPIIEIAPVEGFYDYKNKYSAGATIDTCPAVLTEEQTRKMQTYAEAGCKA
LAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEAAVLGIDYAQLCEKLIEISMR
KYQK
>KF629091.1_14718|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTSKTKDTPLDELGYYLP
LVVKPCSNGSSIGVYICHTEEEYYDAIHKSFDVDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPVSLDEETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQESIKARY
>KF629088.1_14729|FEATURES|farme|multidrug|bepE|antibiotic efflux|1
SYSVVSQLDGKPTAAIAIYQQPGSNSLDVSKGVKAKMQELSQNFPAGIQYNVTLDTTDVI
HASIDEVMVTFLETTLLVVLVIFLFLQNWRAVVIPCITIPVSLIGTLAVMSLFGFSINTL
TLFGLILAVAIVVDDAIVVVENSTRLLDTGRYTSRQAVTEAMGEITGPIVGVVLVLLAVF
IPTTLVSGISGQLYKQFALTIAASTVLSGFNSLTLTPALCALMLQPTRPSKNSLYRGFNH
LYDKTQGVYDRIVEYLLQRPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAVVQL
PPASSLERTQAVGKQINKILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERK
GKEHTAEAVVQRFNMEVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATEMQRA
VETLMEHYRNYPALASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYV
NDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMEPFSSFTRVEEQLGMDQINRY
NMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFV
MALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALS
AKNGILIVEFARDFRVQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGS
RIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629087.1_14730|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCKDILDNGFSSEGQAVRAVWEDGTPAHTIKKFGVVNRYNLQEEFPALTL
RPTAIKSAVDEILWIWQKKSNNIKDLNSHIWDEWADEDGSIGKAYGYQLGVKYDFHQGRM
DQVDNVIWQLKNTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYSVLLMMFAQVCGLEPGELVHVIADAHIYDRHIPIIRELIARPQFPAPK
FELNPEIKDFYDFTVNDIRVTDYQKNEQIKNIPIAI
>KF629085.1_14737|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PAPKFWLNPEVKDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF629079.1_14749|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSRVSVGNFVNNIDREKYETLAVGITKEGRWLYTEATA
AQMADGSWEELAGNMPCVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQ
GLLELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTKWVAANRWEIESDLEGVCDGV
EQKLGWPVFVKPANAGSSVGISKVSSREELKKAIDLALENDRKVVFEAFVDGQEVECAVI
GSDPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNC
EGLARCDFFVEHGTGRVLINEINTFPGFTSISMYPKLMEHEGLPVPALIDRLIALALERK
EKQHG
>KF629074.1_14764|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGTSTERAISTISGTGICKALRQKGHQAILADVFCGVENVDWENPFPEEYDVD
AASAYMSGFDDKIETMKKERRSFFGENILKLCEMADIVFLGLHGSNGEDGRLQATFDLMG
IRYTGTGYLSSAMAMDKGITKQMFMMNHVPTPRGVSMVKSQMTTDLKALGMEFPVVVKTC
CGGSRVGVYIVNDQKEYEQALKDAYSYEDEVVIEEYIKGREFSVAVVDGKAYPVIEIAPI
QGFYDYKNKYQAGSTIETCPAELSPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGDM
YCLEANTLPGMTPTSLIPQEARVLGIDYPTLCEKLIEVSLRKYQ
>KF629073.1_14765|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGCIARYRLEALMSKADELFVSMCQDILDNGTTTEGQKVRPHWEDGTPAYTIKNFGVTNR
YDLREEFPALTLRRTALKSAMDEVLWIYQRKSNNINDLHSHIWDEWADETGSIGKAYGYQ
IAQKSHYAEGDFDQMDRVLYDLQHTPFSRRIMTNMYTFSDLSEMHLYPCAYSVTYNVTEQ
PGDEKPTLNMVLMQRSQDILAANNWNVCQYAILLMMVAQSCGMIAGELLHVIVDAHIYDR
HVDIVRELIARPQYPAPRVSLNPEVTNFYDFTTDDLIVEEYEHGPQIKDIPIAV
>KF629073.1_14766|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDNLKAIVAVCDDWGIGANGDMVVSNRADMRHFVSCTKGHTVIMGRKTLESFPGARPLKD
RRNIVLTRDPLFLCRGAEVVHTIEEALAALEPSELAWVVGGGKVYEQLLPYCCEAEVTRN
HCLRNSDTYFPNLDEDPAWVVVSRSEMQQVAEGEGDAGVFYEFTTYRRRDERAGE
>KF629072.1_14768|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IWQKKSNNIHDLRGNIWDSWADESGSIGKAYGYQLGVKHHYPEGNMDQVDKVLWDLKHNP
ASRRIMTNIYNFADLSEMALYPCAYSMTFNVTGNKLNAILNQRSQDMLAANNWNVVQYAV
LTIMLAQVSGFEPGEFVHVIADAHIYDRHVPMIERIIRNEPKPAPKFIVDPSVDDFYKFT
RDSFRMENYEFTPFDEKIPVAL
>KF629068.1_14779|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IGKAYGYQMGVKHQYKEGMFDQVDRVIYDLKNNPYSRRIMTNIYVHEDLHEMNLYPCAYS
MTFNVTKKPGHDKLTLNAILNQRSNDVLAANNWNVCQYAVLIHMLAQVCDMEVGEFVHVI
ADAHIYDRHVPMIEELISRKPLPAPKFWLNPEVKDFYQFTRDDVKLIDYQTHDQIKNIPV
AV
>KF629068.1_14780|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDSNWAIGKENKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTTDKNYKVKDTVIVHTIEEMLDELKKYDSEDIFVIGGESIYRQLLPYCTKAYITKID
HAYDADTYFPNLDEDPEWEMTKISDEQTYFDLEYVFTIYERR
>KF629063.1_14790|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
FYRSAVHGSVFAAPWAAFLLYPAPKTRTALEKTRKIWYTKPISPERRRVCAIRFVYSHIL
YGKRVKLLVYCSFILLKILFEHSKKCLRSDFLRGKEPFIMKKTVCVIFGGASSEYEVSLM
SSASIIRNLDTEKFDILTLGITKDGRWLLYSGAVENIENNTWMNSETARPAFISPDKATN
GLVVLNADGSYTVLKVDVLFPVLHGKNGEDGTIQGLFKLSGIPYVGCGTLASAVCMDKAV
THTLLSAANIEQAHYLWFYADRYFADGEKIRNKIAARLNFPVFVKPANAGSSVGVSKVTA
PEKLDAAIRLAAENDAKVVVEEGIVGQEVECAVLGNRGKSVASPVGEIGAGAEFYDYDDK
YKNGVAQLFIPARLPEDVAEEVRKTAVRAYNLLGCDGLSRVDFFVTEKEHRVILNEINTL
PG
>KF629048.1_14829|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
MQRAVETLMEHYRNYPALASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMG
EAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGAMVPFSSFTRVEEQLGMDQ
INRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTT
VVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILL
VALSAKNGILIVEFARDFRVQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGA
GAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629041.1_14846|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GLLELAAIPYVGCGVLASACSMDKFYTKVIVDAIGVRQAKFVGVRRHELSNMDEVVARVE
AGVPYPVFVKPSKAGSSQGVSKAENREELVTALHLAAKHDSKILVEETIVGREIECGVLG
MNEPKASGVGEVLSAEEFYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAVAIFKALDCS
GLSRVDFFLTKDTNEVVFNEINTLPGFTAISMYPMLWEARGLNKKALVQKP
>KF629039.1_14851|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MEDNHMKIINIGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGIT
IQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHA
LQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQW
DAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIA
SKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMC
VPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKS
EQREILLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVRMEVICAILEEKYHVEAEIKE
PTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQN
AVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTEL
LEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTY
FTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF629033.1_14867|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADRLFVDMCRKILDEGFSSEGQTVRARWEDGTPAHTIKTFGIVNRYDLQEEFPALTL
RPTAIKSAVDEMLWIWQKKSNNIKDLASHIWDEWADENGFIGKAYGYQLGVKYRFPHGEM
DQVDNVLWQLKNTPYSRRIMTNMYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQD
ILTANNWNVVQYAVLVHMMAQVSGLVPGELVHVIADAHIYDRHVDIVRELIERPQYPAPE
FGLNPDVTDFYDFTTDDLRIGEYMKNPQVKNIPVAV
>KF629033.1_14868|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNAIVVVDENWGIGRDGGLLTHLPGDLKYYKSKTLGKVVVIGRKTLESFPGGRPLPGRTN
IVLTGDADYEAEGCIICHSREELMEVLAGYDPEDIYISGGAAVYRQFLDDCDVFYVTKIY
SGFEADRYFPDLDAAGLEVVWESELQEEKGLAYRFLRYERRPEK
>KF629027.1_14881|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
IKDVAPVSEVAPDIEKIKASRKKPSNILFGDHVIEICQMADIVFMALHGDCGENGKVQAV
FDLFGIKYTGTDSFSSALAMDKSITKQLFLQNGVPTPASHLLTGKDDPYKPEFPCVVKVS
GGGSSVGVYIVQNEKEYADAVQDAFRYDAKVLVEQYIKGREFTDCVIEGKPYPVVEIEPV
SGFYDYKNKYQAGSTIETCPAKISDELTKKIQDTALKAYQVLGIKTYARMDVLMDENGDV
YCLEANTLPGMTPTSLIPQEAAALGISYGELCEMIIEISLNKYN
>KF629025.1_14889|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKLIPAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNETPALH
>KF629018.1_14905|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MNKIRLAVLFGGVSSEYEVSCVSASSVLDNLDKDKYEIYKIGITKDGRWFLTMADTAQIK
DGRWADRKDNISAVISPDRGCRGLLLLKERETESIRIDCIYPVVHGKNCEDGVLQGLLEL
SGIPYVGPGVAASACSMDKAITKLIAGAAGINQADYVLVTASELKADETATLDRVEAYFN
RYPLFIKPANEGSSVGISKVHDRAELGRGLAEAAGYDEKILVEETIVGREIETAVLGNDN
PEVAKIGEIFSCNEFYDYEAKYADIGSRTGIIDDISPELEQQIKETAVRVFKAMGCKGMS
RIDFFLTEDNRIILNELNTLPGFTSISMYPKMWEAAGVPYPQLLDRLIALAME
>KF629012.1_14931|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKRLNIALMAGGDSSEREIALQIASQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQV
DKNDFSITIDGDRKTFDYALILIHGTPGENGRLQGYLDMMEIPYSSCSMTSSVVTFDKIT
TKRTVAEFGIPLARGFFFSRDSRIDPKEIVRTLGLPVFVKPNASGSSFGVTKVKSEADIL
PAVAEAFTESDEILIEECIRGREMGCGMLIAKGREYIFPITEIVSKKEFFDYEAKYTAGC
SDEITPADIAPEIKAELNRLTALAYKACRCRGVVRVDFIVTPEGKPYLIEINSIPGMSGG
SIVPKQVREAGMTLGELYDLIIEDTYDRDRR
>KF629008.1_14944|FEATURES|farme|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILSLAIQVHHAVCDGFHICRFVNEVQE
>KF628995.1_14980|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYASVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYARAGIPIA
PGLALEAGDEVDIDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGVAC
>KF628983.1_15015|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGYSNERDVSLNSGASVCKALRERGHQAYLLDAFMGLDWDSDKLEEVFNQEDG
GLGIAADIQIKEPDLDALWASRPGDSLSYLGPNVLELCSMADITFMALHGSLGENGKLQA
AFDILGIRYTGPNSLGCALSMDKGVTKEIFQAQGVPTPAGTHLFRKDKDCTLDELGFHLP
VVVKPCSGGSSIGVHIVHTDAEYRDAIETSFKKEDEVVIEPFIDGREYACGIVDGKALPL
VEIIPKDGVFDYVNKYQIGGASEICPAQSLNAEQTAQIQAAGEKAFEALRLDVYSRADFI
VDNHTGEFYCLEVNSLPGMTSASLLPKAAKAAGYEYGEFCELIIRKSLETRYQN
>KF628968.1_15048|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
VGITKDGQWKLVDRLDHLEDGSWVNSKTSAYICPDTGRKELLLERDGKVDRISIDVVFPV
LHGMNGEDGTVQGLLELAAIPYVGCGVLASACSMDKFYTKIVVDSIGVRQAKFVGVRRHE
LTHMDEVVARVEAGVPYPVFVKPSKAGSSQGVSKAENREELIDALNLAAKHDSKILVEET
IVGREIECGVLGMN
>KF628959.1_15072|FEATURES|farme|macrolide-lincosamide-streptogramin|DNA-methyltransferase|antibiotic target alteration|0
LARGLLTDDGVIFISIDDNEDRNLRILCDEVFGEANFVSQLIWERAYSPKNDAKYVSNSH
DYVLVYAKSIERFVIGRLPRTDEANARYKNPDNDPRGVWKPSDLSVKTYSPDSDYPITTP
SGRVGEPPAGRCWRLSRNAFRERLQDNRIWFGPNGDSVPCIKRFLTELKYDGMAPTSIMF
YKEVGHSQEGAKEVVSLFDGKGYFDGPKPTKLLQRLITLANLLMCDKEVIEV
>KF628953.1_15090|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
RSGREVNRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANF
IFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVQDFAECGLCGTA
AVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF628952.1_15093|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MARDRRKRIRENRTEFIKKAEATLGYPIFVKPANAGSSVGITKAHDESELREALEKAFSC
DRKAVLEEFVDGFEVECAVIGNYKPMASCIGQIISCNEFYDYTAKYVSDSRLLIPAELPE
DKQNEVRKEAVRAFKTLGCTGLSRVDFFVRKSDGRVMFNEINTIPGFTSISMYPKLMEQS
GVPYPKLLDKLFKLAAEIKEDK
>KF628950.1_15098|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GEKVRPHWPDGTSAYTIKKFGVVNRYDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNI
HDLHSHIWDEWADEDGSIGKAYGYQLGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNI
YVHQDLHEMNLYPCAYSMTFNVTQKIGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVLLH
MLAQVCDMEVGELVHVIADAHIYDRHVPIIKELISRTPYPAPKFWLNPEIKDFYQFTRND
VRADDYVTGEQIKDIPIAI
>KF628950.1_15099|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNLIVAVDKNWAIGNKGELLVRIPADHKMFRQETTGKVVVLGRKTMDTFPGGQPLKNRDN
IILSRNEAYQQKDAQVVHSVEELLEAVKGYDTKEVYVIGGSSVYEQLLPYCDTAHVTKID
HAYEADSWFPNLDEDPDWE
>KF628946.1_15106|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKAIVCADINWGIGKGTGMLFHIPADLKFFKEKTMGSTVIMGRTTFLSLPGQKALPGRKN
IVLTRSDGWSAENVTVCHGIDELADIIENGENVFLIGGEAVYNELIDSCDEAYVTRVNAD
GKAEKFFPDLDRRAGWKLVERSAAQESNGYIFTFDRYVKK
>KF628932.1_15133|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
LERKSRRKKMKIVVLAAGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWED
PVPGRI
>KF628932.1_15135|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
VVVEEYIEGREFSVGVVDGKAYPIIEITPVEGFYDYKNKYSAGAVKEACPAVLTEELTRQ
MQAYAEAGCKALEMESYARLDFIVTKDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPT
LCEELIKVSQKKYA
>KF628929.1_15145|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MKFEEIRPYHDEELPQVFEELIADPAFQQVACAVMPGVPFEAIAQKMRASKTKQEFQENL
CYGILHKLAKDTTDGLILESMAVLNKQSAYTYVSNHRDIILDSGFLSVLLVEQGLDTVEI
AIGDNLLIYPWIKKLVRINKCFTVQRALTMRQMLE
>KF628925.1_15159|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MLSIIACISKVHRAIGYKNRLLYAIPSDMTRFRMLTTGHTIIMGRKTFESLPNGALPNRR
NIVISKTREQITGCEVYTSLEEALAARKEEAARKEEAGNKKTVGSKEASDECFIIGGASI
YEQALPFADKLYLTIVEKEPEHADTFFPEINPAEWEVTEKEMRNENGLPFTFLTLYRKQ
>KF628910.1_15192|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
RNKEENDMRIVVLAGGLSMERNVSLSSGNKICRALRSRGHQAILVDMFLGFEDYEGKLDD
VFDAPDGFCGDYSVAEAEPDLAAVRASRKDQSRSMFGTGVLDVCAKADIVFLALHGTCGE
DGRVQAAFDLLGIPYTGAGYLSSAIAMDKDLTKRLVSEYVITPQWRTVRYTADEIGKLVS
ETKLPCVVKPVANGSSVGVSIAHTGAELKAALEACLQFGAQVVLEQYISGREIQVGIIAG
KALPSIEIIPKTGFYDYANKYQAGAAEEICPSPIPEDWEMRVRTATETVYRLIGLSVYSR
ADFIVTPDGTPYFLEINTLPGMTKTSLLPQEAAAVGIGYEELCEKIVEESLKQKRGL
>KF628906.1_15200|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVSDASNYLLN
ADDPAHIALRPSATSLAQVPGKHEHQLSDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGML
RVANLPFVGSDVLASAACMDKDVTKRLLRDAGLNIAPFITLTRANRHNISFAEVESKLGL
PLFVKPANQGSSVGVSKVTSEEQYTIAVDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQ
ASTCGEIVLTSDFYAYDTKYIDEDGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCAGMAR
VDVFLTPENEVVINEINTLPGFTNISMYPKLWQASGLGYTDLITRLIELALERHAADNAL
KTTM
>KF628897.1_15220|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLTSSAGICKTLIEKGHDAFLLDVFMGLPDAPENLEDVFTLPNH
GLEIAKNISTTEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCALAMDKGVTKVIFQRCNVSTPGGGWLYKKDLDKPLSEMGLSLP
VVVKPCSGGSSIGVYIVNTEEEYREALEKSFQYEDELIIEPYIKGREFACGIIDGKALPP
IEIIPKTGFFDYANKYQDGGSEEICPANISEEISQKMQELTVRAFHALKLNVYSRADFLL
DENDNLYCLEVNTLPGMTAASLLPKEAKAVGIEYGDLCELIIQKSLEARYQ
>KF628896.1_15223|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRNGYHEPEPGFAGQEKADDWGDDFPKTFSVNLIWAEADDKDGRPGAIGFDGGMP
WHLPEDMKRFKELTVSHPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTD
LDAALDIARQEAIPDDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDM
DALVDAGLWEVADPGHWKRTQKDDSGIKRYRFVTYRKIG
>KF628884.1_15257|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAAGTSTEREVSIVSGTNVCKALRSKGHQAILVDVFFGKEGADSATAFDGDYDVD
AEAAYISSFNDQVKDAVASGREFFGPGVIELCKAADVVFMALHGANGEDGRVQAYFDLCG
IPYTGTGYLSSAMAMDKGITKKIFLTSGVPTPRGVELKKGKDSTNLADHNMELPVVVKTC
CGGSSVGVYITKTPEEY
>KF628883.1_15259|FEATURES|farme|trimethoprim|dfrA25|antibiotic target replacement|0
VYVTKVDADPDADSFFPNLDDNPDWRIDSESKVFEENGLKFQYVDYVRN
>KF628875.1_15277|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKQNLAVIFGGQSSEHEISCMSASNIIQCIDAQRYNIILVGITKEGHWVEAADLNAVQD
GSWRQSKTSIVLSPDATRKGLYRMSEDEKAQFVHLDVIFPVLHGLYGEDGTVQGLFKLAG
IPFVGCGLFASAAGMDK
>KF628873.1_15281|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGSS
LEDGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKTDA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASRHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF628864.1_15304|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MITIIAALDRRRAIGYRNQLLFHLSADLRRFKALTTGHTVIMGRRTFESLPKGALPNRRN
IVLTRTPNMTWPNTETFASLSEALDACAQQDDIFIIGGASVYAEALPLADRLCLTHVDAE
APQADVYFPEFSGNEWSITHEEKHEADEKNAQPYTFTDYVRKPRH
>KF628859.1_15314|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSANKMCVALLFGGMSSEHEVSCVSVGNFVRNIDRSKYEVLTVGITKEGRWLYTEATAE
QMADGSWEELPGNMPCVISPDRADHGMILFTPDGRVEKMHLDVVIPVLHGLWGEDGTVQG
LLELAGIAYVGCGVLASSVCMDKAVANALFEANGVPHTKWVAANRWEIEKDLEGVCAGVE
QKLGWPVFVKPANAGSSVGISKVSSQEELKAAIALALENDRKVVFEAFVDGQEVECAVIG
SDPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCE
GLARCDFFVEKNTGRVLINEINTFPGFTAISMYPKLMEHEGLPVPQLIDRLIALAVERTE
KQHG
>KF628842.1_15362|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MGGKSSEHDVSLISAKTVIESIDKERYSVIMVGITKDGQ
>KF628838.1_15372|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VYITKTPEEYEEALQGAFSYEDEVVVEEYIEGREFSVGVVDGKAYPIIEITPVEGFYDYK
NKYSAGATIDTCPAVLTEGQTRQMQAYAEAGCKALAVEGYARLDFLMKEDGSMYCLEANT
LPGMTPTSLLPQEAAALGIDYAQLCENLIEISMRKYQK
>KF628833.1_15382|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MEEQNVKKLSVCVLFGGVSPEHEVSLRSAESVLNNLDKEKYNIFPVGITKTGEWILYGGR
DYSKLPTGEWQHCPENRRAAISPVRGQGLLNFEGDCVVRERIDVVFPVLHGGKRRGRLHS
GPAAAGRSALCRTGRGGLRHLHGQDADEARR
>KF628832.1_15385|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDESFAPEGVDVVH
SIDEALAAVADEPVAWVIGGGDVYRQFLPYCVEAEVTHNHCVHPVDTYFPNLDADPAWEV
SQAGGVATIAAGEGDEGLDYEFVTYRRVEA
>KF628815.1_15432|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target protection|0
VDAHSQGFDENMYLDPGTRTKVEETGGANFLFITKDNTVVTPKSHSILPSITRRSLIYVA
EHYLGLKVEEREVLLDEVKDFAECGLCGTAAVISPVGKIVDHGREILLPAGMEQMGPVTQ
KLYDTLTGIQMGRLEAPEGWIQVIE
>KF628813.1_15438|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKTAPVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF628805.1_15454|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RDIIDNGVSTEGEKVRPKWEDGSFAYTLKKFCVVNRYDLSKEFPALTLRRTGIKSCVDEL
LWIWQRKSNNVHDLKPHIWDSWADEDGSIGKAYGYQMSVKHQYKEGMMDQVDRVIYDLKN
NPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKKKDSDKLVLNGILNQRSQDVLAANN
WNVCQYAVLMHMLAQVCDMQVGEFVHVIADAHIYDRHIPLVEELISREPLPAPTFWLNPE
VKNFYEFTPDDVRLDNYETGSQIKNIPIAV
>KF628804.1_15459|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNIIVAVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQPLKNRTN
IVLTRDVNYKVKDAVIVHSVEELLEELKKYDSEEVYVIGGDSVYSAMLDHCDTAYVTKID
FAYEADTWFPNLDEREDWSAAEASEEQTYFDLEYQFVKYKKNGK
>KF628801.1_15463|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MDKITTKRVLESAGIAQVPYVAIVEGDDVTAKIAEVEEKLTYPVFTKPSNMGSSVGISKS
ENQEELRQALKLAFQYDSRVLVEQGVNAREIEVGLLGNYDVKSTLPGEVVKDVAFYDYDA
KYIDNKITMDIPAKISDDVVAVMRQNAETAFRAIGGLGLSRCDFFYTDKGEIFLNELNTM
PGFTQWSMYPLLWDNMGISYPDLIERLVDLAKESFDKREAHLL
>KF628801.1_15464|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQTIILLYGGRSAEREVSVLSAESVMRAVNYDRFTVKTFFISQSGDFIKTQEFSQTPGQ
EDRLMTNETIDWDKQVAPSAIYEEGAVVFPVLHGPMGEDGSVQGFLGSFENALCWLQHLV
I
>KF628790.1_15493|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
LSLHAIVDAHNQGFDENMYLDPGTRTKVEETGGANFLFVTKDNTVVTPKSSSILPSITRR
SLIYVAEHYLGLKVEEREVLFEEVKDFAECGLCGTAAVISPVGKIVDHGKEIILPAGMEQ
MGPVTQKLYDTLTGIQMGRLEAPEGW
>KF628782.1_15515|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKNILVIFGGTSSEHEVSLKSAYSIIKAIDKNRYTVILVGISKKGQWKYFHGSIEKILYD
TWNNENDCEEAVFDVSKQELIIFKNNIQRKKVDGIFPVLHGKGGEDGTIQGMASLANIPY
MGCGVMSSAIGMDKMMAHTIAESIGITVPKCIWAHKITGDLKYPVFVKPLDGGSSLGITK
VNMKEDLTMAIDRAEKYGGKVIIEEFIDGVEVGVAILKKDNQIICGEMDEVIIEKGFFDF
EEKYTLKTSKIIIPAQIDQKTKNKIVNAGKRIFEKMVCKGFARIDFFVDKNNEIYFNEIN
TIPGFTSHSRFPNMLKAKGYTFEEIVNSIIDEELQNE
>KF628780.1_15522|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKADTIFKENITKIMEEGVWSEQARPKYKDGTTANSKYITGAFAEYDLSKGEFPITTLR
PIAIKSAIKEVFWIYQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVV
KKHDIINRLLAQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDIYLDA
TLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLK
RQPSDCQPRLVLNVPDGINFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF628775.1_15536|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAKPVLEIQNASISFGNFKAVKHVSTTICENEIRFLIGPNGAGKTTLLDAICGKNKLSGG
DIVYHNKGRSYDLPKIRENKIVNIGVGRKFQAPSVFSGITIYENMELAAVENRGLWASLG
SRLPPETRERIDEQLQFIGLYELKDEYPSILSHGQKQWLEIGVLCVSRPRLMLLDEPVAG
MGRRETERTAELLKIIQKDCTIIVVEHDMKFVKEVASWVTVLHDGEVLCEGTMDEVQNNQ
QVIDVYLGRGGE
>KF628764.1_15553|FEATURES|farme|aminoglycoside|AGP_acyltrn|antibiotic inactivation|0
MKRIALIVIRVIWRLPYWWGYKVNKYKHIDKYSADERYGFIHQVVAIVTRKARVELECYG
VENLPKKSGYFVAPNHQGLFDPLAIFQTHSRPIRAIVKKELASVILVKDVIKMLEFI
>KF628764.1_15554|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MINIIVATDEDLLIGKKDSRNGMPWNVPEDLQHFKATTLNKTILMGLTTYQAIGRPLPNR
KTIVVSFEPFEDERVEVRSSLEEVIEEYRSSGEDLFISGGASIYKQCLPIADQLLISRIP
GKHEGETYFPNFDEYGYKLVAQKPFETFTLETYKRG
>KF628764.1_15555|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PPRGLLNPDVKSIFDYKIEDIKIEDYQSHGKLVGKVSV
>KF628758.1_15573|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADMTFIQMCKDILENGTSTEGEKVRPKWPDGTPAYTVKKFGVVNRYDLSKEFPLLTL
RRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVRHQYKEGMT
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGEEKLTLNAVL
NQRSQDVLVANNWNVVQYSVLVHMLAQVCDMQVGELVHVIADAHIYDRHIPIIQELIARQ
PYPAPKFSLNPEVKDFYQFTRNDVSVEDYITGEQIKDIPIAI
>KF628748.1_15599|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLSDKQLAEISALGFAGYR
>KF628746.1_15610|FEATURES|farme|beta_lactam|APU18_25380|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>KF628739.1_15634|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKNILVIFGGTSSEHEVSLKSAYSIIKAIDKNRYTVILVGISKKGQWKYFHGSIEKILYD
TWNNENDCEEAVFDVSKQELIIFKNNIQRKKVDGIFPVLHGKGGEDGTIQGMASLANIPY
MGCGVMSSAIGMDKMMAHTIAESIGITVPKCIWAHKITGDLKYPVFVKPLDGGSSLGITK
VNMKEDLTMGN
>KF628722.1_15672|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYASVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYARAGIPIA
PGLALEAGDEVDIDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRS
>KF628713.1_15694|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLQDGSKTPVD
RNDFSFMNGAEKVVFDFAYITIHGTPGEDGRLQGYFDMIRIPYSCCGVLAAAITYDKFVC
NQYLKAFGVRISESLLLRQGQAVSDEDVVEKIGLPCFIKPNLGGSSFGVTKVKTREQIQP
AIAKAFSEAEEVMIEAFMGGTELTCGCYKTKEKSVVFPLTEVVTHNEFFDYDAKYNGQVD
EITPARISEELTRRVQTLTSAIYDILGCSGIIRVDYIITEGEKINLLEVNTTPGMTA
>KF628712.1_15696|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
LDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASRHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF628701.1_15720|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|0
MGISLFLELPAIVSYWVVTVMCFVAMGVSTMFVVQIYTLVQTQTPPQLVGKIMATLVAVA
MCGQPIGQMVYGILFDVFIQETWVVMFVASIASIMISIYSKRIFQKLEI
>KF628698.1_15726|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLENAPANLEDVFTLPGA
GLEIAKNISTKEPDLEVLKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMD
>KF628690.1_15757|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVHPVWEDGTSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF628688.1_15764|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKDRKIIVLMGGPSKEAEVSRRTGAAIAEALESKGFNAQTLELNPRTVLKDIESLGGEIV
FNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTATSESFN
GNLESAEAIIGHIRKQFTIPVVVKSATQGSSIGVTIVRDEAQLEAAVTEALKYDPILVVE
QFLDGREFTVSVLDGKALSVIEIRPHSGEYDYTSKYTVGATEYLVPAPISEEMTAEMQRI
GELVYREVQGSGVIRVDIMTDHADNMYVLEYNTVPGMTATSLVPKAAKEMGIDFPTLCEK
ILLTASIGKF
>KF628685.1_15773|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQTIILLYGGRSAEREVSVLSAESVMRAVNYDRFTVKTFFISQSGDFIKTQEFSQTPGQ
EDRLMTNETIDWDKQVAPSAIYEEGAVVFPVLHGPMGEDGSVQGFLEVLKMPYVGCNILS
SSLAMDKITTKRVLESAGIAQVPYVAIVEGDDVTAKIAEVEEKLTYPVFTKPSNMGSSVG
ISKSENQEELRQALELAFQYDSRVLVEQGVNAREIEVGLLGNYDVKSTLPGEVVKDVAFY
DYDAKYIDNKITMDIPAKISDDVVAVMRQNAETAFRAIGGLGLSRCDFFYTDK
>KF628682.1_15784|FEATURES|farme|tetracycline|tetPA|antibiotic efflux|1
MFIFAITKRFNLMLIAYLATSTFRTINEPIFSAWLNGHIDDKARSTVLSINGQINSLGQI
LGGPIIGIIATNISVSMGIACTSLLVTPVLVLYIVAMIMDKKVVDKVGGIDYEENN
>KF628679.1_15790|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IYDRHVPAVRELISRTPYAAPKVSLNPEIKDFYDFTTKDLIVEDYQAGPQIRNIPIAV
>KF628677.1_15796|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGTHQTDFYGSRCGHTFRSLPV
>KF628673.1_15809|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
MSYADKIFIDMCQDIIENGVSTEGEKVRPHWEDGTSAYTIKRFGVVNRYDLRKEFPALTL
RRTGLKSAF
>KF628667.1_15826|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LPMPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTM
ATGGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIP
IAPGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGD
KVLVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQIS
PENYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTD
DMTFPQVCDSLIRMGLRRAGIAC
>KF628659.1_15844|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDWKSTSS
DRNHSQKRMV
>KF628659.1_15845|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|0
MKALTVRAFQALKLNVYSRADFILDADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGD
LCELIIQKSMEARYQ
>KF628648.1_15879|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VIFGGQSSEHIVSCMSAVNVIEHIDSARYNIILVGITQEGHWIKADSLEDVKSGAWRDGK
VGAALLPDATRKCILLMDGDKVEEVRVDIVFPVLHGLYGEDGTIQGLLELARIPYVGCGV
LASAVSMDKLYTKIIVSDLGIRQAGYEPVYREELEDMEQVVDRIEKHFPYPVFIKPSNAG
SSRGISKAGNRQELEAGLLEAARHDRKLLVEETIVGREIECSVFGGGRRGIEASGVGEIL
AAAEFYDFDAKYFNEESRTVTDPELPDGATEKVRQAAMDIFRAVDGYGLARVDFFVKDDG
EVVFNEINTMPGFTAISMYPMLWEARGIGKDQLVGMLLSHGMERYA
>KF628637.1_15908|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKPSLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSYNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF628636.1_15910|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SKEYIYMEKIKLAIIFGGKSSEYPVSLHSAGSLIHKINKERYELMFIGISKDGKWYAYDG
DVDGIEHDTWLCEEHCTPCVLSSSEGCKGFLKLHGDGTFTRMEVDCIFPVLHGKNGEDGT
IQGLFELSGIPYVGCGHMSSAICMDKEMAHIVMEHAGITCAPFVCVYEADDLDYRKVYEH
AKEALGLPIFIKPANAGSSFGIHKMESFDGFEEAMKDAFYHDGKGKVILETTIKGFEIGV
AVMGNKELFAGSVDEIETAAPFFDYEGKYEMVDSHIYCPARISPKLFEEAREIAKKAYRA
MNCK
>KF628633.1_15919|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGKLQAAVIFGGQSSEHIVSCMSAVNVIEHIDRTRYDVLLVGITEDGHWIKADSLEDVKN
GTWRDKTVSALLLPDATKKCILLMDGDSVREVRVDVVFPVLHGLYGEDGTIQGLLELAKI
PYVGCGVLSSAVSMDKLYTKIIVDDLGVRQAAYEAVYREQLVHMESVVERVEKHFSYPVF
IKPSNAGSSRGVTKADDRQALEAGLSEAARHDRKILVEETIIGREIECAVFGGGLKEVVA
SGVGEILAAAEFYDFEAKYYNEESRTVTDPELPAGAAERVRQAAMDIFRAVDGYGLARVD
FFVKDDGEGVFNEINTMPGFTAISMYPMLWEARGIGKDQLVGMLLSHGMERYA
>KF628629.1_15929|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVIT
NKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIEIKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>KF628624.1_15945|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EILWIYQKKSNNIHDLNSHIWDAWADADGSIGTCYGDVVGRKFIYKGEETDQMDYVLRQL
KENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDAAEDRLVLNGVLNQRSQDVLAA
NNWNVCQYSILLMMVAQVNDMIPGELVHVIADAHIYDRHVPAVRELISRTPYAAPKVTLN
PEIKDFYDFTTKDLIVEDYQAGPQIRNIPIAV
>KF628624.1_15947|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
MSLHAIVDAHNQGFDENMYLDPGTRTKVEETGGANFLFVTKDNTVVTPKSSSILPSITRR
SLIYVAEHYLGLKVEEREVLFEEVKDFAECGLCGTAAVISPVGKIVDHGKEIILPAGMEQ
MGPVTQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628619.1_15957|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNIVVLAGGSSTEREVSIVSGQGICTALRKRNHKAVLVDAYFGKEEWGGEMFPLTYDIDA
EAAYMKAKSRELEETMKNRKEFFGPNVLDICKAADIVFLALHGSNGEDGKVQSVFDLMGI
PYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGVTLQKGKCGSDLSDYDMDFPVIVKPCC
GGSSVGVCIAKNQAEYEAALEESFSYENEAVVEQFIEGREFSVAVVDSK
>KF628616.1_15964|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGASAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF628616.1_15967|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|1
MALIKCDGISIAYEGQTVVRDLSFWIEQGDYLCIVGENGSGKSTLVKSLLGLKPPFKGQI
LLGDGLKQDEIG
>KF628614.1_15971|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADMTFIQMCKDILENGTSTEGEKVRPKWPDGTPAYTVKKFGVVNRYDLSKEFPLLTL
RRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVRHQYKEGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGEEKLTLNAVL
NQRSQDVLVANNWNVVQYSVLVHMLAQVCDMQVGELVHVIADAHIYDRHIPIIQELIARQ
PYPAPKFSLNPEVKDFYQFTRNDVSVEDYITGEQIKDIPIAI
>KF628609.1_15981|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RDIIANGVSTEGEKVRPKWEDGSFAYTLKKFCVVNRYDLSKEFPALTLRRTGIKSCVDEL
LWIWQRKSNNVHDLKPHIWDSWADEDGSIGKAYGYQMSVKHQYKEGMMDQVDRVIYDLKN
NPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKKKDSDKLVLNGILNQRSQDVLAANN
WNVCQYAVLMHMLAQVCDMQVGEFVHVIADAHIYDRHIPLVEELISREPLPAPTFWLNPE
VKNFYEFTPDDVRLDNYETGSQIKNIPIAV
>KF628606.1_15992|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
DRHIPTIKELIQRETFEAPKVWLNPDVKDFYAFTVDDLHVEDYVTGPQIKNIPIAI
>KF628562.1_16093|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VTADRHWAIGKDGRPLVTIPADRQMFLKETAGKVVLMGRRTLEGLPGGQPFGNRVNIVLT
HDMQYKVKGAVVCHSLEEALKTLENYDESDIYIIGGKSIYRQFLPYCTTVHVTSIDYTYD
GDAYFPDLEKEEGWYLAEEGDEQTYFDLCYTFRR
>KF628544.1_16140|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDKAYVTRTD
FAYDADTYFPNLDEMPEWKL
>KF628543.1_16143|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKGDRTGTGTISIFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHVYGYQWRSWPDYNGGFIDQISEVVETLK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF628542.1_16146|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTAIVCVSQSWGIGRDGALLFRISADHKRFRTLTVGKTVILGHKTLDTFPGGKPLKDRRN
IVLSHRDLDVPGAEIAHSFDEAAALGGDDAIVIGGASVYMALLSRCDRVYVTKVDSDPDA
DSFFPNLDDNPDWRIESESETFEENGLKFRYVDYVRK
>KF628529.1_16175|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IEREQHPAPKFTLNPDVKDFYQFTTKDITIEDYVTGSQIKNIPIAV
>KF628529.1_16176|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDQNWAIGNKNELLVRIPADQKFFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTHDHTYKVPGAVVVHDMDELHEELKKYDSQDIYVIGGETIYRQLLDECDVAHITKID
YAYDADAYFPNLDERPEWKITADSEEQTYFDLEFYFYKYERVQK
>KF628526.1_16184|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVE
EYINGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHY
AEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEE
LIRISFKKYSK
>KF628507.1_16241|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
DYDSLFQELEEKYDATLGIYALDTETNKEISYNADERFAYCSTYKALAAGAILEKYSIEE
LDNVIYFEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLLDGPNGFKQ
SLSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLAFNLKEYVTGDILSDDKKEIFIDW
MSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDA
EYDN
>KF628505.1_16245|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSYIERKRPQNCGMRRKIMKIVVLAGGISTEREISIVSGTQVCKALRSRGHQAILVDVYF
GREDADPMQAFTDEYDVDAAAAYARSFDGQVEKSIQEGKAFFGTNVIALCQAADVVFLAL
HGENGENGKVQAAFDLLGIRYTGSGYLGSAIAMDKGLSKQLFWQNEVPTPAGFILRKGED
ISLEAHGMTLPCVVKPCCGGSSVGVTIPKTQEEYEAAVADAFSYEDVIVVEEYIKGREFS
VGVVDGIAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTKEQTEQMQAYAVKGFKALQ
LDNYGRLDFMMSEDGKMYCLEANTLPGMTPTSLLPQEAQALGMDFADLCEKLIAVSAK
>KF628499.1_16262|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
NRCEHWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAEQG
VNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQ
QLMNV
>KF628495.1_16273|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LSRTAERCFVIGGGSVYRQMLPFCDAAYVTKVHVTPESDTFFPNLDEDKDWYLAETLQSG
EENGTAYEMCLYKRK
>KF628492.1_16282|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MELKSGGIKDKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNR
YDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQ
LGVKHLYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQK
KVTA
>KF628486.1_16300|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
VVLMTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGR
PLKNRRNIVLTRDEDFAVEGVDVVHSIDEALDAVADDPVAWVIGGGDVYRQFLPYCVEAE
VTHNHCTHAVDTYFPDLDADPAWEIVRRGGVATIASGEGDEGVDYEFMTYRRVGA
>KF628485.1_16303|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|0
MISIIAAIDRNLGIGFQNKLLFWLPNDLKRVKAWTA
>KF628479.1_16322|FEATURES|farme|aminoglycoside|aadK|antibiotic inactivation|1
VLKVGSIANLPNVVRHSKTEPNKMKVREEKLRTIIEWSEKNEDVRVLLLTSSLVNPLALV
DEFSDLDIEFVFEDNTNYISDKSWTLKFGNPIAMIEEDESCFNHKHAMKMLLYEDGVKVD
FKLYSKSKFIKETQEKELPEDWDIGYKILIDKDGITKQMLKPTYQISIIKKPSEKEFQNL
INDFWWDTTYVAKCLVRDEIFYAKFMSETVIRTEYLIPLIEWHIASEHNWNITTNKYGRL
FKKYLNQEMWAKTEQTFSGSDIKENWTALFSMTDLVSEIGTELSKKLEYKY
>KF628473.1_16337|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVAADKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDYKVKDAVIVHTIEELLEEIKKYPAEEVYCIGGDSVYKQLLPYCDTAHVTKID
FDYEADSYFPNLDEMPDWKVTAESEEQTYFDLEYTFVKYERK
>KF628469.1_16346|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTE
VEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTP
DEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKR
PLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGK
EAQEESTQNEIEMFKPDFTFQQLLNV
>KF628459.1_16370|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDAIVAVDARWGIGRDGDLLFRISADLRRFKALTMGHTVVMGRRTLQSLPGGRGLPGRRN
LVLSRQGDLAPKGAEAFCEVQQMLDAAGEDAFVIGGAQVYRLLLPVCRRLYVTQIDADGG
ADVFFPEPAPELWRITEQSPWQEEQGLRYRYVTYERKEERDEV
>KF628457.1_16377|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKPIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNETPALH
>KF628449.1_16394|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VVEEEKDMKVVVLAGGISTERDVSLISGKMIYQAMKRLGHQAVLLDVFLGMERDDIDHIF
ESDEDFSAGIEAIHEINPDISAVKALRKDGGKCYFGPNVIKICQMADVVFLGLHGADGEG
GKVQAAFDLLGIRYTGTDFVSGALAMDKCLAKELFMQNGIPTPAGFRLKKGQEPGEGQQP
KFPCVVKVSSGGSSIGVSIVQKEEDYQAALDDAFLYGDEVVVEEYIKGRELTCCVLDGKA
LPIVEIAPKESFYDYKNKYQAGSTIEICPAPIGEESTRKIQKISERVFDALRLHKYARMD
FMMDEAGNAYCLEANTLPGMTPTSLIPQEAAAVGISYDELCQKILDMAFED
>KF628434.1_16434|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPLEDQKKGDDKLTLNAILNQRSQDILAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIA
DAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRNDVRLDNYVTGPQIQDIPIA
I
>KF628432.1_16438|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYEKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKNTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQD
>KF628417.1_16473|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSEDKLCVVVLFGGMSSEHEVSRVSAGTFVDHIDRTRYELMTIGITKEGRWLYTEASSA
QMADGSWEELGSNMPCVLSPDRADHGMILFTPAGQVEKIHVDVVIPVLHGLWGEDGTVQG
LLELAGIPYVGCGVLASAVCMDKAVANALFDANSIPHTKWLSATRWEIESDPEGVCDGVI
AKLGWPVFVKPANAGSSVGITKAHDRDELKAAIRLALANDRKVVFEAFVDGHEVECAVIG
SDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPAKLPEEKLDEVKTYAAMAYTALGCE
GLARCDFFVEKNTGRVLINEINTFPGFTPISMYPKLMEHEGIPVPALIDRLIALALERTE
KQHG
>KF628407.1_16493|FEATURES|farme|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDRSSWKRNAYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQDGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFAMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>KF628404.1_16500|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGM
PWHCAEDMKHLKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSH
>KF628400.1_16507|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDIIVLAGGLSTERDVSFKTGSMVASALKENGHRVILLDVFMGYSDKEENLDGIFDRADE
ISVKVDDIPEVAPDLAAVKASRKDQSPCFFGPNVIRMCQMADIVFMALHGENGENGKLQA
AFDLLGVKYTGSDYLSSAIAMNKGMAKQLFASAGIPAPRGIAMKKENREDDVTKLPLTLP
CVVKPCCGGSSIGVTIVRDAAEFKKALDEAFHWEDELVIEEYVKGREFSVGVIEGKALPV
IEIAPIQGFYDYKNKYKAGSAVETCPADLPEEVSAQMRKYAEQVAEVIGLDTYSRSDFLL
DENNHMYCLEANTLPGMTPTSLLPQEAAVIGINFNELCENLIAISMKKYEG
>KF628397.1_16515|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLEEKRVSFRPMSEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRV
IIEYDTIPIGYAQIYRIQGELFDEYDYHETGR
>KF628396.1_16516|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
DKAILSPSRSDKGLLRFKNNGDIENIKIDVIIPVLHGKNGEDGTIQGLFEIAGIPYVGSG
VLGSAVCMDKCVAKILFKEAGIPQADWITVKTSDISNDNWIKNVEEKLGFPCFIKPSNAG
SSVGISKAHNREELM
>KF628382.1_16550|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
QLDTLDEQILKLIADNARIPFLEVARACNVSGAAIHQRIQKLTNLGILKGSEYVILKGSE
YVIDPEKIGYETCAYIGIYLKDPESFDAVTKALDLPKGALPNRRNVVLSSNPAIQCPGAE
VFPTLEAALQSCQPEEQVYIMGGASVYKQAMPLADMLCLTEIDAEAPQVDAYFPAVESAI
WHEKSRESHLVDEKHPCPYAFVDYIRK
>KF628377.1_16562|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDISLILSVGKNNEIGKNNDLVWHFHEDMKFFRETTTGNTVIMGRKTFESLPKVLPNRRN
IVISSDKSLKIDGAEVVHSVDEALETAKNDKIFIIGGGRIYAEFLPLATKLYLTEIDAEC
QEADTFFPQCDKSEWSREVLSCAEENGISFSHVLYIKK
>KF628376.1_16566|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KSNNVNDLHSHVWDEWADETGSIGKAYGYQMGVKHKYKEGMFDQVDRVIYDLKNNPFSRR
IMTNIYVHQDLSEMHLYPCAYSMTFNVTQKKGDDKLTLNAILNQRSQDILAANNWNVCQY
AVLMHMLAQVCDMRVGELVHVIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYE
FTRNDVRLDNYVTGPQIQDIPIAI
>KF628375.1_16570|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDTHSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>KF628367.1_16591|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTLYKNGSDLSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDGKALPP
IEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF628355.1_16628|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAIL
NQRSQDILAANNWNVCQYAASAYDDGSGM
>KF628344.1_16655|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDLEYPIMVKPVSEGSSYGMSKVNCDGELFDAVKEARKYNAEVLLEEFIDGFFVTVGVLE
RDGKPFATEILEIRTKTEWYDFDAKYTKGLSEFIVPATGLSKEAYELTQKYAVEAHIETG
CSGVSRVDFMVKDDKPYFLEINTNPGMTDTSDLPAQAKAGGIDYDNLVLMILNSVGLNK
>KF628326.1_16703|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLIEKGHDAFLLDVFMGLPYDSDKLEEVFTLPGH
GLEIAKNIATEEPDLAAIKASRPDQSDCFLGPNVIELCRMADITFIGLHGGEGENGKLQA
TFDLLGIKYTGPNSLGCAAAMHKGIAKQIFLESGVPTPNGVCIHKNKNKKDLASLGLSLP
VVVKPCSGGSSIGVYIVNTEEEYNEALEKSFRYEDELVIEEYVKGREFACGIIDDKALPP
IEIIPKTGFFDYANKYQAGATEEVCPANISEEISAKMQDYTVRAFHALKLDVYSRADFLL
DADNNLYCLEMNTLPGMTAASLLPKEAAVTGIEYGDLCELIIKKSLEARYN
>KF628324.1_16709|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FGVVNRYDLSKEFPAITLRKTYIKSATDELLWIWQKKSNNIHDLKSHVWDEWADEDGSIG
KAYGYQLGVKHQYKEGMMDQVDRVIYDLKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMT
FNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIAD
AHIYDRHVPIVKELIERPQYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF628300.1_16769|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDLFIRMCQDIIDNGLSTEGEKVRPVWEDTGESAYTIKRFGVVNRYDLSKEFPALT
LRRTALKSAFDEILWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQLGVKHQYKEGM
TDQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDRLTLNGV
LNQRSNDVLAANNWNVCQYALLLMMIAQVCDMKAGELLHVIADAHIYDRHIPLVKELISR
ETHPAPKVWLNPEVKDFYAFTVDDLHVEDYVTGPQIKNIPIAV
>KF628297.1_16781|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
WAIGKNNSLLVRIPADMKYFRQMTEGNIVVMGRKTLESFPQGRPLANRVNIVISHNPDYQ
VKDAIVVHSVEEAMQECKKHKGEVFVIGGESIYRAMLPYCNIAYVTRTDHVYEADTWFPD
LEKDPDWQKTAETDEQTYFDLEYVFAKYERIK
>KF628294.1_16788|FEATURES|farme|glycopeptide|VanSC|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFNMDEGLPCLTTKKLHWKAT
>KF628270.1_16859|FEATURES|farme|multidrug|cpxA|antibiotic efflux|0
EHGFEGRKEGHITISVGRGGNNLNVVVEDDGTGLADEEHDGMARSSGSGLGTQIINTFVT
NDFGGTVHWEPRRGGGTRVVLDMKLRAAQDN
>KF628264.1_16869|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDIIVAVDADWGIGKDGDLLQRISADMKYFREKTTGNVLVMGRKTLESFPNKKPLPNRVN
IVLTKNKDYQAEGVVLCYDLAELPAVLENYAGKQVFVAGGGTVYAQLLPQCERAYVTKIY
QTYPADTAFPNLDENPDWELEEKGEMQEEKGVRFSFDVYKKR
>KF628260.1_16878|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVF
FGKEGADPATAFDGDYDVDAEAAYISSFNAQVKDAVASGREFFGPGVIELCKAADVVFMA
LHGANGEDGRVQAYFDLCGIPYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGK
DSMNLADYNMELPVVVKTCCGGSSVGVYITKTPEEYEEALEGAFSYEDEVVVEEYIEGRE
FSVGVVDGKAYPIIEIAPVEGFYDYKNKYSAGATIDTCPAVLTEEQTRQMQTYAEAGCKA
LAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEAAVLGIDYAQLCEKLIEISMR
KYQK
>KF628255.1_16892|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDEVVARVEAGVPYPVFVKPSKAGSSQGVSKAENREELIDALNLAAKHDSKILVEETIVG
REIECGVLGMNEPKASGVGEVLSAEEFYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAV
AIFKALDCSGLSRVDFFLTKDTNEVVFNEINTLPGFTAISMYPMLWEARGLSKKALVQKL
IDLAMNRYDV
>KF628254.1_16894|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MMRNPLSKKITGIEPSGIRKFFDLVSEMPDAISLGVGEPDFDTPWRIREEGIYTLEQGKT
FYTSNAGLKDLKIEISKYLERKIHVEYDPDHEIMVTVGGSEGIDVALRAMLDPGDEVLIP
QPSYVSYVPCTILADGNPVVIPLQQKNEFKLTAEELEAAITPKTKMLVMPFPNNPTGSIM
TKEDLEPIAEVVKRHDLYVLSDEIYSELTYKTEHVSISSLPGMKERTLVINGFSKGFAMT
GWRLGYICGPSVIIEQMLKIHQFAIMCAPTNSQYAAIEGLRHCEDEVQQMRNAYNQRRRY
LVNEFAKMKLECFEPFGAFYIFPSIKEFGMTSEEFAMRFLEEEKVAVVPGSAFGESGEGF
LRVSYAYSLEDLKEAIGRLSRFVERLRSQK
>KF628253.1_16895|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VFCLYQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRLL
AQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDVYLDATLTQRSNDML
VAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPRL
VLNVPDETNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF628252.1_16899|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PPLQVPLPRMEINPDVKDIFGFQYEDFNLTGYDPHPHIKGEVAV
>KF628235.1_16933|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADELYRATCLDILENGYSDAEEQVRPHWADGTPAHTIKKFGVVNRYDLREEFPIMTL
RRTYWKSALDEILWIWQKKSNRIADLGSHVWDEWAGPDGTIGKAYGYQLGVKHRYPEGEM
DQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGNTLNAILHQRSQD
MLTANGWNVMQYAVLVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPR
LRLDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF628234.1_16938|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEVGEFVHVIADAHIYDRHIPLVKELISREPLPAPTFWLNPEIKDFYEFTTDDVRLDNYE
THEQIKNIPVAI
>KF628233.1_16942|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MECIVNVPPDWGLGRHGELLVAISADLRRFRQLTQGKTVILGRKTLATFPGGRPLKNRRN
LILSHDPAFQVEGAEVVHSLPELLQAIQKVPEEQLCVIGGAAVYEMLLPYCTTAQVTKSY
VTLKADTFFPDLDADSCWSLAEEGKIEEENGVRFQYLKYVNRSPRQWR
>KF628229.1_16948|FEATURES|farme|tetracycline|tet40|antibiotic efflux|0
RSPWFLPLLAGVVLLYTSHNILMSFPYQIVQYLGGGSGEMGTLLTLQGLMDIPAMVLFSL
LLRRAASWRWVRLAGLSFFLHALLTWLAPSVFFLYGIQIFETTGYALYAVASVYWVNDMT
APADRVQGQTYFTMANTLGIVLSSFLGGFLLDAAGTGPTLAFSTVTGGTGMGILWIMLRQ
GQAKAAVQQG
>KF628221.1_16980|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLRFCAVKLASMALTPEQLADIRTRIPARPETGIPMPYEDLVRRILTEGTLKSDRTGT
GTISLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQEHNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVKNHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQSGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPHIRINKAASLFDYDYSDFEIVDYRHHPTIKAP
VAV
>KF628216.1_16996|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDNLLLIAAIGKNNELGIDNHLLWHLKEDMKFFRETTANKTIIMGRKTFESLPGLLKGRK
HIILSSNESYKVDGATVMHTKEEILDYIKKTDEECFIIGGAKIYKEFLPYCKYLYLTLVD
LEKEADTFFPEFDKTEYDAEIIKKCTEDGVDFTFMKYTKRL
>KF628211.1_17010|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MLSIIACISKVHRAIGYKNRLLYAIPSDMTRFRMLTTGHTIIMGRKTFESLPNGALPNRR
NIVISKTRELITGCEVYTSLEEALAARKEEAARKEEVGNKKTVGSKEASDESFIIGGASI
YEQALPFADKLYLTIVEKEPEHADTFFPEINPAEWEVTEKEMRNENGLPFTFLTLYRKQ
>KF628210.1_17015|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCNNILENGTDTKGEKVRPHWADGTPAYTQKLFCVVNRYDLKKEFPALTL
RRTALKSCVDEILWIWQKKSNNIHDLHSHIWDSWADENGSIGKAYGYQLGVKHKYKEGMF
DQVDRVIYDLKNNPFSRRIMTNIYNHHDLSEMGLYPCAYSMTFNVTEGENGKLVLNGILN
QRSQDVLTANNWNVVQYSVLMHMLAQVCDMEVGEFVHVIADAHIYDRHIPLVKELISREP
LPAPTFWLNPEIKDFYEFTTDDVRLDNYETHEQIKNIPVAI
>KF628201.1_17036|FEATURES|farme|chloramphenicol|CLD_0021|antibiotic inactivation|1
MHFSLIDRTAWDREEYFRHYFSTVPCTYSMTVTLDITGIRAAGRKLYPALLYALTKLVNR
HDEFRTAFNRSGELGIYGDIIPCYTVFHKDSETFSNIWTPFSEDYAVFCRSYEQDLARYG
HIHSMMAKPDMPENVFFVSMVPWESFDGFHLNLQKGFESLLPIFTFGRFYQKEGRWLIPL
SVQVHHAVCDGFHTCRFVSELRELLAAGI
>KF628198.1_17045|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAKNGVIGKDNRLIWHLSDDLKRFKALTMGHPIVMGRKTFESLPKVLPGRVH
YVLTGNPDYKAPEGVLLFHDVKELLAALPAGESFVIGGEHMYRELLPYADTLYITEIEED
FEGDAYFPDFDPSRWKLEESVEGEGKLPHRFCTYRKVTGG
>KF628185.1_17087|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|0
KEELLDELEEYKDEDIFIIGGESIYRMMLPYCDKAYVTRTDFAYDADTYFPNLDEMPEWK
LVKESEEETYFDIEYQFVVYGK
>KF628173.1_17113|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADELYRATCLDILENGYSDAEEQVRPHWADGTPAHTIKKFGVVNRYDLREEFPIMTL
RRTYWKSALDEILWIWQKKSNRIADLGSHVWDEWAGPDGTIGKAYGYQLGVKHHYPEGDF
DQVDRVLYDLKHNPASRRILTNIYNFQDLHEMNLYPCAYSMTFNVTGHTLNAILNQRSQD
MLTANNWNVVQYALLTHMMAQVSGLEAGELVHVIADCHIYDRHIPAVKAMLDREGYPAPT
LRMDKGVTDFYAFTKDNFALEGYQYHSFDFEIPLAI
>KF628172.1_17120|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VTRMTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGR
PLKNRRNIVLTRDEDFAPEGVDIVHSVDEALAAVADEPMAWVIGGGEVYRQFLPYCTEAE
VTHNHCVHAVDTFFPDLDADPAWEIARRDGVATIASGEGDEGVDYEFVTYRRVEA
>KF628169.1_17129|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|0
MNLILAADENWGIGYQGGLLTHLPGDMKYFRKMTLHKTI
>KF628165.1_17141|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VKEVLSLWQKRETERQENRMSYADKVFINMCRDIIENGTSTEGEKVRPKWEDGTAAYTIK
KFGVVNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVHELKSHIWDSWADENGSI
GKAYGYQMQVKHQYKEGMMDQVDRVLYDLKENPYSRRIMTNLYVHEDLHEMNLYPCAYSM
TFNVTKEEGSEQLTLNGILNQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIA
DAHIYDRHIPLIEELISREPLPAPKFWLNPEVKDFYDFTPDDVRLEDYETHPQIKNIPVA
I
>KF628163.1_17145|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
DAHIYDRHVPIVEKMLTQTPAPAPKFAIDPSVTDFYAFTRNSFTMEGYTPAPFEDKIPIA
I
>KF628153.1_17173|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADQEYLSIVKNILDKGALGENRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTAV
KEILWIWQKQSNDVRELQKWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLDMLKKDP
ESRRMVADLWNVKDLPDMALYPCAFLTMWDVSNDGRLNCMLVQRSGDMGLGVPFNMTQYA
ALICMIAQVSGLRPGLFTHVINNAHIYENHVEQLKLQLSRLPEAYAAPRLVLNPDVKDFY
DFKPEDIQLENYRHHDKIAMEVSV
>KF628149.1_17186|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEMDQ
VDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGNTLNAILHQRSQDML
TANGWNVMQYAVLVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPRLR
LDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF628142.1_17202|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|1
MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREY
KRAMELAAARDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYL
AHRLPNAAITGVDISGQCVNVIRAFGGAETRLGDLLCEIPEDEADAALMFKVLPLLERQR
TGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENEL
FYVLKQNEDGRFPVRTVRTARFGAREGRRSPETGGQIAPQTSGYREKRADLGGRGDSSVD
GIYKSE
>KF628139.1_17209|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
GGDSVYMALLARCDRVYVTKVDADPDADSFFPNLDDNPDWRIDSESEVFEENGLKFQYVD
YVRN
>KF628137.1_17212|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAIAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWPNVTVVHTLDEIPIQDTTEDEIFIMGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWKIANSQEVPADEKHAYPYTFVTYTR
>KF628131.1_17226|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DGSIGKAYGYQMGVKHQYKEGMMDQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPC
AYSVTFNVTKKPGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELV
HVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKD
IPIAI
>KF628130.1_17229|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
RNIVLSHRDLDIPGAEIAHSFDEAAALGGDDAIVIGGASVYMALLARCDRVYVTKVDADP
DADSFFPNLDDNPDWRIDSESEVFEENGLKFQYVDYVRN
>KF628125.1_17246|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNIASYALLLMMVAQVTGLEAGDFVH
TLGDAHIYNNHIEQVREQLSREPRDLPKMKLNPDVKSIFDFKYEDFELTDYNPHPHIAGK
VAV
>KF628124.1_17250|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GKLNLWVHQRSCDVPLGLPFNVTQYAVLLSLIAHVTGLKPGTIDWSIKDAHIYVNQIDGI
KEQIERSKTNNDIKAPTLWINPEVTDFFKFDNSKDLKDIKIEGYEHMGPIKFPIAQ
>KF628112.1|FEATURES|farme|aminoglycoside|ilvE_1|antibiotic inactivation|0
DDMVTISECAGVLQYAQTVFEGMKAYTTEDGHIVTFRPDLNGERMEHSAARLEMPVFPKD
RFVDAVVQTIKANAAYVPPYGSGATLYVRPYMFGSDAVIGVKPASEYQFRVFTTPVGPYF
KGGAKPITIRVSDFDRAAPNGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDSKTRTKV
EETGGANFLFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFA
ECGLCGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPKGWIH
VIE
>KF628111.1_17281|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MSPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCQAADIVFMGLHGSNGED
GKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIHDL
GMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYINGREFSVAVVDG
KAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALCIEGYAR
FDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF628108.1_17290|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGTGT
VSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWADE
NGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVENMA
LPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFVWT
GGDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVGYQHHPTIKAPVA
V
>KF628104.1_17300|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKESRIVVLMGGPSREAEVSRNTGKAILEALTSIGYQAISMEYDPHHVVEQLKEAKAD
AVFIALHGKYGEDGTIQSVLELARIPYTGSGVTSSAITMDKIMSSHFFKQAGLPMAFSKP
YYLKDGKENIEEDIRKSFTLPVVLKPACEGSTIGIEIVKEEKDLKEAIDRVFSVEPRILA
EAFLFGDEFTVSVLDGKALPVIQICPHSGAYDYHSKYTKGATDYLVPAPIPEALAEEMSR
LAETGYRMAECEGACRFDFKTDRDGRPHLLEANSIPGMTATSLVPKAAAAAGVSFPSLCE
KILLEAGLDKV
>KF628089.1_17335|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHADADTYAPDV
KSLVESGAWKVLEEGVWQNTRKGSGDIAGFRFMTYAKNREE
>KF628087.1_17339|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNI
>KF628086.1_17340|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TPSLYSMTFNVTQTPGNEKLTLNAILNQRSQDILTANNWNVCQYAILLMMIAQVCDMEAG
ELLHVVADCHIYDRHIPVVKEMIKIKPYPAPIVKLNPEVKDFYQFTTDDLIVENYETWPQ
IKNIPVAI
>KF628083.1_17349|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDLIVAVDNNWAIGNKGDLLVSIPEDHKFFRQTTMGNVVVLGRKTLAGFPNGLPLAGRDN
IILSTDPNYTVRGGTVVHSKEELFEELKKYEDKEIFVIGGGQIYEMLLPYCKYAHVTKIN
YDYAADTHFPNLDELENWEMIADSDEHTYFDLEFYFHKYENKNPLAF
>KF628064.1_17402|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EGEWFLFEGDVSLLPEDKWIKSGKCTKALLSPDRKDHGITVFRESGPEKIHIDVCFPVMH
GKNGEDGTIQGLLELSGIPYVGCGVLASSVCMDKAVTNTLADQAGIAQAKWLATDVNEYR
ENRTEFIKKAEATLGYPIFVKPANAGSSVGITKAHDESELREALEKAFSCDRKAVLEEFV
DGFEVECAVIGNYRPMASCIGQIISCNEFYDYTAKYVSDSRLLIPAELPEDKQNEVLKEA
VRAFKTLGCTGLSRVDFFVRKSDGRVMFNEINTIPGFTSISMYPKLMEQSGVPYPKLLDK
LFKLAAE
>KF628062.1_17409|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLPNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYS
>KF628060.1_17414|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AQACDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTNDLI
VENYETWPQIKNIPIAV
>KF628044.1_17451|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IIKELIQRPTYDAPTFWLNPDVKDFYEFTRNDVRLDNYVTGPQIQDIPIAI
>KF628035.1_17471|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LSKLQIAVLFGGASSEHEVSRMSATTVLRAIDKSRYEVTPVGIKKDGSWWLYPGDIGLIL
DGRWESCPDNLPAFLVPDASVGGLLIRDSDHSDTVKKIDCVIPALHGKNGEDGTIQGLLQ
LAGIPFVGCDMTSSAACMDKVITNVMLEQAGIPQARFTWLYAYEFQSAPDEAVLKIEKDL
GSYPVFVKPANAGSSVGVSKAENREELRAAIAKAAKEDGKILIEENIVGQEVECAVLGNE
DDLLASTVGEIAPSNEFYDYEAKYLSGTSGLYIPAHLESGVIETIRSTAQKAYQVLGCSG
LARVDFFVRNGSEVLLNELNTLPGFTSISMYPKLMEHEGLSNQELIHRLIQLAVKRMGKG
ADA
>KF628023.1_17502|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTQTPGNEKLTLNAILNQRSQDILTANNWNVCQYAILLMMIAQVCDMEAGELLHVV
ADCHIYDRHIPVVKEMIKKKPYPAPIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPV
AI
>KF628020.1_17511|FEATURES|farme|chloramphenicol|CatU|antibiotic inactivation|1
MGYQEIDLETWPRKEHYLHFTKQAKCFVSITKDVDVTQLRAAAKTCGRSFYIAFLYVICK
VINRHGEFKLAYLPEEEKLVQWDEVLPSHLVFHEEDETFTCIWSRWEPDFEAFYRGCQED
IAAGKEYRGYRVPGMPENTFCVSCLPWLKYSALDINLCGDGLFLAPMISWGKAELDGGRM
RMPLSFEIHHGAAGGFHIARFYDEVEQEAVALAEYLSAFGGKSVCC
>KF628013.1_17527|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKPHISLIVARSRNGIIGKEGKLPWRLSEELKFFKQTTMGRPVIMGRRTWESIGRPLPGR
QNIVLTRDPSYKAEGATVVSSLEEALKHFGPDDIVFIIGGADLYRRALPLVDTAWVTEIE
TDVEGDASFDPLNKDEWMLVWSENHPKTEDQPLGFKFQRFERVKHTVY
>KF628010.1_17533|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VSKQIIAIWAEARNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMGRVTFDGMNRRCLPG
RETLILTRDKDFDCEEVTTVTSVEEALAWFEQQDKDLYIAGGAGVYKAFDGHYDVLIKTT
IEADLEGDTYFPQLDTT
>KF628009.1_17535|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PLFRSTIKQFAVVNRYDLSKEFPALTLRRTGIKSCTDEMLWIWQRKSNNIHDLKPHIWDS
WADPDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDLKHNPYSRRILTNIYVHQDLHEMN
LYPCAYSMTFNVTKQPESDKLVLNGILNQRSQDVLAANNWNVCQYSVLMHMLAQVCDMQV
GAFVHVIADAHIYDRHIPLVQELIQREQHPAPKFWLNPDVKDFYDFTPDDVRLDDYVTGP
QIKDIPIAV
>KF628007.1_17541|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQNVVDGSVYPVCSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSMSSK
>KF628000.1_17559|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGYSPERDVSLSSGSLIANALMERGHEVFFLDPWLGIKAGERVHYRTREEGLG
FAYEIGGEAPDLELLGAETGAKKSLIGPGVLEACREADMVFIALHGSTGENGQIQAVLEA
YGIPHTGSGYMGSLLAMDKNISKILMRAAGVATPDWYLAERGKCSQPEFLPCVVKPLDCG
SSVGVTIVDKEEEWHTALEAAFSYGDRVLVEKKITGREFSVGVLGGRALPAIEIIPEKGF
YDYKNKYQPGMTREICPAGIDEKQESRLEAAALTVHRILELGYYSRVDFLMDGDGAIYCL
EANTLPGMTPFSLLPQEAEAAGITYQELCEAIVKNGKGAAL
>KF627996.1_17572|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADELFIENCKEILAHGVWDTEQEVRPRWADGAPAHTVKKFGIVNRYDLRAEFPVQTI
RKMAFKSAVDELLWIWQKKSNNIHDLSSHIWDAWADESGSIGKAYGYQLGVKHRYPEGEF
DQVDRVLYDLKHNPASRRILTSLYNHHDLSEMALYPCAWSVTFNVSGRTLNAVLNQRSQD
MLTANGWNVMQYAVLVHFLARASGLEAGELVHVIADAHIYDRHVPVVEELIARTPYEAPR
LWLDPAVTDFYTFTKDSVRLEGYRFHPLEQPIPVAV
>KF627992.1_17582|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYNAFEVKTYFITQSGDFIKTQEFIETPG
DDEKLMTNDTVEASQAIKPSDIYEEDAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKRILEVAGVPQVAYTGYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENESELRSAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPAHVPAEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDLIKELVALGQEMFDKRESHLI
>KF627971.1_17644|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGAMVCEALRSKGHKVALMDLFFGVEGTDRTVDPFEAPIPQ
AFKKVSPEAPDLAQVRASRKDTSPSAIGQGVLELCAQADVVYLALHGACGEDGRIQATLD
LLGVPYTGSGCLGSAIAMDKDMTKRLVAHKVRTPSWCTVTVTEENLEQLMEETKLPVVVK
PIASGSSIGVTIAHTKDDLRRGLEESIRLGGRTVLEQYVKGREIQVAVLNGKALPSIEII
PQADFYDYANKYQPGAAREVCPAEIPSEWEKKVGDAAVAVFEELGLAVYSRADFIVTEDG
EAYFLEINTLPGMTPTSLVPQEAAAVGMDYATLCETIVASSLKARKEGA
>KF627956.1_17686|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
NSLGVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKK
IENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEV
ISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGM
QYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRM
LAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILS
GEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKI
T
>KF627954.1_17692|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NYKGGFIDQISEAVETIKHNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQ
LYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSR
EPRDLPQMRINPDVKNIFDFKFEDFELVNYNPHPHIAGKVSV
>KF627953.1_17693|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TPEGHVEKVHVDVVIPVLHGLWGEDGTVQGLLELAGIPYVGCGVLASAVCMDKAVANALF
EANGVPHTRWLAADRWEIESDLEGVCEGVEKKLGWPVFVKPANAGSSVGISKVSSRDELK
KAIDLALENDRKVVFEAFVDGQEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKNGVS
QTVIPAHLPEAKLDEVKTYAAMAYTALNCEGLARCDFFVEKGTGRVLINEINTFPGFTSI
SMYPKLMEHEGLPVPQLIDRLIALALERKEKQHG
>KF627935.1_17738|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGEPAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMQVKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGIL
NQRSQDILAANNWNVVSVCGAASYAGTGV
>KF627923.1_17771|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTE
VEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTP
DEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKR
PLPITMIGDAAHLMQTFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGK
EAQEESTQNEIEMFKPDFTFQQLLNV
>KF627915.1_17791|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
IAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMQGTRWEVQLPDGAKAPVDRNDF
SFMLGTEKIRFDFAYITIHGTPGEDGRLQGYFDMMHIPYSCCGVLAAAITYDKFTCNQYL
KAFGVRIAESLLLRQGQSVSDEDVMEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVK
AFEEAQEVLVEAFMEGTELTCGCYKTKDKTVIFPPTEVVTHNE
>KF627903.1_17824|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIIVLAGGLSTERDVSLSSGAGICRTLREKGHDAFLLDPFLGLPDAGDNLEAVFTRPDA
GLSLASGIRSTEPDLEAVKASREDKSDCFFGANVIELCRLADIVFMGLHGDVGENGKLQA
AFDVLGIRYTGSGSLGCALSMDKEITKVIFEANHIPTPKGTWMKRSTADHSLASTGLPLP
LVVKPCSGGSSIGVYITQTEEEFDKAVKESFRYEDEIIIEEYIKVRELACGVIDGKALPV
IEICPKTGWFDYANKYQDGMTEEICTARIPEETAKKIQAISEHAFQALKLDVYARADFLL
TEDGNIYCLEYNSLPGMTAASLLPKEAKAAGIEFGELCELLIEKSMDARYCG
>KF627901.1_17832|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLSDSEHKMSVVVLFGGMSSEHEVSRVSAGTFVDQLDRQRYELLTIGITKEGRWLYTEAD
SAQMADGSWEELPGNMPCVLSPDRADHGLILFTPAGQVEKVHVDVVIPVLHGLWGEDGTV
QGLLELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESDPDGVCDG
VIAKLGWPIFVKPANAGSSVGITKAHDRDELKAAIRLALANDRKVVFEAFVDGHEVECAV
IGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPARLPEEKLDEVKTYAAMAYTALG
CEGLARCDFFVEKDTGRVLINEINTFPGFTPISMYPKLMEHEGIPVPALIDRLIALALER
TEKQHG
>KF627900.1_17834|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYE
>KF627895.1_17842|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MEITKLRKENGIPMSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSG
DFIKTQEFTETPGDDEKLMTNDTVVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFL
ETLKLPYVGTNVLSSRRCHGQDYDQAYSRGCGCTSGCLHCLHRG
>KF627894.1_17847|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDQNWAIGKDGDQLVYLKEDLKRFRTLTSGHTVILGRKTLATFPGGRPLKNRRN
LILSRNPQFQAEGAEVFSSVEELVKQADGDAFVIGGASVYEQLLPYCDTAYVTKIHAGFP
ADTYFPNLDQSGEWEVSEESESLEQDGISYHYVTYSRIQ
>KF627887.1_17859|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWIPNDLKRFKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFILGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF627876.1_17886|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNAILSADRNWGIGYQNKLLISIPSDMKFFRQKTSGHVVVMGRKTLESFPGGLPLKNRVN
IVLTRDESYQAPGAVLVHSREALLEEVKQYDTQDVYVIGGGAVYEMLLPYCDTAYVTKID
FAYQADTWFPNLDEMPEWRLAEESEEQTCFDIEFTFRKYIRKAGKL
>KF627871.1_17897|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
VNAIVVVDQNWAIGRDNDLLFSLPTDMKRFRSLTLGGTVILGRRTLDSFPGGRPLPKRRN
IVITHCPDFSREGAETVSSLAAMREATAGTPPDQLWVIGGGSIYAAMLSQCARAYVTRVD
AAAEGADSFFPNLDKLPGWTVRAVSEPVTENGLTYRFYDYVNTKLCD
>KF627858.1_17927|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MGFFDYVNKYQLGGASEICPAQSLDAVKTAQIQAAGEKAYAALRLDVYSRADFIVDNNTG
EFYCLEVNSLPGMTSASLLPKAAKAAGYEYGEFCELIIQKSMEARYQ
>KF627855.1_17935|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDMIVAVDLNWGIGCNGTQPVVIPEDRKFFRETTAGAAVIVGRRTLADFPGGRPLKNRRN
IVLSKQAGLEIPGAEVVHGLDELRSLLKGVDGKVFVIGGDSVYKLLMPYCEYAIITRINA
SPVVDTFITNLDESPDWELVEKGETKCHEGTEYSFDKYKNLNIKSL
>KF627850.1_17948|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNIP
IAV
>KF627829.1_18003|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNSVMNMIVAVDNNWAIGNHNELLVSIPADMKFFRQETDGKVVVMGRKTLESFPNGMPLV
NRVNIVLTENPDYQVKGAKIVHSLAELQEELKQYRSEDVYVIGGESVYRQLLPYCDVVHA
TRIDMEYQADAHFPNLEKDPEWIVTADSDEQTYFDIPYTFVKYERSRLTVQK
>KF627811.1_18052|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKMIASADNNWAIGYKGSLLAHVSADMKFFKSKTVGNVVILGRKTLMTFPNGKPLKDRKN
IIITTDESFKVEGAEIVHSTDELLETVEKYDDDSLYVIGGGSIYDQLLPYCDTAYITKFD
KTFEADTYIKNLDEDENWKLVEDDGPFEEKGIIFRFCTYKRAE
>KF627806.1_18066|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAIARNGVIGNGNALIWRIAEDLRRFKALTTGHPVIMGRKTYESIGRPLPNRTNV
VVTRRKDYRPEGCLVAGSLEQAVGLFDPSEEIFIIGGAQIYAQAMPMADRLYLIEIDSDY
EGDTRFPEWKREEWTLLSEERHERGERYDRPFAFRNYIRTKE
>KF627781.1_18134|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSLLKDKKATVGVAVLANDETVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYSPLRDKFPDQDITI
SLGELLKYSISQSDNNACDILIEYAGGIDQVNEYVKSLGIKDCNLAATEDLMHTSGDAYL
NWSTPEEVVRLLNIADKHPLFGTQYKDFLQAIMQETSTGKDKLKGQLPADVIVGHKTGSS
DRTPEGIKIADNDAGFVILPNGQKYYIAVFVMESQENDADNAAIIASISKIVYDTLNSDI
Q
>KF627780.1_18140|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAILSADQNWGIGKDGGLLVRISEDMKFFRETTRGHAVVMGRKTFQSLPGALPGRRNIV
LSRGGFCAPGAEVAADLPALFALLGEQKEEAFVIGGGEIYRLLLPYTDRVFVTRWETVFD
ADTFFPDLDASEEFFLAEQSPRQQSDGLSFTFCKYQRKR
>KF627778.1_18149|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KSNNIHDLSSHIWDSWADEQGSIGKAYGYQLGVKHQYAEGQFDQVDRVLYDLKHNPHSRR
IMTNIYTFADLHEMNLYPCAYSMTFNVSGNTLNAILNQRSQDMLTANSWNVCQYAALLCM
IAQASGLKAGELVHVIADAHIYDRHVPIIEKLMEREGYAAPKLCIKEDITDFYAFNTENV
WLEDYQNCGGVGKIPVAV
>KF627775.1_18154|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KEKYDITLAGIEKDGTWYILNQAQDDLVKDSWLEGAVKVEDVYGLLRQQEVVYPILHGMY
GEDGTIQGLLELAEVPYVGCKVLGSSVAMDKIYTKKILETVGIPQVKSLYVKKRYDGTLV
VVDSTFDESTDITGFVQKELGYPCFIKASNSGSSVGCYRVDEEKELMPRLEE
>KF627774.1_18158|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKLIAAADKNWAIGKDGEVLVRISEDMKNFSAMTTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHKKDYNGKGAIVVHSEEELWERTFQI
>KF627743.1_18228|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEVVLMKVGVIMGGISSEREISLNSGNSIMENIDKNKYDVVPVVIDEKADIINKVKDLDF
ALLALHGKFGEDGTVQSVLQTLDIPYSGCGPLSSALCMDKDLTKVVLAANGIRTAKWLNV
KSVEEIDYEAIEKMGYPVFIKPTNGGSSVATFKVYDKEKVQEAVEEGLKWDTEVMIEEFV
DGDEITCPVFDNKLFPIIAIKPKSDFFDYTQKYSAGGADEVIVELEENLHKEVEVMALKT
YKALKCEVYSRIDMIVNKEGIPYILEVNTLPGMTAASLFPKSAKGQGYSYSEFLDLIIET
SLKVNRAV
>KF627742.1_18232|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|0
MMRLTVLVENTASDEALQCVHGLSFYLEAAGKRILFDMGPGAQFAQNAQTMGVALDRVDF
AVLSHGHYDHGGGLDVFLRRNDHAPVYLRTGAFAPHTDGAGNDIGLRPALEKNPRLIFTD
ALCEIAPGVHLFSQVTGRKFWSPINDELLEDGVQDAFSHEQNLLLEEDGKLVLIAGCAHC
GMVNILERAAEIAGRMPDVVVGGMHLAVGRAAPDDFILALAQQLRTYPCRFYTCHCTGAH
PFALLRQVLGEQITALSGGNTLLI
>KF627739.1_18239|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
PQYFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVID
DVLKLSVPNASGEMGPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQM
ESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVM
GLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAA
FQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPN
FYELMQKLQEKFSKKQ
>KF627739.1_18240|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNSKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF627736.1_18253|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPAWEDGTSAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF627735.1_18256|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLNSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQY
>KF627732.1_18264|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNAIVAADKNWGIGYKNKLLISIPSDMKFFRQTTMNHVVVMGRKTLESFPNGLPLAKRTN
IVLTRDQDYKVKGAILVHSEEELLEELKKYEKDDIFVIGGGSVYEMMLPYCNTVYVTKID
FAYQADTYFPNLDEMPEWEMTEESEEQTCFDIEFAFTKYERKA
>KF627728.1_18280|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFTEPPS
DDEKLMTNDTVVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKHILEVAGVPQVAYTVFIEGEDLEVAVAETLEKLTFPVFVKPANMGSSV
GISKAENEAELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPARVPVEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDLIKELVVLGQEMFDKRESHLI
>KF627718.1_18308|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVTAKEQIQPAIAKAFAEAQEVLV
EAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASDEITPARISDDLTRR
VQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGMEMKD
VMTDIIENKFKD
>KF627716.1_18311|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VDRVLYDLRHNPGSRRILTNIYVHQDLHAMNLYPCAYSMTFNVSGNTLNAILNQRSQDML
TANSWNVVQYAALVHLFARCSGLEAGELVHVIADAHIYDRHVPLVEQLMERESYPAPVFR
LDPAVRDFYDVTVDGMALENYQCAPGIGKIPVAI
>KF627716.1_18312|FEATURES|farme|polymyxin|arnA|antibiotic target alteration|0
MLACKGKKNVFPKQGARGKERQFPMKRRGPRPAAGCGYGIAKTKVCISHGLPERSGCGWL
AYGEEKQALAGGRRYETQACPYRAGTDKKRQPRKHRMYFPAEGEGKLSKADQIFLQNCRD
ILEKGVWDTDREVRPRWEDGTPAHTVKLFGVVNRYDLREEFPIQTIRKINYRAAFDELLW
IWQKKSNNIHDLASHIWDSWADENGSIGKAYGYQLGVKHIYPEGEFDQVDRVLGIRPGGP
GAL
>KF627710.1_18327|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AMCQDILENGTSTEGELVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITLRKTYIKSAT
DELLWIWQKKSNNIHDLKSHVWDEWADEDGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYD
LKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLA
ANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPKFWL
NPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF627695.1_18368|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAVDRNLGIGFQNKLLFWLPNDLERFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSSNPAIQCPGAEVFPTLEAALQSCQPEEQVYIMGGASVYKQAMPLADMLCLTEIDAE
APQVDAYFPAVESAIWHEKSRESHLVDEKHPCPYAFVDYIRK
>KF627691.1_18382|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|0
LGIAMALLGEPELLILDEPTNGLDPIGIEELRELIRSFPEQGITVILSSHILSEVQLLAD
KVGIISGGILGYEGALKQGDNLEDLFMNVVRKNQKAGEIHG
>KF627683.1_18401|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKKEGHEKLSLNGMLNQRSNDVLTANNWNVCQYAVLLHMLAQVCDMEVGELVHVI
ADAHIYDRHIPLVEELIKREPLPAPKFWLNPEVKNFYAFTPDDVKLIDYETHEQIKNIPV
AV
>KF627676.1_18420|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MHMNAIVVVDQNWAIGREGDLLFSLPTDMKRFRSLTLGGTVVLGRKTLDSFPGGKPLPGR
RNIVITRNVDFDRAGCEVASNLNTALELAADTEPDKLWIIGGSSVYTAMLSRCNRVFLTK
VDAVAEDADTFFPNLDKLPAWEVEHTSEPITENGVTYRFIDYLNTKL
>KF627667.1_18439|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEER
E
>KF627665.1_18445|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLELCVIFGGQSPEHEISRKSVTSVLNNLNKDKYNISTVGITKNGARYLYTGDYAKIESG
EWEQDTENKKKAILSPDAEDKAILVFDGDKVTKIHPDVIFPVLHGEFGEDGTIQGLFELS
GIPYVGMGVMASANGMDKTSSKIVFASADIPQADWVVVNKTDNFEDKMDEIENKLGYPCF
VKPARTGSSVGVGKAHDRKELKAALENAAQFDRKILVEENIDGHEVECAVLGNEDVKAAT
VGEIMPTVEFYDFDAKYNDNSTELQIPADLPKETIEQIREYAVRAFKALDGSGLSRVDFF
VKHSDGSVVLNEINTLPGFTNISMYPKLWGAVGIEYSELLDKLIELAEKRVK
>KF627662.1_18452|FEATURES|farme|multidrug|mexf|antibiotic efflux|1
PNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEH
LGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALL
GAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIR
LRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQK
LQEKFSKKQ
>KF627649.1_18489|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLQHVLDHGILKEDRTGTGTHSVFGYQMRFDLQDGFPLLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGHIDQIKEAIDTIQ
NNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNIAS
YALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPRDLPKMKLNPDVKSIF
DFKYEDFELTDYNPHPHIAGKVAV
>KF627644.1_18509|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADALFLQNCRDILDHGVWDTDREVRPRWEDGTPAHTVKLFGVVNRYDLREEFPVITV
RKQYLRSAVDELLWIWQKKSNNVHDLNSHIWDAWADETGSIGKAYGYQLGVKHHYPQGDM
DQVDKVLWDLKHDPASRRILTSLYNHHDLSEMALYPCAYSMTFNVSGNTLNGILNQRSQD
MLTANGWNVMQYAVLLHMMAQVSGLEAGELIHVIADAHIYDRHVPIVEELIARTPYDAPA
FWMDRSVTDFYAFTRDSFRLEGYQAHLLEAKIPVAV
>KF627641.1_18520|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LTTGNTIIMGRKTFESLPKGALPNRRNVVLSSNPAIQCPGAEVFPTLEAALQSCQPEEQV
YIMGGASVYKQAMPLADMLCLTEIDAEAPQVDAYFPAVESAIWHEKSRESHLVDEKHPCP
YAFVDYIRK
>KF627635.1_18535|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCKADQIFLANCQEILSRGTWDTHLPVRPRWEDGTPAHTVKCFGLVNRYDLREEFPIQTI
RRMYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEM
DQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGDTLNAILHQRSQD
MLTANGWNVMQYAVLVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPR
LRLDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF627621.1_18573|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCEKILEEGFSSEGMQVRARWEDGTAAHTIKTFGVVNRYDLEEEFPALTL
RPTAIKTAVDEVLWIWQKKSNNIKDLKGHIWDEWADENGSIGKAYGYQMGLKYKFAQGEM
DQVDNVLWQLKNTPYSRRILTNIYKFDDLAEMNLEPCAYSMTFNVTGDRLNAVLNQRSQD
ILAANNWNVVQYSVLLHMFAQVSGLRAGELVHVIADAHIYDRHIPVIEELISRPQYPAPK
FRLNPEIKDFYDFTVDDCDDRRLSEKSADTQYTYSYLT
>KF627605.1_18616|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVNVDSNWAIGYRGKLLVSIPEDMKFFRSETTGKVVVLGRKTLDTFPGGQPLKNRTN
IILTRNPNYQVKGAIICHSVEEVLEELKKYNSEDVYIIGGDSIYKEFLPYCDVAHVTRTD
HVYDADAWFPNLEEDPAWVLTGESEEKTYFDLEFRFCRYERREA
>KF627599.1_18634|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKWIVVADPDGGIGKEGKLLADLPTDMKHFRTKTKGKTVIMGRATLESFPGGKPLPMRRN
IVLSRTLPESKAYEVCRSVDELLELVKDDDPDDLYVIGGGQIYEQLLPYCDEAFVTELET
VFDSDTKIPLLSQMPEWERTEESEPICENGINYRFVVYRRR
>KF627597.1_18637|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF627595.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|0
MKVTLISVGTLSQKAYADAFSEYAKRFSAHGILECAEIREKKIDASPSEAQIAAALDFEG
DAILSKIPPRAFVFAMAIEGKSMTSEAFASLLDRKMTEGVPEFCFVIGSSFGLSDKVKRR
ADALLSMSPMTFPHQLARVMLTEQLYRASQILSGGKYHK
>KF627584.1_18669|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSAANNWNVVQYAVLVHMLAQVCDMNVGELVHVIADAHIYDRHVDAIKELISREPFPAPK
FWLNPEIKDFYQFTPDDVKLEGYQTGEQIRDIPIAI
>KF627566.1_18727|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MVSIIVAVAENGVIGDKNALLWHISEDLKYFKSVTSGHPVVMGRKTYESLGRPLPNRTNV
VVTRQEMEIPGCRVAHSLEEAVALFPAEEEVFVIGGAQIYAQALPLAGRFYLTRVFHAYE
GDTHFPAWNDAEWRLVSSESFASGANYPYPFAFETYERRRN
>KF627563.1_18736|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNAIVVVDKNWAIGKDGGLLVHLPGDLKYYRQKTKGKVIVVGRKTLESFPGGKPLPDREC
IVVTRNRDYIREDCVVCNGKEQVMELISRYDDEDVFISGGAEIYRLFMDVCDDFYVTRIY
DEFDADRYFPNLDQLGYEVTWESPMQEEKGISYRFFKYSKTL
>KF627556.1_18755|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ILKKQHFIRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGEDRLTLNAILNQRSQDIL
TANNWNVCQYAVLVHMLAQVCDMNVGELVHVIADAHIYDRHIPLVEELIQRPVHDAPKFA
LNPEIKDFYDFTPEDVTVTDYVTGPQIKNIPVAV
>KF627536.1_18817|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
RLQVGELVHVIADAHIYDRHIPIIKELIGREQHPAPKFTLNPEIKDFYQFTTKDITIEDY
VTGPQIKNIPIAV
>KF627531.1_18827|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISLIVAVAENGVIGDRNALLWHISEDLRHFKAVTTGHPVVMGRKTWESLGRPLPNRTNV
VITRQNIEIPGCTVVHSLEEAVALFPADEEVFVIGGAQIYAAALPLARKFYLTRVFRAYE
GDTRFPAWDEREWRLVSSESFSGGKDYPWPFAFELYERR
>KF627519.1_18861|FEATURES|farme|beta_lactam|TLE|antibiotic inactivation|0
DATVVINECAGVLQYAQTVFEGMKAYTTEDGRIVTFRPDLNAERMENSAKRLEMPVFPKD
RFIQAVVDTVKANAAYVPPFGSGATLYIRPYMFGTNPVIGVKPADEYQFRVFTTPVGPYF
KGGVKPLTIRVTDFDRAAPHGTGHIKAGLNYAMSMHAIMDAHRQGYDENMYLDAATRTKV
EETGGANFLFVTKDGKVVTPKSDSILPSI
>KF627517.1|FEATURES|farme|aminoglycoside|PLPDE_IV|antibiotic inactivation|0
PPLAVNIDWSSLGFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFE
GMKAYTTEDGHIVTFRPDLNAERMANSAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYG
SGATLYVRPYMFGSDAVIGVKPASEYQFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPNG
TGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPK
SNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHG
KEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF627517.1_18867|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGVM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMDLYPCAYSMTFNVTQTPGNEKLTLNAIL
NQRSQDILTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIADAHIYDRHIPLIEELISRE
PLPAPKFWLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF627516.1_18872|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MRGVAMIIGIWAEDEAGLIGEADKMPWSLPAEQQHFKETTMNQVILMGRKTFEGMNKRVL
PGRISIILTRDETYQSDNEKVLIMHSPKEVLDWYYKQDKDLFITGGAEILALFESELELL
YRTVVHEKFQGDTYFPTHFDFGKFKVVSEIFHDKDERNAYTFTIKKYEKVKQP
>KF627507.1_18895|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NLTFMKAYLDLLRHIQAHGTVKNDRTGTGTISTFGYQMRFDLSEGFPVLTTKRLHLRSII
HELLWFLRGDTNIAYLRENGVTIWDEWADADGNLGPVYGSQWRSWPAPDGRHIDQIAQVV
DQIERNPDSRRLIVSAWNVAEIDRMALPPCHALFQFYVADGRLSCQLYQRSADVFLGVPF
NIASYALLTMMIAQVTGLVPGEFVHTLGDAHIYLNHREQVALQLTRTPRPLPVMRINPDV
RSIFGFRYEDFSLDGYDPYPSIKAPVAV
>KF627500.1_18915|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MRLPYQKPWRIGWKFDFFCGKIKKTIIDVLYYKAILKMVSKKEATDKAVSKKGRNMSKET
LILLYGGRSAEREVSVLSAESVMRAVNYSRFIVKTYFITKGGEFIKTQEFTDTPAEEEKL
LTNDLAESYPKISPAAIYEKDAVVFPVLHGPMGEDGSIQGFLEILRLAYVGPNILSASST
MDKLLAKHVFEAVGVPQVPYVAAFADENQAEIAQEVVEKLEFPVFVKPANMGSSVGISKV
DDLADLQPALSEAYKYDNRVVIEQGVDAREIECAVLGNNSDVSATLPGEVVKDVGFYDYN
SKYIDNKIQMDIPAKVSADLAQKIQEYAKKAYKAVNGAGLSRCDFFVTKDGNVYLNEVNA
IPGFTQWSMYPLLWENMGLSYSDLIEKLVDLAKETFETRENHLL
>KF627497.1_18923|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDQNWAIGNKNELLVRIPADQKFFRETTTGKVVVMGRKTLESLPGAQPLYGRTN
IVLTADPDYRVKGASVCGSVEEVMELLRAYHTDDVYIIGGESVYRQFLPYCDEAQITWID
FAYAADTHFPNLDQDAAWEMVQESDEQTYFDLCYEYRLYKKK
>KF627496.1_18926|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VSDKAVSKKGRNMSKETLILLYGGRSAEREVSVLSAESVMRAVNYSRFVVKTYFITKGGE
FIKTQEFTDKPAEEEKLLTNDLAESYPKISPAAIYEKAAVVFPVLHGPMGEDGSIQGFLE
ILRLAYVGPNILSASSTMDKLLAKHVFEAVGVPQVPYVAAFADENQGEIAQEVVEKLEFP
VFVKPANMGSSVGISKVDDLADLQPALSEAYKYDNRVVIEQGVDAREIECAVLGNNSDVS
ATLPGEVVKDVEFYDYNSKYIDNKIQMDIPAKVPADLAQKMQEYAIKAYKAVNGTGLSRC
DFFVTKDGNVYLNEINAIPGFTQWSMYPLLWENMGLSYSDLIEKLVDLA
>KF627493.1_18936|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPSRSDDRTGTGTRSVFGYQTRYDLTDGFPLLTTKKMFLRPIAEELLWFIKGDTNIKYLV
DRNVKIWNEWPYEAFKKSEDFHGETLEEFVAKIKELPADDPFVVKYGELGPVYGRQWRNF
NNEGVDQVAKLVDSLKNNPLSRRHIICAWNPAEVDEMALPPCHAFLQFYVSNDKKYLSCQ
LYQRSADTFLGVPFNIASYALFTAMLAQVCGYKPKEFVHTIGDAHIYKDHFDVVKEQISR
TPYPKCQLVLNPEVKSIFDFTIDDIKIENYQSHGRLVGKVSV
>KF627492.1_18937|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YILENGQDRDDRTGTGTRSVFGYQTRYDLTDGFPLLTTKKMFLRPIAEELLWFIKGDTNI
KYLVDRNVKIWNEWPYEAFKKSEDFHGETLEEFVAKIKELPADDPFVVKYGELGPVYGRQ
WRNFNNEGVDQVAKLVDSLKNNPLSRRHIICAWNPSQVDNMALPPCHAFLQFYVSNDKKY
LSCQLYQRSADIFLGVPFNIASYALMMEMLAKTCGYEAKEFVHTIGDAHIYKDHIEVIKQ
QIARDPLPKCKLVLNPEIKSIFDYKIEDIKIENY
>KF627489.1_18947|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLE
>KF627478.1_18979|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKKNIAIVAGGDSSEIVISLKSADGIYSFIDKDKYNLYIAIVKRDEWAVILPSGEHTPID
KNDFSFKENGVTRHFDFAYITIHGTPGEDGRLQGYFDMIGMPYSSCGMLVSALTFNKYVC
NHYLKDFGVKIAASIHLFKGETITDEEVVTRLGLPIFVKPNDGGSSFGVTKVKELSAIQP
AIAKAFGEGREVILESFIDGTEVTCGCYKVEGKEVVFPLTEVVTDNEFFDFDAKYNGQVD
EITPARISAELTELIQRKTSRIYDILGAKGLIRVDYIIPADGEPVLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIEDELKNRKTK
>KF627477.1_18982|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRKSGKGIDKRRRYMSYADKVFIDMCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKRFGV
VNRYDLSKEFPALTLRRTAIKSCVDELLWIWQKKSNNVNELKSHIWDSWADETGSIGKAY
GYQMGVKHQYKEGRMDQTDRVIFDLKNNPYSRRIMTNIYVHNDLHEMHLYPCAYSMTFNV
TKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAILLMMVAQVNDMIPGELVHVIADAHI
YDRHVDIVKELISRDTYPAPKVSLNPEIKDFYAFTTADLIVENYQAGPQIKNIPIAV
>KF627476.1_18986|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVAADANWGIGKENKLLVSIPADMKFFRTTTTGNVVIMGRKTLESFPGGLPLKNRVN
IVLTRDKNYRVKDAIVVHSVEEALEEVKKYRKTFTLSAGTAFINRCCLTATRLM
>KF627474.1_18990|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MERKIAIIFGGKSAEHEVSLASATNICNAMDCKRFTPVLLGIDKKGEWCYDKEYPTTGVN
LVKNDYFSKAEHVYLSSSKSHIQVIEKKSNRVLADFDVVFPIVHGTFGEDGTLQGILKSL
DVPFVGPDVLGSAIAMDKDIAKRLFRSAGIPVASSYTLYKHDASSYTFEQIAARLGLPCF
VKPANAGSSVGVSKVTNEAEYLNALQEGFRYDNKVLVEEAVVGKELECGVLGNEEARASV
VGEIVATESFYSYDAKYISSTGATLQVPARIDAALSDSIREYAVRAFHAIGCEGMARVDF
LLSDSGKLVLNEINTLPGFTAISMYPKMWEQTGVPEKELITELIMLAVRRHERDTNLSVA
VKL
>KF627473.1_18992|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
SPDGTHLRRSDRHTSLDALGFRLPVVVKPCSGGSSIGVRRVLDRADVLPAVEEAFKYEDD
ILIEKFVSGREITCGVLGDTALPPAEVIPKGGFYDYAHKYQSGLITEICPAELPVEVTAE
VQDISLRVFRALGLEVYARMDFIYDGRDFYCLEANTLPGMTPTSHLPQEAKAMGISYPEL
CMRIIELSLEKYNK
>KF627472.1_18994|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LRPTAIKSAVDEMLWIWQKKSNNIKDLNSHIWDEWADEDGSIGKAYGYQLGVKYKFPHGE
MDQVDNVLWQLKNTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGNRLNGILNQRSQ
DILAANNWNVVQYSVLIHMMAQVSGLKPGELVHVISDAHIYDRHVDIISEMIERPQYPAP
KFILNPEVKNFYDFTTDDIRVEDYQKNPQIKNIPIAV
>KF627469.1_19003|FEATURES|farme|multidrug|lsaA|antibiotic efflux|0
MQPYTICLAGGVARNPLVRLAAPASASFTADEHIAIVGPNGSGKSLLVDMLIGKYPLKEG
TITYDFSPSTSKTVYENIKYIAFRDTYGSADANYYYQQRWNTHDHDDVPLVRDMLGEVRD
EKLDGGRQGG
>KF627449.1_19069|FEATURES|farme|bacitracin|BcrA|antibiotic target protection|1
MDIALQINNLGKAYGKHQVLENISFTVVKGEIFALLGTNGAGKTTTLECLEGIRRYDTGK
ILINGKLGVQLQSSSLPADITAKEAIMLFAKWQDLEVTDDYFIYLGIKAFLKKQ
>KF627445.1_19082|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
KEYSEMEHDSSRSGYHEPEPGSAGLSATEEDWGDDFPKTFSVNLIWAQARDKEGRAGAIG
LNGGMPWHCAEDMKHFKELTVSHPVIMGRKTWESLGVKYRPLPNRDNIVISHDPMYRAPG
ATVVTGLDDALDLARQEAIPDDGLDRSEIWVIGGAQLFSEALPFADKAYVTDLDATVDAD
AYAPDVESLVEAGLWHEAEAGEWLTPAKDEPGIAAYRFRILRKTK
>KF627419.1_19142|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
DFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTCNQYLKGFGIRVAESL
ILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQPAIEKAFEESDEVMIE
AFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQEITPARLPEDTAERV
RLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSFIPQQVRAAGLDIKDV
MTDIIENKF
>KF627400.1_19191|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMPPYWV
>KF627385.1_19235|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGTTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>KF627383.1_19246|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGSKTPVD
RNDFSFMNGAEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFVC
NQYLKAFGVRISESLLLRQGQAVSDEDVVEKIGLPCFIKPNLGGSSFGVTKVKTREQIQP
AIAKAFSEAEEVMIEAFMDGTELTCGCYKTKEKSVVFPLTEVVTHNEFFDYDAKYNGQVD
EITPARISEELTRRVQTLTSAIYDILGCSGIIRVDYIITEGEKINLLEVNTTPGMIATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF627381.1_19250|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ELLWFLKGSSNVRWLQEHNVHIWDDWADENGDLGPVYGVQWRSWPAPTSEDPNRTIDQIG
NVLDLIRNHPDSRRMVVSAWNPAEVENMALPPCHALFQFYVADGRLSCQLYQRSCDMFIG
VPFNIASYSLLTMMIAQQTGLEPGEFVWTGGDCHVYDNHVDQVLEQLSREPYPYPKIEIR
KADSLFDYQYEDFTIVDYRHHPTIKAPVAV
>KF627363.1|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRIWNEWEDETGDLGHVYGYQ
>KF627342.1_19375|FEATURES|farme|multidrug|cdeA|antibiotic efflux|0
VAKKSTAIDVTQGVIWQQLLSLCVPIFFSSFFQQAYTLIGTYIVGQFGGKLALGGIQATM
VLTELCIGFCVGVGAGCAVITGQYFGQHDDERLSRSVHTAMTLALVGGIAFSILGIVFVE
PMLVLMNTPHELLAEGVAYARCYFAAMVAALLLNMGTALLRSVGDTRGPAVIIASGCLVN
VVLDIIFVAVLHMEALGCGIAVALTICSNATMIVLRMMRAPGAWRLSLSK
>KF627339.1_19381|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
SEREVSLLSGRGVKEALASKGLEVESWDPAVDSVGGLEEGAYDAAFIALHGTLGEDGSVQ
GLLNCIGLPYTGPGVTASAIAMDKELTKNIWRANGISVPAGVRLTAAASDAELERAIAEF
GADGVVVKPGHDGSSIGVTKLDRDALSLHSLRAALNAAAERDAAEVLVEEYIHGREFTVA
ILDGKALPVIEICAPEGSYDFQNKYYTDVVRYECPAKLPEASAKALAAACEKAFAVLGCR
GWSRVDALERADGTFALLEINTSPGMTPHSLVPMAARAVGLSYADLCLRVLGLARTDIA
>KF627333.1_19395|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MKAIVVVDRNWAIGKNGDLLVHLPGDLRYYKEKTIGNVIVVGRKTLDSFPGGRPLPGRTN
IVMTTDPDFEREGCIICHSKDEVMEKLQAFDTEKVFIAGGANVYEQFMDDCDEFYVTKID
EEYEADRFFPDLDAKGLHVTWESEPQQEKGISYRFTIYSR
>KF627329.1_19403|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MNYDELLAPAAKAMRPSGIRKFFDLAADMPHCISLGVGEPDFKTPWSVRDAGIRSLELGR
TKYTANSGLKELRGEICNYLQRRFDLHYKEENILVTVGGSEAIDLTIRAVVQPGDEVIIP
EPCFVCYEPITQLTGGVPVHIATRAEDQFRLTADQLRAAITPRTKLLIFPYPNNPTGAVM
SAAEMEEIAAVLRETNVLVLSDEIYSELTYGLDRHVSIASLPGMAERTIVVNGFSKSYAM
TGWRLGYAACPAPLVKVMTKIHQSCIMSAPTTSQYAAITALRQCDDQIEMMRDEYNRRRR
YVVKALNDMGLTCFEPRGAFYVFPSIQISGLTSSEFCEQLLREKEVAIIPGSAFGASGEG
YARISYAYSVDHLQTAMKRIREFLTEHGWMKK
>KF627321.1_19427|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKLPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLSIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLASQNRG
RTQDRFFRPQCRQHENCR
>KF627319.1_19437|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDTVCSGAEVFPSLETALKSCREDEHIYIIGGASIYQQALSFADELCLTEID
STAPEADAYFPEVSSKVWQEKSREAHPADEKHLCSYAFVDYVKA
>KF627314.1_19454|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target protection|0
MIQYIRIQNFRSVKDIALELGPLNIVFGPNGCGKSNIYNAIHLLTAAAEGRLSGFISEEG
GLENMMWSGERSPLDRHPRRLQIACRTDSFDYELQIGFPEKLPYPTQFMLDPIVKEENIW
LAGYSRRPSSRVLQRKNQAAFLVDVTGEKSTFTESIYENESVFGQLGEPHRFPEVSRVRE
TLRRWRFYHEFAIGRHSPLRQPAVGYRSPVLDSDGQNLAAAFQTIVEIGAEEILHEILAD
AFPGCQFYCENEHSRFA
>KF627313.1_19457|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQAT
FDILGIKYTGPNYLGSALAMDKGVTKQIFTMAGVPTPLGTNLTKDRKDTALSDLGLTLPV
VVKPCYGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPVI
EIIPKTGFFDYANKYQDGCTEEICPANIDEEVTERMQRAAELAFKALKLDIYSRADLFIR
>KF627310.1_19464|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MGRKTLESFPNGQPLKKRVNIVLTHDKNFKAGDAIIVHSMEELREELKKYPSEDIYVIGG
ETIYKQLLDDCDVAHITKIDYAFEADAYFPNLDEMPEWKITQDSEEQTYFDLEYYFYKYE
KIK
>KF627305.1_19479|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILEQQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGESPARCIGEYRNDLNFYTNGR
SVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM
>KF627290.1_19517|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
LIPQPSYVSYEPCAILAGATPVIIDLKAENEFRLTAEEQEAAITDKTKVLILPFPNNPTG
AIMEKSDLEAIAKIIEEHDIFVMSDEIYSELTYKEKHVSIISLPGMKERTVYINGFSKAY
AMTGWRLGYCCGPEAIIQQMTKIHQFAIMCAPTTSQYAAVEALKNGDPDIEEMRTAYNQR
RRFPMNAFREMGLECFEPYGAFYVFPCIKEFGMTSEEFATRFLEEEKVAAVPGTAFGDSG
EGYLRISYAYSLEKLKIAIGRLGHFVEKLRAEQNNK
>KF627287.1_19527|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|0
MSKVSIIAAVDRHMAIGFENKLLFWLPNGLNRF
>KF627282.1_19537|FEATURES|farme|macrolide-lincosamide-streptogramin|lmrC|antibiotic target protection|1
RQAFLFAGTVSSNVGYGEDNASGAAIRKAVAIAQAAEFVESPEVGYSGTVAQGGSNFSGG
QKQRLSIARAVARDPEILVFDDSFSALDYKTDHALRQALREQTSGTTNIIVAQRIGTIRD
ADCILVIEDGAIVGKGTHRELMESCKVYQEIAYSQLSKEELAS
>KF627280.1_19543|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRNDVRLDNYVTGPQIQDI
PIAI
>KF627277.1_19551|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFM
GYSDREEDLTGIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKMCQMAD
IVFMALHGENGENGKIQAAFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGIS
MTRATRQDDITKLDLTLPCVVKPCCGGSSIGVTIVKDAAEFKAALDDAFKWENELVIEEF
VQGREFSVGVIEGKALPIIEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAE
EVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLI
DISLKKYEV
>KF627276.1_19554|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVNADKNWAIGKNNSLLVRIPADMKYFRQMTEGNIVVMGRKTLESFPQGRPLANRVN
IVISHNPDYQVKDAIVVHSVEEAIQECKKHKGEVFVIGGESIYRAMLPYCNIAYVTRTDH
VYEADTWFPDLEKDPDWQKTAETDEQTYFDLEYVFAKYERIK
>KF627271.1_19571|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VKILVLAGGLSPEREVSLSTGTMVCNALREKGQDAILVDLFYGVEELPGDMESFFADKTP
LPPYVIESAVPDLSRLREESRNRPYGTIGKNVIELCKAADIVFMALHGEPGENGMVQAML
DMLNIKYTGAGYRGSAVAMDKALTKHILVSRGINTVEGIMLKRGEPLSDVPLPCIVKPCS
GGSSIGVRRVLDRADVLPAVEEAFKYEDDILIEKFVSGREITCGVLGDTALPPAEVIPKG
GFYDYAHKYQSGLITEICPAELPVEVTAEVQDISLRVFRALGLEVYARMDFIYDGRDFYC
LEANTLPGMPPPAIFPRRRRPWG
>KF627269.1_19577|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTGKRIRVAVLFGGVSSEHEVSLMSVESVLANLPQEYEVLRIGITKDGRWVEYTGKNDEI
TSGAWEQDKSLRTAVLSPDRSHKGFLLLGSDGWELAPVDICFPVLHGKHGEDGTIQGLFQ
LADIPFVGCDAISSANCMDKEMTHTILEAHGIQMAKWLRVDNEKMQDFDAFAKQAEQKLG
YPMFVKPANAGSSVGVGKAHDRAELKSACLHALQEDYKAVVEECIEMQEVETAVLGNSNP
QAAGVVGELVPVVEFYTYEAKYIDGTTALHIPGRVDEEISQQLRRTAEKAFAAIGCQGFA
RIDFFVRKGDHAVILNEINTIPGFTSISMYPKLWAHCGLSYPQLLDRLIQLGLERNAQ
>KF627263.1_19589|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKNNTVAVLMGGVSREADISRKTGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAE
VVFIALHGKYGEDGTIQSILELSKIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKP
YYLKNGIDTVAESIEKNFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILA
EAYLDGKEFTIAVLNGKALPIIQICPHSGQYDFHSKYTSGATDYIVPAPLPGAAADEMTH
MAILGYEAAECSGVVRFDFRTDKKGTPFLLEANSIPGMTETSLVPKAAAAIGIDFPSLCE
NILLKAGVDKV
>KF627250.1_19618|FEATURES|farme|multidrug|bepE|antibiotic efflux|1
DVIHASIDEVMVTFLETTLLVVLVIFLFLQNWRAVVIPCITIPVSLIGTLAVMSLFGFSI
NTLTLFGLILAVAIVVDDAIVVVENSTRLLDTGRYTSRQAVTEAMGEITGPIVGVVLVLL
AVFIPTTLVSGISGQLYKQFALTIAASTVLSGFNSLTLTPALCALMLQPTRPSKNPLYRG
FNRLYDKTQGVYDRIVEYLLQRPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLAV
VQLPPASSLERTQAVGKQINKILDSYPEVKDYIGISGFSVMGGGEQSNAATYFIVLKNWN
ERKGKKHTAEAVVQRFNMEVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGTTEM
QRAVETLMEHYRNYPALASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMGE
AYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQI
NRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTV
VFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLV
ALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAG
AGSRVALGAAVVFGMALNTLLATVYIPNFYELMQKLQERFSKKQ
>KF627233.1_19669|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVSIIVAVAENGVIGDKNTLLWHISEDLKHFKAVTTGHPVIMGRKTYESLGRPLPNRTNV
VITRQQVEIPGCRVVHSLGEAVALFPGDDEVFVIGGAQIYAQALPLADRFYLTRVFRAYE
GDTHFPEWDEAQWRLLSSESFASGTNYPYPFAFETYERRRN
>KF627186.1_19787|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLDSGKNVVVALKEAGYTSVELLDTAADDFMVTMAN
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF627181.1_19801|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MKIVVLAGGISTERTVSLVSGTGVCQALRRKGHQAILVDMFMGLENPPADLNTLFDAPDG
LCPDVKIEVQAPDLDVVRRSRPDQSPSRIGPHVLDICRLADIVFLGLHGQDGEDGRIQAT
LDLLGVPYTGAGYLG
>KF627176.1_19818|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRLNIALMAGGDSSGREIALQSAAQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQV
DKNDFSITIDGDRKTFDYSLILIHGTPGENGRLQGYLDMMGIPYSSCSMTSSVVTFDKIT
TKRTVAEFGIPLARGFFFGRDSRIDPEEIVRTLGLPVFVKPNASGSSFGVTKVKSEADIL
PAVAEAFTESGEILIEEGIRGREMGCGMLIAIGREYIFPITEIVSKKEFFDYEAKYTAGC
SDEITPADIAPEIKAELNRLTALAYKACRCRGVVRVDFIVTPEGKSYLIELNSIPGMSGG
SIVPKQVREAGMTLGELYDLIIEDTYDRDRR
>KF627175.1_19821|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFSVCNELCLKPPRV
>KF627171.1_19834|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTRLKIALLAGGDSPEREIALQSAALIEAALDHSKYDITVIDLHGRDWHHTAPDGRQWQV
DKNDFSITVDGVRKAFDYALIIIHGTPGEDGKLQGYLDMMGVPYSSCSMTSSVITFDKIT
AKRTLAGRVNLAREVFLRRGEAFDPAQIVAELGMPLFVKPNANGSSFGVTKVHAPEELPA
AIEAAFAQGDEILIEECITGREMGCGMLVAGGREYVFPITEIVSKKDFFDYEAKYTAGFS
DEITPADITPEVKAELNRMPREAYRTCRCSGVVRVDFIVTPAGVPYFIELNSIPGMSRGS
IVPKQAREMGMSLGKLYDIIIADTCRK
>KF627168.1_19843|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTALSWPNVTVVHTLDEIPIQDTTEDEIFIMGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWKIANSQEMPADEKHAYPYTFVTYTRRRIENREPSDK
>KF627163.1_19858|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NCQEILSRGTWDTHLPVRPRWEDGTPAHTVKCFGLVNRYDLREEFPIQTIRRMYLKSAVE
ELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEMDQVDRVLYDL
KHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGDTLNAILHQRSQDMLTANGWNVM
QYAVLVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPRLRLDPAVTDF
YAFTPDSVQLENYRYHPLKEKIPVAI
>KF627149.1_19899|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MEAGELLHVVADCHIYDRHIPLIKELIQRKPYPAPVVKLNPEVKDFYQ
>KF627145.1_19909|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEVVLMKVGVIMGGISSEREISLNSGNSIMENIDKNKYDVVPVVIDEKADIINKVKDLDF
ALLALHGKFGEDGTVQSVLQTLDIPYSGCGPLSSALCMDKDLTKVVLAANGIRTAKWLNV
KSVEEIDYDAIEKMGYPVFIKPTNGGSSVATFKVYDKEKGTRSCRRRIKMGYRSNDRRIC
>KF627144.1_19912|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MEKKNYEQSKKLDNVCYDIRGPVMDEAMRMEARGANILKLNIGNPAPFGFYAPDEVILDM
IYNLRNCEGYSDSRGLFSARKAIMQYCQLKGIPNVGINDIFTGNGVSELITLTMQGLLDD
GDEILVPAPDYPLWTASITLAGGKAVHYLCDEQQDWYPDINDLRSKVTPRTKGIVVINPN
NPTGALYPKEILEQIVQVARENDLILFADEIYDRLVMQGEPEHIALASLAPDLLTLCFNG
LSKSHRVAGFRVGWVCPAGDKSHAKGYID
>KF627140.1_19924|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIKEFKSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGRWLLVDS
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKE
IPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDR
TQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDG
FGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF627122.1_19966|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCEKILEEGFSSEGMQVRARWEDGTAAHTIKTFGVVNRYDLEEEFPALTL
RPTAIKTAVDEVLWIWQKKSNNIKDLKGHIWDEWADENGSIGKAYGYQIGQKSHYTEGDF
DQMDRVLYDLEHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKSIPIAV
>KF627114.1_19988|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLARQE
>KF627107.1_20006|FEATURES|farme|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|0
MNTTEFDEIRPYNDEELPQIFEELIADPAFQKAATDAIPNVPFELLAQKIRACKSKLDFQ
ETFCYGILWKIAADHTDGLTLDHTAVPDKSKAYTYVSNHRDIILDSGFLSILLIDQGMDT
VEIAIGDNLLVYPWIKKLVRVNKSFIVQRALTMRQMLESSARMSRYMHYTINEKKQSIWI
AQREGRAKDSNDRTQDSVLKMLAMGGEGDLIDRLMEMNIAPLAISYEYDP
>KF627104.1_20015|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSFLKDKKATVGVAVLANDEIVAVYN
NQIHFPLLSVFKFHVGLAVLDKMDKDHIGLDSLIEVKSSQLKPDTYSPLRDEFPDQDITI
SLGELLKYTISKSDNNTCDILIEYVGGIDQVNEYVKSLGIKDCNLAATETLMHTSGDAYL
>KF627097.1_20033|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
VNSNDYNREKIMNLIAAVDNNWAIGKKNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECDVAHITKVDFEYDADAYFPNLDEKPEW
>KF627097.1_20034|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FSITPFIMPAFVLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVC
QYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPKFWLNPDIKDF
YQFTTDDIKITDYVTGEQIKDIPIAV
>KF627092.1_20047|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MIDYNKVLCPAIKEMKPSGIRKFFDIAQQLEGVISLGVGEPDFKTPWLIRQEAISTLEKG
KTCYTANAGLIALREEIAKYFQRTIHTSYDPNKEIIVTVGGSEAIDLTIRCLIQPGDEVL
IVEPSFVCYRPIVSLCGGVPVVIETKEENEFRLTADELREKITDKTKLLVLPYPNNPTGA
IMRREDLEAIAKVLKDTNIMIASDEIYSELTYSGKHCSIAEIEGMRERTIVINGFSKSFA
MTGWRLGFLGGPKEIVSQMLKLHQYAIMSSPTVSQYAAIVAMHSCQKDIDAMRNEYNIRR
RFVVDSFNKLGLKCFAPQ
>KF627090.1_20053|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLSSAAGICRTLLEKGHDAFLLDVFMGLEHTPENLEDVFTLPDH
GLDIVKNISTEEPDLAAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
AFDLLGIKYTGPDSLGCAVAHA
>KF627069.1_20108|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
QKGHEAILVDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVL
ELCEKCDIVFLGLHGANGEDGKVQAAFDLMGIRYTGTGYLSSAMAMDKRITKEVFLMNNV
PTPGGFTMTRDNLEKDIAKYNLQFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGA
DIVVEEYIKGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTA
KMQENAVKAAKALGLTGYSRLDFMMKGNG
>KF627064.1_20120|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTEREVSISSGTLVAEALRSKGHEVVLLDVFMGYEENICDIDALFKQNYS
FTDGNSIGDDVENTITNIKEAKENRLDKTSRYIGRNVIEICSEADITFLALHGGEGENGQ
LQATLDLFGIKYTGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWNMFPC
IVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPI
EIAPKSGMYDYAAKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLD
KGGFTYCLEANTLPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPKEKSDF
>KF627047.1_20161|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWRVLVEQGID
AREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHVEVPASLPE
ETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMYPKAWEATG
VSYTGLITTLIEGVLR
>KF627047.1_20162|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRD
>KF627045.1_20164|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLYDEKYLSIVKDILDNGYYDNNRTGMPTYKLPHQIMQFNLQKEFPILTTKFVAFKTAV
KEMLWIYQKQSNVVEDLRQMNVKIWNEWEGEDGTIGKAYGYQVKKFHQIDNLIEALKNNS
QDRRMMLNLWNWEDLPEMSLAPCCFLTMWDVTDGHLNCMLIQRSGDMPLGVPFNSAQFSV
LTHMLAQVTGLKPGLFTHVINNAHIYENQIEGMEVQITRANDAYSAPKLWLNPEIKDFYE
FTIDDIKLIDYEYHPAIKMEVSV
>KF627041.1_20178|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTIGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNPEAAAEAARALDGAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEDAFTIESVVDGAVDEKNKYPHRFVTYRRKASK
>KF627031.1_20207|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLRFCAVKLASMALTPEQLADIRTRIPARPETGIPMPYEDLVRRILTEGTLKSDRTGT
GTISLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQEHNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVKNHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQTGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPHIRINKADSLFDYDYSDFEIVGYQHHPTIKAP
VAV
>KF627031.1_20208|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHCAEDMKHFKELTVSHPVIMGRKTWESLGVKYRPLPNRDNIVISHNPMYRAPGATVVTG
LDDALDLARQEAIPDDGLDRTEIWIIGGGQLYREAMPFADKAYVTQISMHADADTYAPDV
KSLVESGAWKVLEEGVWQNTRKGSGDIAGFRFMTYAKNREE
>KF627014.1_20248|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMMAQQAGLEPGEFVWTGGDCHVYDNHVDQFLEQLSRDPYPYPTIEIRKADSLFDYQYED
FTIVGYQHHPTIKAPVAV
>KF626992.1_20288|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
PVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDA
ATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREVYFD
EVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQA
PEGWLKVIE
>KF626991.1_20290|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VNLAFEHDSKVLIEEFVAASEVESAVIGNTDPMVAENIGEIAPANEFYDFDAKYNDSSSK
ITIPANVTKDVEAKLKDYAIRAYKICECGGLSRVDFFVDKESGTVRLNEINTLPGFTSIS
MYPKMWEKSGVGNFKLLDNLINYALDKNNK
>KF626988.1_20298|FEATURES|farme|chloramphenicol|BN488_01641|antibiotic inactivation|1
MAFKKIDKENWGRKEYFEHYFSDVPCTYSITVKLDITRIKEKKQKLYPTMLYYLATVINR
HAEFRTAINENGELGIYSEMIPCYTVFHKDTETFSNLWTEYKANLDDFCAAYEEDMLKYG
KQPGITGKPNIPSNSFTVSMLPWATFEGFNLNLQKGYNYLIPIFTIGKYYQENERIMIPI
SIQVHHAVCDGFHVCRFTNELQELINN
>KF626987.1_20302|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNLIVAVDKNWAIGNKGELLVRIPADHKMFRQETTGKVVVLGRKTMDTFPGGQPLKNRDN
IILSRNEAYQQKDAQVVHSVEELLEAVKGYDTKEVYVIGGSSVYEQLLPYCDTAHVTKID
HAYEADSWFPNLDEDPDWEITADSDEQYYFD
>KF626982.1_20318|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPRGLTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDRLTLNGVLNQRSNDVLAANNWNV
CQYALLLMMIAQVCDMKAGELLHVIADAHIYDRHIPLVKELISRETHPAPKVWLNPEVKD
FYAFTVDDLHVEDYVTGPQIKNIPIAV
>KF626973.1_20337|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
TPRGHAKPLKNVKGNVCYEDVSFHYSDDDTPVLSHVSFEIPAGKSIALVGPSGSGKTTIC
SLLPRFYDVTDGRVTIDGNDVRKLTLESLRSQIGLVSQDVYLFGGSIKDNIAYGKPDATM
DEIVDAAKKANIHDFIMELPDTRLARRAIMPRATLTRWTACCTTSSILRTVAAS
>KF626972.1_20342|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDLIASTDKNWAIGRGGKLLCHLPGDLRYFKEKTTGKTVVMGRKTLESLPGGKPLPNRKN
IILSRDRSFSAEGCFVCHSVEALLNLCGNDDVMVMGGAAIYQQLLPYCDSCYITKIDCAF
DADAYMIDLDERDDFRLAWQSGWMEEKGISYQFTRYDRINI
>KF626962.1_20368|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITLRK
TYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEMDQ
VDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQDIL
AANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPKVT
LNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF626959.1_20377|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMIESRRRFFGPNVLELCEAADVVFLALHG
ANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSITKQFFRAHNVPTPNGVTLEKRPGER
AAFQLRTGASGCCKTVLRRIQRRCLYRAYERGILAGHEGCFLL
>KF626958.1_20381|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITGNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
FAYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF626956.1_20385|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADLLYRETCARILREGVWDTDQSVRPRWADGSPAHTVKCFGVVNRYNLQEEFPLMTL
RRTYWRSCVEELLWIWQKKSNNVHDLGSHIWDSWADESGSIGKAYGYQLGIKYRFPEGEF
DQVDRVLYDLKHNPASRRILTSLYNFADLHEMALYPCAYSMTFHVSGNRLNAILNQRSQD
MLTANNWNVVQYAVLVHMLAQVSGLVAGELVHVIADCHIYDRHIPLVEQMLELEPYPAPE
FRLDPAVTDFYAFTPDSVRVENYCYHPFSARIPVAI
>KF626939.1_20428|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLCGGNSTEREVSINSGYNVCGALREKGHNAILLDAFFGNKDLSIFEKSEKEYDVI
AERDHIRSLSSKVKEEEKSRKSFFGENVLGICAKADIVFLALHGKNGEDGKCQATLDLHG
IKYTGSGALASAIGMDKAVTKQIFIAKGVPTAKSVWIKKGEDTSLEAHGMKAPVVVKACN
GGSSVGVVLVKEASEYDSAVEECFKYDNQILVEDFIEGREFSIGVVDGMAYPIVEIIPNE
GWYDYENKYKEGATTHVCPAKLDEELTKKMQKVAEGACAAIGCEAYSRADVMMDKDGNMF
CLEVNTLPGMTATSLIPDEARAIGIDYPTLCDNLINISLKKYQ
>KF626934.1_20441|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFRLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASVYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREAHPADEKHLCSYAFVDYVRGID
>KF626927.1_20457|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIE
DGDTFF
>KF626902.1_20522|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MKINPDVKDIFSFKYEDFELVNYDPWPHIAGKVSV
>KF626896.1_20535|FEATURES|farme|aminoglycoside|rmtB|antibiotic target alteration|1
MSAKKVFNADEVAASILKSPKYRAIAPDAVNRIAAEECQKGGADCEKRARNRLHQIADAF
MNQKEQSMLWDMLERGDLDAALSQHASTRERMATREEYMSLIARHCPPGGIICDAACGLD
PLMLGAAGYAVRGLDIQMTCVDVINAWARREGWDVKAEGADLLGRAELPKSDLTLFMKLL
PVLDAQRAGEGMRLLSLSSSPRVIVSFPTRTLGGRGVGMERNYGERFESALPVEFEICER
MATGNELFYALRRV
>KF626892.1_20548|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
REPLPAPKFWLNPKVKDFYDFTRDDVKLIDYETHEQIKNIPVAV
>KF626890.1_20553|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
KELISRTPYPAPIVRLNPEIKNFYDFTTDDLIVENYQTWPQIKNIPIAI
>KF626884.1_20563|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DELLWIWQKKTNDITELNSHIWDAWAGDDNTIGKAYGYQLGKKYKFRQGIMDQVDNVIWQ
LKNAPASRRIMTNIYNFEDLSEMGLEPCAYSMTFNVTGNRLNAILNQRSQDVLVANNWNV
VQYAVLVHMLAQVCGYEVGELIHVIADAHIYDKHIPLVEELIGRTQYPAPKFVMNPDVKD
FYEFTLDDFKLEDYQAGPQIKNIPVAE
>KF626879.1_20581|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIFSFKYEDFELVNYD
PWPHIAGKVSV
>KF626873.1_20596|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HMLAQVCDMQVGELVHVIADAHIYDRHIPLVKELISREPLPAPTFWLNPEVKDFYRFTRD
DVRLDNYQTGPQITNIPIAV
>KF626864.1_20615|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
YTTEDGHIVIFRPDLNGARMEDSCRRLEMPVFPKERFVDAVVQTVKANAAYVPPFGSGAT
LYIRPYMFGSSAVIGVKPAEEYQFRVFTTPVGPYFKDGAKPITIRVSDYDRAAPHGTGHI
KAGLNYAMSLYPIMEAHRQGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSDSI
LPSITRRSLVAVAKDYLGLEVEEREVCFDEVKDFAECGLCGTAAVISPVGKINDHGKEIC
FPSGMEKMGPVTQKLYETLTGIQMGRIQAPEGWIKVVE
>KF626860.1_20632|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
LNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVE
ETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDE
WKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPL
PITMIGDAAHLMSPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGKEA
QEESTQNEIEMFKPDFTFQQLLNV
>KF626851.1_20659|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NDYLDTAVLPSCVWSSEWDVTNGKLNCWVHQRSCDVPLGLPFNVTQYATLLCMLAQVCGL
KPGTIDWSIKDAHIYVNQIDGIKEQLKRFDEQGDLPAPKLWLNPEVDDFFKFDSSRDCKD
VKLIDYKHLGKISFPISQ
>KF626850.1_20660|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YRPPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQDILTANNWNVV
QYAVLVHMLAQVSGLKPGQLVHVIADAHIYDRHVDIVREMIQRPQYPAPKFSLNPEITDF
YDFTTDDILIEDYEKNPQIRNIPVAI
>KF626846.1_20668|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
LNIIVAADKNWAIGENGKLLGSIPSDMKFFRQMTEHKVVVLGRKTLATFPNGLPLVNRKN
IILTRNPEMKVKGATIVHSVEEALEELAGYEDEDIFIIGGGHIYEEFLPYCKVAHVTKID
HAYQADTFFPNLDETGEWEITADSDEQTYFDLEYAFLKYERKGEAKPRIRK
>KF626830.1_20716|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKNNTVAVLMGGVSREADISRKTGTAILQALLSLGYHAVKVEYNPSCVLKQLKAVGAE
VVFIALHGKYGEDGTIQSILELSRIPYTGSGVSSSAITMDKIISSRVFKDAGVRMAFSKP
YYLKNGIDTVAESIEKNFKFPVVLKPACEGSTIGLEIVYEKEKLKEALKRVFAIESRILA
EAYLDGKEFTIAVLNGKALPIIQICPHSGQYDFHSKYTSGATDYIVPAPLPGAAADEMTR
MAILGYEAAECSGVVRFDFRTDKRGTPFLLEANSIPGMTETSLVPKAAAAIGIDFPSLCE
NILLKAGVDKV
>KF626802.1_20784|FEATURES|farme|polymyxin|arnA|antibiotic target protection|0
YAMSLYPIMEAHRQGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSDSILPSIT
RRSLVAVAKDYLGLEVEEREVCFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPSGM
NEMGPITKKLYETLTGIQMGRIQAPEGWLKVIE
>KF626787.1_20819|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
EGREQLQADNESGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKFFRQET
MGKVVVMGRKTLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEELKKYDDNE
IYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFPNLDEDPEWEITASSDEQTYFDLEY
TFVKYERK
>KF626778.1_20841|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
VSMALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGL
KLSTH
>KF626771.1_20864|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MVIAYDTGNGSDTHEPLLRVRDLCVEFPLDGGEVRHAVNDVSFDVPQGSVTCLVGESGSG
KSVTAMSTIDLVDEPGRIVGGTITFDGRDVLSLNHKNLERLRGEGISMIFQEPMHSLNPV
LRVGKQLGETIQVHSGASRESAWKRSVQWLKRVGLPNPERVMNMYPHELSG
>KF626767.1_20876|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MGVGSLLAGHAVEALRALGLPKVAVGVYADNKAGNDFWEQQGFAIRD
>KF626747.1_20907|FEATURES|farme|macrolide-lincosamide-streptogramin|ABC_transporter|antibiotic target protection|1
WSFASRIEKVRSSWFPSLPLDRRVSDISGGEYAAIGLAYIELHRPKIVLLDEPSNNLDLA
HRQLLAKLLVDYTATIIIATHDRQLLRYVDSIWEIKAGNLTKIEGTYTDYLTMCSVRQSQ
AKQRLSTASKGIRRLNRAVTDLEKRQSRKRDNNRTAASQKRGSKMSMNGLKSRSEASLGR
DRAKLLERKYDADVARVEAEKEIEKPRHIRLQGFLQTPHAKSQQILRLLDDTGWETIIGG
DDRVALLGENGVGKSSLICSISDLQYRNKLRAWAELVHPDNPSQIAILSQNSLHLCYEKS
VWEELTSSLPEYEKQAVFTILARLSFDENSSNKLIKDLSGGERFRVALAEVLLSKPEKRL
IILDEPTNSLDLASLKATEQMLSQFSGAILVVSHDLEFLQQISVNRWIELTNDGLFELVN
PPDY
>KF626745.1_20921|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHVWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>KF626733.1_20941|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVTSLDDALDMARQEAIPDDGLDR
SEIWIIGGAQLYAKALPFADKAYVTDLAATVDADSYAPDMASLVEAGMWREAEVGEWHTP
AKEESGIDSYRFRILAKTK
>KF626704.1_20990|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RNLYPCAYSVTFNVTKKSGHDKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDM
EAGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQA
GEQIKDIPIAI
>AAC44793|FEATURES|argannot|aminoglycoside|AAC(2')-Ib|antibiotic inactivation|1
VPFQDVSAPVRGGILHTARLVHTSDLDQETREGARRMVIEAFEGDFSDADWEHALGGMHA
FICHHGALIAHAAVVQRRLLYRDTALRCGYVEAVAVREDWRGQGLATAVMDAVEQVLRGA
YQLGALSASDTARGMYLSRGWLPWQGPTSVLQPAGVTRTPEDDEGLFVLPVGLPAGMELD
TTAEITCDWRDGDVW
>CAI46944|FEATURES|argannot|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVQSMRAALDLFGREFGDVASYSQHQPDSDYLAKLLHSRTFIALAAFD
QESVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINLLKQEANALGAYVIY
VQADYGDDPAVALYTKLGIREDVMHFDIDPSTAT
>BAD00738|FEATURES|argannot|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
VSVEIIHLTGNDVALLQSINAMFGEAFNDQDSYARNKPSSSYLQKLLSTSSFIALAAVDE
QKVIGAIAAYELQKFEQQRSEIYIYDLAVAATRRREGIATALIKKLKAIGAARGAYVIYV
QADKGVEDQPAIELYKKLGTIEDVFHFDIAVEQSKNHA
>ABD81100|FEATURES|argannot|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MPLEIKQITENELSQMEALSAVFGEVFSDKETYTENKPSADYVRSLLSSDYFIALAALDE
SKVIGGLAAYELKKFEQERSEIYIYDLAVIAAHRRKGVAIALIERLKIIAAERGAYVIYV
QADTGPEDKPAIELYSKLGVQEEVLHFDIEVKGNHGVT
>AAA26685|FEATURES|argannot|aminoglycoside|AAC(3)-VIIIa|antibiotic inactivation|1
VDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDA
VGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQ
PGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLT
LLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIA
QDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA
>ABC17631|FEATURES|argannot|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
MKYSLNPIRPEESHDWLRLRDLLWEADDHAIEIARFFTGELEETVEVLIARDLEGRAVGH
VELSIREDIDGLNGVKTGYIEGLYVDVLHRSSGLVRQFLRASEQWAKDQGCSAFASDRQD
RVIIHRRFSGGSA
>AAD03493|FEATURES|argannot|aminoglycoside|AAC(6')-Iu|antibiotic inactivation|1
MNILPISESQLSDWLALRSLLWPDHEEAHLQEMRQLLKQTDTLQLLAYSETQHAIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALDN
TISHAMHRALGFHETERVVYFKKNIS
>AFK93816|FEATURES|argannot|aminoglycoside|Ant3Ia|antibiotic inactivation|1
VRASLVAKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSD
IDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKREL
QFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALN
ETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEA
RQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AAL36430|FEATURES|argannot|aminoglycoside|aadA6/aadA10|antibiotic inactivation|1
MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDE
SVRQALFVDLLGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWI
GDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEARQAYLGQGEDCLA
SLTDQLEAFVHFVKHEATKLLGATPMMSKTKLDALST
>CAD99015|FEATURES|argannot|aminoglycoside|aadA11|antibiotic inactivation|1
MREAVTAEISTQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLNE
ATRQALLNDLLEASAFPGESETLRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
ISEPAMIDVDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWA
GDERNVVLTLSRIWYTEVTGKIVPKDVAADWAMERLPAQHQPVLLEARQAYLGQKEDRLA
SRADQLEEFVHFVKGEITKVVGK
>CAA48308.1|FEATURES|argannot|aminoglycoside|aadA|antibiotic inactivation|1
VTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>AAN87151|FEATURES|argannot|aminoglycoside|aadA21|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVARDWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>AAC14728.1|FEATURES|argannot|aminoglycoside|aadA3|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIHYVKGEITKVVGK
>AAF44098|FEATURES|argannot|aminoglycoside|aadA7|antibiotic inactivation|1
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLND
AVRQALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
ARADQVAALIKFVKYEAVKLLGASQ
>CAJ13568|FEATURES|argannot|aminoglycoside|aadA8b|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>CCC83993.1|FEATURES|argannot|aminoglycoside|aadE|antibiotic inactivation|1
MRSEPEMMNMLVKFAMNDKRIRLVTMEGSRTNFNVPPDSFQDYDISYFVTDMDSFKESDQ
WLNVFGDRLMMQKPEDMELFPSELGNWFSYIILFEDGNKLDLTLIPINEVEDYFTNSDGL
VEVLLDKDVLIQEEVIANDHQYWIKKPTAREFDDCCNEFWMVSTYIVKGLARKEILFAID
HLNEIARPNLLRMMAWKIGSEQGYTFSVGKNYKFINQYLPNEDWKSLLSTYSENGYQEMW
QSLLTCYSLFRTYAKAVASSLKYEYPEYDEAITRYTVNIYNSLN
>AAA25717|FEATURES|argannot|aminoglycoside|ANT(4')-IIa|antibiotic inactivation|1
MHLTITYWIDRLREAYPHAVAILLKGSYARGEASAWSDIDFDVLVSDEEVEEYRTWIEPV
GERLVHISVAVEWVTGWERDSADPSSWSYGLPTQETTQLLWAADENIRRRLDRPFKVHPA
AEPEVEDTVEALGKIRNAMVRGDDLAVYQAAQVVGKLIPTLLVPINPPTYARFAREAIDR
ILAFPNVPEGFAADWLTCMGLVDRRTHDPQPTRPNEWCAARSRFCRRMRTSSVRISRGCW
KQDWYLRISART
>ACN81017|FEATURES|argannot|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>CAA88266.1|FEATURES|argannot|aminoglycoside|Aph3Ic|antibiotic inactivation|1
MSEWRRQQVCAPIPMPASMATSLEGYQWAPITIGESGSNVYRLYGKPKAPDLFLKRGKYD
VADDVTDEMVRLRWLAERIPVPTVVNFVRTLDEAWLLTTAMPGRTVYEELEANPDACLAI
ADALADFLRRLHEIPTIECPFNSNHIYRLALARKRIEAGMVEVDDFDDERKGWAAEQVWD
AMHNLLPFTPDPVTTHGDSALENLFVREGKVTGCIDVGRSGVADRYQDIAILWNRLGEFG
SLPQERFVEQYGIADVDRRKLSFHLMLDELF
>AAA76822|FEATURES|argannot|aminoglycoside|APH(3')-VIIa|antibiotic inactivation|1
MKYIDEIQILGKCSEGMSPAEVYKCQLKNTVCYLKKIDDIFSKTTYSVKREAEMMMWLSD
KLKVPDVIEYGVREHSEYLIMSELRGKHIDCFIDHPIKYIECLVNALHQLQAIDIRNCPF
SSKIDVRLKELKYLLDNRIADIDVSNWEDTTEFDDPMTLYQWLCENQPQEELCLSHGDMS
ANFFVSHDGIYFYDLARCGVADKWLDIAFCVREIREYYPDSDYEKFFFNMLGLEPDYKKI
NYYILLDEMF
>CAF29483|FEATURES|argannot|aminoglycoside|APH(3')-VIa|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSDKLKVPELIMTFQDEQFEFMITKAINAKSISALFLTEQELLAIYKETLNQLNAVA
IIDCPFISSIDHRLKESKFFIDNQLLDEIDQDDFEAELWGDHKTYISLWNELNETRVEER
LVFSHGDITDSNIFIDKSGEIYFLDLGRAGLADEFVDISFVERCLREDVSEETAKIFLKH
LKNDMPDKRNYFLKLDELN
>AAB58447.1|FEATURES|argannot|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKQPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESKSYFIKLKYGYHDE
INLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKQ
LGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQ
NSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKE
RDLMFIGGGVGNVWNKPHEIQYFYEGYGEINVDKTILSYYRHERIVEDIAVYGQDLLSRN
QNNQSRLESFKYFKEMFDPNNVVEIAFATEQ
>CAA26428.1|FEATURES|argannot|aminoglycoside|aad9Ib|antibiotic inactivation|1
MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQ
LTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENG
QIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGD
ERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGL
YSKVKALVKYMKNSIETSLN
>CBJ02047.1|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MKRTMLYLSLLAVSCSVSAAKYPVLTESSPEKAGFNVERLNQMDRWISQQVDVGYPSVNL
LIIKDNQIVYRKAWGAAKKYDGSVLMEQPVKATTGTLYDLASNTKMYATNFALQKLMSEG
KLHPDDRIAKYIPGFADSPNDTIKGKNTLRISDLLHHSGGFPADPQYPNKAVAGALYSQD
KGQTLEMIKRTPLEYQPGSKHIYSDVDYMLLGFIVESVTGQPLDRYVEESIYRPLGLTHT
VFNPLLKGFKPQQIAATELNGNTRDGVIHFPNIRTSTLWGQVHDEKAFYSMGGVSGHAGL
FSNTGDIAVLMQTMLNGGGYGDVQLFNAETVKMFTTSSKEDATFGLGWRVNGNATMTPTF
GTLASPQTYGHTGWTGTVTVIDPVNHMTIVMLSNKPHSPVADPQKNPNMFESGQLPIATY
GWVVDQVYAALKQK
>AAF86696|FEATURES|argannot|beta_lactam|ACC-3|antibiotic inactivation|1
MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVT
>ABP49606|FEATURES|argannot|beta_lactam|blaACC-6|antibiotic inactivation|1
MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGK
NYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELR
GSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLL
GMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHGNMEILG
NEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWEQLPY
PVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVM
LANKNYSIDQRVTVAYKILSSLEGNK
>ACJ05686|FEATURES|argannot|beta_lactam|ACT-6|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMANWVMVNMKPDSLQDSSLKEGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AEV91214|FEATURES|argannot|beta_lactam|ACT-10|antibiotic inactivation|1
MMKKSVCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGIAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WKGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKTEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVMVNMKPDSLEDSSLRKGFTLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AFU25650|FEATURES|argannot|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>AFU25647|FEATURES|argannot|beta_lactam|ACT-14|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYLAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AFU25653|FEATURES|argannot|beta_lactam|ACT-15|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKSGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>CAG25812|FEATURES|argannot|beta_lactam|OKP-A-1|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLVSGRTLAAWRANE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIAEKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPASMAERNQQIARIGAALIEHWQR
>ACN65419|FEATURES|argannot|beta_lactam|OKP-A-15|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLLAAWRASERFPLM
STFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITM
SDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAAT
LRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALL
GPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19611|FEATURES|argannot|beta_lactam|OKP-B-3|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMVERNQQIAGIGAALIEHWQR
>AET86558|FEATURES|argannot|beta_lactam|NDM-2|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMAGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AFK80349|FEATURES|argannot|beta_lactam|NDM-3|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTNDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AFS33103|FEATURES|argannot|beta_lactam|NDM-7|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMNALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>CAC33434|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSTIATQEEQRLHARIGIAVLDTA
TNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASTQFESSQLVEYSPITEKHV
APDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSA
IPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIA
DKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD
>AAU95779|FEATURES|argannot|beta_lactam|MIR-3|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLHAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AFJ79785|FEATURES|argannot|beta_lactam|MIR-6|antibiotic inactivation|1
MMTKSLSCALLLSVTSAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTSTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAA71326|FEATURES|argannot|beta_lactam|DHA-21|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ACS44785|FEATURES|argannot|beta_lactam|MOX-7|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLVHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWL
KGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGM
LADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYP
VSEQTLLAGNSPAMIYNAIPAVPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVML
ANRNSPIEARIKAAHAILTQLAR
>ADU79020|FEATURES|argannot|beta_lactam|PER-6|antibiotic inactivation|1
MNVIAKGVFTTTALLMLSLSSWVVSAQSPLLKEQIETIVTGKKATVGVAVWGPDDLEPLL
VNPFEKFPMQSVFKMHLAMLVLHQVDQGKLDLNKTVAVNRAAVLQNTWSPMMKDHQGDEF
TVTVQQLLQYSVSHSDNVACDLLFELVGGPAALHAYIQSLGIKETEVVANEAQMHADDQV
QYKNWTSMKAAAQLLRKFEQKKQLSETSQALLWKWMVETTTGPQRLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDIGVIMLPDGRPLLVAVFVKDSAESARTNEAIIAQVAQAAYQFELK
KLSAVSPD
>AAG13410|FEATURES|argannot|beta_lactam|KPC-2|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPSDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AEN02811|FEATURES|argannot|beta_lactam|blaKPC-18|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ABY91240|FEATURES|argannot|beta_lactam|KPC-5|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ACB71165|FEATURES|argannot|beta_lactam|KPC-6|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ACS35345|FEATURES|argannot|beta_lactam|KPC-10|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AFV48348|FEATURES|argannot|beta_lactam|KPC-14|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
ANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AIX87991|FEATURES|argannot|beta_lactam|KPC-22|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPGSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AAK38324.1|FEATURES|argannot|beta_lactam|JOHN-1|antibiotic inactivation|1
MRKLASIILFLAAVSNSLGQSKNSPLQISHLTGDFYVYRTFNDYKGTKISANAMYVVTDK
GVVLFDAPWDKTQFQPLLDSIKAKHNKEVVMLFGTHSHEDRAGGFDFYKKKGIKTYSIKL
TDDILKKNKEPRAEFIISNDTTFTVGNHTFEVYYPGKGHAPDNIVAWFKKEKILYGGCFV
KSAEALDLGYLGDADVKEWQKSIKKVQAKFKKPDYIISGHDDWTSKESLNHTLKLVDEYL
AQKSAGKK
>AAS78754|FEATURES|argannot|beta_lactam|IND-5|antibiotic inactivation|1
MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKK
GVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPITIDKLKAKYSKATLIIPGHDDWKGGGHVEHTLELLNKK
>ADA13241|FEATURES|argannot|beta_lactam|IND-10|antibiotic inactivation|1
MKKSIQFFIVSMLLSPFANAQVKDFVIEPPIKSNLYIYKTFGVFGGKEYSANAAYLKTKK
GVILFDVPWEKVQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKKYATLK
TNEFLKKDGKATSTEIIQTGKPYHIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTMNKLKTKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ADK25052|FEATURES|argannot|beta_lactam|IND-2a|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHEEWKGGGHVQHTLDLLDKNK
KPE
>BAJ14288|FEATURES|argannot|beta_lactam|IND-15|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVRFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKMKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>BAJ19094.1|FEATURES|argannot|beta_lactam|IMP-18|antibiotic inactivation|1
MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVVTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELT
NELLKKDNKVQATNSFSGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGNASLLQRTWEQAVKGLNESKK
PLQPSS
>BAD81061|FEATURES|argannot|beta_lactam|IMP-20|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>ACX71212|FEATURES|argannot|beta_lactam|IMI-3|antibiotic inactivation|1
MSLNVKQSRIAILFISCLFSISFFSQANTKGIDEIKNLETDFNGRVGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILSEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>AHE78014|FEATURES|argannot|beta_lactam|IMI-4|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKYEKEAKHEDKVIAEASRIAIDNLK
>CAD60969|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGEHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>AAQ54756|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFVILFFMFICLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETGAKFYA
DKEDADVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKITLGNTILTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLNKRKKDSQDK
>AAT68579|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFVCLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYA
DKADADVLRTGGKSDYEMGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAT68580|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>AAR97270.1|FEATURES|argannot|beta_lactam|GES-5|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAY43207|FEATURES|argannot|beta_lactam|GES-9|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGSRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ACS73598|FEATURES|argannot|beta_lactam|GES-10|antibiotic inactivation|1
MRFIHALLLAGTAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLCDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEO12975|FEATURES|argannot|beta_lactam|GES-11|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ACZ98826|FEATURES|argannot|beta_lactam|GES-15|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKESEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ADJ94120|FEATURES|argannot|beta_lactam|GES-16|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAEIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEZ05107.1|FEATURES|argannot|beta_lactam|GES-19|antibiotic inactivation|1
MRFIHALLLAAIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>CAA71325|FEATURES|argannot|beta_lactam|FOX-2|antibiotic inactivation|1
MQQRRALALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSHHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEKLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAA71947|FEATURES|argannot|beta_lactam|FOX-3|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAG28257|FEATURES|argannot|beta_lactam|FOX-7|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYARGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRHWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRATPGVLAA
EAYGIKTGSADLLKFTEANMGYQGDAALKSAIALTHTGFYSVGDMTQGLGWESYAYPLTE
QALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>AGE45503|FEATURES|argannot|beta_lactam|FOX-10|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSISLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNAPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAB61637|FEATURES|argannot|beta_lactam|fonA-2|antibiotic inactivation|1
MVKNTLRKTTLMVATVMPLLFSSAPLWAQTANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDPRDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>CAB61641|FEATURES|argannot|beta_lactam|fonA-4|antibiotic inactivation|1
MVKNTLRKTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDERDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>ADM51921|FEATURES|argannot|beta_lactam|DHA-1|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AAR87489|FEATURES|argannot|beta_lactam|DHA-3|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPDSAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNIEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AEL22919|FEATURES|argannot|beta_lactam|DHA-5|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGRPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>BAL40893|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
LSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKGTPVAHKTGSSGKPDNI
LAVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>ABV89601.1|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRRE
ERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELC
NAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTP
AAMAQTLQKLLNESVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSR
GIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW
>AAL85333|FEATURES|argannot|beta_lactam|bla|antibiotic inactivation|1
MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSAIAMQEEQRLHARIGIAVLDTA
TNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASMQFEPSQLVEYSPITEKHV
APDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSA
IPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIA
DKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD
>AAA21535|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISHIVYEYVTQQID
>AAA21533|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLREIYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDRHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>CBX07044|FEATURES|argannot|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>ADB56658|FEATURES|argannot|beta_lactam|SME-2|antibiotic inactivation|1
MARPSKLALSFSLLLPFLPFTSFAETWPQGDIARQKIVKLEKDFGGRIGVSAIDTGANRT
FDFRADERFPLCSSFKGFLAGAVLSHSQQQEGLLEKRIDYKNRVMEPHSPISAQHSSTGM
TVAQLAAAALQYSDNGATNLLLENVLGGPAGMTTFMRTLGDTTFRLDRWELELNSAIPGD
DRDTSTPHAIARSLQKIALGEALQTAPRQQLVDWLIGNTTGGARIRAGVPVEWVVGDKTG
TCGVYGTANDYAVIWPKTSAPIVLAIYTAKPNKEDKHSDAVIAEVTRAVLESFE
>ACV69996|FEATURES|argannot|beta_lactam|BEL-2|antibiotic inactivation|1
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
CSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSAL
QLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRFDRIEPTLNTNTPGDERDTTTPMSMA
QTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVA
FFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH
>CAA71441|FEATURES|argannot|beta_lactam|imiS|antibiotic inactivation|1
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQQVSGPVYVVEDNYYVQENSMVYFGAK
GVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVISTRQ
TRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYLGPAHSPDGI
FVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPE
LIDHYEALIKAASQS
>CDH98053|FEATURES|argannot|beta_lactam|mecC|antibiotic target replacement|1
MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIAKGNYNEVYKNSSEKSKLAYGEEEII
DRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHW
KLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPEEKY
DDIAHDLQIDKKAIINKVNQKWVQPSSFVPIKKINQKDESIDKLIKLHNLQINTIKSRVY
PLNKATAHLLGYVGPINSEELQSKQFKNYSKTSVIGKKGLERLYDKQLQNTDGFRISISN
IYDNKPLDTLLEKKANNGKDLHLTIDARVQESIYKHMKNDYGSGTALQPKTGEILALVST
PSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKIFTSIIALKENKLDENT
NFDIYGKGWQKDASWGDYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGM
QDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGN
IQNPHVLRKTKSQVWKKDIISKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAEL
KMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQ
FDIDQ
>AAP69912|FEATURES|argannot|beta_lactam|cphA4|antibiotic inactivation|1
MMKGWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSVVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRVGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAAAV
>AFI61435|FEATURES|argannot|beta_lactam|blaTEM-169|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTDGESGNYG
>AAS38487|FEATURES|argannot|beta_lactam|TEM-2|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA46346|FEATURES|argannot|beta_lactam|TEM-16|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAC36883|FEATURES|argannot|beta_lactam|TEM-26|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMD
>AAC32891.1|FEATURES|argannot|beta_lactam|TEM-28|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC43180|FEATURES|argannot|beta_lactam|TEM-29|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA71323|FEATURES|argannot|beta_lactam|TEM-48|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>ABB97007|FEATURES|argannot|beta_lactam|TEM-55|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAEPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACJ43254|FEATURES|argannot|beta_lactam|TEM-57|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLDRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK17194|FEATURES|argannot|beta_lactam|TEM-63|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAM15527|FEATURES|argannot|beta_lactam|TEM-80|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAVTMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAG44570|FEATURES|argannot|beta_lactam|TEM-87|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLHCWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF66653|FEATURES|argannot|beta_lactam|TEM-92|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK85244|FEATURES|argannot|beta_lactam|TEM-34|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKLW
>AAM28884|FEATURES|argannot|beta_lactam|TEM-108|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAELSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTSELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERSRQIAEIGASLIKHW
>AAQ93491|FEATURES|argannot|beta_lactam|TEM-124|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>AAT46414|FEATURES|argannot|beta_lactam|TEM-125|antibiotic inactivation|1
MSIQHFRVALIPFLAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAR10958|FEATURES|argannot|beta_lactam|TEM-131|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEY16488|FEATURES|argannot|beta_lactam|TEM-135|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAX56615|FEATURES|argannot|beta_lactam|TEM-141|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVEDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABD60314|FEATURES|argannot|beta_lactam|TEM-142|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGANERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>ABC96711|FEATURES|argannot|beta_lactam|TEM-149|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGVRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACO07310|FEATURES|argannot|beta_lactam|TEM-154|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABQ00181|FEATURES|argannot|beta_lactam|TEM-158|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>ABM54870|FEATURES|argannot|beta_lactam|TEM-160|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACR22829|FEATURES|argannot|beta_lactam|TEM-168|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAA65888|FEATURES|argannot|beta_lactam|TEM-178|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGSTSGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGSQELTAFLHNMGDHVTRLDRWEPELNEAIPNDEADTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMADKVAGPLLRSALPAGWFIADKSGARERGSR
GIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEL88240|FEATURES|argannot|beta_lactam|TEM-190|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AFC75523|FEATURES|argannot|beta_lactam|TEM-193|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAAHLFLTTIGGPKELTAFLHNMGDHVTRLDCWGPKLTEAIPHDERDTTM
PAAVANTLRKLLTGELLTLASRQQLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGK40892|FEATURES|argannot|beta_lactam|TEM-207|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGGRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIS39742|FEATURES|argannot|beta_lactam|TEM-219|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVFIYTTGSQATMDERNRQIAEIGASLIKHW
>BAE94459|FEATURES|argannot|beta_lactam|PC1|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>CAX33921|FEATURES|argannot|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAE48233|FEATURES|argannot|beta_lactam|CMY-19|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFDIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVSLEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>ABS12249|FEATURES|argannot|beta_lactam|CMY-30|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHGSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>CAP60699|FEATURES|argannot|beta_lactam|CMY-38|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLNAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>BAG14343|FEATURES|argannot|beta_lactam|CMY-41|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAATKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADP37961|FEATURES|argannot|beta_lactam|CMY-57|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQFDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFU25632|FEATURES|argannot|beta_lactam|CMY-74|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRVGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73434|FEATURES|argannot|beta_lactam|CMY-75|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73443|FEATURES|argannot|beta_lactam|CMY-78|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFK73446|FEATURES|argannot|beta_lactam|CMY-79|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQDKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAL63057|FEATURES|argannot|beta_lactam|CMY-87|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AHA49908|FEATURES|argannot|beta_lactam|SME-4|antibiotic inactivation|1
MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNT
FGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYHSPITTKYKGSGM
TLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGD
KRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTG
SCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID
>CAA39164|FEATURES|argannot|beta_lactam|SHV-5|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAF37209|FEATURES|argannot|beta_lactam|SHV-25|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAN04883|FEATURES|argannot|beta_lactam|SHV-41|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATFGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL40899|FEATURES|argannot|beta_lactam|SHV-43|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHFADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLSAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEJ08681|FEATURES|argannot|beta_lactam|SHV-52|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMISTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLAIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEK48092|FEATURES|argannot|beta_lactam|SHV-55|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGA
>CAJ47128|FEATURES|argannot|beta_lactam|SHV-73|antibiotic inactivation|1
MRIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADER
FPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAA
AITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPAS
MAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47130|FEATURES|argannot|beta_lactam|SHV-75|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPHNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47131|FEATURES|argannot|beta_lactam|SHV-76|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVEDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ32371|FEATURES|argannot|beta_lactam|SHV-84|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIG
>ABN49110|FEATURES|argannot|beta_lactam|SHV-93|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGTVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49111|FEATURES|argannot|beta_lactam|SHV-94|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQHLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49113|FEATURES|argannot|beta_lactam|SHV-95|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARLQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49114|FEATURES|argannot|beta_lactam|SHV-97|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDSPASMAERNQQIAGIGAALIEHWQR
>ACI22621|FEATURES|argannot|beta_lactam|SHV-105|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAQ03507|FEATURES|argannot|beta_lactam|SHV-107|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKAGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAI65841|FEATURES|argannot|beta_lactam|SHV-121|antibiotic inactivation|1
MRYIRLCIISLLAALPLVVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADE58494|FEATURES|argannot|beta_lactam|SHV-128|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELRA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGTGAAPIEHWQR
>ADM25824|FEATURES|argannot|beta_lactam|SHV-134|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLREIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23954|FEATURES|argannot|beta_lactam|SHV-148|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ
>AFQ23961|FEATURES|argannot|beta_lactam|SHV-155|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ
>AFQ23963|FEATURES|argannot|beta_lactam|SHV-157|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVMLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23964|FEATURES|argannot|beta_lactam|SHV-158|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLAAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23965|FEATURES|argannot|beta_lactam|SHV-159|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVGDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80959|FEATURES|argannot|beta_lactam|SHV-173|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDQASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJO16042|FEATURES|argannot|beta_lactam|SHV-182|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYTPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIS67768|FEATURES|argannot|beta_lactam|SHV-185|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVMIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CEA29751|FEATURES|argannot|beta_lactam|SHV-188|antibiotic inactivation|1
VVKRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELKLNEALPGDARDT
TTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGER
GARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AKK23733|FEATURES|argannot|beta_lactam|SHV-191|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLVSGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ALI16958|FEATURES|argannot|beta_lactam|blaSHV-193|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
LFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL78275|FEATURES|argannot|beta_lactam|OXY-1-3|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AAL78276|FEATURES|argannot|beta_lactam|OXY-1-4|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AAL78278|FEATURES|argannot|beta_lactam|OXY-2-6|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>CAI43416|FEATURES|argannot|beta_lactam|OXY-5-1|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKHSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>YP_004455304|FEATURES|argannot|beta_lactam|OXA-9|antibiotic inactivation|1
MKDTLMKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVS
PCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQ
QLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVA
HKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKN
GRQVVFARLEIGKEKSDIPGGSKAREDILVELPVLMGNK
>AAC46344|FEATURES|argannot|beta_lactam|OXA-13|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ABL67479|FEATURES|argannot|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AAG35608|FEATURES|argannot|beta_lactam|OXA-26|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMTGSIRNEITYKSLENLGII
>AAK52604|FEATURES|argannot|beta_lactam|OXA-31|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMPPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>CAD32565|FEATURES|argannot|beta_lactam|OXA-43|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYPVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>AAR89917|FEATURES|argannot|beta_lactam|OXA-54|antibiotic inactivation|1
MRVLALSAVLVVASIVGMPAMANEWQEKPSWNTHFSEHKAQGVIVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGQARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATEQVAFLRKLYHNK
LHVSERSQRIVKQAMLTEANSDYIIRAKTGYSTRIEPQIGWWVGWVELDDNVWFFAMNMD
MPTADGLGLRQAITKEVLKQEKIIP
>AAR32651.1|FEATURES|argannot|beta_lactam|OXA-56|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQIFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGAEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>CAG15145|FEATURES|argannot|beta_lactam|OXA-59|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAV
DMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGKQTLVFARLT
QDERKQPVSAGIRTREAFLRDLPRLLAAR
>AAR32134|FEATURES|argannot|beta_lactam|OXA-62|antibiotic inactivation|1
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAALGRITERADWGKLFAAEG
VKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI
>CAH69530|FEATURES|argannot|beta_lactam|OXA-74|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPVSTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAX51234|FEATURES|argannot|beta_lactam|OXA-76|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEKLGIL
>AAW81358|FEATURES|argannot|beta_lactam|OXA-78|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTAVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGTPSSVRKEITYKSLEQLGIL
>AAZ78361|FEATURES|argannot|beta_lactam|OXA-86|antibiotic inactivation|1
MNIKTLLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASIEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC84263|FEATURES|argannot|beta_lactam|OXA-87|antibiotic inactivation|1
MNIKTLLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASIEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKAQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC61637|FEATURES|argannot|beta_lactam|OXA-92|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGSVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47916|FEATURES|argannot|beta_lactam|OXA-93|antibiotic inactivation|1
MNIKALLLITSTIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALISLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47917|FEATURES|argannot|beta_lactam|OXA-94|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPHG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAK50801|FEATURES|argannot|beta_lactam|OXA-98|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAL85435|FEATURES|argannot|beta_lactam|OXA-101|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ABV31686|FEATURES|argannot|beta_lactam|OXA-106|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31692|FEATURES|argannot|beta_lactam|OXA-112|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFPLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABY77907|FEATURES|argannot|beta_lactam|OXA-128|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNVLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACI26264|FEATURES|argannot|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVFASLFLSGCTVQHNLINETPSQIAQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>CAQ51348|FEATURES|argannot|beta_lactam|OXA-139|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLIALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>ABQ15112|FEATURES|argannot|beta_lactam|OXA-141|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIESSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>ACX70402|FEATURES|argannot|beta_lactam|OXA-143|antibiotic inactivation|1
MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKG
KNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEV
NFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMDVTPQVGWLTGWVEKSN
GEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII
>ACO72579|FEATURES|argannot|beta_lactam|OXA-147|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFLLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>ADY06444|FEATURES|argannot|beta_lactam|OXA-163|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYDTKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>ADK34116|FEATURES|argannot|beta_lactam|OXA-164|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFLKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>ADK35873|FEATURES|argannot|beta_lactam|OXA-169|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDERNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADM26744|FEATURES|argannot|beta_lactam|OXA-179|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIAVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADK92148|FEATURES|argannot|beta_lactam|OXA-182|antibiotic inactivation|1
MKKFILPIFSISILLSLSACSSIQTKFEDTFHISNQKHEKAIKSYFDEAQTQGVIIIKEG
KNISSYGNNLVRAHTEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRSYPMWEKDMT
LGEAMALSAVPVYQDLARRIGLNLMQKEVKRVGFGNMNIGTQVDNFWLIGPLKITPIQEV
NFADDLANNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVSPQVGWLTGWVEKSN
GEKVSFSLNIEMKQGMSGSIRNEITYKSLENLGII
>ADZ54048|FEATURES|argannot|beta_lactam|OXA-192|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>ADX07746|FEATURES|argannot|beta_lactam|OXA-201|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEO92079|FEATURES|argannot|beta_lactam|OXA-205|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEGAIVIADERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDAGAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDNARRYLKQIDYGNADPSTIKGNYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKYLMITEAGRNWILRAKTGWEGRFGWWIGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>AEV91554|FEATURES|argannot|beta_lactam|OXA-215|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPTHAAARKEIVYQALTQLKLL
>AEO44980|FEATURES|argannot|beta_lactam|OXA-217|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTAVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFH36331|FEATURES|argannot|beta_lactam|OXA-237|antibiotic inactivation|1
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQGYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>AFN20670|FEATURES|argannot|beta_lactam|OXA-240|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMNQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AGC60012|FEATURES|argannot|beta_lactam|OXA-244|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTGIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>CCE94500|FEATURES|argannot|beta_lactam|OXA-256|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPDAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>CCE73593|FEATURES|argannot|beta_lactam|OXA-258|antibiotic inactivation|1
MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTF
KLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARA
LGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPV
KAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFA
RLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK
>ABK34773|FEATURES|argannot|beta_lactam|J532_3674|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AFP89364|FEATURES|argannot|beta_lactam|blaADC-57|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>ALA14812|FEATURES|argannot|beta_lactam|adc77|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ALA14813|FEATURES|argannot|beta_lactam|adc78|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>CAC17625|FEATURES|argannot|beta_lactam|OCH-5|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWRPDYPAGTQHRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GTLDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVDANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVVLANRNYPIDERVKAAYRILQALDNKQ
>AAX93315|FEATURES|argannot|beta_lactam|CARB-4|antibiotic inactivation|1
MKLLLVFSLLIPSMVFANSSKFQQVEQDAKVIEASLSAHIGISVLDTQTGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGEINPKSTIEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNAAANIILNALGGPESVTDFLRQIGDKETRLDRIEPELNEGKLGDLRDTTTPNA
IVNTLNELLFGSTLSQDGQKKLEYWMVNNQVTGNLLRSVLPEGWNIADRSGAGGFGARSI
TAVVWSEAQSPIIVSIYLAQTEASIADRNDAIVKIGRSIFEVYSSQSR
>AAO59455|FEATURES|argannot|beta_lactam|CARB-8|antibiotic inactivation|1
MDVRKHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAVHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTILMENSRN
>AAF89158|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAQ54753|FEATURES|argannot|beta_lactam|KS04_10900|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AEY68295|FEATURES|argannot|beta_lactam|BlaB|antibiotic inactivation|1
MKNIMRALILVFGFMSFFMFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVTD
KGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTK
MTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCI
IKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEY
QQKQKASN
>ABD49192.1|FEATURES|argannot|beta_lactam|VEB-1|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAK29174|FEATURES|argannot|beta_lactam|VEB-2|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ABM54868|FEATURES|argannot|beta_lactam|VEB-4|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AAX16004.1|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAS13760|FEATURES|argannot|beta_lactam|VIM-9|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSIRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAS13761|FEATURES|argannot|beta_lactam|VIM-10|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQYVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAZ73123|FEATURES|argannot|beta_lactam|VIM-12|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ACB54702|FEATURES|argannot|beta_lactam|VIM-15|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLFGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AJP08641|FEATURES|argannot|beta_lactam|VIM-42|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSIERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AKO63211|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPIVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AKQ98357|FEATURES|argannot|beta_lactam|VIM-2|antibiotic inactivation|1
MFKFLSKLLVYLTASIMAIASPLAFSVDSSGEYPTASEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>BAC06843|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHPKQIVN
QYIESTSKP
>AAM48117|FEATURES|argannot|beta_lactam|CfxA2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKGSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFVATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>CAA63262|FEATURES|argannot|beta_lactam|CTX-M-1|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>ABQ96621.1|FEATURES|argannot|beta_lactam|CTX-M-2|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AAF05311.2|FEATURES|argannot|beta_lactam|CTX-M-9|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTAGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAL86924|FEATURES|argannot|beta_lactam|CTX-M-22|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAL99990|FEATURES|argannot|beta_lactam|CTX-M-23|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AEL20766|FEATURES|argannot|beta_lactam|blaCTX-M-131|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYGDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GGYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AAV97952|FEATURES|argannot|beta_lactam|CTX-M-47|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGRRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97953|FEATURES|argannot|beta_lactam|CTX-M-48|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTNAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACC95405|FEATURES|argannot|beta_lactam|CTX-M-59|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKLLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CAL80726|FEATURES|argannot|beta_lactam|CTX-M-60|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>ACS32293|FEATURES|argannot|beta_lactam|CTX-M-74|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTETTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CAQ42486|FEATURES|argannot|beta_lactam|CTX-M-76|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>CAQ42480|FEATURES|argannot|beta_lactam|CTX-M-77|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLKALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTRGF
>ABV57756|FEATURES|argannot|beta_lactam|CTX-M-81|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLEQSETQKQLLNQPVEIQPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDHTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29347|FEATURES|argannot|beta_lactam|CTX-M-85|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TPAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACR56321|FEATURES|argannot|beta_lactam|CTX-M-89|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>ACQ99521|FEATURES|argannot|beta_lactam|CTX-M-90|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADY02554|FEATURES|argannot|beta_lactam|CTX-M-105|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQREQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AEM44648|FEATURES|argannot|beta_lactam|CTX-M-110|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEEHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGNL
>AEM44652|FEATURES|argannot|beta_lactam|CTX-M-112|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFA51699|FEATURES|argannot|beta_lactam|CTX-M-121|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPITEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFJ59956|FEATURES|argannot|beta_lactam|CTX-M-129|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLRGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFX60298|FEATURES|argannot|beta_lactam|CTX-M-134|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GSYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AGG08693|FEATURES|argannot|beta_lactam|CTX-M-136|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAK69830|FEATURES|argannot|beta_lactam|LEN-2|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AAN05030|FEATURES|argannot|beta_lactam|LEN-3|antibiotic inactivation|1
VISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVST
FKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSD
NSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLR
KLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGP
DGKPERIVVIYLRDTPASMAERNQQIAGIGAALI
>CAG25835|FEATURES|argannot|beta_lactam|LEN-8|antibiotic inactivation|1
ATLPLVVYAGPQPLEQIKQSESQLPGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTHLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>AAL50725|FEATURES|argannot|beta_lactam|LEN-15|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSPRSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGQR
>AAU89706|FEATURES|argannot|beta_lactam|LEN-16|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12347|FEATURES|argannot|beta_lactam|LEN-19|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAP12350|FEATURES|argannot|beta_lactam|LEN-22|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSPRSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>ADW77562|FEATURES|argannot|beta_lactam|LEN-25|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMAIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>AGB34168|FEATURES|argannot|beta_lactam|LEN-26|antibiotic inactivation|1
MRYVRLCVISLLANLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITMSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDMRDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKAERIVVIYMRDTPATIAERNQQIAAIGAALIEHWQR
>ALK01319|FEATURES|argannot|beta_lactam|blaLEN|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGHTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>WP_000732912.1|FEATURES|argannot|beta_lactam|LRA-9|antibiotic inactivation|0
MKKLFVALGLIMGSLHISYAEPASAQQVPGYYHHQFGNYRITSLLDGTIYLDPKLFKNLS
QAEKTKILTKYAAVNEKGIQTSVNAFLVDDGKSLTLVDSGAASCFGPQLGSIAKNLELAG
YQLANVKTVLLTHLHPDHVCGIAQNGKAVFPNATIYAHEREADYWLNPANEKTVPADKKE
NYLGTVKNVKAALAPYQAKKAFKTFKDGDVIQGFEVINTHGHTPGHHSFRLKSKGQQIVF
VGDIVHSHSLQFDAPKTGVDFDVNSEQAINTRLKMFAEISNKQQWVAAPHLPFPGIGHVY
KVNAEQYQWIPLYFNNSLDK
>WP_001211205.1|FEATURES|argannot|beta_lactam|blaADC-30|antibiotic inactivation|1
MSYLFLSCTEELIMRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKY
DVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKI
SFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNP
IGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGY
NQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVN
TMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYV
VFIPKENIGLVMLTNKRIPNEERIKAAYAVLDAIKK
>WP_000155957.1|FEATURES|argannot|beta_lactam|MBL-fold|antibiotic inactivation|0
MTISNTTDLPAPLMPSQQHNGKFRNTRPNQHKPSFGKTLQLMWKFLFNKPKNTVPNREIP
VLSLSKEQLLSAPDRSLFRLGHSTILLKLQDEFWLTDPVFSERASPFQWLGPKRFHQPPI
SIAELPPIKGVILSHNHYDHLDYHAVMQLNDKVEHFLTPLGVGDTLIKWGIPAEKVQQLD
WWGTTQVDGLKLVATPAHHFSGRGMGDSNATLWASWVIIDNDLRVFFSGDTGYFDGFKEI
GLRYGPFDLTMLETGAYDPEWPDVHMQPEQTLQAHIDLKGRHLLPVHNGTFDLALHAWDD
PFERIVALAQQNNLAISTPQMGQILNLNEPNVENYWWRS
>WP_002017666.1|FEATURES|argannot|beta_lactam|BN977_05631|antibiotic inactivation|0
MNLNIRGHLMKNFLTKKMYATRALFFAVGVTALNVSPIVISTTHAATEQKMDNLSTTLSL
IFADKPIEASLFSPQFLGQVPITQIQKIVDDLKVSLGALKNINVSNGSGTIDFEKGELPV
SISLNEQEQISTLWFSAPHFKTISLDEMVKGLHENAIGKTSLLVIVDNKPVVVENDKTPM
AVGSTFKLLVLKAYEDAIKKGELKRETIVSLKEKNRSLPTGVLQNLPAGTPINLELLAQL
MIQISDNTATDSLIDVLKKPRIEALSPRNSPLLTTRELFQLIDSSNEKLRNKFKTGTKSA
RLEALSELDKLPLPSVSSIGKSATWQDAEWYMSAHEICPLLESVQDAPALNSSLNPLFKN
LNWQKIGFKGGSEYGVINFSVIGKTQKGHNVCAVFTANGNEPQPESKLAILFTGILQAVD
SMSH
>AAZ04782|FEATURES|argannot|quinolone|QnrA3|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>ABG56269.1|FEATURES|argannot|quinolone|QnrB10|antibiotic target protection|1
MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ACA28712|FEATURES|argannot|quinolone|QnrB19|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG
>ABC86905.1|FEATURES|argannot|quinolone|QnrB20|antibiotic target protection|1
MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>ACM50952|FEATURES|argannot|quinolone|QnrB21|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>ADM52186|FEATURES|argannot|quinolone|QnrB27|antibiotic target protection|1
MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>ADM52193|FEATURES|argannot|quinolone|QnrB29|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABC17629.2|FEATURES|argannot|quinolone|QnrB3|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFA52646|FEATURES|argannot|quinolone|QnrB62|antibiotic target protection|1
MTPLLYKKTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDTRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABP87778|FEATURES|argannot|quinolone|QnrB6|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ACG70184|FEATURES|argannot|quinolone|QnrD1|antibiotic target protection|1
MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAK
LKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTN
LSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGA
LGELDARRINLDGVKLDGEQALQLVESLGVIVHR
>ABF47470|FEATURES|argannot|quinolone|QnrS2|antibiotic target protection|1
METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFIT
GCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD
>AEG74319|FEATURES|argannot|quinolone|QnrS5|antibiotic target protection|1
METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIT
GCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD
>AAP43110.2|FEATURES|argannot|quinolone|oqxB|antibiotic efflux|1
MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIA
ETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARL
PEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIF
GSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQ
GRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGA
NAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVIL
FLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVE
RNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAIST
VISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVG
KTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIR
KMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKI
AQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFP
ISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQAD
GPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVL
SSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYES
WTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEI
QGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVT
LFGLFLTPVFYVTLRKLVTRRKPVQEDLPA
>ABS30107.1|FEATURES|argannot|quinolone|QnrB11|antibiotic target protection|1
MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRA
ILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNT
NLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNS
ELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG
>ACL82962.1|FEATURES|argannot|glycopeptide|vanXM|antibiotic target alteration|1
MEKGFTFLDEILNDVRWDAKYATWDNFTGKPIDGYEVNRIIGTYELADALLKVQELAFNQ
GYGLLLWDGYRPQQAVNCFLQWAAQPEDNRTKAKYYPNIDRTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTDELVPMGSGFDFMDERSHHEAKGITSNEAQNRRFLRSIMENSGFEAYSF
EWWHYVLINEPYPYSCFDFPVK
>AAR84673.1|FEATURES|argannot|glycopeptide|vanSF|antibiotic target alteration|0
MGKILRGFRSKMIILLGLSMLLSSAITYLLFKVLQLYYYTSVDYGDTLAYFRKIIQNIGD
FNVFLLLFILLSILFFFLLTKPYSAYFNEISKGIHYLAQGDFKHRVQILSNDEFSDIAQS
INLASEKLEQAIERGDFSESSKEQLVVNLAHDLRTPLTSVLGYLDLILKDDNLTENQIRH
YLTIAFTKSQRLERLIDELFEITRMNYGMLPIKKKQIDLSELLIQLKEELYPVFEKNDLI
ARMNITSPLSIMGDGELLARVFENLLINANRYGYEGQYVDINGFIDSEEVVIQVINYGDA
IPPDELPHIFDMLFTGDKARTHQENSTGLGLFIAENIVEQHNGTITAESDLIRTIFEVRL
PMADS
>ABX79408|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGIAPDAMDWYLYTGELENI
RQDTWLLDTKHTQKIQPLFEGNGFWISEAQQTLVPDVLFPIMHGKYGEDGSIQGMFELMK
LPYVGCGVAASALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQRQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIAPALKEAFAYCSAVLLQKNIAGVEIGCGILGNDSLTVGAC
DAISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYHSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEGK
>BAE96114.1|FEATURES|argannot|glycopeptide|vanSD|antibiotic target alteration|0
MKNKNMTSYEDDYLLFKNRLSVKILLMMACSILIISVVYLFVLKDNFANVVVAILDRFIY
HDRDEAVAVYLRTFKAYEIWLFLIAVMGVFFVIFRRYLDSISKYFKEINRGIDTLVHEDT
NDIALPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKIPLSSVIGYLN
LLRDEKQISEELREKYLSISLDKAERLEELINEFFEITRFNLSNITLVYSKINLTMMLEQ
LGHEFKPMLAGKNLKCEFDIQPDMLLSCDANKLQRVFDNLLRNAVSYCYENTTIQVNARQ
AEDHVLIKIINEGDTIPRERLERIFEQFYRLDMSRSSSTGGAGLGLAIAREIVELHHGQI
TARSENGITSFEVTLPTVGKS
>AAV74561|FEATURES|argannot|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR
>ABX79431|FEATURES|argannot|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQ
YLEQTARQFA
>ABX79415.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|0
MKKNQGIEQFRVILAMMVVAIHCLPLHRLWPNGDILITLTLFRIAVPFFFMISGYYVFSD
LATQNSYPARQRIWLFIKKQLQVYLIATLLFLPLAWYSGILGLNMPLDTFIQTLLVNGIL
YHLWYFPAIITGGLLVMGLLTRLSFKQVFFIAVGLYVVGLGGDSWSGLAAQTPITPLYSL
IFQLLDGTRNGIFFAPLFLILGVLARRFAKKPASPHRYSYLMISLICLLLESYLLHHFTT
PKHDSMYVFLPFVLLFLFPIIQQWQAPMIWKQAGRLSLWLYLLHPYTIAVTHFLSQKLPL
LQNNLINFLVVLGLTIGVVHGLFALQKLLPFPKKTPLHLQRAAKEFSAPALLHNLQEIKR
VIPSTTKVMAVVKADAYGCDAQLVARTLERVGVDFFAVATIEEAIELRRAGIKSRLLILG
YTSAQRAKELNRYSLIQTIVSEAHGQALARTGLPIECHLAVDTGMHRLGVAPDLETVRRL
YALPSLKITGIFSHLGSSDQLDTASILRTQAQIICFDDLLAGLSARNIAYGLTHLQSSYG
ILNYPEKHYDYVRPGILLTGSLSVPNEPTKQKINVQPILTLKALLVDKKTVAAGEAIGYG
LATVFDRPTTIGIVSIGYCDGVPRALSNQGFQLSYQGVLLPQVGLICMDMLLIDLTDYPE
LAVESWLEVISDWTNTADQAQTIPNELISRLGSRVPSMSK
>AAY52004.1|FEATURES|argannot|glycopeptide|vanHA|antibiotic target alteration|1
MKNIGITVYGCEQDEADAFRALSPRFGIMPTIINAAVSEANAISAPCNQCISVGHKSEVS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGIAVGNVAYSPDSVADYTMMLMLMAVR
NAKSIVRSVEKHDFRLDSVRGKVLRDMTVGVVGTGHIGKAVIERLRGFGCHVLAYDRSQK
IEANYVPFDALLQNSDIVTLHVPLNADTRHIIGHEQIKRMKQGAFIINTGRGPLVDTDAL
VKALENGKLGGAALDVLEGEEEFFYSDCSQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVEKTIKNCLDFERSQEHE
>AAX19283.1|FEATURES|argannot|glycopeptide|vanHA|antibiotic target alteration|1
MNNIGITVYGCEQDEADAFCALSPRFGVMPSIINANVSESNAKSAPFNQCISVGHKSEVS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVGNVAYSPDSVADYTMMLMLMAVR
NAKSIVRSVEKHDFRLDSVRGKVLSDMTVGVVGTGHIGKAVIERLRGFGCKVLAYSRSQS
IEANYVPFDELLQNSDIVTLHVPLNADTRHIISHEQIQRMKQGAFIINTGRGPLVYTNEL
VKALENGKLGGAALDVLEGEEEFFYSDCSQKPIDNQFLLKLQRMPNVIITPHTAFYTEQA
LRDTVEKTNINCLDFERSQEHE
>AAM09850.1|FEATURES|argannot|glycopeptide|vanHD|antibiotic target alteration|1
MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAEL
SEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLL
RGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTH
KAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAA
LVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDR
VLVDTVSNTIRNCLNFERSLGNV
>AAA65953.1|FEATURES|argannot|glycopeptide|vanRA|antibiotic target alteration|0
MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTS
GLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRY
KKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSEL
LFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK
>AAY52009.1|FEATURES|argannot|glycopeptide|vanRA|antibiotic target alteration|0
MSDKILVVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKTDLDLAILDIMLPGAS
GLAICQKIRDKHTYPIITLTAKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRY
KKYNGVTEQNENVIVHSGLVININTHECFLNEKQLSLTPTEFSILRILCENKGNVVSSEQ
LFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK
>AAD22403.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|0
MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAEL
AVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILY
HLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAV
FHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIP
KHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISIL
QNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRII
SPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYT
SPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFD
LPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGIL
NYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQT
AVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIP
IESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK
>AAX19282.1|FEATURES|argannot|glycopeptide|vanSA|antibiotic target alteration|0
MAIKLKNKNKKTDYSKLKRKLYQYIVVIVMAAVVFVLFLRLFIKGTLGEWIVRFLENSYH
LDRLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNED
KQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLS
LLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQ
MTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILENAAAYSEDNSVIDITAGL
SGDVVSIVFKNAGSIPKDKLAAIFEKFYRLDDARSSDTGGAGLGLAIAKEIIVQHGGQIY
AESNDNYTTFTVELPALPDLVDKRSS
>ABX79438|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAVLFGGNSPEYSVSLTSAASVIQAIDPLKYEVMTIGIAPTMDWYWYQGNLANVRND
TWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCH
VAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGS
SKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVD
GFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIY
LNEINTMPGFTGHSRYPAMMAEVGLSYEILVEKLIALAEEDKR
>AAP74657|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(34)|antibiotic target alteration|1
MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTT
ILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSIT
TAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSF
SPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKV
RQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR
>CBY77552|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(42)|antibiotic target alteration|1
MNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSKIC
KAVNAIEFDSVLADKLSHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILNKL
LDSENPPLDTFLIMQYEPFLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAPNA
NIILGQFSYKDFTDINLEDRHAWKDFLAFVFLEKGVTFKEKTKRIFSYKQQKIILKESRI
NDDSNISNWSYEFWLKMFKLYNSNMVSKDKKVLVNNSYKRMLEHESSLEKIHRNRKQNNR
K
>AAA27452.2|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>AAA22419|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmG|antibiotic target alteration|1
MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEI
DSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSA
TISYLIVEYGFAKRLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSALIVLKRKP
AKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYK
IFNG
>CAA55745|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmU|antibiotic target alteration|1
VPSRYGSRQELGQNFLVDPDIIKLIRRAAERTEGPIVDLGAGDGALTLPLSRLGRPVTAV
ELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWV
SAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERR
PEPLVRERREYQDFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLT
AEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>CAB41414|FEATURES|argannot|macrolide-lincosamide-streptogramin|linB|antibiotic inactivation|1
MLKQKELIANVKNLTESDERITACMMYGSFTKGEGDQYSDIEFYIFLKHSITSNFDSSNW
LFDVAPYLMLYKNEYGTEVVIFDNLIRGEFHFLSEKDMNIIPSFKDSGYIPDTKAMLIYD
ETGQLENYLSEISGARPNRLTEENANFLLCNFSNLWLMGINVLKRGEYARSLELLSQLQK
NTLQLIRMAEKNADNWLNMSKNLEKEISLENYKKFAKTTARLDKVELFEAYKNSLLLVMD
LQSHLIEQYNLKVTHDILERLLNYISE
>AAA26832|FEATURES|argannot|macrolide-lincosamide-streptogramin|tlrC|antibiotic target protection|1
MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERP
DAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDE
ALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALA
ATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDG
RGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAA
FGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAE
LDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHL
RQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIEL
ARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELR
EGVVSGAR
>AAC61671.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatC|antibiotic inactivation|1
MKWQNQQGPNPEEIYPIEGNKHVQFIKPSITKPNILVGEYSYYDSKDGESFESQVLYHYE
LIGDKLILGKFCSIGPGTTFIMNGANHRMDGSTFPFNLFGNGWEKHTPTLEDLPYKGNTE
IGNDVWIGRDVTIMPGVKIGNGAIIAAKSVVTKNVDPYSVVGGNPSRLIKIRFSKEKIAA
LLKVRWWDLEIETINENIDCILNGDIKKVKRS
>AAD44719|FEATURES|argannot|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CBY88983|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgaE|antibiotic target protection|1
MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNV
NHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKK
LANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEK
YEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETR
LEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKV
AIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDE
TLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLE
ALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNN
DDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL
>AAQ55242|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKELDITLLKSMIKDKGYELYPALIHAIVSV
INRNKVFRTGINSEGNLGYWDKLEPLYTVFNKETEKFSNIWTESNASFNSFYNSYKNDLF
KYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKDDKIY
LPFSLQVHHAVCDGYHVSLFMNEFQNIIDNVNEWI
>AAL68645|FEATURES|argannot|chloramphenicol|catB9|antibiotic inactivation|1
MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGS
FCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTE
AMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWP
ESWLKESMQSLCSSDIEGLYLNWQSKART
>CAA33203|FEATURES|argannot|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNR
HSEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYG
NNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKIIKKDNKIILPL
AIQVHHAVCDGFHICRFVNELQELIIVTQVCL
>AEP16488|FEATURES|argannot|rifampin|arr-3|antibiotic inactivation|1
MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPA
VWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTQSYRTCEPLRIVGVVE
DWEGHPVELIRGMLDSLEDLKRRGLHVIED
>ABV26707|FEATURES|argannot|rifampin|arr-5|antibiotic inactivation|1
MTVDWIPISHDNYHQVRGPFYHGTKAELAIGDLISTGFISHFERDRALKHVYFSALMEPA
IWGAELAVALSGSDGPGHIYIIEPTGPFEDDPNLTNKRFPGNPTQSYRTCHPLKIVGILR
EWERHSPEALKTMLDSLADLKRRGLAIIEE
>ABR68540|FEATURES|argannot|rifampin|rif|antibiotic inactivation|0
MELTTFNTNHPFIHSAYPKTFSYVPKNENDIYSVNVTDVRVEAISSPEIKLILPEIKGKG
RVSYLKNYQFLLLDYFEIWLKNKDEHPFLFHKAKSEEIFSTYIINEYHSLNYFTNKDDFL
TTKEGTHADCIIFPKKEISIPLDSLLSAFKIFKDTEIIFNFKFHNIEEIIAYDVEFRRHS
LEQLKKNFSETSLNIRFQFLNVPIISSAELTATNVITKKDVIGKDNTQMMNTSDFSNTIA
VSFHSKSDIFNHENRYIINPGVDYSEDVLVQKWVLNILKDLLIVTTKDMSLSENKKALGF
KDEAVFHEITKNTMTFNKLEKRFCKITIENIPEDHKLYYHTNILSFTRRFQHTKALNVST
LFKKITGVYLPNQKVINFLDIDHSIDIKIVSLPISIWDHELNSHPGDLRSNAMKERDFFF
KNRFLLGMDFNCKDRGYERISLKGGKDIFENLLRERKPFLRKLPIIEFDPAMQRGISLYT
TFISPSLMIYADPSINFTNFLVEIQWKEYDECDPLNLLKRFPCVDLYEMQKITQNPDTQR
ISIESI
>AEK32510|FEATURES|argannot|sulfonamide|sul3|antibiotic target replacement|1
MSKIFGIVNITTDSFSDGGLYLDTDKAIEHALHLVEDGADVIDLGAASSNPDTTEVGVVE
EIKRLKPVIKALKEKGISISVDTFKPEVQSFCIEQKVDFINDIQGFPYPEIYSGLAKSDC
KLVLMHSVQRIGAATKVETNPEEVFTSMMEFFKERIAALVEAGVKRERIILDPGMGFFLG
SNPETSILVLKRFPEIQEAFNLQVMIAVSRKSFLGKITGTDVKSRLAPTLAAEMYAYKKG
ADYLRTHDVKSLSDALKISKALG
>AAN28721|FEATURES|argannot|tetracycline|tet37|antibiotic inactivation|1
MVRYYSNIVGKYGIPVQNALKKLAGIHIDYICSTHGPVWHENVEKVVNLYDRMSKYETDP
GLVICYGTMYGNTEDRTPSMYEYIWIKENREAKVVSSFAANIYLGWGR
>AAA27471|FEATURES|argannot|tetracycline|tetX|antibiotic inactivation|1
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>AAA20116.1|FEATURES|argannot|tetracycline|tetA(P)|antibiotic efflux|1
MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEI
PTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWI
AEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLY
MPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNA
HFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINIL
YISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNS
LGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN
>AM237806_2|FEATURES|argannot|trimethoprim|dfrA17|antibiotic target replacement|1
LKISLIAAQSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGILPNRKYA
VLSKNGISHLPENVLVFSSIENALYELAKVTDHLYISGGGQIYNSLIESADTIHLSIIHK
EVEGEVRFPKIPPNYKLVFEQYYSSNINYTYQIWQKG
>AAN41415|FEATURES|argannot|trimethoprim|dfrB2|antibiotic target replacement|1
MGQSSDEANAPVAGQFALPLSATFGLGDRVRKKSGAAWQGQVVGWYCTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
>BAE15963.1|FEATURES|argannot|trimethoprim|dfrG|antibiotic target replacement|1
MKVSLIAAMDKNRVIGKENDIPWRIPKDWEYVKNTTKGHPIILGRKNLESIGRALPDRRN
IILTRDKGFTFNGCEIVHSIEDVFELCKNEEEIFIFGGEQIYNLFFPYVEKMYITKIHHE
FEGDTFFPEVNYEEWNEVFAQKGIKNDKNPYNYYFHVYERKNLLS
>BAP68758.1|FEATURES|CARD|beta_lactam|ACT-35|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYYILEALQ
>AFR46589.1|FEATURES|CARD|quinolone|QnrB58|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>BAE78082.1|FEATURES|CARD|multidrug|mdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AGPVVEKK
>ACQ82813.1|FEATURES|CARD|beta_lactam|PDC-8|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>CAA45050.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|srmB|antibiotic target protection|1
MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNG
ALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSER
ELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALA
ATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDS
GSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSV
FGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAE
LTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHL
RQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEI
ARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMG
DGRIAEFSAG
>YP_003281576.1|FEATURES|CARD|multidrug|mgrA|antibiotic efflux|0
MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVT
ELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASAS
SLSQDEVKELNRLLGKVIHAFDETKEK
>ADE08374.2|FEATURES|CARD|tetracycline|tet(45)|antibiotic efflux|1
ENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEV
IKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGK
NVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGG
LLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVS
SSLEQKEAG
>BAF80809.1|FEATURES|CARD|aminoglycoside|npmA|antibiotic target alteration|1
MLILKGTKTVDLSKDELTEIIGQFDRVHIDLGTGDGRNIYKLAINDQNTFYIGIDPVKEN
LFDISKKIIKKPSKGGLSNVVFVIAAAESLPFELKNIADSISILFPWGTLLEYVIKPNRD
ILSNVADLAKKEAHFEFVTTYSDSYEEAEIKKRGLPLLSKAYFLSEQYKAELSNSGFRID
DVKELDNEYVKQFNSLWAKRLAFGRKRSFFRVSGHVSKH
>AHE41345.1|FEATURES|CARD|quinolone|QnrS8|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>AHM76779.1|FEATURES|CARD|beta_lactam|ACT-19|antibiotic inactivation|1
MMKKSFCCALLLAISGSALAAPVSEKQLAEVVANTVTPLMKTQAIPGMAVAVIYQGKPHY
YTFGEADIAAKKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTKFWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPEEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMRYEQAMTKRVFKPLRLNHTWINVPKAEAAHYAWGYRDGKAVHISPGMLDAEA
YGVKTNVQDMANWVMANMAPENIADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
KMVIEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>CCK86744.1|FEATURES|CARD|beta_lactam|SHV-164|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGEQGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJG06172.1|FEATURES|CARD|beta_lactam|ACT-37|antibiotic inactivation|1
MMKKSFCCALLLAISGAALAAPVSEKQLAEVVANTVTPLMKAQAIPGMAVAVIYQGKPHY
YTFGEADIAAKKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVIKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPEEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMRYEQAMTKRVFKPLRLNHTWINVPKAEAAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
KTVIEGSDNKVALAPLPVAEVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AFU35065.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lsaE|antibiotic target protection|1
MSLINVSNLTFSYEGSYDNIFENVSFQIDTDWKLGFIGRNGRGKTTFLNLLLGKYAYSGN
ISSTVKFEYFPYDVEDKSLYTIEVMKSICTECMDWEIFREISLLDVQEDALYRPFNTLSN
GEQTKVLLAALFLTASCFLLIDEPTNHLDIDARNVVQNYLKRKKGFILVSHDRSLLDQCV
DHILSINKTNIEIQKGNFTSWWENKTLQDNFELAENKKLLKEIGRLSYAAKRSSNWSNKV
EKSKYGTTNSGSKLDKGYVGHKAAKAMKRAKNIESRHQEAVLQKSELLHNIEQYDDLKIS
PLEFHKECLIEANDLSLSYGDKEVCSNLNFRVNIGDRVAIIGKNGSGKSSILKLINGDDI
KFTGNFMLASGLKISYISQDTSYLKGNLSEFAYNNKIDETLFKTILRKLDFNREQFDKNM
VDFSAGQKKKVLIAKSLCESAHLYIWDEPLNYIDIFSRIQIEKMILEYCPTLLFVEHDDA
FCNNICTKNINLGL
>CAC14594.1|FEATURES|CARD|multidrug|smeD|antibiotic efflux|1
MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFL
VAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARL
SAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRI
GKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVS
ILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDA
VLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQ
KIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK
>AAS79458.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|chrB|antibiotic target alteration|1
MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEA
RDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLD
ISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLL
VVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLV
GMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA
>AJO16046.1|FEATURES|CARD|beta_lactam|CTX-M-159|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLVNYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAD51347.1|FEATURES|CARD|multidrug|smeS|antibiotic efflux|0
MAFAMAKFQLKFGLTAKTFLAIFTACLLVLAVNGIASRVAFQTGFLDYLNDQGDLRMQRL
MPHLQREYREHGGWEHLHGDGDRWARLLRPDLAHGHEGPVPSLSDQTGVPSRLGLFDAQH
RFVAGNPDATSDDEPHAVQVDGQTVGWLGMVPFQTVIATNDLNFYNTQVRAWWVIGIALL
LVTVLLAWLVSRALRQRLAKLAAATHRLAAGDYATRIERTSDDELDALVNDFNRMAQALD
DTERNRRAFIADISHELRTPLAVVRAELEAIEDGIRPLDRANLVGLQGEIRQLGKLIDDL
HDLSMTQSGGLAYRFAPLDLVALLRSELNGMRVRFANAGLALEEDLPATPLQVSGDERRL
QQVLANLLENALRYTHAGGRVRVQAARVPAGVQLVVEDTAPGVPPDKCALVFERFYRVES
SRNRASGGSGLGLAISHNIILAHHGVIHAAPSPLGGLRVVITLPEPA
>CAA71948.1|FEATURES|CARD|beta_lactam|SHV-6|antibiotic inactivation|1
MLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARATTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>ACQ82810.1|FEATURES|CARD|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>BAP34782.1|FEATURES|CARD|beta_lactam|CTX-M-151|antibiotic inactivation|1
MINKRLSIALALAAMIGTPVAMALESQKPGSDSANHIQHQMVQQLSALEKSANGRLGVAV
IDTGSGAIAGWRMDEPFPMCSTSKVMAVAALLKQSEQTPELMSQPQPVASGDLVNYNPIT
ERFVGKSMTFDELSAATLQYSDNAAMNLILAKLGGPQKVTAFARSIGDDKFRLDRNEPSL
NTAIPGDLRDTSTPRAMALSLQKLALGDALGQVQREKLSHWLRGNTTGAASIRAGLPSGW
SVGDKTGSGDYGTTNDIAVVWPTGRPPLVIVTYFTQPQQQAESQRPVLAKAAAIVASHYV
LPKG
>AAC74149.2|FEATURES|CARD|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>AAC75135.2|FEATURES|CARD|multidrug|mdtA|antibiotic efflux|1
MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSRSAAPGATKQAQQSPAGGRRGMRSGPLA
PVQAATAVEQAVPRYLTGLGTITAANTVTVRSRVDGQLIALHFQEGQQVKAGDLLAEIDP
SQFKVALAQAQGQLAKDKATLANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIK
ADEASVASAQLQLDWSRITAPVDGRVGLKQVDVGNQISSGDTTGIVVITQTHPIDLVFTL
PESDIATVVQAQKAGKPLVVEAWDRTNSKKLSEGTLLSLDNQIDATTGTIKVKARFNNQD
DALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWVLNSENKVSKHLVTPGIQDSQ
KVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKATSREYAKKGARS
>AHL30280.1|FEATURES|CARD|beta_lactam|OXA-380|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AHL30277.1|FEATURES|CARD|beta_lactam|OXA-377|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTKGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIT76105.1|FEATURES|CARD|beta_lactam|DHA-16|antibiotic inactivation|1
MKKSLSATLVSALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETSLNDPAVKYQPELTQPQW
KGITLLDLATYTAGGLPLQVPEAVKSSEDLLHFYQQWQPSWQPGKMRLYANSSIGLFGAL
TATAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNNQPVRVTGGPLDAESY
GVKSASKDMLRWAEINMSPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>NP_252897.1|FEATURES|CARD|multidrug|opmD|antibiotic efflux|0
MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSF
FDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLD
YDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTAR
AYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPL
TTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQL
AASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRAR
LRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANER
YRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAG
ETAGANR
>CAA64891.1|FEATURES|CARD|multidrug|mtrE|antibiotic efflux|0
MNTTLKTTLTSVAAAFALSACTMIPQYEQPKVEVAETFQNDTSVSSIRAVDLGWHDYFAD
PRLQKLIDIALERNTSLRTAVLNSEIYRKQYMIERNNLLPTLAANANGSRQGSLSGGNVS
SSYNVGLGAASYELDLFGRVRSSSEAALQGYFASVANRDAAHLSLIATVAKAYFNERYAE
EAMSLAQRVLKTREETYNAVRIAVQGRRDFRRRPAPAEALIESAKADYAHAARSREQARN
ALATLINRPIPEDLPAGLPLDKQFFVEKLPAGLSSEVLLDRPDIRAAEHALKQANANIGA
ARAAFFPSIRLTGSVGTGSVELGGLFKSGTGVWAFAPSITLPIFTWGTNKANLDVAKLRQ
QAQIVAYESAVQSAFQDVANALAAREQLDKAYDALSKQSRASKEALRLVGLRYKHGVSGA
LDLLDAERSSYSAEGAALSAQLTRAENLADLYKALGGGLKRDTQTGK
>AEQ59621.1|FEATURES|CARD|beta_lactam|TEM-191|antibiotic inactivation|1
MPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGSRGIIAALGPD
GKPSRIVVIYTT
>NP_249116.1|FEATURES|CARD|multidrug|MexA|antibiotic efflux|1
MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNA
FRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRY
KLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVT
NGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYP
LEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTR
DLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKT
VPAKNVASAQKADAAPAKTDSKG
>AAA19882.1|FEATURES|CARD|beta_lactam|blaF|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSG
RRITHRLDEMFAMCSTFKGYAAARVLQMAEHGEISLDNRVFVDADALVPNSPVTEARAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTAAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL
>AAD22144.1|FEATURES|CARD|chloramphenicol|cmlB|antibiotic efflux|1
MRSKNCNWRYSLAVTVLLLSPFDLLASLGMDMYLPAVPFMPHALGTTAGTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLAGGAAYVAASIGLVVTSSAGVFLGFRILQACGASACL
VATFATVRDIYAGRKESNVIYGLLGSMLAMVPAIGPLLGAVIDTWFGWRAIFAFLGLGMI
AALTAAWRLWPETRVQRPAALQWSQLLLPIKHLNFWLYTVCYAAGMGSFFVFFSIAPGLM
MGRQGMSQFGFSLLFATVAIAMMLAARFMGRVIAKWGSLSALRMGMGCLIAGAVLLVITE
LWIPQSVLGFIAPMWLVGVGVATAVSVAPNGALRGFDHIAGAVTAVYFCLGGLLLGSVGT
LIISLLPRDTAWPVIAYCLVLATIVLGLSCVSRARDLRGHGEYDAVART
>AAC60780.1|FEATURES|CARD|polymyxin|rosB|antibiotic efflux|0
MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETT
SLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAY
GAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLR
EPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGL
MSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSC
TVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLD
CALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIA
NSMLNMLKIETLTEEDKRPLCPI
>AEP40501.1|FEATURES|CARD|glycopeptide|vanXYN|antibiotic target alteration|1
MHNFYLQLVNQQHPWKSFNHSPQLVQATYAEEKILIDSKVNHQFNQLLETLQLTDRIMIV
DGHRTVAEQKHLWNYSLNAHGVNYTKSYVASPGCSEHHTGLAIDLGLRKTEHDLIAPRFE
GPEAELFLQHMKDYGFILRYPKNKQKITGIAYEPWHFRYVGTPHSQIIMDHGWTLEEYIE
FLKHQIEAVS
>AAB37395.2|FEATURES|CARD|beta_lactam|SHV-9|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASRTLTAWRADER
FPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAA
AITMSDNSAANLLLRTVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPAS
MAATLRNVLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>KIX81495.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYL
LVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLL
LPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLV
LALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLI
VGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGL
VLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTST
AVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSI
MAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH
>AAK60186.1|FEATURES|CARD|trimethoprim|dfrA16|antibiotic target replacement|1
MKLSLMAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSNFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDI
ERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>BAC11911.1|FEATURES|CARD|multidrug|emeA|antibiotic efflux|1
MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPI
AGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVA
DMTTISERPKAMGLVSAAISGGFIIGPGVGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFI
GFILTLTVLKEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSIM
ATINFGFTTSEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIAF
TKNNLVVVFSTFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAAG
ALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM
>CAC14596.1|FEATURES|CARD|multidrug|smeF|antibiotic efflux|0
MEVIPMKSASLFLSIAATLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWR
DFFTDARLQQVIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDA
GVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYG
ADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQ
DRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANAN
IGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIAN
ADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGL
DSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG
>YP_001715321.1|FEATURES|CARD|aminoglycoside|aadA|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>AIT76116.1|FEATURES|CARD|beta_lactam|MIR-12|antibiotic inactivation|1
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AHF20043.1|FEATURES|CARD|quinolone|QnrS9|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>AIT76096.1|FEATURES|CARD|beta_lactam|ACT-31|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>CAI30651.2|FEATURES|CARD|beta_lactam|SHV-62|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAA26742.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmS|antibiotic target alteration|1
MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRAR
RELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLL
PALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSAT
FVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRER
PLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPE
QWLTVFRTLRPVRSRPAGR
>AAR21614.1|FEATURES|CARD|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MSVEIIHLTGNDVALLQSINAMFGEAFNDQDSYARNKPSSSYLQKLLSTSSFIALAAVDE
QKVIGAIAAYELQKFEQQRSEIYIYDLAVAATRRREGIATALIKKLKAIGAARGAYVIYV
QADKGVEDQPAIELYKKLGTIEDVFHFDIAVEQSKNHA
>ACB41775.1|FEATURES|CARD|beta_lactam|IMP-25|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLSDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>WP_000725529.1|FEATURES|CARD|beta_lactam|mecC|antibiotic target replacement|1
MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIV
DRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHW
KLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKY
DDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVY
PLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIAN
TYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVST
PSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNT
NFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGM
QDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGN
IQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAEL
KMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQ
FDIDQ
>AAC75136.1|FEATURES|CARD|multidrug|mdtB|antibiotic efflux|1
MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLY
PGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAA
INAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISG
VGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSA
NDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGA
NIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYL
FLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENIS
RYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAI
LISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTL
SVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDP
AVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQP
TQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYV
NVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTI
RLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEK
TLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPT
AGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQA
CLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYL
LFDRLALWTKSRFARHEEEA
>AHE41343.1|FEATURES|CARD|quinolone|QnrB55|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRAN
LKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG
>YP_002325611.1|FEATURES|CARD|multidrug|adeB|antibiotic efflux|1
MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDS
VVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQ
VVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGA
EKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQL
SSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAV
KTAEGVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLH
NVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIM
ATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILF
SALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMV
IFLVITGITFAGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPD
VKSNTAILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLP
PAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISL
KIDREKLSALGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNL
KVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIA
KLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGI
FGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKL
RLRPILMTSLAFTCGVIPLVIATGASSETQHALGTGVFGGMISATILAIFFVPVFFIFIL
GAVEKLFSSKKKISS
>AGV10818.1|FEATURES|CARD|aminoglycoside|APH(2'')-Ig|antibiotic inactivation|1
MCEFSSPQIPITDIENAMERIGSPVRELRRLDAGDDSEVLLCNGLFVIKIPKRPSVRVTQ
QREFAVYSFLKQYDLPALIPEVIFQCSEFNVMSFIPGENFGFQEYALLSEKEKEALASDM
AIFLRRLHGISVPLSEKPFCEIFEDKRKRYLEDQEQLLEVLENRKLLNAPLQKNIQTIYE
HIGQNQELFNYAACLVHNDFSSSNMVFRHNRLYGVIDFGDVIVGDPDNDFLCLLDCSMDD
FGKDFGRKVLRHYGHRNPQLAERKAEINDAYWPIQQVLLGVQREDRSLFCKGYRELLAID
PDAFIL
>CAE48335.2|FEATURES|CARD|aminoglycoside|AAC(6')-30/AAC(6')-Ib'|antibiotic inactivation|1
MTFLIRPVEQSDAESWERLRNLLWEGDDHKSEITQFFNGEVEEPNEVLLAVTEENDAIAH
IELSLRYDIDGLTGIKTGYIEGLFVEERHRAAGVVLKLLRAAEFWARDQGCLAFASDRDD
RVIIYARYTGAPPNNSLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGG
EEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGV
RGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFER
QGTVTTPDGPAVYMVQTRQAFERTRSVA
>ADM47435.1|FEATURES|CARD|beta_lactam|OXA-134|antibiotic inactivation|1
MKILIFLPLLSCLGLTACSLPVSSLPSQSISTQAIASLFDQAQSSGVLVIQRDQQVQVYG
NDLNRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQA
SAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALA
REQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFS
LNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>AHA80103.1|FEATURES|CARD|beta_lactam|CMY-102|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNCTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAC23556.1|FEATURES|CARD|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY
>AEP40504.1|FEATURES|CARD|glycopeptide|vanSN|antibiotic target alteration|0
MKNKLNDPLIKRILLRYVSTVLLAIGIYGGVLLLLLFLFRLRTWYGDEPFYLFLRTLYIR
FNLIGLVSSGAFLLLLMITLVYIFKLIGYLNETITATKQLLEAPEQRIQLSTELFTVQEE
MNQIRENNNQANRAAKVAEQRKNDLIVYLAHDLRTSLTSVIGYLTLLKEEPQISTELRAK
YTDIALDKALRLEELIGEFFEVTQFNLTKLTINKEIVDLSIMLEQISYEFLPILNEKGLK
WQLAIDKGIKAEVDPNKMGRVFDNLIRNAINYSFSNSTIHLSLEKNGQNLELKITNETHT
LPEEKLTQIFEPFYRVDTSRSSSTGGTGLGLSIVKDIVEASGGRIHAQSSNNQMTFTLTL
PISE
>AAB05625.1|FEATURES|CARD|glycopeptide|vanWB|antibiotic target alteration|1
MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLT
TMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ
>AAO15535.1|FEATURES|CARD|chloramphenicol|cmlA1|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFISPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAEGSRGQGEHDVVALQSAESTSNPNR
>CAA11706.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmO|antibiotic target alteration|1
MARPTQRARTLSQNFLADRAAAAHVARLTAPDRRHPPLVLEVGAGKGALTEPLARRSREL
HAYEIDSRLVPGLRTRFAAAPHVRVVAGDFLAARPPRTPFSVAGNVPFSRTADIVDWCLG
APALTDATLITQLEYARKRTGDYGRWTLLTVRTWPHHEWRLVGRVSRYGFRPAPRVDAGV
LRIERRATPLLTGAAQHGWRDLVELGFSGVGGSLHASLRRAHPRRRVDAAFRAARLDPGV
LVGEVAPARWLRLHEELAS
>AAG33665.1|FEATURES|CARD|beta_lactam|OXA-37|antibiotic inactivation|1
MIIRFLALLFSAVVLVSLGHAQDKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYN
ESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSFAGHNQDQNLRSAMRNS
TVWVYQLFAKEIGENKARSYLEKLNYGNADPSTKSGDYWIDGNLAISANEQISILKKLYR
NELPFRVEHQRLVKDLMIVEAKRDWILRAKTGWDGQMGWWVGWVEWPTGPVFFALNIDTP
NRMEDLHKREAIARAILQSVNALPPN
>AIL92326.1|FEATURES|CARD|beta_lactam|CARB-17|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLTGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>CAA30578.1|FEATURES|CARD|aminoglycoside|APH(3')-VIa|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDTELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>ACQ82814.1|FEATURES|CARD|beta_lactam|PDC-9|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAVEAPADRLKALVDAAVQPVMKANDIPGLTVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>CAA75663.1|FEATURES|CARD|tetracycline|tet(H)|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTTPKAVISTP
>AAB84282.1|FEATURES|CARD|tetracycline|tet(V)|antibiotic efflux|1
MRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVA
TCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAG
ILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSI
GAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFAS
MFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTM
MLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSL
DFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL
>AAF34336.1|FEATURES|CARD|beta_lactam|SHV-22|antibiotic inactivation|1
MLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDKVTRLDRWETELNEALPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>CCQ22388.1|FEATURES|CARD|multidrug|norB|antibiotic efflux|1
MTSTAYKGTNKLIVGIVFGVITFWLFAQSMVNIVPAVQSDLGISSDLLSIAISLTALFSG
IFIVVAGGMADKFGRVKLTYIGLILSIIGSLLLVVTQGSTLLIIGRIIQGLSAACIMPAT
LALMKTYFDGADRQRALSYWSIGSWGGSGICSFAGGAIATYMGWRWIFIISIVFALLGML
LIKGTPESKVVQNTKAKFDSFGLVLFVIAMVCLNLIITRGATFGWTSPITITMLVVFLVS
AGLFFRVELRQANGFIDFSLFKNKAYTGATLSNFLLNAAAGTLVVANTYVQIGRGFTAFQ
SGLLSIGYLVCVLGMIRIGEKILQRVGARKPMILGSGITAVGIALMALTFIPGTLYTVLV
FIGFALFGIGLGMYATPSTDTAISNAPEDKVGVASGIYKMASSLGGSFGVAISATIYGVI
ALSGNIDLAAMVGLLTNVGFCVVSLISVAITTPSAKKALELKAAKE
>ADZ75467.1|FEATURES|CARD|beta_lactam|KPC-12|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELEMNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ABS43901.1|FEATURES|CARD|multidrug|cmeA|antibiotic efflux|1
MKLFQKNTILVLGVVFLLTACSKEEAPKIQMPPQPVTTMSAKSEDLPLNFTYPAKLVSDY
DVIIKPQVSGVIVNKLFKAGDKVKRGQTLFIIEQAKFKASVDSAYGQALMAKATFENASK
DFNRSEALFSKNAISQKEYDSSLATFNNAKASLASARAQLANARIDLDHTEIKAPFDGTI
GDALVNIGDYVSTSTTELVRVTNLNPIYADFFISDTDKLNLVRNTQSGKWDLDSIHANLN
LNGETVQGKLYFIDSVIDANSGTVKAKAVFDNNNSTLLPGAFATITSEGFIQKNGFKVPQ
IAIKQDQNDVYVLLVKNGKVEKSSVHISYQNNEYAIIDKGLQNGDKIILDNFKKIQVGSE
VKEIGAQ
>AGW83452.1|FEATURES|CARD|beta_lactam|OXA-354|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNSVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKMLPFSKDVQEQVQSMVFIEEKNGRKIYAKSGWGWDIEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>YP_001706893.1|FEATURES|CARD|multidrug|adeG|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIA
ETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVYQAMPRL
PEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLF
GSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGR
LTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANA
LQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAIALVVVVVILFL
QTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERN
IEAGLNPREATYGAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVI
SAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRV
ISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKM
SDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQK
YSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGP
MFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQA
DAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGY
SSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYES
LTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFAQELEM
QGATAFRAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVS
FFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH
>CAC41371.1|FEATURES|CARD|tetracycline|tet32|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AAT74613.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>CAJ17558.1|FEATURES|CARD|beta_lactam|TEM-144|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIS67613.1|FEATURES|CARD|beta_lactam|CTX-M-157|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTAPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFR46587.1|FEATURES|CARD|quinolone|QnrB56|antibiotic target protection|1
MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
GNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG
>AAD51346.1|FEATURES|CARD|multidrug|smeC|antibiotic efflux|0
MKPMLLRALAAATMTTVLGGCVSMAPHYQRPEAPVPAQFGNAAIGAAEPALAMPAWRDVF
LEPRLQQVIALALQNNRDLRVAVLQVEKERAQYRIQRAALLPSVDASGSVTRSRVSDANS
ETGVTQVTESDAVQVGISSWELDLFGRIRSLKNEALQNWLASAENQRAVRTSLVAEVATA
WLALAADEQSLAFTQQTLDSQHQTLQRTEARHAQGLASGLDLSQVQTSVEAARGALAKLQ
AQQAQDRDALQLLVGAPLDPALLPTAQALDGSVALAPLPANLPSSVLLQRPDVLSAEHAL
QAANADIGAARAAFFPTLALTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKA
SLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLTAQLDAQRALVADSQRSYTLADA
RYRTGLDGYLQSLDAQRSLYAAQQDLIALQQQEAGNRVTLFKVLGGGADAR
>CAA64682.1|FEATURES|CARD|beta_lactam|TEM-45|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>AGC51118.1|FEATURES|CARD|beta_lactam|mecA|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKS
RNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>AAA22562.1|FEATURES|CARD|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVPGHG
EVGDRGLLLHTLDLLK
>AFU35063.1|FEATURES|CARD|aminoglycoside|ANT(9)-Ia|antibiotic inactivation|1
MLIGVYLYGSAVMGGLRMNSDVDILVITNQSLSEKTRRNLTNRLMLISGKIGNIKDMRPL
EVTVINQKDIVPWHFPPKYEFMYGEWLREQFEKGEIPESTYDPDLAILLAQLRKNSINLL
GPKATEVIEPVPMTDIRKAIKESLPGLIASINGDERNVILTLARMWLTASTGEIRSKDLA
AEWAIPQLPDEHATLLNKAREAYLGECVDKWEGMESEVAELVNHMKKSIESSLNIQLPFR
IV
>AGU69248.1|FEATURES|CARD|beta_lactam|OXA-121|antibiotic inactivation|1
MNIKALLLITNAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLCPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAB03413.1|FEATURES|CARD|beta_lactam|cphA2|antibiotic inactivation|1
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPRTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>AAC76298.1|FEATURES|CARD|multidrug|acrF|antibiotic efflux|1
MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDT
VTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQ
EVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGA
QYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRF
KNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANAL
DTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQ
NMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
MEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRY
LLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKN
EKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDG
FVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGL
EDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRM
LPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAM
ALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSV
MLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVV
EATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFF
VPVFFVVIRRCFKG
>CDG50843.1|FEATURES|CARD|beta_lactam|CTX-M-103|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGN
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>BAA03718.1|FEATURES|CARD|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDIACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>AFK80333.1|FEATURES|CARD|elfamycin|facT|antibiotic efflux|1
MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDL
GASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDL
LVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISW
NPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLT
LGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLL
FSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLA
GAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAG
AASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCAT
EALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPV
TALVLLLPHHRVRREEPAQ
>AIY30332.1|FEATURES|CARD|beta_lactam|OXA-423|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAAPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AGL43625.1|FEATURES|CARD|quinolone|QnrB64|antibiotic target protection|1
MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>AAD51348.1|FEATURES|CARD|multidrug|smeR|antibiotic efflux|0
MSTSPATSTKILIVEDEPRLASVLRDYLAAAGMASEWVDDGGQVIDAFARYQPDLVLLDL
MLPQRDGVDLCRELRASSDVPVIMVTARVEEIDRLLGLEIGADDYICKPFSPREVVARVM
AVLRRYRPDPGARANGGLHIDEPAARATWNGKGLDLTPVEYRLLRTLLATPGRIWARDEL
LDRLYLDHRVVVDRTVDSHVRNLRRKLADAGMEGEPIRSVYGMGYSYEP
>AAU10334.1|FEATURES|CARD|aminoglycoside|aad(6)|antibiotic inactivation|1
EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKG
FSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPS
AREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSV
GKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEY
DRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ
>NP_831795.1|FEATURES|CARD|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEV
HQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>AAC15074.1|FEATURES|CARD|beta_lactam|OXA-17|antibiotic inactivation|1
IACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTF
KIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGE
VRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVK
EALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPL
RKSIPTKIMESEGIIGG
>ABB89122.1|FEATURES|CARD|trimethoprim|dfrA5|antibiotic target replacement|1
MKVSLMAAKAKNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSAWTADNDNVIVFPSIEEAMYGLAELTDHVIVSGGGEIYRETLPMASTLHISTIDI
EPEGDVFFPNIPNTFEVVFEQHFSSNINYCYQIWQKG
>BAI83385.1|FEATURES|CARD|beta_lactam|mecB|antibiotic target replacement|1
MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRY
KRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITK
KWLLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKK
NKKNISKLLSISESTLNKKLKQTWVKEGVFLPLKSYIELDDELKLGIQKYHLTVNQTKGR
VYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVI
TSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLAL
VSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTID
ASTSYNIVTKGWQRNSSWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFI
KGMKALDIGRNIPSDYYFQKGQIANPESLKNNFKNEILLADSGYGQGEILISPVQILSIY
SSLINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFA
GKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENKGMSSYNARKFAEIMD
ELYENGTKKYEIDR
>AIT76117.1|FEATURES|CARD|beta_lactam|MIR-14|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIHMLELATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRIFKPLNLNHTWINVPKTEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLQDSSLRKGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPLVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AGU38146.1|FEATURES|CARD|beta_lactam|ACT-23|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMVPEKVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>ABC17627.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib-cr|antibiotic inactivation|1
MSNAKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLAD
VQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLAN
ASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYG
PAVYMVQTRQAFERTRSDA
>CAJ67339.1|FEATURES|CARD|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYTSGAIAESGSVDTGTTRTDTTFLERQRGITIQTAV
TSFQWKDIKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISARDGVQAQTRILFHALNKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIE
GNDYLLEKYTLGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGR
SVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT
>AHN07454.1|FEATURES|CARD|beta_lactam|OXA-338|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AML99881.1|FEATURES|CARD|multidrug|mdtK|antibiotic efflux|0
MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLG
KEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAV
VLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTK
IPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNP
ALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIA
FSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFA
GLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWG
CRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE
>AHM76768.1|FEATURES|CARD|beta_lactam|CMY-93|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKFSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLRPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRVGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AHX39588.1|FEATURES|CARD|beta_lactam|CTX-M-144|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDL
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AHE41344.1|FEATURES|CARD|quinolone|QnrS7|antibiotic target protection|1
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>BAA34300.1|FEATURES|CARD|multidrug|mexY|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
EEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWML
VYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDI
GRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQ
LMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVV
PLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLE
AARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFF
LVVGRLFRLRKAPRTGNSPQIPTEQA
>AIT76101.1|FEATURES|CARD|beta_lactam|DHA-20|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AIT76107.1|FEATURES|CARD|beta_lactam|DHA-14|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>CAB12108.2|FEATURES|CARD|tunicamycin|tmrB|reduced permeability to antibiotic|0
MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRA
FNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLR
TRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSL
RRFADRLMVKLNHIRIK
>AAZ91704.1|FEATURES|CARD|beta_lactam|CARB-2|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKTDLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGRNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>AAC75733.1|FEATURES|CARD|multidrug|emrB|antibiotic efflux|1
MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGV
ANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLI
PLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVA
VVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVV
AVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYG
YTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMD
FGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTM
WTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEI
FWMSAGIFLVLLGLVWFAKPPFGAGGGGGGAH
>AIT76112.1|FEATURES|CARD|beta_lactam|MIR-11|antibiotic inactivation|1
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAL79549.2|FEATURES|CARD|beta_lactam|CfxA3|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>BAO21229.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iak|antibiotic inactivation|1
MTGSAATIRPAKAADAVAWAQLRLGLWPDADDPLETLVAALAEDAGAVFLACAAGGQAIG
FAEVRLRHDYVNGTDSSPVGFLEGWYVQPQWQGRGVGRALLAAVRAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>CAA01212.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MRFEEWVKDKHIPXKXNHPDDNYDDFKPLRXIIGDTRVVALGENSHFIKEFFLLRHTLLR
FFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYN
KAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQ
AALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNI
QAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFL
SCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKA
ISGCGVTNSFVFFRNIPEDLQSIPNMIRFXSIYMKAELEKAFDGIFQIEKSSVSEVVYE
>AAZ14955.1|FEATURES|CARD|beta_lactam|CTX-M-43|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GGYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAERRRDILAAAAKIVTHGF
>AAA74437.1|FEATURES|CARD|multidrug|MexB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDT
VVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQ
EVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGS
QYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRL
QTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANAL
DTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMAL
SVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAP
YLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLE
KESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKD
AMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGM
SDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARM
NPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAM
AAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVE
AAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWV
PLFYVAVSTLFKDEASKQQASVEKGQ
>AAD25063.1|FEATURES|CARD|tetracycline|tet(Z)|antibiotic efflux|1
MLITATLDAAGLGLVMPILPTLLDQVGAPDDMIPLHVGLLTALYAIMQFLCAPILGRLSD
RFGRRRVLVASLAGATIDYLVLALTDTLWVFYLARAVAGITGATNAVTATVIADITPPDQ
RAKRYGWLGACYGGGMIAGPAIGGLFGGVSPHLPFLVAAALAGITLVLSASLLRETRPPG
SNGSHAQQPGTAKRTAVPGMLILLAVFGIVQFIGQAPGSTWVLFTQQRLDWNPVEVGVSL
SIFGMVQVFVQAALTGRIVSRIGETRAILVGIAADAIGLIGLALIASTWAMLPILAALGL
GSITLPALQTLLSRRAPEQQQGRLQGTLASLNSLTSIIGPVTFTGIFALTRTNADGTLWI
CAAALYVLCALLMIRETCASRRSR
>AHX97725.1|FEATURES|CARD|quinolone|QnrB74|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AGW16417.1|FEATURES|CARD|beta_lactam|OXA-335|antibiotic inactivation|1
MKILILLPLLSCLGLTACSLPVSSLPSQSTSTQAIASLFDQAQSSGVLVIQRDQQVQVYG
NDLNRANTEYVPASTFKMPNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQA
SAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALA
REQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFS
LNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>ABC68330.1|FEATURES|CARD|aminoglycoside|APH(3'')-Ic|antibiotic inactivation|1
MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDW
RVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDML
ARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCLPNI
LVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADTVPGFAEEATAGLAAGYPAQVDPE
RLRFYLALDPLTWG
>YP_009062819.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib8|antibiotic inactivation|1
MSLKPGPKRIAESTGQPDQRQRDNKKTPGNTDKLGITKYSIVTNSTDSVTLRLMTEHDLA
MLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYV
ALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPS
PSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>CAA79966.1|FEATURES|CARD|beta_lactam|NmcR|antibiotic inactivation|0
MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQ
LTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENP
WIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPS
DLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQ
KELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS
>NP_417544.5|FEATURES|CARD|quinolone|patA|antibiotic efflux|0
MNRLPSSASALACSAHALNLIEKRTLDHEEMKALNREVIEYFKEHVNPGFLEYRKSVTAG
GDYGAVEWQAGSLNTLVDTQGQEFIDCLGGFGIFNVGHRNPVVVSAVQNQLAKQPLHSQE
LLDPLRAMLAKTLAALTPGKLKYSFFCNSGTESVEAALKLAKAYQSPRGKFTFIATSGAF
HGKSLGALSATAKSTFRKPFMPLLPGFRHVPFGNIEAMRTALNECKKTGDDVAAVILEPI
QGEGGVILPPPGYLTAVRKLCDEFGALMILDEVQTGMGRTGKMFACEHENVQPDILCLAK
ALGGGVMPIGATIATEEVFSVLFDNPFLHTTTFGGNPLACAAALATINVLLEQNLPAQAE
QKGDMLLDGFRQLAREYPDLVQEARGKGMLMAIEFVDNEIGYNFASEMFRQRVLVAGTLN
NAKTIRIEPPLTLTIEQCELVIKAARKALAAMRVSVEEA
>WP_000572405.1|FEATURES|CARD|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNEL
QDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAM
RRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD
GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRF
LVLYGIAAPDSQRIAFYRLLDEFF
>WP_063864911.1|FEATURES|CARD|beta_lactam|TEM-4|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AKN19287.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib7|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRSDA
>BAL75272.1|FEATURES|CARD|beta_lactam|BJP-1|antibiotic inactivation|1
MKKLTAALCALAFFATGAQAQTVKDFIAAVTKKWTTPFEPFQLIDNIYYVGTDGIAVYVI
KTSQGLILMDTALPQSTGMIKDNITKLGLKVADIKIILNTHAHFDHTGGFAEVKKETGAQ
LIAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRTVKEGDKVTLGETTLTAHATPGHSPG
CTSWEMTVKDGGQDRQVLFFCSGTVALNRLVGQPTHAGIVDDYRATYAKVKAMKIDVLLG
PHPEVYGMQAKRAAMKDGAPNPFVKPGELATYATSLSEDFDKQLAKQTAALEKK
>CAA11707.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|gimA|antibiotic inactivation|0
MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLF
AEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPD
LVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARF
RGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWR
RPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVE
VRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRH
LPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART
>NP_358469.1|FEATURES|CARD|quinolone|pmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>ACQ82809.1|FEATURES|CARD|beta_lactam|PDC-4|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDEMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>BAE06008.1|FEATURES|CARD|multidrug|mexQ|antibiotic efflux|1
MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIA
QTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRL
PDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVW
GAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLG
RLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGAN
ALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLF
LRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVER
HIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTI
LSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVS
GLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIG
LDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASI
PDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTS
FDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPH
RMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQ
AVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLP
LAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGAR
ALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGL
FLTPVFYVLVRALAARLERRAGGSLAHLEGGRP
>BAE06006.1|FEATURES|CARD|multidrug|mexN|antibiotic efflux|1
MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSP
ETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAA
GRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIF
VVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLF
NASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDT
ADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQL
SATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEA
GASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVV
ASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVA
VAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVG
VTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGP
SRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARF
GLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEM
VPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTI
IGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFL
LWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPI
MMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHR
RGTTTSDGGTAGATAT
>NP_252368.1|FEATURES|CARD|multidrug|mexL|antibiotic efflux|0
MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTD
KETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQ
AGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRL
LIGCAEPLDEAEGERHVEEVVALFLRAFAAGG
>BAM46120.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iaj|antibiotic inactivation|1
MEYSIINIVEQNNYQIDAARILTNTFLDIGNKTWPTIQSAIDEVEECIDLPNICIGLIHN
NQLIGWVGLRPMYDKTWELHPLVVRTDYQSKGIGSVLLAEVEKRAREVGIIGIILGTDDE
YNKTSLSEITIDENNIFDAIQNIKNIHNHPYEFYQKNGYMIVGIIPNANGLRKPDIWMWK
SLLN
>AJP77071|FEATURES|CARD|beta_lactam|PEDO-2|antibiotic inactivation|1
MKKIFLMVLFSCSLLGFAQTVTEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTE
KGNILINTGLANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMSEIKKETGAKLYV
DEKDADALETGGKLDYELGKYGISFKPVKPDFLLKNNDKIKLGNTTLTMLHHPGHTKGSC
SFIFDTKDKNSSYKILIANMPSIIVDRKFSEIASYKDIQKDYTETFKAMKKLDFDLWVAS
HASQFELHDKRKSGAPYNPKIFMDKSKFFKNLEDLENIFLEKIKN
>AJP77076|FEATURES|CARD|beta_lactam|PEDO-3|antibiotic inactivation|1
MRYLLSFLLCLSAFASFAQNPKIKIKHLTGDLYVYTTYNTYKGALTDANAVYLVTNKGVV
VIDAPWDATQFQPFLDSIQTKHHQKVVLAIATHSHGDRAGGLAFFKSKGIKTYTNKLTDE
ILKTNKEPRAAYTFTNDTTFTVGQYKINTYYAGKGHTKDNLVVWFPKDKVLFGGCLIKSI
EANDLGYIGESDLAAWPKSIEKLKQKYPDTKIVITGHAAWGNRESLDHTLKLLREKK
>AJP77054|FEATURES|CARD|beta_lactam|CPS-1|antibiotic inactivation|1
MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTD
KGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYV
DEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSC
SFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVAS
HASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK
>ACM47284|FEATURES|CARD|glycopeptide|vanSD|antibiotic target alteration|0
MKNRNKTSHEDDYLLFKNRLSVKILLMMACSILIIAGVYLFILKDNFANVVVAILDSFIY
HDRDEAVVVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDA
NDITLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLN
LLRDENQISEELREKYLSISLDKAERLEELINEFFEITRLIFQISRLCTAKSI
>WP_005813024.1|FEATURES|CARD|glycopeptide|vanWI|antibiotic target alteration|1
MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVL
AEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPE
LLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGM
ETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGG
EFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSH
SLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDE
PDGYPVKPREWSK
>WP_011461306|FEATURES|CARD|glycopeptide|vanKI|antibiotic target alteration|1
MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYR
KMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTI
KTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYR
LPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVR
SFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAP
NHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPL
QPLLYRAFQLYLKRR
>WP_011461303|FEATURES|CARD|glycopeptide|vanRI|antibiotic target alteration|0
MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVD
GFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRF
TKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSE
ELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK
>AGT57825|FEATURES|CARD|macrolide-lincosamide-streptogramin|lnuE|antibiotic inactivation|1
MGKNNVTEKHLFYILDLLKDLQITYWLDGGWGVDVLTGKQQREHRDIDIDFDSQHTDKLV
KKLKEIGYITVVDWMPSRMELKHEEYGYLDIHPLDLKKDGTATQADPKGGFYLFEKDWFT
TTNYKNRKIPCISKEAQLLFHSGYELTEKDQFDIKNLNSINQVKKEGHFSNDF
>EOO80837.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MNKQKAVEIARKYGLEVKDESIIFNESGLDFLVAYAEDDKGEEWVLRFPRRDDVMPRTIV
EKKALDLVNKYATFQVPVWSVYEGDLIAYKKLIGVPAGTIDPEIQNYVWEMDYENVPEQF
HQTLAKALASLHTVPKTEALKVGLFVQTAEEARKSMIERMKKVKAKFGVGESLWNRWQAW
VKNEELWPQRTGLIHGDVHAGHTMIDKDANLTGFIDWTEAKVTDVSNDFVFQYRVFGEAA
LEKLINYYRQAGGIYWPAMKEHVIELNAAYPVAIAEFAIISGLEEYEQMAKETLEVNDR
>ACJ42146.1|FEATURES|CARD|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_042649345|FEATURES|CARD|beta_lactam|MOX-9|antibiotic inactivation|1
MQQQVRMTLLMASTLLWAGLAQATADTQADPLRPLVDASIRPVLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGARVSEQTLFEIGSVSKTLTATLGAYAVVKGALKLDDKVSQHGPWL
KGSAFDGITMAELATYSAGGLPLQFPDEVDSIDKMRAYYRQWTPAYRAGSHRQYSNPSIG
LFGHLAAQSLGQPFEQLMSQTLLPGLGLEHTYLKVPAEAMANYAYGYSKEDKPIRVNPGV
LADEAYGIKTSSADLLKFVGANMTGTGDEAMQQAIALTHKGVYSVGAMTQGLGWESYAYP
VTEETLLAGNSGKVILEANPTAPASNETGSQVLFNKTGSTGGFGAYVAFVPAKGIGIVML
ANRNYPIQARVETAHAILSKLAE
>WP_004714775.1|FEATURES|CARD|beta_lactam|ADC-1|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNRFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857801.1|FEATURES|CARD|beta_lactam|ADC-4|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIYANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNRFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_038405930.1|FEATURES|CARD|beta_lactam|ADC-5|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLTPQKYPTDIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>BAG75524.1|FEATURES|CARD|multidrug|efmA|antibiotic efflux|1
MENEQSVVLTNWKRNYLFFLSGQFLSGITSMVVQYAIIWYLTRETGSATILSFATLLGMI
PMVLLSPFVGPLVDRWDKKALLIVTDIIVAIFALILAVVGTISESFPIWLVFVSLFMRSV
AQTFQMPTIQSIMPTIVPSSHITRTNGQLGMVQSANFIIAPALGAALFSVVPVNYLILLD
VLGAVFGVGLLIFVKIPKVSPEILEVPLTIFKDAKFGLQQLMDNKGLWYITINGAFVMLL
FMPAISLYPLMTLDYFGGSVGQAGAVEVVYAVGMLLGGALISFIGTWKDRMKPIIIAYII
MGLTIGASGLVPNDSQGFLYFLILNAGAGCATPYFNTLLMAMIQQSYESNVLGRVLGNFN
SLMNLAGPIGLLFAGPLADRLGVEKMFLFSGIGILLCGIVLFLTSAARNYDKELQKKLVK
EHHEQKDE
>NP_217362.1|FEATURES|CARD|multidrug|efpA|antibiotic efflux|1
MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGG
MQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRT
FIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAAT
AVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDA
TGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHL
FRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVS
SQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLT
LSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQL
AALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL
>NP_273368.1|FEATURES|CARD|multidrug|farB|antibiotic efflux|1
MDYPPLKGAALAWVTLSLGLAVFMEVLDTTIANVAVPVIAGNLGAATTQGTWVITSFSVA
NAVSVPLTGFLAKRIGEVKLFTAAAVGFVITSWLCGIAPNLQSLVVFRILQGFIAGPLIP
LSQSLLMASYPPAKRTLALALWAMTVVVAPVLGPILGGWISGNWHWGWIFFINIPIGIIS
AWITWKHLKYRETETVKMPTDYVGLTLMVVGIGALQMMLDRGKELDWFASGEIITLGVVA
LVCLSYFIVWELGEKYPIVDLSLFKDRNFTVGVIATSLGFMVYMGTLTLLPLVLQTNLGY
TSTWAGLAAAPVGILPVFLSPLIGRFGNKIDMRLFVTASFLTFAFTFYWRTDFYADMDIG
NVIWPQFWQGVGVAMFFLPLTTITLSHMKGGQIAAAGSLSNFLRVLMGGVGVSVVSTLWE
RREALHHTRFAEHITPYSATLHETAAHLSQHGVSDIQTLGIINNTITQQGFIIGSNEIFM
AGSLLFIIMIPVIWLAKPPFHNGGGGGH
>ABF33001.1|FEATURES|CARD|multidrug|lmrP|antibiotic efflux|0
MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMMITSLMGFVGT
LYGGHLSDALGRKKVIMIGSVGTTLGWFLTILANLPNAAIPWLTFAGILLVEIASSFYGP
AYEAMLIDLTDESNRRFVYTINYWFINIAVMFGAGLSGLFYDHHFLALLVALLLVNVLCF
GVAYYYFDETRPETHAFDHGKGLLASFQNYRQVFQDRAFVLFTLGAIFSGSIWMQMDNYV
PVHLKLYFQPTAVLGFQVTSSKMLSLMVLTNTLLIVLFMTVVNKLTEKWKLLPQLVVGSL
LFTLGMLLAFTFTQFYAIWLSVVLLTFGEMINVPASQVLRADMMDHSQIGSYTGFVSMAQ
PLGAILASLLVSVSHFTGPLGVQCLFVVIALLGIYFTVVSAKMKKV
>NP_416715.1|FEATURES|CARD|peptide|yojI|antibiotic efflux|1
MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLL
LMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITI
AFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRE
TEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSN
IMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLN
KFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGS
GKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPA
NPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQ
DPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASR
DAVARTA
>NP_251215.1|FEATURES|CARD|multidrug|OpmB|antibiotic efflux|0
MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELY
GDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDS
TVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVR
LSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLK
STQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDI
ASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLF
DGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESARE
ALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADI
ERTDERLGRVEEGLPPSP
>NP_416292.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|msrB|antibiotic inactivation|0
MANKPSAEELKKNLSEMQFYVTQNHGTEPPFTGRLLHNKRDGVYHCLICDAPLFHSQTKY
DSGCGWPSFYEPVSEESIRYIKDLSHGMQRIEIRCGNCDAHLGHVFPDGPQPTGERYCVN
SASLRFTDGENGEEING
>ALH22601.1|FEATURES|CARD|multidrug|adeL|antibiotic efflux|0
MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYY
DRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIG
LNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQK
NHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYM
LTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTAL
PFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT
>AEX49906.1|FEATURES|CARD|polymyxin|basS|antibiotic target alteration|0
MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLD
LATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQ
GPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGL
VWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAE
RRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLAR
LDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNL
VGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGS
GLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI
>WP_063857793.1|FEATURES|CARD|beta_lactam|ADC-19|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKKL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>EPF73263|FEATURES|CARD|aminoglycoside|APH(3')-VIII|antibiotic inactivation|1
MKLPQKIRNFIGNNRLIVNKVGQSPSDVYCFERNRETFFLKVSSVQYATTTYSVAREAQM
MLWLADKINVPELVFSEIDQNFEYMLSKSIDAQPISDLSLAQSELIMLYQDVLSQLRSVP
VQNCPFNSDINSRLQESQYFMEIGLLNQVDDENIDIELWGEHQSYLELWTELNNHRVKEN
LVFTHGDITDSNIFVDQSNKIYFLDLGRAGLADEFVDIAFVERCLREDGSEESAQKFLKQ
LSFDDLSKRQYFLKLDELN
>APU52409.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lnuG|antibiotic inactivation|1
MLKQKELMARVKELVQSDERISACMMYGSFTKGEGDQYSDIEYYVFLKDDTISTFDSAKW
LNEVASYTLLYQNEYGTEVVIFENLIRGEFHFLSENEMNIIPSFKESGYIPDTKAMFIYD
ETGQLELYLSELEGPGPNRLTEENVNFLLNNFSNLWLMGINVLKRGENARSLELLSQLQK
NILQLIRIAEENADNWFNMTKNLEKEISPENYEKFKKTTARLNELELYEAYKNSLLLVME
LRNLVEKQYQLTISDDFLGKLFNYMNE
>AMY61250.1|FEATURES|CARD|beta_lactam|HMB-1|antibiotic inactivation|1
MKIHLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVD
GKDAYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASE
QTNELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFV
KPEGLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKK
K
>NP_250963.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKV
AQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGC
GCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG
>AAP82271|FEATURES|CARD|multidrug|TolC|reduced permeability to antibiotic|0
MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQS
RFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYD
ATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFS
NNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQG
RSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAY
TYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTS
INQTAATVGLRHRF
>CAA09666|FEATURES|CARD|beta_lactam|KR51_00036950|reduced permeability to antibiotic|0
MKRKVLALVIPALLAAGAAHAAEIYNKDGNKLDLYGKVDGLHYFSSDSKKDGDQTYLRFG
FKGETQINDILTGYGQWEYNVQANNTETSSDQAWTRLAFAGIKVGDYGSFDYGRNYGVLY
DVEGWTDILPEFGGDSYTYADNFMAGRANGVATYRNSDFFGLVEGLNFALQYQGKNEGQN
AQDINVGTNNRSSDSDVRFDNGDGFGLSTSYDFGMGISAAAAYTSSDRTNDQMTQTNARG
DKAEAWTAGLKYDANDIYLATMYSETRNMTPYGNDGVANKTQNFEVTAQYQFDFGLRPAI
SYLQSKGKDLYNNGRYADKDLVKYMDVGATYYFNRNMSTYVDYKINLLDGNDKFYEDNGI
STDNIVALGLVYQF
>EGP45231.1|FEATURES|CARD|multidrug|AxyY|antibiotic efflux|1
MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEA
VTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPE
SVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAE
AAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLH
TPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVE
TTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQN
LRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMA
EEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFS
AFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGL
AYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEP
VQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFA
LNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQ
LQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDI
SRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMET
LAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVP
LGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEA
ARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFL
IVGRMVGMRARPARPDGREPLETTP
>AAN17791.1|FEATURES|CARD|beta_lactam|BUT-1|antibiotic inactivation|1
MCRTLCHVTYGRFSMMKKTLCCALVLSASFSAFAAQKTLSDKQLEEAVNQTLKPMITAQA
IPGMAVAVIYQGKPHYFTYGVADIAKNQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVK
LSDPAMKYWPELTGKQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPDWAP
GTRRQYANSSIGLFGALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYR
DGKAMHVGPGMLDTEAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLEIAQSRYWRSGS
MYQGLGWEMLNWPVAAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGA
YVAFIPEKQIGIVMLANKMYPNTERVKAANTLLNTLQ
>WP_063857802.1|FEATURES|CARD|beta_lactam|ADC-41|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKNQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGIMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_001159760.1|FEATURES|CARD|beta_lactam|ADC-79|antibiotic inactivation|1
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ASK40562.1|FEATURES|CARD|polymyxin|MCR-5|antibiotic target alteration|1
MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTG
LLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVRE
ASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMD
VLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQEQGRRPR
ALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRR
DYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCL
DEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEA
LVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPD
EQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLAT
CRKGQPQ
>AKR18014.1|FEATURES|CARD|beta_lactam|PDC-74|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18021.1|FEATURES|CARD|beta_lactam|PDC-81|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNLSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AAC77033.1|FEATURES|CARD|multidrug|golS|antibiotic efflux|0
MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAII
KIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCI
GCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN
>YP_040771.1|FEATURES|CARD|quinolone|parE|antibiotic target alteration|0
MAMNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGN
EIDVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFK
ASTSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEV
LHDVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDY
ARRINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVA
DKLPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQS
KNTDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIH
TIGAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPP
LYKLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETR
TLIRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHFEFGMQEDQSILDNSEVQVLENDQF
DEEEI
>CCP43072.1|FEATURES|CARD|ethambutol|iniA|antibiotic efflux|0
MVPAGLCAYRDLRRKRARKWGDTVTQPDDPRRVGVIVELIDHTIAIAKLNERGDLVQRLT
RARQRITDPQVRVVIAGLLKQGKSQLLNSLLNLPAARVGDDEATVVITVVSYSAQPSARL
VLAAGPDGTTAAVDIPVDDISTDVRRAPHAGGREVLRVEVGAPSPLLRGGLAFIDTPGVG
GLGQPHLSATLGLLPEADAVLVVSDTSQEFTEPEMWFVRQAHQICPVGAVVATKTDLYPR
WREIVNANAAHLQRARVPMPIIAVSSLLRSHAVTLNDKELNEESNFPAIVKFLSEQVLSR
ATERVRAGVLGEIRSATEQLAVSLGSELSVVNDPNLRDRLASDLERRKREAQQAVQQTAL
WQQVLGDGFNDLTADVDHDLRTRFRTVTEDAERQIDSCDPTAHWAEIGNDVENAIATAVG
DNFVWAYQRSEALADDVARSFADAGLDSVLSAELSPHVMGTDFGRLKALGRMESKPLRRG
HKMIIGMRGSYGGVVMIGMLSSVVGLGLFNPLSVGAGLILGRMAYKEDKQNRLLRVRSEA
KANVRRFVDDISFVVSKQSRDRLKMIQRLLRDHYREIAEEITRSLTESLQATIAAAQVAE
TERDNRIRELQRQLGILSQVNDNLAGLEPTLTPRASLGRA
>CCP46748.1|FEATURES|CARD|aminoglycoside|gidb|antibiotic target alteration|0
MSPIEPAASAIFGPRLGLARRYAEALAGPGVERGLVGPREVGRLWDRHLLNCAVIGELLE
RGDRVVDIGSGAGLPGVPLAIARPDLQVVLLEPLLRRTEFLREMVTDLGVAVEIVRGRAE
ESWVQDQLGGSDAAVSRAVAALDKLTKWSMPLIRPNGRMLAIKGERAHDEVREHRRVMIA
SGAVDVRVVTCGANYLRPPATVVFARRGKQIARGSARMASGGTA
>ADJ67256|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MNQEVKNKIFSILKITFATALFIFVAITLYRELSGINFKDTLVEFSKINRMSLVLLFIGG
GASLVILSMYDVILSRALKMDISLGKVLRVSYIINALNAIVGFGGFIGAGVRAMVYKNYT
HDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASLILDKITWVRWVLYVVSFFLPLFI
IYSMVRPPDKNNRFVGLYCTLVSCVEWLAAAVVLYFCGVIVDAHVSFMSFIAIFIIAALS
GLVSFIPGGFGAFDLVVLLGFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGT
SAKKYIEGSKYFIPAKDVTSFLMSYQKDIIAKIPSLSLAILVFFTSMINLTIVYDALYDG
NHLTYYILLAIHTSACLLLLLNVVGIYKQSRRAIIFAMISILLITVATFFTYASYILITW
LAIIFVLLIVAFRRARRLKRPVRMRNIVAMLLFSLFILYVNHIFIAGTLYALDIYTIEMH
TSVLRYYFWLTILIIAIIIGMIAWLFDYQFSKVRISSKIEDCEEIINQYGGNYLSHLIYS
GDKQFFTNENKTAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGYDVIFYQV
TDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSGKKRRGFRATLNKFDELNISFEIIEPPF
STEFINELQHVSDLWLDNRQEMHFSVGEFNEEYLSKAPIGVMRNEENEVIAFCSLMPTYF
NDAISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSYLRER
LAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRHK
>AFK58561.1|FEATURES|CARD|multidrug|evgS|antibiotic target alteration|0
MMGKISRAMLAVYSGIAAFLIILFSLFTYFYASNQSHWWGELLRARLLYVPLIFHLLAIS
LGVGLIVFLLLSLIQKTKYGKIEEKLRALSSGNYESKLLLLPIPSASDDLYIKDIDKEIT
KIKEKMIEVSSELQIVTSRPQYVDGQTKEEILELERHRLARELHDSVSQQLFAAMMMMSA
LTEQAEKSETPEMFRKQLKMVAEIINASQSEMRALLLHLRPVNLEEKSLKQGIEQLLKEL
QNKIQISLKWDVEDVKLSSSIEDHLFRIVQELLSNTLRHAKANELEVYLHKIDNNLLLRI
IDDGTGFNMNETKTGSYGLNNIKERVAGIGGTVKIISFKGQGTSVEIKVPLMKEA
>YP_039483.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESETDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEIIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDADEENEDEQSTVSEDGTEQQREAVVND
ETPGNAIHTEVIDSEVNDEDGRIEVRQDFMDRVEEDIQQSSDDDEE
>CCP44620.1|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVAT
GIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAG
AGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGP
TGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLG
VEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRA
GRVQVLPDLSIPGYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAERE
PFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVT
FLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS
>CCP43410.1|FEATURES|CARD|polymyxin|arnA|antibiotic target alteration|0
MADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIG
SPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKD
MTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVY
FDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSE
QIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRY
DLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVE
TDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAA
IKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPI
ETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANS
PIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRAL
MGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGT
RRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPW
EGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDE
RGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGK
VIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPF
LADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEA
QPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVG
YMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQ
ELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIE
LREGEDEDLERAAANLGINLSRNESASVEDLA
>CDO13981.1|FEATURES|CARD|multidrug|phoQ|antibiotic target alteration|0
MRVLVVEDNALLRHHLKVQLQELGHQVDAAEDAREADYYLGEHLPDIAIVDLGLPDEDGL
SLIRRWRSHDVSLPVLVLTAREGWQDKVEVLSAGADDYVTKPFHIEEVAARMQALLRRNS
GLASQVISLPPFQVDLSRRELSVNDQPIKLTAFEYTIMETLIRNRGKVVSKDSLMLQLYP
DAELRESHTIDVLMGRLRKKIQAEYPQDVITTVRGQGYLFELR
>CCP44023.1|FEATURES|CARD|glycopeptide|vanRI|antibiotic target alteration|0
MAGSATVEKRLDFGLLGPLQMTIDGTPVPSGTPKQRAVLAMLVINRNRPVGVDALITALW
EEWPPSGARASIHSYVSNLRKLLGGAGIDPRVVLAAAPPGYRLSIPDNTCDLGRFVAEKT
AGVHAAAAGRFEQASRHLSAALREWRGPVLDDLRDFQFVEPFATALVEDKVLAHTAKAEA
EIACGRASAVIAELEALTFEHPYREPLWTQLITAYYLSDRQSDALGAYRRVKTTLADDLG
IDPGPTLRALNERILRQQPLDAKKSAKTTAAGTVTVLDQRTMASGQQAVAYLHDIASGRG
YPLQAAATRIGRLHDNDIVLDSANVSRHHAVIVDTGTNYVINDLRSSNGVHVQHERIRSA
VTLNDGDHIRICDHEFTFQISAGTHGGT
>AFN51819.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|msrE|antibiotic target alteration|0
MATEAAPPRIAVRLPSTSVRDAGANYRIARYVAVVAGLLGAVLAIATPLLPVNQTTAQLN
WPQNGTFASVEAPLIGYVATDLNITVPCQAAAGLAGSQNTGKTVLLSTVPKQAPKAVDRG
LLLQRANDDLVLVVRNVPLVTAPLSQVLGPTCQRLTFTAHADRVAAEFVGLVQGPNAEHP
GAPLRGERSGYDFRPQIVGVFTDLAGPAPPGLSFSASVDTRYSSSPTPLKMAAMILGVAL
TGAALVALHILDTADGMRHRRFLPARWWSTGGLDTLVIAVLVWWHFVGANTSDDGYILTM
ARVSEHAGYMANYYRWFGTPEAPFGWYYDLLALWAHVSTASIWMRLPTLAMALTCWWVIS
REVIPRLGHAVKTSRAAAWTAAGMFLAVWLPLDNGLRPEPIIALGILLTWCSVERAVATS
RLLPVAIACIIGALTLFSGPTGIASIGALLVAIGPLRTILHRRSRRFGVLPLVAPILAAA
TVTAIPIFRDQTFAGEIQANLLKRAVGPSLKWFDEHIRYERLFMASPDGSIARRFAVLAL
VLALAVSVAMSLRKGRIPGTAAGPSRRIIGITIISFLAMMFTPTKWTHHFGVFAGLAGSL
GALAAVAVTGAAMRSRRNRTVFAAVVVFVLALSFASVNGWWYVSNFGVPWSNSFPKWRWS
LTTALLELTVLVLLLAAWFHFVANGDGRRTARPTRFRARLAGIVQSPLAIATWLLVLFEV
VSLTQAMISQYPAWSVGRSNLQALAGKTCGLAEDVLVELDPNAGMLAPVTAPLADALGAG
LSEAFTPNGIPADVTADPVMERPGDRSFLNDDGLITGSEPGTEGGTTAAPGINGSRARLP
YNLDPARTPVLGSWRAGVQVPAMLRSGWYRLPTNEQRDRAPLLVVTAAGRFDSREVRLQW
ATDEQAAAGHHGGSMEFADVGAAPAWRNLRAPLSAIPSTATQVRLVADDQDLAPQHWIAL
TPPRIPRVRTLQNVVGAADPVFLDWLVGLAFPCQRPFGHQYGVDETPKWRILPDRFGAEA
NSPVMDHNGGGPLGITELLMRATTVASYLKDDWFRDWGALQRLTPYYPDAQPADLNLGTV
TRSGLWSPAPLRRG
>CCP42728.1|FEATURES|CARD|fosmidomycin|rosa|antibiotic target alteration|0
MTDTTLPPDDSLDRIEPVDIEQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAMF
DSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDSLVRMAQPWSLRYPLVDGQGNFGSPG
NDPPAAMRYTEARLTPLAMEMLREIDEETVDFIPNYDGRVQEPTVLPSRFPNLLANGSGG
IAVGMATNIPPHNLRELADAVFWALENHDADEEETLAAVMGRVKGPDFPTAGLIVGSQGT
ADAYKTGRGSIRMRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRDGKLAGIS
NIEDQSSDRVGLRIVIEIKRDAVAKVVINNLYKHTQLQTSFGANMLAIVDGVPRTLRLDQ
LIRYYVDHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVIALIRASETVDIARAG
LIELLDIDEIQAQAILDMQLRRLAALERQRIIDDLAKIEAEIADLEDILAKPERQRGIVR
DELAEIVDRHGDDRRTRIIAADGDVSDEDLIAREDVVVTITETGYAKRTKTDLYRSQKRG
GKGVQGAGLKQDDIVAHFFVCSTHDLILFFTTQGRVYRAKAYDLPEASRTARGQHVANLL
AFQPEERIAQVIQIRGYTDAPYLVLATRNGLVKKSKLTDFDSNRSGGIVAVNLRDNDELV
GAVLCSAGDDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNIDDRLLSLNVVREG
TYLLVATSGGYAKRTAIEEYPVQGRGGKGVLTVMYDRRRGRLVGALIVDDDSELYAVTSG
GGVIRTAARQVRKAGRQTKGVRLMNLGEGDTLLAIARNAEESGDDNAVDANGADQTGN
>CCP45025.1|FEATURES|CARD|isoniazid|kasA|antibiotic target alteration|0
MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKI
GGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAE
RIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAH
AWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFG
EAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGL
SPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVL
TLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY
>WP_009887863.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|1
MAKAKYERTKPHVNIGTIGHVDHGKTTLTAAITKTLYDRYQLGEAVDFANIDKAPEERER
GITISTAHVEYETPNRHYAHVDCPGHADYVKNMITGAAQMDGAILVCSATDGPMPQTREH
ILLSRQVGVPYIVVFLNKCDMVDDEELLELVEMEVRDLLTEYDFPGDDTPIVRGSALMAL
EDPKSEWGDKIVELFEQIDEYIPAPERDTDKPFLMPVEDVFSITGRGTVATGRVERGVLK
VQDEVELVGLTEAPRKVVVTGVEMFRKLLDQAQAGDNIGALLRGVQRNEIERGQVLAKTG
SVKAHTKFTAEVYVLKKEEGGRHTPFFDGYRPQFYFRTTDVTGACKLPEGIEMVMPGDNV
TMEVDLINSIVVEEGLRFSIREGGRTVASGVVATIIE
>AAK11270.1|FEATURES|CARD|trimethoprim|dfrA5|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRDFQKQNGEGFGTSVTYDIWDGISAGFAYSSSKRTDEQNNSTFVSKTDGGRYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGNIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>ABR75897.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MARKTKQQARETRQLILDVALRLFSQQGVSSTSLATIAKAAGVTRGAIYWHFKNKSDLFN
EIWELSDASISDLEIEYRAKFPNDPLSVIREILVYVLEATVTEERRRLMMEIIYHKCEFV
GEMTVVQQAQRQLSLASYERIEQTLKECIAAKLLPANLLTRRAAVLMRSYLSGLMENWLF
APDSFDLHAEARDYVAILLEMYQFCPTLRGPESLSA
>NP_462735.1|FEATURES|CARD|fosfomycin|fosB|antibiotic target alteration|0
MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGHCKDIV
VTIHADNSVSVTDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGV
SVVNALSQKLELVIQRDGKIHRQIYEHGVPQAPLAVTGDTDKTGTMVRFWPSHETFTNVT
EFEYEILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNI
FYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKE
GYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLSEY
LLENPSDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSEL
YLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQEVATLITALGCGIGR
DEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKG
KQEQYIKDDEAMDQYQISIALDGATLHANAHAPALSGEALEKLVSEYNATQKMIGRMERR
FPKALLKELVYQPTLTEADLSDEQTVTRWVNALITELNEKEQHGSQWKFDVHTNTEQNLF
EPIVRVRTHGVDTDYPLDHEFVTGAEYRRICTLGEKLRGLIEEDAFIERGERRQPVTSFE
QALEWLVKESRRGLAIQRYKGLGEMNPDQLWETTMDPESRRMLRVTVKDAIAADQLFTTL
MGDAVEPRRAFIEENALKAANIDI
>NP_463130.1|FEATURES|CARD|multidrug|robA|antibiotic efflux|0
MSHQQIIQTLIEWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGEYIRQRRLL
LAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRREFDRTPSDYRHRL
>AAC76055.1|FEATURES|CARD|beta_lactam|RW25_27295|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAQAAIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVR
MRAVWKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILEL
KLRHLAKLEEMKIRGEQSELEKERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPL
QEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDL
PQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQKVTGE
RGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE
>AIL15701|FEATURES|CARD|fosfomycin|murA|antibiotic target alteration|0
MDKFRVQGPTKLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDVDTSMKLLSQL
GAKVERNGSVHIDARDVNVFCAPYDLVKTMRASIWALGPLVARFGQGQVSLPGGCTIGAR
PVDLHISGLEQLGATIKLEEGYVKASVDGRLKGAHIVMDKVSVGATVTIMCAATLAEGTT
IIENAAREPEIVDTANFLITLGAKISGQGTDRIVIEGVERLGGGVYRVLPDRIETGTFLV
AAAISRGKIICRNAQPDTLDAVLAKLRDAGADIEVGEDWISLDMHGKRPKAVNVRTAPHP
AFPTDMQAQFTLLNLVAEGTGFITETVFENRFMHVPELSRMGAHAEIESNTVICHGVEKL
SGAQVMATDLRASASLVLAGCIAEGTTVVDRIYHIDRGYERIEDKLRALGANIERVKGE
>WP_038583059|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MSHPGATASDRHKVVIIGSGFGGLTAAKTLKRADVDVKLIARTTHHLFQPLLYQVATGII
SEGEIAPATRVILRKQKNAQVLLCDVTHIDLENKTVDSVLLGHTYSTPYDSLIIAAGAGQ
SYFGNDHFAEFAPGMKSIDDALELRGRILGAFEQAERSSDPVRRAKLLTFTVVGAGPTGV
EMAGQIAELADQTLRGSFRHIDPTEARVILLDAAPAVLPPMGEKLGKKARARLEKMGVEV
QLGAMVTDVDRNGITVKDSDGTIRRIESACKVWSAGVSASPLGKDLAEQSGVELDRAGRV
KVQPDLTLPGHPNVFVVGDMAAVEGVPGVAQGAIQGGRYAAKIIKREVSGTSPKIRTPFE
YFDKGSMATVSRFSAVAKVGPVEFAGFFAWLCWLVLHLVYLVGFKTKIVTLLSWGVTFLS
TKRGQLTITEQQAYARTRIEELEEIAAAVQDTEKAAS
>AEA93051.1|FEATURES|CARD|multidrug|OpmD|antibiotic target alteration|0
MILSVLTVIYFINAIIAGITILLKPRDVAAIWAWLLVLIALPVFGFFLYLFFGRGLTDKK
KFYLQQSDLRELENFQNFQEESFELYSQKMPTEEQQQFTDFFSSLNRMPLTKKNDVEIFT
DGTEKFNALMADIKKAQHSIHIEYYAFVTDHIGTKILNLLEEKAAEGVEVRLLYDAFGSK
GTKVHHLNELKKNGGFVQTFITSQKALLKFRLNYHDHRKIVVIDGKVGYIGGFNVADQYA
GTTKKFGYWRDTHLRIQGPATSLLQMRFLMDWNVSSPEKNRVAYQLDYFFKLEALVPEAN
TSIQMIASGPNSDREQIKLAFIKLITSAKKRVWIQTPYLVPDDSVLAALKVAAASGVDVK
IMIPDKPDHPFIYRATQYYGRLLMKENIEILIYNGGFLHAKTMIMDDEVCTVGSANQDIR
SYKLNFEANAVLYDKKIIDQLEAIFLEDRKKCTTMTPEVVRDMSKWLIFKQQISRLFSPI
L
>CAA67349.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|1
MAKAKFERTKPHVNIGTIGHVDHGKTTLTAAITKVLHDAIPDLNPFTPFDEIDKAPEERQ
RGITISIAHVEYQTESRHYAHVDCPGHADYIKNMITGAAQMDGAILVVAATDGPMPQTKE
HVLLARQSGVPYIVVALNKADMVDDEEIMELVELEVRELLSEYEFDGDNCPVVQVSALKA
LEGDKEWGEKLLGLMKAVDENIPQPERDVDKPFLMPIEDVFTITGRGTVVTGRIERGVLK
VNETVDIIGIKTEKTTTTVTGIEMFRKLLDEGQAGENVGLLLRGIKREDVERGQCIIKPG
TVTPHTEFEATAYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVTLKEGTEMVMPGDNA
EMTVNLIQPVAMEEGLRFTIREGGRTVGAGQVVKINK
>WP_002389492|FEATURES|CARD|glycopeptide|vanG|antibiotic target alteration|0
MNYRELMQKKNVRPYVLMARFGLEKENQRSTREGLLATTDHPTVFGNRSYHPYIQTDFSE
TQLELITPVANSGTEMLRFLDAIHDVARRSIPEDEMLWPLSMPPQLPTKDEEIKIAKLDQ
YDAVLYRRYLAKEYGKRKQMVSGIHFNFEYDQALIQQLYDEQSEVTDCKQFKTKVYMKVA
RNFLRYRWLITYLFGASPVSEDGYFRVYDDQPQEPIRSIRNSTYGYRNHDNVKVSYASLE
RYLEDIHRMVENGLLSEEKEFYAPVRLRGGKQMSDLPKTGIRYIELRNLDLNPFSRLGIV
EDTVDFLHYFMLYLLWTDEKEEADEWVKTGDILNEQVALGHPHETIKLIAEGDRIFSEMI
DMLDALGIRKGKEVVGKYYQQLRNPQDTVSGKMWTIIQENSNSELGNIFGNQYQSMAFER
PYQLAGFREMELSTQIFLFDAIQKGLEIEILDEQEQFLKLQHGEHIEYVKNANMTSKDNY
VVPLIMENKTVTKKILSAAGFHVPGGEEFSSFIEAQEAHLRYANKAFVVKPKSTNYGLGI
TIFKEGASLEDFTEALRIAFKEDTAVLIEEFLPGTEYRFFVLDNDVKAIMLRVPANVTGD
GKHTVEELVAAKNSDPLRGTNHRAPLELIQLNDLEKLMLKEQGLTIYSVPEKEQIVYLRE
NSNVSTGGDSIDMTDVIDDSYKQIAIEAVAALGAKICGIDLIIPDKDVKGTRDSLTYGII
EANFNPAMHMHVYPYAGQGRRLTMDVLKLLYPEVVQ
>WP_002356022|FEATURES|CARD|aminoglycoside|sat-3|antibiotic target alteration|0
MQKKRIQKNGFLIVVGLLLVEFLLYFLLTNKWLLLAVIIALDIFLLVVIRLLIRDVEITN
VEKIQEASSIAEQSLDYVVNEVPVGIITYNGETRAVEWLNPYAASIFNKDNQLTLTASQV
TSYLELAERNQDIFTIDENTYRFSVNKEQHTITFEDITKESNLYQEKVEMQTAIGIVSVD
NYDDVTDTMDEKEISYLNSFITTMVSDWMDQYKVFYKRINAERYFFIAQWEDIQKMMDEK
FSILDTIRKESANHEVAITLSMGIAYGGPTLDQTGTTAQTNLDTALVRGGDQVVVKEAKD
EAKPLFFGGKTAVTTKRSQVRSRAMSMAIKGIIAESADIYIMGHRYPDMDALGSAFGVAR
LASFNNRKAWIVLDENEIIPDVKRVLEAIKEYPELEERIISPKEAMKRKKESSLLVMVDY
HKPSLSISQELYERFDKVVIIDHHRRGDEFPAKPLLSYIESSASSASELVTELIEYQSNS
ANKLQAFEATMMLAGIVVDTKSFNTRTTARTFDVASYLRTCGADSSLVQYLLSSDLTSYL
EMNNLISKSEYVTKDTVVVAGSEDKEYDSVTAAKTADTLLSMAGINAAFVITKRTDQQIG
ISARSNGSINVQIIMENLGGGGHFTNAAVQLSNVTVAEVKEQLLDVIRQNINEMYEQE
>NP_462089.1|FEATURES|CARD|beta_lactam|RW25_27295|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNATAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYAELLLSELGQGTADWVPNFDGTMQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAKAAITLIEQPKTTLDQLLDIVQGPDYPTEAEIITPRAEIRKIYENGRGSVR
MRAVWTKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLAFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRSEDEPKPALMSRFGISETQAEAILEL
KLRHLAKLEEMKIRGEQDELEKERDQLQGILASERKMNTLLKKELQADADAYGDDRRSPL
REREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMEGDDQKLLMASDA
GYGFVCTFNDLVARNRAGKTLITLPENAHVMPPLVIEDEHDMLLAITQAGRMLMFPVDSL
PQLSKGKGNKIINIPSAEAAKGDDGLAHLYVLPPQSTLTIHVGKRKIKLRPEELQKVVGE
RGRRGTLMRGLQRIDRIEIDSPHRVSHGDSEE
>CDJ73082|FEATURES|CARD|aminoglycoside|B2K_23630|antibiotic target alteration|0
MYLYIETLKQRLDAINQLRVDRALAAMGPAFQQVYSLLPTLLHYHHPLMPGYLDGNVPKG
ICLYTPDETQRHYLNELELYRGMSVQDPPKGELPITGVYTMGSTSSVGQSCSSDLDIWVC
HQSWLDSEERQLLQRKCSLLENWAASLGVEVSFFLIDENRFRHNESGSLGGEDCGSTQHI
LLLDEFYRTAVRLAGKRILWNMVPCDEEEHYDDYVMTLYAQGVLTPNEWLDLGGLSSLSA
EEYFGASLWQLYKSIDSPYKAVLKTLLLEAYSWEYPNPRLLAKDIKQRLHDGEIVSFGLD
PYCMMLERVTEYLTAIEDFTRLDLVRRCFYLKVCEKLSRERACVGWRRAVLSQLVSEWGW
DEARLAMLDNRANWKIDQVREAHNELLDAMMQSYRNLIRFARRNNLSVSASPQDIGVLTR
KLYAAFEALPGKVTLVNPQISPDLSEPNLTFIYVPPGRANRSGWYLYNRAPNIESIISHQ
PLEYNRYLNKLVAWAWFNGLLTSRTRLYIKGNGIVDLPKLQEMVADVSHHFPLRLPAPTP
KALYSPCEIRHLAIIVNLEYDPTAAFRNQVVHFDFRKLDVFSFGENQNCLVGSVDLLYRN
SWNEVRTLHFNGEQSMIEALKTILGKMHQDAAPPDSVEVFCYSQHLRGLIRTRVQQLVSE
CIELRLSSTRQETGRFKALRVSGQTWGLFFERLNVSVQKLENAIEFYGAISHNKLHGLSV
QVETNHVKLPAVVDGFASEGIIQFFFEETQDENGFNIYILDESNRVEVYHHCEGSKEELV
RDVSRFYSSSHDRFTYGSSFINFNLPQFYQIVKVDGREQVIPFRTKSIGNMPPANQDHDT
PLLQQYFS
>CAG39240|FEATURES|CARD|tetracycline|tetL|antibiotic target alteration|0
MNFFDIHKIPNKGIPLSVQRKLWLRNFMQAFFVVFFVYMAMYLIRNNFKAAQPFLKEEIG
LSTLELGYIGLAFSITYGLGKTLLGYFVDGRNTKRIISFLLILSAITVLIMGFVLSYFGS
VMGLLIVLWGLNGVFQSVGGPASYSTISRWAPRTKRGRYLGFWNTSHNIGGAIAGGVALW
GANVFFHGNVIGMFIFPSVIALLIGIATLFIGKDDPEELGWNRAEEIWEEPVDKENIDSQ
GMTKWEIFKKYILGNPVIWILCVSNVFVYIVRIGIDNWAPLYVSEHLHFSKGDAVNTIFY
FEIGALVASLLWGYVSDLLKGRRAIVAIGCMFMITFVVLFYTNATSVMMVNISLFALGAL
IFGPQLLIGVSLTGFVPKNAISVANGMTGSFAYLFGDSMAKVGLAAIADPTRNGLNIFGY
TLSGWTDVFIVFYVALFLGMILLGIVAFYEEKKIRSLKI
>NP_415372.1|FEATURES|CARD|multidrug|adeJ|antibiotic target alteration|0
MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREEL
VTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAE
SLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENS
YQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR
>CAC30845.1|FEATURES|CARD|rifampin|rpoB|antibiotic target alteration|0
MLEGCILPDFGQSKTDVSPSQSRPQSSPNNSVPGAPNRISFAKLREPLEVPGLLDVQTDS
FEWLIGSPCWRAAAASRGDLKPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDEVKAPVE
ECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLV
RSPGVYFDETIDKSTEKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKA
LGWTSEQITERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLF
FKEKRYDLARVGRYKVNKKLGLHAGELITSSTLTEEDVVATIEYLVRLHEGQSTMTVPGG
VEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINI
RPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHY
GRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIEYLTADEEDRHV
VAQANSPIDEAGRFLEPRVLVRRKAGEVEYVASSEVDYMDVSPRQMVSVATAMIPFLEHD
DANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGHVVVAEKSGVIEEVSADYITV
MADDGTRRTYRMRKFARSNHGTCANQSPIVDAGDRVEAGQVIADGPCTENGEMALGKNLL
VAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEV
LADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVP
HGESGKVIGIRVFSHEDDDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILP
AEDMPFLPDGTPVDIILNTHGVPRRMNVGQILETHLGWVAKSGWKIDVAGGIPDWAVNLP
EELLHAAPNQIVSTPVFDGAKEEELQGLLSSTLPNRDGDVMVGGDGKAVLFDGRSGEPFP
YPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYG
AAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSS
DGAAIELREGEDEDLERAAANLGINLSRNESASIEDLA
>WP_010891786.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MSVNHQKIINTPLDNIVGESYAKYAKYIIQDRALPDIRDGLKPVQRRILYAMSELGIFYD
KPYKKSARTVGEVIGKYHPHGDSSIYEAMVRMSQDWKNNLCLLDMHGNKGSIDGDNAAAM
RYTEARLSKIASVMLANLKKDVVKFSPNFDDSEKEPSILPSLFPNLLINGATGIASGYAT
NIPPHNPNEVFDALIYRIDHPDCSVEKLIEICPAPDFPTGGEIHDLNGCANAHKTGEGKF
IIRACIDFKINDNKINQIIISSIPYETNKALIIKEIEDIIYNKEVAGLIEVRDESDAKGI
SIIIDTKKDINLENVKNYLYKKTNLEISYNTKFIAIVHRTPTLVNLSTYLDAQINHSLDV
INKVDLYDLNKILLRIEIVEGLIKCVDLIDEIIKIIRASESRQDAKNTLIQVFNFTNNQA
EAIIMMRLHNLTRTDIFDLKNEWQTLQDEAKTLQERINSLQVRKNYLKQKMIEFKKTFGF
ERKTKLFDELVKVEINEDQMIEKQNLNLVISRDGYIKTVSKKSFESSKYDELGLKTNDIL
FYHNIINSHDKILIITSKAKLINLVAHKITSMRWKDVGEHLNNYVKFDANEKVIAVYIWN
EQFKIDEYQLVLASRLNLIKRIELSELDINKNSKQISIMKLNDNDNLISANLIKKGHNQF
IIAISKLGLALLFLVHEINCLNRLAKGIKIMKLKPNDEVSAILITPNNGYNVQLFLERGS
KCFNISELKLSKRAATPTNLYPITKKVQNVLAAFLVAHENVFYLLDQQQKINPYYLSNPK
PTKLDTKISIYENDQMITDVVKDCFLSDEAISDFKKINMYANEFDNEMLKINKNHDDSQL
ELIDEEEEKK
>CDJ72759|FEATURES|CARD|rifampin|rphB|antibiotic target alteration|0
MISGILASPGIAFGKALLLKEDEIVIDRKKISADQVDQEVERFLSGRAKASAQLETIKTK
AGETFGEEKEAIFEGHIMLLEDEELEQEIIALIKDKHMTADAAAHEVIEGQASALEELDD
EYLKERAADVRDIGKRLLRNILGLKIIDLSAIQDEVILVAADLTPSETAQLNLKKVLGFI
TDAGGRTSHTSIMARSLELPAIVGTGSVTSQVKNDDYLILDAVNNQVYVNPTNEVIDKMR
AVQEQVASEKAELAKLKDLPAITLDGHQVEVCANIGTVRDVEGAERNGAEGVGLYRTEFL
FMDRDALPTEEEQFAAYKAVAEACGSQAVIVRTMDIGGDKELPYMNFPKEENPFLGWRAI
RIAMDRREILRDQLRAILRASAFGKLRIMFPMIISVEEVRALRKEIEIYKQELRDEGKAF
DESIEIGVMVETPAAATIARHLAKEVDFFSIGTNDLTQYTLAVDRGNDMISHLYQPMSPS
VLNLIKQVIDASHAEGKWTGMCGELAGDERATLLLLGMGLDEFSMSAISIPRIKKIIRNT
NFEDAKVLAEQALAQPTTDELMTLVNKFIEEKTIC
>AAC76733.1|FEATURES|CARD_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>AAC12650.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|oleR|antibiotic inactivation|0
MTLEEKLSFVHWSYHTSDESAKVYLPGVPRLGIPEMRATDGPAGITIHRPSLALPAPVAL
ASTFDDGLARSYGAVIGREGRAFGQDVVFAPMVNSIRVPYAGRNFETFSEDPLVTSRMAA
AEIKGIQSQGLIAATKHYAANNQEKNRFSVNVNVDEQTLRERELPGFESAVAAGTGSVMC
AYNKVNGQPACGSDELLNKVLKEQWKFRGWVTSDWLATQSTDALTKGLDQELGIELDHEP
APGEPIPGGKFFGDPLKTAIREGRIPESALDEAVTRIVSQMARFRLLDEDPPARPARDLA
GGLKVARQVAEDGAVLLRNEGATLPLTTETAADIAVIGPTAKVPKVTGLGSSYIVPDGAS
APLDTIRERAGAGSTVRYSTGEETVGVPVPQSAPLXXXXPSGEVFPAGGGGVLYDGTITV
PVTGSYRIAARAQGGNAYVELDGQEPFGRRPWVYGDVSSRPMRLAAGTHKLRITGAALAK
SPMTFELTWVTPQAAQEAIDRAVSIARTARTAVVFAYDDGSEDGDRTSLSLPGRQDDLIS
AVAAVNPRTVVVLNTGSSLTMPWLRKTAAVLTMWYPGQAGAEATTALLFGDADPGGRLTQ
TFPADEGQTPFAGDARRYPGVDDQLDYSEGIYSGYRWYEQQGVQPLFSFGHGLCYTSFDY
RDLKVTATADGGLDVCFTLRNTGTRTGKEVPQVYVGPSPHVRVAQAKRALAAYGKVELRP
GESRRLTLHVERRALQNWDSGAHTWVTGPGRQVMVGPSLGRLPLSATAP
>B9J113|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKHKNQATHKEFSQLEKKFDARLGLYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQ
QNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGG
PKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKR
NILTEWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSS
KDEKEATYDNQLIKEAAEVVIDAIK
>YP_001119417|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFILLGGGFAIRALPVAQYPDIAPPVVSIYASYPGASAQVVEES
VTALIEREMNGAPGLLYTSASSSAGSASLYLTFKQGVNADLAAVEVQNRLKTVDARLPEP
VRRAGIQVEKAADNIQLVVSLTSDDGRMTDVQLGEYASANVVQALRRVDGVGRVQFWGAE
YAMRIWPDPDKLAGHGVTASDIASAVRAHNARVTIGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRTQPDGSALYLRDVARVEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVA
TERRVRAAMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMQALGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EERLEPYEATVKAMQQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALALAVSIAFS
AFLALSLTPALCATLLKPVDGGHHDKRGFFGAFNRFVARATQRYATRVGTMLARPLRWLV
VYGALTAAAVLMLTQLPSAFLPDEDQGNFMVMVIRPQGTPLAETMRSVREVDAYLRREEP
AAYTFALGGFNLYGEGPNGGMIFVSLKDWRARKAARDHVQAIVARINARFAGTPNTTVFA
MNAPALPYLGSTSGFDFRLQNRGGLDYAAFSAAREQLLAAAGRDPALTDVMFAGMQDAPQ
LKLDVDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGQHRVDPDDV
KKLRVRNARGEMVPLAAFTTLHWTLGPPQLTRYNGFPSFTINGSAAPGHSSGEAMAALER
LAATLPAGIGHAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMPLIDAAREA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGVITATVLAVFLVPLFFV
MVGRVFDVGPRRRGASQPTTMEGSH
>R9J7C1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAVLFGIVQGITEWLPVSSTGHMILVNEFVTLNVTPEFWDAFLVVIQFGSILAVV
VLFWNKIFPFDFKKKPVIKKDTFVLWFKIAVACIPAIVIGLPFDDLFSELFYNYVCVAVA
LIVFGVLFLLVENRNKRVKPKVTDLAGVTYKMAFVIGIWQLAAAVFPGTSRSGATIIGAL
LLGISRTTAAEFTFFLAIPVMFGASLLKLLKFGLAFSSTEWSILLVGMAVAFGVSVAVIR
FLMGYIKKHDFKVFGWYRIVLGVVVLGYFMFLA
>S7U9M1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MERMHWIELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQ
LGSILAAVVVFKDRFLDLLGFRGRHPGGHPRLTLLHVIVGLLPAGVLGVLFEDYIDEHLF
STKTVLIGLVLGALLMIAADKFAKKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGS
TISGGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTTADIPFFIAGFLSAFVF
ALLAIRFFLELINRIRLVPFAVYRIVLAIVIYFLYF
>L5N4U7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLWVFLVAVVLGFVEGLTEFAPVSSTGHMIIVDELWLHSRELFSEPVANTFKVVIQLGS
ILAVVVIFKDKFKQMLHVGKPVDRSGPKLKLSQVIVGIIPAGILGFLFEDYIDTYLFSVQ
TVIIGLAAGAVLMIFADYYQKGQRHTTMTVDRITYRQAFGMGLFQCIGLWPGFSRSGSTI
SGGVLLGMSHRASSDFTFIMAVPIMLGASGLSLMKNLEYFTVDAFPFIAVGFISAFVFSL
ISIRFFLKLINRIKLVPFAIYRILLAGLLYVLYF
>A0A109KXU6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERSYTGLSLHAKLREAATALLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLHQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVQMSETIGNTLDFFLREAMLEIA
DKK
>A0RD31|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQERLNYYREDKPHMTFY
>A0A0A1Z240|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
QRHSRARELLARLGLSGHTTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVSDGEIVSDKANERAGLELPSDTP
IEPKRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGLIGISLSYALGF
LFSLFVKEWEMVFSLGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>P08457|FEATURES|ARDB_deepARG|streptothricin|sta|antibiotic inactivation|0
MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFP
DDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKG
IGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEH
ALYMSMPCP
>A9A031|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNTPTAVEKSHEILRLENLCRVYRSGDIEVHALRDISLTIEAGEFIAIMGPSGSGKSTLL
HTLGLLDRPDSGTYTLFGRDTTKMDDDTLATLRNHLAGFVFQQFHLLQRSSALDNVALPL
VYAGRRQKKDRAEKRLAEVGLSHRSGHRPGELSGGEQQRVAIARALVNNPAVIFADEPTG
NLDTKSEADIMAVLKDLNRRGKTIIMVTHEKEVAEHAGRIILMRDGKIVSDEKKAAPVPG
DPPPAPDLPDRGAGRIAFTDHLRQAFASVFSHKMRSFLSILGILIGVAAVIAMLALGRGA
KSSIEESLKSLGSNLLAIRPGTSIMRGVHTAGGDTAQFTDADVTAVAKLPSIRYSTGMVG
GAGQIVFQNKNWSTRVEGVGYDYGVMRASLPVVGRWFTKDELRRRAKVLLVGTTVARELF
GETSPIGKTVKFNRINFTVIGVLPPKGSNAWRDNDDVVLMPVTTAMYRVLGKTHLDFMYA
EALNQELMATAEQEVGSLLRTRQRLSRGQDDTFTIRNLSDIQETLTATTRTMGILLGAIA
AISLLVGGIGIMNIMLVSVTERTREIGLRMAIGARSRDILMQFLIESVVMTFWGGLLGTL
MGVGTAMALSHFAGWTTLVGPDSILLATVFSVAVGIGFGLWPARKAAHLNPVEALRYE
>A0A0Q0IKR0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGHTSGSGGLTMSRALLELKGVTRRFVAGEKDFIALNDINLTINAGDLIAITGASGSGKS
TLMNVLGCLDHANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVE
MPAIYAGTGKSMRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILA
DEPTGALDSVSGKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNT
DRPIINEKATERLPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGIT
SVVSIVAIGEGAKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSQYY
IDSATPNIGRNMLLRYRNIDVSATVSGVSPSYFQVRGTKMGSGVGFNKDDARRQAQVVVI
DYNTRIRLFGPKVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLL
GQSYLDSITVRVKDGQPSKVVEDNVNKLMQKRHGTKDFFTYNLDSVMQTVQKTSQSLALL
LSLIAVISLAVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGG
VIGIGLSFVIGYVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEA
LARD
>A0A0N0JV56|FEATURES|UNIPROT_deepARG|aminoglycoside|IP84_09695|antibiotic inactivation|1
MSSIRVEVLTARGDPQPWLAMRARLWPDCTAADHLREAEDMLHDPARTGVAIAFLDGAPV
GFIELTLRTDYVTGCDHSPVAFIEGLWTEPDARRHGVARALVAHAVQWAKLRKVRELASD
TQLHNLLSQATHEALGFTETERVVAYKITL
>P59655|FEATURES|UNIPROT_deepARG|sulfonamide|sulA|antibiotic target alteration|1
MSSKANHAKTVICGIINVTPDSFSDGGQFFALEQALQQARKLIAEGASMLDIGGESTRPG
SSYVEIEEEIQRVVPVIKAIRKESDVLISIDTWKSQVAEAALAAGADLVNDITGLMGDEK
MPHVVAEARAQVVIMFNPVMARPQHPSSLIFPHFGFGQAFTEEELADFETLPIEELMEAF
FERALARAAEAGIAPENILLDPGIGFGLTKKENLLLLRDLDKLHQKGYPIFLGVSRKRFV
INILEENGFEVNPETELGFRNRDTASAHVTSIAARQGVEVVRVHDVASHRMAVEIASAIR
LADEAENLDLKQYK
>J7Y9N9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILMGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>A0A0J5S4K1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEISQLNKWVGSAESPTHILKNIRLTIEKGDFVAIIGASGSGKSTLMNILGCLDTAS
DGSYKINGTETQQLSGDQLSQLRRQQFGFIFQRYNLLSSLTALENVALPAIYAGVEKHKR
LEKAKILLEKLGLGDKLHHKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSHSGE
TVMATLQSLHQEGHTLILVTHDPNIAAHAQRVIEIKDGEILRDERQKPLNTPPATADAPH
RSPRLWDQLYESFKMATSAIMAHKLRALLTMLGIIIGIASVISVVALGKGSQQQILSNIN
SLGTNTMSIFNGTGFGDRRANLTKNLTIGDVSALAQQRYIESVTPNSMHSGTIIAGNIAV
TGQINGVGEQYFDVRGIKLRDGRLFNPDEVHRAAQVIVIDPNTQKSLKLNQPIGKQILID
KKPLEIIGVAEQANNPSSNLNLWTPYTTLMQRISGAKNIDSIAVKIRDNVESQTAEKSLT
DFLTYRHGKKDFFVMNTDTIKQTIESTTNTMTLLISSIALISLIVGGIGVMNIMLVSVTE
RTKEIGVRMAIGAKQGNILQQFLIEAMLICLLGGVIGILLAVGVILAFNTLGTDFKMVLS
GSSVIIAVLCSTLIGIVFGYIPARNASRLNPITALAQE
>A0A087NQC8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGEPPRVMSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0E0TNZ5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A070KNT4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVAMLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
INTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>S2JV88|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MALARLLPLLAATALALGSTAAQAGRSLKTQVDEVIEPVMREHAIAGMAVAVFANGQAHY
FSYGVASKATSAPVTADTLFEIGSLSKTYTATLAALASAEGKLDLQAPARRYQPALAGTP
LGDASVLELGAYSADCLPLQFPDEVQTDSQALDFLRNWKPRTVHGTRRCYSNPSLGLFGD
LAARAQQQPFSELMSQGLLPQMGLQHTYLQVPAHAQKSYAQGYDAKDRPVRVNPGPYADA
AYGIKTNARDLLRFVRLNMQPAELKPALREAAAITQAGYFQVGAMVQGLGWERYAYPVSL
DTLVDGNSASFALEPQPTRRLDPALPASPLAWYNKTGSTSGFGAYAAFIPGEGKAIILLA
NRNYPNEARVRAAYRILSSIDL
>A0A0A0QAU4|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMAPQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A142FK24|FEATURES|UNIPROT_deepARG|aminoglycoside|aph(3')-VIh|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSGKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDTELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>Q5YEX7|FEATURES|UNIPROT_deepARG|beta_lactam|blaampC|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPLNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARFAAAWQILNALQ
>N8W275|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIIDLLKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFEHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIAVGFVAAFIAALLVVSALVK
FVERHTLRVFAWYRIVLGVILLFIFL
>YP_407239|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MPGLDVRRYFSLSVWCFTNFQPISADMIQPGMLAVVEQYQAGIDWVPTSMTAYLAGGMFL
QWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLCFIGAVGYA
AIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFGL
QRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIIIT
GEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVI
SSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTVGIEIS
KHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A1VYW8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKKLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGIMVLEIL
QKLNAQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLTLKTMSKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGRGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>J8LGQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A117LZU1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLKMIILSIVQGITEVLPISSSGHLILTGKFLDFDISGDLFFLSILHLGTTLAVVLFY
RKILFKNFFTKEKWIFFLKLALASLPAALAGVFLQDYIASTLHGTKIIAISLIVVGVLFI
LFENILKNGKVEETEKLPLWKMILIGVGQTLALIPGTSRSGITTLTGMMLGLDKYSAFNF
SFILGIPILLGSSLYEILKEYLAVTTPSFFTASVVVAKTAPFILITFVIGYFALLLVSKF
KKSKWLTVFGTYRILLGILILLLAI
>A0A127SMV6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNSKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>B9U319|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRSVSIVIPVYNEQESLPELLRRTEAACHQLHHDFEIVLVDDGSRDESANMLEEA
AGRENSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAEAEKGY
DVVGTVRGNRQDSALRRYPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIIDAMLACRERS
TFIPILANSFARHTTEIVVAHAEREHGDSKYSPMRLINLMFDLITCMTTTPLRLLSIVGF
AMAGLGVLFAVALIVLRLAFGAGWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSQPADPAPAVTVDGLSSTATSSTSDQVLS
>A0A026UMU2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHSEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>B1LIV8|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLILSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>AAF81096|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGENDQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSVKVKNPQTVDQINYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLSNKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>YP_271816|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVDKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>J5VYT0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQSIILALVEGLTEFLPVSSTGHMILTEGILGMESTAYLKAFTVMIQFGAILSVVVY
YFRRFLPFPIFGLKPDPTTSLGGWRLYGLMIIGCIPAAILGALFNDTIDDLLGNTWVVLT
MLFLGGILMIYFDRIFTGKTERKVTAQNAFIIGLFQCLAMVPGVSRSMATIFGGMQQGLT
RRQAAEFSFFLAVPTMFGATLLKGYKLYKELGMGVFEENWQTLLIGNVVAFLVALLAIKF
FISFVTKYGFRAFGYYRIILSVGIAIALLLGANISLG
>D6NSN2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0S1LIW3|FEATURES|UNIPROT_deepARG|beta_lactam|OXA116|antibiotic inactivation|1
NFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQM
APDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEMWNSNHTPKTWMQFSVVWVSQEIT
QKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNL
PVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVS
ALTGNLGSNLTSSIKAKKNAITI
>V6I5U0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSSFFPFSGESFEFDDLFDIFIQSGAILSVLFLYREKFGSQILSSFQYLTK
RNSDPQGFYFLVQIVIGAFPILVLGFLAKKFLDTIKTRSDLLDILAGAWIFGGILILVAE
WFFQKRQGAEEKKPVGFRDAILIGIFQCAALIPGVSRSAATIVTARFLGKDTKSSAEFSF
FLAVPVLFAAGIYKLIKHRSILNETTIPILAFGFLISFLLCALVIRLFLRYLQKHSFGVF
GIYRILLGVGVLVFTKFIR
>NP_744962|FEATURES|ARDB_deepARG|multidrug|MexD|antibiotic efflux|1
MSRFFIHRPNFAWVVALFISLAGLLVIPSLPVAQYPNVAPPQISITASYPGASAKVMVES
VTSIIEQSLNGAKGLLYYESTNNSNGVAEVMVTFEPGTDPDMAQVDVQNRLKQAEARMPQ
AVLTQGLKVEQASSGFLLIYALTSTAGNRGDTTALADYAARNINNELLRVPGVGKLQFFA
SEAAMRVWVDPQKLVGYGLSIDDINSAIRGQNVQVPAGSFGSTPGASEQELTATLAVQGT
LDTPEAFAGIVLRANPDGSSVRLGDVARMAIGSENYNLSARLNGHPAVAGAVQLAPGANA
IQTATLVKERLAELSQFFPEGVEYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFL
QNVRYTLVPSIVVPVCLLGTLMIMKLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERL
MAEEGLSPVEATIKAMGQVSGAIIGITLVLAAVFLPLAFMSGSVGVIYQQFSVSLAVSIL
FSGFLALTFTPALCATLLKPVPHGHHEKAGFFGAFNRGFARVTERYSLLNSELVARAGRW
MLAYVGILVVLGYSYLRLPEAFVPAEDLGYSVVDVQLPPGASRVRTDHTAEALEKFLMSR
DAVANSFIVSGFSFSGQGDNAALAFPTFKDWSQRDKAQSAEAETAAINAQFAANGDGAIT
AVMPPPIDGLGNSGGFALRLMDRGGLGREALLAARDQLLARANGNPVILYAMMEGLAEAP
QLRLHIDREKARALGVSFEAINSTLATAFGSAVINDFTNAGRQQRVVVQAEQGERMTPES
VLRLYAPNANGEQVPFSAFVTTQWEEGPVQLVRYNGYPSIRIAGDASPGHSTGQAMAEME
RLVSELPPGIGYAWTGLSYQEKVSSGQAASLFALAILVVFLLLVALYESWAIPLTVMLIV
PIGALGAVWAVTLTGMPNDVYFKVGLITIIGLAAKNAILIVEFAKELWEKGYSLCDAAIE
AARLRFRPIVMTSMAFILGVVPLAIASGAGAASQRAIGTGVIGGMLSATLLGVVFVPVCF
VWVLTLLKRKPSPVQQAVEEAE
>A0A0S4KWV8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEWGPALAVILGIIEGLTEFLPVSSTGHLILAGHALGFTGETAANAEIAIQLGAILAVL
VFEREKIGRLLSGAWQEQAELRALAKKGGSSTWSACLKTSVQTHRHLWFVIGLGVAFLPA
ALVGLSAHGWITAHLFTPRTVGATSILGGMIILLVESMKRTNRTTTLEHVSLSHAAWIGL
AQCASLIPGMSRSGSTIIGGLLAGLDRKVATEYSFFLALPTIIAATLYETWKARAAFTDQ
DFMALGIGMLVSFLVAWAVIAAFLSYVQRHTLRVFAYYRIILGVAVLAIVH
>D8AFK5|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9530_05369|antibiotic inactivation|1
GGAPRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAV
IYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKY
WPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYAN
SSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVS
LGALDAEAYGVKSTIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWE
MLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEK
ELGIVMLANKNYPNPARVTAAWQILNTLQ
>S2XGJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELFDLLKALILGFVEGMTEFAPVSSTGHLIIVDDMWLKTSEFLGKPSANSFKIFIQLGS
ILAVIVVFWKRLFSLVGLYKMKDTTTGSKLKLTHVIVGLIPAGVLGVLFEDFIDEHLFRT
ETVLIGLVIGAILMIVADKFGPKKPKTQTLDQITYKQAFTVGLVQCLSLWPGFSRSGATI
SGGVLFGMSHRTAADFTFIMAVPIMFGASFLSLLKNWEDINPSDTSFYVVGFISAFVFAL
ISIKFFLKLIEHVKLTPFAIYRLVLAAVLFVIYVL
>A0A125P117|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLAKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDEKAKVFDIAIQTGAILAVI
IVYWQKIHSTLVALPRQHKAQRLVLNVLIGFLPAVVLGLLFGKLIKAHLFTAVVVASTFI
IGGFIILWAEKRPPGSVRVEHVDDMTPWDALKVGLVQCFAMIPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGAYSLYKERALLSVADLPMFAVGLVFSFASAWLCVRWLLK
YISTHSFVPFAWYRIVFGIVVLGTAWSGAVVWAE
>M1IEX6|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-22|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAPVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVG
>A0A0V1YIL9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDVAV
VNTAPGWRQFASSLREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0K6IZV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSAADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>D3EK33|FEATURES|UNIPROT_deepARG|chloramphenicol|GYMC10_3621|antibiotic inactivation|1
MNFHTIDIERWNRLPYFEHYTNVNQCTYSMTLDTDITLLLQALKIRGYKLYPAFIYMVTR
VVNERAEFKTSYSPEGQLGYWDSMTPSYTFFHKDDHTFSCLWTEFVNDFDRFHDLYEQDM
ERYRDVKGIFVKENPPPNTFPISMIPWARFSGFNLNIANDKEYLLPIITGGKYAEQGGRM
LLPVSMQVHHAVCDGYHASMFFQALQKMADSCEDWLK
>A4L314|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTDFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>M4X0K0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSAFQAFVLGVVEGLTEFLPISSTGHQIIVADIIGFGGERAQAFNIIIQLAAILAVV
WEFRRKILDVVVGLPTQARAQRFTANLLVAFAPAVVLGVAFADLIHHYLFNPITVAVALV
IGGVVMLWAETREHRIRAETVDDMTWKDALKVGCAQCLALVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPDDLPVFAVGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWQFDLIDWSSVKP
>A0A009JW93|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLIKGFFSGDAEARHFAFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFEHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTKDNMLNIAVGFVAAFISALFVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>L2F9F9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLILKSVIMGIVEGISEFLPISSTGYLILSADVMNFWTAAKRELFVVFIQLGAILAV
IYDYFGRLWQAFLGLVTGKAVGLKNPRRLGISLMIATLPVMVLGFTLADVIKQAFHPLIV
AFMLIVGALLIFYVEKRPQPIIADEAENIDFKTALKIGLCQCLALIPGTSRSGATIVGAL
WLGVSRRASTEFSFFLGIPVIVGAGLLDLSKHYTILQTAEDWTVLGVGTLVSFIVALLCI
RMMVAWVSKKDFTVFAWLRIVTGVVVLLAYFGFGYHIES
>ABG26481|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLP
PRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR
>A0A0F5F3V0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGSGRLSLIHILLGMVPAVVVGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEFLKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDMYKSIGFLTMADFPMFAVGFVTAFIVALIA
IKAFLELIKRISFVSFAIYRFIVAAAVYMVFM
>YP_002029850|FEATURES|ARDB_deepARG|multidrug|smeD|antibiotic efflux|1
MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFL
VAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQIEDASYRAQANSARAQLARAEATANAARL
SAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRI
GKSSVTQGALVSAGQATALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQQTPVS
ILMEDGSEFAHKGTLEFSEVSVDPATGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDA
VLVPMQGIARDPKGDTSAMVVGKDNKVEARPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQ
KIGPGMPVNVTEQGAAPAKPAAAQPAAAAAGAK
>J0CG35|FEATURES|UNIPROT_deepARG|aminoglycoside|Rleg4DRAFT_4114|antibiotic inactivation|1
MEAIIEIGTVKDIEPWAQLRMALWPHHSLDDHRAELSQAVLSQNGEAVAFIARDAANEAV
GFAEATLRHDYVNGCSSSPVLFLEGIYVRPVDRRKGVARLLCNAVADWGKLLGCIEFGSD
TLLENSASHALHTALGFEETQRVVFFRKPL
>Q937T8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKTLCCALVLSASFSAFAAQKTLSDKQLEDVVNQTLKPMITAQAIPGMAVAVIYQGKP
HYFTYGVADIAKKQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVKLSDPATKYWPELTG
KQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPAWAPGTRRQYANSSIGLF
GALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYRDGKAMHVGPGMLDT
EAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLELAQSRYWRSGSMYQGLGWEMLNWPV
AAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGAYVAFIPEKQIGIVM
LANKMYPNTERVKAANTLLNTLQ
>Q933M6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMIKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGTLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>G8LN29|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKKTIPEYTPVDLSRWARKEHFEVFQSFAQSTFNQTVQIDITALLKDIKELGWKFYPTMI
SLLSKIVNNHSEFRMAMKNNELVIWNEIHPSYTIFHNETETFSSLWSHFDGNIDHFQNVY
SEDVARYGNTLSYWPKEESRENVFFVSAIPWSSFTSFNINVANMQNFFAPMFTMGKYVNQ
GGKVLLPLAVQVHHSVCDGFHVARLFNELQAMCDDLRHHSGERQVQSKTHRA
>Q9KZX7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNEINESYDTDSVREFTVSDADAGPYALAEGPDGALWFTLVHRGAVARRDPDDGRVTVHP
VGDGPTVIAPGPDGALWFTEYRAHRIGRITPEGHYASFAPLTPEGGPFGITAGPDGAMWF
TLSSADRVGRVTMDGEVTEHPAPGAFPSALTAGPDGALWCTLNQGNAIGRLTPDGHGTAY
PLPTPGAAPVGIAAGPDGALWFTEIGAGRIGRITVTGDLTEYPLSDPAARPHAVTAGPNG
ALWFTEWGSGRVGRITVDGRVTSYPLSRTDCEPHGIAVHDGALWCALETGSLARIQVPA
>A0A0X1SFC9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKRVLAALVLSGLPLVPTPALAAEPSTRVAAAVEQAYRPLLKAYDVPGIAVAVIREGHS
TVFTFGLADRERQRPVTRDTLFEIGSVSKTFTATLVSYAEGLGRLSLADAPSRFLPELRG
SALDRVSLLDFGTYSAGGLPLQFPDAVADEAAMIAYFRRWQPAAPPGTQRLYSNPSLGLF
GAAAAAAMGGDFADLMETRLFPGLGMQRSFIRVPASESERYAWGYGKDGTPIRVDPGVLD
GEAYGVKSSAADMIRFVEVNLDPTRLDPPMRQAVQGTQIGYVRVGGMVQGLGWEQLPYPI
SLERLQAGNAEPMRFEAQPAARLDPPQTPTEVTLFDKTGSTNGFGAYVAFVPAKRIGLVM
LANRAFPIRARIAAAHAVLEALAAEEP
>V2V4D4|FEATURES|UNIPROT_deepARG|beta_lactam|F990_01630|antibiotic inactivation|1
MIASRMLFFTVGLLSCYSSVWAQPLSEQQVKEIVDQQFKPLLDQYKIPGLVVAVTLKGQH
YFVNYGVASKQSNQPVSNKTLFELGSVSKTFNATLTGYAQAQGQLSLSDHPAKYFPELKN
TAVNKATILNLGTYTAGGFPLQFPDEVVSQQDMIQYFQTWQPKTKVGAARQYSNPSIGLM
GYVTALALKRPYSELLEKTLFPQLGLSQSFIHVPEQQMPQYAWGYKNDQPIRVSAGMFDA
EAYGVKSSSFDMLKFLDAQIYPQKLKQPLRKAIENTHVGYFKVGAMTQGLGWEQYAYPVQ
LETLLHGNSSKMALESHAVTPIKQPKRASAATLFNKTGSSNGFGAYAAFIPQQKIGIVML
ANTNFPNDARITASYHVMQQLLQANTAQ
>A0A0N7HWV8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWQAIILAIVEGLTEFLPVSSTGHMVIASSLMGISAFEFTKMFTVAIQFGAILSVVVL
YWKRFINSFDFYKKLLVAVIPALAIGFVLKDVVDAMLERVEIVAISLLLGGILLIFVDRW
FKDRENPVTTPSYKNAFIIGMFQCIAMIPGVSRSASSIIGGLTQNMTRKSAAEFSFFMAV
PTMLAAATYTVLTDLLHLEISDVIKFNLPKIQAGFASITPQDWQVLAVGNVVAFLVAMAA
IKFFVGFLTKYGFKLFGYYRIVVGLIILLLLSLGVDLQIV
>A0A0J5JNP0|FEATURES|UNIPROT_deepARG|beta_lactam|AB685_17190|antibiotic inactivation|1
MTFSQIKVAVGTLALGTFLLVGCSNSQSETQPQKEEPDVAEFKDLEKEYDARIGVYALDT
GSNKSVSYRADERFIYASTHKALAVGALLHKKSIEDLEELITYTEGDLVNYNPITEKHLG
KGMTLKELSDASIRYSDNTAGNLIFNAIGGPEGFKEVLREIGDNTTEPERIEPDLNNVKP
GETRDTSTPKALAESLQAFTLGDALPPEKQNLLIDWLKNNTTGDALIRAGVPEGWIVGDK
TGAGSYGTRNDIAVIWPPKGAPIILAVLSSRDEADAEYDDALIAKATDEALKQLEKK
>A0A0J1LGZ2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGIQALMDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQKRVAISPDDVALTLHHKLCQAARHLLEEALPAI
KTGDYAELSQQEAEATCFGRRTPEDSFLDWNKPTAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNDIAAQPGTVISVSPLLIACVDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRLLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEDGRCDGEIINIGNPQNEASIQELAEMLLSCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>YP_302016|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHVTYSVSDISKSINFYKDILKAKILVESDKTAYFILGGLWLALNEEKDIPRNEI
RYSYTHMAFTIEESEFEEWYQWLNDNNVNILEGRTRDVRDKKSIYFTDPDGHKFELHTGT
LQDRLDYYKEEKPHMKFYEWDEVDKTDNNRE
>A0A0U1YUG5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAREWQENKSWNVHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARRI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A127SBE7|FEATURES|UNIPROT_deepARG|beta_lactam|LCR-1|antibiotic inactivation|1
MPKLILLACSLCISFFVRAEDAAIEQLFRNAGIDGTIVIESVTTGQRFVHNDPRSRQGFT
AASTFKVLNTLIALEEGAISGSDAIFHWDGTPYEVADWNRDQTLTSAFKVSCVWCYQQLA
RQVGSLKYPTYIQQSSYGQLRQPFNVAEFWLDGSLTISAEQQVAFLRQIVERKLPFKASS
YDTLKKIMVIDETGRYRLYAKTGWATRTPPSVGWYVGYVETSGDIWLFALNLATRDAKDL
PLRIQIAKDALKAKGVLPTN
>B3ZJ81|FEATURES|UNIPROT_deepARG|chloramphenicol|AK40_1014|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>A0A0U4CGU1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQYAVPGMAVGIVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTMTATLAADAQEGGELSLADPAGKYLPA
LQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRNDADLMRYLDAWRPAYAPGTRRTYSNVAI
GMLGYLTAKAMHKDFAVLMEQRLFPALGMMHTYINVPAARQADYAQGYAKDGKPTRMTPG
MLWQPAYGVRTTAADLLRFVQANMGLIQTSPRLQRAIERTHTGYFSAGPLTQDLIWEQYP
YPVALPTLIEGNAPPMLFNATPASAIKSPLAPNPNTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANGNVPIEDRVKAAYRILGSLGDGR
>I1V580|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSESDKTLLNQRVEIKKSDLINYNPIAEKHVNGTMTLAELSAAALQYSDNT
AMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNL
TLGKALAETQRAQLVTWLKGNTTGSASIQAGLPTSWVV
>B3X1U0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSRFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0J6GJ87|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSRKLSAIALSMAGLCAFANVALAQTPEPKLDAVVQNGARHVMQQYAVPGLVIAVSVNGK
HHFYTFGVASKTTLAPVTPDTLFEVGSVSKVFTATLATYAQAKGQLSLTDTVAKYVPALE
GTPFGKVMLSHLATHTAGGFPLQVPDSVQNEQQLMDYLKTWKPVYPAGTQRSYANPSIGM
LGMIAAKSMNMPFDQAMEQQLFPALGLESSYLTVPASKMGLYAQGYNKQDEPVRLTPGVL
GNEAYGLKTTARDLIHFTELSLGQGKLGTDLRRALTDTRTGYFRVGPMTQDLIWEQYPYP
VELKSLLVGNSNKMAYENNDAIALNPPLAPQQAVWVNKTGSTNGFGAYAVFVPAEQKAIV
ILANKNYPNDARVELAYQILKALN
>A0A0M9D1I9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKRFSVLTGSLLLAASLGAQATNTPAQPHLTNTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDSSKEDNTPVTKETIFELGSVSKTFTGSLISWAQVTGAISLSDKASQHFQPLA
GSTFDNINLLNIATYTAGGLPLQFPDEIDSNSKMVDWFQHWQPKYTPGTYRQYSNPSIGL
AGYIVAQRLEKPYSILVKNQILSPLGLHHTWFNVPEQEMKNYALGYSKENKPIRINPGVL
DEEAYGLKASAQDLIGFVDANIDPSRVGDNKLAQAIQATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAEIAYQANKTTELSPPEPPTDALFINKTGSTNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILKALK
>U3NGG9|FEATURES|UNIPROT_deepARG|beta_lactam|cblA|antibiotic inactivation|1
MKAYFIAILTLFICIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQNISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISLSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>A0A0U5LBB1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTEMLIQKISVVIPVFNEQESLPELLRRTDAACQRCELDYEIVLVDDGSQDDSGEMIAAA
ANQPGSHVVAILLNRNYGQHSAIMAGFSHVSGDLIVTLDADLQNPPEEIPQLVAAAQQGY
DVVGTVRQNRQDSWFRRRASRTINLLIQRVTGKAMGDYGCMLRAYRRHIIDAMLNCHERS
TFIPVLANTFARRTIELPVTHAEREFGESKYSFMRLINLMYDLITCLTTTPLRMLSVLGS
LIALTGFAFSITLILLRLFFGSAWAGDGIFMLFAVLFIFIGAQFIGMGLLGEYIGRIYND
VRARPRYFIQRVIYPQSGASAQDSES
>A0A087NSQ7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACATAVAGRAAAFTQNDIHATVTRHVAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLSDPAAKYLPA
LQGKPFGGVTLLELGTHTPGGMPLQVPDSIRDDAGLIRYLDAWQPAYAPGTRRTYSNVAI
GMLGWLTAKAMNRDFSVLMEQRLFPALGMTHTYINVPDARTADYAQGYTQDGKPIRMTGG
MLWQEAYGVRTTAADLLRFVQANMGLVETAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNAPKMLFDATPASAIKPPLAPNPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKTAYRILESLGDGR
>D1LFH9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDATTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWT
>J5KXZ7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKNIVKKFKVGDSDIEILHSINLSIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSSG
QYLLDGANISNFDSDALAKLRRNKFGFIFQRYNLLATMNALQNVALPSVYAGVDKKSREQ
RAHEILASLELDDKAQSLPNKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSGLKV
MEILVNLHKLGHTIIIVTHDPKIAEYANRVIEIKDGNIISDTTKKDEIFTAKKHDAPQKS
AFVYYKDQLIESFKMSISAMLSHKLRSLLTMLGIIIGIAAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMRSGRVKTLVISDAQMLEKQPFLESVTPNTSTSGTLTYENISL
SASLRGGGSGSFDVNGLKLASGRLYDDDEVASSASVAVIDHTTKISVFPNIDPIGKIILF
NKKPLRVIGVLQKDDFTFGDASTLKIYAPYTTVINKITGDKYISSITVRVKESVNAQVAE
KNLTELLTIKHGKQDFFTRNSDSIKQTIEETISTMRLLISSIALISLIVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIAFSYVIGYVFNNFLEGFS
MIFSNASIVVALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>J9ASZ6|FEATURES|UNIPROT_deepARG|beta_lactam|ieo_00372|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREVGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLSTLKATE
>NP_756938|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQASDTLRRTEPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>YP_001089504|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MMSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAIL
AVVVLYWKKIKDSVIEFFKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLF
NLQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSA
STIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALVVGFIVAF
IVSIIVMEKFVNFLKKKPMRVFAVYRIIMGVVLAVLAFTNIISV
>K1JW12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDWLYLLQAAFLGIVEGLTEFLPVSSTGHLIVAADLVGFTDATSDTFVVAIQAGAILAV
CWYYRMRIIRVLRGLFSEPVQQRLVVNTLVAFLPAAVVGVLVSDLLKTYLFNPLTVATAL
VIGGLIILYVEHRHEKLGIEPRVKEMDDMDWKDALKVGVAQCLAMIPGTSRSGATIIGGL
IFGLSRKAATEFSFFLAIPTIFGATVWDLWQAREQLVAANLPGLAVGTVVSFFSALVVVH
WLIRFVSRHDFRGFGWYRIIFGGVILLTWATGLVSW
>AAA26087|FEATURES|ARDB_deepARG|beta_lactam|SHV-1|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADAMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRNVGLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGAR
GIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGKALYEHWQR
>A0A147K5K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNEWIIAIILGILEGLTEFLPVSSTGHLILAANLLEFHGETAKTFEVVIQLGAVLAVLI
LYWKRFVSFLSTEQFEGNQLNLVHIALAMLPAVVVGLLLHSFIKAYLFGPETVLVGLVVG
GIFMIVAEKLKKTPKASNLDEITYRQAFGIGMFQCFALWPGFSRSGSTIAGGILLGVNHR
SAAEFTFLVSVPIMMAATGLDIVKSLDTLVAEDFALFGVGFLTSFIVAMIAIKTFLHLLK
KLSLSVFAYYRFVLAAVYFFIVL
>YP_001454848|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELSEKIGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHTTMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTE
LGIDPALRAENISVAQYCQMANYLSENAPSKES
>A0A0K1K2P3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIFALKALVMGLVEGFTEFLPISSTGHLILAGSLLDLQRNVSKEVIDVFEIVIQAGAI
LAVCWEYRARIASVLSGLTSDHKARKFVLNLIVAFLPLAVLGLAVGKHIKAVLFKPVPVA
LAFIIGGFVILWAERRAKTNPTAVRIHSVEDMSVSDALKVGFAQAFALIPGTSRSGATII
GGMLFGLSRKAGTEFSFFLAIPTLLCATFYSLYKERALLSADLTGFFSIGTVAAFVSAFL
CVRWLLRYISSHDFTVFAWYRIVFGLVVIVTSYTGMVAWVD
>L1QBQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLEIIKAIILGIVEGITEWLPISSTGHMILVDEFLKLNVSPQFMEMFLVVIQLGAIFA
VIVLYWKKIFPFTFDNGVKIEKDTISMWFKIIVACIPAAVVGLLFDDVLNELFYNPITVA
IMLILFGILFIVIENYNKNKRPTVTTLSEITYQVAIMIGIFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEFTFFLAIPVMFGASALKLLKFGFSFTGNEMVLLLTGMIVAFIVSIMA
IKFLMSYIKTNDFKIFGWYRIILGIIVLAYFYFIK
>A0A0J7XPG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDSATWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRREPVSWRFLRNLLLAFMPAAIVGLALHDYVEMLLGAPKVVAWALI
VGGVAILLIERMVKEQRFHGIADIPAIRALGVGLIQCISMIPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKKGDQITSATVGWDSIALGFIVSFFVALLVIKWFV
GLVSKHGFTPFAWYRIVAGCAALIWLGMR
>A0A0V9JS97|FEATURES|UNIPROT_deepARG|beta_lactam|APU02_07270|antibiotic inactivation|1
MLKERFRQTVFIAAAVMPFIFSSTSLHAQATSDVQQVQKKLAALEKQSGGRLGVALINTA
DNSQVLYRADERFAMCSTSKVMTAAAVLKQSETHDGILQQKMTIKKADLTNWNPVTEKYV
GNTMTLAELSAATLQYSDNTAMNKLLAHLGGPGNVTAFARSIGDTTFRLDRKEPELNTAI
PGDERDTTSPLAMAKSLRKLTLGDALAGPQRAQLVDWLKGNTTGGQSIRAGLPARWVVGD
KTGAGDYGTTNDIAVIWPEDRAPLVLVTYFTQPRQDAKWRKDVLAAAAKIVTEGK
>A0A0D7KT93|FEATURES|UNIPROT_deepARG|chloramphenicol|AZ66_01480|antibiotic inactivation|1
MKFHLIDIDTWNRKPYYTHFLNETRCTFSLTANIDITVLLDNLRVKNKKLYPALIHMTAK
IVNAYPDFRISYDEDGELGYWESMNPSFTIFHPEDNTFSSLWTPYMEEFHAFHESYLADV
GQYGKVKGLIGKKDQPANTFPISCIPWVSFTGFNLNVFNEGTYLLPIITFGKYFEQTGRV
LLPVSLQLHHAVCDGYHAGLFVGELQRFADHSKEWVDDPK
>A0A099S024|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLIIQAIIMAIVEGLTEFIPVSSTGHLILAGKLIGFTGEFANLFSVVIQLGAILAIVVL
YWNKLWNSVKNIFAPDRRGLKFWTNIIVAAIPGVILGFLFDDMIEAKLFYTFPVSIALVV
GGILMIVMENKYRRGKKINDVDQITVRQAFMVGVFQCLALWPGMSRSASTIIGGWIAGLS
TVAAAEFSFFLAIPMMVGASGLSLIKGGMAMSSIEVVALTIGFIASFIVALVVVEKFLKF
LQKKPMRIFAVYRIFIGIILLILSAIGIM
>A0A0E0VEP4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTTAWQILNTLQ
>A0A0N2A4Q2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSIVIPVYNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDNSADMLTA
AAEKPDSNVVAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SIVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGAQQDHNTQEEE
>A0A103WSK3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACATATAGRAGAATQDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVGKYLPA
LQGKPFGVVTLLDLGTHTSGGMPVQVPDGIRDDAGLIRYLDAWRPAHAPGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGLPASAIKPPLAPSANTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSFPNEDRVKAAYGILGALDGRW
>ZP_04113961|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDERAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVKEGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAATGLDLIKSWHVLSSADVTLFATGFVTAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFIM
>D1QNN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTLIIAIVEGLTEFLPVSSTGHMIITQNLLGVPQGDPFVHAFTFIIQFGAILSVVC
LYWKRFFQMRTKEEFFSKMKFYGLLIVGVIPAVIVGLLAKKSGLLDRLLDSVEVVAVTLV
LGGVFMLFCDRLFNKGTEDNKVDWKRALKIGCFQCLSVIPGMSRSMSTIVGGMQQKLTRR
RAAEFSFFLAVPTMAGATLLDLLDMFKEGTDWATTHNIEMLVLGCVVAFIVAIFAMKWFV
SFLTRYGFKAFGWYRIIIGTVILLLLATGHSLVMVD
>N9H5V2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIIEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIVSGEPQGRRLGIGLILASIPIILIGLTLGQTVKQFLFNDIAIAIG
LIVGGLIIIWIEKHPPQVRAHEVEDLSIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVLNTTEDWAVIGVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIASGLLILLFAYTGWKLW
>V5ALM1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFTLPLIEKVSVVIPVYNEQESLPELIRRTTTSCAQIGIDYEILLVDDGSSDDSARMLTD
AAEQPGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKANEG
YDVVGTVRQNRQDSLFRKLASRGVNHLIQRATGKAMGDYGCMLRAYRRHIVDAMLRCHER
STFIPILANTFARRAVEIPVQHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALFGFSLSLLLVILRLAFGAQWAGEGVFTLFAILFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQDHDVSQEEKNQ
>C0WB87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSALILGIVEGLTEFLPVSSTGHMIIVGHMIGFDGNLAKIFDVVIQLGAILSVLVLYRG
RFARFFTKEGWQLGKGLSAYHVLAGCIPTMAFALLVHSFIKKYLFSPFTVAIGLVLGALL
MMAAERKIRGHEAELVQDVDHISLKQALYIGFYQFLSLWPGFSRSGSTIGGALLVGVSRK
AGADFTFIMALPIMVAACLYELLKNLSALSSGDFAVLGLGFAVAFAVAYFSILWFIGFLN
RSTLKSFAVYRILLALFTLWYFYC
>C6B407|FEATURES|UNIPROT_deepARG|beta_lactam|Rleg_2695|antibiotic inactivation|1
MNRNWIKILSAALVSTCISTSGLAADALKLKAISDAAIRPIMDKYGIPGMAVAIAVDGQN
HIFNYGVESKDTNRPVSPATMFELGSISKTFTVTLTSYADVTGRLSLSDKASKYLPAMKG
RPFGDVVLTDLGTHTAGGFPLQVPDEVKTEKQLMEYLATWKPSYAAGTHRTYANPSIGML
GYITAKSMNDGFVALMEGKLFPSLGLKSTFIDVPKSRMADYAQGYKRNGEPARMTPAILS
SEAYGVKSTASDMIRFIDANMGLVELGDKLQQAINNTHRGYFDVGAMTQDLIWEQYSYPA
TLTTLLDNNSSAMLKTIPVKQLTPAMEPREDVWINKTGSTNGFGAYVAFIPKERLGIVIL
ANKNYPNEDRVSAAYRILTDITSAR
>R7AAL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIFNLIKAFFLGIIQGITEWLPISSTGHLIIFDTIWPLTPAAFFEVFKVVIQFGSILA
VLFLYFRKLNPFDPEKSSKKKRETFHLWKLVIIGCIPAAVIGFFLDDIIEQFLSANFVIA
VALITYGIIFIITAKHPKKVTIESLNELDVLTSLKIGFFQCLALIPGTSRSGATILGGLY
CGCSRYVASEFSFFIAIPVMAGASLLKIVKYFMETGMFTLDQWALLFVGTFVSFVVSVFA
IQGLLNYVKKHDFTSFGWYRIALGIFVLLFFYIL
>C4S9Z8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MPALIERTSAACKLLTQPYEIILVDDGSSDNSADILTAAANEPDSGIIAVLLNRNYGQHS
AIMAGFNQVSGDLVITLDADLQNPPEEIPRLVAVAEEGYDVVGTVRANRQDSLFRKTASR
MINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHERSTFIPILANTFARRTTEITVHH
AEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVGSVIALSGFTLAVLLVVLRLVFG
PEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQKVVGGEQTENN
QEIEK
>A0A0N1RW44|FEATURES|UNIPROT_deepARG|beta_lactam|PAGR_g2350|antibiotic inactivation|1
MTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTADGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTCLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>YP_151445|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAIFKLPVAQYPTIALPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>V4RHY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLIAVLLGVVEGLTEFLPVSSTGHLLLLTHFLKFETTGKTFEVLIQLGAVLALLTLYF
QRLWGVVVTLPTEPKSRGFVISVLVAFLPAMVLGVLLHDFIKGVLFESPQLICISLIVGG
ILLWAVDKWAPKPVHDDAMVLTWKTSLIIGLFQCLAMIPGMSRSGSTLIGAMLCKVDKKA
AAEFSFFLAMPTMAGAFAYDVFKTYKQMDFSDIWLIVVGFTAAFVTAVLVVKALLAYVSR
HGYGVFAVWRVCVGVVGLVLLQMGF
>YP_002215174|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDISDFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAAEHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>D0FI74|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-42|antibiotic inactivation|1
LLFGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVM
AAAAVLKKSESEPNL
>A0A0R1PIL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNEPTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNNVEKKQTWSIWFKVIVAILPSVIIGLPLNDWMDKHLTSWQVISA
TLLIYGILFIVVENWLKNKEPQTADLDSLSYKTAFQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIFKYFKHGNTFTGDQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVIAYFGSKALMA
>C2WPN3|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0023_30420|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFVKLEKEFDAKLGIYAL
DTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKY
VDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGDTVTNPERFEPELNEV
LPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVA
DKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIALGVLKAKN
K
>A0A0W8JCL0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIHSVILGLVEGITEFLPISSTGHLIIVSDWLGLPQTESNKAFEVIIQLSAILAVLTN
YKERFHPRYLTLWMKVVIAFLPIAAIGFLFQNQVKVLFTIQVVPIMFIIGGIIFLMVERF
LKNHAPTAETLDQITYRQAIWIGIAQVFALVPGTSRAGSTIVGALLVGVSRKASAEFSFL
LALPVMLAASGLDLLKHHQSFQGESALPLIVGFITSYIAAWVVMKVFLAFLNRFTFNAFG
IYRIVFGGILLYWAY
>A0A086G9R8|FEATURES|UNIPROT_deepARG|aminoglycoside|JL05_07470|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVECARRQGWATRLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>A0A0K4KM82|FEATURES|UNIPROT_deepARG|multidrug|yceL|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMACVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGTIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>Q2FC32|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIEL
>A0A076PWP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVMLVYW
QKIRDTLVELPSSRQAQKFALNVFIGFLPAVVLALLFGKYVQEHLFTPVIVATTFILGGF
VILWAENRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGLSRKA
ATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLRFIST
NSFVPFAWYRIVFGVIVLVTAYTGIVDWHH
>YP_408684|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHATRQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>L3PCH9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLITIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0D6A449|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGITEFLPISSTGHLYLADYFIKLNQPKSFINMFMVVIQLGAILSVI
LIYFNKLNPFAPSKSHQEKEATWQLWLKVIIAVLPSVIIGLPLNDWLDKNMTTWQVIAAT
LIIYGILFIILENYYKKRTPSLTKLNKLSYRIAFFIGCFQVLSLIPGTSRSGATIMGAML
LGTSRFVSTEFSFFLAIPTMLGASVLKLGKYFMIGNAFVGNQLAVLLVGMIVSFLVAYIS
IKFLLRYVRSHDFKAFGWYRIILGILVIIIGSIFA
>A0A076Q0T5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-161|antibiotic inactivation|1
NQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAF
ARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWL
KGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLILVTYF
>A0A0G3I352|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMLRYSIIIALILGIVEGMTEFMPVSSTAHLLLVSRLLGVDLSVLTVLVQLGAVSALLYV
YFNRIVSIFFFFPFSAATRYFSLTLFFGFFPAAVVGFFAYNFIKSILFKETIIAYVALII
GGVILLLVDRLKFQSKYFCIEKYPILLSIKIGLFQCIAMIPGVSRSGATIVGALILGADK
RSAAEFSFFIAIPTIIGACALDFYKNYSIIVNDMGTEIIIGCISSFITSLIVIRYSLRFI
AKKGYTPFALWRILIGFIGLSVEIFF
>YP_001246098|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGISGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKEQNM
>R6C4U9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKAILFGIVEGVTEWLPISSTGHLILLEEFVKFENVSENFSEMFDVVIQLGAILAV
VVLFIKQIWPFCRKGHGYKQSGPLAYVNMDIMTLWFKILVACVPAAVIGVLFDDVLNELF
YHWYVVAAALIVFGIAFIVVENWNKGRTPKVTALSGLTYKAALIIGIFQVIAAVFPGTSR
SGATIVGALLIGIARPVAAEFTFFLAIPVMFGASLLKIVKFGLAFTGTELAVLLVAMVAA
FLVSVVVIRFLLTYIKKHDFKVFGWYRIVLGILVILFFLLR
>YP_001452662|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFAAEEKLFLRRVIVAFGLVVVCFGVLIVNLYDLQIRQHQYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNITWYDISVTPYKIADMDALLRQLTPLVDLTPDDIAAFHHALK
SGSRYRPVVLKNALSDVEIARFSVNQFHFNGVTINSYEDRQYPYGAELAHVLGYVSKIND
SDLKALDEKGLAENYAADHNIGKQGIERYYENDLHGKTGYREVEVDNHGRIVRLLKNVPP
VAGKDIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSTPSYDPNPFVKGISHQ
DYGRLLHDKDLPLINRVTQGLYPPASTVKPYIAMSALLNGVITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAWMMGIDRINTMLGQFGYGKPTGIDLDEE
YNGLLPSREWKERVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
QSEVSGKTVMPWQAPQTETQIADAASPYWGLVRQAMFGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAVALILENGGSDGVTAAP
VMRQIMDHLFAPQ
>YP_001453577|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGLAQNIWQFLLLRALLGLLGG
FVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPLAGGLLADQYGLRPVFFITASVL
LVCFLLTLFFTRERFQPVSKKEMLHVREVVGSLKNPKLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIISVLLL
IPMSFVQTPWQLGVLRFLLGAADGALLPAVQTLLVYNASNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRETLAAK
>A0A064AGJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPFFIIIILAVVEGLTEFLPVSSTGHMILAEFFLGKNSFRQEFMNHFLIIVQLGAILAV
VFFSWKKLNPFSRSKEEFRKKFQLWAKIIVGVFPAAVIGLLFDDYIEQHFMNNIYIVIFT
LIFYGVLLMGIEHHHKKTAMKVRYGNFRKLRYRTALFIGCFQCLAMIPGTSRSGATIIGA
LLLGVSRPLATEFSFYLAIPTMFGASLLKLLKGGIVYTKQEWYYLGIGTSIAFLVAYIVI
SWFMNYIQKRDFSLFGWYRILLGIIVLVIYLLG
>R6JXC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIVEGITEWLPISSTGHMILLNEIMPLKVSDAFYSMFEVVIQLGAIIAVVILFWHQLWP
FGKKNNKEPLAESGAGAYVKWDIFKLWFHILVSCVPAAIVGILFDEQLEALFYNYTTVAI
MLIIFGIAFIIVETMHHGKKPKVRHLTGITYKLAFYIGLFQLIAAIFPGTSRSGATIVGA
LIFGISRTVSAEYTFFLAIPVMFGASLLKGVKFLMHNSMTSMEGMILLVGMLVAFIVSLV
VIKFLMGYIKKHDFKVFGWYRIVLGIIVLICGFAGVIGA
>ABC36050|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVVILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPNDSYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GAGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQNEDEFGDIVVKTAPDGGVTRLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAEHYGRGVR
GVLSRKAVMLGVYLVLVGATLMVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QKYAAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GYSSGQAQAAVERIAAQTLPRGVKFEWTDLTYQQILAGDSAFWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVEASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAQKDSAGYGVPAPDA
>A0A133QX03|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF3215_00041|antibiotic inactivation|1
MIYKNYNCNIGGFILKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKS
GQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>ZP_03042915|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLCTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPDQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>AAK51920|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MSIQHFQTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPAPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRSVA
>CAE53425|FEATURES|ARDB_deepARG|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKKPQEFVNCTFGIFLYIRGSAGMSP
>H3K9E4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFTLEIIKAIVLGIVEGLTEWLPVSSTGHMILVDEFMSLNVSKAFMDMFLVVIQLGAILA
VVALNFDRLNPFSKRKTYLKKRQTISLWGKVIVGCIPAAVIGLAFNDYMEEHFMNAQVVA
FTLILYGVLFIIVENYNKHRTPSIKDIDYLDYKTALIIGFFQVLSLVPGTSRSGSTILGG
ILFGTSRVVATEYTFFLAIPVMFGASALKLFKFGLNYTFEEVILLLVGMVVAFIVSIISI
KFLLRYVRTNDFKAFGWYRIILGLIVFVYFYFQG
>A0A104LVZ9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKRTQFVIRMWLALSCCLAIAAHAARSIEPADVGRIVDAVAQPLQEKYGIPGLAIAVSI
DGRHYFYNYGVASKATRRPVTGRTLFEIGSLSKTFTATLAAYAQEGGELSLADSVSRYLP
ALQGSSFDRISLLNMGTQTSGLPLFVPDTITNTAELLDYLKNWRPDRAPGTHRVYSNLGI
GTLGMIAAASMNERFETLIEKNLFPEFRMLHSYIDVPAERQDDDAQGYTKQGAPIRLRAG
MLASEAYSVRSCATDLIRFVDANMGLVPLSDKWARAMKATHVGYYEADGMIQSLIWEQYP
YPVSLGKLLAGNDLIGKDVVAKPFDPPLPPKPDVWINKTGSTNGFSTYVAFVPSKKVGVV
ILANKSYPLNERVTIGYTIIDSIVRAER
>U2M1S6|FEATURES|UNIPROT_deepARG|beta_lactam|L581_3751|antibiotic inactivation|1
MLKKSLSCVLLLATSGSLFAAPQTEKQIADIVNRTVAPLMQEQGIPGMAVAVIYQGQPYY
FTWGLADVAGKKPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPASKYWPALSGKQ
WQGITLLHLATYTAGGLPLQIPENVTDEASLQNYYQTWQPQWAPGTKRLYSNASIGLFGA
LMVKPSGMSFEQAMTKRVFQPLKLSQTWINVPQQEDKHYAWGYRDGKAVRVSPGMFDAEA
YGVKSSIQDMASWVQANMAPAKVKDASLQKGITLAQSRYWHAGDMYQGLGWEMLNWPVKE
KTVVEGSDNKNALAALSVTKVTPPAPLSSASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKNYPNPVRVEAAYRILDALQK
>T6HP09|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDGDLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0A8BXH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILAGSLLDFNDDKGKVFEIVIQFGAILAVC
WEFRAKIAQVVLGLGGDAKARRFAINVIAACVPAIVLGLLFGKHIKAVLFNPIVVATAFI
VGGVIILLVERHNRRNVEAGRLPRVNSIDDLSLADALKVGFAQCLALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATVYELYKARSTLSVDDFSLFGIGFIAAFVSAFIC
VRWLLRYIASHDFTAFAWYRIVFGIVVLATGYSGLVVWAD
>A0A0T9KWJ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MTALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTTSNAGTSDTIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILIGNMPATIVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLKTAEQTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A127SI36|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-119|antibiotic inactivation|1
MMKKSLCYALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWIQVNMDASRVQEKMLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAAEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A0K6KM09|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MNVKNKAGIQFGICIGLLCLSFTGFNPLFGSADAEAKSIENTKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKV
ALNALK
>A0A0A8X211|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWELFVAFILGLVEGLTEFAPVSSTGHMIIVDDLLLHSKQLFTEPVANTFKVVIQLGS
ILAVVIVFKDRFINLLALKKGVSIGDSKGRLSLPKVIVGLIPAGLTGVLFEDYIDEYLFS
VETVIIGLVVGAFLLILADRLQPKQLKAEDVDQISYKQALGVGLFQCLGLWPGFSRSGST
IAGGVLLGMSHRAAADFTFIMAVPIMLGASSISLLKNWDYFTVDVLPFFTVGFISAFVFA
LIFIKFFLRLINKIKLVPFAIYRIILAAVIYFIFL
>R8U3R6|FEATURES|UNIPROT_deepARG|beta_lactam|IKC_03480|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQETYKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTERMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALR
>A0A0J5N1E8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTLEPVNKISIVIPVYNEQESLPELLRRTSAACEKLNRDYEILLVDDGSSDDSAAILTR
AAEAPDSRIIAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKRASKMINLLIQRTTGKAMEDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVHHDERQFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SIIALFGFALAVLLVVLRFALGSHWAADGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRIIRRETALSSEDNQ
>AAT61949|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIQLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>YP_001445425|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKEEASSLIKLATPVLIASVAQTGMGFVDTVMAGGVSATDMAAVSVAASIWLPSILF
GVGLLMALVPVVAQLNGSGRRVKIPFEIQQGIVLALLISIPIIGVLFQTQFILGLMDVET
AMTEKTIGYIHAVIFAVPAFLLFQTLRSFTDGMSLTKPAMFIGFIGLMLNIPLNWIFVYG
KFGAPALGGVGCGVATAIVYWVMFGLLLLYVTTSARLKSINLFGEFHKPQLKAQIRLFKL
GFPVAAALFFEVTLFAVVALLVSPLGSIIVAAHQVAINFSSLVFMLPMSVGAAVSIRVGH
RLGEENVDGARVASRVGVMVGLALAMMTAILTVLFREQIALLYTNNPEVVELAMVLLLFA
AIYQCTDAVQVIAAGALRGYKDMRAIFNRTFIAYWLLGLPIGYVLGRTDWIVEPMGAQGF
WLGFIIGLSSAAFLLGIRLRWMHRQEPEVQLNFSQQ
>ABG72268|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAIAEGQCWQSDWRIT
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPATKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMALRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQVQGATQ
>A0A0M1EY50|FEATURES|UNIPROT_deepARG|aminoglycoside|ABW44_02935|antibiotic inactivation|1
MDETGSTAGEMLLPQAWQQDLAGARFELQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGQPAPTVMATAEEAGRRWLLMSALPGRDLATSADLPPQQVVAVLV
DALRDLHALPVSACPFDQRLASRLHAAQARVEAGVVDADDFDDERLGQSAQQVFVELCAS
RPAHEDRVVCHGDACLPNLMVADGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGVIADERRLAFYRLLDEFF
>AAA16406|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFALGQLIYGPMADSFGRKPVVL
GGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVINALMRDIYPKEEFSRMMSFV
MLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAMIFFLIKETLPPERRQPFHI
RTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVAPENFGYYFALNI
VFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISALLGLGFWSLVVGVAAFVGC
VSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGALLSLATFNSAWPMIWSIAFC
ATSSILFCLYASRPKKR
>A0A158FNN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNYTDAQSKTFDVVIQFGAILAIC
WEFRAKIASVVTGLPARADARRFTINVIIATIPAIVLGLLFEKHIKSVLFSPVPVSVALI
VGGIVILWAEARQRDRGGLTRVHSVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATIYEMAKYWRTLTVDDLGLFAIGLVAAFISAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>N9BUG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDFLLLLKAAIMGIVEGITEFLPISSTGHLILASELLNFWTPEKSAVFVVAIQMGAIAA
VIYEYWSRLWGAAIGMVTGEAKGRHLAISLIIASIPIILVGLTFGQTVKDLLFNDIAVAV
GLIVGGLIIMWIEKNPPKVNAVEVENITFKQAIWIGLIQVLSLIPGTSRSGATIIGAMFL
GVSRKAATEFSFFLGIPVIIGAGLLDLYQSHDVFQGQQDWIVLAVGLLVSFISALLLIRA
LVAYVAKRDFMIFAWYRIFSGLIILLFAFTGWKLW
>A0A0M3USU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVFVVAIT
LITYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIILLY
>G9Z2X8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKPPEHEGTGSGRLSLIHIILGMIPAVVLGLVFHDAIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKQPRAVGIDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLVGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLTTGDIPMFAVGFIMAFLVALV
AIKTFLQLIKHISFIPFAIYRFIVAAAVYFVFM
>A0A089L6F4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQDSIMKTYEIVIQLGAILAIAI
VYRQRILNLLGIGRSGRSRGGVMPASRLNLIHVMLGIVPALAVAFFARDFIKGLFGASTV
LWALVAGGILMIIAEWVNKRKIRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYRNFTNDTIWYFAIGFVISFVVAY
VVVVLFMRLIQKIRPTHFAIYRFILAAVFWLFVMR
>A0A142V4Q9|FEATURES|UNIPROT_deepARG|beta_lactam|Y979_22870|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWSELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0S3BMH9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVVIPVYNEEASLPALLSRVTAACDQLSQDYEVILIDDGSHDGSTELIRDA
AGEGSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGYD
VVGTMRRNRQDSWFRKTASKLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERST
FIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGSV
VAGIGFTFSILLILMRLILGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTDV
RARPRYFIHQIVRSATTPSQQEAEQ
>AAV58817|FEATURES|ARDB_deepARG|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVAFALREAQIHAAAL
GYGLLLWDGYRPRTAVDCFLRWAAQPEDKLTKEKFYPNIERAELITKGYVASQSSHSRGS
AIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGDAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>G6B980|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLFN
LQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSAS
TIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALVVGFIVAFI
VSIIVMEKFVNFLKKKPMRVFAIYRIIMGVVLAVLAFTNIISV
>A0A0T9Q7Z7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAVVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGAVPHEGKTSGHLTLGHILLAMIPAVVLGLVFHDVIKSLFDPRN
VMYALVAGGVLLLAAEWFKPKNPKSVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A0N0LA27|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
ANRECSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRSIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLVNLMFDLITCMTTTPLRLLSIVGF
AMAGLGVLFAIALIVLRLAFGASWAGGGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRGQPAMPAPVVTVDGLTSTSSDQVLS
>A0A0P0P3C8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLIEGLTEFIPVSSTGHLLLVGHFLGFHSPGNTFQVLIQLGAILAITGVY
FGRLWGLLTTAPSDPGSRRFILGVFLAFLPAVVVGVLAHDFIKTVLYESPLLVCITLITG
GFALLALDRMKLEPRYTDVSDYPLKTAFIIGLFQCLALVPGVSRSGATIAGALLLKCDKR
SAAEFSFFLAMPTMAGAFAYDLYKNIDKLSTNDLGLIGLGFLAALVSGVFVVKTVLDFIS
KHGFAPFAWWRIAVGVVGLGLLYIPR
>B7ALY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTMGDLSTLEVIIIAIVEGLTEFLPVSSTGHMIITQNLLGIESTEFVKAFTVIIQFGAIL
SVVWLYWKRFFRLNHTPVPEGTSALKRFLHKFDFYWKLLVAFVPAAILGFLFSDKIDEML
ESVTVVAVMLVIGGVFMLFCDKIFSKGSEDTVLTERKAFNIGLFQCIAMIPGVSRSMATI
VGGMAQKMTRKAAAEFSFFLAVPTMFAATMYKMLKLFLDGGTEIIMNNMPALIIGNVVAF
VVALLAIKFFISFVTKYGFKAFGWYRIIVGGIILLLLLTGHNLEVV
>R9LPA8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLELMKAIILGLVEGLTEFAPVSSTGHMIIVDDMWLKTEELLGSKYVANTFKVVIQLG
SILAVLVVFRNRFIDLLGLSRWMPKAKGEAARQSGPRLKLMQVIVGLIPAGILGVLFEDF
IDEHLFSTATVLIGLVIGALLMIAADRFAPKRASVDTVDQITYKQALGIGLFQCLSIWPG
FSRSGSTISGGVLLGLSHRAAADFTFIMAVPIMAGASFISLVKNLEYFTIDALPFFVVGF
ISAFVFALLAIRFFLKLIDRIKLVPFAVYRILLALVIWVVYF
>A0A0J1LUV6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGIQALLDAGYEIAAIFTHADNPAEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDDILNLAPVGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQRVAISPDDVALTLHHKLCQTARQVLEQVLPAI
KTGDFQERPQQKTEATCFGRRTPDDSFLDWRKPAAQLHNMVRAVSDPWPGAFSYVGTQKF
TVWSSRLSAHRAAAQPGTVLSVSPLLIACADGALEIITGQAGDGITMQGSQLAQVLGLVA
GSHLNSQPLSTRKRRTRVLILGVNGFIGNHLTERLLREDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYQKRIIFPSTSEVYGMCSDKVFDEDSSNLTVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALFRIIENDGGRCDGEIINIGNPDNEASIQELAEMLLACFERHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPSIEMLETVEETLDFFLRSVDITEQRS
>A0A0K5QM22|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LITCSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A127SY63|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
QQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARG
EIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPA
WAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAW
GYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQ
TGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGG
FGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ
>Q9KJD4|FEATURES|UNIPROT_deepARG|beta_lactam|acc-1b|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVT
VNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGMSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>D9T7E9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTQPAIREIPLTGPGSGPYSITVGPDGALWLALAGSGGVARLGLDGEVRTYRDDPPGSRP
LIIVGGPDGALWYTRSGDDRLGRITVDGETGSVALPPGCGPCGLVVGADGALWYAGMSDD
TIGRVSVDGEVTSFPLPVTKGFPSMLAAGPDDALWLTLNQANAIARVGLDGSVTVHPLPT
EAAGPVGITRGGDGALWFVEIVAGQIGRITPDGRIDEFPLPDRAARPHAIVADPAGGCWF
TEWGANRIGHIDPDGHITAHTLPTPASEPHGLTVTPDGAVWAALEIGAVAHLTPSPR
>A0A0H3YUP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGITEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKIIDVVVGLPKERQAQKFTVNLLIAFMPAVVLGVAFADLIHEYLFNPITVAAALV
IGGVVMLWAERRDHAIRAETVDDMTWTLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQLGMIDWSTAVG
>A0A0G1Y176|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTSLQAFILGVLQGLTELLPVSSSGHLILAESFFDMEIDPLSMLGFNVLLHAGTLLALVL
CYFTEWRKLLLSPFTGDATYRRLLILLIIATVPGALAGLAFEDVIAQKLSSPLAVVLAFL
VTAAVLLLGERSEQSRQAEHLTGSRALVIGLAQACALVPGLSRSGCTISAARLFHTTRRD
ALDFSFLLAVPIIAGATGVSLWHLLAGTVALPAAGIIVVGFVSSFVASILAIRFLRSFVT
QHSLAWFSWYLVVISVLLLARGI
>ZP_03030545|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIT
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRAMGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAAQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>YP_002022792|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHL
AALDKRRRYDELVRDRAVSERDHTEALAHERQAKAAVASARAELARAQLQLDYATVTAPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>A0A061MRW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAEQIIIALVLGLVEGLTEFIPVSSTGHLILIGHFLGFKSAGTFEVLIQLGAILAILLVY
FNRLVQIAKALPVSVKARHFVLAVLFGFLPAAIIGALAHDFIKGVLFETPILICISLILG
GIVLLVIDRIEFKPKYTSAYDFSWPMAIKIGFFQCLAMIPGTSRSGSTIVGALLLGADKR
SAAEFSFFLAMPTMVGAFTLDLWKSRNDLSFADGQLIVIGFVAAFITALFVVRALLDFVS
RRGYAPFAWWRIGVGILGLIGLYTVG
>YP_406903|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDNKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTAPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A0A0X7JK15|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSRPEVTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGQVARVTTAGDVTTYPLRTAT
GGPTMIATGTDGALWCTEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDG
AVWFTESAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQADAIGRITPD
GDTVLHDLPTPKAGPVGLTAGPDGALWFVEIAAGQIGRITTDGTVEEFPLPDPACRPHAI
AAGPDGALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGALWAALETGSVV
RIAVAAEGA
>A0A0W0B540|FEATURES|UNIPROT_deepARG|beta_lactam|VO69_07495|antibiotic inactivation|1
MSRILLPGLLAAGLIFSLPASAASGCMLFADGTGKPISSQGDCSSQLPPASTFKIPLALM
GYDSGFLVDENLPALPFKPGDDDWLPAWRETTTPSRWLTYSVVWYSQRLTEWLGMERFQQ
YVDRFDYGNRDLAGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGMGYPKLLDGTLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVFAALPDQLKKL
>D8MYI9|FEATURES|UNIPROT_deepARG|beta_lactam|RPSI07_mp0046|antibiotic inactivation|1
MTKLRLTAAGALLAVLASFAHARPLCTLVADAATGQPIVQEGQCGERVTPASTFKIALSL
MGYDAGFLKDEHAPTLAFKPGDPDWGGAAWHEPTDPARWLQYSVVWYSQRIAHALGAERF
QSYVRQFGYGNQDVAGDPGRNNGLDRSWILSSLKISPEEQVGFLRKLVNRQLPVSAHALD
MTARIAEVSRLPGGWVVHGKTGTGAPGTWSPDGTWDQAHAYGWFVGWVTNGTKTYVFAHL
LQDERIEPRPAGGRARDAVLDALPAMLARGHG
>A0A0Q8PU15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTLALKALIMGIVEGFTEFLPISSTGHLILAGSLLNFTGDKVKVFEIAIQAGAMLAVC
WEYRLRIAKVVTGLGSDRSAQRLVINLIIAFIPAAVLGFLFNKSIKTVLFAPVPVALAFI
IGGLIILWVERRNRRMPISARVDSVDDMTAMDALKVGLAQAFALIPGTSRSGATIIGGMM
FGLSRKAATEFSFFLAIPTLFAATIYSVYKERALLSAADLPWFGIGAASAFVSAFLCVRW
LLRYISSHDFTVFAWYRIVFGFVVIASAYGGWVVWAD
>A0A0R2DJB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKSIILGIIEGITEFLPISSTGHLYLANDLLHLDQSPEFINMFMVVIQLGAILSVI
VLYFHKLNPFTTKKTTLEIKQTWSLWAKVLVATIPSIIIGLPLNDWMDEHLTSWSVIAST
LFVYGVLYIILERFNKNRKPILNDLNKMTYRFALAIGFCQVLSLIPGTSRSGSTILGAMF
FGASRFVSAEFSFFLGIPTMFGASLLKLYKFFSHGGQFVGLQLPILLIGMVVSFIVAYLA
IKFLLNYVKSHDFTAFGWYRIILAIVVVLFFGLLK
>A0A0M3ETW6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFNEIKKVSVVIPVYNEEESLPQLLERTIKSCQSLKQAYEIVLVDDGSRDRSAEMLTQA
AEIPENHVVAVLLNRNYGQHSAIMAGFRQADGDLVITMDADLQNPPEEIPRLVEKAEEGY
DVVGTRRANRQDSWFRKTASKMINKMIIAATGSAMGDYGCMLRAYRRHIIDAMLQCHERS
TFIPILANTFARKTIEIDVKHAEREFGDSKYSFLKLINLMYDLLTCLTTAPLRLLSIVGS
IIAASGFLLALLLIILRVAFGALWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGAQAKETSETENQEKN
>I1V564|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKKSESEPNLLNRRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNL
TLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVV
>A0A0P9LYF6|FEATURES|UNIPROT_deepARG|polymyxin|ALO78_02187|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQEDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPR
>A0A0Q8HQ23|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLCSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIVVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLATARRGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHGKLRTAAADLLRDTLP
ALLQGKATETPQDESKATVFGRRTPADGKLVWARPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGLAPGRVISVDPLRIACGQDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLSDDRYEVYGLDIGSDAIDRLR
SHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
ERPAEESC
>I2IGT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDEHAKTFDVVIQLGAILAVC
WEYRRRIGSVVSGLPSRPDARRFTLNVIIATIPAIVLGLLFEKTIKAALFSPVPVAFALV
AGGVVILWAESRQRTRGETVARVQNVDDLSALDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATAYELHKDWHQLSVDALGTFTLGFVAAFISAFACVR
WLLRYIAAHDFTAFAWYRIGFGLLILLVGYSGALSWTE
>ZP_03029420|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVIMVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>AAD42181|FEATURES|ARDB_deepARG|glycopeptide|vanSD|antibiotic target alteration|0
MKNRNKTSHEDDYLLFKNRLSVKILLMMVYSILIIAGVYLFILKDNFANVVVAILDSFIY
HDRDEAVAVYLRTFKASEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDA
NDIGLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLPSVIGYLN
LLRDENQISEELREKYLSISLDKAERLEELINEFFEITRFNLSNITLVYSKINLTMMLEQ
LGYEFKPMLAGKNLKCEFDVQPDMMLSCDANKLQRVFDNVLRNAVSYCYENTTIRVKARQ
TEDHVLIKIINEGDTIPGERLERIFEQFYRLDVSRSSSTGGAGLGLAIAKEIVELHHGQI
TAHSENGITSFEVTLPVVGKS
>N9Z7I3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGVDFLFILKAIIIAIVEGLTEFIPVSSTGHMILASSIIGFNDPKVFVDMFEVVIQLGAI
LAVVVLYWKKIKDSVIEFFTYIFTKGKKGKTGFQFGINVLIGCIPMGVIGIVFYRQIKML
FNPKIVVAGLIVGGILLIIIENKFRKNRKYSTKNIDSITPLQSLKVGVFQVLAVWPGMSR
SASTIMGGWVAGLSTPIAAEFSFFLAVPAMIGSTAKDLFEFDFSMMNMTLWITLIVGFIV
AFIVSLVVMEKFVAYLKKRPMRVFAVYRVGIGIIFAILMMLGMNLNM
>C7H9C2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALIEFDAVCKYYQMGDTTVKAADHITMKIEKGEFVAIVGQSGSGKSTCMNIIGCLDVP
TAGTYRLNGRDVGKMSRNELASIRNEMLGFIFQQYNLLPKLNLLENVEVPLVYAGIPRAE
RHRRAREVLEQVGLGDKLKNKPNQLSGGQQQRVSIARALVRNPAIILADEPTGALDSHTG
REVLGMLQDLHGQGHTVVLITHDNSIAVQADRIIRLEDGQVVYDGDSRAPEAIVQPTLNF
EPAEQEGNK
>K1IXU9|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1168_00877|antibiotic inactivation|1
MSRLLLSSLLAAGLIAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>A0A0F4HDH2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKALILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVV
VLYFHKLNPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIA
LIVYGVLFIVIENHNQNLRPRFDSLNTLPYKVAILIGCFQILSLIPGTSRSGATILGAIL
IGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLILAVGVIVSFVVAYAS
IRFLLNYIKTKDFKAFGWYRIILGVIVIAYFALLAH
>A0A0U1HYR0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_1|antibiotic inactivation|1
MMKKSIINTLIFTTIASSPLYTLAQTKFTEHQVATIVNNTLTPLLEKQDIPGMAVAVFYN
GKPQFFNYGMADIKTGRPVTENTLFELGSVSKTFTGVAGEYAVQAGIMNLNDPVSEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQFYQQWQPEWAPGVMRNYSNASI
GLFGALAVKRSQLTFEKYMKEYVFQPLNLKHTFITVPESMLPNYAWGYKNGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMEPESLPADNDKLKKAIIASQSRYFRVGEIFQGLGWEM
YNWPINPQRVVANSDNDIALKPRKVEALLPAQPAIKASWVHKTGTTDGFGAYIVFIPEEK
IGIVMLANKNYPNTVRVQAAYDILQALR
>A0A080URR3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGINHLLFSVSNLERSIEFYEKVFTAKLLVKGRKTAYFDLKGLWLALNLEVDIPRNE
ISKSYTHIAFTIDPLDFDQMHKKLINLNVNILPGRPRNKQDQKSIYFTDPDGHKFELHTG
TLQDRLNYYKNEKPHMKFYI
>K8DVY7|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILIMLALILSACNTKHSTNNDIEKLEKKYGANIGMYALNTQNSEALSFNENKRFA
YASTLKAISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITIKKLIEATMLF
SDNTANNKIIDELGGYEHVKNRLTDLGDTTTHPSRKEPDLNFYSPKDKRDTTTPMAYGKS
LNKLIVDGNLSKANKDLLLDLMLKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVAL
VYPDGQDKPIILVIFTNKDKKDGKPNDKIVSEVAEIVLKNMSK
>J0VYY2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTPEPIKKVSVVIPVYNEQDSLPELLRRTTEACQKLNRDYEILLIDDGSSDDSAAMLTR
AAEAPDSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSWFRKRASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVHHDERQFGDSKYSFMRLINLMYDLITCLTTTPLRLLSVVG
SIIALSGFALAVLLVVLRLALGPQWAADGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVSSETALSSEENQ
>I1VJ14|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-82|antibiotic inactivation|1
LCCALLLTASCSTFAAPGTLTEKQIGHVVDKTIAPLLKEQAIPGMAVAVIYQGKPYYFTY
GKADIANNQPVTTQTLFELGSLSKTFAGVLGGDAVARGEIRLSDPANKYWPELNGRQWQN
ISMLDLATYTAGGLPLQVPDEVTDKAALLNFYQTWQPQWAPGEKRLYANSSIGLFGSLAV
KPSGLSFEQAMTQRVLAPLRLSHTWIKVPASEESHYAWGYSSGRPVRVSPGMLDAESYGV
KSSIADMASWIKANMNPQQVKDKTLRQGMELAQSRYWRIGSMYQGLGWEMLNWPVKAKVV
VDGSESKVALAATPAVAIRPPAPPVNDSWVHKTGSTGGFGSYVAF
>A0A085GTE8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSNSEVNKSTDNTIKKVSVVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDA
SAEILTQAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRL
VETAEQGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEA
MLHCHERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPL
RLLSIVGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGE
YIGRIYNDVRARPRYFVQKIVSADALKTHESVEQQEEE
>A0A0Q7CX15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWIAAVILGLVEGLTEFIPVSSTGHLLLTKKLLGLPSGFWDTFTVMIQLGAILAVVVL
YFQRLWGVFIRLPSDPSARWFAASVVISVLPSMVVAFFAHDFIKTVLFESITLICVMLIV
GGVILLLVDRWAPEPKEADAMNLTWKRALGVGLCQCLAMVPGVSRSGATIVGGVLIGIDR
RAAAEFSFFMAIPTMVGAFALDFWENKDVLTGDNLGLIAIGFVVSFLSGLIVVKTMLDFI
NRFGLAPYGWWRIGAGLVGLGVLYFHGG
>C6C761|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MQNEAINKVSVVIPVFNEQDSLPELIRRTTAACEQLHRDYEILLVDDGSSDNSAQMLTDA
AQTPGSHVVAVILNRNYGQHSAIMAGFSHVSGDVIITLDADLQNPPEEIPRLVDTAEQGY
DVVGTIRENRQDSWFRKTASRMINHLIQRTTGKAMNDYGCMLRAYRRHIVEAMLHCHERS
TFIPILANTFARRTTEILVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVGS
VIAIAGFALAVVLVALRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYND
VRARPRYFIQRIVGNDPRFSKQDNEE
>A0A0M0L2X1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKVKGINHLLFSVSHLYTSIDFYQKVFDAKLLAKGKTTAYFDLNGIWLALNEEPDIPRND
IKASYTHIAFTIEDQEFEEMSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMDFYD
>J2LT98|FEATURES|UNIPROT_deepARG|beta_lactam|UUU_18620|antibiotic inactivation|1
MMKEKRGIVNQQNAGLFLFVASLLAFIGPHSRMYVVMRYIRLCIISLLATLPLAVHASPQ
PLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGD
EQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGL
TAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLL
QWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPA
SMAERNQQIAGIGAALIEHWQR
>A0A0I9QQQ8|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNKIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0Q9R809|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSVKGLNHLLFSVSNLENSISFYRQVFDAKLLVKGRNTAYFDLNGMWLALNVERDIPRNE
INHSYTHIAFSIEEADFDNLYEKLNKLRVNILPGRPRDEKDKRSIYFTDPDGHKFEFHTG
TLQDRLEYYRQEKTHMEFNEE
>W0ATD2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITRSDPVTKYWPELTAKQW
NGVTLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITSPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>A0A064DPK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFSLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLIFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A023VF21|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSEEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQSVAISPDDVALTLHHKLCQAARHLLEQALPAI
KTGDYAERPQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNSLAAQPGTVISVSPLLIACVDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTSSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLSCFEKHPLRQHFPPFAGF
RDVESSTYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHIS
>R5Y4J9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYILDVLKSILFGIIEGITEWLPISSTGHMILLEKICKFKEVSPNFFEMYLVVIQLGAII
AVVVMFWNKLWPFKKKQLENGKSKVAVKPRIIELWFKVIIGSIPAGILGIIFNDLLDKYL
YNYVTVAITLIIYGVLFIAVEIYNRKRRPKVTKLTEVSFKNAFFIGCFQALSLIPGTSRS
GSTILGGIMLGNSRRVASEFTFFLAVPAMLGASLIKIIKFGLGFTVTEFVILFVGMITAF
TVSLVVIRFLMNYIKNHTFTAFGIYRIILGAIVLITYFVTK
>A0A0M2WSL7|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MSFLQLFILSIVQGFAELLPVSSSAHVIMAEKLMGLDPTSPELTMLLVMLHTGTMFAVIV
YFWKSWRATYFSSASAFRSNVLLLAAATALTGIVGFGLLKGITHFMSKDAPGFEIEHLFG
NAKLMAAALAAAGVLIIVSSRQQARQHGTLSIGKAMVIGAVQGLCLPFRGFSRSGATISA
GIAMGVPQRRAEEFSFALAVVLTPAVLVKEGWRFYQAVASGSLDHLEHGNSLLHLLGPSL
LGMLLSFLAGLLALRWLSRWLEQGRWHLFGAYCLAASMVVLYLG
>F0JX56|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELSNIRRSFPSGEDVVEVLKGINLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGIYKVAGQDVSTLDSDSLAQLRREHFGFIFQRYHLLSHLTALQNVEVPAVYAGIERKQ
REARAQALLQRLGLGERVDYRPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRERGHTVIIVTHDPHVAAQAERVIEIRDGEIVSNPPAKNSAIAQTFSDSS
AQPRSGWRQFIAGFREALTMAWLALATNKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAIQKQSWVASATPAVSQNVRLRY
GNIDVAAAANGVSGDYFNVYGMTFSEGNTFNKEQLNARAQVVVLDNNTRRQLFPHKANVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMASRVMGQSWLNSITVRVKEGY
DSDQAEQQLTRLMTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVMVCLVGGALGICVSLLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTITGILFGWLPARNASRLDPVEALARE
>V5T9H5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKRVNGTMSLAELSAAAL
QYSGNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIA
>A0A158AQV2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMCKALVLGVVEGLTEFLPVSSTGHLIVAGSLLNYTNAQSKVFDVVIQFGAILAIC
WEYRRKIGTVVGGLPTRPDARRFAVNVIIATIPAIVLGLLFEKAIKSVLFSPVPVSVALI
VGGIVILWAEARQRDRGVAPTVTSVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYELAKYWRTLSVNDFGLFAVGLIAAFISAFVCVRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>A0A0A0Q7X6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_pao|antibiotic inactivation|1
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDHPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>J7V3D8|FEATURES|UNIPROT_deepARG|beta_lactam|IE3_02842|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQAKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKKDAKYDDKLIADATKI
VLDFLKVTNKS
>A0A0H3KCN0|FEATURES|UNIPROT_deepARG|bacitracin|upk|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVVTGLPSRPDARRFALNVVIATIPAIALGLVLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSIDELTPLDALKVGVAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDALGLFVLGLVSAFVSAFVCVRW
LLRYVATHDFTVFAWYRIVFGLFVLLVGYSGWLNWA
>A0A120G0K1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSTGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERSDTGLSLHAKLRDAAAALLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLDWKQPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVQMSETIGNTLDFFLGEAMLEIA
DKK
>YP_002385300|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MSRHLSRLILCGLLGGATLLSGCALVRKDSAPHQQLAPEQIKLADDIHLASAGWPQAQWW
RQFNDPQLNALIERTLQGSHTLAEAKLRVEKAQSQADLLEAGSQLQVAALGMLNRQRVSA
NGFLSPYAMDAPHLGMDGPYYTEATVGVFAGMDLDLWGAHRSSVEAAIGAQNAALAESSA
VELSLTTGVAQLYYSMQASYQMLDLLEKTRDVIDYAVKAHQSKVASGLEAKVPYHGARAQ
ILAVEKQIAAVKGQLRETRESLRALMGAGASDLPEIKPVALPLVNTGIPSSLSYELLARR
PDLQAMRWYVQASLNQVDAARALFYPSFDIKAFFGLDAIHLDSLFKNTSRQFNVIPGLKL
PLFDGGRLNANLEGTRATSNMMIERYNQSVLNAVRDVAINGTRLQTLNNQREIQAERVEA
IRYTQKAATAAWKQGLSSRLQATESQLPVLAEEMSLLMLDSQRVVQSIQLIKSLGGGYQA
IPASK
>G7ZT54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVDVDNNQQRRSKPRRLNLLHVLVGMIPAGILGLLFDN
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNQQTVDQINYLQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIILVIFIAILYFGFGIGKGI
>A0A0W0I3A7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WAFRRKILDVVMGLPTQPKAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVHAETVDEITWKDALKVGVAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>A0A0E9F3H2|FEATURES|UNIPROT_deepARG|bacitracin|uppp_5|antibiotic target alteration|0
MITMIEIIKTIILGIIEGVTEWLPISSTGHLILANEILQLDVSPKFQDMFNVVIQLGAIF
AVVILYFNKLNPFEGKKNRKEFLATIELWKKVIIGCIPAIVGGLLLNDFMDEYFNKAIVI
ATTLIVYGIAFIVIERRHKTVEPRIHSFEELDYITAIKIGLFQTLALIPGTSRSGSTILG
GLLIGTNRFVATEFSFFMSIPIMFGASGLKLLKFGFHYTSAELIILLVGSVVSFFVSLIV
IKFLLSYLKRNDFQAFGWYRIILGIIVLASSFFLK
>A0A029P305|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLHFYQNWQPVWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMHTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAC33146|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIRYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A127SC68|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MEIIGMLSVTKKGFRLSFFTLAIGLSTYSNAYDVEKNKDNIETTINQSFKPLMEKYGVLG
MAVGVIYKGGNHEQYYGIQSDIDNKAVDSQTIFELGSVSKIFTATAGAYAKSQGKLSFQD
HPSKYWPELQKSEINKVSLLELVTYTSGNLPLQFPDNVKTDQQVLEYFQNWHIKNPPGQY
RQYSNPSIGLFGEITARSMKVPFTSLLENVIFPKFNMNHTYINVPKEQKEHYAFGYDQMN
QPIRVSPGALDAQAYGVKSSLPDMLKFLNANLNPEKSNSDFKKAILETHKGYLKLGNMTQ
ALGWETFSYPTTLAILQESNSEKVVMRSNPVVKETTQEKSKVFHKTGSTNGFGTYVFFVP
EENFGLVMLMNKKIPNEERIKAAYKVFNTIKSS
>A0A0J5V4L1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MAIQGLNHFLFSVSDLDRSIAFYQEVFHAELLVKGRSTAYFDLNGMWLALNEEKDIPRQD
IQHSYTHIAFSVKEEDMDTMYDRLEKSGACILGGRERDSRDKKSIYFTDPDGHKFEFHTG
TLEDRLSYYREDKKHMEFYDDRKKP
>AAM48116|FEATURES|ARDB_deepARG|beta_lactam|CfxA2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTKEEMSADHNKAYSNYTSPLGAAMLMNRWFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A089MWI9|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-155|antibiotic inactivation|1
MSLLYSPLSALTQGCIVVMRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGM
IEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYS
PVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWE
TELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLP
AGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALID
G
>A0A0G1X018|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIVDALILGIVEGVTEFLPISSTGHLILTAQLLGLSGEFVKSFEIAIQLGAILAVLVLY
GARFLKNPQIQKNVLVAFLPTAVGGLFLYKIVKTVFFESIPLILAALFLGGIALILFEKL
YKEKGDTLADLEKMSYRQAFSIGCFQVIAMVPGVSRAAATIIGGLLVGLSRRAVVEFSFL
LAAPTMLAATALDLIKSGTAFSAGEHGLLVLGGLTAFISALIAVRWFVSFISSHDFTRFG
IYRIALALAWWVAL
>A0A127SZY1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGAAGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>Q8X659|FEATURES|UNIPROT_deepARG|multidrug|mdtQ|antibiotic efflux|0
MNRDSFYPAIACFPLLLMLAGCAPMHETRQALSQQTPAAQVDTALPTALKNGWPDSQWWL
EYHDNQLTSLINNALQNAPDMQVAEQRIQLAEAQAKAVATQDGPQIDFSADMERQKMSAE
GLMGPFALNDPAAGTTGPWYTNGTFGLTAGWHLDIWGKNRAEVTARLGTVKARAAEREQT
RQLLAGSVARLYWEWQTQAALNTVLQQIEKEQNTIIATDRQLYQNGITSSVEGVETDINA
SKTRQQLNDVAGKMKIIEARLIALTNHQTKSLTLKPVALPKVASQLPDELGYSLLARRAD
LQAAHWYVESSLSTIDAAKAAFYPDINLMAFLQQDALHLSDLFRHSAQQMGVTAGLTLPI
FDSGRLNANLDIAKAESNLSIASYNKAVVEAVNDVARAASQVQTLAEKNQHQAQIERDAL
RVVGLAQARFNAGIIAGSRVSEARIPALRERANGLLLQGQWLDASIQLTGALGGGYKR
>A0A0E2M2N8|FEATURES|UNIPROT_deepARG|aminoglycoside|L360_05017|antibiotic inactivation|1
MSHIQRETSCSRQRLNSNLDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>YP_219359|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFSWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK
>A0A0H5BDI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLGDLIEATCLGLLEGLTEFLPVSSTGHLLLAGHFLGFDSPGKTFEVLIQLGAILAILV
VYFAKFTGIAMRLRTDPAARRFVIGIVAGFLPAALIGVAAHGFIKTVLFHTPALICVSLI
VGGVALLIVDRLTLTPRHHDATALSPLTCFYIGCCQTVAMIPGVSRSGATIVGAMLLGVD
KRAAAEFSFFLALPTMAGAFSYDLYKNWSTLDVDHGLLIFVGFVAAFCAAVLVVKSLLDF
ISRHGFAPFAYYRIAAGTAGLLALWLVG
>X6FIV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFQSTGKAFEILIQLGAILAILN
AYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVTALVVVRYLLDY
VSRNGYSLFGWWRLVVGIAGLVALMIWG
>A0A127SBR6|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKISYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>R9NE84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKVIILGIVEGITEWLPVSSTGHLILVGDLLKPGLSDEFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPGKTHKQKMLTWQMWIKVVIASVPAGVVGILFNDILDELFYKPLPVAVM
LIVYGILFIVVENRNAGTMPSVRKISELTVPMLLGIGVFQMLALIPGTSRSGATIVGALL
IGVSREVAAEFTFFLAIPAMCGASLIKLKDFGLGFTGTELGLLLLGCAVSFGLSVVAIRF
LMGYIKKNDFKVFGYYRIILGGIIMLMAFVS
>A0A0K2Z808|FEATURES|UNIPROT_deepARG|aminoglycoside|BN2069_36810|antibiotic inactivation|1
MDEHNATPDGMPLPLAWQKALADARIERQSMGVSRADVARVLRPGRPDAFLKSELIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEAGRHWLLMSALPGRDLASSPELAPQQRVEILA
DALRGLHALPVAACPFDQRLASRLPAAQARVEAGRVDADDFDDERLGQSPQQVFAQLCST
RPDHEDLVVSHGDACLPNLMVSEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VTPLFQRYGAVADERRLAFYRLLDEFF
>A0A0S7XZE8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELNSVNKTYRIGKIEVKALQDVSLKIVPGEFVAIIGPSGSGKSTLLHILGFLDKPDSG
SYSLNGKETSDFTDDELALLRNQMAGFVFQQFYLLPRMTALENVELPLIYAGKKESTQIA
KEKIAEVGLAHRESHRPNELSGGEQQRIAIARSLVKQPLIILADEPTGNLDTKTEKEIIS
IFKRLNDRGQTIIMVTHEKDIAEHAKRIIEMRDGRIIGDRTIDRKSALSPKIIPVNNILT
RSQSVLGTAKFVDHLRQALNAVVTHKMRSFLSMLGILIGVAAVITMLALGEGAKQSMSER
LASLGTNLLTIRPGARHMGGVFLEAGAVTRFTLEDAEAISKLPLVKSVSPYVIGRGQLVY
SDKNWNTQIMGVGVDYAVMRASIPIAGRFFTKSELIGRQKVALLGLTVVGNLFENKDPIG
STIKINRINFRVIGILPKKGSSFHGDQDDVVIIPVTTAMYRLLGREYVNSIDAEIKQADL
MEKAKDSISNLIIKRHRISETNQNSFTIRNMAEIQEILEGTTQTMAMLLGFIAAISLLVG
GVGIMNIMLVSVTERTKEIGLRKAIGARKRDIMMQFLVESVVMTLSGGIMGIVFGVGAAI
LLTIFVGWVTEVSLYSIIITTAFSIGVGIVFGLLPAKQASKLDPIQALRYG
>N9BIZ5|FEATURES|UNIPROT_deepARG|beta_lactam|F946_02659|antibiotic inactivation|1
MLSKTQKLFKTSLFTLAVGCSVHSNAYEIEANQKDIETAVNQSFKPLMEQYGVAGMAIGV
IYKGENYEHYYGLQSNNDNKKVDSRTIFELGSVSKLFTATAGAYAKAQGKLSFKDHPSQY
WPALKNSEIDRVSLLELATYTSGNLPLQFPDYVKTDEQILDYFQNWHIKKPSGKYRQYSN
PSIGLFGELTARSMKVPFPSLLEQVIFPSLHLKHTYVNVPEEQIEHYAFGHDQKNNLIRV
NPGALDAQAYGVKSTLPDMLNFLNSNLNVEKNSSKIKTAILETHKGYFKLGNMTQALGWE
TFSYPTTLEILQESNAESVVMQSNPVIKDISQSKSKVFHKTGSTNGFGTYVLFIPEKGFG
LVMLMNKRIPNEERIKAAYNVFNTVKSI
>A0A0D1AFA5|FEATURES|UNIPROT_deepARG|aminoglycoside|TQ38_26290|antibiotic inactivation|1
MMVRIEVAGEHNLDDWANLRAALWPVADAADHRDDLLEALSEPGSLIGFLGRNAAGEAVG
FAEAALRSDYVNGCDTSPVAFLEGLYVAESSRRLGVGRGLIEAVEAWARSMGCRELASDA
LLENTAAHDVHAALDFEETERVVYFRKVLDEAPTLS
>C5T978|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVALPSQQRAQRFALNVFIGFLPAVVLGLLAGKAIKAHLFTPVVVASTFI
LGGFIILWAERRPPSATRIQEVDDMTPLDALKVGLAQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDYSFFLAIPTLIGAGVYSLYKERALLQASDLPLFAVGLFFSFVSAWLCVRWLLR
YISTHSFVPFAYYRIVFGVVVLVTAWTGWVQWAD
>R8CTG7|FEATURES|UNIPROT_deepARG|beta_lactam|ig9_04086|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILRDMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AAL59749.1|FEATURES|CARD_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDAYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFLFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>A0A0C5L922|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEILVAILLGIVEGVTEFLPVSSTGHLILASELLGYDSEQWAMFNVVIQLGAILAVVVL
YWRTFWAVAVGLLQLNPVSWRFLRNLVIAFIPAAVIGLALHDHIEALLGSPRVVAVALIV
GGIAILVIERLVRDAHIVGIADIPVVRVIGIGLIQCMAMVPGVSRSGATILGALSLGVER
RTAAEFSFFLAIPTMLGATVLGLAKHGGTLASGRVGWTEIGVGFVVSFLVAILVIKWFVG
IVSKHGFTPFAWYRIVAGSAALIWLSMR
>F7U483|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAVIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLVALLVFG
>A0A066PBY7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPLPRQSRAAAPKEPLP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
GLAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>H3SCS0|FEATURES|UNIPROT_deepARG|chloramphenicol|PDENDC454_06565|antibiotic inactivation|1
MKFHPIDMENWGRKPYFEHYLHAARCTFSMSANINITSLLPVLRAQGVKLYPAFLYMVTK
TVNAHREFRTCYDPKGRLGYWESMVPLFTFFHKDDCTFSAMWTDYSDDFNRFYQNYLEDM
RRYGEVKGIRVKENEPLNTFSVSCIPWISFTGFNLNIFGDGRYLLPIVTSGKYFEQNGQT
LLPVSLQVHHAVCDGYHASVFINELEGLAQHYGDWLNVE
>A0A107EXS9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIFKTLTLGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>A0A0U3A6C6|FEATURES|UNIPROT_deepARG|beta_lactam|TEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKQLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIK
>F0F6H4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLMGVPQGDSFVHAFTFIIQFGAILSVVC
LYWRRFFRIDRTPAPADCRSPFLRMIHPVRFYWLLFVGVLPAVVIGMAAKKSGLLDWLLD
SVWVVAVMLVAGGVFMLFCDDIFDKGREENEVNEKRAFNIGLFQCLSVIPGTSRSMATIV
GGMANGLTRRRAAEFSFFLAVPTMAGATLLDLLDLLKEDGSWATAHNLAMLAVGCIVSFV
VALLAMKWFVNFLAKYGFKWFGWYRIIVGAVILVMLLSGASLNMVD
>M1LXT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQFLVLIKACFLGIVEGLTEFIPVSSTAHLIFIGKLINFNSCNGMVFEVFIQVGAIFSA
IFLFRYYIFDILLGVLRLDVRYLLFLAKVIFSVMPSIIVGAIFIRYIKKLFLCPSLIAIS
LIIGGLIIIAVENRRNINSKEKSCCYSDLYNISIKQSLCVGFAQCISMIPGVSRFGATVI
GGMLSGLSRSIATRYSFIIAIPTMLGASLYDLWFNINNLSYIDFSSIFIGSISAFISAFF
LVKYIVRFVETNSYIVFALYRIMVGILILFIC
>AIJ27543.1|FEATURES|CARD_deepARG|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
MRSEKEVYDIVLNFAKTDKRIRMVTLEGSRTNTNIPPDDFQDFDITFFVTDMDSFTSDDK
WLDIFGERLILQKPEDMELFPAVEKGFSYLMLFTDDVKIDLTLLPLELIDEYFTWDKLVK
LLLDKDNRIVKPPIPTDIDYHLQKPTQRMFDDCCNEFWNTTTYVVKGLCRKEILFAIDHM
NDIVRKELLRMISWLIGIKQGFHFSLGKNYKFMKQYVPEELWERLMSTYNMDSYPHMWES
FEQCMALFREVSSEVACQLDYQYPLYDEKISNYVIRQKKKYGIEDDNK
>YP_001486998|FEATURES|ARDB_deepARG|multidrug|Mdr|antibiotic efflux|1
MFSSFIFKLIIAKIRRERKQGVNEMNHVDNGKASTRFVVIGLLLGIFMAAMDNTIVATAM
GSIVADLGSFDKFAWVTASYMVAVMAGMPIYGKLSDMYGRKRFFLFGLIFFLIGSALCGI
AQTMDQLIIYRAIQGLGGGALLPIAFTIIFDIFPPEKRGKMSGMFGAVFGLSSVLGPLLG
AIITDSIGWHWVFYINVPIGIVSVFLIARYYQESLEHRKQKIDWSGAITLVVAVVSLMFA
LELGGKSYAWDSVQILTLFAVFLVFGTIFFIVERKAEEPIISFWMFKNRLFATSQILAFL
YGGTFIILAVFIPIFVQAVYGESATSAGFILTPMMIGSVIGSMIGGTMQTKVPFRRLMAI
SVISFFAGMLLLANMSPDTARLWLTIFMMISGFGVGFSFSLLPSASMNDLAPRYRGSANS
TNSFMRSLGMTLGVTIFGTIQTNVLSNRLADAFSGMKGASSQIGDPQAIFQEGARSQIPS
DILNKVIDAMSQSITYVFLIALFPIALAAITVLFMGNARVRTSNEMKENE
>Q58L89|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-20|antibiotic inactivation|1
AAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADITNNHPVTQQTLF
ELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQ
IPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
PLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDA
SHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDNKVALAA
>N9MYJ9|FEATURES|UNIPROT_deepARG|beta_lactam|F900_03302|antibiotic inactivation|1
MIASRMLFLLAGLLSCNSSIWAKSLSEQQVKEIVDQQFKPLLDQYKIPGLAVGVTLDGKH
YFINYGLASKSNEQAVSNNTLFELGSVSKTFNATLAGYAQAKGQLLLSDHPAKYFPELKN
TAVNKATILSLGTYTAGGFPLQFPDEVVTQQDMLQYFQTWQPKTNVGTARQYSNPSIGLM
GYITALALKRPYSELLEKTLFPQLGLSQSFVQVPEQQMSQYAWGYKNDQPIRVSAGMLDA
EAYGVKSSSSDMLKFLDIQIHPQKLKQPLRAAVETTHVGYFKVGAMTQGLGWEQYAYPVK
LETLLQGNSSKMALESHIVTPIKQPKRAPAATLFNKTGSSNGFGAYAAFIPQQKIGIVML
ANTNFPNEARITASYHVMQQLLQKNTAQ
>BAG79902|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATMLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAAQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>G3EST9|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-20|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0M8PU08|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHLLFSVSNLEKSIAFYEKVFDAKLLVKGKSTAYFDVNGLWLALNVEQDIPRNE
IHQSYTHIAFSIQEDDYDKMYEKLIQLNVNILEGRQRDVRDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKMHMEFFDVL
>A0A090NNR4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLHREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIDKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNIRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMLGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTQEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDVLARE
>YP_002861121|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VatB|antibiotic inactivation|1
MNKFGPNPNSIYPNENIKSICYIKNVIKNPNIQVGDYTYYDDINGAEKFEAHVTHHYEFI
DDKLIIGKFCAIAKGIEFVMNGANHRMKSITTYPFNIMGGGWEKAMPTLEDLPLKGDTVV
GNDVWIGQNVTVMPGVHIGDGSIIAANSVVTKDVPPYHIAGGNPCKIIKKRFDDELIDYL
LNLKWWDWSEEKIFKNLEVLCSPDLDKIKSIK
>F0EAA8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPRLRKALIATTITLALGHTTAQAHDPLQAKVDQVVRPLMQEQGISGMAVAIYAHGHAHY
FSYGVASKADSVPVSRDTLFEIGSLSKTYTATLAALASAQGKLDLSAPAKRYHPALAGAP
IGEASVRDLGAYSADCLPLQFPDDVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQQQSFSTLMSEGLLAPMGLRATYLQVPASAQGLYAQGYDAADKPVRVGPGPYADE
AYGIKTSARDLLRYVRLHLQPQGLPPTLQQALSITRQGYFQVGAMTQGLGWERYPYPVAL
DTLVDGNSPRLIREPQPVTRLQPAQPALPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFAILSGL
>A0A083ZXG9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAVLLELSDIRRSYLSAGQSVDVLKGISLRIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SGGTYRIAGKDVATLDSNALAELRREHFGFIFQRYHLLPYLSAAQNVEVPAVYAGLGKAA
RSARSIALLTRLGLAERVTYRPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSQSG
EEVMLVLKQLREQGYTVIIVTHDLAVAQQAERIIELRDGEIIADSGSRLQGKRPVKTLEL
TTSVASWRQMAGRWREALVMAWRSMATNKMRSALTMLGIIIGIASVASIKVIGDAAQQQV
LADIKSIGTNTVELYPGKDFGDDDPIYRQALKYDDLEALREQPYVRALSPNISSSMRVRF
GKTDVAANVAGVSEQYFRVYGMAFSQGSGIDAVQVQSQAQVVVIDANTQRRLFPYQENVV
GEVILVGNMPATVIGVAQEKQSMFGGSSSLRVWLPYTTMSNRIMGNNYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTDNMDSLVQAVEKTTYTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDIMQQFLIEAVLVCLIGGGVGMLLSFSICLLAQG
LLPGWQFSFSMAALLSAFFCSTAIGVIFGYLPAQRAAKLNPIDALARE
>A0A101KNY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPYDRLTRHFVIGILIAFLPAAIIGALAHDFIKTILFESPRLICIMLI
IGGVVLLAVDRMNLKPVYHDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIIAVGFVAAFVTALFVVRFLLDF
VSRKGYSLFGWWRLVVGGLGLVALMIWG
>A0A0G3CFM7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MIKTPFFNALLLPLLSALITPVGYAADKSEIDNIVQPLIQKYSIPGMAIAISVDGEHQFY
NYGVASKQTQQPITNTTLFEIGSLSKTFTATLASYAQNEGKLSFSDSASHYLPTLKNTSF
DNVSLLNLATHTSGLPLFVPDEVTNNAQLMDYYQHWKPEHEVGSYRVYSNLGIGMLGMIT
ANSYHQSFADAMETKMLSALEMKHTYIKVPSSQMADYAQGYNKQDQPVRVTPGPLDAESY
GIKSSTVDLIHYLDANMQVAQVDEKWQQAINDTHIGYYKAGPFTQNLMWESYAYPPKLEE
LLSGNDAGMIMNGSKATTITPPQAAMSDAWYNKTGSTGGFSTYAVFVPSHKIAIIILANK
WFPNDERIETAYKIMQVLDKPVVDK
>A3SKG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSESILVAAFLGLLEGLTEFIPVSSTGHLLLAGHFLGFESPAHTFEVVIQLGAVLAILTV
YSAKLWGVLRAAPRDPEARRFLASVLLAFLPAALVGVMAHGFIKSVLFETPHLIAAMLIV
GGVVLLFVDRFAPAPRYEDPTRIPMPVALGIGLFQCLAMVPGTSRSGATIVGGLLMGVGK
RAAAEFSFFLSMPTMAGAFGYDLYKNHDVLDLSAMGDIAVGFAVAFVAAVVVVKWLLNFV
SKHGYALFGWWRIAVGLLTLGLLWAVG
>H6NCZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLWKAVIMGIVEGLTEFLPVSSTGHMILTGHLLEFEGDKASTFKVVIQFGAVLAVLVL
YWRRFFGFLRISPRMLERPGLNPLHVGAALVPFLVAGLTIYGYMKKHLFGPTPVLIGLVA
GGVLMIAADRFRGRVTAETMDDITYKQAFGIGLFQCLAIWPGFSRSGSSISGGMLLGTSQ
KAAAEFTFIISVPIMFAASAYDLYKSREFLSIGDLPLFLTGLGTAFLVAMLAIVTFLNLI
KRLSLSWFAVYRFVLALVFVIILYF
>ZP_04001960|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVHNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A143SQQ2|FEATURES|UNIPROT_deepARG|beta_lactam|KF707C_27510|antibiotic inactivation|1
MSTTTLLRQGLLMLACGLPLPLVAADGLDLRVADEARQVMTEYGIPGLAIGLTQGGEQRF
YNFGVASRETRTPVDRDTLFEVGSISKTFTVTLAAYAEARGKLSLQDSPARHLPELRGSR
LEEVTLLNLATHTAGGFPLQVPDNVRNQADLTRYFRTWEPEYAVGSTRSYANPSIGLLGV
VAARSLGLPFIEAMEAQLFPRLGLKDTWLRVPASAERRYAQGYNRDDQPVRVNPGPLADE
AYGVKTSSRDLLRFVEAQLGRPGLEPALARALATTRNGHYRLGAMTQDLIWEQYAFPVSL
ATLERGNGASMALESHPEEAISPTLPPQRDVWVNKTGSTNGFGAYVAFVPARETGIVVLA
NRNYPNEARVRLAYRILCRVEACSAKE
>A0A0F5SA30|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQHVAISPDDVALTLHHKLCQAARHLLEQALPAI
KTGDYAERPQQEADATCFGRRTPEDSFLDWNTPAAELHNQVRAVSDPWPGAYSYVGTQKF
TVWSSRVCVNNSAAQPGTVISVSPLLIACGDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTTKRRTRVLILGVNGFIGNHLTERLLQEDHYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPQNEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVNITEHTS
>A0A087L373|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSSAEPISKVSVVIPVFNEQESLPALLERTTAACKQLTQPYEIILVDDGSSDNSAEMLTA
AAEQPGSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRLINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIEVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFILAVLLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGEKQTQNTQEEE
>A0A0H3W0X0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
AIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAI
NSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNK
IIKEIGGIKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANG
KLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSE
PIVLVIFTNKDNKSDKPNDK
>A0A127SNM6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNRKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A0G1U8K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQSIIFGIVEGVTEFLPISSTGHLILTAKLLKLEQTNFMKSFEIAIQFGAILSVVAL
YWRSLFVNREVMKRIAVAFVPTGILGLLLHGFVKQYLLSSDLTVVLALLIGGILLIAFEF
AYVEKETSLEDVAHLSYWRAAMIGVAQSVAMIPGVSRSAATIVGGMLAGLKRKTIVEFSF
LLAVPTMLAATILDLSKSYKGFSADQFDVLVVGFVVSFLVALVSIKWLLKYVQRNSFISF
GVYRIALAILFLLFVL
>E5ATG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKALVLGLVEGLTEFLPVSSTGHLILVGELIDFTGDGSKVFDVAIQFGAILAVC
WEYRERIGQVVRGLTTKPPARRFALNVIVACLPAVVMGLLFEKHIKALLFSPVPVAVALI
VGGIILLWVEAAHRRRDGAAYVARVQSIDELTVVDALKVGLAQCFALIPGTSRSGATIVG
GLLTGLERRVATEFSFFLAIPLIFGATVYELVKARDALSVSDMGPFTVGFATAFVSAFAC
VRWLLRYIATHDFTVFAWYRIGFGLLVLGASYLAGVTFSH
>YP_002791441|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDVDLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>CAB41446|FEATURES|ARDB_deepARG|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKITLSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNRDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILDTLNL
>S4YFY5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRIHKLAVALLTALAIPAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYG
VASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKS
LNQPFAQAMEQRLFPALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVK
SNAQDLIRYLEANMQVAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVALARLTE
GNNAGMIMNGTSATAITPPQREQGAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFP
NDDRVAATYRIVQALEKP
>D6CZ15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLQVAFIPAAILGFLFSDKIDEMLES
VAIVAVMLVIGGIFMLFCDKIFSKGSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILVNNMPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>R8PSE8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKEEATTYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSADDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>G9QRH1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGDNEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKEISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKSSEIYEAAKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDEDEVLNSASVALIDQNTKNSIFKNDDPIGKIILF
NKKPLRIIGVLQKDDFKMGDSNTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KTLTELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>A0A0J6WUK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDYMIAVILGIVEGFTEYLPVSSTGHMILVGDWLGFTGPQAGVFEVFIQLGAILSVLVI
YKAKFIRMFRQYRCWDLLRRENWFRNDTGLTLAHVAAGIVPVMGIGYLAHHAIKAYLFSA
GTVIIGLIVGGIFMLAAERSHMRIVCHDVEKMTIMQAFMVGAFQILALWPGFSRSGSTIA
GGLFLGLSRKAAADFSFIIAVPVMIVACFYDLLKSLAYLNVNDLIMIAIGFVTAFVVAYI
SVLWFLKFMNKSTLASFAYYRFLIAIVSFAYFFILK
>T2D0T1|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
FKPLLDKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGG
YAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFF
KDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQ
MQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPLKYPKDIQRSIYET
HKGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVT
>A0A0D6EBN2|FEATURES|UNIPROT_deepARG|aminoglycoside|HALO3509|antibiotic inactivation|1
MVPDEARQAQSIVEDVHGESIVGIYLFGSAVTGGLKRNSDVDILVVVNDSPTHKQREALI
AQLMKVSGTIGNAQATRPIELTVITVSDVVPWRFPPRAELIYGEWLRDEFEAGHIPKPAY
DPDLAIVLKKVVDNSLPLYGINAAEVLEPVPMADIQRAIRDSLPTLLSETAGDERNVVLT
LSRMWLTAATGEIASKDVAAEWAKGQLAKEHAALLDYAKQGYLGNIEDRWDEKQWEFKAL
TCCLRKSIEACLGTWQREGSDDQNEYC
>A0A0Q6H584|FEATURES|UNIPROT_deepARG|beta_lactam|ASG65_27855|antibiotic inactivation|1
MKSLSNIFSTSTFRKIVPVLFLSCATLVGCSNNNDHAELTKPKKQETANNHDFAKLEEKF
DAKLGVFALDTGTNQTVTYHPDERFAYASTHKALAVGALLQQKSINQRITYTREDLVNYN
PITEKHVDTGMTLKELSDASLRYSDNTAGNLILKQLGGPTGFKKALEEIGDNVTNPERFE
PDLNEVNPGETHDTSTPRALATSLQAFTLGDTLPTEKRELLIDWMKRNTTGDALIRAGVP
KGWVVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDKKDADYNDKLIAEATEEVIK
ALKVKNK
>A0RE09|FEATURES|UNIPROT_deepARG|chloramphenicol|BALH_2148|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEENKIM
LPVSLQVHHSICDGYHASRFIEDLQELSNSCNEWLK
>A0A0N0S2F8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVVVVMWKRMLNLVGLYKIDGQTTSVKGHFNLVHVIVGMLPAVILGFAFKDFIDDHLF
KVEHVIYALVAGALLMIAADKLAPKRPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYVVGFISSFIF
ALLSIKFFLALISKVKLMPFAVYRLVLAAVLAVIIFM
>E0THF6|FEATURES|UNIPROT_deepARG|beta_lactam|PB2503_13554|antibiotic inactivation|1
MLRSKLSLLCALILMPCTAQSATEYLSDDSFQKIAAQTFRPVIDDHDLPGLVIGLSYHGE
HYVFTYGLADQANEMPVDANTLFELGSVSKLFNVALAALADEKGVLSLASPVSTVVPELK
GSAFDQITIEDLAAHANGGLPLQVPSSLESEEELIRWLAAWEPIAAPDTIRSYSNVGTGL
LGMIAGEAFDTSYEEAITAHLLNPLGLNDTYITVPEEALPHYAYGYISGSAEPIRVTPGV
FDAESYGIKSSVNDMLRFIDVHLGRIDIPVEIESALSRTREAIYDTAYYGQGMVWEEYNW
PIDLARLTEGNSNEMAREPHSITRRDGPIDGTTFLNKTGSTNGFGVYIALIPDENIGVVV
LANQRYPNPVRAEATVHLIEHVLSGDDTE
>A0A0K2D1V6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIGSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYFAAFVMDSYETDEDNANIIARISRMVYDAMR
>A0A031JEC4|FEATURES|UNIPROT_deepARG|aminoglycoside|BV97_05195|antibiotic inactivation|1
MGSNADLLEWSALRTSLWPDGSEAEHQEDVVQLMAEPQPFIGFLARDQRGALVGFAEAAL
RVDYVNGCETSPVAFLEGLYVVEECRRQGIGRGLVDAVEAWARSMGCAELASDAMLDNTV
SHAMHAALKFEETERVVYFRKVLTPMPLLS
>A0A0A8FIR0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTTACEQLSQDYEILLVDDGSSDNSAALLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVSTAEQG
YDVVGTIRENRQDSWFRKTASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRTTEILVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIAISGFTLALLLILMRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRIVGNDPRFSEQDNEE
>B6VKV8|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MRDPDMKHSPLRRSLLLAGITLPLVNFAFPAWAGALPSSLYKQLAELENSTKGRLGVTLI
NTANGQEIQYRGDERFPFCSTFKLIVVAAVLHKSMSQSELLAKHINYSETDLLSYAPIAR
KHLNQGMSITQLCAATLQYSDNTAVNLLIKELGGVEAVNHFTQSLGDHTFRLDRWEPDLN
SAIPDDHRDTTTPAAMAASVKKIVFGEVLAELQRDLLIDWLKGNTTGDASIRAGVPTGWV
VGDKTGGGDYGTTNDVAILWPPKGAPVILAVYFTQPQKDAESRRDVLASATRLVMEHLA
>A0A0M2WQY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDLILALKAIIMGLVEGFTEFLPISSTGHLILAGSLLDFTKDVSKEVMDVFEIAIQAGAI
LAVCWEYRQRIGSVLTTFGSEAKSRKFVLNVAIAFLPLAIIGLAIGKMIKHALFKPVPVA
MAFIIGGIVILLVERRARTNPVTVRVNSVDEMTPFDALKVGCAQAFALIPGTSRSGSTII
GGMLLGLSRKTATEFSFFLAIPTLLAATAYSLYKARDILSATDVPLFGLGTVSAFISAFL
CVRWLLRYISSHDFTFFAWYRIVFGLLVLASAHYGWVVWAE
>A0A0W1RV22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLIAALLGVIQGIFMFLPVSSTAHLVLTQHWLIEKGHQLPPPDSPEMILFDLVVHVGT
LVSIVVVFWPSLWRFTRYTSTGALHWASAAGRHEGMPLYVRLFLLGMLSVLATAAIGFGL
KATFEQVFATPALIAVTLTLTGILLWWTDKLGPRRRGLKGINAKVATVIGVAQGFALVPG
LSRSAMTIVFSLFTGLKRRWAAEYSFFLAIPTILAATLVQSLEVWGDVGLNGVGLMALTV
GFVVSALVGIVSLKLVIYFLYRAQLKIFSFYVWILAAAVLFGWIDLPT
>U2PXQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIDIIKVFILSLVEGLTEFIPVSSTGHMIIVDQFLQLSKNEEFANAFKIIIQLGAILSV
VVYYWKRIFPFAKGLSQSQRMDIVQMWIKIVIAVLPAVVLGLLFDDVIDKVLFNSVVVAI
TLIIYGVILIWLESGEKKEGKITSITQMPIKTAIGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRILATEFSFFLAIPTMLGATLLKLVKLGTALSGYEWFLIALGFVLSFIFAYAVIKV
FMSYIKKHDFKVFGYYRIILGIIVLALYFVGVIK
>A0A075P5J9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MYEHMRNVTILGLLLGAGNCMAATDIRQAVDATIKPLMQQQAIPGLAVAILHNGKTQYFN
YGVAAKDSQRPVTENTLFEIGSISKTFTATLAGYAQATGKLKLSEPASHYLPALRGSLFD
HISVLNLGTYTAGGLPLQFPPEADNAQQMVSYFQHWKADFAPGTQRQYSNPSLGLFGYLA
AQSLQQPFDVALEQTLLPRLGLKHTYLTVPKAQMGLYAQGYDKAGKPVRVSPGALDSEAY
GVKTSPADLARYMALNIDPTALEQPLQQAIAATHTGYYTVGNTTQGLGWEMYPYPLGVDE
LVAGNSTPMAMEPHPVNWLAPAQPLRADTLVNKTGSTGGFGAYIAYVPSKGIGVVILGNK
NYPNAERVKAAHAILQAMEP
>A0A0F5RXM7|FEATURES|UNIPROT_deepARG|chloramphenicol|OA45_00670|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGVKFYPVFIYLISKV
VNNHKEFRTSFNDEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
YYASVHGLFTKENTPPNVFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSDSCNEWLK
>J5WZ87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKTVVLGIVEGLTEWLPISSTGHMILVDEFIKLDVSKSFMDMFLVVIQLGAILAVVV
LNFEKLNPFSSWKSSWEKRDTWQLWYKVILACVPAAVIGLLFNKFMEEHFMTAPVVAATL
IFYGVMFLVVETYNKRRTPRVREIERLDYKTAFIIGLFQVLSLVPGTSRSGATILGGILF
GTSRYVAAEFTFFLAIPVMFGASLLKMVKFGWHYTGSEILILVVGMATAFVVSILSIKFL
LRYIKNNDFKAFGWYRIVLGIIVVLYLYFVGDPVQG
>ACJ76644|FEATURES|ARDB_deepARG|beta_lactam|IMP-4|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>A0A0Q4CNK2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWITYVILGIIEGLTEFLPVSSTGHLILAGEMFGYTDDSSVVFKIAIQLGAILAVLVAY
RERFTGVALGLTRGDRQAIAFTRNILIGFLPALVAGALFYDGIRAVMQRPAIVATALVVG
GILILLIERMVKQARIRSVEEMSVGKAASVGAMQCLAMLPGVSRSGATIMGALLMGVERR
TAAEFSFFLAVPTMIAATVYSLYKDRALLTLDDLHGIAIGFVAAFVVALLVVKAFVKVVS
RFGFAPFAWYRIVVGSAALVWLALR
>A0A0G3SLS0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LGQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVQLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>YP_001949526|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MDNMHNTNGLMRIAKVAAASTLLATLLAACAVGPDYKRPDVTTPAAFKEAPTLAPGEQAG
TWKPAEPADGAHRGEWWKVFGDPVLDALEEQALAANQNLKAAAARVEEARAATRTARSQW
FPQVGVGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREEALKLVQRRFNEGDIS
ELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPLVPVAVKIPPG
LPSALLERRPDVAAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQNAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGEAPTAVDGAAAAKAEIAGR
>A0A127SKC8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLYINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>A0A125U4Q9|FEATURES|UNIPROT_deepARG|beta_lactam|bla1|antibiotic inactivation|1
MQVEAKEKKGQIKHKNQATHKEFSQLEKKFDARLGVYAINTGTKQTIAYRPNERFAFAST
YKALAAGVLLQQNSTMKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNT
AGNILFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAF
TAGNALPNHKRNILTEWMKGNATGDKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVWPPN
RAPIIIAILSSKDEKEATYDNQLIAEAAEVIVNAFR
>A0A127STU0|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLVTASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>I4L7V8|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVASALV
VGGVIMLWAEQRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADFPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLVILATWQFGWIDWTAVKP
>F9D456|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQTIIIAIVEGLTEFLPVSSTGHMIITQNLLGVQTGDPFVHAFTFIIQFGAILSVVC
LYWRHFFQMRNREELAAKARFYKLLIVGVLPAVVVGLAAKKSGLLDWLLDSVHVVAVTLV
LGGVFMLFCDRIFNKGSERNEVTPRRAFLIGCFQCLSVIPGVSRSMSTIVGGMQQKLTRR
NAAEFSFFLAVPTMAGATLLDLLDMFGEDTAWATPHNITMLAVGCVVAFVVAMLAMKWFV
GFIGKYGFKAFGWYRIIVGGVILAMLLAGQSLVMVD
>L0HR61|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
DNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHV
NGTMSLAELSAAAQQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAI
PGDPRDTTS
>D2BVP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDTAKTFEVIIQLGSILAV
VVVFWRRMFGLIGIHFGQPPEHEGRGKGHLTLAHIILAMIPAVVLGLVLHDAIKSLFNPV
TVTYALVAGGVLLLLAEWRKPKKPTAEGLDDISYLQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVNRYAASEFSFILAVPIMLGASGLDLYKSWHFLSLSDLPMFVTGFVTAFVVAMI
AIKTFLQLIKRVSFVPFAIYRFIVAAVVWLVLM
>X7RXC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFINSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKHFMDNTLIIAIT
LIVYGVIFIGIEVVYKLKKIKPKVKRFGGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>A0A0D0MF90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVFEALILGILEGLTEFLPISSTGHLTLAAHLLHLDIENDPFIKSFIVVIQLGAILAVL
ALYFKRFLQDMQVWKRIIVAFIPTGILGFALADVIENVFLGNDLIVVINLIGVGVLLLFV
DRWLQSHQRYDDVNQLPAPYAALIGLFQAIAMMPGVSRSGATIVGGMALGLSRRAAAEFS
FILAVPTMLSATGFSLLRHMDEFRADSWGLLAVGFLAAFVSALLTVRWLLAFVSRNSFVP
FAIYRILIGVVYGVFFLR
>C8PBS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDIVKAIILGIIEGITEFLPISSTGHLYLADYLVKLNQPSSFINMFMVVIQLGAILSV
ILIYFDKLNPFSKNKNKQKRKETWNLWFKVVVAVIPAAVIGLPLNDWLEAHMSTWPVIAS
TLIVYGILFILLENYCQHNQANITKLGSLSYQMAILIGCFQVLSLIPGTSRSGATILGAL
LLGASRYVSTEFSFFLAIPTMFGASLLKLIKFFAKGHSFHGDQLIILLVGMLVSFLVAYA
SIKLLLKFIKNHNFKSFGWYRIALGIIVILAGLSHLI
>G2S3J0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETMGKAYEILLVDDGSSDNSAQMLTD
AAEVEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SVIALAGFAISVLLVALRLIFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>A0A084DK59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPGRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVVSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0S8GA69|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKNVSKIYRMGVVRVPALKDVSLAIETGEFVAIMGPSGSGKSTLLNILGCLDVSTSG
QYRLDGTSVSQLSDSELAEIRNERVGFVFQTFNLLPRLTALSNVELPLIYAGGQDKRRQR
AMNALEAVNLGDRALHRPTELSGGERQRVAIARALANEPSIILADEPTGNLDSRSGQEIL
SILAELHKRGITVIVVTHDESVASHAQRIIRLKDGEVVEDEKIPDRPAPDEVPAYLRGDK
KKRKLSIAELKESLLMAMFAIFSNKLRSSLTMLGIIVGIASVIAMIAIGQGAGAQITERI
SQLGANLLTVRPGAYHRGPARGAPGSMTTLTFEDAQSIAEECPSVAKVDAMYSGRGQVVY
GNSNTNTSISGVTPNYPEVRNFPLDRGSFITDEDNRLMRRVAVLGKTVVEELFGEEDPVG
EYIRIERVIFQVAGVMSEKGSSGWTDEDDVIFIPLRTAQKRLFGVDYVSRINVQATDEDV
MDRASREITALLRDRHDIREDQELDFNVRSQAEILSAVQETSRTFTMLLAGVATVSLIVG
GIGIMNIMFVSVSERTREIGIRKAIGAQKRDILSQFLIEAVTLSLSGGAIGILLGMLVST
LMSHFGDWPTVITTGSVLLSCSFAFAVGIFFGFVPARKAAFMNPIEALRYE
>C2KV73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIVELLKVIVFSLVEGFTEWLPISSTGHMILLQSIIPLQQSKEFFSTFEVLIQLGAVGA
VIKEFFFRIWPVARRSQGKGYYLEQGKCILIGKILVACLPAAVLGLLLDDFLDAHLYNAF
VVSLMLILYGIFFILLERRNEGHQFHTLTVEELSWKNALLIGLFQCLALIPGTSRSGATI
LGAMLLSVGRLAATEFSFFLSVPVMAGASLLKLIKHAGNFGAGQWFMLLLSMLLSYFVSL
YCIRFLLRYIRSHNFLPFAYYRILFGGVILLWFAVSHLVL
>A0A0D0MXW7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHMARSTLAGAFLLLCGATTGFAQDRIEETVNAAIEPLMKQQDIAGMAVAITLDGQRHFF
NYGVASKDTRQAVTDQTLFEIGSVSKTFTATLGAYALAQGKLSLSDPASRFAPELRGSAF
DGISLLNLATYSAGGLPLQFPQEADHPERMFGYFKTWKPLYPAGTQRLYSNPSIGLFGYL
AARSLGQPFEQAMEQTLMPKLGLTHSYVRVPPDQLERYAQGYAKDGKPVRVGPGALDAQA
YGVKTNSADLIRFVEANLQPEKLDADLRQAIATTHSGFYTMGGMTQGLGWEFYPYPVTLD
ALLAGNSVEVAMQPNKVQPLEPPRPAPDDAWINKTGSTGGFGAYAAFVPGRHMGIVLLAN
KNYPIEERVKVAYRILTALDKQ
>M8D6I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELIKALILGLVEGMTEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLHLRKRERKNGPHLTLGHIFIGLVPAGVLGVLFEDYIDEHLFSTE
TVLIGLVLGALLMIAADRFGKRTVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTISG
GVLVGMSHRAAADFTFIMAVPIMAGASAISLLKNWEHITLDALPFFIVGFISAFIFALIA
IRFFLRLINRVRLVPFAIYRIVLAAVIYIVYFA
>A0A127SHY8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-47|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGGR
>A0A0R5RP88|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
GMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLS
DPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGT
QRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREG
KAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMY
QGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYV
AFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0H4IVL4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLSQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A060KZD2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCITSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLALAAKIVTNGL
>F2KYP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLMGVQQGDAFVHAFTFIIQFGAILSVVC
LYWRRFFHIDHTPVPADCKSPFLRMIHPVRFYWLLFVGVLPAVVIGMAAKKSGLLDWLLD
SVWVVAVMLVVGGVFMLFCDRIFNKGKEENRVNEKRAFNIGLFQCLSVIPGTSRSMATIV
GGMANGLTRRRAAEFSFFLAVPTMAGATLLDLLDLLKEDGSWATAHNLTMLAVGCIVSFV
VALLAMKWFVNFLAKYGFRWFGWYRIIVGVAILVMLLSGMSLNMVD
>Q1GR76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDLATIILLGIIEGLTEFLPVSSTGHLILASEMLGFTGEGSAAFKIAIQLGAILAVLVA
YRARFWGVGMGLLRADPAAVAFTRNILIGFLPAMLVGAVAYEGVRALLESPATVAVALLV
GGIAILAIERMVKVVKVESVEAMPLRTAIAIGAVQCIAMIPGVSRSGATIMGALLMGVER
RTAAEFSFFLAVPTMMGATAYSLWKDRAILTFDDMNAIAIGLFVAFLVALVVVKAFVAIV
GRFGFAPFAWYRIIVGGGALLWLAWK
>Q3YA66|FEATURES|UNIPROT_deepARG|beta_lactam|blaOKP-A-11|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMLDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>A0A136QP48|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLDYSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARNHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTAQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLENTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPERLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
ATLIDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYVAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>ZP_03381912|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRR
LFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALV
VGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGV
SRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALIAIKTFLQ
LIKRISFIPFAIYRFVVAAAVYVVFF
>I6ZI82|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNRTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A0M4R2M4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSVPRKLSGLTLVLAGFCAFGTPALAQNLDPQLDAAVTEGARQVMQTYGVPGLSIAVSVN
GRQHFYNFGVASRATQAHITPDTLFEVGSISKTLTATLATYAQVNGQLSLSDPVSRYVPE
LQGSAFGKVQLSHLATHTAGGFPLQVPDAVQNESQLMDYFKDWKPVYPTGTQRSYANPSI
GMLGLITARSMNLPFVQAMENTLFPALGLHSTYIEVPKSKMALYAQGYDKQDQPVRLNSG
MLGNEAYGVKTSSRDLIHFAELNAGLGEPPAKVGRAIRDTHTGYFRVGPMTQDLIWEQYA
YPVTLKNLLVGNSDKMVYNNNDVIALHPPLAPQEAVWLNKTGSTGGFGGYIALVPAKKQA
VVILANKNYPNSARIELAYKIFNALD
>AAR29485|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPMLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>P75830|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|1
MKKRKTVKKRYVIALVIVIAGLITLWRILNAPVPTYQTLIVRPGDLQQSVLATGKLDALR
KVDVGAQVSGQLKTLSVAIGDKVKKDQLLGVIDPEQAENQIKEVEATLMELRAQRQQAEA
ELKLARVTYSRQQRLAQTKAVSQQDLDTAATEMAVKQAQIGTIDAQIKRNQASLDTAKTN
LDYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSAMLVKAQVSEADVIHLKPG
QKAWFTVLGDPLTRYEGQIKDVLPTPEKVNDAIFYYARFEVPNPNGLLRLDMTAQVHIQL
TDVKNVLTIPLSALGDPVGDNRYKVKLLRNGETREREVTIGARNDTDVEIVKGLEAGDEV
VIGEAKPGAAQ
>YP_776581|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MDNMYNSNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDVSTPAAFKEAPTLAAGEQAG
TWKTAEPADGEHRGEWWKVFGDPVLDSLESQALAANQNLKAAAARVEEARAATRTARSQW
FPQVGAGFGPTRQGLSSASQLQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELRDQALKLVQRRFNEGDIS
ELDVSRAKNELATAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKVPAG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGAFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGNAPAPTAVGDAATGKADVAAR
>N8RBQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTPEKSAVFVVLIQIGAIAAV
IYEYWSRLWNAATGMVTGEEKGRRLGFSLIFASIPIVLVGLTFGQWIKEVLFNDLVVALG
LIIGGLIIIWVEKNPPQINAAEVENITFKQAIWIGLIQVLALIPGTSRSGATIIGAMYLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYHVLDGFDDWIVLAVGLIVSFISALLLIRAL
VAYVAKRDFMVFAWYRIASGLLILLLFFTGWKLW
>A0A127SIG6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLIPASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLETYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>R8S2C7|FEATURES|UNIPROT_deepARG|beta_lactam|IGM_02891|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQTKQIKQIKQENTGHDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGD
TVTKSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLDTLKVTNKN
>U2FPG6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGENEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
EYLLDGKDISKFDSDSLAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIVRALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKNSKIYEASKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
NASLKGGGVGSFDVNGLKLEEGRIYDEDEVLNSDSVALIDQNTKNSIFKNDDPIGKIILF
NKKPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKITGDKFISSITAKVNEGVNAQIAE
KTLTELLEIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYVIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>E6WQV8|FEATURES|UNIPROT_deepARG|aminoglycoside|Psesu_0777|antibiotic inactivation|1
MNPARVRPPRAADLPAWAALRAALWPEVDPELLASEASDLLHAVDGGVFVAEADGQLVGI
AEASLRHDYVNGTASSPVGFIEAWYVAPGWRGRGVGRALLRAVEAWTRGLGCTELASDAL
LDNSASHAAHRACGFEETERVVYFRKRVG
>A0A0E2GD41|FEATURES|UNIPROT_deepARG|beta_lactam|F958_01824|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNSSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQCAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>D4GF03|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLMKIYFTALLVALSASSSATDLSSQEIASRVKDVITPLMAEQGIPGMSVAVLYKGRPQY
LNFGVADTATDRRVTENTLFELGSVSKTFTGVLAGVMIRNSELRLNDPVQKYWPALKGPQ
WQAIRMVHLATYSAGGMPLQLPASVVDQDSLLRYAQQWQPGVAPGIQRQYSNVSLGLLGY
LMVKGEFEEAMQKNVFTPLRLTRTFYTVPASMMFDYAWGYKDGQPVRVSPGMLSAETYGV
KSTARDMMTFMQANANPNGLSSGNTVLRNGILTAQSHYLTAGQLSQGLGWEIYPWPVKEQ
TLIDASDTKTALEAQPATLVNPVKAADRASWIHKTGSTNGFGAYIAFVPQLNSGIVMLAN
KNYPNPERIKAAVAILDALQ
>Q5MDG4|FEATURES|UNIPROT_deepARG|beta_lactam|tem|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVCYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRS
>V2UV65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAFAL
IIGGLIIFWVESKNFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIGVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>ZP_01259020|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKEEASSLIKLATPVLIASVAQTGMGFVDTVMAGGVSATDMAAVSVASSIWLPSILF
GVGLLMALVPVVAQLNGSGRRVKIPFEIQQGVVLALLISVPIIAVLLQTQFILGLMDVEA
LMAEKTVGYIHAVILAVPAFLLFQTLRSFTDGMSLTKPAMVIGFIGLLLNIPLNWIFVYG
KFGAPELGGVGCGVATTIVYWVMFAMLLLYVMTSERLKSINLFGEWHRPQWKAQVRLFKL
GFPVAAALFFEVTLFAVVALLVSPLGPIIVAAHQVAINFSSLVFMLPMSIGAAVSIRVGH
RLGEENVDGARVASRVGIMVGLALSVLTAILTVLSREWIAELYTSNPEVITLAMHLLVFA
AVYQCTDAVQVIAAGALRGYKDMRAIFNRTFIAYWILGLPIGYVLGRTDWIVEPMGAQGF
WLGFIIGLSSAAFMLGVRMRWMHRQEPEVQLNFSVQ
>G7MDG1|FEATURES|UNIPROT_deepARG|chloramphenicol|CDLVIII_2656|antibiotic inactivation|1
MGFNIINMNTWDRKECFNHFFNNAKCTYSITVNIDITNLYNYTKTNKFRFYPTFTWVVSK
AINNYKEFKMAFDEEGRLGFFDEIGPSYSVLDDKTKVMSDLYTAFDNVFLNFYKDMENSL
DSYKQDTNFSTKFQNNFFIVSCLPWFNYTSFNVNNEGSSPFLFPMVTWGKFFEEGKKIIM
PVTIQVHHAVADGYHCSLFFSEIKEISSNPEQYLK
>A0A0D1A374|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGEFAKMFEVIIQLGAILA
VVVLYWEKIKESVVEFFKFIFTKGKEGKTGFKFGINVIVGSIPIGITGLLLYHKIKALFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFIQALKVGLLQILSIWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSIKDLFEFDYSIMTPTLWSALILGFIVAFI
VSIIVMNKFVSYLKKKPMKIFAIYRILAGLLLAVLVFTKIIILTA
>I0F3L2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MELEQQEISILHSDSGPYGIAISHEGKVWFTQHKANKISCIDKKGKIQAYTIPTPDAGAM
CLTVSSKGDIWFTENRANKIGKLTEKGQFREYPLPHKHSAPYGITEGPNGDIWFTEMNGN
RIGKLTAEGKIYEYELPNEGSYPSFITLGSDDSLWFTENQNNAIGKITESGEVTEFPIPT
PGAGPVGITKGHDDALWFVEIIGNKIGRITVSGDITEYDIPTPNARPHAIAAGRKSDLWF
TEWGGNKIGRLTSDHKIEEYTINTPHAEPHGIGCANDGTVWFALECNKIGKLRLTK
>W8FAQ8|FEATURES|UNIPROT_deepARG|aminoglycoside|X971_2251|antibiotic inactivation|1
MSLQFSIRHASASLDDWCLLRHRLWPDASVAEHRAELQNLSDNDAGFIAHDLVGMAIGFA
DVSLRRDYVNGCDTSPVAFLEGVYVEEEFRGQCVAAALIAEVTRWAISKGVSELASDADI
ANVDSHRMHAALGFEETERVVYFRKLLPSHS
>A0A145IJ21|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGTLALLEAGYDIAAIFTHPDAAGENHFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLICDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQRVAIDADETALELHHKLCTAAQSLLRDALPAI
LNGTFSETEQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLNNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDASSLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPENEASIRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>G5JL51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSQFLGTQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEDISQLPKRSKPKRLNLLHVLVGMIPAGILGLLFDD
FIEEHLFSVPTVMVGLLIGAIYMIIADKYSATVKHQQTVDQINYLQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHFGDIQLVDIPFYIVG
FLAAFTVGLIAIKTFLHLINKIKLVPFAIYRIILVIIIAILYFGFDIGKHI
>A0A060KQ86|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESGPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0A3J5R3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHLLFSVSNLEESITFYEKVFDAKLLVKGNSTAYFDVNGLWLALNVEKDIPRND
IHHSYTHIAFTIAEDDFDKVYDRLVQLKVNILAGRPRDEKDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKQEKQHMVFFDN
>NP_459470|FEATURES|ARDB_deepARG|multidrug|acrb|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>BAB38070|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIITSVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGISAWNMLIGI
LIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>L0MGI2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELTEICRSYQSGEQTVDVLKNVTLSIDAGEMVAIIGASGSGKSTLMNILGCLDKP
SAGTYRVAGQDVATLSGDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGKAA
RRERATALLQRLGLGERVSYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMQILKQLREQGHTVIIVTHDPTVAQQAERIIEIRDGEIVNDSRPASAPNPQAKPLEL
AAPAPSWQQAGGRFREALVMAWRAMAANKMRTMLTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPAYRQSLKYDDLEALREQPYVGALSPNISSSMRLRM
GNVDAAANVSGVSEQFFRVYGMAFSQGSGIDPLQVQSQAQVVVIDANTKRRLFPHQKEVV
GEVILVGNMPATVVGVAQEKQSMFGSSKTLSVWVPYSTMANRLMGNAYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIGLSLAIGLLVQL
VLPGWQISFPPVALLSAFICSTAIGVVFGYLPARNAARLNPIDALARE
>A0ZUB1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQALLQLTGITRSFTAGDREFLALKDINLTINAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYRINGQETRDLDDQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGIPAP
QRHARARELLARLGLDGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNQRDTGQLSDEDV
PPKPPATRRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGAK
NYVLKDISAIGSNTIDIYSGSSFGDKRAASIETLVPADVTALNQLYYVDSATPVVGRSML
LRYRNIDLDAQINGVSDQYFQVRGIKLEAGITFSESDARRQAQVVVIDYNTRHRLFGEGV
DPLGQVILIGNLPCTVIGVAAENKNLFASGKTLNVWVPYETAAGRILGQRFLDSISVRIK
DGQSSKVVENHVTQLMLQRHGIKDFYTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHL
FSLFIKEWEMVFSMASVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>A0A0N0FCA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADLIHHYLFNAITVATALV
IGGVIMLWAERREHAVRTETVDDMTWTDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>M8L215|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPGNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>YP_002421432|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKAAPNDGTHDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFS
>CAR63502|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VGTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>Q2FC62|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLISIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
>Q9AMA3|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRHLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVIYLGK
>A0A069DJ13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILSSIIMGIIEGLTEFLPVSSTGHMILTAHLLGLSTDEESVKTFEVVVQLGAVLAVVV
LYWHTFIGLFKIKPLDRTVPRLNLLHIFLAMVPAGVAAVLLRDVIKAYLFGPETVVYSLV
AGGLLMIAAEKWHKKPTAVTIDDITYKQAFTIGLFQILALWPGFSRSGSTISGGLLARVS
HTAAAEFTFLVSVPIMFAATLLDLMKSASYLSVSDIPYFAAGLITSFAVGMLAIRTFLHL
LKRLKLSTFAYYRFGLALVIFVFVL
>A0A089QVG8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGVTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPVHEGLGAGRLSLIHVLLAMVPAVVLGLVFHDFIKSLFNPV
TVMYALVVGGLLLIAAELFKPKEPKTQGLDDMTYRQAFLIGCFQCLALWPGFSRSGSTIA
GGMLLGISRYVAAEFSFLLAVPMMMGATALDIYKSLGFLTAADIPMFAVGFVTAFIVALI
AIKTFLHIIKRITFIPFAIYRFIVAAAVYAVFM
>Q3RFT8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSLLWLSTIPPMFELFTALMLGILEGITEFLPVSSTGHLLIAEHWLGSRSDFFNIVIQA
GAILAITFVFRKRVWSLATGLDKYSNRDYVMKLATAFLITAVVGLAVRKANWQLPETIQP
IAWALIIGGIWILIAESVAKHLPERENVTWSVAIAVGLAQVVAGVFPGTSRSASTIFLAM
LLGLSKRSAAAEFSFLVGIPTMFSASSYACFELFKRGELLHENWLEVSVAFVAAMLTGFA
VVKWLLGYIKNHSFAPFAYYRIALGLVLLTWLT
>Q39LU0|FEATURES|UNIPROT_deepARG|beta_lactam|Bcep18194_C7532|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAATQDDLHDTVTRYIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVNGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAGKYLPA
VQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRDDAGLIRYLDAWRPAYAPGTYRTYSNVAI
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTRTYINVPEARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLIEGNSMKMLRNGVVATAIKPPLAPSADTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSYPNEDRVKAAYGILGALDGRR
>W3V4K1|FEATURES|UNIPROT_deepARG|beta_lactam|PTE_02723|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLVNFTFPAWAGAIPSSLHQQLAELENRTKGRLGVTLINTANG
QEIQYRGNERFPFCSTFKLMLVAAVLHKSMSQSELLAKHINYSESDLQSYAPIARKNLNQ
GMNITQLCAATLQYSDNTAANLLIKELGGLAAVNHFAQGLGDRAFRLDRWEPDLNSAIPD
DPRDTTTPAAMATSVKKIVLGETLAAPQREQLVGWLKGNTTGDASIRAGTPDGWVVGDKT
GGGDYGTSNDVAILWPPEGGSPVVLAVYFTQHQKDAESRRDVLASTTRLVMKHLA
>A0A0P9STU2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHA
PEDPNHPLWVERVAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPHYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVPISATDTALTLHGKLREAATDLLSETLP
LLAQDRLSGTPQDESRATCFGKRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCAVGDN
KLIIWAADLELRNDGEAPGTVISHDPLRIACGEGSLVIRAGQRGDAGLYLSGAQLAREFG
LVEGSQLLDTQKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TQPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIANARQLIGWTPGIELSTTIGKTLDFFLREAMIEKA
DQR
>J2NGH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAIAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHHYLFNPITVASALV
VGGVIMLWAEKRQHEVHAETVDEITWQDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGFKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHTYVAFAWYRIVFGLVILATWQFGWVDWAAVEP
>W6SKC9|FEATURES|UNIPROT_deepARG|chloramphenicol|catB|antibiotic inactivation|1
MGFNVIDLNTWDRKERFNHFFNNAKCTYSITVNIDITNLYNYTKTNKLRFYPTFTWIVSK
VINNYKEFKMAFDEKGRLGFFDEIGPSYSVLNNKTKVMSDLYTSFNNVFANFYMDMENSL
NKYKENANFTTKFQNNFFIVSCLPWFTYTSFNVNNEGSTPFLFPMVTWGKYFKEDNKIIM
PLTIQVHHAVADGYHCSLFFSDVKEISLNPEKYLK
>A0A0U2ITE7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDIFNAIILGIIEGITEFLPISSTGHIIVAAQWLGIEATATNQAFGVIIQLAAILAVLAN
YKDKFTPKHLNLWIKIAIAFIPLGIIAFIFSDVIKALFNVPVVGVMFIVGGVIFLLLERN
YKEQNCTTTDVTQVTYKQAIWIGIAQVFALIPGTSRAGSSIVGAMLCGLNRKASAEFSFL
LGLPVLAAASGYDLLKHYDLFTFDDLTALAVGFVTSFIVAYFTIKLFIRFLENFTFVSFG
IYRIIFGVILLTIAYV
>A0A102D7R4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSLNLTAVVLGIVEGLTEFLPVSSTGHLVLATDLFGYDLKDWEVFNIVIQLPAIMAVVV
VYWRTFVDVAHGALRRERESLHFIRNVLIAFIPSAVLGVLLKKKIDLLLESPSVVAVALI
VGGVAIIVIERLARQRAYEPVSALPVRRSFLIGVVQCIAMIPGVSRSGATIMGALAMGEN
RKTAAEFSFFLAVPTMFGATAKQLWDNRHALAAHSSPIGFTQIAIGSVVSFVVSLVVIRL
FIGYISRHGFIPFAIYRILAGSFALYWLLRA
>Q7P1I3|FEATURES|UNIPROT_deepARG|aminoglycoside|CV_0230|antibiotic inactivation|1
MTIAPACSRPDVWLALRAALWPDCPSDEHRREIDAQTAEPARYAAFVATDASCGAIGLIE
VALRHDYVNGTHHSPVGFIEGLYVAPAHRRTGVAGRLLGAAKDWSRDRGCAELASDTALD
NLVSQQAHQALGFEETERVVFYRMAL
>AAA19915.1|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVEPSCEPSG
>A0A150BSY9|FEATURES|UNIPROT_deepARG|beta_lactam|AT269_26200|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAAEVIVKALK
>A0A0B5A120|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
LRAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVL
LCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAA
NLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLT
GELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKP
SRIVVIYTTGSQATMDERNRQIAE
>CAE51025|FEATURES|ARDB_deepARG|beta_lactam|VIM-4|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFVPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>A0A0R0CSD7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAILAVVLAFRQ
RLWTLATGLNQAENRDYVMKLGVAFLVTAVVGLPVRLAGWELPETVTPVAWALVIGGVWM
LLAERFAGRLPDSTTITWKVAVAVGLAQVIAGVFPGTSRSAAAIFLAMLLGLTRRAAAAE
FVFLVGIPTMFAASGYALLEMAKKGQLGNENWTDVGVAFVAAAITGFIVVKWLLSYIKRR
PFTGFALYRIALGFGLLLFLPAGN
>N6ZL25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLSLLLVALVLGIVEGLTEFLPVSSTGHLIIIGDLLGYNDDTSKVFKIVIQLAAILAVC
WDYRERLIKVASGLTTEPSAQRFVWLLFIGFLPAAILGLMFHSTIKGLLFNPITVATALV
VGGLIILYVEKRAYHPRINDVDDMRWTDALKVGFAQALAMIPGTSRSGATIMGGVIFGLS
RKTAAEFSFFLAIPTMFAATAYDLYKNWALLRVEDLPVFAVGFVASFVAAMWAVKSFIKF
ISNHTFIAFAWYRIVFGIFVLATWYFGWVEWSEP
>U6BP97|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-163|antibiotic inactivation|1
AYYFAAFCLPVVAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIVVIYTTGSQATMDERNRQIAEIGASLLYLSRCV
>C2QC63|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0009_22280|antibiotic inactivation|1
MKGMMILKNKKMLKIGICVGILGLSLASLEAFKGGSLQVEAKEKPRQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTHQTIAYRPNERFAFASTYKALAAGVLLQQNSIEKLNEVITY
TKGDLVEYSPVTERHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMED
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVHKRNILTEWMKGNATG
DKLIRAGVPNGWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
EEAAKVVIDAIK
>Q47757|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_pc|antibiotic inactivation|1
FILKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKR
FAYASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASM
TYSDNTANNKIIKEIGGIKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFG
KTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDV
AFVYPKGQSEPIVLVIFTNKDNKSDKPNDK
>ABX00620|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmU|antibiotic target alteration|1
MPSRYGSRQELGQNFLVDPDIIKLIRRAAERTEGPIVDLGAGDGALTLPLSRLGRPVTAV
ELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWV
SAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERR
PEPLVRERREYQDFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLT
AEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>Q0SYP9|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
MADRSGRKPVAIPGSALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTFSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A089G7P8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|glnQ|antibiotic efflux|1
MTALLELRNIRRSYPSGEEQVEVLKDISLQIHAGEMVVIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSMLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLQRLGLSDRVDYHPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAGRVIEIHDGKIVHNPPAQEKGREQGVAAAA
VNTASGWRQFASSFREALAMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLAAIQKQPWVNSATPTVSKSLRLRY
GNMDIAVNANGVSGDYFNVYGMSFSEGNTFNVVQQRDRAQVVVLDANTRRQLFPNQANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNRNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGQKDFFTWNMDSILKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEISFSLIALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>P44469|FEATURES|UNIPROT_deepARG|beta_lactam|mrdA|antibiotic target replacement|1
MNLKKFFNTPTHEPFRDKKAERNLFARRTLVAFLGILLLTGVLFTNIYQLQIVNFDTYQT
RSNGNRIKLLPLPPTRGLIYDRYGKLLAENLTFFGLYIVPEKTENLDRTLDELRYIVGLT
DNDIENFKKERRRGTRYTPILLKPNLTEEQISRFAVNGYQYPSLEVRPYFKRHYLYGETM
AHILGYVGKMNDKDVERLKREDKFANYAGTNDIGKLGIERYYEDILQGTTGFEEVEINNR
GKVIRTLRSRPAVAGKSIHLTIDLALQRYITELLSGLKGAVVVLDPKDSSVLAMVSTPSY
DNNLFVDGISSEDYKRLLNDLARPLYSRATQGAYPPASTVKPFIAVAAQTENVITPNTTI
FDPGYWVLPNSTKRFRDWKKTGHGDTDLNKAITESSDTYFYQVAYNMGIDRLSNWMKDFG
FGMPTGIEIQEETAANIPTREWKQKRYKRPWVQGDTISVGIGQGYWTATPLQVAKATTIL
VNNGKVNTPHLMKAIEGAVLEPYEDPLLYPDINTPKVAAWEAAKRGMYNVVNAANGTGRK
AFADANYRVAGKSGTAQVFSLKENEKYNTAGLKKELHDHAWFTAYAPYDNPKLVVTVILE
NAGGGSSNAAPLARKVMDYYLNQRLPQVEKYNVPIQQKKDLSQESEQINGR
>A0A0A0Q8P2|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-8|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRHYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0U3LPM2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114x|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGDPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>YP_002383661|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKYQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTNYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDLLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDLEHSHKVEHH
>A0A118HZB6|FEATURES|UNIPROT_deepARG|beta_lactam|WJ33_13645|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPRANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVGELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDETFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQYAQWLLGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTINDIGVLWPPARGPIVLTVYYTQARPDAKRKDDVIAAATRIAIAALG
>D1YJY8|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9209_0012|antibiotic inactivation|1
MFIFLNTFKYVSAHETITLINASIILKKEEYEYSTFPCRPYSLFAAFCLPVFAHPETLVK
VKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLG
RRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFL
HNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWME
ADKVAGPLLRSAFRLAG
>W8FS12|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MRKAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>E7T2Q6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTECLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0D6XTE6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELIKALILGIVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGSESAFTFKVVIQLGS
VFAAAWIFRHKYYEMLHIGKYAPKHQEGRRSKPRRLKLTHILVGMIPAGVLGLLFDDLIE
KYLFSMPTVLIGLFLGAIYMIIADRYSRNVRNPINVDEISYFQAFVIGLSQAVAMWPGFS
RSGSTISTGVLMKLDHKSASDFTFIMAVPVMLAASTLSIVKHYNYIDLSHIPFYIIGFLA
AFIVGFISIKLFLKLIQNVKLLPFAIYRIVLVVVIAVVYYVIL
>N9QSQ4|FEATURES|UNIPROT_deepARG|beta_lactam|F889_02977|antibiotic inactivation|1
MDEITLQNKSVKSLIVANLFHFSCLVIMSKKLKCLALLTPLILILPLTACQSPSQKKQQV
VSLQNEQQRVANLFQQAQTTGVLVIYDGKQIQTYGNATRRADQRFIPASTFKILNALIGI
QHHKTTPNEVFKWDGQKRAFSSWEKDLSLAEAMQASAVPVYQELARRIGLELMTREVKRV
GYGNKHIGTQVDNFWLVGPLKITPVEEVRFVYALAKQKLPFDQSTQQQVKDMLLVDEHQG
TKIYAKSGWGMDVTPQVGWWTGWIEQPNGKIIAFSLNMQMSQPAHADARKVIVYQALQEL
GLLAN
>N9WGM9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASKWAIFNIAIQPGAILAIVVL
YRKLFWDMFTGFFRRDPVAIAFVRNLLVAFIPAVVLGLAFGDYIETLLENAVVVAWALVI
GGFAILLVEKLAKPKESGGVAKLTLRQSIMVGLVQCLAMIPGVSRSGATIMGAMAMGVDR
KTAAEFSFFLALPTLTGATVLQLAKHRDAITSNDMGLIALGAAVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIVGGAALIWLTMR
>R2T3G4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLSSLWKAIILGIIEGVTEWLPISSTGHLILVDEFIKMNLSKDFMTMFNVVIQLGAIMA
VVVLYFHKLNPFSPKKDETEKKDTWILWSKVVVACAPAAIIGIPLDDWLDAKFHNFFTVA
LMLIIYGIAFVVIEKRNRNRKPKCTDLNNFTYKAAAIVGFFQVLSLIPGTSRSGATILGA
IIIGASRFVATEFSFFLGIPVMFGASFLKIGKFLLKGNTFGFTETIILLTGSIVAFVVSI
IVIKFLLNYLKRNDFTAFGWYRIVLGVLLISYWLFS
>A0A0A4GEX0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGIVEGLTEFLPISSTGHQIIAADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPGARRFTANLLIAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGFIMLWAERRQHEVHAETVDEITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRALFVPADFPVFAIGFVTAFIFAMIAVRGLLRF
IASHSYAVFAWYRIVFGLLILATWQFGWVDWATARP
>A0A150EFG7|FEATURES|UNIPROT_deepARG|beta_lactam|AT270_13635|antibiotic inactivation|1
MILKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKNGQIKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKED
LVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAVATNLKDLTVGNALPHQKRNILTDWMKGNATGDKLI
RAGVPTDWVVADKSGAGSYGTRNDVAIVWPPNRSPIIIAILSSKDEKEAAYDNQLIAEAA
EVVVNAFK
>A0A118Q612|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAQAKTFDVVIQFGAILAVC
WEYRRRIVSVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGETPRVQSVDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLVASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWS
>A0A076PYK1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-161|antibiotic inactivation|1
NQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAF
ARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWL
KGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLILVT
>CAG34258|FEATURES|ARDB_deepARG|multidrug|smeF|antibiotic efflux|0
MEVIPMKSASLFLSIAAVLALAGCSTLVPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWR
DFFTDARLQQVIDQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMQRQGTDA
GVNEQFTAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYG
ADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQ
DRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANAN
IGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIAN
ADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGL
DSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVMGGGWHERS
>YP_002405849|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>A0A0H4SL58|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
LCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGK
ADIAANKPVTPQTLFELGSISKTFTGVLGGDALARGEISLDDPVTKYWPELTGKQWQGIR
MLDLASYTAGGLPLQVPDEVTDDASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKP
SGMRYEQAMTERVFKPLALHHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAQAYGVKT
NVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEAKTVVD
GSDSKVALAALPAVEINPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYP
NPARVEAA
>A0A0B2UA51|FEATURES|UNIPROT_deepARG|beta_lactam|DH17_02625|antibiotic inactivation|1
MRFKKISCLLLPPLFIFNTSIYAGNTPKEQEIKKLIDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKSVNSNTIFELGSVSKLFTATAGGYAKTKGKISFEDTPGKHWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIG
LFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGP
LGAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKIYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0Q9FEF6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRMTTIKLGLTTAILFSLTATVFAADGEQARIAATVDKAIRPIMGEYKVPGMAIAVTVD
GQHYFVNYGVASKETKAPVTENTLFELGSISKTFAGTLASYAQVLGKLSFDDHPGKYMPD
LSGSAIDKATLLNLATYTAGGLPLQFPDEVKSNADMLTYFSNWKPGAEPGKERRYSNPSI
GLFGHAAGLAMGSNFATALETELFPKLGLKHSYVTVPRSAMGSYAWGYGKADKPIRVNPG
MFDAEAYGVKSSAADMIRFVEANIQPEQFDGPVRKALEGTHIGYFDTGKMIQSLGWEQYP
YPVSLERLLDGNSGTMAMEANPATALNPPKRPDGATLYNKTGSTSGFGGYVAFVPEKKIG
VVMLANRNFPNPERIKAVHAILKTLATAAE
>A0A150I2K9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPKHLSMNLKKLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVA
VTLNGQHYFVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAK
YFPELNNTAVNRATILNLGTYTAGGFPLQFPDEVVTQQDMVKYFQKWQPKTKISVARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLFPQLGLKQSFIHAPESQMGNYAWGYKNDQAMRV
SAGMFDAEAYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWE
QYTYPVSLATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEARITASYQTIQQLLKQQ
>A0A0A2N3N0|FEATURES|UNIPROT_deepARG|chloramphenicol|JT27_16930|antibiotic inactivation|1
MDSMKIQEKMMASYQKFDLESWGRREHFEVFKTYAQNAFSITVEIEITGFLSWVKVRRCK
FYPAMIHEVAAVLNRYPEFRMAMKDDELIVYDRLNPSYTIPHVQQESFSSIWSAYHEKKE
DFLAEYERDLEKYGEDTRYFPRSDTPENVFYISALPWVSFTSFSMQFASLHNLFTPIVTL
GKYFERDGKVYIPVAIQLHHAVCDGFHTGRFMTELQKGCHDY
>A0A0B6FRY7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKTSIISSLIFTTLAASPLYASEQKILTQQQIATIVNNTLTPLIEKQDIPGMAVAVFYDG
KPLFFNYGFADIKNRRPVTENTLFELGSVSKTFTGVVGGYAEQTGILNLSDSATKYSPEL
TGLQWKDISMLNLATYTAGGLPLQVPDSVTSMKLLWQYYQQWQPQWAPGVMRNYSNASIG
LFGTLAVKKSNLSFEDYMTQNVFQPLKLTHTFITIPDYMQSDYAWGYKDGQPVRVTPGVL
AAEAYGVKSTAQDMVKFMQANIEPEKLLADNDKLKKAIIAAQSRYYRSGNMFQGLGWEMY
DWPINSQEVIASSSNEIALQPHKINALMPPYSAVPASWVHKTGSTNGFGAYIAFIPEKKI
GIVMLANKNYPNPVRVEAANHILQSLY
>ZP_04185253|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFFIM
>A0A0E1LLJ9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLNEVGKINIKGINHLLFSVSNLERSIEFYEKVFHAQLLVKGQKTAYFDLNGLWLALNLE
ADIPRNEIHKSYTHMAFTIDPKDFDAIHQRLKNLNVNILNGRPRDKQDQKSIYFTDPDGH
KFEFHTGTLQDRLSYYKKDKPHMKFYI
>N9AHM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAVIQGLAELLPVSSSAHVILAEKLMGFDPSAPNMTFLLVMLHTGTMFAVIV
YFWHSWKKTYFSDWASFKQRAWDVLLATAMTGVLGLLLQSLIKHVFFGGASSFEIEHLFS
NAKLMAAALAAAGVLIILSSRLDRGQQGDVRLPSAIIIGAVQALCLPFRGFSRSGATIST
GLFLGISRQKAEEFSFALAVVLTPAVIAKELLRLLHAQQATTGTAHLALSSLFLPSLFGM
VFSFLTGLLALKWLSAWLEHGRWYLFGIYCLAFSGVVLALA
>ZP_04168943|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPVTEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAAEVIVKALK
>Q19RM1|FEATURES|UNIPROT_deepARG|beta_lactam|blaPER-1|antibiotic inactivation|1
AVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEK
FPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQ
LLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWT
SMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIK
AGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIMRRCSDC
>D6LI05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNALILVIILAVVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFTNSFLIIIQLGAIFSV
VVYFWKDLTPFVETKEKFVLRFRLWLKIIVGVLPAMVIGLFLDDIIDKYFMDNVTTIAIT
LIVYGVIFIAIEVIYKLKNIKSKVRNFNNLKYSTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLVFTEREWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVLILLR
>C4V2L1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLKAVILGIVEGLTEWLPVSSTGHMILVDEFIRLNVSTAFMDMFLVVIQLGAILAVVVLN
AKKLNPFLGSKSRSERRDTLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPVVASMLIL
YGILFIVVERWNKRRTPRVESLAALDYRTAFIIGVFQVLSLVPGTSRSGATILGGIIFGA
SRYVATEFTFFLAIPVMFGASFLKLVKFGWHYTGAELLILAVGMVTAFAVSILSIQFLLR
YIKRNDFTAFGWYRIALGILVLAYLFMIGDPTKE
>M5REJ6|FEATURES|UNIPROT_deepARG|chloramphenicol|C883_1388|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTVTRCTYSLVIDLDITKLYAILKEKRLKVYPVQIYLLARAV
QKIPEFRVDQVNDELGYWEILHPSYTILNKETKTFSSIWTPYDENFAQFYKSCVADMDTY
SKSNNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDITYLLPIFTLGQFKMKEEKIILP
VAIQVHHAVCDGYHVGQYVEYMRWLIEHCEEWLDDSLDMS
>G8NTF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPLLKVLILAIVQGLAELLPVSSSAHVVVAEKLLGLDPSSPEMTLVLVMLHTGTMFAVIF
YFWAQWKRAYFATADAFKRFAIRAIWATGLTAVIGYPIIKIIEKTAFKGAPKAEIELLFS
RLDLVAYALFAAGLIILWAGMKERAAETASTTAYDRSVTRSGDNVTFSQAGWMGAVQGLC
MPFRGFSRSGATISAGLLTGANRERAERFSFALAVILTPPVIAVEAHRLLKASHEAAAAG
MPINLHASLIASLLGMVFSFFAGLAALRWLSSWLENGRWYLFGIYCLVASCVVFYLHHIG
Y
>A0A0K4A5T0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTVPV
VNMASGWRQFASGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQLWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADAV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0P0AKZ7|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-42|antibiotic inactivation|1
VTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSK
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AEKKSL
>A0A0R0C007|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLFSALLLGIIEGLTEFLPVSSTGHLLIAQHWLGSRSDFFNIVIQAGAIVAVVLVLRQ
RLWSLATGLGQADNRDYVLKLGTAFLVTALVGLPVRLLGWELPETVTPVAIALIIGGLWM
LLAEKRASLLPDRTTVTWTVAVGVGLAQVVAGVFPGTSRSAAAIFLAMFLGLSRRAAAAE
FVFLVGIPTMFAASGYALLEMASEGQLGNEAWAEVALAFVASALTGFVVVKWLLGYIKNH
SFNGFAWYRIALGIGLLLLLPAGS
>A0A127SBX9|FEATURES|UNIPROT_deepARG|beta_lactam|OCH-8|antibiotic inactivation|1
MRKTTVSALSITAVASLLTSVSVQAANAPSEKEIRHLVDETIKPVMAEHKIPGMAVAVTA
GGKTYFFGYGVASKESGQKVTEDTIFEIGSVSKTFTATLGGLGLAEGAFKPGDTATKYAP
KLAGSSFDNVSMLDLGTYTAGGLPLQFPDSVTDHKTMIDYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAAQSMGEPFDKVMETRLIPAFGLKHTFIQVPESQMKNYAYGYSKANKPIRVSP
GAFDAQAYGIKTTAPDLIRFVQLNMDSTSLGQPMQKAVAATHTGYYKVGDMTQSLGWERY
AYPLSLKTLLGGNTSDMAMKSHKIEKLAPPLQPSDDMLLNKTGSTGGFGAYVAFVPGKKI
GIVMLANRNYPNDARIKAGYRILKALDGNQ
>A0A0C5S3E7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKILEVVFGLASQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGIIMLWAERREHSVQVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWSTAHG
>A0A0E9B870|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKIYFTALLVALSASSSATDLSSQEIASRVKDVITPLMAEQGIPGMSVAVLYKGRPQYLN
FGVADTATDRRVTENTLFELGSVSKTFTGVLAGVMIRNSELRLNDPVQKYWPALKGPQWQ
AIRMVHLATYSAGGMPLQLPASVVDQDSLLRYAQQWQPGVAPGIQRQYSNVSLGLLGYLM
VKGEFEEAMQKNVFTPLRLTRTFYTVPASMMFDYAWGYKDGQPVRVSPGMLSAETYGVKS
TARDMMTFMQANANPNGLSSGNTVLRNGILTAQSHYLTAGQLSQGLGWEIYPWPVKEQTL
IDASDTKTALEAQPATLVNQVKPADRASWIHKTGSTNGFGAYIAFVPQLNSGIVMLANKN
YPNPERIKAAVAILDALQ
>A0A0T6UKC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYWGAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAIAFNIIIQLAAILAVV
WEYRRKILDVVVGLPTQPSAQRFTANLILAFLPAAVLGVIFADQIHEYLFNPITVAIALV
VGGVIMLWAERRSHNVHAETVDDMTWKDALKVGFAQCLAMIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAMPTMVGAAVYSGWKYRELFVMSDLPVFAVGFVTSFIFAMIAVRALLKF
IANHSYAVFAWYRIGFGLLILATWQLSWIDWSTAQG
>G6B7I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYWRYFDLETFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSNTFISTFL
VVIQFGSILAVLVIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDID
RLFFNSTVVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSR
SGSTIIGAVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVA
FVVSIVVIKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>A0A0B0I2U6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB2|antibiotic inactivation|1
MKLQGINHICFSVSNLDASTAFYENVFGAKRLVKGRKLAYFDLEGLWIALNEEDAKREAM
PRTYTHIAFSVAEEEFDLWPRRLRELDVTILPGRERDEKDKRSVYFLDPDGHRFELHTGT
LQDRLDYYRAEKGHMTFYDE
>A0A0V9R869|FEATURES|UNIPROT_deepARG|beta_lactam|APU18_25380|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSADEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>G4KYT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIELIKAAILGIVEGITEWLPISSTGHMILVDEFLKLNLPESFRNLFLVVIQLGAILAV
VVLYWKKLFPVSFGKRPALRKDILAVWGKILISCIPAAIIGLLFDDQIEALFFNYQTVSV
TLIVYGILFIIIENRNRTHSSTINAISQISYRTALLIGIFQLLALIPGTSRSGATILGAI
LIGTSRTVAAEFTFYLAIPVMFGASFLKILKFGLHFTGLELGILLVGMGVAFLVSILAIK
FLMQYIKKHDFKVFGWYRIALGILVIAFFLVQSHGVI
>A0A0F0E7J4|FEATURES|UNIPROT_deepARG|chloramphenicol|UB47_19735|antibiotic inactivation|1
MVNNTLGYTKVDVANWARKEHFEILSTVGSCTFSQTAQLDVTELLAYTKAEGLKFYPVMI
HVIAKLVNRFPEFRMAMKDGELVLWDVIHPSYTIFHESTETFSSLWTCYEDDLGAFLQGY
SSDREKYGRDLSYFPREEYAENVFYVSANPWVSFTSFNFNVADASNFFAPMFTIGKYYSQ
GERVFMPLAVQVHHAVCDGFHVGRIINEVQKSCNALSGI
>R9B7I6|FEATURES|UNIPROT_deepARG|beta_lactam|F896_00546|antibiotic inactivation|1
MNQPKAFSMTLKKLFLFTGLLSCGSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQTVSSNTLFELGSVSKTFNATLAGYAQAQGQLSLSDHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDEVVQQQEMVKYFQTWQAKTKVGAARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLLPQLGMTQSFIRVPEQHMPQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRQAIENTHVGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATYFNKTGSSNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYRVIQQLVQSNSAQ
>U2B600|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIWTAMKALILGIVEGLTEFLPISSTGHLIVVGDLLDFNGETATAFKIIIQLGAILAVM
WEFRQRIFDVVCGLPSEPQAQRFTFNLLLAFIPAVILGLAFADLIEHWLFNPITVATALI
VGGIVMIWAEKREHEIKAETVDDMTWSLALKVGFAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVAATVYSLFKYRDILQLSDLPTFAIGFVTTFIVAMFTVRALLKF
IANHSYALFAWYRIGFGLLILATWQLQLIDWSTAQG
>K1GPI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNALILVIILAVVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFTNSFLIIIQLGAILSV
VVYFWKDLTPFVGTKEKFVLRFRLWVKIIVGVIPAMVIGLFLDDIIDKYFMDNVTTIAIT
LIAYGIIFIAIEVIYKIKNVKARVRSFSDLKYSTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLVFTEREWAYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVLVLLR
>R7GLD6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLYLKTILFGIVEGITEWLPISSTGHMILLNEFVKLDVSKDFYSMFQVVIQLGAILAVV
VIYWNQIWPFKKNTNPMVKGFFKYVDRDIFDLWLKIIFACIPAAVVGLLFDDVFEALFYN
PPCVALALIIFGIGFIVIENRNASLRPKINSLKAINGKTAFLIGMFQLIAAIFPGTSRSG
ATILGGLMLGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGLAFTASQLAVLGLGMLVAFV
SSILIIKFLMSYIKKHDFKVFGWYRIVLGLLVLAYFFIIK
>A0A0R0AD96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLISQHWLGARSDFFNIVIQAGAILAVTLAFRE
RLWTLANGLDQRENRDYVMKLGVAFLVTALVGLPVRLAGWQLPETVTPIAWAVLIGGVWM
LVAERLASRLPDSETVTWKVAIAVGLAQVIAGVFPGTSRSAAAIFLAMLLGLTRRAAAAE
FVFLVGIPTMFAASGYAFMELARDGALGSENWGEVGVAFAAAVVTGFIVVKWLLDYIKRR
PFTGFALYRIALGIGLLLFLPAGN
>A0A0J6RHG3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSGASLTLSGVWRRFPSGDEEVAVLKEVSLDIRAGEMVAIIGASGSGKSTLMNILGCLDQ
PSAGRYQVGGRDVGALDKDQLATLRREHFGFIFQRYHLLPHLNAIDNVAMPAVYAGMSQE
ARRERARQLLERLGLAGKEDYRPGQLSGGQQQRVSIARALMNGGDIILADEPTGALDSHS
GEEVMNILKELHAAGHTIIIVTHDPSIAAQTERIIEIRDGEILRDSAADAPPPAADAREP
RRPKPGPAWRERMSEAFKMAMLAMLANRLRTVLTMLGIIIGITSVVSIIAVGEGARNYVL
NDIRSIGTNTISVFRGKDWGDDKADGVRTFLPGDLAALAEEPYVDSVSPVTTNSMRIRYR
NVDVNASVSGVDSAFFRVRGMKLVSGLGFSRDDVRMQRQVVVIDNNARRKLFADAEAIGQ
VVLVGSVPATVIGVVEIKDNSGGKSLQMWMPYSTAGSRLFGQAYFDYMVVRIKEGQPTAL
AEKALSHLLTLRHGSKDFFTYNMDEVLKTVENTSRTLALLLTLIAVISLVVGGIGVMNIM
LVSVTERTREIGIRMAVGARQSDVLQQFLTEAVLVCLVGGAIGIGLSYGISFVFALLVSK
WKMALSLKAIVLAVACSTAIGVVFGYLPARSAARLNPIDALARE
>A0A126ZD44|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAIMGIVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVI
LVYWQKIKSTVVALPRQPKARRLALNIVIGFLPAVVLGLLFGKVIKEHLFIPVVVATTFI
IGGFIILWAEKRPPGSVRVEHVDDMTPWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYKERALLSVADIPMFAVGLVFSFLSAWLCVRWLLK
YISTHNFVPFAWYRIAFGIVVLVTAWTGMVVWAE
>A0A099FL63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHNTLVAAALGLLEGLTEFIPVSSTGHVLLAGHFLGFDSPGRAFEVLIQLGAIMAILGV
YSGRLWRIFTSAPHDPRARRFILAVLLAFLPAVVIGVLAHRIIKEVLFETPALIAIMLIV
GGVVLLFVDRMATRPRHFSAEDFPLPMALKIGFIQCLAMIPGVSRSGATIVGALLLGADK
RSAAEFSFFLSMPTMLGAFVYDLYKNRDILDAAATGNIVLGFVCAFLAAVVVVRGLLNYV
STYGYGFFAWWRIVVGAVVLLALQAGW
>G8EXA6|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGA
TWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEA
L
>A0A0A3ZPE6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEEKDIRKVSVVIPVYNEEESLPELVRRTDAACAVLNLDYEILLVDDGSSDRSGEMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPNLVQAAQQG
YDVVGTVRQNRQDSWFRRRASRTINQLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVAHAEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSIVG
SLIALAGFAFSLVLIVLRLFLGADWAGDGVFMLFAVLFIFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVINSQKDVSSVQEIEQ
>B2ZTR1|FEATURES|UNIPROT_deepARG|beta_lactam|PER-1|antibiotic inactivation|1
VSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLH
LAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSD
SVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILK
KFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDL
GIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQ
>A0A0A1P9X9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAEHDIPGMAVAVTVDGRSSVFTYGAASRETDRSVDGATLFEIGSVSKTFTATLAGYAQV
LGKLSLDDHPSRYLRDLRGSAIDRATLLHLGTYTAGGLPLQFPGEVADTAQMTRYFRQWR
PDAAPGTQRRYSNPSLGLFGHLAARAFGRDFSQAMESEVFPRLGLRNSHVRVPQEARANY
AWGYARENRPIRVNPGLFAAEAYGVKTTAGDLIRFVEANIDPSRLEEPMRRAVQATHIGY
FRTGDMVQGLGWEQYAYPITLDRLLAGNGRALNADPAAALMPPQAPTGPTLFNKTGSTNG
FGAYVAFVPARRIGLAMLMNRNVPIPARIKAAHAILERLGEASRQ
>J7XXF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVA
GAFLMIFAEAKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMFGATGLDLLKSWKYLSADDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>A0A127SGF4|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLGALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>A0A142KT10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAMILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVV
VLYFHKLNPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIA
LIVYGVLFIVIENHNQNLRPRFDSLNTLPYKVAILIGCFQILSLIPGTSRSGATILGAIL
IGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLILAVGVIVSFVVAYAS
IRFLLNYIKTKDFKAFGWYRIILGVIVIAYFALLAH
>CAJ43792|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNKKNIKDSQNFITSKRNVDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKVVFESIA
DESYLIVEYEFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISYKDKQKYNYFVMKWVNKEYKKIFTKNQFNKSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A8EW13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTIFDSILLGIIEGFTEFLPISSTGHLIVLSEILGLEQNNVNKAFEIIIQFAAIMALVF
VYPSKFTFSHIELWKKIVVAFLPIGIVGFLFSSQIKNLFSIEIIAWMFIIGGIVFLIIEK
FYDENKTHTLNVEDVSYKQAIFIGVMQIFALIPGTSRAGASIIGAMMAGLNRKTSAEFSF
LLAVPVMCATTGYDLVKHHEELLVGANLLNLAIGFIVSFIVALIVIKLFLKFLERFTFVA
FGIYRIIFGILILLIF
>L0RGF0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTSLFTAAILGVVEGLTEFLPVSSTGHLIITGHLLGFTGEKAASFEVAIQLGAILAVVVL
YWSRFRGLIVPAPGQRFSGVRGLYMLFLTSLPASVLGLLTHGYIKEHLFTPYTVAWALGI
GAIMILIVEKKEPRPNCFTLDEVTPKLALGIGLFQCLALWPGFSRSAATIMGGMLLGAKR
SVAAEYSFIAAVPIMFAATGYDMLKSYKLFTTADIPFLSVGFLVSFVSAWIAVKGFIYLL
GKLTLRPFAYYRLALAPLILFFWS
>A0A0T9L0X9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGEKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKKVANDGQTGGHLTLGHILLAMIPAVVLGLVFHDAIKSLFQP
QSVMYALVVGGLLLLAAEWLKPKNPKAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLTGVSRYAASEFSFILAVPMMLGASGLDLYKSLHFLTLGDLPMFAVGFATAFVVAL
IAIKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A066RS80|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKNLVCHSKKLIISVLYLASVAAPLASAAAPVHSQTTKNDATLKLAVDQQAKQLMETYNI
PGMAFGITINGKAHYYNYGLADIQRHQPVTENTLFELGSVSKTLAATLASYAQQQGKLSF
DDQVSKYLPELKGSTIGNTQLIRLATYTAGGLPLQFPENVTDHATMLDYYRHWQPVFPAG
TRRQYSNPSIGLFGYLAARSMGSEYPSLMENRILPELGMSNTFVNVPETKMRNYAFGYNA
AGDAVRVNPGVLDTEAYGIKSTSADMVRYIEANVGTASVQPVMKQALANTKTGYYQSGAL
TQGLGWEMYAYPVTLDTLLDGNANQMILNPMPIKANASPKPLSEHIWVNKTGSTGGFGAY
VAYIPAQKTGLVILANKSYPNADRIKAAYAILKAAEK
>N8QLK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLGVGIIVAFVSALVVIRALI
RYVSKHDFTAFAYYRIIFGLFILATWWTGWVHW
>A0A0U4HJS2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRAEPISKVSVVIPVYNEQESLPALLERTTAACKQLLQPYEIILIDDGSSDNSAAMLTA
AAEQPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIEVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFVLAVLLIVLRLVLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAKPTQNNQEEE
>J7XPQ3|FEATURES|UNIPROT_deepARG|beta_lactam|IE3_02950|antibiotic inactivation|1
MEQTCYLESLLCVRIKTGVQIGYSVLNLPLVFSIKSLKGMMILKNKRILKIGICVGILGL
SLISLETITGGTLQVEAKEKTGQVKHKNHATYQEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAYASTYKALAAGVLLQQNSIDKLNEVITYTKEDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPAHKRNIFTEWMKGNATGDKLIRAGVPNDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVVINALR
>A0A0Q9VC66|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGLNHFLFSVSDLDKSTEFYEAVFGAKLLVKGNSTAYLDLNGMWIALNLEKDISRNE
IKDSYTHVAFSIDEKDFDGIYEKLESLQVNILTGRERNERDKRSIYFTDLDGHKFEFHTG
TLQERLDYYKQEKSHMTFYL
>A0A0E2TWM0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
DVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>AAO38186|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNIPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACA
PVLGALSDRFGRRPILLVSLAGATVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>A0A0J1CNP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILFCKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTNAQAKTFDVVIQFGAILAIV
WEYRRKIGSVVAGLPTQPKARRFALNVIIATIPAVVLGLLFEKHIKAVLFAPVPVSVALI
VGGIVILWAEARHREKNVAPRVTSVDDLSYADAFKVGLAQCFALIPGTSRSGSTIIGGML
FGLERKVATEFSFFLAIPIIFGATLYELAKQWRTLSVDSVGLFIVGLVAAFISAFVCIRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>F8GE57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLFKALILGVVEGLTEFLPVSSTGHLILVGDLLDFNDERAMVFTIAIQLGAILAVC
WEYRSKIIDVIRGIGSNPAANRFVINLLIAFLPAAIMGLLFIKTIKYYLFHPVPVALALI
IGGFLILWAERRKHVIEVEQVDDMDWKHALKVGLAQCLALIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAIPIMFAATFYDVYKHREFLEWDDLGLFAVGFVAAFLSALLAVRGLLRF
ISNHDFTVFAWYRIVFGIIILLTAYTGVIGWSEM
>YP_409239|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDITY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSIVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>J8EDB2|FEATURES|UNIPROT_deepARG|beta_lactam|II3_04930|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPAVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKTLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALATSLQTYALGDILSTEKQNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKHDDKLIADATKI
VLDALKVTNK
>V5YUG6|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTSGQLKLGHILLAMIPAVVLGLVFHDVIKSLFAP
KNVMYALVVGGLLLLAAEWLKPKKPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTWSDLPMFAVGFVTAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFL
>Q6HPB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>A0A0E9MT86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPLLLTAILLGIVEGLTEFLPVSSTGHLILASELLGYKAETWATFNVVIQLGAILAVIVL
YWRTFWAVATGLFQREPTSWRFLSNLLLAFLPAAVIGFLLHKQVEALLGNAIVVAVALIL
GGIAILVIEAAVKRATIEPGVAAMPASRALGIGVIQCLAMIPGVSRSGATIMGALALGVE
RRTAAEFSFFLAVPTMLGATTLEALKNREALTSGAVDWGLVGVGFVVAFLVAIVVIRWFV
GLISKRGFAPFAWYRIIAGSAALVWLLAR
>B3GN44|FEATURES|UNIPROT_deepARG|beta_lactam|oxa-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPYAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKNFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>A0A0A5LEQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFDGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPAQGHATLSLVHIILGMLPAVIIGLAIHSWIKANLFGPQTV
MYALVAGGILLIIAEKFRPAVRSETLDDISYKQALGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDLLSMADFPMFAVGFITAFVVAMIAIK
TFLALIRRLDFIPFAIYRFVVAFAVYLVFVA
>W8V367|FEATURES|UNIPROT_deepARG|beta_lactam|KPNJ2_05580|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLGTVANSRW
>A0A085ZKE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAVSLLIGGLILLKVDEW
FNNPNTAETSQEITYLQALKIGLFQCIAMIPGVSRSGASIVGGMSQKLTRTTAAEFSFFL
AVPTMLGATVKKCYDYYKDGFELSHDQTTLLIIGNVVAFIVALLAIKTFIGFLTKNGFKI
FGYYRIIAGIVLLLIHFFIHPLTII
>A0A024KYU3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLLAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPAAVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPHTSAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>D2K8A5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCARB-2|antibiotic inactivation|1
MLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSTRIGVSV
LDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVI
EKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDL
NEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGW
NIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYT
SQSR
>K0MBW5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDSTLHLLKAFFLGIVEGLTEFIPVSSTGHLIVIGDWINFASSSGKVFEVVIQFGSILA
VMWIFRARLWQLIRGTLTGVRQEVNFTRNLLLAFLPAAVIGAIFIKSIKQVFYHPGVVAV
TLVVGGFIMLWVERRAPHTPGDAPGAADDTASDERATAHTLEQISAKQALGVGVAQCVAM
IPGVSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAALYDLYRNIGLLSQHDMSAIA
VGFVAAFLSALVVVRAVLRFVANHTYRVFAWYRIALGLVVAAWIYAK
>A0A0H2QEA2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFKDEFEEIKKVSVVIPVYNEEQSLPILLERTIAACKQLSQTYELILVDDGSSDRSAKL
LTEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVKTA
EQGYDVVGTRRANRQDSWFRKTASKMINSMITRATGRSMGDYGCMLRAYRRHIIQAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSVIAISGFLLAVLLIVLRLIFGAMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGTDVKADKNQEEN
>CAL44990|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|linA|antibiotic inactivation|1
MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVDWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFS
ETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT
>W7CN54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWIVAIVLGIVEGLTEFLPVSSTGHMILAAELMGVQNTWKQINTFEVVIQLGSIMAVV
VVFWRRLWAVVGVKTGEYKGRKNQLNLIHVIVGCIPAIIAGLIFDDMIDKHLFSYQTVII
ALIAGGILMLIAEKVAHKNRNLSETLDQLSYKQALYIGFFQVLALWPGFSRSGSTMSGGL
IVGVGRKTAAEFSFIIAVPMMIGATGLKVYKALDTMTMSDVPIFIVGSIVAFVVAMLAIV
FFLKLIERVTLRGFAYYRFIIAFIFILYMIFR
>A0A0E3YQ31|FEATURES|UNIPROT_deepARG|aminoglycoside|XB05_09780|antibiotic inactivation|1
MSTQAGWRVRAAVGADAQALLALRLALWPDADAGLAELRAALAQADASHLLAVDDADAAL
GFAEVSVRHDYVNGTESTPVGFLEGWYVSPAWRGRGLGRALVAAAVEWTREQGCAELASD
ARLDDSGAQAAHAACGFEPTERVVYYRLQLA
>X6QGC1|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1562_2717|antibiotic inactivation|1
MKNLFRHGRLLVAVSLALTSLSSAALTQSDVDSIIKPLMKQQQIPGMSVAISVDGQHFIY
HYGIQSKQTKAPVTDNTLYEIGSLSKTFTATLASYAQGQGKLDFSQPVSHYLPELKNTVF
DKVTVMNLATHTSGLSLFVPNTVTNSAELIQYYQQWSPEKPIGEYRSYSNLGVGLLGMVT
AKQLGTTFSQATDNMMLPALGMKHTYLQVPQEKQQNYAQGYNKQHQPVRVTPEILDNEAY
GLKSTAKDLIHFLDINMQVVDVKKSWQEAVEDTHTGVYMTDSFVQDLMWESYPWPVSLAQ
LQQGNRDDMALKPQKVEAIQPPLPPESAAFYNKTGSTNGFAAYAAFIPDEKIGIVLLSNQ
WYPIPERINAAYQLIEKVKH
>A0A0H3NS18|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSESKKIKKVSIVIPVYNEQESLPILIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRAHRQDSVFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARHTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>A0A0H0SN12|FEATURES|UNIPROT_deepARG|beta_lactam|AA984_14190|antibiotic inactivation|1
MKVHHSKLFGFTVKTIFLTLLTLAGCSSAETPVGKTETPASAMDQKFAALENKFDARLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYTKDDLVTYSPIT
EKHVATGMTLREVADAAVRYSDNTAGNLLFKELGGPKGFEAALRQIGDGVTTSERYETEL
NEAKPEDIRDTSTPKALATSLRAYTVGNVLPSDKQKILIEWLQGNTTGAKLIRAGVPKDW
KVGDKTGAASYGTRNDIGIIWPPNKKPIVIAVLSKRDKQDAAYDDALIAEATKIAVDALT
AAKP
>W3Z1G8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFINSFLIIIQLGAIFSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLNNVLIVAIT
LMAYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIILLY
>E3G2W0|FEATURES|UNIPROT_deepARG|beta_lactam|Entcl_2980|antibiotic inactivation|1
MTNTQGSAMWSTRPVAPLVMAAALLMASNTAMAEKTQNLDELVNSTITPLMKQQDIPGMA
VAVIVDGKTHIYHYGLADVKNQRPVTDDTLFELGSVSKTFTGIAGGYAVQSGILRLNDPV
ARYAPQLTSPQWRKITMLQLATYTAGGLPLQVPDDVDNTDALWLYYQHWRPQWTPGTQRQ
YSNASIGLFGALAVKNSGLSFDAFMKQHVFTPLQLNHTWINVPAEAEKDYAWGYRNGQPV
RVSPGMLDAEAYGVKTTVKDMAAFMQANIDPEALAAKEAGLAKAIAIAQTGYYKIGDMYQ
GLGWEMYPWPADAEKVITASGNDLALKARPAKRLSPSRPVTAATWLHKTGSTNGFGAYIV
FIPEKKVGIVMLANKNYPNPARVSAAWQILQKLP
>V9QY24|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPQHLLSGVRNFTALAVFIAAGNCLAATDLQAVVDANVKPLMQQQAIPGLVVGVVQDGKA
QYFNYGVAATDTRQPVSENTLFEVGSVSKTFTATLAGYAVATGALTLSDPASHYLPALGG
GPFEHISVLNLGTYTAGGLPLQFPAKADNSQGMISYFQHWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQAMEKTLLPALGLKHTFVKVPQSQMSLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSAADLLKYVDVNMHPANLDKTLQQAITVTHTGYYSVDGMTQGLGWEMYPYPI
QLDALIAGNSTPMAMEPHKVNWLTPPQAPRADTLVNKTGSTNGFGAYVAYVPSKGVGVVI
LANKNYPNAERVKVAHAILSGMDQ
>A0A0E3ZIR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLGKALILGVVEGLTEFLPISSTGHLILVGDLLNFNDERGKAFEVIIQFGAILAVC
WEFRAKLWKVVSTIKTSAVSRRFILNLLIASIPAMGLALVLGKHIKAVLFAPIPVASAFI
LGALVIFWAERRQKIVLSAKSHIQAVDDLSPMDALKVGLAQCAALIPGTSRSGATIIGGM
LFGLPRAVATEFSFFLAIPVIGGATAYELIKLWKNPVPLSGEFTLVIVVGFIAAFISAFI
CVRWLIHYVSGHNFIPFAWYRIVFGVLVLVSAYTGLVAWSH
>YP_002396538|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQAAYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETSRINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>J2TZP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVIEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHHYLFNPITVASALV
VGGIIMLWAEKRQHEVHAETVDEITWQDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLVILATWQFGWVDWTAVKP
>A0A0D8LPG6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSIFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFG
SVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASQEEDRS
>BAG80629|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>R6Q303|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEVLKVIILGIVQGITEWLPISSTGHLILVEQLIQLKQSEAFTNMFNVVIQFGSILAVV
VIYFHKLNPFSPTKTEKQKKMTIQLWIKVVIGTIPALIGGVLLNDLIESKLSNAYVVALM
LIVYGILFIVIEKRNETREPKVKRISQLSVKTVLLIGVFQMMAMIPGTSRSGATIVGALA
LGVSRSVAAEFTFFLAIPVMFGASALKLFKFGLAFTPMQVFLLLLGMIVSFAVSVIAIKF
LMKYIKNHDFKAFGYYRIVLGIVVFLFFGIQALFK
>A0A0M2CJX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLNLSKDFMEMFNVVIQLGAIMA
VVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDYLDAHFYNFLTVS
IMLIVYGIAFIIIEKRNKNVAPKCTNLKDFTYKAALIVGAFQVLALIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIILLTGSIVAFVVSI
IAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>YP_717427|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>B7H4R5|FEATURES|UNIPROT_deepARG|bacitracin|bacA1|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVEHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLIQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0N0HZC9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTTVAAFGADAGPYDVVTGPDGALWVTLVAAGAVAHISPDGEVRTHGLDVSGCGPTVITP
GPDGALWFARTHDHRIGRVTTDGVAESFALPTPECAPFGIAAGADGALWFTETTGNRIGR
LTTDGEITEFPLPVSGAFPSALVAGPDDALWCTLNQADALCRIALDGEITVHRLPTEGAA
PVGLVRGPGEDGRDELWFVEIGAGQLGRISTEGRVVEYPLPDRAARPHAVAVTPDGTCWV
TEWAAGRVTARAPSGRFTAYPLPHAEAEPHGLTVGPDGAVYVALEAGEVVRVSPSPSEN
>T0PID4|FEATURES|UNIPROT_deepARG|beta_lactam|K931_20132|antibiotic inactivation|1
MKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNSYWKSIGAKVVSTRQTR
ELMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVYDGDFSLQEDKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPELI
DHYETLIKAAPQA
>ZP_02901198|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRKRKLLIPLLFCSAMLTACDDKSTENAAAMTPEVGVVTLSPGSVNVMSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQGDALVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREINATKAIGNQWIVTAGLQAGDRVIVSGL
QRIHPGIKARAISSSQENASTESKQ
>V1DKE9|FEATURES|UNIPROT_deepARG|beta_lactam|SHD_1818|antibiotic inactivation|1
MRALALSAVLLVASIIGMPAEAKEWQETQSWNTHFTEHKTQGVVVLWNENKQQGYTNDLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFRWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLQAFDYGNEDISGNLDSFWLDGGIRISAIQQIEFLRKLYHNK
LHVSERSQRIVKQAMLTEANADYIIRAKTGYSVRIEPKIGWWVGWVELDDNVWFFATNMD
MPTSDGLGLRQTITKEVLKQEKIIP
>F3MH92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYVANTFKVVIQLGS
ILAVIVVFKDRFLDLLGLKRKKPEAGVPAGTGRLRLSQVIVGLIPAGVLGVLFEDLIDEH
LFSTETVLIGLVIGAIFMIVADKVSSKQEPKVVTVDQITYRQAFSVGLIQCLSLWPGFSR
SGSTISGGVMLGMSHRAAADFTFIMAVPIMFGASFLSLLKNWEYFTLEALPFFIAGFVAA
FVFALISIRFFLKLINRIKLVPFAIYRIVLAAIIALVLYL
>A0A022PEY0|FEATURES|UNIPROT_deepARG|beta_lactam|BA1DRAFT_04049|antibiotic inactivation|1
MTKQFSALTGGLLLAASLGAQASNTPDQPHLANTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDASKENNTPVTKETIFELGSVSKTFTGSLISWAQVTGAISFSDKASQHFQPLA
GSAFDNINMLNIATYTAGGLPLQFPDEIDSNSKMVDWFQHWQPKYTPGTYRQYSNPSIGL
AGYIAAQSLKKPYSILVKNQILSPLGLHHTWFNVPEQEMKNYALGYSKENKPIRISPGVL
DEEAYGLKTSAQELIGFVDANIDPSRVGDSKLAQAIRATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAQLAFQANKITELSPPEPPTDALFINKTGSTNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILKALK
>B2PUM5|FEATURES|UNIPROT_deepARG|beta_lactam|PROSTU_00250|antibiotic inactivation|1
MDNSMKNIFRQGRLFIALSLAMTSISAFALTQQEVDDIIKPLMKQEQIPGMSVAISVNGK
QAIYHYGVQSKQTQIPVSDRTLYEIGSLSKTFTATLATYAQIQGKLDFSQSVSHYLPELK
GSAFDNVSVMNLATHTSGLSLFVPSDIKTNDQLMAYYQKWLPDNEVGQYRSYSNLGVGLL
GIVTAKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKSQEKYYAQGYNKQNQPVRLNLAILG
PEAYGLKSNAKDLIRYLEINMQSIKVAKTWQEAIENTHTGVYLTDSFVQDMMWESYPWPV
SLSQLLQGNRDDMALKPQKVELIKPAMAPEVRAYYNKTGSSNGFATYAIFIPEEKIAIVM
LSNKWIPIPQRITATYQLLEKIER
>D1LFJ3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRADLPTSWT
>Q2FC44|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDSQMIS
>A0A0Q7P0I5|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD46_12665|antibiotic inactivation|1
MSLQFSIRDAAAFLDDWSLLRHRLWPDASVAEHRAELQNLSDNDAGFIAYDLVGMAIGFA
DISLRRDYVNGCDTSPVAFLEGVYVEEEFRGQGVAAALIAEVTRWAISRGVSELASDADI
ANVDSHRMHAALGFEETERVVYFRKLLPSHS
>A0A060KZ93|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELGRQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNLIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNPTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A127L2J1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSALLTLNAIRRSYPSGDGQVEVLKGINLEIHAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGTYRVAGTDVSTLSSDALAQLRRDHFGFIFQRYHLLSHLSAAQNVEVPAVYAGTERKT
RLVRARALLSRLGLGDRADYLPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGELISNPPARAKAITSAHEEEG
LTQAGGWRQFISRFHEALTMAWHAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRSIGTNTIDVYPGKDFGDDDPQYRQALKYDDLTAIQKQPWVRSATPSVSQNLRLRT
DNIDIAASANGVSGQYFNVYGMTFSEGASFNDEQLKGRAQVVVLDSNTRRQLFPNKASVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTIAGRIMGQSWLNSITVRVNEGY
SSEQAEQQLTRLLMLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLSQFLIEAVFVCLVGGALGVTLSMVIAMTLQL
FLPGWEIGFSPVALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>ZP_02685589|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLNSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A0J7FUI5|FEATURES|UNIPROT_deepARG|chloramphenicol|TU62_26660|antibiotic inactivation|1
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISKL
VNNHKEFRTCFNDEGVLGYWEEMTPSYTIFHKDDKSFSSIWTDYSSGCYIFYKNYEEDMR
CYANVHGLFTKENIPPNTFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFLEDLQELSNSCNEWLK
>A0A124C5H3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb_2|antibiotic inactivation|1
MTSRRPAVSIQEFSVSDAEAGPYGIAAGPDGALWFTLVHAGRVGRLTPDGETASYALPSA
SGGPSVITAGPDGALWFTEFKGHRIGRITTAGEVTCFALPTPDAGPFGIAAGPDDALWFT
EAGAGRIGRITTEGEVVEFPLPVAGAFPSAIAAGPDGRLWFTMNQANAIGAVTPEGEVTV
HPLPTPGAAPVGIAAGGDGALWFVEIGAGQIGRITPDGKIDEFPLPDRGSRPHAIVADTE
GGCWFTEWGANRVGRITYDGHHHEIHEHALPTPASEPHGIALGPDGSVWTALETGSVARL
RAVADAG
>A0A0W0PBQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVVGLPTQRNAQRFTVNLIIAVLPAVVLGVVFANAIKHYLFNPITVATALV
VGGLIMLWAERRQHAVHAETVDDITWKDSLKIGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFITSFIFAMIAVKGLLKF
IASHSYAAFAWYRIGFGLLILATWQFGWIDWSAATA
>A0A0Q8Z403|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTLKKYAISALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIAGLTIAVIQHGKVQYFN
YGVAAKDTQAPVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFD
RISLLQLATYTPGGLTLQFPDAADSATTMMDYFKHWKPTYAPGEQRLYSNPSIGLFGYVT
AKSLDLPFTVAMEKTLLPKLGLTNTYTRVPADKAGLYAQGYDSQQKPVRVNPGALDFEAY
GIKSSSQDLARYVIANMHPQTLEQPVQQAIATTHAGYYTVNGMTQGLGWERYPYPIALQA
LLEGNSTPMAMEPHKVNWLKPAQAQPANVLYNKTGSTGGFGAYVAFVPSKDMGVVILANK
NYPNAERVKLAYEILSTMDQ
>B7UFR6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYGLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>ZP_03069403|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>V1H2E6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGIIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A023RRC8|FEATURES|UNIPROT_deepARG|beta_lactam|B224_5390|antibiotic inactivation|1
MSRILLSSLLAAGLFCSLPASAATGCMLFADGSGKPFSAQGDCASQLPPASTFKIPLALM
GYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSRWMTYSVIWYSQRLTEWLGAARFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGMGYPKLLDGSLDRDQQIGWFVGWASKQDKKLIFVHTVIQKP
GKQFASLRAREEVFAALPEQLKKL
>A0A0H5LZ74|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGATPHEGKTNGHLTLGHILLAMLPAVGLGLVFHNAIKALFNPHS
VMYALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLSLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A014MBR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDKADTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGNVPHEGTGRGHLTLIHILLGMIPAVVIGLIFHDKIKLLFNPVN
VMYALVVGGVLLLAAEFLKPKKPKAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMLGATILDLYKSRGFLTMADFPMFAVGFITAFIVALIA
IKVFLKLIQNISFVPFAIYRFIVAIAVWFLFVQI
>A0A059N5C0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLDFIEILKVIFLGIVEGITEWLPISSTGHMILADKFITLNMSEAFKEMFFVVIQLGAI
LAVVVMFWNKMFPFQLKDKSQPLVKKDTFSLWFKVAVACIPSGIMGILFDDYLDAYLQTP
IVISIMLIFYGLLFILIENWNKKRTPTTMALSDISYKTAILIGAFQVLSLIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPTMLGASAFKLLKFGFDFTSAELLALVLGMAVAFAVS
VLVIKFLMNFIKKHDFKVFGWYRIVLGILVVLITVM
>D8FQG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSYKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLVKFFKAGHVFFGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>A0A0I9PAV3|FEATURES|UNIPROT_deepARG|beta_lactam|BN1200_410167|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>A0A0R1FMR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPRKNTTEKRDTWVLWSKVLLAVIPSVIVGLPLNDWMDEHLMNWAVVSAT
LIIYGILFIVIENHNKQLTPRFANLQTLPYTTALFIGCFQLLSLIPGTSRSGATILGAIL
IGTSRYVATEFSFFMAIPTMFGASLLKLVKYFAHGGSLAGLQGAVLAVGVIVSFVVAYLS
IRFLLDYIKKNDFKAFGWYRIVLGVLVIGYFTLIH
>AAB03644.1|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRRQFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
EEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLPQR
NERTSI
>A0A147FU02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQERHEGVGSGKLTLIHILLGMVPAVVIGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMIGATGLDLYKSMGFLTMQDFPMFAVGFVTAFIVALLA
IKVFLELIKRISFVSFAIYRFIVAAAVYAIFM
>A0A0G1P0W3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILHSLIFGIVEGLTEFLPISSTFHLITVGRLLGLESNPFTSMFEVVIQGGAILSLLFI
YTQTFLKNHTLTLKVLFSFIPTAVIGLILYKVIKGVFFSTNALMLAVFVGIGILFLLIEH
RVTLGKLSLHKSLTSISWKEALLIGLAQSTAVIPGVSRSGSVILLMMYLGFRRDEAAKYT
FLLSVPTILAASFLDLYQNRLIFVDNPANFTPLAVGFIASFIVAYLVVQWLLHYLGSHTL
RLFAWYRFAIAIFILFILGV
>A0A0U1YUQ0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLRAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>J2XVE7|FEATURES|UNIPROT_deepARG|beta_lactam|PMI35_00271|antibiotic inactivation|1
MTDPINLGRLKILAVCAAMLAAGQALAQDHLESIVSEAVRPVMQEQGIAGMAVAVTHNGK
QQYFNYGVASKESGNPVTQDTLFEIGSVSKTYTATLLAYAQATGKLALTDNASAVLPALR
GSAFDHISVLQLATYSAGGLPLQFPAEADSAEKMLGYFQQWKPLYAVGSHRLYSNPSIGL
SGYLAAQSMGQPFDEAMANTLLPKLGLKHTWLKVPQEQMAQYAQGYSKDDKPVRVGPGAL
DAEAYGVKTSAADLIGFVQANIKPASLDKPLQQAIALTHTGYYSVGDMTQGLGWEMYRYP
VTLDRLLAGNSTAMAMQAHQVQWLNPPQTQPANVLLNKTGSTGGFGAYAAYVPSKDMGVV
ILANKNYPNAERIKIAHKILSALAL
>A0A022IAZ9|FEATURES|UNIPROT_deepARG|aminoglycoside|J699_02921|antibiotic inactivation|1
MPVTEPLLADWLQLRRLLWPDHEDAHLLEMRQLLEQPQTLQLLSYNDQQQAIAMLEASIR
YEYVNGTQTSPVAFLEGIYVLPECRRLGVASTLVQQVEHWAKQFACTEFASDAALDNTIS
HAMHRALGFQETERVVYFKKNIS
>A8RD70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAILYGIIEGITEWLPVSSTGHLILFEEFMPMDVSPKFWNVFLVVIQLGAILAVV
LLFWNKIFPFNFTNKNRPFLKYDIWTLWFKILVACIPAAVIGLLFDEFLEEHLYKSVVVA
IMLILVGIAFLWIENNNRKKTARVTRLEDISYKDAMIIGVFQLIAAIFPGTSRSGATILG
GLMIGVSRGVAAEFTFFLAIPVMAGASLLKLIKYGLAFSGMELTLLAVGMVVAFIVSLLV
IRFLMSYIKKHDFKIFGYYRIILGIIVLACFFTGVLSI
>A0A097R7U8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|AT03_06410|antibiotic efflux|1
MNPIIELRHVYREFVAGNQTHVVLNDITLTIAQGEMVAIIGASGSGKSTLMNIIGCLDKS
TRGEVLINGISVNETDSDRLAELRSCYLGFIFQRYHLMPYLTAEENIAIPALYTAMPESE
RKARIQMLGQKLGLKSRLGYRPAQLSGGQQQRVSICRALINGAQVILADEPTGALDSVSG
KALMGVLHQLHADGHTVIIVTHDHGVAKQAQRIVEISDGRIIADEINQSCPEDRLAQHIP
VVRDNGRASLWRSIHESMRMAWRSLLGHRMRTFLSMLGIIIGISSVVSSMAVGEGARQTI
MNEIGKLGNTTLEIRPGTGWGSKRPDMERALSLNDVVSLQKQPWAEGVSPQVSSMATAVR
KGYDSSMMLSGVSQDFFALQGIRFIQGNGFTARDVAEGEPVLVLDETSRDTLFQDGEDPL
GQIVQIAGASWRVVGVAVKPGPKVVGGFMAGWLPYTSLQQRISGDKPLEAIVLRFQESLT
PQDAMQTVEHLLTREHGKKDFFSQTDDQLTKAMQKTSDSMSLLITAIAAISLLVGGVGVM
NIMLVSVTERTHEIGIRLSVGARPSDIMHQFLIEAVMICTLGGLVGVGGSWIAAQIFALI
TDEFSMAFTWLPVAIACAFSALIGLTFGYFPARSAAKLNPTEALARE
>YP_002384137|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MSPGGCLSLVNHPPVQTVTVMPLFCKLSSNNQTIKQAIRYSRNMMNKKIKLLIPLLVCTT
MLTACDNKPAENTSAALPKVGVVTITPGTVSVTSELPGRTVPFEIAEIRPQVGGIIVKRN
FIEGDKVKQGDSLYQIDPAPLKAALDSAKGNLAKAQSAASNARLTFNRQSSLLHSNYVSR
QDYDNARSQLNEAEANVTVAKADVEQAAINLKYANVTSPITGISGKSSVTVGALVTANQS
EALVTVQRLDPIYVDLTQSVQEFLRLKEEIASGQIQQVKGQTPVALNLENGKRYAQTGTL
KFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALLDEGSRQNVLMVPQEGVTHNAQGK
ATALILDKDDVVQQREINAVKAIGNQWLVTAGLQPGDRVIVSGLQRIRPGIKAQAISSDE
NTASNPAKQ
>A0A085JHY7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVEALIEAGFDITAIFTHLDNPSENHFYGSVAHLAAEHNIPVFSPD
NVNHPLWVERLRESAPDIIFSFYYRDLLSEEILSIPPAGAYNLHGSLLPRYRGRAPLNWV
LVNGETETGVTLHKMVKRADAGGIVSQQRVAIADSDDALRLHKKLTQAARELLQATLPAI
SQGNVTLSPQDEHQATYVGRRTPEDGRLDWTQPATVLHNLVRAVSEPWPGAFSYVGNTKF
IVWKSRVHTDLPAARPGQVLSVSPLVIACGQGALEIVTGQTEQSVYMQGRELVRPLGLTE
GSLISTQPVVAQKKRTRVLILGVNGFIGNHLTERLLKDDNYEVFGMDIGSDAVSRFLGNE
RFHFVEGDITIHTEWIDYHIKKCDVILPLVAIATPVEYTRNPLRVFELDFEENLKIIRGC
VKYKKRIIFPSTSEVYGMCTDETFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNSARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
ADGIEALFRIIENKQGNCDGQIINIGNPENEASIRELAEMLYRCFERHPLRKQFPPFAGY
RDIESSSYYGKGYQDVEHRKPNIRNAQRLLSWTPAIGMEKTVEETLDFFLNTVTTPEKTR
>A0A072WZW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAF
TMIIQLGAILAIVVLYWGKIKSSFENFAPSKPKSGFKFWLNIAVAAVPAGILGLKFHSKI
NEKLFNPGSVTAALIVGAIWMIFAEKRYRGKFTTRDIDNVTIKQAFIIGCFQCLALWPGM
SRSASTIIGAWIVGLSTVAAAEFSFFLALPVMFGLTLKSLIFDINIFTLGSMHIIGLTIG
FIVSFIVALIVVDKFITFLKKRPMRVFAIYRILLGIVLIILSLFNVISM
>A0A022PLW1|FEATURES|UNIPROT_deepARG|beta_lactam|BA1DRAFT_00723|antibiotic inactivation|1
MKHSPLRRSLLLAGITFPLINFAFPAWSSATPSSLHKQLAELENSTKGRLGVTLINTVNG
QEIQYRGDERFPFCSTFKLILVAAVLHKSMSQSELLAKHIHYRESDLLSYAPIARKNLNQ
GMSVAQLCAATVQYSDNTAANLLIKELGGLEVVNHFTQGIDDPAFRLDRCEPDLNSAIPG
DLRDTTTPAAMATSVRKIVLGEVLAAPQREQLIVWLKGNTTGDASIRAGAPADWVVGDKT
GGGDYGTTNDVAVLWPPKGAPVVLAVYFTQPQQDAESRRDVLASATRLVMAHLT
>R8P6X1|FEATURES|UNIPROT_deepARG|beta_lactam|IKQ_02135|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAIGALLQKTSIEDLDQIIKYTSKDFV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNK
>I4N321|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNQKAVVFAYHDIGCAGINALLEAGYDIAAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPIWIERIAKLDADFIFSFYYRNLLSEAVLACAKQGAFNLHGSLLPRYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAIIAQQRVAIERSDTALSLHAKLREAASVLLNETLP
LLAKGEVSETAQDESQATVFGRRTPADGLLDWSRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWGAEVVAGNQGFEPGHVISVEPLRIACGTDALQITAGQRNNDGLYLSGPQLARELG
LVDGSKLIGKAAGRPVRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIEHLR
GNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RHCVKYNKRVIFPSTSEVYGMCQDSHFDENTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGEQKRTFT
DVDDGIEALARIIENRDGKCDGEIINIGNPTNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREIESKAFYGNGYQDVTHRTPSIENARRLIDWTPTIELSETIGKTLDFFLREAMVEIE
SKR
>Y0KKD9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLLKAAIMGIVEGATEFLPISSTGHLILAGDLLNFMDHDKRSVFEIAIQLGAILAV
VWEYRQRFVSTFAGIGRDPIANQLIINLAIAFLPLAILGLSFGDKIKAALFKPVPVAIAF
IVGALIILWAEKREHTVTIETVDEIKPIDALKLGLAQAVALIPGMSRSGSTIIGGLFFGL
SRKAAAEFSFFLAVPTLGIASIYSMYKDRALLSMDDMGAWIVGLIFAFISAMIAVRALIR
YVSHHDFTIFAWYRIAFGVIVLVTAYTGLVDWTVQ
>YP_002401983|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQQAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIIIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>F9PCY0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFFEILKAIFFGIVEGITEWLPISSTGHLILAQEFIQFKDQNETFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKDKVQVRRTWQLWSKVFVATLPLLAVFKFDDWFETHFYNKVSVA
IMLIVYGVAFIYLEKRNKAQAIEPTVTDLDKLPYKTALYIGLFQVLALLPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGEVLSFGQFFLLLVAMVVAFAV
SMVAIRFLTSYVKKHDFTVFGKYRIVLGSVLLLYSFVRLFV
>A0A0U4ECK9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114w|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>A0A0S4R682|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MIKLQDIKKKFITGGVETEVLKGINLSINRGEFVAIIGQSGSGKSTLMNILGCLDTPSSG
KYLLEGQDISKFDRDALSNLRLKTFGFIFQRYNLLSSNDVKNNVALPGVYAGMDKKDRLN
FAKELLSKLGLESKFDTYPNQLSGGQQQRVSIARALMNGGDILLCDEPTGALDSTSGVMV
MEILKDLHKSGHTIIVVTHDKDIASWADRIIEIKDGNILSDNKKQNNIYEFKKVSEGIKK
GFKASLDRFLESFSMSVGAIKAHKLRSFLTMLGIIIGIASVVCVVALAKGSQEKILNEIN
KVGTSTIMLNPGKAPGDPNRNKIKKFTLDDAELLSKLEFVDYATPTVSQSGLLVYANQNA
NANLRAGSENYLKITGVKVVLGRDFSSDDIKNSESVIIIDTDVKSSFFGQNDPIGKTILF
NKKPFKIIGVAKKDEGAFGSENLTVYMPYSTAVNKITGDRNLRSITVKLKSNVNAQLAES
TIKEVMSVKRGDSDFYTRNSDTIMQTIKSTTDAMSLLISGIALISLMVGGIGVMNIMLVS
VFERTKEIGIRMAIGAKSKDIMIQFLIEAILLCAIGGAIGVGLAYLIGYLFNMFGASFKM
IFSTSSIFIALGVSSLIGIIFGYMPARNAAKLNPIDALSRE
>Q2L9X2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAMQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>X2KKG4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
AFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVT
ENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAG
GLPLQVPDAVKSRADLLHFYQQWQPSWQPGDMRLYANSSIGLFGALTANAAGMPYEQLLT
ARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAE
MNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQP
HPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTEKSQS
>A0A069EYV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWYELFIGFLLGVVEGLTEFAPVSSTGHMILVDDLWLNSSSFLGQEVANTFKIVIQLGS
ILAVIVVFRNRFKELLNPKELLAIRSSGPTKKLNLLHIFIGLLPAGVLGLLFEDYIDENL
FSIKTVLIGLVIGAFFMIAADLLGVKRQTTATLDEISYKQALGVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMFGASALSLYSNWEYFTMATLPVFVVGFISAFL
FALLSIKFFLKLINKVKLTPFAIYRIVLAAVIYFLYF
>B3WFR9|FEATURES|UNIPROT_deepARG|beta_lactam|oxa-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGYADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>F0T1S4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTNTLFMIKAVIIGIVEGITEFLPISSTGHMIIVGHFINFEGDFAKLFQIVIQLGAILA
VIVLYRKRIFQSLNNLKPGEYGFKLWSSLIVAFIPTGLIAFLLHDKIETLLMSPVPVAAS
LLAGGFWMMFAETRYRNHHKTVKVEDVTYRQAVIIGLFQSLAVIWPGFSRSASTIIGGWI
VGLSTVAAAEFSFFLALPTMVVATGYSLLKTKLILSSIEIIALVVGFIISFFVALVVIDR
FIAYLQHKPMKGFAVYRIIVGVILLTMAVFHVL
>A0A0M9DM58|FEATURES|UNIPROT_deepARG|chloramphenicol|ADM90_08130|antibiotic inactivation|1
MKFNKIDINHWERKEVFHHFFNQQTSFSITKNIDITELYNTSKEKGYKFYPAFIFLITHI
ANSNGHFRMSFNSEGALGYWEKVVPMYTIFDKPSTLFSALSTNTDTGFQNFYVNYIADTE
KYSNTGKMFPQTVLPKNIINISMIPWTSFTGFTLNVNNSPNYLLPIVTAGEFIENNKSIY
LPLSLQVHHAVCDGYHAALFMNKFQTLANHPQELLK
>A0A143WR85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDMYEWVIAFILGVVEGLTEFLPISSTGHMILVGNLLNFTSDKAKTFEIIIQFSSILAV
VVVFWRRLFSLIGIHFSQFPRNDIGHTRLHLGHILLGIIPAVLLGLVFHKQIKNIFSLIY
VIYAMIAGSMLLLLGEWFKPKIPRASGIDDLTYIQAFLIGCFQCLGLLPGFSRSGATISG
GLIVSVSRYAASEFSFVLAVPMILGATILELYKSLILLTWQDLPMFAIGFFTSFMISLLT
IKFFMKIIKSISFIPFAIYRFILAIVVYWILIT
>A0A0U1YUD7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAREWQENKSWNVHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>D0EJY7|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-16|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A133L9K7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF3212_03797|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A0P9SL63|FEATURES|UNIPROT_deepARG|beta_lactam|ALO50_101023|antibiotic inactivation|1
MPRNKTLLCAALVLNASLACAQDPAPDLDAVVQQAAQQVMQENNIAGMSIAITRNGTQQF
YNYGVASKANRQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTDSIDTYLPQLNDTR
LGKIPVFHLGTHTAGGFPLQVPDKVQNTRQLMDYFKAWQPDYLPGTHRTYANPSVGLLGL
VAARSMKLPYEKALQQRLFSALTLSSTYVTVPDEKQKLYAQGYNKLDEPVRVNPGPLASE
AYGVKSSARDMIRFVEANLGPGQYDAPLQRALTDTRISYFKVGGMTQDLIWEQYPMPVGL
AQLLEGNASAMLNTLKTEVIEPPQAAQSAVWVNKTGSTNGFGGYVAFIPEKQLGIVILAN
KNYPNEERVRLAYRILGESGCCSKP
>A0A095EJS1|FEATURES|UNIPROT_deepARG|beta_lactam|DM42_6630|antibiotic inactivation|1
MRFNATRFAATLLVAACATATAGRAAAVTQDDLRDTVTRQIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLADPAGKYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPAYAPGTHRKYSNVAI
GMLGWLTAKAMHQDFATLMEQRLFPAIGMTHTYINVPAARMADYAQGYTKDGKPVRMTEG
MLWQPAYGVRTTAADLLRFVQANMGMIHTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYA
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIG
IVMLANGNVPIEERVKAAYRILGSLGDAR
>A0A0M2QNY2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFSKMMTAMTQAVLFCAAGAMLGIADTAFAAADRVQAVVDETIRPLMTEKQIPGMAVGV
VVDGKAHVFNYGVASKESGRPVTNATLFELGSVSKTFTATLASLAEVDKQLSLSDKVETY
LPPLLGSDFGKVRLLDLGAHTVGGLPLQVPDDVHDEAELISYLKHWHAAHAPGTFRTYSN
ISIGTLGILTANRLQQDSTSLMEGRLFPGLGLKNTFIDVPAAREADYAQGYTAAGKPIRM
KMEVVGREAYGVKSTAGDLLHFMQGNMKLIPLEASLQRAVTQTHTGYFQAGPMTQDLIWE
QYPYPVALKTLLIGNGPAMLFKGMKVTEIRPPEAPRDDVWINKTGSTNGFSSYVAFVPAK
RMGIVILANRSYPIEDRVAAAYRILTALDGAGQ
>A0A060KZA5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRKFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0P6U9A3|FEATURES|UNIPROT_deepARG|aminoglycoside|JI76_37075|antibiotic inactivation|1
MSDHCEPGAASPVLLGVGGDWLPVTAGESGASVFRAADATRYAKCVPAADTAGLEAERDR
IAWLSGRGVPGPRVLDWYAGDAGACLVTAAVAGVPADQVRAEDLRASWGHIADAVRRLHE
VPVASCPFRRGLDSVVDVARDVVARGAVNPEFLPVEQQRVPPAELLDRLTGEIPRRRDQA
AAGTVVCHGDLCLPNIILDPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RVADAEFAERYGMPLDQERLRFYLHLDPLTWG
>ZP_04639026|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIILMLAGILAIMKLPVAQYPTIAPPAISISANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMQQEDIADYVGSNVKDPISRTTGVGDVQLFGS
QYAMRIWMDPHKLNNYNLTPVDVINAIKVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQIMLKVNTDGSQVRLKDVAIVQLGAESYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPAGLKVVYPYDTTPFVKISINEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFIPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIAKGEHGPKTGFFGWFNRMFEKSTHHYTDSVANILRSTGRY
LVIYLVIVIGMGVLFLRLPSSFLPEEDQGVFLTMVQMPAGATQERTQKVLNQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERPGEQNKVPAIVGRASAAFSQIKDG
LVFAFNLPAIVELGTATGFDFQLIDQGNVGHQKLTAARNELLGMVAQHPDMLVGVRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQAGAPFRM
LPGDIDKWYVRNNAGQMVSFATFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELAAKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSRRNEDVEHAHAVDHKAK
>I3IEQ0|FEATURES|UNIPROT_deepARG|beta_lactam|O59_000556|antibiotic inactivation|1
MKAFLAAILFLLSNITFAEDPLPELEIKKIEEGVYLYTAYEKIEGWGLVGSNGLVVLDNK
DAYLIDTPISAKDTEVLLQWIDAQGLTAKASISTHFHSDSSGGIAFLNSKSIPTYASKLT
NKLLKNKGEAQATHSFIKNPFWLVNKKIEVFYPGAGHTSDNVVVWMPEQKILFGGCFVKP
EGLGNLSHAVIEEWPASAEKLITRYGTAKLVVPGHGKVGDASFLEKTKQRAFEATAAKK
>A0A0P9DY30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEAFVALILGLVEGLTEFAPVSSTGHMIIVDDFLFQSKDIFSPSVANTFKIVIQLGS
ILAVVVLMWDRFMNLLGLKKMPGQTSSGPRLNLLQVFVGLVPAGILGVLFDDYIDEYLFS
TKTVVVGLVLGAVLMLAADWFRPRRPKTETADQITYKQAFLVGLVQCLSLWPGFSRSGST
ISGGVLLGMSHRAAADFTFIMAVPIMAGASFLSLLKSWDSITMDAIPFFVVGFISAFVFA
LLSIRFFLKLINRIKLVPFAIYRLVLAAIIYFVFL
>ACC96132|FEATURES|ARDB_deepARG|aminoglycoside|AadD|antibiotic inactivation|1
MKLRNEYWINMGMMLMAIGVYGSLGRQTDGPYSDIEMMCVMSTEEAEFSHEWTTGEWKVE
VNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVYQTAKSVEAQTFHDAIC
ALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLHHRICYTTSASVLTEAV
KQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTERHGYIVDVSKRIPF
>R8WKI6|FEATURES|UNIPROT_deepARG|beta_lactam|WEW_04326|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNDIVHRAINPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSGDLLRFYQNWLPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQARVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMAHWAQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVDPDSII
NGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYIAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A127SU17|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTVNEMPE
FRTALTEKGLGYFSEMHPAYTIFNQEQETFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YAPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKKMLPLAIQ
VHHAVCDGYHVGRFIELLQKKIIGFDSGCNSAPSDISATVKGRIK
>G3IW27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILTIKTIILGIVEGLTEFLPVSSTGHLILVGDLLNFNDDKGKLFEIVIQVGAILAVC
WEYRSKITAVIIGLPSQKSAQKFAFNLMIAFIPLASLGLLFGKYIKAVLFKPIPVALAFI
VGAFVIIWAEKREHNIRIHEVEDLSPLDALKLGIAQAFALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAIPTLIVASIYDLYKHRDLLDLATDAPYFAAGLVAAFLSALLAIKALLR
YISHHDFIIFAWYRIVFGLLVIATSYSGLVQWTVD
>A0ESH7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPKKVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>A0A0T9UUT1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIITTLVFTAIAAFPLCTSAKTILTKQQVAAIVNNTLTPLIEKQDIPGMAVAVFYD
GKPQFFNYGVADIKTGRRVTENTLFELGSVSKTFTGVAGEYAVQTGMMNLNDPVTEYTSE
LTGEQWKQVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKKSQLTFENYMTKNVFQPLQLKHTFITVPESMQSSYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPDSLPAGNDKLKQAIIASQSRYFQAGEMFQGLGWEM
YNWPINPQRVIADSGNDIALKPRKVEALEPAQPAIPASWVHKTGATNGFGAYIVFIPEEN
IGIVMLANKNYPNPVRVQAAYHILQALR
>A0A106DP26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSVVSGLPSRPDARRFTLNVVIATIPAIALGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGQPPRVMSVDALTPLDAFKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVSAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWS
>R4WT84|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFRTLSFLATAIFSFSAMPAITHAADLDSAKIKATVDDTIKPLMALHGIAGMAVGVVVQ
GKPYVFDYGVASKETKQPVTRDTLFELGSVSKTFTATLASYAQLEGDLSLNDPVSKHLTS
LAGSEFGKVTLLNLGTHTPGGLPLQVPDDIHNNAQLMQYFKTWRPAQPPGTIRTYANPGI
GTLGLITAQSMRQDFNALMQTRLFPALGLKHSYIDVPAAKQRDYAQGYAKNDAPIRMKGG
VLASEAYGVRSTAADMTRFMQINMNMVRIDPTFQRAVDATHTGYFHAGPMTQDLIWEQYP
YPVALQSLLDGNSQSMIMNATPVTAIDPPQAPRDDVWINKTGSTNGFGTYIAFVPKERVG
IVMLANRNIPNEERVKAAYAIITSLAGAR
>J6H1B3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIVFLQAVFLGIVEGITEWLPVSSTGHMILVNQIWPMRVNPDFMSMFLVVIQLGAIMAVV
ITFWNDIWPFTSDKSKKYIRKDVWSMWFKVIVACIPAVIVGLKWDDAIEEHFYNYKVVSI
MLILIGILFIIAENRNKHSKPETNSIDDLSYKQAFIIGLFQLVSAVFPGTSRSGSTILGA
LLLGVSRKTAAQFTFFLAVPVMFGASLLKLLKYGLNFTVSEAAILLVGMIVAFVVSMFII
KFLMNYIKKHDFKVFGWYRIVLGAIVLLYFFFD
>A0A0V9H6D9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELNNVSRLYTNGEEDTVVLDQISLTINAGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYKVAGQCVAEMESDQLAALRREHFGFIFQRYHLMAHLTAEQNVEIPAIYAGKSTEQ
RKERARALLTRLGLAERIHYRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSG
KEVMAILKQLNQQGHTVIIVTHDPLIAQQADRIIEIKDGQIISDNNNHHSVPVKKAPAPI
QTASYFNQVIGRFTQALNMAWRAMVVNKIRTLLTMLGIIIGIASVVTIIVIGDAAKDRVL
ADIKAIGANTIDIYPGKELGSDSPEDKQSLTIQDVEALKQQSYIQSVTPQIYFSSRLRRG
NQDAPATVSGVNEDYFSVYALKFAQGGTFTPDMIHRQAQVVVIDENTRHRFFPNKQAVIG
EQIIIRNIPSTIIGVVAEQKSTFGDNKSLRVWVPYSTLSSRIYNRSYLDNITVKVKEGYD
ASVAEQQILRLLTIRHGKKDIFTYNIDSFIKAAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIESVLVCLVGGLLGISLSLAIAMFASMM
LPNWHFVFQPTALISAFACSTAIGVIFGFLPARNAAKMNPIDALARE
>CAJ45367|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYINWKFKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDILGAMI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>A0A0A3IIR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYNIEGQAKSINGRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFVF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>A0A0J6KGM6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVMLLAKALLLGIVEGLTEFFPISSTGHLIVVGDLIDFQNNADVFEVVIQLGAILAVVW
EYRQRFLGVAQGALQRDAQSLRFISNLLVAFLPAAVIGFFAIKAIKHYLFNPVTVALALV
VGGVIILLVERRQRVPRVISVDDMSWQDALKVGIAQVFAMVPGTSRSGSTIIGGMLFGLD
RKVATEFSFFLAVPTMFAATFYDVYKHWHQFTATDVPVIGVGFIAAFISAFFAVRGLIRY
VSSHNFNVFAWYRIVFGLVILATWQLGLVNWSA
>A0A0G8WG87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWSLATGLGERANRDYVLKVGVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWTDVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGAALLLWLPAAAG
>CAA67774|FEATURES|ARDB_deepARG|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRILNELQQYCDEWQGGA
>CAE50480|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MLRSRVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
SPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIA
EADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGM
GFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELH
AIGNGADYVRTHAPGDLRSAITFSETLAKFRSRNARDRGLDHA
>A0A0J9GIV8|FEATURES|UNIPROT_deepARG|beta_lactam|AC240_12925|antibiotic inactivation|1
MFPRWSKTFALALTACALVMGATQAHAELVVRDDLKRVFDEAGVAGTFVLMDISGDRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVIPYGGKPQPFKQWEKDMALPEAIR
VSNVPIYQEVARRIGPARMQAYVDAFDYGNRQIGSVIDQFWLRGPLEISAFEEARFTSRL
ALKQLPVKPRTWDLVHRMLLIEKQGDAALYAKTGVATEYQPEIGWWVGWVEREGKVYAFA
LNIDMPLEADMAKRIPLGKRLMQALEVWPTP
>W0TY33|FEATURES|UNIPROT_deepARG|beta_lactam|blaCARB-12|antibiotic inactivation|1
MCDNQNYGVTYMKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQN
GEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVG
QAITLDDACFATMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKL
GDLRDTTTPKAIASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADR
SGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>A0A137RR23|FEATURES|UNIPROT_deepARG|beta_lactam|AYK81_05465|antibiotic inactivation|1
MKKNILLKLGVCVSLLGTTQFVSTISSVQASQKVEQKVMKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKCVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAALAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
GDNIVVWLPQYNILAGGCLVKSADAKDLGNVADAYVNEWSTSIENVLKRYRNINLVVPGH
GEVGDRGLLLHTLDLLK
>A0A127SHS7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQTLEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREKIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPPK
AYYNWSTPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>E6TYF3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGLNHFLFSVSNLDKSIEFYEKVFDARILVKGKTTAYFDLCGMWLALNEEKYIPRNEI
KHSYTHIAFTIDESDFDEMLAKLKQWNVTILPSRPRDTKDKKSIYFTDPDGHKFEFHTGT
LQDRLSYYKADKTHMKFY
>V6GT30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFYGENFEFDDLFDIFIQSGAILSV
LFLYQEKFRSQIVSSFRYVLKQSSDSEGFNFLIQIGMGAVPILIAGFVAKKFLDTIKTRP
DLLDILSGAWIFGGVLILIAEWYFHKKQGNVEKKPINFKDSILIGIFQCMALVPGMSRSA
ATIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGHTIPVLMFGFLVSFL
LCTLVIRWFLRYLQKHSFSIFGVYRILLGVGVLVLTKLI
>Q59694|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2b|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKGVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>P06548|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESNKQTNQTNQVKQENKRNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TRKDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>A0A0N0ZP77|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGPMSLWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPIQEDPFLKTFLIAIQLGAIL
AILLLYGRRFAVDRALWLRIGAAFLPTAAMGFLLYPLIKGKILGNDGIVVFFLFSVGLVL
LLADRLAERARYGDVLELPLAQVALIGLFQGLAALFPGTSRSGATILGGLLLGLRRKAAA
EFSFLLALPTMLAAVGYDLLKSAPAVPEGGWNLLGMGFLAALVTALLTVRWMLSFVERHG
FRPFAYYRMALALVYAYFFLR
>A0A127T2J2|FEATURES|UNIPROT_deepARG|beta_lactam|DHA-20|antibiotic inactivation|1
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAISQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>J9APR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>M4QHL2|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
FAHPETLVKVKDAEDQLGARVGYIELDLSSGKILESFRPEERFPMMSTFKVLLCGAVLSR
IDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIG
GPKELTAFLHNMGDHVTRLDRWEPELNEAV
>A0A0P9LPB9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKVVVFAYHDIGCVGLQALLDADYEIAAVITHVDDPEEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWIDRVSKLAPDFIFSFYYRALLSEPLLACAKRGAFNLHGSLLPRYRGRAPVN
WVLVNGETETGVTLHKMVKCADAGPVFAQQRISISATDTALTLHGKLREAAIALLSDALP
LLARDQLSGTPQDESLATCFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGEH
KLLIWAARVEPSNNGVAPGTVISHNPLRIACGEGALIIRAGQRGDEGLYLSGTQLAREFG
LVQGSQLRDAKKQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
AKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFA
GFRDVESQSFYGKGYQDVSHRKPGIDNARQLIGWAPGIALSETIGKTLDFFLREAMAEKA
DQC
>A0A0G4JQD6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTEEKTINKVSVVIPVFNEQESLPELIRRTDGACRGLGLEYEILLVDDGSQDLSADMISA
AADRPGSHIVAILLNRNYGQHSAIMAGFSYVSGDLIITLDADLQNPPEEIPRLAAAAQEG
YDVVGTVRQNRQDSWFRRRASRAINHLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRATELPVTHAEREFGNSKYSFMRLINLMYDLVTCLTTTPLRMLSVLG
SLIALAGFAFSVLLVALRLFLGAEWAGDGVFMLFAVLFMFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVIHHQKDASVQETEQ
>E8RAY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILALIQSVILGVVEGLTEFLPISSTGHLIIAGDLLAYTGEQAKTFEICIQLGAILSVC
WLYRQRLLRVMTGLGHEASARKFALNLIVGVLPSAVFGLLLHKLIKAHLFNPVVVAVALI
VGGLIIFWVERRERVPRITEVEQMEWPDALKLGLAQVVSLIPGTSRSGATIIGGMFCGLS
RKAATEFSFFLAIPTMFLATGYDVYKSWHTLAQQDLAFFAVGFVTAFFSALLAIKGLIRY
VAHHDFKVFAWYRVIFGAIALLYFLR
>D7WU18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLG
SILAVIVVMWKRMLSLVGLYNIEGQAKSINGRFNLLHVIVGMLPAVVLGFAFKDFIDDHL
FKVEHVVYALVAGAILMIAADKLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSG
ATISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFV
FALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>A0A091AX27|FEATURES|UNIPROT_deepARG|beta_lactam|JM66_04455|antibiotic inactivation|1
MSRILLPGLLAAGLLFSLPASAASGCMLFADGSGKPISSQGDCSSQLPPASTFKIPLALM
GYDSGFLVDEKLPALPFKPGDDDWLPAWRETTTPSRWLTYSVVWYSQRLTEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGMGYPKLLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFSSIKAKEEVFAALPEQLKKL
>F3WRI8|FEATURES|UNIPROT_deepARG|beta_lactam|SB521682_5028|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>E0FLT1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGSGENTAHVLKDINLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCKIDGKETLNMTSDELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYAGMDNTSR
KARANQLLEKLGLADKTGNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILKDLHKEGHTIIMVTHDANIAANASRIIEIKDGYIIRNERQQPYSEDLKLTKREY
KKPRFFDQLIESFKMAINAITAHKLRALLTMLGIVIGITSVISVVALGQGSQQQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDAMMLNKQQFVDSTTPSSNLSGTVIYGNTNV
TASINGVGEQFVNVKGLKMISGRFFDADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILV
DKKPLTVIGMAQESNNLNQTSLKMWMPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKS
INELLTAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAILICLLGGIIGILFAMAIIFSFNTLGTNFKMI
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>K1IQB1|FEATURES|UNIPROT_deepARG|aminoglycoside|HMPREF1170_03087|antibiotic inactivation|1
MTNIGWQIVPLDETLLAQWATLRQQLWPHHALSAHLQEGVEMLANAHLNAFLALDEQSQA
VGFADAALRHDYVNGCNSSPVIYLEGVYVQPASRQRGVAQALIAQVAQWGRELGCRELAS
DAAIDNLDSQQMHQQLGFAETERVVFFKKALG
>A0A0Q7RTF6|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD52_25030|antibiotic inactivation|1
MSLSHEFFGRSPFEWVPVVTGESGDFVYQRSDGRAYAKVATADRSAELSGERDRLLWLQG
KGILTPEVTDWHIADEGACLIISAIEGIPAVDLSAADLLEAWPSMAWQLGSLHALDAGQC
PFDRGLAPMFARAADVVARDAVNADFLAVDDQETPAHELLARVERELAVRLEQETGDRVV
CHGDPCMPNFMIDPRTLRCSGMIDLGRLGTADRYADLALMTANARESWTSPDQEQRAFAI
LFDTLGIVAPDRARLDFYLRLDPLTWG
>J7K0Y9|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRLFSTALGAALSLSALAGAPAQAAILCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
VKAAAYDLAENLFEVGEAGGWRMHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>A0A0A0FZ93|FEATURES|UNIPROT_deepARG|beta_lactam|EL75_4012|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCALLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPL
DINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ
>A9WCL9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRVQSITLPRSGLFIGFSVLLAFSLLITVPANPDWWQIVVLGIVQGITEWLPISSTAHLL
LISELLNYQGSIGGTFEIAIQFGTVCSVLIFYWRDLLTQANAVIGRGDTLTVTTARTLWL
GIIIAFVPAAAVGLLARDFIKAVLFESPLLMATTLIIGGFIFLWIEWNGTRQTQTTATVD
FSNVSYRRALIVGIAQTFALIPGVSRSGASIVGGLLAGFDRATATAFSFYLAIPTLGLAT
LVDLIGSLDQIQSGDWGRLLLGATVAMIVGYGCIGWLLRYIATHNFTLFGYYRIIAGVLI
IGAVALGIL
>U2BEX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAVLFGIVEGITEWLPISSTGHMILLNEFVTLDVSPEFWEVFLVVIQLGAILAVV
VLFWNKLFPFDFSKRRKKNGIIKTDIFVMWFKVLVACIPAMIYGILLDDLVEPYLYNATT
VAIMLILFGVAFIVIENWNKGRKPRIKSLASLTYRDALIIGLFQLIAAVFPGTSRSGATI
VGALLIGVSRVVSAEFTFFLAIPVMFGASLLKLVKFGLGFSMTEASLLIIGMVVAFVVSM
GVISFLMGYIKKHDFKVFGWYRIVLGILVLLYFYVIAA
>A0A0B5ECT0|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
WAWIERRVYYIKLDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIH
YSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>A0A0J6AH33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGKTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYALVIGGFLLLAAEWFKPKEPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFVVGFVTAFVVALIA
IKTFLKIIKRISFIPFAIYRFIVAGVVYMVFM
>A0A142LGX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLALLVKAVILGIVEGLTEFLPVSSTGHLILVGHLLDFNDEKGHVFEIFIQAGAILAVC
WEYRARLVFTFRGITNEPRAQRFVLNLFIAFLPLAILGLLFNKQIKAVLFHPVPVALAFI
VGGIVILFAERWYKARTKNELLLLPDQAPGIVARPMIASVDDLTWRDALKLGLAQCAALI
PGTSRSGATIIGGLFFGLSRKCSTEFSFFLAIPTLFAATLYTLWKARALLSTSDIPMFTV
GFIAAFVSAFIVVRWLIRYVSTHDFTIFAWYRIVFGFVVLATAYSGSVDWRAH
>A0A0X3WPP9|FEATURES|UNIPROT_deepARG|beta_lactam|ADL32_22165|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGHGSGSVSDAERRLAGLER
ASGARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDQNGEFLSRRIFYTQ
DDVEQADGAPETGKPENLANGMTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSL
GDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANT
TSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDG
LVADAARVLAETLG
>A0A085HDH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGSGKGRLTLLHILLGMIPAVVLGLVLHDTIKSLFNPIN
VMYALVVGGVLLIAAELLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSYHFLTAGDIPMFAVGFITAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>D7JEK2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWFEAIIIAIVEGLTEFLPVSSTGHMIITQGLLGMHSDEFIKAFTVIIQFGAILSVIVL
YFKRFVQVAPISVFRLPADSNFGTWQKLRYFLGQLIRKYDFYWKLLIAFVPAAVLGFLFS
DAIDRLLERVEVVAVMLIVGGVFMIFVDKIFDKTDADQTIGWRKALFIGFCQCVAMIPGV
SRSMATIVGGMSQRLTRKNAAEFSFFLAVPTMFAASAWKFYKLFADPASRQLLGQNIDTL
IIGNVVAFVVAMLAIKFFIGFLTKYGFKAFGYYRIAVGAILLILLLANVNLSVI
>YP_002045964|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIANFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQPGQAP
>ZP_04295911|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLKRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>A0A137XVM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILT
VYSAKLLKILTDFPRDARTRRFVFGILVAFLPAAFIGALAHGFIKSVLFETPMLVCIMLI
IGGFILLWVDQLNLRPRYHDVMDYPLPMCLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLYKSRDMLSFNDAALIGVGFVMAFISGVFVVRYLLDY
VSRHGFKLFAWWRLIVGSVGLAALLVWG
>P31776|FEATURES|UNIPROT_deepARG|beta_lactam|mrcA|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELQQPMQIYTADGKLIGEVGEQRRIPVKL
ADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGASTITQQLARNFFL
TSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAAQTYFGKSLNEL
TLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEYDAALKEPIVAS
YHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEAQKAVRNNLIDY
DMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKGGADILLASGEK
MTLSTNAMRWTGRSNPVKVGEQIWIHQRANGEWQLGQIPAANSALVSLNSDNGAIEAVVG
GFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISIQKPGQKMWQPK
NSPDRYDGPMRLRVGLGQSKNIIAIRAIQTAGIDFTAEFLQRFGFKRDQYFASEALALGA
ASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIECNDIPVIYGET
KDKINGFANIPLGENALKPTDDSTNGEELDQQPETVPELPELQSNMTALKEDAIDLMAAA
KNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSIKRSDIGGKTGT
TNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYMKTALSDKPERK
LSLPPKIVEKNIDTLTGLLSPNGGRKEYFIAGTEPTRTYLSEMQERGYYVPTELQQRLNN
EGNTPATQPQELF
>A0A157H282|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKKTVPDYTPVDLSRWARKEHFEVFQSFAECTINQTVLIDITALRKHIKEVGWKFYPTII
FLLSKIMNRHPEFRMAMKDNELVIWNEIHPSYTIFHPETETFSSLWSHFDGNIQHFQNTY
AEDVARYGSNLSYWPKEESRENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDGLSELSEEFNG
>A0A0V2E9N1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNIRRSYPSGEEQVEVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSMLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLQRLGLSDRVDYHPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAGRVIEIHDGKIVHNPPAQEKGREQGVAAAA
VNTASGWRQFASSFREALAMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLAAIQKQPWVNSATPTVSKSLRLRY
GNMDIAVNANGVSGDYFNVYGMSFSEGNTFNVVQQRDRAQVVVLDANTRRQLFPNQANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNRNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGQKDFFTWNMDSILKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEISFSLIALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>N9R9U6|FEATURES|UNIPROT_deepARG|beta_lactam|F889_00606|antibiotic inactivation|1
MNLNDISRTSKQLLFMTGLVCASPMLWAQPLNEQQVKAIVDQQFKPLLAQYNIPGMAVAV
TLNGQHYFINYGLASKQSQQAVSNNTLFELGSVSKTFNATLASYAQAQGQLSLSDHPAKY
FPELKNTAVDRATLLNLGTYTAGGFPLQFPDQVVQQQDMIKYFQTWQAKTKVGAARQYSN
PSIGLMGYVTARAMKKPYAELLEKTLFPQLGLTQSFIQVPEQQMPQYAWGYKADQALRVS
PGMLDAEAYGVKSSSADMLRFLDVQINPQHLKQPLRKAIENTHVGYFKVGAMTQGLGWEQ
YAYPVKLETLLQGNSSKMALESHPAIAIKRPKIAPAATYFNKTGSSNGFGAYAAFIPEQK
IGIVMLANTNFPNEARIQASYTVVQQLLQANTAQ
>A0A0M2ZIB3|FEATURES|UNIPROT_deepARG|beta_lactam|AAV95_16190|antibiotic inactivation|1
MTRLSRRRVLIGGMTLMATAATAPKLAVADPVPTVEAQIAALEVQHGALIGVYASNLDLQ
RTVAHRAQERFAMCSTFKTYAAGRTLQMAERGELSLEQSLFVDPEDILINSPITEARAGG
ELTLAELCQAALQRSDNTAANMLLATLGGPQAITAFARSIGDSESRLDRWETALNSAIPG
DPRDTSTPQALGFGYRNLLAGDALAPPERSRLEDWMRANQTSSMRAGLPDGWTSADKTGG
GDYGSTNDVGIAYGPDGQRVLLALMTRSQTADPNAPGLRPLIGELTSLVLPALLA
>A0A127SK92|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQLAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGRPADLVAMLRLFQKKS
WVS
>A0A0A0Q7Y5|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-10|antibiotic inactivation|1
MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNP
SIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>W0IK68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYISAIILGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LVDLVLGWRDPVNRDYAAKLIVAFLITAILGLVVKRLGFELPETATPIAWALIIGGIWMI
FAEWAAARRPPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFRDGGAAGEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGFIA
>YP_001572785|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLIAMTTHSLTVLIVASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQT
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>BAA07922.1|FEATURES|ARDB_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRAVRVSPGMLD
AQAYGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWP
VEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIV
MLANTSYPNPARVEAAYHILEALQ
>F9P4C6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIVEMLKSIIFGIVEGITEWLPISSTGHLILVQEFLKYKDQNAAFMEMFNVVIQLGAIL
AVVVIYFDKLNPFKPGKTAREVQKTWELWAKVVIAAAPAAIIGLPLDDWFDAHFYNFISV
ACMLIIYGVAFILLEKRNKTVEPAITNLDRLPYKTALYIGLFQVLSLFPGTSRSGATIVG
GLLNGTSRSVVTEFTFFLGIPVMFGASGWKILKFIIKGNTLGFGQFFLLLVAMGVAFGVS
LYVIRFLTDYVKKHDFTIFGKYRIGLGVLLIVYGIFKAIF
>B7IUU0|FEATURES|UNIPROT_deepARG|bacitracin|bacA1|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAIVMIFAEVKKKEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWEYLSVDDIPMFAVGFITSFTVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>J9AUM8|FEATURES|UNIPROT_deepARG|beta_lactam|IEO_01947|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTDVENLKGMMILKNKRMLKIGICVGILSLSLTSLEAFKGGPLQV
EAKEKTGQVKHKHQATYKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKA
LAAGVLLQQNSTEKLNEVITYTKEDLVDYSPVTEKHIDTGMTLGEIAEAAVRNSDNTAGN
ILFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVG
NALPLHKRNILTGWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAP
IIIAILSSKDEKEATYDNQLIAEATEMIVKALK
>F0H5N9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLMGVQQGDAFVHAFTFIIQFGAILSVVC
LYWRRFFHFDHTPVPADCKSPFLRMIHPVRFYWLLFVGVLPAVVIGMAAKKSGLLDWLLD
SVWVVAVMLVVGGVFMLFCDRIFNKGKEENRVNEKRAFNIGLFQCLSVIPGTSRSMATIV
GGMANGLTRRRAAEFSFFLAVPTMAGATLLDLLDLLKEDGSWATAHNLTMLAVGCIVSFV
VALLAMKWFVNFLAKYGFRWFGWYRIIVGVAILVMLLSGMSLNMVD
>Q9LAR9|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-19|antibiotic inactivation|1
LLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>ACE95087|FEATURES|ARDB_deepARG|quinolone|QnrA1|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQEPCFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYIS
GCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>A0A0H3DYA6|FEATURES|UNIPROT_deepARG|beta_lactam|ETAF_2879|antibiotic inactivation|1
MIRLLNVGFDDELVMMNTRLSCTLALSALLLSSGAQASTPPSAEMRVAEAVKQTIPALMQ
QQQIPGMAVAVIYQGTPYYFSYGVADKATRRAVTPQTLFELGSVSKTFTGVLGGYALQRG
DIRLQDTVASQWPALNGPQWRAITLQQLATYTAGGLPLQVPDAVTDTAQLLDFYQRWQPR
WAPGTMRSYSNASIGLFGMLAVRPSGMDFSQAMTRWVLQPLGLKHTYFRVPPAAEGEYAW
GYREGKALRVSPGMLEQEAYGIKSSAQDMATWLQANLDPAAVTQATLRQALLRAQTRYYQ
SGEMYQGLGWEMLSWPLQAQTLIDGSDNRVALQPQPVHLIEPPTPPQPASWVHKTGSTNG
FGAYIAFIPGSRLGIVMLANKNYPNPARVQAAYTILQQLQ
>A0A094Z1B0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFESSIIFALILGFVEGITEFIPVSSTAHLLLASRFLGVDLGSSFTILVQLGAVLALLYV
YFYRIIYIFFSFPYDSSSRHFAMILLFGFLPAGILGFFAHHFIKSILFKETIVIYISLIV
GGFILLAVDRVHFQSKYFDIKNYPLLLAIKIGFFQCLAMIPGTSRSGATIVGAIVLGADK
RSAAEFSFFLAIPTMIGACALDSYKNYTSIVSEMRSAIIIGCLASFITSLIVVRFLLNLI
SKRGYTPFAVWRIMIGLIGLISETIF
>A0A029PJ08|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVTRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNNQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A086HV77|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MYLSDLNAQQREPPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRG
ELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMG
QQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERE
LPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEE
NWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>C6CLN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFDGDIAKTFEVIIQLGSILAV
VVVFWRRMFGLIGIHFGQPPQHEGRGKGHLTLAHIILAMIPAVVLGLVLHDTIKSLFNPV
TVTYALVAGGLLLLLAEWCKPKKPKAEGLDDISYLQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVNRYAASEFSFILAVPIMLGASGLDLYKSWHFLSLSDLPMFATGFVTAFVVAMI
AIKTFLHLIKRVSFVPFAIYRFIVAAIVWLVLM
>YP_002384138|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIERPVFAWVLAIILMLAGGIAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMTGLDGLMYMSSTSDAAGNAQITLTFETGTSADIAQVQVQNKLQLAMPSLPQ
EVQQQGISVDKSSSNILMVAAFISDDGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
QYAMRIWLDPQKLNKYNLEPQDVISQIKIQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QSPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSKAVKSELDRLSAWFPASLKTVYPYDTTPFIQISIQEVFKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
SEEGLAPKEAAHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATLLKPTKEVTTGNSLFARFNRLFEASTNHYTDSTRRLLGTTGRYMV
VYLLIVAGMAVLFLRTPTSFLPEEDQGVLMTTAQLPSGSTMVNTSKVLDEITDYYLTKEK
NNVESVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTGIIQRAMVALSAINKAVV
FPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLAMAAQAPDQVTGVRPNGLED
TPMFRVNVNAAKAEAMGVSLSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLP
DNINQWYVRNASGAMAPLSAYSSTEWTYGSPRLERYNGLPSMEILGEAAAGKSTGEAMDF
MASLVAKLPAGVGYSWTGLSYQEKLSTNQAPMLYAISLIVVFLALAALYESWSIPFSVML
VVPLGVIGALLATDLRGLSNDVYFQVGLLTTIGLAAKNAILIVEFAVEMMQKEGKSPVEA
IIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVP
VFFIVVEHLFSRFKKRT
>A0A0A8GWS4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRLINIQKKINNTTILENVNLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSNGKYFL
DQYEVTNLNKDEKARIRREKIGFIFQRYNLLNLLNAKDNVALPAVYAGKNKQERSQKAKE
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNEQGHTVVLVTHDREIAARAKRVIEIKDGKIISDNGTKKADEIKVKLMPKEKKNFNL
LKNQLFESLKMSIAAIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQNILASISSIGT
NTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLPYLEAVEADVGKVGVVTYKNNSLQARIH
GVGPNHLRLRGFVMVDGRFINNEDIKDNANICIVDENALRILFDNINAKYVLGKSIIFNK
QPLTIVGVLKKERDNKDFRPDENTIKIYTPYSTLMNKITGDKQIRAIVTKVKDEVNPALA
EEAMVKILEIKRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAIFGVMLSFVIIEVFNSLNIGF
TMILSLNSVFLGLLSSVLIGVIFGFFPAKNAANLNPISALSKE
>A0A078KQC4|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MMVNKTFIALGLLFCTSTWAEGTCFLAKENQTLLKQEGKDCEQRYAPQSTFKIALSLMGF
DSGILKDESHPLWPYKKGYEFYFNVQQYPKDPHSWIRDSCVWYSQVLTQDLGMERFKAYV
DAFHYGNQDVSGDKGKNNGLTRAWLSSSLAISPMEQIQFIQQIVNKKLALSPKAFTMTKK
ILYIQELFGGWKLYGKTGSGQQQGWFVGWIEKDGRVIAFADHMTERKESKVPASFRAKND
ALTQLYFLINDLEKNA
>R6C0P7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTIIISIVEGLTEFLPVSSTGHMIIAENLLGVDIQDKFVNAFTVIIQFGAILSVIC
LYWKRFFYPEAVKTGEKTYLKAMFDFYARLVVGTLPAVVLGLAFNDFIESNLGNVQLVGW
MLVIGGIFMLFCDKIFNKGSEQTKLTYKRALIIGFIQCIAMIPGVSRSMSTIVGGMSQRL
TRKAAAEFSFFLAVPTMFGATCLEVYKLISHGGGSLLTQGNNLFTLILGSVVAFIVAILA
IKFFINYVTKYGFAAFGWYRIVVGLIIIICGLCGVDMQMVD
>A0A0A3GDY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRTDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPAATG
>YP_042788|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSLGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKEQNM
>BAB71968|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTAI
TSFQWKNTKINIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMREMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPLYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0N1KK96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVVGSLLNFTDDHAKTFDVVIQLGAILAVC
WEFRRRIGSVVVGLPSRPDARRFTLNVIIATIPAVVLGLLFEKAIKAALFSPVPVAFALV
AGGVVILWAEARQRARGDVAARVQNVDDLSPLDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATAYELYKDWHLLSVDALGSFALGFVAAFISAFACVR
WLLRYISAHDFTVFAWYRIGFGLLILLVGYSGALSWAD
>D9R5S6|FEATURES|UNIPROT_deepARG|chloramphenicol|Closa_2701|antibiotic inactivation|1
MFQKIDRSTWKREEYFNHYFSNLPCTYSMTLQLDITILRKKNLSLYPTMLYLITSVVNRH
EEFRTALDNSGDVGVYDYLSPCYTVFHKESETFSNLWTTYSPDYEKFCADYKKDIQEYGS
IDRMIAKPHAPENTFPVSMIPWSSFDGFNLNLQKGYDYLLPIITMGKFKVVNGRYFLPLA
VQVHHAVCDGFHLSRFFNELQELIEQFLKN
>B2UN93|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILEIIILGIVEGLTEYLPVSSTGHLLLTESLLNMSQSKEALDALAVCIQGGAILAVLS
LYFPRVKAMAQGMRGNNPAGLKLLVNLILAFLPAAVVGLCCASLIKEYLFNTYTVAYSWI
VGGGVILAYCAWRAREGRSNEGDSGASIESLTPAKALTVGALQCVAMIPGTSRSLMTMLG
GMFVGLSVEAAVEFSFLLGLITLGAATVHDAYKDGALMLESFGWEALAVGTAVSWLSAWL
AVKWMVSYLQRHSFSVFGWYRIAIGIVTLVLLSMGLVH
>I6YE46|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
RIMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDE
RFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSA
AALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPR
AMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTN
DIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAA
>A0A0M9Z3R9|FEATURES|UNIPROT_deepARG|beta_lactam|ADK97_23745|antibiotic inactivation|1
MSSRDRQRERRGDVEQTRRAVLTLGAGVALGAALPAGAARAAAPGGGGEAVRRLRALERE
YGARVGAYARDTGRGRTVLYRADELFPMCSVFKAPAAAAVMRDLDRDGEFLARRIHYTQG
DVTAAGGGSVTERPENIAGGLTVAELCSAAIAQSDNCAANLLLRELGGPTAITRFCRSVG
DRTTRLDRWEPELNSAEPSRVTDTTSPRAIARTYGRLVLGDALVPRHRELLTRWLVSNTT
SDDRFRAGLPRDWVIGDKTGAGSYGTNNNVGIAWPPGRPPVELAVLTTKPDAAAPRENAL
VARAAEVLAAALT
>T0QJB3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELRGIERSYSAGEQQIKVLDDVTLSIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SRGEYRVAGQNVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKTV
RRQRAIELLGRLGLDKRVNYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAVQAQRIIEIKDGHIMNDSGSQLSKTVTEAPPIT
AKISSIRQIFGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SDIKEIATNTISVYPGEDFGSDDPASKQALKIADVNAIRAQPYILAVSPDIEGGARLRKG
NIDVAARVSGIGDEYFQVYALRFAQGMGFTSDMVRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSALGSDSSLHVWLPYSTMTSRLLNRNYLDSITVRIKDGHN
SKEAEQKIVRLLTLLHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGILGIALSYTIAFIAQLA
LPGWSFVFPASGFTECFRLFYRNWSDIWVFAGP
>A0A0M0L8K5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIQGINHLLFSVSNLEKSIEFYQNVFDARLLVKGRATAYFDVGGMWLALNEEDISRNEI
HQSYTHIAFTIKDSDFDEMYEKLRSLNVNILSGRQRDQRDKKSIYFTDLDGHKFEFHTGT
LQDRMDYYIQDKKHMEFFNDSKPQ
>A0A0H3EMD5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKSASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQTGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A127SCS6|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MLLSGLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALMGYD
SGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQLSVIWYSQRLTEWLGEARFQHYVD
SFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAKTLRHTANL
MRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQKPGKQ
FASLRAREEVFAALPARLKTL
>D8NMT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIRGLPNDPRQQRFAVNVIVATIPAITLALIFGKTIKAHLFNPIVVASAFI
IGGLVILLVEWRERRRGQTHDPRGNALLEAAKAGAPRIETLDDLRLSDAIKVGLAQCFAL
IPGTSRSGATIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGIIVLVTAYTHLIAWQA
>A0A0H5A4E3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLLDFTGDRFNAFNIIIQLGAILAVV
WEFRGKIFEVVSGLPTQRKAQRFTVNLLIAFFPAVVLGVIFADLIHHYLFNPITVATALV
VGGVIMLWAERREHEVHAETVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0K2PET5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDTDVEVLKGVSLTIHAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLDSDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
RQARARELLARLGLEARVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPNVAAQAERVIEIRDGEIISNPPPVATRDGAGLNAQP
HDAPALGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPAVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKASVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSVTVRVKEGYD
SGEAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSLLIAFSLQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARSAARLNPVDALARE
>A0A0G0QUG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILHIFTLSVVEGLTEFLPISSTGHLILTSKLLGIGDSNFVKTFEIVIQLGAIMAVVVL
YTKRFLSIKLLKKLFVAFIPTAIVGLTLYPFIKNFLLGNSVVTLNALFWGGVALVIIERL
LQKRELGGPVDYEKVTYKKAFLIGSFQCLSIIPGMSRAAATIIGGLSTGINRATATEFSF
LLAVPTMMAASALDVYKSRQYISQSGTLTLFIGTVFSFIFAMIAIKFLVNYVKKHNFIVF
GVYRIILAILFWLFVM
>A0A0S3K9F1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLSNLWKAIILGIIEGVTEWLPISSTGHLILVDEFIKMNLSKDFMEMFNVVIQLGAIMA
VVVLYFHKLNPFSPQKDQTEKKDTWILWSKVVVACAPAAIIGIPLDDWLEAKFHNFFTVA
LMLIVYGIAFVVIEKRNRNRKPKCTDLREFTYKAAAIVGFFQVLSLIPGTSRSGATILGA
IIIGASRFVATEFSFFLGIPVMFGASFLKIVKFVMKGNSFGFGEIIILLTGSIVAFVVSI
VVIKFLLNYLKRNDFTAFGWYRIILGVLLISYWLFS
>W4CN95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGLVEGLTEFAPVSSTGHMIIVDDMWLKSQELFGQYTANTFKIVIQLGS
ILAVVVIFRNRFIDLLGLRRFSRKQLDPVTEKLPQLEQGGHLKLTQVLVGLVPAGVLGVL
FNDYIDEHLFSTSTVLIGLVIGAILMIIADLFGPKKIRTESVDQITYKQALGVGLVQCFS
LWPGFSRSGSTISGGVILGMSHRAAADFTFIMAVPIMAGASLLSLMKNWQYFTMDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIILAAVVYFVFF
>AAC43174|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWXQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYSMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIAAHNAALAETA
AVELSLATGVAQLYYSMQASYQMLDLLEQTHDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIRPVALPQVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLHTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AGPVVEKK
>A0A059WIE4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDRLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>E6SNV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLSTLEVIIIAIVEGLTEFLPVSSTGHMIITQNLLGVESTEFVKAFTVIIQFGAILSV
VWLYWKRFFHLNPIKVFDAEATVGKTFFAKLGIWLKRFLQKFDFYWKLLVAFVPAAVLGL
LFNDKIDELLESVAVVAVMLVIGGVFMLFCDKIFNKGSDDTVLTEKRAFNIGLFQCIAMI
PGVSRSMATIVGGMAQKLTRRQAAEFSFFLAVPTMFAATAFKVLKLFTDGGMEIIVNNMP
ALIIGNIVAFIVALLAIKFFIGFVTKYGFKAFGWYRIIVGGLILILLLTGHTLEIM
>ZP_03280975|FEATURES|ARDB_deepARG|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLALHARWNTGAYLTCGDLWVCLSYDEARQYVPP
QESDYTHYAFTVAEADFEPFSQRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGNLA
ARLAACREKPYAGMVFTSDEA
>A0A0N7CNR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVV
VLYFHKLNPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIA
LIVYGVLFIVIENHNQNLRPRFDSLNTLPYKVAILIGCFQILSLIPGTSRSGATILGAIL
IGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLILAVGVIVSFVVAYAS
IRFLLNYIKTKDFKAFGWYRIILGVIVIAYFVLLAH
>J9C964|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDGRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>D7PIH2|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKS
>A0A0R0CRS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLLAALLLGIIEGITEFLPISSTGHLLIAERWLGHRSDLFNIGIQAGAILAVVLIYRR
RLWGLLSAFAGHDAPAKYDPLGIASTPAQSRTYAYKLMLAFAVTAVCGLLVKRLGWELPD
RVQPIAWALILGGIWMVVAEYFASRRALALGERNTITWTVAILVGIAQVVAGVFPGTSRS
AATIFVALLAGTTQRSAATEFAFLVGIPTMFAATGYELIDVIQSGEAANEDWSAFLVAFI
ASAITAFIAVKWLLTYIQSHRFTVFAVYRVVLGAALLIFV
>A0A0B1YBY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIEVVKGLPNDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGFVILWAEWRERHRGETHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGVIVLVTAYTHLIAWQA
>N9PMC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKDTYFSSWESFKRQAWYVVLATLITGVLGLALQALIKHVFFGGASSFEIEHLFS
NSKLMAAALAAAGILIILSSRLDRGQQGNINLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQRAEEFSFALAVVLTPAVILKELYRLVHAQGGQAVANGQLSHVITPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCLGFAVVVLCIH
>G8LJX8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTQPASLPRSISLQEIDMFSAPPVQKVSVVIPVYNEQESLPELISRTTAACDTLGKAYE
ILLVDDGSSDNSALMLTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDAD
LQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCM
LRAYRRHIVDAMLHCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMY
DLITCLTTTPLRLLSVFGSIIAVFGFALSVLLVLLRLIYGPQWAAEGVFMLFAVLFMFIG
AQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKASQEEIHP
>J3A3M6|FEATURES|UNIPROT_deepARG|chloramphenicol|PMI05_03422|antibiotic inactivation|1
MKFQRIDLENWSRKSYFEHYLNRVNCTFSMTANIDITELLPALRQKGMKLYPAFLYMVTN
VVNAHREFRTSFHTDGELGYWESMIPSYTFFHQDDQTFSTMWTEFADEFHVFYQNYVADM
KQYGDNKGLVAKELEPPYTFPVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFEQEGKT
LLPVSLQVHHAVCDGYHASLFINDLQKWAKDYKEWLGVE
>YP_002081114|FEATURES|ARDB_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
EEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWML
VYALVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDI
GRLHVRNEQGEMVPLATFAKAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEQ
LMQGLPEGIAHEWSGQSFEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVP
LGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEA
ARLRLRPIVMTSLAFGFGVVPLALSSGAGSGAQVAIGTGVLGGIVTATVLAVFLVPLFFL
VVGRLFRLRKAPRTGNSPQIPTEQA
>A0A0K9MK87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLWEAFVAIVLGLVEGLTEFAPVSSTGHMIIVDDFLFHTKDLFSPEVANTFKIVIQLGS
ILAVVVLMWDRFMSLLGLNRLAGKREVQAGPRLNLATVIVGLIPAGILGVLFDDYIDEYL
FSTKTVVIGLVLGALLMLAADWFRPGRPKIESVDQITYKQAFLVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMAGASFLSLLKRWDAITMESIPFFVIGFISAFV
FALLSIRFFLKLINRIKLTPFAIYRLVLAAVIYFVFM
>A0A0E3Z6W4|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
VAPIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMM
STFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITM
SDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATT
LRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAAL
GPDGKPSRIVVIYTTGS
>A0A0F5SB35|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDHSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDVIITLDADLQNPPEEIPRLVATANEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSILLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>A0A0W0PCC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAMQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKIMEVVTGLPTQRNAQRFTLNLFIGFLPAVVLGVIFADKIHEYLFNPITVAVALV
LGGFIMLWAEKREHAVRVHHVDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKFHHLFQPADFPVFALGFVVSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLIILATWQFGWIDWSSAQG
>A0A0Q7FG97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
IYEYWGKLWGAAIGLFSGEPKGRHLGISIIAASIPIMLVGLTFGDIVKELLFNDISVAIG
LIVGGLIIWWVEKNPPKVNAVEVENISIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLG
VSRKAATEFSFFLGIPVIVGAGLLDLFKNYHIYETTQDWTVFFVGLIVSFVSALILIRVL
VAYVSKRDFMVFAWYRIASGLLILLFALTGWKLW
>X0RUF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLFVQAVIMGIVEGITEFLPISSTGYLILSADVMGFWTKEKVDLFVVVVQLGAILAV
IYDYWGRLWQALMGLLTGKAEGMTNPRQLGLSLIVSTIPVMIVGFTFADEIKAYLFNPIV
VAIMLIIGGLLIFYVEKRPKTVIAEEAEDVSIKTALMIGLFQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHGDVLTNSEDWLVLGIGTIVSFVVALLC
IRLLVAWVSRRDFTIFAWLRIITGVIVLVAAWGFGYQMAG
>BAG76461|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>ZP_04213166|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDDMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGSFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETF
YPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNI
NAVVPGHGEVGNKGLLLHTLDLLK
>ZP_02779032|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0W0BBE0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDLIYACARIDCASHGVGVTYIHHETHQMEKATTRSLLVLSTLLLSPLSHAKEAEPLTAV
VDGAIQPLLKEHRVPGMAVAVLKEGKAHYFNYGVAARESGARVSEQTLFEIGSVSKTLTA
TLGAYAAVKGGFQLEDKASQHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSTDKM
HAYYRQWTPAYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQV
PESAMANYAYGYSKEDKPVRVSPGMLAAEAYGIKTGSADLLKFVEANMGYQGDAAVTSAI
ALTHTGFHSVGGMTQGLGWESYAYPVTEQVLLAGNSPVVSFQANPVTRFAVPKAMGEQRL
YNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPNEARIKAAHAILEALAAE
>AAS50177|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|lnuA|antibiotic inactivation|1
MKIDNVTEKDLFYILDFFEKMEVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLKDIGYKIEVDWMPSRMELKHKEYGYLDIHPINLNDDGSITQANPEGGNYVFQNEWFS
ETNYKGRKIPCISKEAQLLFHSGYDLTEKDHFDIKNLKSIT
>A0A0P0GHP6|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM1|antibiotic inactivation|1
RPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVR
ELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNDAIPNDERDT
TMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGER
GSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKH
>A0A0L0L7J1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSARRPTVSIQEFPVSDAEAGPYGIAAGPDGALWFTLVHAGRIGRLTPDGETTSYALSSA
SGGPSLITPGPDGALWFTEFREHRIGRISTAGEATSFALPTPDAGPFGIAVGPDDALWFT
EAGADRIGRITTEGEIVEFPLPVSGAFVSAIAAGPDGRLWFTMNQANAIGAITPDGEVAV
HPLPTPGAGPVGITAGGDGALWFVEIGAGQIGRITPDGKIDEFPLPDRESRPHAIVADSD
GACWFTEWGANRVGRIAYDDRHPETPEIHEHELPTPSSEPHGIALGPDGALWTALETGAV
ARVRPAGNAG
>A0A0H3WJJ7|FEATURES|UNIPROT_deepARG|beta_lactam|TEM|antibiotic inactivation|1
PEETFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRE
LCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTT
MPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRS
>ZP_03052661|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>F7UWG2|FEATURES|UNIPROT_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIIEALKSFLIGIVEGITEWLPISSTGHMILVDEFVKLQVSDQFLALFLVVIQIGAIMAV
LILYFHKLNPFSPRKTAVEKKSTWRLWGMVVIGCIPAAILGFAFDDWVNEHFYNKVTVAA
MLILYGVIFIVLEHRNRRRLQEAEAAIAAPRGRHARIADGDLADEAEAQLFKITEVDDID
WKTALKIGCFQVLAMIPGTSRSGATIIGGMLCGCSRTAAAEFTFFLAIPVMLGWGLVKAV
KFIAAGIAMTSTEIVVLVVGIVTAFVMSVISIKFLMGYIKKNDFTVFGWYRIVVGVLVIG
YFVFETMGMLP
>AAY68306|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYINWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDVLGAVI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGIFALLLLGTLYTFVYMPINA
LFPLISMEYFNGKPVHISITEIAFASGMLVGGLILGRLGNFEKRVLLITGSFFIMGASLV
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDFK
>J7XPB3|FEATURES|UNIPROT_deepARG|beta_lactam|IEE_01997|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISLSQLNKNVWVHTE
LGYFNGEAVPSSGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFENMKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNMNSVVPGH
GDVGDKGLLLHTLDLLK
>Q849S7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
KRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLDIN
AADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDA
TFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNALGEQQRAQLVTWL
>A0A089PVJ1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGEEQVEVLKGISLTIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SHGSYKVAGVDVAGLDNDALATLRREHFGFIFQRYHLLSHLNASQNVEVPAVYAGTTRAQ
RQQRAHELLGRLGLKERVEYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLRERGHTVIIVTHDPAVAAQAQRIIEIRDGEIISNPPPVHQPSARAVENQA
LRSGSSVQQVISSFREALGMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LEDIRSIGTNTIDVYPGKDFGDDDPQFQQALKYDDLLAIRQQPWVSSATPSISSNLRLRY
GNVDAAASVNGVSGDYFDVYGMTMSQGASFNDEQMNGRAQVVVLDANSKRQLFPNKSEVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKVLRVWLPYNTMAGRVMGQSWLNSITVRVKEGY
DSHEAEQQLNRLLLLRHGKKDFFSYNMDGLLKTAEKTTRTLQMFLTLVAVISLLVGGIGV
MNIMLVSVTERTKEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQL
VLPGWQIGFSPVALLTAFGCSTATGVLFGWLPARNAARLNPIDALARE
>X8KA26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYLIEILKSIFFGIVEGITEWLPISSTGHLILVEEFVQYKDQNEAFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKNKAEVRRTWQLWSKVLVATLPLLLVFKLDDWFDTHFHNMVSVA
IMLIIYGVAFIYLEKRNKAQAIEPTVTELEKLPYKTALYIGLFQVLALFPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGQLLSFGQLFLLLVAMGVAFAV
SMVAIRFLTSYVKKHDFTLFGKYRIVLGSVLLLYSFVRLFV
>Q1WBU3|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_shv2|antibiotic inactivation|1
SLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFK
VVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNS
AANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKL
LTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNN
KAERIVVIYLRDTPASMAERNQQIAGIGAALINLGT
>YP_001346276|FEATURES|ARDB_deepARG|multidrug|OpmD|antibiotic efflux|0
MKHPHFPRLALALGIAASLAACSVGPDYQRPQTPATRIASQHAGEFSAERRQAPWWSFFD
DPQLVRLVDQALARNHDIREARANLRSARALYDERWLDQLPQVTSQAGYNRSLAQQADYD
GEPRRRLSESYRAGFDAQWEIDLFGRLGHLSDAALARAEAASADLELARLSIAADTARAY
FEVQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEEVENAQANLSRSEAAVPPLTS
ALEAARYRLDVLRGEAPGSGAPVLDGGAAPLAKNLPLGDVDYLILQRPDVISAERQLAAS
SEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPAVSWPAFRLGNVRARLRA
AEAQSDAALARYQRTLLLAQEDVGNALNQLAEHQRRLVALVRSASHAGNALEIANERYRA
GAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGTDSRLPEVRQLAAGEGR
>J1ZMY6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSPRAASFQRFPVSDSGAGPYALTPGPDRALWCTLVHAGQIARLTPDGQLACHQLDSAIC
GPTVITAGPDGALWFARSQDHRIGRITVTGEATSFPLPTPGSGPFGMVSAPDGALWFTQL
HADRIGRITTDGQVTEFPLPVSGAFASALTTGPDGALWFTLNQAHAIGRISLRGEITTYP
LPTENAAPVGITCGADGALWFVEIGAGRIGRISTDGRIEEFPLPDPASRPHAIVAGPDGD
CWFTEWGANRIGSITPDGRIEEFDLPTPSSEPHGLTFGPDGALYVALETGEIVRMVP
>AAM48125|FEATURES|ARDB_deepARG|beta_lactam|CfxA2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKANNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLVTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A0A0XCI2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNQVEMTEFPVGKPEEALYGVASTPDGALWFTLAKGNAIGRLSPDGEVSRFPLPHADGQP
TTITCGPDGRPWFTLSSANAVGRLSPDGALRMFELPRPASRPFGIAAGHDGCLWFAEMAG
DRIGRITIDGDIEEYDLPVKGGYPSCMAAGRDGLMWFTLNQAGAIGSISATAAPRIFPLG
AADAAPVGIASDAQGALWIAQAGNGAIARFDAGGRITEFPLHSRAARPHALAADAAGNLW
FTEWGANRIGRISEAGDTAGYELAAPGSEPHGIAIDPHGCVWAALETGSLVRLQASPRD
>A0A0M9IB77|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTTLYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWINFESSQGKVFEVVIQLGSILA
VMWIFRARLLQLIRGTLTGVASEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPGVVVV
TLVLGGLIMLYVERRTRHTPGDVPGAADDTASDERATARTLEQITWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMDLLTQHDLSGIA
VGFVAAFLSAIVVVRAVLRFVANHTYRVFAWYRIVFGAIVAAWIFTR
>A0A0N1DPX8|FEATURES|UNIPROT_deepARG|aminoglycoside|AOG23_11490|antibiotic inactivation|1
MESMIEVGTIKDLEPWARLRLALWPHHSLEDHRAELSRAFLSENAEAVAFIARNAANDAV
GFAEATLRHDYVNGCSSSPVLFLEGIYIRPVDRRKGIAGLLCNAVAVWGKSLGCVEFGSD
APLENSASHALHAALGFEETQRVVFFRKPL
>NP_976271|FEATURES|ARDB_deepARG|aminoglycoside|str|antibiotic inactivation|1
MRTEKEILNLVSEFAYQRSNVKIIALEGSRTNENIKKDKFQDYDFAFFVSDIEYFTHEES
WLSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGL
VKILVDKDNLVTQEIVPDDSNYWLKKPTEREFYDCCNEFWSVSTYVAKGVFRREILFALD
HFNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFNMLLATFEMNGYRKTY
QSFKLCCELFKYYSNKVSCLGNYNYPNYEKNIENFIRNNYEN
>A0A0A0Q8Q2|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVVLANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A074LBM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILSSIIMGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVLAVVV
LYWRRFLSLFDFRRKISSQPRLNLLHIILAMIPAGLIGVLFRDVIKQYLFGPETVLYSLV
IGGLLMIAAEKFHPPIRSHTLDEITYKQAFTIGVFQVLALWPGFSRSGSTMSGGLFARLS
HTAAAEFTFLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITSFIVGMLAIKTFLGL
LKRLSLTTFAIYRFVLAAVFFFIIL
>NP_832233|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALK
>U4TMQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIVKAILLGIIEGITEFLPISSTGHLYLANEFIKLDETKAFITMFMVVIQLGAILAVV
VLYFHRLNPFSPKKSHTEKHDTWILWFKVILAVIPSMIVGLIANDWMDAHLNTWQVISAT
LIIYGVLFIVIERWNAHRTPKETDLAQLKPATGFEIGLFQLLSLVPGTSRSGATILGGIT
IGTSRYVATEFSFFLAIPTMVGASGLKLVKYLIKGNTFSGDQLLILIVGTAVSFIVAYFA
IRFLLNYIKRNDFQGFGWYRIVLGLLVIAWFSFHG
>A0A151V1F1|FEATURES|UNIPROT_deepARG|beta_lactam|B4079_1038|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNEAGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLITSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKQYGNINLVVPGHG
EVGDRGLLLHTLDLLK
>A0A0R1JME6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKAVIIGIVEGLTEFLPVSSTGHIDLVNSVIHLHESANFTAMFTYVIQLGAIFAVI
LLYFNKLNPLDPRKTKPERRSIWVLWSKVIVAVIPSVIIGLPLNDWMDTHLHKPLVVASM
LILYGILFIVIENLYRHRQPRITNLAEIGFNTALFIGLFQALSIVPGTSRSGATILGAII
LGTSRYVATEFSFFLAIPTMFGVSILKIGKFLLTGGSFTGQEWAVLLTGTLVSFVVAWAT
IKWLLHFVQGHDFKPFGWYRIALGLVVILVLFL
>J9Z0M8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIDYLFYIFYSIIQGVTEFIPISSSGHLNLLELLYSKGDSRNYLYETTAHFSSLLALVF
YLYRQNHLEFNNIKLNVIPITLATIPAVVVGALLILFDINFFSFQIIGYTSILGGILLYL
SDLKVFQVIKISDKKIKFLLAGFFQCLAFLPGFSRSGSCIIAFRLMGENRKNSSVMSLYL
GMPIILISFLSNIRDIDTIQFDFNLLIIFIFTFIFAYLTLRLFISYINDIGFKPFVIYRL
IFGLIILFLLS
>U4VDG9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHNHEVYSSVMRKYTTLLIGFLAGSAIIPPAGGALAAGTINDEELRRIVDETVRPLMAGQ
KIPPGMGVAISIDGKSHFFGYGVASKESGQKVDEDTIFEIGSISKTFTATLGGYGLATGA
FSPPSDPATRWAPELASSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFRKWKPD
YRAGTQRRYSNPSIGLFGYLAARSMGQPFDVLMEQKLLPAFGLKNTFVHVPESRMKDYAY
GYAKADKPIRVASGTRDAEAYGIKTTAPDLLRFVELNIDSASLATDFQKAVAATHTGYYR
VGGANNQGLGWEIYTYPVTLKTLLAGNSSDMALKSHKIEKFDPPHAPSADMFINKTGSTK
GFGAYAGFVPAKKTGIVLLANRNYPNDERIKAAYRILQAIDKSE
>CAY49038|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFWTAIQAVILGVVEGLTEFLPISSTGHQIIVADLLDFTGDRFNAFNIIIQLGAILAVV
WEFRGKIFEVVSGLPTQRKAQRFTVNLLIAFMPAVVLGVIFADVIHHYLFNPITVATALV
LGGIVMLWAERREHEVHAETVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFVIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWIDWTAAKA
>AAA21890|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGKGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAHEAAQRSCEPSG
>A0A060KZB3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFPLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A132BKQ3|FEATURES|UNIPROT_deepARG|beta_lactam|AU385_04395|antibiotic inactivation|1
MKSTRMLKIGMCVGILSLSLASVKFFIGQPLQVEAKEKTEQTNHTNHATHREFAQLEKKF
DARLGVYAIDTGTNQTVTYRPNERFAYASTYKALAAGAVLQQNSIDKLNEVITYTKNDLV
TYSPVTEKHVDTGMTLGEICEAAIRYSDNTAGNLLFKKLDGPKGFEEALRQIGDKVTVAD
RFETDLNEAIPGDIRDTSTAKTLATDLKAFTVGNALPADKRKILTDWMRGNATGDKLIRA
GVPKDWEVGDKSGAGSYGTRNDIAIIWPPNRAPIIIAILSSRDKKDATYDNELIAQAAKV
TINALK
>A0A0D5WTP9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVRALVEAGYDIAAIYTHPDNAAENNFFGSVARTAAEFGIPVFAPE
DVNHPLWVDRIKDAQPEVIFSFYYRNLLSEEILDCASVGAFNLHGSLLPKFRGRAPLNWV
LVKGETETGVTLHRMVKRADAGDIVAQERVAIAAEDTALTLHHKLCETAKSLLAKSLPVI
KTGHFPQTAQDEAKATYFGGRSPKDGAISWEGSAAEANNLVRAVTEPWPGAFSYVGGGKF
IIWKSRVLESNNGAKAGTVISVNPLVIACGTGALEVVTGQAENGVYMQGSQLAQSLGLVS
GAILSSKPVSAIKRRTRVLILGVNGFIGNHLTERLLRDDNFEIFGLDIGSDAISRFIGNE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKSFDEDNSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
GDGIEALFRIIENKNNNCDGQIINIGNPENEASIKQLAEMLLESFERHPLRSQFPPFAGF
REVESSAYYGKGYQDVEHRKPSIRNAQRLLDWTPEVHMEKTIDETLDFFLKTVELTDPAS
>A0A0K6N4S5|FEATURES|UNIPROT_deepARG|beta_lactam|BN2127_JRS10_05047|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILTTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>A0A0J1KXS5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGINHLLFSVSDLETSIDFYTKVFNAKLLTKGRTTAYFDLNGLWLALNVEKDIPRQD
IHHSYTHIAFSIDEEDVDPMYNKLKDLNVNILPSRPRDERDQKSIYFTDPDGHKFEFHTG
TLKDRLDYYKLEKTHIEFYE
>A0A098T387|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGQRAMAFNIIIQLGAILAVM
WEFRRKILDVVTGLPTRPEARRFTANLIVGVLPAMVLGVLFSDLIHEYLFNPITVAVALV
VGGFIMLWAENRQHVIHAETVDEMTWVDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAASVYSGYKYRDLFQPGDLAVFAVGFIASFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWVDWSSVQG
>D9SE32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLLKAVILGVVEGLTEFLPVSSTGHLILVGDLLNFNDDRGKVFEIVIQFAAILAVC
WEYRAKLQSVTTGLLQKQEAAQRFTLNLFIAFLPLAILGLLFGKAIKAHLFAPVPVALAF
IIGGFIILWAEKRTHTESIGSVDEMHWRDALKMGLAQALALIPGTSRSGATIIGGLFFGL
SRRAATEFSFFLAIPTLTMATLYEVVKYRDQFHADDLGIFLAGSIASFISAFIAVRGLLR
YISRHDFTIFAWYRIAFGLIVLGTSYSGLVSWTV
>NP_645128|FEATURES|ARDB_deepARG|multidrug|mepA|antibiotic efflux|0
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
VFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQ
IAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNI
ILDPILIFGFDLNVVGAALGTAISNVAAALFFIVYFMKNSDVVSVNIKLAKPNKEMLSEI
FKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMANKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQDIVEMATFILK
VTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLL
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>A0A145IKI7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTLGKAYEILLVDDGSSDDSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SIIALAGFTLSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEENHP
>A6UJ74|FEATURES|UNIPROT_deepARG|beta_lactam|Smed_4921|antibiotic inactivation|1
MAAIALLSCGGGAHAAGQGDEGQLARVVDEAIRPLMEENGVPGMAVAVTVSGKRYVFNYG
LASKEGGKKVTDDTMFEIGSISKTFTATLAAYAEARGNLSLAEPASKYLPALSGTPFDEI
RLLDLGTYAAGGLPLQFPDAVSGEESMIEYFKSWRPTYAAGTYRLYSNPSIGLFGYLAAK
SMGAPFADLMEETVIRGLALKSTFISVPDDRMDDYAYGYSKAGKPIRVTRGVFDSQAYGV
KTTAADLLRFVEASIDDTGLEEMLRHAITATHTGYFKVGPMTQGLGWEMYAYPPKLDDLL
TGNSARMALEPSKVDKIVPPSAPRKDIWINKTGSTNGFGAYTAFVPAERIGIVMLANRNY
PIAARVKAAYRILSTLDDKLGSADPR
>M5JYP7|FEATURES|UNIPROT_deepARG|aminoglycoside|D584_07793|antibiotic inactivation|1
MGTLVARREHAEAWAQLRHALWPDTSLEQHLQEIYETLDQDDPDAVTFIAESAGGQIAGF
AEAALRRDYVNGCETSPVLFLEGIYVSPEYRQRGTARLLCEAIANWGREKGCTEFASDVL
LENRDSQSFHTALGFDETERVIFYRKLL
>A0A0Q7EWI0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDITLALQALIMGLVEGFTEFLPISSTGHLILAGSLLNFVGEKVKVFEIVIQTGAIVAVM
WEYRARLASVLGGMFSDARAQRFIVNLIIGFLPAAILGFLFNKAIKAHLFSPVPVASAFI
IGGFVILWVEKRAKANPAAVRVESVDDMSALDAFKVGCAQAFALIPGTSRSGATIIGGMM
FGLSRKAATEFSFFLAIPLLLSATVYSLYKERALLSAADLPMFGIGLVAAFVSAFLCVRW
LLRYISSHDFTIFAWYRIIFGLVVLATAYSGLVVWAD
>A0A0A0DJI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLQAALLGLIQGLTEFLPISSSGHLVLARALMDLNEVPVLFDVLLHIATLLVVVWVFR
RRLGWFLASLFRYFSRQTRESDKPNLRLFLRLLVATAITAIVAYIVSGLRVRESPVIVSA
FLMLTALILLSTVSVKGNKNLEELSWVGTLVTGTAQGFGVFPGISRSGITIASGMMVGMD
RRAAGEFSFLLLIPAVAAAFLLSLRDAAELSNTVSISALLVGFTSALIAGYASLKFLLWL
IARGRLWFFAIYLIPVSIMGLLHFGF
>A0A095EWE1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSAREAPPLLELVGVERRFALGDGEVAVLKGIDLRIRRGELLAITGQSGSGKSTLMNILG
CLDRPSSGSYRIDGQEMRTLDGDALARLRREHFGFIFQRYHLLPHLSAEENVQIPAIYSG
AARQARLARARALLARLGLAERSAYPPAKLSGGQQQRVSIARALMNGGEVILADEPTGAL
DTRSGREVMNILLELNAIGHTVILVTHDRNVAAHAHRVVEINDGEIVADRLRDETANPAQ
DETENEPATPLAVLPGDAAPMPPPPARGGADSIHAGSLGAAFRIAWIAMITHRLRTLLTM
LGIVIGIAAVITVVALGQGAQRSVVAAIEAIGTNTIDLSPGRDWGDENARSIHTLSAADA
AALRAQFYVDSATPLVASSQTLQHANVKASASVRGVGEDYFRVHGTRFAQGERFDASQVL
RRAQVVVIDDNTRQRLFRSWEQPIGQIILVGSLPCTVIGVTARNDGLFGPRTDLEVFIPY
TTAADRLTGQSWLNGITVRIRDGVPNGIAEQNITKLMSSRHGIKDFFTNSSDSIVQTVQR
TTGTLTLLILSVAVVSLLVGGIGVMNIMLVSVTERTHEIGIRMAVGARQSDVMQQFLIEA
VLICVVGGLFGVLLSFAVSGAFSLFVKIIVMRFSLLAMLVACLCSTLIGVAFGFWPARNA
ARLDPIDALARE
>Q6QUZ6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGEREILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0M7G5A1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTTLYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWLNFESSQGKVFEVVIQLGSILA
VMWIFRARLLQLIRGTLTGVPSEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPSVVVV
TLVLGGLIMLYVERRTRHTPGDVPGAADDTASDERATARTLEQITWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMDLLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAIVAAWIFTR
>ZP_04263080|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVEKMKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNK
NVWVHTELGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTVLTAELAKKNGYEEPLGDLQTITNMKFGNIKVETF
YPGKGHTEDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNM
NLVVPGHGEVGDRGLLLHTLDLLK
>ZP_02948686|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEFLEIIKAIILGIVEGITEWLPISSTGHMILVDQFLKLNVSKDFMDMFLVVIQLGAILA
VIVLYWEKIFPFKFSNGIKIEKDTMIMWVKIVIACIPAAVIGLLFDDQLNELFYNPTTVA
VMLILFGILFIVIENYNKGKRSKINSLSEITYNVAIMIGLFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEFTFFLAIPVMFGASALKLLKFGLATGFTMTGNELSILLVGMIVAFIV
SILAIKFLMSYIKNNDFKAFGWYRIILGIIVIAYFYLIK
>A0A0D1KLC3|FEATURES|UNIPROT_deepARG|chloramphenicol|SR38_06470|antibiotic inactivation|1
MSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRMLNELQQ
YCDEWQGGA
>A0A127SDJ8|FEATURES|UNIPROT_deepARG|beta_lactam|GES-1|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSPLASERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>W6LZI9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLILKALLLGLVEAASEFLPISSTGHLIIVGDFLDFTGSRAEAFEIFIQLGAILAVV
WIYRERLLDIALNVDWDRKVQRLVINLAIAFVPAAVLGLLLHKTITHYLFNPVSVAGALV
LGGFAILLIERYARTGRVQAMEEMRWKDALLVGIAQSLALFPGVSRSGATIMGGMVGGMS
RFAATEFSFFLAIPTMFAATFYSLYKEWHNLNLADVPMFAVGFMAAFLGGLVVVRFLLAY
VGKHSFAPFAWYRIVFGGLLLLYFHYHPWVGKGG
>A0A103TU92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPVQREARRFTMNVVIATLPAIALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEARQRERGAPARVQSIDELTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFSVDSIGLFSIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWVEWS
>A0A0Q8D3C6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGHRSDLFNISIQAGAILAVVLIYRQ
RLWQLATGFMQRENRDYLLKLIVAFGVTAVLGIVVKKLGFELPDKVLPIAWALVLGGVWM
LLAEHYAAKRAQTLGERTNITWTVAILVGVAQVIAGVFPGTSRSGATIFVALLAGTTSRA
AATEFAFLVGIPTMFAATAYELLDVIGTPAAANEDWTALAVAFAASAVTAFVAVKWLLHY
IQSHRFTVFAYYRFALGAALLLLMPSGS
>P45272|FEATURES|UNIPROT_deepARG|multidrug|hmrM|antibiotic efflux|0
MNFRLLSQYHADIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWM
PLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQY
MQMESKMSDLARDYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNY
IFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTL
KKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMAT
TILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAA
NLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPH
IDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK
>R8HNN6|FEATURES|UNIPROT_deepARG|beta_lactam|IIC_03106|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEATEVIVKALK
>A0A0T9M378|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGITVPLLNFALPSWAVGAKMSLDNQLAELEKSSNGRLGLALINTGKG
TKIHYRGGQRFPFCSTFKLMLAAAVLGRSQSQPNLLSKHITYHESDLLAYAPITRKHLAQ
GMTVAELCAATIQYSDNTAANLLIKQLGGLAMVNQFARSIGDQTFRLDRWEPELNTALPN
DPRDTTTPAAMAASVNKLVLGDALAAPQREQLALWLKGNTTGAATIRAGAPTDWVIGDKT
GSGDYGTTNDVAVLWPAKGAPLVLVIYFTQLKKEAEPRRDVLAAATKIVLAHLS
>YP_002235907|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHKNFNLLLMLVLLVAVGQMAQTIYIPAIADMAVALNVREGAVQSVMAAYLLTYGISQ
LFYGPLSDRVGRRPVILVGMSIFMLATLVAITTHSLPVLIAASAMQGMGTGVGGVMARTL
PRDLYEGAQLRHANSLLNMGILVSPLIAPLLGGILDTLWSWRACYAFLLVLCAGVTFSMA
KWMPETRPEGAPRTKLLTSYKTLFGTGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMAVSILFILPIPAAFFGAWFAGRPNKRFPTLMWQSVICCLLAGLMMWIPGLLGIMTVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMMPQT
GQGSLGLLMMLMGLLILLCWLPLASRFTHHQQPV
>U4T5W1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKEKVDLFVVVVQLGAILAV
IYDYWDRLWQALMGLLTGKSDSMANPRQLGLSLIVATIPVMIVGFTFADEIKTYLFNPIV
VAIMLIIGGLLIFYVESRPKAIIAQEAEDVTLKTALMIGFLQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHGDVLSNSEDWLVLGIGTIVSFVVALLC
IRLLVAWVSRRDFTIFAWLRIITGIIVLVAAWGFGYQMAG
>A0A0V2F910|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLIEGLTEFIPVSSTGHLLLVGHFLGFHSPGNTFQVLIQLGAILAIVSVY
FGRLWGLLTTLPTNPGSRRFVIGILLAFLPAVFIGVLAHDFIKTVLYESPALVCTTLIVG
GFILLGLDRLKFEPKHTDVADYPLKTAFIIGLFQCLALVPGVSRSGATIAGALLLKCDKR
SAAEFSFFLAMPTMAGAFAYDLYKNIDQLSTKDMGMIGLGFVAALISGVFVVKTVLNFIT
RHGFAPFAYWRIAVGVVGLALLYIPR
>N8V0G1|FEATURES|UNIPROT_deepARG|beta_lactam|F971_01394|antibiotic inactivation|1
MPNSKRFSIPAKKLCVLAGLLSCSAPLWAQQLSEQQVKAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNNTLFELGSVSKTFNATLAGYAQAQGRLSLSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTIGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPELQMPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLKQPLRKGIENTHVGYFKVGAMTQGLGWE
QYAYPTKLETLLQGNSSKMALESHAVTSIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYNVIQQLIQQNSAR
>A0A0T5MH99|FEATURES|UNIPROT_deepARG|aminoglycoside|aphA|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>A0A0X3R5M4|FEATURES|UNIPROT_deepARG|aminoglycoside|AR275_13080|antibiotic inactivation|1
MASAPTIRQATPADAGAWAQLRLGLWTDADDPLEELTQSLADAEGAVFLACAADGEAVGF
AEVRLRHDYVNGTESSPVGFLEGWCVQPQWQGRGVGRALLTAVQAWTRDAGCRELASDSR
VEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>W4EL93|FEATURES|UNIPROT_deepARG|chloramphenicol|C176_21376|antibiotic inactivation|1
MKFNIIDRENWNRKEYFEHYLQQQTTFSITNEINITVLMKNLKKKNYKLYPAFIFMITKI
VNSHREFRTSFNPEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNVSRFSEFHSQYEKDVE
EYNGTGSLFPKTPIPDNNIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQIKDELF
LPVSLQIHHAVCDGYHASVFMNELQRFADESADWL
>ZP_03947553|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGGGEDGAIQGLFVLSGIPY
VGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSF
GVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHG
IFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDG
GIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR
>A0A098B8M7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALVEIFKAILLGIVEGITEWLPISSTGHMILVDEFIKLNMSAAFMEMFFVVIQLGAILA
VVLLYWKKLNPFTFDRGVSVKQETIEMWFKIIVSCIPAGVIGLLWDDVFNALFYNYQTVA
VMLIIFGILFIVIENYNKGKRPRVNHLSQITYTTAFMIGIFQLIAAIFPGTSRSGATIVG
GLLLGVSRTVAAEFTFFLAIPVMFGASALKLLKFGFNFTGPELMILLIGMVVAFIVSVIS
IKFLMGYIKKNDFKIFGWYRIILGVIVLLYFSARTIIG
>P16898|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ermA|antibiotic target alteration|1
MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYL
PDCTPTTGSISSR
>A0A0R1Z315|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPKKTHVEQHETWVLWFKVIVAVLPSVVIGLLLNDWMDAHLMNWQVVSAM
LLIYGILFIVIENRNAHRTPQLTDLGRLSYKTAFIIGMFQLLSLVPGTSRSGATILGGIL
IGTSRYVATEFSFFLAIPTMFGASLLKVYKYFHHGGVFTGMQTTILLTGMIVSFLVAYVA
IRFLLNYIQHNNFKVFGWYRIILSVIVITYFGFLAR
>ZP_03281410|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDVISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFGKILLKVNPDGSQVRLRDVAKVELGGENYDVIAKFNGKPASGLGIKLATGANAL
DTAAAIRAELKKMEPFFPSGLKIVYPYDTTPFVQISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAIFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVQKGGHGEHKGFFGWFNRMFDKSTNHYTDSVGSILRSTGRY
LLLYIIIVVGMAFLFVRLPSSFLPDEDQGVFLSMAQLPAGASQERTQKVLDEMTDYFLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGKENKVEAITGRAMGTFSQIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLTGVRPNGL
EDTPQYKIDVDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRM
LPNDINNWYVRGSNGQMVPFSAFSTSHWEYGSPRLERYNGLPSMEILGQAAEGKSTGEAM
AMMEQLASKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLDAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSRKNEDVEHSHPVERH
>H7E9P2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAERIIEIHDGKIVHNPPAQEKKREQDVAAAA
VSTASGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNASGVSGDYFNVYGISFSEGNTFNAVQQRDRAQVVVLDANTRRQLFPNKANVI
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSNQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>B0BNQ6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGSGENTAHVLKDINLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCKIDGKETLNMTSDELSDLRQRKFGFIFQRYNLLPALTANENIALPAIYAGMDNTSR
KARANQLLEKLGLADKTGNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILKDLHKEGHTIIMVTHDANIAANASRIIEIKDGYIIRDERQQPYSEDLKLTKREY
KKPRFFDQLIESFKMAINAITAHKLRALLTMLGIVIGITSVISVVALGQGSQQQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDAMMLNKQQFVDSTTPSSNLNGTVIYGNTNV
TASINGVGEQFVNVKGLKMISGRFFDADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILV
DKKPLTVIGMAQESNNLNQTSLKMWMPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKS
INELLTAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAILICLLGGIIGILFAMAIIFSFNTLGTNFKMI
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>A0A0W7W790|FEATURES|UNIPROT_deepARG|chloramphenicol|AUL38_02610|antibiotic inactivation|1
MSAATPIDLAAWPRRQHFDHYRTVVPCTYSMTVELDVDNFVEALGQSGRRTYLAQIWALA
SVVNRHSEFKMSLLPGGAPAVWDVIHPSFTIFRAETETFASVWCPFDADFGTFHDSAAAL
IRKHRDETDMFPQGPPPPNVFDVSSLPWASFTGFNLNIAESWDHLAPIFTLGKFVERVGQ
TKLPLAVQVHHAAADGFHVSRLVNEVQALMNDPVWVE
>A0A0P7K0P7|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MQLNQSNKYIRIKDFLMEHNYPNFRMKQILHAIFKERIDKFNEMNVLPKSLREKLVKEFG
ESILDVVPLMEQHSEQVTKVLFGIAGDEKIETVNMKYKAGWESFCISSQCGCNFGCEFCA
TGDIGLKRNLTSDEITDQILYFHLKGHSIDSISFMGMGEALANVQVFDALNVLINPELFA
LSPRRLSISTIGIIPSIKKLTQNYPQVNLTFSLHSPFNEQRSKLMPINERYPLLDVMETL
DEHIRVTSRKVYIAYIMLPGVNDSIYHAKEVISLLRGRYKRGNLFHVNIIRYNPTISSPT
RFQEVNEHHVVSFYKELKSAGINVTIRSQFGIDIDAACGQLYGNYQKNNIQ
>ZP_04226949|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVVAMFAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFFIM
>A0A0B2Y181|FEATURES|UNIPROT_deepARG|beta_lactam|QQ25_13645|antibiotic inactivation|1
MTGLSRRNVLIGSLVAVAAVGAGVGNAAPAFAAPIDDQIAELERRDNALIGLYATNLDSG
RTITHRPDEMFAMCSTFKGYAAARVLQMVGRRQISLDNRVFVDPDAIVEYSPVTEPRAGG
EMTLGELCRAALQQSDNTAGNLLLKTIDGPPGITAFARSIGDQRTRLDRWETELNSAIPG
DPRDTSTPAALAGGYREILAGDALSPPQRRQLQDWMRANETSSVRAGLPEGWTTADKTGS
GDFGSTNDVGIAYGPDGQQLLLAVMTRSQADDPKADNLRPLIGELAALMLPSLL
>A0A0A7KEM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIVYGIVEGITEFLPISSTGHLILTGNLLGVPWPPDVKNTFEVVIQGGAILAVLA
YYWRDFLKIRHIGTDKSQQTLWLGVVVACIPAVILGLLFGDVIKANLFRPSVVAWALIVG
GVVMWLVESRKATPVIHDIETIGVRKSLLIGTIQCLALLWPGFSRSASSILGGMVLGLDR
PTATKFSFYLGVPTLGGAALLDFIQSRDILAQIGVINVVLGAAVSFVVAYLAIGWLLRFI
STNNFKGFAVYRVVVGALILVLIATGVMGNGSLA
>ACI80986|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHHCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>W8Z1P0|FEATURES|UNIPROT_deepARG|beta_lactam|BTDB27_002992|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADTSLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGGEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>A0A0H3W0W5|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
AIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAI
NSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNK
IIKEIGGIKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANG
KLSKENKKFLLDLMLNNKSGDTLIKDGVSKDYKVADKSGQAITYASRNDVAFVYPKGQSE
PIVLVIFTNKDNKSDKPNDK
>A0A0D8DXU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>ZP_02463551|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARMRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKAQAAYL
AALDKRQRYDELVRDRAVSERDHTEALADERQAKAAAASARAELARAQLQLDYATVTSPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAAEVESLRRAVKSGRAAGIAQ
QDIEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AIARDAILVPRDALLRTADGATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VDDAAQFEAGATVKAVERGGAAQPASGSAVAAAPDKRQT
>A0A0Q7PIS8|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD14_09375|antibiotic inactivation|1
MTSRWQVRRAAEADVGAWAELRAALWPEDDAASHAVELRRVLAQPCGTIGFLAIDADGRA
CGFAEAALRRDYVNGTGSSPVGFLEGWYVVPEARGRGAGRALVAAVEQWTREQGCAELAS
DVLLDNQPGHRAHVACGFEETERVVYFRKHLSG
>V6F3R4|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
METILHALLLGIVEGLTEFLPVSSTGHLILLGDLLGFQGPPGKTFEIVIQLGAILAVCVV
YWRRLSGAAIGMFTNDRDMFFVRNILIGFLPAMLVGVVAYKHIRALLDSPIIVAIALVVG
GVVILVLERVNKHPRFHAVEDFPVSLSVKIGLFQCLAMVPGVSRSGATIMGALLVGADRK
AAAEFSFFLAIPTMLGATAYSLYKNWSELSFDNMGLIALGFAAAFIAALVVVRAAIGLIL
RYGFTPFAWYRIVFGGAMLVFLLGR
>A0A0D0PVW2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKVVIFAYHDIGCTGIESLLQAGYQIQAVFTHADDPGENRFFDSVAQLCAEHDLPVFSPE
DVNHPLWIERIRELAPEAIFSFYYRNMLKQEILDIPTVGAFNLHGSLLPAYRGRAPINWC
LVNGETETGITLHRMTAKPDAGDIVAQQAVAIADDDTALTLHGKVRQAAHALLEGELVKL
KRGESRFTPQDESKASYYGRRTPADGELHWHRPARELNNLVRAVTQPYPGAFSFAGDRKL
TVWKSQPLAIQSDRQPGTILSHDPLRVACGEGVLEILAGQAEGGLYVRGTQLARELGLVE
GMKIGAKASNALRKARLTRVLILGVNGFIGNHLTERLLQDGGYEVYGLDIGSSAVDRFIG
HPNFHFVEGDISIHTEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVR
YCVKYNKRIIFPSTSEVYGMCDDHSFDEDESRLIVGPINKQRWIYSVSKQLLDRVIWAYG
KKEGLNFTLFRPFNWMGPRLDSLDSARIGSSRAITQLILNLVDGTPIQLVDGGAQKRCFT
DIEDGIEALFRIVENRDDRCNGQIINIGNPDNEASIREMAEVLLAKFDAHPLRDHFPPFA
GFKLVESKSFYGDGYQDVSHRRPSIRNARKLIDWEPTIEMEETIGKTLDFFLQGAVTTGV
EHD
>C7CLJ2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKAAQNDGTHDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFG
>U7A3B2|FEATURES|UNIPROT_deepARG|beta_lactam|P308_21355|antibiotic inactivation|1
MRQTTLTGLTMISACTLLVLAPHALAETSPEHALKATVDATIRPLMHQQGIPGMAVAIIA
GGQRHYFNYGIASKDNQRPVDNDTLFEVGSVSKTFTATLGGYAQASGKLALQDPASQYLP
ALRGSVFDGVSLLQLATYTAGGLPLQFPDEVQGEAKTLDYYNTWKPRFEPGTQRQYSNPS
IGLFGYLAARSLGQPFDQLMEGLLFPKLALKHSYLHVPKDQLEHYAQGYDKQNRPVRVGP
GPLDAEAYGVKTSAPDLLQFVADNLQPGQLDGTLQRALASTQSGYYQVGDMTQGLGWERY
AYPVPLARLMAGNSTPMALEPHPVQWLTPAQPPKADALYNKTGSTNGFGAYVLFVPGQQV
GIVLLANKNYPNEERIKPPTRSSTPWIAHAKGAPRRPSSQAPRAGNGYVAPGLSPWPRRL
DSMNPLDRLPRQGWPTAARLYQDRVRKPADLQAQACTLNLPRPFPVDNCNRARVASVLQA
TGQVSKPPERRPVITTMQIARIKAWGAHGFTATGVVSALLATLALFDNQPKACLLWLGVA
LLVDGVDGSLARKVKTSSVLPNIDGSVLDLVIDYLTYVFIPALFIYRYIPLPEYSALLAT
SLILLSSLLCFCNVNMKSHDNYFQGFPAAWNVVALCFYLIEPGPWITLLSIFVLALLTAT
RVQFLHPFRVRKWMPVNIIVTFVWLLSGALLILGHPQHNPAIMGLWLAASAYFLGICLWR
SAQDWLGKAS
>F1DI12|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
ETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGG
PGGVTAFARAIGHETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQR
AQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDY
>A0A0H4RWU0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MFYTSKLKKMMPALALSCAAVVGFSSSGVQAETVKCQKQETKSDREFAKLEEKYDANLGV
FALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLVNYNPIT
EKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPERFEPDL
NEVNPGETHDTSTARALASSLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRAGVPKSW
EVADKTGAGSYATRNDIAILWPPNGDPIVLAILSDRTEKDAEYHDKLIAEAAKQAVKALK
ATYK
>A0A0A0Q8L1|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKSVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGA
LAVKPSGMNYEQAMTTRVFKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A119Q4D9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACVTATAGRAGAATPDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVGKYLPA
LQGKPFGVVTLLDLGTHTSGGMPVQVPDSIRDDAGLIRYLDAWRPAHAPGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQADYAQGYTPDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGLPASAIKPPLAPSANTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSFPNEDRVKAAYGILGALDGRR
>B0BL23|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLARTFDGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLASRADQ
LEEFVHYVKGEITKVVGK
>A0A0A7ME56|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKYFGSGDNKAHILKNVNLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRIDGKETQQMNSDELSDLRQRKFGFIFQRYNLLSALTANENVALPAIYAGMDSRSR
KARADQLLDKLGLSDKTLNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLQILQDLHKEGHTIIMVTHDPNIAATASRVIEIKDGQIIRDERQQPYSEELKLVKREH
RPPRFFDQLIESFKMATSAIMAHKLRALLTMLGIVIGITSVISVVALGQGSQERILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDATMLNKQAYIDSTTPSSSLSATVISGNTNV
TATVNGVGEQYLNVRGLKMVSGRFFNTEDVVLSAQVVVIDANTKKDLGLAEPVEGKVILV
GKKPLKIIGLAAESNNMNQTSLKMWMPYTTLMQRISGEKHIDSLTVKVKDNIESQTAEKS
ITELLIAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQSNILQQFLIEAILICLLGGVIGILFAIAIIVTFNTLGSNFQMV
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>A0A0C2H7B8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQGVNHLLFSVSDLEESITFYKNVFDAELKVKGRTTAYFDMNGIWLALNEEQGIPRNE
IHDSYTHIAFSIDEADFEDMVEKLHSCNVNILEGRKRDTRDRRSIYFTDPDGHKFEFHTG
TMQDRLDYYKGSKPHMEFYE
>A0A0M9B0H7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAIAFNIIIQLGAILAVV
WEFRRKILDVVTGLKTQPSARRFTANLLIAFMPAVVLGVIFSDLIHHYLFNPITVAAALV
VGGIIMLWAEKRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGFKYRHLFVPADFPVFAIGFITAFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWVDWAAAKP
>M7NZT5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIKGINHFLFSVSDLERSIKFYSDVFGAKLLVKGKSTAYFVLNGMWLALNEEPDIPRKE
IHESYTHIAFTVDEADFDGQVARLRELGVNILQGRERDERDRKSVYFTDPDGHKFEFHTG
TLEDRLEYYRQEKPHMTFYE
>ZP_03041010|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MNLQAINHLCFSVSHLERSIDFYRDVFGAKLLVRGRKLAYFDLNGLWIALNEEDVDRSTA
NRTYTHIAFTIDEQDVEPTLLRLQSLQVEILPGRARDEKDKKSIYFLDPDGHMFEFHTGG
LQDRLDYYRTDKEHMIFYDTE
>K9E7X9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIVQGITEWLPISSTGHMILVDELITLNVTPEFREMFLVVIQLASVLAV
ILLYFHELNPIAFSKSKDQKEETWNIWFKVIVGVIPAGVMGLLFDDLIDRYFFNWLTVAI
MLIVYGIAFIIIEHYNKGRTFPIQTWESLSYKTAFLIGCFQVLALIPGTSRSGATIVGAL
LIGTARPIAAKFSFFLSIPVMLGASLLKLLGFGLSFTTGELTILLVGCLVSFAVSVIAIK
FLMAYIRRNDFTAFGWYRIVVGIIVIAYFGFIAA
>ZP_04175489|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKEGGEKMKMHSLLKVGVCVSLLGATQFVSTISSVQAERTVEQKVIKNETGTISLSQLNK
NVWVHTELGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFGNMKVETF
YPGKGHTEDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLIRYGNI
NINLVVPGHGEVGNRGLLLHTLDLLK
>A0A127D3M3|FEATURES|UNIPROT_deepARG|chloramphenicol|UP17_01645|antibiotic inactivation|1
MKFNIIDRENWYRKEYFEHYLQQQTTFSITNEINITVLMKNLKKKNYKLYPAFIFMVTNI
VNSHREFKTSFNPEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNVSRFSEFHSQYEKDVE
EYNGTGSLFPKTPVPDNNIPISMIPWNSFTAFNLNINNGGDFLLPIITGGKYSQIKDEWF
LPVSLQIHHAVCDGYHASVFMNDLQRFADESADWL
>U1SF44|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRPSLRPLLVTLGLCLGSQSAFAELNQAVDAAVKPMMQTYAIPGMAIAISHKGQQHFFEY
GVASHESGQAVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNASQYLPELRGTAFDH
ISLLDLATYTPGGLPLQLPDAVSSERQMLDYYRNWQAVYAPGMQRLYSNPSIGLFGHLAA
ASMAKPFQQLMEKDLLPQLGMQESYVQIPAEQMTRYAWGYRDDKAVRVGPGALDAEAYGL
KSTAADMLRFIDANLHPDKLPTPLRQAVSSTHRGYYQVGDMTQALGWERYAYPISLARLQ
AGNSAEMALQPQPVERFSVPKPAEGDLLLNKTGSTNGFGAYILLLPARDTGLVILANRNY
PNAERVRLALQLLESLEP
>Q8VN25|FEATURES|UNIPROT_deepARG|beta_lactam|kluA-5|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTAGNSH
ILYRADERFAKCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>A0A0B1ZPM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTFTAILLGIVEGLTEFLPVSSTGHLILATELFGYNASQWATFNIVIQLGAILAVIVQ
FWRTFWAVGTGLLELNPTSIRFVRNVLVAFLPSAVIGLALKDYIDQMLGQPSIVAWALIV
GGIAILVIEKVAKQGPLTGVAELPLKKCVGVGVAQCLAMVPGVSRSGATIMGALAMGVER
RTAAEFSFFLAVPTMMGATTLELWGARDKLMAGVGPVGWNEIAIGFVVSFVVALVVIKAF
MAFVSRSGFAPFAWYRIAAGALALFLLAKV
>Q5W3I4|FEATURES|UNIPROT_deepARG|beta_lactam|nps-1|antibiotic inactivation|1
MPKLILLACSLCISFFVRAEDSAVEQLFRSADIDGTIVIESVRTGQRFVHNDPRSKQPFS
AASTFKVLNTLIALEEGVISGADAIFQWDGTRYEIANWNNDQTLESAFKASCVWCYQQLA
RRVGAVKYPPYIQQSDYGQLRQPYNETEFWLDGSLTISAEQQVAFLRQIVERKLPFKASS
YDTLKKIMLTDVTERYRLYAKTGWATRNVPSVGWYVGFVETSDDIWLFALNLVTRDAKDL
PLRIQIAKDALKVKGALPSS
>A0A0J1MNX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGVLLIVAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>U6RW24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTIQTIIIAIVEGLTEFLPVSSTGHMIITQALLGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPLPEGASPLKRFLHKFDFYWKLLVAFIPAAVLGLLFSDEIDALLES
VVVVAVMLVIGGIFMLFCDRIFSKSDKDFKMTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKMTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEVLMNNMSALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVLLMCGYNLEIA
>ZP_01769103|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFV
CVGRMFDVVPRRRGGAQAALEAK
>B9E4L9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIMELIFIIKAAIIGVVEGITEFLPISSTGHMIMVGDLINFKAPTYDKAYINMFEIVIQ
LGAILAIVVLYWDKIFNSLKNIKPGKWGFKLWVIILIAFLPSAVLGVIFNNLIQEKLFNS
ITVASALIVGGVLMIYMENKYRRGNSTKNIEDVNIFQAFKIGCFQCLALWPGMSRSASTI
MGGWISGLTNVAAAEFSFFLAIPTMIAASGWSLIKVKIDMSIMQVIALSVGFIVSFLVAL
VVVEKFMNFLKRKPMRVFAIYRIFIGIIVLILTVTKVISV
>YP_808159|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MKNKKSMMNLAISNLFLVFLGAGLVIPVLPTLKEQMHFSGTTMGMMISIFAIAQLIASPI
AGALSDKIGRKKLIAIGMIIFSFSELLFGLAQAKTGFYISRALGGVAAAMLMPSVTAYVA
DMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAHFGIRVPFYVAAILAFIGFILTITIL
KEPERTMEANHETEKVSFLDILKNPLFGSLFIIILISSFGLQAFESIYSIMASINFGFSM
GEIALVITVSGILALFFQLFLFDTIVNKIGELGLIQLTFFASAIFIAIIAFTKTNLVVAL
STFVVFLAFDLFRPAVTTYLSKHAGNRQGAINGLNSAFTSFGNILGPMAAGYMFDINHLF
PYYISAIILLGTGFLSLFLNRKNWGKA
>Q4KC82|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSNKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENTFYGSVAQLCARKGIAVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAIIAQERVAIERSDTALSLHHKLRDAAASLLRDTLP
ALAQGKITETAQDESKASYFGRRTAADGKIDWQRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGQDSLVITSGQRNANGLFLGGPQLANELG
LVDGSLLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDKYDVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDCCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIDNAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DRAKQEAR
>C0B1M1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPALLELNEVSRIYNNGEEETVVLNKISLTINAGEMVAIIGASGSGKSTLMNILGCLDKP
NSGEYKVAGQSVAKMDGDQLAALRREHFGFIFQRYHLMSHLSAEQNVEIPAIYADKNATQ
RKERARELLTRLGLGERIDYRPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
KEVMAILKQLNEQGHTVIIVTHDPLIAAQAERIIEIKDGEIINDNCHQITVNKVKKRDNS
CFTISLFRANIRAFYTSIRYGLACHGCE
>A0A0R2ZFN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WAFRRKILDVVTGLPTQRNAQRFTVNLLIAFLPAVVLGVVFADLIHHYLFNPITVATALV
VGGIIMLWAERREHQVHAETVDEITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIGFGLLILATWQFGWIDWSAANA
>E2XE24|FEATURES|UNIPROT_deepARG|beta_lactam|SD1617_4203|antibiotic inactivation|1
MAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSD
PATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQ
RLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGK
AVHISPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLHQGIQLAQSRYWQTGDMYQ
GLGWEMLDWPVNPDIIVNGSDNKIALAARSVKAITPPTPAVRASWVHKTGSTGGFGSYVA
FIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>J8ANH1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLINAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFTEVKKVEATAFLLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAIGFITSFIVTMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>T9SP00|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFGYAGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQASDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>D2T3U9|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDIGCTGLRALAEAGYQIAAVFTHADNAAENHFFASVARTATQLGVPVYAPE
DVNHPLWIDRIRSMAPDVIFSFHYRHMLNDAIINSASRGAFNLHASLLPKYRGRAPLNWV
LVNGEQETGVTLHRMVKQADAGAIIAQKKVPIADRDDALTLHHKVCAAAGELLAITLPDM
QSGNDVGHPQDESLASYVGRRTPEDGRIDWRLPAQRIHNLVRAVTDPWPGAFSYVGSGKF
IVWQSKVRHDCPANRPGTILSVAPLVVACSAGALEIVTGQSDSGIYMQGSQLAQTLGLVA
GALLHNQPAAVLQRRTRVLILGVNGFIGNHLTERLLVDENFDVFGLDIGSDAISRFIGHE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDTTFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGGQKRCFTDI
HDGIEALFRIIENRQHNCDGQIINIGNPENEASIKQLAEQLLASFERHPLRNRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLNWQPEVALDKTIDDTLDFFLQSVEPGDAG
>A0A090TT39|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSEEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQSVAISSDDVALTLHHKLCQAARQLLEQALPAI
KTGDYAERPQQEAEATCFGRRTPEDSFLDWNKPTAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNDLAAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRQHFPPFAGF
RDVESSTYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>A0A084JKS4|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYNKMNQIVSDLKLPDYRYEQLTNAIFHQKIDQFDNMQILPKALRKALTNEFGN
RVSSVKSVFIQDSKQAEKLLFELTDGEKIEAVGLKYKQGWESFCISTQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFLFNNHRLSSVSFMGMGEAFANPELFDAINILTDQKLFGL
GQRRVTISTVGIIPGIQRLTKEFPQVNLAFSLHSPFDKQRSDLMPVNKRFPLNEVMKALD
EHIIHTGRRVFIAYIMLDGINDSKDHAEAVAGLLKSRGSWGHLYHIDLIPYNSTDKTTIR
FQSSNAIRQFCSTLKKAGISVTIRTQFGSEISAACGQLYFENEV
>ABO60996|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPIAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASTEALTCNAYADAAEKKFDAQLAKETAGAR
>G4CPW9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRCFGSGANRVHVLKDINLKIEKGDFVAIIGQSGSGKSTLMNILGCLDTPS
SGSYVVDGVETAKMEADELAGLRRKRFGFIFQRYNLLNALSARDNVALPAVYAGLPHKER
YNRANALLHRLGLEDKEENKPSELSGGQQQRVSIARALMNGGEILLADEPTGALDSKSGE
NVMEIIRQLHGEGHTIIMVTHDPNIAALANRVIEIKDGYIISDISKNSEVAPGSVETLPE
NRSWLFRKDQLLESFRMSVQAIMSHKMRSLLTMLGIIIGIASVVSVVALGRGTQTKILGD
IASIGTNTISIYPGKGFGDRFSGKIKTLTVADAEVIGRQSYVSNVTPMTASSGTITYRNA
DLTGQLYGVGNQYFDVRGFKLDKGRLFDEQDVKDNAQVVVIDQNTLKKLFPEDENPLGKV
ILFKKRPLTIIGTVKEEKNAFGGDSDSLQLWSPYTTVMNQITGERHISSLIVKVGDNASS
QAAENGLTELLISRHGTEDFFMRNSDSIKQTVESATGTMTLLISSIALISLVVGGIGVMN
IMLVSVTERTKEIGVRMAIGARQGNILQQFLIEAVLICLIGGMTGIALSVLIGMTFNHFV
TDFAMTFSAMSVVGAVACSTIIGVVFGYIPANRASKLNPIDALAHD
>A0A089KKU1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFYKRFIDLLGLKRFSRKEMTAVPDGVPQVETEGRLKLGQVLVGLIPAGVFGLL
FEDYIDEHLFSTSTVLIGLVVGAVFMIIADRFAPKKPKTETVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLVKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIVLAAVVYLIWF
>X4ZM17|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLAILKAVILGLVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVVIFRNRFIDLLGLKRFSRGALEPVPDGQPSPNPGSGRLKLGQVLAGLLPAGVAGM
LFEDYIDEYLFSTSTVLIGLVIGAIFMICADLFAPKRVKVQTVDQITYGQALTVGLIQCF
SLWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASFISLLKNWQYFTLDALPF
FIAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIVLAAIVYIIFF
>YP_001778540|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MNNLHNTNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDAAAPVAFKEAPTLAAGEQAG
TWKTAEPADGEHRGEWWKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQW
FPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREQALKLVQRRFNEGDIS
ELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKIPPG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGNAPAPTAVGDAASGKADVAAR
>A0A060KZW1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADAQQKLAELERQSGGRLGVALINTADNSQ
ILYRANERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLATWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>R8ATG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLIAFILGVVEGLTEFLPVSSTGHLILVGHLLGFEGPKAATFEIIIQLGSILAVVVV
FWRRMFGLIGIHFGEKPQQSGGHLTLLHIILGMLPAVVIGLLVHDWIKANLFGPQTVMYA
LVVGGVLLLVAEYFKPKTTAHNIDEISYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLG
VGRHAAAEYSFILAVPMMLGASGLDLLKSWSILSLSDLPMFAVGFITAFVVAMIAIKTFL
AAIKRISFVPFAIYRFILAAMVYWVVIG
>A0A0M8YUA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILL
VYFRRLLAIATAVPSDPKARRFVLGILVAFLPAAIIGGLFSKLIKAYLFNPWIVCATLVA
GGLVLLVIDDTDLEVKKKDVYDFTLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLLDNYKYLSSNDVGLIVIGFVVSFISALFVVRVLLDYV
SRHGFWLFAWWRIIVGALGFAGLIILG
>A0A0D8DAA3|FEATURES|UNIPROT_deepARG|aminoglycoside|SG34_20990|antibiotic inactivation|1
MKIREATRKDINDWSEMRTKLWPETDDGHLSEINSFFDEESIDIVKVYLAEEENEIVGFL
ELNIRNFAEGSRNASVPYVEAWYIKPEHQGKGFGKQLMEQAEYWALSLGFTELASDTEID
NALSIKLHKRMGFQETERIVCFLKSLKNT
>YP_970399|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFILLAKAAVMGVVEGLTEFLPVSSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVV
LVYWQKIRETLVALPTQPRARRFALNVLIGFLPAVVLALIFGKAIKAHLFTPVVVASTFI
LGGFVILWAERRAPGAVRVDSVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERHLLSMADLPLFAVGLLFSFVSAWLCVRWLLR
YISTHSFVPFAYYRIAFGIVVLATAWTGWVHWGE
>E9CM62|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLQLNGIRRSYQSGDQTVDVLKDVSLSIESGEMVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAMLNDDALAQLRREHFGFIFQRYHLLPHMSAAHNVEVPAVYAGLGKAE
RRERAEALLRRLGLGERVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
DEVMNILKQLCAQGRTVVIVTHDPAVAQQAERIIEIRDGEIIADLRNNQKGNQKVKSFGL
DAIVPSWQQMVGRLREALVMAWRAMTANKMRTALTMLGIIIGIASVVSILVIGDAAKQRV
LADIKSIGTNTIDIYPGKDFGDDNPTFRQSLKYEDLDALREQPYVSVLSPTIGSSTRLRL
GNVDVAANVSGVNEQYFRVYGMTFTQGAGIDVMQVQSQSQTVVIDANTQRRLFPHQKQVV
GEVILVGNMPATVVGVAKQKQSMFGSSKTLNIWVPYSTMANRLMGNTYFDSITVRIRDGY
SSHEVEQQLTRLLTLRHGKKDFFTYNMDSFVQAAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAILVCLVGGALGITLSFAIGLLVQL
LLPGWQISFPPTALLSTFVCSTGIGVVFGYLPARNAARLNPIDALARE
>CAG30893|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
MNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDA
FADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVV
VDALAAFMRRLHAIPVSECSFNSDHACRLARARERIEAGVVDVDDFDKEREGWTAEQVWE
AMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFE
PSLQERLVAQYGIADPDRRKLQFHLLLDELF
>A0A0Q6ZDG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWAKIRSTLVALPTERQAQRFALNVFIAFVPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAERRPPSATRIHSVDAMTPLDAIKVGLVQCLAMIPGTSRSGATIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPLFATGLVFSFLSAWLCVRWLLR
YISSHSFVPFAYYRIVFGVIVLVTAWTGWVQWAD
>A0A0T6BTP5|FEATURES|UNIPROT_deepARG|beta_lactam|AB447_210840|antibiotic inactivation|1
MKTKFFKKTAISLLFTCAALAGCSNDSAHSAQPKQSDRQSNQFSRLEDQYDARLGVFALD
TGTNKTVTYRADERFAYASTHKALAVGALLKQTSIADLNQRITYTRDDLVNYNPITEKHV
DTGMTLKELCDASIRYSDNTAGNLILKQIGGPSGFKQSLREIGDNVTNPERIEPDLNEVK
PGETHDTSTPKALAKSLQAFTVGDALPKEKREMLVDWLKRNTTGDALIRVGVPKGWEVAD
KTGAGSYGTRNDIAVIWPPKGDPIVLAVLSSRDKKDADYNDKLIAEAAKEVIKVLK
>A0A0U1AMC0|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPNELASLEKDFGGRIGVYALDTGSGDTVG
HRTDERFLMCSTVKTFIVSAILHRSLSEPGLLDRRIQYTQSDVLEWAPITSQHVPTGMTV
SELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPDSAPIVMAVLTVPEDPTSTKGKPTIAAAARIVLRAFGA
>A0A0M0N1H9|FEATURES|UNIPROT_deepARG|beta_lactam|ACU52_03190|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGSVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>Q2KX31|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDSTLYFVKAFFLGIIEGLTEFIPVSSTGHLILFGDWINFESGSGKVFEVVIQLGAILA
VMWIFRARLWQLIRGTLSGQRQEMLFTRNLLLAFFPAAIIGAIFIKAIKQTFYHPGVVAV
TLVLGGLIMLWVERRAPRSDGSASETATEERATAHSLEEISWKQALGVGVAQCLAMIPGT
SRSGATIIGGMVAGIQRKTATEFSFFLAMPTMLGAAVYDMYRNIDLLTSHDLGAIAVGFV
AAFLSALLVVRAVLRFVANHTYRGFAWYRIALGVVVAAWLAF
>A0A0D5YDV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFSPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTDDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALLVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>YP_002929946|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLEILKAILFGIVEGITEWLPISSTGHMILLDQVVKLNVSADFYKMFQVVIQLGAIMAV
VILFWNKLWPFYMKKTGDSKKAAWKDGALAMWIKIIIACIPAAIVGLIFDDKIDELFYHP
IPVAIALIVVGIVFIVVENAKKGSKPAIRSIGEITYKAAIIIGLFQLIAAVFPGTSRSGA
TIIGALIIGVSRSVAAEFTFFLAVPVMFGASLLKIAKYAAVGMAMTGTEWIVLIVGCLVA
FFVSVFVIKFLMGYIKKHDFKVFGVYRIILGIAVIALSFVLF
>C6J4F8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLELIKAIILGLVEGLTEFAPVSSTGHMIIVDDMWLKTGELLGSKYVANTFKVVIQLG
SILAVLVVFRNRFIDLLGLSRWMPGRAKGAATAGQGGPRLKLMQVIVGLIPAGILGVLFE
DFIDEHLFSTATVLIGLVIGALLMIAADRFAPKRASVETVDQITYRQALGIGLFQCLSIW
PGFSRSGSTISGGVLLGLSHRAAADFTFIMAVPIMAGASLISLVKNLEYFTIDALPFFVV
GFISAFVFALLAIRFFLKLIDRIKLVPFAVYRILLALVIWVVYF
>Q9LAR5|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-23|antibiotic inactivation|1
LLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAGTLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>A0A099Q132|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGERANRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETVHPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGVGSENWTDVAVAFVAATLTGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPVAA
>Q39IU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVMSVDELTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFVLGAVAAFVSAFVCVRW
LLRYVASHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0L1LR10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
AVVVIFKDRFINLLGLGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSL
NTVLIGLVVGAVLMILADLFGPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASGLSLVKNWQYFTSDALPFFIAGFISAFIFAL
ISIRFFLKLINRIKLVPFALYRIVLAAILYFVFL
>ABS72697|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|LmrB|antibiotic efflux|1
MENAQPSKQYKVMPIMISLLTAGFIGMFSETALNIALTDLMKELHITPATVQWLTTGYLL
VLGILVPVSGLLLQWFTTRQLFIVSLAFSIIGTLIAALAPSFPFLLAARIVQALGTGLLL
PLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVL
ALLFGIAYMQNVSDITKPKIDVLSIILSTIGFGGIVFGFSNAGEGSDGWSSPTVIGSLTV
GAIALILFSIRQLTMKQPMMNLRAFRYPMFVLGVVIVFICMMVILSTMLLLPMYLQSGLM
LTAFTSGLILLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVITATALSFFSNINGASTA
LLIVALHTCLMIGISMIMMPAQTNGLNQLPPEFYPDGTAIMNTLQQMAGAIGTAVAVSIM
AAGQKNYMSTVKNPNDPSAYSHALIAGVQHAFIFAMIVAVIGLISAFFMKRVKVNHS
>A0A127T4D7|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKGLMIVEAGRNWIPRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>A0A0J5FU56|FEATURES|UNIPROT_deepARG|aminoglycoside|AB204_07245|antibiotic inactivation|1
MYIPPEANKVLLIIQKRLAESLVAVYLHGSAVVGGLRPCSDVDLLVVIDQPMTSEVRECL
AADLMRISGRHPSDPDGRRPVELIVFLRADLAASLYPARSEFIYGEWLRHEYEMGEIPKP
ICDPELTLVLAQSRQEAIPLVGPNASSLLPAISRSDICRAIKDVLPDLIETLQGDERNVL
LTLARMWRTLVTGEFVPKDVAADWASARLPAMQATVLADARETYLRGCEKDWRNRQQELQ
ITVSSLHDCVLMNL
>C5BC70|FEATURES|UNIPROT_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNHLSSTRRLGRRALLFPLCLVLYEFATYIGNDMIQPGMLSVVQTFGVDESWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLIGTLYFAATCLAILLTNSIEQFTLMRFLQGISLC
FIGAVGYAAIQESFEESVCIKITALMANVALIAPLLGPLAGAAWVHLFPWEGMFILFAAL
SLLAFLGLYKAMPETATRRGEKLSLSALGRDYTLVLKNRRFLCGSLACGFASLPLLAWIA
QSPVIIISGEGLSSYDYGMLQVPIFGMLILGNLTLARLSGRRPVRRLIQLGAWPMVGGLA
IAAASTLYSAHAYLWMTAGLSLYAFGIGLANAGLYRLTLFSSTMSKGTVSAAMGMISMFI
YTLGIEVGKYAWLLGGNGAFNLFNLISGLLWLALIARMLRDQLVGRMAGR
>A0A069DL07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFDFINLLKSIILGIVEGLTEFAPVSSTGHMIIVDDMWLNSKEFLTQYVANTFKVVIQL
GSILAVVVVFKDRFINLLGLDRLWSKNKAAAIPASGTNRLKLMQVIVGLIPAGVLGLLFE
DYIDEHLFSVNTVLIGLVIGAFFMIAADLFAPKTPRVETVDQMSYKQALSIGLIQCLSLW
PGFSRSGSTISGGVLLGMSHRAASDFTFIMAVPVMFGASFLSLVKNWEYFTLDALPYFIA
GFIAAFIFALISIRFFLKLINRVKLVPFAIYRIILAAVIYFVFVM
>R7WZT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSAPAMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKYDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGTGHSEIEHLFG
NMYIISAGLAMAGILILISGTRRPPMGDRPMRGADSAWIGAVQGICLPFRGFSRSGSTIS
TGMLRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQTFSGHFMTVLTPSLVGMA
FSFLAGLVALRWLSRWLERGRWYLFGVYCLVASAVVLAASQSL
>A0A0G2NQ65|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILSLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>Q2SHK3|FEATURES|UNIPROT_deepARG|aminoglycoside|HCH_03105|antibiotic inactivation|1
MGDEPLKIRYVMEADKANWLALRQELWPETPPQEHEAEIHAYFSMPDLATFVAIADNGDM
LGFLEAGLRSYGEGCASHPVAYVEGWYVLPSHRRQGVGRRLMDAAEEWALDRGLREIGSD
MLVNNEISLKAHAALGYTEVERLIHVVKKIDSA
>E8JRQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELLKAIFLGIVEGITEWLPVSSTGHLILVQEFIKLNQDKAFLDMFNIVIQLGAILA
VIVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPFDDWFEAHFNYMIPIA
IALIVYGVAFIWIEKRNANVEPEVTDLARMPYLTAFWIGCFQVLSIVPGTSRSGATILGA
IIVGTSRSVAADFTFFLAIPTMFGYSGLKAVKFFLDGNVLNFSQFLILMVASVTAFLVSL
YVIRFLTDYVKKHDFTVFGKYRIVLGTILILYSIVKFIF
>A0A127SQ57|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>ABD85195|FEATURES|ARDB_deepARG|beta_lactam|GloB|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>A0A0K2W925|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIQGINHLTFSVVNLEASIAFYRDVLEGTLLVQGERMAYFDLQGIWLALNVQEDIPRTE
ITHSYTHIAFTIDEQDFPVYVQRLQKLGVTIREGRSRDKAEAQSVYFTDPDGHLFEFHTG
NREQRIQHYKDEKKPMTFYI
>A0A0C7KVI2|FEATURES|UNIPROT_deepARG|beta_lactam|BN1007_71037|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLPGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTHLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>R9VM70|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGTQALLDAGFEIAAIFTHPDSANENHFFGSVARIAAERGIPVYAPD
DVNHSLWVDRIRDLNPDVIFSFYYRNLLCDNILNTARIGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVSRADAGAIIAQQRVAIAENDEALSLHRKLAEAAKGMLASVLPTI
KTQTFSETAQDDSKASYYGRRTPEDGRLDWEKPAQTLQNLVRAVSDPWPGAYSYAGTHKF
IVWKSRVRTDVAPARAGTVLSVSPLLVACGDGALEILTGQMDNGVYMQGAQLAQSLGLVA
GALLTSKPVVAVKRRTRVLILGVNGFIGNHLTERLLRDDNYEIFGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDNNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
HGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLASFEKHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLHWEPTVDMRQTIDETLDFFLRTVELTDEK
>A0A0U5HP52|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRGNREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLELARDGQLGSENWTEVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFALYRIALGAALLLWLPSGS
>F3MJQ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQITVQEYKIANRESGPYGIAAGRDGAIWFTEQKGNRIGRITKGGDMRTFDVPTPDAGVM
SILSAPNGDLWFTEYKANKIGRMTTEGIFTEFELPEAGSSPYGLTEGPDGAIWFTQLIGN
RIGRITPAGVITEYDLPRAGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPT
EQSGPVGITAGGDGALWFVQINGNQIGRITTAGEITEFKLPTGNARPHAIAAGAREDLWF
TEWGANRIGRITCTGDITEYPIPTPSAEPHGIAVDSGGEVWFAEECDQVGRFIVQYEDS
>R7II76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIYYIQVMLMGIVEGLTEFLPISSTGHLIVAADVMRFSPPDRETFIVGIQAGAIFAVC
WFYRDRIWKVVMNFLRPGREQNLAVNTVVAFLPAAVAGVLFAHFIQSRLFNVVTVSTTLV
IGGLIILAVERMIASGKIAPRVHEMDDMNWRDALKVGVMQCFAMIPGVSRSGATIIGGMI
CGLSRKAATEFSFFLAIPTIFGATVYDLWKMRDSVGDLNVGGLLLGGAVSFFSALIVVNW
LLRFVAHNNFRGFGWYRILFGALVMGLWYTGVIQ
>A0A0A0Q8K1|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTNAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0K8M0Y5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVVWEFRRKILDVVVGL
PKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVVGGVIMLWAERRVH
TVRTETVDDMTWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMP
TMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKFIATHSYAVFAWYRI
AFGLLILATWQFGWIDWASAKA
>A0A144UMK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGAGKGRLSLIHILLGMIPAVVLGLVFHDAIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSYHFLTAGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0A7HG88|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
EDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIH
YSPNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDERDTTTPAAMATTLRKLLTGELLTLASRQQLIDWMEADKV
AGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAE
>L7YEI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYIQSILLGIIEGLTEFFPISSTGHMILAASIMGILEKKITKLFLISVQLGAVFSVVFF
IGKKIFFQKADFYLKIFLASFPIGIFGFFLNRRTNFFLGNPLIVAFFLIIGGIILLKVEN
FYEKNLDKSNHINYFQAFIIGLCQCMALIPGVSRSAATIVACLLQNVHRKNAIEFSFFLS
VPVIVIATCKKLFDYYFQLTSFSFPWNFRIIISMSKELFLQEIQFLIIGNIVAFITGILS
IKCFMAYLKRNNFKLFGYYRIILGLFFIVIHYFFQPIEKFKI
>I1VJ13|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
LCCALLLKEQAIPGMAVAVIYQGKPYYFTYGKADIANNQPVTTQTLFELGSLSKTFAGVL
GGDAVARGEIRLSDPANKYWPELNGRQWQNISMLDLATYTAGGLPLQVPDEVTDKAALLN
FYQTWQPQWAPGEKRLYANSSIGLFGSLAVKPSGLSFEQAMTQRVLAPLRLSHTWIKVPA
SEESHYAWGYSSGRPVRVSPGMLDAESYGVKSSIADMASWIKANMNPQQVKDKTLRQGME
LAQSRYWRIGSMYQGLGWEMLNWPVKAKVVVDGSESKVALAATPAVAIRPPAPPVNDSWV
HKTGSTGGFGSYVAF
>Q5P6K4|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLPLFVIALILGIVEGLTEFLPISSTGHLIIIGDLLGYNDATSKVFKIVIQFAAILAVC
WDYRERLARVAAGVGSEPAAQRFVGLLFIGFLPAAVLGLMFHSTIKSLLFNPLTVATALV
VGGVLILWLERRAYHPRINAVDEMRWADALKVGFAQAAAMIPGTSRSGATILGGLVFGLS
RKAAAEFSFFLSIPTMFAATVYDLYKNRDLLHMGDLPVFAIGFVASFFAAMFAVKAFIRF
ISNHTFIAFAWYRIVFGLVVLATWQLELVEWSEP
>A0A127T4T2|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQRKPGTTRLYANSSIGLFGA
LAVKPSGMSYEQAMTTRVLKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAI94891|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPVWMVMVVLFIRSVGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEISFASGMLAGGLLLGRLGSFEKRVLLITGSFFIMGASLA
VSGLLPTSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIKSLAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>B7VAE6|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
WEFRGKIFQVVRDLPSQRQAQRFTANLLIAFFPAVVLGVLFADLIHEWLFNPITVALALV
VGGVVMLWAERRKHVIHAEHVDDMTWKDALKIGCAQCLAMVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFRPEDLPVFAVGFVTSFVFAMLAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFHLIDWSTAGEM
>U3N9N0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114q|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQSTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAKAGAWRP
>B0NPP4|FEATURES|UNIPROT_deepARG|beta_lactam|BACSTE_01456|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNKVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLQQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQK
AYANWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEEDAAIIAHISRMVYDEMK
>A0A0G3DN81|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRLENIQKKINNTTILENINLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DAYEVTNLSKDEKARIRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKNKQERSQKAKE
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNEQGHTVVLVTHDREIAARAKRVIEIKDGKIISDNGAKKADEIKAKLMPKEKKSFNL
LKNQLFESLKMSIASIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQNILASISSIGT
NTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLPYLEAVEADMGKVGVVTYKNNSLQARIH
GVGPNHLRLRGFVMVDGRFINNEDIKDNTNICIVDENALRFLFDNDGAKNILGKSIIFNK
QPLTIVGVLKKERDNKDFKPDENTIKIYTPYSTLMNKITGDKQIRAIVTKVKDEINPALA
EEAMVKILEIKRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAIFGVMLSFIIIEVFNSLNFGF
TMILSLNSVFLGLLSSVLIGVVFGFFPAKNAANLNPISALSKE
>F3PV16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDLSTLEVIIIAIVEGLTEFLPVSSTGHMIITQNMLGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPLPEGASGLGRFLHKFDFYWKLLVAFVPAAILGFLFSDKIDAMLES
VTVVAVMLVVGGIFMLFCDKIFSKGSEDTVLTEKKAFSIGLFQCIAMIPGVSRSMATIVG
GMSQKLTRKAAAEFSFFLAVPTMLAATAYKILKLFLDGGTEIIMNNMSALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGLILILLLTGHNLEVM
>YP_254597|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGDFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A0M8UDN8|FEATURES|UNIPROT_deepARG|beta_lactam|ADK98_37990|antibiotic inactivation|1
MSPRDRQRERRGDVEQTRRAVLTLGAGVALGAALPAGAARAAAPGGGGEAVRRLRALERE
YGARVGAYARDTGTGRTVLYRADELFPMCSVFKAPAAAAVMRDLDRDGEFLARRIHYTQG
DVTTAGGGSVTERPENIAGGLTVAELCSAAIAQSDNCAANLLLRELGGPTAITRFCRSVG
DRTTRLDRWEPELNSAEPSRVTDTTSPRAIARTYGRLVLGDALVPRHRELLTRWLVSNTT
SDERFRAGLPRDWVIGDKTGAGSYGTNNNVGIAWPPGRPPVELAVLTTKPDAAAPRENAL
VARAAEVLAAALG
>I6ZM32|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKPIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>ABO60991|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTGGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRT
GAQVVANAETAVLLPRGSSNDLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKGTTGAR
>A0A0D6IB21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDNALYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWINFESSQGKVFEVVIQLGSILA
VMWIFRARLLQLIRGTLTGVPSEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPAVVVV
TLVLGGLIMLYVERRTRHTPGDQPGAADDTASDERATAMTLEQISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMDLLTQHDLSGIA
VGFVAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGGIVAAWIFTR
>A0A0G0NRX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIWQSFVLGIIEGLTEFLPISSTFHLIFVSKFLMIENSDFLKFFEVFIQAGAIIAVLFL
YGKELWQDRELDKKIILSFIPTAIVGFLLHSIIKSFFFETDWLMIGSFMLVGIIFIVYEW
QLKKNKKIDKEIKDLTWKQSIVIGIGQALATLPGVSRAGAVMLSMMVMGQKRSQAAKYSF
LLALPTICAAAGYDMFKLIGKTTLSSEEILLTAIGFVTAFVVAFFVLKWFIAYLQKHTLT
GFGIYRIVMASVLLLIFGSALF
>YP_078703|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MENNKILGINHLLFSVSDLSVSISFYEKVFDAKWLVKAEKTAYFDLNGIWLAFNEEKDIK
RQEIHDSYTHIAFSIQQEDLPFWEKKLHDLGVNVLKGRKRHEGDRDSIYFSDPDGHKFEL
HTGSVFDRLQYYQNEKPHLSFHEGHIKALYDRNK
>AAA92254|FEATURES|ARDB_deepARG|aminoglycoside|AadD|antibiotic inactivation|1
MNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTE
EAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVY
QTAKSVEAQKFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLH
HRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTER
HGYIVDVSKRIPF
>W7RJR5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLGINHLLFSVSDLSVSISFYEKVFDAKWLVKAEKTAYFDLNGIWLALNEEKDIKRQEIH
DSYTHIAFSIQQEDLPFWEKKLHDLGVNVLKGRKRHEGDKDSIYFSDPDGHKFELHTGSV
FDRLQYYQNEKTHLSFHEGHIKALYDRNK
>A0A0T6BWI1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQLNINEYPLPDLASGPYGIARGADGALWFTEQKGNRIGRITAAGQITEYDVPTQDAGVS
IIAAGNSGELWFTEYKAGKIGKITVQGELTEYALPAGSAPFGITEGPDDAVWYTDMAGHK
IGRMSRSGEVAEYELPSGSFPSFITEGSDGALWFTQNQSNAIGRIAPEGGIREFQIPTSQ
SGPVGIAAGPDGALWFVEINGNQIGRITVSGEICEYPLPSENARPHAITSGEDGALWFTE
WGANQIGRITVEGDITEYPIPAEYAEPHGIAAAGGGIWFAEECGQIGRLTIR
>N9C8F6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWSRLWGAATGMFTGEVKGRHLGFSLIMASIPIVLVGLTFGQAVKDLLFNDIAVAIG
LIVGGFIIIWIEKHPPKVNAQEVENISYKEAMWIGLIQVLSLIPGTSRSGATIIGAMFLG
ISRKAATEFSFFLGIPVIIGAGLLDLYQSYDVFKTTEDWSVLATGIIVSFVSALILIRAL
VAYVAKRDFMIFAWYRIASGLLILLFAFTGWKLW
>AAT45231|FEATURES|ARDB_deepARG|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKTFRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFL
SEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG
>C6Q0G6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLILKAVVIGIVEGLTEFLPVSSTGHMIIVGNLINFKAPAYPKAYVDMFEVVIQLGA
ILAVVVLYWGKIKETLLNFLPSDRVSAKESGLRFWIIVLIACIPAIIIGFPLKDKIEDKL
FYPIPVAVALVVGAVWMIYAENKYRSNNRNITISNINARQALIIGAFQCLALWPGMSRSA
STIIGAWIAGLSTVVGAEFSFFLAIPMMVGASGLSLIKHNVLSTCNSAQIIALIVGFVIS
FIVALVVIDGFIKFLKKRPMRVFAVYRIFVGVIILVLALTHKL
>A9VF66|FEATURES|UNIPROT_deepARG|chloramphenicol|BcerKBAB4_2222|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDNKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNLK
>E5B3E7|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDIGCTGLRALAQAGYQIAAIFTHTDDAAENHFFASVARTAAQLGVPVYAPE
DVNHPLWIDRIRSMAPDVIFSFHYRHMLNDAIISSASRGAFNLHASLLPKYRGRAPLNWV
LANGERETGVTLHHMVKRADAGAIIAQSKVPIADHDDALTLHHKMCAAAGELLAKTLPDI
RTGSDVAHPQDESQASYVGRRTPEDGRIDWQLPAQRIHNLVRAVTDPWPGAFSFVGSGKF
IVWQSKVRHDYPANRPGTILSVAPLVVACAEGALEIVTGQSDSGVYMQGSQLAQTLGLVA
GAWLHNQPAAVLQRRTRVLILGVNGFIGNHLTERLLLDDNFDVYGLDIGSDAISRFIGHE
RFHFVEGDISIHSEWIKYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDATFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGGQKRCFTDI
HDGIEALFRIIENRQHNCDGQIINIGNADNEASIRQLAEQLLASFERHPLRNRFPPFAGF
REVESSSYYGKGYQDVEHRKPSISNAKRLLNWQPKVTMDKTIDDTLDFFLQNVEPGDAAQ
>H1G1D3|FEATURES|UNIPROT_deepARG|aminoglycoside|ECTPHS_02421|antibiotic inactivation|1
MVEYGNCEVPKEARDALGILRDELAGKLVGVYLYGSAVAGGLQPNSDVDVLALVRERPDV
GTRRRIVSRLMTVSGTPELDGTPRPLEVTVLCLSDLVPWRYPPRCELLYGEWLRETLEGG
TIPPAALNPDLAIVLTKAIADNVVLFGPPVGSVVDPVPAKDVRKAIADSLPELIGGLEGD
ERNVLLTLARMWMTVETGEIVSKDNAAAWAVSRLPAGHRPLMEIARRAYLGECRDSWRGR
ESDVGALVGYMHGVIEQTLAQRAS
>A0A142I9K1|FEATURES|UNIPROT_deepARG|beta_lactam|blaPDC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>YP_002638141|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLAGHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEILHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>A0A087NDI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDSATWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRREPVSWRFLRNLLIAFIPSAVIGLALHDYIEIMLGAPQIVAWALI
VGGIAILLIERAVKEQRFHGIADIPMVRVLAIGFIQCLAMVPGVSRSGATIMGALMLGVE
RRTAAEFSFFLAIPTMLGATALELIKKGDRITSAAVGWDSIALGFVVSFIVALLVIRWFV
GLVSKHGFAPFAWYRIIAGIAALIWLGAR
>K8CM75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGLGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VMYALVVGGVLLIAAELLKPKEPKALGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMSFLTMADLPMFAVGFVTAFVVALVA
IKTFLHLIKRISFIPFAIYRFIVAAAVFAVFM
>A0A0U2ZQ75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWFDLLKALILGFVEGMTEFAPVSSTGHLIIVDDMWLKSQEFLGKYPANTFKIVIQLGS
ILAVVVVFWKRLFSLVGLYKIEGQQASSSFNLLHVIIGMLPAVIFGFAFKDLIDDHLFGV
ETVIYALVAGAILMIVADKFGPKKPTVNSLDDITYFQALKIGLVQCLSLWPGFSRSGATI
SGGVLFGLNHRVAADFTFIMAVPIMFGASLVSVLKNWDTLSMDYLSFYVVGFVSAFVFAL
ISIRFFLKLISRIKLMPFAIYRLVLAAVLAIIVFL
>NP_955645|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLYGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>NP_754683|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKSASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>AAK53979|FEATURES|ARDB_deepARG|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDEVYLQPEAAKQWERLVKALKLENEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPLFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQ
YLEQTARQFA
>J8B0R8|FEATURES|UNIPROT_deepARG|beta_lactam|IEI_01625|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTVSSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLIDSSWDDKLTKELIEMVEKKFKQRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFENMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNINAVVPGH
GEVGDRGLLLHTLDLLK
>I6Z9H7|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSPAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>X2L725|FEATURES|UNIPROT_deepARG|beta_lactam|cmy-84|antibiotic inactivation|1
CALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKAD
IANNHPVTQQTLFELGSVSKTFNGVLGGDTIARGEIKLSDPVTKYWPELTGKQWRGISLL
HLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSG
MSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSV
IDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGS
DSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNP
ARVEAAWRI
>A0A0T9UUD0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGATPHEGKTSGHLTLGHILLAMLPAVGLGLVFHNAIKALFNPHS
VMYALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLSLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A0S2DPV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAVVVIYWK
RLWGLAVGFTQRDNLDYLLKLGLAFGITGVLGIVVKKAGFTLPDHVAPIAWALVLGGVWM
IAAEHFAAKRAAALGERSDITWTVATLVGIAQVVAGVFPGTSRSAATIFVALLAGTTSRA
AATEFAFLVGIPTMFAASGYELMGVLGTPAAAQEDWSALAVAFVASAVTAFIAVKWLLRY
IQSHRFTAFAIYRLVFGVALLWLMPSGS
>CAR60300|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAIFKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMNPTELTKYQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTDEFGKILLKVNQDGSQVRLRDVAKIELGGENYDVIAKFNGQPASGLGIKLATGANAL
DTATAIRAELKKMEPFFPPGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
TEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRLFDKSTHHYTDSVGNILRSTGR
YLLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLTMVQLPAGATQERTQKVLDEVTDYYLN
KEKANVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEKNKVEAITQRATAAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGEVAKYPDLLVGVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDINDWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MAMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
VEATLEAVRMRLRPILMTSLAFMLGVMPLVISSGAGSGAQNAVGTGVLGGMVTATVLAIF
FVPVFFVVVRRRFSRKSEDIEHSHSTEHR
>A0A127T095|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>M8AWN8|FEATURES|UNIPROT_deepARG|aminoglycoside|H009_22258|antibiotic inactivation|1
MSAQFAIETAGEASLDEWSLLRHRLWPDASPAEHRAELQDVSDNEVGFIAYDPAGMAIGF
AEASLRHDYVNGCDTSPVAFLEGVYVEEAFRKQGVAAALIAEVTRWATSKGVSELASDAD
ISNVDSHRMHAALGFEETQRVVYFRKSLPLGS
>A0A0A0Q800|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-23|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPLVKASWVHKTGSTGGFGSYVAFIPEKQFGIVMLA
NKSYPNPARVEAAYHILDALQ
>A0A0U9HGM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLLKAALMGVVEGLTEFLPISSTGHMIIVGDFINFKGDSFYTMFEIVIQLGAILAVIF
YYRYKIIDSLRHLRPGDRGFKLWLKIFVAFLPAAIIGLLINDIVEKYLFSSFTVAIALIV
GGFLMIVAEGIFGRGGLNDMDKVDLKQAFIIGIGQCLSLIPGMSRSASTIMGGMAAGLSV
KAAAEFSFFLAIPTMIAATAFSLAKGFSTTTLQQFQALGVGFVVSFIVALFAVDAFLTYL
KQHSLKPFAYYRIILGIVMILLITTGVI
>W0HQX6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCVGVTALIKAGFTIEAIITHPDAPTEKPFFGSVARIATEHGIPVFAPD
DVNHPLWVARIKALAPDVIFSFYYRQLLCQEIVSLPTVGAFNLHGSLLPRYRGRSPLNWV
LVNGEEETGVTLHRMTARVDAGNILAQRGVAITPQDDAPSLHRKLCEAAAAVLESILPAI
REQRFSETPQDDSAASYVGRRTPEDGRLDWCQPAATLANLVRAVTDPWPGAFSYAGGEKF
IVWKAQVRPNSDAAQPGTVLSVDPLVIACGSDALEIQTGQSQQGVYMQGGQLAQALGLVN
GALLNPCPLVSHKRRTRVLILGVNGFIGNHLTERLLRDGNYEIYGLDIGTDAISRFMVNP
LFHFVEGDISIHSEWIEYHIKKCDAVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRHC
VKYQKRIIFPSTSEVYGMCTDPVFDEDDSSLIVGPINKQRWIYSVSKQLLDRVLWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGAQKRCFTDI
SDGIEALFRIIENKDQNCDGQIINIGNPDNEANIRQLAELLLASFERHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRLLDWAPTVPMAQTIDETLDFFLQTIDLQDAPQ
>A0A0A2YAK9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKVDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFAVGFVTAFVVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>A0A086W640|FEATURES|UNIPROT_deepARG|aminoglycoside|JN27_22530|antibiotic inactivation|1
MSSIKPCTSVEQAGWLQLRMALWLDDRDKHLQEMQELCAQPGRYAQFIACSRLGEPQGLV
EVALRSDYVNGTASSPVGFLEGLYVDPAFRKQGIAAMLVQTAEEWVRRQGCTEMASDALL
ENTASHAMHRALGFAETERVVYFRKLLS
>ZP_04557016|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITD
SMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEG
IQAQTKLLFNTLQKLQIPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQNVVDGSVY
PVCSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAM
FNIGINELLDAITSFILPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRI
NDSEKFIKIKNLKTINQGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQH
PALKSSVRPDRPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLL
EERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESD
ISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYV
FRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPL
NTSKDYASEVSSYTKGLGIFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSMSSK
>Q5SLX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRVSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDPFLKTFLVAIQLGAIL
AVLLLYGRRLAADRALWLRIAVAFVPTGVIGFLFYPLIKGVILGNDAVVAFFLFFVGAVL
LFADRLAERAQYQDVKALPLARVAWIGVFQGLAALFPGTSRSGATILGGLLLGLNRQAAA
EFSFLLALPTMFAAVGYDLWKSAPEVPEGGWSLLLLGFLAALVTALVTVRWMLAFVARHG
FRPFALYRMALAAVYAFFFLR
>X6EWM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFQSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVTALVVVRYLLDY
VSRNGYSLFGWWRLVVGIAGLVALMIWG
>A0A0C7G6B4|FEATURES|UNIPROT_deepARG|bacitracin|bacA1|antibiotic target alteration|0
MIEMLKAVILGIVQGITEWLPVSSTGHLILVEQFVKFNLTDVFVSTFMVVIQLGSILAVL
TLYFRKLNPLDNSKTEKEKRATIDLWLKVIVAVIPSAILGFLFDDAIDALFFNPTTVSIT
LILYGVIMIILENRNKKPIVSDFSQLTYKLAIGIGIFQCLALIPGTSRSGATIIGAVFLG
ASRYIAAEFSFFLAIPTMFGASALKLLKTGASFSGFEWGVIGVGFVTAFIVSVFAIKFLM
DYIKKHDFKAFGYYRIVLGIIVLAYFNFIL
>A0A077NHD0|FEATURES|UNIPROT_deepARG|beta_lactam|XBP1_2830046|antibiotic inactivation|1
MPFSSLRLTRISATIFPLLGTLITFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSIITYRGHERFPLCSTSKMMAVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLAELSAATIQYSDNTAMNLLLGQLGGAHSVTRFARSIGDNAFRLDRKEPELNMVTP
GDERDTTTPQAMADSLYKLALGNTLAATQRTQLVEWLKGNTTGGTSIRAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPLILVTYFTQPSDKDAKAHNDVLAATARIMTQER
>E1P2H0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLVGFHSNHKVFEIAIQLGAVLAVVV
EYRRRFAGVLHGLGKDKKANRFVLNLAVAFMPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSHTVPKKIDVDALRPVDALMIGIAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLNDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIAIIILWLSGRISWE
>A0A0J5Q073|FEATURES|UNIPROT_deepARG|beta_lactam|ABW06_06170|antibiotic inactivation|1
MAAAVLCALPASAMAVAPAQLQALVSETILPLMQQQQIPGMAVAVIYQGKPWFFTYGQAD
VARQRPVTRDTLFELGSVSKTFTGTAGGYAAASGLVNLNDPAAGYGPELRGAQWRQITLL
QLATYTAGGLPLQLPDAVTDEKRLWDYYRGWQPQWPPGTMRRYSNASIGLFGALAVKKSG
LGFEQYLQQHVLTPLKLEHTFFRVPDAEASNYAWGYGRDGKPLRVTPGMLDAEAYGIKTT
VADMATFMQANIDGLRLKNRDPLLAKAIGAAQSGYYRAGEMYQGLGWESWPLPVNPERLI
AASANDIALKPAPVEPQRPAREPLPASWLHKTGSTNGFGAYIALIPERRVGIVMLANKNY
PNPQRVTAAWHILSQLQ
>A0A081Y4G1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFWNAFQAFVLGVVEGLTEFLPVSSTGHQIIVADLLGFVGERAQAFNIIIQLAAILAVV
WEFRGKILEVICGLPSQPRAQRFTVNLLVAFFPAVVLGVAFADLIHHYLFNPITVAAALV
VGGVVMLWAEKREHRIRAESVDDMTWKDALKVGCAQCLALVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAVGFVTSFIFAMIAVRGLLKF
IANHSYAMFAWYRIGFGLLILATWQFSLIDWSSAAP
>R5IVR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKAIFFGIVEGITEWLPISSTGHMILLNELVKLDVSQEFYDMFQVVIQLGAIIAVV
ILFWKQIWPVKKEKEKLTLDKNILSLWGKILVACIPAAIIGLLFDEVFEKLFYNYVCVAI
ALIVFGIAFIIIENKNKGKNSKINSLAELSYNTVLLIGIFQLIAAIFPGTSRSGATIVGA
LLLGVSRTVAAEFTFFLAIPVMFGASLLKLVKFSFAFSGMELAILLVGMVVAFITSMFII
KFLMSYIKKHDFKVFGYYRIVLGIIVLLYFVFTQAL
>A0A0A0EQ25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLAALLLGILEGLTEFLPVSSTGHLLIAQHFIGEQRPDLFNIVIQAGAILATTLVFR
HRLWALATGLGERANRDYAMKLAVAFGVTAAVGLPVRLLGWELPETVTPVAWALILGGVW
MVVAERLAARRPESAHITWTVAVLVGLAQVVAGVFPGTSRSAAAIFIALLAGTGQRSAAT
EFVFLVGIPTMFAASAYALLEHVLDGNAAPVAWDELALAFAAATATGFVAVRWLLGYIKQ
HSYTPFAVYRIVLGVALLLWLPVGM
>N9FBW9|FEATURES|UNIPROT_deepARG|beta_lactam|F927_00802|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVLFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL
>YP_002750791|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MRKNTLLKLGVCVSLLGTTQFVSTISSVKAEHKLEHKVIKNETGTISISHLNKNVWIHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPIGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLSQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLTRYRNINAVVPGH
GEVGDRGLLLHTLELLK
>A0A0Q5FI89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTDDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A0A0Q8R2|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A127T2S0|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
FKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGY
ADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGIT
LLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKP
SGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKS
TIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIIN
GSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYP
NPARVAAAWQILNALQ
>B7NG89|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGCEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0X6ZXA6|FEATURES|UNIPROT_deepARG|aminoglycoside|L904_09415|antibiotic inactivation|1
MSGQFVIETAGEASLGEWSLLRHRLWPDASPAEHRAELQDVSDNEVGFIAYDPAGMAIGF
AEASLRHDYVNGCDTSPVAFLEGVYVEEAFRKQGVAAALIAEVTRWATSKGVSELASDAD
ISNVDSHRMHAALGFEETQRVVYFRKSLPLGS
>F0PPC1|FEATURES|UNIPROT_deepARG|chloramphenicol|YBT020_12220|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIEKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEAMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEDDMR
NYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEKNKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>A0A059WI70|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAAHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLIEASAFPGESETLRAIEVTLVAHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPDQYQPVLLEAKQAYLGQKEDHLTSRAD
HLEEFIRFVKGEIIKSVGK
>ZP_04060517|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MKKQLFTLYFNIFLIFVGIGLVIPVLPVYLKDLGLKGSDLGILVAIFSLSQMIISPFGGS
LADKLGKKLIICLGLVFFTISEFLFAMSHSFILLIVSRILGGFSAGMVMPGVTGMIADIS
IAKDKAKNFGYMSAIINSGFILGPGIGGFLAEVSHRLPFYFAGALGIIAFVISVILIRQP
QNTAESHHIHFETKELSKIQWGVFITPIILTFVLAFGLSSFETLFSLYTSAKANYAPGDI
SIAIVGGGVAGAVFQIFFFDKFMRYTTELTFITWALLYSVIVIFSLIIAHSYWSIMLISF
IVFIGFDLIRPALTNYYSNIAGNRQGFAGGLNSTFTSMGNFVGPLVAGSLFDVNIEFPLY
MSIIVMLFGVVIIFIEKKLQLNRSRCD
>A0A085I084|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIEAIFTHPDNAGENNFFGSVARLAAEQGITVYAPE
DVNHPLWVDRIRAMAPDVIFSFYYRNLLSDDILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMTNRADAGDIVAQQTVAIADSDVALSLHRKLCAASQTLLGDVLPKI
RSGQTQERAQNDAEATYVGRRTPEDGRLTWEKPAQELHNLVRAVSDPWPGAFGYVGTNKF
IVWKSRVRTDMAAAKPGTVLSVAPLVVACGEGALEIVTGQSANGVYMQGTQLAPAMGLVA
GALLSSRPFVAVKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDANFDEDTSNLVVGPISKQRWIYSVSKQLLDRVIWAYGDK
TGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLDCFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLDWQPTVEMQQTVEETLDFFLRTVELTDEKP
S
>A0A100HRB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALVIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WELRHKIIEVVKGLPSDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGFVILWAEWRERHRGQTHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGIIVLVTAYTHLIAWQA
>A0A010YU80|FEATURES|UNIPROT_deepARG|chloramphenicol|K413DRAFT_0385|antibiotic inactivation|1
MKFNKINMEQWNRREHFEHYFKHVKCGFSITENIDITKLLTMSKAKEYAFYPLVLYIASV
GVNAQMELRTYVNEAGEVGYWEQVHPSYTIFHKDTHTFSELWTEYSKEFKVFYQNYQADM
HLYGNDQSFFPKKDCPLNNFPVSCIPWSSFSGFNLNLFGDNKFLSPIITFGKYFEQGDTV
QLPVSVQIHHAAADGFHVSQFLIELQKLALTTEEWLF
>ZP_00155442|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVEALKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKG
GAEILLASGEKMTLSSNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPSANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRVIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLPLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>A0A0F0DE40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAEAFNIIIQLAAILAVV
WEFRRKILEIVVGLPTQRKAQRFTLNLLIAFFPAVVLGVTFADYIHHYLFNPITVAVALV
VGGVIMLWAEKRQHVVHAETVDDMTWKEALKVGCCQCLALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDIFQPADLPVFAIGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLLILATWQFALIDWSSAKP
>A0A062BVQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGIVEGITEFLPISSTGHLILASELMDFWTKEKSAVFVIAIQMGAIAAV
IYEYWSRLWDAATGMITGEEKGRRLGFGLILASIPIVLVGLTFGQQVKELLFNDVAVAIG
LIVGGLIIIWIEKNPPKVNAPEVENISIKQAIWIGLIQILSLIPGTSRSGATIIGGMMLG
LSRKSATEFSFFLGIPVIIGAGLLDLYQSYDVLESNFDWLVIGWGILVSFISALFLIRVL
VAYVAKRDFMIFAWYRIASGLLILLFAFTGWRLW
>YP_001350571|FEATURES|ARDB_deepARG|multidrug|mexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLAGLLVISRLPVAQYPSVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGVEVEQTSAGFLLIYALNYKEGVQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSEQELSATLAVKG
TLDNPQEFGQVVLRANEDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGLSPAEATAKAMRQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARLTGHYSLLNSKLVARAGR
FMLVYAGLVAALGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRMRTDATGEELERFLET
REAVDSVFLVSGFSFSGQGDNAALAFPTFKDWSERGPGQSAAAEIAAVNEHFALPDDGTI
MAVSPPPIDGLGNSGGFALRLMDRGGVGREALLQARDTLLGEVRGNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVGFESISGTLSAAFGSDVINDFTNAGRQQRVVIQAEQGARMTPE
SVLRLYVPNARGELVPLSAFVSMKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLAAQLPAGIGYEWTGLSYQEKVSAGQATALFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVTGMANDVYFKVGLITIIGLSAKNAILIVEFAKELWEKGHGLRDAAI
EAARLRFRPIIMTSMAFILGVVPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSKPAPIEPAATARE
>A0A0C2XXI4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDLDASIRFYQEVFGAKLLVKGRSTAYFDLNGIWLALNVEHDIPRNE
IRQSYTHIAFSIEEGQYDETYDKLEKLNVHILSGRPRSERDKKSIYFTDPDGHKFEFHTG
TLQERLDYYRQEKKHMEFYD
>D2U3U7|FEATURES|UNIPROT_deepARG|aminoglycoside|ARN_33380|antibiotic inactivation|1
MSIIIRKMEKTDRMVWATMRLQLWDKQARASHLNDIDNILSNKQNAAYIALLANHQAVGF
AEISLREYANGCSKQTVPFLEGIWVKPEYRQQGIAQALISQITTDLIAKGFDELCSDAEI
GNTLSYKAHQNWGFDEIERVICFRKKLI
>A0A0J6Q8U7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDISTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVAYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEMLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A009YWT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLLLLKAAIMGIVEGITEFLPISSTGHLILASELLNFWTPEKSAVFVVAIQMGAIAAV
IYEYWSRLWGAAIGMVTGEAKGRHLAISLIIASIPIILVGLTFGQTVKDLLFNDIAVAVG
LIVGGLIIMWIEKNPPKVNAVEVENITFKQAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSHDVFQGQQDWIVLAVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIFSGLIILLFAFTGWKLW
>A0A0C6ERQ2|FEATURES|UNIPROT_deepARG|aminoglycoside|AO964_14910|antibiotic inactivation|1
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>A0A0D7FL84|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPSENRFFGSVAQLCARHGIPVHAP
EDVNHPIWVERIRALEPDFIFSFYYRNLLSNDVLACAKRGAYNLHGSLLPRYRGRAPANW
VLVNGETETGVTLHRMVQRADAGAIVAQQRVAIAADDTALTLHAKLREASQTLLRDSLPA
LAEGRLSEREQDESQATTFGRRSAADGELEWSRPAVELGNLVRAVTQPYPGAFGWIGDRK
LIVWSAQARQESHGQTPGSVLSLEPLRIACGEGVLEIQAGQLGDNGLYLSGPQLAREAGL
VAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADGEYEVYGLDIGSDAIERLKAN
PNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRH
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGA
KGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDV
DDGIEALFRIIENRGGRCDGQIVNIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGF
REVESKSFYGDGYQDVAHRKPSVENARRLIDWQPTTAMAATVGKTLDFFLREALAQREA
>A0A0K0SYN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIYLMLKAVIMGLVEGATEFIPVSSTGHLIITGEWLDFLSKDKRDVFEIIIQLGAILAV
CVEYRQRLWHTVQRIQTDTNAQHFVRNLIIAFLPAALIGLAFHHQIKEHLFSSFTVGIAL
VVGGILILLIEKFAPEGQTREIDQITAKQALQIGFAQSLALFPGMSRSGATIMGGMCFGL
SRQTATEFSFFLALPIMFAATGLDLYQAKDLLSADDALIFLIGFVVSFLSALMVIRALIR
FVAQHSFAVFAWYRIVFGILVLVFFAH
>E7GCM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILEILKAVLFGIVEGITEWLPISSTGHMILLDEFVKLDVSPEFYSMFQVVIQLGAILA
VVVLFWNDFFPFGKKDNQQPLAQTGVLSYVKWDKFMLWFKILVSCVPAAVVGLLFDEQLE
AMFYNYQTVSIALIVFGIAFIVIENRNASQHSRINSLADITFNTALLIGIFQLIAAIFPG
TSRSGATIVGALLLGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGFLFTTAELIILVIGM
IVAFMVSVVVIKFLMGYIKKHDFKVFGWYRIVLGILVLAYFLMR
>B2ZTR6|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
LFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQ
DKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQL
ATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKP
FDQVLEKIIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLP
DMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSE
QIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIK
>A0A0B2WH64|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDDIKNVSIVIPVYNEEESLPVLIERTLAACRQIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIITVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMVDYGCMLRAYRRHIVIAMLRCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFLGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>A0A0D1KPL2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEETKLTKVSVVIPVFNEQDSLPALIARTCNACASLGLDYEILLVDDGSLDQSAQLIAD
AAATSDGHIVGVMLNRNYGQHSAIMAGFSHVSGDVIITLDADLQNPPEEIPRLVAAAQEG
YDVVGTVRQNRQDSWFRKKASRTINGLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARKTIELPVTHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRLLSVLG
SVIALAGFAFSLTLVVLRLFLGAAWAGDGVFMLFAVLFMFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQCVIRTPQAPSSQEIK
>H4USK7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQTMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>A0A0B1Q485|FEATURES|UNIPROT_deepARG|aminoglycoside|LA66_00505|antibiotic inactivation|1
MVDIDREESCAIPFVPSNMSVEVHGYKWARDTIGQAGGAVYRLYGRVGAPDLFLKHGRDE
VADDVTDEMVRLRWLAGYTSVPSVQNFVRTKDEAWLLMTAIPGKTVYQVLEENADARFIV
VDAIAAFLRRVHAIPVCECPFNSDYTYRLSRARARIDSGLVDADDFDTEREGLTPEQVWE
EMQHLLPFPADPVVTHGDFSPDNLLMNEGEILGCIDVGRVGIADRYQDLAILWNRLEEFG
SPLQERFFQRYGVADVDRRKLQFHLMLDEFF
>T0PK46|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKQNIRQREGVFLENIIFVIKSVILGIVEGITEFLPVSSTGHLVIFQNLIGFKGITDKYV
EMYTYVIQLGAILAVIVLYWRKIVETLINFFPGKVSYEKSGFRFWFIIFIACIPGGVFGI
LLDDLAEQYLFSPVTVAITLFLGALWMIYAENTFKNKSAANIRNSLGSDLKITTRQAVII
GLFQCLAIIPGMSRSASTIIGGWISGLSTVAAAEFSFFLAIPVMVGMSFLKIFKIGGLLS
LTHLELISLGVGFAVSFGVALIVIEKFISYLQKKPMKIFAVYRIIFAVVVLITGFLGIF
>W1U394|FEATURES|UNIPROT_deepARG|chloramphenicol|Q607_CBUC00214G0114|antibiotic inactivation|1
MPWFNYTSFNVNNEGSNPFLFPMVTWGKFFEENNKIIMPLTIQVHHAVADGYHCSLFFSD
IEEISRNPEQYLK
>A0A0M2LGB4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVYWQKIRDTLVELPSSRQAQKFALNVIIGFLPAVVLALLFGKYVQEHLFTPVIVATTFI
LGGFVILWAEKRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLR
FISTNSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>B2CD71|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
SPKERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVR
ELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDT
TMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQDH
>R8QI36|FEATURES|UNIPROT_deepARG|beta_lactam|IIQ_01397|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKYKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRSNERFAFASTYKALAAGVLLQQNSIEKLNEVITYTKDDLVEYSPVTEKHVDTGMALGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPVHKRNILTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVVINALKS
>E5YAE9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKIIEAEGINKFFGTGQNRVHVLKDMSFAIEEGDFVAIIGQSGSGKSTLMNILGCLDTQS
SGVCRIGGVDIGTLDSDELAELRGKRIGFIFQRYNLLSTLSATENVALPAVYSGVDKKAR
LDRAKSLLADLGLPDKLENKPNELSGGQQQRVSIARALMNGGSIILADEPTGALDSKSGE
NVMDILTELNRRGHTIIVVTHDHHIAGFASRVIEIKDGSIISDTRSREFVPAPERELPRS
PRASFLFRKDQFVEAFKMSVQAILAHKMRSVLTMLGIIIGIASVVSVVALGRGSQEKIIA
NISSMGTNTINVYPGQGFGDRKSDKVKTLTVADSDVLGKQSYIDSATPNTTAAGTLVYRN
ITVNAQLSGVGEQYFDVKGLKPAEGRFFNRDDVRANHSYVVIDDNTRKKLFPNGGDPVGQ
VLLFNRQPLEIIAVAEKQDSVFGPTDTLNLWAPYTTVMNKITGQRHISSVIVKVKDNVMP
LMAEKNLTALLTARHGKTDFFTVNTDSIKKTIESTTGTMALLISGIALISLVVGGIGVMN
IMLVSVTERTREIGLRMAIGAKQGNIMEQFLIEAVLICVIGGVLGIVVSYLIGVVFDLLV
SNFAMSYSAGSMLLALVCSSAIGIVFGFMPARNASRLNPIDALSRE
>A0A0W0NPD4|FEATURES|UNIPROT_deepARG|aminoglycoside|AO265_40620|antibiotic inactivation|1
MIRIQPGVIANPHQWLQLRQALWPDCPADEHQAEIRQMLAEPQRYGCWLALAADSQALGL
AEASLRHDYVNGTDSSPVVFLEGIYVAPEHRRQGIAQRLIEQVSQWGRQLGCTQLASDTG
LDNLASQALHQALGFAETERVVYFKKAL
>A0B212|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIGAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
DRHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEAFAEVGV
GAAATTETAADTRSAPASGDAPPPANNDTAADPAPRARRFAAGTGRFAEACRMAWIALVS
HRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSIGTNTISLYPGSDWGDSRADT
IQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVHALVSGVGDSYFQTRGMRFALG
VPFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGEAILVDNVPCVVIGVTADKKSAFGSV
KSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNM
DSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSD
ILQQFLVEAVLVCLLGGTIGIALSFGLGALFSVFVAQWKMVFSAGAIVTAFVCSTLTGVI
FGFMPARNASRLDPIDALARD
>A0A150B098|FEATURES|UNIPROT_deepARG|beta_lactam|AT274_14125|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKED
LVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLI
RAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIKEAA
EVVIDAIK
>A0A069D0F9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTILQTIIIAIVEGLTEFLPVSSTGHMIIAQNMLGVQSTEFVKAFTVIIQFGAILSV
VCLYWKRFFKLNTCTVFDNEGVSGLSATQKMLVYGKRILYKFDFYWKLLVAFLPAAFFGL
LFSDKIDEMLESVAVVAVMLVLGGIFMLFCDQIFVNQEEQTELTEKRAFKIGLFQCVAMI
PGVSRSMATIVGGMTQKMTRKAAAEFSFFLAVPTMFAATAYKVYKLFTTGGMQILADNMG
ALIIGNIVAFVVALLAIKFFISFVTKYGFKAFGYYRIIVGGIILVMLMFGYNLEIV
>ABB53349|FEATURES|ARDB_deepARG|glycopeptide|vanRB|antibiotic target alteration|0
MSIRILLVEDDDHICNTVRAFLAEAGYQVDACTDGNEAYTKFYENTYQLVILDIMLPGMN
GHELLREFRAKNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMQILLKRVEALLRRS
GALAKEIRVGRLTLLPEDFTVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFESDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEES
>A0A0Q9H6P8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHNLIEAFVLGIVEGLTEFLPVSSTGHLLLIGHFLGFESNGKTFEVLVQLGAILAITLVY
FRRLLDIALRIPSDPSARRFVIGVLIAFLPAAVIGALLHGFIKGVLFNPFIVCCTLIAGG
LILLVVDELELQEKHTDATTFPLPMYFKIGLIQCLAMVPGVSRSGSTIVGAMLLGASKRA
AAEFSFFLAMPTMAGAFAYDLLKSYKFLTFDDGVMIGVGFVAAFISALVVVRSFLDFVSK
RGFAPFAWWRIIVGMVGLAGLWIVG
>A0A0A0QAW4|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEMSLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKSEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGIQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>X5QUQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFIAAFLTALIVVRFLLDY
VSRNGYSLFGWWRLVVGAVGLVALFIWG
>A0A0D0KNK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGGFGDNRGKVFEIAIQTGAIFAV
ILVYWQKIKSTVVALPRQPKAQRLALNILIGFLPAVVLGLLFGKVIKAHLFIPTVVASTF
IIGGFIILWAEKRPPGSVRVEHVDDLTAWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLG
LSRQAATDFSFFLAIPTLIGAGAYSVYKERALLSMADVPLFAVGLVFSFISAWLCVRWLL
KFISTHNFIPFAWYRIAFGIVVLVTAWTGTVVWAD
>D8FHR3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFDLFKVLILGIVEGLTEFLPISSTGHLILFGKFIELSPKEFSNAFFVIIQLGAILSVL
YLYFNDLNPIGKYKIQEKVGDKYKSLSLKDKWKLRDMPTMRLLAKIIIGFLPAAVLGFLF
DDLIDKYLFNEVTVSIALIFYGIIIILMEKKNKDSYFKYNDLDDISLKTAFFIGVFQCLA
MVPGTSRSAATIIGAMLLGCSRTSAAKFSFYLAIPTMLGATALKVIKIGISFGLWQWFLI
IVGGIVSYIVALIVIKKFLSYIRNNDFTYFGIYRIILGILVLFIRFI
>X8JRM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQFIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAF
VVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLLYGAVKLIFG
>F2A966|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAALLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPENRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGVWMI
FAEWAAARKAPHKQITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAAGEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMATSGLIA
>A0A031H3R6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIIIQAGAILAVVLVFRQ
RLLQLATGFGQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGIWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLELAKEGNLGSENWTDVGVAFLAAAITGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>CAE32228|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDSTLHLLKAFFLGIVEGLTEFIPVSSTGHLIVIGDWINFASSSGKVFEVVIQFGSILA
VMWIFRARLWQLIRGTLTGVRQEVNFTRNLLLAFLPAAVIGAIFIKSIKQVFYHPGVVAV
TLVVGGFIMLWVERRAPHTPGDAPGAADDTASDERATAHTLEQISAKQALGVGVAQCVAM
IPGVSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDLYRNIGLLSQHDMSAIA
VGFVAAFLSALVVVRAVLRFVANHTYRVFAWYRIALGLVVAAWIYAK
>R6VWT8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKAIIYGIVEGITEWLPISSTGHLILVERLIPFKQTSEGFFDMFDVVIQLGAILAV
VVLFWNKIWPFYLKKNKQPKKGGIVKSAKDPAMGNVALSMDAFWMWVKIVVACIPAVVYG
LLFDDAVSEAFKKEIGTSGVTVQVIVVAVMLVLVGVLFIVIENWNKNRVPTTTTLSQLTY
RDALIIGFCQLVAAALPGTSRSGATILGAIMIGISRTVAAEFTFFLAIPVMFGASLLKVL
KFGFAFTGMELACLLVGTVISFIVSLFVLRFLMGYIKKHDFKVFGWYRIVLGIIVLLYFL
VFA
>H0A419|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAFALLSALLMGVVEGLTEFLPISSTGHLILLAEAIGFTGPPGKTFEITIQLGAILAVI
WVFRETLLRIAFGMWRRGSTEYYMAMNLLLAFLPAMVLGATLHGYITTLLFTPLVVALAL
IIGGIAIIVIERNRPNPSIHSIQEMGPLAALLVGFGQALAMIPGTSRSGATIISALLVGV
ERKTAAEFSFLLAIPTMVAATAFSLFKARAELDFSSMGQIGVGFFSAFIVALLIVRWLLS
VISRIGFTPFGWYRIALGALILVWLALRSGGAAA
>YP_793056|FEATURES|ARDB_deepARG|multidrug|oprJ|antibiotic efflux|0
MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVD
AELRRLVGVALDNNRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAG
NRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYL
SYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQ
KQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRAR
NADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSWSFLPTLTLPIFDGGRNRANLS
LAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYE
SGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS
>G2IEQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFNLILKGGYNILEVLLLLKSVIIAIVEGITEFLPVSSTGHMIIVGDIINFVETSGVNF
AHMYEIVIQLGAIIAIMVLYRKKIIDSIIHLKEYGFKMWFYIIIAFLPSAIIGVLVDDII
KAKLFNTFSVSLGLIIGGIILLVVEKYFSTKNVDKQTCDIKNINFKQALGIGCFQVLSLC
PGMSRSSSTISGAWIFGCSTKLAAEFSFFLAIPTMIGASAYELLGTDYSNFTFSHGIALI
VGFLVAFLVALLVVDIFMKFLRKYPMKYFAYYRIVIAILLIVLVNLNIIKV
>A0A0F5XWN1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRDVKPINLLSVVIPVYNEQESLPELIRRTRAACDPLELEYEILLVDDGSSDRSAEVIEQ
AAALPDSPVIGVLLNRNYGQHSAIMAGFSHVRGDVIVTLDADLQNPPEEIPRLVDAARQG
YDVVGTVRQQRQDSWFRRQASRTLNRLIQRVTGQAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARHTIELPVIHAERAFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SLIALTGFAFSLVLIVLRLFFGAAWAGDGVFVLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQRVVKAPQAPSVQPSVQESSL
>ABI81214|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTAI
TSFQWKNTKINIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTAVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTSFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0ESF0|FEATURES|UNIPROT_deepARG|beta_lactam|len-1-like|antibiotic inactivation|1
GSLRVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFP
MVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAI
TLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLERWETALNEALPGDARDTTTPASMA
ATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVA
LLGPDGKPERIVVIYLRDTPASMAERNQHIARDRRSADRALP
>A0A0Q8J3A3|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD86_23995|antibiotic inactivation|1
MKAGWRVRRAEAADRAEWSLLREALWPQEDASRHPEDIDELLSRPHNAVGFLALDAGGIA
RGFAEATLRGDYVNGTDGSPVGFLEGWYVQPEFQREGVGRALIEAVERWTVQCGCSELAS
DALLDNLDSHRAHEACGLRETERVVYFRKRLRDGG
>C4K574|FEATURES|UNIPROT_deepARG|beta_lactam|HDEF_1020|antibiotic inactivation|1
MESFRLTLISIFAAFSLPALAHQATIDKVKESERQLNARVGYVELDLANGQILNTYRPEE
RFPMMSTFKVLLCGAVLSRVDAGLEQLDRRIKYRQSDLVKYSPMTKQHLADGMTVAELCS
AAITVSDNTAANLLLSTIGGPKGLTSFLQKTGDQVTRLDRWETELNQALPGDERDTTTPK
IMAQTLHNLLTGKILSVKSRQQLQTWMVMNKVGGPLLRSVLPANWFIADKTGAGNHGSRG
IIAALGADGKPSRIVVIYLTETQATMDERNKQIAEIGASLIKNWYS
>A0A0B5IE07|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPQGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMIGRADAGDIVAQQSVAIGADDVALTLHRRLCTAASELLGQALPAI
REGNVAARAQDESQATYVGRRTPEDGRLDWEQPAQVLHNLVRAVSDPWPGAFGYTGANKF
IVWKSRVRRDLPAAKPGTVLSTAPLVVACQDGALEIVTGQTDRGVYIQGTQLAQALGLVS
GAVLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLENP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
AALRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLDCFERHPLRGNFPPFAGF
RDVESSDYYGKGYQDVEHRKPSIRNAKRCLSWTPTVPMEETVEHTLDFFLRTVELADDKT
S
>W1RRF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVHSVVLGLVEGATEFLPISSTGHMIVVSQWLGMAQTEGNKAFEVIIQLAAILAVIAN
YKERFSFKHTRLWCQVFVAFLPVAIVGFLLRHQIKDLFSVSVVATMFIVGGVVFLLTEKV
IKNRTPSVERLEALSVKQALWIGLAQVFALIPGTSRAGSTIVGALFVGLSRKASAEFSFL
LALPVMMAASGYDLLSHYDAFVGEEWLPLAVGFVVAFVSAFVVMKLFMAFLERFTFVAFG
WYRIVFGGLLLLLV
>A0A060KTK2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MMKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>L4J083|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLKLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0A8XDM2|FEATURES|UNIPROT_deepARG|beta_lactam|P23_0303|antibiotic inactivation|1
MFDELIMRFKKISYLILPSLFIFNTSIYAGNTSKEQDIKKVVDQNFKPLLEKYDVPGMAV
GVIQNNKKYEMYYGLQSVQDKKSVNGNTIFELGSVSKLFTATAGGYAKTKGKISFEDTPG
KYWKELKNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQY
SNPSIGLFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPI
RVTPGPLDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALG
WEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVLFIPKEN
IGLVMLTNKRIPNEERIKAAYAVLNAIKK
>Q6UIV2|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGK
>B7NL82|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDPPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>YP_371057|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MNNLHNTNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDVSTPTAFKEAPTLAAGEQAG
TWKTAEPSDGAHRGEWWKAFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQW
FPQIGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFGLRQLDSDQDLYRRTVELREQALKLVQRRFNEGDIS
ELDVSRAKNELATAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKVPPG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGAFGYEASTLGSLFMWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGAAPTAVGDAASVKAEVAAR
>A0A099VSK4|FEATURES|UNIPROT_deepARG|aminoglycoside|LS69_04805|antibiotic inactivation|1
MIRKAEKNDLVVLANLAALIWDCSVDTLFHEFSETIAKENYQFFLKFANDEPVGFAQCSL
RYDYVEGTKTTPVGYLEGIFVKEGFRNKGYAKELLAACEVWAKDKGCKEFASDCAIDNMD
SFYFHKSMNFTEVNRIICFTKVL
>A0A0T9LT84|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MHKTLSCVLLLVASGSVLATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYYF
TWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSQYWPALSGKQW
EGISLLNLATYTAGGLPLQVPDNITDEASLQNYYETWQPQWKPGTTRLYSNASIGLFGKL
AVKPSGMSFEQAMNKRVFQPLNLTHTWIQVPLREEKHYAWGYRDGKAVHVSPGMLDAEAY
GVKSSIEDMASWVRANIAPSEVKDVSLRKGILLAQSRYWQVGDMYQGLGWEMLNWPMKAT
VAVDGSDNKVALAPLSAAEINPPAPALNASWVHKTGSTGGFGSYVAFIPEKNLGIVMLAN
KSYPNPARVEAAYRILDALQ
>A0A0Q3C508|FEATURES|UNIPROT_deepARG|beta_lactam|AM266_00770|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGKQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>BAD95833|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-VIIIa|antibiotic inactivation|1
MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDALRDA
VGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQ
PGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLT
LLHHAEALAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTETEAFPYGRVVPEGVWPFTVI
AQDMLAAGIGRTGRVAAAPCHLFEAADVVRFGVEWIESRMGGAAGGA
>G2RSR9|FEATURES|UNIPROT_deepARG|beta_lactam|blaP|antibiotic inactivation|1
MKTWKKMFHASKLQKMLPVFALSCAAVVGFSSSGVQAETVKCQKQESMSDREFAKLEEKY
DAHLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDEVTLPE
RFEPDLNEVNPGETHDTSTARALATSLQTYVLGQALPEDKRELLTDWMKRNTTGDALIRA
GVPKSWEVADKTGSGSYATRNDIAILWPPKGDPIVLAILSDRTEKDAEYNDKLIAEAAKQ
AVKALKATRK
>A0A066WWP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFYGIAQDDFTKLFTIVIQLGAILSVVIL
YFKRFFQTFDFYFKLLVAFIPAVVLGLLLSDIIDDLLENPVTVAVSLLIGGLILLKVDEW
FNNPNSAENSQEITYLQALKIGLFQCLAMIPGVSRSGASIVGGMSQKLTRTTAAEFSFFL
AVPTMLGATAKKCYDYYKAGFELSQDQTNLLIIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIILLLIHFFIHPLSII
>A0A0U5L0V4|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQVKHEGTGKGHLTLIHILLGMVPAVVIGLVFHDQIKTLFNPIN
VMYALVVGGVLLLVAEFFKPKQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSMGFLTMADFPMFAVGFITAFVVAMIA
IKIFLELIKRISFVSFAIYRFIVAAAVYMVFM
>A0A061CGG5|FEATURES|UNIPROT_deepARG|bacitracin|upk|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSYKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLFKFFKAGHVFVGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>D0ZHC6|FEATURES|UNIPROT_deepARG|multidrug|mdfA|antibiotic efflux|1
MQNRLSSTRRLGRRALLFPLCLVLYEFATYIGNDMIQPGMLSVVQTFGVDESWVPTSMTA
YLAGGMFLQWLLGPISDRIGRRPVMLTGTLYFAVTCLAILLTNSIEQFTLMRFLQGISLC
FIGAVGYAAIQESFEESVCIKITALMANVALIAPLLGPLAGAAWVHLFPWEGMFILFAAL
SLLAFLGLYKAMPETATRRGETLSLSALGHDYALVLKNKRFLGGALACGFASLPLLAWIA
QSPVIIISGEGLSSYDYGMLQVPIFGMLILGNFTLARLSGRRPVRRLIQLGAWPMVGGLA
IAAVSTLYSAHAYLWMTAGLSLYAFGIGLANAGLYRLTLFSSTMSKGTVSAAMGMISMFI
YTLGIEVGKHAWLLGGNGAFNLFNLISGLLWLALVALMLRDKRVGGTTER
>A0A0H0ZZR4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKCFSFWHFGIFTATSLLFGTAVQAADQSLIENVVNEAVRQVMEENEIPGMTVAITVRGE
RHVFNYGVASRENGRKVTDNTLFEIGSISKTFTATLASYAEARSALSFSDNASEHLPALA
GSSFDRISLLDLGTYTAGGLPLQFPDHVTDRETMIAYYKSWRPAHDTGTQRQYSNPSIGL
FGHIAAASLNEPFDELMEETIFPAFGLSSTYIRVPEDRMDDYAYGYSKAGKPIRVTPGVL
DSEAYGVKTRSADLIRFVEANMDGSELDETMLHAIASTHTGYYKVGDMVQGLGWEMYAYP
ATLETLLAGNSSDMALKPNEASKLVPPLAPQRDLLINKTGSTNGFGAYVAFIPARSVGIV
MLANKNYPIPARVKVAHRILEALASGSGSEQIR
>K8AUV1|FEATURES|UNIPROT_deepARG|beta_lactam|BN133_883|antibiotic inactivation|1
MKSKACALVMMMLMGGSAQAATGWTPDDVVKPLMAQYQIPGMAVAVSVNGETHFWHYGVA
SKETRKPVDEKTLFEIGSLSKTFTAALASYAQQEGKLDFSAPASRYLPELKGSAFDGVTL
QNLATHTSGMPLFVPDDVKNTAQLMDWYRAWQPKQPAGRERVYSNLGIGMLGLITAKALD
KPFSEAMEQGVLAEFGMTQSFVNVPAAAMGDYAQGYNKDDKPVRVTPGPLDAESYGLKSS
SADLLRYLQIQLGERAVSPRWRASLDATHNGYYRSGEFTQAMMWEYYPWPSSPEKLREGN
SSQRIMQGLKAQAIVPPQKAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYQIIEHLDK
>CAG34257|FEATURES|ARDB_deepARG|multidrug|smeE|antibiotic efflux|1
MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDS
VTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQ
EVQRQGINVAKSSSGFLNVIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGG
KYAMRIWLDPNKLHTYGLSVAEVTAAIKAQNAQVAIGQLGGAPSIKGQQLNATINAQSRL
QTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANAL
DTAAGVNAALEDMKSFFPAGLKAEVPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMAL
SVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIH
RPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALEN
HFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDANNGVMPITGRAMAALGQ
IKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRP
NGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQP
FRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASG
DAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVP
TAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGAG
LIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGV
FFVPLFFVVVQRVFKRKSTT
>F0JTB6|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MACVSQARNLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLLRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLLYDFRLVCATGAILFVMCAAF
NAWLLPAWKLSTVRAPVREGMSRVMGDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
TPSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMLPVGLVGSLPHL
FTLICIFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAVGYIGGGWLFDMG
KALQQPELPWMMLGIIGIITFLGLGWQFSHKHTASRMLGPDARS
>D2UGR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDPLSALLLGIIEGLTEFLPVSSTGHLLIAEQWLGHRSDFFNIVIQAGAILATMLVYRQ
RLWTLATGLGEPANRDYVFKLSAAFLVTAVVGLTVRKAGWQLPESVHPVAWALVIGGVWM
LAAEQIAGRLPERETVTWKVAIAVGLAQVVAGVFPGTSRSATTIFLAMLLGLSKRSAAAD
FAFLVGIPTMFAASGYSFLELYKHGALGSENWGDVSIAFAAALVTGFMVVRWLLGYIKSH
RFTAFAAYRIVLGAALLLWLPAA
>A0A0J6D1K6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MAIKGLNHLLFSVSNLEQSIKFYKNVFGAKLLVKGANTAYFDLNGMWLALNVEENIPRDE
ISESYTHIAFTIDEKDFLEMYNKLNELNVTLLTGRPRNERDKKSIYFTDPDGHKFEFHTG
TLKERLDYYKEEKPHMTFYD
>ABO68144|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MRIGGINHLTFSVSDLEKSIHFYQNVFGAKLLVKGRNLAYFDLNGIWLALNVQQDIPRND
IQHSYTHIAFSVKEEDFDHVVEKLKELGVNILPGRERDERDKRSVYFTDPDGHKFEFHTG
TLNDRLSYYKSEMHHMQFFD
>A0A0U5MMF9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLAMIEALLLGIVEGLTEFLPISSTAHLMLIGDMLGFEGPAGKTFEIVIQLGAILAVCVV
FWPRLWGVATTLNQPRSVAFVRNVLLAFLPAAVIGATLYKYIKQMLESPLIAAVALVVGG
FAILLIERLVKRARIHDIEDMSPALAFGVGFCQVLAMVPGVSRAGATIMGSMLLGLDRRA
AAEFSFFLAIPTMCGASAYSLYKNWATLSFDGAGLIAIGFVAAFLSALVVVRGFIGFVGR
HGFAPFAWYRIVFGSVMIALILSR
>W2DEK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQRNAQRFTINLLIAFMPAVVLGVIFADLIHEYLFNPITVATALV
IGGVIMLWAERREHQIHAETVDDITWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFQPADLPVFAVGFVVSFIFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0M5JBV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFWEIFVAVILGLVEGLTEYAPVSSTGHMIIVDDLWLKSNELVSDEAAYVFKIVIQLGS
ILAVAIIFRDRILNLLGLKRKISKEQEQGNKLTLAQIFVGLVPAAVLGFLFEDYIDQYLF
SVQTVAIGLIGGAILMLVADWINKRKPTTDSVDQISYKQAIGMGLFQCISLWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAIPIMAGASCLSLVKNMEALSMDLLPFFAVGFITAFVV
ALVVVQFFLQLINRIKLVPFAIYRIVLGIILLLLFM
>AAY92510|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSQFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKITLTITFALGTDLDNAQVQVQNRVTRTQPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDKRYDMLYLSNYALLNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVTAIREQNRQVAAGALGAPPAPTATSFQLSVNTQ
GRLVTEEEFENIIIRSGEDGEITRLKDIARIELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIEISNEVRAKMAELKQSFPQGMDFSIVYDPTIFVRGSIEAVVHTLFEALILVVLVVIL
FLQTWRASIIPLVAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLNPVEATKRAMREVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKEHHAPKDRFSKILDKLLGGWLFKPFNRFFDRASHGYVGTV
RRVIRGSGIALFLYAGLMVLTWFGFAHTPTGFVPAQDKQYLVAFAQLPDAASLDRTEDVI
KRMSDIALKQPGVESAVAFPGLSINGFTNSPNNGIVFVTLKPFDERKDPSMSAGAIAGAL
NGKYADIQDAYMAIFPPPPVQGLGTIGGFRLQVEDRSGLGYDELYKEVQNVITKSRSVPE
LAGLFTSYQVNVPQVDAAIDREKAKTHGVAISDIFDTLQIYLGSLYANDFNRFGRTYQVN
VQAEQQFRLEPEQIGQLKVRNNKGEMIPLATFIKVSDTAGPDRVMHYNGFVTAEINGAAA
PGYSSGQAEAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQEEGLDPLAAVLEACRLRLRPILMTSFAFIMGVVPLVISSGAGAEMRHAMGVAVFSGML
GVTFFGLLLTPVFYVLIRNYVERSEARKAARALQLEAQQ
>E3DEF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGDKAQTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVQHEGIGQGRLSLIHILLGMAPAVVTGLLLHDQIKLLFNPVN
VMYALVVGGVLLIAAELLKPKQPKSPGVDDITYRQAFIIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMIGATGLDLYKSMGFLTMADFPMFAVGFVSAFIVALIA
IKSFLHIIKRISFIPFAIYRFIVAAAVYALFVL
>Q7M0V8|FEATURES|UNIPROT_deepARG|beta_lactam|TLE|antibiotic inactivation|0
APIDDQLAELERRDNVLIGLYAANLQSGRRITHRPDEMFAMXSTFKGYV
>A0A0N1IA11|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
METFSLLEVFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSDTFISTFLVVIQFGS
ILAVLVIFFKKLNPFDSSKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNST
VVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIG
AVLLGASRYVAAEFSFFLAIPTMLGASALKLLKAGFGFSGFEWLILGVGSIVAFIVSIVV
IKFFMDYIKKHDFKVFGYYRIVLGIIVLAYFFLF
>A0A137XVQ5|FEATURES|UNIPROT_deepARG|aminoglycoside|AYJ56_20090|antibiotic inactivation|1
MHSITAQRKHAEAWAQLRHALWPNTSLEQHLQDICDTLDQDNPDAVTFIAESAIGLIAGF
AEAALRRDYVNGCSTSPVLFLEGIFVSPEYRQHGVARLLCEAIANWGREKGCTEFASDVS
LENLDSQNFHAALGFDETERVIFYRKSL
>A0A0R0CSI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGVTEFLPISSTGHLLIAQHWLGARSDFFNIIIQAGAILAITLVFRQ
RLWSLATGLHQRENRDYVMKLGAAFLVTAVVGLPVRLAGWELPETVSPVAWALIIGGIWM
LLVEAYTARLPDRDRVTWTVAIGVGIAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAATE
FVFLVGIPTMFAASAYAFLELAKEGNLASENWTDVGVAFLAAVVTGFVVVKWLLGYIKSH
KFTAFAVYRILLGAGLLLWLPAGN
>BAH63712|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYFVEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVVAQLNGSGRRERIAPQVRQGFWLAGFVSVLIMVVLWNAGYIISSMHNID
PLLAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATASVYWVMFASMLWWVRRARTMRDIRCVERFNGPDFAVLLRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIIDVAGHQIALNFSSLMFVLPLSLAAAVTIRVG
FRLGQGSTIDAQVSARTGVGVGVCLAVFTAIFTVLMRKQIALLYNDNPEVVTLASHLMLL
AAIYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYLLALTDMIVPRMGPAG
FWCGFIIGLTSAAIMMMLRMRFLQRQPSSIILQRAAR
>R4RPE6|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-146|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAKRNQQIAGIGAALIEHWQR
>C2XT27|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKAHMTFY
>A0A084YYC3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKINRLAAALLATLILPAGHAADKADIDAIVQPLMQKYGVPGMAIAVSVGGKQQFYHYG
VASKQTGKPITNQTLFEIGSLSKTFTATLAAYAQNEGKLSFSEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNNTQLMAYYKNWQPQHPAGSTRVYSNLGIGMLGMITAKS
LNQPFAQAMEKTLLPALGMTHTYIHVPTAQMANYAQGYDKQDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQIKVTEKWRSALAATHVGYYKAGVFTQDLMWENYAYPVDLARLTE
GNNAGMIMNGTPATAITPPQQEQAASWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQLLDKP
>A0A0L7DAI8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCVGINALLSAGYEITAIFTHNDVATENHFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRTMAPEMIFSFYYRHLLSDEILQCAQKGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKRADAGNILAQQKVAIEDQDNALTLHRKLTQAAVQLLGDVLPRL
REGEVSEWPQDESQATRVDRRTAEDGRIDWNQPAQTIHNLVRAVTDPWPGAFAFAGSVKF
IVWKSRVHPQQHQAKPGTVLSKQPFLIACGEGALEIQTGQSEHGVYMNGSQLAQSLGIVP
GALLYSKPQSALQRRTRVLILGVNGFIGNHLTERLLQDEHFEVYGLDISSDAISRFLDHP
RFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDDSFDEDCSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
QDGVEALFRIIENKQLNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPTVTMDVTIDNTLDFFLRTVEPQADK
>ZP_04240432|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQIVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGITALKERGIKAHSTALTAELAKNSGYEEPLGDLQTITSLKFGNTKVETF
YPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDKGLLLHTLDLLK
>A0A0S9QY42|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMGIAKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAILA
VYFRRLLGITLALPNDPKARRFVLGILVAFLPAAIIGGLFSKYIKYYLFNPWIVCATLVA
GGIVLLVLDETDLEVKKHDVFDFTLPMDFRIGLFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSRDDTGLIVIGFIVAFISAFIVVRTVLDYV
ASHGFRLFAWWRIIVGSLGFAGLIIFG
>A0A0B5WYI7|FEATURES|UNIPROT_deepARG|beta_lactam|VEB-4|antibiotic inactivation|1
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWDYYLNK
>A0A0G1PK81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLHYAPRIIVLVTFFQAIILAIVEGLTEFLPISSTGHLILIQRYLSITSSEFSKTFDIVI
QLSAILAVVWIYRKTLFSQFGIWKQSMVAFIPTGIIGFLFYKLIRNVLLEEPIIIVYSLF
IGGVILLVVDKLTKINRGQGRILNLPPNKLIFIGILQSISVIPGVSRSATAIIGGLSTGL
SRSQAVEFSFFLAIPTMFAAAGFDLLKSGMSFSAQEYSVLLVGCFFSFISALIAVRFFID
YVQKNNFTSFAIYRIVLALVVLLTMKA
>A0A0G4QAM5|FEATURES|UNIPROT_deepARG|chloramphenicol|cmlA|antibiotic inactivation|1
MNYKKVDLEQWNRKEHFLHYRHNVQCGFSLTTKIDITALKTVLDKNNLNLYPVMIYLIAK
TVNSYPESRMALKNNELVIWDYINPAYTIFHPKTETFSELWSEYFEDWHSFSQGYNRDYQ
KYKDNLSLSAKSNFPENHFCISMISWVSFDGFNLNVANVKDYFPPIFTMGKYTLQSGKFL
LPISIQVHHATCDGFHIARMINTLQELCDSFSG
>E0NKK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIYAIILGIIEGFTEFLPISSTGHLVLAGEYIKLSPKEFQNAFNVIIQLGAILAVVWV
YFKNLNPLDKDKLVNKHGEAARNFTFKERLRNYDVKTINLWVRIIIGFLPAAVLGFLFDD
LIDKYLFNKVTVAIALVFYGIVILLIEGKDRDSSYESIYQIPVKTLILIGLFQCLAMVPG
TSRSAATIIGAILLGCSRVVAAEFSFYLAIPTMLGATVLKILKLGNVLSLNQWLIILVGA
VVSFVVALIVIKKFLEYVKRHDFKVFGIYRIVLGILVLIMYFIKG
>A0A127SMN6|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDRSIWKRNEYFEHYFTNIPCTYSMTVKLNITQIKKKRMKLYPAMLYYLATVVNR
HSEFRMTINQAGELGIYDEMIPSYTIFHEDTETFSNLWTEYVPNIEEFSRAYENDMQLYG
SNHGMIGKPDVPENVFTVSMVPWSTFESFNLNLQKGYSYLIPIFTLGKYYEEDGKILLPL
AVQVHHAVCDGFHICRFVNELQELING
>A0A098CMQ0|FEATURES|UNIPROT_deepARG|beta_lactam|blaoxa58|antibiotic inactivation|1
AVFLKHLGGFAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYG
THLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQA
STVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLA
QGQLP
>L9LY55|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MENFELFKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELVRGFFSGDVHARHFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGLIIFAVEARKFEPKTIEATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLMNISVGFVAAFIAAILVVKALVK
FVEKHTLRVFAWYRVVLGIILLIVFL
>A0A100M496|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1_2|antibiotic inactivation|1
MPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLNDAVRQ
ALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAGIFEP
ATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWAGDER
NVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLPARAD
QVAALIKFVKYEAVKLLGASQ
>A0A075TDM3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLEASASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRVWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0R2WGS9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAETSTIVAALLGLLEGLTEFIPVSSTGHLLLAGHFLDFESAGKTFEVVIQLGAVLAVLT
VYAAKLWGVVTAAPNDPQARRFIGAVLIAFLPAVVIGVAAHDFIKSVLFETPILIASTLI
LGGIVLLFADRLAARPVHDQAMRFSPMMAFKIGVIQCLAMVPGVSRSGATIVGALMLGAS
RRAAAEFSFFLSMPTMAGAFAYDLYKNRTLLDASALSDIAVGFVMAFVAGVLVVKWLLNF
VSNHGFSLFGWWRIAIGSLALVALLLRF
>CAP69686|FEATURES|ARDB_deepARG|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLISAVSESGVIGSGPDIPWSVKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDIKFPIMPENFNLVFEQFFMSNINYTYQIWKKG
>A0A0Q9HT28|FEATURES|UNIPROT_deepARG|chloramphenicol|ASE46_23765|antibiotic inactivation|1
MKFKFIDRENWYRKEYFEHYLQQQTTFSMTNDINISILLKNIKKKKYKLYPAFIYMVTKT
VNSHREFRTCFNSEGKLGYWEEMIPSYTIFDNESSMFSSIWTQNSSSFAEFYDMYQDDIK
KYNSLEKLFPKPTIPANNFPISMLPWSSFTGFNLNINNGGDFLLPIITAGKYSKKENGIF
FPISIQLHHAVCDGYHASVFMKNLQKLADESEDWL
>A0A140REQ9|FEATURES|UNIPROT_deepARG|aminoglycoside|UN86_29535|antibiotic inactivation|1
MNRTNIFLGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>V5PMK2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILAGSLLNFNDEKGKVFEIVIQFGAILAVC
WEFRAKIAQVVAGLGSDAKARRFAVNVIVACLPAIVLGLLFGKYIKAVLFNPIVVATAFI
VGGVIILLVERHNRSNTMAGKSPRVTSIDDLSFADAVKVGFAQCFALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATVYELYKARSILSVDDVSLFGVGFIAAFVSAFIC
VRWLLRYIASHDFTAFAWYRIAFGIVVLATGYSGLVVWAD
>R6BN08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSEIIKAILFGIVEGITEWLPVSSTGHMIILDELIKLNVSKEFLEVFLVVIQLGAILAVV
MLYWNQLFPFSFKKGEDTIRKDVFSMWFKVIAACIPAAVVGILFDDQINELFYNYQTVAT
ALIVFGILFIVIENKNQTKKARITSIAQITYRDAMLVGLFQLIAAIFPGTSRSGATILGG
ILIGLSRTTAAEFTFFLAVPVMAGASLLKILKFGLAFSGAEMMILLVGMAVSFVVSVLVI
KFLMNYIRKHDFKIFGWYRIVLGILVILFFTFR
>K0XK08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILEILKVIIIGIVEGITEWLPISSTGHMILIDELIRLNASTEFKSMFMVVIQLGAILA
VVVLYFKKLNPFSRGKSSKMRRLTIELWKKIIIACLPAAMLGFLIDDWLDAHLYNGFVVS
MALIIYGILFIMIENSNKKRIDSIKSVHAIDYQTALFIGFFQVLALIPGTSRSGATIIGG
MILGASRAVSAEFSFFLSIPIMFGASLLKLVKFGFHYTAAEVVYLLLGMIVAFVVSVFSI
SFLLNWIKKNDFKFFGYYRIGLGLVVLVWYFVSSLMG
>A0A0A0D593|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLAAPVFAGLAALLLGAAPDPADAPIARIVDDAIRPVMARNDVPGIAVAVTAGGRHHFFS
YGVASKESGQAVTEDTLFELGSVSKTFTATLGATAQLQGALALSDAASRHMPELAGSRFD
RISLLDLATYTAGGLPLQFPDEVTDDAGMIAWYRGWRPDWAPGTRRLYSNPSIGLFGHLA
ALSLGRPFDELMQQRIFPALGLSHTFIRVPPERMPAYAWGYNKTGKPVRVNPGPLDAEAY
GVKSTAADMIRFVDANIDGAGLDDSTRRAIAATHAGYDRVGDMTQGLGWEMYAWPVALDR
LLAGNSPEMSSKPNPVDRLDPPLPPQDDVLLNKTGSTNGFGAYVAFVPSRRIGVVILANR
NYPIADRVTAAYRILTALGGTTGTE
>A0A127SAW2|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-46|antibiotic inactivation|1
LGVKGNLMAIRFLTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEGAIVIADERQAK
HTLSVFDQERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVNRSFAGHNQDQDL
RSAMRNSTVWVYELFAKDIGEDKARRYLKQIDYGNVDPSTIKGDYWIDGNLKISAHEQIL
FLRKLYRNQLPFKVEHQRLVKD
>A0A127EIA7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLSYIFSFIGLKTSGDKRKYEKRLAESKTGFRFGINVIIATI
PAAILGFLFDDEINKYLFSTKTVAVGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLGIPVMVGASGLKLFKF
DYSQMDGTYLIALILGFIVAFIVSLVVIDKFINYLKKKPMRVFAIYRVFAGIVLAILIFT
KVIS
>A0A0J1KGD8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYDIAAIFTHADNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERIAQLAPDVIFSFYYRHLLSDEILRLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRITISPDDVALTLHHKLCQSAREVLAQALPAI
KAGDFQEYPQQEADATCFGRRTPEDSFIDWNKPCAQLHNMVRAVSDPWPGAFSYAGTQKF
TIWSSRQSANTSAALPGTVISVSPLLIACADGALEIITGQAGDGITMQGSQLAQVLGLVA
GSRLNSQPVSASKRRTRVLILGVNGFIGNHLTERLLREDNYEIYGLDIGSDAIERFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKDFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALFRIIENDGGRCDGEIINIGNPDNEASIQELAEMLLSCFEKHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRCLNWEPTIDMQETVEETLDFFLRSVDITEHTS
>A0A089WQY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWSAAQAIILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKIGDIVVGLPRQPRARRFTLNLLIAFMPAVVLGVIFADLIHHYLFNPITVAAALV
IGGVIMLWAERRVHRIEVEHVDEMNWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RQAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFALGFVVSFIFAMIAVRALLKF
IAHHSYAAFAWYRIVFGVLILATWAFGWVDWSTAIA
>A0A0F4T9B2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLASGIEIAAVFTHADDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERIAKLDPDYLFSFYYRNLLTEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQPVAIERSDTALTLHGKLRLAATDLLRDTLP
ALLQGKVTETAQDESKATVFGRRTPADGKLFWKKPAEELFNLVRAVTQPYPGAFCDVGEH
KLIVWNAEVAKGNEGLAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DHSTEKAC
>F9EN57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVFVVAIT
LITYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYMVI
KWFMDFIKKKKFCFIWII
>H7E7I1|FEATURES|UNIPROT_deepARG|aminoglycoside|SEHO0A_01569|antibiotic inactivation|1
MDIRQMNKTNLERWRGLRKQLWPTHPDDAHLADGEEILQADHLASFVAMEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0M2WVR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAIL
SVLFLYREKFGSQIRSSLRYVTKQNSDPQGFYFLVRIVIGALPILVAGFIAKNFLDTIKT
RSDLLYILAGAWIFGGVLILVAEWFFQKRRGAEEKKPVGFRDAILIGIFQCAALIPGVSR
SAATIVTARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNEVTIPVLTFGFLIS
FLLCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>W0D6B8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIKLENIKKSFITGGVSSEVLKGINLEIKKGEFVAIIGQSGSGKSTLMNILGCLDTPTSG
KYLLDSLDISKFKKDELSNLRLKKFGFIFQRYNLLSSNDTKSNVALPGIYAGMSKADRIN
RAKDILVKLGLETKFDTMPNHLSGGQQQRVSIARALMNGGEILLCDEPTGALDSSSGVMI
MQILDSLHKDGHTIIVVTHDKDIAAWADRIIEIKDGNIISDTRKNSQIYELKQNLKEIKP
SLKAIRDQFFESFVMSLGAIKSHKLRSFLTMLGIIIGIASVICVVALAKGSQQKILSDIN
NMGTNTITIFPGKGFGDMHSGRVRSLSIDDSNLLGKLDFVDFSTPRMNTSGLLTYANQSF
SGSLRSGSEYSLAISGLKIEKGRDFTKDDIINSRSNIIIDQFTKDAFFKDVDPIGKVILF
NKQPFTIVGLVKRDETSFSGDNLTVYAPYTTTMNKLTGDRDIRSIMLKLKDGVNAQVAEQ
SIIEVLKIRRGSKDFFTRNSDTIRQTIESTMNTMSLLISGIALISLMVGGIGVMNIMLVS
VFERTKEIGIRMAIGAKSKDIMTQFLIEAILLCAIGGSIGIGLAYAIGYGFNVFGGDFKM
IFSTASIFIALGVSSLIGIVFGYIPARNASKLNPIDALLRE
>F1DI07|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GMIEMDLDSGRTLTAWCSDERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVD
YSPVSEKHLADGMTVGELCAAAITMSENSATNLLLATVGGPAGLTAFLRQIGENVTRLDR
WETELNEALPGDSRDTTTPA
>A0A0U0X8L3|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVGKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>A0A0P7FVD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDPISALLLGIIEGLTEFLPVSSTGHLLIAQHWLGARSDFFNIVIQAGAILATTLVFRQ
RIWQLTTGLGNREHRDYSAKLFVAFAVTALVGLPVRMAGWQLPETVTPVAWALIIGGVWM
LVAEYLSEKRGDNTHVTWTVAVAVGLAQVVAGVFPGTSRSATTIFLAMLLGLSRRSAAAE
FAFLVGIPTMFAASAYAFLELWMDQGLSEEAWGDVAIAFVAAMVTGFIVVKWLLGYIKAH
RFTGFALYRIALGAGLLLLMPSGF
>A0A0K3NB69|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYSAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDLQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKYFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>B1LIU5|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRTARRLLERDA
>A0A077KUS2|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLRCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>B5WXV7|FEATURES|UNIPROT_deepARG|beta_lactam|cfxA|antibiotic inactivation|1
LVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPCEIGVAVIVNNRDTVKVNN
KSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLT
VRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAY
SNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKT
GSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLM
QTSVKS
>A0A0B5GCJ2|FEATURES|UNIPROT_deepARG|bacitracin|bcrD|antibiotic target alteration|0
MVLDFIEILKVIFLGIVEGITEWLPISSTGHMILADKFITLNMSEAFKEMFFVVIQLGAI
LAVVVMFWNKMFPFQLKDKSQPLVKKDTFSLWFKVAVACIPSGIMGILFDDYLDAYLQTP
IVISIMLIFYGLLFILIENWNKKRTPTTMALSDISYKTAILIGAFQVLSLIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPTMLGASAFKLLKFGFDFTSAELLALVLGMAVAFAVS
VLVIKFLMNFIKKHDFKVFGWYRIVLGILVYLLYL
>ACA48664|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRDSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>CAT00058|FEATURES|ARDB_deepARG|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKILRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFL
SEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG
>ZP_04151022|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLINGFNHLCFSVSDLERSIQFYETVLEGKLLVKGRKLAYFDICGVWVALNEEADIARNE
IHQSYTHLAFSVKQEDFGRLLKRLEENKVHILQGRERDVRDCQSIYFIDPDGHKFEFHSG
TLQDRLKYYKEAKPHMKFY
>A0A086GGQ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAEALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVARQAERIIEIRDGEIIADSRPAPQENAQAKPLAL
AAAAPSWRQMGGRFREALIMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPMQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNSYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A098U8V1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILALKAIIMGLVEGFTEFLPISSTGHLILAGSLINFTGEVAQVFEIAIQAGAILAVM
WEYRARLGAVLGGITSDPRQQKLVVNLIVAFLPAAVLGFLFSKAIKAHLFKPEPVAAAFI
VGALVILWAERRHKVLPGAHRIQTVDDMTIMDAFKVGCAQCFALIPGTSRSGATIIGGML
FGLSRTAATEFSFFLAIPTLLAATVYSVFKARHDLHATDLPLFLIGGVAAFISAFLCVRW
LLRFISTHDFTGFAWYRIVFGVVVLITAHFGWVVWAE
>A0A0Q4MHQ4|FEATURES|UNIPROT_deepARG|beta_lactam|ASE99_23780|antibiotic inactivation|1
MFMNTFRQKACLTVALMPLLFSSAPLWAQTPAQAKAVQQKLAELEKSTGGRLGVAMIDTA
SNTQTLYRADERFAMCSTSKVMAASGILKASETDKNLLNKHVDIKKSDLVNYNPITEKHL
DSGMTLGELGAAAIQYSDNVAMNKLIAHLGGPAKVTQFARSLGDETFRLDRTEPSLNTAI
PGDKRDTTSPLAMAESLRKLTLGNALAEPQRAQLVEWLKGNTTGAASIRAGLPATWQVGD
KTGSGDYGTTNDIAVIWPDNHAPLILVTYFTQPQQDAKARKDVLAAAAKIVTENL
>BAB37346|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEA
EKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASSGISDTSYSGSKTRGAAGTQYDD
SNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINA
SISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLIN
QLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
SARTTTSNGHNPFRN
>D7AWL3|FEATURES|UNIPROT_deepARG|beta_lactam|Ndas_2389|antibiotic inactivation|1
MLLSPLRRTGLAALAAVTLVPAAACGADGSGPAPGTEPSAGPSAEGSAGRSAPADLSAGF
ADEFADLEEEFDARLGVYAVDTGSGEEVAHRPDERFAYCSTHKAFSAALVLQRNTPEEME
EVVTYDADDVFGHSPVTEQHVDTGLPLMEVADAAVRYSDNTAANLLFDELGGPDGFEGAM
EEMGDDVIEADRVEPGLSRWAPGDTRDTSTPRAMAGSLREFVLGDALPEDRREVLTRMLV
DNLTGDELIRAGVPEGWEVGDKTGSGNYGTRNDIAVIWPPEGDPIVLAVMSSRDEEDAEY
DNALIAGAAEVVVEALG
>A0A0S3NSE4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNQPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>Q5UCE5|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampC)|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KRYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNRFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A7TUE6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANK
NYPNPARVAAAWQILNALQ
>YP_002085096|FEATURES|ARDB_deepARG|chloramphenicol|catB7|antibiotic inactivation|1
MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIG
SFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPAFAGAVNGYQPAGDTLIGHDVWIG
TEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWD
WPLADIEAAMPLLCAGDIPALYRHWKQRQATA
>A0A0A2WNA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEFLAALLLGIIEGITEFLPISSTGHLLIAERWLGHRSDLFNIAIQAGAILAVVVIYRQ
RLWQLADSFVHPGKAQAVHGQPPRDYAIKLAAAFIVTAVLGVIVKKLGFELPEEVAPVAW
ALVIGAVWMVIAEQLAAKRAKTLGERAAITWTVAILVGVAQVVAGVFPGTSRSASTIFVA
LLFGTTDRKAATEFAFLVGIPTMFAATGYELIDVARDGGLAGEDWGSLAVAFVASALTAF
AAVKWLLRYIQTHTFTVFAVYRVILGVALLLLVPSN
>I0JL77|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MDFIQVIKVMLLGMFEGLTEFAPVSSTGHMIIVDEMWLHSREFLGYYTANTFKIVIQLGS
ILAVVITFRHRFIDLLGAGSRVQANSSRLKISHILTGLLPAALLGFLFEDYIDEHLFTVE
TVIIGLLLGSFFMIFADLYGVRNASLKSVDQITYRQALLIGLMQCFSLWPGFSRSGSTIS
AGVLVGMNHRSAADFTFIMAVPIMLGASSLSLIDNMEYFTAQALPLFAIGFFSAFVFALI
TIRFFLKLINRVKLLPFAFYRIGLAAVIAFIYY
>A0A0Q7PN65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDLFAALLLGIIEGITEFLPISSTGHLLIAERWLGHRSDLFNIAIQAGAILAVVLIYRQ
RLWQLATQFLADRESRDYAWKLAAAFGVTAVLGVAVKKLGFQLPETVAPIAWALVIGAAW
MVVAEYFAGRRAAVLGERSQITWTVALLVGLAQVVAGVFPGTSRSAATIFVALLAGTTSR
AAATEFAFLVGIPTMFAATAYELIDVIGNGEAAHEQWGALAIAFVASAITAFISVKWLLH
YIQHHRFTVFAAYRVVLGLALLLLVPAGQ
>H6D988|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDLCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0M1F4H3|FEATURES|UNIPROT_deepARG|aminoglycoside|ABW45_03845|antibiotic inactivation|1
MEAPRARMEGMPLPHAWQEALADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEEGRRWLLMSALPGHDLASSPALAPQHRVQLLA
DALRGLHALPVATCPFDQRLASRLQAAQARVEAGRVDADHFDDERLGQSAQQVFAELRAT
RPDHEDLVVSHGDACLPNLLAVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFRSYGIVPDERRLAFYRLLDEFF
>I8XUN4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTIQTIIIAIVEGLTEFLPVSSTGHMIITQALLGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPLPEGASALKRFLHKFDFYWKLLVAFIPAAVLGLLFSDEIDALLES
VVVVAVMLVIGGIFMLFCDKIFSKSDKNFKMTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKMTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEVLMNNMSALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVLLMCGYNLEIA
>W6N2K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYMLFIIKAIIIGIVEGVTEFLPISSTGHMIIVGDLINFSAPAYRKAYVDMFEIVIQLGA
ILAILVLYWNKISGSLKNLTPGKWGFKLWCNIIIAFIPAAVIGFLLDDIIQAKLFNSITV
ACALILGGFLMIFMENKYRRGNKTDRIEDVTAKQALKIGCFQCLSLWPGMSRSASTIMGA
WTSGLTNVAAAEFSFILAIPTMIAATGFSLLKVKITMTTPEIIVLIIGFVVSFIVALVVV
DKFISFLKRKPMKVFAIYRIFIGVLVLILAYINIINVTK
>A0A0Q7UVP7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MHHSDAPATREISVADKGAGPYGIAAGPDGALWLTLAHSGRIARLTLDGELNEYPLDSSE
CRPTVITPGPDGALWFTRSQDHRIGRVTADGERESFPTPTPDSGPFGITAGPDGAVWFTE
MNTDRIGRITCKGEITEFALPRKGAYPSAITAGPDGALWFTLNQANAIGRITVHGDIVIH
PLPTPSAAPVGITSDGAALWFVEIAAGQIGRISVDGGIKEFPLPDRTAKPHAIVAASTGD
CWFTEWGANRIGHITDSGEIAEYSLPSPSSEPHGITIGSDGALWVALETGGVARLEL
>J2FI81|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MIRIEPCQSAHQAGWLSLRQALWPDCPAEEHRDEIASLLDDPRRYINLLAYTADGQPVGL
AEASLRHDYVNGTEHSPVVFLEGLYVSAEQRRQGIAERLIDAVAQWGREQGCVEMASDTG
LENLVSQTVHKALGFEETERVVYFRKSL
>YP_002382193|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELSNIRRSFPSGEDVVEVLKGINLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGIYKVAGQDVSTLDSDSLAQLRREHFGFIFQRYHLLSHLTALQNVEVPAVYAGIERKQ
REARAQALLQRLGLGERVDYRPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRERGHTVIIVTHDPHVAAQAERVIEIRDGEIVSNPPAKNSAIAQTFSDSS
AQPRSGWRQFIAGFREALTMAWLALATNKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAIQKQSWVASATPAVSQNVRLRY
GNIDVAAAANGVSGDYFNVYGMTFSEGNTFNKEQLNARAQVVVLDNNTRRQLFPHKANVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMASRVMGQSWLNSITVRVKEGY
DSAQAEQQLTRLMTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVMVCLIGGALGICLSLLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTITGILFGWLPARNASRLDPVEALARE
>F6IK24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTLTAILLGIVEGLTEFLPVSSTGHLILATELFGYDAAQWATFNIVIQLGAILAVIVQ
FWRTFWAVGMGLLKLEPVSIRFVRNVLLAFLPSAVLGLLLKDWIEGLLGQPSIVGWALIV
GGIAILVIEKVAKQGPLTGVSELSMKTCVGVGLAQCLAMVPGVSRSGATIMGALAMGVER
RTAAEFSFFLAVPTMMGATTLELLGAREQLMAGTGPVGWGEIAVGFVVSFIVALVVIKAF
MAFVSRSGFSPFAWYRIAAGSLALYLLT
>V1GQY5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEPVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGAYRVAGQDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLLRLGLSDRVDYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAERIIEIHDGKIVHNPSAQEKKREQSIAAAT
VSTASGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQFRQVLKYNDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFSEGNTFNAVQQRDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEIGFSLTALASAFLCSTFIGILFGWLPARNAARLDPVDALARE
>A0A0N8RUI8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIKFVSIVIPVYNERQSLPELLRRTEAACEQLDHRFEIVLVDDGSRDDSADILQRA
AERADSPFVAVILNRNYGQHAAIMAGFEQCQGDVVITLDADLQNPPEEIPRLVKLAEQGY
DVVGTVRSNRQDSAWRRWPSKLINLAVQRSTGVAMNDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEVLVDHAEREHGDSKYSPMRLINLMFDLITCMTTTPLRLLSIIGF
SMALLGVSFAALLIVLRLIFGASWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVVRSSSPVATDNIDSSVTPYMNKVAP
>C6CAT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADVHTLLVAFILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGQVPHEGRGNGHLTLGHILLAMIPAVVLGLVFHDAIKTLFNPTT
VSYALVAGGILLLLAEWVRPTRPRAEGLDDITYGQAFLIGCFQCLALWPGFSRSGATISG
GMLFGVSRYAASEFSFILAVPMMLGASALDLYKSWHFLSLADLPVFAVGFVTAFVVAMIA
IKTFLQLIKRISFIPFAIYRFIVAAAVWLVFM
>A7I0J2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIDAVILGIVEGLTEFLPVSSTGHLILTAGLLNLEQTDTLKCFEVVIQLGSILAVVFT
FFERLKRDKQLWIKLIIGFLPTAAIGYLLYSHIKSLFSQNVVVYMLIIWGVIFIVVELLR
KKNPPENEILTLDGISYKQAFFIGLSQCFAMVPGTSRSGATIIAGLLSGLNRQTAAAFSF
LLAVPTMFAATFYDTYKNREIFAANMDNIQLFLLGGFVAFLVALFAIKMFLKFVSRFDYI
PFGIYRILIAFAFMFFVL
>A0A0G5EJY7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_1|antibiotic inactivation|1
MRLTITALALLLIGQTALAQPNKLHATVDAAVQPAIEQYRIPGLAVAIVHKGERHFFNYG
VASRDSGQAVDEHTLFELGSVSKLFTATLGAYAQAEDKLRLDDPASQHLPALQGSAFDHI
ILLDLATYTPGGLPLQFPDAVSSERQMLDYYRAWQPVYPAGSQRLYSNPSIGLFGHLAAA
SLGKPFDQLLESQLFPQLGMRESHVRVPQGQMARYAWGYRDDQAIRVQPGPLDAEAYGVK
STAADMLRFIEANLDPSQLPTSLRQAIATTHQGYYRVGDMTQGLGWESYAYPITLQRLQA
GNSSQMALEPHAVERFATPQPAEGDLLLNKTGSTNGFGAYVVLLPARDTGLVILANRNYP
NAERVGIALAILATLEP
>D9Y5A9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILYLKAVILGIVEGLTEFLPVSSTGHLIVAGSLLDYTGQEADTFYIAIQAGAIFAVC
WHYRQRLIDICLGLFSDKVQQRLAINTIVAFLPAAVIGVLVASYIKKWLFNPIAVATALV
VGGVIILIVEYFQDKKTYKPRVETMDDMSWKDALRVGFLQCLAMIPGTSRSGATIIGGLC
IGLSRKAATEFSFFLAIPTIFGATVYDLWKSRDVLTATALPMISVGFVVSFFSALVVVRW
LLHYVSKHDFSAFGWYRIFFGGVILLTWWTGLVQW
>D7PIJ5|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTRSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>A0A0M5JBM2|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRNTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>A0A0V7Z3N3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILA
VYFRRLIGIATALPTNPQARRFVIGILVAFLPAAIIGGLFSKVIKAYLFNPWIVCATLVA
GGLVLLVLDDTDLEVKKTDVYDFTLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLFDNYKYLSRDDVGLIVIGFIVSFISALFVVRVLLDYV
SRHGFRLFAWWRIIVGALGFAGLIILG
>A0A0U3SWZ9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-2|antibiotic inactivation|1
DIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTF
NGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKA
ALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWI
TVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQ
QGIALAQSRYWRIGDMYQGIRLGDAELAAES
>A0A0K0HXA0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKKMQSTLKLLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKDYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSELEGK
>NP_708081|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVSAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIALLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
PLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>C3Q9Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFSDKIDEMLES
VAIVAVMLVIGGIFMLFCDKIFSKGSEDTVLTERKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILLNNMPALIIGNVVAFIV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>A0A109QF45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGEYVTAIILGIVEGLTEFLPVSSTGHLILTETLLGATEEKWKTFAIVIQLGSICAVLLL
FWKRILGLLGISRRHALGPQLNLLHIIIGILPAGIAGVLLHDFIKEKLFSAWTVLLSLII
GGILMIAAEKLQPRATARTVDDISYRQAFGIGLFQCLALWPGFSRSGATIAGGILLGTSH
KAAAEFTFILAIPVMMGATGLDLIKSWDYLSVSDFGFFATGFITAMVVAMLAIVSFLKLL
ERVSLTPFAIYRFALAVVFYFFILK
>A0A0Q2UC27|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSRILDVPVSGGPYALTAGPDGAMWVTLVHSGEIARVAADGGLEVYPVAPQSKPSIIVAG
PDGALWFTRNGDDRIGRITTDGDLSEFELPKGSAPFGLTAGPDEALWFTAMTSGVVGRIG
VDGVVTEVAFPGGTPSMITAGPDGALWFTLNQANGVGRLEPSGDLTIRDVPTPRAGPVGI
AATHDDAVWFTEILADKLGRIPVDDAIQELDLPGKPHAVVADPTGGVWVSLWGSDQIARV
SADGEVSSIDLPAGSEPHGLAIGPDGALWVALEAGYVMRLPTV
>A0A097J9F4|FEATURES|UNIPROT_deepARG|beta_lactam|blaACC-6|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVT
VNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHGNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>R5U270|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEGDLNLLQTIIIAIVEGLTEFLPVSSTGHMIIAQNVLGVESTEFVKAFTFIIQFGAILS
VVCLYWKRFFRLNHKPAPEGASTLKRFLHKYDFYWKLLVAFIPAAVLGLLFSDMIDAMLE
SVIVVAVMLIVGGVFMLFCDKLFGNGSETTELTEKRAFCIGLFQCISMIPGVSRSMATIV
GGMAQKLTRKAAAEFSFFLAVPTMFAATVYKMLKLFMDGGTEIITANMEALIVGNVVAFV
VAMLAIKFFISFVTKYGFAAFGWYRIIVGGVILIMTALGYNLELA
>A0A089UGS4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVRALVEAGYDIAAIYTHPDNAAENNFFGSVARTAAEFGIPVFAPE
DVNHPLWVDRIKDAQPEVIFSFYYRNLLSEEILDCASVGAFNLHGSLLPKFRGRAPLNWV
LVKGETETGVTLHRMVKRADAGDIVAQERVAIAAEDTALTLHHKLCETAKSLLAKSLPVI
KTGHFPQTAQDESKATYFGGRSPKDGAINWEGTAAEANNLVRAVSEPWPGAFSYVGGGKF
IIWKSRVLESNNGAKAGTVLSVNPLVIACGTGALEVVTGQAENGVYMQGSQLAQSLGLVS
GAILSSKPVSAIKRRTRVLILGVNGFIGNHLTERLLRDDNFEIFGLDIGSDAISRFIGNE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKSFDEDNSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
GDGIEALFRIIENKNNNCDGQIINIGNPDNEASIKQLAEMLLESFERHPLRNQFPPFAGF
REVESSAYYGKGYQDVEHRKPSIRNAQRLLDWTPEVHMEKTIDETLDFFLKTVELTDPAS
>Q1W757|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
NFSLPTWAAAISGSLDKQLAALEHSANGRLGIAMINTGNCTKILYRGARRFPFCSTFKFM
LAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAHGMTVSELCAATIQYSDNTAA
NLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAAMAASINKLVL
GDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKTGSGDYGTTNDIAVLWPTKGA
PIVLVVYFTQREKNAKPRRDVLALWRPKKIFCP
>S1D3S1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGAQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>I7MQJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIIELLKAIFFGIIEGITEWLPISSTGHLILVQEFVRLNQDKAFTEMFNIVIQLGAILA
VMLIYFERLNPFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPLDNWFEAHFYFMIPIA
IALIVYGIAFIWIEKRNAQVEPQIKDLSRMTYKTAFLIGCFQVLSIVPGTSRSGATILGA
IILGTSRTVAADFTFFLAVPTMFGYSGLKVMKFFLDGYHLGFAQALILLVASLTAFVVSL
LAIRFLTDYVKKHDFTIFGKYRIVLGSLLLIYSFFKFIF
>A0A0M2SJB7|FEATURES|UNIPROT_deepARG|aminoglycoside|WN59_12960|antibiotic inactivation|1
MNGYDKKARRQIDEVLEVSKRVIGQSMKAAYLFGSTAAGGLKKDSDIDILIMCKRELRAC
EKRQLIDAYMKISGEIGNPENKRYMEITIVDESDISPWHYPPKQEVLYGEWLRQDFEAGE
VPVKEENPDLVIVLKQLLDNHYILYGDKPEEFIPEIPDTDVKKAIRDTLPELMESYAGDE
RNTLLTLCRMIVTVKTGEIIPKHHAAERVQNSLPENHQELLQCAISGYLGEYDDRGSYKG
EDMKSLVDYLGRALGKLLVEGNQL
>A0A0J1HNW1|FEATURES|UNIPROT_deepARG|chloramphenicol|ABW01_23680|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYCNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQKLSNSCNEWLK
>A0A0W1B555|FEATURES|UNIPROT_deepARG|aminoglycoside|UQ64_03725|antibiotic inactivation|1
MNTQALLDKIVALFKEELKGSLLGIYLHGSLAMGCFNPLKSDVDFLVVVKEKLTPVNNSR
IAKIALSLHDEMSGISNERGIEFTIILETHLKTFVYPTPFEFHYSDYHREKYRTDENYLC
GGFEDKDLASQIVVAYERGITLYGKPLSELYEPINSQYYLDSILNDVEGCADEIIDNPPA
YLTPMYLTLNFCRVLYYVKEGKISSKREGGEWGRTYLPQRFQPLVKHCLTAYTDETANGE
KSNSNPDLQNLLAFVEYMTQEIKQNVSLRSRAG
>A0A0A2HC53|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIISTLKNFFPSDRVPVKKCGLKFWINIVIASIPAAVIGIPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKVISIDDVNAKQAIIIGVFQCLALWPGMSRSAST
IIGAWIAGLSTVAAAEFSFFLAIPAMIGASGISLIKHNVFSTCSSIELIALAAGFIVSFV
VALVVIDKFIAFLKKKPMKVFAIYRIVLGIILIILIYANIISWH
>T1Z1E9|FEATURES|UNIPROT_deepARG|beta_lactam|bla(CTX-M)|antibiotic inactivation|1
SESEPNLVNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVG
GPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQ
RAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTTDIAVIWPKDRAPLILV
>B5SZM8|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVEREPPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>C8C0T4|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MLEKLISAAKFNRLSTRCKSNTLIASDGPGHPFAFNYGTDFMMKKSICCALLLTASFSTF
AAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTL
FELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPL
QIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVL
QPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMD
ASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAV
EVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEK
LQ
>ABO12177|FEATURES|ARDB_deepARG|multidrug|adeB|antibiotic efflux|1
MMSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTIND
SVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLP
QVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFG
AEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQ
LSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANA
VKTAEGVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFL
HNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERI
MATEGLNPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSIL
FSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMM
VIFLVITGITFAGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNP
DVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSAVNTSMANSTEGETMAVL
PPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNIS
LKIDREKLSALGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILN
LKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLI
AKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLG
IFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAK
LRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFI
LGAVEKLFSSKKKISS
>A0A0W3BA48|FEATURES|UNIPROT_deepARG|beta_lactam|AL503_01490|antibiotic inactivation|1
MLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAYSDNTANNKIIKE
IGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSK
ENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVL
VIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0E4HFB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MTDVIKAIILGIIEGLTEFLPVSSTGHLILAGDLLSFEGDAAITFKIVIQLGAVMAVLIL
YWRRYLAIGANLIRMDFSKSKGLNVIHMILAMLPALILYLLFKDIIKSRLFGPTPVLIGL
VAGGLLMILAARSRKTNTADTIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLNSDDLILMLIGFTTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFALAALFYLIVIL
>U2ABT6|FEATURES|UNIPROT_deepARG|beta_lactam|N880_16905|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVVAILSNRFMKDANYDNALIAEAAKV
VLNDLK
>W3YLE8|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1568_2704|antibiotic inactivation|1
MKNLFRRGRLLVALSLAFTSLSSVALTQSDVDSIIKPLMKQQQIPGMSVAISVDGEHFIY
HYGVQSKQTQVPVSNNTLYEIGSLSKTFTATLAAYAQGQGKLDFAQTVSHYLPELKNSAF
DKVTVMNLATHTSGLSLFVPDAVTNRAELIHYYQQWFPVKPIGEYRSYSNLGVGLLGMVT
AKQLNQSFPDAIEKMMLPALGMKHTYLQVPQNQQKNYAQGYNKQHQPVRVTPQILDNEAY
GLKSNAKDLIHFLDINMQVADVAKPWQEAVEDTHTGVYMTDSFVQDLMWESYPWPVSLAQ
LQQGNRDDMALKPQKVDAIQPPMPPESRSLYNKTGSTGGFATYAVFIPEEKIAVVLLSNQ
WYPIPERINTAYQLIEKVKH
>U2H5H3|FEATURES|UNIPROT_deepARG|beta_lactam|L810_4248|antibiotic inactivation|1
MARPDLLSTQPSEIEGTATMRFNATRFAATLLVAACVTATAGRAGAATPDDLHDTVTRHI
APLMKQYAIPGMAVGIVADGKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAAD
AQEGGELSLADPVGKYLPALQGKPFGVVTLLDLGTHTSGGMPVQVPDSIRDDAGLIRYLD
AWRPAHAPGTYRTYSNVSVGMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQ
ADYAQGYTQDGKPIRMTGGMLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTH
TGYFRAGPLTQDLIWEQYPYPVALPTLLEGNSMKMLRDGLPASAIKPPLAPSANTWINKT
GSTNGFSTYVAFVPSKRIAIVMLANRSFPNEDRVKAAYGILGALDGRR
>A0A085J9F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHHLFVAAILGIVEGLTEFLPVSSTGHMIIVGHLLCFEDKTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIRFGQVPHEGEGQGQLTLIHILLGMIPAVVIGLLLHDRIKALFTPMN
VMYALVAGGVLLILAEKLKPAQPKAVGLDDITYRQAFMIGLFQCLALWPGFSRSGATISG
GMLTGVSRFAASEFSFLLAVPMMMGATALDLYKSMGFLTVSDIPMFATGFIMAFIVALVA
IKTFLGVIKRMSFIPFAIYRFILAAIVFAIFS
>A0A0R1N3U0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQTTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPKKTHLEQHDTWVLWFKVIVAVLPSVVIGLLLNDWMDAHLMNWEVVSAM
LLLYGILFIVIENRNANRKPQFTDLNRLSYRTAFIIGMFQLLSLVPGTSRSGATILGGIL
IGTSRYVATEFSFFLAIPTMFGASLLKVYKYFHHGGTFDGLQTAVLLTGMLVSFVVAYLA
IRFLLNYIQHNNFKAFGWYRIILSIVVIGYFGLRVLI
>J8WRA1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIDFHSNHKVFEITIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIVDVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>A0A150DX69|FEATURES|UNIPROT_deepARG|chloramphenicol|AT272_13830|antibiotic inactivation|1
MKFHVIDREKWNRKQYFEHYLKLKCTFSMTVHVDITRLLKELHQKGIKFYPVFIYLISKV
VNNHKEFRTSFNEEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYRNYQEDMR
LYTNVHGLFTKENIPPNVFPISSIPWASFTGFNLNINNEGDFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFLEDLQQLISNCNKWLK
>A0A0Q4QNM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYEIICAIILGILEGLTEFLPVSSTGHLILAGNLLGFEGDKATTFKIVIQLGAVMAVFML
YWKRYMDILKDLLTFNFSAKNKLNAIHMVIAMIPALIVYLIFKDDIKSHLFGPAPVLIGL
IVGGILMIIAARAKRKVTAENTDDITYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFIIAVPVMLGATILDMYDSRELLNGDTLLLFLIGFITAFVVAMIAVVTFLN
LIKRLRLEWFAFYRFALAAVFFIFVM
>R6GRQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYIEIIKAIILGIIQGITEWLPISSTGHMILVDEFIKLDFSAEYINTFLVVVQLGSILA
VVILYFNKLNPFSLSKNTQEKQETWNLWIKVFIAIIPSGIVGVLFEDKIDELFFNPTTVA
ITLIIYGVIFIFLEDRDKRPTILNFSDLSYKTAFGIGIFQVLALIPGTSRSGATIIGATL
IGASRFIAAEFSFFLAIPTMFGASAVKLLKAGFHFDAFQWIILLTGSFVSFIVSIFAIKF
LMDYIKKHNFKSFGYYRIVLGLLVLLYFYVIAI
>AAD43097|FEATURES|ARDB_deepARG|beta_lactam|CARB-3|antibiotic inactivation|1
MFDVIGASTMSTQQGMRPKTKLAILWSLMLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVF
ASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLL
YDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSA
VGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSE
MNQKKKESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSI
YLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>A0A0J5UXH4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHICFSASNLERSIIFYQKVLGAELLVKGKSTAYFILNGMWLALNEEKDIPRSEI
QYSYTHLAFSISIESFDQAKELLKQHNVNILPGRNRDERDKKSIYFTDPDVHKFEFHTGT
LQDRLAYYQEEKPHMTFYSPKE
>W7P7F7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHHKLNATAQAVLRDALPAI
LSGTFSETAQNESKASSFGRRTPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMELTIDETLDFFLRTVELSEQDS
>U1SWG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWVAFQALILGIVEGLTEFLPISSTGHLIVVGDLLGFNGEKATAFKIIIQLGAILAVI
WEFRAKVLGVVVGLPSNPNAQRFTFNLLLAFIPAVIFGLAFADLIEHWLFNPITVAMALI
IGGIIMLWAEKREHAIKAETVDDMTWKLALKVGLAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVAATVYSLVKYRDILQMSDLPIFAIGFVSTFIVAMITVRALLKF
ITSHSYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>A0A0F6REB8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGITLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDRDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPLVAAQAERVIEIHDGEIVRNPPAKRAAQGQGIQEPT
VKTASGWSQFISGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAIQKQPWVTSATPAVSQNLRLRY
GNTDVAASANGVSGDYFNVYGMTFSEGTTFNREQLNGRAQVVVLDSNTRRQLFPHKANVV
GEVILVGNMPATVIGVAQEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>B7LQA4|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYINEARQLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSLLIMLVLWNAGYIIRAMDNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYVFIY
GHFGMPELGGVGCGVATAAVYWVMFVAMLSYVKNARSMRDIRNQQHSGKPDTAVMKRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPLSLSAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATVTAIFTVSFREQIALLYNDNPQVITLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVQPMGPAG
FWIGFIIGLTSAAIMMMLRMRYLQRLPSAIILQRAAR
>A0A142FK11|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-60|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMSATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>J2ZZB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLIEIIKAIIFGIVEGITEWLPISSTGHLILVEEFIKFKDANAPFTNMFNVVIQLGAIL
AVVVIYFDRLNPFKKGKTVREVQLTWQLWLKVIIAALPAAIIGLKINDWLDAHFQNFFTV
ALMLIIYGVAFIYVEKRHENIEPVITRLADMPYKTAIYIGLFQVLSLIPGTSRSGATILG
GILVGTSREVATEFTFFLGIPIMFGASLYKIFKFIKSGTVLMGSQLLILLVAMLVAFVVS
LYVIRFLTDYVKNHDFTFFGKYRIGLGTLLIMYGLITAVFG
>A0A0J8YFV7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|AI28_01875|antibiotic efflux|1
MEPIIILRHVCRAFRAGTQTLPVLSDISLTIGHGEMVAIVGASGSGKSTLMNIIGCLDRP
TSGEVLIDGAAVHLADSQHLAELRSRYLGFIFQRYHLMPYLTAEENIAMPALYTAMPEKE
RHARIHSLADKLGLRERLHHRPTQLSGGQQQRVSICRALINGAQVILADEPTGALDSVSG
KALMDVLHQLHAAGHTVIIVTHDHQIARQAQRVIEIRDGRIIKDARQTRPATPVSLPEQD
NGRASLTRSLTESFRMAWRALRGHRMRTFLSMLGIIIGISSVVSSMAVGEGARQTIMNEI
GKFGTTTLEIHPGSGWGNQRPDMTRALSMDDVSSLEKLPWVVGVSPLLSSMTTAVRKGYD
ASVMLNGVSQNYFALQGLQFVQGHGFGARDVAESEPVLILDETGRDALFPDGEDPLGKIV
QIAGAPWRVIGVASRPGPKMIGGFVSGWIPYTSLQQRITGDKPLEAITLRFQETLKPAEA
TRRAVDHLVRSHGKKDFFTQTDDKLATALQKTSDSMSLLITAIAAISLLVGGVGVMNIML
VSVTERTHEIGIRLSVGARPSDIMNQFLIEAVTICVLGGLAGIAGSWLVGTLFSLITDEF
TMVFTLFPLVIACLFSAAIGVTFGYFPARRAARLNPMEALARE
>A0A098MYL2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
LFLYREKFKSQIVSSFRYILKQNSDSEGFHFLIQICIGAFPILIAGFIAKKFLDTIKARP
DLLEILSGAWIFGGVLILVAEWYFHQRPEEKKSIGFKDSILIGIFQCMALIPGMSRSAAT
IITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLC
TLVIRWFLRYIQKHSFSVFGVYRILLGVGVLVLTKLI
>S6BXR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMFIEVLKAFFIGVVEGITEWLPISSTGHMILVDEFVKLNVSAEFLELFLVVIQLGAIM
AVLILYFHKLNPFSPKKTSAEKRGTWRLWGMVAIGCIPAAAIGLTLDDFFNEYFYNAWTV
AIALIVYGVVFILLERRNRRREAAYLASRAPRRPRGAHARPVPEVGPGDDGDDAEMALFR
VRTVDEIDWKTSLKIGCFQMLAIIPGTSRSGSTIIGGMLCGCSRTAAAEFTFFLAIPVMF
GWGVLKLIKYLMAVGLAMTATEIAVLVVGIVTAFVVSVISIKFLMGYIKKNDFTAFGVYR
IIVGLVVLAYFGVKVLL
>G9Z639|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGEDSVEVLKGITLSIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYQVAGTDVATLDGDALARLRREHFGFIFQRYHLLSHLSAAQNVEIPAVYAGTERKA
RQQRAHQLLERLGLGERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMSILHQLKEQGHTVIIVTHDPQVARQAERIIEIRDGEIVANPPSSAAAGQAFEDTVI
EEPSSWRQFTSGFREAMSMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
ADIRAIGTNTIDIYPGKDFGDDDPRFQQSLKYDDLLAIQKQPWVSSATPAVSKSLRLRKG
NIDVAANAEGVSGQYFNVYGMTFSEGNTFNDIQLNGRAQVAVLDSNSRRQLFPDKASVVG
EIILVGNMPATVIGVADEKQSMFGSSKVLRIWLPYTTMSGRVIGQSWLNSITVRVKEGQD
SAQAEENLTRLLTLRHGKKDFFTWNMDSLLKTAERTTHTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVSLSLLIAFVLQLF
LPGWEIGFSPLALLTAFFCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0U4VU15|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPSENRFFGSVAQLCARHGIPVHAP
EDVNHPIWVERIRALEPDFIFSFYYRNLLSNDVLACATRGAYNLHGSLLPRYRGRAPANW
VLVNGETETGVTLHRMVQRADAGAIVAQQRVAIAADDTALTLHAKLREASQTLLRDALPA
LAEGRLTEREQDESQATTYGRRSAADGELEWSRPAVELNNLVRAVTQPYPGAFGWIGDRK
LIVWSALARQEAHGQAPGSVLSLEPLRIACGEGVLEIQAGQLGDNGLYLSGPQLAREAGL
VAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADGEYEVYGLDIGSDAIERLKVD
PNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRH
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGA
KGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDV
DDGIEALFRIIENQGGRCDGQIINIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGF
REVESKSFYGDGYQDVAHRKPSVENARRLIDWQPSTAMAATVGKTLDFFLREAMAQREA
>U0ZBY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPILLFHSLIMGLVEGITEFLPISSTGHLILTGDLLGFLDKEKRDVYEIFIQLGAMLAV
VWEYRRKIGHTMAGAVRPGSERNLLLGIVIAFIPAAIAGLLFSKQIKAVLFNPVCVAIAF
IVGGLIILWAEKREHKVAVETVDDLSLKDALKVGLCQCLALIPGTSRSGATIIGGLFLGL
SRKAATEFSFFLGIPTLGAASLYSLIKHRDALSADDIGVFAVGFAASFVFAFLAIRALLR
FISTHSFAVFAWYRIAFGLIVLGTWWSGLVEWSA
>Q104Z6|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC31)|antibiotic inactivation|1
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ZP_03053667|FEATURES|ARDB_deepARG|multidrug|Mdr|antibiotic efflux|1
MNHVDKGKASTRLVVIGLLLGIFMAAMDNTIVATAMGSIVADLGSFDKFAWVTASYMVAV
MAGMPIYGKLSDMYGRKRFFLFGLIFFLIGSALCGIAQTMDQLIIYRAIQGLGGGALLPI
AFTIIFDIFPPEKRGKMSGMFGAVFGLSSVLGPLLGAIITDSIGWHWVFYINVPIGIVSV
FLIARYYHESLEHRKQKIDWSGAITLVVAVVSLMFALELGGKSYAWDSVQILTLFAVFVV
FGTIFFIVERKAEEPIISFWMFKNRLFATSQILAFLYGGTFIILAVFIPIFVQAVYGESA
TSAGFILTPMMIGSVIGSMIGGTMQTKVPFRRLMAISVISFFAGMLLLANMSPDTARLWL
TIFMMISGFGVGFSFSLLPSASMNDLAPRYRGSANSTNSFMRSLGMTLGVTIFGTIQTNV
LSNRLADAFSGMKGAPSQIGDPQAIFQEGARSQIPPDILNKVIDAMSQSITYVFLIALFP
IALAAITVLFMGNARVRTSNEMKESE
>A0A0G1T7L5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPKVIPLAFFKSTHTGLSICYTSRMNIIHGLVLSLVEGITEFLPISSTGHLIITSQLLGI
AQTEFIKSFEIAIQLGAVLAIVAFYWKTLVRDMRVWTRIIAAFIPTGVLGLLLYSFVKAH
LLGNMTVVVWALLLGGVVMLVVEYVVERKAVKQVETTIADLSYPRAILIGAIQGISIIPG
VSRAMATIFGGLGVGLTRKTATEFSFLLAIPTMLAATGLDLLKTSATFTSQEFVALAVGF
MGAFLAALIAVKYLIGFVQHHSFRVFAWYRIAVAIVLLALL
>K4ZDS3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKVQGLNHLCFSVSNLDRSIAFYEHIFGAKLLVKGRKLAYFGLNGLWIALNEERDVPRYD
IQPTYTHIAFTINEREFDEMRARLVQYGARLLPGRERDERDKQSIYFADPDGHRFEFHTG
QLNDRLNYYKETMPHMTFFDE
>A0A0F7NPZ6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-416|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDTFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>ZP_03233797|FEATURES|ARDB_deepARG|glycopeptide|VanSA|antibiotic target alteration|0
MKNKNKNKKIDYSKLKRKLYQYILTIVMAAVVFVLFVRLFIQGTLGEWIVRFLENSYHLE
RWDAMIIYQYTIRNNIEIFIYVAVAISILILCRVMLLKFVKYFEEINTGIDILIQNEDKQ
IELSAEMEFMEQKLNTLKRTLEKREHDAKVAEQRKNEVVMYLAHDIKTPLTSVIGYLILL
DEAPDMPREQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKKYIDLYYMLVQMT
DEFYPQLAAKGKQVVLHASEDLTVFGDPDKLARVFNNILKNAAAYSENDSVIDITAGLSE
DVVSIVFENVGNIPKDKLATIFEKFYRLDDARSSDTGGAGLGLAIAKEIIVQHGGQIYAE
SNDNSTTFTVELPAFQGLVDKGNS
>A3WSI9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MISDAIRAVILGVIEGVTEFLPVSSTGHLLLAERFFDLGSGNFWDTFTVLIQPGAILAIV
VIYFAKLWQVALGMFSNPADRRFVIGVLAAFLPAVIVGLIAGKYIKELLFNPWVVCFSLI
VGGAVLMWVDQLDHRPREHDATAFPLPMYVWIGIAQCVAMIPGVSRSGATIVSAMLLGAD
KRAAAEFSFFLAIPTMTGAFAYDFYKNHADMTTDNLGTVAIGFVVSFVTAIIVVKAFLSY
VTRNGFTFFAWWRVIVGTLGLIALALGR
>L0FJY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFDVVFGLTSQPMARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWQFGWVDWATAHG
>F0L514|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAIIAILL
VYFQKLVSIAVAMPTSAKARRFVLAVAVAFLPAAVIGALAHDFIKTVLFETPILICIVLV
IGGVILLAVDRMPLKPRYTDIMDYPPSLAFKIGLFQCLAMVPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDALSFDDSALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLAALLLYR
>A0A0D6S5B8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNIENSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCGSIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>A0A0U7E5R5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTRGRLKLGHILLGMIPAVVLGLIFHDVIKSLFAP
KNVMYALVVGGLLLLTAEWLKPKKPRAEGLDDITYRQAFLIGCFQCLALWPGFSRSGATI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLELYKSLHFLTWGDLPMFAVGFVTAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFL
>A0A127SX63|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGQKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>A0A076VFQ8|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
TALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAI
IGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKY
LKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIPTEALVTE
AAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESK
>A0A127SAU1|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MTQIKKKGMKLYPAMLYYIATIVNRHSEFRTAINHEGVLGIYDEMIPCYTIFHDDTETFS
NLWTTYIPDFEAFLMAYESDMRQYKNNHEMIGKPNAPENVFNVSMIPWSTFEGFNLNLKK
GYDYLVPIFTMGKYYQEDGRTILPLAIQVHHAVCDGFHICRFVNELQELINS
>N9QWC7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALFPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMLVLGVGIIVAFISALIVIRALI
RYVSKHDFTAFAYYRIIFGLFILVTWWTGWVHW
>A0A0V8H7A5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLIKGLNHFLFSVSDLEKSILFYQRVFEAKLMVKGRSTAYFDLNGMWLALNEEKGIPRNE
IHQSYTHTAFTVEEAEFDDIVHKLKKMNVNILAGRTRDERDKRSVYFTDPDGHKFEFHTG
TLGDRLDYYKKEKGHMDFYE
>J9AHF0|FEATURES|UNIPROT_deepARG|chloramphenicol|IEO_01843|antibiotic inactivation|1
MKFHIIDRENWNREQYFEHYLKLKCTFSITVNVDITMLLKELHQKRIKFYPVFIYLISRV
VNNHKEFRTCFNDEGVLGYWEEMTPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGLFTKENIPPNAFPISSIPWTSFTGFNLDINNDADFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNLK
>H7FPR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIASDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTWDFYFKLFVAFIPAVVLGLLFSDMIDELLESPVTVAVSLLLGGIVLLKVDDW
FNHSEDTKVTYLKAFKIGLYQCLAMVPGVSRSGASIVGGMSQKLARTSAAEFSFFLAVPT
MFGATAKKCYDYYKDGLELNHDQINLLIIGNVIAFIVALLAIKSFIGFLSKKGFKVFGYY
RIAAGIILLIIHFFIHPLTII
>A0A060RFS8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNINVNEYKLPMDKSGPYGITVGPDGAMWFTENRGNKIGRITTKGEITEYLLPTLDAEPL
IITKGIDGAMWFTEYKANKIGKITIGGKVTEYDIPTTNAGPYGITLGPDGAMWFTEITSN
KIGRITVNGEISEYDLPNPGSFPSMIIAGSDGALWFTENQGNRIGRITISGDITEFNIPT
MASGPVGICKGGDDAIWFVEIMGNKIGRITISGEFTEYSLPTQNAKPHAIVSGKDGELWF
TEWGGNQIGRIKSCGEIIEYQIPTIDSEPHGLVLGPDGAIWFTEECGKIGQLIY
>K1LG09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPIIDLIEFAKIIILSIIQGITEWLPISSTGHLILVEDLLQLQLDPNFMEMFRTVVQFGS
ILAVVLLYFNRLNPLNPRKSQQEKKDTWILWSKVIIATIPAGVLGLLIKDYMEEYFNTPY
VVAAALIIYGFAFIWIENRQTGQHDKIDRHLQDVSYTRSFKIGLFQALSLIPGTSRSGST
ILGGLLLGMDRTVATEFSFFMSMPVMLGASLVKLKDFGLDFSQADLIYLLSGMFVAFIVS
VLVIQSLLKYIRRNDFKAFGYYRIILGTIVILYYLFK
>A0A127SRT9|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-166|antibiotic inactivation|1
YRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGERFP
MMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCAAAI
TLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPEAMA
RTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRGIIA
ALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>A0A0M8R0Z7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPSRPEVTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGRVARVTTAGDVTTYPLRAAT
GGPTMIATGTDGALWCTEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDG
AVWFTESAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQANAIGRITPD
GDTVLHDLPTPGAGPVGLTAGPDGALWFVEIAAGQIGRITTDGTVEEFPLPDPACRPHAI
AAGPDGALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGALWAALETGSVV
RIAVAAEGAQPGR
>B5ZZ48|FEATURES|UNIPROT_deepARG|aminoglycoside|Rleg2_2923|antibiotic inactivation|1
MESMIEVATINDVEPWARLRLALWPHHSLEDHRAELGRAFLSESAEAVAFIARNAANDAV
GFAEATLRHDYVNGCSSSPVLFLEGIYIRPVDRRKGIAGLLCNAVADWGKSLGCVEFGSD
APLENSASHALHAALGFEETQRVVFFRKPL
>I9L6P7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNENLIAVIIGIVEGVTEYLPVSSTGHMILAGSMLGFEGEKASVFEVFIQLGAILSVLFL
YQEKFSRMLKPQQLNVYGNGLSIKHVLAGVVPVMGIAYLLHKPIKEYLFSPYTVIIGLVV
GGIFMLFAEKVAKRPVTTDVDKITMQQAFFVGLFQVLALWPGFSRSGSTISGGLLLGLSR
GAAAEFSFIIAVPLMAVACIYDLLKVWDTLNIADIQMFSIGFAVAFVVAYISIVWFIKFL
NKSTLASFAYYRFVVAAISYYYFFL
>A0A0F4BHT9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRASRAAAPKEALP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKASVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARSSDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0Q8RFU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELSLLSIVLLGIVEGLTEFLPVSSTGHLILAGEVMQVPQGTETFDIVIQLGAILAVVVL
YRGRFAAVLGGLARRDPTAIRFTRNVLVGFLPSAVIGAVAYGAIKAMLTTPIIVAVALIV
GGIAILVIERLVRHPTCDSVEGMSVRTTLGIGFIQCLSMIPGVSRSGATIMGALTLGVER
RTAAEYSFFLAIPTMLGATTLALWKARHELGNSQATAIAIGFLVSFVVAMAVIRWFLNVV
TRHGFAPFAWYRIIAGSIALTWLVFR
>A0A0F5S974|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKVPHEGTGKGRLTLGHILLGMVPAVVLGLIFHDIIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWTFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0Q8XU96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENALYLIKAFVLGILEGLTEFIPVSSTGHLILVGDWINFQSGEAKVFEVVIQLGSILA
VMWVFRARLLKLIRGTLTGVASEVAFTRNLLIAFLPAAVIGAIFIKSIKSVFYHPAVVVV
TLVLGGLIMLYVERRAHHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAAYDMYKNFGVLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAIVAAWIFTR
>ZP_04079630|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKN
IWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVII
THAHADRIGGIKTLKERGIKTHSTTLTAELAKKNGYEEPLGVLQAITKLKFGNMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>J3TGF2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIIFAYHDIGCIGITALINAGYTIVTIITHPNAQSEKIFFGSVSHIAAEHNIPIFAPD
NLNHPIWISRLKALEPDVIFSFYYRNLICQDILNLPKRGAFNLHGSLLPRYRGRSPLNWV
LLNGETETGITLHRMIKRADSGNILAQYTVPITSQDDAMTLHKKLCKEAKKLLEQILPKI
RKQQYIEKQQDESIATYVRRRKPEDGEIDWTKPANTLINLIRSVTEPWPGAFSYAGGKKF
IIWKASVDFTNTLHQPGKILSIDPLIISCGENILKIQTGEVQPGVYMHGYQIAQELNLEK
GAILNRPPPLINNNRRTRILILGINGFIGNHLTERLLREGNYEIYGLDIGTDAIKRFMLN
SLFHFIEGDISIYAEWIEYHIKKCDIILPLVAIATPIEYIRNPLRVFELNFEENLKIVRH
CVRYKKRIVFPSTSEVYGMCTDPFFDEYNSRLIVGPINKQRWIYSVSKQLLDRILWAYGE
KEGLRFTLFRPFNWIGPRLDNLDAARIGSSRAITQLISNLIEGKPIKLIDGGEQKRCFTD
INDGIEALFRIIQNKENNCDGQIINIGNPRNEVSIRQLAELLLESFERHPLRPRFSPFAG
FQNVNSSSYYGKGYQDVKHRKPSIRNAQRLLAWTPSIPIRQTIDQTLDFFLKTIDLTKET
R
>A0A0P9DNR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYDWWVAVIIGIVEGLTEFLPVSSTGHMILTSTLLGIPDTDELIKTFEIVIQLGAILAGV
VVYWKRILRLFGLSKEKPKAGKGMNLLHIMLAIVPTLAIAYLTKDFIKAYLFSPETVLIG
LILGGVLLIIGEKFQPKVTAHDVDELTYKQAFFIGLWQIISIWPGFSRSGSTIAGGMLAG
ASRGAAADFTFIIAIPVMVVATGYELIKNLDAFSSGDVGFFAIGFIVSFVVALLAVVTFI
KFVQKFSMSYFAYYRFAAAALFWMFVLR
>YP_002847505|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANFFIERPVFAWVLAIIMMFTGGIAIMNLPVAQYPQIAPPTITISAAYPGADAKTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASIILTFKTGTSPDIAQVQVQNKLQLAMPSLPQ
EVQQQGISVDKSSSNILMVAGFISDNNSLSQYDIADYVASNIKDPLSRTAGVGSVQLFGS
QYAMRIWLDPQKLDKYNLTPEDVITQLKVQNNQISGGQLGGMPQSADQQLNASIIVQTRL
QTTDEFGKIFLKVQQDGSQVLLRDVARIELGAENYATVARYNGKPAAGIAIKLAAGANAL
ATSQAVKQELNRLSAWFPASMKTVYPYDTTPFIEISIQGVFHTLIEAIILVFLVMYLFLQ
SFRATLIPTIAVPVVILGTFAILDVAGFSINTLTMFGMVLAIGLLVDDAIVVVENVERII
AEEHLSPKAATHKAMGQLQRALVGIAVVLSAVFMPMAFMSGATGEIFRQFSITLISSMLL
SVFVAMSLTPALCAMLLKSHEGEKENTHFLFTRFNHFMEKCTQHYTDSTRRLLRRTGRYM
VVYLVIGAGMIVLFLRTPTSFLPEEDQGVFMTTAQLPSGSTMVNTSKVLGEITDYYLTKE
QKNVASVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIRRAMMALSTINNAV
VYPFNLPAVAELGTASGFDMELLDNGNLGHEKMMQARNQLLALANQSSGEVDGVRPNGLE
DTPMFRIHVNAKKAEAMGVALSDINQTISTAFGSRYVNDFLNQGRVKKVYVQADTPFRML
PDNINHWYVRNASGSMAPLSAYSSTEWTYGSPRLERYNGQPAMEILGQPVEGKSSGDAMK
FMASLINKLPAGVGYAWTGLSYQEALSTNQAPMLYGISLIVVFLALAALYESWSIPFSVM
LVVPIGVVGALLATDLRGLSNDVYFQVGLLTTMGLSAKNAILIVEFAVEIMQKEGKTPLE
AAVEAAQMRLRPILMTSLAFILGVIPLAISNGAGSGAQNAVGTGVIGGMLAATVLAIYFV
PVFFVLVENTLARFKARR
>A0A0T5XPY8|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARSLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQFVQQ
GLGVFGGAIADRFGAKPMIVTGMLLRAAGFATMAIAHEPWLLWFSCFLSGIGGTLFDPPR
TALVVKLIRPQHRGRFFSILMMQDSAGAVVGALLGSWLLQYDFRLVCATGAVLFILCALF
NGLFLPAWKLSTVKAPVREGLDRVLSDKRFVTYVLTLTGYYMLAVQVMLMLPIMVNDIAG
TPAAVKWMYAIEACLSLTLLYPIARWSERRFRLEHRLMAGLLLMTLSMMPIGLVSSLQQL
FMLICTFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLALGGALGYTGGGWLFDAG
KALHQPELPWVMLGMVGFMTLIALWWQFSDKRSTRGMLEPGA
>A7U968|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-109|antibiotic inactivation|1
PSSSDGRGRGADESESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYS
DNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTL
RNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVG
>A0A0K1PJL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPLIAAILGVVEGLTEYLPVSSTGHLILVSRWLGLEGEGADAFDVVIQLGAILAVLVHY
RSLLWERATGLTSGKKESVALLVALALGFLPTAVLGVLLRKKIKALLFGPAPVAIALIVG
GIVMIAIEFVRKKRGHEGDLGLEHVTPKRAFLIGLGQCISMWPGSSRSMCTIMAGQLTGL
STATAAEFSFLLGLPTLGAATLYEMLKSREALAGLGGANLVVGLAVSFLVAWAVIAAFIA
YLKRFGLSPFGFYRIAVGALVFWTLVR
>YP_002149473|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELATEK
>T2L580|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKMLAANCGLIMTGSLLLNGSAWASGTPESADIEALVNDTIAPLMAEHRIPGMAIALSI
NGQQHYFNYGLANQEAGIPVTDETLFELGSVSKIFTASLAGYAQASGALSLSDPASRYLP
ELEGSAFDEVTLLELGTYTAGELPLQFPESVQSEEAMIDYYRQWQPESAPGSHRLYSNPS
LGLFGYLAAQSLGQPFEMAMEEALFAPLGLEHSYFQVPEAQQANYAYGYSKEDEPIRVNP
GMLDAQAYGLKSTAADVLTLVEANMSGAELNEPLSQALAATRTGYFEVGNMTQGLGWESY
AYPVALDQLLAGNSLEMILQPNPANRLTPPLAPRQEALYNKTGATNGFGGYVAFVPSEQI
GIVLLANRNYPNQARIEAAHHILTKLTEAP
>B7NJS0|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTNGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A127SFS3|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDKNSWKRNEYFEHYFTNIPCTYSMTVKVDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGVYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINN
>A0A0A0Q8P5|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0T9LIQ7|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSLNEPIKKVSIVIPVYNEQESLPALIDRTTAACKLLTQAYEIILVDDGSSDNSAELLTT
AANDPDSQIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVHVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGNSKYSLMRLINLMYDLITCLTTTPLRLLSLVG
SAIALLGFTFSVLLVALRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAEQTENNQDVEK
>A0A107AKJ6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNLGIKCALAAALISTCAVATIGYAANDRSDAVKSATDNVVLPIMTKYGIPGMAVGIVAD
GQSYVFNYGVASRQDQRPVTRDTLFEIGSVSKTLTATLASWAQAAGQLSLSDKTEKYLPN
LQGSPFGNVTLLELGTHTPGGMPLQVPDDVRNEAQLMRYLDAWRPAYSPGTYRTYSNVSI
GMLGLITATSMGQKDFAVPLSRHLLSPLGMKNTYIDVPKARMTDYAQGYAKDGAPVTTTP
DVLSSKTYGVKTTAADLLRFVQANMGDVKLDKPLQQAITDTHTAYFKAGPMTQDLIWEQY
PYPVALKTLIAGNSPSITFDATPVDAIKPPQAPQPQVWINKTGSTGGFGAYVAFVPARHM
GIVILANRHYPNEERIAAAYRILTSLGLDAR
>CAH58703|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-VIIIa|antibiotic inactivation|1
MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDALRDA
VGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQ
PGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLT
LLHHAEALAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTENRGVPYGRVVPEGVWPFTVI
AQDMLAAGIGRTGRVAAAPCHLFEAADVVRFGVEWIESRMGGAAGGA
>ZP_02371789|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVVILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPNDSYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GAGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQNEDEFGDIVVKTAPDGGVTRLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAEHYGRGVR
GVLSRKAVMLGVYLVLVGATLMVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QKYAAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQHADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GYSSGQAQAAVERIAAQTLPRGVKFEWTDLTYQQILAGDSAFWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVEASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAQKDSAGYGVPAPDA
>A0A077LRD2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVWAAVQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRSKIFEVVLGLPRQRQAQRFTGNLLIAFMPAVVLGVLFADLIHHYLFNPITVAVALV
LGGIVMLWAERREHVIKVEQVDDMKWTDALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADFPVFAIGFVVSFIFAMIAVRGLLKF
IATHSYALFAWYRIAFGLLILATWLFGWVDWSTAQG
>G8AP61|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA|antibiotic inactivation|1
MRIERCTHETLDDLVALRWELWPEAPIETHRTEAADDLSVPDRAVAFIVRDEGGVAVGFA
EASLRRDYVNGCETSPVAFLEGIYVRAEQRKRGIARRLIQAVESWGKEKGCSEFASDADI
GNDVSQRMHAALGFEETERVVFFRKPLCRR
>X5EQ65|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDDIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHKAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0A8P164|FEATURES|UNIPROT_deepARG|beta_lactam|blaMOX-10|antibiotic inactivation|1
MQQRQSFLWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQILLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>CAD55841|FEATURES|ARDB_deepARG|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGVFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTTPKAVISTP
>A0A132CK49|FEATURES|UNIPROT_deepARG|beta_lactam|WS62_15880|antibiotic inactivation|1
MKIKHALSSALVLLGCIAASAHAETICTAIADAGSGKFLLKDGDCSRRATPASTFKIAIS
LMGYDSGFLRNEHEPVLPYRDGYIDWGGAAWKQPTDPMRWLKYSVVWYSQRVTHNLGAQR
FARYAKAFDYGNADVSGDPGKNNGLDRAWIGSSLQISPLEQIGFLSKMLNRKLPVSATAI
DMTEQIVEKTTLADGAVVHGKTGMAYPLLADGTRDRAHGFGWFVGWITRGKETLVFAHLT
QDEGKQPVSAGIRTRDAFLRDLPTLLATR
>B5WQR5|FEATURES|UNIPROT_deepARG|beta_lactam|BH160DRAFT_5418|antibiotic inactivation|1
MKTRALKHIATATFALFTLCAAAPASHAAEPVAAQLKPAVDAAIRPLMAKYHIAGMAVGV
IDDGKPYVYNYGVASTQTGKPVTRDTLFELGSVSKTFTATLASYAQLDGKLSLSDGTERY
LPTLRGRPFGKVSLLNLGTHTPGGLPLQVPDEIHNDAQLLRYFHDWQPAHAPGTFRTYSN
PGIGTLGLISAKSMGQDFTVLMQQRVFPALGMKSTYIDVPAAKMPDYAQGYTKDGAPIRL
TGGVISAEAYGVKSTAADMLRFVQANMNLIPLDSQFQRAITDTHTGYFQAGVLTQDLIWE
QYPYPVELRTLQAGNSPEMVLNGTPSTEIKPPLPPQQNVWINKTGSTNGFGAYVAFVPQK
RIGIVMLANRNFPNEARVSAAHQILTALDSGGH
>ZP_02961649|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MIEKSEMNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQ
VIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVA
ASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLV
VMFWFRETKNTRDNADTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLF
TENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAF
ISKGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFA
VIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>W7PEF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
AVMFWRRLFGLIGIHFGRPPQHEGMSKGRLSLIHILLGMIPAVVLGLVFHDAIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSYHFLTAGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0W7TMG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDYLFAALLGVIEGITEWLPISSTGHLILADEFIHMSTSDAFKEMFDVVIQFGAILAVV
VIFWSKLWPFRINRDACGSGVSGLVDRYCRKDVWDMWFHVLVAIVPSAVIGLPLDDWMTE
HLHNPPVVSAMLILYGVFFVRMESTVGKRRPQVRRIGQINYRMALFIGLFQFLALVPGTS
RSGATILGAMLIGCSRTVAAEFTFFLAVPTMAGASLVKVVKFLADGGGFSGSEVGILLTG
CAVAFAVSMLCIRFLMNYVKKHDFKVFGWYRIGLGALVLAYFYLLKPAL
>F2F9K6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLQTKEFLGSGSANTFKIVIQLGS
ILAVVFVMWKRLLSLVGLYKIEGQKKTRFNLGHVIIGIIPAGIFGVLFEDFIDENLFSIK
TVIVGLIIGAIFMIIADKFGPKKPAITTLDDISYSKALKIGFIQCLSLWPGFSRSGSTIS
GGVLLGLDHKTAADFTFIMAVPIMAGASGLSLVKNWDQINADHFWFYVVGFVSAFVFALI
SIKFFLKLISKVKLTPFAIYRIVLALILIIVLAV
>N8QA12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENIEIFKALFLGFIEGLTEFLPISSTGHLILFGHIIDFQSDDGRVFEVVIQLGAILAVC
WLYRKKIFDLIKGFFSGDPEARHFAISVIIAFIPAVVIGVLAVDFIKQVLFSPLVVAIAL
IIGGLIIFWVESKQFEHKTTEATAITFKQALIVGFVQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTQDNLLNISLGFITAFIAALLVVQALVR
FVEKHTLRVFAWYRIILGVIIMIVLF
>N4NQC1|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMSLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAMMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A140CVN0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQTQPKAESRRDVLASAAKIVTDGL
>A0A0K2IVY2|FEATURES|UNIPROT_deepARG|aminoglycoside|YH67_08905|antibiotic inactivation|1
MGAPDPFTDGLPLPRAWQEALADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGVPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVELLA
DALRRLHVLPVAACPFDQRLASRLQAAQARVEAGLVDADDFDDERLGQSAQQVFAELCST
RPEHEDLVVSHGDACLPNLMAVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGALVDERRLAFYRLLDEFF
>A0A158GGR1|FEATURES|UNIPROT_deepARG|beta_lactam|AWB74_01351|antibiotic inactivation|1
MKFRALSLLATAIFSFAAMPGTAFASDAASIKSTVDETIKPLMALHGIAGMAVGVVVDGK
PYVFDYGLASKATKQPVTRDTLFELGSISKTFTATLASYAQTQGDLSLNDPVSKYLPTLG
ASEFGKVTLLNLGTHTPGGLPLQVPDEIHDNDQLMQYFRTWRPAQPPGTIRTYANPGIGT
LGLIAAKSMRQDFDALMQTRLFPALGLTHTYMNVPASKQRDYAQGYAKNDAPIRMKGGVL
SSEAYGVRTTAADMTRFLQINMNMVRIDPAYQRAVDATHTGYFQAGPMTQDLIWEQYPYP
VALQALLDGNSASMILNATPVTRIDPPQPPRDDVWINKTGSTNGFGAYIAFVPKERVGIV
MLANRNIPNEERVKAAYAIITSLTGSR
>A0A0M3HEH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVVFWRRLFGLIGIHFGRPPMHEGEGSGRLSLIHILLGMIPAVVLGLVFHDLIKSLFNPV
NVMYALIVGGFLLIAAELFKPKEPRAVGIDDMTYRQAFAIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSIGFLNTGDIPMFAVGFIMAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0E8XDF2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MAALLELEGIRRSYQSGEEIVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQNVDELDDDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKNEQIVAAAELMS
LTPAAPSWQQLVGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVHDDMAALKAQSYVSAVSPSIGGSMRLR
FGNIDVAASVLGVSDEYFRVFGMAMEQGAPITREQVERQAQTVVIDLNTQRRLFPHMKDV
VGQVILVGNMPATVVGVVAEKKSMFGSNKALRVWVPYSTMANRLMGRSYFDSITVRIKEG
YSSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEKTTQTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAVLVCLIGGALGITLSFAIGLIVE
MFLPNWRITFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0M4FMY7|FEATURES|UNIPROT_deepARG|chloramphenicol|AM499_05690|antibiotic inactivation|1
MKFNIINRDNWYRKEYFEYYLQQQTTFSITTEINITILMRNLKKKNYKLYPAFIFMVTNL
VNSHIEFRTSFNLKGNLGYWTEICPSYTIFDEKTHTFSGIWSPNLANFSEFHSQYEKDVE
KYNGTGSLFPKTPIPDNNIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDELF
LPVSLQIHHAVCDGYHASVFMNGLQRLADDSAEWI
>A0A096YLY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFTMNVVIATLPAIALALLFEKTIKSVLFAPVPVAVALV
VGGAVILWVEGRQRERGKPSRVQSIDALTPLDALKVGLAQCFALIPGVSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWHAFNVDSIGLFAIGLAAAFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWIEWI
>YP_002242988|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNSVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>E3I422|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIYLQAAVLGVIEGLTEFLPVSSTGHLIVFGELLGFNGPPGKTFEVMIQLGAIVALIFL
YFRKLFGTLFGLPTDPAARRFALSILVAFLPALVLGATLHGFIKSVLFSPVVVAVALIVG
GIVILIAEETQKRVLYTQADNVPLKTSFLVGCGQALALVPGVSRSGATIIAGLLLGLERR
AAAEFSFFLSIPTMTGAFVYDAVKNRHELSSGDAGVIAVGFFAAFIAAMLVVKPFLAIVT
RIGFAPFAYYRIAFGTFILAVIYVFNAWPSNGAG
>F3PFE7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MYEINNMGLRYTLIYVLCFSMSIALQAQQQTLESKIGDFLKGKKAMVGVAVLTDRNKILL
HNNKMNYPLLSVFKFHVALTVLDKMNKQGTPLDHIVHVKASQLQPNTYSPLRQKYPNQDL
DISLGELLRYSISLSDNNACDILIEYAGGIGHIHQYINKLGVCDFNLSETEDSMHRNPSK
TYLNWSTPAEMVRLLEIADKKELFDPIYKDFLWNTMIATSTGSNKLKGLLPSNAIVGHKT
GSSDRNSEGVKIADNDAGVVIMPDGKKYYIAVFVMNSRETDDENAAIIARISRMVYDEYL
SENYISQEGER
>Q2Y6P3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFLLLKGLILGIVEGLTEFLPISSTGHLILVSDLLNFNDEKGKVFTIVIQLGAILAVC
WEYRVKLRHVVTDIGSRQDANRFVLNLLIAFLPAAILGLLFIKTIKQYLFHPVPVALAFI
VGGLLILWAERRPHVVDVERVEDMDWKHALKVGLAQCLALIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAIPVMFAATFYDLYKNRDILHLDDASVFAIGFVASFISALLAVRGLLRF
VSQHDFSVFAWYRIGFGIIVLITAYSGMVQWSG
>S1RJX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANFIKAIILGIVEGITEWLPISSTGHLILVDNILKMQISKEFTSMFNVVIQLGAIMA
VVYLYFNKLNPFDQQKSKLEQKQTWDLWLKVVVACFPSAVIGLLFDDWLDAHLYKPFPVA
LMLIIYGIGFIWVENRNRNIKPKCTDLNRFTYKAAIMIGVFQVLALIPGTSRSGATILGG
ILIGASRYVAAEFSFFLGIPTMFGASGLKIFKFIKNGNFFDLQSTFILLTGMIVSFIVSV
LVIKFLMDYIKKHDFSVFGWYRIILGSIIILTMIF
>I6ZI70|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQPGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>ABO42050|FEATURES|ARDB_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFGVQSMPRASKQQARYAVGRCLMLWSSNDV
TQQGSRPKTKLDIMRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSD
IDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKREL
QFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALR
ETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEA
KQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>L0NGP2|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA|antibiotic inactivation|1
MTLKPVSVRPLTSLDGEPWSRLRQALWPDQPADAHLVEIEEMLGGQGAVGYGYGAFDPEG
ELVAFAEVSIRAYANGCTSTPVPFLEGIFVEERSRRTGVAGQLLAQIESDLRNRGFVELC
SDAEMHNTSSHLAHRQWGFVETERVIYFRKPLGT
>A0A0C2RDW6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLQLTGITRSFTAGDREFLALKDINLTINAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYRINGQETRDLDDQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGIPAP
QRHARARELLARLGLDGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNQRDTGQLSDEEQ
VPAKPPATRRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KNYVLKDISAIGSNTIDIYSGSSFGDKRAASIETLVPADVTALNQLYYVDSATPVVGRSM
LLRYRNIDLDAQINGVSDQYFQVRGIKLEAGITFSESDARRQAQVVVIDYNTRHRLFAEG
VDPLGQVILIGNLPCTVIGVAAENKNLFASGKTLNVWVPYETAAGRILGQRFLDSISVRI
KDGQSSKVVENHVTQLLLQRHGIKDFYTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGH
LFSLFIKEWEMVFSMASVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>G4E3M3|FEATURES|UNIPROT_deepARG|beta_lactam|ThisiDRAFT_0902|antibiotic inactivation|1
MRIQSLLFLLFTIAFPLCGAAQDRSDWGTFFDKFNAKGTIVVVDERNKNYPVWVYGQERA
AKRFSPASTFKIPHTLLALDSGAVSDEFQVFEWDGVERGFSDHNRDQNLRSAMRVSALWV
YEQFAKKIGEEAARRYLEQLDYGNADPTSREGAYWVDGNLAISAYEQISFLQRLYRNELP
FKIEHQRLVKDIMIVEAGREWILRAKTGWEGQIGWWIGWVEWPTGPVFFALNIDTPNRMG
DLAKREQIARAILQSIDALPTPQ
>A0A0T9TBD4|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MLQNEQIKKVSVVIPVYNEQESLPALIQRTSAACKLLSQPYEIILVDDGSSDSSAELLTA
AANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>CAB61230|FEATURES|ARDB_deepARG|glycopeptide|vanSA|antibiotic target alteration|0
MKNKNKKNDYSKLERKLYMYIVAIVVVAVIFVLYIRSMIRGKLGEWIVRFLENEYGLNQL
DAMKLYHYSIRNNIEIFIYVAIAISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIE
LSAEMDVMEHKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDE
APDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDE
FYPQLSAHGKQAIIHASVDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGNM
VSIVFKNTGSIPKDKLAAIFEKFYRLDNARSSETGGAGLGLAIAKEIIVLHGGQIYAESN
DHYTTFTVELPAFPDLVDKRDS
>YP_001836040|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRKFYLLLIILIRLFAMSC
>A0A0G1LR69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIWQFWNSLLLGVIEGVTEFFPVSSTGHLIIAEKLLGITEPSLFFNVVIQLGAILAVVV
FFWKRIVQILQSFVSPVSTSQKKTWMLFVAGTIPVLIIGALFHSTIEKLQASVHVVALTT
FLIAFILVWAEKKLHHTLVHGVKKSTLKFWDYIVVGIFQAISVIPGVSRSGITIVGALTR
KLSFDDAVETAFILGIPAMGAAAVFESLKLIKEPAGLTTALLMQTAVGFIAAFITAFFTI
SATLPLLKKYGFTPFVIYRIALAILLLFLFPLAL
>J2NUC4|FEATURES|UNIPROT_deepARG|beta_lactam|PMI22_02065|antibiotic inactivation|1
MYTDKLPRLGLYSAFALTLGAAPCIAATPSEQQLETLVNAAVVPVMQQQNITGLAVAITQ
NGQPHYFNYGVTSKENRRPVSQNTLFEIGSVSKTFTATLAAYAQANGKLSLSEPASAVLP
ILRGSAFDHISVLQLGTYTAGGLPLQFPSEADHPETMLGYFKQWTPVYPAGTHRQYSNPS
IGLSGYLAAYSMGQPFDVLMEKTLLPKLGLKHTYLTVPQDQMGLYAQGYNKEDKPVRVGP
GALDSEAYGVKTSTSDLLRYVDANMKPGKLEKPLQQAIATTHTGYYTVGDMTQGLGWELY
PYPVTLDRLLAGNSTEMAMNAHTVHWLNPPQAEQESVWINKTGSTGGFGAYIAFVPSKDI
GIVILANKNYPNPERIKIAHTILNALME
>F2K9P9|FEATURES|UNIPROT_deepARG|beta_lactam|PSEBR_a1891|antibiotic inactivation|1
MHMAKSILAGTFFLVCGAAPGFAQDRIEDAVNATIQPLMKQQDIAGMAVAITYNGQRHYF
NYGVASKDTKKPVTDQTLFEIGSISKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAF
EGISLLNLATYTAGGLPLQFPAEADHPDRMFSYYTTWKPLYPAGTQRLYSNPSIGLFGYL
AARSLERPFDEVMERTLMPGLGLQHSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLMRFLEANLRPEKLDADLKQAIATTHTGFYRVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALTPQKVEPLNPPRPAPDGAWVNKTGSTNGFGAYAAFVPGKDMGIVMLAN
RNYPIEERVKAAHRILAALDVK
>W4QNI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWFEALLIGFVQGISEFLPISSTALMLIVQRLLHISIGEDFKLAFETFLHIASVLAVIV
YFRYDLKQISSDFLSHLKTKQPSTQTNFRFTVLIIISTLITIFTVTVLEFYVGDNLTNPS
TVGLFLVITGLSLIVMEHGLSHGIRSLPHLRWSDSVIIGLAQAISLIPGMSRTGSTLFVA
LLLGLDKKTSLRYSIILSIPVFLGMSLLKLPDLIRSYNETQLLALTTAFTTSFLFALVGI
RWIISLVENTKLSYFACFCIALGFLSWGWL
>A0A0P0ES86|FEATURES|UNIPROT_deepARG|beta_lactam|blaIMP|antibiotic inactivation|1
YGWGVVPKHGLVVLVNAEAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGG
IEWLNSRSIPTYASELTNELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVV
VWLPERKILFGGCFIKPYGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASP
GKHTK
>ACQ66103|FEATURES|ARDB_deepARG|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMINLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>CAR68723|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSEQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>A0A136C1G6|FEATURES|UNIPROT_deepARG|beta_lactam|ACS95_07610|antibiotic inactivation|1
MKKNTLLKVGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGMKTLKERGIKAHSTVLTAELAKKGGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSASSKDLGNVADAYVNEWPISIENVLKRYGNINSVVPGH
GGVGDRDLLLHTLDLLK
>A0A073IK72|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENTTIVAAFLGLLEGLTEFIPVSSTGHILLAGHFLGFDSAGKTFEVVIQLGAVLAILTL
YSARLIAVFSAAPSDPQARRFIWSVLLAFLPAVVIGVMAHGFIKEVLFETPMLIAVMLIL
GGIVLVFVDRIAPEPKHDDAMKLPIPMAIKIGFIQCLAMIPGVSRSGATIVGALMLGASK
RAAAEFSFFLSMPTMAGAFAYDLYKNRDVLDTSAMGEIAVGFVMAFISAVVVVKWLLDYV
SRNGYAMFGWWRIVVGSLALVFLISGF
>A0A0L0WC43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METISLVIKSIILGIVEGITEFLPVSSTGHLVIFQNLIGFKGINPKYVEMYTYVIQLGAI
LAVVILYWKKIKETLVNFFPQKVGYEKSGFKFWFMIFIACIPGGVFGILLDDLADKYLFT
PVSVAATLFLGAIWMMYAEKKFRNNNLKGQELNVTVKQAVIIGLFQCLAIIPGMSRSAST
IIGGWVSGLSTVAAAEFSFFLAIPVMVGMSFLKILKVGGILSLTSVELISLAVGFLVSFV
VALAVINKFISYLKKKPMKIFAIYRMIFAVIVLVTGALGIFH
>I0RBL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILEILKVIIIGIVEGITEWLPISSTGHIVFIEQLFNFNVSENFKDMFDVVIQLGAILA
VAVVYFKKLNPFNKGRNKKKMYLTVELWKKIIVACLPAAMLGLLINHWVKEHLLNGFVIS
MALIIYGILFIMIENSNKNRAYSIKSVYSINYQTALFIGFFQVLALIPGTSRSGATIIGA
MILGVSRSVSVEFSFFLSIPIMFGASLLKLVNFGLHYTMAEIVYLLLGMTVAFFVSVFSI
GFLLNWIKKNNFKFFGYYRIVFGLIILVWYFTSSLPK
>R2T479|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLSNLWKAIILGIIEGVTEWLPISSTGHLILVDEFIKMNLSKDFMEMFNVVIQLGAIMA
VVVLYFHKLNPFSPQKNETEKKDTWILWSKVVVACAPAAIIGIPLDDWLEAKFHNFFTVA
LMLIIYGVAFVVIEKRNRDRKPKCTDLRDFTYKAAAIVGFFQVLSLIPGTSRSGATILGA
IIIGASRFVATEFSFFLGIPVMFGASFLKIAKFVMKGNSFGFTETFILLTGSIVAFVVSI
VVIKFLLNYLKRNDFTAFGWYRIVLGVLLISYWLFS
>A0A0D8C9P8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLTLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKKAARAQTVDEITYKQAFLVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFLSAFVFALL
AIRFFLELINRIRLVPFAVYRIVLAVVIYVLYF
>Q8G2M6|FEATURES|UNIPROT_deepARG|multidrug|bepE|antibiotic efflux|1
MNRFFVDRPVFAAVISIVLVLAGLICIRILPVAQYPELTPPQVVVSATYPGASAETVAQT
VAAPLEQQINGVENMLYMQSSSLGSGTMQLTVTFALGTDPDQATINVNNRVQRATSSLPQ
EVQRLGVTVDKRFTTILGMVAMFATTDRYDRTYVGNYALLNVVDDLKRLPGVGDVQLLGN
IDYSMRVWLRPDKLAQYNLTPSDVSAAIQEQNAQFAAGRFGDQPDPHAGPFTYTATTQGR
LPDAAAFENIILRSSSQNAATLRLKDVARVELGTESYLVDSNLNGTPAVPIAIYLQPGAN
ALNTMELIQNRMNELKASFPAGIDYAIPFDTTKFIKVSIEEVVHTFIEAIILVVLVVFIF
LQNWRATLIPVIAVPISIIGTFAGMYVLGFSINLLTLFGLVLAIGIVVDDAIVVLENVER
IMTTEKLSPRKAAIKAMGEVTGPVIAIVLVLCAVFIPVAFMGGLVGEMYKQFAVTIAISV
TLSGLVALTLTPALCALILKPGHHEPILPFRIFNRAFERVTSGYTRGVRFFLKRATIGLI
IFAGLLGSTYYLFERVPGSLLPDEDQGFLFGVAVLPPAASLERTTVVLDQVSENIRKNPA
VDNVFAVSGFDLLSGGLKTSAGTMFIMLKDWKERTTPDADARNLPRTIMGMNAGIKDGMV
LAFNPPPIMGLSTTGGFELYVQDRTGGGVESLTQATKLITEAAAKRPELQGVRTTFDPNV
PQYDIQLDREKAKAMGVPINSVFTAMQATFGSLYVNDFTLYGRNYQVNLQSEAEFRRDPG
DLKHVFVRADSGSMIPLDALVTVKRIVGPDQLERFNAFNAAKVTGNPAPGYTSGDAIKAM
QEVAAQVLPQGYQIAWTGSAYQEVSTSGTGSQAMIFGLIMVFLILAAQYERWSLPLAVIT
AVPFAIFGALLATDLRGLTNDVYFQIGLVTLIGLAAKNAILIVEFAVLERESGKSAIEAA
ASAARLRFRPIVMTSLAFILGVVPLAVSTGAGSASRHSIGTGVIGGMLAATFIATFFIPM
FYSLIARKPPKKHEDETADTPETPGGTGGGI
>G9A2L0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRNIRLQTLGALAAASLFCGASSQAIASDSPEHIERVVDEAIRPLMKQYDVPGMAVAVAV
EGRRYVFNYGVASKESGQKVGDETLFEIGSISKTFTATLASYAQARGDLSLSDMASQHMP
ALAGTSFDGISLLDLATYTAGGLPLQFPASVTDQNEMIAYFKGWRPSYAPGTHRLYSNPS
IGLFGYLAAKRMAEPFDDLMEKTLFPGLGLARTHISVPEQRMGDYAHGYSKAGKPVRVNP
GVLDSEAYGVKTTAADLIRFVEANIDGVALDDTLQRAIAATHTGYFKVGDMTQGLGWEMY
PYPVDLKQLLGGNSPEVSFKPNRVTRLDPPLPPRDDALINKTGSTNGFGAYAAFVPAEHI
GVVILANRNYPIPARVKAAYQILTELQRAAASAP
>G8EXA0|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGARGVTVVGA
TWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKAVVGGHDSPLHGPELIDHYEA
L
>A0A0M4RGQ6|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPRLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEQIRRGVDTLSDITGQAVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLADGSLGAPQIPVDLPTFDEVVGPELNAADFNSYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLAQARARDINFHPLRDLLPTDLNSVPAGQLSRGQLDGREGWLGVQKP
>A0A0N2A603|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLVE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKH
>CAJ65911|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDMYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGIGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>E0QIG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRGKMTDIIRVVLLSFVEGLTEFIPVSSTGHLIIVNEFIKLKPENFANIFNIIIQLGAIM
AVVVLYFHKLNPFSKDEKHKKETLNIWKKVIIGALPAAVLGLLFDDIIDAHLMNAKVVAT
MLFLWGVVIILIEKRNMKNENNIAGMTYMTAFMIGIFQCFAMIPGTSRSAATIIGAMLLG
LSRVESAEFSFFLAIPTMLGATSLKVVKLFIKHTPITSFQVILILLGVVLSFVFALIVIR
KFMDYVKNHDFIVFGIYRMILSIVVLTYFLLK
>A0A081P2H3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEVFVGFILGLVEGLTEFAPVSSTGHMIIVDDFLFHSKEMFPPSVANTFKVVVQLGS
ILAVVVLMWDRFMNLLGLKKLPGQTPSGPRLNLLQVFVGLVPAGILGVLFNKKIDEYLFS
TQTVIIGLVLGAILMLAADWFRPRRPKTETADQITYVQAFFVGLFQCLALWPGFSRSGST
ISGGVLFGMSHRAAADFTFIMAVPIMTGASFLSLLKSWDSITADTIPFFVAGFISAFIFA
LLSIRFFLKLINRIKLAPFAIYRLVLAAVIYFVFL
>E4PYM7|FEATURES|UNIPROT_deepARG|beta_lactam|SUO_0014p2|antibiotic inactivation|1
MLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKE
IGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSK
ENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVL
VIFTNKDNKSDKPNDKLISETAKSVMKEF
>S6FHV4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIELTHINKFFGEGENRTQVLKNINLNIQKGDFIAIIGQSGSGKSTLMNIIGCLDTAT
SGSYQIAGQEVSQLDRDALSNLRQKKFGFIFQRYNLLSTLSAVENVALPAIYAGIDQPTL
LARAKSLLEKLGLGDRLENKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVMEILTQLHSEGHTIILVTHDKNVANFANRIIEIKDGEIIEDRRKAEQISEKQAVSVQS
RKKPLQFYRDQFVESFKMSINAIVAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKILS
NINAIGTNTMDIYNGTGFGDQRAAKNQNLTVSDANILAKQSYIDSVTPNSSVSGTLTYGS
QSFSAQVRGVGEQFFNVKGLALAQGRFFTADEVKTSEQVAVIDENTLKDVFNHQNPLGKI
LMMNKKPLRVIGVAKSNNFGMNSSSLNIYIPYTTAMNKISGNQKISSITVKIRDEINSKV
AEKDLTNLLTVRHGKKDFFVMNTDTIKQTIESTTNTMKLLISSIALISLVVGGIGVMNIM
LVSGTERTKEIGVRMAIGARQFNILQQFLIEEVLICLIGGSTGVLLSLLIGTVFNLFVQD
FTMIFSTFSIVAALLCSSLIGVIFGYMPAQNASQLNPIIALAQE
>NP_287199|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGXWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARXRGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSVHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>V5MBT3|FEATURES|UNIPROT_deepARG|beta_lactam|YBT1518_17595|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPEDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKRALGVLKAKNK
>U3N7B5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114t|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A069RH52|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METILFILKSIILGIVEGMTEFLPVSSTGHLVIFQKLMGFDGTSKNYVEMYTYVIQLGAI
LAVVILYWKKIKDTLMNFFPQQVGYERSGFRFWFMIFIACIPGGVFGILLDDLAEKYFFT
PTSVAATLFIGGIGMIYAENKFRKNRIRSSELSVTMRQAWLIGAFQCLAIIPGMSRSAST
IIGGWVSGLSTVAAAEFSFFLAIPVMVGMSILKLLKVGGVSNITPQELTSLVVGFVVSFI
VALMVINKFISFLKKRPMRIFAFYRMAFAVVVLSAGFMGLF
>YP_002244306|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSLGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAIAAILASVM
IFALIKETLPVERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVPPQDFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFAMAVWMVFSA
LMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFTSAWPMIWSIALCAACSILFYLYASRPKKR
>YP_310429|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRMPSAIILQRASR
>R8PSZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDTIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAFL
YHKRLVSLCNIKPLLQKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKPEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGLLAKVNY
NAASEFSFLIALPVMVGATGLDLLKSWEHLSIDDIPMFAVGFITSFVVAMLAVVTFLKLL
SKIGLKPFAYYRILLAIVFTIFVLL
>A0A127SXP6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVDAAWQILNALQ
>A0A104NM81|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFNARSLMMAAAFSMSAIPVSSHAADHAQDRLGSVVSEAIQPVMAKYDVPGMAVGIIVN
GEPHVFNFGVASTATHAPVTRDTLFELGSVSKTLTATLASYAQASGKLSLSDPASRYLPA
LRGSRFGEVKLVNLGTHTPGGFPLQVPEQIGNDDQLMQYFKEWRPAYPAGTYRTYANPSI
GMLGVITAKSMGRDFTTLMEQWLFPSLGMKSTFINVPAAQMGNYAQGYTKAGAPIRVAPG
MLSAEAYGVKSTVADMLRFVQANMALVQLDGTLQQAITDTHTGYFQAGPMTQDLIWEQYP
YPTKLQALQDGNSARMVFEATPVVALNPPQKPRQDVWINKTGATNGFGAYVAFVPEKQLG
IVILANKNIPNDERIAATYRIFASLADGAQ
>D9P930|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGSGENTAHVLKNINLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCKIDGKETLNMTSDELSDLRQRKFGFIFQRYNLLPALTASENVALPAIYAGMDNTSR
KARANQLLEKLGLADKTGNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILKDLHKEGHTIIMVTHDANIAANASRIIEIKDGYIIRDERQQPYSEDLKLTKREY
KKPRFFDQLIESFKMAINAITAHKLRALLTMLGIVIGITSVISVVALGQGSQQQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDAMMLNKQQFVDSTTPSSNLSGTVIYGNTNV
TASINGVGEQFVNVKGLKMISGRFFDADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILV
DKKPLTVIGMAQESNNLNQTSLKMWMPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKS
INELLTAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAILICLLGGIIGILFAIAIIFSFNTLGTNFKMI
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>A0A0U0GJ49|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRA
GVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEV
IVNAFR
>W8SQG3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
DMCSTSMVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDI
AVIWPKDRAPLILVTYFTQ
>A0A059WMV8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>ZP_04096643|FEATURES|ARDB_deepARG|beta_lactam|BLA1|antibiotic inactivation|1
MEQIYFGDCLLCVSKKSVKNLKGMMILKNKRMLKIGICVGILGLSLTSIEAFTGGPLQVE
AKEKKGQIKHKNQATHKEFSQLEKKFDARLGVYAIDTGTKQTVAYRPNERFAFASTYKAL
AAGVLLQQNSTMKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGN
ALPNHKRNILTEWMKGNATGDKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPI
IIAILSSKDEKGATYDNQLIAEAAEVIVNAFR
>A0A0T9R5D3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_4|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLEERVNYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPNVAAQAERIIEIKDGRIMADSGSKTVPTVVASEAVS
LAPSAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDIYPGKDYGDDDPSTRQALVYDDMVALKEQSYVSAVSPTISGSMRLR
YGNVDVAASVSGVSEQYFHVYGMKLEQGTPITREQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPNWQIAFPPLALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0M4FTW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWELFVAFILGLVEGMTEFAPISSTGHMIIVDDFLFQTKKMFSQEAANTFKVVIQLGS
ILAVVVLMRDRFLNLLSLKKIKGQTVTENHFNLFHVLIGILPFGILGFLFEDYIDTYLFS
AERVVIGLVLGAILMLTADWFRRSKPRTETVDQITFKQSLSVGLIQCFALWPGFSRSGST
ISGGVLLGMSHRVAADFTFIMAVPIMAGASGLSLLKNWDSITVDVLPFFAVGFISAFLFA
LVSIRFFLKLINRIKLVPFALYRLVLAAVIYFVFL
>K0A8Q8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIELLKALLLGFVEGMTEFAPVSSTGHMIIVDDMWLQTSEFLGQYSANTFKIVIQLGS
ILAVIVVFWKRLFSLIGLYKIEGEHDASGTHKLKLRHVLIGLLPAAVLGLLFEDFIDENL
FSIDTVIIGLAAGAILMIAADKLGPKEPKTTTLDQISYRQAALIGLFQCISLWPGFSRSG
STISGGVFLGMNHRTAADFTFIMAVPIMFGASALSLVKNWQYINAGDLGFYAVGFIASFA
FALLSIRFFLKLINKIKLVPFAIYRLVLATILAVIVYM
>A0A0H2WNR1|FEATURES|UNIPROT_deepARG|aminoglycoside|aac|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHLALGFEETERVIFYRKRC
>G2RPG9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB2|antibiotic inactivation|1
MIQGINHMCFSVSNLERSITFYQKVLGAELLVKGKSTAYFSLNGLWLALNEEKDIPRSEI
QYSYTHLAFSISIESFDQAKELLKQHNVNILPGRNRDERDKKSIYFTDPDGHKFEFHTGT
LQDRLAYYQEEKPHMTFYSPKE
>BAA02494|FEATURES|ARDB_deepARG|beta_lactam|CMY-79|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A0F7LMP6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELRGIERSYSAGEQQIKVLDDVTLSIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SRGEYRVAGQNVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGATKTV
RRQRAIELLGRLGLDERVNYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAAQAQRIIEIKDGHIMNDSGSQLSKTVTEAPPIT
VKISSIRQIFGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SDIKEIATNTISVYPGEDFGSDDPASKQALKIADVNAIRAQPYILAVSPDIEGGARLRKG
NIDVAARVSGIGDEYFQVYALRFAQGMGFTSDMVRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSALGSDSSLHVWLPYSTMTSRLLNRNYLDSITVRIKDGHN
SKEAEQKIVRLLTLRHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGILGIALSYTIAFIAQLA
LPGWSFVFQPVALLSAFACSTAIGVIFGFLPARNAARLDPIDALARE
>A0A0K2Y1S3|FEATURES|UNIPROT_deepARG|bacitracin|bcrD|antibiotic target alteration|0
MVLDFIEILKVIFLGIVEGITEWLPISSTGHMILVDEFITLNMSEAFKEMFFVVIQLGAI
LAVVVMFWNKMFPFQFKNKAQSIVKKDTFSLWFKVAVACVPSAIMGILFDDYLDAYLQTP
IVISIMLIFYGLLFILIENWNKKRTPTTMALSDISYKTAILIGAFQVLSLIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPTMLGASAFKLLKFGFEFTSAELLALVLGMAVAFAVS
VLVIKFLMNFIKKHDFKVFGWYRIVLGILVVLIKI
>G5NCT1|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSEINV_2403|antibiotic inactivation|1
MDIRQMNRTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0T9SPD0|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSESEKIKKVSIVIPVYNEQESLPILIERTSAACKLLTQPYEIILVNDGSSDNSAELLTA
AANEPENHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRAHRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>R4MR46|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAI
TMSDNTAANLLLTTIGGPKELTVFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMA
TTLGKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERG
>J3A7E7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MPQLQGLNHLLFSVSDLEKSFCFYRDVLHAKPLVRGRKLAYFELNGYWLALNEEPGIPRN
EITESYTHMAFTITEESFDEWYAHLEKHGVTILHGRDRSERDKRSIYFTDPDGHKFELHT
GTLQDRLAYYRDEKHHMTFFE
>A0A0W7YJ77|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQHINHLLFSVSNLEESIAFYENVFDAKLLVKGKSTAYFDVNGLWLALNVERDIPRNE
IHHSYTHIAFTICEDDYNKMYDKLLQLKVNILTGRQRDEKDKKSIYSTDPDGHKFEFHTG
TLQDRLAYYQQEKPHMTFFDN
>A0A0A0QAW0|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEITDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADATLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVGGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>A0A096AQY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFTKEMWKLYGLLIIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDKLFNQGKEENEVTPKRAFFIGMFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKENVNWATSDNLMLLVVGCFISFVVAILAMKWFVSFLTK
YGFKAFGWYRIIVGGILLAMLLSGVSLNMVD
>A0A0J6BTD4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MPQLQGLNHLLFSVSDLEKSFCFYRDILHAKPLVRGRKLAYFDLNGYWLALNEEPDIPRN
EIAHSYTHMAFTITEESFDEWCAHLEKHGVTILHGRDRSERDKRSIYFTDPDGHKFELHT
GTLQDRLTYYRDEKHHMTFFE
>A0A0K1XG65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWWTAVQALIIGIVEGLTEFLPVSSTGHQIIVADLLGFGGQRAKAFNIIIQLGAILAVM
WEYRRKIIQVVVGLPSEAPAQKFTANLLIAFIPAVIMGLLFADLIEQWLFNPITVASALV
VGGLVMLWAEKRPHQVRAKEVDDMTWQQALKVGCAQCLALVPGTSRSASTIVGGLFFGLS
RKAATEFSFFLAMPTMVAATVYSVFKHRELFSNASDIGIFAIGFVTSFIFAMIAVRALLK
FIANNSYAVFAWYRIGFGLLILLTWQIGVIDWSTALD
>H2IT99|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAHYEPIRKVSVVIPVYNEEESLPALLSRTQAACQQLTQQYEIILVDDGSSDSSGDMLSA
AAEQPDSHIIAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRANRRDSWFRKTASKMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARKTVEIPVQHSEREFGDSKYSLMKLINLMYDLITCLTTTPLRMLSVVG
SVIAIFGFVLAVFLILMRLINGPEWSAEGVFTLFALLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGVRSEDNSQEEE
>A0A0J9D5V6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVMIQLGAILAVVV
LYWRTFWAVAMGLLRLDPVSIRFVRNLLVAFIPAVVIGLALHDYIDTLLGSPRVVAVALV
VGGVAILVIERLIREQRFHGIADIPLVRVIGIGFIQCLAMVPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQLTSAQVGWDSIALGFVVSFIVALLVIKWFV
GLVSRHGFAPFAWYRIIAGIGALVWLSLR
>YP_002386341|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A087KEZ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTVSEMSVADKDAGPYGIAAGPDNALWLTFAHSGRIARLTLDGELDEYPLESPECRPTVI
TPGPDGALWFTRSQDHRIGRITTDGETDSFPVPTPGSGPFGITAGPDDAMWFTEMNSDRI
GRITSTGEITEFVLPCTGAYPSAITAGPDGALWFTLNQANAIGRITVHGDIVIHPLPTPS
AAPVGITSDGDALWFVEIAAGQIGRISVEGAIKEFPLPDRTAKPHAIVATSTGACWFTEW
GANSIGHITGSGEITEYRLPSPSSEPHGIALGPDGALWAALETGGVARLEP
>A0A0Q9XY39|FEATURES|UNIPROT_deepARG|beta_lactam|ACA30_14580|antibiotic inactivation|1
MKLRSLTFSTLPMLLLLCLVIAGCAEDSKDSAQPKHQDADFAKLEEEFDARLGVFALDTG
TGETISYRADERFAYASTHKALAVGALLQQISIEDLNQKVIFAEGDLVNYSPITEKYVDK
GMTLSELSEASLRYSDNTAGNLILKELGGPDEFKKALKKIGDDITKSERFEPSLNEVKPG
ETHDTSTPKALATSLKAFTLEDELQKEKRLMLVDWMKRSTTGDTLIRAGVPKDWEVADKS
GAALYGTRNDIAIIWPPNENPIILAILSDRATEDADYDDKLIEQAAETVIAGLKDSAQE
>D9QFD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHLLLLGHFMGFESEGKTFEIVIQLGAILAIISVY
FQRLWALATRWPHDPQARHFIIGVVIAFLPAAFAGVFMYDIIKEIFFETPVIICIALIVG
GVLLLALDRMKRVPKYLDVNTYPFRVYGLIGLFQCLALLPGVSRSGATVAGGLLLGTDKR
SAAEFTFFLALPTMGGAVAYDLFKSRNDLDFTDVGLIAVGFITAFLTALVVVRLLLDFIS
RHGFAPFAWWRIAVGTLGLALIWGGVGG
>W1FUL7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKQHQSKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDNSAQLMMNA
SQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEGF
DVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERS
TFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLGS
VIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYND
VRARPRYFVQHVIRPQTTQSTEENRA
>K8D8D7|FEATURES|UNIPROT_deepARG|beta_lactam|BN128_875|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDENTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDNVTL
LNLATHTAGTPLFVPDAVKNTTQLMDWYRAWQPEKPVGTERIYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPVAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATAIVPPQPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIQELDK
>J8IYL9|FEATURES|UNIPROT_deepARG|beta_lactam|III_02053|antibiotic inactivation|1
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHTD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNTNSVVPGH
GDIGDKGLLLHTLNLLK
>A0A0H3FQM8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGEVDVLKGITLSIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYQVAGVDVAHLSGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGKERRI
RLERARDLLTRLGLGERAEYFPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIIELRDGEIVRNPPPSSSEKGGVLRAEA
RGEPSVWRQFSSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVSSATPAVSKSLRLRA
NNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKAKVV
GEVILVGNMPATIVGVADEKQSMFGSSKILRVWLPYSTMAGRVMGQSWLNSITVRVQEGY
DSATAEQQLVRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARARDVLQQFLIEAVLVCLVGGAIGVSLSLMIAFILQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0A0QAV3|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-7|antibiotic inactivation|1
MRDTRFPCLCGIAASILLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFSDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>YP_001389785|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIISTLKNFFPSDRVPVKKCGLKFWINIVIASIPAAIIGIPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKVISIDDVNAKQAIIIGVFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFI
VALVVIDKFIAFLKKKPMKVFAIYRIVLGIVLIILIYTNIITWH
>A5UZ93|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVALALLGIALLIAVPTASDWWKAAVLGIVEGLTEFLPISSTGHLLIVSNLLSFEGSIG
GTFEIFIQLGAVLAVVGYYASDLLRQARMAPRDPHTRRFWIAIGVAFLPAAIIGLALHGW
IKAVLFSPVVIGTALIVGGIVLIIVERLPRRTATVHDATRLSLRQALGIGIAQVLALTPG
VSRSAASIIGGMVVGLDRRAATTFSFYLAIPTLGAATVVDLLTSLEQVTPGDVGRLFLGL
VVSLIVAWLSIDWLLRYVANHSFVAFGIYRIMAGSIVLALVAAGRL
>A0A097QYS9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGQPPVHEGKTQGHLTLGHILLAMIPAVVLGLVFHDAIKTLFAPQT
VVYALVVGGFLLLAAEWLKPKQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRFAASEFSFILAVPMMMGATALELYKSLPFLSMADLPMFAVGFVTAFIVALIA
IKTFLSVIKRISFVPFAIYRFIVAAVVYMVFL
>Q6ZY67|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
ATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVL
CGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAAN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTS
QRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGLNNKAE
RIVVIYLRDTPASMAERNQQIAG
>A0A127SNG7|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MTVKVDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAFNQAGELGIYDEMLPSYTIFHE
DTETFSDLWTEYVPNIEEFSRAYENDIRLYGSNHGMIGKPDVPENVFTVSMVPWSTFESF
NLNLQKGYSYLIPIFTLGKYYEEDGKILLPLAVQVHHAVCDGFHICRFVNELQELING
>A0A023V6T4|FEATURES|UNIPROT_deepARG|aminoglycoside|CFNIH1_06155|antibiotic inactivation|1
MREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>P94458|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
KTEMKDDFAKLEEQFDAKLGIFALDTGTNRTVTYRPDERFAFASTIKALTVGVLLQQKSI
EDLNQRITYTRDDLVNYNPITEKHVDTGMTLKELADASLRYSDNTAQNLILKQIGGPESL
KKELRKIGDEVTNPERFEPELNEVNPGETQDTSTARALATSLQAFALEDKLPSEKRELLI
DWMKRNTTGDALIRAGVPEGWEVADKTGAGSYGTRNDIAIIWPPKGDPVVLAVLSSRDKK
DAKYDDKLIAEATKVVVKALNMNGK
>A0A127STI7|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
GKYHIPLSIQVHHAVCDGFHICRFVNELQELINS
>A0A0D6Z7T0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIWELFVAFILGLVEGLTEFAPVSSTGHLIIVDDLLLHSKEIFTEPVANTFKVVIQLGS
ILAVVIVFKDRFMNLLGLKKGVSIADSRGRLSLSKVIVGLIPAGILGVLFEDYIDKHLFS
VETVIIGLVIGAILMIIADRLHSGVIKMDDVDQISYKQALGVGLFQCLGLWPGFSRSGST
IAGGVLLGLSHRAASDFTFIMAVPIMLGASAISLLKNWQYFTVDALPFFTVGFISAFLFA
LLFIRFFLKLINTIKLLPFAIYRIILAGVIYFIFF
>I0JIH8|FEATURES|UNIPROT_deepARG|fosfomycin|yndN|antibiotic inactivation|1
MSIQGLNHFLFSVSDLHKSIQFYREVFEAELLVKGENTAYFDLNGMWLALNVEKNIPRHE
ISQSYTHIAFSIEPSEYEAIYNKLEALNVNILSGRPRSEHDKQSIYFTDPDGHKFEFHTG
TLEDRLNYYKQEKPHMEFYDRS
>U2RC35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFADIIKVFILSLVEGLTEFIPVSSTGHMIIVDQFLQLSQNEEFANAFKIIIQLGAILSV
VVYYWKRIFPFAKGLSKSQRADIIQMWIKIVIAVLPAVVLGLLFDDIIDKVLFNSVVVAV
MLVIYGVILIWLESRKKKEGGIASITQMSVKTAIGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRVLATEFSFFLAIPTMLGATLLKLVKLGTALSGYEWFLIALGFVLSFVFAYAVIKV
FMNYIKKHDFKIFGYYRIVLGIVVLLLYFMGAIK
>U2MIG3|FEATURES|UNIPROT_deepARG|beta_lactam|L580_0134|antibiotic inactivation|1
MLKKSLSCVLLLATSGSVFAAPQTEKQIADIVNRTVAPLMQEQGIPGMAVAVIYQGQPYY
FTWGLADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLGDPASKYWPALSGKQ
WQGITLLHLATYTAGGLPLQIPENVTDEASLQNYYQTWQPQWAPGTKRLYSNASIGLFGA
LMVKPSGMSFEQAMTQRVFQPLKLSQTWINVPQQEDKHYAWGYRDGKAVRVSPGMFDAEA
YGVKSSIEDMASWVQANMAPAKVKDASLQKGITLAQSRYWHAGDMYQGLGWEMLNWPVKE
KTVVEGSDNKNALAALSVTKITPPAPLTSASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKNYPNPVRVEAAYRILEALQK
>AAR14158|FEATURES|ARDB_deepARG|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKSD
>A0A095UK13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHHLFVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEDETAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKVPHEGTGQGHLTLIHILLGMIPAVVLGLILHDRIKTLFTPIN
VMYALVAGGILLLLAEYFKPKQPKSVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGISRYAASEFSFLLAVPMMMGATALDLYKSLSFLTVSDIPMFGIGFIMAFIVALIA
IKTFLELIKRISFVPFAIYRFILAVVVYMIFA
>YP_001465866|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRVGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPLQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNSGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>A0A0A0Q9J3|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQNKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPKAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A5Z547|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDFIEIIKVIFLGIVEGITEWLPISSTGHMLLVDEFIKMNVSADFKEMFFVVIQLGAIL
AVVVLFWNKMFPFQFKDKSKPVIEKDIFSMWFKVVVACIPGAVVTILFDDFIEAHLHTPI
VIAITLIVYGIAFIVIERWNKTRTPKVLTLNDITYKTAFIIGLFQILSIIPGTSRSGSTI
IGALLIGVSRVAAAEFTFFLAVPVMFGLSFLKIIKFGLAFSATELTVLVIGTVVAFLVSI
LVIKFLMGYIKKHDFQIFGWYRIVLGILVMLYFSFV
>ZP_04299268|FEATURES|ARDB_deepARG|glycopeptide|VanSA|antibiotic target alteration|0
MIVMAAVVFVLFLRLFIQGTLGEWIVRFLENSYHLERWDAMIIYQYTIRNNIEIFIYVAV
AISILILCRVMLLKFVKYFDEINTGIDILIQNEDKQIELSAEMEFMEQKLNTLKRTLEKR
EHDAKLAEQRKNEVVMYLAHDIKTPLTSVIGYLILLDEAPDMPREQKAKYVHITLDKAYR
LEQLIDEFFEITRYNLQTVTLTKKNIDLYYMLVQMTDEFYPQLAANGKQVVIHASEDLTV
FGDPDKLARVFNNILKNAAAYSEDDSVIDITAGLSGNVVSIVFKNAGNIPKDKLATIFEK
FYRLDDARSSNTGGAGLGLAIAKEIIVQHGGQIYAESNNNSTTFTVELPAAPDLADKGSS
>A0A127SKD1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
PMAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAV
IYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKY
WPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYAN
SSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVS
PGALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWE
MLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEK
ELGIVMLANKNYPNPARVTAAWQILDTLQ
>X6QAB8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATLLELHNITRQYPAGEQEITVLKKVSLKIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYYVAGQNIAELDNDQLAQLRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGAGKAQ
RQERAEKLLQRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMKILKDLCAQGHTVIIVTHDPKVAQQAERIVEIKDGEIINDSGALAVKVAEFPAKAV
IRKNPLGQWVSRFSEALLMAWRAMVVNKMRTLLTMLGIVIGIASVVSIMVIGDAAKGMVL
NDIKSIGTNTISVYPGKDFGSDDPENRQVLKASDISAIAQQPYVQSVTGSIETSARLRKG
NLDAVARVSGVGTDYFQVYGSHFSEGMGFTQDMLTRRAPVVVIDRNTKRRFFPNKQNVVG
ETLLIGNMPATIIGVLGEQKSIFGSSKSLEVFLPDTTINSKLINRSYYDSIVVRVNEGVD
AKVAEQQLVRLLTLRHGKKDIFTYNIDTLVKTAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLIGGLMGIGLSYGVSLIAQMA
LPGWTFEFDPIALISAFACSTAIGVIFGFLPAKNAAKLNPIDALARE
>A0A0Q3SUT1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWQIFVAFVLGLVEGLTEFAPVSSTGHMIIVDDILLHSKTLFSPEVANTFKVVIQLGS
ILAAVIVFKDRFLSLLGLKKISPDGNGPGHKLRLSQVFVGLLPAAVLGLLFNDYIDEYLF
SINTVLIGLVAGAVLMIAADWFRPGKPKAASVDQITYKQALIIGLFQCIALWPGFSRSGS
TISGGVLLGLSHRAASDFTFIMAVPVMAGASFLSLLKHWQYITADTLPFFIVGFISAFLF
ALLAIRFFLKLINKIKLVPFALYRIVLAAVIFFLVM
>YP_001715981.1|FEATURES|CARD_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEV
QYSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGT
LENRLNYYKETKPHMVFYK
>A0A0R1ER98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVDQVVKLSQGREFMNMFEYVIQFGAILAVI
LLYFNKLNPFSKPTVKEQNATWQLWAKVIIAVLPSVVVGLPLNDWMDKHLHTPLVVATTL
IVYGVLFIIVENYLKNKPSHITTLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLWQGNGFTGEQWIVLLTGSVVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFL
>A0A127T4M0|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQKWQPQWKPGTTRLYANSSIGLFGA
LAVKPSGMSYEQAMTTRVLKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGVGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAN41430|FEATURES|ARDB_deepARG|beta_lactam|OXA-47|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASQLFEGTEGCFLLYDASTNAEIAQFNK
AKCAAQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKIPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVRNSAIENTIDNMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>J7W2D0|FEATURES|UNIPROT_deepARG|beta_lactam|IE7_03007|antibiotic inactivation|1
MIVLNKFFNILHYKKVVPVVFLSCATLLGCSDGNTQSELSKQTKQTNQTNQTKQETTGND
SFVKLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQR
VLYTREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLRE
VGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRN
TTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPTNKKPIVLAILSNHDKEDAKYDD
KLIAEATKIVLDALKVTNK
>A0A0B4S6D3|FEATURES|UNIPROT_deepARG|chloramphenicol|QR42_05840|antibiotic inactivation|1
MFKKIDGNYPRKEHFHHYMKVTRCSYSLVIDLDITKLHAISKEKKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADIEAY
SESNKLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDETYLLPIFTLGKFKVEEEKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCEEWLSDSLYT
>YP_001066170|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MKAMMKPRARRRGARAARRPNGPRAWPLAVAAALVAGCTLAPRYERPAAPVPAHYWSTAT
GAPREAGPAAAGGPRAMPDARRGDAGRDARDARLDDWRAYFTDPALRALIDAALANNRDL
RIATLRIQEARGLYGVARADRLPSIDGSLGYERTRLYDPVLRESATSSLYRASVGVSAFE
IDLFGRVKSLSDAALAEYFATAEAQRAARISLIAEVASAYVTERALVDQLGLAERTLAAR
DAAYALTQRRYAAGTSTAIELRTAEMLVASARASKAALEREHTQAASALKLLAGDFMTAL
PADAPALDALAVARVSPGLSSDLLEQRPDIRQAEQRLVAANANIGAARAAFFPRIALTTD
VGSVSDAFSGLFSAGSSVWTFAPRLTLPIFAGGRNRANLDVADARKHIAVAEYEKTIQTA
FREVADALAARDQIDAQLAAQQAVYGADAERLRLAQRRYDSGVASYLELLDAQRSTFESG
QELIRLKQLRLTNAITLYRALGGGWSRAGCGGDGCA
>A9KNK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKVIFLGIVEGITEWLPISSTGHLLLVDEFLKVNLSKDFMSMFNVVIQLGAILA
VVVLFFKKLWPFSKEEKNFIKKDTFTLWFKIVVACIPGIVMIPFDSKIEDLFFNPQTIAT
TLILYGILFIIIENRNAGKQPKVAKLSDITYQMAFMIGLFQILAMIPGTSRSGATIIGAM
LFGASRYVAAEFTFFLAIPTMFGASLLKLLKFGFTFTGAEIVALITGMLTAFIVSIIVIK
FLMGYIKKNNFKVFGWYRIVLGAIVAGYFLLAR
>A0A0C1E431|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGQIPSYRSIFPIPIPLHPEIQTGKRRLKTKKESNMDILTLLKALIMGIVEGLTEFLPIS
STGHLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIFEYRQRFTSVLSGLGKDRTANRFVLN
LAVAFVPAAVVGLLFSKQIKLYLFNPITVATMLVLGGFFILWVEKRQSTIKPKVKSVDEM
RPIDALVVGCAQICALVPGTSRSGSTIMGGMLWGIERKAATEFSFFLAVPMMIAATGYDV
LKHYKLFTLQDVGLIAVGFIAAFLAGLLAIKSLLKFVSSKNYVPFAYYRIVFGGLILLTW
AMGWVKWAA
>V7EB76|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEALLATAKKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVVIERTDTGLSLHAKLRDAATNLLRDALP
QLAQGKLTETAQDESKATYFGRRTAADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWNAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDNCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIDNAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>AAR37059|FEATURES|ARDB_deepARG|glycopeptide|VanHD|antibiotic target alteration|1
MNKKMDITVFGCESDEMEVFQKISYELGVTATLIKDSISESNAGLADGCCCVSVSHKAEL
SEPILLALKNAGVKYISTRSIGFNHIDIQAAGLLGMVVGTVEYSPGSVADYTVMLMLMLM
RGTKSILRETQRQNYCLNDLRGKELRDMTVGVLGTGRIGQAVMERLKGFGCKVLAYDRNQ
KAGTDYVSFHELLKKSDIVTLHIPLAEDTRHMIGCEELEMMKQEALLINTGRGALVDTAA
LVEALKGQKIGGAALDVLEGEEGIFYHDCTQRTIEHPFLSVLQGMPNVIVTPHTAYHTDR
VLVDTVSNTIRNCLNFERSLGNV
>A0A0L0JD58|FEATURES|UNIPROT_deepARG|aminoglycoside|IQ60_37615|antibiotic inactivation|1
MSDHCEPGAVSPVLLGVGGDWLPVTAGESGASVFRAADATRYAKCVPAADTAGLEAERDR
IAWLSGRGVPGPRFLDWYAGDAGACLVTAAVAGVPADQVRGEDLGASWGHIADAVRRLHE
VPVASCPFRRGLDSVVDVARDVVARGAVNPEFLPVEQQRVPPAELLARLTGEIPRRRDQA
AAGTVVCHGDLCLPNIILDPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RVADAEFAERYGMPLDQERLRFYLHLDPLTWG
>W7ZAL6|FEATURES|UNIPROT_deepARG|beta_lactam|JCM19045_414|antibiotic inactivation|1
MKRYVAFFALMVLGACSTPETAEQGKQQQNQEDDLTAPFSELEDQYDARLGVYALNTGNG
QTIAFNEDERFAYASTHKALAVGVMLQQLSIEDLDKQVTFSEAELVTYSPITEQHVETGM
SLREISDASIRYSDNTAANLVFNEINGPAGFKEALRAIGDDVTEPERMETELNDVNPGET
RDTSTPKALAESLYAFSFGDALDKEKQTLLNDWLIHNTTGDDVIRAGVPDDWVVGDKTGS
ASYGTRNDIGIIWPPNDEPIVIAVLSSKDEQDGKSDDALIAEATEAALRLLIDDFE
>A0A0W0MW01|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTYQKTLISALLLGCGYCAAATDMRQVVGSRVEPLMRQQGIAGLSVAVVNNGKVQYFN
YGVASRETQQPVTEDTLFEVGSLSKTFTATLGGYAQAIGKLTLSDKASQHLPALAGSAFD
SISLLQLATYTPGGLPLQFPATADSAATMLTYYQHWKPAYAPGTQRLYSNPSIGLFGYLA
AQSLGQPFNVLMEQTLLPKLGLSNTYLSVPANKAGHYAQGYDSQQKPVRVSPGALDSEAY
GIKTSTQDLARYVIANMHPETLEKPLQQAVATTHAGYYSVNGMTQGLGWERYPYPITLQA
LIDGNSTAMAMQPHTVTWLTPAQPQPADVLYNKTGSTSGFGAYVAYVPSKDMGVVILANK
NYPNAERVKVAHAILSAMAP
>J9BEQ4|FEATURES|UNIPROT_deepARG|beta_lactam|IEM_00124|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIEKLNEVITYTKDDLVEYSPVTEKHVDTGMALGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVVINTLR
>Q9RX61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLYSLIYGIVEGITEFLPISSTGHLILTGNLLHVPWPKEVKDTFEVVIQGGAILAVLV
YYWRDFLKIRHIGHDRGQQRLWLGVVLACIPAVILGVLFGDTIKAYLFRPSVVAWALIVG
GVLMWLLESRKATPDTHDIENISAGKALAIGAAQCLALLWPGFSRSASSILGGMLLGLDR
PTATKFSFYLGVPTLGGAALLDFIKSREILAQIGVVNVAIGAVTSFVVAYFAIGWLLRFV
STNNFKGFAVYRVVVGVLILVLIARGVLQNGSLA
>A0A0J0YD49|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLIGGLILLKVDQW
FNQPNATEASQEITYLQAFKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKDGFVLSHDQINLLIIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGIYRIIAGIILLAIHFFIHPLTII
>J3GC95|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHGKLRAAASDLLRDTLP
ALLQGKVSETAQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGLAPGRVISVDPLRIACGEDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>D7YA18|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9540_04473|antibiotic inactivation|1
PRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELG
IVMLANKNYPNPARVAAAWQILNALQ
>A0A0A0Q8K3|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-10|antibiotic inactivation|1
MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNP
SIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGSD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>K8BX95|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGETDVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLSDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAKIRPWRARR
GQARARELLARLGLEARVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPPVGKRDAGGLPAQP
QDAPAFGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPTVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRNKVVVIDSNARRQLFPNKANVVG
EVVLVGNMPATVIGVAGEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
SGEAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIALALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARNAARLNPVDALARE
>F5P3L3|FEATURES|UNIPROT_deepARG|beta_lactam|SFK227_5108|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAACQILNALQ
>A0A0F0DV39|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHRVSIVIPVYNEEASLPELLRRTTTACEQLGRDYEIVLIDDGSRDSSADLLQEA
AQAPGSHVVAVILNRNYGQHAAIMAGFEQCQGDLVITLDADLQNPPEEIPRLVAEAAKGY
DVVGSVRQQRQDSALRRWPSKLINLAVQRSTGVAMNDYGCMLRAYRSSIVKAMLACRERS
TFIPILANSFARHTSEILVAHAEREHGESKYDFLRLINLMFDLVTCMTTSPLRLLSFVGG
GMAVAGFAFALMLLVLRLLFGAAWAGHGVFVLFAVLFMFTGVQLVGMGLLGEYLGRMYND
VRARPRFFIERIVRAETPRAEITTSSPTFESIQP
>CAD11599|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHIGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>A0A0L0GVI8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGSVDVLKGITLSIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGTYRVAGTDVATLDGDALAKLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGTERKA
RRQRSLELLKRLGLDDRVDYQPSKLSGGQQQRVSIARALMNGGQVILADEPTGALDTHSG
DEVMAILHQLKEQGHTVIIVTHDPQVAAQAERIIEIRDGEIIANPPAKSAAQSQAVSPRQ
VNGSGWRQFTSGFREALSMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
ADIRAIGTNTIDIYPGKDFGDDDPQYQQSLKYDDLLAIQKQSWVSSATPAVSKSLRLRAG
NIDVAANAEGVGGQYFNVYGMTFSEGNTFNDIQLNGRAQVVVLDSNSRRQLFPNKARVVG
EVILVGNTPATVIGVADEKQSMFGSSKVLRVWLPYTTMSGRVVGQSWLNSITVRVKEGYD
SALAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAERTTHTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAVVLQLF
LPGWEIGFSPLALLTAFFCSTLTGVLFGWLPARNAARLDPVDALARE
>I0L9A2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTVEIREIPLVGPDTGPYGITVGPDGALWLTLVQAGGIARLGPDGEVRTYPLEPAGGRPL
IITTGPDGALWFTRSGDDRIGRLTVDGEQRTIALTAGTGPGGIAAGPDGALWYAGMTSDA
IGRVDTDGTVTTFPLPVTGGFASMITAGADDALWFTLNRANAIGRIDLDGHVKLHPLPTA
DAGPVGITLGADGTVWFVEIAAGQLGRIDPDGVLVEVPLPDRAARPHAIVADPAGGAWFT
EWGANRIGHIDATGRIESYDLPTAHAEPHGITKTPDGVWAALEIGAVAHLIPNPTA
>A0A0U2WJN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPAGTQRERMEGCRLSDIWIGIIMGIVEGLTEFLPVSSSGHMILTAHLLDFTGERAKTFE
IVVQFGAVLAVLVLYRRRFLSLLNFNLAKSKGLNALHVVMAMFPTFVAAVLFYSPIKTYL
FGPMTVVWALVAGGILMIVAEKANRRITAETLDDLTYRQAFGIGCFQILSLWPGFSRSGS
TISGGMLLGASKTAAAEFTFIVSVPIMFGASGYDLYKSWEYLDWADWPLFLTGLVASFLV
AMLAVVTFINLLKRISYTWFAVYRFLLAAVFFFVIL
>A0A127SDD2|FEATURES|UNIPROT_deepARG|beta_lactam|LCR-1|antibiotic inactivation|1
MHAEDAAIGQLFRNAGIDGTIVIESVNTGQRFVHNDPRSKQAYAAASTFKILNTLIALEE
EAISGADAIFHWDGTRYEIADWNQDQTLGSAFKASCVWCYQQLARRVGAPKYLPYIRQSN
YGQLRQPFNETEFWLDGSLTISAEQQLAFLRQVVERKLPFKASSYVTLKTIMLAEEAEQY
RLYAKTGWATRNPPSVGWYVGYVETRGDTWLFALNLATRDARDLPLRIQIAKDSLKIKGV
LLAK
>A0A0N2IPA7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTEFPVGKPEEALYGVASTPDGALWFTLAKGNAIGRLSPDGEVSRFPLPHADGQPTTITC
GPDGRPWFTLSSANAVGRLSPDGALRMFELPRPASRPFGIAAGHDGCLWFAEMAGDRIGR
ITIDGDIEEYDLPVKGGYPSCMAAGRDGLMWFTLNQAGAIGSISATAAPRIFPLGAADAA
PVGIASDAQGALWIAQAGNGAIARFDAGGRITEFPLHSRAARPHALAADAAGNLWFTEWG
ANRIGRISEAGDTAGYELAAPGSEPHGIAIDPHGCVWAALETGSLVRLQASPRD
>U1AFV5|FEATURES|UNIPROT_deepARG|aminoglycoside|O166_18240|antibiotic inactivation|1
MNVVPAASRPDAWLALRAALWPHCPLDRHQEEIDAQSADVRRCAAFVALDGRGDAVGLIE
LALRVDYVNGTSSSPVAFVEGLYVAPEHRRAGMAALLLAAAKNWAIRRGCAELASDTGLD
NLVSQQAHLGLGFEETERVVFYRMAL
>A0A0K6J3S3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB_3|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLRRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRADKPHMTFY
>A0A0J6KWS9|FEATURES|UNIPROT_deepARG|beta_lactam|VK90_19325|antibiotic inactivation|1
MKNKRILKIGICVGILGLSLTSLETITGGSLQVEAKEKTGQVKHKNHATYQEFSQLEKKF
DARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVINYTKDDLV
EYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMAD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRA
GVPTDWEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEV
IVNALR
>R8KC10|FEATURES|UNIPROT_deepARG|beta_lactam|ICS_04670|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKNPIVLAILSNHDKEDAEYDDILI
ADATKVVLNTLKATE
>A0A0G1TAA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENIYAIIYGVVEGITEFLPISSTGHLMLVTQLLGNDSSFIKSFEIIIQLGAILAIIALY
PKRLLADKQTILRVSAAFIPTALLGLLFYKIIKTYLLASVPLVLVTLFLGGVIIIWFEKF
WLNKKEVKREKTVNDLPIAHAAYLGLIQCIAFIPGVSRSAATIFGGMFFGLSRKEAVEFS
FFLAVPTMAAATGLDLIKNYQTFSVDDVSFLVIGFVTSFVVALLAVKWLTRFVASNDFTY
FGIYRMGIAILGYFLFFY
>A0A0Q4MZJ8|FEATURES|UNIPROT_deepARG|beta_lactam|ASF13_11450|antibiotic inactivation|1
MEDDTMLKKTLTTLLFTAFASAPLMAQVQTPLSQQQVAKIVNDTLSPLMAEQQIPGMSVA
VLVNGTPHYFNYGVANIKSGQPVTAGTLFELGSVSKTFTGVAGGVAVQRGEIRLDDPAAD
YAPQLSGHWRGITLLQLATYTAGGLPLQVPDAVTDQAALWHYYQQWQPQWPAGSMRNYSN
ASIGLFGQLAVQRSGLSFETYMNKYLFTPLKLNDTFITVPKAKEADYAWGYRDDKPVRVT
PGMLDQQAYGVKSTARDMARWMQANMDPLSLPAGDATLKKAIASAQTRYYRFGDMYQGLG
WETLDWPVDAKRLVADSANGVALQPKKAQALLPAQPPVAASLVNKTGSTNGFGSYIAFVP
QQKIGIVMLANKNFALPVRVEAALKILQALDREQSTAKEQQQSAAQQ
>A0A127AYN1|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-216|antibiotic inactivation|1
LSVFAHPETLVKVKDAEDQLGAPVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAV
LSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLL
>E4ZEV9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKNISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGSKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEILASKVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A127STN1|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDINSWTRHEYFEHYFTNIPCTYSMTVKLDITQIKKKQMKLYPAMLYYLATIVNR
HPEFRTAINQAGELGIYDEMIPSYTVFHKDTETFSNLWTEYMPNIEAFSRAYENDIQLYG
SNHGMTGRPDVPENVFTVSMIPWSTFESFNLNLQKGYSYLIPIFTLGKYYGEDGRIMLPL
AIQVHHAVCDGFHICRFVNELQELINS
>A0A0P1D0M7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGEGENRVHVLKNINLTIQKGDFVAIIGQSGSGKSTLMNILGLLDTPT
SGAYSIAGTETSKMSADELAAMRRKRFGFIFQRYNLLSSISARDNVALPSVYAGLDYAER
SERADSLLDKLGLKGKEKNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDSGSGE
NVMEIIHELYAEGHTIIMVTHDPKIAAQANRVIEIKDGEIISDSSKTTEIAPSNVKSIQE
KHGLAFYKDQFQEACTMSVQAIVAHKMRSLLTMLGIIIGIAAVVSVVALGKGSQEKILAD
INSMGTNTISIFPGKGFGDRNRSRIKTLTVADGQAIAKLSYVEATTPSTSTSGTLTYQNT
DLTASLYGSGEGYFDVRGLKLGTGRLFDASDVKDNAQVVVIDNNTAEKLFPAGTNPLGKT
ILFRKRPLTVIGVLQKEDNMMGGSDSLNLYSPYTTVMSQISGDKFISSLAVKVKDNVDSQ
VAEKSITELLLVRHGTEDFFMLNSDSIKQTIESTTGTMTMLISCIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARQSNILQQFLIEAILLCLIGGVSGVLISFGLAAVFNHFVT
DFAMSFSTASIVGAVVCSTAIGVVFGYMPAKNASKLNPIDALAHD
>CAD90667|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGVVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>E1SDH6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQAIPGMSVAVLYKGRAQFV
NLGVADLESRRRVTENTLFELGSVSKTFTGTLAGIMIRNGEIRLNDPVQKRWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDEVTDQASLLRFYQNWQPTAAPGLQRQYSNASIGLFGSL
MVKGDYEQAMERHVFQPLRLTRTYITVPPSMMLNYAWGYKNGQPVRVSPGMLDAEAYGIK
STARDMLTFMQANIDPNRLSAGNAVLRNAIRTAQSRYFKVGSLYQGLGWEIYDWPVDAET
LLSDNDNAVALKPRPATQVNPVGPSQSASWVHKTGATNGFGAYIAFIPEQNSGIVLLANK
NYPNPLRIRVAWQILQALQQGTPE
>A0A0B5E3B9|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
DMQTVADSRVSYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRR
IHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHN
MGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>ABD46539|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0X7JDW7|FEATURES|UNIPROT_deepARG|beta_lactam|ADL21_29550|antibiotic inactivation|1
MRKPTTSLTRRSVLGVGLGLGGALALGSTTASAASAGAVTSGTTRPGTTSSGNLAAVRRL
RALEREHQARVGVFALNLATGATLLHRAHELFPICSVFKTLAAAAVLRDLDHDGTQLSRV
IHYTGADVTKSGHAPVTKDHIDTGMTIRALCDATIRYSDNCAGNLLLRELGGPTAITRFC
RSLGDPVTRLDRWEPELNSAEPDRRTDTTAPYAIARTYQRLVLGNALDRPDRALLTDWLL
RNTTSVERFRKGLPKDWKVADKSGGGSTYGTSNDVAIAWTPDGAPIVLALFTHKPTQPTA
SGDTPLVIEAATVMSEAVTTA
>E6XMB4|FEATURES|UNIPROT_deepARG|beta_lactam|Sput200_3270|antibiotic inactivation|1
MRLFVISAVLVMSSISASPVFAASSPQKEWQETRSWDASFTQHQAKGVVVLWNENKQQGF
TNNIKRANQGFLPASTFKIPNSLIALDLGMVKDEHQVFKWDGKNRDIAAWNRDHNLISAM
KYSVVPIYQEFARQIGDARMGKMIAVFDYGNEDISGNLDSFWLDGGIRISAKEQIDFLRR
LYHNKLHVSERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWVELDDNVWFF
AMNMDMPSADGLALRQAITKEVLRQEKIIP
>YP_001477378|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSETALPQAKGSAVKGTAFSILGAISVSHLLNDMIQSLILAIYPILQADFSLSFVQI
GMITLTYQLTASLLQPLIGYYTDKHPQPYSLPIGMGFTLCGLLLLSVANTFPLVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGLAQSLFQVGGNFGSSLGPLLAALIIAPYGKGNVAW
FSLAALLAIVVLLQVSKWYQQQHRATKGQPKTASLVKPLPKRTVTYAIGILLVLIFSKYF
YLASISSYYTFYLMHKFGVSVQNAQFHLFAFLFAVAAGTIIGGPLGDKIGRKRVIWGSIL
GAAPFTLILPYASLYWTGILTVFIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGLGAAVLGYVADLTSIELVYQICAFLPLIGIITALLPNMEHNSQ
>A0A0E0VMU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSNESGYIMFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTF
KIVIQLGSVFAAAWVFRERFLEILHIGKHKHVEGDNNQQRRSKPRRLNLLHVLVGMVPAG
ILGLLFDDFIEEHLFSVPTVMIGLFVGAIYMIIADKYSVKVKNPQTVDQINYFQAFVIGI
SQAVAMWPGFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIA
DIPFYILGFLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIILVIFIAILYFGFGIGKGI
>A0A085U7Z0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSQPEMIKKVSIVIPVYNEQESLPTLLERTKAACQKLSQPYEIIMVDDGSSDNSAAMLTA
AAEQPGSAVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPHLVSVAEEG
YDVVGTVRANRQDSLFRKTASKLINMMIQKATGKSMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMNLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLSVLLVALRLIFGPEWAGGGVFTLFALLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGSKPADTTQEKE
>Q2FC58|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVSYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
FK
>A0A158C250|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIASVVTGLPSRPDARRFTVNVIIATIPAIVLGLLLEKHIKAVLFSPVPVSVALI
VGGIVILWAESRQRERGAMTRVHSVDDLSYADALKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVSDFGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A0H5AEX4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLHVQKILISAVLLGSGTCMAATDLRTLVDSRVAPLMQQQNIPGLSVAVVDKGQVHYFN
YGVAAKDTQQPVTEDTLFEIGSVSKTFNATLGGYAQAIGKLKLSDKASAHLASLRGSAFD
SISLLQLATYTPGGLPLQFPDAADSAEAMLGYFQHWKPKYAPGEQRLYSNPSIGLFGYIA
AQSLGQPFNDAMEKTLLPKLGLKNTYVSVPTDKAGLYAQGYDKDQKPVRVSPGALDSEAY
GVKTSAQDLARYVIANMHPDTLEKPLQQAIATTHTGYYTVNGMTQGLGWESYPYPITLQA
LLDGNSTPMAMQPHKVNWLKPAQTHRTQVLFNKTGSTAGFGAYVAYVPAKDIGVVILANK
NYPNAERVKVAHAILSAMDN
>D2TQT6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ROD_35091|antibiotic efflux|1
MTPVIVLRQVCRTFTAGTQQIAVLRDISLTLHAGEMVAIVGASGSGKSTLMNIIGCLDKP
TSGEVLINGTPVHEADELHLADLRSRYLGFIFQRYHLMPYLTAEENIAIPALYTAMPEAE
RKARTQRLARQLGLENRLSHRPAQLSGGQQQRVSICRALINGAHIILADEPTGALDSVSG
KALMDVLHQLHAAGHTVIIVTHDRDVARQAQRIIEISDGRIISDVRHTAVRRSVALPEQD
NGRASLGRSLHESVRMAWRSLLGHRMRAFLSMLGIIIGIASVVSSMAVGEGARQAIMSEI
GKLGSTTLEIRPGTGWGSKRPDMERALSLDDVRSLQALPWITGVSPVVSSTSLAVRKGLD
SSVMLSGVSQDYFALQGLRFVQGNGFTARDVAEGEPVLILDETGRDTLFPGGEDPLDGIV
QIAGAPWRVSGIATRPGPKVVGGFMAAWVPHTALQQRLTGEKPLESLIARFQPSLEPHQA
AQRAERHLLREHGRKDFFIQTDDQLANALQKTSDSMSLLITAIAAISLLVGGVGVMNIML
VSVTERTHEIGIRLSVGARPSDIMNQFLIEAVMICALGGLLGVLGSWVAGQLFAFITDAF
SMVFTVTPLLMACGFSALIGLTFGYFPARRAARLNPTEALARE
>C6S8Q2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIDFHSNHKVFEITIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIVDVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLR
FVSKKNYIPFACYRIVFGIAIIILWLSGWISWE
>A0A0H2LXF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDDKAKVFDIAIQTGAIFAVI
LVYWQKIHSTVVALPRQPKARRLAINVVLGFIPAVVLGLVFGKMIKAHLFTPVVVASTFI
IGGFIILWAEKRPPGSVRIEHVDDMTMWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGAYSLYKERALLSVADIPLFSVGLVFSFISAWLCVRWLLK
YISTHDFIPFAWYRIAFGIVVLATAWTGTVVWAE
>NP_783299|FEATURES|ARDB_deepARG|qa_compound|Qac|antibiotic efflux|0
MPYLYLVIAIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYA
TWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH
>A0A117DR71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHAELVLKTLMMGVVEGITEFLPVSSTGHLILAGNALSFLAKEKRDVFEVFIQFGAMLAV
IWEYRARLASVVVSAHADQGSRRFLVNLAIAFMPAAVLGLLIGSHVQRLLFSPGPVAVAL
VVGGIAILWAERRPVQVKAERAEQISRIDALKIGFVQCLALWPGTSRSGATIIGGLWFGA
SRQAATEFSFFLGIPILGAASVYNLFKHWGALSSDDIGVFAMGFIASFAFALLAIRLLMR
YLTGHGFGVFAWYRIALGTLILVAVAT
>A0A0T9NU73|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MTALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNK
RRERANMLLTRLGLGDRVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTAPGIAASDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTALKAQSYVNAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILIGNMPATIVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YNSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLKTAEQTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A154UCB1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGNGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMDSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSSGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESYTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
DFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>V8MKY4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANIV
GEVVLVGNMPVIVIGMAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>R8U618|FEATURES|UNIPROT_deepARG|beta_lactam|KQ3_05130|antibiotic inactivation|1
MFILSKFFNITHYKKIVPVVLLSCVTLIGCSNSNTPSESPKQTKQTNPIKQENTGNDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDERITY
KREDLSNYNPITEKHLDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNK
>Q65GV9|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MNFQTIELDTWYRKSYFDHYMKEAKCSFSITANVNVTNLLAVLKKKKLKLYPAFIYIVSR
VIHSRPEFRTTFDDKGQLGYWEQMHPCYAIFHQDDQTFSALWTEYSDDFSQFYHQYLLDA
ERFGDKRGLWAKPDIPPNTFSVSSIPWVRFSNFNLNLDNSEHLLPIITNGKYFSEGRETF
LPVSLQVHHAVCDGYHAGAFINELERLAADCEEWLV
>YP_001026319|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRAWGAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>F5Y4E4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGALLGFHDAKAKVFEIAIQTGAILAVI
IVYWQKIRGTLAALPTERQARQFAANVAIGFLPAVLLGLAFGKAIQAHLFTPAVVATTFI
LGGFVILWAERRPQDAVRIHDADQMRWQDALKVGLVQCFAMIPGTSRSGATIIGGMLLGL
SRKAATDFSFYLAIPTLVGAGVYSLYRQRALLSAADIPMFGVGLLFSFLSAWLCVRWLLR
YISSNSFTPFAWYRIAFGILVLLTSWAGWVDWSA
>A0A0S3AHM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFILLLKALILGVVEGLTEFLPISSTGHLILFGDLLDFNDEKSKVFTIAIQLGAILAVC
WEYRKKITGIVMGIGSDASANRFVLNLFIAFMPAAVMGLLFIDVIKQYLFNPLSVATALV
IGGVVILWAERRDHVIDVEQVDDMDWKHALKVGMAQCLALIPGTSRSGATIIGGLLFGLS
RKAAAEFSFFLAIPIMFAATFYDVYKNRAILELSDVSMFAVGFMGAFFSALVAIRALIRF
ISNHDFTIFAWYRIVFGIVILVTAYTGVIGWSEM
>A0A0B1PWI8|FEATURES|UNIPROT_deepARG|aminoglycoside|PZ78_10490|antibiotic inactivation|1
MAIPTIPSEAQQAQQVAKKVLGESIVGIYLFGSAVVGGLKPDSDVDILISVAQPLCREQR
KALAAQLMSVSGAIGNIHGIRPLELTAIMVSGDAPWPFPPQAEFVYGEWMREQFEAGSVP
APARDPDLVIVLKKVREHGLALHGPNAAEVIPSIPIDDIRVAIQHALPTLLAESQGDERN
VILTLARMWLTASTGTIEPKDAAAEWAEKRAPSRYAAQLKYAREGYLGVVDDQWLDRQEE
FDALVRYMERAITLSLS
>A0A060KTR7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYGDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A066UCK4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MATPILSLKNIKKSFAFGDDSLEVLKGIDLDIYRGEMVAIVGQSGSGKSTLMNIMACLDT
PTSGEYRIDGLCTQDMNGEQLASLRRDKFGFIFQRYQLLSSLNATANVAMPAIYAGVSQK
TREQKAQALLAKLGLEQRLDHYPNQLSGGQQQRVSIARALMNGGQIIFADEPTGALDSQS
SRDVMAILTELNREGHTIILVTHDPKIAQSASRIITIADGQIISDDNNSNDTVNTTQDFQ
QNTHRTLNFQAIGRIKEAFHMAVLTMLASKMRTLLTMLGIIIGIASVVLIVALGNGSKQQ
ILNQINSMGSSTISVFMGGDNEDDTTPPNDLTFDDMYALETLPSVASTSPDLSMSMTAQL
GNHSKGVQVDGVGLNHHRLQNVQFVAGGMFRQSDLDNFSQNVIISEKTKQNFFKQNNALG
QILILNGVPTKVVGVFKYNGIEGNFDRNLKVWLPYRTYQARFAGESPRLNSITVLLKPNE
SSALASESINQLLTQRHGKKDFTLFNSDSLAKTVEKTAQSLTLLIGAIAVISLLVGGIGV
MNIMLVSVTERTGEIGVRMAVGATYGDIVWQFLIEAMVVCALGGVLGVLLAFGLGGLLQL
FDIKVIFSATSIALAVGCASLIGLVFGLMPAHKGAKLNPIEALNKG
>YP_001487997|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MVDLFKRSELKGKKIMNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKEIIT
PEAANTFKVVIQLGSILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPA
VILGFLFEDYIDKYLFDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIG
LFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFTFIMAMPIMAGASFLTLVKNAEYLTT
DMLPFFIVGFVSAFVVALFVVRFFLKLINKIKLVPFAIYRIILGVILFILFM
>CAS07946|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQAAYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A0A0W1IBR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASKWAIFNIAIQPGAILAIVVL
YRKLFWDMFVGFFRRDPVAIAFVRNLLVAFIPAVVLGLAFGDYIETLLENAVVVAWALVI
GGFAILLVEKLAKPKESGGVAKLTLRQSIMVGLVQCLAMIPGVSRSGATIMGAMAMGVDR
KTAAEFSFFLALPTLTGATVLQLAKHRDAITSNDMGLIALGAAVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIVGGAALIWLTMR
>K8B6D2|FEATURES|UNIPROT_deepARG|beta_lactam|BN132_459|antibiotic inactivation|1
MKRKVSVLLMMIVLGSAAQAAPVSRPDAVVNPLMAHYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDEKTLFEIGSLSKTFTATLASAAQQEGKLDFSAPASRYLPALSGSAFDRVTL
RNLATHTSGMPLFVPDDVKNTAQLMAWYRAWQPAQPVGTERVYSNLGIGMLGMITAKALD
KPFSEAMEQGLLADFGMTHTFINVPEAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSS
SADLLRYLQIQLGERDVAPRWRQAINATHNGYYRTGEFTQGMMWEYYPWPSPLSRLVEGN
SSQRIMKGLTATAIVPPEPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYDIIQELDK
>A0A077QC52|FEATURES|UNIPROT_deepARG|beta_lactam|XBI1_1260030|antibiotic inactivation|1
MLFSSLRLTRIAATIFPLLGVLITFPIHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSTITYRAHERFPLCSTSKMMTVSALLKKSETDEGLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLADLSAATIQYSDNAAMNLLIDQLGGTHDVTRFARSIGDNAFRLDRKEPELNMVTP
GDERDTTTPQAMANSLYKLALGNTLAATQRTQLVEWLKGNTTGGASIRAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPLILVTYFTQPNDKDAEAHPDVLAAAARIMTQER
>A0A0T9TXX6|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_2|antibiotic target alteration|0
MLIGWLMHSQRLWGHTVSQNEAIKKVSIVIPVYNEQESLPALIARTSAACQQLTQPYEII
MVDDGSNDSSGDILTAAANEPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQ
NPPEEIPRLVTVAEEGYDVVGTVRSNRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLR
AYRRHIVEAMLHCHERSTFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDL
ITCLTTTPLRLLSLVGSVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQ
FVGMGLLGEYIGRIYNDVRARPRYFIQKVVGGEQTENNQEVEK
>Z4WZ68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILESIILAIVEGLTEFLPVSSTGHMILTEGILGMESTAYLKAFTVMIQFGAILSVVIF
YFRRFLPFPILGFHPDETTSLGGWRLYALMIVGCIPAAVLGGLLNDQIDALLGNTWVVLA
MLSLGGILMIYFDRIFGAKGEKRVTVTNAFIIGLFQCLAMIPGVSRSMATIFGGMQQGLT
RRQAAEFSFFLAVPTMFGATLLKGYKLYKELGMQVFQENWQTLLIGNVVAFLVALLAIKF
FIDFVTRYGFRAFGYYRILLSVGVAIVLLLGANISLS
>YP_849917|FEATURES|ARDB_deepARG|fosfomycin|FosX|antibiotic inactivation|1
MISGLSHITLIVRDLNKTTTFLQEIFDAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGE
SLQERTYNHIAFRIHAEEMDEYTERIKSLDVEIKPERSRVTGEGRSIYFYDYDNHLFELH
AGTLEERLKSYHG
>Q57TH0|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGSKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>A0A0J1NFA5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPPQNPSGGRDISEST
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQP
>A0A033UW15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFILELIKAIILGIVEGLTEFAPVSSTGHQILVDDMWLKSKAFLGSESAFTFKVVIQLGS
ILAAAWIFRNRYFEMLHIKQNEQQKRKLKLSHIIVGLVPAGILGLLFDDFIEEHLFSVPT
VLIGLLLGAIYMIGADMYSKRVTNPHKVDDMNYPKAFVIGLSQAIALWPGFSRSGSTIST
GVFLKLDHKAASDFTFIMAVPIMFAASAKALLGNLQFITLDQIPFYIVGFIASFIFGLIS
IKLFLKLINRVKLIPFAIYRIILVIIIAIAYFGFGIGQNIG
>A0A105C5F1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITAISMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLPMALNAMPVEEIKPPQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>A0A127SPX9|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_okp|antibiotic inactivation|1
RAGERFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVG
ELCAAAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDT
TTPEAMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNR
GSRGIIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>A0A0U1YUX5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAAAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0Q9M6I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHTIFEAIIIGIVEGLTEFLPVSSTGHMILAQSLLNTQNDEVMKTFDFVIQLGAIMAVVI
IYWKRILSLFGLVNRKSESKTGKKLNLIHILIGIIPAGVIGVLFNDVVDEKLFNTTTVLI
GLVLGGILLIIAEKKKEQPKTTVLDDLTYRQAFAIGLWQLISIWPGFSRSGSTIAGGMLS
GVSRAASADFTFIMAIPIMFGASGVYFLKNYEALSSDDLAFFVVGFLVAFVVALLAVVSF
IKFVQKMKLTYFAYYRFAIAIIFALYMFLK
>A0A0Q9D914|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIHATLVALPTQRQAQRLVLNVVIGFLPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAERRSPAATRIQSVDDMTPLDALKVGLVQCLAMVPGTSRSGSTIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSVADLPMFVTGLVFSFLSAWLCVRWLLR
YISTHSFVPFAYYRIVFGIVVLVTAWTGWVHWAD
>A0A060KQ24|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>AAY52002|FEATURES|ARDB_deepARG|glycopeptide|vanRA|antibiotic target alteration|0
MSDKILVVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKTDLDLAILDIMLPGAS
GLAICQKIRDKHTYPIIMLTAKDTEVDKITGLTIGADDYITKSFRPLELIARVKAQLRRY
KKYSGVAEQNENVIVHSGLVININTHECFLNEKQLSLTPTEFSILRILCENKGNVVSSEQ
LFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK
>B2VGE1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKKSLNTLLLGTAFAAAPWLHAAAAPMTQQQITQLVDNTIKPLLEKRQIPGMAVAVLYH
GQPQFFNYGVAETEHQRAVTQDTLFELGSVSKTFTGVAGGVAVQSGLINLNDTVAQHSPE
LKGEQWQKITLLNLATYTAGGLPLQLPDAVTDPAGLWRYYQGWQPQWPAGTMRNYSNASI
GLFGALAVKNSGLNYADYLKKSVLQPLKLTQTFITVPPSAQANYAWGYQDGKPVRVTPGM
LDAEAYGVKSGTGDMMKFMQANINPAGLSPENKVLAKGITRAQSRYYRIGNMYQGLGWEM
VDWPIVPAEVIAGSGNEMALQARPASALKAPQSAVASSWVQKTGSTNGFGAYIAFIPEKQ
LGIVMLANKNYPNPDRIAAAWQILKVLADRP
>ZP_03982909|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MAVFLWRRQIMTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIF
AIAQLITSPIAGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAAL
LMPSVTAFVADMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAYLGIRAPFFAAAFLAF
IGFILTLTVLKEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSI
MATINFGFTTSEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIA
FTKNNLVVVFSTFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAA
GALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM
>AAG14406|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQMVADYVDRVRREFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
KEGLAKLLLTYETAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAA
E
>X6DVK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTFVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGGVGLVALMIWG
>A0A0K3EAG7|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRATGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>Q9KIU8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKGVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>E0XD05|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
STSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSD
NTANNKIINEIGGIKKIKKRLKNLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLN
KLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKS
>ZP_04174725|FEATURES|ARDB_deepARG|beta_lactam|BL2a_III|antibiotic inactivation|1
MEQTCYLESLLCVRIKTGVQIGYSVLNLPLVFSIKSLKGMMILKNKRILKIGICVGILGL
SLTSLEAFTGGTLQVEAKEKTGQVKHKNHATYQEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAYASTYKALAAGVLLQQNSIDKLNEVITYTKEDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVVINALR
>S4Y532|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGIFRRDPDSLRLALALAFAFFPAALVGLLFHKAIKAHLFGPGPVAVALIAG
GFLMIGVESARRRRPDQGAPRVEDVTLQRALAIGVAQCFSLWPGASRSMATIVGGQLSGL
STAAAAEFSFLLAIPTLGAATVFDLAKNGRALLDAPGGAAALAVGLAVSFAVALLVIAVF
LRYLKRYGLAPFGWYRIALGAVVLWLWLASRTAPVDAGAAAEPAPGGDVAASAGALARAG
DHPSRP
>R6G6P2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIEMLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVPKDFMEMFLVVIQLGAILAV
CVIYFHKLNPFSPKKSAKEKRETVDIWGKVIVGCLPAAVIGLAFNDKIDALFYNAPTVAF
TLILYGILFIIVENYNKHREPQVGELSDLTYKIAVIIGCFQVLALIPGTSRSGATIIGAM
ILGTSRFVAAEYSFFLSIPVMFGASFLKLVKYGFHYTGMEVAILVVGMLVAFIVSIIAIK
FLLGYIKKNDFKAFGVYRIVLGIVVAAYFLFVK
>AAR22397|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYTDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A127SMK8|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
KKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQ
MPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSI
ASFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTET
GANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETD
EDNANIIARISRMVYDAMR
>A0A0A3IEC4|FEATURES|UNIPROT_deepARG|chloramphenicol|CD31_17265|antibiotic inactivation|1
MRFNKIDINNWERKEIFNHFLNQQTSFSITRTIDITELYKITKDKGYKFYPVLIFLITHV
ANSHKHFRMNFNSAGEFGYWDKVVPMYTIFDKQSELFSAIYTNTDEGFKKFYENYISDTE
KFNGKGKLFPKTPIPENVVNISMIPWTSFTGFNLNVNNSPNYCLPIITAGRFINKTSNIY
LPLSLQVHHSVCDGYHAALFMDRFQTLVENKLEFLV
>A0A0W1CP95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAVFNIAIQPGAILAIVVL
YRKLFWEMFTGFFRRDRQAIAFVRNLLLAFFPAVVLGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTVDVGGVANVSARQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITTNDLGLIAVGSLVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIAGAAALIWLGMR
>A0A0Q0C3S9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGCGGGLNMNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGE
LVAIIGASGSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRY
HLLPHLDAVRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSI
ARALMNGGQVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIE
VSDGEIISDRRTAQTTQPAPEAQPATPPGPAPRRLLASLGLFREAFNMAWIALISHRMRT
LLTMLGIIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLL
PSDVAALNQLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSD
QDARRQAQVVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNL
WMPYETAAGRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQ
TVQKTSRSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQF
LVEAVMVCLMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVP
ARNAARLDPIEALARD
>A0A0M1X7D8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTVEKKDTWTLWFKVIVACIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGS
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>A7H1R9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGNLYALILGIIEGLTEFLPVSSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLSVGFFPTGVIGFFVAKYLNALFNGWVVVGMLIFGGVMFILIEFAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLSNANSLIPLGIGFITAFVVAVLVIKFFLKFISKFDFIPFG
IYRIILGFVFFYLYYSGILNAGSEFKL
>A0A0D5XZI6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSQKAVVFAYHDIGCAGIEALLNAGYDIAAVFTHADDPKENTFYGSVAQLCSLKGIPVHA
PEDANHPLWVERIAKLNPDFIFSFYYRNLLSEALLATAGKGAFNLHGSLLPSYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQQRVAIERSDTALSLHGKLRDAAASLLRDTLP
ALAQGKVNETAQDESKASYFGRRTAADGKLQWSQPAERLFNLVRAVTKPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GSKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGAQKRCFT
DIADGIEALARIVDNENDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPSIEMKETIGNTLDFFLREAMLEIA
DKR
>A0A0F7LQY7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILIDDGSSDKSAEILIQA
AEQPENNIIAILLNRNYGQHSAIMAGFNQVNGDLVITLDADLQNPPEEIPRLVKTAEQGY
DVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYNFMKLINLMYDLLTCLTTAPLRLLSVVGS
VIAVSGFLLAVLLMTLRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGNKKTNDNSENQEEY
>G9YYC7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0880_00216|antibiotic inactivation|1
MQKMLNGVLALAALSLSTAGIAAPKTLTAEQIAQAVNRTIVPLLKEQAIPGMAVAVIYQG
QPYYFTWGKADVQNNRPVTTQTLFELGSVSKTFTGVLGGDAVARGEIKLSDKANQYWPEL
NARQWQGITMLDLATYTAGGLPLQVPDNVTDNASLLEFYQQWQPKWAPGTTRLYANSSIG
LFGALAVKPSGLGFEEAMNQRVLQPLNLKHTWITVPASEEKNYAWGYRDGQPVHVSPGML
DAESYGVKSSVTDMAAWLQANMAPQHASSPTLKKGLEMAQARYWRIGSMYQGLGWEMLNW
PVNGAAMAKDGDGAVALAPHPAAAVEPPVPAVAASWVHKTGSTGGFGAYVAFIPEQQLGI
VMLANKSYPNPARIQAGYTILKALQ
>A0A0T9UWY8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_7|antibiotic efflux|1
MTALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKITQDVVSSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITHEQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPLALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>Q9LAR8|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-20|antibiotic inactivation|1
LLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>A0A0G4D9U2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLIQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGIVA
GAILMIFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>S0F3D2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA26|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAVKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A0U0PYT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLIQKEKKFNAFHIFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0H4LBP8|FEATURES|UNIPROT_deepARG|chloramphenicol|ABB44_06020|antibiotic inactivation|1
MEFTKIDLDTWTRKEVFNHFIEQKTTYNMTSNVSITKAVKFAKDNNYDFYPLFIYSIVRV
INSNYLYRMDFNEQGELGYYDSSVPFYSIFDSRTELSSHIDTPDAYTFAEFDRDYLSDVK
KYRGTGKLFPKQPVPKNVVNISMIPWVNYTGFNLNSSNKDNYLLPTVTAGRFERTGDEIK
LPVTFQIHHAVCDGYHASQFFIKLQDILNNVDEL
>D7PIK2|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-1|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKQSDLVNYNPITEKHLN
DGMTIGELAAAALQYSDNAAMNKLIEHLGGPHKVTDYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKS
>Q1I990|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTRHLCLTATLALVSLPTLADSLQSTVDGVIQPLMREQGIAGMAVALYVNGESHYFNY
GYANKQEKQAVTRDTLFEVGSVSKTYTATLAALAGAEGKLDLAAPASRYQPALAGTPIGS
ASVLELGAYSGDCLPLQFPDEVQTDEQVLAFYQHWQRRFEHGTMRCYSNPSLGLFGNLAA
RAQQRPFAEVMTQDVLPRLGLHHTYLEVPANARGLYAQGYDAADKPVRVGPGPFADEAYG
IKTSASDMLRYVQLQVRPNELDPALRKAIAITHAGYFQVGAMTQGLGWERYPYPVALDTL
LAGNGANMIREPQATKALVPSLPAEPAAWYNKTGATNGFGAYIAFVPSKQMGIVLLANRN
YPNEERVRAAQRILASLER
>A0A0R2YF96|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRNLQTLLVSALLLGSGSCMAAADIRQVVDSNVKALMQQQAIPGLSVAVVNQGKVQYFN
YGVAAKDTQAPVTEDTLFEIGSVSKTFTATLGGYAQAIGKLKLSDMASQHLPALAGSAFD
YISLLQLATYTPGGLPLQFPKKADSANTMLGYFQHWKPTYAPGEQRLYSNPSIGLFGYLA
AQSLGQPFNLAMEETLLPKLGLHNTYISVRTDKAGLYAQGYDKQQNPVRVSPGALDSEAY
GIKTSSQDLARYVIANMHPQTLEHPLQQAIAATHAGYYTVNGMTQGLGWERYPYPITLKA
LIDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANR
NYPNAERVKVAHAILSALGQ
>A0A0L0TNN7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILFCKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTNAQAKTFDVVIQFGAILAIV
WEYWRKIGSVVAGLPKQAKARRFALNVIIATIPAVVLGLLFEKHIKAVLFAPVPVSVALI
VGGIVILWAEARHRERNIAPRVTSVDDLSYADALKVGLAQFFALIPGTSRSGATIIGGML
LGLERKVATEFSFFLAIPIIFGATLYELAKEWRTLSVDSLSLFIVGPVAAFVSAFVCIRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWTD
>ZP_04606269|FEATURES|ARDB_deepARG|thiostrepton|tsnr|antibiotic target alteration|0
MPSLDVITERSDPAVQRIIDVTKHSRSVVRTVLIEDAEPLVEGIRAGLEFIEVYGVETSP
LPGEVLAACQQRDIPVRLVGSPIMNDLFKTDKKPKAFGIARVPRPWSFDELARTTGDIIV
LDGVKIVGNIGAIVRTSFALGAAGIVLVDSDLATIADRRLVRASRGYVFSLPIVLASRAD
AIAHFRRTGIPLVAFDTEGDLAVSELRDADEQLALLLGSEKTGTSRSFESIASHSVSIPI
NPAAESLNVSVCAGIALYERRHWNLADRRSPHAPRADRPAAGRGTGRPTRSAYPGRRSR
>A0A0K1HEZ0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MLKLENINKNFNLGKNKVQVLNDINLEIKKGEFVAIIGQSGSGKSTLMNIIGCLDTQSSG
KYYIDDKDISKFLSDEKASLRRKKFGFVFQRYNLISNLTALENVCLPGIYEGLDDRKTKG
LNLLDKLDIKEKAYSRPNQLSGGQQQRVSIARALINGGEVILADEPTGALDSKSGIMVME
ILSNLHKNGHTIILVTHDKNVANYANRVIEIKDGKIINDETKKNEKFTIQNLDKNKNKSS
FGYKFLEALKMAISSIFSHKLRSFLTMLGIIIGIASVICVVALGEGSQEKILSSIRAIGT
NTINIYPGKNFGDLRAGKVKSLSVDDSRILGMQNYLDYSTPNTSTSGVITYKNLSLNANL
RGGGVNSLAVNGIEIQTGRSFELSDIANSNSVVIIDQNTKNSFFKDENPLGKNIFFNQKP
LKIIGIAKEDENAFGGSDNLRLYAPFSTVINKITGDRHIHSITVKVKDDINAQLAEEAIV
SILTQKHGKKDFFTRNSDTIKKTVESTMATMRLLISSIALISLIVGGIGVMNIMLVSVSE
RTKEIGIRMAIGAKESDILIQFLIEAIILCIIGGIIGLFTAYSFGYLFNSLSGNFYMKFS
TMPAIIALMSSCLVGTIFGYLPAKNASKLNPIDALLQE
>A0A0A0Q7Y7|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDHPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AAP22012|FEATURES|ARDB_deepARG|chloramphenicol|cmx|antibiotic efflux|1
MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAA
FARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANTGFLAVALSTATTLV
PANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTN
NVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEA
WVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLV
LVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLA
PVWVASVLTAIALVIMLLTRRALTKTAAEAN
>A0A060KQ96|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASATKIVTDGL
>A0A157ZS06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPARSDARRFTLNVIIATIPAIVLGLLFEKHIKSVLFSPVPVSVALI
VGGIVILWAEARQRERGALTRVHSVDDLSYGDALKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVSDIGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>YP_415787|FEATURES|ARDB_deepARG|multidrug|mepA|antibiotic efflux|0
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
VFAILMGLGNLFDVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVALPFSDQ
IAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVSLNI
ILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEI
FKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMSNKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQAIVEMATFILK
VTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGVVIIPVLFIMNALFGLTGVMWSLL
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>F7XFR6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSRPFASSGCCAPGTRRSSGASGLTDGRIPPCGRDPHEHEVWTPVMTHFSATKFVMAAAA
LLCCGAGAHAADRGEEGELARLVDETIRPLMREHGVPGMAIAVTVRGKKYIFNYGLASRE
SGQKVTDETMFEIGSVSKTFTAMLASYAEARGDLALSDPAGKYLPALAGTRFDDISLLNL
GTYTAGGLPLQFPDSVTDQESMIDYYRDWRPTYAAGTHRLYSNPSIGLFGYLAAKSMGEP
FADLMEKSIFPAFGLTSTFIAVPQDRADDYAYGYSKAGKPIRVTRGVLDSEAYGVKTTAA
DLIRFVEANIDGTGLDEPIRRAIAATHTGYFKVGAMTQGLGWEMYPYPTKLDDLLAGNSS
RMALEPHKVSKLVPPAAPQENLWINKTGSTNGFGAYAAFVPAERIGIVMLANRNYPIPAR
VKAAYQILSTLESGPGSADAR
>YP_001402028|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGALAIMKLPVAQYPTIAPPAITIAANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMQQEDIADYVGSNIKDPISRTPGVGDVQLFGS
QYAMRIWMDPHKLNNYKLTPVDVINAIKIQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQILLKVNTDGSQVRLKDVAIVKLGAESYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPSGLTVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIALVLSAVFVPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIKKGDHGPKTGFFGWFNNMFEKSTHHYTDSVANILRSTGRY
LVIYLAIVIGMAVLFMRLPSSFLPEEDQGVFLTMVQLPAGATQERTQKVLNQVTDYYLDK
EKNVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERKGEQNKVPAIVSRASAAFSKIKDG
MVFAFNLPAIVELGTATGFDFQLIDQGNLGHQQLTDARNQLLGMAAQHPDMLVGVRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPDDIDKWYVRNNMGQMVSFATFSTAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELAAKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATLRGLENDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLESVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPLFFVVVRRRFSRKTDDIEHSHPVNTPVK
>I3V367|FEATURES|UNIPROT_deepARG|beta_lactam|YSA_09980|antibiotic inactivation|1
MLRPRLATLAAAITFALGHASAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLEAPAKRYHPALAGVP
IGDATVLELGAYSADCLPLQFPDTVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLTKMGLKNTYLQVPASAQGLYAQGYDADDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPQGLPPALVKATAITQQGYFQVGAMTQGLGWERYPYPVTL
STLIDGNSPRLIREPQATTRLQPALPALPAAWYNKTGATNGFGAYAAFVPAEQLAVVLLA
NRNYPNQARVQAAFDILSGL
>A0A0D6PLG0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTRASEPLLRLQDISRIYHTGDVEVQALSRVSLTIEKGEFVAIMGASGSGKSTLMAILGC
LDQPSSGQYWFEGVDVAVLPEPALASIRSQRLGFVFQSFNLLARTSAAENVALPLYYTSE
GPVSGPARRQRALEALANLGLTGRENNTPGQLSGGQQQRVAIARALINAPDLLLADEPTG
NLDTRTSHEIMDTLMALNRKQGVTILVITHEADIADYADRVLTMRDGEIVSDKCKGPLPQ
SRVLPKRPAHEPARRFPATSILAFGRMISGAAIQALARNRMRSALTILGVFIGVAALVAM
VAVGQGANRAVRKQIESLGTNLLVVLPGAATSSGAHGGFGSASTLTVADAEAIKRQNPAV
GSVSYVIRSLAQIRYGNRNWATSVMGVSLHYTTMTNWSVTSGHLFTPADEEHGALVALIG
RTVYRELFPAGESPIGATILVRSTPLRVIGLLSSKGQTAFGQDQDDVVMIPFTTAEQRVL
GAAAPTQQQTQLNWPYPPWPNPYDLQPRLTGYVNQLYIQANSPLNVGVAMREVTQTLMAR
HQIKPGAIQDFSVHNLSQIAEAAQSVGRVMALLLAAVASIALLVGGIGIMNILLVSVTER
TREIGLRMAIGARRLHVLLQFLAEAVFLSVTGGLAGILLGIAVSATITLVAGWPAPVSFL
AIFGGFLFSVAVGVFFGLYPARKAARLNPIEALRYE
>V2TC98|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYDSVARLAAERGIPVYAPD
NVNHPLWVKRIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMHETIDETLDFFLRTVDLTDKPS
>Q1MMI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAAILGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LVDLVLGWRDPVNRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARRPPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRASATEF
AFLVGIPTMYAASAYELLKTFRDGGAAGEDWTALGIAFVVSTVVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGLIA
>CAQ86961|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MGLMFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGAD
YLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEE
PLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHEN
IMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPR
RLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>A0A0A0CI41|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELKGIERSYPAGEQQVKVLDDVTLSIYAGEMVAIIGASGSGKSTLMNILGCLDQP
SNGEYRVAGQNVAELSNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKAA
RRQRAIELLGRLGLEERIDYQPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAAQAQRIIEIKDGCIMSDSGTQVSRKVTKAPSLT
SKISSIRQTLGRFNEALFMAWRAMVANKMRTLLTMLGIIIGIASVVTILVIGDAARASVL
SDIKEIATNTIDIYPGEDFGLDDPVNMQALKIEDADAIKAQPYILAVSPEIEGQMRLRKG
NIDVASRVTGVGDEFFQVYALRFSQGMGFSLDMIRRQGQVVVIDKNTQRKLFPHQKNVIG
DVILVGNMPATIVGVVSDKRATFGSSKSLHVWLPHSTMTSRLVNRNYLDSITVRIKDGYN
SKDIEKKIVQLLTLRHGKKDIFTYNVDMMVKTAEKTAHTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGVLGIALSYTIALIAQLA
LPGWHFVFQPIALLSAFACSTAIGVIFGFLPARNAARLDPIEALARE
>A0A0L0REK1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMFHAARRAVLHALATVAGCSLFSLMAVSGAQAGSPPAKADQSATSGQPARAEPVPAGAD
IDDAVHALMQEYDVAGLAIAVTREGQHEFRNYGVASLQTHTPVSRDTLFELGSISKTFTA
TLATYAQALGKLSLSDSPARFVPALQGTAFGKLNLIHLGTHTGGGFPLQVPDAVTDDAQL
MAYLAAWTPRYAPGTYRTYANPSIGMLGVVAAKSLGEPYAQAIEKTLLPRLGLSNTYIHV
PAAKMGDYAQGYNKQNAPVRVNPGVLADEAYGVKTSASDLIRFVDANMGVASAPREFSAK
AAREAKIAQDVVGDAVIAKALADTHVAYYDVGAMTQDLAWEQLAYPVTLDALLAANAGTM
NSQSQPAKALTPPQSPRADVWINKTGSTNGFGAYVAFVPARKVGVVILANRNIPNEARVR
LAYRILEADAR
>V3T3E2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAGAEKIKKVSVVIPVFNEQESLPELIRRTTAACDLLGTDYEILLVDDGSSDDSTELMTA
AAQATDSHIVAVVLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVQTANEG
YDVVGTIRQNRQDSMFRKLASRLINQLIQRTTGKAMSDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRTTEITVQHAEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSLVG
SVIAISGFTLALLLIVLRIFFGSVWAAEGVFTLFAVLFTFIGAQFVAMGLLGEYIGRIYN
DVRARPRYFIQHIVSNDRQLSHQDNEE
>N8W0H1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAFTGQEQGRRLSLNLIIASIPIVIIGLSFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>A0A126S5J3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MNMTVELSPHLARPADQQQPLLRLQRVSRSFMAGDREFLALKGIDLQIHAGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVSGQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
LRNVEIPAVYAGVPQAGRHARARELLGRLGLGTHLAHRPSQLSGGQQQRVSICRALMNGG
EVILADEPTGALDTASGKEVMNILLELHAAGHTVILVTHDPKVAAHAERIIEVSDGQIVS
DRRTRPEAPAPAAEAAPAVEQAPRRLVASLGLFREAFKMAWIALVSHRMRTLLTMLGIII
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGTSFGDSRAKAIETLMPADVTALNE
LYYVDSATPVIGQSSLVRYRNIDADVQLNGVSEQYFQVRNIPLASGIVFSADDARRQAQV
VVIDHNTRKRLFGDGVNPLGQVILVGKLPCTVIGVTAENKNLFVAGNTLNVWMPYETAAG
RVLGQRHLDSISVRIKDGMPSKRVEEEVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSL
TLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCL
IGGVIGIGLSYGIGYLFALFVKQWEMVFSLGSIVTAFVCSTLIGIVFGFVPARNAARLDP
IEALARD
>A0A0Q7IHK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLSQPATFIVLIQLGAILAVIT
VYFAKLGMLIRDALTGKAYAWQFALAVILACLPAVVAGVLLRDFIQGDLWESAQLICWTL
LIGGVILLVVDRLKLTPKYDDIYHFPWHLALIVGLFQMLSLVPGVSRSGSTVVGAMLFGA
SKRAAAEFTFFIALPIMIGAFGYDLYKSRELIDTSLALNVGVGFAAAFIVGALVVRYLLG
FVGKYGFAPFAWWRIAVGAAGLVAIYMLGR
>M8K4C2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDLFLRTVDLTDKPS
>ZP_03555962|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLNLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFFSAFVFALL
AIRFFLELINRIRLVPFAVYRIVLAVVIYFLYF
>A0A0J3V903|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAALAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVALGRPVAAHEEIHHHA
>G3ESU3|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-24|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>J8AYM5|FEATURES|UNIPROT_deepARG|beta_lactam|IEE_02800|antibiotic inactivation|1
MEQTCLLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIEKLNEVITYTKDDLVEYSPVTEKHVDTGMALGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVIVNALR
>D4XMW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTTEKSAVFVVAIQIGAIAAV
IYEYWSRLWNTATGMVTGEEKGRRLGLSLIFASIPIVLVGLTFGQFIKEVLFNDVIVALG
LIIGGLIIIWVEKNPPKINAVEVENITFKQAVWIGLIQVLALIPGTSRSGATIIGAMYLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYHVFDGLEDWTVIAVGLVVSFISALLLIRAL
VAYVAKRDFMIFAWYRIASGLLILLLFFTGWKLW
>A0A085AG15|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGSVDVLKGITLSIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGTYRVAGTDVATLDGDALAKLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGTERKA
RRQRALGLLKRLGLEDRVDYQPSKLSGGQQQRVSIARALMNGGQVILADEPTGALDTHSG
DEVMAILHQLKEQGHTVIIVTHDPQVAAQAERIIEIRDGEIMTNPPAKTATQGAAIREQH
ANASGWRQFTSGFREALSMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
ADIRAIGTNTIDIYPGKDFGDDDPQYQQSLKYDDLLAIQKQSWVSSATPAVSKSLRLRAN
NIDVAANAEGVGGQYFNVYGMTFSEGNTFNDIQLNGRAQVVVLDSNSRRQLFPNKAKVVG
EVILVGNTPATVIGVADEKQSMFGSSKVLRVWLPYTTMSGRVVGQSWLNSITVRVKEGYD
SALAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAERTTHTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAMVLQLF
LPGWEIGFSPLALLTAFFCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A127T0M9|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>R4LP68|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITEIGIATPGAGPYAITAGPAGALWVTCTHSGQIVRVDPDGSTRTVDLGAPRCQPSVI
TTGPDGALWFTRTGDNRIGRLTTDGTLSEFALPTPGSGPYGITAGPDGALWYTAMTTGHV
GRLDLDGTVREYPAGRFPAMITAGPDGALWYTLNQGNAIGRISTTGDVRQFPLPTAGAAP
VGITSDGTDLWFVEIGAGQLGRLSTDGTLSEFALPDRDCRPHAITAAGPGDLWWTEWGAN
RIGHRSPGGGCTSIGLPTAQAEPHGITVGPGGDIWAALEIGSIVRLELQRG
>BAA34540|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTK
PEKQTVDFLQKNVSFEVPKWKVHERDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPEN
FINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQ
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRVFDDE
GLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE
>NP_625085|FEATURES|ARDB_deepARG|tetracycline|tet|antibiotic target protection|1
MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTDDGGIERRRGITIRSAV
AAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLR
LPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLNEVADAGTPRARVTRRPPDGRTAQA
LAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGL
IPAATPGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEV
SGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHP
EQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPG
RVRFLERPAGTGEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQ
AVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVL
HEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPG
LTRGEAVWSSRPCEDRPLKPGNSGPGTGVGGHSGE
>A0A0J6EFI6|FEATURES|UNIPROT_deepARG|chloramphenicol|AB432_04625|antibiotic inactivation|1
MKFQRIDLNNWSRKPYFEHYLNRVNCTFSMTANIDITELLPALRQKGMKLYPAFLYMVTN
VVNAHREFRTSFHADGELGYWERMIPSYTFFHQDDQTFSTMWTEFADEFPMFYQNYVADM
KQYGDNKGLVAKELEPPYTFPVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFEQEGKT
LLPVSLQVHHAVCDGYHASLFINDLQNWATTYKEWLGVE
>B5B4Y6|FEATURES|UNIPROT_deepARG|beta_lactam|blaPER|antibiotic inactivation|1
SPEQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQ
YQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTG
TSGVRAGKTAATNDLG
>M6VHU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENFEFDDLFDIFIQSGAILSV
LFLYREKFRSQIVSSFRYILKQNSDSEGFNFLIQIGMGAVPILIAGFVAKKFLDTIKTRP
DLLDILSGAWIFGGILILIAEWYFHKKQENVEKKPIDFKDSILIGIFQCMALVPGMSRSA
ATIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGHTIPVLIFGFLVSFL
LCTLVIRWFLRYLQKHSFSVFGVYRILLGVGVLVLTKLI
>A0A0H3KN52|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTHSSQRRILLLAAATAPLALSLGACAARDATVSDAASPVGAAPASFAALERAAGGRLGV
CAIDTATGRRALHRADERFPFCSTFKAMLGAAVLAQSVAHPGLLQQRVTYGRSDLVNYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAANLRVLVLGDALPPAQRAQLIEWLRGNKVGDKRIRAGVPT
GWRVGDKTGTGDYGTTNDVGVLWPPSRAPIVLAVYYTQTRADAKAKDDVIAAATRIASAT
LA
>A0A0X3WIX0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNLPDPPSVEEIPVGDEKDGPYGIASGADGALWLTFAGSGRIARLAPGGGLRTYALDAPG
CRPTVITPGPDGALWFTRHGDHRIGRVTVDGDSTSFPLPTPDSGPFGITAGPDGALWFTE
TRTDRVGRITVAGEVTEFGLPGTAPGAFPSAITAGPDGALWCTLNQADAIGRVTVDGEVT
TYPLPTSGAAPVGITSDGTALWFVEIGAGRIGRISVDGAIEEFPLPDPAARPHAVVAPAP
GECWFTEWGANRVGRLTGDGEITEYDLPTPASEPHGITSGPDGALWAALETGGVARIVP
>E4UBQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFESSIIFALILGFVEGITEFIPVSSTAHLLLASRFLGVDLGSSFTILVQLGAVLALLYV
YFHRIIYIFFSFPYDSSSRHFAIILFFGFLPAGILGFFAHYFIKSILFKETIVIYISLIV
GGFILLAVDRIHFQSKYFDIKNYPLLLAIKIGFFQCLAMIPGTSRSGATIVGAIVLGADK
RSAAEFSFFLAIPTMIGACALDSYKNYTSIVNEMRSAIIIGCLASFITSLIVVRFLLNLI
SKRGYTPFAVWRIMIGLIGLISETIF
>ZP_04262238|FEATURES|ARDB_deepARG|beta_lactam|BL2a_III|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPVTEKHVDTGMTLGQ
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRSGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAAEVIVKALK
>A0A0G3K7A8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFILAAAVYVVFF
>A0A0D1KD57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLLKSLVIGIVEGLTEFLPVSSTGHIIIAESFMNIPGGAVWTKSFTAMFDYAIQLGAI
FAVIQLYFKKLNPFSPSKSSLEKRQTWTLWFKVIVGVLPAVIAGLALNDYMDAHWLNAWV
VAAMLIVYGVLFIVVERYLANKNAILTDLNAMSYKMALFIGLFQVLSIVPGTSRSGSTIL
GALILGASRFVAAEFSFFMSIPVMFGVTILKVGKYLLDGGGFTGAQTGVMVVGFIVSWIV
AYFAIKVMMNYIKNNDFKVFGYYRIVVGIVVVALGAAGMLHMH
>YP_002775228|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGLWEAFVAIVLGLVEGLTEFAPVSSTGHMIIVDDFLFHTKDLFSPEVANTFKIVIQLGS
ILAVVVLMWDRFMSLLGLNRLAGKREVQAGPRLNLATVIVGLIPAGILGVLFDDYIDEYL
FSTKTVVIGLVLGALLMLAADWFRPRRPKIESVDQITYKQAFLVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMAGASFLSLLKRWDAITMDSIPFFVIGFISAFV
FALLSIRFFLKLINRIKLTPFAIYRLVLAAVIYFVFM
>A0A0A2RFA0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFNEIKKVSVVIPVYNEEESLPQLLERTIKACQSLKQAYEIVLVDDGSRDRSAEMLTQA
AEIPENHVVAVLLNRNYGQHSAIMAGFRQAGGDLVITMDADLQNPPEEIPRLVEKAEEGY
DVVGTRRANRQDSWFRKTASKMINKMIIAATGSAMGDYGCMLRAYRRHIIDAMLQCHERS
TFIPILANTFARKTIEIDVKHAEREFGDSKYSFLKLINLMYDLLTCLTTAPLRLLSIVGS
IIAASGFLLALLLIILRVAFGALWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGAQAKETSETETQEKN
>Q93NA3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTGLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A118LDH6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATAAAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAAKYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDGIRDDAGLIRYLGAWRPDYAPGTHRKYSNVAI
GMLGWLTAKAMHRDFATLMEQRLFPALGMTHTYIDVPDARMADYAQGYTKDGKPTRMTQG
MLWQQAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIA
IVILANGNVPIEDRVKVAYRILGSLGDGR
>A7Z3J5|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKARIQFGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKTSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKVVL
NDLK
>V8R5V7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTERNAQRFTLNLLIAFFPAVILGVLFADAIHEYLFNPITVAVALV
VGGIVMLWAEQRSHVVSVEHVDDMRWSLALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLLILATWLFGWVNWTAAAAA
>Q53770|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDFVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLTPIVLEQAFRKAGTELLEPYL
SFKVYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVIIIGEIPARCIQDYRNDLTFFTNGL
SVCLAELKGYQVTTGEPVCQTRRLNSRIDKVRYMFNKIT
>A0A0K1QSE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPNARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAEQRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFITAFIFAMIAVRGLLKF
IAGHSYAAFAWYRIAFGLVILATWQFGWVDWTAVKP
>A0A0F6RFN1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEALPITKVSVVIPVYNEQESLPELLRRTTAACESLGKDYEILLIDDGSSDNSAQLLID
ASEAEGSHVVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKTASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAVTGFTLSILLVILRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIRPESSHSTKENQQ
>A0A0B2BY43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLTAILLGILEGLAEFLPISSTGHLILAQSFFGFDPGQWAQFNVVIQLGAILAVVVT
YWKLFLDTGLGLLRRDATAWRFARNIVLGFLPAAVIGLMAKDAISAMLESPLVVAWALLV
GGIAILLLERTVRPGPDEGVAALPMRTALLIGFAQCLAMIPGTSRSASSILGALAMGVGR
KTAAEFSFFLAVPTMLGAATVKIADDPALFTGGAVIGWGEIGLGFTAAFLTALVVIRAFV
AYVSRYGFAPFAWYRIAIGGGTLLWLALG
>F0PQF4|FEATURES|UNIPROT_deepARG|beta_lactam|YBT020_12650|antibiotic inactivation|1
MKGMIVLKNKKMLKIGMCVGILGLSITSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAINTGTKQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>I7J0W2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSDFIFLLKAAILGVVEGVTEFLPISSTAHLLILGDWLNFDAGQDKVYEIVIQLGSILA
IVWLYRSELLKIAAGSMRARKPDLLFVRNILLAFLPAAVIGLIFIKQIKKLLDDQFIVYA
ITLVLGGLIMLWVESRPEFSKRVRDDENIMVKSKTISIEEISIMQALAVGFAQCLAMIPG
TSRSGASIIAGMMAGIERKVATEFSFFLAIPTMMGATALSIYKYGHLLSESNIIAVVIGF
VTAFFSALFVVKGLLRFVAKHSYVPFAWYRIIFGAIVALWVWNIL
>A0A0F4STK1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSESDMYQYKLPRLATYSVFALLLGTAPCFAATPSDQQLEALVNATVGPVMQQQNITGL
AVAITQNGQKHYFNYGVASKEDGKPVSQDTLFEIGSVSKTFTATLAAYAQASGKLSLSDT
ASAVLPALRGSAFDHISVLQLATYTAGGLPLQFPDNADHADKMLGYFKQWTPVYPAGTHR
QYSNPSIGLSGYLAAYSMGQPFDTLLEKTLLPKLGLEHTYLNVPKNQMGLYALGYNKDDK
PVRLEPGALDSEAYGVKTSASDLLRFVEANMKPAGLEKPLQQAIATTHTGYYTVGNMTQG
LAWEFYPYPVTLDRLLAGNSTEMAMEAHKVNWLNPPQPQQENLLFNKTGSTGGFGAYVAF
VPSKDIGIVILANKNYPNPERIKIAHTILSALTE
>A0A126VK89|FEATURES|UNIPROT_deepARG|beta_lactam|AXX16_2525|antibiotic inactivation|1
MLKKTLTLLPLCLALLPAFSQAVEKSDIDKIVQPLMEKYAVPGMTLAISVDGKPQFYNYG
VASKQSKQPVTQDTLFEIGSLSKTFTATLAAYAQHTGKIDWAQPASHYLPQLRGSAFDRV
SLLNLATHTSGLPLFVPDEVTNEQQLMDYYRLWQPTHPIGSYRVYSNLGIGLLGMITANS
LKQPFAAAMEQRLLPALGMTHSYVNVPPTAQKDYAQGYNKEDKPVRVTPGPLDAESYGLK
ASSGDLIRYLNANMGLVKVTPDWQQALDGVHRGYYRASEFTQDLMWESYPYPVKLNTLLA
GNDAKVIMNGVPAQAITPPQAPQQQAWYNKTGSTNGFSTYAVFIPVQKTAVVMLANKNFP
NDERVKAVYQIVQSLAH
>A0A0M3R8A5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLDINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAATKIVTEGL
>Q8KLJ5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVTERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>W8UGN3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB2|antibiotic efflux|1
MAALLELKGIRRSYQSGEETVDVLQDVSLSINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQFQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKAGPSSVDSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMTALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVFGMKLAQGTAITSEQVARQSQVVVIDRNTQRRLFPHIKDV
VGQVMLIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMANRLMGRSYFDSITVRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPNWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>D2WSB1|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-11|antibiotic inactivation|1
SEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETE
LNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAG
WFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRE
>A0A144P4M1|FEATURES|UNIPROT_deepARG|beta_lactam|A3K91_1255|antibiotic inactivation|1
MSKLLPLTLIFLLLFIESVGKYPMKISSQKPLTSLVFSLLAATLFISETAQAACSDACLK
SKVDEQAKQLMVSHNIPGMAFGVIIDGKSHFYNYGLADTQRNKPVSEDTIFELGSVSKTF
TATLASYAELNGTLALNDTADKYIPYLKNSAIGNTKLINLGTYSAGGLPLQVPESIEDHK
TLMRYYKSWQPEFPVNSTRLYSNASIGLFGYIAALSMDTDYTELMENKVLPSLSMSNTFV
NVPADKMGNYAFGYNKSDEPIRVNPGMLDAEAYGIKSTSADMTRYLAMNMGLLPLDNQIQ
QALDNNRKGYYRTSSFTQGLAWEMYPLPTTLATLLEGNSTDTILKPQPIQVNEPPAPVRD
DVWVNKTGSTNGFGAYIAYVPAKKTGIVILANKNYPNTERVKAAYTILESAIGQ
>C2YRW4|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0028_22820|antibiotic inactivation|1
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFKGGPLQVEAKEKTEPVKRNNHATYKDFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQKNSTEKLNEVVTY
TKEDLVDYSPVTEKHVGTGMTLGAIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDNRDTSTAKAMATNLKDFTVGNALPDDKRSILTDWMRGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALK
>ZP_04576183|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM
>B8ZI07|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASXALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKN
>B5EGT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFEAIILGIVEGLSEFLPISSTGHLILASALMKLQQSEAHKVFEVTIQLGAMLAVVQIYR
KQLLSRPELLKKVCFAFLPTGILGYLLYKVVKSFFQPSLVSYTLIAGGIAFILIELWMKN
RPASTASLDHMSYRQAFTIGLIQSLSMVPGVSRSGATIMGGLVIGMNRKDAAEFSFLLAL
PTMLAATCYDIYKNYAVFHMGDWQNIAVGFVTSFVFAVIGIKALLKIITSHTFIPFGIYR
IAVGIVFLVFLT
>A0A011N376|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLLLLKALILGIVEGITEFLPISSTGHLILAGDLLGFNDERGKLFEIVIQSGAMLAVC
WEYRAKIGSVVRGLPSEPAAQRFALNILVAFLPLAVIGLLFGKAIKAHLFNAPVVAAAFI
IGGLVILWAERREHRIRIESIDDLSLADALKLGLAQALALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAMPTLIGASIYQLYKERALLSFDDLGMWVVGFVASFISAFWAVRGLLRY
ISTHDFSIFAWYRIAFGIVVLLTWHYDLIAWTAG
>NP_631702|FEATURES|ARDB_deepARG|chloramphenicol|cml|antibiotic efflux|1
MPLPLYLLAVAVCAMGTSEFMLAGLVPDIASDLGVTVGTAGTLTSAFATGMIVGAPLVAA
LARTWPRRSSLLGFILAFAAAHAVGAGTTSFPVLVACRVVAALANAGFLAVALTTAAALV
PADKKGRALAVLLSGTTVATVAGVPGGSLLGTWLGWRATFWAVAVCCLPAAFGVLKAIPA
GRATAAATGGPPLRVELAALKTPRLLLAMLLGALVNAATFASFTFLAPVVTDTAGLGDLW
ISVALVLFGAGSFAGVTVAGRLSDRRPAQVLAVAGPLLLVGWPALAMLADRPVALLTLVF
VQGALSFALGSTLITRVLYEAAGAPTMAGSYATAALNVGAAAGPLVAATTLGHTTGNLGP
LWASGLLVAVALLVAFPFRTVITTAAPADATR
>W8TNT7|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
KALIVFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATM
>U7FRP9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGQTIVNALILGIVEGLTEFIPVSSTGHILLLGHFLGFDSTGKTFEVLIQLGAILAILS
VYFGRLWTLLITLPSDPSSRRFVAGILIAFLPAAVIGVLLHGFIKEVLFETPALICTTLL
LGGIVLLWIDRLPLKPRYTNVMDYPLSLCLKIGFCQCLAMVPGVSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRNVLSMDDAMLIGIGFVASFIAGVFVVKGLLDF
VSKHGFAPFAWWRIFVGIAGFAGLYFLG
>A0A076V9Z9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
SEPNLLNQRVEIKKSDLDNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGP
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
QLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVT
>A7XQR6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLNIMREAMIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVD
GGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPW
RYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPE
QDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQ
YQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>A0A156XZC1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTDVQDMASWVMVNMKPDSLQDASLRQGIDLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILDALQ
>T0JCC8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLTITAILLGIVEGLTEFLPVSSTGHLILATRLFGYDSSQWATFNIVIQLGAILAVIVQ
FWRTFWAVGMGLFKLNPTSIRFVRNVLLAFVPSAVLGLLFNNYIEGLLGEPAVVAWALIL
GGIAILGIEKVAKPGPLTGVSELPAVKCLGVGLAQCLAMVPGVSRSGATIMGALSMGIER
RTAAEFSFFLAVPTMIGATTLELLKHHEDLMAGTGPVGWDEIGIGFVVSFVVALVVIKAF
MAFVSRSGFAPFAWYRIVAGALALFLLSQA
>Q932L5|FEATURES|UNIPROT_deepARG|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEFMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>A0A068QVK4|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MNRIGFATALASLLSVLFTLPASATVHTNQIAHQNEISPSKKANEIMHQLAMLEKNANGR
LGAVLIDTSDHSTLSYRANERFPLCSTSKLMAVSAILKQSETDAHLLHQRIHYQPSDLVE
YSPITEKHLKEGMTLAELSAATLQYSDNTAMNLLLNQLNGPDGVTTFARTIGDHDFRLDR
QEPELNTVVPGDERDTSTPQAMANSLSHLALGNALATTQREQLVAWLKGNTTGSTSIRAG
VPKDWIVGDKTGRCDYGTTNDIAVIWPVPKRAPLVLVTYFTQPDDKQAHARPDVLATAAR
IMTQNF
>J2LAA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTILALKALIMGIVEGLTEFLPISSTGHLILAGSLLHFAGPAFPKEKVDVFEIVIQAGA
ILAVCWEYRARIASVIGGLFSDRKAQRLVINLIIAFLPAAILGFLFSKKIKAVLFAPVPV
AIAFIVGGLIILWVERRNKGRAVYARIDSVDDMTPLDAFKVGCAQAFALIPGTSRSGATI
IGGMMFGLSRKAATEFSFFLAIPTLFAATIYSLYKERALLSAADAPLFTIGTVAAFISAF
LCVRWLLRYISSHDFTVFAWYRILFGLVILGTAYSGVVAWVE
>S6KZG2|FEATURES|UNIPROT_deepARG|aminoglycoside|CF161_04258|antibiotic inactivation|1
MSRIEPCQSAQQTGWLELRQALWPDSSRQEHLDEITDLLGDPQRYINLLAYTADGHPVGL
AEASLRRDYVNGTDHSPVVFLEGLYVVAEQRRQGIAEQLIDAVAQWGRDQGCGEMASDTG
LENLLSQTVHKALGFEETERVVYFKKTL
>D1LFC8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGTTT
>A0A0B2XSL7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAVIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSLIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQQGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSMVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAIVVLCVN
>A0A0C1CSN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQSFDFYFKLLVAFIPAVVFGLLFSKKIDALLESPVTVAVSLLIGGIILLKVDDW
FAVPEVGFPVSKEITYIQAFKIGLFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFF
LAVPTMLGATAKKCYDYYKDGYVLTHDQINFLIIGNVVAFIVALLAIKSFIGFLSRKGFK
LFGYYRIIAGILLLIIHFFIHPLTII
>A0A0F5SD41|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPSHKPSTGRDIAEPT
VKTASGWGQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0A4GD33|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHMTRSILAGTFLLGCGMMPGFAQERLEDTVNAVIEPLMKRQDIAGMAVAITLDGQPHYF
NYGVASRETKQPVTEQTLFEIGSVSKTFTATLGAYAQAQGKLSLSDPAGRYAPELQGSAL
ENVSLLNLATYTAGGLPLQFPDSADHPDRMFGYYKTWKPLYPAGTQRLYSNPSIGLFGYL
AARSLDRPFDDAMEQTMMPGLGLKHSYLRVPASESSRYAQGYAKDGKPVRVGPGAMDSEA
YGVKTSASDLIRFVEANLRPETLAPDLQQAIATTHTGFYQVGGMTQGLGWEFYPYPVTVS
QLLAGNSVEVAMQPNKVEPLDPPRPAPDNAWINKTGSTGGFGAYAAFVPGKNRGIVLLAN
RNYPIEERVKAAHRILMALEER
>A0A102EQG5|FEATURES|UNIPROT_deepARG|aminoglycoside|WS45_17420|antibiotic inactivation|1
MPSVSFTVRAVLPHDIGAWCSLRRLLWQHVSDDEHILETQRLLADQHRYATFIAFSSDSA
PIGFAEAAVHHDYVNGCKTSPVLFLEGIYVMPNVRRVGIAKALCAAIGQWGSAHDCTEFA
SDTQVDNVRAQALHCALGFEETERVVFFRKRLTC
>P39438|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDQYLDAALLGLIEGLTEFLPVSSTGHLIIFDTLLGFEGPPGKVFEVVIQLGAILAIC
TVYFARLWKVVTGLKDDPGARHFAMAVILAFLPAMVLGAALHGVIKAVLFNPTVVSIALI
LGGVAILMAERLVPAPRYHQIERFPAPLALKIGLCQCLALVPGVSRSGATILGSLLMGVD
RRTAAEF
>A0A127SCQ5|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDILDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>A0A0K0N4T7|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
HFXXALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERF
PMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAA
ITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAM
ATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGII
AALGPDGKP
>YP_002400178|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLMVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSSFNCYLLMLIGGLAGIAAFEASSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A0A2ZBG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAGHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKVDQNKAHLNLIHIILGMIPAVVLGLVFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFAVGFVTAFIVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>A0A0Q4HC64|FEATURES|UNIPROT_deepARG|chloramphenicol|ASE68_04225|antibiotic inactivation|1
MTRPDPIDLATWTRRETFEHYRRSVPCTYAITVELDVTAFAAALARSSRKTYIAQIWAIA
TVVNRHREFRMAVSDAGEPAAWPVVHPAFTVFNAERETFAAVWVPYDADFARFHDVAAKV
LATAASATTMFPQGELPADVFDVSSLPWTSFTGFTLNIDGGSNHLLPIFTLGRYLERDGR
TLLPLAVQIHHAAADGFHTARLVRELEDLIAEPSWVDG
>ZP_03570951|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGMASLYLTFRQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTGVQLGEYASANVVQALRRVDGVGRVQFWGAE
YAMRIWPDPVKLAGHGLTASDIAAAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRSQADGAALYLRDVARIEFGGSDYNYPSYVNGKVAVGMGIKLAPGSNAVA
TEKRIRAAMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGAMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EERLAPYDATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIAFS
AFLALSLTPALCATLLKPVDDGHHDKRGFFGWFNRFVARSTQRYATRVGAMLNKPLRWLV
VYGVLTAVAALMLTRLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYLRREEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWNARQAARDQVQAIVARVNERFAGTPNTTVFA
MNSPALPDLGSTGGFDFRMQNRGGLDYAAFSAAREQLLAAGAKDAALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGQHRLDPDDV
KKLRVRNARGEMVPLAAFATLHWTLGPPQLTRYNGYPSFTINGSAAPGHSSGEAMAAIER
IAATLPAGIGHAWSGQSFEERLSGAQAPLLFALSVLVVFLALAALYESWSIPLAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLLAQRMSLAEAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQTAIGTGVLGGVIAATVLAVFLVPLFFV
VVGRLFGFGTRRRGSAPAVNVEGSR
>ZP_03573945|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MDNMHNTNGLMRIAKVAAASTLLATLLAACAVGPDYKRPDVTTPAAFKEAPTLAPGEQAG
TWKPAEPADGAHRGEWWKVFGDPVLDALEEQALAANQNLKAAAARVEEARAATRTARSQW
FPQVGVGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREEALKLVQRRFNEGDIS
ELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPLVPVAVKIPPG
LPSALLERRPDVAAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQNAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGDMPASTAVGDAATGTQDVAVR
>E7RUA8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESLYALPLMVKAVILGIVEGLTEFLPISSTGHLILTSSLLGWDDEKASVFAIAIQTGAI
LAVIWYYRERIGKVLAGLTSDRVQQRFALNIIIAFIPAAVLGVLFSKLIKTHLFGPVPVA
IALVVGGLIIFLVEKRQENIAPRITDIDSLTAVDALKLGLAQAFALIPGTSRSGATIIGG
MIFGLSRQVATEFSFYLAIPTLIGASVYDTWKSRDLLSAGDIPLFAVGTIFAFFSALACV
HWLIRFVASNSFRVFAWYRVIFGLLILAVTYTGVLHWGSAMD
>A0A0U4B7T1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIVYGIVEGITEFLPISSTGHLILTGNLMGVPWSKEVKDTFEVVIQGGAILAVLA
YYWKDFLQIRHIGRDKTQQNLWLGVVVACIPAVILGVLFGDTIKAYLFRPSVVAWALIVG
GILMWLIESRRVTPNVDAIEKIGVRRSLMIGTLQCLALLWPGFSRSASSILGGMILGLDR
PTATKFSFYLGVPTLGGAALLDFIKSRDILAEIGVLNVLLGAAVSFVVAYLSIGWLLRFV
STNNFKPFAIYRVVVGVLILVLIAAGVLNNGNLA
>A0A0W0SWB0|FEATURES|UNIPROT_deepARG|beta_lactam|Ldro_1246|antibiotic inactivation|1
MKKISTILGMTLLYCVSTWAQGSCFLIYEEQTLLKQEGKDCNQRFAPQSTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNTWKYPHNPHSWIRDSCLWYSQVLTQQLGMKRFKNYV
DAFHYGNGDVSGDKGQNNGLTHAWLSSSLAISPLEQILFLQEIINKKLPLSQKAFTMTKD
ILYIQELAGGWKLYGKTGNGRQLTKDQNQKLSLQHGWFVGWIEKDNRVITFANHIADSKE
KATFASFRVKNDTLNKLFYLINELEK
>YP_002226185|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAWQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>A0A0A7FWC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDLILIFKAIIISIVEGLTEFVPVSSTGHMILVGELIDFKGEFANMFTVVIQLGAILA
VVVLYWKKISSSVVQFFQYIFTGGKEGKTGFRFGINVIVGSIPAMIIGLLLHDAIKGLFT
PVAVIYGFIVGGILLIVIENIFRKRRPKATNIDDITPKESLVVGVAQCFAMWPGMSRSAS
TIMGGWIGGLSTPVAAEFSFFLAIPAMFGSTLLDMIKFDYSIMDTTNWVALAVGFVVAFI
VALVVMNKFVSYLKKKPMRVFAVYRVIVGVLLAVLVFTKIISLPPL
>A0A0S1RS53|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEVGQADGWR
>C2TGH5|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0016_22500|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHVSRFIEDLQELSNSCNEWLK
>A0A0J6JZJ3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSGAGLTLSGVWRRFPSGAEEVAVLKDVSLNIRAGEMVAIIGASGSGKSTLMNILGCLDQ
PSAGRYQVGGRGVSELDSDQLATLRREHFGFIFQRYHLLPHLSAIDNVAMPAVYAGIGHE
ARRERARQLLARLGLAGKEDFRPGQLSGGQQQRVSIARALMNGGDIILADEPTGALDSHS
GEEVMAILKELHAAGHTIIIVTHDPAIAAQTERIIEIRDGEILRDSAAGAAEAAAEERAP
RSAKPGPAWRERMSEAFKMAMLAMLANRLRTMLTMLGIIIGITSVVSIIAVGEGARNYVL
NDIRSIGTNTITVYRGKDWGDDKADGVRTFLAGDLAALAEEPYVDSVSPVTSNNLRIRYR
SVDVNASVSGVDSTYLRVRGLKVVAGLGFDRDDVRMQRQVVVIDSNARRKLFADADPIGK
VILVGSLPATVIGVAETKDNGYGGKSLQMWMPYSTAGSRLFGQVFFDYMVVRIKEGQPTA
LAEKALSQLLTLRHGSKDFFTYNMDEVLKTVENTSRTLALLLTLIAVISLVVGGIGVMNI
MLVSVTERTREIGIRMAVGARQADVLQQFLTEAVLVCLVGGAIGIGLSYGISFVFALLVS
KWKMALSLKAIGLAVACSTAIGVVFGYLPARSAARLNPIDALARE
>H5UY48|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGIEALLKAGFDICAIFTHPDRASENHFFGSVARLAAEQGIPVFAPD
DVNHALWVERIQKMAPDMIFSFYYRALLSEKILATARLGAYNLHGSLLPTYRGRAPLNWV
LVNGESETGVTLHRMVARADAGDILAQERIAIADDDDAMSLHQKLVAGAKTLLASCLPTM
KQGLIDGVKQDESRASVMPGRTPEDGRIEWSLPAKSIANLVRAVTDPWPGAFGYVGTTKF
IVWKAKAHDIVHTAKPGTALSINPLIIACGEGALEVLTGQSEQGVYMNGSQLAQSLGLVE
GALLYSQPMAAIKRRKRVLILGVNGFIGNHLTERLLQDKNFDVYGLDISSDAISRFIGHP
RFQFVEGDISIHSEWIQYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCHDSNFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
QDGVEALFRIIEDKHNHCNGQIINIGNPDNEASIKELAERLLAHFERHPLRDQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLDWTPMVNMDITIENTLDFFLRSVEPQDDVR
>A0A0R2CSP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIKAVILGIVEGITEFLPISSTGHIVLVNEFIKLNETKAFTDMFNVVIQLGAILAVVVLY
FHKLNPFSPRKSHRERSHTWTLWWKVLLAIVPSVIVGLPLNDWMDAHLMNWAVVSATLII
YGILFIVIENHNRGLTPKFSDLNTLPYQTALFIGLFQLLSLVPGTSRSGATILGAIIIGA
SRYVATEFSFFMAIPTMLGASLLKIVKFYAHGNAFNAEQGWVLFIGVVVSFIVAYLSIRF
LLNYIKKNDFKAFGWYRIILGALVIGYFVLFA
>I2NWC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILTLLKALLMGIVEGLTEFLPISSTGHLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIF
EYRQRFTSVLSGLGKDRAANRFVLNLAIAFVPAALMGFLFRKQIKLYLFNPKTVAIMLVL
GGLFILWVERRQSKVKPKVKSVDEMRPIDALVVGCAQVCALVPGTSRSGSTIMGGMLWGI
ERKAATEFSFFLAVPMMIAATGYDVFKHYELFTLQDIGLIAVGFIAAFLAGFLAIKSLLK
FVSSKNYVPFAYYRIVFGGLILLTSHMGWVKWTA
>A0A0Q0X3P4|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPRLLELLEEAGVKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SQAQLIEQIRRGVDTLSDITGQPVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLADGRLGAPQIPVDLPTFDEVVGPELSAADFNAYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLTQARARDIHFQPLRDLLPADLNDLPAGQLSRGVLEGREGWLGVQKP
>K6U9H6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDILFIIKAIIMGIVEGLTEFIPVSSTGHLILTGSIINFTGDFPEMFEVVIQLGAILA
VVVLYWEKIRNSVVDFFAYIASRGKRGEVGFRFGVNIIVGSIPMMILGVIFYKKIKTVLF
GPWPVVIAFLIGGMLLIVIENKFRKNKHAVRDIDKITPIESLKIGFFQCLAMWPGMSRSA
STIMGGWVSGLSTAVAAEYSFFLAIPAMVGSSGMDLLKFNYSEMNMTNAIALAVGFIVSF
IVALIVMKKFIDYLKKRPMRVFAVYRIGAGIVFGILMLSGILKM
>A0A0Q4R0V5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLIRREPKSWLFLRNLVVAFIPAAVIGLALHKYIEALLGNAEVVAIALIV
GGFAILAVERFAPRSDISGVADIPLKTVIGIGFLQCLAMIPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALELLKNRDAIASGGGVGLGAIAIGAAVSFVVALLVVKWFV
GIVTKHGFVPFALYRVVAGSAALIWLLSK
>A0A0Q7L8M1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIHSTVVALPRQPKARRLALNVVIGFLPAVVLGLLFGKMIKAHLFIPTVVASTFI
IGGFIILWAEKRPPGSVRIEHVDDMTPWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGAYSLYKERALLSVADIPMFTVGLAFSFISAWLCVRWLLK
YISTHNFIPFAWYRIAFGIVVLATAWTGAVVWAE
>F8EI51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFQALILAVIEGITEYLPISSTGHMILASSFMGIASDPFVKFFTVAIQLGAILSVVVL
YFKRFFRSLDFYFKLVVAFIPSAVFGILFSDAIDALLESPLGVAISLLVGGIILLFVDKW
FTKTYIESSDEVDYLTAFKIGFFQCIAMIPGVSRSGATIVGGMSQRLSRKAAAEFSFFLA
VPTMFAATAKKAYDFYKEGFVLTDEQIKLLAVGNVVAFIVAMLAIKFFIDFLAKYGFRLF
GWYRIIVGGAILTLMLAGYKLEIV
>D5WBL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVVGSLIDFSDEHAKTFDVVIQLGAILAVC
WEFRRRIGNVIVGLPNRPEARRFALNVIIATIPAIVLGLLFEKSIKEALFAPVPVAFALV
AGGVVILWAEARQRARGDAAVRVRSIDDLSPLDALKVGLAQCFALIPGTSRSGSTIIGGM
LFGIERRAATEFSFFLAIPIIFGATAYELYKDWHLLTTDALGSFALGFVAAFVSAFICIR
WLLRYVASHDFTVFAWYRIGFGLLILLIGYSGGLSWAD
>W6N7A9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYLLLIIKAIVIGIVEGVTEFLPISSTGHMIIVGDLINFKDPTYRKAYVDMFEIVIQLGA
ILAILVLYWNKISGSLKNLAPGKWGFKLWCNIIIAFIPAAVIGFLLDDIIQAKLFNSVTV
ACALIFGGFLMIFMEKKYRRGNKTNKIEDVTTGQAIRIGCFQCIALWPGMSRSASTIMGA
WTSGLTNVAAAEFSFILAIPTMIAATGYSLGKAIFKSKIIMTSPEVIALVVGFVVSFIVA
LFVVDGFISFLKKKPMRVFAIYRIFIGILVLILSYANIIHA
>A0A127SLZ6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKSTVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A0R2EX17|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAAIIGIVEGLTEFLPISSTGHIDLVDQIVKINQSPAFMAMFEYVIQFGAILAVV
LLYFNKLNPWAPSKSKPERAATWTLWFKVIVAVLPSVIIGLPLNDFMDAHLHKPIVVASM
LILYGILFIIIENYFKDRSPKITTLADISFQTALFIGLFQALSIVPGTSRSGATILGAII
LGASRYVATEFSFFLAIPTMVGVSILKIGSYLMKGNVFTGLQWGILLTGMLVSFLVAIVA
IKWLLKFVQTHDFKPFGWYRIALGLVVLLVLFI
>P28018|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MKNKRMLKIGMCVGILGLSVTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIASNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRA
GVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAPEV
IVKSLK
>ZP_02654724|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRIACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGVEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A0D4ZY85|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVFNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDNSAEMLTV
AAEQPGSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRLINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIEVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFILAVLLITLRLILGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGNAQARNTQEEE
>Q6AKL2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVFQTIILGIIEGITEFLPISSTGHLIVASNWLSIEQNETNKAIEVIIQLAAILAVIAN
YRDKFTLKHKVLWSKVVLAFIPIGAIGLLFHKEIKTLFTVPMVGTMFIVGGIVFLVLEHF
YQERSSHVQEVEAISYRQALWIGIAQVFALIPGTSRAGASIVGALLMGLSRKASAEFSFL
LALPVLAAAAGFDLLTHYSDFSRGDMLTLSVGFITSFLIAYLTIRVFIGFLQRFTFVSFG
IYRIAFGALLLWLG
>A0A068Z394|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MSCVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLTQPYEIILVDDGSSDGSAEILTA
AAQQPESQVIAVLLNRNYGQHSAIMAGFNQVTGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLVTCLTTTPLRLLSVVG
SVVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQQIHKIQEEE
>J8CGU7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLAGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>ABF69686|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0Q6Q0G9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYMSSIVLGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LVDLVLGWRDPENRSYAAKLIVAFLITAVLGLIVKKLGFELPENATPIAWALIIGGIWMI
FAEWAAARRPPHKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAANEDWTGLGIAFVVSTIVAFIAVKWLLSYIRSNR
FTVFAVYRIILGAILLGLAASGVIA
>U2ITU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFTKEMWKLYGLLIIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDKLFNQGKEENEVTPKRAFFIGMFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKENVSWATSDNLMLLGVGCVISFFVAILAMKWFVSFLTK
YGFKAFGWYRIIVGGILLAMLLSGVSLNMVD
>C3HSS6|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0012_55600|antibiotic inactivation|1
MLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENIVNHSFAKLEKEFDAKLGIYAL
DTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIENLNQRILYTREDLVNYNPITEKY
VDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLIEIGDTVTNPERFEPELNEV
HPGETHDTSTPKALATSLQAFALGDVLSTEKRNLLIDWMKRNTTGDNLIRAGVPGGWEVA
DKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIVLDTLKTPN
KQ
>Q933R1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMIKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>P59523|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTMTTNIFNAIILGIVEGITEFFPISSSGHLLIFTNILEMKNNEIKILNTIIQTGAALSI
LLHFKEKFVIFLEQIFICKQITKKNDLIYHHIILGNIPIIFIGLCIYQYIKYLSNFYSII
YALIFGTILLILTEISKTKISSNKNIETPQILIIGIFQCLALWPGFSRSCATISAGILSG
LKQSKSVEFSFILSVPIFFGASVLDVINNFYDISINNIPMLFSGFLSAFITSNIVIKRCL
NTMKNCSLIPFIIYRSILSIIIYLFFMH
>D1W4K5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIETIILAIVEGLTEFLPVSSTGHMIITRDLLGMEANDPFINAFIVIIQFGAILSVVT
LYWKRFFRLDHTPAPAESTPVRAFLHKWDFYWKLLVAFIPAAVIGLLANHLIEKMLGSVV
VVAVMLVIGGVFMLFCDRLFNHGSESTPLTEKRALRVGLFQCIAMIPGVSRSMATIVGGM
AQGLTRKRAAEFSFFLAVPTMFAATCLDVFKLIKNGGVEALSAHVPTLLLGSGVAFVVAL
LAMKWFVAFLTKYGFKAFGVYRIIVGGAILIWLMMGHQLAMVD
>C2XDR5|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0025_28660|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFVKLEKEFDAKLGIYAL
DTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKY
VDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGDTVTNPERFEPELNEV
PPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVA
DKTGSGSYGTRNDIAIIWPPNKKPIVVAILSNHDKEDAKYDDKLIAEATKIVLDALKVTN
K
>AAO38916|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSALDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGRVFKIEYSKKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>N8WWG0|FEATURES|UNIPROT_deepARG|aminoglycoside|F964_03251|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDNFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETSKIFLKH
LKNDRPDKRNYFLKLDELN
>YP_405948|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFRQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSLV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWLVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAVVIVVFTLAGLLNRVRQHQAAELAEER
>A0A0B7GUY4|FEATURES|UNIPROT_deepARG|chloramphenicol|catB|antibiotic inactivation|1
MKQSQETLFSKIDIESWERKEYFLHYYNDVRCTYSVTVNVDITEVYNRVKYQSLRLYPTL
IWWIANTVNHFEFLRFNHDEDGNIGYYDEINPSFTFMPPNSEKFYVLWCEYDRSFKAFYD
RCVEVMDIFNTSKMFPMLDMPRNCFDISSVPWIEFTSFNLNVFSTGTHLPPIFTTGELIK
ENGRVKLPFSLQVHHAVCDGYHAGQFFAYLQKFADKASDWMKH
>R4Z5N6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGAALILVLMLGTLTIAGTFVTSRVGASSGSPIGATTAGATNGTADVPGTDGGASPTDEI
PPDTAAAREQMNPAKAVVLGVVEGVTEYLPISSTGHLYVTQRLLGVGDTGATEAPADSFA
IVIQAGAILAVLVLYRRRIATVFQGLIGRSEEGRNLLIALVVAFLPAAVIGFLFEGPIKS
RLFAGWPIVAAWAVGGVAILLISDRIAKKQAAEAAAGGSGSGGGKGADTAGSIGTTPGQD
ARPPGRVGRSLDAITPRHALIIGVAQAFAMWPGTSRSLVTIVAAVLVGLSVSAAVEFSFL
LGLLTLGAATAYEALSNGSLLVEAYGGIEITLGLVVAFVTAAAAITWMVRWLEQRSLAIF
GWYRLVAAGVGALLLITGTIG
>J8PGZ0|FEATURES|UNIPROT_deepARG|beta_lactam|IKS_04788|antibiotic inactivation|1
MFILNKFFNILHYKKIVPAVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>Q9KJC1|FEATURES|UNIPROT_deepARG|multidrug|arpC|antibiotic efflux|0
MTKSLLSLAVTAFILGGCSLIPDYQAPEAPVAAQWPQGPAYSPTQSADVAAAEQGWRQFF
HDPALQQLIQTSLVNNRDLRVAALNLDAYRAQYRIQRADLFPAVSATGSGSRQRVPANMS
QTGESGITSQYSATLGVSAYELDLFGRVRSLTEQALETYLSSEQARRSTQIALVASVANA
YYTWQADQALFKLTEETLKTYEESYNLTRRSNEVGVASALDVSQARTAVEGARVKYSQYQ
RLVAQDVNSLTVLLGTGIPADLAKPLELDADQLAEVPAGLPSDILQRRPDIQEAEHLLKA
ANANIGAARAAFFPSISLTANAGSLSPDMGHLFSGGQGTWLFQPQINLPIFNAGSLKASL
DYSKIQKDINVAKYEKTIQTAFQEVSDGLAARKTFEEQLQAQRDLVQANQDYYRLAERRY
RIGIDSNLTFLDAQRNLFSAQQALIGDRLSQLTSEVNLYKALGGGWYEQTGQANQQASVE
TPKG
>A0A0X8EWR1|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPRLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPQFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGQDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEQIRRGVDTLSDITGQAVECSAAAGWRADERVVQAKETFGFRYNSDCRGHSLFR
PRLADGSLGAPQIPVDLPTFDEVVGPELSAADFNSYILDRFSPQKLNAYTIHAEVEGILM
ANDFRQLLAQARTRDIHFQPLRDLLPADPDSIAAGQLSRGVLDGREGWLGVQKP
>A0A0G1QP33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIILHSLILGIVEGLTEFLPISSTFHLITAGRLLGLPNNSFTSMFEVVIQGGAILSLLFI
YTKTFLANRELTLKVIFSFIPTALVGLILYKIIKGIFFSTHWLMLVVFVGMGILFLLVER
LVTQGKLSLHKSLDSLSWKEAFLVGLAQSSAVMPGVSRSGSVISLMMYLGYRRDEAAKYT
FLLSVPTILSASLLDLFQSRSLLVANPENFIPLLVGFVASFIVAYFVVKWLLHYLGTHTL
ALFAWYRFIVAALVLFILGT
>A0A0D1K8B2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLLKSLVIGIVEGLTEFLPVSSTGHIIIAESFMNIPGGAVWTKSFTAIFDYAIQLGAI
FAVIQLYFKKLNPFSPSKSSLEKRQTWTLWFKVIVGVLPAVIAGLALNDYMDAHWLNAWV
VAAMLIVYGVLFIVVERYLANKNAILTDLNAMSYKMALFIGLFQVLSIVPGTSRSGSTIL
GALILGASRFVAAEFSFFMSIPVMFGVTILKVGKYLLDGGGFTGAQTGVMVVGFIVSWIV
AYFAIKVMMNYIKNNDFKVFGYYRIVVGIVVLALGAAGMLHMH
>A0A154TFF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAIVGLLFSKQIKLHLFNPITVATMLVL
GGFFILWVEKRQATAKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGWVSWSE
>A0A010K902|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSIIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQSGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSIVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAIVVLCVN
>Q9AMA0|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVLYIGX
>R9JIX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVELLKAILFGIVEGITEWLPVSSTGHMIILDELIKLNCTPEFLEMFLVVIQLGAILAVV
ILFWNKIFPFQFRDKENPVIEMDKIVLWLKIIVACIPAAIVGILFDDVFEALFYHASSVA
LALIAFGVAFIVVERRNKGKSAKVRKLDDITFQTAFIIGIFQLIAAIFPGTSRSGATIVG
ALLIGVSRSVAAEFTFFLAIPVMFGASLLKLVKFGLSFTTLEAGVLIIGMLVSFFVSIFV
IKFLMDYIKKHDFQVFGWYRIVLGILVLALGAAGVINV
>A0A086GFG9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTTGACKQLSQPYEIILVDDGSSDNSADMLTA
AAEKPDSHVIAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGAQHDHNTQEEE
>B7HS58|FEATURES|UNIPROT_deepARG|beta_lactam|bla1|antibiotic inactivation|1
MQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFAST
YKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNT
AGNILFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDF
TVGNALPHQKRNILTEWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPN
RSPIIIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>A0A0F7LGM5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
FGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQ
NDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHV
TRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGP
LLRSALPAGWFIADK
>R8PHU3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEIYSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYILPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIMGNKIGRITFEGEVKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>A0A060I0S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAVLLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPANRDYAAKLIVAFLITAILGFVVKRLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAAGEDWTALAIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAVYRIILGVLLLGMATTGLIA
>F6IBB9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MALSNLLILAIIQGLAELLPVSSSAHVIMAEKILGLDPSAPDMTLLLVMLHSGTMFAVIV
HFWKSWRSTYFSSVAAFKHYALRIFIATMMTGIVGLTLQHIIKVYFAGNTSNFEIESLFS
NSKLIASGLLVSGILIIVSSRIKESHTENLSLIQSVLVGMVQGFCLPFRGLSRSGASIST
ALSIGVARKTAEEFSFALAVVLTPVVIFKEVVRAFHNSAVLSISSIVFPSLLGMVFSFIA
GLVALRWLAGWLEHDKWHLFGGYCLLAACVILWIG
>J7TAK1|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MKQTKTKYGKIKQIVSNLKLPDYRYEQLTKAIFHQRIDNFEDMHILPKALRMALVNEFGK
NVSSVIPVFSQDSKQAQKLLFELTDGERVEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDENLFGL
SQRRITISTIGIIPRIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCNTLKKAGISATVRTQFGSEISAACGQLCYENEL
>A0A0D8IYH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDYLFAALLGVIEGITEWLPISSTGHLILADEFIHMSTSDAFKEMFDVVIQFGAILAVV
VIFWSKLWPFRINRDACGSGVSGLVDRYCRKDVWDMWFHVLVAIVPSAVIGLPLDDWMTE
HLHNPPVVSAMLILYGVFFLLMESTVGKRRPQVRRIGQINYRMALFIGLFQFLALVPGTS
RSGATILGAMLIGCSRTVAAEFTFFLAVPTMAGASLVKVVKFLADGGGFSGSEVGILLTG
CAVAFAVSMLCIRFLMNYVKKHNFKVFGWYRIGLGALVLAYFYLLKPAL
>A0A0D9NFV7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVQQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFKPEMWKLYGLLIIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDNIFNKGREENEVTPKRAFLIGLFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKGDVKWATSDNLFLLGVGCVVSFAVAIFAMKWFVNFLTK
YGFKAFGWYRIIVGVILLAMLLSGMSLNMVD
>A0A085P9R5|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVLCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSSLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>ABC18266|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>A0A103U1G0|FEATURES|UNIPROT_deepARG|beta_lactam|WS86_03395|antibiotic inactivation|1
MKIRYALSSALVLLGCVAASAHAKPVCTAIADAATGRFLLKDGDCGRRATPASTFKIAIS
LMGYDAGFLRNEHEPVLPYRDGYVDWGGAAWKQPTDPTRWLKYSVVWYSQQVTHHLGAQR
FAQYAKAFDYGNADVSGDPGKNNGLERAWIGSSLQISPLEQIGFLRRMLNRELPVSAHAI
DMTERIVDTATLADGTVVHGKTGMAYPLLADGTRDEAHGFGWFVGWIARGKQTLVFASLT
QDERKEPVSTGIRTRDAFMRELPQRLAVR
>R8HZ57|FEATURES|UNIPROT_deepARG|beta_lactam|IIC_01061|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>J2VLA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTILALKALIMGIVEGLTEFLPISSTGHLILAGSLLEFSGPAFPKEKVDVFEIVIQAGA
ILAVCWEYRARIAGVLGGLFTDRKAQRLVINLIIAFLPAAVLGFLFSRRIKEQLFNPVSV
AIAFIVGGLIILWVERRNKDRMSMASARIETVDDMTPLDALKVGIAQAFALIPGTSRSGA
TIIGGMMFGLSRKAATEFSFFLAIPTLFAATIYSLYKDRALLSAADAPLFTVGTVAAFVS
AFLCVRWLLRYISSHDFTIFAWYRIVFGIVVLVTAYSGMVVWAE
>A0A101BCK4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSLVREIGGGPYALAPGPDGAMWVTLVHDGAIARVGADGAVDRFPVAAGARPSLITAGPD
GALWFTRNGDDRIGRITTEGELTDFPLAEGSAPFGICVGADGALWFTEMGSGGIGRITVD
GEVSGWASVGGTPSMITRGPDDAVWFTLNQGNAIGRLDPGDGVTMRELPTRNAGPVGITA
THDDAIWFTEILADKLGRIPLEGALQEIDLPGKPHAVVADPAGGVWVSLWGADRLARVGA
DGDVETFDLPPGSEPHGLAFGPDGALWVALESGFVLRMPD
>A0A0S1Z249|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARLLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0R2HLC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MITYLLSLFFGIVEGITEWLPVSSTGHLIILESFLNMKKMLGADFYSMFEVVIQLGAIMA
VVVIFWNEIWPFRNKQEEEGIKRYVDFEIINLWLKILVACVPAAIVGVLFDELFEKWFYN
PLCVSIALIVFGVAFIVVENKNKDMKPRVRSLKAINGKTAFLIGMFQLIAAIFPGTSRSG
ATIVGALMIGVSRTVAAEFTFFLAIPVMFGASLLKMVKFGFAFTSTQLITLIIGCVVSFA
VSMVIIKFLMAYIKKHDFKVFGWYRIILGILVLLLGVMGVITTH
>A0A064DBW1|FEATURES|UNIPROT_deepARG|beta_lactam|AF42_04072|antibiotic inactivation|1
MMKKSICCALLLTASFSTFATAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTTRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQIDAEA
YGVKSSVVDMTRWVQANMDASQVQEKTLQQGIKLAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>E6VX83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MASWYVAVILGIVEGLTEFLPVSSTGHLILTSHLLGFTGPKAETFTIVIQLGAILAVLTL
YLDRFIGLLRFDPQKNFSGPRGLWLLFLTSLPASLLGLAAHKYIKAYLFSPFTVACALAA
GAVMILVVESVDKQEKAATLDEITPWQALGIGLFQCLALWPGFSRSAATIMGGMLLGLRR
TVAAEYSFIAAVPIMVAATGYDFLKNYELFVADDLFFLAVGFGVSFIAAWAAIKGFIYLL
GRLTLRPFAVYRLTLVPLIFLFL
>A0A0K9GGS4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIELLKAFILGLVEGLTEFAPVSSTGHMILVDEMWLKSTEFLGQYTANTFKIVIQLGS
ILAVVIIFKDRFIDMLGLNRLFGKKEDKRTAEGNHLRLTHVIVGLIPAGVLGLLFEDYID
EHLFSIETVMIGLLVGSFLMIAADIVSGKKKEPKVTTVDQITYKQALSIGLIQCLSLWPG
FSRSGSTISGGVLLGLSHRAAADFTFIMAVPIMAGASLLSLVKNWEHFNLDALPFFIVGF
ISAFIFALISIRFFLKLINKIRLMPFAIYRIVLVAAIYFLYF
>A0A0Q7RTP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFLGFESNGKTFEIVIQLGALLAIVSVY
FKRLWALATRWPFDPEARRFLIGLLVAFAPAVVIGFLAYDFIKTVLFETPLVICIALIVG
GVLLLWLDRMKKVPTFLEADGYPLRVYFLIGLFQCLAMIPGVSRSGATIAGGLLLGTDKR
SAAEFSFFLALPTMGSAVAYDLLKSWDGLDFSDAGLIVIGFVTAFLTALAVVRFLLDFVS
RHGFAPFAWWRIAVGVAGIVGLALTGGL
>ZP_04167983|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLIKSWDILSTADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>H6D900|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MSVQHFRVALIPFFAAFCLPVFAHPETLLKVKDAEDQLGARVGYIELDLNSNKILESFRP
EERFPMMSTFKVLLCGAVLSRADAKQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0M0TL08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLIGGLILLKVDEW
FNNPNTAETSQEITYLQAVKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQINILVIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGYYRILAGIILLLIHFFIHPLTII
>U1SQC2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLTYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVDQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFALALIVMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSSADQVQS
>A0A0R1U9N0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDIFKAIIIGIVEGLTEFLPISSTGHIDLVQSLIHMGQSQQFKDMFNYVIQLGAIMAVV
ILYFNKLNPLAPSKEPAEKRSTWLLWAKVIVAVLPSVLIGLPLNDFMDEHLQTPPVIATT
LILYGILFIVIERWNDKRKPVINSLADVSFQLALCIGLFQALSIVPGTSRSGATILGAII
LGTSRYVATEFSFFLAIPTMFGVSILKLGKFFMQGNSFTGEQFAVLAVGFIVSWVVAWLT
IKWLLRFVQGHDFQGFGWYRIALGIVVILVMVL
>V7UGR5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTIACESLGKAWEILLIDDGSSDSSAELMVK
ASKEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>YP_002806276|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPKVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHSIAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A0D0N5E4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGDRAAAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVILGVIFADLIHHYLFNPITVATALV
IGGVIMLWAERREHVVHAETVDDMKWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDVAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>N9K3Z7|FEATURES|UNIPROT_deepARG|aminoglycoside|F909_03665|antibiotic inactivation|1
MNIMPISESQLSDWLQLRSLLWPDHEDAHLVEMRQLLTRTDTLQLLAYSEMQQPIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEHRRSGIATQLIQQVEQWAKQYACTEFASDAAIDN
TISHAMHQALGFHETERVVYFKKNIS
>D3ILG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQTIIVAIVEGLTEFLPVSSTGHMIITQALLGIESDEFVKAFDVIIQFGAILAVVVL
YWKRFFRLDHSTPPEGLTPVQRTLRKWDFYYKLLIAFIPAMIIGGLCNKYIDALLGNVMV
VAVMLVVGGVFMLFCDKLFGNGSPETKLTTRRAFAIGVFQCLAMVPGVSRSMATIVGGMT
QKLTRKDAAEFSFFLAVPTMFAATCLDLLKLFLHMHKIGDYSMLASHVGTLLLGSVVAFV
VALVAIKAFIAYLTKYGFRAFGVYRIIVGGAILAWLLAGNSLAMVD
>F0V6U1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A068QRL9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSTLLELKGVSRCYQAGEGQVTVLEDISLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGEYWVAGRNIADLDSDQLAELRREYFGFIFQRYHLLTHLTAEQNVEIPAIYSGASKIQ
RRERALELLGRLGLENRINYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSTSG
QEMMEILKELCQRGHTVVIVTHDPHIAAQAQRVIEIKDGRIMSDSRTSEHHTLPHTSSVN
AKTVNVKTSFVQQAWGRFNEALLMAWRAMNVNKLRTLLTMLGIIIGIASVVTIIVIGDAA
KSMVLSHIKSIATNSISIYPGKDFGSDNSLDTQAMKLADIPAIQSQPYIQAVSPQFMGSG
RLRQGNIDANAQVSGVGSDFFQVYAMKFAQGIPFTSEMVERQSQVVIIDDNTRKKFFPYQ
NNVIGKELLLANIPLTVIGVIANGQSFYGGDSLQIWLPYSTMNNRLIKQSYLSSIVVRLR
DGYDSNEAEEKLSNLLIFRHGKKNFHIYSINKTIEIMDKTTQTMQIFLTLVAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARTSDILQQFLIEAVLVCLIGGILGITLSSSLSLM
AQWMLPKWDFAYSPIAFIIAFGCSTAIGVIFGFLPARNAARLDPIEALARE
>M4VCY6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELRQIKKSYVMGDSTLEILKGIDLRIDDGEFVAIMGPSGSGKSTLMNILGLLDVPSDG
SYKFNEIETAHMSEDELAIVRRREIGFIFQQFNLLSRMTAAENVSLPLLYSKQAVGFERA
HKLLTDVGLESRLDHKPNELSGGQQQRVAIARALINNPRMILADEPTGNLDSKSEKEIME
ILKKLNASGITVVIVTHEEEIGHQAKRLIRMRDGQILSDERIEDYQKADNSSSGAWIETK
NSIKDFWVYFNQGFKTLLANKVRTVLSMLGVLIGVAAVVTILALGKGAEAQIKENLSSLG
TNLLMVRPGVTRVGGIAQSTGAANRLLYSDADVIKDKIESAHRVSAVVSTRAQVTFSAKN
WNTTVQGNSSDWAEMHSSVPLVGRFFTTDEDDQRARVAVIGATVKNELFGDQNALGEMIK
INKVIFNVIGVLPAKGASGWRDQDDIILVPLKTAMFRLMGTTSVSYIEVEVDKPENMVQA
QDSIVSALNTAHRIPDTRAEPAFEVRNMADIQEAMESTIGAISLLLSSIAAISLLVGGIG
IMNIMLVSVTERTREIGLRKALGARANDILSQFLSESVVVSVTGGLMGVLLAGIISMGIN
IFGGWATSITLQSVVLAMVFSSSIGVVFGVYPALKAARLNPIDALRSD
>A0A0J5GHK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLFLAKALLLGVVEGLTEFLPVSSTGHLIVVGDLIGFFNEGKVFEVAIQLGAILAVLF
EYRQRFVSVATGLRSDPKAQRFVLNLLVAFLPAAVMGLLFIKQIKYYFFNPVSVATALIV
GGLLILYAERRTHTARVHQVDDIGWRDALKVGCAQVLAMIPGTSRSGATIIGGMFFGLDR
KVAAEFSFFLAVPTMFAATFYDLYKHRDVLSLSDAPMFAVGFVAAFVSALLAVRTLVRFI
ATHTYEVFAWYRIVFGVVILATWYWGWVSWSV
>AAP92507|FEATURES|ARDB_deepARG|peptide|vph|antibiotic inactivation|0
METSPTMRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLP
GRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAV
ARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELA
ALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGE
ELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR
>A0A0W7XGU7|FEATURES|UNIPROT_deepARG|chloramphenicol|AMR95_16350|antibiotic inactivation|1
MFKKIDENYPRKEHFHHYMKVTRCSYSLVIDLDITKLHSILKEKKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADIEAY
SESNKLFPKPHMPENMFNISSLPWIDFTSFDLNVSTDETYLLPIFTLGKFKVKEGKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCEEWLDDSLGKS
>A0A068N6C3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGKLLVRGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKSHMTFY
>Q88IX3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLRPRLAALAAAITLALGPASAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLEAPAKRYHPALAGVP
IGDATVLELGAYSADCLPLQFPDTVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLTKMGLKNTYLQVPASAQGLYAQGYDADDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPQGLPPALAKATAITQQGYFQVGAMTQGLGWERYPYPVTL
STLIDGNSPQLIREPQATTRLQPALPALPAAWYNKTGATNGFGAYAAFVPAEQLAVVLLA
NRNYPNQARVQAAFDILSGL
>D8B6L7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9547_03543|antibiotic inactivation|1
MSWVASQTNHFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPG
MAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSD
PATKYWSELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQ
RLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGK
AVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQ
GLGWEMLDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVA
FIPEKKLGIVMLANKNYPNPARVTAAWQILNALQ
>E2XRX7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLLFSRFKLSQPRGYESLKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEII
LVDDGSRDNSAQLLEDAAAEAGSHVVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQ
NPPEEIPRLVEQAALGYDVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLR
AYRRTIVDAMLACRERSTFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDL
LTCMTTTPLRLLSIVGFSLAALGVVFAFALIVMRLAFGAQWAGDGMFVLFAVLFVFTGGQ
FIGMGLLGEYLGRMYSDVRARPRFFIEKVLRNTPAAPAPVVVVDGLASSHSSTSSDQVQS
>D6GRD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEFLKVFILGIVEGVTEFLPISSTGHLILVHQFFSLSPENFSNAFDVIIQFGAILSVVT
IYFKELNPFSKEKNAEQKKSAVSLWKKVIIGVMPAIVLGLLFDDLIDKYLFNPISVAVML
VFWGIGIIILEKKSKSVFQFNTVHDISCKTAFMIGLFQCLAMIPGTSRSAATIIGAMILG
CSRTTAAEFSFFLAIPTMLGATMLKVLKVGLHFDLFQWFLVLFGSVISYIVAILVIQKLM
SYIKKHDFQFFGYYRIVLGILVLIFSFFH
>S5YF28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHNTIVAAILGLLEGLTEFIPVSSTGHILLAGHFLGFDSPGRAFEVLIQLGAILAILGV
YAGRLWQIFSAAPHDPKARHFIYAVTLAFIPAVIIGVIAHDTIKNVLFETPKLIASMLIL
GGIVLLLVDKYAKNPKYHRAEDFPLPMALAIGVIQCLAMIPGVSRSGSTIVGALAFGADK
RSAAEFSFFLSMPTMLGAFVFDLMKNRDVLTEAAVSNIVIGFICAFIAAVIVVKGLLNYV
SAHGYALFAWWRIIVGAVALLALSIHG
>AAT97115|FEATURES|ARDB_deepARG|beta_lactam|SHV-5|antibiotic inactivation|1
MLYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>O52248|FEATURES|UNIPROT_deepARG|multidrug|ttgB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLVGALSILKLPINQYPSIAPPAIAIAVTYPGASAQTVQDT
VVQVIEQQLNGIDNLRYVSSESNSDGSMTITATFEQGTNPDTAQVQVQNKLNLATPLLPQ
EVQQQGIRVTKAVKNFLLVIGLVSEDGSMTKDDLANYIVSNMQDPISRTAGVGDFQVFGA
QYAMRIWLDPAKLNKFQLTPVDVKTAVAAQNVQVSSGQLGGLPALPGTQLNATIIGKTRL
QTAEQFESILLKVNKDGSQVRLGDVAQVGLGGENYAVSAQFNGKPASGLAVKLATGANAL
DTAKALRETIKGLEPFFPPGVKAVFPYDTTPVVTESISGVIHTLIEAVVLVFLVMYLFLQ
NFRATIITTMTVPVVLLGTFGILAAAGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATKRSMEQIQGALVGIALVLSAVLLPMAFFGGSTGVIYRQFSITIVSAMGL
SVLVALIFTPALCATMLKPLKKGEHHTAKGGFFGWFNRNFDRSVNGYERSVGTILRNKVP
FLLAYALIVVGMIWLFARIPTAFLPEEDQGVLFAQVQTPAGSSAERTQVVVDQMREYLLK
DEADTVSSVFTVNGFNFAGRGQSSGMAFIMLKPWDERSKENSVFALAQRAQQHFFTFRDA
MVFAFAPPAVLELGNATGFDVFLQDRGGVGHAKLMEARNQFLAKAAQSKILSAVRPNGLN
DEPQYQLTIDDERASALGVTIADINNTLSIALGASYVNDFIDRGRVKKVYIQGEPSARMS
PEDLQKWYVRNGAGEMVPFSSFAKGEWTYGSPKLSRYNGVEAMEILGAPAPGYSTGEAMA
EVERIAGELPSGIGFSWTGMSYEEKLSGSQMPALFALSVLFVFLCLAALYESWSIPIAVV
LVVPLGIIGALIATSLRGLSNDVYFLVGLLTTIGLAAKNAILIVEFAKELHEQGRSLYDA
AIEACRMRLRPIIMTSLAFILGVVPLTIASGAGAGSQHAIGTGVIGGMISATVLAIFWVP
LFFVAVSSLFGSKEPEKDVTPENPRYEAGQ
>Q8E9K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MDLIYFIKAFFLGVIEGITEFLPISSTGHLILIGDWINFSSNEEKVFEVVIQLGGILAVC
WLFRDKIINLINGVLKSDPVAQRFAVIVMISFLPSAIIGALFIHDIKNVLFNTTVVATAL
IVGGLIILWVENRKDSEKFKIENIEKIGFKQAIIIGIAQCIAMIPGTSRSGATIVGGMLS
GVSRKAATEYSFFLAIPTMLGAAIYDASKNYHLLNTDDILAILIGFSAAFISALIVVNAL
IRFVAKHSLSVFAWYRIALGLIIFSVN
>Q57R58|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQTRARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLAGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>Q898B8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIILAIVEGLTEFVPVSSTGHLILVSDVINFKGDYANLFNVVIQLGAILAVVVV
YWDKLLNSVKDIFAPDRRGLRFWINIVVACIPAVIFGFSLDDYIDKYLFNPITVAIGLVI
GGILMIIVENKYRRRSKTKNIYDMKLRQSIFVGMFQCLALWPGMSRSASTIMGGWIAGLS
PVVAAEFSFFLAIPVMVGASGLKLVKSGFYMTNIEFIALIVGFVGAFLVSLVVIEKFIKF
LQKKPMRIFAIYRIFIGAILLILAIFKIVTI
>A0A0S3BUF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A010PI61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEILKVILLGIIEGVTEWLPVSSTGHILLLDEFIKLNMSDAFKSMFTVVIQLGAILAV
VVIYWNKVWPFKKGQSHLISISKSKMIMWAKIIVACIPAAIIGIKFDDYIEEHFYNYFVI
SLALIIFGILFIIIENRNKESHKKLVDSIDKITYKQAFIVGLFQVIAAVFPGTSRSGATI
LGGIAIGLSRTIAAEFTFFLAIPTMFGASLLKLVKFGFSFTAMEAFVLLLGTAVSFVVSV
ITIKFLMNYIKNNDFKVFGYYRIALGVLVLIYFGLIR
>S9T6N5|FEATURES|UNIPROT_deepARG|beta_lactam|PAAL66ix_06808|antibiotic inactivation|1
MKHTRIRKIALFVGILTLSLANSNMFTGVSLQAEAKDKNEQQLKPVNQVHQQFVQLEKKY
DARLGVYAIDTGTNQSITYRSNERFAHASTFKALAAGVLLQQNSIKQLDKVITYTKDDLV
EYSPVTEKHVDTGMKLGELAEAAVRFSDNTAGNLILKELDGPKGFEKALRQIGDQVTHAD
RFETELNEAAPGDIRDTSTPQALADDLKALTVGNALPPDKRKLLTDWMRGNATGDKLIRA
GVPKDWEVADKSGAGGYGTRNDIAIIWPPNRAPIIIAVLSSRDKKDAAYHNELIAEAAKV
TMKALQ
>A0A0W0ZF05|FEATURES|UNIPROT_deepARG|beta_lactam|Lsan_0267|antibiotic inactivation|1
MKKISVLLGMTLLFCVSAWAQKTCFLARENQTVLKQKGDDCDQRYAPQSTFKIALSLMGF
DAGILKDAFHPEWPYKKEYELYLNVWKYPQNPHNWMRDSCVWYSQVLTQQLGMKRFKEYV
DAFHYGNEDVSGDKGQNNGLTHAWLSSSLVISPTEQMQFLQKMITGKLPVSQRAFDMTKD
ILYIQELAGGWKLYGKTGTGEQLTKDKNQKLSLRQGWFVGWIEKDNRKVTFVNHITDCKE
SFAGLKARNEALIQLFYLINELEK
>A0A096ZJW0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGETIKSVGK
>CAA63528|FEATURES|ARDB_deepARG|tetracycline|tetS|antibiotic target protection|1
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGRIKELGSVDSGTTKTDTMFLERQRGIT
IQTAITSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHA
LRKMNIPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQW
ETVIVGNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVIT
SKLFSPTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMY
TSINGELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKS
VQREKLLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRK
PTVIYMERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTEL
LEPYLSFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTF
FTNGRSVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>A0A0K1JST4|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTFSVTKEFDITLLKSMIKNKGYKLYPALIYIIVNI
INQNKVFRTGINSEGNLGYWDKLNPLYTVFNKETEKFSNIWTESNVSFNSFYNSYKSDLL
EYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITMGKFYSKNNKIY
LPVSLQVHHAVCDGYHASLFMSEFQNMVDSVNEWI
>D2KB72|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-1|antibiotic inactivation|1
SLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFK
VVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNS
AANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALXGDARDTTTPASMAATLRKL
LTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNN
KAERIVVIYLRDT
>A0A150QN86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHQSEAAKTLDIVIQLGAVLAVVVYF
RERLAVTVRGIVRRDPDSLRLALALAFAFFPAAFVGLLFHKAIKAYLFGPGPVAVALIVG
GVVMVVVEAVRRRRPDPGAPRLEDVTLQRAAAIGFAQCFALWPGASRSMTTIVGGQLSGL
STAAAAEFSFLLAIPTLGSATIFDLARNGRALLDAPGGPAALGVGLAVSFAVALLVIAVF
LRYLKRYGLAPFGWYRIALGAVVLWLWLASRAAPVEAGAAAEQPGAPSDVAAAEAGSAHG
DHPSRP
>G4HMT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYVANTFKVVIQLGS
ILAVVVVFKDRFLDLLGLKRKKPEAGAPAGTGRLKLSQVIVGLIPAGVLGVLFEDFIDEH
LFSTETVLIGLVLGAIFMILADKMSSNKEAKVVTVDQITYKQAFSVGLIQCLSLWPGFSR
SGSTISGGVMLGMSHRAAADFTFIMAVPIMFGASLLSLLKNWEYFTMDALPFFIAGFLAA
FVFALISIRFFLKLINRIKLVPFAIYRIVLAAVIALVLYL
>A0A0E3U577|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSTPAMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKHDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGSEHAEIEHLFG
NLYIISAGLAMAGILILISGRKRPPMGDRPMRGSDSAWIGAVQGVCLPFRGFSRSGSTIS
TGMLRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQTLSGHFMSVLTPSLVGMV
FSFLAGLIALRWLSRWLEHGRWYLFGIYCLVASAVVLAASQYL
>J7QFV6|FEATURES|UNIPROT_deepARG|polymyxin|arna|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFTYVGQKFT
VWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQG
SRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHPH
FHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLLIIRYCV
KYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEKE
GLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIR
DGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFR
VVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>X2GN15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYNIDGQSKSMTGRFNLMHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVIYALVAGSILMIAADKLAPRRPKVNSLDEISYGMAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGISHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYLGFYVVGFISSFVF
ALLSIKFFLALISKVKLMPFAIYRLVLAAILSVIIFM
>A0A0P7F3U6|FEATURES|UNIPROT_deepARG|chloramphenicol|AKG37_13355|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTLARCSYSLVIDLDITTLHAILKEKKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCMTDIETY
SENNKLFPKPNMPENMFNISSLPWIDFTSFHLHLSTDETYLLPIFTLGKFKVEEGKITLP
VAIQVHHAVCDGYHTGQYVEYLRWLIEHCEEWLSDSLYT
>A0A127SC00|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLSTASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVDAAWQILNALQ
>A0A0M3HC87|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENQFFGSVARIAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLCDEILNIAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQAVAIGPDDAALALHRKLCAAASDLLGQALPAI
REGKTEERAQDHSQATYVGRRTPEDGRLDWDKPAQTLHNLVRAVSDPWPGAFAYAGANKF
IVWKSRVRADLPAAKPGTVISVAPLVVACQQGALEIVTGQTERGVYMQGAQLAQALGLVT
SAVLSSKPVVAVKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPENEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPTVEMEETVEHTLDFFLRTVELTDDKN
S
>A0A0S6UJ95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVG
LYFRKLWDVVIGLFTGDAYARRFVIGVLVAFLPAVIVGLLAGKYIKLMLFNPWVICFTLI
VGGAVLLWVDKLELKPREHDATRFPLLMYLYIGIAQCVAMIPGVSRSGASIVAAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKSRAEMTMDHINIVVIGFVVSFITAIIVVKTFLTY
VTRHGFVLFAWWRVIVGTLGLIALALGR
>E5WKU7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MEFKLQEIDLASKDTGPYGIAVSDKGEVWFTQHKANKISCIGLDGELTEYPLPTPDAKVM
CVIVSSKGEVWFTENAGNKIGRITKEGTILEYPLPHPDSAPYGITEGPNGEIWFTEMNGN
RIGRIKDDGSIHEYELPTQGSYPSFITLGSDDALWFTENQNNVIGRITEYGEVTEFTIPT
PASGPVGITKGNDGALWFVEIIGNKIGRINTSGDITEYEIPTWNARPHAITAGAGNDLWF
TEWGANKIGRLTDNGIIEEYPIETPSAEPHGISSSDGKTIWFALECDKIGKLTIMND
>1703286A|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
VNTSYSQSTLRHNQVLIWLCVLSFFSVLNEMVLNVSLPDIANEFNKLPASANWVNTAFML
TFSIGTALYGKLSDQLGIKNLLLFGIMVNGLGSIIGFVGHSFFPILILARFIQGIGAAAF
PALVMVVVARYIPKENRGKAFGLIGSLVAMGEGVGPAIGGMVAHYIHWSYLLLIPTATII
TVPFLIKLLKKEERIRGHIDMAGIILMSAGIVFFMLFTTSYRFSFLIISILAFFIFVQHI
RKAQDPFVDPELGKNVFFVIGTLCGGLIFGTVAGFVSMVPYMMKDVHHLSTAAIGSGIIF
PGTMSVIIFGYIGGLLVDRKGSLYVLTIGSALLSSGFLIAAFFIDAAPWIMTIIVIFVFG
GLSFTKTVISTVVSSSLKEKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIGFLDHRLLPI
DVDHSTYLYSNMLILFAGIIVICWLVILNVYKRSRRHG
>W1HY09|FEATURES|UNIPROT_deepARG|chloramphenicol|catA1|antibiotic inactivation|1
MACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLKTWPIWTTSSPPVFTMGKYYTQGDK
VLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>C9CQD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFTNFIKAILFGIIEGITEWLPISSTGHLILADEFIGLNVTPEFMTMFNVVIQLGAILA
VVYLYFHKLNPFSPQKNELEKKDTWTLWFKVVVAVLPSVIIGLPLDDWLDAHFYNFFSVS
IVLIVYGIGFIVVEKRNKNKAPKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGA
IMIGASRYVAAEFSFFLGIPTMFGASALKIFKFLKDGNAFDFQGTVILLTGTIVSFIVSI
IAIRFLMNYIKRNDFTVFGWYRIVLGIILIGYWLIQL
>CAA08847|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSKTFIALAAFD
QEAVVGALAAYVLPKFEQARIEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>A0A0K1QT80|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
ASRDCSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRSNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRSIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLINLMFDLITCMTTTPLRLLSIVGF
AMAGLGVAFATVLIVLRLVFGASWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSQPATPVPVITVDGLNSTSSDQVLS
>A0A142IX48|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAKSRRDVLASAARIIAEGL
>A0A0B4XGL0|FEATURES|UNIPROT_deepARG|aminoglycoside|RGR602_PC02196|antibiotic inactivation|1
MESIIEIGESWAELRVALWPHHSLEDHRVELCRAFLSESGEAVAFIARNAANEAVGFAEA
TLRHDYVNGCSSSPVLFLEGIYVRPVDRRKGIARLLRNAVADWGKSLGCVEFGSDALLEN
SASHALHTALGFEETQRVVFFRKPL
>J2NG18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFGGLMELWTAVQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLG
AILAVVWEFRRKILDVVTGLPTQRNAQRFTINLLIAFLPAVVLGVIFADLIHEYLFNPIT
VATALVVGGVVMLWAERRQHEIHANTVDEISWKDALKVGFAQCLAMIPGTSRSGSTIIGG
LLFGLSRKTATEFSFFLAMPTMVGAAVYSGYKYRNLFQPDDLPVFAIGFITSFIFAMIAV
RGLLKFIANHSYAAFAWYRIAFGLVILATWQFGWVDWTSVHS
>M5P3G2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEDRMIHGLNHLLFSVSDLEASIAFYEKVFGAKWLVKAEKTAYFDLNGIWLALNEEKNIP
RTEIHDSYTHIAFSIKQEDVPEWEKKLTALGVNVLKGRKRHKGDKDSIYFTDPDGHKFEL
HTGSVLDRLAYYQKEKPHLSFHEANIKALYEKNK
>A0A0L8NVG7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGQVARVTTAGDVTTYPLRTATGGPTMI
ATGTDGALWCTEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDGAVWFTE
SAADRIGRITPDGTVTEYPLPVRGAFASVIATGPDGALWFTANQANAIGRITPDGDTVLH
DLPTPKAGPVGLTAGPDGALWFVEIAAGQIGRITTDGTVEEFPLPDPACRPHAIAAGPDG
ALWFTEWGAGRIGRITTSGRVDGYDLPDPASEPHGIALGPDGAMWAALETGSVVRIAVAA
EGA
>A0A060KZC4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLVAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRLDVLASAAKIVTDGL
>A0A0C2MSF7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSFINQSKVNICSAFGVIFAATTCMAATPSDEQLQALVNKAVAPVMQQQQVPGLAVAVTV
HGQPHYFNYGVVAKDTGQKVSENTLFEVGSVSKTFAATLAGYAQATGKLDLSTKASQIWP
ELKGSAFDGISVLQLGTYSAGGLPLQFPDPWDSADKMLGYYQQWKPSFPAGSQRLYSNPS
LGLFGYLAAKTLGQPYDQVMSETLLPKLGLQHTYLQVPKAQMSLYAQGYDKNNQPVRVTP
GAMDAQAYGVKTSAADMLRYVQANLKPASLDTPLQQAIANTHTGYYTVGDMTQGLGWEIY
RYPISLDRLLAGNSTEMAMQPHKVKWLNPPQPQADNVLLNKTGSTGGFGSYVAFVPSKDV
GVVILANKNFPIPERVKIAHTILSVLTD
>A0A0R5RPR9|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTINEMPE
FRTALTEKGLGYFSEMHPAYTIFNQGQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHIGRFIELLQEKINDFDSSFNSTSYEISAGGAV
>A0A0S6U0N9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGEFAKMFEVIIQLGAILA
VVVLYWKKIKESVVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKALFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQHIDSITFVQALKVGLLQILSLWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTSTLWGALILGFVVAFV
VSIIVMNKFVSYLKKKPMKIFAIYRVLAGLLLAVLVFTKIIVLTA
>R0FK27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTILALKALIMGIVEGLTEFLPISSTGHLILANSLLQFTGPSFSKEKADVFEIVIQAGA
ILAVCWEYRVRIATVLCGMFTDRKAQRLVINLIIAFLPAAILGFLFSRRIKEVLFNPVSV
AIAFIVGGLIILWVERRNKDRMSMASARVETVDDMTPLDALKVGIAQAFALIPGTSRSGA
TIIGGMMFGLSRKAATEFSFFLAIPTLFAATIYSLYKERALLSAADVPLFTVGTVAAFVS
AFLCVRWLLRYISSHDFTIFAWYRIVFGIIVLVTAYTGVVAWVE
>A0A0A8BDJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSTPAMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKHDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGSEHAEIEHLFG
NLYIISAGLAMAGILILISGRKRAPMGDRPMRGSDSAWIGAVQGVCLPFRGFSRSGSTIS
TGMLRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQTLSGHFMSVLTPSLVGMV
FSFLAGLIALRWLSRWLEHGRWYLFGIYCLVASAVVLVSSQYL
>A0A0A3AVW8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIDVGRLNKYFGEGDNRVHILKDIDLQIKKGDFIAIMGTSGSGKSTLMNILGCLDTAS
DGSYKIDGVETSPLSRDQLSDLRQKKFGFIFQRYNLLSALNAVENVALPAVYAGLPHDQR
LQKAKNLLEKLNLSDKFDNKPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSKSGL
MVMQILQDLHREGHTIILVTHDKDVADYANRIIEIKDGRIINDSRRSDEIIEKDIAVSIQ
KNRISRLKDQLVESFNMSVSAILAHKMRSLLTMLGIIIGITSVICVVAIGNGSQQKILSN
INSLGTNTMDIYNGTGFGDRRANRSKNLTVQDSDVLAKQHYIESATPNSAVSGTLTYGSK
AVSAQVRGVGDQFFNVKGLTLKQGQVFNQDDVKNSSQVAVIDENTQRELFPDKSPLGQII
MIDKKPLKIIGVAATNNNMGMMSSNLTIWIPYTTAMNKISGEKTIDSITVKVKNNINTQI
AEKNLTQLLTMRHGTKDFFVMNTDTIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIM
LVSVTERTKEIGVRMAVGARQSNILQQFLIEATLICVIGGVVGIVLSYFVGLLFNTFMSD
FTMLFSPASIIAAVICASLIGLIFGFLPAKNASQLNPITALSRE
>Q9R974|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-19|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>C2S3U8|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0013_22950|antibiotic inactivation|1
MKGMIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>A0A0S2KCV8|FEATURES|UNIPROT_deepARG|beta_lactam|PS2015_1163|antibiotic inactivation|1
MQTVLRLSVAVVLTGVMACTPQLDAPEDQSINLQSLVDSAITPVIEEYAIPGMAVALIHE
GQVHYFNYGVSSLQSGDAVTQHTIFELGSVSKLFNATLTTYAQAVGALSLRDYPSRFMPE
LQNTPVDSASLLHLGTYTAGGFPLQFPAYVTDHASMVEYYRQWQPDFGPGESRLYSNPSI
GLMGHLAGLALGQSYTEVVEGQVFPAMGMTESYIQVPETESEHYAWGYNAEDQPIRVTPG
VLDAEAYGVKSSSSDMIRFVRANISPDSLDALWSQAITDTQKQYFRLGEFIQSLGWEQFH
LPVSAELLRSGSAASIVLEPNTVEALDPDNSTATPVWIHKTGSTNGFGAYVVVLPAQQSG
IVMLANRNYPNTARIQAAWDILSPLLDL
>A0A0G3K7D9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0U4CCY3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
MTVRRFSCALGAALSLSALAGVPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
FKLPIALMGADAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVF
ARLLQDEKATKPNAGLRARDDLMRDWPAMADAPRQ
>A0A109ZRN4|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
FSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKK
AVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATY
TSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQ
VLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDML
SFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIV
MKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLT
>A0A0N0Y9N3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDIIVAIILGLVEGLTEFAPVSSTGHMIIVDDLWLKSKEIFGHDVAVTFKVCIQLGS
VLAVVVVMKDRFIDLLGLGKKKDGEGSRLKLTQVIVGLLPAGILGLLFEDKIEEFFTVNL
VIYSLIGGAILMIAADWFRPARPKVETVDQITYKHAIGIGLFQCIAVLWPGFSRSGSTIS
GGVLMGLSHRAASDFTFIMAVPIMLGASTVSLLKNWEHFTMDALPFFIVGFASAFIFALL
SIRYFLKLINKIKLVPFAIYRIVLALILFLVVS
>A0A060KTT7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAERHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0R3BLB5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLIAERFFHLGEGAFWDSFTVLIQLGAILAIVG
LYFRKLWDVVIGLFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKLLLFNPWVICFTLI
VGGAVLLWVDKLELKPREYDATRFPLLMYLYIGIAQCVAMIPGVSRSGASIVAAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKSRAEMTMDHINIVAIGFVVSFITAIIVVKTFLTY
VTRHGFLLFAWWRVIVGTLGLIALALGR
>Q8L1M4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEENQMKKSLCAVLLLTASCSALAAPQTEKQIADTVNRIMTPLMKEQAIPGMAVAVIYQG
KTHYFVYGKADIAANQPVTQHTLFELGSVSKTFTGVLGGEAIARGEIRLDDPASKYWPAL
TGKQWKGITLMHLATYTAGGLPLQVPDEVTDQAALLHFYQNWQPQWTPGAKRLYANASIG
LFGMLAVKPSGMDFEQAMATRVFQPLELNHTWINVPAAEEKHYAWGYRDGKPVHVSPGML
DAESYGVKTTIEDMASWVRANMNPAGVKDEMLKQGIELAQSRYWRIGEMYQGLGWEMLNW
PVKAKTVVDGSDNKIALASLTAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNIGI
VMLANKSYPNPARVDAAYRILDTLK
>A0A150DDN8|FEATURES|UNIPROT_deepARG|chloramphenicol|AT261_17945|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITLLIEKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNEEGVLGYWEKMIPSYTIFHKDDKSFSSIWTNYSSDFRIFYKNYEEDMR
YYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDENFLLPIITCGKYFNEGNKVM
LPVSLQVHHSVCDGYHASQFIEDLQQLSSTCNEWLK
>ZP_04227541|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSILFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFAVEQKDFERLLHRLEENNVHILQGRERNVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>A0A0J6KPZ9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHLLFSVSNLEESITFYEKVFDAKLLVKGNSTAYFDVNGLWLALNVEKDIPRND
IHHSYTHIAFTIAEDDFDKVYDRLVQLKVNILAGRQRDEKDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKQEKQHMVFLDN
>D4W9K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFSDKIDEMLES
VVIVAVMLVIGGIFMLFCDKIFSKGSEDTMLTERKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILLNNMPALIIGNVVAFIV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>G2S1M0|FEATURES|UNIPROT_deepARG|beta_lactam|Entas_0373|antibiotic inactivation|1
MKKSLCCALLLTASCSALAGTMSEKQLADVVERSVTPLMKAQAIPGMAVAVIYQGKPHYF
TFGEADVAAHLPVTQQTLFELGSISKTFTGVLGGDAIARHEISLSDPATKYWPELTGKQW
QGIRLLDLATYTAGGLPLQVPDEVTDNASLLNFYQHWQPQWKPGTTRLYANASIGLFGAL
AVKPSGMSFEEAMTKRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAEAY
GVKTNVKDMANWVMANMAPDTVADASLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAK
TVVGGSDNKVALAPLPAAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLAN
KSYPNPARVESAYRILSAL
>YP_001478113|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MAPAPKLINWKRNLFVAWLGCFLTGAAFSLIMPFLPLYVETLGVTGHQALNMWSGLVFSI
TFLFSAIASPFWGGLADRRGRKLMLLRSALGMSIVMLLMGMAQNIWQFLALRAVLGLLGG
FIPNANALIATQVPRNRSGWALGTLSTGGVSGALIGPLIGGLLADQYGLRPVFYITAGVL
LTCFVLTLLYVKEQFTPVQKKDMLHARQVFAALKSPKLILSLFVTTMIIQIATGSIAPIL
TLYVRDLAGDIHNLAFVSGLIASVPGVAALMSAPRLGKLGDRIGPERILVFMLIVSVLLL
IPMAFVQTPWQLGVLRFLLGAADGALLPAVQTLLIYNCTNQVAGRIFSYNQSFRDIGNVS
GPLMGAAVSASYGFRAVFCVTALVVLFNAVYSWWCLQRRPTRMREDTLQEE
>I3VNW6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-24|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTHPQQNAERRRDVLASAARIIAERL
>U2NC50|FEATURES|UNIPROT_deepARG|beta_lactam|L581_3703|antibiotic inactivation|1
MSIPFDVMCNNNVQHCYAVEKYGLKTKYTLVKKSTLMKWKGFMSRTGRLSVFFSAIFPLL
TLTNMAEAASQPPQVTVDKLKRLENDFGGRIGVYAIDTGSNKTFGYRANERFPLCSSFKG
FLAAAVLSKSQQQEGLLNQRIRYDNRVMEPHSPVTEKQITTGMTVAELSAATLQYSDNGA
ANLLLEKLIGGPEGMTSFMRSIGDNVFRLDRWELELNSAIPGDDRDTSTPKAVAESMQKL
AFGNVLGLTERHQLMSWFKGNTTGGARIRASVPANWVVGDKTGTCGVYGTANDYAVIWPV
GHAPIVLAVYTSKPDKESKHSDAVIADASRIVLESFNIDALRMATGKSIGF
>A0A127SF92|FEATURES|UNIPROT_deepARG|beta_lactam|VEB-1a|antibiotic inactivation|1
MENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQ
KIEITPQDLLPKTWSPIKEEFPNGTTLTI
>K9LL58|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-1|antibiotic inactivation|1
MKNTIHINFSIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>A0A0T9N349|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEDIFTMKTSIISSFIFTTLAASPLYASEQKILTQQQIATIVNNTLTPLIEKQDIPGMAV
AVFYDGKPLFFNYGFADIKNRRPVTENTLFELGSVSKTFTGVVGGYAEQTGILNLSDSAT
KYSPELTGLQWKDISMLNLATYTAGGLPLQVPDSVTSMKLLWQYYQQWQPQWAPGVMRNY
SNASIGLFGTLAVKKSNLSFEDYMTQNVFQPLKLTHTFITIPDYMQSDYAWGYKDGQPVR
VTPGVLAAEAYGVKSTAQDMVKFMQANIEPEKLLADNDKLKKAIIAAQSRYYRSGNMFQG
LGWEMYDWPINSQEVIASSSNEIALQPHKINALMPPYSAVPASWVHKTGSTNGFGAYIAF
IPEKKIGIVMLANKNYPNPVRVEAANHILQSLY
>A0A0G2BK63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSLFSALVLGVVEGFTEFLPISSTAHLNLAADLLRLAQTDYMKTFEIAIQSGAILAVLV
LYGKRFLRRDVLTRVAVAFLPTGILGLVLYKLVKTYLIGNTLVVLWALAAGGVLLILFEK
FHSEKDAVASIGEISYAHSFVIGVFQSVAMIPGVSRAAATIVGGMLLGLRRELIAEFSFL
LAVPTMFAATGLDLAQNIHAFSAGEMDLLLVGFVASFVTAVAGIKFLLAYIRAHSFTGFG
VYRIVLVAAFLAMMVFA
>YP_002850217|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASVGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPEDVALTLHHKLCQAARHLLEQTLPAI
NAGSYSEFPQQDADATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNDIAAQPGTVISVSPLLIACVDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQERCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPQNEASIQELAEMLLSCFEKHPLRNQFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>NP_457596|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>J9T1H8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA114|antibiotic inactivation|1
PASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQ
LTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLDFLRKVVN
RQLPVKAAAYELADNLFEVGQADGWRL
>A7XQR7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MLVGSSNDVTQQGSRPKTKLDIMRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAV
DGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIP
WRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVP
EQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPA
QYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>A0A0A0YXE3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPGWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>Q32DT3|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLTKYRGRAPLNWV
LVNGETETGVTLHRMVTRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQASDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>YP_001038094|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VatB|antibiotic inactivation|1
MQYGPDPSSIYPNENIKSICYIKNLITRPNIIVGDYTYYDDINGAERFEEHVTHHYEFIG
DKLIIGKFCAIAKGIEFVMNGANHRMCSVTTYPFNIMGHGWEKATPTLGDLPFKGDTVVG
NDVWIGQNVTVMPGVHIGDGAIVAANSVVTKDIPAYHIAGGNPVRITKKRFDDDLIDYLL
KLKWWDWPARKIFDNLEVLCSGNLSRIKEIK
>A0A0E1XVE6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDIVKAIILGIIEGITEFLPISSTGHLYLADYLVKLNQPSSFINMFMVVIQLGAILSV
ILIYFDKLNPFSKNKNKQKRKETWNLWFKVVVAVIPAAVIGLPLNDWLEAHMSTWPVIAS
TLIVYGILFILLENYCQHNQANITKLGSLSYQMAILIGCFQVLSLIPGTSRSGATILGAL
LLGASRYVSTEFSFFLAIPTMFGASLLKLVKFFAKGHSFHGDQLIILLVGMLVSFLVAYA
SIKLLLKFIKNHNFKSFGWYRIALGIIVILAGLSHLI
>J1GB62|FEATURES|UNIPROT_deepARG|beta_lactam|A936_17376|antibiotic inactivation|1
MKMIRLMIIPLLAGMCTPALSTPVNITDTIQTTEDHIKGRVGFTEIDFLSGKVLGSHRHE
ERFPMMSTFKVLLCGAVLARVDKGLEQLERRITYNEHDLDDYSPVTSLHLADGMSVSELC
NAAITTSDNTAANLLLSTIGGPEGLTQFVRSTGDNYTRLDRHEPSLNEALPGDERDTTTP
AAMAQTLRKLLNGSLLKIASQQKLITWMQEDKVGGPLFRSVLPAGWMIADKTGAGEHGSR
GIVALLGPRGKPSRIVILYITNTHSSMNELNEHIAGIGDSIIKHW
>A0A0A0Q9J0|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_pao|antibiotic inactivation|1
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYSAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLRRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>P05364|FEATURES|ARDB_deepARG|beta_lactam|ACT-7|antibiotic inactivation|1
MMRKSLCCALLLGISCSALATPVSEKQLAEVVANTITPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDAVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>Q478U2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPILLLKALILGIVEGLTEFLPISSTGHLILAGDLLNFNDDRGKLFEIVIQSGAILAVV
WEYRERLLKVARGAFSEPAAQKFILNLFVAFLPLAILGLAFGRAIKAHLFNPVTVASTFI
LGAFVILWAERREHKIRIQTVDEMSMLDALKLGIAQAFALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAIPTLIVATFYQLYKERALLNADDLAMWAVGFVAAFVSAFLCVRWLLRY
ISTHDFTAFAWYRIAFGIVVLATWQFGWVQWAAD
>A0A146A8A1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEK
QLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ
>Q30UH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILDSIILGAIEGFTEFLPISSTGHLIVASEFLGLEQNAINKAYEVIIQFSAILAVIFN
YKDKFSIKKIDLWMKVFIAFLPLAIIGFIFSTQIKELFSLHVVAVMFIVGGVVFLIVEKF
FINEDEKTIYEVEAISLKQSLIIGFAQIFALIPGTSRAGSTIIGALLVGLSRKASAEFSF
LLAFPVMGAVTAYDLLKHYKDFSEANLIILGVGFVTSFVVAYLSIKLFLKFLEKFTFFFF
GVYRIVFGVILLLFFN
>B1MW96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDFIKSIIIGIVEGLTEFLPVSSTGHIILAEALMKIPGGMVWTKSFTAVFDYAIQLGAI
FAVIQLYFHKLNPFSPRKTSREQFQTWRLWIKVIVGVLPAMVFGLLLNNFMDAHLLNPWV
VSATLIIYGIAFIVIENRQKNIAPVVTEVNRITFKMALFIGLFQVLSLVPGTSRSGATIL
GAVILGASRFVAAEFSFFLSIPVMFGVTILKVGSFLLKGGSFTGAQLFVMLIGFVVSWVV
ALFAIKVMMRYIQNNDFKIFGWYRIVVGILFLILGIAGLVKM
>A0A0K8NXB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILLKAAVMGVVEGLTEFLPISSTGHLILAGALLDFTGETAKVFDIAIQTGAMLAVI
WEYRVRLLATVRGIADEALAQRFARNVLIAFVPAAVFGLAFGSLVKRHLFAPVPVATAFI
VGGLIILWVERRHRRSYGERDLQGERRARIETVDDMGWQDALKVGLIQCLALIPGTSRSG
ATIIGAMLLGFSRRSATEFSFFLGIPTLVGAGAYSLWKQRALLQASDLPVFAVGLLFAFL
SALVCIRWLIRYVATHDFTVFAWYRIVFGGIVLLTAWTGWVQWVD
>D7YMD6|FEATURES|UNIPROT_deepARG|aminoglycoside|HMPREF9548_03739|antibiotic inactivation|1
MPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQ
EGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVD
VVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPK
TLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLEIEAPDRERL
AFYLRLDPLTWG
>K7QZZ2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY2-12|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A0J8Q4A7|FEATURES|UNIPROT_deepARG|aminoglycoside|STRNTR1_0556|antibiotic inactivation|1
MIDSVPTIRQATPADVAAWAQLRLGLWPDADDPLEELAESLADAEGAVFLACLAGGEAVG
FAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGHAVGRALLAAVQAWTRTAGCSELASDS
RVEDVQAHAAHRACGFEETERVVYFRMVLDAELPR
>E7DDD2|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-42|antibiotic inactivation|1
VGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLV
EYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLD
RWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDW
>A0A072NT24|FEATURES|UNIPROT_deepARG|aminoglycoside|M670_04457|antibiotic inactivation|1
MMRDFSNEKIPKQAMQALKIVEELLGSSIVGVYLFGSAVSGGLRINSDVDVLVVVNHSLP
EVTRKKLTDRLMLISGKIGNTDSVRPLEVTVINHSDVVPWLYPPRNEFTYGEWLRSEFEK
GQIQEPTYDPDLAIVLAQVRKNSISLFGPDASDIFDPVPMTDIRRAIKDSLPGLIESIKG
DERNVILTLARMWQTVSIGEISPKDIAAKWALPRLPKEHSTLLDLARKAYRGEHFDKWEG
LDSEVTALVNHMKNSIESCLSQTQEKQ
>A8FRR3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKHNQNIDFVSIVIPVYNEEASLPELLSRTLAAADSMGKHYELVLIDDGSRDNSANIIEA
AAAEPDSHVVGIILNRNYGQHNAIMAGFEHVRGDLIITLDADLQNPPEEIPNLVAKAEEG
YDSVGTVRRHRQDSALRRYPSKLINKLVKRSTGVEMNDYGCMLRAYRRHVVKAMLECHER
STFIPILANGFARHTAEIDVHHSERSQGESKYGFMNLINLMFDLLTSMTTAPLRMLSIVG
GGIASFGILFGLFLILLRLIYGAEWGVDGVFPLFSILFIFIGAQFVGLGLLGEYIGRIYS
DVRARPRYYVQDILVGEATKGARISDENKNN
>ZP_04150458|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVTQGPSLNLLHIIIGMIPAGVLGVLFHSKIKEVLFGPGPVVISLIVG
GILMIVAEKFSRPSTAKTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFATGFITAFLVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYYFFIM
>C2UNE1|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0018_55180|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSELPKQTKQTKQTKQTKQTNQTKQETTGNDSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLV
NYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
ALGVLKAKNK
>S5R7R5|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-123|antibiotic inactivation|1
QIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQL
ERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAF
LRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWM
VDDRVAGPLIRSVLPAGWFIADKNGASKRGARGIVA
>Q1WLM9|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA6|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAARLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAMEHLPDQHKPVLLEARQAYLGQGEDCLA
SRADQLAAFVHFVKHEATKLLSAMPVMSNNSFKPTPLRGAA
>A3D4C4|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal_2086|antibiotic inactivation|1
MQRHTLLATMPLLSGVLLTATLFSNVTTAQTLNTKDIQSLVDSAVKPLMAEYGIPGAVIG
ITIDGKQYFYQYGVSSKITGQSVTEHTLFEIGSISKTFTATLANYAQGEGKLTLTDMASD
YVPALKGSHFDKISLINLATHTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAPGTHRNYA
NPTIGLLGMIAAQSLNKTFQQALEQTLFPQLGMTSSYINVPSSKMADYAQGYDKQDMPVR
VNPGILADEAYGVKTTATDLLHFVEANMQMHPLAKPLQTALDETHTGYFDVGMMTQDMIW
EHYSYPIDLDKILMGHTQEVVFGSTPVKPIVPPLAPQQNVWINKTGSTGGFAAYAAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTGIEKLQK
>A0A0L0H0G2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSYPPVQKVSVVIPVFNEQESLPELIRRTGAACASLGRDYEILLVDDGSSDDSAQMLCD
AADAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSFFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVLHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALLGFAFSIALIVLRLALGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQGETVSQEEDRS
>D7N396|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
SARAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDTSKNPEIPESGIERIKE
QTSWLFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISAMGTNTISIFPGSGFGDRRSGRIKTLTIADAKVIAQQSYVASATPQTTSSGTLTYRNT
DLSASLYGVGEQYFDVRGLKLESGRLFDEADVKEDAQVVVIDQNTKDKLFGTDVDPLGKT
VLFKKRPLTVIGVMQKEENSFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKNDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQVIESTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNHFVT
EFPMEISVMSVIGAVVCSTAIGVAFGFMPANRASRLNPIDALAQD
>A0A099YDG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIELIKSFIFGLVEGITEWLPISSTGHMILLDQFVKLDVSKSFYSMFEVVIQLGAIMAV
VVIYWKRIWPFHHSQAVGIDAPKGIWRYVDKDIMIMWLKIFISCLPAGIIGVAFNDTFER
LFYNPVSVAIALIVFGVAFIWIETAHKGKKAKVNSIAEISYNMAVMIGFFQLIAAVFPGT
SRSGATIVGALLLGVSRTVAAEYTFFLAIPVMFGAALFKLLKFGLAFTSMEFWIMMVGLI
TAFVSSIIVIKFLMRYIKKHDFKVFGWYRIALGLLVLLYFLVLK
>A0A0H3I8F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGHTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYALVIGGFLLLAAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFVVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>J5B8E2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVVTGLPSRPDARRFALNVVIATLPAIALGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSIDELTPLDALKVGVAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDALGLFVLGLVSAFVSAFVCVRW
LLRYVATHDFTVFAWYRIVFGLFVLLVGYSGWLNWA
>N9C806|FEATURES|UNIPROT_deepARG|beta_lactam|F949_00487|antibiotic inactivation|1
MQTKYELKVKRLMMQSKYQNLFSNKTLMLIGLLSCSSSLWAQPLTELQIKKIVDQQFKPL
LKEYKIPGLAVAVTLDGQHYFVNYGVASLQSKQAMTNSTLFELGSVSKTFNATLAGYAQA
QGWLSLSDHPAKYFPELKNTSVNQATLLNLGTYSAGGFPLQFPDEVVTQQDMIQYFQNWK
TKTKIGEARQYSNPSIGLMGYVTALAMKKPYAELIEKTLLPQLGMTQSYIHVPEQKMSQY
AWGYKNNQAIRVSAGMFDAEAYGVKSSSSDMLKFLDAQINSAQLDQPIRQAVENTHIGYY
KVGAMTQGLGWEQYAYPVKLETLLQGNSSKMALESHAVTLIKHPQIASQSTYFNKTGSTN
GFGAYAAFVPQHKIGMVMLANTNFPNEARIKATYQAMQQILKQKAAP
>A0A084YVD4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTSAACKQLTQPYEIILVDDGSSDNSADMLTA
AAEQPGSCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVRVAEEG
YDVVGTVRANRQDSWFRKSASRIINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLNCHER
STFIPILANTFARRTTEIEVLHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFVLAVLLIALRLIMGPEWSGGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQPTHNTQEEE
>D0WAU7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLVGFHSNHKVFEIAIQLGAVLAVVV
EYRRRFAGVLHGLGKDKKANRFVLNLAVAFMPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSHTVPKKIDVDALRPVDALMIGIAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPVMVAATAYDVLKHYRFFTLNDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIAIIILWLSGRISWE
>NP_266279|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MKNKKSMMNLAISNLFLVFLGAGLVIPVLPTLKEQMHFSGTTMGMMISIFAIAQLVASPV
AGALSDKIGRKKLIAIGMIIFSFSELLFGLAQAKTGFYISRALGGVAAAMLMPSVTAYVA
DMTTIAERPKAMGLVSAAISGGFIIGPGVGGFIAHFGIRVPFYVAAILAFLGFILTITIL
KEPERTIESHQEIEKVSFLDILKNPLFGSLFIIILISSFGLQAFESIYSIMASINFGFSM
SEIALVITVSGILALFFQLFLFDAIVNKIGELGLIQLTFFASAIFIAVIAFTKSNLVVAL
STFVVFLAFDLFRPAVTTYLSKHAGNRQGAINGLNSAFTSFGNILGPMAAGYMFDLNHLF
PYYISAIILLGTGFLSLFLNRKNFSKI
>J5PUQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAAILGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRVPENRDYAAKLIVAFLITAILGLIVKKLGFELPETATPIAWALIIGGFWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAANEDWTALGIAFVVSTVVAFVAVKWLLAYIRSNR
FTLFAVYRIILGVLLLGMAATGLIA
>A0A0F5I709|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWWELFVALILGLVEGATEFAPVSSTGHMIIVDDILLKSKELFSEPVANTFKVVIQLGS
ILAVVVVFKERILQLLGLKKENSASGSSGTRLSLLHVLVGLIPAIILGFLFEDYIDEHLF
SVHTVLIGLVAGAFLMLAADWLAPSHVRTETVDDITFSQAFLVGLFQCIALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAMPIMAGASALSLFKNWEYFTMEALPFFTVGFISAFIF
ALLSIRFFLALINRIQLTPFAIYRIVLAAVIYFFFL
>A0A0L8MSV8|FEATURES|UNIPROT_deepARG|beta_lactam|ADK76_27725|antibiotic inactivation|1
MRKPTTSLTRRSVLGVGLGLGGALALGSTTASAASAGAVTSGTTRPGTTSSGNLAAVRRL
RALEREHQARVGVFALNLATGATLLHRAHELFPICSVFKTLAAAAVLRDLDHDGTQLSRV
IHYTGADVTKSGHAPVTKDHIDTGMTIRALCDATIRYSDNCAGNLLLRELGGPTAITRFC
RSLGDPVTRLDRWEPELNSAEPDRRTDTTAPYAIARTYQRLVLGNALDRPDRALLTDWLL
RNTTSVERFRKGLPKDWKVADKSGGGSTYGTSNDVAIAWTPDGAPIVLALFTHKPTQPTA
SGDTPLVIKAATVMSEAVTTA
>K7QCS8|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQGGKVRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
IGGHDSPLHGPE
>A0A154U588|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAIVGLLFSKQIKLHLFNPITVATMLVL
GGFFILWVEKRQTTAKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGWVSWSE
>U7UUN1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIVETIILAIVEGLTEFLPVSSTGHMIITRDLLGMRADDSFINAFIVIIQFGAILSVVA
LYWKQFFRLDRSPAPAGSTAVRAFLHKWDFYWKLLVAFIPAAVIGLLVNHLIEKMLGSVV
VVAVMLVIGGVFMLFCDRLFNHGSKMTPLTEKRALRIGLFQCIAMIPGVSRSMATIVGGM
AQGLTRKRAAEFSFFLAVPTMFAATCLDVFKLIKNGGVEALSAHVPTLLLGSGVAFVVAL
LAMKWFVAFLTKYGFKAFGVYRIIVGGAILIWLMMGHQLAMVD
>A0A0N0GBD7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0Q8ZD01|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>A0A0J1HTA6|FEATURES|UNIPROT_deepARG|beta_lactam|ABW01_18255|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSLTSLEAFTGGPMQVEAKEKKGQIKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKED
LVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRQMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLI
RAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAA
EVIVNAFR
>YP_002086467|FEATURES|ARDB_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
EEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWML
VYALVIGVVALFFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDI
GRLHVRNEQGEMVPLATFAKAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEQ
LMQGLPEGIAHEWSGQSFEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVP
LGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEA
ARLRLRPIVMTSLAFGFGVVPLALSSGAGSGAQVAIGTGVLGGIVTATVLAVFLVPLFFL
VVGRLFRLRKAPRTGNSPQIPTEQA
>S5MUL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLIFHDTIKSLFNPI
NVMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTVADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>B1ZF74|FEATURES|UNIPROT_deepARG|beta_lactam|Mpop_1481|antibiotic inactivation|1
MAARPHHRHEPRRKRALSARRKLTLVALVLSGLSSGPPPAAAEASSAQIAEAVERAYRPL
LKEYDVPGLAVAVTRDGQSAVFTFGLADREVQRPVTRDTLFEIGSVSKTFTATLAAYARA
LGRLSLEDAPGRFLPSLRGSALDRVSLLELGTYTAGGLPLQFPDGVAEEAAMIAWFRDWQ
PSAPPGTQRRYSNPSLGLFGAAAAAALGGNFTDLMETRLFPKLGFRNTFIRIPEAEMDRY
AWGYGKGDRPIRVNPGVLDAEAYGVKSSAADMIRFVEANLDPGRLDPPLRQAVEGTHVGY
FRVGAMVQGLGWEQYPYPVSLERLQAGHAPAMTLEAQPAARLDPPQVPSGPTLFNKTGST
NGFGAYVAFVPDKRIGLVMLANRAVPIPARIAAAHAVLEVLAEAP
>ZP_02902573|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMACVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>YP_001849482|FEATURES|ARDB_deepARG|quinolone|MfpA|antibiotic target protection|0
MEHWVDCEFTDRDFRDEDLSRLRTERVVFSECNFGGVNLTESEHRGSAFRNCSFERTTLW
HSTFAQCSMLGSVFVSCRMRPLVLDEVDFTLAVLGGNDLRGVDLSGCRLREASLVETDLR
KSVLRGADLRGARTNGTKLDDADLRGANLDPSLWRSASLAGARIDVPQALSFALAHGLRL
DS
>H1HM88|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLQTLIISIVEGLTEFLPVSSTGHMIIAQNLLGVPQGDPFVHAFTFIIQFGAILSVVC
LYWKRFFQMRTKQEFFDKMKFYGLLIVGVVPAVIVGLIAKKSGLLDRLLDSVEVVAATLV
IGGVFMLFCDRLFNKGTEENKVDWIRALKIGCFQCLSVIPGMSRSMATIVGGMQQQLTRQ
RAAEFSFFLAVPTMAGATLLDLLDMFKEGTDWATTQHIETLVLGCIVAFIVAILAMKWFV
GFLAKYGFRAFGWYRIIVGTVILILLATGHSLVMVD
>A0A0M1EXV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVTPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKDGKLGSENWTDVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>C3RGQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTWEAIIIAIVEGLTEFLPVSSTGHMIITQNVLGVESTEFVKAFTFIIQFGAILSV
VVLYWKRFFRLNHTPAPEGASSLARFLHKYDFYWKLFVAFIPAAVLGLLCSDFIDAMLES
VTVVAVMLIIGGVFMLFCDKIFNKGSEQTELTEKRAFWIGMFQCISMIPGVSRSMATIVG
GMAQKLTRKAAAEFSFFLAVPTMFAAMVYKMFKLFRDGGMDIIVNNLPALFVGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGVAILALLLTGHTLEMA
>BAE92853|FEATURES|ARDB_deepARG|quinolone|qacA|antibiotic efflux|1
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQW
LQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>A0A0T1WSF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQRLLAIAMALPSSEKARRFVLSIILAFLPAAVIGAVAHGFIKSVLFETPMLICIVLI
VGGIILYAIDRLPLKPIYRDVMDYPPSLALKIGLCQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALDFNDVSLIAFGFIAAFLAALVVVRSLLNF
VSNRGFAPFAIWRIIVGCAGLIGLWLVG
>R8QB82|FEATURES|UNIPROT_deepARG|beta_lactam|IIQ_02275|antibiotic inactivation|1
MKKNTLIKVGLCVSLLGAIQFVSTISSVQAEQKVEQKVIKNETGTISLSQLNKNVWVHTE
LGYFNGEAVPSSGLVLTTSKGLVLVDSSWDDKLTKELIKMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSTEAKDLGNVADAYVNEWSTSIENVLNRYKNMNLVLPGH
GEVGDRGLLLHTLDLLK
>B7LM76|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGVQALLDAGYEISAIFTHADNPAEKVFYGSVSRLAALAGIPVYAPD
DINHPLWVERIAQLAPDVIFSFYYRNLLNNEILKLAPHGAFNLHGSLLPKYRGRAPLNWV
LENGENETGVTLHRMVAKADAGAIIAQQRVAIDPEDAALTLHKKLCQSASQMLEYALPAI
KQGQTQETAQNESEATYFGRRKPEDSFLDWNKPATVLHNMVRAVADPWPGAFSYVGTQKF
TIWSSRVHPRVNAAQPGSVISVAPFLIACGDGALEVITGQSVDGITMQGSQLAQTLGLVE
GSRLNSQPVCTVQRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLTHP
NFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VQYHKRIIFPSTSEVYGMCTDKFFDEDHSNLIVGPINKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENTGNRCDGEIINIGNPDNEASIEELGKMLLASFDKHPLRQHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPTIDMQETIDETLDFFLRTVDIVEKSS
>U3N9N2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114v|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRRLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>A0A0N8TFG9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLESGYQIAAVFTHADDPAEKTFFGSVAQLCAQHDIPVHA
PEDPNHPLWIERVGKLDPDFIFSFYYRQLLSEPLLACARKGAFNLHGSLLPRYRGRAPAN
WVLVNGERETGVTLHQMVKRADAGPIMAQQRVPISALDTALTLHGKLRKAAANLLSDALP
LLARGRLPGTPQDESQATYFGRRTAADGLIDWARPAAQLNNLIRAVTQPYPGAFCPVGEH
KLIVWGARVEEADHGLAPGTVIDCDPLRIACGEGALVIGAGQRGADGLYLSGVQLAREFG
LVQGSRLQGQNQSRPTRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFSEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVVDGIEALARIIENRGERCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFREVESQSFYGKGYQDVSHRKPCVDNAKRLLDWTPTIELSETIGKTLDFFLREAMAEKA
DQR
>J4QKW1|FEATURES|UNIPROT_deepARG|beta_lactam|BURMUCF2_B0489|antibiotic inactivation|1
MRITVTRVVATLLVATAAIATTGRAAELTQAHIRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLVADAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMEQRLFPALGMTHTYIDVPDARRADYAQGYTTDGTPIRMKPG
GLWQPAYGVRTTAADLLRFVQANMGAIDIAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGER
>ZP_04621202|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVVLGLAFHDVIKSLFDPRN
VMYALVAGGVLLLVAEWFKPKNPKSIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLGDLPMFAVGFTTAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAAAVYWVFM
>A0A099JBC0|FEATURES|UNIPROT_deepARG|chloramphenicol|GY21_09535|antibiotic inactivation|1
MTEKRAIDLDTWPRREHFEHYLTRVECTYAMTVELDVTEMVAALRVVPWKSYIAQIWAIA
SVVNRHAEFRMTLTADEAPATWDIVHPAFTVFNPERETFANVWSPFHNDFSTFHERTADV
LARYRTATSFQPQPDIPSNVFDISSVPWASFTGFSLQTRDGWKHLSPIFTLGRYRETEGR
TVMPVAIQVHHAAADGFHTARIVQELQELFSDPGWLPK
>A0A0S3NIU2|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GQGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMACVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>ZP_04637931|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYSLFVAVVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAVVVV
FWRRLFGLIGIHFGAVPHEGKTSGHLTLGHILLAMIPAVVLGLVFHDVIKSLFDPRNVMY
ALVAGGVLLLVAEGFKPKNPKSVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISGGML
VGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLGDLPMFAVGFITAFIVALIAIKT
FLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A0M6WQP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAILFGIVEGITEWLPISSTGHMILLNEIVSLNVSDEFYSMFEVVIQLGAILAVV
ILFWNQIWPFGKKDNKEPLAKTGAGAYIKWDIFKLWFHILVSCVPAAIVGVLFDEQLEAL
FYNYQTVAIMLILFGVAFIVIENYHKGKKAKVNTLVGIDYKLAFWIGMFQLIAAIFPGTS
RSGATIVGALLLGVSRTVAAEYTFFLAIPVMFGASLLKGAKFLMNATMTSQEGVILVVGM
VVAFAVSLVVIKFLMGYIKKHDFKVFGWYRIILGVIVLLCGFAGFIG
>V7FMF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTVVEALLLGMLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFHRLWKMLLELPYDRLTRHFVLGILIAFLPAAVVGALAHDFIKTVLFESPRLICIMLI
IGGVILLLVDRMKPKPYYHDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFVAAFVTALIVVRFLLDY
VSRHGYALFGWWRLVVGIVGLAGLAIWG
>Q1RPS3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVSVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>P13924|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIVGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNILFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTAFFLLETTSWFMTIIIVFVLG
GLSFTKTVIPTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
GVDQSTYLYSNLLLLFSGIIVISGLVTVNVYKHSQRDF
>A0A142CM20|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVNGGLKPHSDIDLLVTVTVRLNE
TTRRALLNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>E4PYK2|FEATURES|UNIPROT_deepARG|beta_lactam|SUM_0029|antibiotic inactivation|1
MFCKNYNCNIGGFILKKLIFLIVMALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKS
GQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A126E3U4|FEATURES|UNIPROT_deepARG|beta_lactam|blaSFO-1|antibiotic inactivation|1
MVKNTLRQTTLMVATVMPLLFGSAPLWAQSANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSEMDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAELSAAAIQYSDNTAMNKILEHLGGPAKVTEYARTIGDKTFRLDRTEPTLNTAI
PSDKRDTTSPLAMAKSLQTLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>A0A0M4FM41|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MLKNSWRKSALMAAAVPLLLASGSLWASADTIQQKLADLEKSSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAS08424|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGKDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTFLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>G0ETS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRTRIGNVVRGLRADPLAQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFI
VGGVVILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLNADDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLVTAYSGLVSWHA
>K0FM29|FEATURES|UNIPROT_deepARG|beta_lactam|blaCI|antibiotic inactivation|1
MEQTCFLDCQLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGSLQVEAKEKNGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIS
YRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDLVEYSPVTEKHVDTGMTLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQIGDRVTMSDRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPDHKRKVLTEWMKGNATGDKLIRAGMPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATEVIVKSLK
>A0A0Y6SBY6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDDIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHKAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0G0SMS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYTWYMSVLHVFILSLIEGLTEFLPISSTGHLILASKLLGISETNFVKTFEIVAFIPTAV
VGFTLYPLIKDVLLGSSTVTLDALFWGGIALIGIELFLKKRNGSVRSNEIDYERITYKKA
FLIGVFQCLSVIPGVSRAAATIIGGLATGLNRPMATEFSFLLAVPTMIAATALDVYKSRE
FISQTGFLTLFAGSVLSFIFAMLAVKFLINFVKKHSFIGFGIYRIVLAILFWIFVK
>F0HXL2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFASSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIVLENYYAKRQPSLTDLNKMSYKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLFKFFKAGHVFVGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>A0A0S8G5K0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELMLLVQAVILGIVEGLTEFLPVSSTGHLIIVGDTLGFTGERAKAFEIFIQLGSILGVM
WYYRARVWALASGMHRAPERRFILNLFIAFLPAAVIGLLTHKYIKAYLFSPITVAVALIV
GGFLIFVIERWHKHRGARIHSVDEVTPLDAFKVGIAQTFSLFPGTSRAGATIMGGLLTGL
SRTTATEFSFFLAMPTMFAATLYDLFKSREYLQASDTLLFAVGFVVAFITAVFVVKGFLK
YVARHTFRPFAWYRIGFGSLVLFYFW
>A0A089M8N5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVIKAIILGVIEGLTEFLPVSSTGHLILAGNLLSFEGDAAITFKIVIQLGAVMAVLIL
YWRRYLAIGSNLIRMDFSQSKGLNVIHMILAMLPALILYLLFKDIIKSQLFGPTPVLIGL
VAGGLLMIIAARSRKTETADTIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLNSDNIILMLIGFTTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYLIVIL
>H0PT64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLPQYLVALILGIIEGLTEFLPVSSTGHLIIFGDLLNFNDEVGKVFEIVIQFGAILAVC
WDYRQRLTDVALGITRYASARRFVTLLFVGFLPAAVLGLLFHSKIKALLFNPLTVATALI
VGGLVILYLEKRNHRPRIHAIDDMRWTDALKVGFAQALAMIPGTSRSGATIMGGLIFGLS
RKTAAEFSFFLAIPTMFAATVLDLYKNRALLHLHDFPMFAIGFVAAFLSAMWAVRGFIRF
VSNHTFIAFAWYRIAFGLFVLATWYFGWVQWTAA
>A0A0F2JDL9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDLLSALILGIVEGITEFLPISSTGHLIIVSQFVGFTEQFAKMFDVVIQLGAILSVVVY
FRKRLIPSGRNYLSENHRIFDLWKKTIVGVIPALGIGFVAGKYIQERLFNSTVVGLALIV
GGIILVYIEKRKPLNRISSVEQLTYKTALLIGLIQCLAMIPGTSRSAATVIGAMLLGASR
VVAAEFSFFLAIPTMVAASGYTLFKSGSILTPHEFLVVAVGLIVSFVVAWLVIAGFMNYV
SKRDFKPFGYYRIVLGIIVLAYFTFLKF
>A0A0J7XQY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTFTAILLGIVEGLTEFLPVSSTGHLILATRLFGYDSSQWATFNIVIQLGAILAVIVQ
FWRTFWAVGTGLLKLNPTSIRFVRNVLLAFIPSAILGLLLKHYIDALLGEPAVVAWALII
GGFAILGVEKIAKPGPLTGVAELPAKQCLGVGLAQCLAMVPGVSRSGATIMGALAMGVER
RTAAEFSFFLAVPTMVGATTLELLGAREELMAGTGVVGWSEIAIGFFVSFVVALVVIKAF
MAFVSKSGFAPFAWYRICAGALALFLLSRV
>D2ZIZ2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MQDIDMFSAPTVQKVSVVIPVYNEQESLPELLRRTTAACETLGKAYEILLVDDGSSDDSA
HMLTDAANEPGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVA
KADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAML
HCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRL
LSVFGSVIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYI
GRIYNDVRARPRYFIQRVVRQEHKASQEEKHP
>A0A0R2TJ83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAETSTIVAALLGLLEGLTEFIPVSSTGHLLLAGHFLDFESAGKTFEVVIQLGAVLAVLT
VYAAKLWGVVTAAPNDPQARRFIGAVLIAFLPAVVIGVAAHDFIKSVLFETPILIASTLI
LGGIVLLFADRLAARPVHDQAMRFSPMMAFKIGVIQCLAMVPGVSRSGATIVGALMLGAS
RRAAAEFSFFLSMPTMAGAFAYDLYKNRTLLDASALSDIAVGFVMAFVAGVLVVKWLLNF
VSNHGFSLFGWWRIGIGSLALVTLLLGF
>ABO60993|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVQTTEGAVLLDGGMPQMAGHLLDNMKAREVAPQDLRLILLSHAHADHAGPVAELKRRT
GAQVVANAETAVLLPRGGSNDLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LPTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKETTGAR
>F1DI15|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
ETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAVLSAPALQYSDNTAMNKLIAQLGG
PGGLTAFARAIGDETFLLDRTESTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQR
AQLLTWLKGNTTGAASIRAGLPTSWT
>A0A0A0YXB4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEASQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>A0A0J7AWV2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNVFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVNDIPMFVVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>M1Z9P5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLNLIALIMGIVEGLTEYLPISSTGHLILVGSWLGFTGETAKIFEVFIQLGSILAIAVL
YRHRFYSFFTLAQFQKKGLNLLHIFLGILPAAVLGFVFYDWIKTLFSPYVVVFALLAGAI
LMIAAQLAKRKVTAESLDQLTYRQAFLIGLFQTLALWPGFSRAGATISGGLLLGASYKTA
AEFSFLVAVPIMFGTTGFDLIKNLDVLHPQDFGVFAIGFVTAFVVAMLAVVTFLKVLNRL
KLIPFAIYRILLAGVLFYYLYF
>A0A135I056|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMKTLFDALILGLLEGLTEFIPVSSTGHLLLAGHFLGFQSTGKTFEVLIQLGAILAILS
VYFGKLWKMLLALPHDPRTRRFVLGILIAFLPAAIIGAMAHGFIKSVLFETPMLVCIMLI
LGGFILLYVDRLDLKPRYHDVMDYPLSLCLKIGFVQCLAMIPGVSRSGSTIVGALLMGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKNRHILSFDDATVIFTGFVMAFIAGVFVVRYLLDY
VSRHGFALFAWWRLIVGAAGLAALLVWG
>A0A0J7B093|FEATURES|UNIPROT_deepARG|beta_lactam|TU52_03225|antibiotic inactivation|1
MKNTLLKLGVCVSLLGTIQLVSTVSSVKAEQKLEQKVVKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLVLTTSKGVVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGIKTLIERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYKILAGGCLVKSVSAKDLGNVADAYVNEWSTSIENVLTRYRNINAVVPGHG
EVGDRGLLLHTLDLLK
>YP_002243989|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIHENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>A0A0F0SVC4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELTDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLARAQALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRASRAAAPKEALP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQIFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A017H653|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPFFIIIILAVIEGLTEFLPVSSTGHMILAEFFLGKNIFRQEFMNHFLIIVQLGAILAV
VVFFWKKLNPFTKSKEEFRKKFQLWSKIIVGVLPAAIIGFLLDDYIEQHFMNNIYIVIFT
LIFYGILLMGIEHHHKKTAMKVRYGNFRKLRYRTALFIGCFQCLAMIPGTSRSGATIIGA
LLLGVSRPLATEFSFYLAIPTMFGATLLKLLKGGVVYTKQEWYYLGIGTSIAFLVAYIVI
SWFMSYIQKRDFSLFGWYRILLGIIVLVIYLLG
>C7XR02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKFIGGEYLSPTFINSFLIIIQLGAIFSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLNNVLIVAIT
LIAYGVIFIGIEIIYKLKNIKPKVKRFSGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMLGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYMVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>V4PIK2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHYLLAALLGLIEGLTEFLPVSSTAHLLISEKLLGFSDPGGNFTVMIQLGAILAVVVLYF
ARLWKAVITLPTSEESRRFALSVIIAFIPAVIFGVIIKKSGLLAALFDNIPVICIALIVG
GIALWAVDKYGPAPTSDDSMKLDLKTSLIIGLFQCLAIIPGMSRSGSTLIGAMVCKVDKR
AGAEFSFFLAIPTMLGAFVMEFADSHKLLTSDQYSFIAIGFAVAFISALLVIKPFITFVQ
KRGYGFFALWRIVVGVGGLVWWFGMAH
>X6Q2F4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIIEGLTEFLPVSSTGHMIITQNLLGVPSGDEFVHAFTFIIQFGAILSVVC
LYWKRFFHIDHTPVPADETCTFKKIIHPIRFYWLLFIGVLPAVIIGLAAKKSGLLDWLLD
SVWVVAIMLVVGGIFMLYCDKLFNKGKEENQVTEKRAFSIGLFQCLSVIPGTSRSMATIV
GGMANGLTRKRAAEFSFFLAVPTMAGATLLDLLDLLKGDSAWASAHNLIMLAVGCVVSFI
VALLAMKWFVSFLAKYGFKWFGWYRIIVGVIIIIMLLCDIPLNMVD
>A0A101VIA7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METWHVILLGLIEGLTEFIPVSSTGHVLLAGHFLGFCSPGKTFEVLIQLGAILAILSVYS
AKLLRLLIDLPFDARTQRFVLGILIAFLPAAVIGALGHSFIKSVLFESPMLICVTLIVGG
IILLVVDRLALEPRYADVMDYPPSLAFKIGLCQCLAMVPGVSRSGATIVGALLLGTDKRS
AAEFSFFLAMPTMAGAFAYDLYKNWSNIDTSDAASIAIGFVMAFITAVFVVRFLLEYVSR
HGFALFGWWRIIVGGVGLGALLILGNASVCA
>ABS75156|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
ILAVAIVFKDRILHLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLF
SVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALWPGFSRSGS
TIAGGVIVGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSYDMIPFFLVGFICAFVV
ALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>A0A0D8L0S8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAIIAILL
VYFQKLVSIAMAMPTSAKARRFVLAVFVAFLPAAVIGAIAHDFIKTVLFETPVLICVVLV
IGGFILLAVDRMPLTPKYTDIMDYPPSLAFKIGLFQCLAMVPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDALSFDDSALIAVGFVAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLVALLVYR
>A0A0P6RRU0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSSIQSSKVISCATVGLLFGATSCLAAVPSDAQLQTLVNDAVTPVMQQQDIPGLTVALTI
NGQAHYFNYGVAAKDTGQKVSENTLFEIGSVSKTFTATLAGYAQATGKLDLSTKASRLWP
ELKSSAFDNISVLQLGTYSAGGLPLQFPDDADSSDKMLGYFQHWKPVYPAGSHRQYSNPS
LGLFGYLAAKSLGQPFDQAMTQTLLPKLGLQHTYLSVPAAQMSLYAQGYNKDGKPVRVTP
GALDSQAYGVKTSAVDMLRYVQANLKPETLEASLQKTIANTHTGYYTVGDMTQGLGWEMY
RYPISLDRLLAGNSTEMAMEAHKVQWLNPPQPQPHDVLINKTGSTGGFGTYVAFVPSKDI
GIVIMANKNFPIPERVKIAHTILSAVAD
>D1LFJ5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
TLLNQRVEIKKSDLINYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIVHLGGPDKV
TAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNLTLGKALAETQRAQLV
TWLKGNTTGSASIQAGLPTSWV
>AAA26651|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|lnuA|antibiotic inactivation|1
MKIDNVTEKDLFYILDLFEKMEVTHWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
KKLEDIGYKIEVDWMPSRMELKHKEYGYLDIHPINLNDDGSITQANPEGGNYIFQNEWFS
ETNYKGRKIPCISKEAQLLFHSGYELTEKDHFDIKNLKSIT
>A0A0F0DVA7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTQQTIVFAYHDFGCAGIEALLAAGYQIDAVFTHADDPKENRFYGSVAQLCARLGIPVHA
PEDVNHPLWVARIRELQPQYIFSFYYRHLLSEELLACAAKGAYNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGGILAQQSVAIGADDTALVLHGKLREATRELLASALP
RLARGELQEVAQDESRASYFGRRTPADGQLDWKRPARELHNLVRAVTQPYPGAFAPVGDR
KLIVWSSRVAAGNNGMAPGSVLSVDPLRIACGEDSLEILSGQQNDSGLFLAGPQLAREMG
LVDGSRLHGAVGKPKRKTRVLILGVNGFIGNHLSERLLRDGNYEVYGLDIGSDAIERLKG
NPDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVR
YCVKYNKRVIFPSTSEVYGMCADANFDEDKSNLIVGPINKQRWIYSVSKQLLDRVIWAYG
QKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGEQKRCFTD
VDDGIEALARIIDNEGSRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRDQFPPFAG
FREVESRSFYGDGYQDVSHRKPSIENARRLLDWQPSVELSATIGKTLDFFLREALAERVG
GVPHAFPLKKSIAG
>A0A0D0M8P1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGERANRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETIQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMMLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWTDVSVAFIAATLTGFVVVKWLLGYIKKH
RFTVFAVYRILLGAALLLWLPAA
>G8HDC7|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
QLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYS
QNDLVEYSPDTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDH
VTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAG
PLLRSALPAGWFIADKSGAG
>ZP_04433622|FEATURES|ARDB_deepARG|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEVLLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWELERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPL
SMDYQPTHHKTLLTVEELRLGYEKNWLFAPLSFSINAGEIVGITGKNGSGKSSLIQYLLG
DFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLETLILSVKPAMLVIE
HDAHFMKKITDKKIALKS
>A0A0R1KAE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLKESTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNQHEKKQTWSIWFKVILAIIPSVVIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKNKQPQTAELEDLSYKTAFQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKILKFFAHGNTFSGDQIIILLIGTFVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVVAYFGIKAMVA
>R0CFW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
VVVMYFHKLNPFSPTKTSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVA
AALIVYGVLFIVLENSSVCTNPRFTKAGQISAKTAFLIGMVQLLALIPGTSRSGSTILGA
MVLGCSRAAAAEFSFFLGIPVMFGASLLKIVKYFLAGNAFTGPQIFYTILGMLIAFVVSI
YSIRFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>J8JAA9|FEATURES|UNIPROT_deepARG|beta_lactam|IIO_05852|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQKITY
THEDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSAFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKIVLNTLKATE
>A0A0Q6XAN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVILLIKAAVMGIVEGLTEFLPVSSTGHLILTGSLLGMTDAKSKVFDIAIQSGAILAVL
IVYWARIREALGGITNSAKQQRFVANIAIGFLPAGLVGLTVYKAIKAHLFNAPVVAGAFI
VGALIILWVEKRAQPVARVQSVDDMTALDALKVGLVQCLGMIPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLISAGGYSLWKERHALSMADAPMFAVGFIVSFLAAWACVRWLLR
YVATHNFVPFAWYRIAFGVVVLATWLTGTVIWAD
>A0A0J1NEV1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPG
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARQLLEEALPAI
KTGDYAEHAQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQRF
TVWSSRVCKNDRAAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTAKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAISRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>E3HNJ0|FEATURES|UNIPROT_deepARG|aminoglycoside|AXYL_02534|antibiotic inactivation|1
MKTTAITSSRNAAWLQLRMALWPDASAAEHQQDMDDQVSSPDRYAQFLVSSDGGQALGLA
EASIRTDYVNGTDSSPVAFLEGLYVIPEARQRGAARALVAAVREWALDRGCKELASDTAL
DNLVSQAAHSRLGFKETQRVVYFNMPL
>A0A127SV59|FEATURES|UNIPROT_deepARG|beta_lactam|CfxA6|antibiotic inactivation|1
MLNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSIS
QIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVK
INREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFI
AKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNAL
KECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFV
KDFKGNESQASQFVAHISAVVYSLLINTALN
>A0A0X3R1K7|FEATURES|UNIPROT_deepARG|aminoglycoside|AR275_20405|antibiotic inactivation|1
MGAPNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFS
ELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLA
DALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRAT
RPAHEDLVVSHGDACLPNLMVADGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRC
VATLFQRYGAVPDERRLAFYRLLDEFF
>A0A0L1LT32|FEATURES|UNIPROT_deepARG|beta_lactam|ACS78_21095|antibiotic inactivation|1
MKTWKEMFRTSKLKKMMPVLALSCAAAISFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGVFALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLDERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALAASLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKGAEYNDKLIAEAAKQ
AVKALRVAHK
>A8YZV4|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGDNDQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNPQTVDQISYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>N8VLI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAFTGQEQGRRLSLNLIIASIPIVIIGLSFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLAVGIIVAFISALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>A0A0E2ERJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFEIIKAIIFGIVEGITEWLPISSTGHLILVEEFIHFNNANAAFTNMFNVVIQLGAIL
AVVVIYFDRLNPFKSGKTAREVQITWQLWAKVILSALPAAVIGLIFDDWLDAHFQNFFSV
ALMLILYGIAFIYVERRHQGVEPQVTHLVSLPYKTAFFIGLFQVLSLIPGTSRSGATILG
GILLGTSRQVATEFTFFLGIPIMFGASLVKVLKFIVSGTILTGSQLFILLVAMLVAFAVS
LYVIRFLTDYVKNHDFTFFGKYRIGLGIFLLFYGLMKVLFG
>J8B7I0|FEATURES|UNIPROT_deepARG|beta_lactam|IEQ_02112|antibiotic inactivation|1
MKNKRLLKIGICVGILGLSLTSLETFTGGALQVEAKEKTGQVKHKKHASYKEFSQLEKKF
DARLGVYAIDTGTNRTIAYRPNERFAFASTYKAVAAGVLLQQNSTDKLNEVITYTKDDLV
EYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMAD
RFETELNEAIPGDIRDTSTAKAIAINLKAFTVGNALPDHKRNILTEWMKGNATGDKLIRA
GVPTDWGVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATEI
IVNALR
>A0A0S3NSC4|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLTGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASIFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMTIMGVAVLMLSLFILKE
THPAAPATSNKPQENTESLLNRFFLSRVLITTLSVSVILTFVNTSPVLLMEIMGFKRGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMIASQLLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGVGAWNMLIGI
LIACSIVSLLLIMLVAPGRTVAAHEEIHHHA
>D5WHB3|FEATURES|UNIPROT_deepARG|beta_lactam|BC1002_3846|antibiotic inactivation|1
MKTRALKLITTATFALFTLSAISPAGHAAEPAAAQLQSTVDAAIRPLMAKYHIAGMAVGV
IDDGKPYVYNYGVASTQTGKPVTRDTLFELGSVSKTFTATLASYAQLDGKLSLSDGTERY
LPTLRGRPFGKVSLLNLGTHTPGGLPLQVPDDIRNNAQLLQYFHDWQPAHPPGTFRTYSN
PGIGTLGLITAKTMGQDFTALMQQRVFPALGMKSTYIDVPAAKMPDYAQGYAKDGAPVRL
TGGVISAEAYGVKSTAADMLRFVQANMNLIPLDSQFQRAITDTHTGYFQAGVLTQDLIWE
QYPYPVELPTLLAGNSLAMVLNGSPSTEIKPPLPPQQNVWINKTGSTNGFGAYVAFVPQK
RLGIVMLANRNFPNEARVSAAHQILSALDDGKR
>K5EBC6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQELIRVVILAIVQGIAEFLPISSSGHLVILGSMLGELGESVTLEIILHAGTLGSILVVF
WQRIWALLLKDRRVIGLLVIGTLPAVVIGLTIKTQFPEILRSPLLAGAMLIVTGVMLIVL
GRLTPKSGTYDRLGLGAAFLVGCFQAFAILPGISRSGSTILGGRLMGLDRDDSVTFSFLL
AIPAILGATVLAIKDLLEDGSSGETSIEVLLIGAAVAFAVGIVALRWLIRWSREDRLHWF
AYWCIPAGLLVVLLNLR
>A0A127SDL6|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGYAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>M4WT30|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPINRVSIVIPVYNEEASLPELLRRTTAACDTLGRDYEIILIDDGSRDSSADLLLEA
AEAPGSHVVAVILNRNYGQHAAIMAGFEECRGDLVITLDADLQNPPEEIPRLVEQAAQGY
DVVGSVRQQRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRASIVKAMLACRERS
TFIPILANSFARHTSEILVAHAEREHGESKYDFMRLINLMFDLVTCMTTTPLRLLSLVGG
TMALAGFCFALLLLALRLVFGAAWAGHGVFVLFAVLFTFTGVQLVGMGLLGEYLGRMYND
VRARPRFFIERVVRPRAALEARTTTPSSSLESLQP
>R8XL67|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKENVAGGTEPV
VKTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTITGILFGWLPARNAARLDPVDALARE
>A0A068JFY8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLEPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTSSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIMSVGK
>D8MNJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWAFACHENVIFISQRENVLSLFHVLLLAVVQGLAELLPVSSSAHVIMTEKLLGLDPSAP
DMTLLLVMLHAGTMFAVIVYFWKSWVETYFSSVRAFKKNMLLIFLASLCTGIVGLLLLKV
ITALYAKNAPHFEIEQLFSNTKLIAGGLAAAGLLILYSSRQKENKDGELSPKSAMIVGIV
QGLCLPFRGFSRSGATISAGMASGVSRKRAEEFSFALAVALTPPVIIKEVVRVYQHGGQA
AAAGGHGAMSGILVPSLVGMVFSFLSGLLALRWLSRWLEHGRWHLFGGYCLLAAVVVGVF
G
>A0A064D7K3|FEATURES|UNIPROT_deepARG|beta_lactam|AF41_03335|antibiotic inactivation|1
MFKKRGHQTVFIAAVLAFFTASSPLLARTQGDPAQVQEKLAALEKQSGGRLGVALINTAD
RSQILYRGDERFAMCSTSKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYVD
KEMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPELNTAIP
GDERDTTSPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGDK
TGGGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL
>A0A0L6NED3|FEATURES|UNIPROT_deepARG|beta_lactam|AGA26_18605|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPHAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSHYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
SNPARVTAAWQILNALQ
>CAJ75666|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|lnuA|antibiotic inactivation|1
MKINNVTEKDLFYILDLFEKMEVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVDWMPSRMELKHKKYGYLDIHPINLNDDGSITQANPEGGNYVFQNEWFS
ETNYKGRKIPCISKEAQLLFHSGYDLTEKDHFDIKNLKSIT
>I1V584|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAALQYSDNT
AMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNL
TLGKALAETQRAQLVTWLKGNTTGSASIQAGLPTSWVV
>A0A0A1RJP3|FEATURES|UNIPROT_deepARG|chloramphenicol|catA4|antibiotic inactivation|1
MIFLLAKVVNKHTEFRMAIKNNELVIWNEIHPSYTIFHNETETFSSLWSRYDGNIHHFQN
TYSEDVARYCHNLSYWPKGESPENIFFVSAIPWVSFTSFNINIANMQNFFAPMFTLGKYY
EQDGKVVLPLAVQVHHSVCDGFHLARLINELQEMSHDLRHHSEERNV
>A0A0Q7TTT3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAAPIIRLDHVSRTYRVGDVDVHALRDVSLEIDAGEFVAIMGASGSGKSTLMNVIGCLDR
PTSGHYFFEDLDVATLSEPERARLRGERLGFVFQSFNLLARTSALENVALPLFYAAAGPA
GLAPRNTRARAMLSLLGLAERERNTPGQLSGGQQQRVAIARALINEPGLLLADEPTGNLD
TRTSHEIMETLTTLNRKQGVTIIVVTHEADIAAYADRVITMRDGSILSDVRNPKPGDTRP
ASKAVPARAVAVQHPTAAWAFARMIVAAALQAIHRNMMRSALTMLGVFIGVAALIAMVAV
GQGANEAVRKQIESLGTNLVVVLPGARTAGGMRGGFGSASTLTTADAHSIKREATAVSEV
SYIIRQSGQVQSGNQNWATSIQGVSANYPPMTNWRVAEGREITDDDDSAAALVVVIGQTV
VKQLFGEAVNPIGALIQVKTTPMRVIGILASKGQTPFGQDQDDLVMMPFATAERKVLGVA
APTQTQTPLNWIYPAPPNPYGLTPHLAGYVNQIFVQAGSSSDVQIAVQQVTDVLKRRHRV
KPGDEEDFSVRNLSQIAETAESSSRIMALLLAAVASISLVVGGIGIMNILLVSVTERTRE
IGLRMAIGARRLYVLLQFLAEAILLSVTGGIAGIVTGVAASLGVGLLTGWPTPISGAAIA
IGFLFSAAVGIFFGYYPARKAARLDPIEALRFE
>YP_001669149|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPITVATALV
VGGVIMLWAERREHRVQVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWSTAHG
>A0A0C2V569|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLAMLEALFLGIVEGLTEFLPISSTAHLMLIGDMLGFEGPPGKTFEIVVQLGAILAVCVV
FWPRLWGVVTTITQPRSFAFARNVMIAFLPAAVIGATLYKYIKQMLESPLIAAIALVVGG
IAILIIERLINRARIHDIEDMSPALALGVGFCQVLAMVPGVSRAGATIMGSMLLGLDRRA
AAEFSFFLAIPTMCGASAYSLYKNWSTLSFDGAGLIALGFVAAFVSALVVVKGFIGFVGR
HGFAPFAWYRIIFGSTMVVLILMR
>R7QWH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEMMELLKVVLFGIVEGITEWLPISSTGHMILLNEVVSLHVSDEFYSMFQVVIQLGAILA
VVLLFFKQIWPFGRKNNEEPLTAHGAGAWIKTDIFKLWFRILVSCVPAAVVGILFDDILE
EMFYNYRTVAIMLILFGVAFLIVENRNHGKKAQVTSLKDITYRLAFWIGMFQLIAAIFPG
TSRSGATIVGALLLGVSRTVAAEYTFFLAIPVMFGASLLKLVKFGLAFSAAETAILLTGM
VVAFVVSLIVIRFLMGYIKKHDFKVFGWYRIILGAIVLLCGVCGLLP
>A0A0D1JRY7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKSINHICFSVRNLNDSIHFYRDILFGKLLLTGKKTAYFKLAGLWIALNEEKDIPRNEI
HFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGT
LENRLNYYKEAKPHMTFYK
>A0A022FVB8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRIPVATIATIATIAMACSLFAANASAADSVGQRQIERAVNDAIRPLMAAHGVPGMAVA
VTAGGKRYVFNYGVAAKAGGRKVDGDTLFEIGSVSKTFTATLASYGQARGALSLADPAGK
YLPALAGSSLGATSLLDLGTYAAGGLPLQFPDAVTDTRSMLDYFRGWRPRYAAGTHRQYS
NPSIGLFGYLAASSMGQPFDDLMEKTLFPALGLAHTYIRVPKARMGDYAYGYSKDGKPVR
VAPGVLDAEAYGVKTTAADMIRFVEANIDSAGLDDKLRRAIAGTHTGYFKVGDMVQGLGW
EMYAWPTRVDSVLAGSSPQVVLEANPVSRLEPPLSSPADVLVNKTGSTNGFGAYVVFVPA
KRIGIVMLANKNFPVPERVKAAFRILAVLDGVPAGAGSR
>A0A084ZNX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQRPHEGFGKGRLSLIHILLGMIPAVVLGLVFHDTIKSLFNPVN
VMYALVVGGLLLIAAECLKPKEPRAQGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFVTAFIVALIA
IKTFLQLIKRISFIPFAIYRFIVAAAVYAVFM
>A0A098FLV7|FEATURES|UNIPROT_deepARG|fosfomycin|yndN|antibiotic inactivation|1
MSIKGLNHFLFSVSDLDSSIEFYQKVFDAKLLVKGRTTAYFDLNGMWIALNEEKDIPRNE
ISQSYTHIAFSIEEADFMNMYEKLIGLNVNILSGRPRDEKDKKSIYFTDPDGHKFEFHTG
TLQNRIDYYKQEKAHMEFFD
>A0A0A0QAX2|FEATURES|UNIPROT_deepARG|beta_lactam|MIR-10|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLANVVERNVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEEAMTERVFKPLKLNHTWINIPHAEEPHYAWGYREGKAVHVSPGLLDAEA
YGVKSNVKDMASWVMANMAPDTIQQPALKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVDGSDNKVALAPLPAAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPLRVETAYRILDTLQ
>A0A0B0KLG8|FEATURES|UNIPROT_deepARG|beta_lactam|PJ15_3374|antibiotic inactivation|1
MPNSKRFSILAKQLCVLAGLLSCSAPLWAQQLSEQQVKAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGMASKQSQQPIRNNTLFELGSVSKTFNATLAGYAQAQGRISLSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMVKYFQAWQPKTTIGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQMPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLKQPLRKGIENTHVGYFKVGAMTQGLGWE
QYAYPTKLETLLQGNSSSHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQKIGIV
MLANTNFPNEERIKASYNVIQQLIQQNSAR
>A0A109EN22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGEPPRVMSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVSAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>Q8L319|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLQAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFGPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>E2PJ30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILS
VYSAKLVKIATDFPRDARTRRFVLGVLVAFLPAAVIGALAHGFIKGVLFETPMLVCIMLI
VGGFILLWVDQLNLRPRYHNVMDYPLPICLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKSRNILSFNDGALIVVGFIMAFISGVFVVRHLLDY
VSRHGFALFGWWRLIVGSAGMAALIIWG
>Q3LS62|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_sm|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPEVRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>CAE12904|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHFARKRFGQNFLTDQFVIDSIAAAINPQPGQAVLEIGPGLGALTEPVGERMD
KMTVVELDRDLAARLQVHPQLKDKLTIIQQDAMTVNFGELSQQRGKPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPGSKTFGRLSVMAQYYCQVIPVLEVPPTA
FTPAPKVDSAVVRLVPHKSIPHPVKNIRMLSRITTQAFNQRRKTIRNSLGDLFTVEQLTE
LGIDPSTRAENISVEQYCKMANWLSEQPEMQS
>L0MG14|FEATURES|UNIPROT_deepARG|beta_lactam|D781_2591|antibiotic inactivation|1
MLKKTLTLLPLCLALLPAFSHAVDKTDIDKIVQPLMEKYAVPGMTLAVSVDGKPQFYNYG
VASKQSKQPVTQNTLFEIGSLSKTFTATLAAYAQHTGKIDWAQPASHYLPQLRGSAFDRV
SLLNLATHTSGLPLFVPDEVTNEQQLMDYYRQWQPSHPIGSYRVYSNLGIGLLGMITANS
LKQPFAAAMEQRLLPTLGMTHSYLNVPPAAQKDYAQGYNKDDKPVRVTPGPLDAESYGLK
SSSSDLIRYLNANMGLVKVTPDWQQALDGVHRGYYRASEFTQDLMWESYPYPVKLETLLA
GNDVKVIMDGTPAQAITPPQAPQQQAWYNKTGSTNGFATYAVFIPAQKTAVVMLANKNFP
NDERVKAVYQIVQSLAH
>K1JLC1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVVIPVYNEEASLPVLLSRVTAACDQLSQDYEVILIDDGSHDGSTELISEA
AAREGSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTMRRNRQDSWFRKTASKLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
VVAGIGFVFSILLILMRLVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHRIVRTATTPSQQEAEQ
>G5D5E6|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-143|antibiotic inactivation|1
KVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDN
SAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRK
LLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLAPN
NK
>NP_756936|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDSLIQRTLSGSHPLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPIVEKK
>A0A0L0M879|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRARIINVVGGLPTRPDARRFAINVIIATIPAIVLALLLEKQIKAVLFSPVPVSVALI
VGGIIILWAEGRQRDRQHPPRVHSIDDLTPADALKVGLAQCFALIPGTSRSGSTIIGGML
FGLDRRVATEFSFFLAIPVIFGATLYEMAKYWRTLSVNDIGLFAIGLVAAFVSAFICVRW
LLRYVASHDFSAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A0K2ZH55|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFSALLLGILEGLTEFLPVSSTGHLLIAEQWLGRRSDFFNIVIQAGAILATTLVFRQRLW
TLATGLGDRANRDYVLKLGTAFLVTAVVGLAVRKAGWQLPESVQPVAWALVIGGVWMLVA
EHFAARMPERERVTWKVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAADFAF
LVGIPTMFAASGYSFLELYKNGAVGSEDWGDVAVAFAAAVVTGFIVVKWLLGYIKSHRFT
AFAVYRIVLGAALLLWLPAA
>ZP_02194849|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKEEASSLIKLATPVLIASVAQTGMGFVDTVMAGGVSATDMAAVSVAASIWLPSILF
GVGLLMALVPVVAQLNGSGRRVKIPFEIQQGIVLALLISIPIIGVLFQTQFILELMDVEA
VMTEKTIGYIHAVIFAVPAFLLFQTLRSFTDGMSLTKPAMFIGFVGLMLNIPLNWIFVYG
KFGAPALGGVGCGVATTIVYWIMFGLLLLYVTTSARLKSINLFGEFHKPQIKAQIRLFKL
GFPVAAALFFEVTLFAVVALLVSPLGPIIVAAHQVAINFSSLVFMLPMSVGAAVSIRVGH
RLGEENVDGARVASRVGVIVGLVLAMITAILTVLFREQIALLYTNSPEVVELAMVLLLFA
AIYQCTDAVQVIAAGALRGYKDMRAIFNRTFIAYWLLGLPIGYVLGRTDWVVEPMGAQGF
WLGFIIGLSSAAFLLGIRLRWMHRQAPEVQLNFSQH
>D4W9A8|FEATURES|UNIPROT_deepARG|beta_lactam|CUY_1556|antibiotic inactivation|1
MCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTV
SVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPV
ISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPHSSFQIAYTEEEMSADH
DKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVI
AHKTGSGDVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVY
SLLINTALN
>A0A0K0NPH4|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMAT
TLRKLLTGELLTLASRQQLIDWMEADKVTGPLLRSALPAGWFIADKSGAGERGSRGIIAA
LGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>N8RL48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIIDLLKGFFSGDSEARHFAFSVLIAFFPAVMIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFEHKTTEATRITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIAVGFVAAFIAALLVVSALVK
FVERHTLRVFAWYRIVLGVILLFIFL
>E6WD64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGETAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGTGKGHLTLIHILLGMVPAVVIGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEFLKPKQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSMSFLTMQDLPMFAVGFVTAFVVALIA
IKAFLELIKRISFVSFAIYRFIIAGVVYMLFT
>ZP_04200496|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHICFSVANLEKAIDFYQTILQAKLLVKGRKVAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTNNEFDSLKEILIQNHVNILPGRERDDRDKRSIYFTDLDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>A0A142FK12|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-26|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVARLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0C4YIK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHRIVTVVGGLATDEKARRFAINVIVATVPAIVLALVFGKWIKAHLFNPITVATAFI
VGGVVILWAEWRESHRGQVSHPQGNALLEAAKAGAPRIESVDDLNWRDAVKVGLAQCFAL
IPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKSRALLSADDLGIFG
IGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIIFGIVVLATAYSGLIAWHA
>ZP_03989103|FEATURES|ARDB_deepARG|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
TSFCWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMD
IPTIIFINKIDQNGIDLRRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIETITETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPQKKASYTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEG
VRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGR
SVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM
>J5AR16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEQYVIALILGVIEGITECIPVSSTGHMIIIGHMLNFEGTHADVFEVFIQIGAILAIYTH
YRRTFNGFLKRKNWIKTRGVSLLHISAGMLPVLMAGYLLQYIIKEYLFGPIPVIVGLIIG
AIFMIYAEKRTVSGRLVDSVNNLTIYQCFQIGLYQMLCLWPGFSRSGATIAGGMLIGCTR
RAAADFSFIMAVPVMIIVCVYDLVRVIHALELNDIIMFIIGTVVSYIVGYITVKGFLWYL
NRSSLASFGYYRIIVAILAIIYLYM
>S6JTS1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVILGVLFADWIHHYLFNPITVAAALV
VGGLVMLWAEKRQHQVHAETVDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>A5TVI0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFINSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFMDSTLIIAIT
LIVYGVIFIGIEVVYKLKKIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>A0A0S9JI63|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKRVLAAIVLSGLPHVTAPALAADPSARVAAAVEQAYRPLMKAYDVPGIAVAVTRAGHS
TVFAFGLADRERQRPVTRDTLFEIGSVSKTFTATLVAYAQGLGRLSLDDAPSRFLPSLRG
SALDRISLLDLGTYSAGGLPLQFPDAVTDEAAMIAYFRRWQPSAPPGTQRLYSNPSLGLF
GAAAAAAIGGDFVEMMETRLFPGLGLKHSFIRVPASESERYAWGYGKDGAPIRVNPGVLD
GEAYGVKSSAADMIRFVEANLDPTRLDPPIRQAVQGTQIGYFRVGAMVQGLGWEQFPYPI
SLERLQAGNAEPMRFEAQPAKRLDPPQRPTGGTLFDKTGSTNGFGAYVAFVPAKRIGLVM
LANRAFPMPARIAAAHAVLEALAAEEP
>A0A0M1N4P5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLRSEEFLTKYVANTFKVVIQLGS
ILAVIVVFKDRFLDLLWLKRKKPEAGAPAGTGRLKLSQVIVGLIPAGVLGLLFEDFIDDH
LFSTATVLIGLVIGAVFMIVADKVSSKKEPKVVTVDQITYRQAFSVGLIQCLSLWPGFSR
SGSTISGGVMLGMSHRAAADFTFIMAVPIMFGASFLSLLKNWEYFTLDALPFFIAGFVAA
FVFALISIRFFLKLINRVKLVPFAIYRIVLAAVIALVLYL
>YP_002147194|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLIYGPMADSLGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAIAAILASVM
IFALIKETLPVERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVPPQDFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFAMAVWMVFSA
LMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFTSAWPMIWSIAICAACSILFYLYASRPKKR
>A0A0A1YSW9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMIKRADAGAILAQQKVVIDRTDTGLTLHAKLREAASHLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLEWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>J3H1E2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFMPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAEQRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFVIGFVTAFIFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTSVKP
>A0A0W0IB01|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDESLATCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDTGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>U1WPC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQPKTSGGVSMDMIELLKAVLFGLVEGITEWLPISSTGHMLLLDQFVKLNVSKDFWDMFL
VVIQLGAILAVCVLFFHALNPFSGKKSSDERHDTWRLWAQIIVACIPAAAIGIPLDDWME
AHLGSPFVIAAALIVYGVLFIVIESRRDSRAQQLAARGSSARHMATPVTSNPSELADADA
RVTDVRHMPWLTAIGIGIFQVLSIVPGTSRSGSTIIGGLLLGCSRTVAAEFTFFLAVPVM
VGASGLRLVKFFLKGNSFAPNELTLLLAGCAVAFVVSLLAIRFLMGFVKKHNFKPFGWYR
IVLGVAVVAYFLLVH
>CAA68507|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENN
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>A0A009G730|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTSIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKE
>N8Y3D6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTDDATKITFRQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALLVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>V1H3Z1|FEATURES|UNIPROT_deepARG|aminoglycoside|SEI61121_11461|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRQQLWPGHLDDAHLADGEEILQSDHLASFVAMEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLVAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0F5ZNT1|FEATURES|UNIPROT_deepARG|aminoglycoside|VM57_08830|antibiotic inactivation|1
MEAPNPFTDGMPLPWAWQEALADARVERQSIGVSRADVARVQRPGQADAFVKSEVIDAFS
ELGDEIARLRWLQEQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVELLA
DALRGLHALPLAACPFDQRLHLRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELCST
RPDHEDLVVSHGDACLPNLMVVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGAVADERRLAFYRLLDEFF
>A0A154WVA0|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKKTAPKYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKAVGWKFYPTII
FLLSNIMNRHPEFRMAMKDNELVIWNEVHPSYTIFHPETETFSSLWSHYNGNIHHFQNTY
AEDTARYGNSLSYWPKEESRENVFFVSSIPWVTFTNFNMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPLAVQVHHSVCDGFHVARMFNELQEMCDGLPGLSEERNG
>A0A0M4HC96|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRDAVIAEISTQLLEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A127SY10|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDAPENV
FNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHIC
RFVNELQELINS
>A0A099RVW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIAVQALILGVVEGLTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRKIIGVVVGLPKEREAQKFTLNLLIAFMPAVVLGVLFADLIHHYLFNPITVATALV
IGGIVMLWAENRDHRIEAETVDDMRWTHALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFPVFAIGFVTSFLFAMLAVRALLKF
IGNHSYAAFAWYRIVFGIVILATWQFGLIDWSTAVG
>ADH03009.1|FEATURES|CARD_deepARG|aminoglycoside|AAC(1)|antibiotic inactivation|1
MGIIRTCRLGPDQVKSMRAALDLFGREFGGVATYSQHQPDSDYLGNLLRSKTFIALAAFD
QEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>J9WBN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSCLMHKFIGLEVGMMLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQTTQFTD
MFNVVIQLGAIMAVVVLYFHKLNPLSPKKTHVEQHQTWVLWFKVIVAVLPSVVIGLLFND
WMDAHLMNWQVVSAMLLIYGVLFILIENRNANRQPLFSDLNTLSYRTAFIIGMFQLLSLV
PGTSRSGATILGGILIGTSRYVATEFSFFLAIPTMFGASLLKVYKYFSHGGAFTGMQTAV
LLTGMLVSFVVAYFAIRFLLNYIQHNNFKIFGWYRIILSLIVIGYFGFLAH
>Q1NEF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVAMGLLRREPVSWRFLRNLVVAFIPAAVIGLALHDYIEILLGAPQVVAWALI
AGGVAILLIERMVKQDLFHGIADIPMVRVIGIGFIQCLAMVPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATALELIKKGDRITSAAVGWDSIALGFVVSFLVAIVVIKAFV
GLVSKHGFAPFAWYRIVAGASALVWLAMR
>A0A0N9I2M0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIEEFDAASPDSGPYGITAGPDGAMWFTCVKADKIARFHAGEARLFDVTQGSAPTVIVQG
PDGALWFTQYQGHRIGRITVEGDLTEFELPTPEAEPYGIAAGPDGALWFTEINLDRIGRI
TPDGAITEFPLPVAGAFPGHITAGPDNGLWFSLNQANAIGRIDVGGDVTVHPLPTEGAAP
VGITDGGDGGLWFVEIGAGQVGRIAVDGHVDEFPLPDKECRPHAIVAADDGTLWFTEWGA
NKIGCITLAGKIDEYDLPTPNSEPHGIAVAQDGTVWAALENGKIAKLTPR
>A0A081BRY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLFLKAILLGIIEGITEFLPISSTGHLILVGDYLEFTGDFAETFEVVIQLGAILSVVVY
FFKDLYPFSPKLPPERRREIFTLWQKSVVAVIPAIVLAAIFYDAIKARLFNPTVVATTLL
VGGVIILLIERRKMTPKILSVKDLSYQMALAIGGCQCLAMIPGVSRSAATIIGAMLLGAA
RPVAAEFSFFMAIPMMVAASGGSLLKAGFAFSATEWGALAIGFVVAFLTAWGVVALFMSY
IRKHDFTVFGYYRILLAGLVLWLLS
>A0A0K6MI71|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>A0A0S2G2U1|FEATURES|UNIPROT_deepARG|aminoglycoside|LG3211_1185|antibiotic inactivation|1
MSETWLVRAAARADLQAWAQLRQALWPDEDPSRHADDIEAMLARGERFAAFVAADESGGL
FGFAEASLRTDYVNGTDSSPVAFLEGWYVRPQRQHRGVGRALIDAVAAWARERGCSELAS
DALLDNPQAHRAHEGCGFEETERVVYFRRSLV
>A0A120G7V1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTLKKYAVSALLLGAGSCMAATDMRQVVDSHVTLLMKQQGIPGLTVAVVQHGKVQYFN
YGVAAKDTQAPVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFD
RISLLQLATYTAGGLTLQFPDAADSATTMMDYFQHWKPTYAPGEQRLYSNPSIGLFGYVT
AKSLGQPFTVAMEKTLLPKLGLTNTYTRVPADKAGQYAQGYDSQQKPVRVNPGALDFEAY
GLKSSSQDLARYVIANMHPQTLEQPVQQAIATTHAGYYTVNGMTQGLGWERYPYPISLQA
LLDGNSTPMAMEPHKVTWLTPAQAEPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANR
NYPNAERVKVAHAILSAMDQ
>A0A0Q9Q2U0|FEATURES|UNIPROT_deepARG|beta_lactam|ASG76_13535|antibiotic target replacement|1
MRSLRLGIAVVLVGVGSACSALGGDDADPASDLATDLAAALSEHSLGDVPLGDESQRAAF
DELVAPLDEVPVAVAVSSIEVVEEEGWADATLAWRWDVTDDATWEYDTTVRLAQGGEEPE
EWRVQWSPESFAPGLAQGETVGLRTLAPARGDITGDAGAVLVAERPVLRYGLDKTKVEGP
GVARSARGIARVLDLDVASYVARAEAMGPDAFVEALVLREDDPLEVLPAFRQVPGALAVR
DTLPLAPTREFAAALLGRVGPATAELVEGSEGRIVAGDEVGLSGLQARYDDQLRGTPGTA
VVARGADDRLRTLFEVPATDGTDLVTTLDPGLQQRAEDALATLGEQAPAAALVAIRPSDG
AVLASANGTGAAGADLAATGQYAPGSTFKVVSSLALLRSGLGVDDVVSCPATTVVDGRSF
KNYDDYPSSALGDIPFVQAIAQSCNTALIGNADRLXPGGLADAAAALGLGVDHDLGFGVY
FGQVPPAGTETGAAADMIGQGTVLASPMAMATVAASVAAGRTVLPVLLPEHEVEQVAPEV
PLTPQEAGTLRGLMRAVVTTGSGRFLLDVPGEVGAKTGTAEYGEPDASGALPTHAWMIAT
RGDLAVAVFVETGVSGSQTAGPVLEAFLS
>R9KMG5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVVYGIVEGITEWLPVSSTGHMILLEELMPMEVAKEFWNMFLVVVQLGAILAVV
LLFWNRIFPFRLNRRKQVRMDWDIMNLWGKILVACIPAGIVGVLFDDWLEEHLYNFWVVA
VMLIAVGMIFILVENRNRGMKPIIRTTGELDYRIALLIGLFQLAAAVFPGTSRSGATIIG
ALMVGVSRTVAAEFTFYLAIPVMFGASLLKLLKFGFAFTGMELGILFTGMAVSFVVSIVV
IRFLMGYIKRHDFKVFGWYRIVLGAVVLLYFGLIAGIE
>A0A0M2VSU0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIAAIILGIVEGLTEFIPVSSTGHMILTAKAMGYNDQTPIMKTFEIIIQLGAILAIAI
VYRHRILNLLGWTSSRPLRKPPVSAKRLNLIHVFLGIAPALGVAFLAKDFIKGLFSAETV
LCALVAGGIFMMFAEWYNKAKTNIITAHELDDLTYKQALLIGLYQIISVLWPGFSRSGST
ISGGMLSGVSYKAAADFSFLIAIPIMCAATGYELLESYRYFTPDVLGVFIAGFIVSFVVA
YFVVLAFMKLIQKIRLTHFAIYRFILAAVFWLFMMQ
>YP_002397219|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDPPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN
>A0A0Q4G0D5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTVLLAKAAAMGVVEGLTEFLPISSTGHLILAGALLGFDDEKAKVFDIAIQTGAIFAVI
LVYWQKLRETLVALPHQRQAQRFALNVLIGFLPAVVLGLLFGKAIKEHLFTPVVVATTFI
LGGFVILWAERRPPSATRIASVDEMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLVGAGAYSLYKERALLTVADVPMFAVGLLFSFVSAWVCVRWLLR
YIASHSFVPFAWYRIAFGIVVLATAWSGLVVWAD
>A0A0R0CAI7|FEATURES|UNIPROT_deepARG|aminoglycoside|ABB27_14230|antibiotic inactivation|1
MKRAGVEIRRALASDWPAWAQLRRALWADCDTDLAELQQLLEEDASTVLLAFAQGQPVGL
AEASLRHDYVNGTSSSPVGFLEGWYVIESLRGKGIGRALVAEVARWARAQGCSELASDTA
LDNAQAQAAHKASGFVETERVVYYCMGLDEPTE
>X6BFE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILTAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
VGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFIAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGTVGLVALMTWG
>AAV84883|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>A0A094YXM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIVLTLNVIKAIILGVVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGA
ILAVVVLYFHKLNPFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNW
VVASMLILYGILFIVIENRNKQRTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATI
LGAILIGTSRFVGAEFSFFMAIPTMIGVSILKIGKFFYQGNTFTGDQSIILLVGMVVSFI
ISIISIKFLMGYIKKNDFKVFGWYRIILGVLVLGAMFL
>A0A0E1YJG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLIIKAIIMGVVEGIAEFLPISSTGYLILSADIMNFLSGEFRNLFIVFIQLGAILAV
IYDYWGRLWGAFIGLVTGHSPDLTKPRQLGFSLMIASLPVVVVGFTMADFITNALFHPLV
VATMLILGALIIIYAEKNPRPIHAPEAENISFKTALGIGLCQCLALIPGTSRSGSTIIGA
LLLGTSRKAATEFSFFLGIPVIIGAALLDLIKHFDAIQTLTDWLILLIGTGVSFVIALLC
IRLMVAWVSQKDFMIFAWLRIATGVLVLIAFFGFNYQIQA
>A0A0E3Z7K1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMH|antibiotic inactivation|1
MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEEAMTERVFKPLKLNHTWINVPHAEESHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILDALQ
>J4W167|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKVVILSLVEGITEFIPVSSTGHLILVNEFIKLKPESFANMFSIIIQLGAILSVIL
IYFNKLNPFSHKKSASKKRETIEIWKRVIIGVLPAAVLGLKFDDFIDEKLMNPYVVMTTL
FVWGIVIIFIEARHKKAKIKSISDMSYKTALLIGLAQCIALVPGTSRSAATIIGAMLLGC
SRTVSAEFSFFLAIPTMFGATSLKIVKAILRGTPMSMWQVFLILLGTVLSFIFALIVIRK
FMKYVKEHNFIAFGLYRVVLSVVMAIYFLIIAK
>A0A0M2T3K3|FEATURES|UNIPROT_deepARG|beta_lactam|SD53_15990|antibiotic inactivation|1
MPGVIKSICIATALMMLTFSTFKALAQSPLLKEQIESVVSGKKATVGVAVWGPDDLEPLL
VNPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQSVTVNRARVLQNTWAPLMKDYQGDEF
SVPLQQLLQYSVSHSDNVACDLLFELVGGPAALHDYLHSIGIKETAVVANEAQMHADDQV
QYQNWTSMKAAAQILKKFEQKTLLSETSQALLWKWLVETTTGPERLKGLLPAGTVVAHKT
GYSGIKAGKTAATNDIGVIVLPDGRPLLVAVFVKDSTESTRTNEAIIAQVAELAYQFELK
KLSAVSPAQ
>I8TY68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNENLIAVIIGIVEGVTEYLPVSSTGHMILAGSLLGFEGEKASVFEVFIQLGAILSVLFL
YQEKFSRMLKPQQLNIYGNGLSIKHVLAGVIPVMGIAYLLHKPIKEYLFSPFTVIIGLVV
GGIFMLVAEKVAKRPVTTDVDKITLQQAFFVGLFQVLALWPGFSRSGSTISGGLLLGLSR
SAAAEFSFIIAVPLMAVACIYDLLKVWDTLSIADVQMFSIGFAVAFVVAYISIIWFIKFL
NKSTLASFAYYRFIIAAISYYYFFL
>K1JAX6|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1170_00477|antibiotic inactivation|1
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKQ
>A0A127SHC0|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MCAEEDGTENRRMAVTFHKIDMQAWERKKRYEHYAEAVPCTYSMTVALDVTKLLCGVREK
GLPFFPVVLYGLAREVNRHAEFRMAQDEMGNVGYYSHCDPCYTVFHKETESFTEVWTAYD
ASPAVFLARYREDMARYRNAPELSKPPAGKNLFNVSCIPWSSFTGFNLNLQNGYDYFLPI
FTIGKYFSDGGKMRLPLAVQVHHAVCDGYHLSRFMNGLQTWMDAFPQELEQEIEQQPGKP
PR
>A0A127T207|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MGIKEKLMAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQAD
RAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDL
RSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIA
FLRKLYRNELPFRVEHQRLVKDLMIVGAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFF
ALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>J0MGT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDFIKSIIIGIVEGLTEFLPVSSTGHIIIAESLMKIPGGAVWTKAFMNVFDYVIQLGAI
MAVIQLYFHKLNPFSPKKNGIEKQQTWQLWFKVIVACLPAAVIGLLLNDFMDAHFMTPTV
VASALIFYGILFIFMEKHNEREDVQPWLTDVNKMSYKLAFTIGLIQVLSIVPGTSRSGAT
ILGAVFLGVSRVAAAEFSFFLSIPVMVGVSILKLGSFFHKGGTFTGMQGIVLAIGFIVSW
IVAWYAIKFMMNYIKQNDFKAFGWYRIVIGIVVIILGAFGLLHM
>YP_776583|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARN
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLSAGDRV
IVNGTQRVRPGEQVKPHMVPMTGGDAPSAPLASTAKPAAPAKADS
>ZP_04005119|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMAKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKSASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>J8H3A6|FEATURES|UNIPROT_deepARG|beta_lactam|IIO_02555|antibiotic inactivation|1
MEQTCFLDCQLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIS
YRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDLVEYSPVTEKHVDTGMTLGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMSDRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPAHKRNIFTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEAVYDNQLIAEATEVIVKALK
>W6J512|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCVGTQALLDAGFEIAAIFTHPDSANENHFFGSVARIAAERGIPVYAPE
DVNHPLWVDRIRDLNPDVIFSFYYRNLLCDNILNTARIGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVSRADAGAIIAQQRVAIAENDEALSLHRKLAEAAKGMLASVLPTI
KTQTFSETAQDDSKASYYGRRTPEDGRLDWEKPAQTLQNLVRAVSDPWPGAYSFAGTHKF
IVWKSRVRTDVAPARAGTVLSVSPLLVACGDGALEILTGQMDNGVYMQGAQLAQSLGLVA
GALLTSKPVVAVKRRTRVLILGVNGFIGNHLTERLLRDDNYEIFGLDIGSDAISRFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDNNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
HGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLASFEKHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLHWEPTVDMRQTIDETLDFFLRTVELTDEK
>A0A0A0Z0E9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQERHEGTGTGKLTLIHILLGMIPAVVIGLLLHDQIKTLFNPIN
VMYALVVGGVLLLAAEFLKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSMGFLTMQDFPMFAVGFITAFIVALLA
IKVFLELIKRISFVSFAIYRFIVAAAVYAVFM
>J1AGR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVIL
YFKRFFQTFDFYFKLLVAFIPAAVLGLLLSDFIDGLLENPVTVAISLLIGGLVLLKVDEW
FNKPNDPEVSTEITYAKALKIGLFQCLAMIPGVSRSGASIVGGMAQKLTRTSAAEFSFFL
AVPTMLGATAKKCYDYYKAGFELSHDQVNMLVIGNIVAFAVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIILLLIHFFIHPLTII
>R4RZD7|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-new4|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQHLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0D5L9T7|FEATURES|UNIPROT_deepARG|beta_lactam|BW21_4524|antibiotic inactivation|1
MRKRTQFVIRMWLALSCCLAIAAHAARSIEPADVGRIVDAVAQPLQEKYGIPGLAIAVSI
DGRHYFYNYGVASTATRRPVTGRTLFEIGSLSKTFTATLAAYAQEGGELSLADSVSRYLP
ALQGSSFDRISLLNMGTQTSGLPLFVPDTITNTAELLDYLKNWRPDRAPGTHRVYSNLGI
GTLGMIAAASMNERFETLIEKNLFPEFRMLHSYIDVPAERQDDDAQGYTKQGAPIRLRAG
LLASEAYGVRSCATDLIRFVDANMGLVPLSDKWARAMKATHVGYYEADGMIQSLIWEQYP
YPVSLGKLLAGNDLIGKDVVAKPFDPPLPPRQDVWINKTGSTNGFSTYVAFVPSKKVGVV
ILANKSYPLNERVTIGYTIIDSIVRAER
>A0A0Q8CL89|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD69_19860|antibiotic inactivation|1
MSDAGRVRPATAADLADWARLRGALWPDEEGEEPNDHEGEMREALARPERDLCVLAFDAH
GRACGFAEASLRTDYVNGTDSSPVGFLEGWYVAPEQRGRGVGRALIGAVERWTRERGCEE
LASDSLLDNHDAHHAHAACGFEETERVVYFRKRLG
>A0A099VHD4|FEATURES|UNIPROT_deepARG|aminoglycoside|LS81_08155|antibiotic inactivation|1
MIIKATKKEVGTISKLALLLWQKHNIEELEQEFLEILDSKNSAIFLKYIDENIVGFAYVN
LRNDYVEGSLRSPVGYLEGIFIKENFRKRGFAKELLEFCEKWAKEQGANEFASDCELDNQ
KSFSFHRALGFSEVNRIICFIKKL
>E3XRD1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMHLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0T9UXH6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSIINTLVFTAFAATPLYISAQTILTPKQVAAVVNDTIDPLVEEQDIPGMAVAVFYNG
KPQFFNYGVADKKTGRPVTENTLFELGSVSKTFTGIAGEYAAQTGIMNLNDPVTKYAPEL
TGDQWKDVKMLHLATYTAGGLPLQLPDSVIDQTTLWQFYQQWQPQWAPGVMRNYSNASIG
LFGALAVKRSQLTFENYMTQHVFHPLKLDHTFITVPEAMQSNYAWGYKDGQPVRVTLGML
GEEAYGVKSSSHDMVKFLQANMNPNSLPAGNDVLKKAITASQSRYFQAGEMFQGLGWEMY
NWPINPQHVVADSGNDIALKPRKVEALVPPVNAMPASWVHKTGATNGFGAYIVFIPEENI
GIVMLANKNYPNPVRVQAAYNILQALR
>A0A125XE69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGENKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAGYVVFF
>Q5L3H7|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIMVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLNLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFFSAFVFALL
AIRFFLELINRIRLVPFAVYRIVLAVVIYFLYF
>J3IRW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
VGGVIMLWAEKRQHEVHAETVDEITWQDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWSAAKP
>E8RLK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLIALLLGFVEGLTEYIPVSSTGHLLLLSHFLGFESPSNTFAVLIQLGAVLALLSLYF
NKLWNVLITLPTSAESRGFAISILVAFFPALVIGVLAHDYIKSVLFESPRLICISLIVGG
IVLWLVDKYAPTPDKSDAFRIDFKTSLIIGVFQCLAMIPGMSRSGSTLIGAMLCRVEKKA
AAEFSFFLAMPTMLGAFTYDVYKTHNQMNFNDMGLVAVGFIAAFVTALIVVKAVLNFVAK
NGYGIFALWRIVVGGVGLVLLSLGH
>A0A126P797|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENWVEALVLGLVEGLTEFLPVSSTGHLLLLGHFLGFESNGKSFEVLVQLGAILAITLVY
FRRLLDIALRLRTDPTARRFLIGVLVAFLPAALIGAVLHGFIKGVLFNPFLVCCALIAGG
LVLLVVDELELEVKHTDATTFPLPMYLKIGFIQCLAMIPGVSRSGSTIVGAMLLGASKRA
AAEFSFFLAMPTMAGAFAYDLLKNYKVLTFDDTILIVIGFVAAFCSALVVVRVFLDYVSK
RGFSLFAWWRIVVGLVGLAGLWIVG
>CAJ77843|FEATURES|ARDB_deepARG|multidrug|AdeC|antibiotic efflux|0
MENTMSKSAIVSRGLILSTLSVTLVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYK
EFISDPKLVQVIEISLNNNRDLRTATLNIERVQQQYQITKNSQLPTIGVTGNAVRQVSPS
INPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVW
LNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKT
QIQQAKNLLDLLAGHPVPQNLLPNHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRA
AGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNI
KIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARY
RAGVDSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGISKV
>A0A0K3YWK2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAETEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVCGIGV
MNIMLVSVIERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A6BIT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKVIILGIVEGITEWLPVSSTGHLILVGNVLKPSMSDAFMEMFDVVIQLGAIMAVV
VLYFHKLNPFSPRKSHKQKMLTWQMWIKVLIASVPAGIVGVLFNDILDEIFYKPIPVAVM
LIVYGILFIVVENHNAGKKPSVTRISQLSVQMLLWIGFFQMLALIPGTSRSGATIVGALL
IGVSREVAAEFTFFLAIPAMFGASLLKLIKFGFHFTGAEFGLLMLGCIVSFGLSVIAIKF
LMGYIKQHDFKVFGYYRIVLGGLIIVWTIIQTVIA
>A0A127SQN8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVDAAWQILNALQ
>Q2VCE4|FEATURES|UNIPROT_deepARG|beta_lactam|blaPLA-5A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLITHWSADENRP
>YP_002848913|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDAPINWKRNLTVAWLGCFLTGAAFSLVMPFLPLYVESLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGLAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPLAGGLLADQYGLRPVFFITASVL
LVCFILTLFFIRERFQPVSKKEMLHIREVVASLKNPKLVLSLFITTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALISAPKLGRLGDRIGPEKILLVALIVSVLLL
IPMSFVHTPWQLGVLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISANYGFRAVFCVTAGVVLFNALYSWNSLRRRRSTEVVG
>A0A077L803|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNTAFQPLMKTYAVPGMAIGVLYNGKSYEKYYGVQSLANAKAVNKNTLFELGSVSKIFTA
TAGTYAQNLGKISLQDHPGKYIPALKNSDINQVTLLELATYTSGNLPLQFPDQIKTDAQT
LQYFQDWKVKNPIGQFRQYSNPSIGLFGEATAKAMNMPFSALLEQVIFPKLELQHTYVQV
PKAQQGNYAFGYDQNNHPLRVTAGAFDAQAYGVKSSLPDMLHFLNLNLNPDQAKAAIKPA
ILATHTGYFKMGGMTQALGWESFSYPATLNTLLESNSDRVVMQSNPVEKTLVKTGSRVFH
KTGSTNGFGTYVIYIPQENFGLVMLMNKKIPNAERIKAAYEVLNSLKQKSNP
>A0A010K5X5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKSVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTTISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ZP_04661876|FEATURES|ARDB_deepARG|multidrug|adeB|antibiotic efflux|1
MMSQFFIRRPVFAWVIAIFIILFGLLSIPKLPIARFPSVAPPQVTISAVYPGATPKTIND
SVVTLIERELSGVKNLLYYSATTDTSGMAQISATFKPGTDVDMAQVDVQNKIKAVEARLP
QIVRQQGLQVEATSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFG
AEKAMRIWVDPNKLVSYGLSISDVNAAIRENNVEIAPGRLGDLPAEKGQLITVPLSAQGQ
LNSVEQFKNISLKSKTNGSVIRLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANA
VKTAEGVRAKIEELKVNLPEGMQFSIPYDTAPFVKISIEKVIHTLIEAMVLVFIVMYLFL
HNVRYTLIPAIVAPIALLGTFSVMLLAGFAINVLTMFGMVLAIGIIVDDAIVVVENVERI
MATEGLPPKEATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGIIYKQFTLTMSVSIL
FSALLALILTPALCATILKPIDEHHQKKGFFAWFDRTFDKLTKKYEVILFKVIKHTIPMM
VLFIIITAATFAGMKFWPTAFMPEEDQGWFLTTFQLPSDASTERTKSVVKEFEASIQDNP
DVKSNTSILGWGFGGSGQNVAVAFTTLKDFKERKSSASEMTNSINGTLAHSKEGSSMAVL
PPAIDELGTFSGFSLRLQDRANLGMPALLAAQDQLMAMAAKNKKFYMVWNEGLPQGDNIS
LKIDRDKLNALGVKFADVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMKLQDILN
LKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGDAMREMEQLI
AKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWSIPLSVMLVVPLG
IFGAIIAIMTKGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLVEATVAAAK
LRLRPILMTSLAFTCGVVPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFV
LGAAEKLFSSKQKVKS
>A4Y717|FEATURES|UNIPROT_deepARG|beta_lactam|Sputcn32_2029|antibiotic inactivation|1
MQQHPLLASMPLLSSVLLSVTLFSNVSAAQALNAKEMQSLVDSVVKPLMTEYHIPGAVIG
LTIDGKQYFYRYGVSSKTSGQSVTEHTLFEIGSISKTFTATLANYAQLKGKLTLTDMASD
YVPALKGSHFDGISLINLATHTAGDLPMQVPDKVTNNAELMAYLKQWQPSFAPETHRNYA
NPSIGLLGMIAAQSLNQTFQQALEQTIFPQLGMTSSYVKVPSDKMADYAQGYNKQDMPVR
VNPGVLADEAYGVKTTATDLLQFVEANMQMHPLAKPLQTAIDETHRGYFDVGVMTQDMIW
EHYSYPIELDKLLMGHTQEVVFGSTPVNPIVPPLEPQQNVWINKTGSTGGFAAYIAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTGIERLQK
>T4HX36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSNTFISTFLVVIQFGSILAVL
VIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNSTVVAIA
LIVYGIIMIGLEKRNKKPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIGAVLLG
TSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVAFVVSIVVIKFFM
DYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>YP_001348697|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
WEFRGKIFQVVRDLPSQHQAQRFTVNLLIAFFPAVILGVLFADLIHEWLFNPITVALALV
VGGVIMLWAERRQHVIRAEHVDDMTWKDALKIGCAQCLAMVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFRPEDLPVFAVGFVTSFVFAMVAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFHLIDWSTAGDL
>ABF67771|FEATURES|ARDB_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDI
DLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQ
FGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNE
TLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEAR
QAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>U7UC47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDYIIAVILGIVEGVTEYLPVSSTGHMILVGDWLGFTGVRAGVFEVFIQLGAILSVLLI
YKDKFLYMLQQYRCWHLLSPVNWRRRDTGLTLAHVAAGIVPVMIIGFFAHHAIKTYLFSA
GTVIIGLIIGGLFMLAAEKSRVRTVCDDVNELTVIQSFFVGAFQILALWPGFSRSGSTIA
GGLFLGLSRKAAADFSFIIAVPVMMIACFYDLLKSLADLNGNDMIMILIGFVVAFVVAYI
SVLWFLKFLNKSTLASFAYYRFVVALVAFIHFFVIS
>A0A0E4AR36|FEATURES|UNIPROT_deepARG|beta_lactam|XM57_27510|antibiotic inactivation|1
MTHSSQRRTLLLAAAAAPLALTVSACASSRGSTQDVASATSFAALERAAGGRLGVCAIDT
ASGRRAQHRADERFPFCSTFKAMLGAAVLARSIAQPALLQQRVAYGKADLVSYSPVTEQH
VGAGMTVAELCAATIQYSDNTAANVLMKLIGGPQAVTAYARSIGDATFRLDRWETELNTA
LPGDPRDTTTPAAMAASLRALMLGDALPSAQRAQFVEWLRGNKVGDKRIRAGVPAGWRVG
DKTGTGDYGTTNDAGVAWPPSGAPIVLAVYYTQARADARAKDDVIAAATRIAVATLR
>A0A0Q8Z7K7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSTGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERSDTGLSLHAKLRDAAAALLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLDWKQPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVQMSETIGNTLDFFLREAMLEIA
DKK
>ZP_01802436|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSLDVIFILKSVIIAIVEGFTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLFN
LQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSAS
TIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALVVGFIVAFI
VSIIVMEKFVNFLKKKPMRVFAVYRIIMGVVLAVLAFTNIISV
>CAJ88549|FEATURES|ARDB_deepARG|tetracycline|tet|antibiotic target protection|1
MHIPNTLNIGILAHVDAGKTSLTERLLFDHGAIDRLGSVDAGDTRTDDGGIERRRGITIR
SAVAAFTVGDTQVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRTLR
RLRLPTLVFVNKIDRAGARTEELLADVRRLLTPHVAPLTEVTGAGTGHARVTRRTPDGRT
AEALAEVDPGILAALVDGPEPTAGELAAALAARTADGSFHPLHHGSALGGQGVAELVESL
LRLVPPASPPAAGPAAPRGTVFALRPASGGERTAYLRLHAGEVRPRQRLTFLRRESDGRT
TEVTGRVTRLDVIGRPGTLTAGNIAALTVPGGLRVGDRLGARTDRAPQFAPPTLETLVRA
RHPGQAGPLRAALLDLADQDPLLHARPAASGATALLLYGEVQMEVLAATLSEDFGIEADF
APGRARFLERPAGTGEAAEEMPWLDRTRYWATVGLRVEPGPRGSGGVFAHETELGALPRA
FHQAVEETVHATLLTGLTGAPVTDYRVTLTRSGFSSPVSTAADFRGLTPIVLRRALGRAG
TRLHEPLHAFEAEVPPDALAPVTARLASLGAEFTGTTGGGSGWLITGELPARRVREAELG
LPGLTRGEAVWSSRPSGDRPLDPPR
>A0A0E9BCZ4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLKAGFTISAIYTHADTASENHFFGSVARIAAENSIPVYAPD
EVNHPLWIDRIKSAEPDVIFSFYYRNLLSDQILNSAKQGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKKADAGDIIAQQRVAIADEDNALTLHRKLVDCASALLESALPAM
KQGNIVGTPQNEADATVVGRRTPEDGRINWALPASQINNLVRAVTDPWPGAFAFAGTTKF
VVWKAKVLSTPHNVRPGTVLSAEPFVVACGEGALEIQTGQTANSVYMNGVQLAQHLGMVN
GALLYSQAVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVFGLDIGSDAISRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYGKRIIFPSTSEVYGMCTDANFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLFDGGRQKRCFTDI
SDGVEALFKIIENKNNNCDGQIINIGNPDNEASIKELAERLLESFERHPLRASFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLGWTPTVEMNTTIDNTLDFFLRTVELQDDKE
>A0A0Q9J6P7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFTILKAIILGLVEGVTEFAPVSSTGHMIIVDGMWLQSEQYLTKYVANTFKIVIQLGS
ILAVVIIFRDRFLELLGLRQGKQDEGQLPSGPKSKLKLTHVLVGLLPAGVLGLLFDDYID
EYLFSIKTVLFGLVIGAVLMIIADRFRPAKTKVETVDQITYKQALSVGLIQCLSLWPGFS
RSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASMLSLAKNWQYFTLDTLPFFIAGFLS
AFVFALVSIRFFLKLINKIKLVPFAIYRIVLAVIIYIVYF
>ABW39616|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLEFIADSSAFAFLAFISEGWL
DFPVLILLAGGGIALPALQGVMSIQTKSHEQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>A0A0P9I5J7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADLIHHYLFNAITVATAL
VIGGVIMLWAERREHAVRTETVDDMTWTDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>AAG42234|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDM
MLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFH
SIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEE
LVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVELFFD
LLGIKPDWEKIKYYILLDELF
>J2KK32|FEATURES|UNIPROT_deepARG|beta_lactam|PMI12_03407|antibiotic inactivation|1
MNPPIQRRSLLLAASVLPLAGACTAWSRAGSPSSAEAQLAELERASGGRLGVAGFHTGRG
ARIQHRAHERFPLCSTFKLMLAAAVLERSAKDASLLARRIGYGKADLVSWSPITEKHVAD
GMTVAELCAATVQYSDNAAANLLLKMLGGPATVTAFARGIGDQAFRLDRTEPELNTAIPG
DLRDTTTPAAMSDSVQRLALGDALGTAQRDQLTTWLLGNTTSAERFLAGVPAGWKVGDKT
GSGSYGSTNDVGVLWPPAGAPVVLSVYLTFPQKDAKGRSDVIASATRIVVAALAG
>A0A090V2D5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTTLLELRDIRRSYPSGEGMVEVLKGVTLDIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGSYRVAGVDVATLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKA
RLARANALLKRLGLAERESYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDAGHTVIIVTHDPQVAAQAERIIEIRDGEIIRNPPPAVKPEAVRQQPSV
QPDNGWQQFSSGFREALTMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVL
ADIRAIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVRSATPAVSQNLRLRYG
GTDVAASANGVSGQYFNVYGMTFSEGTTFNDQQLTGRAQVVILDENTRRQLFPNKAKVVG
EIVLVGNMPATVIGVAQEKQSMFGSSKILRVWLPYTTMSGRIMGQSWLNSITVRVNEGYS
SERAELQLTRLLTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLLVGGIGVM
NIMLVSVTERTREIGIRMAVGARKTDVLSQFLIEAVLVCLVGGALGVCLSMLIAFTLQLF
LPGWEIGFSPVALITAFVCSTFTGVLFGWLPARNAARLDPVEALARE
>A0R8Y3|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>A0A0A2H5X2|FEATURES|UNIPROT_deepARG|beta_lactam|KS04_10900|antibiotic inactivation|1
MKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVMVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISDY
QQKQKASN
>A0A127SSQ6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELKNRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>D1LFD7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWMKGNTTD
>A0A0U1YWK2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQATLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>D0UX55|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-30|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDRERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>ZP_02904981|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVAGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARS
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLSAGDRV
VVNGTQRVRPGAQVKAHMVPMTGGDAPSAPLASTAKPAAPAKADS
>A0A0P6SFW3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGVQALLDSGYDIAAVFTHADDPKENAFYGSVAQLCAAKGIPVHA
PEDVNHPLWIERIAKLNPDYVFSFYYRNLLSESLLATAKHGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQPVTIERSDTALSLHGKLRIAATDLLRDTLP
AMLQGKTSETPQDESKASVYGRRTPADGKLLWSKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNDSQAPGRVISVDPLRIACGEDSLVILSGQRNDTGLFLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPHFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMLEQA
ELSNKEAG
>W4EI78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFNEQDSIMKTYEIVIQLGAILAIAL
VYRQRIVDLLGFGRRDRGGVMPAARLNLIHVLLGIVPALAVAFFARDFIKSLFGASTVLW
ALVAGGILMIIAEWVNKRKIRVTAHDLDDLSYGQALSIGLFQIISVLWPGFSRSGSTISG
GMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKNFTSETIGYFVIGFIISFIVAYVV
VVLFMRMIQKIRPTHFAIYRFILAAVFWLFIMR
>A0A127SVD2|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MFTFGKYYEDGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK
>R8WUX3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGEIETGVTLHRMVKRADAGAIIAQQRVAISPDDVALTLHHKLCQAARHLLEQALPAI
KTGDYAERPQQEADATCFGRRTPEDSFLDWNTPAAELHNQVRAVSDPWPGAHSYVGTQKF
TVWSSRVCVNNSAAQPGTVISVSPLLIACGDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTTKHRTRVLILGVNGFIGNHLTERLLQEDHYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCEGEIINIGNPQNEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVNITEHTS
>A4W5P7|FEATURES|UNIPROT_deepARG|beta_lactam|Ent638_0339|antibiotic inactivation|1
MEENQMKKSLCAVLLLSASCSTLAAPHTDKQIADTVNRIVTPLMKEQAIPGMAVAVIYQG
KTHYFVYGKADIAANQPVTQRTVFELGSVSKTFTGVLGGEAIARGEIKLDDPASKYWPEL
TGKQWQGITLLNLATYTAGGLPLQVPDDVTDRAALLHFYQNWQPQWSPGAKRLYANASIG
LFGMLAVKPSGMDFEQAMTTRVFQPLQLNHTWINVPAAEEKHYAWGYRDGKPVHVSQGML
DAEAYGVKTTIEDMASWVQANMNPAGVKDEMLKQGIELAQSRYWRIGEMYQGLGWEMLNW
PVKAKTVVDGSDNKIALAPLMAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNIGI
VMLANKSYPNPARVDAAYRILATLK
>AAV74563|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAIFSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQVIEKGGKPEARTLTYPVFVKPARSGSSFGV
TKVNSTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMIIVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR
>A0A0G2NMG9|FEATURES|UNIPROT_deepARG|aminoglycoside|SG9_1532|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHLALGFEETERVIFYRKRC
>A0A0Q9HH59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
AVVVIFKDRFINLLGFGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSL
NTVLIGLVVGAVLMILADLFGPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASGLSLVKNWQYFTSDALPFFIAGFISAFIFAL
VSIRFFLKLINRIKLVPFALYRIVLAAILYFVFL
>Q63BG1|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKKYEEDMR
CYASVHGLFTKENIPPNIFPISGIPWTSFTGFNLNINNDAGFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHVSRFIEDLQELSNSCNEWLK
>A0A0Q0DTF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATAL
VLGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>Q9AMA2|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVIYIGK
>B8K1T9|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
STSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQY
SDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQT
LRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNIIA
>A0A0F5IK67|FEATURES|UNIPROT_deepARG|chloramphenicol|HMPREF1212_05044|antibiotic inactivation|1
MKFNQIDIEKWNRKEYYIHYMNELRCTYSLTVNIDITGLKAAVKEMSKRIYPVQIYMIAT
VVNQCEEFRMDINSYGELGYWSEVNPCYTIFNKDSKTFSSIWTSYNRVFSRFYDSCIEDI
DKYSRSTSLKPKQNEPSNSFTISALPWMGFTGFNINVFNEGRYLPPIFTIGKFIETESSV
LMPLSIQVHHAVCDGFHVGRFVQLLQELSSNHKEWLL
>A0A009K866|FEATURES|UNIPROT_deepARG|aminoglycoside|J537_2225|antibiotic inactivation|1
MKIMPVTEPFLADWLELRRLLWPDHEDAHLLEMRQLLEQTQTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQSSPVAFLEGIYVLPEYRRSGVASALVQQAEDWAKQFACTEFASDAALDN
TISHAMHRALGFQETERVVYFKKNIS
>YP_560128|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDEHAKTFDVVIQLGAILAVC
WEYRRRIGSVVSGLPSRPDARRFTLNVIIATIPAIVLGLLFEKTIKAALFSPVPVAFALV
AGGVVILWAESRQRTRGETVARVQNVDDLGALDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATAYELHKDWHLLSVDALGTFALGFVAAFVSAFACVR
WLLRYIAAHDFTAFAWYRIGFGLLILLVGYSGALNWTE
>K7SGI0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLEIKAINRWFGTGENRVQVLKDINLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDVPS
SGSYKIDGVETAAMTADEQAALRRRSFGFIFQRYNLLGTLTARENVALPAVYAGMEYDER
MKRADELLAQLGLDGKEENRPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTGSGK
NVMEILHKLHDAGHTIVMVTHDPTIAANANRVIEISDGRIIADHSKNTDIPPSNIESIEE
HNSWHFYRDQFFESFLMSIQAIMAHKMRSFLTMLGIIIGIASVVSVVALGRGSQEKILEN
INAMGTNTVSVYPGYGYGDRRSSRIKTLTVGDAEVLKQQDYVDSVTPGVNTSGTLTYDNQ
SLSAQLYGVGDQYFDVRGIKLAFGRLFNEDDVTQNSQVVVIDDNTKNKLFADGTNPLGKV
ILFNKRPLRIIGVTEPNNNGFSDSDSLQLFTPYTTLMNRISGSKYITSVTVKVKDNVNSQ
TAEKGIIELLKVRHGTEDFFTRNSDTIKQTIESTTGTMTLLISSIALISLVVGGIGVMNI
MLVSVTERVKEIGIRMAIGARQHNILEQFLIEAVLICLIGGLVGVLFSFAISMLFNLLAT
DFAMSFSTISIVMAVLCSSVIGVLFGFMPAKRASQLNPIDALSRD
>A0A0A0Q8L6|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-28|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAYYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A0E3MJD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>CAE46077|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEREKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKARYMFNKIT
>ACB20261|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIKDIADELRGADYLVWR
NGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSA
LLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSS
RGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQ
AYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>A0A0S1RIV0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
AERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSV
VWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFL
RKVVNRQLPVKAAAYELADNLFEVGQADGWRLYGKTGT
>NP_459919|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLAGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>D7PIJ9|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVSLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>A0A0L0IXR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTSDTIISAFILGIVEGLTEFIPVSSTGHILLLGHFLGFESTGKTFEVLIQLGAILAILS
VYFGRLWSIATALPNDRRAQRFVAGILLAFLPAAVIGVLAHGFIKSVLFESPALICTTLL
LGGVALLVIDRLPLKPRYHNAMDFPLHLCLAIGFVQCLAMVPGVSRSGSTIAGSLLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRDVLSMDDATIIAIGFVTSFVAAVFVVRRLLDF
VSRHGFAPFAWWRIGVGLAGFAGLYFFG
>Q57QJ1|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLVFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMIPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALTQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>A0A127T7H2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKVITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>R4WEE6|FEATURES|UNIPROT_deepARG|beta_lactam|cphA7|antibiotic inactivation|1
MMKGWIKCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGARG
VTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>A0A0U3EBL2|FEATURES|UNIPROT_deepARG|beta_lactam|tem1|antibiotic inactivation|1
STFSCRPYSLFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGI
IAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>YP_001457720|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0M4FUW8|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKLSNKYRRIKEFLWEHNYPNFRMKQILNAIFKDRINKFNEIIVLPKSLREILVKEFGES
ILDVVLLKEQHSEQVTKVLFEISGNEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATG
DIGLKRNLTSDEITDQILHFYLQGHSIDSISFMGMGEALANVQVFDALDVLTDPTLFALS
PRRLSISTIGIIPSIKKMTLNYPQVNLTFSLHSPFNEQRSKLMPINDRYPLLDVMDTLDE
HIRVTSRKVYIAYIMLPGVNDSIDHAKEVVSLLKGRYKEGRLYHVNLIRYNPTFSSPLRF
GEVDEGHVVNFYKKLKSSGINVTIRSQFGIDIDAACGQLYGNYQKSNKQ
>A0A0H1AU57|FEATURES|UNIPROT_deepARG|chloramphenicol|WQ59_12165|antibiotic inactivation|1
MDASIPTPTPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQV
WALTTVVNRHEAFRMCLTASGDPAVWPVVHPAFTVFNPQRETFACVWAPYDPDFGTFHDA
AAPLLAEHSRATDFFPQGNPPPNTFDVSSLPWASFTGFTLGIRDSWDHLAPIFTLGRYTE
REARLLLPLSVQIHHAAADGFHTARLTNDLQTLLADPTWL
>B8EAB0|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal223_2079|antibiotic inactivation|1
MQRHTLLATMPLLSGVLLTATLFSNVTTAQTLNSKDIQSLVDSAVKPLMAEYGIPGAVIG
ITIEGKQYFYQYGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQGEGKLTLTDMASD
YVPALKGSHFDKISLINLATHTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAPGTHRNYA
NPTIGLLGMIAAQSLNKTFQQALEQMLFPQLGMTSSYINVPSSKMADYAQGYDKQDMPVR
VNPGVLADEAYGVKTTATDLLHFVEANMQMHPLAKPLQTALDETHTGYFDVGMMTQDMIW
EHYSYPIDLDKILMGHTQEVVFGSTPVKPIVPPLAPQQNVWINKTGSTGGFAAYAAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTGIEKLQK
>ZP_04638972|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSDTALPPAANASVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLTYQLTASMLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGMAQSVFQVGGNFGSALGPLLAAILIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYQQQQRATHGKAIKISSAKMLPKKTVIKTLAILMVLIFSKYF
YLTSISSYYTFYLMHKFGVSVQNAQIHLFVFLFAVAAGTIIGGPLGDRIGRKYVIWGSIL
GVAPFTLILPYASLYWMGILTVIIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGLGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPNIEDK
>U6SQ41|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGINHLLFSVSNLERSINFYKSVLNAKLLAKGKRTAYFDLNGMWLALNEERHIPRAE
IEHSYTHIAFTVEDEDFDELFQKLQKLQKLRVTILPGRPRAEGDKRSVYFTDPDGHKFEF
HTGTLQDRLNYYKQEKTHMEFY
>A3K9E2|FEATURES|UNIPROT_deepARG|aminoglycoside|SSE37_15566|antibiotic inactivation|1
MSVRTATESDLEAWVALRLLLWPDTSPDTHRAEAAAVLAAPEATAFLEKAEDGSMRAFAE
AALRHDHVNGCETSPVAFLEGIFVRAEDRGRGHGARLLAAVRDWARGRGCAELASDAHLS
NVGSRAFHAALGFDETEHVVFFRMPL
>A0A084ZMP5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|GTGU_04410|antibiotic efflux|1
MEPIIALRHVYREFSAGTQKIPVLTDISLSIAAGEMVAIVGASGSGKSTLMNIIGCLDKP
TAGEVIINGTAVHNASSLRLAELRSRYLGFIFQRYHLMPYLTAEENIAIPALYTAMPEAQ
RVSRTQALAQKLGLEDRLQHRPAQLSGGQQQRVSICRALINGAQVILADEPTGALDSVNG
KALMAVLHQLHASGHTVIIVTHDRDIASQAQRIVEISDGRIVADIRQTEAVNNAVTLPEQ
DNGRASLGRSIHESVRMAWRSLLGHRMRAFLSMLGIIIGISSVVSSMAVGEGARQAIMSE
IGKLGNTTLEIRPGTGWGNKRPDMERALSMDDVSSLQKLPWILGVSPMVSSMTLAVRNGL
DSSMMLSGVSQDYFPLQGLRFVQGNGFTARDVAEGEPVLILDETGRDTLFPGGEDPLGQI
VQIAGAPWRVIGVAVKPGPKVVGGYMAAWVPHTSLQHRITGEKPLEAIILRFQETLTPQE
ATQRVERHILREHGKKDFFTQTDDQLANALQKTSDSMSLLITTIAAISLLVGGVGVMNIM
LVSVTERTHEIGIRLSVGARPLDIMNQFLIEAVMICALGGLIGVIGSWVAGNLFSLFTDE
FSMVFTAFPVVMACGFSALIGLTFGYFPARRAARLNPTEALARE
>A0A0Q3WUL9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKGINHLLFSVSNLENSIDFYEKVFDAKLLVKGNTTAYFDLNGIWLALNEEKDIPRNDIH
YSYTHIAFSIEEQEYEHFLSKFQNLKVNILPGRNRDEKDRKSIYFTDPDGHKFELHTGTL
EDRLTYYKEEKKHMNFYT
>A0A0M2VRW6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MRVKGLNHLCFSVSDLEQSIAFFEHVIEAKLLVKGRKLAYFDLSGLWIALNQEDIERDRA
PSSYTHTAFTVEEEDFDELLGRLNRYKVHILPGRKRDPLDKRSVYFTDPDGHLFEFHTGT
LADRLSYYKSEKKHMTFYRDKKE
>A0A095YKK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYEYFAALIIGIVEGITEYIPVSSTGHMIIVGDMIGFSGTKESVFEVFIQLGAILSVLLI
YKDKFKMMLRRENWFKKRGTSCYNLVCAMLPAMAIGYLTHHFIKTYLFGWQTVVIGLILG
GILMLFAERVNIRTRTDDVDDITTKQAVLIGVFQILSLWPGFSRSGSTISGGLLLGISRK
AAADFSFIMAAPLMFVACTYDLLKIWRYLHWSDFGVFALGFVTAAVVAYASVLWFLKFLN
NSSLASFAYYRFALAVATCLYFWL
>A0A089NJW3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDLETSIEFYKNVLDARLLVKGRTTAYFDLNGMWLALNEEKDIPRNE
ISKSYTHIAFSIEEADLEQMYGKLLSMNVNILSGRPRHEKDKQSIYFTDPDGHKFEFHTG
TLQDRLDYYKQEKTHMDFFDL
>A0A150I408|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
FYPTLVMADDFQVKAEAVFAPLMQEFKVPGLIVGITRDGVHEFYATGMASREQQTPVTPD
TLFELGSISKIFTATLAAWAEQQGKLDLSETAAHYLCADTCTIGDKITLMDLATHHSGGL
PLQVPDEINDVAGLVNWLKDWRPSDPDARSYSNISIGMLGYISGKALGSNYRQAVQTMLF
PALGLGNSWIDVPSDKMETYAFGYDRRTDAPIRVTPDVLDAEAYGVKSTARDMLKLLDIE
LGRGSVSHQLREAISRTQQGQYRTALFTQDMIWEQYPWPIAVKQMVEGNGYDFIMKPQPV
EKIAPPLPPQKQVILNKTGSTNGFGGYVAMIPDEKLGIVVLANKNYPNEARVTATHALIE
GLLKK
>R5E9L9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILYLKAVILGIVEGLTEFLPVSSTGHLIVAGSLLDYTGQEADTFYIAIQAGAIFAVC
WHYRQRLIDICLGLFSDKVQQRLTINTIVAFLPAAVIGVLVASYIKKWLFNPIAVATALV
VGGVIILIVEYFQDKKTYKPRVETMDDMSWKDALRVGFLQCLAMIPGTSRSGATIIGGLC
IGLSRKAATEFSFFLAIPTIFGATVYDLWKSRDVLTATALPMISVGFVVSFFSALVVVRW
LLHYVSKHDFSAFGWYRIFFGGVILLTWWTGLVQW
>V8MP10|FEATURES|UNIPROT_deepARG|aminoglycoside|L287_02619|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>N8V8B3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTPEKSAVFVVLIQIGAIAAV
IYEYWSRLWNAATGMVTGEEKGRRLGFSLIFASIPIVLVGLTFGQTIKEVLFNDLVVALG
LIIGGLIIIWVEKNPPQIKAVEVENITFKQSIWIGLIQVLALIPGTSRSGATIIGAMYLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYHVLDGFDDWVVLAVGLIVSFISALLLIRAL
VAYVAKRDFMVFAWYRIASGLLILLLFFTGWKLW
>A0A0C2V6U3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MHIQGVNHLLFSVSDLQRSIAFYRDALGARLLAEGRKLAYFDLAGIWLALNVEEDIPRRD
IHLSYTHLAFTVAEAELPAWEHRLREHGVTILESRERDPRDRNSIYFTDPDGHKFELHTG
TLQNRLQYYRSAMPHMKFYER
>A0A0E1QI47|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRINNFDDMHILPKALRIALVNEFGK
NVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHADAVIGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>N8WGV2|FEATURES|UNIPROT_deepARG|aminoglycoside|F966_00106|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHDDAHLQEMHQLLKQTDTLQLLAYSETQHAIAMLEA
SIRYEYVNGTETSPVAFLEGIYVLPEYRRSGIATQLVQFVEEWAKQFACTEFASDAALDN
HISHAMHRALGFHETERVVYFKKNIG
>A0A0B5RE95|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRA
GVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATEV
IVKALR
>A0A0B1FNN5|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVLCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSSLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>A0A077J9U7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLMILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLQSENFLTKHGANTFKVVIQLGS
ILAVVVTFKDRFINLLSFGRFSHGTNQGKGRLKLSQIIVGLIPAGVLGVLFEDYIDEHLF
STKTVLVGLVIGAIFMILADFFGPKNPKTKTVDEISYKQAFLVGLIQCFSLWPGFSRSGS
TISGGVLVGMSHRVAADFTFIMAVPIMAGASFLSLLSNWEYISLDALPVFIAGFISAFVF
ALLSIRFFLKLINRVRLVPFAIYRIVLAVIIYFVFL
>A0A0P6VCD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWGLATGLGERANRDYVLKVGVAFLVTAVVGLLVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWTDVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGAALLLWLPAAAG
>T0F737|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESFLNALIRSIIEAVTEFLPVSSTGHLFLFSSFFPFSEGGEFDDLFDIFIQSGAILSVI
VLYHDRFLRHGQLSVNYLLGKEKNPEGILFVSQILVGCIPILVAGFLFKGKLDVIKARSD
LLLILGSAWISGGILILLSEIWFRKSSQIHNPEPVRLKDAILIGIFQCAALIPGVSRSAA
TIVTARFLKKDARHSAEFSFFLAVPVLLSAGAYKLYKYRHILNGDTLPILAFGFLASFLL
CILVIRWFLKYLQSHSFDAFGIYRIILGLAVLIFYKLN
>A0A0Q8FBI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGILEGLTEFLPISSTGHLLIAQHWLGERSDFFNIVIQAGAILATTLVFRR
RIWELTTGCWRDAEARDYAMKLAAAFLVTALVGLPVRLAGWELPETVTPIAWALILGGVW
MLFAEHVAEKRGDVATITWKVAILVGLAQVVAGVFPGTSRSAAAIFMAMLAGTSRRSSAA
EFVFLLGIPTMFAASGYAFLELVQDDALGSENWGEVALAFAAATATGFVVVKWLLGFIKA
HRFTGFAIYRIVLGALLLLLMPAGS
>YP_002401190|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSAEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>A0A128AF63|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNLIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>C6JQ58|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPFLIVIILGIVEGMTEFLPVSSTGHMILVEKFINSSFFSKSFMDSFLIIVQLGAILAV
VIYFWKDINPFVKEKEVFVQRFRLWAKVVVGVFPAAVIGLLLDDYISEYFMGNVVVVAMT
LIFYGIILIVVEKCYDGVAHIDSFQKLGYKTAFTVGLFQCLAMIPGTSRSGATIIGSLLL
GLSRGVATEFSFFLAIPTMFGATLLKLMKNGLKFSPIEWQLLGVGSVVSFVVAYLVIRWF
MQYIKKRDFVSFGIYRIILGIIVLFFVFA
>A0A142D587|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLNLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADQFAKKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTTADIPFFIAGFLSAFVFALL
AIRFFLELINRIRLVPFAVYRIVLAVVIYFLYF
>A0A0D5WUG9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTPETIQKVSVVIPVYNEQDSLPELLRRTTEACQKLNRDYEILLIDDGSSDDSAAMLTR
AAEAPDSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSWFRKRASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVHHDERQFGDSKYSFMRLINLMYDLITCLTTTPLRLLSVVG
SIIALSGFALAVLLVVLRLALGPQWAADGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVSSETALSSEENQ
>A0A127SDB7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNCKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>ZP_02904979|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MDNMYNSNGLMRFAKVAAASTLLATLLAACAVGPDYKRPDVSTPAAFKEAPTLAAGEQAG
TWKTAEPADGEHRGEWWKVFGDPVLDSLESQALAANQNLKAAAARVEEARAATRTARSQW
FPQVGAGFGPTRQGLSSASQLQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELRDQALKLVQRRFNEGDIS
ELDVSRAKNELATAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKVPAG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGAFGYEASTLGNLFLWSSRT
FLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLADLRLL
DDQIRAQDAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVST
VNLIRALGGGWGPAPTAVGDAAAVKVEVAAR
>A0A0I9QQQ6|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVYSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A083UJS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WQFRRKIFDVVVGLPTQPNARRFTANLLIAFFPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAEKRQHEVHAESVDDMTWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFITAFIFAMIAVRGLLMF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>L2VNH4|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVLCSLSETSTLFLVGRFMQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAMMGITVLMLSLFILKE
TRPAAPAASDRPRENTESLLNRFFLSRVLITTLSVSVILTFVNTSPVLMMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQMLFLAAGIILAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVIGISAWNMLIGI
LIACSIVSLLLIMLVAPGRPVAAHEEIHHHA
>I0HV05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLMLLAKAAIMGLVEGLTEFLPISSTGHLILAGSLLDFTGETAKVFEIAIQTGAMLAVV
WEYRQRLGRTVSGIGHDPVARRFALNVLIAFIPAVVLGLAFGKMVKAHLFHPVPVATAFI
VGGIIILLVERRHRRAFGERDLEGVRRARVESVDDMTPLDALKVGLVQCLALIPGTSRSG
STIIGSMLFGFSRRCATEFSFYLGIPTLVGAGAYSVLKQRDALHWGDAPLFLVGSAFAFF
SALLCIRWLIRYVSTHDFTVFAWYRIVFGGLVLLTAWTGAVTWAE
>A0A013WXX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDSATWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRREPVSWRFLRNLLIAFIPSAVIGLALHDYIEILLGAPQVVAWALI
VGGIAILLIERAVKEQRFHGIADIPMVRVLAIGFIQCLAMVPGVSRSGATIMGALMLGVE
RRTAAEFSFFLAIPTMLGATALELIKKGDRITSAAVGWDSIALGFVVSFIVALLVIRWFV
GLVSKHGFAPFAWYRIIAGIAALIWLGAR
>A0A0D7FBE8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPSENRFFGSVAQLCARHGIPVHAP
EDVNHPIWVERIRALEPDFIFSFYYRNLLSEDVLACAKRGAYNLHGSLLPRYRGRAPANW
VLVNGETETGVTLHRMVRRADAGPIVGQKRVAIAPDDTALTLHAKLRETSQALLNEVLPT
LASGTVQEREQDESQATTYGRRSAADGELEWGRPATELSNLVRAVTQPYPGAFGWIGDRK
LIVWSAQARQQAHDQAPGSVLSLEPLRIACGEGVLEIQAGQLGDNGLYLSGPQLAREAGL
VAGARLHRRDRRTKRRTRVLILGVNGFIGNHLSERLLIDGEYEVYGLDIGSDAIERLKLD
PNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRH
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGA
KGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDV
DDGIEALFRIIENQGGRCDGQIVNIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGF
REVESKSFYGDGYQDVAHRKPSVENARRLIDWQPTTAMAATVGKTLDFFLREALAQREA
>AAY67968|FEATURES|ARDB_deepARG|glycopeptide|vanC|antibiotic target alteration|1
MKKIAVLFGGNSPEYSVSLASAASVIQAIDPLKYEVMTIGIAPTMDWYLYQGNLANVRND
TWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCH
VAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGS
SKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVD
GFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIY
LNEINTMPGFTGHSRYPAMMAEVGLSYEILVEQLIALAEEDKR
>A0A031IWM4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSMFSGMRNLTAAAALFATGHCLAATDLQAVVDASVKPLMQQQAIAGLVVGVVQDGKA
HYFNYGVASQETGQPVSENTLFEVGSVSKTFTATLAGYAAATGKLKLSAPASDYLPALGG
GKFDHISILNLGTYTAGGLPLQFPPEADNNQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLTAQSLKQPFDQAMEKTLLPKLGLKHTFVKVPPSQMSLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSASDLLRYVQANMNPAKLESAVQRAVSITHTGYYTVDGMTQGLGWEMYPYPI
TLDALTDGNSTPMAMEPHKVNWLTPAQTPHANTLVNKTGSTNGFGAYVAYVPSKGLGVVI
LANKNYPNAERVKAAHAVLSALDH
>A0A0F2NTE3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIQSIILAIVEGLTEFLPVSSTGHLIITSSLMGIADDSFTKTFTIAIQFGTILSVVVL
YWKRFFQTVNFYFKLFIGFLPAAFFGLLLNDFIDSLLENVIVVATMLFLGGIILIFVDKW
FKKTEVEGTSEVTYPTAFKIGLFQCLAMVPGVSRSAATIIGGLTQKMNRQAAAEFSFFLA
IPTMFAATSYKLLKFFQEGNGFEKEEIQLLLIGNVVGFIVAIIAIKGFIAFLTNHGFKLF
GYYRIVVGLLILILHFSGVEITLY
>A0A084A9L6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLNFEQFGVLLVACLVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIVLLIYAAFKAFLG
>K5CND3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNNTPVPAGTSWLKRLLHRFDFYWKLLVAFIPAAILGFLFSDKVDELLES
VTVVAVMLVIGGVFMLFCDRIFTKGSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKEAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEVLMNNMPALIIGNVVAFIV
ALLAIKFFINFVTKYGFKAFGWYRIIVGGAILVMLLMGYNLQID
>ABB70056|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTELEQWDVVIE
GNDDLLEKYMSGKSLEALELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGR
SVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT
>J8RR07|FEATURES|UNIPROT_deepARG|beta_lactam|ICE_00194|antibiotic inactivation|1
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGSQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0A5FXA5|FEATURES|UNIPROT_deepARG|aminoglycoside|N783_03805|antibiotic inactivation|1
MSFNWETCSSDIKDFILNLHKEITKIINDNMVGFYIHGSVAMGGFNPISSDVDILVVTEK
PITVVTKRKLAKLFLTCSNSPYPVEISFLNLDQLKYWKHPCPFDFHYSETWRERYENDLL
RGTYYFLNGDVKTDSDLAAHITITNNRGICIVGAPIIDVFPIVPRSDYISSIVGDFKDCL
ENIEEDPIYCTLNLIRVYWYLKEGVISSKQEAGNWGLGTFPKEFSMTVKKVVDCYANHKN
AYELEKDELLLLRDYISDRVQKLLYREFKSTF
>F4DR85|FEATURES|UNIPROT_deepARG|beta_lactam|MDS_2137|antibiotic inactivation|1
MRSSLRPLLVTLGLCLSSQAAFAELNQAVDAAVKPMMQAYAIPGMAIAISHKGQSHFFEY
GVASRESGRAVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNTSQYLPALRGSAFDH
ISLLDLATYTAGGLPLQFPDAVSNEQQMLDYYRNWQAVYPPGTQRLYSNPSIGLFGHLAA
ASLAEPFQQLVEKDLLPQLGMQESYIRIPSEQMKRYAWGYRDNKAVRVNPGALDAEAYGL
KSTAADMLRFIDANLHPERLPPPLRQAISATHRGYYQVGDMTQALGWERYAYPISLEKLQ
AGNSAEMALQPQTVERFSVPKPADGDLLLNKTGSTNGFGAYILLLPARETGLVILANRNY
PNAERVRLALQLLEAIKP
>CAR59764|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQAPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>YP_002108838|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAAAFAVVFIAGLGTFGAIRVNAGAPEKSAAPLPEVDVATVLSKTITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKD
GRKVPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIVGGLAASERI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPRAAQGNARA
>A0A0Q4N0N1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFDVVFGLTSQPKARRFTGNLLLAFMPAVVLGVLFADLIHHYLFNPITVAAALV
VGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWATANG
>J3HBJ9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGLETLLASGYEIAAVFTHADDPQENAFYGSVAQLCARQGIPVHA
PEDVNHPLWIERIAKLNPDYLFSFYYRHLLSELLLATATKGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQKKVAIERSDTALSLHGKLRVAATDLLRDTLP
ALLAGKVSETPQDESKATVFGRRTPADGKLMWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWNAEVALGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDAKFDEDTSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIDNAKRLLDWAPNVQMSKTIGNTLDFFLREAMLEIA
DKR
>B7SNP8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>R7N9C0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAILFGIVEGITEWLPISSTGHMILLNEIMPLKVSDAFYSMFEVVIQLGAIMAVV
ILFWNKLWPFGKNNNKEPLSSEGAGAYIKCDIFKLWFHILVSCIPAAIVGVLFDEKLEEL
FYNYTTVAIMLILFGIAFIIVETMHHGKKAKVRTIEGIDYKLAAYIGLFQLIAAIFPGTS
RSGATIVGALILGVSRTVAAEYTFFLAVPVMFGASLLKGVKFLLHNSMTSQEGIILLVGM
LVAFVVSLFVIRFLMGYIKKHDFKVFGWYRIVLGIIVLICGFVGVIG
>A0A068R4P9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELKSISRSYQSGEGQVNVLQDISLSIQAGEIVAIVGASGSGKSTLMNILGCLDQS
SHGEYWVSGRNVADLDNNQLAELRREYFGFIFQRYHLLTHLTAEQNVEIPAIYSGMSKIQ
RRERAIELLKSLGLENRIYYRSNQLSGGQQQRVSIARALMNGGKIILADEPTGALDSASG
QEMIDILKALCQQGHTVIIVTHDPNIAAQAQRVIEIKDGRIISDVRSSEHQTLPHPSSPE
AKMANAKKSSPIQQTWGRFNEAVLMAWRAMNVNKLRTLLTMLGIIIGIASVVTILVIGDA
AKSMVLSQIRSISTDSISIYPGKEYGSNEDLSLQALKMSDVSAIKSQPYVQSVSPKFIYN
GRLRQGRIDTTAQVAGVGSGFFQVYAMKLSQGVYFTAEMIYQQAQVVIIDDKARQKLFPH
QNEVIGKQVLLENIPLTVIGVVAPKQDIYNTGNLLQIWVPYSTMNSRLVNQSYLNLIVIR
LKSGYSSDEAEKKLNQLLIFRHGKKDFQAESMNRILTAMDKTTQTLQIFLTLIAVISLVV
GGIGVMNIMLVSVSERTREIGIRIAVGARTSDIMQQFLVEAILVCFVGGILGITLSYCLS
LIVQVMLPTWDFVYNPITFIVAFGFSTVIGLTFGFLPARNAAHLNPIEALARE
>A0A0E0UI29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLAIALALPTSVKARRFVFSVLLAFLPAALIGAAAHGFIKSVLFETPMLICVVLI
VGGIILYAIDRLPLTPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFALDLYKNRDALSFDDVGLIAAGFIAAFIAGIFVVRSLLDF
VSHRGFTPFAIWRILVGTAGLVGLWLLG
>A0A0D8AWQ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNVQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGRGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDVGRILNNDDVKNSTNVAVLDFNAKKNLFPNEKNENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAMIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVIFGFFPARNAANLNPISALSKE
>A0A127KXV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHQPHEGTGTGRLTLGHILLGMVPAVVLGLVFHDTIKSLFNPLT
VTYALVVGGVLLIAAEVLKPKVPRAEGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSMGFLTTGDIPMFAVGFITAFIVALIA
IKTFLHVIKRISFIPFAIYRFIVAAVVYLVFL
>D2ERZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFIEILKSIFFGIVEGITEWLPISSTGHLILVEEFVQYKDQNEAFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKNKVEVRRTWQLWSKVFVATLPLLLVFKLDDWFDANFHNMVSVA
IMLIIYGVAFIYLEKRNKAQAIEPTVTELDKLPYKTALYIGLFQVLALFPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGQLLSIGQLFLLLVAMGVAFAV
SMVAIRFLTSYVKKHDFTLFGKYRIVLGSVLLLYSFVRLFV
>D0SP26|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0026_02236|antibiotic inactivation|1
MMQSKYQNLFSNKTLMLIGLLSCSSSLWAQPLTELQIKKIVDQQFKPLLEEYKIPGLAVA
VTLDGQHYFVNYGVASLQSKQAMTNSTLFELGSVSKTFNATLAGYAQAQGRLSLSDHPAK
YFPELKNTAVNQATLLNLGTYSAGGFPLQFPDEVVTQQDMVQYFQNWKTKTKIGEARQYS
NPSIGLMGYVTALAMKKPYAELIEKTLLPQLGMTQSYIHVPEQKMSQYAWGYKNNQAIRV
SAGMFDAEAYGVKSSSSDMLKFLDAQINSAQLDRPIRQGVENTHIGYYKVGAMTQGLGWE
QYAYPVKLETLLQGNSSKMALESHAVTLIKHPQIASQSTYFNKTGSTNGFGAYAAFVPQH
KIGMVMLANTNFPNEARIKATYQAMQQILKQKAAP
>YP_002150494|FEATURES|ARDB_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MDTKRVGYTVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFI
YIISLLVNKHAEFRMAMKDGELVIWDSVNPGYTIFHEQTETFSSLWSYYHKDINHFLKTY
SEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNVANINNFFAPVFTIGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK
>A0A0D1LHC4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGIEALLKAGFDICAIFTHPDRASENHFFGSVARLAAEQGIPVFAPD
DVNHALWVERIQKMAPDMIFSFYYRALLSEKILATARLGAYNLHGSLLPTYRGRAPLNWV
LVNGESETGVTLHRMVARADAGDILAQERIAIADDDDAMSLHQKLVACAKILLASCLPTM
KQGLIDGVQQDESRASVMPGRTPEDGRIEWSLPAKSIANLVRAVTDPWPGAFGYVGTTKF
IVWKAKAHDIVHTAKPGTALSINPLIIACGEGALEVLTGQSEQGVYMNGSQLAQSLGLVE
GALLYSQPMAAIKRRKRVLILGVNGFIGNHLTERLLQDENFDVYGLDISSDAISRFIGHP
RFQFVEGDISIHSEWIQYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCHDSNFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
QDGVEALFRIIEDKHNHCNGQIINIGNPDNEASIKELAERLLAHFERHPLRDQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLDWTPVVNMDITIENTLDFFLRSVEPQDDVR
>AAP70377|FEATURES|ARDB_deepARG|beta_lactam|BL3_cit|antibiotic inactivation|1
MKVFLAVSLFLISNLLFAEDPLPELEIKKIEEGVYLYTAYEKVEGWGLVGSNGLVVLDNK
DAYLIDTPISAKDTEVLVKWIDAQGFTAKASISTHFHSDSTGGIAFLNSKSIPTYASKQT
NKLLKNKGEAQATHSFTKNPFWLVNKKIEVFYPGAGHTSDNVVVWMPEQKILFGGCFVKP
EGLGNLSHAVIKEWPASAEKLITRYGSATLVVPGHGKIGDASLLEKTKQRALEALAAKK
>D5WZ09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAHSAIVVVILGLVEGITEFLPISSTGHLILAASLLGWVSDKAKVFEIAIQSGAILAVM
WHYRLRIGEVLTGLAAAEPARRSTAWRFAINVLIGFIPAAILGLLFASAIKRWLFAPVPV
ALAFIVGALVIFWAEAWQKRSAQHVRIHHVDDMRASDALKVGIAQAFALIPGTSRSGASI
IGGMLFGLSRAAATEFSFFLAIPTLLAATAYELYKNRALLSLSDAPTFGLGLAVAFVSAL
MVVRWLLRYVGGHSFVPFAWYRVVFGALVLVTAWGGWVNWSG
>A0A075P2M4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTLNLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
IGGVIMLWAERREHAIHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFQPADLPVFAVGFVVSFIFAMIAVRGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>C4IGD6|FEATURES|UNIPROT_deepARG|chloramphenicol|CLP_1841|antibiotic inactivation|1
MGLNIIDMNTWDRRECFNHFFNNAKCTYSITVNIDITNLYKYIKNNKLRFYPTFTWVVSK
VINKYKEFKMSFDEEGRLGFFDEIGPSYSVLNDKTKVMSDLYTSFDNVFIKFYKDMENSL
NSYKKDNKFMTTFQNNFFIVSCLPWFNYTSFNVNNEGSNPFLFPMVTWGKFFEENNKIIM
PLTIQVHHAVADGYHCSLFFSDIEEISRNPEQYLILC
>T8IZ76|FEATURES|UNIPROT_deepARG|beta_lactam|G893_03727|antibiotic inactivation|1
MAGRFVWKPDPMLKTTLCALLITASCAALSAPQQLNDIVHRAINPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSGDLLRFYQNWLPTWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQARVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMAHWAQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVDPDSIINGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYIAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0P9URR5|FEATURES|UNIPROT_deepARG|beta_lactam|ALO63_01502|antibiotic inactivation|1
MPRNKTLLCAALVLNASLACAQEPAPDLDAVVQQAAQQVMQENNIAGMSIAITRNGTQQF
YNYGVASKANRQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTDSIDTYLPQLNDTR
LGKIPVFHLGTHTAGGFPLQVPDKVQNTRQLMDYFKAWQPDYLPGTHRTYANPSVGLLGL
VAARSMKLPYEKALQQRLFPALNLSNTYVTVPDEKQKLYAQGYNKLDEPVRVNPGPLASE
AYGVKSSARDMIRFVESHLGPGQYDAPLQRALSDTRISYFKVGGMTQDLIWEQYPMPVGL
GQLLEGNASAMLNTLKTEVIEPPQAAQSAVWVNKTGSTNGFGGYVAFIPEKQLGIVILAN
KNYPNEERVRLAYRILGESGCCSKP
>I5BWK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDQTIVGALLLGILEGLTEFIPVSSTGHILLAGHFLGFESTGKAFEVLIQLGAILAILS
VYAARLWQMLIDLPRDPATRRFVIGILIAFLPAAVIGVLAYKIIKTVFFETPLLICVMLI
LGGFVLLWVDRRATKPRYHDITKFPLSMYLGIGLFQCLSMIPGTSRSGATIVGGLLMGAD
KRSAAEFSFFLAMPTMTGAFAYDLYKNYDLLTAADVKIIAIGFIAAFFAALMVVRWLLGY
VSRRGYALFGWWRLFVGSVGLIALLVWG
>Q45414|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_III2|antibiotic inactivation|1
MIVPKKFFHISHYKKMLPVVLLSCVTLIGCSSSNIQSEPPKQTKQENTGNQSFVKLEKEY
DAKLGIYALDTSANQTVTYRSDERFAYASTHKALAVGAVLQKKSIEDLEQRIKYTSKDLV
NYNPITEKYIDTGMTLKELMDASIRYSDNTAQNLILTQLGGPSGIQKIMREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVENRNFLIDLMKRTTTGDNLIRA
GVPGEWEVPDKTGSGSYGTRNDIAFIWPPNKKPFILAILSNQAKEDAKYDDKLIADATKI
VLDVLTVPNK
>K8DMM9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSQVSALLIMLFLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDEKTLFEIGSLSKTFTATLASKAQQDGKLDFSAPARQYLPALKGSAFDHVTL
LNLATHTSGTPLFVPDAVKNTAQLMDWYRAWQPAQPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLTDFGMTHTFINVPEAAMGDYAQGYNKDDKPVRVTPGPLDAEAYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLTATAIMPPQSAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVRAAYAIIQALDK
>A0A0J6ZM31|FEATURES|UNIPROT_deepARG|beta_lactam|TQ94_11775|antibiotic inactivation|1
MILKKKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHIGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALR
>C6DDL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGHTAGRLKLTHILLAMIPAVVLGLVFHDVIKSLFYPQN
VMYALVVGGFLLLAAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLSDVPMFAVGFVTAFLVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>B7U9E3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVXSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0K9JN64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMIKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIVNVVGGLPTRPDARRFAVNVIIATIPAIVLALLFEKQIKAVLFSPVPVSVALI
VGGIIILWAEGRQRDRQHPPRVHSIDDLSPADALKVGLAQCFALIPGTSRSGSTIIGGML
FGLDRRVATKFSFFLAIPVIFGATLYEMMKYWRTLSVNDIGLFAIGLVAAFVSAFICVRW
LLRYVASHDFSAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A0Q5IQX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIVYGIVEGITEFLPISSTGHLILAGNLMGVPWPKEVKDTFEVVIQGGAILAVLA
YYWRDFLKIRHIGHDRGQQRLWLGVVVACIPAVVLGLLFGDTIKANLFRPSVVAWALIVG
GVVIWLVESRRVTPKVHDIETIGVGRSLLIGALQCLALLWPGFSRSASSILGGMVLGLDR
PTATKFSFYLGVPTLGGAALLDFIKSREILGQIGVLNVVLGAAVSFVVAYIAIGWLLRFV
STNNFKGFAVYRVVVGALILVLIATGVMTNGSLA
>W4B529|FEATURES|UNIPROT_deepARG|beta_lactam|C169_12522|antibiotic inactivation|1
MNKSYNAIFGPHIIKMAQLMFIFALISLSGCTKADVAPPVAPTENTPQTAPAALADPDFV
QLESKFSARLGVYAIDTGTERIVAYRPDERFAYASTFKALAAGAVLQQNSMDTLDKVITY
TSKDLVTYSPITEKNVNTGMTLRELSEAAIRYSDNTAGNLLLKELGGPDGFRTALKQAGD
NVTNPERFETDLNEAIPGDNRDTSTPRALATTLQAYTVGDELPTDKRTLLIDWLKGNTTG
DKLIRMAVPEGWEVGDKTGAGGYGTRNDIAVIWPPNKEPIVIAILSSRDTPDATYDDALI
AQAAKVALDALK
>A0A0Q1J454|FEATURES|UNIPROT_deepARG|beta_lactam|APD31_00100|antibiotic inactivation|1
MRFKKISCLLFSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>V6HL65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESFLNAFVRSVIEAVTEFLPVSSTGHLFLFSSFFPFSEGGEFDDLFDIFIQSGAILSVI
VLYHDRFLRHGRLSLNYLLGKEKNPEGILFVSQILVGCIPILVAGFLFKGKLDVIKARSD
LLLILGSAWVSGGILILLSEIWFRKSSQIHNPEPVRLKDAILIGIFQCAALIPGVSRSAA
TIVTARFLKKDARHAAEFSFFLAVPVLISAGAYKLYKYRHILNGDTLPILAFGFLASFLL
CILVIRWFLKYLQSHSFDAFGIYRIILGLAVLIFYKLN
>YP_607927|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFITRPIFAAVLSLVLLIAGSISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTASDVVAAIREQNRQVAAGQLGAPPAPGSTSFQLSINTQ
GRLVNEEEFENIIIRAGANGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIEISDEVRAKMAELKKEFPEGMDYSIVYDPTVFVRGSIEAVVHTLFEALILVVLVVIL
FLQTWRASIIPLMAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPLEATQKAMSEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKDHHAPKDRFSRFLEKLLGSWLFAPFNRFFDRASHGYVGGV
RRVIRSSGIALFVYAGLMGLTYLGFSSTPTGFVPAQDKQYLVAFAQLPDAASLDRTEAVI
KKMSEIALKQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAQAIAAAL
NAQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEALYKETQNIIAKSRSVPE
LAGLFTSYQVNVPQVDAAIDREKAKTHGVAITDIFDTLQVYLGSLYTNDFNRFGRTYQVN
VQAEQQFRLDAEQIGQLKVRNNLGEMIPLATFLKVSDTSGPDRVMHYNGFITAEINGAAA
PGYSSGQAEAAIEKLLKEELPNGMTFEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
EQAKGLDPLAAVLEACRLRLRPILMTSIAFIMGVVPLVFSSGAGSEMRHAMGVAVFSGMI
GVTVFGLFLTPVFFFLIRRFVERRQARKAERSVALENHA
>A0A0Q8FF76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLISIALALPTSAKARRFVLAVALAFLPAAVIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLIALLVFG
>A0A0T6RJ84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPSRDHATLSLVHVILGMMPAIVVGLAIHSWIKANLFGPQTV
MYALVAGGILLIIAEKFRPAVTAETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMVAASGLDLYKSRDFLSMADFPMFAVGFITAFVVAMFAIK
TFLTLIRRIDFIPFAIYRFIVAFAVYLVFVA
>A4GWT3|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-24|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTAGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>A0A0Q4ETJ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPES
QRHSRAHDLLTRLGLAGHTTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDEANDSVGLELPSEAP
IEPKRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVEALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSYAIGY
LFSLFVKEWEMVFSVGSIVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>J7K4G1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELADNLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A0S3JGS6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIAAIFTHPDNSGENHFFGSVARLAAEQGITVYAPE
DVNHPLWVDRIRAMAPDVIFSFYYRNLLSDDVLSTARHGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMVNRADAGNIVAQEVVAIDDNDVAMTLHRKLCAAAQTVLRDALPAI
RDGKTKETAQDDSQATYVGRRTPEDGRLEWEKSAEQLHNLVRAVSDPWPGAFGFVGTNKF
IVWKSRVRHDLAAAKPGTVLSVAPLTIACGKGALEIVTGQSENGVYMQGAQLAQALGLVG
GALLSSRPFVAVKRRTRVLILGVNGFIGNHLTERLLADDNYEIYGLDIGSDAISRFLNSP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDNSFDEDTSNLVVGPINKQRWIYSVSKQLMDRVIWAYGDK
ADLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLECFERHPLRNNFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLDWEPTVEMQQTVEETLDFFLRTVELSDSAK
>U1BJ81|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSGADLELAGVWRRFPSGEDEVAVLKDVTLRIAPGEMVAIVGASGSGKSTLMNILGCLDQ
PSAGRYRVGGRDAGSLDKDQLAALRREHFGFIFQRYHLLPHLSALDNVAMPAVYAGMALK
ERRERAQALLARLGLAGKEHHKPGQLSGGQQQRVSIARALMNGGRIILADEPTGALDSHS
GEEVMRILKELNAAGHTVIIVTHDPAIAAQTDRVIEIRDGEILRDSGAAVPAAQIDGMAQ
TDGGPSLRERMAEAFKMAMLAMLSNRLRTALTMLGIVIGITSVVSIIAIGEGARDYVLND
IRAMGTQTITVFRGKDWGDDKAEGIRTFLPGDIAALAEEGYVDSVTPETSQAQRIRYRNV
DVNGSVSGVGREFFRVQGMKLAEGQGFSRDDIRMQRQVVLLDKNARRKLFGDGEAVGRVI
LVGTVPATVIGVVAQRDRGFGGNSLQLWMPYSTTASRLFGQQHFDRFVIRVKDGQPTKLA
EKAITALLTQRHGGKDFFTHNMEDVLKTVESTSRTLALLLTLIAVISLVVGGIGVMNIML
VSVTERTREIGIRMAVGARQGDVLQQFLTEAVLVCLVGGAIGVALSYGISFVFALFVSSW
KMSLSPTAILLAVACSSLIGVLFGFLPARSAARLNPIDALARE
>Q9WWZ8|FEATURES|UNIPROT_deepARG|multidrug|ttgC|antibiotic efflux|0
MTKSLLSLAVTAFILGGCSLIPDYQTPEAPVAAQWPQGPAYSPTQSADVAAAEQGWRQFF
HDPALQQLIQTSLVNNRDLRVAALNLDAYRAQYRIQRADLFPAVSATGSGSRQRVPANMS
QTGESGITSQYSATLGVSAYELDLFGRVRSLTEQALETYLSSEQARRSTQIALVASVANA
YYTWQADQALFKLTEETLKTYEESYNLTRRSNEVGVASALDVSQARTAVEGARVKYSQYQ
RLVAQDVNSLTVLLGTGIPADLAKPLELDADQLAEVPAGLPSDILQRRPDIQEAEHLLKA
ANANIGAARAAFFPSISLTANAGSLSPDMGHLFAGGQGTWLFQPQINLPIFNAGSLKASL
DYSKIQKDINVAKYEKTIQTAFQEVSDGLAARKTFEEQLQAQRDLVQANQDYYRLAERRY
RIGIDSNLTFLDAQRNLFSAQQALIGDRLSQLTSEVNLYKALGGGWYEQTGQANQQASVE
TPKG
>A0A022GNP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRARIGNVVRGLRADPLAQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFI
VGGVVILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLTWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLNADDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLVTAYSGLVSWHA
>Q5MDG3|FEATURES|UNIPROT_deepARG|beta_lactam|tem|antibiotic inactivation|1
AHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRV
DAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGG
PKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGDWGAQT
>C3WAT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPFLIVVILGIVEGMTEFLPVSSTGHMILVEKFIGNGNLSKNFMESFLIIVQLGAILAV
VIYFWKDLTPFVKEKNQFISRIRLWTKVIIGVLPAAIIGLLLDDYISAYFMDNVFVVATT
LIFYGIILILIEKYYKTAGKIDTLGKLSYKLAFIIGFFQCLAMIPGTSRSGSTIIGSLLL
GLSRGVATEFSFFLAIPTMFGATLLKLIKNGMNYSTQEWRLIGVGTIVSFLVAYLVIKWF
MSYIKKKDFVFFGVYRIILGILVLIALFI
>A0A0L6FTM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWSALQAIILGVVEGLTEFLPISSTGHQIIVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQVPARRFTANLLIAFFPAVILGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERRQHRVEVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFALGFVVSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWEFGWVDWSTAHG
>W0A131|FEATURES|UNIPROT_deepARG|beta_lactam|AH4AK4_4246|antibiotic inactivation|1
MPRILLSGLLAAGLFCALPASATTGCLLFADGSGKPLSAQGDCASQLTPASTFKIPLALM
GYESGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSNWMKFSVIWYSQRLTEWLGEARFQQ
YVDRFDYGNRELSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKMPVSAEAVRRT
SILLRQPDIDGWQIHGKTGMGYPKLLDGSLNRDQQIGWFVGWASKQDKKLIFVHTVVQKP
GKQFASLRAKEEVFAALPTELKKL
>A0A073K870|FEATURES|UNIPROT_deepARG|chloramphenicol|BAGA_08185|antibiotic inactivation|1
MKFHLIDRENWDRNPYFEHYLNLKCTFSMTANIDITRLLEQLRHKGIKLYPTFIYMISKA
VNSHKEFRTCFNDEGVLGYWDKMIPSYTIFHNDNKSFSSIWTAFSNEFSTFYKNYQDDIK
EYGDVHGLFTKENVPKNSFPISSIPWVGFTGFNLNIINDNDFLLPIITGGKYFNQNDKIL
LPISLQVHHAVCDGYHASKFIEEVQELANNFHEWFC
>X2HAM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLFLKALILGIVEGLTEFLPVSSTGHLIVVGNLLKFETTGEVFDITIQLGAILAIVF
EYKHRFAHIITHIGKEPATNRFVLNLAIAFIPAAIMGLLFSEQIKHYLFNPITVATALVI
GGLLILWIEKRQSRTEPKVKTVEDMRPRDALIVGLAQILALIPGTSRSGSTIMGGMLWGI
ERKAATEFSFFLAVPVMIAATGYDMLKHLHEFTRDDLLLIAIGFVAAFLSALVAVKALLR
FVAHKNYIPFAWYRIIFGGIILVTWATGWVKW
>I6YE73|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQALRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>BAA08271|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSKPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>A0A0C1WYC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTERNAQRFTLNLLIAFFPAVILGVLFADAIHEYLFNPITVAVALV
VGGIVMLWAEQRSHVVSVEHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLLILATWVFGWVNWTAAAAA
>A0A0P6S5L3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
VGGVIMLWAEKRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFITAFIFAMIAVRGLLKF
IASHSYAAFAWYRIGFGLLILATWQFGWVDWAAAKP
>U2ENR8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGDNEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKNDREK
RGMEILDSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVNDNVKSSEIYEATKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGRVKTLSISDANMLSKQSFLDSVTPNTSTSGVLTYENISL
TATLKGGGVGSFDVNGLKLEKGRIYDDEEVLNSDSVTLIDQNTKNSIFKNEDPIGKIILF
NKKPLRIIGVLQKDEFKIGDASSLKIYAPYTTVINKITGDKFISSITVKVNESVNAQIAE
KSLTDLLTIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIAFSYAIGYIFNNFLDGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>ZP_03941859|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLNLIDERFGFMLDIIKAVILGIVEGITEFLPISSTGHLILVNEFIKMRESTQFTDMFN
VVIQLGAIMAVVVLYFHKLNPLSPKKDPFEKHATWILWFKVIVAVLPSVVLGLLFNDWMD
AHLMNWEVVSAMLLIYGILFIVIENRNANRRPRFTDLNNLPYQTAFIIGMFQLLSLVPGT
SRSGATILGAILIGTSRYVATEFSFFLAIPTMFGASLLKVYKYFDHGGTFNGTQSIVLAT
GIIVSFVVAYLAIRFLLNYIKNNNFKIFGWYRIVLSLIVIAYFGLIAR
>S9TBG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALVIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIEVVKGLPSDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGFVILWAEWRERHRGQTHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGIIVLVTAYTHLIAWQA
>A0A0E9DS96|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MPAMIELLKALLFGIVEGITEWLPISSTGHMLLLEKFVVLDVSPAFWHMFLVVIQLGAIL
AVCVSFFKELNPFGLSLTKLQRNTIWTLWAKIIVACIPAAVIGIPLDDWMDEHLSSPFVI
AAALVVYGVVFLCLRDSQSNLAMHKGKHAKAVQSEQRRHTFLDKRITTHAIDNLSWKQTI
GIGCFQVLSIIPGTSRSGSTIIGALLMGCSRSVAAQFTFYLAVPVMVGASGLRLIKFFIK
GNTFSTMEAATLAVGCLVAFLVSMAVVKFLMRYIKRHDFSIFGWYRIALGIAVATYFWLI
>A0A0K0S236|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAITIL
YHKRLVSLCNIKPLLQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMLFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKINY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0J0IAS8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDHSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDVIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSILLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>B9YZB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLLLAKALLMGVVEGLTEFLPISSTGHLIVAGDLINFHSETSAVFEVVIQLAAILAVV
WEYRARFTGVAENLGRDASAQRFVFNLLLAFLPAAIIGFLFIKVIKLYLFNAVSVALAFI
IGGLVILLVERKDRRAQVHSVEAMTGRDALKVGLAQVFALIPGTSRSGATIIGGMLFGLD
RKVATEFSFFLAVPTMFAATIYDVYKHRALFALSDAPVFAVGFVAAFFSAFLAVRGLIRY
VSGHNFNAFAWYRIGFGVLILLTWKMGWVDWAA
>A0A0U4VX67|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDTLKVILFGIVEGITEWLPISSTGHMILLEEFITLNARREFWDIFLVVIQLGAILAVV
WINFNQLNPFAPSKSKAEKEETWMTWFKVVVGCLPAAIAGLLLDSWMEANLMNWFVVAVM
LIVYGIWFIWIENRNKNRLAKINSMAEMTYMDAFKIGLFQVLSLVPGTSRSGSTILGATI
VGTSRPLAANFSFFMSIPIMFGASALKLVKAFLSGFVFTGTEIWLLLVGMVVAFVISVLT
IKLFLKYIKANDFKVFGWYRIVLGIVVILYFLLFNS
>AAK53751|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>A0A0B2T2G8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGDVPHEGHTAGRLKLTHILLAMIPAVVLGLVFHDVIKSLFYPQN
VMYALIVGGFLLLAAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFIVALIA
IKTFLKVIKRISFVPFAIYRFIVAGVVYLVFM
>A0A0U1YUG1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQAFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>F6G3R3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAVNVIVATIPAITLALIFGKTIKAHLFNPIVVASAFI
IGGLVILLVEWRERRRGQTHDPRGNALLEAAKAGAPRIETLDDLLLSDAIKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSADDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGIIVLVTAYTHLIAWQA
>C6Z584|FEATURES|UNIPROT_deepARG|beta_lactam|BSFG_02190|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATFIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A0T6ZPM8|FEATURES|UNIPROT_deepARG|beta_lactam|N184_08310|antibiotic inactivation|1
MTTIKLGLTTAILFSLTATVFAADGEQARIAATVDKAIRPIMGEYKVPGMAIAVTVDGQH
YFVNYGVASKETKAPVTENTLFELGSISKTFAGTLASYAQVLGKLSFDDHPGKYMPDLSG
SAIDKATLLNLATYTAGGLPLQFPDEVKSNADMLTYFSNWKPGAEPGKERRYSNPSIGLF
GHAAGLAMGSNFATALETELFPKLGLKHSYVTVPRSAMGSYAWGYGKADKPIRVNPGMFD
AEAYGVKSSAADMIRFVEANIQPEQFDGPVRKALEGTHIGYFDTGKMIQGLGWEQCPYPV
SLERLLDGNSRTMAMEANPATALNPPKRPDGATLYNKTGSTNGFGGYVAFVPEKKIGVVM
LANRNFPNPERIKAVHAILKTLATAAE
>YP_333454|FEATURES|ARDB_deepARG|multidrug|OprA|antibiotic efflux|0
MMKPRARRRGARAARRPNGPRAWPLAVAAALVAGCTLAPRYERPAAPVPAHYWSTATGAP
REAGPAAAGGPRAMPDARRGDAGRDARDARLDDWRAYFTDPALRALIDAALANNRDLRIA
TLRIQEARGLYGVARADRLPSIDGSLGYERTRLYDPVLRESATSSLYRASVGVSAFEIDL
FGRVKSLSDAALAEYFATAEAQRAARISLIAEVASAYVTERALVDQLGLAERTLAARDAA
YALTQRRYAAGTSTAIELRTAEMLVASARASKAALEREHTQAASALKLLAGDFMTALPAD
APALDALAVARVSPGLSSDLLEQRPDIRQAEQRLVAANANIGAARAAFFPRIALTTDVGS
VSDAFSGLFSAGSSVWTFAPRLTLPIFAGGRNRANLDVADARKHIAVAEYEKTIQTAFRE
VADALAARDQIDAQLAAQQAVYGADAERLRLAQRRYDSGVASYLELLDAQRSTFESGQEL
IRLKQLRLTNAITLYRALGGGWSRAGCGGDGCA
>X2H3S7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLEIKAINRWFGTGENRVQVLKDINLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDVPS
SGSYKIDGVETAAMTADEQAALRRRSFGFIFQRYNLLGTLTARENVALPAVYAGMEYGER
MKRADELLAQLGLAGKEENRPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTGSGK
NVMEILHKLHDAGHTIVMVTHDPTIAANANRVIEISDGRIIADHSKNTDIPPSNIESIEE
HNSWHFYRDQFFESFLMSIQAIMAHKMRSFLTMLGIIIGIASVVSVVALGRGSQEKILEN
INAMGTNTVSVYPGYGYGDRRSSRIKTLTVGDAEVLKQQDYVDSVTPGVSTSGTLTYDNQ
SLSAQLYGVGDQYFDVRGIKLAFGRLFNEDDVTQNSQVVVIDDNTKNKLFADGTNPLGKV
ILFNKRPLRIIGVTEPNNNGFSDSDSLQLFTPYTTLMNRISGSKYITSVTVKVKDNVNSQ
TAEKGIIELLKVRHGTEDFFTRNSDTIKQTIESTTGTMTLLISSIALISLVVGGIGVMNI
MLVSVTERVKEIGIRMAIGARQHNILEQFLIEAVLICLIGGLVGVLFSFAISMLFNLLAT
DFAMSFSTISIVMAVLCSSVIGVLFGFMPAKRASQLNPIDALSRD
>A3D8D6|FEATURES|UNIPROT_deepARG|beta_lactam|Sbal_3522|antibiotic inactivation|1
MRSFAISTVLVMSSLLASSIIAAPTFASTAAKTEWQETRSWDAIFTQHQVELKQAKQQQV
KPQKTKSQQASGVVVLWNENKQQGYTNSLKRANQGFLPASTFKIPNSLIALELGVVKDEH
QVFKWDGKSRDIDTWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDIS
GNLDSFWLDGGIRISATEQIDFLRRLYHNKIHASERSQRIVKQAMLTEANSDYIIRAKTG
YAVRAEPSIGWWVGWVELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP
>A0A0P9HV92|FEATURES|UNIPROT_deepARG|polymyxin|ALO90_00035|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQEDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRXXXXXXXXXXXGCLSWI
LKKT
>A0A127AL46|FEATURES|UNIPROT_deepARG|beta_lactam|blaDHA|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGAATGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>D6BDL7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGG
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKDDIDSQVAQKSITDLLKAKHEKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSGFSIVMAVLFSTLVGVIFGYMPAKNAAKLDPIEALSRE
>A0A0M3STF3|FEATURES|UNIPROT_deepARG|beta_lactam|IMI-3|antibiotic inactivation|1
MSLNVKPSRIAILFISCLFSISFFSQANTKGIDEIKNLETDFNGRVGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILSEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>A0A083ZSS3|FEATURES|UNIPROT_deepARG|aminoglycoside|SY94_2150|antibiotic inactivation|1
MSGQFVIGNAADYPDAWCLLRHRLWPDTTPAEHREELQDVGETGAGFIVRDPAGVAIGFA
EVSLRRDYVNGCDTSPVAFLEGIYVEQAFRKRGVAALMVEEVTRWAISQGVSELASDADI
SNTDSHRMHAALGFEETERVVYFRKMLRLNDEPEQ
>S4YKB3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|M621_20535|antibiotic efflux|1
MTAKATPVIVLENVSRDFNAGEHRVRILKHISLCIRRGEMVAIVGASGSGKSTLMNIIGC
LDKPSQGVVRINDVAIQQVDGERLAQLRSRHVGFIFQRYHLMPYLTASENVAIPALYTAM
PAAERRLRAQSLLARLGLSQHGRRRPAQLSGGQQQRVSIARALMNGAEIILADEPTGALD
SVSGQELMGILHALHVAGHTIVIVTHDRRIAEQAERIIEIGDGEIVTDRHNDTRRVSADG
HFPALSAPLRRAHLWPAFREAVSMAWRALLGHRVRALLSMLGIIIGIAAVVSSIAIGEGT
RQNILNEISQLGTSSLEIRPGLGWEKKRPDFERSLSLQDVALLSALPYIDSVSPVASAQV
LAVRDGKQVQLPVMGVGNGYFRTQGTRLISGSTFTQQDLDQREPVVIIDTQLRQVLFSSL
RDPIGEVLPLAGVPYRVIGVAERKGAKYAGAQPLAWLPYTSLTGRISGDMPLESIVMRVR
EGLSLTQARGDVERRLMLEHGRRDFFTVTDDQMTQALQKASASMSWLITAIAGISLLVGG
VGVMNIMLVSVTERTHEIGIRLAVGARERDIMRQFLIEAVVICSLGGAMGIACSALVCLA
LAWLTPQVTMVFTWPPLLLACGFSALIGVGFGFFPARTAARLQPVEALARE
>A0A0W5CXN7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRAAEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>A0A0W1FB41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEIMTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAGRWAIFNIAIQPGAILAIVVL
YRKLFWDMFTGLFRRDPQAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALIV
GGFAILLVERYAKTVDVGGVANVSTRQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITPNDLWLIAIGSLVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIVVGIAALAWLGMR
>A0A0N0JN33|FEATURES|UNIPROT_deepARG|aminoglycoside|IP85_04510|antibiotic inactivation|1
MTGFGVRRATEKDLDAWASLRHQLWPHLSLEGHRAEITDALAQPEKLVAFLCVSATGNAI
GLAEANVRSDYVNGCETSPVAFLEGIVVDPSFRRQGVAASLVAAVTDWAKDEGLSELASD
AEIHNTVSHAMHAALGFEETQRVVYFRKSL
>YP_746446|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWLILIKAFLLGIVEGLTEFLPISSTGHLILAGDLLDFNDDKAQVFTVAIQLGAILSVC
WEYRARLINVARGWGTRRANRFVLNLCVAFLPAAILGLLFIKTIKYYLFHPLPVAIALVT
GGVLILWAERREHRIEVENVDDMNWKHALKIGCAQCLALIPGTSRSGATIIGGLLSGLSR
KAAAEFSFFLAIPIMFAATFYDVYKHREFLHSDDLGMFVVGSIAAFISALIAIRGFIRYV
SHHDFTLFAWYRIGFGLIVLLTAHFGLINWSAG
>A0A060KTG5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAGLSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>E3D233|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>R9WJA6|FEATURES|UNIPROT_deepARG|chloramphenicol|LRI_2025|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRV
INSNTAFRTGYNSDGELGYWDKLEPLYTIFDSVSKTFSGISTPVKNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSISIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIQELADRPNDWLF
>A4EC27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGHRPHRPQNNYRRVSNEGVPLDIIELLKSAFMGLVEGITEWLPVSSTGHMILVDEFVKM
NVSETFWNMFLVVIQLGAILAVCVLFFYDLNPFSPSKGKEGRRDTWVLWGKIVLGCIPAA
AIGLPLNDWMEEHFYNAPVVALALIVYGVLFIVIENWRANKRDQAALAGSFGSRAVVAGG
RPAGAHFAAPAATATADDDDNLDFGSIATLEDLSWKTALGIGCFQVLSLVPGTSRSGSTI
IGGLLLGCTRSVASKFTFFLAIPVMFGASALKLVKYFIKGGTFGTNEIAILGVGCIVAFA
VSLIAIKWLMGFVRRHDFKCFGVYRIILGIVVLAYFFVLEPMLGL
>X8IDE6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMEILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFSE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKDDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSVFSIVMAVLFSTLVGVIFGYMPAKNAAKLDPIEALSRE
>A0A095X005|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIINLIKVLILSLVEGITEFLPVSSTGHLILVNQFVKLEPEGFSNAFNVIIQLGAILSVV
VIYFEKLNPWAKSKQELPKKYKDLNAQSKAYYLATHPDKTTINLWLKVIVGVLPAMVLGL
LFDDLIDAYLFNPTTVAAMLLLWGIIIIFIEKKNKTIKYDSLKDVPYTTIIMIGLFQCLA
MVPGTSRSAATIIGAMILGLSRPAAAEFSFFLAIPTMLGATLLKLIKNLGDFTGTEWTLI
LLGMILSFIVAFIVIKQFLAYVKKHDFIPFGIYRIILAVVVFVYFLLINR
>A0A0B6A108|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MQVKAKEKAEKTKHANHATHREFAQLEKKFDARLGVYAIDTGTNQTVTYRPNERFAYAST
YKALAAGAVLQQNSIDKLDEVITYTKDDLVEYSPITEKHMDTGMTLGEIAEAAIRYSDNT
AGNLLFKKLDGPKGFEKALRQIGDKVTMADRFETDLNEAIPGDIRDTSTAKTLATDLKAF
TVGNALPTDKRKILTDWMRGNATGDKLIRSGVPKDWEVDDKSGAGSYGTRNDIAIVWPPN
RAPIIIAILSSRDKEDATYDNELIAQAAKVTINALK
>A0A073HCK9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQALPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>I1V599|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQHSDNV
AMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNL
TLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVV
>E7MQJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILNIIKSVIFGIVQGVTEFLPISSTGHLILLQTFMPLNVFADPVKNKAFWDVYKVVI
QFGSILSVLLLYWKRLCPLGKNVSEPKKKNIYHTWLMVVVASVPLVAGMLLNDWIDNVMS
APYVIGITLILYGILFIWMENRKKKYTIEHVSQITAKKAFGVGMFQILALIPGTSRSGST
IFGATLLGFNRSTAAEFSFFMAIPAMFGASLLKILKADFSFGFWPLMILLIGTVVSFIVS
IIAIRTLMNYIRKNDFKVFGIYRIILGIIVLILCITRLIA
>R7WZU2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTRPYLTLCAALAATTAIGWMAFSAHSYAAERGAAAPTEPRQAEIKALVDKTITPLMARQ
NIPGMAVGVVFDGRTYVFNYGVADKATKKPVTADTLFEIGSVSKTFTATLAAYAQTTGAL
SLTDKTSRFVPELAGTPFGDVKLVNLGTHTTGGMPLQVPDDIHNIDQILQYLKAWKPAQP
TGTVRTYSNVSLGAFGWITARAMHGDFSTLVTEHVFKPLDMKHTFIRVPEDQQANYAWGY
GKDDKPVRVTPAVFEKEAYGVKTTASDLLRFVRANLGTPVRDNSLQQAIHATHTGYFADK
PMTQDLVWEQYPYPVSVDALLEGNSARMARESTPARELSPPMAPTPAAWVNKTGSMRGFG
TYVAFVPSKQMGIVLLANKNYPMGERIRAAHHILTTLDGGTRTAAASRK
>U2UGV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAV
VWEFRSKIFEVVFGLTHQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAAL
VVGGVIMLWAERREHRVQVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVTSFIFAMIAVRALLK
FIANHSYAAFAWYRIVFGLLILATWQFGWVDWSTAHG
>Q5Q117|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
EGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWP
ELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSS
IGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEHKNYAWGYREGKPVHVSPG
QLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEML
NWPLKADSIINGSDSK
>U7GTN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIVDLIKGFFSGDTEARHFTFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVESIMFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQENMLNIGVGFVAAFIAALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFIFL
>A0A0C2RTZ0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIEALLNSGFDIAAVFTHADDPKENAFYASVAQLCANKGIPVHA
PEDANHPLWIERIAKLDPEYIFSFYYRNLLSEPLLALAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQRVAIERSDTGLTLHAKLRTAASDLLRDTLP
NMLQGKITETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTRPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGQDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMRETIGNTLDFFLREAMLEIA
DKK
>A0A0A6UJ15|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTVRSFAVPAGAYAVVAGPDGALWFTVAGGGQVGRLAPGGEPALFDVGAGSTPTVLTTGP
DGALWCTLNQADAICRITTAGVVTTHPLPTPGAAPFGIAAGPDGALWFTEGGAGRIGRIT
TGGVITGFPVPGGGYPAAITAGGDGAMWFALNQANAIGRIAATGEISLFPLPTPDAAPVG
VTLGPDGAVWFVEIGAGQAGRIGTDGTITEFPLPDRAGRPHAITTGPDGRLWMTEWAGNR
ISAMTTDGKVDSYELPQPGSEPHGITTGPDGAMWAALECGALARVGIGA
>A0A0Q3QK03|FEATURES|UNIPROT_deepARG|chloramphenicol|AN957_06145|antibiotic inactivation|1
MKFNRIDRKNWHRKEYFEHYLQQQTTFSITNEINITILMENLKKKNVKLYPAFIFIITKI
VNAHREFRTSFNSEGKLGYWTEVLPSYTIFDKKTCTFSSIWSSNVTIFSEFYSQYEKDVE
RYNGTGRMFPKTPIPENNIPISMIPWSSFTGFNLNINNGGDYLLPITTGGKYSQINGELF
LPVSLQIHHAVCDGYHASVFMNEFQRLADESVEWL
>W2DF52|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MYEHVRNVTILSLLLGAGNCMAAADLRQVVDATVKPLMQQQAIPGLAVAIVQDGKVRYFN
YGVAAKDSQQPISENTLFEIGSVSKTFTATLAGYAQATGKLKLSEPASHYLPALRGSLFD
HISVLHLGTYTAGGLPLQFPSEADNAQHMISYFQHWKADFAPGTQRQYSNPSLGLFGYLA
AQSLQQPFDVVMEKTLLPKLGLKHTYLTVPKAQMSLYAQGYDKTGKPVRVSPGALDSEAY
GVKTSPADLIRYVAVNMNPTNLEKPLQAAIATTHTGYYTANGTTQGLGWEMSAYPLTVDT
LMARNSTAWAMEPHKVNWLTPPQPLQPNTLVNKTGSTGGFGAYVAYVPSKAIGVVILANK
NYPNAERVKAAHAILQAMEQ
>N8TJL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELIRGFFSGDVAARRFAINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVSFAL
IIGGFIIFAVEARKFEPKTIEATDITLKQAILVGFAQCLAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLINISVGFVAAFIAALLVVKALVK
FVEKHTLRVFAWYRVVLGIILLFVFL
>1112175A|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmE|antibiotic target alteration|1
VSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELR
PDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAE
PPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTW
PLFEWEFVEKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRR
RVEAAFDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTG
GQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGR
PGRRGGPGQR
>R8E0T4|FEATURES|UNIPROT_deepARG|beta_lactam|IIU_05321|antibiotic inactivation|1
MDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEK
YVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGDTVTNPERFEPELNE
VPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEV
ADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIVLDALKVT
NK
>A0A101AKG1|FEATURES|UNIPROT_deepARG|beta_lactam|AU195_01160|antibiotic inactivation|1
MAHSVTRRRLLSATAVLGGAAAFATYAGRPAFAQPPVGGVENLERANNAVIGVFAQNLDT
GRTVAHRAQESFAMCSTFKAYLAAQILQLVGRGERSLDQRLSVNAADLQPNSPRTEPRVG
GEMTLTELCQAILQVSDNAAANILLRNVGGPPAVTAFARGIGDPRSRLDRYEIELNSAVP
GDPRDTSTPEALAGGFRAILTGEALAPPQRRLLEDWMRANETSSMRAGLPPGWTTADKTG
SGDYGTTNDVGIAYGPQGQRLLLAVMTKTATDDPDAENMRPLVGEVTAAVFPELLRRG
>1BLC|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
KELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNK
KVHINKDDIVAYSPILEKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLK
ELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLN
NKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDK
PNDKLISETAKSVMKEF
>D4W9A2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGFIEYLKVIFLGFVEGITEWLPVSSTGHMILVDEFIKLNMSASFMEMFFVVIQLGAILA
VIFMFWNKIFPFEFKGGFKIKQDTMNLWFKIIVACLPAAVIGLAFDDWLDEHFYNYQTVA
LMLIIYGVLFIVIENRNKGRKPVVTNLSQITYKFALMVGVFQLLALVPGTSRSGATILGA
ILIGASRYVASEFTFFLAIPVMFGASLLKLVKFGFAFTSAELITLALGSFVAFVVSIFAI
KFLMGYIKKHDFKVFGWYRIILGIVVLAYFFFFGA
>A0A024HIF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIWNAVQAFILGVVEGLTEFLPVSSTGHQIIVADLLGFVGERAQAFNIIIQLAAILAVV
WEFRSKIIEIIVGLPTQRRAQKFTVNLLIAFAPAVVLGVAFADKIHKYLFNPITVAAALL
IGGLIMLWAERREHAIRVDQVDDMTWRDALKVGCAQCLALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPSDLPVFAIGFVTSFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLLILATWQFDLIDWSSAKS
>A0A0D1BU19|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKIKQIVSNLKLPDYRYEQLTKAIFHQRIDNFEDMHILPKALRMALVNEFGK
NVSSVIPVFSQDSKQAQKLLFELTDGERVEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDENLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCNTLKKAGISATVRTQFGSEISAACGQLCYENEL
>D6J5D0|FEATURES|UNIPROT_deepARG|beta_lactam|ECEG_02802|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIENMARWVQSNLKPLDINEKTLQQGIQLAQSRYWKTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYAAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0M2AL21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTVEKKDTWTLWFKVIVACIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>YP_001477377|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MHNSTPLITTIVGGLVLAFLLGMLANRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKHIAIPGAVAQIAVATLLGIGLSKLLGWDLISGLVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFGNMLGNNNA
SSGQLLIELAVTIGKVIAFIALMIVVGRRLVPWILAKTASTGSRELFTLAVLALALGIAY
GAVKLFDVSFALGAFFAGMVLNESELSHRAAHDTLPLRDAFAVLFFVSVGMLFDPMILIN
EPLAVLATLAIIVFGKSAAAFLLVKMFGHSKRTALTISASLAQIGEFAFILAGLGITLGM
MSEHGRNLVLAGAILSIMLNPLLFTLLERYLAKTETIEDQILEEAVEDEKQIPVDMCNHA
LVVGYGRVGSLLGAKLAEAGIPLVVIENSRPRVEALREQGIKTVLGNAANPEVMDLARLD
CARWLLLTIPNGYEAGEIVASARTKRPNIEIIARAHYDDEVSYISDRGANQVVMGEREIA
NSMLNILKLDTLTEEEKMGGCPI
>AAM46773|FEATURES|ARDB_deepARG|beta_lactam|FOX-7|antibiotic inactivation|1
MNANFIHHENNHMQQRRAFALLTLGSLLLAPCTYARGEAPLTAAVDGIIQPMLKEYRIPG
MAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDD
KVSQHAPWLKGSAFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRHWSPVYPAGTH
RQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKED
KPVRVTPGVLAAEAYGIKTGSADLLKFTEANMGYQGDAALKSAIALTHTGFYSVGDMTQG
LGWESYAYPLTEQALLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAF
VPARGIAIVMLANRNYPIEARVKAAHAILSQLAE
>A0A0Q6VPL3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLARDGFVAEFPALVNAIEVDQAIKPLLEKNAIPGMAVALSVNGTHYFYNYGVASKETGQ
AVSNATLFELGSLSKPFTTTLAAYAQAQGKLGLTDPVSRHVPALRGSVFDRVNLIHLGTH
TVGDFPMQVPDRIKTYAQLMDYYKDWQPGHAPGTHRTYSNLGIGLLSIAAAGSLGVPYVD
AVERTLFPALGMEHSYIKVPEAQMAQYAQGYNSKGAPVRVNPGVLADEAYGVKSNTRDMI
RFVDANMGLLPLDAKLARAIADTHAGYYKVGAMTQALIWEQYPGQAGLEQLLTSTAEKMV
WQANPVDAIAPPSAPQGDAWLHKTGATGGFAAYALFNPGRKVGIVMLSNRGLPGSERVSA
AYEVLNRVAPAAAPAAAPAAR
>B7INI5|FEATURES|UNIPROT_deepARG|beta_lactam|BCG9842_B2020|antibiotic inactivation|1
MIVLNKFFNILHYKKVVPVVFLSCATLIGCSDGNTQSELPKQTKQTKQTNQTKQETTGND
SFAKLEKEFDAKLGIYALDTDTNQIVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQR
VLYTREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLRE
IGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRN
TTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDD
KLIAEATKIALGVLKAKNK
>U6A6K4|FEATURES|UNIPROT_deepARG|beta_lactam|blaFONA-1|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDERDTSSPLAMAKSLQNLT
LGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
>A0A0F0YAB9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENHFFSSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDVLFSFYYRNLICDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIIAQHRVAIDADETALKLHQKLCTVAQSLLRDALPAI
LNGTFSETAQDESKASTFGRRTPEDGRLDWNQPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIITGQTDSGLYVQGTQLAQSLGLVA
GALITSAPVVAVKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGQIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQVS
>ZP_04202328|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVKEGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAATGLDLIKSWDVLSSADVTLFATGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A0D5WT53|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGEEQVEVLKGISLTIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVSGLDSDALATLRREHFGFIFQRYHLLSHLNASQNVEVPAVYAGTTRAQ
RQQRAHELLGRLGLKERVEYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EDVMATLKQLRERGHTVIIVTHDPAVAAQAQRIIEIRDGEIISNPPPVHQPAARTVENQA
LGSGSSIQQLISSFREALGMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LEDIRSIGTNTIDVYPGKDFGDDNPQFQQALKYDDLLAIGQQPWVSSATPSISSNLRLRY
GNVDAAASVNGVSGDYFDVYGMTMSQGASFNDEQMNGRAQVVVLDANSKRQLFPNKSDVV
GEILLVGNMPATVIGVAEEKQSMFGSSKVLRVWLPYNTMAGRVMGQSWLNSITVRVKEGY
DSHEAEQQLNRLLSLRHGKKDFFTYNMDGLLKTAEKTTRTLQMFLTLVAVISLLVGGIGV
MNIMLVSVTERTKEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLVIAFTLQL
VLPGWQIGFSPVALLTAFGCSTATGVLFGWLPARNAARLNPIDALARE
>A0A089HM65|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MIAEISTQLLEVLSVIERHLEPTLLAVHLYGSAVNGGLKPYSDIDLLVTVTVRLNETTRR
ALLNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>AAY52007|FEATURES|ARDB_deepARG|glycopeptide|VanYA|antibiotic target alteration|1
MKKWGFLLLLCLGFVFINKALFFQEKVEIQNYDQNPKDHLDNRGTSESTQTKTITNEQIY
QGNLLLFNSKYPVRQESVKSDIVNLSKHNELINGYGLLDTNIYMSKGIAQKFSEMVNDAV
KEGVSHFIINSGYRDFDEQSVLYQEMGADYALPAGYSEHNSGLSLDVGSSLTKMERAPEG
KWLKENAWKYGFILRYPKDKTDVTGIQYEPWHIRYVGFPHSAIMKEKNFALEEYMDFLKE
QKSITTTIDHQVYKIFYYPISQNTTIHVPANGQYEISGNNMDGVIVTVYSGKRD
>ZP_04623897|FEATURES|ARDB_deepARG|polymyxin|rosB|antibiotic efflux|0
MGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKD
LLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQ
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
TLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMV
LNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLHEPLAVLASLAIIIFGKSAAA
FILVRMFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLMSEHGRNLVLAGAILSIMLN
PLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPVDLCNHALLVGYGRVGSLLGAKLHAEG
IPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARIDCARWLLLTIPNGYEAGEIVA
SARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIANSMLNMLKIETLTEEDKRPL
CPI
>H6CP56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILSSIIMGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVMAVVV
LYWRRFLSLFDFRRRTSSQPRLNLLHIILAMIPAGLIGVLFRDVIKQYLFGPETVLYSLV
IGGLLMIAAEKFHPPIKSQTIDEITYKQAFTIGLFQVLALWPGFSRSGSTMSGGLFARVS
HTAAAEFTFLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGL
LKRLSLTSFAIYRFVLAAVFFFIIL
>A0A103DWZ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWVLIVKALVLGIVEGLTEFLPVSSTGHLIVAGSFLHFHAEYAKTFDVVIQFGAILAVC
WEYRRRIANVVTGLPTQPLARRFALNVVIATVPAVALALLFEKTIKSVLFAPVPVAVALI
AGGAVILWVEGRRDRAAPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGMLF
GLERRVATEFSFFLAIPVIFGATLYETVKDWRAFDADLLGLFGIGLIAAFVSAFACVRWL
LRYVASHDFTPFAWYRIVFGLFVLLVGYSGWIDWA
>A0A0Q6W9P1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYISSIILGIVEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRDPQNRSYALKLIVAFLITAVLGLIVKKLGFQLPETATPIAWALIIGGIWMI
FAEWAAARRPPHTEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAYELLKTFKDGGAANEDWTGLGIAFVVSTIVAFIAVKWLLSYIQTNR
FTVFAIYRIILGAALLGMAATGIIA
>D1LFE1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWTVGE
>A0A0T7FMH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFLPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYARKLLQIAADLPTSPKARRFVATVLIAFLPAAVIGALAHDFIKAVLFETPMLICVMLI
LGGFVLLVVDRIKFQPKYHDVMDYPLSLAFKIGLCQCVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRNALSFDDGAVIAVGFVAAFVTAIVVVRSLLDF
VSSRGYAPFAYWRIVIGAAGLIALLLGA
>A0A088X6K4|FEATURES|UNIPROT_deepARG|aminoglycoside|DM82_4268|antibiotic inactivation|1
MTHPASLCTIRAAAASDAAVWRQLRRALWPHADHAEHARDVAQQLDAPNRHACFIAWTPD
GAPLGFAEVAVRHDYVNGCDTSPVLFLEGIFVDPAARRRGAARALCSAAAAWGATRGCAE
FASDAPLGNAVSHALHRALGFDETERVVFFRKTLAR
>Q4HTD3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MIKLENISKKIGQNTILKQINLQIEKGEFVAIIGQSGSGKTSLLNIIGTLDEPSGGRFFF
ENYEVTNLNKDEKARLRREKIGFIFQRYNLLPLLSAKENVSLPSVYAGKKSEERNQRATN
LLENLELSHKMNSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGVMVLEIL
QKLNTQGHTIILVTHDPKIAAKAGRVIEIKDGEILSDTKQNSKMREFEIKTMLKEKKSFN
LLKNQVFECFKIAYSSIIAHKLRSFLTMLGIIIGIASVVCVVALGLGSQVKVLQTTSSLG
TNTIEIRPGRGFGDLRSGKTRLNFSDLETLRSLEYLEAVEASERTSGVLTYTNKSLNARA
EGVGVNSFNMDGLKLEVGRILDEKDLSVSANVAVLDFNAKKNIFPNVKSEELLGKIVIFN
STPFKIIGILQKDTRRPISDNIVRLYIPYTTLMNKLTGDRKLREIIVKVKDNVSSSLAEN
AIIRVLELKREQRDFFTFNIDSFKEAITANKRTTTILTICVALIALVVGGIGVMNIMLVS
VSERTREIGIRMAVGARREDILMQFLIEAVMICVIGAFMGVALSFGVIFVFNLFASDFLM
IFSGSAVLTGLLSSVLIGLIFGFFPAKNAANLNPINALSKE
>R6A4K8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKSAFMGLVEGITEWLPVSSTGHMILVDEFVKMNVSETFWNMFLVVIQLGAILA
VCVLFFHELNPFSPSKGKEGRRDTWVLWGKIVLGCIPAAAIGLPLNDWMEEHFYNAPVVA
LALIVYGVLFIVIENWRASKREEMAVAGSFGSRAVVSGGRPAGAHFAAPAAATAEDEGDD
EDLDFGSITTLEDLSWKTALGIGCFQVLSLIPGTSRSGSTIIGGLLLGCTRSVASKFTFF
LAIPVMFGASALKLVKYFIKGGTFGANEVAILGVGCVVAFVVSLIAIKWLMGFVRRHDFK
CFGVYRIILGIVVLAYFFVLEPMLGL
>A0A024E3R8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACRLLRHDYEIVLVDDGSRDNSAQILEEA
ANRECSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQTERGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRSIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLVNLMFDLITCMTTTPLRLLSIVGF
AMAGLGLLFATALIVLRLVFGAEWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFVEKVLRSQPATPAPVVTVDGLTNTSSDQVLS
>V6IZQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTHLLIAIIMGAVEGLTEFAPVSSTGHLILAGELLHFTNDTAKTFDVIIQLGSIMAVVVL
YWKRLWSLFGFYRNEPKNGPEHLNLLHIIIGGIPAGILGILLHDFIKKYLFSYQSVLVAL
VVGGILMIIAERITSQRSGMGTKELSYKQAFVIGLFQIFSIWSGFSRSGSTIAGGLIAGV
ERKTAAEFSFILAVPMMIGASGIDFVKSLKFLHASDIPLFVTGFVAAFVVAMLAIVFFLK
LLRRFTLVPFAIYRFILAAVFAAFILL
>D5T3E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKSIIIGIVEGITEFLPVSSTGHIILAEALMGIPGGDVWTNSFKPVFDYAIQLGAI
FAVIQLYFNRLNPFSSQKTSRERFQTWRLWIKVVVGVIPAVIFGLLFNDFMDAHLLNFWV
VSAMLIVYGIAFILIENRQKNIAPKITDVNKITFKLALFIGLFQVLSLVPGTSRSGATIL
GAVILGASRFVAAEFSFFLSIPIMFGVTFLKVGSFLIGGGRFTGMQSLVFLVGFIVSWLV
AFFAIKVMMRYIQNNDFKIFGWYRIVVGIVFLLLGVIGVVK
>A0A0U5NV03|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MIEIIKAFIFGIVEGITEWLPISSTGHLILLNEFIKLDVSRKFYSMFEVVIQLGAIMAVV
VLFLKDIFPLGQTNNNISAKSQVYIKKDVLILWFKILVACIPAGVIGILFNEKFEDLFYN
YQTVAFALIVFGVALLIIESKYKDKSARINSLSELTFDIVFTIGIFQLIAAIFPGTSRSG
ATIVGALLLGVSRKVAAEFTFFLAIPVMFGASLLKILQFGLLFSTFEFTILLVGMITAFV
SSLLIIKLLMAYIKKHDFKIFGWYRITLGIIVLMYFTLKQ
>AAZ98835|FEATURES|ARDB_deepARG|glycopeptide|vanRD|antibiotic target alteration|0
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGTDALKCIESTPLDLAILDIMLPDID
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSIADDYITKPFNPLEVVARVKAQLRQYM
RYRQPHFKQEDERSEYDIRGMTISKNSHKCILFGKELQLTPTEFSILWYLCENQGKVVST
EELFEAVWGEKYMDNNNTVMAHIGRLREKMKERAKNPKFIKTVWGVGYTIEK
>YP_002552549|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDTLLLLKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQRIRATLVALPTERQARRFALNVLIGFLPAVLLGLLLGKAIKAHLFTPVVVASTFI
LGGFVILWAERRQQAAVRIHAVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDYSFFLAIPTLIGAGVYSLYKERALLSAADIPLFAVGLVFSFISAWLCVRWLLR
YISSHSFVPFAWYRIAFGLVVLVTAWSGLVTWAE
>A0A133HH81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFTMNVVIATLPAIALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEARQRERGAPARVQSIDELTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFSVDSIGLFSIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWS
>C1D4X7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLLAKAAIMGIVEGLTEFFPISSTGHLIVVGDLINFDDRIGNVFEVVIQLGAILAVC
WEYRARLWQVAIDLPTSTMARKFVLNLLIAFLPAAIVGVLLIKTIKSYLFNPVAVACALV
VGGLVILWAERRECTARVHRIDDMSHLDALKVGLAQIASLIPGTSRSGSTIIGGMLFGLD
RRVATEFSFFLAIPIMFAATAYDVLKHWELFTAADLPTFGTGFLFAFLSAFVAVRGLIRF
VASHTFNVFAWYRIVFGLIILGSWWLGWINWAS
>A0A0F5R1F7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKLDGMNHICFSVSDLDRSISFYAEAFGAKLLVKGRSLAYFDLGGLWIALNEEKEIPRDE
IRLSYTHLAFSMQAVELDHAVRRLEAIGAEVLPGRERDERDRRSVYFRDPDGHLFEFHSG
TLQDRLDYYRETKPHMVFGELDYPAE
>W0JK45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIFHAIVLGIVEGVLEFLPVSAAGNLTLVGKLLGIPSSDFIKIYEIVMQLGAVFAVLIL
YAKRLLVDIKTLKKVIYAFIPTGILGLIVYKPVKHYLLYNDKITVISLIIGGIIIIAIEL
SKKKPTIYKIDDLSTKKAILLGFIQALAFIPGVSRSGATIVGGILLGMDRKTSVEFSFLL
AIPTILSAGSYALLKDHAQISHSDFLAMGVSFVTALIFAIISVKTFLRFISTNNLMAFGF
YRIIVGIAYLVFA
>U2MCW0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELSDIRRSYLSGDQTIDVLKNVSLRINAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGTYRVAGQDVATLDGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAAALLQRLGLGERITYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPQAQGNPQAKMLDM
ATPAPSWQQVAGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMI
LADIKSIGTNTVDIYPGKDFGDDDPSFRQALKYGDLSALREQPYVSALSPNISSSMRLRF
GNIDVAANVAGVGEQFFRVYGMTLSQGVGIDALQVQSQAQVVVIDANTQRRLFPHKKNVV
GEVILIGNMPATVVGVAKEKQSMFGSSKALSVWVPYSTMANRLMGNDYFDSITVRIREGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIALSFAIGLLVQL
VMPGWQISFPPVALLSAFLCSTGIGVVFGYLPARSAARLNPIDALARE
>L9M7P6|FEATURES|UNIPROT_deepARG|beta_lactam|ACINWCA92_2656|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSITIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>F3PNS1|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9446_00361|antibiotic inactivation|1
MEKNRKKQIVVLCIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGNVNENGVLAAHNDVAYICLPNNVSYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A7N8N9|FEATURES|UNIPROT_deepARG|beta_lactam|VIBHAR_06370|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAAKLNEDISAIEEHISGRIGVSVWNTQTDDHWDYRGDERFPM
MSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEATML
MSDNTAANIVLRSIGGPRGVTTFLRSVGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPIYISIYITETDLSLQARDQIIAQVSQLILDEYNTI
>A0A151A730|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFILELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSAFLGSESAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYKSQPIDGLRHKPKRLNLLHILVGMIPAGVLGLLFDDVIE
KYLFSVPTVMIGLLIGAVYMIMADIYSKRVPNPKTVDQINYLQAFIIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKAASDFTFMMSVPIMLGASCLSLIKNIEFIHLNQLPFYILGFLA
AFVFGLITIKLFLHLISKVKLLPFAIYRIILVIIIAILYFGFGIGHHITSA
>A0A0T9NHX1|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGISVPLVSFVLPAWAAAIPASLDNQLAELEQTSNGRLGIALINTANG
KKVQYRGGQRFPFCSTFKLMLAATVLGHSQFQPNLLNKHLRYHENDLLSYAPITRKNLAQ
GMTISQLCAATLQYSDNTAANLLIKELGGLGSVNQFARSIGDQTFRLDRWEPDLNSALPN
DPRDTTTPVAMAASLQKLVLGDALAAPQREQLARWLKGNTTGGETIRAGAPADWVVGDKT
GSGDYGTTNDVAVLWPTQGAPLVLVIYFTQRNKEATSRRDVLASATKIVLSHLA
>A0A0E2QSM7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1564_1833|antibiotic inactivation|1
MKNLFRHGRLLVAVSLALTSLSSAALTQSDVDSIIKPLMKQQQIPGMSVAISVDGKHFIY
HYGIQSKQTKVPVTDNTLYEIGSLSKTFTATLASYAQGQGKLDFSQPVSHYLPELKNTVF
DKVTVMNLATHTSGLSLFVPNTVTNSAELIQYYQQWSPEKPIGEYRSYSNLGVGLLGMVT
AKQLGTTFSQATDNMMLPALGMKHTYLQVPQEKQQNYAQGYNKQHQPVRVTPEILDNEAY
GLKSTAKDLIRFLDINMQVVDVKKSWQEAVEDTHTGVYMTDSFVQDLMWESYPWPVSLAQ
LQQGNRDDMALKPQKVEAIQPPLPPESAALYNKTGSTNGFAAYAAFIPDEKIGIVLLSNQ
WYPIPERINAAYQLIEKVKH
>M8JR02|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYPAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0B2BAA2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACVTATAGRAAAATQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAGKYLPA
VQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRDDAGLIRYLEAWRPAYAPGTYRTYSNVAI
GMLGWLTAKAMHKDFAALMEQRLFPALGMTHTYINVPEVRQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGIQATAIKPPLAPSADTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSYPNEDRVKAAYGILGALDGRR
>A0A0J5VGF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIMILKAIILGFVEGMTEFAPVSSTGHMIIVDDMWLNTKEFLSKYEANTFKVVIQLGS
ILAVVIIFRDRFIEMLGLGGRGKSSEEKQSRLKLSQVIVGLIPAGILGVLFEDYIDEHLF
STETVLIGLVIGAFLMIFADIFGGKNPKTVSVDQITYKQALSIGLIQCFSLWPGFSRSGS
TISGGVLLGLSHRAAADFTFIMAVPIMAGASFLSLIKNLEYFSVEALPFFIAGFISAFIF
ALVSIRFFLKIIGKIKLIPFAIYRIVLAGVIYFVFL
>V9HDR8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGEGENRVHILKNINLTIQKGDFVAIIGQSGSGKSTLMNILGLLDTPT
SGTYSIAGTETSKMSVDELAAMRRKRFGFIFQRYNLLSSISARDNVALPSVYAGLSHAER
NARADLLLDKLGLKGKEKNKPSALSGGQQQRVSIARALMNGGEIIFADEPTGALDSGSGE
TVMQIIHELYAEGHTIIMVTHDPQIAAQANRVIEIKDGEIISDTSKTTEINPSNVQAIQE
KHGLSFYKDQFSEACKMSVQAIVAHKMRSLLTMLGIIIGIAAVVSVVALGKGSQEKILAD
INSMGTNTISIYPGKGFGDRRSGKIKTLTVADSQAISKLNYVESTTPSVNSSGTLTYRNT
DLSASMNGAGSQYFDVRGLKLDKGRLFNDEDVQENAQVVVIDDNTAKKLFTDGQNPLGKV
VLFKKRPLTVIGVLKKDDNPFGGSDSLNLYTPYTTLMNQISGSKFISGISVKVKDNIDSQ
IAEKGIKELLLSRHGTEDFFMFNSDSIKQTVESTTGTMTMLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARQNNILQQFLIEAILLCVIGGISGVLISFGIGVIFDYFVK
DFAMSFSTGSIVGAVLCSTAIGVVFGYMPAKNASKLNPIDALAHD
>A0A0L6N8J3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGTFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCNDKYFDEDHSNLTVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>U7A0U5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRQTTLTGLTMISACTLLVLAPHALAETSPEHALKATVDATIRPLMHQQGIPGMAVAIIA
GGQRHYFNYGIASKDNQRPVDNDTLFEVGSVSKTFTATLGGYAQASGKLALQDPASQYLP
ALRGSVFDGVSLLQLATYTAGGLPLQFPDEVQGEAKTLDYYNTWKPRFEPGTQRQYSNPS
IGLFGYLAARSLGQPFDQLMEGLLFPKLALKHSYLHVPKDQLEHYAQGYDKQNRPVRVGP
GPLDAEAYGVKTSAPDLLQFVADNLQPGQLDGTLQRALASTQSGYYQVGDMTQGLGWERY
AYPVPLARLMAGNSTPMALEPHPVQWLTPAQPPKADALYNKTGSTNGFGAYVLFVPGQQV
GIVLLANKNYPNEERIKAAHKILDALDSPR
>BAH61691|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHSTMPYPVKEIRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTE
LGIDPAMRAENISVAQYCLMANWLSDNLPTKES
>A0A070F4A6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAETEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0C2VQU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWWAIIVAIILGVVEGLTEFAPVSSTGHMIIVDDLWLKSKELFNPDVANTFKIVVQLGS
ILAVVVVFKERLINLVKINNKSTTTNAPVLRWQMVAVGLLPAVIFGFLFEDFIDEHLFSI
ETVLIGLIGGSFLMIAADILHKRNNHITTTVDKLTYKQALLMGLFQCIALWPGFSRSGST
ISGGVILGISHRASADFTFIMAVPIMLGASGLSLFKNWSYMSIDVLPFFIAGFVSAFLFA
LLSIRFFLAMISRIKLLPFAVYRLVLSGILIVIVYF
>A0A0B5SBY0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>W7PFH5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEVLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKVNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>J8D640|FEATURES|UNIPROT_deepARG|chloramphenicol|IG7_02207|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTGYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>A0A0E1E9E4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSHKAVVFAYHDIGCAGIEALLNAGYEIGAVFTHADDPQENTFYGSVAQLCSLKGIPVHA
PEDANHPLWIERIAKLKPDYIFSFYYRNLLSEALLATASKGAFNLHGSLLPSYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAIIAQQRVAIERSDTALSLHGKLRDAAASLLRDTLP
ALAQGKVSETAQDESRASYFGRRTAADGKLLWSKPAEQLFNLVRAVTKPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISTNPLRIACGQDSLLINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
DHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GSKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKSFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMKQTIGNTLDFFLREAMLEIA
ESSKEEAC
>AAZ98839|FEATURES|ARDB_deepARG|glycopeptide|VanD|antibiotic target alteration|1
MYRINVAVLFGGCSEEHTVSIKSAMELAANIDTEKYQPFYIGITKSGVWKLCEKPCLDWE
QYAKYPVVFSPGRNTHGFLIQKEDRYEIQPVDVVFPIIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKSLAYTTVKNAGIEVPDFQIIQDGDSPKTECFSFPLFVKPARSGSSFG
VNKVDKAEDLCAAINEARQYDRKVLIEQAVSGSEVGCAVLGTGTDLIVGEVDQISLKHGF
FKIHQEAQPEKGSENATIEVPADLPAKVRERIQKTAKKIYQVLGCRGLARIDLFLREDGH
IVLNEVNTMPGFTSYSRYPCMMTAAGFTLSELIDRLIELALRR
>AAF72364|FEATURES|ARDB_deepARG|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHCVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVAFALREAQIHAARL
GYGLLLWDGYRPKSAVDCFLRWAAQPEDNLTKEKYYPNIERAELITKGYVASQSSHSRGS
TIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGNAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>A0A0B4ZZH9|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
FRAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVL
LCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAA
NLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLT
GELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKP
SRIVVIYTTGSQATMDERNRQ
>YP_407313|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHMVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALVRE
>J8PUJ0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MGQSINHICFSVSNLEQSIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QHSYTHIAFTVTNNEFDSLKEILIQNHVKILPGRERDERDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>C0B3B9|FEATURES|UNIPROT_deepARG|chloramphenicol|PROPEN_03931|antibiotic inactivation|1
MNYKKVDLEQWNRKEHFLHYRHNVQCGFSLTTKIDITVLKIVLDKNNLKLYPVMIYLIAK
TVNSYPESRMAIKDNELVIWDYINPAYTIFHPKTETFSELWSEYFEDWHSFSQGYNQDYQ
KYKDNLSLSAKANFPENHFCISMIPWVSFDGFNLNIANVKDYFPPIFTMGKYTLQSGKFL
LPISIQVHHATCDGFHIARMINKLQELCDNFSG
>A0A0M3EZ60|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNAIRRSYPSGDGEVEVLKGISLQVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLSGDALAKLRREHFGFIFQRYHLLSHLSAVQNVEVPAVYAGVERRK
RLERAQALLTRLGLGERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIVEIRDGELVSNPPAKQGQTRSQQVALP
PPSGWRQFASSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQFQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVILDANSRRQLFPNKAKVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
TQAEQQLARLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQLFL
PGWEIGFSPMALMTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A127SIJ3|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0Q6T5Z2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVILLIKAAVMGIVEGLTEFLPVSSTGHLILTGSLLGMTDAKSKVFDIAIQSGAILAVL
IVYWARIREALGGITNSAKQQRFVLNIAIGFLPAGIVGLTVYKAIKAHLFNAPVVAGAFI
VGALIILWAEKRAEPVARVQTVDDMTALDALKVGLVQCVGMIPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLISAGGYSLWKERHALSMADLPMFAVGFIVSFLAAWACVRWLLR
YVATHNFVPFAWYRIAFGIVVLATWVTGTVIWAD
>A0A0R2X4P9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNNWIMTVVLGVVEGITEFLPISSTGHLLLMGHLFALQRSELFTIGIQSGALLAVLLIYA
PRLKAMVVGEEGQKGKAYLKKLGAAFMVTAVLGLTASEMGLKLPDSPRPIAWALLVGGVL
IWLAERRLLLHRGKEDLGWWVALVIGASQMLAAVFPGTSRSGATILAGMFCGLSRTAATD
FSFLLGIPTLLAACALSFYRQLKATGVPVQEEWMHLGLGLAVSAITAYFAVKWLLGYVRT
NTLIPFAWYRIGMGLVWLWMVK
>YP_001778538|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVNANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQTDWQRAQRLIGDNAIAKRDYDEKQNAAREANANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARS
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGTLVPGLYARVKVG
GSAPHEALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQPGMQHGNRRVIVSGLAAGDRV
VVNGTQRVRPGAQVKPHMVPMTGGDEPSAPLASTAKPAAPAKADS
>A3Q393|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSLIREIAGGPYALAAGPDGAMWVTLVHDGAIARVGADGAVDRFPVADGSRPSLISAGPD
GALWFTRNGDDRIGRLTTAGELTEFPLSEGSAPFGICAGADGALWFTEMGSGGIGRITVD
GETSGWASVGGTPSMITRGPDDAVWFTLNQGNAIGRLHPRDGVTMRELPTRGAGPVGITA
THDDAIWFTEILADKLGRIPLDGALQEIDLPGKPHAVVADPSGGVWVSLWGADRLARVSA
DGDIETFDLPPGSEPHGLAFGPDGGLWVALESGFVLRMPD
>AAZ85968|FEATURES|ARDB_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>M3EPQ4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRRPPFPTEGLASMSARRPTVSIQEFPVSDAEAGPYGIAAGPDGALWFTLVHAGRIGRLT
PDGETTSYALASASGGPSLITPGPDGALWFTEFREHRIGRISTAGEATSFALPTPDAGPF
GIAVGPDDALWFTEAGADRIGRITTEGEIVEFPLPVSGAFVSAIAAGRDGRLWFTMNQAN
AIGAIAPDGEVTVHPLPTPGAGPVGITAGGDGALWFVEIGAGQIGRITPDGKIDEFPLPD
RESRPHAIVADADGACWFTEWGANRVGRITYDDRHPEAPEIHEHELPTPSSEPHGIALGP
DGALWTALETGAVARVRPSGNAG
>K0PYR4|FEATURES|UNIPROT_deepARG|aminoglycoside|BN77_3951|antibiotic inactivation|1
MRKEPGLPVATVRGCADHLREWSRLRAALWPSHSSGYHADELDTMIARNSDEMFGIVAPL
PDGVLAGFAEACLRHDYVNGCSSSPVLFLEGIYVEPAYRRQGIGRALFDAVRSAGKALGC
VEFASDASIDNIESHLFHRALGFEEAERVVFFRQSL
>A0A127SD79|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-4|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMAPDSTFKIVLSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>Q84GI2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGKQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINIPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQNKNLRQGIQLAQSRYWRAGGMYQGLGWEMLNWPVSA
EVVINGSDNKVALAATPVTAVKPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>Q18BJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
METFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSNTFISTFLVVIQFGS
ILAVLVIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNST
VVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIG
AVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVAFVVSIVV
IKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>YP_600745|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHLEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYHPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0F6BS68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIMILKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVVVFKERFIDLLGLRGRHRDGQPRLKLMQVIVGLIPAGVLGVLFEDYIDEHLFSTA
TVLIGLVLGALLMIAADVFAKKAPKAQTVDQITYKQAFIVGLVQCLSLWPGFSRSGSTIS
GGVLAGMSHRAAADFTFIMAVPIMLGASVLSLLKNWQYFTMDALPFFIAGFISAFVFALV
SIRFFLRLINQIRLVPFAVYRIVLALVIYIVYF
>F0JNW3|FEATURES|UNIPROT_deepARG|beta_lactam|ECD227_3785|antibiotic inactivation|1
MAGRFVWKPDAMFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPEWASGTQRLYANA
SIGLFGAMAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKHYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLNPRDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDTIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>E6WIX2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLQAGFEISAIFTHPDTAGENHFFGSVARIAAEQGIPVYAPD
DVNHPLWVDRIKAMSPEIIFSFYYRNLLNDAILNSARLGAYNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGDIVAQTRVAIAEQDNVLTLHRKLVQSATQLLEDTLPAM
KRGEINAVPQDEKEATVVGRRTPEDGRIDWSRPATEINNLVRAVTDPWPGAFAYAGTVKF
VVWKGRVHPAAHGAKPGTVLSVEPFLIACGEGALEVVTGQSDNGVYMNGSQLALSLGMVP
SALLYSKPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDISSDAISRFLGHP
GFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDRHFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
RDGVEALFRIIENKQNNCDGQIINIGNPENEASIKELAEQLLASFERHPLRDQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLGWTPEVQMDITIDNTLDFFLRTVELQDKP
>A0A0X8BUC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWSALQAIILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WAFRRKILDIVVGLPSQPQARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALV
IGGLIMLWAERREHQVTVEHVDQMSWHQALKIGLVQCVAMIPGTSRSGSTIIGGLLFGLS
RTAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFALGFVVSFLFAMIAVRGLLKF
IAHHSYAVFAWYRIGFGLLILATWLFGWIDWTTAQG
>A0A0T9UNS3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLISQTLIATVLASVCSMSIAAAPDVATTVSKAIKPLMQQQGIPGMAVAVVVKGQPYYF
TWGMADEEQRRSVTEDTLFELGSVSKTFTGVLGGVAVAKGEIALNDPASKYWQALNIPQW
SHITLLQLATYSAGGLPLQVPDAVTDENELVNFYKQWQPQWSPGKTRQYANSSIGLFGVL
AVKPSGLSFEQAMQQRVFTPLKLNHTFITVPDEVKNTYAWGYHEGKPVRVSPGMLDAESY
GVKSSIKDMSRWMQANMNPQQVADKTLQQALDLAQTRFYRTDALYQGLGWEMLNWPDQAV
MIVNGADNKVALGPQQVQDAKSHPRVDASWVHKTGATGGFGAYVAFIPEKQVGIVMLANK
NYPNTERVKTAMQILKALQ
>J3DVE0|FEATURES|UNIPROT_deepARG|beta_lactam|PMI18_03355|antibiotic inactivation|1
MTNNRSTARLKILAACVTVFGASHCVAAAQTDQPIDTIVNDAIRPVMQAQGIPGMAVAIT
LNGKQHYFNYGVASKETGRPVAKDTLFEVGSVSKTFTATLAAYAQATGKLPLSDKASQVL
PTLRGSAFDSISVLQLGTYTAGGLPLQFPGDADHQEKMLGYFKQWKPTYAAGTHRQYSNP
SLGLFGYLAAHSMGAPFDKLMEKTLLPKLGLKHSYLKVPQDQMGLYAQGYNKDDKPVRVE
PGALDSEAYGVKTSASDLLRYVEANMNPTSLEKPLQQAIALTHTGYYQVGEMTQGLGWEL
YNYPVTLDTLLAGNSSQMAVEAHEVKWLNPPQPQHNTALINKTGSTGGFGAYVAFIPAKD
IGIVILANKNYPNPERVKIAHKIMSALTE
>A0A031IF77|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELLKALLLGFVEGMTEFAPVSSTGHMIIVDDMWLQTTEFLGKYSANTFKVVIQLGS
ILAVIVVFWKRLFSLIGLYKIEGEHDATGTHKLKLRHVLIGLLPAAILGLLFEDFIDENL
FSIETVIIGLAVGALLMIAADKLGPKEPKTTSLDQITYRQAAFVGLFQCISLWPGFSRSG
STISGGVFLGMNHRTAADFTFIMAVPIMFGASFLSLVKNWDNIHASDFGFYAVGFIASFV
FALLSIRFFLKLINKIKLVPFAIYRLVLAAVLAVIVYM
>A0A0Q4MPP7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAQFEVIKKVSVVIPVFNEEDSLPILISRTVAACRKLAQPFEIILIDDGSTDNSAQMLTE
YAEQPENCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVLKAEEG
YDVVGTVRANRRDTWFRKSASKVINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARKTVEIPVQHAEREFGDSKYSLMKLVNLMFDLITCLTTTPLRMLSVVG
SFIALFGFVLALVLILMRVILGPEWAAEGVFTLFALLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVIGAKPVDVDTDQENK
>C5MRD2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1h|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQCQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>Q3KCC1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIQALLDSGYDIAAVFTHAHDPKENTFYASVAQLCANNGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLALAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQRVAIERSDTALSLHGKLRTAASDLLRDALP
AMLQGRITETPQDESKATVFGRRTPADGKLVWAQPAEKLFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRGPRRTRVLILGVNGFIGNHLSERLLRDERYEVYGLDIGSDAIDRLR
SHPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDRSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMLEIE
RPSNKEAC
>A0A0F7LVF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGLHFGEVPHEGKTNGKLKLSHILLAMLPAVTLGLLFHDTIKSLFNPQS
VMYALIIGGVLLITAEILKPKTPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLTASDIPMFAVGFITAFIVALIA
IKTFLALIKRMSFIPFAIYRFIIAAVVYWVFM
>G8QPK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPLLLLKALILGIVEGLTEFLPISSTGHLILAGDLLDFNDARGKLFEIVIQSGAILAVC
WEYRARIARVLLGLPREREAQRFVINLIIAFIPLAVLGLLFGKAIKAHLFNAYVVATTFI
VGGLFILWAERRKHRIRVETVEELDVIDAFKLGIAQAFALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAIPTLGIATLYQLYKERELLSFDDVGMWVVGFVAAFVSAFIAVRGLLRY
ISSHDFTAFAWYRIVFGGIVLWTAWSGTVSWSAG
>L2VQQ6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDEILQLAPTGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCYAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSVLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHASTAQPGSVISAAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVE
GSRLNSQPVCTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCNDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENTGNRCDGEIINIGNPDNEASIEELGQMLLASFEKHPLRHHFPPFAGF
RIVESSSYYGKGYQDVAHRKPGIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDK
>E6UY86|FEATURES|UNIPROT_deepARG|beta_lactam|Varpa_2415|antibiotic inactivation|1
MNPLVHRRTLLLAASVLPLASACTAWSAKGAQQDAFAQLAALERASGGRLGVVGFNTATG
ARVQHRADERFPLCSTFKLVLAAAVLGRSAKENGFLARRVNYTKGDLVTYSPITEKNVAT
GMTVAELCAATVQYSDNGAANLLMKMLGGPAAVTTFARSAGDDVFSLERWETELNTAIPG
DLRDTTTPAAMAASVERLVLGNALGAAQREQLKTWLLGNTTSTERFLAGVPAGWKVGDKT
GSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPDKDAKGRNDVVASATRIAVGALA
>D8PC81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWGPELAIILGVIEGLTEFLPVSSTGHLILVGHALGFTGDIASNVEISIQLGSILAIIA
YERTKLASLASHAFREQRDFRSLVAARGNASWATLIQQSIQAQPNLWFVIGLGLAFLPAA
LVGFLAHKSIKAYLFSPTTVAISLIVGGIIILVVERMRDRVRVKELLQVTPRLALWVGLA
QCASLIPGMSRSGATIVGGLLAGLDRRVATEYSFFLALPTMIIATIYQMLKSQAAFSQDD
YVALGIGLVVSFAVAWAVIAAFLTYVQRHSLSVFAYYRMVLGVIVLLVVR
>AAR96043|FEATURES|ARDB_deepARG|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMSLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILQTLAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIFTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>A0A0F1D5F1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGAGKGRLSLIHILLGMIPAVVLGLVFHDVIKSLFNPI
NVMYALVVGGLLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSYHFLTAGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>CAA10366|FEATURES|ARDB_deepARG|trimethoprim|dfrA16|antibiotic target replacement|1
MKLSLMAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSNFSTNDEGVMVFSSIQDALINLQEITDHVIVSGGGEIYKSLISKVDTLHISTVDI
ERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>H3SN34|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKPTSKYETIGQILSDFKQPAYRYGQIMDAIFKQKIAEYERITILPKFLREELARTLGPY
VSSVIPVKELTSQQVSKVLFAIGGGERIEAVRLSYKRGWQSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFHVNGHALDSVSFMGMGEALANPHLFDALAILTNPHLFSLG
HRRITVSTIGLLPGIDRLTREFPQVNLTFSMHSPFDDQRSELMPINKRFPLRDVLNALDR
HIRHTGRKVYIAYILLRGFNDSAEHAKAVAALLRGRGAWEHLYHVNLIPYNSTEVTPQSY
LPSDPERIKMFVRTLKINGVNVTVRTQFGSDINAACGQLYRTE
>A0A0U1AM92|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MATRSLEVVTEADKMFTRSSASARVTSDSSRCRSSTPQQLVANLRRLVLDEGLDSRGRDL
LTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKGETNDIAVIWPPGRAPIVMAVLTVPE
DPTSTKGKPTIAAATRIVLRAFGA
>A0A011ACS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPSAFKNMFLVVIQLGAILA
VLVLYFDKLNPFSVRKKPAQKQATLVLWSKIILACIPAAVIGFLVDDILDEYLMNGYVVA
ATLILYGVLFIVIENRNQYRSFEVQKVGDISYQTALWIGLFQLLALIPGTSRSGATILGA
MILGCSRAASAEFSFFLGIPVMFGASLLKVVKYGMNFTGTQVFYLILGMVIAFVVSVYSI
KFLMGYIRQHDFKFFGYYRIVLGAVVLLYFTITAFLG
>A0A0T9TPD1|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLTHFALPAWATPPESLDKQLAELERKSNGLLGIAMINTANGR
KIQYRGTQRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHIKYHESDLLSYAPITRKNLAQG
MSVSELCAATIQYSDNTAANLLIRELGGIAAVNEFARSIGDHTFRLDRLEPDLNTALPND
PRDTTTPAAMAASLNKLVLGDALPAAQREQLAIWLKGNTTGGETIRAGAPADWIVGDKTG
GGDYGTTNDIAVLWPPTGAPIILVIYFTQREKDAKARRDVLAEATKMVLSHLS
>A0A088BG72|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-1|antibiotic inactivation|1
MVMRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTT
PASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGA
RGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A150EQT6|FEATURES|UNIPROT_deepARG|beta_lactam|AT258_05650|antibiotic inactivation|1
MKTTLLKLGVCVSLLGTIQLVSTVSSVKAEHTLEQKVIKNEAGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGIKTLKERGIRAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLTRYRNINAVVPGHG
EVGDRGLLLHTLDLLK
>A0A120LNN1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRDITPINMLSVVIPVYNEQESLPELLQRTSDACDAINFEYEILLVDDGSSDRSAELIEQ
AATVPGSRITGVLLNRNYGQHSAIMAGFSQVRGDLIITLDADLQNPPEEIPRLVEAARQG
YDVVGTVRQQRQDTWFRRKASRTLNHLIQRVTGKAMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARHTIELPVIHAERAFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SLIALSGFAFSLVLIVLRLFFGAAWAGDGVFVLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQRIVQAPEEPSVQDIQS
>K4NP95|FEATURES|UNIPROT_deepARG|chloramphenicol|catA2|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQNKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISR
AVNQFPEFRMALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTA
EYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQLMCDNILK
>NP_240031|FEATURES|ARDB_deepARG|beta_lactam|pbp1b|antibiotic target alteration|0
MFFNFKKYFLIKVFFFVLILTLCYGLYLYVKINRFINGKVWNFPTSIYGRIVNLEPGNSY
SQKEVLHLLKSTMYRKVDLVMLPGEYSIKNNTIEFIRRAFDFPDIREDEFHARLYFNKDT
LVKIKNIDNNHDFSFFRLEPKLIAMLKSPEAKKRMFIPRNQYPEMLVKTLLAIEDKYFYE
HDGIHLSSIGRAFLVNLMAGRTIQGGSTLTQQLIKNLFLTNTRSILRKINEIYMALILDR
FYTKDRILELYLNEVYLGQDGDEQIRGFPLASIYYFGRPINELNLEQYALLVGMVKGASL
YSPWTNPNLALKRRNLVLFLLYKQKYITRKIYKDLCKRSLNVQPKGNIISSHPSFIQLVC
EEFHKKIYNPIKNFPGTKIFTTLDYTSQNAVEQAVKIEIPILKRKKRLKDLEVAMIVIDR
FTGEVQALIGSSKPEFNGYNRALKTRRSIGSLSKPITYLTALSQPEKYHLNTWISNYPLS
IKLDSGQYWTPKNNNFSFSKKVLLLDALIHSINIPTVNLSINIGLKKLVDSWLLLGISKK
YITPLPSISLGAINLTPFEIAQVFQIIGSGGYKSSLSSVRSIISDDGKVLYQNLPQSIHI
ESSEASYLTLYGMQQVVKSGTAKSLGTIFKEFSLAGKTGTTNNLVDNWFVGIDGKQIVIT
WIGRDNNHTTRLYSSSGAMQIYKRYLQYQRPVPLVLKAPNNINMFYINNLGELFCKKNNQ
HNRMLPIWSIKNKKICNDKLSERFSIKKKKNFLFWLKNLF
>A0A0K6JF03|FEATURES|UNIPROT_deepARG|bacitracin|uppP_3|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLEFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIIAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>J0VP79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAALLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWHEPANRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGIFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAANEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAVYRIILGVLLLGMAATGLIA
>A0A016QLA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIIYGIVEGITEFLPISSTGHLIVAGNLMGVPWPKEIKDTFEVVIQGGAILAVLA
YYWRDFAGQARVIGRDQPTQRLWLGVVVACIPAVILGLLFADTIKANLFRPSVVAWALIV
GGVLMWLIESRKAIPAVHDLKQIGVGRSFLIGAVQCLAILWPGFSRSASSILGGMLMGLD
RPTATKFSFYLGIPTLGGAALIDFIKSRDLLAQIGLVNVVLGAAVSFGVAYLAIGWLLRF
VSTNNFKGFAVYRVVVGVLILLLVGAGRLPNGGL
>ZP_03938934|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLNLIDERFGFMLDIIKAVILGIVEGITEFLPISSTGHLILVNEFIKMQESTQFTDMFN
VVIQLGAIMAVVVLYFHKLNPLSPKKDPFEKHATWILWFKVIVAVLPSVVLGLLFNDWMD
AHLMNWEVVSAMLLIYGILFIVIENRNANRRPRFTDLNNLPYQTAFIIGMFQLLSLVPGT
SRSGATILGAILIGTSRYVATEFSFFLAIPTMFGASLLKVYKYFDHGGTFNGTQSIVLAT
GMIVSFVVAYLAIRFLLNYIKNNNFKIFGWYRIVLSLIVIAYFGLIAR
>A0A0K4QTT2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMVPAVVLGLLFHDTIKSLFNPV
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>R5DC77|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELFHQTLLYIIVERKETMLDALKVIILGIVEGITEWLPVSSTGHLILVGDVLSPNLSRD
FMEMFNVVIQLGAIMAVVVLYFHKLNPFSPKKTHKQKLLTWQMWIKVAIACVPAAVVGIL
LNDWLDSVFYKPLPVSIMLIVYGILFIVVENRNKNRKPEVTKISELDIRMLLWIGAFQML
ALIPGTSRSGATIVGALLIGVSREVAAEFTFFLAIPVMFGASLLKLVKFGFAFTGAEFGY
LMLGCIVSFGLSIVAIKFLMNYIKKNDFKVFGYYRIILGAIIIIMTVVKAVLA
>YP_369007|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIAIFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLMYTSATSSAGMASLYLTFKQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTAVQLGEYASANVVQALRRVEGVGKVQVWGTE
YAMRIWPDPVKMAGHGLTASDIASAVRAHNARVTIGDIGRTAVPANAPIAATVFADAPLK
TPADFGAIALRTQADGSALYLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVS
TEKRVRATMDELSAYFPSGVKYQIPFETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLGPYDATVKAMKQISGAIIGITVVLTSVFLPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGWFNRFVANSTQRYATRVGAMLKKPVRWLV
VYGALTGVAALMLTQLPTAFLPDEDQGNFMVMVIRPQGTPLAETMQSVQEVESIIRRDEP
TAFTYALGGFNLYGEGPNGGMIFVTLKNWKERKSEDAHVQAIVARINERFAGTPNTTVFA
MNSPALPDLGSTSGFDFRLQNRGGLDYATFSAAREQLLETGRKDPALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGLHRLDPDDV
KKLRVRNTHGEMVPLAAFTTLHWTLGPPQLTRYNGFPSFTINGSAAAGHSSGEAMTAIER
LAGKLPAGTGFSWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRMMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGVITATVLAVFLVPLFFV
IVGRLFDVGPRRRGGAQPATMEGSQ
>A0A0Q5CRB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPHDPRARRFVLAILIAFLPAAIVGGLFSKYIKFYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKAAPGEGPTEHPRKTNVFEFSLPMALKIGLFQCVAMIPGVSRSGA
TIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVAAFIS
ALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFG
>A0A135WFY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFDLIKALILGFVEGMTEFAPVSSTGHLIIVDDMWLKTEQFLGKYPANTFKIVIQLGS
ILAVVVVFWKRLFSLLGLYKIDGKKMNSRFNLAHVIVGMLPAVILGFAFKDLIDDYLFGV
ETVIWALIAGAILMIVADKFGPKKPKVNSLDEITYKQAFKVGLVQCLSLWPGFSRSGATI
SGGVLFGMNHRVAADFTFIMAVPIMLGASLVSVLKNWEHMSMDYLNFYIVGFVSAFVFSL
ISIRFFLKLISRIKLVPFAIYRIILAIVLAIIVFL
>EDJ91555|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRAEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKG
GAEILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPAANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLIQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYSVFDNGGFLIEPYIIEKIQDNTGKELFVANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLTLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPTPAAQPEELF
>A0A0M0LI12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDFLVLVKAFILGLVEGLTEFLPVSSTGHLILADHFLNFRQGVITKQVATTFEVVIQLG
SILAVVVVFWKRLWSSVDFRKRNFTHSFNIFHIIIGIVPAGILGVLFQSDIKDKLFGPQT
VVYALIAGGILMLVAELYSRKTVPTTVTMDELSYKQAFAIGLFQCLALWPGFSRSGSTIA
GGLFVRASHQIAAEFSFIVAVPIMFGATALDLYKSAEYLSMDLWPVFAVGLVTAFLVALL
AIVTFLKLVSRLKLIPFAIYRFVIAIILLLVFL
>B8ZI18|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAK
>A0A0J5FUK7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEKIKKVSIVIPVYNEEESLPQLLKRTIATCQQLEQKYEVILVDDGSRDNSADILIQAA
EFPENNVIAILLNRNYGQHSAIMAGFHQADGDLIITLDADLQNPPEEILRLVKTAEEGYD
VVGTRRANRQDSWFRKSASKIINAMIIKATGRSMGDYGCMLRAYRRHIVRAMLQCHERST
FIPILANTFARKTIEIDVSHAEREFGDSKYSFMKLVNLMYDLLTCLTTAPLRLLSVVGSV
IALTGFLLAVLLITLRLIFGSMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYNDV
RARPRYFIQKVVGVRKTNDNQEES
>W5IU08|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTLVFAYHDIGCAGIEALLAAGYQIDAVFTHADDARENRFFGSVAQLCAQRGIPVHA
PEDVNHPLWIARIRELQPQFIFSFYYRHLLGEELLACARRGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAIIAQQRVAIDAEDTALSLHGKLREAAGELLGRLLP
AMLEGDFVEREQDESQASYFGRRTPADGLLDWRRPASELHNLVRAVTQPYPGAFAPVGER
KLIVWQSKVVPGNQGRPAGAVLSVEPLRIACGEDSLEIVAGQQGDAGLFLAGAQLAREMG
LVIGSRLHAVGKPRRKTRVLILGVNGFIGNHLSERLLRDGHYEVYGLDIGSDAIERLKSN
PDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVRY
CVKYGKRVIFPSTSEVYGMCSDASFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQ
KGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDV
DDGIEALARIVDNDGGRCDGQIVNIGNPDNEASIRELGEELLRQFEAHPLRAHFPPFAGF
REVESRSFYGDGYQDVAHRKPSIDNARRLLDWEPKVHMRETIAKTLDFFLREAIAEQQQA
GKLRIAS
>A0A0M0M852|FEATURES|UNIPROT_deepARG|beta_lactam|WH43_04400|antibiotic inactivation|1
MISAVFFITCAQLCLAAVPIEQANWQATFTKFNAKGTLVIADERVTPAKLLVFNPERAKQ
RMSPASTFKIPHSLMALDAGVLKDEFQLFRWDGVERSFAGHNQDQNLRSAMRTSALWVYE
IFAKQIGEKRAGEYLQKIGYGNANPSTDKGTYWVDGKLAISAEEQIAFLKKLYLNQLPFA
KEHQLLVKDMMINEAGKEWILRAKTGWEGRFGWWVGYVEWPTGPVFFALNIDTPERMADL
YKREAIVREVLQSIGALPAETD
>YP_001588578|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMIPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALTQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>A5W485|FEATURES|UNIPROT_deepARG|beta_lactam|Pput_2813|antibiotic inactivation|1
MLRPRLAALAAAITLALGHASVQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLEAPAKRYHPALAGVP
IGDATVLELGAYSADCLPLQFPDTVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLTKMGLKNTYLQVPASAQGLYAQGYDADDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPQGLPPALVKATAITQQGYFQVGAMTQGLGWERYPYPVTL
STLIDGNSPRLIREPQATTRLQPALPALPAAWYNKTGATNGFGAYAAFVPAEQLAVVLLA
NRNYPNQARVQAAFDILSGL
>A0PFL4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MAREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLD
ETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILA
GIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDW
AGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRL
ASRADQLEEFVHYVKGEITKVVGK
>C6SFF4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSPSSGSPGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRY
NLLSSLTARDNVALPAVYMGAGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSI
ARALMNGGEIIFADEPTGALDTASGKNVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIE
IRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTML
GIIIGIASVVSVVALGNGSQKKILEDISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAK
IIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKE
DAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTT
VMHQITGESHTNSITVKIKDNANTQVAEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTT
GTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVL
ICVIGGLVGVGLSAAVSLVFNHFVTDFPMDISAMSVIGAVACSTGIGIAFGFMPANKAAK
LNPIDALAQD
>CAQ06447|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTAI
TSFQWKNTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDPVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>Q2FC38|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDXRXX
XXXXXKAXNSAILLEXVPYNXLNKKIHINKDDXVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRXXXEXNYXXPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKP
>R5GFN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWIESIIIAIVEGLTEFLPVSSTGHMIITQGLLGMESTPFLKAFTVIIQFGAILSVICL
YWRKFFYPETMQTKGYTWWQAIWRFYLRLIVGVLPAVVLGLAFNDFIESNLDNVMLVAVM
LIVGGVFMLFCDSLFSHSSEQTPMTLKRAFLIGCFQCISMIPGVSRSMATIVGGMAQKLT
RKAAAEFSFFLAVPTMFGATCLELYKLMSHDGGNVLTQGDNLSLLLVGCVVAFIVAALAI
KFFINYVAKYGFVAFGWYRIIVGAAILIMAALGYELTLE
>ZP_03835208|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIESIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELAQTMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPAPKVDSAVVRLVPHATMPYPVKDVRVLSRITTEAFNQRRKTVRNSLGNLFSVEVLTE
LGIDPAMRAENISVAQYCRMANYLSENAPSKES
>A0A0A0Q7Z2|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-23|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>A2W4Q2|FEATURES|UNIPROT_deepARG|beta_lactam|BCPG_05352|antibiotic inactivation|1
MRFNATRVATILFVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPQVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVARYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDGIRDDADLIRYLDAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHEDFATLMEQRLFPALGMTHTYIDVPAARMADYAQGYTKDGKPVRMTQG
MLWQPAYGVRTTAADLLRFVQANLGMIQTAPRLQRAIERTHAGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIG
IVMLANGNVPIEDRVKVAYRILGSLGDGR
>AAG03815|FEATURES|ARDB_deepARG|multidrug|mexB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDT
VVQVIEQQMNGIDNLRYISSESNSDGSMTITVTFEQGTDPDIAQVQVQNKLQLATPLLPQ
EVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGS
QYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRL
QTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANAL
DTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMAL
SVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAP
YLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLE
KESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKD
AMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGM
SDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARM
NPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAM
AAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVE
AAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWV
PLFYVAVSTLFKDEASKQQASVEKGQ
>A0A0R1M361|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGVTEFLPISSTGHLVLADQFIKLEQSSQFVDMFNVVIQLGAIMAVV
VIYFHKLNPWSPQKSSLEKKNTWTLWKKVVVAVLPSAIIGLPLNDWMDEHLMNWFVVSTA
LIVYGILFIIIENRNHDIEPKYADLNTLSYKTAIAIGLFQILSLVPGTSRSGSTILGGIT
IGTSRYVATEFSFFLAIPTMFGASLLKLFKYFKHGGSLAGLPGVVLAVGVIVSFIVAYIS
IRFLLNYVKKNDFKAFGWYRIILGIIVIGYFALIH
>F7NWF3|FEATURES|UNIPROT_deepARG|beta_lactam|Rhein_2116|antibiotic inactivation|1
MSVLKLSFSILCLASASFCSAAEPAKTADWQATFTKFNAKGTLVISDERAKPATLQVFNP
ERAKQRMAPASTFKIPHSLMALDAGALKDEFQLFRWDGVERSFAGHNQDQNLRSAMRTSA
VWVYELFAKQIGEKRAGEYLRKIGYGNANPTTDKGTYWVDGNLAISAEEQIAFLQKLYLN
QLPFAKEHQLLIKDMMVNEAGKDWILRAKTGWEGRFGWWVGYVEWPTGPVFFALNIDTPD
RMADLYKREAIVRDVLVSIGALPAPTETD
>Q84GI3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSPFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVSA
GVLINGSDNKVALAATPLTAVKPPAPPLKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>BAC53608|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-3|antibiotic inactivation|1
MVKKSLRQFTLMATATATLSLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ZP_04623431|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLSWGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAAAVYWVFM
>W6X4X4|FEATURES|UNIPROT_deepARG|beta_lactam|PMI06_007078|antibiotic inactivation|1
MKLSTVSARVAAMLCAMWMTSGASHAADATQDDLKRAVDAAIQPLMTKDKIPGMAVGVIV
DGRAVVFNYGVASTETGKPVTDATLFELGSVSKTFTATLTAWAQVDNRLSLTDSVAKYLP
TLRGTQFGSVSLLNLGTHTPGGLPLQVPDDIQNDDQMIRWFKAWRPAHAPGTVRTYANPG
IGALGMITAKSMGQDFTALIERRLFPALGLKNSFIDVPVDRAPDYAQGYTKTGQPIRMAG
GEFAPEAYGVKSTAADMLRFIEANMKQVKLDAQLQRAITDTHTGYFQAGPMTQDLIWEQY
PYPVSLNALMEGNAPAMALDATPVTKIEPPEAPKDNVWINKTGSTNGFGSYVAFVPQKHM
GIVILGNRNFPIADRVAAAHRILTSLEQP
>A0A0Q4GDE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVAMGLVKGEPKSWLFLRNLVVAFIPAAVIGLALHHYIEALLGNAEVVAIALVV
GGFAILAVERFAPRSDISGVADIPLRTVVGIGFLQCLAMIPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALELLKNREALTSGAGVGLFAIAIGAIVSFVVALLVVKWFV
GIVTKHGFVPFAWYRIVAGSAALIWLLTK
>A0A0U3GYH8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-467|antibiotic inactivation|1
MKLLKILSLVCLSISIGACVEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>O24684|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCSALLVTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A151UPR3|FEATURES|UNIPROT_deepARG|beta_lactam|B4079_5004|antibiotic inactivation|1
MKGMMILKNKRMLKIGICVGILGISLTSLEVFKGETLQVEAKEKTGKVKHKNQATHKEFS
QLEKKFDAQLGVYAIDTGTNETIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPITEKHIDTGMTLGEVAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPDDKRKVLTDWMKGNATG
DKLIRAGVPTDWEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
KEAAEVVIDAIK
>AAZ32816|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPEPG
TVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSL
AVLFSTKANTLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>ABW72062|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVLAIIMMLAGALAIMSLPVAQYPTVAPPAVTISASYPGADAATVQNS
VTQVIEQNMNGIDNLMYMSSTSDSAGNASITLTFEAGTDPDIAQVQVQNKLQLAMPSLPQ
EVQQQGVSVDKASSSILLVAGFISEDGSLSQDDIADYVASNIKDPLSRTQGVGSVQLFGS
QYAMRIWLDPNKLNKYNLTPVDVVSQIKVQNNQIAGGQLGGTPPVPGQQLNASIIVQTRL
KDPTEFGKILLKVQQDGSRVLLRDVARVELGAENYGTIARYNGKPAAGIAVKLATGANAL
DTAKAVKTELAKLAPYFPASLKTVYPYDTTPFVQLSIDEVVKTLLEAIVLVFVVMYLFLQ
NIRATLIPTIAVPVVLLGTFAILEIVGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSSMVL
SVLVAMILTPALCATMLKPIAKGDHGVQTGFFGWFNRLFEKSTHHYTDSVGRILRGTGRY
LVIYLLIVVGMGLLFIRLPTSFLPEEDQGVLLTMAQLPPGATQERTNNVLKQVSQYYLTK
EKDNVESVFTVSGFGFSGQGQNNGLAFVSLKPWDERKGDQNKVTAIIQRAAGAFSKINDA
MVYPFNLPAIVELGTASGFDFELIDQANLGHEKLTEARNQLLGMAAQHPDLLVGVRPNGL
EDTPQFKLDIDQEKAQSLGVSLADVNQTISAALGGAYVNDFIDRGRVKRVYVQADAPFRM
LPSDIDNWYVRSSNGQMVPLSAFSSSRWEYGSPRLERYNGLPSMEILGEAAPGKSTGEAM
ALMESLVAKLPAGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLATSLRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAVDLMHKEGKGLV
EATLEAVRMRLRPILMTSLAFIHGVMPLVISNGAGSGAQNAVGTGVMGGMVSATILAIFF
VPVFFVVVRRRFGRRGEDIEHNHPVEPHNK
>M6AYK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIEFDDLFDIFIQSGAIL
SVLFLYREKFESQILSSFQYLTKRNLNPEGFYFLVRIVIGAFPILVLGFLAKKFLDTIKT
RSDLLDILAGAWIFGGVLILVAEWLFRKRQGVEEKKPVGFRDAILIGIFQCVALIPGISR
SAATIVTARFLGKDAKSSAEFSFFLAVPVLFAAGIYKLVKHRSILNETTIPVLTFGFLIS
FLLCALVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>W4AKT0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITAIILGIVEGLTEFIPVSSTGHMILTAKVLGYDDQTAIMKTFEIVIQLGAILAIAI
VYWNRILNLLGWSRSESLNKKAPRKKLNLIHVFLGIAPALLVAFFARDFIKSLFHAQTVL
FALVAGGIFMIFAEWYNKNKVQVTSHDLDELTYKQALLIGVYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYPYFTSDTIGVFLAGFIVSFVVAYF
VVLAFMKLIQKIRLTHFAIYRFVLAAVFWLFIMH
>A0A0K2JNF9|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILVVLALILSACNSKNSTNNDIEKIEKKYGANVGMYALNTQNGKELSFNENKRFA
YASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKKITLKKLIEATMLV
SDNTANNKIIDELGGYEQVKTRLIDLGDSTTHPSRKEPNLNYYSPKDKRDTSTPLAYGKT
LKKLISDGNLSKANKDFLLDLMFKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVAF
VYLDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLKNINE
>YP_002382998|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MIVGKITTAQQNRNCSTLDFPGGEMACVSQARNLGKYFLLVDNMLVVLGFFVVFPLISIR
FVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLLRAAGFATMGIA
HEPWLLWFSCFLSGLGGTLFDPPRSALVVKLIRPEQRGRFFSLLMMQDSADAVIGALLGS
WLLQYDFRLVCATGAILFVMCAAFNAWLLPAWKLSTVRAPVREGMSRVMGDKRFVTYVLT
LAGYYMLAVQVMLMLPIMVNDIAGTPSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHR
LMAGLLVMSLSMLPVGLVGSLPHLFTLICIFYIGSIIAEPARETLSASLADARARGSYMG
FSRLGLAIGGAVGYIGGGWLFDMGKALQQPELPWMMLGIIGIITFLGLGWQFSHKHTASR
MLGPDARS
>F5LER1|FEATURES|UNIPROT_deepARG|aminoglycoside|butA|antibiotic inactivation|1
MNESTRNWPEELLGLLGQTELTVNKIGYSGDHVYHVKEYRGAPAFLKIAPSVWWRTLRPE
IEALAWLDGKLPVPKILYTAEHGGMDYLLMEALAGKDGSHETIQAKPEFFVKLYAESLRR
IHSLDIRECPLSNGLEKKLRDAKRIVDESLVDPTDIKEEYDCTPEELYRLLLASKPVTED
LVFAHGDYCAPNLIVDGEKLTGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLE
LYGLDGLDEDKVKYYIRLDEFF
>E0I690|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDDLVKAVIMGIVEGLTEFLPISSTGHMIVTGKLLDFTGDRAKTFEVVVQLGAVLAVLML
YWKRFMNLLSFNLKKPGLNILHIIIGMFPASVLGLVLHGFIKDYLFGPKTVVVSLIVGGL
LLIAAEKIRRRPSAETLDDITYRQALGIGCFQILSLWPGFSRSGSTMAGGMFFGVKKEAA
AEFTFLMSVPIMLGASGVDLIKSREFLEWSDTGLFLTGLLASFVVAMIAIVTFLNLLKRI
SLTWFAYYRFVLAAVVFFVLL
>A0A0D1AFP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFIRLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFEAHFNHMLPIA
IALIVYGVAFLWIEKRHQTLEPRVVKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSLFKSLF
>A0A028E7I2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQPSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0G1MU32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSVLQTLILSIVEGITEFLPISSTGHLILVSELLSISQTEFVKSFEIIIQLGAIMAIVVL
YFNKLIENKKIYPKILAAFLPSAIIGFILYKFIKQYLIGDSRIVLVSLFIGGILLIILEK
ILAKIKIKNDLTIEELDLKSCLLVGLSQAISMIPGVSRAAATIIGGMSVGLSRSNAVEFS
FLLAVPTMAAATGLDLIKSYQYFSAQDIKLLILGFIVSFTSAKIAVEWLIKFMKNHSLAA
FGVYRIILAIAFWIFIK
>A0A103ZT65|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSRPLLKLSAVTRRFPAGDKDVVVLNNVNLSIHAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGHVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEALAEALA
EAGAGVGTAEALAEAGDGTAEAVAKTGVGTAEARGVAAGALSARDRHDTPPPAAADSDPR
ADPAPRTRRFAAGSGRFAEACRMAWIALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAK
RYMLDEIGSIGTNTINIYPGTDWGDSRADAIQTLVPADVAALAEQPYVDSATPETSRTLL
LRYRNVDVNALVSGVGDRFFQARGMRFALGVAFDEDAVRRQVQVAVIDQNTRRKLFGATR
NPIGEVILVDNVPCVVIGVTADKKSAFGSVKSLNVWVPYTTASGRLFGQRYLDSITVRVR
DGQPSAAAEKSLETLMKQRHGRKDFFTYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARQSDILQQFLVEAVLVCLLGGTIGIALSFGLGVL
FSMFVAQWKMVFSAGAIVTAFVCSTLTGVIFGFMPARNASRLDPIDALARD
>A0A0I9QPR6|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDNATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A127SKI3|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
KPDPMFKTTLGTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYY
FTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQ
WNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGA
LAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEA
YGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNP
DIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLA
NKNYPNPARVTAAWQILNTLQ
>A0A0F5FHA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLVLGIIEGLTEFLPVSSTGHLLLAGHFFGLSQPATFIVLIQLGAILAVIT
IYFAKLGVLIRDAFAGKAYAWHFALAVILACLPAVIIGVLFREYIQQVLYETPLVICTTL
LLGGIVLLIVDRMPKNVRYDDIYHFPWHLALIVGLFQVLSLIPGVSRSGSTVVGAMLFGA
SKRSAAEFTFFIALPIMTGAFGYDLYKSRELIDMSLGINIAIGFAASFVVGALVVKYLLD
FVTRHGFAPFAWWRIAVGGAGLIAILVFGL
>A0A0H4IV36|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-129|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDANRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>YP_854844|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEA
EKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDD
SNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINA
SISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLIN
QLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
SARTTTSNGHNPFRN
>A0A0T6URX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPSQDHATLSLIHVILGMLPAIVVGLAIHSWIKAHLFGPETV
MYALIAGGILLIIAEKFRPAVSAETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMMAASGLDLYKSRDFLSMADFPMFAVGFITAFVVAMFAIK
TFLALIRRLDFIPFAIYRFIVAFAVYLVFVA
>YP_002114165|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMIPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>M2Y590|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLAVIEALLLGIVEGLTEFLPVSSTAHLMLVGDLLGFEGSSGKTFEIVIQLGAILAVCWV
FRIRLWDVATTLGQPRSFAFVRNVLLAFLPSAVVGAVAYKYIRQMLDSPLVAAVALVVGG
IAILVIERLAKRARIHDIEDMSPALALGVGACQLVSMIPGVSRAGATILGAMLLGLDRRA
AAEFSFFLAIPTMCGASAYALYKNWASISFDGIGLIAIGFVAAFFSALVVVRGFIGFVGR
HGFTPFAWYRIVFGSVMMAVILLR
>A0A0K6B537|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGKDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0S3NIA5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGVERKR
RLARAQELLQRLGLEERVDYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPATENMNVVAGTESI
VKMSSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQRQPWVASATPAVSQNLRLRY
SNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNSRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFALQL
FLPGWEIGFSPLALLLAFLCSTVTGVLFGWLPARNAARLDPVDALARE
>J8KM50|FEATURES|UNIPROT_deepARG|beta_lactam|IIO_02293|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLEQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLRDIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYVLGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDALKVTNK
>I2WCZ0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAETEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRNLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARARDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A098EXY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIWNLFVALILGIVEGLTEFAPVSSTGHMIIVDDLLLHSKELFSPQVANTFKVVIQLGS
ILAVVIVFKDRILGLLGLAKKKADEETGESLSLLKIFVGLLPAGITGVLFEDYIDEHLFS
VKTVVVGLVLGAILMIIADFVRPKKPKAETVDQVGYKQAFGIGLFQCLGLWPGFSRSGST
IAGGVLLGMSHRAASDFTFIMAVPIMMGASGISLLKNWEYFSMDALPFFIVGFLAAFVFA
LISIRFFLKLINRIKLVPFAIYRIVIAILIYVLYF
>ABV57476|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLTPIVLEQAFRKAGTELLEPYL
SFKVYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVIIIGEIPARCIQDYRNDLTFFTNGL
SVCLAELKGYQVTTGEPVCQTRRLNSRIDKVRYMFNKIT
>A0A0A7Q8V1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRSKIFEVVFGLTHQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERREHRVQVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFALGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLFILATWQFGWVDWSTAHG
>A0A0S4UFZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSRLGGRETCRPARFRFSPFFLFPPDRMDIALAIKALILGIVEGLTEFLPISSTGHLILA
GQLLDFNDEKGKIFEIVIQFGAILAVCWEFRHKIIDVIKGLPNDPRQQRFALNVIVATIP
AITLALIFGKAIKAHLFNPIVVASAFIIGGLVILWAEWRERHRGQTHDPRGNALLEAAKA
GAPRVETLDDLRISDAFKVGLAQCFALIPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAI
PVIFGATVYELYKERALLSTDDLSIFGIGFVAAFISAFFCVRWLLRFIASHDFRGFAWYR
IVFGVIVLVTAYTHLIAWQA
>A0A0N0VBA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILA
VMTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIA
IALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGA
IILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSL
VVIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>A0A098FLY9|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MNKRWFYQILAPIGLVLMVAGCSDEEKQVVQQSETEQTGGTNQTSENITAKEATIKKFEQ
LEKEYDAKLGVYAIDTGTKETVEFHENERFAFTSTHKALAVGALLQQKSIEELNQRITYT
SEDLVNYNPITEKHVDTGMTLKELSDASLRYSDNTAGNLILEQLGGPAGFKKVLEGIGDN
VTNPERIEPDLNVVNPSETHDTSTPIALATSLQAFTLGDALPTEKRELLIDWMKRNTTGD
ALIRAGVPKGWVVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDEKEADYNDELIA
EATEEVIKALKVKGK
>A0A0M2EJJ1|FEATURES|UNIPROT_deepARG|chloramphenicol|ER50_02410|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMKVTRCSYSLVIDLDITKLHSLLKEKKLKVYPVQIYLLARAV
QKIPEFRMALVNDELGHWELLHPSYTILNKETKTFSSIWTPYDENFAQFYKSCVADIETF
SKSSNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTKEIYLLPIFTIGKFKVEEGKIILP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCDEWLNDSMPIT
>A0A0R1KWN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEVTYFILCLQRRLAVLEIIKAVILGIVEGITEFLPISSTGHLYLADEFVKLNESTAFI
NMFMVVIQLGAILAVLVLYFNKLNPWAPNKDHLERHQTWTLWFKVIVAVLPSVIVGLPLN
DWMDAHLTSWQVISATLIIYGILFIVIENFNRKRHPRFTDLRQISYQLALMIGLFQVLSL
VPGTSRSGATILGAILIGASRYVATEFSFFLAIPTMFGASLLKIVKYFVTGNTFTGSQLM
VLLTGVVISFAVAYLSIKFLLNYIRNNDFKPFGWYRIGLGIIVISYFGLIR
>A0A135NUB0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWSALQAIILGVVEGLTEFLPISSTGHQIIVADVIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVLGLPTQGPARRFTANLLIAFFPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERRQHRVEVDHVDEMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFALGFVVSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWEFGWVDWSTAHG
>I4A5F6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAIVEIFKAILLGIVEGITEWLPISSTGHMILVDEFIKLNMSKAFMEMFFVVIQLGAIMA
VVLLYWKKLNPFTFDRGVSIKQETIEMWFKIIVACIPAGVIGILWDDVFNALFYNYQTVA
VMLILFGVLFIVIENYNKGKRPRVNQLSQITYTTAFMIGIFQLIAAIFPGTSRSGATIVG
GLLLGVSRTVAAEFTFFLAIPVMFGASALKLLKFGFSFTGPELMILLIGMVVAFIVSVIS
IKFLMGYIKKNDFKVFGWYRIILGVIVLLYFSARTIIG
>A0A0N7AKR5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
VYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAK
VVATSQTRDLMKSDWAEIVAFTRKGLPDYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPA
HTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDS
PLHGPE
>S3VTE0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSYLNAIFRSIIEAVTEFLPVSSTGHLFFFSSFFPFSEGAEFDDLFDIFIQSGAILSVL
VLYRRKFLDQTGSAVSYILGKNEDKKGFQFLLQVVLGCLPILLAGFLFKGFLDKIKERGD
LLLILGLAWFVGGILILISEYWFQKRATVQTPREITTKDAILIGIFQCIALIPGVSRSGA
TIVTARFLGKDTRHSAEFSFFLAVPVLLTAGAYKLYKHRHILNAESLPILLLGFFASFLL
CILVIRWFLKYLQAHTFNAFGIYRILLGVAVILYYKASFSGSSAFIVPTSLLAQACSFGI
GLKFVMQD
>A0A0N7H0W3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPINCVSIVIPVYNEEESLPELLRRTEAACQLLKHEYEIVLVDDGSRDNSAQILEEA
AEREGSQVVAVILNRNYGQHAAIMAGFEHCKGDVVITLDADLQNPPEEIPRLVEQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVQHAEREHGESKYSPMRLISLMFDLLTCMTTTPLRLLSIIGF
SLAALGMLFAFLLIFLRLIFGASWAGGGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKILRNKPASPAPVATVDGLPSTTTDQVSP
>K5C7Q2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLNAFLRGIIEAATEFLPVSSTGHLFLFSYFFPFENLNIDHEAFEDLFDIFIQTGAI
LSVVALYFKVLWIHTKTAVQFVTKTSDDKSGFQFYRNLIVGILPIIVLGFVFKNILDQIK
MRPDLLLILGLSWFVGGLVMVFVELKHYDESDGRVIGIKESVFIGLFQCFALIPGVSRSA
ATIITARTLGVSKKDSAEFSFFLAIPVLTLAGLYKLYKHRAILNSETIGLLLFGSIVSFV
ICYFIIRLFMAFIRRRSFLSFGIYRILLGILVILYFVRG
>A0A0N0KYZ9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRSFKPSKAFSYSAFALFFGSVACHAATPSDGQLQALVSQAVTPVMQQNNIPGLTVAITL
NGQAHYFNYGVAAKDTGQKVSESTLFEVGSVSKTFTATLAGYAQATGKLDLSSKASQLWP
ELKGSAFDNISVLQLGTYSAGGLPLQFPAEADSSDKMLGYYQQWKPQFPAGSHRLYSNPS
LGLFGYLTAKSLGQPFDQAMTQTLLPKLGLRHTFLSVPPAQSKLYAQGYDNADQPVRVSP
GALDAEAYGIKTSAADLLRYVQAQLKPASLAPDLHKAIVNTHLGYYRVGDMTQGLGWERY
AYPISLEKLQNGNSTPMAMEPHTVEWLTPPQAEPANVLFNKTGSTRGFGAYVAFVPSRDM
GVVILANKNYPNAERVKIAHTVFAALAD
>A0A0R2XSC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLSYTDAAILGLVEGLTEYLPVSSTGHLIIANALLGLDGDTPMTDQSGTPILVEDDDGN
RRAYTIGDAAYAYVIVIQAGAIVAVVLLYWRTILTLILGCLGKDRNGLKLAINLIVAFIP
AAVLGLLLNDLIESALGNNTFAVAGALIVGAFVMLIVERWRHHGNKGAVPPEDGPGLTEL
TLGKSVMIGFCQCFAMWPGTSRSMATIVGGYLAGLSPAHAAEFSFLLGLITLSAASAYKF
LTDGSEMLAALNIGPVLVGCIVAFISAALAVKWLVGYLSKHGLAVFAWYRIALAIAIFAM
MK
>ZP_02371790|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MRTSRSRIAAATFAVVVIAGLGAFGAIRVNASAPEKSAAPLPEVDVATVLSKTITDWQSY
SGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLAAAQ
ARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAQAALETARINLGYTRI
TAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLRYIGGAKDGRK
VPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNADGSLVPGLYARVKVGGSA
PHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIAGGLAAGDRIVVN
GTQRVRPGEQVKPHLVPMTGGDDAAATPVAGGVQRPQGAPGNARA
>A0A127SFQ1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDGVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>C2PQC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVA
GAFLMIFAEAKKAELTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMAGATGLDLLKSWKYLSADDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>A0A124RDQ9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHRIKCIMAAALFSTCATATIGYAADDRQDTAKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGIASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPD
LQGSSFGNVTLVELGTHTPGGVPLQVPGDIRNEDQLMRYLKDWRPTYSPDTYRTYSNVSI
GTLGLITATSMGQRDFAVPLSRHLLSPLGMKSSYVEVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPHQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVKEIKPAQAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>C4K4T3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MPVLEIEPIKKVSVVIPVYNEQASLPALIERTAAACKTLSQSYEIILVDDGSSDDSSALL
TAAAEKEDLYITAILLNRNYGQHSAIMAGFNHASGDLIITLDADLQNPPEEIPRLVQTAE
EGYDVVGTIRSNRQDSFFRKTASRLINAIIQNKTGKQMKDYGCMLRAYRRHIIDAILNCH
ERSTFIPVLANIFARRTHEIPVQHAERTFGESKYGPMRLINLMYDLLTCLTTTPLRLLSL
IGSVIALSGFTLALLLIILRLSFGSIWAVSGVFTLFAILFMFIGAQFVGMGLLGEYIGRI
YHDVRARPRYFIHKIITAQPVKNPQGKK
>YP_001844878|FEATURES|ARDB_deepARG|beta_lactam|oprD|resistance by absence|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATLAVLISAAIISSAQASEQSEA
KGFVEDANGSILFRTGYLTRDKKQGAKDTSSVAQSAIVSIESGFTPGIVGFGVGVVGDGS
FKIGENKNAGNQMIPKHNDGSAYDHWARGGGSVKARFSNTTVRYGTQVLDLPVLASNTGR
MVPEYFTGTLLTSHEIKNLEVVAGKFTKDQMSDQINTDADASGRGLDRAIVWGAKYKFND
NLNASYYGLDSKNALERHYANVNFKQPLANDSSLTYDFSGYHTKFDANAHTYSATGTVAP
NYAADGIAGEEKTNNIWAISGTYATGPHSVMLAYQQNTGNVGYDYGQNADGFQSIYLPNS
YMSDFIGNHEKSAQIQYNVDFGKLGVLPGLNWTTAFVYGWDIKVRNVTDDAQEREFFNQV
KYTVQSGFAKDASLRIRNSYYRASDAYQGAYIGDTNEWRIFLDIPVKLF
>C7MP69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIEVLKSLFLGFVEGVTEWLPISSTGHMILVDEFLKLNVSEQFLALFLVVIQIGAILAV
IILYFHKLNPFSRTKTPEGRRATWRLWGMVVIGCIPAAIVGLLLDDWVHDHFYNAVVVAS
ALIIYGIVFIVMERRNRRLEDQVVAAVDGRHARPTTSPSGSIFRVETVDDIDIPTAIKIG
LFQCLAIIPGTSRSGSTIIGGMLFGCSRTAAAEFTFFLAIPIMFGWGLVKTLKFLAGGLA
MTQTEIVVLVVGVLTAFIVSIISIKFLMGYIKRNDFTAFGWYRIVVGVVVLGYFGAKAIG
LF
>ZP_04114929|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIAMNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIVILSSKDEKEATYDNQLI
AEATKVIVKALR
>A0A0D7XLE6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQIRMTEYHVPDPESGPYGIAVCANGRIWFTEQKGNRIGMLTESGDITEYTIPTKSAGAS
IITPGISGELWFTEYKAGKIGKMTPQGEITEYALPPGTAPFGITVGCDDAMWYTDMAGHQ
IGRLSSSGEITEYKLPKPGAFPSFITRGADDALWFTQNQSGSIGRITADGDISEYPLPGE
QSGPVGITAGPDGALWFTEINENQIGRIAVSGKISEYPLPTANARPHAITAGGDGALWFT
EWGAGQIGRITVNGDITEYPIPTAESEPHGIAAGPAQSIWFAEECGRIGKISILD
>J2WV54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTTTQVSILGLVEGLTEFLPISSTGHQIIAADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILEITTGLPTQRNAQRFTLNLLIGFLPAVVLGVMFADKIHQYLFNPITVAVALV
IGGIIMLWAEQREHVVVIDHVDEMRWTDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQAADLPVFALGFVAAFVFAMIAVRGLLKF
IANHSYAVFAWYRITFGLLILATWFLGWVDWNHLSEGA
>A0A0Q6FTM6|FEATURES|UNIPROT_deepARG|chloramphenicol|ASG53_08300|antibiotic inactivation|1
MTSAIPIDLSTWPRRQHFEHYRSVVPCTYAITVELDATVFVETLRASARKSYVAQVWALA
TAVNQHDAFRMCLTSDGAPATWPVVHPSFTVFNPELGTFASIWAPYDTSFATFHDTAAAL
LVEHRTATEMFPQGPAPENSFDVSSLPWTSFTGFTLAVQQGFDHLAPIFTLGRYVEREGE
VLLPVALQVHHAAADGFHAARLLGTVQELLDDPTWVD
>YP_001455919|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQTLFDMSKWRALTLQEKSAGIQDV
TFQTDQQTLILNTASAYFKVLNAIDVLSYTQAQKEAVYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVTNFKTDKPQAVNALLKEA
ENRNLTLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGVSDTSYSGSKTHNSTQYDDSN
MGQNKIGLSFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDANEAGYSVGTRTIVDVLDATTALYEAKQQLANARYNYLINQL
NIKNALGTLNEQDLVALNNALGKPISTSPDNVAPETPQQDAAADGYNASTVQPASARSTS
SNGNNPFRN
>L2W248|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNVLGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRARQLLQRLGLEERAEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTVLHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPAIEKNTAAANSEPG
VKTASGWWQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMSFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAAKLDPVDALARE
>D2T2T5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADIHQLWVAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGDKAQTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGIGQGRLSLIHILLGMAPAVVIGLLLHDLIKSLFNPVN
VMYALVVGGVLLIAAELLKPKQPKSPGVDDITYRQAFIIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMIGATGLDLYKSMGFLTMADFPMFAVGFVSAFIVALIA
IKSFLHIIKRISFIPFAIYRFIVAAAVYVLFVL
>ZP_03065589|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTECLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPQLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0H3J0T0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEGILLIFKSVILGIVEGVTEFLPVSSTGHLVIFQNLIGFGGTSTSYVDMYTYVIQLGAI
LAVIILYWKRIKDTLVNFSPKKVGYEKSGFKFWFMIFIACIPGGILGVLFDDLAEKYLFA
PIPVAITLFVGAILMILAENKFRNNTSKGKELNVTIKQAFIIGVFQCLAIIPGMSRSAST
IIGGWISGLSTVAAAEFSFFLAIPVMVGMSILKIIKIGGLFTLTSQETVALAVGFVVSFI
VALIVIDKFIAYLKKRPMRIFAVYRIIFAIVVLIAGFSGIF
>A0A071LXK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLHSLGVAGILGVVEGLTEFLPVSSTGHLIIVGHLLGFEGEKADTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGSVPHEGSGTGKLTLLHIIAGMVPAVVLGLVFHDFIKTLFNPVT
VMYALIVGGFLLIAAECLKPKKPRAEGVDDMTIRQAFVIGCFQCLALWPGFSRSGSTISG
GMLMGVSRYAASEFSFLLAVPMMIGATALDLYKSIGFLSMADAPMFAVGFVMAFVVALIA
IKTFLELIKRISFIPFAIYRFIVAAAVYLVFVH
>AAM48122|FEATURES|ARDB_deepARG|beta_lactam|CfxA2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMVMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A100YEA2|FEATURES|UNIPROT_deepARG|beta_lactam|M2E15_0562|antibiotic inactivation|1
MKEGVEKMKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNK
NVWVHTELGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETF
YPGKGHTEDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNT
NSVVPGHGDIGDKGLLLHTLNLLK
>I2NXD0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
STRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLSASLYGVGEQYFDVRGLKLESGRLFDEGDVKEDAQVVVIDQNTKEKLFGTDVNPLGKT
VLFNKRPLTVIGVMQKEENSFGNADVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVESTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNHFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>A0A0N7AFF3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
SLTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLE
VINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLP
NVVHDGDFTLQGGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAY
PQTLERLKAMKLPIKTVIGGHDSPLHAPE
>A0A060LRK5|FEATURES|UNIPROT_deepARG|chloramphenicol|BleG1_0189|antibiotic inactivation|1
MTFTVINRRTWKREEVFSHYIKQKTSFSLTTELEVDVLYKRVKQKGYTFYPAFLYLVTSV
VNKHVAFRMSFNQEGELGYWSQLEPVYTIFHEKTKLFSGIWTSMNRDFNHFHTSYLQDVM
TYQGSKALFPKKHMPENTVSVSMIPWTSFTGFNLMIQQDTNYLLPIVTAGKLIEKNQTLY
LPVSLQVHHAVCDGYHASMFMNDCQQLANQAHEWIK
>A0A0F7CIS0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDYIIAIIQGIVEGITEFLPVSSTGHLILTGELLGFKGEKADTFEIIIQLGAILAVAVI
YWRRILGLLGLIKFESDNEDTTGKQKLNLIHVILACLPAMALGLILHSFIKTYLFSPYTV
LAGLVLGGVFMLFGQKKKITVQAKSIDQLSYKQAIAIGLFQCLSLWPGFSRSGATIAGGL
LAGASYKAATNFSFLIAIPMMFAASGYELLKSYHTLTTADAGFFITGFLVSFIVALLAVI
TFLKLLDRLKLAPFAYYRFGLAAIFLIYLLMN
>D4C360|FEATURES|UNIPROT_deepARG|chloramphenicol|PROVRETT_09033|antibiotic inactivation|1
MNYTKFNIETWLRREHYNIYEKTINCGFSLTTKIDITNLKRYIDSNGYEFYPSVIYLLSR
VVNTYKEFRFAKKNDELILWDEVHPSFTIFHKDTETFSSLWCKYSSEITTFMENYHQQLT
LHKDNLDLHPQPQQVENVFYVSSLPWVSFDSFNLNIADITNVFTPIFTLGKYYSENNKMW
LPLAVQVHHAVCDGFHVGQFLTTLQKLCDELTH
>A0A0G3QD89|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFETSPINKVSVVIPVFNEQDSLPELIRRTTAACDLLGKDYEVLLVDDGSSDDSAKMLVD
AAQADGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVASAEEG
YDVVGTVRQNRQDSLFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANMFARRATEIPVHHAEREYGDSKYSFMRLINLMYDLVTCLTTTPLRMLSVFG
SVIALVGFALSVVLVVMRLALGPQWAAEGVFTLFAVLFTFIGAQFVGMGLLGEYVGRIYN
DVRARPRYFIQRVIRQETPNSIEEIES
>A0A0G1UVV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAIVEGITEFLPISSTAHLLITSRILGLPVTEFVKSFEIAIQLGAILAVAAMYRKQIMDP
KLWGRLLAGWVPTAAAGAALYPFIKGELLENLGVTIAALFAGGIILILLEKSSIFKVQYS
MKKTADLPLWKYLIIGVFQAMSIVPGVSRAAATIIGGMMVGLSRREAVEYSFILAVPTMA
AAVGWDLFKSGGNFGRGEWVIMAVGFAGAFVSAAAAVKWLISYVRTRDLSYFGWYRIILG
AVIYLIFIFR
>I6S3T9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAAILGIIEGITEWLPISSTGHLILADQFIKLDASTQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKTTIEKKDTWTLWFKVVVACIPAIIIGLPLDDWLEEHFHKFLPVA
IVLIVYGIAFIVVEKRNKTKTPRWTTLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETIILLVGTLVSFIVSV
LAIKFLLSYLKKNDFTIFGWYRIILGIILIGYWFIAM
>A0A0A0QAU6|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTYLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AAT45026|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQRQQNAESRRDVLASAARIIAEGL
>A0A031FMV0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRSVSIVIPVYNEQESLPELLRRTEAACRQLHHDFEIVLVDDGSRDESATMLEEA
AGRENSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAEAEKGY
DVVGTVRGNRQDSALRRYPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIIDAMLACRERS
TFIPILANSFARHTTEIVVAHAEREHGDSKYSPMRLINLMFDLVTCMTTTPLRLLSIVGF
AMAGLGVLFAIALIVLRLAFGAGWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSQPAAPAPAVTVDGLSSTATSSTSDQVLS
>A0A158DUS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVVGLPARADARRFTLNVIIATIPAIVLGLLFEKTIKSVLFSPVPVSVALI
VGGIVILWAEARQRERAAMTRVYSVDDLTYMDAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVNDFGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A089J800|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDIMKAIILGIIEGLTEFLPVSSTGHLILAGDLLSFEGEAAITFKIVIQLGAVMAVLIL
YWKRYLEIGSNMVRMDFSKSKGLNIIHMILAMLPALIMYLLFKDTIKSRLFGPTPVVIGL
VVGGLLMIIAARNRRTETADTMDGISYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLNSDDVLLMLIGFAASFIVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYFIVIH
>A0A0F5HLM8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKAIILGLVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGQYAANTFKIVIQLGS
ILAVVIVFKDRFIDLLGLNRIFNKNEYNQAAANHLKLTHVIVGLVPAGVLGLLFEDYIDE
NLFTTETVLIGLFIGAVFMIVADLFRSKNPKVVSVDQISYKQALGVGLIQCLSLWPGFSR
SGATISGGVLLGMNHRTASDFTFIMAVPIMAGASFLSLLKNWEYFTLDALPFFIVGFISA
FVFALISIRFFLKLINKIKLIPFAIYRIILVLVIYFLYF
>CAB61231|FEATURES|ARDB_deepARG|glycopeptide|vanXA|antibiotic target alteration|1
MEIGFTFLDKIVHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELAEALLKAKELAATQ
GYGLLLWDGYRPKRAVNCFMKWAAQPENNLTKEIYFPNIDRTEMISKGYVASKSSHSRGS
AIDLTLYHLDTGELVPMGSGFDFMDERSHHAAKGISGNEVQNRRRLRSIMENSGFEAYSF
EWWHYVLRDEPYPNSYFDFPIK
>K8R7N2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFRALSLLAAAIFSFGAMSGAAYADDAASVKSTVDQTIKPLMALHGIHGMAVGVVVDGK
PYVFEYGVASKATKQPVTRDTLFELGSISKTFTATLASYAQIEGDLSLNDPVSKYLPSLD
GTEFGKVTLLNLGTHTPGGLPLQVPDEIHDNEQLMQYFKTWRPARPPGTIRTYANPGIGT
LGLITAKSMKQDFAALMVTRLFPALGLKQSYINVPASKQRDYAQGYTKDDAPIRMKGGVL
SPEAYGVRSTAADMTRFLQINMNLVRIDPAFQRAVDATHTGYFQAGPMTQDLIWEQYPYP
VALQPLLDGNSSSMILNATPVTRIDPPQAPRDDVWINKTGSTNGFGAYIAFVPKARVGIV
MLANRNIPNEERVKAAYAIITSLSGGR
>A0A142F7T1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMNEGKNGMTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGNLMNPEAANSF
KVVIQLGSILAVAIVFKDRILHLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFE
DFIDRYLFSVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALW
PGFSRSGSTIAGGVIVGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSYDMIPFFLV
GFICAFVVALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>A0A064DQ14|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPEDVALTLHHKLCQAARQLLEQTLPAI
KTGDYAERPQQEAEATCFGRRTPEDSLLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWTSRVCTNDFAAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTASKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYHKRIIFPSTSEVYGMCTDNVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLSCFEKHPLRNHFPPFAGF
RDVESSTYYGKGYQDVEHRKPNIRNAKRCLNWEPGIEMQETVEETLDFFLRSVDITEHTS
>E1HXX3|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9535_00934|antibiotic inactivation|1
PRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELG
IVMLANKNYPNPARVAAAWQILNALQ
>J3GXJ7|FEATURES|UNIPROT_deepARG|aminoglycoside|PMI33_05772|antibiotic inactivation|1
MFRIQHCQSGEQAGWLPLRQALWPDASEQEHRDEIAEQLRQPQRYINFVAYDAGEQPVGL
AEASLRHDYVNGTDSSPVVFLEGIYVVPQQRRHGVAARLIEHVAQWGRVRGCVEMASDTD
VDNRPSQETHKALGFEETERVVFFRRQL
>A0A0A7HF66|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
EDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIH
YSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDEHDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKV
AGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAE
>I6SR65|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC-63|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTGTAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYSADIQRAINETHQGRYQINTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>A0A0Q0SPA8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTATQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTQPSARRFTTNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALV
IGGVIMLWAERRQHVIRAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDFPVFAIGFVTAFIFAMIAVRALLKF
ISNHSYAAFAWYRIGFGLLILATWKFGWIDWSAAG
>G2ILK9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDSAIPTALLLGILEGLTEFLPVSSTGHLILASELLGFTGESSVTFKIAIQLGAILAVIM
VYWRRFWGVGMGLLQMKPGPVAFTRNIIVGFLPAMVIGVLVYEAIRVAIQTPMVVAVALI
VGGIIILVLERRVKHVRVESVETMPLGTALGIGFVQCTAMLPGVSRSGATIMGGLMMGVE
RKTAAEFSFFLAVPTMLAATVYALWHDRALLNADDLNLIAIGFAAAFVAALLVVKAFVAI
VGRYGFTPFAWYRIVVGSTALIWLLMR
>A0A0A3W5I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIVSGEPQGRRLGIGLILASIPIVLVGLTFGQTVKELLFNNIAIALG
LIIGGLIIIWIEKHPPKIRAKEVEDLTVKDAVWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIVGAGLLDLYQSFDVFSGTQDFVVLTVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIFSGLLILLFAFTGWKLW
>R8Z908|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSLCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADNYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQIATGSIAP
ILTLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISAHYGFRAVFLVTAGVVLFNAVYSWNSLRRRRLPQVSN
>YP_002806550|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRVGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPLQLVGLPLLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNSGRLPFHLLAVVAGVIVVFTLAGLLNRVLQHQAAELAEER
>A0A0Q6NSH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRDVLSSADLPIIAVGFVAAFVTALIVVRFLLDY
VSRKGYALFGWWRLVVGGVGLVALMIWG
>S4CWC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVLLGIIEGITEWLPISSTGHLILADEFIKLDVSSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPTKSKIEKSDTWTLWFKVVVACLPAVILGLPLDDWLEANFHKFLPVA
IMLIVYGIAFIVVEKYNKDRKPRWTSLNDFTYQAALIVGLFQVLALIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGMKIVKFLAEGNSFRFEETMILLVGTVVSFIVSI
FAIKFLMNYLKRNDFTVFGWYRIVLGVILIGYWFIAM
>J4UBX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILEILKVIIIGIVEGITEWLPISSTGHMILIDELIRLNASTEFKSMFMVVIQLGAILA
VVVLYFKKLNPFSRGKSSKMRRLTIELWKKIIIACLPAAMLGFLIDDWLDAHLYNGFVVS
MALIIYGILFIMIENSNKKRIDSIRSVHAIDYQTALFIGFFQVLALIPGTSRSGATIIGG
MILGASRAVSAEFSFFLSIPIMFGASLLKLVKFGFHYTAAEVVYLLLGMIVAFVVSVFSI
SFLLNWIKKNDFKFFGYYRIGLGLIVLVWYFVSSLMG
>AAA26550.1|FEATURES|CARD_deepARG|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MSIQHFQRKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRRFA
>A0A0G8F8G6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKERKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFKCLIKRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A0F4BBC8|FEATURES|UNIPROT_deepARG|beta_lactam|SG71_20105|antibiotic inactivation|1
MMTKTLCCALLLSTSCSALAGPLSEKQLAEVVEQTVTPLMKAQAIPGMAVAVIYEGQPHY
FTFGKADVAKNKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQ
WQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVQPSGMSYEQAITTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPEALQDTSLGQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0F0H8V7|FEATURES|UNIPROT_deepARG|beta_lactam|UK14_14215|antibiotic inactivation|1
MEQTRRAVLTLGAGVALGAALPAGAARAAAPGGAGGEAVRRLRALEREYGARVGAYARDT
GTGRTVRYRADELFPMCSVFKAPAAAAVMRDLDRDGGFLARRIRYTAQDVAGAGGGSVTG
LPENIAQGLTVAELCSAAIAQSDNCAANLLLRELGGPSAITRLCRSVGDRVTRLDRWEPE
LNSAEPWRVTDTTSPRAIARTYGRLVLGDALVPRHRELLTRWLVSNTTSGDRFRAGLPRD
WVIGDKTGAGSYGTNNNVGIVWPPGRPPVELAVLTTKPEAAAPRENALVARAAEVLAAAL
A
>F0GTZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIVDFLKVLILSIVEGVTEFLPVSSTGHLILVNQFVKLEPEGFSNAFNVIIQLGAILSVV
VIYFKRLNPWDLEKTERYFPKNYDNLNKQSRAYYRLTHPDKKTMELWKRVIVGILPAMVL
GLLFDDIIDEYLFNPMVVAAMLLIWGLIIIFVEKRNRNNKGFRHDNIAMVPYKTVLAIGF
FQTLAMIPGTSRSAATIMGAMILGLSRSAAAEFSFFLAIPTMLGATLLKVVKNFSGFTGY
QWGLILLGMVLSFLVAYIVIKKFMEYIRNNDFIPFGIYRIILAIVVFIYFALV
>A0A0G8G3Y5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAHAFQTLVIHIFIDYNKEVNQSRYIQKGLLIIMIIELIKAFLFGIVEGITEWLPISSTG
HMILLDQFVKLDVSKSFYSMFEVVIQVGAIMAVVVIYWNKIWPFHKSKQTGPLAPTGIWR
YVDKDIIIMWIKIIIACLPAGIIGVAFNDTFEKLFYNPVSVAIALIVFGIAFIWVETVHK
NKCAKISSLAELSYYTVILIGFFQLIAAVFPGTSRSGATIVGALILGVSRTVAAEFTFFL
AIPVMFGASLFKLLKFGFVFSPAELLILIVGLITAFVSSIIVIKFLMQYIKKHDFKVFGW
YRIVLGLLVLLYFLVIK
>G4EVI7|FEATURES|UNIPROT_deepARG|beta_lactam|BSSC8_23670|antibiotic inactivation|1
MKLKTKASIKFGICVGLLCLSITGFTPFFNSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDIGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRMILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVVAILSNRFTKDANYDNALIAEAAKV
VLNDLK
>A0A0U1YUI3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQV
GEARMSKMLHAVDYGNEDISGNVGSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>YP_001116032|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTTRSRIATAAIATLAVVGLGTFGAMRVNANAPDKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAETDRAAAQLA
AAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITVGNVVSAGAAATPLTTLVSVSPIYASFDADEQTYLQYINGARD
GRKVPVELGLANETGYSRSGVIDSVDNRLDTSSGTIRVRARFDNADGTLVPGLYARVKVG
GSAPHPALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLAAGDRV
IVNGTQRVRPGEQVKPHMVPMTGGDDPSAPLADAAKPAAPAKAES
>YP_311196|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPAEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGHRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A060KTQ6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>B0MI88|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVIEIVKSIVLGIIQGITEWLPISSTGHLILFDNIWPMASSPEFFEVFKVVIQFGSILA
VLVLFFHKLNPFSPRKSRREKRDTYNLWKKVIVGCIPIIIVGLPLDMVLEDYLSGVYVIA
ATLILYGIAFIVIESRNRRPSMRSLEDLTYKAAFFIGCFQVLAAIPGTSRSGATILGAVL
LGCSRYVASEFSFFLAVPVMAGASGLKLIKYFLKVGMFSGSEWILLTVGTLVSFLVSILA
IRLLLSYIRKHDFKVFGVYRILLGIVVIVYFGFLA
>A0A127I0J6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
QRHSRARELLARLGLSGHTTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVSDGEIVSDKANERAGLELPSETP
IEPKRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGLIGISLSYALGF
LFSLFVKEWEMVFSLGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>K7WQC2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLNLEQFGILLVACLVAF
GVSMIAIKFLTDYVKKHDFTFFGKYRIVLGIVLLIYAAFKAFLG
>P21598|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIEITEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0H5AFW3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAFALIIMRLVFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNTPAAPAPVVVVDGLVSSHTSTSADQVQS
>ZP_04239522|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEASVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>A0A024E3J7|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MELWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVVGLPTQPNARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALV
VGGIVMLWAEQRQHEVHAHTVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADLPVFAIGFVTAFIFAMIAVRGLLVF
IGSHSYAAFAWYRIAFGLFILATWQFGWVDWAAARP
>AAQ21216|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIVMLAGTLSILKLPIEQYPNVAPPAIEITATYPGADAKTLQDS
VTQVIEQNMNGIDGLMYMGSSSDSSGTLQLTLTFESGTDADIAQVQVQNKLQLATPLLPQ
EVQQQGISVQKSSSSFLMVAGFINDSGTMTQNDISDYVGSNIKDPLSRVSGVGDTQLFGA
QYAMRIWMDPHKLNNYQLTPVDVISAINTQNAQVAAGQLGGSPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNADGSRVRLSDVAHIELGGENYEVIARYNGQPASGLGIKLATGANAL
DTAAAVKAELVKLEPFFPSGLKVVYPYDTTPFVKISINEVVKTLVEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAIISAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLSPKEATRKSMDQIQGALVGIALVLSAVFIPMAFFGGSTGVIYRQFSITIVSAMVL
SVIVALILTPALCATMLKPINKGDHGKTTGFFGWFNRLFDKSTHHYTDSVGHIVRSTGRY
LVIYLLIVVGMAFLFLRLPTSFLPEEDQGVFLTMAQLPAGATQERTQKVLDQVTDYYLNK
EKTNVNSVFTVNGFGFAGRGQNTGLAFVSLKPWDERSGAENKVPAITGRAMGALSAIKDA
MVIPFNLPAIVELGTATGFDFQLIDQGALGHEKLTAARNQLLGMIAQHSDTLVGVRPNGL
EDTPQYKLTIDQEKAQALGVSLSDINTTLAAAWGGSYVNDFIDRGRVKKVYVMGGAPYRM
LPTDIGNWYVRATNGEMVSFNAFASAQWVYGSPRLERYNGLPSMELLGQPAAGKSSGEAM
NLMQELASKLPTGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFAV
MLVVPLGVIGALIFTTLRGLSNDVYFVVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLV
EATLEAVRMRLRPILMTSLAFILGVLPLAISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSKNKDDIEHSHPVDKH
>A0A0E2DQL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAILSVLFLYREKFGSQIRSSLRYV
TKQNPDPQGFYFLVRIAIGALPILVAGFIAKNFLDTIKTRSDLLSILAGAWIFGGVLILV
AEWFFQKRRGVEEKTPVGFRDAILIGIFQCAALIPGVSRSAATIVTARFLGKDTKSSAEF
SFFLAVPVLFAAGIYKLIKYRSILNEVTIPVLTFGFLISFLFCTLVIRLFLRYLQKHSFG
VFGIYRILLGVGVLVFTKFIR
>C2KII6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDLIKAIIIGIIEGLTEFLPVSSTGHIILAEALMKIPSGNVWTKAFSSVFDYSIQLGAI
FAVIQLYFDRLNPFSSKKTDHEKFQTWRLWIRVIVGVLPAIVFGFALNDFMDAHLMNFWV
VSATLIIYGIAFIVIENRQKSIVPVITNVNQITFKLALYIGLFQVLSIVPGTSRSGATIL
GAIILGASRFVAAEFSFFLSIPVMFGVTFLKMGSFFRDGGSFTGMQSIVMLVGFIVSWIV
AWFAIKFMMNYIKNNDFKVFGYYRIIIGAIFLVFGILGIVG
>A0A156H1Z0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGGMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A024KYN2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNERESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHITGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>C8SZL2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQAVAIGADDAALTLHRKLCAAATELLSRALPAI
LAGTTDERPQDHSQATYVGRRTPEDGRLDWELPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVISIAPLIVACQDGALEIVTGQTERVVYMQGAQLAQALGLVS
GAVISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAINRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIAAPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPLLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDDKN
P
>A0A0Q7VYU9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPAWDTFIVLIQLGAVLAVVAV
YFQRLWQVVVGLPTKPEARRFALSVIIGCIPAFAAGLLLHGVIKHFFENPFLPQVICVSL
IVGGFLLLWVDRSKLPVREEDGMALSLKTAFLIGLFQCLSLVPGVSRSGSTIVGSMLLGV
ERKAAAEFSFFMAIPIMVGAFALDLLKSYKDIDPSHAGTIAIGFVVSFLSGLVVVKTMIA
FIGKRGFTPFAWWRIVVGVIGLGLIYLPR
>D3A171|FEATURES|UNIPROT_deepARG|aminoglycoside|NEIMUCOT_06662|antibiotic inactivation|1
MDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEF
MPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCN
CPFNGDRVFRLAQAQSRMNNGLVGASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD
FSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDM
NKLQFHLMLDEFF
>A0A0D5NNV8|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKPTSKYETIGQILSDFKQPAYRYEQIMDAIFKQKIAEYERITILPKFLREELARTLGPH
VSSVIPVKELTSQQVSKVLFAIGGGERVEAVRLTYERGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFHMNGHALDSVSFMGMGEALANPHLFDALAILTNPHLFGLG
HRRITISTIGLLPGIDRLTREFPQINLTFSLHSPFDDQRSELMPINKKFPLRDVLNALDC
HIRHTGRKVYIAYILLRGFNDSTEHAKAVAALLRGRGSWEHLYHVNLIPYNSTEVTPQSY
LPSDPDRVKTFVRTLKINGVNVTVRTQFGSDINAACGQLYRTE
>D3D1L5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIPNYGSAVIHETRIAGPDAGPYDLSAGPDGALWVTMVHAGQIVRLVRDGHLDSYQLAPA
SCGPSIITEGPDGAMWFTRNRDHRIGRIALDGETTSFPVPTPDSGPFGITTGSDGALWFT
EMNSDKIGRITTDGAITEYPLSVSQALPAAIIAGADQAVWFTLNQGNAIGRITPAGLITL
HPLPTPGAAPVGICRDTDGAIWFVEIAAGQIGRISPDGRIEEFPLPDRDARPHAIIADPT
VGGCWFTTWAAGRIGHIAPDGKIDEYDLPTPSSEPHGLAVTGDGIVHVALETGGLARLER
VAIDP
>T44117|FEATURES|ARDB_deepARG|beta_lactam|mecR1|antibiotic target replacement|1
VLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>I1V578|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNT
AMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQL
TLGHALGETQRAQLVTWLKGNTTGAASIRAGLPASWTV
>N9GYB3|FEATURES|UNIPROT_deepARG|beta_lactam|F926_00791|antibiotic inactivation|1
MTKPNDFSRTFKKLLMVAGLISFSSALWAENLTEQQVKAVIDQQFKPLLTQYKVPGMAVA
VTLNGKHYFVNYGLASKQSQQAVSNKTLFELGSVSKVFNATLAGYAQAQGQLSFSDHPAK
YFPELKNTAVNQATLLNLGTYNAGGFPLQFPDDVVKQQDMIRYFQEWQSKTKIGAARQYS
NPSIGLMGYVTALAMKKPYVELIEQTLFPQLGMTQSFINVPKPYMSQYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINVQQLQQPIRKAIENTHVGYFEVGAMTQGLGWE
QYAYPVKLETLLEGNSSKMALESHAITPIKQPKIASPATYFNKTGATNGFGAYAAFIPQQ
KIGMVMLANTNFPNEARITATYQAMQQILKQNAAQ
>A0A0J1NDE4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDNSAQLMMN
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQHTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>A0A0X2NX14|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MALLELSGISRSYQSGDQTVAVLKNVSLRIDAGEMVAIMGASGSGKSTLMNILGCLDKPS
AGVYRVAGQDVATLNGDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAAR
RERAVALLQRLGLSERVGYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGE
EVMTILKQLREQGHTVIIVTHDPAVAQQAERVIEIRDGEIIADSCPDQRSNPNAKPLEMA
APAPSWQQTAGRFREALVMAWRAMAASKMRTALTMLGIIIGIASVVSILVIGDAAKQMVL
ADIKSIGTNTVDIYPGKDFGDDDPTFRQALKYDDLAALREQPYVSALSPTIASSMRLRLG
NVDVAANVTGVSEQFFRVYGMTFTQGTGIDQLQVQSHSQTVVIDANTQRRLFPHQKDVVG
KVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIREGYN
SQEAEQQLTRLLTLRHGKKDIFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQVV
LPGWQISFPPAALLSAFVCSTAIGVVFGYLPARSAARLNPIDALARE
>A0A0K4ACT9|FEATURES|UNIPROT_deepARG|multidrug|yceL|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSHLGLAIGGAIGYIGGGWLFDLG
KSVHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0F7LFU0|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-109|antibiotic inactivation|1
AAAVLKESESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMN
KLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLG
KALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTN
>B1LEM1|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRAAR
>K0FHY0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MFVLNKFLNILHSKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQKITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A060L001|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAKSRRDVLASAAKIVTDGL
>BAH18719.1|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKE
KAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKR
DIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNA
TTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTN
FGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYRGP
ERLREICIDKK
>F2KHX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLLADWIHHYLFNPITVATALV
VGGLVMLWAEKRQHQVHAETVDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPTDFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>AAL14440|FEATURES|ARDB_deepARG|multidrug|adeB|antibiotic efflux|1
MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDS
VVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQ
VVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGA
EKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQL
SSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAV
KTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLH
NVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIM
ATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILF
SALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMV
IFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPD
VKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLP
PAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISL
KIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNL
KVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIA
KLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGI
FGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKL
RLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFIL
GAVEKLFSSKKKISS
>YP_001583350|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVLILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLAAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEEEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLGFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGMSARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRRFNKVFHRGAENYGRGVR
GVLSRKAVMLGVYLVLVGATVLISKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QQYASIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVSVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GYSSGQAQAAIERIAHETLPRGVRFEWTDLTYQQILAGDSAIWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTHGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGVPAPDA
>E9LZM7|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-40|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVARPLL
>YP_621023|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIAIFIMLGGLFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVDARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTDVQLGEYASANVVQALRRVEGVGKVQFWGAE
YAMRIWPDPVKLAGHGLTASDIASAVRAHNARVTIGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRAQPDGSALFLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVS
TEKRVRATMDELSRYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLAPYDATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGGFNRFVARATQRYATRVGAMLKKPVRWLV
VYGALTAAAALMLTQLPTAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRAVESAIRRDEP
TAYTYALGGFNLYGEGPNGGMIFVTLKNWKERKATRDHVQSIVARINERFAGTPNTTVFA
MNSPALPDLGSSSGFDFRLQNRGGLDYATFSAAREQLLAVGGKDRALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVMVQADGRHRLDPDDV
KKLRVRNARGEMVPLAAFTTLHWTLGPPQLTRYNGYPSFTINGSAAAGHSSGEAMSAIER
IAAKLPAGIGYAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGVITATVLAVFLVPLFFV
TVGRLFDVGPRRRGGAQPTTMEGSQP
>A0A026S2N1|FEATURES|UNIPROT_deepARG|beta_lactam|BW79_11640|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>D6I9J6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPVCTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>B1ZWC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRIRLLLLATVLVASAAAQPVLEKAAPPPAGPLAELSLADAAVLGAVEGITEYLPVSSTG
HLIIAARALRVDSNLPLRRANGEVHWFVPPTAKHPDGVPLTLKLAADTYVVVIQFGAIAA
VGMLYWRQLVAMLLGLLGRDPAGLRLLRNVLLAFLPAAIVGFLVHDWIDTHLFSLEAVIA
AQVAGAGLILWAERYRRRRVATTARHPEFPTDLSMGAAFRIGLLQCVSLWPGTSRSMMTI
IGGYLAGLDPRRSAEFSFLLGFVTLSAATVYKSLKTGEAMIMIFGWPHVLFGCVVAAITA
ALAVKFLVGWLSRHGMAIFAYYRLALAAGLGILAAVGWL
>A0A127SF31|FEATURES|UNIPROT_deepARG|beta_lactam|AER-1|antibiotic inactivation|1
MGTKAAAGVKIAVTCIFAAFLSTPVFALNTAKLTEVVQSEESALQARVGMAVFDANTGMT
WQYRGDERFPLNSTHKVFSCAAMLAKVDGKHLSLDQSVSINRGMLVTYSPITEKSLSPKT
ITLGKVCQAAVSYSDNTAANVVFDAIGGSAGFNAYMRSIGDEQTRLDRKEPELNEATPGD
VRDTTTPNAIVSSLRKILLGDVLSDPSRSELTQWMLDDQVAGALLRASLPSDWKIADKTG
AGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGAVLKDAVGP
>A0A0E3V2H3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQIIQIKVLNKFFGDGDNQTQVLKNINLEIKKGDFIAIMGASGSGKSTLMNIIGCLDTAS
SGSYKIADTEVSLLNKDALSDLRQKKFGFIFQRYNLLSTLTALENVALPAIYAGIDQKTR
LERAKNLLAKLGLQDKLTNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
MVMAILQQLHREGHTIILVTHDPKIAEFANRVIEIKDGSIIQDTKKSDWIAEKLDTPNVQ
KGRFTFYKDQFIESFKMSVNAIVAHKLRSLLTMLGIIIGITSVVSVVALGNGSQQQILSN
ISALGTNTMDIYNGTGFGDRYAERMQNLTVNDSNMLAKQSYIESATPNSAVGGSLTYGNQ
NFTAQVKGVGDQFFDVKGIKLLQGQLFTASDVEQSAQVAVIDSNTLQQVFNHRSPLGEII
MINKKPLRIIGVANQSNMNSNRSSLNIWLPYTTAMYKISGNAQIDSITVKVKDDINTQVA
EKDLTNLLTVRHGKKDFFVLNTDTIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIML
VSVTERTKEIGIRMAIGARQSNILQQFLIEAVLICMLGGMVGILLSLAFGLIFNQFTSNF
TMIFSTFSIIAAVVCASFIGIIFGYMPAKNAANLNPINALARE
>ABG36698|FEATURES|ARDB_deepARG|trimethoprim|dfrA15|antibiotic target replacement|1
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSSDENVLVFPSIDEALNHLKTTTDHVIVSGGGEIYKSLIDKVDTLHISTIDI
EPEGDVYFPEIPSSFRPVFSQDFVSNINYSYQIWQKG
>A0A0K0HBZ3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENAFFGSVSRQAAGLGIPVYAPD
NVNHPVWVDRIAELAPDIIFSFYYRHLLSEEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVANQRVAIAQDDMAITLHHKLCQAARQMLDRILPAM
KCGDISSVPQCESDATYYGRRRPEDGLIDWNKPVSTAHNLVRAVAAPWPGAFSYSGSQKF
TIWSSRICPDAPGALPGSVISVSPLRIACADGALEIITGQAGDGITVQGSQLAQTLGLVV
GARLNRPSAAGTKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAIGRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYHKRVVFPSTSEVYGMCTDTSFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPENEASIQELATLLLDSFDKHPLRRHFPPFAGF
QIVESGSYYGKGYQDVAHRKPNINNARRCLDWEPSITMRDTVEETLDFFLRSVEIADRAS
>A0A0P9K4B7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHSGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRKLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQTTQPAPEAQPATPPGPAPRRLLASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPSDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>X8HVY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFINSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFMDNTLIIAIT
LIVYGVIFIGIEVVYKLKKIKPKVKRFGGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIVLLY
>T5TUU0|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAALAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
STIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVALGRPVAAHEEIHHHA
>E9LY84|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVTGEIIKSVGK
>A0A116R5A8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFKVFGYYRIILGVILLVYAFITFLF
>A0A0U1HN37|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MAALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAELDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGRNE
RRERANLLLTRLGLGERVDYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPNVAAQAERIIEIKDGRIMADSGSKIEQTDAKSEAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVAVIDRNTQRRLFPHLKEV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMANRLMGRSYFDSITVRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPGWKIAFPPAALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>I4YQ68|FEATURES|UNIPROT_deepARG|aminoglycoside|MicloDRAFT_00068420|antibiotic inactivation|1
MNDGSLPKIEPCTLQSLEEWAKLRHALWPDGPVQEHRSEAQAMLWEQKKAVAFLVRLADG
TAAGFAEAALRHDYVNGCATSPVAFLEGIYVEPEHRHRGLARVLCRAVEDWARRLGCREF
ASDVLIENIASQDMHRALGFEETERVVYYRKPLSPG
>A0A0J6L6Q7|FEATURES|UNIPROT_deepARG|beta_lactam|VK90_14775|antibiotic inactivation|1
MIVSKKFFPISHYKKMLPVVLLSCATLIGCSNSNTQSESPKQTKQEHISNQSFVKLEKKY
DAKLGIYALDTGLNQTVTYRSDERFAYASTHKALAVGALLQKKSIKDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKKNTTGDNLIRA
GVPGEWKVADKTGSGPYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIAGATKI
VLDSLKVTNKS
>A0A0F4LQY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVFKAIILGIIEGITEFLPISSTGHLYLANEFIKLQESPAFINMFMVVIQLGAILAVV
VIYFHKLNPFSPHKTVLERRQTWTLWGKVLLAVMPSVIIGLPLNDFMDEHFNTWPVIAAT
LLIYGVLFIIIENYNQTKTPRLTDLNKLPYSIALAIGAFQVLSLIPGTSRSGATILGAIL
IGTSRYVATEFSFFLAIPTMFGASLLKLLKFFMHGNVFTGLQSFVLLVGTVVSFIVAYAA
IKFLLDYIKRNDFKAFGWYRIVLALIVIGYFGFCK
>M4Q6F4|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
TLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQ
EQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKEL
TAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLI
DWMEGIKL
>A0A0D6WNL4|FEATURES|UNIPROT_deepARG|chloramphenicol|SF12_15700|antibiotic inactivation|1
MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTIFAAALRRSPRKSYLAQV
WALATVVNRHEEFRMCLTDSGDPAVWPVVHPAFTVFNPERETFACVWAPYDPDFGTFHDT
AAPLLAEHSRATDFFPQGDPPPNTFDVSSLPWASFTGFTLNIRDGWDHLAPIFTLGRYTE
REGRLLLPLSVQIHHAAADGFHTARLTNDLQTLLAAPTWL
>ZP_04635128|FEATURES|ARDB_deepARG|polymyxin|rosB|antibiotic efflux|0
MGSLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKD
LLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLVTGLVFGLCLSTASTVVLLRALEERQ
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
TLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMV
LNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLVSLAIIIFGKSAAA
FILVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLMSEHGRNLVLAGAILSIMLN
PLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPVDLCNHALLVGYGRVGSLLGAKLNAEG
IPLVVVENSRPRVEALREQGINAVLGNAASADIMSLARLDCARWLLLTIPNGYEAGEIVA
SARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIANSMLNMLKIETLTEEDKMPV
CPI
>F5SLG5|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MFPVKRGWILVKSWNTVLSKKIAPVLLLSCVALVGCSENSAAQPKQQNQETAIKDDFAKL
EEKFDARLGVFALDTGTNQTVTYRPDERFAYASTHKALAVGALLQQKSIEDLDQKITYTR
DDLVDYSPITEKHVDTGMTLKELCDASLRYSDNTAGNLILEQLVGPSGFKKSLRKMGDDV
TNPERIEPELNEVKPGETQDTSTPKALATSLQAFTIGDVLPREKSKMLTDWMKRSTTGDS
LIRAGVPKSWEVADKSGAGLYGTRNDIAIIWPSKGDPIVLAVLSSREKKDAEYNDKLIAQ
ATRVALDSLK
>I4K7K8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTLKKYAISALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIAGLTVAVVQHGRVQYFN
YGVAAKDTQAPVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFD
RISLLQLATYTPGGLTLQFPDAADSATTMMEYFQRWKPTYAPGEQRLYSNPSIGLFGYAT
AKSLGLPFTVAMEKTLLPKLGLTNTYTRVPADKAGLYAQGYDSQQKPVRVNPGALDFEAY
GIKSSSQDLARYVIANMHPQTLEQPVQQAIATTHAGYYTVNGMTQGLGWERYPYPIALQA
LLDGNSTPMAMEPHKVNWLKPAQAQPANVLYNKTGSTGGFGAYVAFVPSKDMGVVILANK
NYPNAERVKVAYAILSAMDN
>A0A0M8JEH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
YRKLFWDMFTGFFRRDPVAIAFVRNLLLAFFPAVVLGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTKDVGGVANVSTRQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITSNDLGLIAVGSLVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIAGVAALIWLGMR
>J8D454|FEATURES|UNIPROT_deepARG|beta_lactam|IG7_02318|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEVFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTIADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEATEVIVKALK
>A0A089I9A4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIMKAIILGIVEGLTEFAPVSSTGHMVIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVIIFRNRFIDLLGLKRFSRKELTAVPEGQPPVETEGRLKLAQVIVGLIPAGILGFL
FEDYIDEHLFSTSTVLIGLVIGAIFMIFADRFAPKKIKTESVDQITYRQALSVGLIQCLS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLVKNWQYFTIDALPFF
IAGFISAFLFALLSMKFFLKLINRIKLMPFAIYRLVLAGVVYLVWF
>H1PIR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFELLKAIIYGIVEGITEWLPVSSTGHLILLKNIMPMKVSDNFWNFFLVVVQLGAILAVV
IYFWNKIWPFNTKVKGKSFIRYDVMQLWVKIIVACFPAAIVGILLDDWVDKHLYNPTTVA
IMLILVGIAFIFVENKNVNKEPRITSLRDISYKDALIIGAFQLIAAVLPGTSRSGSTIIG
GLLIGIDRTIAAEFTFFLAIPVMFGASLLKLLKFGLHFTALEFGILFVGIIVSFIVSLFC
IRLLMAYVKKHDFKVFGWYRIALGAVVLAYFKLILA
>A0A0D0FA69|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MFVKGLNHFLFSVSDLEKSIKFYQDVFDAKLLVKGRSTAYFDLNGMWLALNLERNIPRNE
IRQSYTHVAFSIEEADFDRVYNKLEKLGVNILIGRPRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLEYYKQEKPHMEFYI
>A0A085GHK3|FEATURES|UNIPROT_deepARG|beta_lactam|GEAM_1268|antibiotic inactivation|1
MKKNQMLVLALFPLTLLSASVHAATDKAEIDKIIQPLMQKYHVPGMTIAVSENGKHTFYN
YGVASKQTKAPITNTTLFEIGSLSKTFTATLAAYASNQGKIDFKDPASKYLPSLKGSAFD
HVSLLNLATHTSGLPLFVPDDVTNNTQLMTYYKNWQPKHPIGTYRVYSNLGIGMLGMITA
QSLDIKFSDAMEKQLLPAVGMTRTYVNVPEDQMHDYAQGYNKDDKPVRVNPGPLDAESYG
LKSNSLDLIRYLDANMQVKKIDDTWQKAINDTHTGYFKAGVFTQDMMWENYAYPPELKQL
VTGNAAGMILDGMPTTAITPPKPGTPENWYNKTGSTGGFSTYAVFIPSRKIAVVMLANKW
FPNDDRVNATYNIIQTLDK
>A0A0A0WUC6|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ1|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANPIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>G2IZG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLLLAKALLMGIVEGLTEFLPISSTGHLIVAGDLINFHSETSAVFEVVIQLAAILAVV
WEYRARFIGVAENLGRDVSAQRFAFNLLLAFLPAAIIGFLFIKVIKLYLFNAVSVALAFI
IGGLVILLVERKDRRAQVHSVDAMTGRDALKVGLAQVFALIPGTSRSGATIIGGMLFGLD
RKVATEFSFFLAVPTMFAATIYDVYKHRALFALSDAPVFAVGFVAAFFSAFLAVRGLIRY
VSGHNFNAFAWYRIGFGVLILLTWKMGWVDWAA
>A0A077KX16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELIRGFFSGDVAARRFAINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGFIIFAVEARKFEPKTIEATDITLKQAILVGFAQCLAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLINISVGFVAAFIAALLVVKALVK
FVEKHTLRVFAWYRVVLGIILLFVFL
>NP_290714|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAITEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIHQGRDLLHAWDATWNSAQA
LDNALQPDKAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A0U4X5L2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSGIPRAHRSCGLLLGLALPILAQAAPSLDDEVRTAARAVMAEQDVPGLAIGVSAPGLRR
LYYFGVADRRSSQPVDAATLFEIGSLSKTYTATLGAYAAATGRLRLDESAAQVRPALAGS
AIGQASLLQLATYSAGGLPLQFPNAITTEAQATGFYRDFQPPFPAGSRRLYSNPSIGLFG
ALAAQRLDEPFATALQRHVLNPLELGHTYLQVPAAAQDHYAWGHGKKGEPLRVNPGVYAE
EAYGIKTTAGDLLGFIEANLNPGRLPAPLAKAITTTQQGYYRSGPMTQGLAWEAYPYPLP
KTQLLAGNTPAMALEPQPVDWQWPPLPASGARLLNKTGSTNGFGAYALFIPERQLGLVIL
ANRNYPNSARIEAAWRILQKLDGGVP
>A0A0W0B896|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPPQDHATLSLVHIILGMLPAVIIGLGIHSWIKANLFGPETV
MYALVAGGILLIIAEKFRPAVRSETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDLLSMADFPMFAVGFITAFVVAMIAIK
TFLALIRRLDFIPFAIYRFIVAFAVYLVFVA
>A0A089UB05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLPTLAIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGQTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPEHEGVGTGRLSLIHILLGMIPAVVLGLLLHDAIKSLFNPV
NVMYALVVGGVLLIAAECLKPKVPRAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTMGDLPMFAVGFVTAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAVVFFIFT
>A0A0W1G8V7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAAKWAVFNIAIQPGAILAIVVL
YWRTFRDIFTGLLRRDPVAFAFVRNLLLAFIPAVVLGLAFGDYIEALLENAVVVAWALII
GGVGILIVERFAKPKESGGVAALSTRQSIIVGLVQCIAMIPGVSRSGATIMGAMALGIDR
KTAAEFSFFLALPTLTGATVLQLAKHHDAITKNDIGLIALGAFVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIVGVAALVWLAAR
>NP_598114|FEATURES|ARDB_deepARG|multidrug|MexD|antibiotic efflux|1
MSLFFIRRPNFAWVVALFISMAGLLAMPFLPVAQYPSVAPPQITISATYPGASAQVLTDS
VTGVIEEELNGAKNLLYFESSSNANGIAEITVTFQPGTNPELAQVEVQNRLKKAEARMPQ
AVLTQGIQTEQASAGFLLIYALRYKDGVNHENTTALADYAVRNINPEIRRLPGVGKLQFF
DSEAAMRVWINPQKLVGFGLSIDDVNNAIRGQNVQVPAGAFGSTPGTSEQELTATLAVKG
TLDTPEEFGRIVLRANQDGSSVLLGDVARLEVGSQSYNFSSRQDGKPAVAAAVQLSPGAN
AIRTAEAVKQRLDELSASLPDNVEVSVPYDTSRFVDVAISKVITTLVEAMVLVFLVMFLF
LQNVRYTLIPGIVVPVCLAGTLTFMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMADEGLPPVEATIKAMGQVSGAIIGITLVLSAVFLPLAFMAGSVGVIYQQFSLSLAVSI
MFSGFLALTFTPALCATLLKPIPQGHHEKRGFFGGFNRVFGRLTQRYTALNSKLVPRAGR
FMFIYLAIVVVMGFFYLRLPESFVPAEDQGYMIVDVQLPPGATRERTSETGAQLEEFLMS
REAMGSSFLVLGFSFSGMGENAALAFPVLKDWSERNSDQSVEAETAAVNEHFANLDDGTI
MAVPPPPIEGLGNSGGFALRLQDRGSLGREALLAARDELLGQVNGNPKFLYAMMEGLAEA
PQLRLVIDREQARAQGVSFESISTALSTAFGSTVINDYSNAGRQQRVVVQAEQGERMTPE
SVLKLHVPNDSGGLVPLSAFVTTKWEEGPVQMSRYNGYPSIRITGDAAPGVSTGEAMAEL
ERIIGELPAGIGYEWTGLSYQERVASGQALMLFALAIVVVFLLLVALYESWAIPLTVMLI
VPIGALGSVLAVTSVGLSNDVYFKVGLITIIGLAAKNAILIVEFAKDLWEQGYSLRDAAI
EAARIRFRPIIMTSMAFILGVVPLVIASGAGAASQRAIGTGVIGGMLSATLLGVIFVPIF
FVWVLSLLRSTPHTPSTTDGPVARIKD
>BAG21957|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTVEKAPREPEDNAVPAPVKGLRGHPWLTLFAVAIGVMMVALDGTIVAIANPAIQK
DLGATLADVQWITNGYLLALAVALITAGKLGDRFGHRQTFLIGIAGFAASSAAIGFSKEI
GLVVLFRVLQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPIVGGLLV
EHVSWQSVFFINVPVGVIALVFGLVILKDHRAANAPRSFDILGIVLLSGAMFSLIWGIIK
AGESWGWGDGRTWAWLGLAILLFVAFGLWQNKVKEPLVPLGMFRSVPLTAGVVLMMLMAF
AFMGGLFFVTFFLQGVHGLSPVDSGLHLLPLTAMMIVSSPVAGLLITKFGPRVPLVGGMV
CTATAMFGMTTLSESTGTFAMSLWFALLGCGLAPVMVGATEVIVGNAPMELSGVAGGLQQ
AAMQVGGALGTAVLGAVMSSKVSAEFADNWAGAGLPGAPDPKLEEAAEFGMVPAEQLAKA
PGMTPDIIDRIGGVIHDTFMSGMGLAFTVAGIVAVIAAFVATLTKRGENAEAGAGVGHI
>A0A100WQU4|FEATURES|UNIPROT_deepARG|beta_lactam|RMCFA_2899|antibiotic inactivation|1
MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSG
RRITHRLDEMFAMCSTFKGYAAARVLQMAEHGEISLDNRVFVDADALVPNSPVTEARAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL
>A0KQX4|FEATURES|UNIPROT_deepARG|beta_lactam|AHA_4258|antibiotic inactivation|1
MSRLLLSSLLATGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAKLKTL
>A0A024HLW8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTAKTIVFAYHDIGCAGIEALLAAGYQIDAVFTHADDPRENRFFGSVAQLCALRGIPVHA
PEDVNHPLWISRIRELQPQYIFSFYYRNLLGEELLACASQGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRPDAGAIVAQQRVAIADEDTALSLHGKLREASRELLGKTLP
ALLKGDVQETAQDESKASYFGRRTPADGQIDWNRPARELHNLVRAVTQPYPGAFAPVGER
KLIVWSSKVVAGNDGRPAGSVLSADPLRIACGQDSLEVLAGQQGDAGLFLAGPQLAREMG
LVEGSKLYSVSKPKRKTRVLILGVNGFIGNHLSERLLRDGNYEVYGLDIGSDAIERLKTN
PDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVRY
CVKYNKRVIFPSTSEVYGMCTDPNFDEDKSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQ
KGLSFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDV
VDGIEALARIVDNEGGRCNGQIVNIGNPDNEASIRELGEELLRQFEAHPLRSNFPPFAGF
REVESRTFYGDGYQDVSHRKPSIENARRLLNWEPTVHMRETIAKTLDFFLREAIAEQEAA
KAAKAGNNA
>ZP_04618869|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MTPNPAPINWKRNLFVAWLGCFLTGAAFSLIMPFLPLYVEVLGVSGHQSLNMWSGLVFSI
TFLFSAIAAPFWGSLADRKGRKIMLLRSALGMGIVMILMGLAQNIWQFLALRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALIGPLIGGLLADSYGLRPVFFITGSVL
FACFTMTWFYVREQFAPVLKKDMLNGRQVFNSLKKPKLILSLFVTTMIIQIATGSIAPIL
TLYVRELAGDIQNLAFVSGMIASVPGVAALMSAPRLGKLGDRIGPERILIAMLALSVLIL
IPMAFVQTPLQLGILRFLLGATDGALLPAVQTLLIYNCTNQVAGRIFSYNQSFRDIGNVS
GPLLGAAVSASYGFRAVFCVTAVVVLFNALYSYRCLQRQPLKARCDAEQQ
>A0A127SRX8|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNSKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>A0A0S1RS40|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
ILVQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQP
TDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSL
RISPLEQLAFLRKLVNRQLPVKAAAYELA
>A0A0G3SH82|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSIVIPVYNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDSSADMLTA
AAEKPDSHIIAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SIVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGVQQDHNTQEEE
>A7FMC1|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHFARKRFGQNFLNDQFVIDSIVSAIHPVPGEAVVEIGPGLGALTEPVAARMD
HMTVIELDRDLAARLASHPQLKDKLTIHQQDAMKVNFSELSEQAGQPLRVFGNLPYNIST
PLMFHLFSYTDAIRDMHFMLQKEVVNRLVAGPNSKAYGRLTVMAQYYCNVIPVLEVPPTA
FTPAPKVDSAVVRLIPHVQMPHPVGDVRMLSRITTQAFNQRRKTVRNSLGDLFTSEQLIE
LGIDPILRAENISVAQYCKLANWLSAQSTPQK
>U5EGK1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MADIVQVIDVPGAPYGVTTGPDGALWFTLVAQGAIGRYGDGVVRTFPADPAGQPTVLVTG
PDGALWFTEFRGGRLGRITTDGVIDGIAADGPYGLCAGPGDTLWFTEIQAGRVGRRTPDG
RIEHAAVDGMPSMITPGSDGAVWFTLNQGNAVGRVDDDLAVTVYPLPTPAAAPVGITAGP
DGALWFVEIGAGAVGRITIDGTVTEFALPDPAARPHAIVTGPDGALWFTEWAGNRLGRIT
TDGTVSHLALPGEEPHGLTVDPAGHLWVAMESGALVEVSP
>V6M3W5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MPKLNGINHFWFSVSDLERSFCFYRDVLGARPLVRGRKLAYFEWNGYWLALNEESDIPRR
EIQDSYTHLAFSIDEESFDTWKSHLEAHQVHILPGRERDERDRRSIYFTDPDGHKFELHT
GTLEDRLAYYRDEKHHMTFFE
>W6J4X2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFNLPPVEKVSVVIPVYNEQESLPELIRRTTESCDVLGIDYEILLVDDGSSDNSTLMLSE
AAEQPGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKANEG
YDVVGTVRQNRQDSLFRKMASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRAVEIPVQHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIAVLGFSLAVLLVVLRLAFGPQWAGEGVFMLFAILFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQENDVSQEEKNQ
>ZP_03930663|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIVDFFKVLILSLVEGVTEFLPVSSTGHLILVNQFVKMEGETFSNAFNVIIQLGAILSVV
VIYFKRLNPWDREKTSKYFPKNYDKLNGQSRAYYRLTHPDRKTIELWKRVIVGVLPAMVL
GLLFDDFIDEHLFKPMVVAAMLLVWGLVIIFVEKKNKRENRVKHDNIAMVSYKTILAIGF
FQTLAMIPGTSRSAATIMGAMILGLSRSAAAEFSFFLAIPTMLGATLLKVVKNFSGFTGY
QWVLILVGMLLSFLVAYFVIKKFMAYIRNNDFIPFGIYRIILSVLVLVYFLIF
>AAN41000|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>A6W0K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLHSVILGLVEGATEFLPISSTGHLIVVSQWLGMEQTEGNKAFEVIIQLAAILAVVAN
YKERFTLKHFRLWCQVFVAFLPVAMVGFLFRHQIKAMFSVSVVATMFIVGGVIFLMTERW
IKHKSPSVDNLDNLNFKQALWIGIAQVFALIPGTSRAGSTIVGALFVGLSRKASAEFSFL
LALPVMMAASGYDLLSNYKEFAGEQWMPLVIGFVVAFLSAFVVMKLFMAFLEKFTFVAFG
WYRILFGGLLLFLA
>A0A147DB24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTIQIFEAMILGVIEGLTEFIPVSSTGHLILARDLMGFKSTGNTFEVLIQLGAVLAVLS
VYFGKLWHLVTTLPSSPRSRHFITGILVAFLPAVVIGVIAHDFIKEVLFETPMVICVALL
LGGIALLIIDRIPSQPRYTDIESYPLSLCLKIGLFQCLAMIPGTSRSGSTIAGALLLGTD
KRSAAEFSFFLAMPTMAGAFAFDLLKNYKSLNSADAVTIGVGFVMAFLSALVVVRSLLAF
VSRYGFAPFAWWRIVVGSIGIGVLLALR
>A0A0U5FQ12|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKSIIIGIVEGITEFLPVSSTGHIILAEALMRIPSGNVWTNSFTAVFDYAIQLGAI
FAVIQLYFNRLNPFSQKKTSKERFQTWRLWIKVVVGVIPAVIFGFLFNDFMDEHLLNFRV
VSATLIIYGIAFIWIENRQKNIAPKITNLNKITFKLALFIGLFQVLSLVPGTSRSGATIL
GAVILGASRFVAAEFSFFLSIPVMFGVTILKVGTFLLHGGRFTGMQSIVMLVGFVVSWIV
ALFAIKVMMRYIQNNDFKIFGWYRIAIGAIFLLLGFAGFVK
>D7WXF9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHLLFSVSNLEESITFYERVFDAKLLVKGNSTAYFDVNGLWLALNVEKDIPRND
THHSYTHIAFTITEDDFDKMYDRLVQLKVNILAGRQRDEKDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKQEKQHMAFFDN
>E1PKH3|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKTVVFAYHDMGCVGINALLNAGYEITAIFTHNDVATENNFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRTMAPEMIFSFYYRHLLSDEILQCAQKGAFNLHGSLLPKYRGRAPLNWA
LVNGERETGVTLHRMVKRADAGNILAQQKVAIDDQDNALTLHRKLIQAAEQLLSDVLPRL
RQGEVSEWPQDESQATRVGGRTAEDGRIDWNQPAATIHNLVRAVTDPWPGAFAFAGSVKF
IVWKSRVHPQQQQAKPGTVISKQPFLIACGEGALEIQTGQSEHGVYMNGSQLAQSLGMVP
GALLYSKPQSVLQRRTRVLILGVNGFIGNHLTERLLQDEHFEVYGLDISSDAISRFLEHP
RFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDASFDEDFSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
QDGVEALFRIIENKQQNCDGQIINIGNPDNEASIKELAEQLLESFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPTVTMDVTIDNTLDFFLRTVEQQADK
>C0LRU8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY-2-9|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDETFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A072NFS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTILKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLQSEQFLTKYVANTFKVVIQLGS
ILAVVVVFKDRFIEMMGLGKRGRQALHEKGHLKLTHVIVGLIPAGILGVLLEDMIDEHLF
TTGTVLIGLVLGAILMIIADKFTKNKPMVQTVDQITYKQAFTIGCIQCLSLWPGFSRSGA
TISGGVLVGLSHRAAADFTFIMAVPIMAGASGISFLKNLEYFSLDALPFFILGFISAFVF
ALISIRFFLKLINRIKLVPFAIYRIVLAAVIYVVYF
>AAD42180|FEATURES|ARDB_deepARG|glycopeptide|vanRD|antibiotic target alteration|0
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGKDALKCIESVELDLAILDIMLPDVD
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYM
RYKQPSLKQEAECTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVST
EELFEAVWGERFFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK
>A0A0T7FJN1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFLPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYARKLLQIAADLPTSPKARRFVATVLIAFLPAAVIGAFAHGFIKAVLFETPMLICIMLI
LGGFVLLVVDRIKFQPKYHDVMDYPLSLAFKIGLCQSVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRSALSFDDGAIIAVGFIAAFVTAILVVRSLLDF
VSSRGYAPFAYWRIVVGALGLIALLLGA
>W1IVD4|FEATURES|UNIPROT_deepARG|aminoglycoside|ant|antibiotic inactivation|1
MTIPPEADKVLLIVQKRLAESLVAVYLHGSAVAGGLRPRSDVDLIVVIDQPMTTEVRKRL
AADLIRISGRYPFDPDGRRPIELIVFSRADLAASLYPARSEFIYGEWLRQKYEMGEIPKP
VCDPELTLVLAQSRQEAIALVGPDASNLLPAPSKLEILRAIKDSLPGLVEALQGDERNVL
LTLARMWETSVTGKFVPKDVAADWAAARLPAIQAAVLADAREAYLRGCEENWQNRQQALQ
LTVNSLLEGVITNL
>AAD42182.1|FEATURES|ARDB_deepARG|glycopeptide|VanYD|antibiotic target alteration|0
MMEYQNNNGNYDKRNRRKAKKRKLLFYRAACVTLCLLIVSVIFGVVHFLGESKDPGLLSK
ENTKTDKNYSWLTDDQNEAVPSVPEPAISDQANKISVNITAANAIVMNKDTNEVLYQKKS
TAKIAPASTAKMIMALTALDYCSPEDEMKVGAEIGMIQSDSSTAWLMKGDTLTVRQLLIA
LMLPSGNDAAYTLAVNTGKAIAGDNSLTSQQAIEVFMDKVNEKAVALGATNSKFVAPDGY
DAEGQYTTAYDLAIIAKACLDNPIISEIVASYSSYEKWSNGREVTYNNSNELLDPNSPYY
RPEVIGLKTGTSSLGGACIVSAAVMDGETYICVVMGSTKESRFQDSVDILDKIKAQ
>A0A029LSQ5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDGDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNIDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>R8V9D8|FEATURES|UNIPROT_deepARG|beta_lactam|KQ1_03380|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSVISSVKAEQKLEQNVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNINAVVPGH
GEVRDRGLLLHTLDLLK
>W0P4B9|FEATURES|UNIPROT_deepARG|bacitracin|baca|antibiotic target alteration|0
MIEFYKIITSIILGIVEGITEFLPISSTGHIIIASHWLGIQNNNNTKILDIFIQLGSVFG
TLYFFHKKIINMLILKINIKNKKTNVIHVFFSIAPTIILGYIFYKRIKILFNINSVMYAL
ILGSLFFIISEIFKPKKYKISNLNKINLSQSIIIGLFQIFCLCPGFSRSGMTIGTGILLG
IKRSVAIEFSFIISIPLLIGASLYDLINNFHNIKILDLPVFFIGFIISFTISIICIKKLL
KFIDKTSLIFFGIYRLIMALLIYFIN
>A5N0R4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIFIIKAAIIGVVEGITEFLPISSTGHMIMVGDLINFKAPTYDKAYINMFEIVIQLGA
ILAIVVLYWDKIFNSLKNIKPGKWGFKLWVIILIAFLPSAVLGVIFNNLIQEKLFNSITV
ASALIVGGVLMIYMENKYRRGNSTKNIEDVNIFQAFKIGCFQCLALWPGMSRSASTIMGG
WISGLTNVAAAEFSFFLAIPTMIAASGWSLIKVKIDMSIMQVIALSVGFIVSFLVALVVV
EKFMNFLKRKPMRVFAIYRIFIGIIVLILTVTKVISV
>A0A0S4P7G7|FEATURES|UNIPROT_deepARG|beta_lactam|BN2497_10997|antibiotic inactivation|1
MLTLSPNRTKSIAIVIAASCFAPINSHAADSDARIRAIVDKAIRPLMAEYKVPGMAVAVT
LDGQPHVFNYGLASVKDNTPVGDATLFELGSISKTLTSTLASYAQVLGKLSLDEHPSTYM
PELKGSPIDKVTVLNLGTYTGSGLPLQFPDEVTDATMTDYFRQWKTQAAAGAQRRYSNPS
LGLFGHLTALALKSDFSDAMEQQLFPQLGMKTSYLRVPESAMVNYAWGYGDDKQARRMKP
DALAAQAYGVRSTAADVLRFVQANIDPQQLDEPMRRAVEGTHVGYFKVGAMVQGLGWEQF
PYPVTLQRLQAGNSSAMIMEPNAAKRLAVAPAAFAKTLFDKTGSTGGFGNYVAFVPGKKI
GIVILANKNYPIPARVKAAYAILKQLAP
>A3F6A3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALIHDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0A0Q8R3|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-28|antibiotic inactivation|1
MKTKSLCCALLLSTSCSILAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVMDNASLLRFYQHWQPQWKPGATRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNIQDMASWLKANMNPDALSDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>Q98DM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFNSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICTMLI
IGGVILLAVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVTALFVVRYLLDY
VSRNGYSLFGWWRLVVGIVGLVALMIWG
>A0A0A0IA03|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLLFIIKIIIIGIVEGITEFLPVSSTGHMIIVEELIKFKEGIQPISLYTKQYKDAFTM
IIQLGAILAIVVLYWDKIKKSFRNFAPSHPKSGFKFWLNIAVAAVPAGVIGLKYHSRINE
KLFNPASVTAALIVGAIWMIFAEKRYRGKFKTRDIDSVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGVSTVAAAEFSFFLALPVMFGITLKSLKDINVFALSSIHIIGLTVGFLV
SFFVALIVVDKFINFLKKKPMRVFAIYRILLGIVLIVLFLFNVIQI
>W5ILL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVEGLTEFLPVSSTGHQIIVADLLGFVGERAQAFNIIIQLAAILAVVWEFRGKILEVICG
LPSQPRAQRFTVNLLVAFFPAVVLGVAFADLIHHYLFNPITVAAALVVGGVVMLWAEKRE
HRIRAESVDDMTWKDALKVGCAQCLALVPGTSRSGATIIGGLLFGLSRKAATEFSFFLAM
PTMVGAAVYSGYKYRDLFQPSDLPVFAVGFVTSFIFAMIAVRGLLKFIANHSYAMFAWYR
IGFGLLILATWQFSLIDWSSAAP
>ABB70054|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTAI
TSFQWKNTKINIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0G8CQW8|FEATURES|UNIPROT_deepARG|beta_lactam|B4147_1099|antibiotic inactivation|1
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDTKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLHKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0E3M167|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRFYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>F1CGM0|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
LPLAVHASQQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCG
AVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLL
LATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQR
LSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAER
>A0A090YYS0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIIAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSAADIPLFASGFITAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFLM
>G5RV67|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSEURB_2311|antibiotic inactivation|1
MNKTHLEHWRGLRKQLWPDHPDDAHLADGEEILQADHLASFVAMADGVAIGFADASIRHD
YVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQK
VHQALGFEETERVIFYRKRC
>A0A0M4FQ26|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKFDLREFNLSIPDSGPYGIASTQDGKVWFTQHKANKISCINQSGEIKDFIVPTPDAKVM
CLTVSSRGDIWFTENGANKIGKLTTTGIFTEYPLPQSDSAPYGITEGLNGDIWFTQISGN
RIGKLTTEGAIHEYDLPNKGSFPSFITLGSDNALWFTENQNNAIGRMTDTGELTEYPLPT
QEAGPVGITSGNDGALWFVEIAGNKIGRITTSGEISEYDIPTPNSRPHAITKGKDCEIWF
TEWGANKIGRITSDQTIHEYPIQTENAEPHGIAFGNDGSVWFALECNKIGKLNLSE
>A0A127H143|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKDKVDLFIVVVQLGAILAV
IYDYWGRLWQALMGLLTGKAEGMTNPRQLGLSLIVATVPVMLVGFTFADEIKTYLFNPMI
VAIMLIIGGLLIFYVEKRPKTIIATEAEEVSLKTALMIGLFQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHGDVLTSSEDWLVLGVGTVVSFIVALLC
IRWLVAWVSRRDFTIFAWLRIITGVVVLLASWLFGYQMAG
>C6RK20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGIVEGITEFLPISSTGHLILASELMDFWTKEKSAVFVIAIQMGAIAAV
IYEYWSRLWGAATGMITGEEKGRRLGFGLILASIPIVLVGLTFGQQVKELLFNDVAVAIG
LIVGGLIIIWVEKNPPKVNAPEVENISIKQAIWIGLIQVLSLIPGTSRSGATIIGGMMLG
LSRKSATEFSFFLGIPVIIGAGLLDLYQSYDVLESNFDWLVIGWGILVSFISALFLIRVL
VAYVAKRDFMIFAWYRIASGLLILLFAFTGWRLW
>D2U0I5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPHEIIKMLKLFPALLKVTWSLPTLRHQKDKGMSALLELCDIGRNYRSGEQQVAVLKNIS
LTINAGEMVAIVGASGSGKSTLMNILGCLDKPSYGQYFLAGQNIAELDNEQLSVLRREYF
GFIFQRYHLLPYLTAEQNVEIPAIYAGACQQERRKRAIALLTRLGLNDRIKYYPTQLSGG
QQQRVSIARALINGGKIILADEPTGALDSYSGDEVITILKQLCQQGYTVILVTHNMQIAE
QAERVIEIKNGEIIRNSVQRESAKILPPVFSTKKSQISMTQWLNQFREALLMAWRAILIN
KMRTLLTMLGIIIGIASVVSILVIGNAAKGLVLADIQSIATNTITVFPGRGFGDMSPQDR
RALKVSDVDALQNQPSVLAISGKMSTDVRLRYGNQNSAARAFGIGESYFDVYAMPMSEGI
ILTRDMVKHHAQVIVIDQNTKNMFFPQHKQVVGEVMLVGNIPVTIVGVAAEQKSMYGNSN
MLQIWMPYTTMSSRLMNRSYFDNLDIRIKQGYSSLEAEQQLTRLLTVLHGKKDIFTYNFD
TLIKTIEKTTNTLQLFLTLVAVISLLVGGIGVMNIMLVSVTERTKEIGIRIAIGARNSDI
MQQFLIEAIFICLFGGFLGILLSYLVALIARVVLPDWQFAFSLMPLLGALLCSTVIGLIF
GFLPARNAAKLNPVDALARE
>A0A0H2LPW0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSHADEFDEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQSYELILVDDGSSDRSAAM
LTQAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTA
MQGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIQAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSIIAAGGFLLAVLLIALRLIFGAEWAADGVFTLFAVLFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADPKSDKNQEED
>A0A127SII2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAGI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>A0A0K9TC80|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPANEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQEVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A023Y951|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAILAITLVFRQ
RLWTLATGLHERANRDYVMKLGTAFLVTAVVGLPVRLAGWELPETVTPVAWALIIGGIWM
ILVETYSARLPDRDEVTWKVAILVGLAQVVAGVFPGTSRSAAAIFIAMLFGLSRRAAATE
FVFLVGIPTMFAASAYAFLEMAKDGKLGNENWTDVGVAFLAAAVTGFVVVKWLLGYIKSH
KFTAFAFYRIALGAALLLWLPAGN
>A0A127SCT8|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGYQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>B8ZI05|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTALEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKN
>Q8KT53|FEATURES|UNIPROT_deepARG|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRWFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A0Q7EWQ2|FEATURES|UNIPROT_deepARG|beta_lactam|ASC94_15090|antibiotic inactivation|1
MIAMAALGCVAGLAGVPAHGAEICTAIADAATGKVLMQRGDCQRQVTPASTFKIPLSLMG
YDAGFLTDEHAPQLPFRRGDPDWRPSWRSATDPAKWMSESVVWYSQRITVALGQARFAAY
TRRFEYGNADVAGDARNDGLTASWLGSSLRISPLGQLSFLGRVVNRQLGVSEKAYEMTAR
LTRYGQPVEGWSVNGKTGSGSGFGWYVGWAEKGGRKYVFARLIEKEQGEPQDVPAGVLAR
DGLVAEFPALANAIEVDQAFKPLLEKHGLPGMAVALSVNGKHYFYNYGVASQETGQPVSE
ATLFELGSVSKTFTVTLAAYAQAQGRLALTDPVSRHLPALRGSVFDRVSLVHLGTHTAGD
FPLQLPQEITTHAQLMAYYKGWQPGHAPGSHRTYSNPGIGLLSLATAASLGVPYADAVEQ
TLFPALGLAHSYLRVPAGQMAQYAQGYNSKGAPVRMNPGVLAEEAYGVKSTTRDLIRFVD
ANMGLLPLEDKLARAVAATHTGYFKTGAMTQDLVWEQYPGHAGLDQLLVSTAEKVVFEPN
PATEITPPLPPQADAWLHKTGSTGGFSAYVLFNPARKAGIVMLSNRSFSGAQRVSAGFEV
LSRVAPAGPAVAPAAQSAAAN
>U2EWC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWDILKAIILGIIEGLTEWLPVSSTGHMILADEFIHMDITPAFKEMFLVVIQLGAILSIV
VLFWNKLWPFSFKKGQPHVKKDTFQLWFKVLVASIPALIVGLPFNDQIDALFYNYITVSI
TLILYGVLFIWMENRNRRYQPRVRNLGQLTYKHAFIMGCFQVLALIPGTSRSGATILGAV
LVVGCARPVAAEFSFFMAIPAMAGASLLKLVKFGFSFTGMEVAILAVGSLVAFVVSMLSV
GFLMNYVKKHDFKVFGWYRIVLGAVVLAYFLLFAK
>A0A0U1YWL1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHLTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>L7CL63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQELIRVVILAIVQGIAEFLPISSSGHLVILGSMLGELGESVTLEIILHAGTLGSILVVF
WQRIWALLLKDRRVIGLLVIGTLPAVVIGLTIKTQFPEILRSPLLAGAMLIVTGLMLIVL
GRLTPKSGTYDRLGLGAAFLVGCFQAFAILPGISRSGSTILGGRLMGLDRDDSVTFSFLL
AIPAILGATVLAIKDLLEDGSSGETSIEVLLIGAAVAFAVGIVALKWLIRWSREDRLHWF
AYWCIPAGLLVVLLNLR
>A0A127SHI1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAGI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLTTYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>J1GA83|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVRALVEAGYDIAAIYTHPDNAAENNFFGSVARTAAEFGIPVFAPE
DVNHPLWVDRIKDAQPEVIFSFYYRNLLSEEILDCASVGAFNLHGSLLPKFRGRAPLNWV
LVKGETETGVTLHRMVKRADAGDIVAQERVAIAAEDTALTLHHKLCETAKSLLAKSLPVI
KTGHFPQTAQDESKATYFGGRSPKDGAISWEGSAAEANNLVRAVTEPWPGAFSYVGGGKF
IIWKSRVLESNNGAKAGTVISVNPLVIACGTGALEVVTGQAENGVYMQGSQLAQSLGLVS
GAILSSKPVSAIKRRTRVLILGVNGFIGNHLTERLLRDDNFEIFGLDIGSDAISRFIGNE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDKSFDEDNSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
GDGIEALFRIIENKNNNCDGQIINIGNPDNEASIKQLAEMLLESFERHPLRSQFPPFAGF
REVESSAYYGKGYQDVEHRKPSIRNAQRLLEWTPEVHMEKTIDETLDFFLKTVELTDPAS
>A0A0Q8FIG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPTWDTFIVLIQLGAVLAVVAV
YFQRLWQVVVGLPTKPEARRFALSVIIGCIPAFAAGLLLHGVIKHFFENPFLPQVICVSL
IVGGFLLLWVDRSKLPVREEDGMALSLKTAFLIGLFQCLSLVPGVSRSGSTIVGSMLLGV
ERKAAAEFSFFMAIPIMVGAFALDLLKSYKDIDPSHAGTIAIGFVVSFLSGLVVVKTMIA
FIGKRGFTPFAWWRIVVGVIGLGLIYMPK
>ZP_03040189|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VatB|antibiotic inactivation|1
MPYGPDPNAIYPNEAIKSICYIKNVVTRPNIIVGDYTYYDDLNGAEKFEEHVTHHYEFIG
DKLIIGKFCAIAKGIEFVMNGANHRMGSVTTYPFNIMGNGWEKSTLALADLPLKGDTVIG
NDVWIGQNVTVMPGVHIGDGAIIAANSVVVKDVPPYHIAGGNPSRVIKKRFDDELIDHLL
AIQWWDWPARKIFDHLETLCSGDLTKIKEI
>YP_002705656|FEATURES|ARDB_deepARG|multidrug|smeB|antibiotic efflux|1
MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENA
VTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQ
AVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQ
EYAMRIWLDPEKMRQYALMPSDVETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRL
HTPEQFAQVVLKADANGSVVHLGDVATIGLGPESYDSISTFNGKPSASLGIELNAGANAI
AVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQ
NWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVM
TFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMIL
SVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVD
GFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMD
RLSAAAVKDDSVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTAAMAS
VPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRY
ASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGAAE
ARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAALQRYNGVSAMEITGQPAPGVSSG
EAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVP
FAVMLAVPVGVFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKS
TREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGM
FFVPLFYLLVRRLFPGRAPAEATAPEASP
>B7UPX2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTSKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNTLQ
>ZP_01819864|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLTFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>M1XY99|FEATURES|UNIPROT_deepARG|chloramphenicol|catA1|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPELRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRCLMNTTVLR
>ZP_03280821|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MTNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
ELTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMDFGELSTKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYFCNVIPVLEVPPTA
FTPPPKVDSAVVRLVPHKTMPYPVKELRVLSRITTEAFNQRRKTIRNSLGNLFTVDVLAE
LGIDPTMRAENISVEQYCKLANYISDNAPPKES
>A0A0Q4FKS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSMSHILIVILLGIVEGVTEFLPVSSTGHLILAGAILGFHGESAGTFDIVIQLGAILAVL
ALYWRRFWDVAVGLFGLQAGALAFTRNLALAFLPSAVIGILVYKSVKALLESPTVVAVAL
IVGGVAILVIERLVKAPRVRSVETMPWTTALGIGIAQCLSMIPGVSRSGATIMGALGMGV
ERKTAAEFSFFLAVPTMLAASGYDLYKNGAALGQGEWTSIAIGFVVSFVVALVVIRWFVG
IVGRYGFAPFAWYRIIAGTIALIALQF
>R6B0T3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYDYFCAFIVGVVEGLTEYIPVSSTGHMIIVGHMLGFEGTLADLFDVFIQLGAILSVLVV
YREKFTFILNTHHWFRTKGPSLLNLAIAMFPACLLGLVFHGFIKNTLFGPMTVIIGLVLG
GIFMIAAEKMHKHFSVTDVDHITWKQALKIGLFQCLSLWPGFSRSGSTIAGSLLLGISRK
AAADFTFIMAVPLMFLACIYDLLKTIKYLEMGDFGILAVGFVTAFFVAYASILWFLKFLN
TSTLTGFAIYRFLVALIALIYFW
>A0A0K9F8Q1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVVVVMWKRMLNLVGLYKIDGQSKSVKGHFNLMHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVIYALVAGALLMIAADKLAPKRPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYVVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLAVIIFM
>I0QQ55|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|SPM24T3_16860|antibiotic efflux|1
MNSLSPPPLLCLTAVSRRFKTGDALISVLDNISLSIKAGEMVAIVGPSGSGKSTLMNILG
CLDTPSSGHYQVDGQNVEQLSSDQRAGLRRERFGFIFQRYHLIPSLSVRENIEIPARYAH
QSRQLRLDHARRLLDRLGMQGFEDRNVRRLSGGQQQRVSIARALINGGEVILADEPTGAL
DSRSGSEVMQLLQGLHQQGHTVIIITHDAKVADYAERIIHLADGKIVSDLPNDGDSDGKI
TEKLPQRFVTMSHNFANNRGWRTRWQEYQDAFRSAGRSLAAHRLRSCLTLLGIVIGIVSV
VSLNAAGAGARQYVLDTLSSLGGNVVTLYPGKGYGDDQAASIHSLRDRDLSVLAPQRWIT
AATPNVSTNLRIRRQRTDINATVNGVSAEFMSIGNMNLLQGRSLLPRDITQQSSVVVVGE
LLKDKLFPRGSNPLGEIILVGTLPAKIVGVARSGSLSGGNTLNLWLPWSTATSRLLGQDW
FDSIAVSLPESVSAETAKSTINRMLTRLHGRQDFYMLDSAAFVNSVEKTSFALSLFLSLI
ALISLLVGGIGVMNIMLVSVSERTRETGIRMAVGARRWDIQRQFLTEAVLLCLSGALVGV
TLSLVLGISLSWLIHPWQLIFSLPAILTAVGCAVLVGVISGWLPAWQAAKLDPAEALTRE
>A5Z1N4|FEATURES|UNIPROT_deepARG|beta_lactam|adc|antibiotic inactivation|1
NGGFLKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQN
NKKYEMYYGLQSVQDKKAVNSITIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKE
LKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSI
GLFGKVVALSMNKPFXQXLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPG
PLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFS
YPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVM
LTNKRIPNEERIKAAYVVLNAIKKKK
>A0A0P9SMB4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MDRGIQPLRPYPIKFVSIVIPVYNERQSLPELLRRTEVACKHLNHRFEIVLVDDGSRDDS
AEILQQAAERSASPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLV
ALAEQGYDVVGTVRSNRQDSAWRRWPSKIINLAVQRSTGVAMSDYGCMLRAYRRTIVDAM
LACRERSTFIPILANSFARHTTEVLVDHAEREHGDSKYSPMRLVNLMFDLITCMTTTPLR
LLSIIGFSMALLGVLFAGLLIILRLIFGAPWAGDGTFVLFAVLFVFTGGQFIGMGLLGEY
LGRMYSDVRARPRFFIEKVVRSSSEVVSESVDSSVTPYMNKVAP
>A0A0S2SHF2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYTLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPSQDHATLSLVHIILGMLPAVVIGLMIHSWIKANLFGPVTV
MYALVAGGILLIIAEKARPAVRAETLDDISYKQAFGIGCFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASALDLYKSRDFLSLADFPMFAVGFVTAFVVAMFAIK
TFLALIRRLDFIPFALYRFVVAFAVYLVFVA
>A0A127S9W4|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERYRQIAEIGASLIKHW
>P20174|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDTVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0N8R1H5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVVGLPRQQQAQRFTLNLLIAFMPAVVLGVIFADAIHHYLFNAITVATAL
VVGGVIMLWAERREHTVRTETVDDMSWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFVTSFIFAMIAVRGLLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0E8TM01|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ_1|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSELPKQTKQIKQIKQENTRHDSFAKLE
KEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITYTRE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADA
TKVVLDTLKVTNKN
>A0A0H3R7A0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>B3YD81|FEATURES|UNIPROT_deepARG|aminoglycoside|SeKA_A1070|antibiotic inactivation|1
MDIRHMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>YP_002258163|FEATURES|ARDB_deepARG|multidrug|MexC|antibiotic efflux|1
MNIERLRRDGGVHALLVAMLAGCGPSEPQSTPPAPQVATTSVAPTHLELTEDLPGRVAAV
RVAEIRPQVSGIVLRRLFEQGTEVRAGQPLFQINPAPFRADADTAAAALRRAEAALARAR
VQTTRLQPLVEADAVSRQVYDDAVSQRDQAAADVEQARATLARRQLDLKFATVEAPIPGR
IDQALVTEGALVNSGDSNPMARIQQIDQVYVDVRRPASSLEALRRTLATQTAGAGNGLPV
AVLRGNGEPYEAKGRILFSGINVDAGTGDVLLRVLVNNPQRQLLPGMFVRARVPHVRYTD
ALTVPQQAVVRVGGQPQVWTLDANGHARLKPVELGELVDRRYRIRTGLSAGQKIVVEGME
RLSDGAAVTAHDWKSPEPVPAGPAH
>ACL27011|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTRDFASNINYSYPIWQKG
>A0A158LX91|FEATURES|UNIPROT_deepARG|beta_lactam|F962_01147|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPINQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGHYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYTVLNAIKK
>E9LZM8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-40|antibiotic inactivation|1
MSIHHFRVAVIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVARPLL
>A0A0F3G9L8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWVAFQALILGIVEGLTEFLPISSTGHLIMVGDLLGFNGEKATAFKIIIQLGAILAVI
WEFRAKVLGVVVGLPSDPNAQRFTFNLLLAFIPAVIFGLAFADLIEHWLFNPITVAMALI
IGGIIMLWAEKREHAIKAETVDDMTWKLALKVGLAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVAATVYSLVKYRDILQMSDLPIFAIGFVSTFIVAMITVRALLKF
ITSHSYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>F4SGI5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTVRRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0R5RQ00|FEATURES|UNIPROT_deepARG|beta_lactam|ROB-1|antibiotic inactivation|1
MLNKLKIGTLLLLTLTACLPNSVPSVTSNPQPASAPVQQSATQATFQQTSANLEQQYQAR
IGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYS
PETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLE
PDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATP
TSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFH
TLQLN
>K7QCU9|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREQSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A077UGL2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKSINHICFSVSNLNNSIHFYKDILCGELLLSGNKTAYFNIAGLWIALNEEKDIPRNEI
QLSYTHIAFTIDENEFNYWYQRLKNNKVNILEGRVRDVRDKQSIYFTDPDGHKLELHTGT
LENRLNYYKSTKPHMTFYK
>X2GXV8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MAIQTINHFLFSVSDLAQSIAFYQNIFDAKLLVKGRSTAYFDVNGLWLALNEEADIPRNE
IHQSYTHIAFSIDAKDFDTIYEKLVHYKVNILEGRVRDEQDKQSIYFTDPDGHKFEFHTG
TLQDRLAYYKKEKPHMEFFND
>Q5XLF9|FEATURES|UNIPROT_deepARG|beta_lactam|cfxA2|antibiotic inactivation|1
KSATKDSANPPLTNVLTVSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVH
QALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSD
NNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLM
NRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAA
HNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQT
>A0A0L6JBK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILA
VYFRRLIGIATALPTNPQARRFVIGILVAFLPAAIIGGLFSKVIKAYLFNPWIVCATLVA
GGLVLLVIDDTDLEVKKTDVYDFTLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLFDNYKFLSRDDVGLIVIGFIVSFLSALFVVRVLLDYV
SRHGFRLFAWWRIIVGALGFAGLIILG
>S3IMM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEYVNSIILGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LVDLVLGWRDPRNRAYAAKLIVAFLITAVLGLIVKKLGFELPENATPIAWALIIGGVWMI
FAEWAAARRPPHKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAYELLKTFKDGGAANENWTSLGIAFVVSTIVAFVAVKWLLSYIRSNR
FTMFAIYRIILGAILLGMAATGVIA
>A0A0G1NKX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLVQALIMSIVEGVTEFLPVSSTAHLVLASKLMGISQTGFVKSFEIAIQLGAILAVVVL
YFKDLTANYRVWPKIILAFVPTAVLGFIFYGFVKSVLLGNSAVTSIALAAGGLLFIVIER
VCAKLVPALNTNTHGFYQELAKLPSLKLLGIGVMQSVSMIPGVSRSAASIAGGMLVGLTK
QTAIKFSFILAIPTMLAATSLDLYKSGFMFNPNELTVLTIGFLGSFGFALLAVKTFTGYL
QKHSFVLFGIYRITIGLLWFFVLM
>W0HA36|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTTQPLLELQGITRRFSAGAKDFIALDNINLTINEGELVAIIGASGSGKSTLMNVLGCLD
HADAGSYKVSGRETHALTDDELAALRRDHFGFIFQRYHLLGHLSAVNNVEMPAIYAGVGE
SARNDRAQELLSRLGLGEHLSNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDTA
SGKEVMKILLELNAAGRTVILVTHDEKVAAHAQRVIEISDGKIVSDRINPDRQAPQDQEQ
DQLPTKNRKGNRLVASFELFREAFTMAWVALISHRMRTLLTMLGIVIGITSVVSIVAVGE
GAKRYVLNDIAAIGSTTIEIFPGTDWGDSRSAAIETLSLGDVAALGEQYYIDSATPNVGR
NLLLRYQNLDVTATVNGVGDNYFRVRGIKMGEGVGFSKEDSIRQAQVVVIDHNTRIRLFG
PKTDPLGQVILVDNLPCVVIGVTEDKKSVFNTSKNLNVWMPYETASGRLLGQRYLDSITV
RVKDGQPSKLVEENLTKLIEKRHGTKDFFTYNLDSIMQTVQKTSQSLALLLSLIAVISLV
VGGIGVMNIMLVSVTERTREIGIRMAVGARPSDIRQQFLVEAVMVCLLGGLIGIGLSFAI
GYVFSLLVKEWQMVFSLGSIITAFVCSTLIGIVFGFVPARNAARLDPIEALARD
>V2Y3Q9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGAFFEIIKAVIFGIVEGVTEWLPISSTGHMIVLQNYIPLDVSPGFWKIFEVVIQLGAIM
AVVLLFWKKLWPMKTVKGRNFLKLGTVRLWIKIIIACLPAAIVGIALDDFIDEHFYNPKM
VAAALIFVGIMFIYIESKLKLANKAAVTKLSEITYKEAFYIGIFQLMAAIFPGTSRSGAT
IIGGLMLGLSRKVAAEFTFFLAIPVMFGASLLKIVKYLIAGGVAFTGLEVAILIIGTVTA
FVVSVFVIGGLMSYIRKKDFTPFGWYRIVVGAVIIIGSIVSKT
>AAW82909|FEATURES|ARDB_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ZP_03836256|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSQVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEKRGRFFSILMMQDSAGAVVGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVKIPVREGMSHVMHDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLLMSLSMMPIGLVGNLQQL
FTLICTFYIGSIIAEPARETLSASLANARARGSYMGFSRLGLAIGGAIGYVGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSLKRPTRGMLEPDA
>K4ZIH3|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKPTSKYETIKQILSDFKQPAYRYRQIIDAIFEQKVAEYERITILPAFLREELARTLGPN
VSSVIPVKELTSQQVSKVLFAIGGGERVEAVRLSYKRGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFHLNGHALDSVSFMGMGEALANPHLFEALAILTNPHLFGLG
HRRITISTIGLLPGIDRLTREFPQVNLTFSLHSPFDEQRNELMPINKRFPLRDVLNALDR
HIQHTGRKVYIAYILLQGFNDSTEHAKALAAHLRGRGCWEHLYHVNLIPYNSTDVTPQSY
LPSDPERINTFVRTLKIFGVNVTIRTQFGADINAACGQLYRADSKMNG
>Q323U7|FEATURES|UNIPROT_deepARG|multidrug|mdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGADMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A0F6P2I5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-405|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSPKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>A0A0G3WRQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLSFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVMSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>R4WCX7|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMDRFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLRAKEEVLAALPAKLKTL
>K8FWY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWSLATGLGERANRDYVLKVGVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGAALLLWLPALA
>L0A790|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEYLAAAISGVVEGITEFLPISSTGHLIVTSELLRFDTQGAFEIIIQLGAVLSVVWFYR
QQLLRQAREVRTNTGTRRFWLGVLLAFLPAALVGFLLGDLISQYLFKPTVVASSLIVGGV
VMWLVESRPQRSEAVSVEQVRPMQALTIGVIQLLALVPGVSRSASTIIGGMLTGLSRPAA
TEFSFYLSMPTLGAASLYSLLKHRDEVATQGWGVVAIGLVVSFIVALLAIGWLLRYISRH
DFKGFAVYRVFAGIAILLFFHFRGN
>CAS11304|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A0A0F7S9|FEATURES|UNIPROT_deepARG|beta_lactam|EL76_4246|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCALLITASCST
FAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMACWVRSNMNHR
DINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIVNGSDNKIALAARPVKAI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>N6UB98|FEATURES|UNIPROT_deepARG|aminoglycoside|RHSP_08625|antibiotic inactivation|1
MRIETAGDQHQGAWARLRAELWPDGSIEHHRSEIEKICSAEGNIGFVAIDAADHVIGFAE
ATLRHDYVNGCETSPVLFLEGIYVRKESRRQGVAWALCAVVAEWGRAAGCTEFASDALID
NLESHALHDALGFVETERVVYFRKSLS
>A0A110AZV8|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLECEKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>V2V5V4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTLEKREMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAVTVAIA
LIVGGFIILWAERRQHQVISPEVEDLTFKQAALIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAILAVGIIVAFVSALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>YP_001590869|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSDRVGRRPVILVGMS
IFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGTQLRHANSLLNMGI
LVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRPAGAPRTRLIASYK
TLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSILFILPIPAAFFGAW
FAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAALFFFGAGMLFPLAT
SGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLLMTLMGLLILACWL
PLASRISHQGQTV
>A0A0D5WQ75|FEATURES|UNIPROT_deepARG|beta_lactam|VW41_01335|antibiotic inactivation|1
MKKSLCLTLLLAASCSSFAAQKELTAPQIERLVNRTIAPLMKEQAIPGMAVAVIYKGYPL
YFTWGKADVQRNVPVTQQTLFELGSVSKTFTGVLGGDALARGEVSLSDPAQKYWPELNGD
QWKGITLLQLATYTAGGLPLQVPDSVTNSEALLKFYQDWQPQWAPGTQRLYANASIGLFG
ALMVKPSGMSFEQAMSKRVFEPLSLTHTWINVPATEESHYAWGYRDGKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMAPDRLEDKTLAQGIQLAQSHYWRVGSMYQGLGWEMLNWPVK
AKTVIDGSDNKVALAPHPATLIEPPVSKVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNTERVKAAYAILEALK
>R6DNY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIEILKVVILGIIQGITEWLPISSTGHMILADTFLQLQQPKDFMDMFYVVIQLGSILA
VVVLYFNKLNPFSRAKSRAERLSTFQLWFKVIVAILPIGVIGLLVDDWVTEHFYTPTVIA
IALIFYGVLFILLEKRNHRVKPRIRNFEQLSYRTAVCIGILQLLAIIPGTSRSGSTILGA
MLLSCSRFVATEFSFFMAIPVMFGASGYKILKFILKTGLASITGFQWGLLLIGSLVAFVV
SLFAIKFLMNFIRKHDFTAFGWYRIVLGIIVILFFGAKAIFA
>W5YXS9|FEATURES|UNIPROT_deepARG|aminoglycoside|AU15_06645|antibiotic inactivation|0
MNLQPIFSQAGAALLALFVLSLGSVAQADDWSPTLQKEIERIDRTFSGDLGVYIRHLGTG
QKVSHNIDQDWYLASTVKIPLAIVLMQRAENEGLDLKQKLTLRAADYVDGTGDLLWVDPG
ARYSLEELNRRSIVDSDSTATDMLIRFLGEKSFGEDVARLVPEGLGPITTILQVRYDAYR
EVHPSVSVLTNRDFIDLKTARTYQARYDMLLEKLNITAREAEAKGVREAFERYYQRRINS
GSLEAFGALLEQLVRGELLNDAHTDQLLGYLSEITTGDHRIAGGLPAGTHFAHKTGTQVA
RSCDIGLLNPQAPDEAVIVAVCARDYAALSEAERAYQAIGKALHEPGLTGTVD
>A0A0N1J774|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0T9Q8A7|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_2|antibiotic target alteration|0
MSESEKIKKVSIVIPVYNEQESLPALIERTLVSCKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFALAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVSAEQTENNQEVEK
>YP_002188856|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTVGPKDGTPLAPPGKGARGSLRGRPWLTLFGVAIGVMMVALDGTIVAIANPAIAD
DLDTSLAGVQWITNGYLLALAVALITAGKLGDRFGHRQTFLIGVAGFALASGIIGLSSSV
SLVVAFRVLQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPIVGGLLV
EHVSWQSVFFVNVPVGVAALVLGLFILKDHRAENAPRSFDVPGIVLLSGAMCSLIFAIIK
TGDGWSWSDGRTWGLLGFSVVCFAAFAFWQTRAKEPLVPLAMFRSVALSAGTVLMVLMAI
AFLGGIFFVTFYLQGVHRLSAVDSGLHLLPLTTMMIITSPIAGVLITRFGPRVPLVGGML
ATAASMFGLSTLEADTGTVTMSLWFALLGLGLAPVMVGATEVIVGNAPLELSGVAGGLQQ
SAMQVGGALGTAVLGAVMAARVNKDLPGNWTDAGLPKLTGAQLDQTSQAVQLGVPPIPPH
TPKEVAAQITTVAHDTFMSGMGLACTVAGIVALVAAAVATLTKRGDNAVEGAGAAHV
>A0A150HXJ6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPKHLSMNLKKLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVA
VTLNGQHYFVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAK
YFPELNKTAVNRATILNLGTYTAGGFSLQFPDEVVTQQDMVKYFQKWQPKTKISAARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLFPQLGLKQSFIHVPESQMDNYAWGYKNDQAMRV
SAGMFDAEAYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWE
QYTYPVSLATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEARITASYQTIQQLLKQQ
>Q9AGT9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFIATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>B2CD48|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
HLLVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGCFLA
>T1YC08|FEATURES|UNIPROT_deepARG|beta_lactam|SAKOR_01889|antibiotic inactivation|1
MIYRNYNCNIGGYILKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTK
SGKEVKFNADKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKS
GQAITYASRNDVAFIYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>A0A142LZW0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSQTIINALLLGLLEGLTEFIPVSSTGHILLAGHFLGFNSTGKTFEILIQLGAILAILS
VYATKLWQMLVTLPSDPKTQRFVAGILIAFLPAAVIGALAHDFIKTVLFESPQLICVMLI
LGGLVLLFLDRLDLKPRYGDVTNFPLSVYLKIGLFQCLAMIPGTSRSGATIVGSLLMGVE
KRAAAEFSFFLAMPTMAGAFAYDLYKNRDILSAADLPVISVGFLAAFITALIVVRHLLDY
VSRNGYALFGWWRLLVGGAGLIALMVWG
>ZP_03561873|FEATURES|ARDB_deepARG|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWIYMIGALIAIIVFALYIKNA
KRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVILNRWTQSEK
>A0A0H4IQK7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-122|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHSVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLQPLKLAHTWITIPQNEQKDYAWGYREWKPVHVTPGQLDAEA
YGVKSSVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>G9W794|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGVLPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>W2DGE5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENTFYGSVAQLCARHGIPVHA
PEDANHPLWVERVAKLNPDFIFSFYYRNLLGEALLATARQGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQTVMIERSDTGLTLHAKLREAATQLLRDALP
QLAQGKLSETAQDESQATCFGRRTPADGKLHWQKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGQAPGRVISVNPLRIACGEDSLVINFGQRNDNGLYLTGPALADELG
LVDGSILRGAESGGKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKAFYGAGYQDVAHRKPSIANAKRLLNWEPSVEMSETIGNTLDFFLREAMLEIA
PSSEAGE
>A0KWQ2|FEATURES|UNIPROT_deepARG|beta_lactam|Shewana3_1990|antibiotic inactivation|1
MPESLQPAVKTARFLRLSNPSPFLGLVLLTAVPLVANAAPQVQTKAMQSLVDSAINPLMK
EYGIPGAIVGISMNGQQYFFPYGVSSKTTEHHVSKNTLFEIGSISKTFTATLANYAQVEG
KLTLTDKVSQYLPELTGSAFDQINLINLATHTAGDLPMQVPDKVTNNAELMRYFKEWQPA
YAAGTHRNYANPSIGLLGLIAAKQLGQSFPNAMEQTLFPQLGMTHSYLQVPSNKLADYAQ
GYNKQDQPVRLNPGVLAEEAYGIKTSAVDLLRFVETNMQQHPVPSVLQQAIDATHVGYFD
VGMMTQEMIWEHYPYPIALDKLLAGHTQEVVFGSVPVKAIVPPQAPQPDLWINKTGSTGG
FAAYVAYIPAKKLGMVLLSNKNYPVPPRVTVGYQILTGLTALPAK
>A0A0T9NNZ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MTALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAQLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLAKHE
RRERANMLLTRLGLGDRVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKMVRTVASSAAMR
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQR
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVNDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVFGMKLEQGTAITHEQVERQSQVAVIDRNTQRRLFPNMKNV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>ABC76093|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MGLCRYGAHNCCLFARPIPIVEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAA
IEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRY
ALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVR
FFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSR
KSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDA
RDRGLDHA
>A0A0K9TFL4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIPKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEVEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0Q4MRE3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLNILILAIIQGLAELLPVSSSAHVIMAEKILGLDPSAPDMTLLLVMLHTGTMFAVIV
HFWRSWRETYFSSTAAFKHNALRIILATMMTGIVGLILLHLIKKFYASDASTFEIESLFS
NSKLIASGLVAAGILIIVSSRIKESHSKELSLFQSMTIGIVQGLCLPFRGFSRSGATIST
GLSLGVARKTAEEFSFALAVVLTPVVIIKEFVRVYQNGPTAYPAGMLSSILLPSLLGMVF
SFIAGLLALRWLAGWLEHGKWHLFGGYCIFAACVVLWIG
>A0A0K2P9L1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGVGKSRLSLVHILLGMVPAVVLGLLFHDFIKSLFNPIN
VMYALVVGGVLLIAAELFKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVYAVFM
>N9PSH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALFPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMLVLGVGIIVAFISALIVIRALI
RYVSKHDFTAFAYYRIIFGLFILVTWWTGWVHW
>Q4K4L6|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MTPIEPGSSANAGGWLQLRQGLWPDCPQDEHQAEIQQILAEPQRYGCWLACTENGEAVGL
AEAALRHDYVNGTDSSPVVFLEGIYVAPGHRRQGIAQRLIEQVTYWGQQQGCVEMASDTS
LDNLASQDLHHALGFEETERVVYFKKRL
>A0A0D0STS1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLILELIKGIILGIVEGLTEFAPVSSTGHMILIDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYKSEPIDGIGQKPKRLNLLHILVGMIPAGILGVLFDDVIE
KYLFSVPTVMIGLFIGAIYMIVADIYSKKVTNPKTVDQINYFQAFVIGLSQAVAMWPGFS
RSGSTISTGVLMKMNHKAASDFTFIMAVPVMLAASALSLVKNMEYIHISDIGFYILGFLA
AFIVGLIAIKTFLFLISKVKLIPFAIYRIILVIIIAILYFGFGIGQGITNA
>A0A0F6MFP9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGNYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>YP_002846930|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRSVNLLLMLVLLVAVGQMAQTIYIPAIADMARELNVREGAVQSVMAAYLLTYGLSQ
LIYGPLSDRVGRRPVILAGMSIFMLATLVAITTHSLTVLIIASAIQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGMLDTLWNWRACYIFLLVLCAGVTFSMA
RWMPETRPAGAPRPLLIASYKTLFGNSSFTCYVLMLIGGLAGVAVFEACSGVLLGARLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLVAGLMMWIPGLFDVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWFSAMLPQT
GQASLGLLMTLMGLLIFVCWLPLASRVSHQGQAV
>A0A063BIV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSLLDFNDAHEKTFDVVIQFGAILAVC
WEYRRRIASVVTGLPSRPDARRFALNVVIATIPAVALGLLLEKKIKAVLFSPVPVAFALV
AGGAVILWAEARQREGGEPPRVQSIDALTPADALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWHAFSVDSLGLFGLGLAAAFVSAFGCVRW
LLRYVAAHDFTVFAWYRIGFGLLVLLVGYSGWLDWG
>O32579|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDCMARGEIKLSDPVTKYWPELTGKE
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWLPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYALGYREGKPVHVSPGRLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSSGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEGAWRILEKLQ
>YP_001144148|FEATURES|ARDB_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLNIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDI
DLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQ
FGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNE
TLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEAR
QAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>A0A0N7AFE8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
YYVQENSMVYFGAEGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNA
YWKSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKL
RAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIK
TVVGGHDSPLHGPELIDHYE
>YP_002115369|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A127SV07|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
TASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVT
QQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAG
GLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQ
TRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVR
SNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAA
HPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQ
ILNALQ
>R5XV41|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLNIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEEISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMEILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSVIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDISEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSDVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKNDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSGFSIVMAVLFSTLVGVIFGYMPTKNAAKLDPIEALSRE
>A0A0U2B7P0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLFIKAVIMGIVEGITEFLPISSTGYMILSADIMNFWDKGKRDLFIVFVQLGAILAV
IYDYWGRLWTAFMGLLTGKADGMTNPRGLGISLIIATIPVMVVGFTLKDFITGTLFHPLV
VATMLIIGALLIIYVEKHPRSIKAQEAEHIDIKTALKIGLCQCLALIPGTSRSGSTIIGA
LWFGASRKAATEFSFFLGIPVIVGAGLLELIEKKDVLQTGGDWAILGVGTAVSFVVALLC
IRLLVAWVSKRDFMIFAYLRIITGVIVLLAYFVFGYQIQG
>A0A0U1YUZ7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKVLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKAGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A068HII6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKKPEHEGQGSGRLSLIHILLGMIPAVVLGLIFHDTIKSLFNPI
NVMYALIVGGVLLIAAEVLKPKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDMYKSIGFLNAGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A099I281|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLFDMIKAVLLGIIQGITEWLPVSSTGHMILFNSFFPMSSSLAKPDTPEFAFWGLFLVV
IQLGSILAVCVLYFHKLNPFSPRKSISEKRSTWDLWFHVLVASIPGIIGIFLNDYVEKYM
NNAIVVAIALIVFGIGFIVLESTKHHPKYRRVGEITYQTAFLIGLFQLIAALVPGTSRSG
ATILGASILGCSRFVASEFSFFMAIPAMAGASGLKFLKYFMHYGFSMSGGNIALLVVASI
IAFVVSMFAIRFLMNYIRNHDFKIFGYYRIVVGVAVLICYFLGVLNLSAI
>AAL78279.1|FEATURES|megares|beta_lactam|OXY-1-2|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEG
>AAK21276.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGFQKQNGEGFGTSVTYEIWDGISAGFAYSSSKRTDEQNNSTYFSKSYQRTYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGDIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>AVN57400.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAA
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAML
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>AFK60290.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MKSLAGHVVKYGKHRERRSFARISEVLELPNLIEIQTDSYQWFLDEGLREMFEDILPIDD
FNGNLSLEFVDYELKEPKYTVAEARAHDANYSAPLHVTLRLTNRETGEIKAQEVFFGDFP
LMTEQGTFIINGAERVIVSQLVRSPGVYFHGKVDKNGKEGFGSTVIPNRGAWLEMETDAK
DISYVRIDRTRKIPLTVLVRALGFGSDDTIFEIFGDSETLRNTVEKDLHKNASDSRTEEG
LKDVYERLRPGEPKTADSSRNLLNARFFDPKRYDLANVGRYKVNKKLDLKTRLLNLTLAE
TLVDPETGEIIVEKGTVLTHQVMETLAPFIDNGLNSVTYYPSEDGVVTDPMTVQVIKVFS
PRDPEREVNVIGNGYPEAAVKTVRPADIIASMSYFLNLMEGIGNVDDIDHLGNRRIRSVG
ELLQNQFRIGLARMERVVRERMSIQDTETLTPQQLINIRPVVASIKEFFGSSQLSQFMDQ
TNPLGELTHKRRLSALGPGGLTRDRAGYEVRDVHYSHYGRMCPIETPEGPNIGLINSLSS
YAKVNKFGFIETPYRRVDRETGRVTDQIDYLTADIEDHYIVAQANSPLNEDGTFAQDVVM
ARAQSENLEVSIDKVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLINP
QAPWVGTGMEYKSAHDSGAALLCKHDGVVEYVDASEIRVRRDNGALDKYDVTKFRRSNSG
TSYNQRPIVHLGEKVEKGDTLADGPSMEQGEMALGQNVLVGFMTWEGYNYEDAIIMSRRL
VKDDVYTSIHIEEYESEARDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVQDGDL
LVGKVTPKGVTELSAEERLLHAIFGEKAREVRDTSLRVPHGGGGIVHDVKIFTREAGDEL
SPGVNMLVRVYIVQKRKIHEGDKMAGRHGNKGVVSRIMPEEDMPFLPDGTPIDIMLNPLG
VPSRMNIGQVLELHLGMAARQLGIHVATPVFDGASDEDVWETVREAGMASDAKTVLYDGR
TGEPFDGRVSVGVMYMIKLAHMVDDKLHARSIGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTYKSDDVVGRVKTYEAIVKGEPIPKPGVPESFRVLVKELQSLGLD
MRVLDIEETEIELRDMDDEDDDLITVDALTKFAEQQTAKELEKKAAEQVEDEKDDVIQNF
ETAEDNLD
>ABS18770.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLNVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>AAK52605.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASALPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>NP_627789.1|FEATURES|megares|glycopeptide|vanJ|antibiotic target alteration|0
MMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFG
GLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLA
REYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERG
PLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALA
GITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGV
SW
>ACD56151.1|FEATURES|megares|trimethoprim|dfrA5|antibiotic target replacement|1
MAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYAVVSRS
GSVATNDDVVVFPSIEAAMRELKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDSEPEGN
VFFPEIPKEFNVVFEQEFHSNINYRYQIWQRG
>CAJ13500.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPTASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>BAQ56017.1|FEATURES|megares|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|1
MYTKNAAIVLRLMTESDLPMLHAWLNRPHIVEWWGGEDKRPTLGEVLEHYSPRVLAEQAV
VPYIAMLDDEPIGYAQSYTALGSGDGWWEDETDPGVRGIDQSLANPSQLNKGLGTTLVRS
LVELLFSDPAVSKIQTDPSPNNHRAIRCYEKAGFAQDKIILTPDGPAVYMVQTRQAFESQ
RNAA
>AEL00446.1|FEATURES|megares|quinolone|QnrB13|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>CAE51638.1|FEATURES|megares|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSIHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCNEWQGGA
>CAJ68315.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|1
MSLIVFDYGKRTYIMGILNVTPDSFSDGGDFNNLDIAIQHAKDMVDQGADIIDLGGESTR
PGHSYVDSDEELRRVIPVIKKLKQELDIPISIDTYKADVAEEALKLGVTMVNDVWGLRKD
KNMASVIGKYDAEVCIMHNQDGTNYDKDIMESIKDFFKVSIEMAMSCGVKKEKIVLDPGV
GFGKDFEQNIEVLRRLNELKDLGYPILLGTSRKSVIGKVLPVEPKKRLEGTIATTVLGIR
DGVDIVRVHDVYENLMAARMTDAIYRK
>WP_012578770.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MAKAKFERNKPHVNVGTIGHVDHGKTTLTAAIATICAKTYGGEAKDYSQIDSAPEEKARG
ITINTSHVEYDSPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVCAATDGPMPQTREHI
LLSRQVGVPYIIVFLNKCDLVDDEELLELVEMEVRELLSTYDFPGDDTPVIRGSALAALN
GEAGPYGEESVLALVAALDSYIPEARACNRQSILDANRRRILNFWSWYSSNRPC
>BAA35952.1|FEATURES|megares|peptide|phoP|antibiotic efflux|0
MRVLVVEDNALLRHHLKVQIQDAGHQVDDAEDAKEADYYLNEHIPDIAIVDLGLPDEDGL
SLIRRWRSNDVSLPILVLTARESWQDKVEVLSAGADDYVTKPFHIEEVMARMQALMRRNS
GLASQVISLPPFQVDLSRRELSINDEVIKLTAFEYTIMETLIRNNGKVVSKDSLMLQLYP
DAELRESHTIDVLMGRLRKKIQAQYPQEVITTVRGQGYLFELR
>WP_078132003.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MLSKANRAKTAICGIINVTPDSFSDGGQFFALEQALQQARKLIAEGASMLDIGGESTRPG
SSYYVEIEEEIQRVVPVIKAIRKESDVLISIDTWKSQVAEAALAAGANLVNDITGLMGDE
KMAHVIAKDGAKVVIMFNPVMARPQHPSSLIFPHFGFNQAFTEEELADFETLPIEELMET
FFERALARANQAGIAQENILLDPGIGFGLTKKENLLLLRDLDKLHQKGYPIFLGVSRKRF
VINILEENGFEVNPETELGFHNRDTASAHVTSIAARQGVEVVRVHDVASHRMAVEIASAI
RLADEAENLDLKQYK
>YP_003614006.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNITEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKI
YIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKEILSAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRRAPTPAEAKTALISRPWDLGNV
AAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSAERLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNEGDELIGVDLTSGKDEVMLFSAAGKVVRFKEDAVRAMGRTATG
VRGIKLAGEDSVVSLIIPRGEGAILTVTQNGYGKRTAEGEYPTKSRGTQGVISIKVTERN
GSVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDSIDGSVAEGDDDIAPEVDTDDDAADDADE
>AEK32501.1|FEATURES|megares|aminoglycoside|AadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>WP_001833269.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDKSYR
KSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMRYTE
ARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATDIPP
HNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVVVRS
KTEIEKLKGGKEQIVITEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLRIAI
ELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVILAR
SRFDKEKAEKRLHIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAEAIV
TLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKKFATPRLS
SLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLIFVQ
SAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEEILYVEVLDQFD
DATTYFAVTRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVVLVS
QNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRVSIE
EILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSNKGT
IYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK
>CAH14593.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAVAEAKPQYSHAEKKRFRKSFGKQTDIMPIPNLLEIQLKSYRDFLQTDTKLSEQLNTGL
HAAFSSVFPIESFSGNARLEYVGYKLGEPAFDVRECKLRGLTYSAPLRVKIRLVVLDKDA
SDDPKPIKDIREQDVFMGEIPLMTDVGTFVVNGTERVVVSQLHRSPGVIFEHDKGKTHSS
GKLLYSARIIPYRGSWLDFEFDPKDCVYVRIDRRRKLPVTILLRALGYEAEDILNEFFET
TCCHLKNGEYHIDLIPQRLRGEIASFDIHVPETGELIVEQGRRITARHIKQMEKSQMQDL
VVPRDYLIGKTLAKNIIDTSTGEFLAQANDEITEELLDAMASHGILQIDMIYTNDLDHGS
YISDTLKIDPTGSQLEALVEIYRMMRPGEPPTKEAAEALFKNLFFVEERYDLSAVGRMKF
NRRVGIKSDEGPGTLTKEDILSVIKTLIDIRNGIGMVDDIDHLGNRRVRSVGEMTENQFR
VGLVRVERAVKERLSLVESENLMPQDLINAKPVSAAIKEFFGSSQLSQFMDQVNPLSGVT
HKRRVSALGPGGLTRERAGFEVRDVHTTHYGRVCPIETPEGPNIGLINSLSVYARTNEYG
FIETPCRKVVNGRVTDEVEYLSAIEEVDQYIAQSNVELDAQGNILADLVPCRHQNEFSLT
TPDKINYMDVSPKQIVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRSEKPLVGTGME
RIVASDSGVSVVAKRGGVIDLVDASRIVVRVNDDETTAGETGVDIYNLTKYFRSNQDTCI
NQRPIVSTGDRIQRGDVLADGPCTDMGELALGQNLLVAFMPWNGYNFEDSILISERIVHD
DRFTTIHIEELTCIARDTKLGTEEITADIPNVGESALSNLDESGVVYIGAEVKAGDILVG
KVTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPSGMNGTVIDVQVFTRDGLEKDARA
KSIEEEHLARVRKDLIDERRIREEDIYHRVSHLLLDKVATGGPGSLKPGSKITQDYLDKV
EREKWFDIRIEDDAISQQLEQLSKQLELLTKEMEKRFNDSRKKIIQGDDLAPGVLKIVKV
YLAVKRRIQPGDKMAGRHGNKGVISIVVPVEDMPHMEDGTAVDIVLNPLGVPSRMNIGQV
LETHLGLAAKGLGRKIAQMLDEKQTPEAIKAYLEKIYNHDGVQRVNLKCLNDDELMTLAD
NLRAGVPMATPVFDGATEQEIKSMLQLADLPADGKTVLIDGRTGNKFDNPVTVGYMYMLK
LNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVK
SDDVGGRTKIYKNIVDGDHRMDPGMPESFNVLLKEIRALGIDIELEHD
>ABQ54809.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MVYLAKEVLPVNIEDELKQSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMSELGNDWN
KPYKKSARVVGDVIGKYHPHGDTAVYDTIVRMAQPFSMRYLLIDGQGNFGSVDGDAPAAM
RYTEVRMSKVAHALLADLDKETVDFSPNYDETEFAPVVLPSRIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINACIALVDEPDTSLEDLMEIIPGPDFPTAAIINGRAGIIEGYRTGKGRV
VIRARTEIETDENSGRQSIIIQELPYQVNKARLIERIAELVRDKKIEGISGLRDESDKQG
MRVVIELKRNEVADVVLNNLFAHTQMQNVFGINMVALVDGQPRTLNLKQILEYFIKHRRE
VVTRRTIFELKKARNRAHLLEGLGIALANIDEMIALIKQSPTPQDAKNALLSKIWQPGLV
KAMLEKAGSNASRPDDLTEEYGLHENGYKLSEAQAQAILELRLHRLTALEQDKIINEFEE
LLNLIKELLDILASPERLMQVIRDELIEIKSQFGDERRTEITASQEDLTIEDLITEEDVV
VTLSHQGYVKYQPITAYQAQRRGGKGKSATHVKDEDFVERLVIASTHDTLLCFSNHGKLY
WLKAYQLPQASRTSRGRPIINILPLAEGEEINAMLPVREYKDGSYVFMATKKGTVKKVPL
NAFSRPRSNGIIAVDLEEDDSLVGVDITDGARDIMLFTDAGKVIRFDESKVRPMGRTARG
VRGIRVEKDQAVKSLVVVDPSGGTILTATENGYGKRTHIDEYRVSGRGGQGVISIQVTER
NGKVVRSLQVTDNDEAMLITDKGTLVRFKVNELSVIGRNTQGVRLINVSSGETVVGMQKI
VDLGEELEESEDSSLNADDNSDE
>AAT30688.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MTTLKVKQLANKKGLNILEDSIEINESGVDFQVAHVTEQNGDKWILRIPRRPESMRHALR
EKEALEIMKKHAAFQVPNWSIFSEELIAYKQLSGFPAATIDIEQQKYVWNFNEKNVPTEY
YISLGKVLANVHSLSQQKFNNIGVEILTANELRTSMKQRMNRVKEQYHINQNLWDRWQAW
LAEDSFWPSHVGVKHGDIHPGHILIDKKNNVTGLIDWTEVGIGDVSIDFTSHYLLFGKDG
LTKLIHSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKDMHEAAIHMLATEC
>CAC85829.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFSRTHEPRPLRDGLAVLAALKETARIR
>AAD25062.1|FEATURES|megares|macrolide-lincosamide-streptogramin|myrA|antibiotic target alteration|1
MSALAAPGLSAIRDSLRCPICAGRLELTPGALRCRQRHTFNIARHGYVSLLSGTNAISGD
DAPMIQARERFLATGAYEPIRRAVSTMVSHTIPRDGIVLDVGCGTGYYLAGALDKVTGAR
GLGLDSSVRALRVAARVHERAAAASWDVFRPYPLADQSVDAVLNMFAPRNPGEFHRVLRP
NGSLIVVRPTVDHLAELRRDVPDSVTIDVSKEQRLHDALAPFFEQERDQHVGYIAEIEPQ
TARDLLGMTPSARHITPAEVSDDDLPERVTISVLVSSYRLRET
>WP_000952923.1|FEATURES|megares|beta_lactam|mecA|antibiotic target replacement|1
MLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDM
MNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIK
AFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLP
TVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEK
VCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDS
MPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFV
LYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEW
NQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISA
IEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGY
VETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>CAA94712.1|FEATURES|megares|quinolone|gyrB|antibiotic target alteration|0
MYVGSTGERGLHHLIWEVVDNSVDEAMAGYATQVDVRLFDDGSVEVADNGRGIPVAVHAT
GVPTVDVVMTQLHAGGKFGGKDSGYNVSGGLHGVGVSVVNALSTRVEVDIKRDGYEWSQF
YDKAVPGILKQGEATEATGTTIRFWADPDIFETTKYDFGTVARRIQEVAFLNKGLTINLV
DERVKQDEVVDDVVSDTAEAPVAMTVEEKSTESSAPHKVRHRTFHYPGGLVDFVKHINRT
KTPIQQSIIDFDGKGAGHEVEVAMQWNGGYSESVHTFANTINTHEGGTHEEGFRSALTSV
VNKYAKDKKLLKDKDPNLTGDDIREGLAAVISVKVSEPQFEGQTKTKLGNTEVKSFVQRV
CNEQLIHWFEANPVDAKAVVNKAISSAQARIAARKARELVRRKSATDLGGLPGKLADCRS
TDPRSSELYVVEGDSAGGSAKSGRDSMFQAILPLRGKIINVEKARIDRVLKNTEVQAIIT
ALGTGIHDEFDISRLRYHKIVLMADADVDGQHISTLLLTLLFRFMRPLIEHGYVFLAQPP
LYKLKWQRMDPEFAYSDSERDGLLETGLKLGKKINKEDGIQRYKGLGEMDAKELWETTMD
PSVRVLRQVTLDDAAAADELFSILMGEDVDARRSFITRNAKDVRFLDV
>AFQ65930.1|FEATURES|megares|beta_lactam|ampH|antibiotic inactivation|1
MALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLND
PLSKYAPPGARVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLST
ATLKAAPGSQAAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQ
RLMIPEKGASPCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQR
NQLTRVIGMDVPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFV
VVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ
>CAJ87111.1|FEATURES|megares|trimethoprim|dfrA17|antibiotic target replacement|1
LKISLIAAQSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGILPNRKYA
VLSKNGISHLPENVLVFSSIENALYELAKVTDHLYISGGGQIYNSLIESADTIHLSIIHK
EVEGEVRFPKIPPNYKLVFEQYYSSNINYTYQIWQKGX
>YP_001706375.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MQLISLPKQILQCGQLQLDLSQPHVMGILNVTPDSFSDGGKHNQLDQAVDHALSMIEQGA
TIIDIGGESTRPGASEVAVEEEVRRVVPVVEALSHHNVILSIDTSQPEVIRAAKAAGAHI
WNDVRALTGPNALKTAVELDIPVVIMHMRGEPTTMNQLDQYTDVTLDVMQELQQRIDEAL
AAGVKKHNIIVDPGFGFAKNAQQNLKLLKEFWKLNELGYPILSGLSRKRFIGEALQGAPA
DQRAVGSVTGHLLSIQQGASIVRAHDVKEMHEAILVWKAMQQA
>AAA63165.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPLRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFEN
LENFLGGSIVLQFEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKIKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRTISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>ABQ56518.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSENYTAEAIEVLSGLEPVQRRPGMYTDTTRPNHLAQEVIDNSVDEVLAGFASRIIVTLH
EDGSIEVEDDGRGMPVDLHPQLGLSGVEVIMTRLHAGGKFSDKNYSFSGGLHGVGVSVVN
ALSERLDVTIKRNGIIYQMTFANGDKLCELNETGVTKKRETGTVIRFWPNGKYFDTTKIS
VKHLTHVLRAKAVLCSGLSMTFINKITNEEMNWCYEQGLTDYLQQTLPEDYLPEEPFAGA
FKSDEATVDWALAWSDSANGNLNESYVNLIPTIQGGTHVNGLRSGLFEAMSEFCELRNLL
PRGVKLTADDLWESCQYVLSIKMKEPQFAGQTKERLSSRQTSGLVSNVIKDAFAIWLNQH
RNQGEAIAALAIERAQKRLKQAKQVARKRVSQGPALPGKLADCLQTDLSQAELFLVEGDS
AGGSAKQARNKDYQAILPLRGKILNSWEVDSSQVLASQEIHDISVAIGVDPGSSDLEGLR
YGKICILADADSDGAHIATLICALFLRHFKPLVKAGHVFVAMPPLYRIDAGKLIHYALDD
EEKNRIIQHLSQTTKSKVNVQRFKGLGEMNPIQLRETTMDPNTRRLVQLTLDDEEQTEAI
MDMMLNKKRAADRKLWLETKGNLAEI
>AEA35203.1|FEATURES|megares|tetracycline|tetA(P)|antibiotic efflux|1
WIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLW
LYMPENNFKPSAPGDLNTFKKMVYTFKSGLKIVKSKSIIMILLAVTLFYGLSSEGYDRLS
NAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCIN
ILYISSMLIFALTKNFSLMLIAYLATNTFRIINEPIFSAWLNGHI
>EEW38810.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFDQ
>AEU17993.1|FEATURES|megares|multidrug|phoQ|antibiotic target alteration|0
MLGAAALAVLFMLALLPALQRAFGIALENTIEQRLAADVATLVSAARVEKGRLVMPEHLP
VEEFNLPEAKVLGYIYDQNGDLLWRSTSAADESINYTPRYDGRGNEFHTTRDAKGEEFFV
FDVEIDLLRGKQAAYSIVTMQSVSEFESLLKGFREQLYLWLGGALLVLLGLLWLGLTWGF
RAMRGLSSELDQIESGERESLSEEHPRELLRLTHSLNRLLRSEHKQRERYRHSLGDLAHS
LKTPLAVLQGVGDQLAEEPGNREQVRVLQGQIERMSQQIGYQLQRASLRKSGLVRHREQL
APLVETLCDALDKVYRDKRVSLQRDFSPSFSVPVERGALLELLGNLLENAYRLCLGRVRV
GARLGPGYSELWVEDDGPGVPAEQRARIIRRGERADTQHPGQGIGLAVALDIIESYDGEL
SLDDSELGGACFRIRFATV
>CAA58028.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_000918672.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MFRDISPIEDFTGNLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVK
EQEVFMGDFPLMTDTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRG
AWLEYETDAKDVVYVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTE
NTEQALLEIYERLRPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFN
QKLAEPIVNTETGEIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSI
KVYVPNDDEGRTTTVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRR
LRSVGELLQNQFRIGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLS
QFMDQANPLAELTYKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLI
NSLSSYARVNEFGFIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFM
DDEVVCRFRGNNTVMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAV
PLMNPEAPFVGTGMEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELD
RYPLAKFKRSNSGTCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDG
YNYEDAVIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRG
IVYIGAEVKDGDILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVL
DVKVFNREEGDDTLSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYL
PDGRPIDIMLNPLGVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEA
GMARDGKTVLYDGRTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPES
FRVLMKELQSLGLDVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>CAB64978.1|FEATURES|megares|macrolide-lincosamide-streptogramin|msrC|antibiotic target protection|1
ANGVGKTTLLEHIRKQGEGILLSPKVSFQVYQQKGYQMTSEESIIRFVMRQTEFSESLVR
SLLNHLGVAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDMATIEALEK
LMQIYPGTILFTSHD
>CAD55840.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARRCL
>CCC87252.1|FEATURES|megares|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNA
QRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQTYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVILNRWTQSEK
>ACF06160.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRLEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>ADD83116.1|FEATURES|megares|tetracycline|tetX|antibiotic inactivation|1
MTMRINTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKKFSDWDERYKELIHATLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>AAV74572.1|FEATURES|megares|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTLX
>CAR63501.1|FEATURES|megares|rifampin|arr-2|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLCSQIPTIKGLKMVKDWIPISHDNYKQVQGPFYHGTKANLAI
GDLLTTGFIFHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFED
DPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED
>AAZ73126.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIR
RIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAETDCRLV
VMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPA
PETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNGAD
YVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_041202518.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHFEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>EJR71705.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mphB|antibiotic inactivation|1
MNKQKAIEIARKYGLEVKEGSIIFNESGLDFLVAYAEDYKGEEWVLRFPRRDDVMPRTIV
EKKALDLVNKYATFQVPVWSLYKNDLIAYKKLTGVPAGTIDPEIQNYLWEMDYENVPERF
HQTLAKALASLHTIPKEEALKVGLFVQTAEEARKSMIERMEKVKAKFDVGKSLWNRWQAW
IKNEELWPQKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSNDFVFQYRAFGEAS
LEKLIQHYRQAGGIYWPAMKEHVIELNAAYPVAIAEFAIISGLEEYEQMAKETLQVNDR
>WP_000202263.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDGKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIIGELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
VELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>BAJ34818.1|FEATURES|megares|macrolide-lincosamide-streptogramin|Erm(42)|antibiotic target alteration|1
MDMNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSK
ICKAVTAIEFDSVLADKLTHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILN
KLLDSENPPLDTFLIMQYEPFLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAP
NANIILGQFSYKDFTDINLEDRHAWKDFLAFVFLEKGVTFKEKTKRIFSYKQQKIILKES
RINDDSNISNWSYEFWLKMFKLYNSNMVSKDKKVLVNNSYKRMLEHESSLEKIHRNRKQN
NRK
>WP_003690105.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MNYSFTEKKRIRKSFAKRENVLEVPFLLATQIDSYAKFLQLENAFDKRTDDGLQAAFNSI
FPIVSHNGYARLEFVYYTLGEPLFDIPECQLRGITYAAPLRARIRLVILDKEASKPTVKE
VRENEVYMGEIPLMTPSGSFVINGTERVIVSQLHRSPGVFFEHDKGKTHSSGKLLFSARI
IPYRGSWLDFEFDPKDLLYFRIDRRRKMPVTILLKALGYNNEQILDIFYDKETFYLSSNG
VQTDLVAGRLKGETAKVDILDKEGNVLVAKGKRITAKNIRDITNAGLTRLDVEQESLLGK
ALAADLIDSETGEVLASANDEITEELLAKFDINGVKEITTLYINELDQGAYISNTLRTDE
TAGRQAARVAIYRMMRPGEPPTEEAVEQLFNRLFFSEDSYDLSRVGRMKFNTRTYEQKLS
EAQQNSWYGRLLNETFAGAADKGGYVLSVEDIVASIATLVELRNGHGEVDDIDHLGNRRV
RSVGELTENQFRSGLARVERAVKERLNQAESENLMPHDLINAKPVSAAIKEFFGSSQLSQ
FMDQTNPLSEVTHKRRVSALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLIN
SLSVYARTNDYGFLETPYRRVIDGKVTEEIDYLSAIEEGRYVIAQANADLDSDGNLIGDL
VTCREKGETIMATPDRVQYMDVATGQVVSVAASLIPFLEHDDANRALMGANMQRQAVPCL
RPEKPMVGTGIERSVAVDSATAIVARRGGVVEYVDANRVVIRVHDDEATAGEVGVDIYNL
VKFTRSNQSTNINQRPAVKAGDVLQRGDLVADGASTDLGELALGQNMTIAFMPWNGYNYE
DSILISEKVAADDRYTSIHIEELNVVARDTKLGAEDITRDIPNLSERMQNRLDESGIVYI
GAEVEAGDVLVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRMPTGMSGTVIDVQV
FTREGIQRDKRAQSIIDSELKRYRLDLNDQLRIFDNDAFDRIERMIVGQKANGGPMKLAK
GSEITTEYLAGLPSRHDWFDIRLTDEDLAKQLELIKLSLQQKREEADELYEIKKKKLTQG
DELQPGVQKMVKVFIAIKRRLQAGDKMAGRHGNKGVVSRILPVEDMPYMADGRPVDIVLN
PLGVPSRMNIGQILEVHLGWAAKGIGERIDRMLKERRKAGELREFLNKLYNGSGKKEDLD
SLTDEEIIELASNLRKGASFASPVFDGAKESEIREMLNLAYPSEDPEVEKLGFNDSKTQI
TLYDGRSGEAFDRKVTVGVMHYLKLHHLVDEKMHARSTGPYSLVTQQPLGGKAQFGGQRF
GEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYENIVKGEHKIDAGMPESFNVLVKEI
RSLGLDIDLERY
>WP_000167933.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MTKTKIMGILNVTPDSFSDGGKFNNVESAVTRVKAMMDEGADIIDVGGVSTRPGHEMISL
EEELNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDIINDQWAGLYDHRMFQVVAK
YDSEIVLMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKEMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>CCQ22202.1|FEATURES|megares|tetracycline|tufab|antibiotic target alteration|1
MAKEKFDRSKPHVNIGTIGHVDHGKTTLTAAITTVLAKKGYADAQAYDQIDGAPEERERG
ITISTAHVEYQTDSRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIVVFMNKCDMVDDEELLELVEMEIRDLLTEYEFPGDDIPVIKGSALKALQ
GEADWEAKIDELMEAVDSYIPTPERDTDKPFMMPVEDVFSITGRGTVATGRVERGQVKVG
DEVEVIGIEEESKKVVVTGVEMFRKLLDYAEAGDNIGALLRGVAREDIQRGQVLAKPGSI
TPHTNFKAETYVLTKEEGGRHTPFFNNYRPQFYFRTTDVTGIVTLPEGTEMVMPGDNIEL
AVELIAPIAIEDGTKFSIREGGRTVGAGVVSNISK
>ABX79419.1|FEATURES|megares|glycopeptide|vanC|antibiotic target alteration|1
MKKIAIIFGGNSPEYTVSLASATSAIEALQSSPYDYDLSLIGITPDAMDWYLYTGELENI
RQDTWLLDTKHKQKIQPLFEGNGFWLSEEQQTLVPDVLFPIMHGKYGEDGSIQGLFELMK
LPYVGCGVAGSALCMNKWLLHQAAAAIGVQSAPTILLTNQANQQEQIEAFIQTHGFPVFF
KPNEAGSSKGITKVTCVEEIASALKEAFTYCSAVLLQKNIVGVEIGCGILGNDSLTVGAC
DTISLVDGFFDFEEKYQLISAKITVPAPLPETIETKVKEQAQLLYRSLGLKGLARIDFFV
TDQGELYLNEINTMPGFTSHSRYPAMMAAVGLSYQELLQKLLVLAKEEVK
>ACH50233.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYAELLLSELGQGTADWVPNFDGTMQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAKAAITLIEQPKTTLDQLLDIVQGPDYPTEAEIITPRAEIRKIYENGRGSVR
MRAVWTKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLAFRRDTVRR
RLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGISETQAEAILEL
KLRHLAKLEEMKIRGEQDELEKERDQLQGILASERKMNTLLKKELQADADAYGDDRRSPL
REREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSN
QPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMEGDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPENAHVMPPLVIEDEHDMLLAITQAGRMLMFPVDSL
PQLSKGKGNKIINIPSAEAAKGDDGLAHLYVLPPQSTLTIHVGKRKIKLRPEELQKVVGE
RGRRGTLMRGLQRIDRIEIDSPHRVSHGDSEE
>AKZ58683.1|FEATURES|megares|multidrug|drrA|antibiotic efflux|1
MRRRLDLAASLVGRPDVLFLDEPTTGLDPATRIALWETVEKLVAGGTTVLLTTQYLDEAD
RLADWITVLSKGRVVASDTTDRLKADLGHRSVRVVLPPAADLTAAAAALTAGGFRPRSDA
GEHALTTPVDTSAGIAGVIRALDTVGTQAVELTVKEPSLDDVYLALTHPSPAADAA
>AFI47934.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLAS
RADQLEEFVHYVKGEITKVVGK
>CAH15775.1|FEATURES|megares|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQHLIALLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGIKEIIFPIYTRDTKLFQQIDHFKIIVYPFINAPNGFTQNLTEKQWHQ
LGKVLRQIHETSVPTAIQQRLRKETYSPKWREMVRSFYNKIGFDDSDDQITTDFKTFFNQ
NIDSIHRLVDSSEELSKKIQPDLDKYVLCHSDVHAGNVLVVNEESIYIIDWDEPMLAPKE
CDLMFIGGGIGNVWNKHHEINYFYEGYGKTNVDKIILSYYRHERIVEDIAVYGQDLLSRD
QNDESRLESFKHFKSMFTPNDVVEIAFSSD
>WP_011764800.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTQFAKETLPISLEEEMRHSYLDYAMSVIVGRALPDARDGLKPVHRRVLYAMHELSNDWN
RAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQDFSLRYMLVDGQGNFGSVDGDNAAAM
RYTEIRMARIGHELLADIDKETVDFGPNYDGSEKEPLILPARIPNLLINGSSGIAVGMAT
NIPPHNLGEVVDACLKLLEDPETDLEALIEIVKAPDFPTAGLIYGLHGVHEGYRTGRGRV
VMRARTHIEPIGKNSDREAIIVDELPYQVNKRTLLERIAELVNEKKVEGISEIRDESDKS
GMRVVIELKRNEMPEVVLNNLYKHTQLQDTFGMNMVALVDGKPRLLNLKQMLVCFLEHRR
EVVTRRTIFELKKARDRGHILEGLAVALSNVDEIIALIKAAPTPADAKRGLMERTWRSPL
VEEMLSRALADSYRPEGLDPEFGFSAQGYKLSDAQAQAILELRLQRLTGLEQDKIVGEYR
EVMDLITDLLDILARPERITAIIVEELTAIRNQFGDPRRSEIVLSTAEINIEDLITPEDM
VVTLSHTGYFKRQPLADYRAQRRGGRGKQATSMKDEDFIDHLFVANTHDTVLCFSSRGRA
YWLKVYEVPEGTRNSRGKPIVNLFPLIEGEKITAVLPVQTFDEEHFVFMATSEGTVKKTA
LTAFANPRKAGIIAVNLDDGDHLIGVAITDGECDVMLFSDAGKAVRFAESDVRPMGREAR
GVRGMTLEDGQRVIAMLVAKGETQSVLTATENGYGKRTPVAEYTRHGRGTKGMIAIQTSD
RNGKLVGAVLVDPTDEVMLISTGAVLIRTKVQDIRELGRATQGVTLINLDEGTYLAGIEK
VAESGAEADELVEGGEEGAADGEDAGAPGAAGEGEQE
>WP_001071160.1|FEATURES|megares|peptide|mprF|antibiotic target alteration|0
MNQEVKNKIFSILKITFATALFIFVVITLYRELSGINFKDTLVEFSKINRMSLVLLFIGG
GASLVILSMYDVILSRALKMDISLGKVLRVSYIINALNAIVGFGGFIGAGVRAMVYKNYT
HDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASLILNKITWVRWVLYAVSLFLPLFI
IYSMVRPPDKNNRYVGLYCTLVSCVEWLAAAVVLYFCGVIVDVHVSFMSFIAIFIIAALS
GLVSFIPGGFGAFDLVVLLGFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGT
SAKKYIEGSKYFIPAKDVTSFLMSYQKDIIAKIPSLSLAILVFFTSMIFFVNNLTIVYDA
LYDGNHLTYYLLLAIHTSACLLLLLNVVGIYKQSRRAIIYAMISIILIIVATLFTYASYI
LITWLVIIFALLIVAFRRARRLKRPIRMRNLVAMLLFSIFILYINHIFIAGTFYALDVYT
IEMHTSVLKYYFWITILIIAIIVGAIAWLFDYQFSKVRISSNIEECEEIIDQYGGNYLSH
LIYSGDKQFFTNEDKNAFLMYRYKASSLVVLGDPIGDENAFDELLEAFYNYAEYLGYDVI
FYQVTDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSGKKRRGFRATLNKFDELNISFEII
EPPFSTEFINELQHVSDLWLDNRQEMHFSVGQFNETYLSKAPIGVMRNENNEVIAFCSLM
PTYFNDAISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSY
LRERLAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRHK
>CCQ19309.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAETPNQRITEINLNKEMRTSFLDYAMSVIVARALPDVRDGLKPVHRRILYAMNDLGMTS
DKAYKKSARIVGEVIGKYHPHGDTAVYFTMVRMAQDFSYRNMLVDGHGNFGSVDGDMAAA
MRYTEARMSKISMELLRDINKDTIDYADNYDGSEREPVILPARFPNLLVNGSSGIAVGMA
TNIPTHHLGEVIDGVLALSHDPEITIRDLMEYIPGPDFPTAGMIMGRSGIRRAYESGRGS
ITVRGRVDIEEKKNGKETIVITEIPYQVNKARLVERIAELAREKKIDGITSLNDESDRSG
MRIVIEVRRDISASVIVNNLFKMTALQTTFGINMLALVDNHPKVLNLKEILYYYLEHQKV
VIRRRTEFELRKAEARAHILEGLRIALDNIDAIIKLIRGSKTSDVAKEGLMTQFNLSDKQ
AQAILDMRLQRLTGLEREKIEEEYQNLVALINDLKAILADDERILEIIREELEEIKVKYA
DKRRTEILAGDLVSLEDEDLIPEEEVAITLTKRGYIKRLPLSTYRSQRRGGRGIQGMSTH
EDDFVEHLVATSTHDTLLFFTNTGKVYRSKGYEVPEYGRTAKGIPIINLLGIESQEQVNA
VINLSEFTDDSYLFFTTKHGVVKRTTLSQFAKIRQSGLRAVELRENDELISVQMTDGSKN
MIIATKHGQSIYFPEENIRVMGRTAAGVRGIRLREDDEVIGMEVLEDDEKVLVVTEKGYG
KQTPASQYPLRNRGGMGVKTVTITEKNGNLVAMKTVTGEEDLMLMTVSGVLIRFEIDTVS
QTGRSAMGVKLIRLDEDEKVATVAKVPKEEDEVELEEEIDETLITQVPDESFEDAPGSDI
EE
>AAN79199.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|0
MITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVE
MEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPF
LLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRA
GENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQF
YFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAK
VLG
>ABL75154.1|FEATURES|megares|beta_lactam|OKP-B-6|antibiotic inactivation|1
CLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASERFPLMS
TFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMS
DNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTL
RKLLTTPSLSARSQQLLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLG
PDGKAERIVVIYLRDTAATMAERNQQIAGIGAAL
>AKF41838.1|FEATURES|megares|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMNSLKQ
>AEE66480.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MANNFQCGRFEFDLERPLVMGIVNVTPDSFSDGGEHADTDSAIAHARQLIDEGAHILDLG
GESTRPGAQPVSAADELARILPLIEGLRDCGVPLSIDTFKPEVMRAVLDAGADMINDIYG
FRQPGAIDAVARSRCGLCVMHMKGEPRTMQEAPEYADLMGEIGVFLGARAQRLRAAWVDP
RRIVLDPGFGFGKTMDQNYQLLRRLASLRVSSYPLLVGVSRKSMIGAATGKPVGDRLAGS
VAAALACVARGAAIVRVHDVAATVDALKVWQAAEQGAVPT
>NP_274695.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MARHVWQAGRFEIGLDKPKIMGIVNLTPDSFSDGGVYSQNAQTALAHAEQLLKEGADILD
IGGESTRSGADYVSPEEEWARVEPVLAEVAGWGVPISLDTRRTVIMEKALALGGIDIIND
VAALNDEGAVELLARQADTGICLMHMQGLPKTMQINPKYQDVVGEVARYLKARSAECIAA
GIAPQRIILDPGFGSGFGKPLQHNIALMRHLPELMAETGFPLLIGVSRKSTIGELTGEAN
AAERVHGSVAAALASVARGAQIVRVHDVKATADALKVWEALGINL
>AHH83941.1|FEATURES|megares|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIARLEDEIAREHELEETQRYFFAAASH
ELKTPIAATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVP
IAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQN
TPQGGEVRIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLA
IVQKTLDAMSLQYALENTSDGVLFWLDLPLTSTL
>WP_011244871.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAEEDVPRLRERQIDEEMKESFIDYAMSVIVSRALPDVRDGMKPVHRRILYAMFELGMTP
DKPYKKSARIVGEVLGKYHPHGDTSVYDAMVRMAQDFSYRYMLVNGHGNFGSIDGDSAAA
MRYTESKMSKISMELVRDLNKDTVDFIDNYDGTEREPKVMPSRFPNLLVNGTSGIAVGMA
TNIPPHQLGEVIDGVLALAKNPDISIPELMEYIPGPDFPTGGEILGRSGIRKAYSTGRGS
ITVRAKTEIVENKGKQSIIVTELPYQVNKARLIEKIAELVRDKKIDGITELRDSSDRNGM
NIVIDVRRDANPNVILNNLFKQTALQTSFGINMLALVNGRPEVLNLKQTLEQYLAHQVEV
IRRRTQFDLNKAEARAHILEGLRIALDHIDEIIALIRGSDTAEIARNGLIERFELSYDQA
QAILDMRLQRLTGLERDKLEQEYKDVLARIAELRAILASDEKVIDVIQEEILAIKEKFND
ERRTVISASEEHLEDEDLIPRQNIVITITHNGYIKRLPISTYRAQKRGGKGVQGMGTNDD
DFVQHLFTTNTHHTVLVFTNKGKAYRLKGYEIPELGRTAKGIPAINLLPFDPGETISTVI
PIECFDDDSYLFFVTEHGIAKRTKLSAFANIRKGGLFAINLREGDSLHGVRLTDGNREVM
IGTKQGMAIRFPETDVRLMGRTAGGVKGITLSENDGVVGMEVVDENQSVLVVTEKGYGKR
TPLDEYRVQSRGGKGIKTCNITDKNGPLVSLKMVADEDDIMIVTANGIIIRTNVDGISTT
GRNTQGVTLIRVNEGEEVATVARVNINDDEVDDLEDDDEQEQPTSEENAE
>AKF41839.1|FEATURES|megares|beta_lactam|OXA-23|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVINQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ACO84640.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MEERIDNTKDYDVTKLTSLEKLEPVRVRPGMYIGSTGIKGLHHCIWEILDNAIDEISNGY
GDTAEVILNKDKSVTVVDNGRGIPTGIHPIKKKSGVEMVFTELHTGGKFNNSIYKTSGGL
HGVGASVVNALSEWTEVEVYQNDKIYKQRFEYALDKKLNKKMPGTPVTKLKIVGDTDKTG
TRVTFKPDKEVFSTIDFKFDVIDERLQELAFQNKGIILKLIDNRKEEPEIKEYHSERGLL
DFIDYLNESKAPIHNPAVLFEGEKEINNLKMEGEICFQFTDSSTENIASYVNNIPTTEAG
THETGFKTGMTRAFKEGAKKLSLIKEKDKEFDGDDLREGITAIVRIKISNPVFEGQTKTK
LGNNEAYTMMNDLAYSKFLEWIEDNKEVSTLIINNALAAAARREKIKKINEAEKKKIGKG
LAPLAGKIAVCTLRDSNVTEFIVVEGDSAGGSAKQARDRRFQSIMPSKGKIMNTEKQKIE
NVLGSEELKIFNTAIGTGVLDNYKEEDLKYDKIIILSDADVDGYHIRTLWMTYIYRYMKS
LVANGHLYIAMPPLYKVYKKDKKGEKSVYCYNDEELQKAKKQIGRGYLIQRYKGLGEMNP
EQLWETTLNPETRTLQRITIEDAAKAEKMVSLLMGDVVEPRKNYLYKYAEF
>EHL91134.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFAE
>ADI55020.1|FEATURES|megares|beta_lactam|PER-1|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSLN
>AAK91783.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNLAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPSFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>ADQ43422.1|FEATURES|megares|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWNGDG
AARLLAHEGPAILIERARGDSLRQRSIEGDDDACTAILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAVLPPLLEQCRSLAEGLLRDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYATMFSNPDLCGPGIHVATRPERFAIRLEQVCALAELERTRLLRWIAASTA
LSAVWFRDDGDPADIDETVARMALEALAEA
>ACH52168.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVVFEIRDNKLQME
LIPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDIKHIEVPVEYIAGKVVSKD
YVDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETVRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRRVVDGVVT
DEIHYLSAIEEGNYVIAQANSNLDDEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVSGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDDEVLRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>AAP97130.1|FEATURES|megares|beta_lactam|cphA|antibiotic inactivation|1
MMKGWIKYGLAGALVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYLGPAHTPDGIF
VYFPDQQVLYGNCILKETLGNLSFADVKAYPQTLERLRAMKLPIKIVVGGHDSPLHGPEL
IDHYEELIKASPHS
>AFK58771.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MENRQEVQELTLEEVMGDRFGRYSKYIIQERALPDIRDGLKPVQRRILFAMNKDGNTYDK
GFRKSAKSVGNIMGNYHPHGDSSIYEAMVRMSQDWKLREVLIEMHGNNGSMDGDPPAAMR
YTEARLSKLSGEMLADIEKETVDLVWNFDDTEKEPTVLPARYPNLLVNGSTGISAGYATE
IPTHNLAEVIDGTIYMIDHPQASLEKLMEYIPGPDFPTGGILQGKDEIKKAYETGRGKVI
LRSKTKIEAMKGNKQQIVITEIPYEVNKATLVKKMDEIRLNKKIDGIAEVRDESDRTGLQ
IVVELKKDANAQGILNYLFKNTELQINYNFNMVAIDHMTPHQVGLKDILRSYIEHRKQVI
TKRSQFDLAKAQKRQHIVEGLMKALSILDEVIATIRESKDKKDAKKNLVDVFQFTEEQAE
AIVTLQLYRLTNTDITELQKESESLIAQITELNKILSNDKELFSVMKKELREVKKNYSSA
RLTTIEDEIEEIKIDTQVLVAQEDVIVSVTREGYVKRTSLRSYSASKPEEIGMREGDYLL
YSGELSTLDHVLLITNKANVIYRPVHELPDLKWKDAGEHISQTISNLSVDESILAVFPYQ
KIQAEKTFVFISKNGLIKQTRMTEFEPWRTYKSRPLSCMKLKAEEDELIAVYLKEDQPGL
DVFLVTHQGMGLRYPLTDVPVVGAKAAGVKSMNLKDGDRIINGLLVLAEGDTPIVIVTQR
GAVKRMLAQEISQTSRAKRGVTVMRELKKNPHRIIYMSEGRSKEITLMNQKGQQLTIDPT
DFPIGDRTSNGSFAMDEKKGGEVIEVIDAPEIFIES
>AAO47225.2|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTVLADGGVRVVDNGRGIPVGMHPV
EKRPAVEVVLTVLHAGGKFGGGGYAVSGGLHGVGLSVVNALSTRLSAEIWTDGHRWTQDY
RDGAPTAPLARHEATSRTGTSLTFWADGDIFETTEYSFETLARRHQEMAFLNGGLTLTLT
DERSSARATAAVDEADSDPTAKTVSYRYDGGITDFVVHLNARKGEPAHPSVITIAAEDTE
RLLSAEIALQWNGQYTDSVYSYANAIHTHEGGTHEEGFRTALTTVVNRYAREKRLLRDKD
ANLSGEDIREGLTAIISVKLGEPQFEGQTKTKLGNTEVRTFVQKIVHEHLADWFDRNPNE
AVDIVRKAVQAATARVAARKARDLTRRKGLLETAALPGKLSDCQSNDPATSEIFIVEGDS
AGGSAKAGRNPQYQAILPIRGKILNVEKARIDKVLQNQEIQALISAFGTGVHEDFDIAKL
RYHKIILMADADVDGQHISTLLLTFLFRFMRPLVEEGHVHLSRPPLYKIKWSREHVEYAY
SDRERNTLLERGRRDGRRIRDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGQVTLDDAAF
ADDLFSVLMGEDVEARRHFIQRNAQDVRFLDI
>CCJ23762.1|FEATURES|megares|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
MAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTKRIETGEVVTAQHWKNGRELSSNEMK
QTRVAHLLKKIHNSRPLLSMLKRMEMEPITPEIMLNKINASLSREVLTHHIVRKSLTYLE
EHIPSLDSRFFTVVHGDVNHNNWLLSDRDELFLVDWEGAMIADPAIDIGMLLYNYVPQQQ
WSEWLETYGVQESLNLNKRMKWYTVIQSIGLVQWYEEQKRYKDMNTWLKFLNEVMNSNMF
I
>CAP69659.1|FEATURES|megares|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>AJG01375.1|FEATURES|megares|beta_lactam|OXA-381|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQDQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLELLGIL
>ACZ52980.1|FEATURES|megares|trimethoprim|dfrA17|antibiotic target replacement|1
MGVLPNRKYAVVSKNGISGSNENVLVFPSIENALQELSKITDHVYISGGGQIYESLIEKA
DIIHLSTIHVEVEGDIKFPILPEGFNLVFEQFFVSNINYTYQIWKKG
>CAQ45829.1|FEATURES|megares|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPALRTPHARLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWNGDG
AARLLAHEGPAILIERARGDSLRQRSIEGDDDACTAILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAVLPPLLEQCRSLAEGLLHDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAIRLEQVCALSELERTRLLRWIAASTA
LSAVWFRDDGDPADIDETVARMALEALAEK
>CCE94501.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib'|antibiotic inactivation|1
VTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>AAQ76279.1|FEATURES|megares|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHAQASEWNDSRAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>WP_011246832.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MAKQHVEYNEDAIQVLEGLEAVRKRPGMYIGSTDVRGLHHLVYEIVDNAVDEALGGYGNT
IKVTIHKDQSVSIEDEGRGMPVGMHRSGKPTPEVIFTVLHAGGKFGQGGYATSGGLHGVG
ASVVNALSEWLEVEIKRDGYRYTQRFEQGGKPVTTLEKKGKTRASGTTVRFKPDEGIFST
IQFNSEILAERLREAAFLLKGVQIELTDKRPEKELHEVFKFDTGLEAFVDYLNEGKEALH
PVVSFSGSANDIQMDFSFQFHDAYTENVLSFVNNVRTRDGGTHELGAKTAMTRIMNEHAR
KIGVLKEKDKNLDGSDIREGFTAVVSVRVPEAKLQFEGQTKSKLGTPEARSAVDAIVSEN
LSYFLEENPAVATMLLKKAMKAAQAREAARKAREDARNGKKNKRKDVLLSGKLTPAQSRN
PARNELYLVEGDSAGGSAKQGRDRKFQAVLPLRGKVINTEKAKLDDIMKNEEIRTIIHTI
GAGVGADFDSADCNYDKVVIMTDADTDGAHIQVLLLTFFYRYMKPLIDEGKIYIALPPLY
KVSKGSGKKEQVEYAWDENELQAALKKVGRGSTVQRYKGLGEMNATQLWETTMDPATRTL
IRVRLEDAARAEKHVATLMGDKVEPRRKWIESHVAFGLEEDTNILENENLQVGEEA
>AFK58770.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MYIGSTDSRGLHHLVYEIVDNAVDEALSGYGSEIDVTIHEDNSITVADSGRGMPVGMHAS
GIPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGASVVNALSKWLIVTIVRDGVEYQQKFK
NGGKPDGTLKKIGKTKKANGTTVHFLPDDTIFSTTKFSYEILAERLRESAFLLKGVKISL
SDLRGEEPVKEIFHYEEGIKEFVDYLNEEKDTLTPVVYFSGEKEGIEVEVAYQYNDGYSE
NVLSFVNNVRTKDGGTHEAGMKAAMTKSYNEYARKVGLLKERDKNLEGSDFREGLAAVLS
IRVPENLLQFEGQTKEKLGTPVARTVVDNVISEQMGFYLQENSEMSQMLVRKAIKAREAR
EAARKAREESRNGKKRKKGESLLSGKLTPAQSRNPKKNELYLVEGDSAGGSAKQGRDRKF
QAILPLRGKVINTEKAKMQDILKNEEINTMIYTIGAGVGPEFSIEDCNYDKVIIMTDADT
DGAHIQVLLLTFFYRYMKPLIEAGKVYIALPPLYKVSKGQGKKQVIEYAWTDDELAAMIK
KVGKGYMLQRYKGLGEMNAEQLWETTMDPTSRTLIRVRIDDAAQAERRVTTLMGDKVEPR
RKWIENHVQFTLEEDGSILDKKEDTEISPSVSNDLLDEERADKNENNQLFEVE
>ABS43870.1|FEATURES|megares|quinolone|rpoB|antibiotic target alteration|0
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDTAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDNKDVSLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKEKQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIHNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARVRAHILEGLKIALDNIDEVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSIGVRAINLNENDELVTAIIVQRDED
EIFASGGEENLENQEIENLDDENLENEESASTQGKMLFAVTKKGMCIKFPLVKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSVSAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDL
>CBA33605.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDLTHDGAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNA
SAKFKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFA
AMRYTESRLSKYAEVLLGELGQGTVDYVPNFDGTLNEPKMLPARLPNILLNGTTGIAVGM
ATDIPPHNLREVAKAAVSLIDSPKTTLDELLDIVQGPDYPTEAEIITSRAEIRKIYQSGR
GSVRMRAVWKKEDGAVVISALPHQVSGARVLEQIASQMRAKKLPMVDDLRDESDHENPTR
LVIVPRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILTEWLVFRRD
TVRRRLNYRLDKVMRRLHILEGLLVAFLNIDEVIEIIRGEDEPKPVLMSRFGISETQAEA
ILELKLRHLAKLEEMKIRGEQSDLEKERDQLQGILASERKMNTLLKKEIQADADAYGDDR
RSPLHEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAKALSYKAGDNWLSSAK
GKTNQPVVFIDSTGRSYALDPVSLPSARGQGEPLTGKLTLPPGAVVEHMLMTGEDQKLLM
ASDAGYGFVCTFNDLVARNRAGKALITLPENAHVLKPLEIEHDDDMLLAITAAGRMLMFP
VADLPQLSKGKGNKIISIPSADAAKGDDKLAYLTILPPQSTVTLHVGKRKIKLRPEELQK
VHGERGRRGTLMRGLQRIDSVEVDAPSRPKADDGEA
>ABX45064.1|FEATURES|megares|beta_lactam|OXA-70|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQHEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVRPQG
NIVAFSLNLEMKKGIASSVRKEITYKSLEQLGIL
>AAG34545.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|0
DQATPNLPSRDFDSTAAFYERLGFGIVFRDAGWMILQRGDLKLEFFAHPGLDPLASWFSC
CLRLDDLAEFYRQCKSVGIQETSSGYPRIHAPELQEWGGTMAALVDPDGTLLRLIQN
>NG_047757.1|FEATURES|NCBI|trimethoprim|dfrI|antibiotic target replacement|1
MNQNRDDHNRAADREKTAEKRGENQCIISLILAMADNGTIGDKNALPWHLPNDLQFLKKS
TMGKPIVMGRKTYQSIGRPLPGRTNVVISRSLEKEALPGCLIYSDLSVAIAALKKEPEVE
EIMIMGGAQIYRAALPMMDRLYLTHVHANIEGDTQMPPFDFSHATLIFEEKHFKDEKNRY
DYTFEIWDFKK
>WP_039569351.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ic|antibiotic inactivation|1
MIVICDHGNLDAWLALRTALWPSGSPEEHRAEMREILASPHHTAFMARGLDGTFVAFAEV
ALRYDYVNGCESSPVAFLEGIYTTERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_045095476.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKKLIQEQQIIELLNKHYGIDIHAAQLIPGGADMNALAYKADSKSNSYFVKLKYGYHNE
INLSIIRLLHDSGINEIIFPIPTLEAKLFQQWDHFKIIVYPFIHAPNGFTQNLTEKQWEQ
LGKVLRQIHETSVPSLIQQQLRKEIYSTKWREIVRSFYSKIELDASDDKITAGFKSFFNQ
NIDSIRQLVDSAEELSKKIQPDLDKYVLCHSDIHAGNVLVVNEESIYIIDWDEPMLAPKE
RDLMFIGGGVCGVWNKPHEIHYFYEGYDQTNVDKTILSYYRHERIVEDIAEYGQDLLSRN
QNDESRLESFKHFKSMFEPNNVVETAFATG
>WP_061466569.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQHLIALLKVYYGIDIHTVQLIVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGVKEIVFPIYTLEANLFQQVDHVKIIVYPFIDAPNGFTKNLTEKQWKQ
LGKILRQIHGTSVPTSILQRLRKETYSPKWREIVRSFYSQLGFDECDDQITTDFKSFFNQ
NIDLIHQLVNSSEELSKKIQPDFEKYVLCHSDIHAGNVLVVDEESIYIIDWDEPMLAPKE
RDLMFIGGGIGNVWNKPHENDYFYEGYGKTSVDKTILSYYRHERIVEDIAVYGHDLLSRD
QNAQSRLESFKHFKSMFDPNDVIEIAFASE
>ACA23029.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>AAK40353.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDFWAFIGIGLIVSGVAVLNPLSKVSAH
>NP_862227.1|FEATURES|NCBI|multidrug|tet|antibiotic efflux|1
MAPDYARTDAVAPASVKETFAYLSALPNALDRRWWAGLLLIQALIVAVYTTQSNLFGRSV
DPLTGGEVPLLGTGTRAFVWTVGLALACMLVEMFLRALGNYVVGLKVARASIDLRRRCLD
AILRAPVPRVMELGTGNVITRMTKDIDDVVQTITAIGSRVLTTVFVFPITFIGLLLIDVR
FALILLLICICTYPFARAVVRAIPDASNAVSVAEARRNAVLLDTVRGLPTLRAFDLERWA
LARMRRTSWGAVEAEMDRVHWFIRLTGIGQVAFAAWVLLTLGVGAWLASAGVVTRAAQRA
GRPLCHARGGTTTALVGTSGAGKSTLAALIAGLVEPTAGSIRVGAVETSQVSDTWTAKNV
TLLTQDVHLFAGTLREDLSMAAQDATDADLLRALASVGLDPEGTQFARLFPKGLDTAVGA
GAEDIPPEVEQQLALARVALSGPKVLILDEATAEAGSDATNALEDAAARITADTTALVVA
HRLDQAAAADRILVMDAGRIIEDGTHTELVAADGRYAQLFAAWSGGGH
>AGC82133.1|FEATURES|NCBI|aminoglycoside|rmtF|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPXDAEKXARTHLHQITGAFMT
ADAQKKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLA
CGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAAL
LMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTL
SVRDRFTVSDELVYLVERT
>WP_052285801.1.|FEATURES|NCBI|aminoglycoside|aac|antibiotic inactivation|1
MQYSIRSVRVSDTSDWLRLRNLLWEGDDHETEIAQFFAGALAEPNEVLVAHDDAGAVVGH
VELSIREDVAGLEGIRAGYIEGLYIEEAHRSSSVATQLLRHSEQWAQSQGCRAFASDRED
RLIIHKRFSVSPLSNPSFQRTAFGGR
>WP_005475717.1.|FEATURES|NCBI|fosfomycin|fosA|antibiotic inactivation|1
MILGLNHITIAVSDLERSLKFYRETLGFTAHAKWDNGAYLSVGELWFCLSHDEPCPKTDY
THVAFDIEPKEFEAFAKRVVSLGVEVWKQNKSEGQSLYILDPDGHKLEIHSGSLKSRLES
LRTKLYSGLVWL
>WP_023376089.1|FEATURES|NCBI|aminoglycoside|LTSEINV_2403|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSLRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023239286.1|FEATURES|NCBI|aminoglycoside|CFSAN002050_14495|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTEHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023220234.1|FEATURES|NCBI|aminoglycoside|SeKA_A1070|antibiotic inactivation|1
MDIRHMNKTHLEHWRGLRKQLWPGHTDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLSSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_011342944.1.|FEATURES|NCBI|quinolone|qacF|antibiotic efflux|0
MSPYIPLSIAIVAEVIATTAMKSSDNFTRLVPSVIVVVGYVVAFYFLSITFKFIPTGIAY
AIWAGAGIVLITLMGWIVHKQTLDLAAMLGMGLIVSGVLVINIFSKSGAH
>WP_031786790.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKIFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_063856693.1|FEATURES|NCBI|glycopeptide|vanD|antibiotic target alteration|1
MYRINVAVLFGGCSEEHTVSIKSAMELAANIDTEKYQPFYIGITKSGVWKLCEKPCLDWE
QYAKYPVVFSPGRNTHGFLIQKEDRYEIQPVDVVFPIIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKSLAYTTVKNAGIEVPDFQIIQDGDSPKTECFSFPLFVKPARSGSSFG
VNKVDKAEDLCAAINEARQYDRKVLIEQAVSGSEVGCAVLGTGTDLIVGEVDQISLKHGF
FKIHQEAQPEKGSENATIEVPADLPAKVRERIQKTAKKIYQVLGCRGLARIDLFLREDGH
IVLNEVNTMPGFTSYSRYPCMMTAAGFTLSELIDRLIELALR
>AHN05315.1|FEATURES|NCBI|multidrug|hp1184|antibiotic efflux|0
MAKNMEILETDSVKKIYFRYLIPSLVGMLLMSLNIVIDGIFVGHKLGGVALAGINIAVPV
FTIFTAISIWIGIGAATQFSFAIGEKNVAKAQTIFTNAILAVVSITVIIGIIAFIFKVPL
AYFLGANDDTIGYVLEYMNILLVFGFALTLENILSIFVRNDGDPNLSMIALIVTAISNVI
LNYLFLFVFEWGVTGSALATMIAIIIGVLILITHFFKKSSRLKFVKVDWNKAFFKKTLAI
GLPSFLAEVGVSVFTLGYNISIAAIAGTAGVAAFSVLNYTHSVILMLFLGMGSAIQPLIS
YYRGAKARQKEIETLKIAIMVAFSTGVGFLLVGLFGSNLLVSMFGNFSPEIKDLASNGIK
LFYTAYLFMGFNFVMMTYFQTSDKVKMATWITISREIIFMVIFLLVLPPIIGIPGVWLAI
PISEMIVAASIIFYMKKKHILFK
>WP_039639671.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGDDVVLRPVGDGEGEVLDRIVREPEVAAWWSPPEDYEGMLAIVFEGEVIGAVQFEEE
TDPEFRRAGIDIFLTARHHGKGLGADAVRTLARWLVRECGHHRLTIDPAAANTAAIRSYG
KVGFRPVGIMRAYGRDHQTGLWQDALLMDLLAEELT
>WP_033268654.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGDRVVLRPVAEGDPEVLDRIVREPEVAAWWSPPDDYAGMLAVVLGGDVIGAVQFDEE
TDPEFRRAGIDIFLTARRHGQGLGTDTVRTLARWLVRERGHHRLTIDPAAANTAAIRSYR
KVGFKPVGIMRKYWRGHRTGTWQDGLLMDLLADELT
>WP_047139664.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTAPADTPVLDAIVREPEVARWWPPPEAYAAMLAVVVDGEVIGAIQFSEE
SDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTRAIRSYR
KVGFAPVGIMRAYWRDHRTGAWEDGLLMDLLAAELT
>WP_023529211.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELHGDRVALRTVVDADTDTLHRIVREPEVAAWWSTPEDFDGMLVIVLDSEVVGAVQYEEE
DDPDYRHASIDLFLSARHHGRGIGAETVRTLARWLIEVRGHHRLTIDPAAANTTAIRSYT
RVGFKPVGVLRAYERDPLTGTWRDGLLMDLLAGELT
>WP_030695745.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
EQRGERVLLRSTVPADTPVLDAIVRESEVARWWPPPEAYAAMLAVVVEGEVIGAIQFSEE
SDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTHAIRSYR
KVGFAPVGIMRAYWRNHRTGAWEDGLLMDLLAAELT
>WP_000155092.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKE
KRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITS
LAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDN
DVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKT
LIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGV
>WP_026966955.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MEIKDIQDLAREHGLLLSEEMEFNEMGIDFRVGFAKDLDGRPWLLRIPRREGLGEQIDEE
KRILKLAGQHLSVQVPDWKIATPNLVAYPLLDGKPALTFDADTYEVTWNMDQNSPHYIPS
LAKALVELHGIPQEEVRANGLKVLSPQAVRTEIADRLQLVKSELGISEALEQRYLKWLDQ
DALWPDFTRFIHGDLYAGHVLTSPTGAVSGIIDWSTAQVADIALDFSGHATVFGEESLKA
LVTEYQKQGGEVWDKLFEQSLERAAAAPLAYGFFAVETQDEKHILGAKAQLGV
>WP_014386803.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANE
KRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPS
LAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDN
DALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKN
LIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGV
>WP_000369216.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASTNNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>1SD6_A|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEELSQDEIEELRNIL
NKK
>WP_025904161.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYDISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>AIS76191.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSMWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDHVQSLDPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LFPLISMDYFNGTPMHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_012102963.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAMI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFIADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_002941309.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVALVRIPKLGDQVQSLEPNFIGEMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLIMASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>ETI84131.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_012818050.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIETNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_031784491.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQENFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_002487653.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEILAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELIKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>CAB82516.1|FEATURES|NCBI|nitroimidazole|nimE|antibiotic inactivation|1
MFREMRRKRQLLPQEESVAILEKMTNGTLALHGDNGYPYAVPLSYVYADGKIYFHCAKIG
HKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYILTDETEKRMALTLLMNKY
SFGEPGLSDEIAKSFNHLLMVKIDIEHMTGKEA
>EFF39147.1|FEATURES|NCBI|multidrug|PmpM|antibiotic efflux|0
MLLDLDRFSFSVFLKEIRLLTALALPMLLAQVAQVGIGFVDTVMAGGAGKEDLAAVALGS
SAFATVYITFMGIMAALNPMIAQLYGAGKTGEAGETGRQGIWFGLILGIFGMILMWAAIT
PFRNWLTLSDYVEGTMAQYMLFTSLAMPAAMVHRALHAYASSLNRPRLIMLVSFAAFVLN
VPLNYIFVYGKFGMPALGGAGCGVATMAVFWFSALALWIYIAKEKFFRPFGLTAKFGKPD
WAVFKQIWKIGAPIGLSYFLEASAFSFIVFLIAPFGEDYVAAQQVGISLSGILYMIPQSV
GSAGTVRIGFSLGRREFSRARYISGVSLVSGWVLAVITVLSLVLFRSPLASMYNDDPAVL
SIASTVLLFAGLFQPADFTQCIASYALRGYKVTKVPMFIHAAAFWGCGLLPGYLLAYRFD
MGIYGFWTALIASLTIAAVALVWCLEKYSMELVKSHKAV
>WP_023318187.1|FEATURES|NCBI|beta_lactam|OKP-B-7|antibiotic inactivation|1
MRYVRLYLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>WP_003651390.1|FEATURES|NCBI|beta_lactam|OXA-324|antibiotic inactivation|1
MYKKALIVTTSILFLSACSSNSVKQHQIHSMSANKNSEEIKSLFDQAQTTGVLVIKRGKT
EEIYGNDLKRASTAYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
NAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AMQ12639.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGFIIAAFLLAR
>AAS18386.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIIAAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_031989990.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVSEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_058662444.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGDGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>YP_007547181.1|FEATURES|NCBI|sulfonamide|sul2|antibiotic target replacement|1
RNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>CAY33090|FEATURES|NCBI|trimethoprim|dfrK|antibiotic target replacement|1
KVSLIAAMDKNRVIGKENDIPWRIPEDWEYVKNTTKGYPIILGRKNLESIGRALPGRRNI
ILTRDKGFSFNGCEIVHSIEDVFELCNSEEEIFIFGGEQIYNLFLPYVEKMYITKIHYEF
EGDTFFPEVNYEEWNEVSVTQGITNEKNPYTYYFHIYERKA
>WP_032989463.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDNAGQPARD
YTHYAFTVSEADFPLMVGKLIASGVKTWKSNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYRGMTFFD
>CCP89052.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MNKIAVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKEIDISDFITSI
DDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFPKVKKLKRPDINLIDTKEISYLGW
NDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTY
TKKGDYICYDSFKCNQNLDDINNLYEFIVKTK
>WP_018685137.1|FEATURES|NCBI|aminoglycoside|kamB|antibiotic target alteration|1
MRRVTGKQVVDLGPSEFAELRARHVGAVLDVGTGDGKHALHLARTHPDHLVIGLDAAKDN
LRKSAAKSAASPRKGGLPNLLYIWAAAEQLPAELREITELHVLMPWGSLLRGILGDDPAM
LSGLANLCAPDARFLITLNLHAWRPPVPEVGDNPEPTPDSATESLGPLLAAAGWHLDEAA
YLDADAIAALATSWTRRLNSSRDQLEVLALTGVVNP
>WP_037420882.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LNPAQPLSSAPPYTLFEQWAQPVAPFQMFPHVYYVGTRNLSSVLLSTPEGLILIDAALDA
SAPTIKAHIEALGFDIKDLRYILNSHARLDQAGGIARLKAWSGAKVVASAANAEQLALGG
KQDFALGDALSFPPVKADIIVGEGDSITLGGLTLTALMTPGHLPGATSWLTTLRQGEQNY
RLVYADSLATPDYYLIDNKNYPDLVQDIRGSFARLAEQQADIFIANKGTRFDLENKMVRL
RAGDLDAFVDRQGLQHYVKESQKVFEAQLA
>CEJ95855.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNQNIKFTQNFITNEKLLSNIMKQINIDENDIIYEVGTGKGHLTSKLAEKCKHVYSIELD
KKLYELSSNKLQDNSRVTLINQDILQFNYPYRKKYKIVGNIPFNISTQIVKDAVFRSQAS
EMYFIVEEGFYKRMIDTRRTLSLQLQTQVYIQQLLPIPAGSFHPKPKVNCILIKLTRHIS
DIKDKHKKKYEFFISKWVNKEYSKLFTKNQYHQALKHARIKDLNKISYEQVLSVFESYIL
FNPRK
>WP_000960976.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MLVQQGRLAIRALQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTVIEVFIEDQGETTPC
LVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRD
YLITDKAAQRLVLDPQSRNSRAIACYEKCGFEKLRLLPAHEMHEGQLQDCWLMQYYPARS
SLMASSRPKI
>CAM88403.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MLVEQGRLAIRALQKSDAPVMLHWLQDERVLEFYEGRDKRFDLQTVIEVFIEDQGETTPC
LVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRD
YLITDKAAQRLVLDPQSRNLRAIACYEKCGFEKLCLLPAHEMHEGQLQDCWLMQYYPARS
SLIASSRPKI
>AKI29920|FEATURES|NCBI|beta_lactam|blaOXA-460|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVTRRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>WP_007810578.1|FEATURES|NCBI|beta_lactam|JOHN-1|antibiotic inactivation|1
MRKLVVSIILFLTILSNGFGQSKNSELPISHLTGDFYIYKTFHDYKGTQISANAMYLVTD
KGVVMFDAPWDKAQFQPLLDSIKAKHNKEVIMCFATHSHDDRAGGIAFYKQKGIKTFTAK
LTDEILKKNKEPRARYVIPNDTVFSVGQHAFRVYYPGKGHAPDNIVVWFEKEKILYGGCF
IKSTEAEDLGYLGDADVKEWEQSIKRVESKFKNPKYIIPGHEDWENTESLNHTLKMVQEY
NAE
>WP_047502869.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDITRDEILNTFNSRDTTIRSNVE
KLMNVQLTKEQAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYI
GWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKGFYSICNKESRVALFMRKTRTGNDGQ
YTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ
>WP_044096634.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAYLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_031730929.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCEFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>ABL74962.1|FEATURES|NCBI|glycopeptide|vanXYC|antibiotic target alteration|0
MELRTPRLRLIPLDPDRDASGLHAAFGDPEVMRWWNHVVCADVAETRERLRESVDRDGAH
LWVIRRGEACEPAGMVGLLGEVDVPGLTWLLCKDAWGRGLATEAAGAVVEHALGPLDLPR
VEAWVEATNERSLAVARRVGLTERGRLAQRYPHRERPHEMVVLGRARDHEPTPMLNAEVA
LPVRDVAATLTLLREALGGRTLFSVGDPPEVAGVSFGPWSVGPRLQLVSTRRWRIARVTL
YLDVGVELEALHDRAVDAGADVVQRPTEQPWGMRECVVQLPEGHHIVLTAPA
>AAW53146|FEATURES|NCBI|fosfomycin|fosB|antibiotic inactivation|1
ITNVNHICFSVSDLNTSIQFYKDILHGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNEIS
HSYTHVAFSIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDLDGHKIELHTGTL
KDRMEYYKCEKTHMQFY
>AHB87392|FEATURES|NCBI|fosfomycin|FosB|antibiotic inactivation|1
IQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEVQ
YSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGTL
ENRLNYYKETKPHMVFY
>AAP50248.1|FEATURES|NCBI|fosfomycin|FosK|antibiotic inactivation|1
MITGINHITFSVRDLRASIEFYRDLLGMKLHVFWDTGAYLTAGNTWLCLSLGQPEPAKDY
THVAFSVREGELLELRAKLKQAGVEEWKQNTSEGDSIYLLDPNGHRLELHCGTLATRLAE
LESSPYKGLVWS
>EMI48985.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iak|antibiotic inactivation|1
MTGSAATTRPATAADAVAWAQLRLGLWPDADDPLETLVAALAEDAGAVFLACAAGGQAIG
FAEVRLRHDYVNGTDSSPVGFLEGWYVQPQWQGRGVGRALLAAVRAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>ENV20093|FEATURES|NCBI|beta_lactam|OXA-230|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNGKATNTEVFQWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLKLMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIESRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPAERKQLTLSILDKLGLFFYLR
>BAQ33942.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQLYPYQFNYIKERIAHLLNTYKSVNDLNTITSIKETTKEDIYQQFHQTDDTLIEAID
KLMNIRISKTQVDKILATLQTYVRPFEHPSKKQIEKTFRKIKKLKSPLISDEILLESTYI
GWNDIASNRKFIIYYDEQELLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQ
YTKKGDYICFDSIKCNQQLSDITQFYQFVDKIQS
>AAA88548.1|FEATURES|NCBI|aminoglycoside|aac(6')-Ie|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DNATNVKAMKYLIEHYFDNFK
>AAA88548.1|FEATURES|NCBI|aminoglycoside|aph(2'')-Ia|antibiotic inactivation|1
VDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIE
YSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECT
IDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLL
LDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQ
DIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYK
>ZP_18898211.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PTLMPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCST
FKAPLAAAVLIGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVS
DNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLM
GRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSP
AGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLD
>WP_044247329.1|FEATURES|NCBI|beta_lactam|blaA|antibiotic inactivation|1
MRLLVTTLSLIPSIILATPQLHDSFKSLENKYDGKIGIFTVNTDNKTNIKYNENYHFPIC
SVFKFLLVGAVLDYDMHNQGFLDKKIPITQDDIGTLGYAPITAKNIDKSLTISQLNYAAI
LSDNPAANILVREIGGLQNLNKFIKKLGDKDTIIIADEPKVNHTKPDSNINKTTPKAITK
DIYKLAFGNVLDKKHKDIFIKYLQDNNTGANRIAFSMPKDWIIGDKTGTCGQYAATNDVA
IIWPKNQQPIGLGILYTNPNYKNAPSNEEIIQQAAKLIANDLANVYK
>WP_044139565.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKWLFSGIVLMALCISQSSSTEARSPAWSVDEFFKNREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDSWNRDHTLGSGMRDS
VVWYYQAMARDIGEKRMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYE
ETLPFDLKTMRTVKRMMVQEEEKHATLYGKTGSGSGIDWYVGFIKHENKTYIFATNIEGT
GIEAKDITYRILKKYHLIEASA
>WP_034280751.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKHMKWLFCTIMLMAFCIGQPSSSEGTSPAWSVDEFMKDREGTFVIQEVKEKSPWVYN
KKRANERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNKDHTLGSGMRDS
VVWYYQAMARDIGEERMNHWVKAIHYGNEDISGGIDQFWLSSSLKLSPVEQVHFLKQLYE
ESLPFDLSVMRTVKRMMIQEEEKHATLYGKTGSGSGIGWYAGFIKHENKTYIFATNIEGT
GLKAKEITYRILKKYHLMEASV
>WP_023204046.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLVLSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAAPLRAAQREYLGLEQQDWH
ILLPAVVRFVDFAKTHIPTQFT
>WP_039517854.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTDAACRLIIRVTGDTLRAIHLYGSAVAGGLKSNSDIDLLVTICQPLTE
AQRVTLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQQDWH
VLLPAVVRFVDFAKAHIPTQFT
>WP_052934797.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
TQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLAPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPAAQLLKALRYPLGLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRTAQREYLGLEQQDWH
ILLPAVVRFVDFAKAHIPTQFT
>WP_038985126.1|FEATURES|NCBI|beta_lactam|MUS-1|antibiotic inactivation|1
MRKILSTVALLICATVAHAQSDKLKIEKLNDHMYVYTTYQEFKGVQYSSNALYILTNDGA
LLIDTPWDKDQYEPLVNHIKKEHHKDVKWVITTHFHEDRSGGLDYFNKLGAQTYTYSLTN
DILKDRNEPQALHTFGQEKQFTFGKEKLAVYFLGEGHSKDNTVVWFPKEKILYGGCLIKS
AEATTIGNIEDGNVADWPKTIEVVKRKFSEAKQVIPGHDAWDMSGHIENTERILSAYAQQ
NSIKNK
>WP_042391810.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
NISAQVIDTIVDWIDDNLHQPLRIDDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLR
LAAQELRDTDQKVFDICVKYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_007370976.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFMQYKGESLGRYIRERKLA
LAAQDLRNTDQKVYDICLKYGFDSQQTFTRTFTRTFNQPPGAYRRENH
>WP_048286929.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHRPLRIDDIARHAGYSKWHLQRLFLQYKGESLGRYIRTRKLY
LAARDLRDTDERVYDISLKYGFDSQQTFTRVFTRAFKQPPGAWRKEHQ
>WP_052283763.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVIDTLVEWIDNNLHQPLRIDEIARRAGYSKWHLQRIFLQHKGESLGRYIRTRKLN
LAADELCTTDQKVYDICLKYGFDSQQTFTRIFTRTFNQSPGAYRKENH
>WP_024549283.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETISDWIDENLHKPLRIDDIARHAGYSKWHLQRLFQHHKGESLGRYIREKKLK
LAAQDLRATNDRVLDISMKYGFDSQQTFTRLFTRRFSMSPGSYRRQRD
>WP_004871504.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
FISESVIAVIIDWIDDNLHKPLRIEQIAHYSGYSKWYLQRLFLQYKGESLGRYIRHKKLD
SAARDLRETDENIYSIGLRYGYDSQQTFTRLFTRHFHLPPGEYRKKNK
>WP_064377368.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
FISEAVIAVIIDWIDNNLHKPLRIEQIARYSGYSKWYLQRLFLQYRGESLGRYIRNKKLD
SAARDLRETDENIYSIGLRYGYDSQQTFTRLFTRHFHLPPGEYRKKNK
>AAL55263.1|FEATURES|NCBI|beta_lactam|blaCGB-1|antibiotic inactivation|1
KKSIPFFIISMLLSPLANAQDTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLVT
KKGVVLFDVPWQKTQYQSLMDTIQKRHHLPVIAVFATHSHEDRAGDLSFYNKKGIKTYAT
AKTNEILKKEGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGGC
LVKSKAAADLGYTGEANVAQWPKTMEKLKSKYAQATLIIPGHDEWKGGGHVEHTLDLLNK
K
>ACY01749.1|FEATURES|NCBI|beta_lactam|blaIMP-26|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLS
>WP_032492430.1|FEATURES|NCBI|beta_lactam|KHM-1|antibiotic inactivation|1
ALVISFGLLLFTNMVCADDSLPELDIQKIEDGVYLYTAYEKIEGWGLVGSNGLVVLDNKN
AYLIDTPISATDTEKLVKWIDAQGFTAKASISTHFHTDSTGGIAFLNSKSIPTYASKLTN
QLLKNKGEEQATHSFGKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPE
GLGNLSHAVIAEWPASAEKLIARYSNATMVVPGHGKVGDASLLEKTRQRAVEALAAKK
>AMP47005.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSM
>AMP47132.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFVSGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDALIMQTVVDGLVYPICSQTYIQEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINAYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVYKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQMASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSM
>WP_008148693.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSI
>WP_049432229.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSLWRLRRDGEAIETPRAHLWPVLTAAGEPAMLKVSDEPEEQNAHRLLRWWAGDG
AAQLLAHEGPAILIERAGGDSLRQRSIQGDDDACTTILCEVLQRLHRPRSATPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAEGLLQDEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRSERFAARLQQVSALAGLERTRLLRWIAASTG
LSAVWFRDDGDPADIDETVAQMALEALAEA
>WP_062197191.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEIPNISESEWEVMKVLWKRAPQTANDVISSLQEQTDWKPKTIRTLLDRLVHKKVIGVNK
NQRVYTFFPLYSQDECQRAEAQSFIKRIYGGALKSMLVQFVQEDSLSETEIRELRSILNE
R
>WP_047911872.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KQVPKISESEWEVMTVLWERAPRTAGEVIDALQQRTDWKPKTIRTLLDRLVKKQAVSINQ
DTKVYTFAPLFSQYECQQAETQSFVKRIYGGTMKSMLVHFFEDNAVSDEEIKELRSLLNE
K
>ADE08372.2|FEATURES|NCBI|tetracycline|tet(45)|antibiotic efflux|1
ILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSD
QLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPK
ENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEV
IKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGK
NVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGG
LLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVS
SSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLL
LFAGITIISWLVTIKMHKRSRGNI
>AAB28795.1|FEATURES|NCBI|tetracycline|tet(K)|antibiotic efflux|1
VLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYMLTFSIGTAVYGKLSD
YINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAFPSLIMVVVARNITR
KKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIVTIPFLIKVMVPGKS
TKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHISRVSNPFINPKLGK
NIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIFPGTMSVIVFGYFGG
FLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMGGLSFTKTVISKIVS
SSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLEFINYSSGVYSNILV
AMAILIILCCLLTIIVFKRSEKQF
>WP_028502503.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAINGLCAFLVAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGFGGAIWVLVLARVIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALSGIGTMIGPAIGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRIATIKLRDVQPFAVFKDAFGRKELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDIVIQGVLLGILLPRIGERGVIVSGIIAQMIGLAALAIVASVFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAAIVVSRAHIADTAKRPTGDTTGETPAELAETVG
>WP_055874188.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLAAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGFGGAIWVLVLARVIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALSGIGTMIGPAIGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRIATIKLRDVQPFAVFKEAFGRKELRGLMIGFGLIALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGVVDILIQGVLLGILLPRIGERGVIVSGIVAQMFGLAALAIVASIFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAVIVVSRAHIANSAKRPEGPVVHGISTEVAETVV
>CAA53389.1|FEATURES|NCBI|tetracycline|tet(A)|antibiotic efflux|1
KPNIPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACAP
VLGALSDRFGRRPILLVSLAGATVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIA
DITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLL
PESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRF
HWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGW
MAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAA
SITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQ
>WP_015431547.1|FEATURES|NCBI|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLTLYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAACASAMSD
VTPAKNRTRYFGFLSGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTT
>EFZ06149.1|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNMHGESRYML
PLNH
>WP_011727797.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAV
EVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRR
LLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDA
GLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQIRQRLPTPVPRTWLRANGIAPN
SLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVG
QRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASF
DSSASTTLVSRKARVNGPTPPGLGDT
>WP_050236693.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKINSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_007596156.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIFEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFDPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_040356223.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MKQKNPKHTQNFITSRKHVKEILKYTNISKQDKVIEIGSGKGHFTKELVEMSQWVTAVEI
DENLCKTTEKAVKPFNNIEVIHEDILKFNFPKSNDYKIFGNIPYNISTDIVKKIAFDSQS
KYSYLIVERGFAKRLRNTQRALGLLLMLELDIEILKKVPPTYFHPKLSVDSVLIVLERHK
PLILKKDYKKYRSFVYKWVNREYHVLFTKNQLRQALKHGNVSDLDKISNEQFLSIFNSYK
LFQ
>WP_064968553.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LENFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRLISEKFEINLNSQI
VCLSPSQWKNCFLEMLEVVPEKFHPS
>WP_023912127.1|FEATURES|NCBI|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
MHHTIARWVDRLREEYADAVAILLKGSYARGEAATWSDIDFDVLVGTQDVEDYRTWIEPV
GDRLVHISAAIEWVTGWERDTVDPSSWSYGLPTQETTRLMWAIDDDTRRRLDRPYKPHPA
AEPEVEDTVEALGKIRNAIARGDDLGVYQSAQTVARLLPTLLIPINPPAVVSHARQAIEV
ILAFPRVPEGFADDWLTCLGLVEQRTAQSTATAAERMVRGVLEMLPPDPDVVGEDIARLM
NAGLLEKYVQQ
>WP_064582324.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVPVWKDNKSEGQSFYFLDPDGHKLELHAGDLA
SRLAQCREKPYSGMRFGSGK
>WP_047360629.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGLSFYFLDPDGHKLELHVGDLA
SRLTQCRERPYPGMRFGPGK
>ABY48974.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
TVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEIL
QEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAAHADPAIVVAEMARALR
DLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFLQMPGA
EQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQFF
IEYGEPNPNIAKIEYYRILDEFF
>WP_060732357.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWGAVGDGASGADVYRLRGGGRELFVKVAAAEPGVGLFGEAERLA
WLAEAGISVPRVVESGGDGKVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHAL
DWERCPFDRGLAVTVPQAARAVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLVV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECVAAF
LREYGRGWDGEVSEEKLAFYRLLDEFF
>AAO32357.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MKTFNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>WP_063840321.1|FEATURES|NCBI|aminoglycoside|aac(6')-ib-cr|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTRQAFERT
RSDA
>WP_063840283.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPAPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>WP_063840282.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPCIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>AIT97187.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iae|antibiotic inactivation|1
EYKIVDIALDSKLVKVAAEILFYTFSEINNESWPTINSATEEVKECIEDKNICIGVLVED
KLVGWIGLRPMYENTWELHPMVVLSKWQGKGLGKILIFELEKRAKEQGINGIVLGTDDET
FRTSLSMKELDKNDLFEEIKNIKNINHHPYEFYQKCGYKIIGVIPDANGKNKPDIWMWKK
I
>ACO54181.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MNTRETIAADLSRLGVQSGALVMVHASLKAIGPVDGGAASIVSALLDAVGPTGSLMGYAS
WDRSPYEETLNGARMDAELRHRWPPFDPAISGTYRGFGLLNRFLLQTPGARRSAHPDASM
VAVGPLAGTLTRPHELGQAFGPGSPLERFVERAGKVLLLGAPLDSVTVLHYAEAIARIPN
KRRVSYEMPIRSEDGGVRWKRAEDFDSNGILDCFAIEGEPDAVETITNAYVELRRHREGL
VGQAHCYLFEARDIVSFGVDYLQRHFGS
>WP_052095933.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MRSKATITADLRRLGLRPGDLVMVHASLKALGPVEGGAAGVVQALMDAVGPGGTVMGYAS
WDRSPYEETLNGVRMDEALRRDWPAFDPRTAGTYRGFGLLNRFLAELPGARRSAHPDASM
VAVGPLAGTLVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPMQGPDGRTVWEAATDFDSNGILDCFAVEGRPDAVETIARAYVETGRHREGM
VGAARCHLFDAQDIVAFGVGWLERHFGS
>WP_011749422.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRGKASITADLRRLGLKPGDLVMVHASLKALGPVEGGAAGVVQALLDALRPGGTVMGYAS
WDRSPYEETLNGARMDEALRRDWPAFDPRTAGTYRGFGLLNQFLADLPEARRSAHPDASM
VAVGPLAGTLDEPHRLGQALREGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPMPGPDGRTIWEAATDFDSNGILDCFAVEGQPDAVETIARAYVATGRYREGM
VGAARCHLFDAQDIVAFGVDWLERQFGS
>WP_003525983.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRGSIIESLQKLGVQPGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPSGTVMGYAS
WDKSPYEETLNGARLGDEARRSWPPFDPATAGTHRGFGLLNQFLVQAPGARRSAHPDASM
VAVGRLAETLTQPHDLGHALGEGSPVERFVRLGGKVLLLGAPLNSVTALHYAEAVADIPN
KRRVTYEMPIAGNDGEVVWETAADFDSNGILDCFAMEGEPDAVETIATAYVQLGRHRDGI
VGSAPCYLFDAQDIVSFGVSYLEQHFRP
>WP_009492021.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MASRTSITTELRRLGMSGGDVLMVHASLKKIGPVVGGAHAIVGALCHAVAPAGTLMGYAS
WDRSPYGETLNGAQLDEEMRHNWPPFKPDTARVYPGFSLLNQFLVDTPGALRSAHPDAST
VAVGPHAAELIEPHRLGQAFGPGSPLERFVKREGKVLMFGAPLDSVTVLHYAEAIADIPT
KRRVTYEMPLLGPNGQTVWERAEDFDSSGILDCFANDGEMDAVETIARAYVALRRHQEGR
VANAHCYLLDAQDIVSFGASYLEQRFAG
>WP_020696664.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
ESEIVNQLRTLGVEAGGVLLVHTSFRALRPIEGGPLGLIAALRTALGPDGTLVMPSWTGD
DATPFDPATTPAAADLGVTADLFWRQPGVVRSDHAFACAASGPKAEAIVKTALPLPPHAP
DSPVGRVRDHDGQVLLLGVGHDADTSLHVAELLTPVPYGVPRHITGRGDDGRPMRVDYRE
NDHCCQRFALADDWLRARGLQAEGPVGHGTARLARAQDIVRLAVDALRAVPLLFLHGAEE
GCEECDEARASVP
>ODT18015.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
VSDVVGQLRALGVEAGGVLLVHTSFRALRPIEGGPPGLIAALRTALGPDGTLVMPSWTGD
DATPFDPATTAAAPDLGVTADLFWRQPGTLRSDHAFACAAVGPKAEAIVKTALPLPPHTP
DSPVGRVRDHDGQVLLLGVGHDADTSLHVAELLAKVPYGVPRHITGRGDDGRPMRIDYRE
NDHCCRRFALADDWLRAWGLQAEGPIGHGTARLARAQDIVRLAADALRDDPLLFLHGAEE
GCEECDEARASLP
>WP_010788791.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSESEMMRLILDLGNRDKRIRLVTLEGSRTNKNVPRDRFQDYDISYFVTDIDSFKSNDEW
LKHFGEMIMMQKPEDMELFPPELGDWFSYLMLFKDDSKIDLTLIPIDQMEQYFSDSDGLV
EVLLDKDLRVKNTITATDERYHIKKPTAREFDDCCNEFWMVSTYVVKGLMRKEILFAWDH
LYEILRPNLLRMISWNIGIQHNFSLSVGKNYKYIQRYMDEKDWGHLLNTCVGDTYENMWK
SLFGCYELFRKYSRTVAAQFNYDYPHYDEQLSAYSMKFYN
>WP_061861938.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEDEMMKLILDIAMKDERIRLVTLEGSRTNKNVPRDRFQDYDISYFVTDMDSFTSDESW
LDQFGERMMMQKPEDMELFPPELGDWFSYLMLFKDHHKIDLTLIPLSQTEDYFTQGDGLA
EIVLDKDDRINHKIIASDEQYHIKKPTPREFDDCCNEFWMVTTYVIKGLMRKEILFALDH
MNDILRPNVLRMIAWNIGIENQFSLSVGKNYKYIQHYMNAKDWEILLNTYVGNTYESVWK
ALFDCQGLFRAYSKSVAVLLRYEYPEYDQQITEYTLKHYQ
>WP_065292925.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RTEREMMDLFIEFAKQDDRIRLVTLEGSRTNKNIIPDTYQDYDISYFVTNLDSFKADDQW
LDVFGARLMMQKPEDMELFPPELGNWFSYLILFEDGNKLDLTLIPMNEVEAYFADSDGLV
EVLLDKDTLVPDGVVPDDRQYWIKKPSAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LHEVARPNLLRMMAWHIGTEHGYTFSVGKNYKFIDRYLIEEDWDLLLSTYAESSYPSMWQ
SLFTCYELFRKYSKAVAEHHGYPYPDYDRAITTYVREIYD
>WP_035204920.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMALFLDFAKNDERIRLVTLEGSRTNKAITPDKFQDYDISYFVTDIDSFKENDQW
LDPFGKAIMMQKPEDMKLFPPELGNWFSYIILFEDGNKLDLTLIPLNEVKDYFSQSDGLV
EVLLDKDRLVKNEIVADDRHYWLKKPTEREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNGIARPNLLRMMAWYVGSERGYTFSVGKNYKFIDRYLPKEDWEALLSTYCEKGYAETWQ
SLFTCYELFRKYSKGLSASLGYNYPDYDEAITAYSASIYD
>WP_036624446.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNLFLDFAAKEDRIRLVTMEGSRTNVNIPPDSFQDFDISYFVTDMDFFKESDEW
LGVFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPVNESELYFAESDGLV
KVLLDKDRLVKNEATATDRGYWLKKPTAREFDDCCNEFWMVSTYVVKGLARQEILFAIDH
LNEIARPNLLRMMAWHIGSVHGYTFSVGKNYKFIDRYLPREDWETLLSTYNGTGYPEMWR
SLFTCYELFRKYSKAVAESLGITYPDYDEAITKYTGAIYD
>WP_043066377.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNMLVDFAMKDNRIRLVTLEGSRTNKNIPPDTFQDYDISYFVTNIDSFKENDQW
LNIFGNRMMMQKPEDMELFPSELGNWFSYIILFEDGNKLDLTLIPINEVEDYFTKSDGLV
KVLLDKDTLIKNEVIADDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGSEQGYTFSVGKNYKFINRYLPNEDWEAILSTYSQNGYQEMWQ
SLFACYELFRKYSKAVAGSLGYKYPDYDEAITTYTVNIYN
>WP_032944434.1|FEATURES|NCBI|quinolone|qnrB30|antibiotic target protection|1
ALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKD
AIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSY
ANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGD
LDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_038635452.1|FEATURES|NCBI|beta_lactam|EY04_27815|antibiotic inactivation|1
AITLTHFKGPLYIVEDKAYVQENSMVYIGADDITIIGATWTPETAEALEKEIRKVSALPI
KEVINTNYHTDRAGGNAHWKKLGASIVSTQMTYDLEKSQWKSIVDFTRQGFDKYPRLKES
LPDKVYSGDFELQSGRVRALYLGPAHTEDGIFVYFPSERVLYGNCILKEKLGNLSFANRT
EYPKTLKKLKELIDQGELQVESIIAGHDTPIHGVELIDHYLALLE
>WP_033669393.1|FEATURES|NCBI|beta_lactam|bcere0021_23020|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSLTSLEAFTGGPMQVEAKEKKGQIKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRQMGDRVTMS
DRFETELNEAIPRDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAE
VIVNAFR
>WP_041184920.1|FEATURES|NCBI|beta_lactam|bla|antibiotic inactivation|1
ILKNKKMLKIGMCVGILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKKQATHKEFSQLEKK
FDAQLGVYAIDTGSNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRKMGDRITMS
DRLETELNEAIPGDIRDTSTAKAVAMNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAE
VVVNAFK
>Q45726.1|FEATURES|NCBI|beta_lactam|BcI|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKQKTGQVKHKNQATHKEFSQLEKK
FDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDL
VDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKRIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIR
AGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEATE
VIVKALK
>AAM48120.1|FEATURES|NCBI|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQVLALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSV
>WP_005801014.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITINNDI
HYPMMSVFKFHQALALADCMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTIGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_046982544.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRPHMLALSLAAAVLPIACASAAEAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTENL
TALLVQTAEGAVLLDGGMPQMAGHLLDNMKARGVAPQYLRLILLSHAHADHAGPVAELKR
RSGAHVVANAESAVLLARGGSDDLHFGDGITYPPANADRIVMDGEVVEVGGIEFTAHFMP
GHTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLKGNPRYPRLVEDYKRSFATVRALPC
DVLLTPHPGASNWDYAAGARAGAKALTCKAYADAAEQKFDAQLAKETAGAR
>WP_045184442.1|FEATURES|NCBI|beta_lactam|blaB1|antibiotic inactivation|1
KGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYVVTDK
GVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISDYQ
QKQKASN
>WP_001608097.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTMLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_020366668.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKCYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQSPTVESRSHDLNHNINTTKPVQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKSLLYLKYLKRQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_054192916.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNVNNQAPKVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLIVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDRHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYIAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQKNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKEMGVLNGQ
>WP_049305913.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLVFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNLNNQAPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKNKINKILFNHQYKRNIVIRKAESIHSPTTFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKSYAEAIMDSVLKTPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQISKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>WP_025663215.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQSPTVESRSHDLNHNINTTKPVQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKSLLYLKYLKRQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKYEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQLSKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFSTHLSDEKASGENAKLINEKILKEMGVLNGQ
>WP_000952924.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQYEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_053000968.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEGNANGEKAQQISERILKEMELI
>OBP41431.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGAGPVGLTMARLLQQNGVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
MKKAGLLQTYYDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQN
NTVIWDRKLVALEPDKEKWVLSFEDKPNETADLVIIANGGMSKVRKYVTDTEVEETGTFN
IQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQ
VDFQNRNSVVDFLLKKFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQ
NEIEMFKPDFTFQQLLNV
>AKL03765.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MDKLPNFIFENYSDLKIERDTEGWSPAEVYSVTTKKKRWFLKRSHTRYNKTTYNVRREKE
IIEWAYPKFRVPQIIHYEEAKEYNSLLMNHIGGSSLEMLGPSITLEKYIDYYVQSLKLMQ
SINIENCPYNNCIKNRIIELEYLLENDLADINSNNWEEDTREHFRNGKDLFNYIVNNKPN
EDLVFSHGDMTNSNIFIENEEVGFIDLGRCGLADKWVDIAFCVRDIREISNENKWIKMLF
DKLEIVPNWDKMRYYILLDELF
>WP_034602208.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|0
VKILSRGLLAVYLVILIWLVLFKLQYDILSVFNYNHRSLNLNPFAAPLKLNGSINFGEMI
NNFIIFIPFGMLINVNYKRVGFLPKFTMILGFSLTAELIQFIFAIGATDIIDVITNTVGG
ILGLKLYSFSNKYISSIVLDRVIIAFGTLLLVFLLYYRIFILRLIY
>ABG88877.1|FEATURES|NCBI|aminoglycoside|aadA3c|antibiotic inactivation|1
TIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRA
LLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
MIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERN
VVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>WP_052484405.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKSWLFLTVAILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVLKSIPIGVAY
AVWSGLGVVLVTAVAWGLYGQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>WP_025265915.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLSAAIICEVIATSSLKPSEGFTKIAPSLLVIIGYGAAFYLLSLTLKSIPVGIAYA
IWSGLGIVLVTLIAWFIHGQKLDLWGYVGMGLIVGGVVVLNLLSKTSAH
>WP_027069939.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KSWLFLAIAIVAEVVATSALKSSEGFTRLGPSALVVGGYGVAFYFLSLVLKTIPVGVAYA
VWSGLGIVLIAAVAWLVHGQKLDAWAFVGMGLIVSGVAVLNLLSRTSVH
>ACS73595.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWIFLAVSILGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>WP_049237932.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSMPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDFWAFIGIGLIVSGVAVLNLLSKVSAH
>WP_049194240.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWIFLAVSIFGEVIATSALKSSHGFTKLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDLWAFVGMGLIVSGVAVLNLLSKVSAH
>WP_043106116.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLAIAIFGEVVATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAVAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>WP_049392010.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGNKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_000733620.1|FEATURES|NCBI|beta_lactam|SH09_09290|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_049401912.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKTNKNFLLDLMLNNKNGDTLIKDGIPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>WP_005128660.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDIKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYVSSELKDLFKSGNFAWSIGPSIDLLIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDVLATHAHMGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGISKV
>WP_002049977.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALIACVNMQAPQPAITSHIPQNFSQNHSGKTIAERSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSVKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHTIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATEATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMKFNNQIEIYKALGGGISKS
>WP_032041245.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGRAARQVDLSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKIQLDSYRLNKKRFEVGIDSEVPLKQAQISVEIARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRAGV
DSYFSVLDAQRSAYAAQQGLLALEQMKLNNQIEIYKALGGGISKS
>WP_050548367.1|FEATURES|NCBI|chloramphenicol|cat|antibiotic inactivation|0
MPKLTSAIPVLTALDVAAAVQFWTRQLGFSELFNSAGEFAGVGRDSVTLYISYAEDQSIP
DNTQAWIRVADLDALHAEWQEVLGADAAGSSDATLTDIGEMPWGNEFVVIDPAGNCVHFA
AE
>AMP47510.1|FEATURES|NCBI|beta_lactam|BL1_sm|antibiotic inactivation|1
RCNKNVLSVVLLGALTLSAGSAFGQLSRADVDAVIRPLMSQYQIPGMAVALSVDGQHTFY
NYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQFNELASHYLPSLKGSAF
DRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQTWQPTSPIGSQRVYSNLGIGMLGLIT
AQSLQKPFSEAMEQDLLTPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPLDAEAY
GLKSSSADLLRWLDLNMAISPLSPAWQHAIAESHKGYYQTGEFTQALMWEYYPWPTTKEK
LLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANK
WYPNDARIEVAYELIERLKK
>WP_049065661.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSSSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVKALEIGKPIGENTFQTISFTPVKVDKVIHDGEVVKLGKFKLKATLTPGHTPGCTTWST
EVKSNGKNLNVVFPCSLSLAGNVLQNNHQYPNIVADYRKSFDRLKNMKADIVLTSHPEVA
DVLGNKARKDDGQINAFIQPEKLSNIVKDAEMAFEKSLVSSHP
>ESK39014.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MSETLQLEQLTGSLQQLLGESLFAIYLYGSAVDGGLGPESDLDVLVVVSQALTLQQRQQL
AETLLKISYPIGAAQRALEVTIVLKAQILSGSYPLSYELQFGEWLREELNQGALLRTHTD
PDLSILLKKAQVHHRSLLGPSLTQWSTAIPEQHLWQAMADTYPSIVEHWDEDADERNQIL
ALCRIYFSLVTSEIVPKDQAAHWVIAQLPSQHQPILQRMIQEYKGEIGKQSWQQQHQALG
AVVDFLSSKIDEQFKKKS
>ENX32354.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MLETLQLDQLQTALQQLLGESLFAIYLYGSAIDGGLGPESDLDILVVVNQVLTLQQRQQL
AETLLLISHPIGRAQRALEVTIVLKQQILSGSYPLSYELQFGEWLRDALSQGAILSTHTD
PDLSILLKKAQMHHRTLLGPSLTQWSAEIPNQQLWLAMADSYPSIVAHWDEDADERNQIL
ALCRIYFSLVMDDIVPKDQAAQWVIPQLQQQHQIALQRMSQEYKGEIGKQHWPSEHPTLQ
AIVDFLNMKITALLEHKI
>WP_075446173.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALLDKNIRLVTLEGSRVNKKAKKDKYQDYDVSFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPNLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTTSIKQIKKTRKKLEILFHKNAKFVAKKNDFKLFPYRKNVKKYCKILRKL
>ARF19224.1|FEATURES|NCBI|quinolone|QnrB17|antibiotic target protection|1
MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG
>KZQ37978.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGKFTRAQ
LKDAIFKSCDLSMADFTHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>SMC86227.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KIREEKLEQIIQWAENNPDIRAVLLTSSLVNPYAPVDDLSDLDVELVFESRKDYESGNSW
LQLFGDPISMIEEDDTVFEGRHAMKMVLYRDHVKVDFKLYQVSEFMEEVQKGALPEDWDV
GYKVLIDKDGLTKDLKPPTYQSIMIHKPDEKEFQQLMNDFWWDTTYVAKCLKRGDIFYAK
FMSENILRAEYLVSLVEWHIGNDHNWDNMTTNKHGRLFKKYLPEDLWSRMEATFSGSSID
ENWTALFAFADLVHELGTALAQKLNFTYPSKLESDIRTYLLEVKS
>WP_087879616.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFVLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>WP_026141143.1|FEATURES|NCBI|beta_lactam|blaAQU-2|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQFMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSE
QTLLTGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAANAILSKLAP
>WP_026141765.1|FEATURES|NCBI|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVLKGGQAH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANISGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAEPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>WP_044639852.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
IGPDPNDKYPIPGNSNLQFIKNMITKPNIIVGDYSYYDALNGESFEDQVLYHYEIIGTKL
IIGKFCSIAPEVRFLMDGGNHRMDGSTFPFNIFGNGWEVHTPSLKDLPIKGDSIVGNDVW
IGRRATIMPGVRIGDGAIIGAEAVVVKDVEPYTIVGGNPAREIQKRFSPEIIQELLDIQW
WDAEIELINLYIGAIVSGDINTLRKMKQ
>WP_094943952.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MNPYVLLISAILFEVFGSSMMKASNGFKKLVPTVGLVIGMGSAFYFLSKALEHIPLGTAY
AIWSGAGTALTAIVGILVWKEKFNLKILLGLLIIIAGVVVLKLSH
>AFN94077.1|FEATURES|NCBI|qa_compound|emrE|antibiotic efflux|0
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGYFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>CAA25642.1|FEATURES|resfam|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVM
PSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLP
LPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVR
VDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFL
HPPEGGMRRMRCRSPVDWLSS
>ACX47985.1|FEATURES|NCBI|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
MQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
GDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRLDRPYKTHPA
AEPEVEDTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEA
ILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLM
NAGLLEKYVQQ
>2BFK_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADCIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2BC2_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGXLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_001420781.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MRKLSLLIAGLFLFGLFTAGMKPAHAAEGSAAKDVTLTQLAPHVWMHTSTGTADGNPVPA
NGLLLETSKGIVLIDTPWNDSLTEQLMTQIKKRFPGKRMTDAIVTHAHDDRIGGLNTLYK
YGVKVHSTKLTADFARQQGYDRPLGDLKNVTKLQFGDMKIETFYPGKGHTEDNITVWLPE
DKLLFGGCLIKALETKEIVPTPGFYPDQWPRAVRKVMKRYRDISIVVPGHGSPGDDRLLP
HTINLLKET
>WP_009879416.1|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
MEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVH
TELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAH
ADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKG
HTEDNIVVWLPQYNMLVGGCLVKSASAKD
>WP_003190608.1|FEATURES|NCBI|beta_lactam|M2E15_0562|antibiotic inactivation|1
MKEGVEKMKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNK
NVWVHTELGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTRERAYRR
>WP_006229611.1|FEATURES|NCBI|beta_lactam|GIM-1|antibiotic inactivation|1
MNKLILSLLFVFSLTSLPSFAENNNSKLDITLVTDNVYLVKSYRILKPLDPLEQSITMDA
NSIIYVDGKDAYYIDTPWNATDMPELMAWLDDHELILKKTVFTHFHEDQTGGLNYLLDHK
FETYASQKTNQLLIKEGKSAANNEFTVGSFEFLKDKIEVYYPGAGHTSDNLVVWLPKENV
LIGGCLLRASEIKNIGWIGDADTEQWTQSVQKVQGKFPNVKFVIPGHGAVGGNHSIITHT
IKVVNEFNTKK
>YP_001761954.1|FEATURES|NCBI|beta_lactam|BL3_shw|antibiotic inactivation|1
MSKQIDLFITKFKVIRLFTHLLPCLFLLGVSSITAAAPSSSQVNWSSELIKITQVYPTLY
LVKSYKTIKLYQDKPAQTFDSNSFIYVDNSDAYLIDTPWSESDMPDLMRWLEVKKLQLKG
TIVTHYHQDRAGGLGYLDRLGSATYASKMTNKLLVNDKQPTSNHSFSGDKFALLKGKIEA
FYPGSGHSMDNLVIWLPEEKVIVGGCLLKDNKVNNLGWTGDADLANWYHSISKVKAEFPK
VEFIFPGHGEGAKGQSILDHSLSVTKEVARFE
>ACU65242.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPAHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>1WUP_A|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
AESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNAEAYLIDTPFTAKDTEKLV
TWFVERGYKIKGSISSHFHSESTGGIEWLNSRSIPTYASELTNELLKKDGKVQATNSFSG
VNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKPYGLGNLGDANIEAWPKSA
KLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKKPSKPSN
>ACE77794.1|FEATURES|NCBI|beta_lactam|VIM-17|antibiotic inactivation|1
MFKLLSKLLVYLTASSMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>WP_008199227.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKTQAFLLILLFVYQQQSVFGQKKEFAYNSESLQVEQISQNTFLHISYLNTDDFGKVACN
GMIVINEGEALVFDTPANEEASLELINWLEKEQQVTVKGVVATHFHWDCLGGLDEFHRKG
IHSYASAKTIALAKSVGYPVPEIDFKKKLILEAGSIKIVNQFFGEGHTKDNFISYVPADQ
VIFGGCMIKAIGAGKGNLEDANLSEWSATVEKVKSAFPDTQIVIPGHGKIGGTELLDYTA
EMFEKK
>WP_003002951.1|FEATURES|NCBI|beta_lactam|PEDO-3|antibiotic inactivation|1
MRFNKSIFLILFLLTMAHSGFSQEPGLKIEKLTKDFYIYTTYVAYSGVKTSANALYMLSK
DGVILFDTPWDPDQYQPLLDSIRNRHHQEVIAVYATHSHEDRAGGFGFFN
>ADL70857.1|FEATURES|NCBI|beta_lactam|NDM-10|antibiotic inactivation|1
MGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYP
GPGHTSDNITVGIDCSDIAFGGCLIKDSKAKSLGNLGDADTEHY
>YP_004391384.1|FEATURES|NCBI|beta_lactam|cphA6|antibiotic inactivation|1
MMKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>BAF47409.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLAKETAGAR
>WP_005413585.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRDAMKEAHASFWASFKRTWIMRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWL
QPMAPLQVADHTWQIGTEDLTALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLR
LILLSHAHADHAGPVAELKRRTGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRI
IMDGEVVTVGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPR
YPRLIEDYKRSFATVRALPCDLLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFD
AQLARETAGTR
>BAF47406.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLQTLAISLAALLPAAAYAAEPQLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVQTPQGAVLLDGGMPQMADHLLRNMKARGVAPQDLRLILLSHAHADHAGPVAALKRST
GAQIVANAESAVLLARGGSHDLHFGDGITYPPANADCIIMDGEVVTVGGIDFTAHFMPGH
TPGSTAWTWTDTRDGTPVRIAYADSLSAPGYQLQDNPRYPHLIDDYRRSFATVRALPCDI
LLTPHPGASNWNYSAGAKAGAKALSCKAYADEAEKKFDAQLAKETAGAR
>BAF47408.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
HTWQIGTEDLTALLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHAD
HAGPVAELKRRTGASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEGVTVG
GIAFTAHFMPGHTPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRR
SFATVRGLPCDLLLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETAGA
R
>ADC79554.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITALLVK
TPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATGAQL
VSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHTPGS
LSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLLITP
HAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLK
>NP_001170718.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MDGEVITVGGIAFTAHFMPGHTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLQGNPRY
PHLIEDYRHSLATVRALPCDVLLTPHPGASNWDYAAGSKASAKALTCKAYADAAEQKFDA
QLAKETAGAR
>YP_002131811.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MIRRTYGISGAAVLWAAAFACPAAAQGQAPEPGNAPVKPFQVADGVWWVGASDVAAYLIQ
SNKGLILIDGGYESTAPQILDNIRRLGFDPAGQVKIILNSHAHVDHAGGLSALKAATGAK
LYASAEDGRLMARGGKGDFFLGDKYAYPPVKPDRTLRDGQKVKLGERTLTARLTPGHTRG
CTTWTFPVTVAGVERQAMILCSNTVLPGYRLTGQESYPGIAADFEKSYAVWRQAPCEVFL
ASHAMFFRAHEKAKSGRPDAFMDPEGCRAFFEKGYAGFKAILSRQQQAADR
>WP_001082971.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_001238554.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MLVATLSLAAGSAAAQSLPDLMKQMIAAWNKPTEPFKVIDNIYYVGTNGLASYLITTPQG
HILIDTVMPESTAQIEASIAKLGFKVADIKYILNTHAHIDHTGGLAQIKQETGAQMVAGA
KDVPLLEGGFYPGREQESHLNFPPVKVDRAVHEGDTVTLGGVTLTAHETPGHSPGCTSWT
TDVKDGEATRSVIFFCSATVALNQLVGRPTYPGIVDDYKKTYAWAKTVHPDILLAPHPEM
FDLAAKRAKIAEGGPNPFVRPGEFNAYLDRLETQFNEGLSKQTAALQTGK
>WP_010239973.1|FEATURES|NCBI|beta_lactam|AIM-1|antibiotic inactivation|1
MSARLAALAALALVAGGCAPAPESPATADPVAHDVVSSPDMAASFPQSAFLEKCEDWDEW
DTPAPPFELLGDTWYVGTCGISALLVIGDGEHILIDSGVEDAAPLILANIRALGIDPRDV
GYLLMSHEHFDHVGAHAALVEATGAEVIASPIAAQVLSSGEASADDPQAAIHPAMTPVKV
DRIVSDGEVLTLGGKEFTAHFTPGHTPGAMSWTWNACSLPWQPPVCRRVAYVDSLSPVSA
DDYRFSDHPAVVADFRRSIAKVAKLPCDLLTTPHPSASGMLDRMADGGLLDGAACADYAK
AIEKRLNERLAKEGE
>NP_462637.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_001438455.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MSFQLSRIKKALIILRLLIQEMIMKPRIALFSCLMSLLSVPAHAALDPAQPLAEAPPYSL
FEAWAKPVQPFAIWPGVWYVGTENLSSVLLTTPQGHILIDAGLDASAPQIRRNIEALGFR
MADIRYIANSHARLDQAGGIARLKAWSGARVIASHANAEQMARGGKEDFALGDALPFPPV
SVDMEAQDGQQWHLGGVTLAAIFTPGHLPGATSWKVTLADGKTLIYADSLATPGYPLINN
RNYPTLVEDIRRSFARLEAQQVDIFLANKGERFGLMDKMARKARGENNAFIDKAGLAQYV
AQSRAAFEKQLAAQRAQP
>YP_828073.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MPTFSVRCALIAAFAAGSAAQSSSSWTEPFPPHRIAGNLYYVGSRGLASYLIATPEGHIL
INSSLKTSVPLIETSITKLGFQLSDVKILLVSHAHWDHNAGSADLKGRTGAKYMVMEPDV
PVTEDGGKSDFFYGDSPESLYPPAKVDRVLHDGDQVKIGGSVLTAHLTPGHTKGCTTWTM
KVSEGGKTYDAVIVGSPNVNAGFQLVNNAKYPRIADDYVRTFEVLRALHCDIFLGAHGDY
YGLERKFSRYAANGPGVFIDPDGYRAYVAEREEAFRRELERQKKK
>YP_616949.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MIEVMSLFLWLAGAGGTPVPAIDPLTQPIETSRSAEWLAPAEPEKIFGNTYLVGFAGLSV
ALIDTGDGLVLVDGALPQAAPAILANVRKLGFDPQDIKYILSTEPHFDHAGGLAALARDT
GAAVVASVRGAEGLRSGRHAADDPQLGYGGSWPAVANVRTMKDGEVLRLGTTAITAIATP
GHTMGSMSWTWQACEGRVCKAVVFASSLNPVSADGYRFTSRAGKPFIKGFEASYRKMDAV
PCDILISAHPDNAGNGRYSEKAGACRAYADRSRRALARRLASERVETPK
>YP_003124215.1|FEATURES|NCBI|beta_lactam|LRA-12|antibiotic inactivation|1
MTLPKKLLPIALIAALIGGMTPRSQAQKLIKDLYVDKEWSADYQPFRIAGNLYYIGTYDL
GMFLITTPKGHILINTGVAGSDTLIKAHMKTLGFKFKDIRILLTTHAHYDHVGAMAAVKQ
QTHAKMMVNEKDAALLADGGNSDYVMGGKGSMFLPVKADRLLHDGDSIQLGGMKIVMRQH
PGHTPGANSFLFDVKDAVRTYKVLIANIPSILNDTKLSGMPLYPEVGKDYAYTLKAMKAL
KFDLWLAPHAGQYELHKKHQPGDAYNPAAFSDRAGYDDVLDEWQQIYDKRVKEE
>ABO48510.1|FEATURES|NCBI|beta_lactam|ETAF_2879|antibiotic inactivation|1
MMNTRLSCTLALSALLLSSGAQASTPPSAEMRVAEAVKQTIPALMQQQQIPGMAVAVIYQ
GTPYYFSYGVADKATRRAVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDTVASQWPA
LNGPQWRAITLQQLATYTAGGLPLQVPDAVTDTAQLLDFYQRWQPRWAPGTMRSYSNASI
GLFGMLAVRPSGMDFSQAMTRWVLQPLGLKHTYFRVPPAAEGEYAWGYREGKALRVSPGM
LEQEAYGIKSSAQDMATWLQANLDPAAVTQATLRQALLRAQTRYYQSGEMYQGLGWEMLS
WPLQAQTLIDGSDNRVALQPQPVHLIEPPTPPQPASWVHKTGSTNGFGAYIAFIPGSRLG
IVMLANKNYPNPARVQAAYTILQQLQ
>YP_410551.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>WP_004874984.1|FEATURES|NCBI|beta_lactam|ampC_2|antibiotic inactivation|1
MMKKSLITTLVLTAIAASPLSTSAQTKLTEQQVAAIVNDTLKPLIEKQDIPGMAVAVFYD
GKPQFFNYGVADIKAGTPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTDYAPE
LTGSQWKAVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPEWAPGEMRNYSNASI
GLFGALAVKRSQLTFEEYMKKSVFQPLKLNHTFITVPESMLPNYAWGYKEGQPMRVTLGM
LGEEAYGVKSTTKDMVRFMQANMNPESLPVENDKLKQALIAAQSRYFQAGEIFQGLGWEM
YNWPIDPQRVIADSGNDVALKPRKAKELLPPPPAVRASWVHKTGATNGFGAYIVFIPEQN
IGIVMLANKNYPNPVRVQAAYNILQALR
>CAM96571.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|ErmN|antibiotic target alteration|1
MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMT
VEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVR
LIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFD
RGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARK
VLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR
>WP_001082092.1|FEATURES|resfam|tetracycline|tet41|antibiotic efflux|1
MPDFSIGRFMNRSLFIIFATIALDAIGIGLIFPILPLLLQDMTHSTHISIYMGILASLYA
AMQFIFSPLLGALSDRWGRRPVLLISLAGSAVNYLFLTFSHSLILLLVGRIIAGITSANM
AVASAYIVDVLHENNRAKYFGLINAMFGAGFIIGPVLGGFLSEYGLRLPFFAAAILTGLN
LLSAYFVLPESRKVTLENKQLSTLNPFKIFAGISSIRGVLPLITTFFIFSAIGEVYGVCW
ALWGHDTFQWSGFWVGLSLGAFGLCQMLVQALIPSHASRLLGNRNAVLAGIACSCFALAV
MAFAQSGWMIFAIMPIFALGSMGTPSLQALASQKVSADQQGQFQGVIASTVSMASMIAPM
FFSTLYFQFQEKWPGAIWLSVILIYLLTLPIILYSTRPVVQQR
>YP_792720.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLP
PDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQ
VFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAF
AAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVR
AKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLI
PVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPF
EAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTL
SPMMCSRLLRHEENPSGLAHRLDLIFEGLKRRYQRALHGTLDTRPVVLVFAVLVLALIPV
LLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYN
GVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFV
LNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDL
GVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIE
THERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYV
QEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYT
QVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVI
PLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH
>YP_001670703.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLASVVSLLILLLGFQAWNKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASAEGIDYMTSVSRQNFSIISIYARIGADSDRLFTELLAKANEVRNKLP
QDSEDPVLSKEAADASALMYVSFYSKEMSNPQITDYLSRVIQPKLATLPGMAEAEILGNQ
VFAMRLWLDPVKLAGFGLSATDVTNAVRRYNFLSAAGEVKGEYVVTSINASTELKSAEAF
AALPVKTSGDSRVLLGDVARVEMGAENYDTVSSFDGTPSVYIGIKATPAANPLEVIKEVR
RIMPELQSQLPSALKVSIAYDATLFIQASIDEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHMEEGKSPF
DAALEGAREIAMPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGIVALTL
SPMMCALLLRQEQNPSGLAHRLDQLFERLKVRYQKLLHATLDSRPVVLVFAVIILCLIPV
LLKFTQNELAPNEDQGVIFMMSSSPQPANLDYLNAYTDQFTPLFKAFPEYYSSFQINGFN
GVQTGIGGFLLKPWNERERTQMELLPLVQAKLEEIGGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYPALLEVAQRIKARAQESGKFAFLDVDLAFDKPEVVVDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERPYRDNPGWLNNYYVKNDQNQLLPLSTLIT
LTDRARPRQLNQFQQLNSAIIQGVPMVSLGEALKTVQDIAREEAPEGFAFDYAGVARQYV
QEGSALWVTFGLALAIIFLVLAAQFESFRDPLVILVTVPLSICGALLPLFLGISSMNIYT
QVGLVTLIGLISKHGILIVEFANQLREERGLSVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGTVIATGMSIGTLFTLFVLPCIYTLLAHKAKAKEAAIA
>WP_011763962.1|FEATURES|resfam|multidrug|MuxB|antibiotic efflux|1
MFNWIVRYSLANRLFVLALALLMMAYGAYTAWKTPVDVFPDLNKPVVTVLTEAGGMAPEE
VEQLVTFPLETALGGMPGVTRVRSVSGVGLSIVYAEFDWGTDIYRNRQLVSERLSLVREQ
LPTGITPMMGPVSSIMGEVMLIGLPLAADGKVSAMQAREYADFVLRPRLLSIAGVSQVIP
IGGEVRQLRVEPDTARMAQVGVSLTQVEEALRGFASNAGGGFIDLNRREYLIRHLGRGNN
VEDLAGLAVAWKDGRPVLLEQVATVRFAPSLKRGDAGYNGGPAVIVSVQKQPDADTVKLT
GQIEVALAELDHGRPAGLAAPKVLFRQANFIEASIGNVSEALRDGAIMVAIVLFAFLLSA
RTTLISLVAIPLSLAVTALVFQLLGQSINVMTLGGLAIAIGELVDDAVVDVENILRRLKQ
NRALPNPAPVLEVVAAASVEVRSGIVYATIIVCLVFVPLFALPGIEGRLFSPLGIAYIVS
ILASMLVSMTVTPALSSFLLPRMKRLDHGDSPLVAKLKVWDAKLLTWSFPRAKLLIGIAA
LAVAAAAASVPFFPRAFLPAFNEGSLVLGMVLNPGTSLEEANRLGALAETLIREVPEVTQ
VGRRTGRAELDEHAEGVHAAEIDVDLHPSERGREAVMADIRDKLSVLPAQVAIGQPISHR
LDHLLSGVRAQVAVKIFGDDIDTLRGLAEQMRQGLASVPGLVDLTVEKQVLIPQITVRLD
HRKAAQAGLTPGEAVRLLQALTDGAHSAEIVDGPRRYDLVLRLADARRSPQDLARTLIDT
PAGRLPVSAIATVQETDGPNQVGRENGRRRIVVYANTDGSDMGRVIADVRAVIARTPMPA
GNFVTLEGQFQAQEQATRLIAGLSLVSLAMIFLVLYSRYKSAVLAGVIMANIPLALIGSV
VAMWLAGVTLSVASMVGFITLAGIATRNGILKVSHYINLCRFEGETFGDAMIVRGSLERL
TPVLMTALVAAFALTPLLLAADAPGKEILHPVAVVIFGGLVSSTLLDTLLTPVIFRLVGE
KPTRRLLEGGEEGAVQGLPQEAY
>WP_011767098.1|FEATURES|resfam|multidrug|adeJ|antibiotic efflux|1
MAAEQGLAGRLAAAFQRNAITPLIALVLMLAGVFATLVTPREEEPQIDVTMANVIVPFPG
ASARDVEALVARPAEQVLSRMAGVEHVYSVSRPGMAVITVQFEVGVPNQTALVRLYDTVH
SNRDWLSPQLGVGEPVVKPKGIDDVPILALTLWSADDTRAAYEMQQVSRALELELKRLPG
TRDVQTLGGPDRVVKVDMDVARMNAHGISAQDLRGALQLANASQPAGSMVADNREVLVQT
GAFIESAEDVRQLVVGVSGGRPVYLRDVAEVGDGPDQPSRYVWFGSGAAAAAKGIDGAGR
FPAVTLALSKKPGANAADVAAAALARVEALRGSLIPDGVQLTVTRNYGETANDKAQKLIG
KLVFATAAVVALVFFALGWREALIVGIAVSLTLAATLFASWAWGFTLNRVSLFALIFSIG
ILVDDAIVVVENIHRWHTLEPDTPLWRLIPRAVDEVGGPTILATFTVIAALLPMAFVTGL
MGPYMSPIPINASMGMFISLVVAFVVTPWLAQRLLKSAEAGHHPGDDALTRRLDGMFRRV
MTPMLDATHGARARARLWLAVLVLIAVSLALPAMQWVVLKMLPFDNKSEFQVVLDMPVGT
PVEETARVLGEIGEHLGTVAEVTDWQAYAGTAAPINFNGLVRQYYLRSSPELGDIQVNLT
DKAQRTRKSHEIAVSVREAVAAIARRNGGNAKVVEVPPGPPVLSPIVAEIYGPDYAGQAE
VAARVRAVFERTADIVGVDDTVDEAAPKLLLRVDQAKAARLGVAQADIVDVLRLGLAGEN
VTPLHGGDNKYEVPVRVQLPARHQSDIGNLLAMKVRARGAESGGRLVAVGELVTVQETRR
EQVIYRKDLLPVVYVTGDMGGRLDSPLYGMFGIRVEVKDMALGGAPGLAGTLDEWFIRPP
ADAWSGYSLKWDGEWQVTYETFRDMGAAYAVGLVLIYLLVVAQFRSYLVPLIIMAPIPLT
LIGVMPGHALLGAQFTATSMIGMIALAGIIVRNSILLVDFINQQLAEGSDFGEAVIRAAA
VRAKPIGLTALAAMIGAVFILDDPIFNGLAISLIFGVFISTVLTLVVIPMLYFAAMRRRA
GALNSQPQGETA
>resfam_SHV-4|FEATURES|resfam|beta_lactam|SHV-4|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQLQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-16|FEATURES|resfam|beta_lactam|SHV-16|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETDRWETELNEALPGDARD
TTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGE
RGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-21|FEATURES|resfam|beta_lactam|SHV-21|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_065365892.1|FEATURES|resfam|beta_lactam|SHV-86|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASRRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-90|FEATURES|resfam|beta_lactam|SHV-90|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-103|FEATURES|resfam|beta_lactam|SHV-103|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALRGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-114|FEATURES|resfam|beta_lactam|SHV-114|antibiotic inactivation|1
MRYIRLCIISLLAVLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-115|FEATURES|resfam|beta_lactam|SHV-115|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWHADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAKRNQQIAGIGAALIEHWQR
>resfam_SHV-124|FEATURES|resfam|beta_lactam|SHV-124|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLDQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_004143591.1|FEATURES|resfam|beta_lactam|SHVL-9|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGLNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAV91761.1|FEATURES|resfam|beta_lactam|SHVL-75|antibiotic inactivation|1
LEQIKLSESQLSGRGGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAMLARVDAGDQ
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLVPNNKAERIVVIYLRDTPAS
RAERNQQI
>ABD90508.1|FEATURES|resfam|beta_lactam|TEML-40|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASWQQLIDWVEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIK
>ABQ14361.1|FEATURES|resfam|beta_lactam|TEML-46|antibiotic inactivation|1
AIIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14371.1|FEATURES|resfam|beta_lactam|TEML-82|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKANDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRFVVIYTTGSQATMDERNRQIAEIGA
>ABQ14366.1|FEATURES|resfam|beta_lactam|TEML-86|antibiotic inactivation|1
ARIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELPTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14436.1|FEATURES|resfam|beta_lactam|TEML-89|antibiotic inactivation|1
GLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLFRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTAIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDGRDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14423.1|FEATURES|resfam|beta_lactam|TEML-90|antibiotic inactivation|1
ALIPFFAAFCLPVLAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYPPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHATRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14367.1|FEATURES|resfam|beta_lactam|TEML-99|antibiotic inactivation|1
ALIPFFAAFCLPVFALPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNGLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
LDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>resfam_TEM-7|FEATURES|resfam|beta_lactam|TEM-7|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-102|FEATURES|resfam|beta_lactam|TEM-102|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-123|FEATURES|resfam|beta_lactam|TEM-123|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>resfam_TEM-41|FEATURES|resfam|beta_lactam|TEM-41|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
TGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-37|FEATURES|resfam|beta_lactam|TEM-37|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-51|FEATURES|resfam|beta_lactam|TEM-51|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
HGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-60|FEATURES|resfam|beta_lactam|TEM-60|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDPNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-46|FEATURES|resfam|beta_lactam|TEM-46|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_063864910.1|FEATURES|resfam|beta_lactam|TEM-35|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-42|FEATURES|resfam|beta_lactam|TEM-42|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGVRVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-65|FEATURES|resfam|beta_lactam|TEM-65|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI20743.1|FEATURES|resfam|beta_lactam|TEML-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIDEIGASLIKHW
>AAD28531.1|FEATURES|resfam|beta_lactam|TEML-127|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAV54522.1|FEATURES|resfam|beta_lactam|TEML-131|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGALVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABQ43167.1|FEATURES|resfam|beta_lactam|TEML-142|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEASPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>2XDO_A|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MGSSHHHHHHSSGLVPRGSHMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDND
REARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRF
DNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGG
MSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNN
GALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATR
IFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAV
KNYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV
>YP_001084779.1|FEATURES|resfam|multidrug|adeB|antibiotic efflux|1
MNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEM
AQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNV
VEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDL
PAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILEN
GKPATAAAIQLSPGANAVKTAEGVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIH
TLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAI
GIIVDDAIVVVENVERIMATEGLNPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGS
VGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTK
KYELMLLKIIKHTVPMMVIFLVITGITFAGMKYWPTAFMPEEDQGWFMTSFQLPSDATAE
RTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSA
VNTSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNK
KFYMVWNEGLPQGDNISLKIDREKLSALGVKFSDVSDIISTSMGSMYINDFPNQGRMQQV
IVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIP
NFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAAL
YESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKM
LKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMI
SATILAIFFVPVFFIFILGAVEKLFSSKKKISS
>WP_011764345.1|FEATURES|resfam|multidrug|oprM|antibiotic efflux|0
MTASVARLRLAPVLLAALVAGCAFTEPVARPDQPLPAQWTEQPGPAAATPLPDTWWQSFG
SPALDALVAEALVASPDLQVQAERVLQAELALRQTRASLFPWLTLDADSGWRRADAGDRG
ASTVTETKTTSLGLSASYEVDLWGRVAANVGSARASLNATRYDRDSVRLSLAASVATTYF
QLLTLQERLEIARQNLAIAERVLRVVEARYRNGAASALEVSQQRTTVLTQRAAIEPLEVS
VRQTRSALAILLGRNPQDAAPEFERLEALAIPTVTPGLPVELLLRRPDLASVEASLAAAS
ADIAAARAALLPSISLSAGGGVASSLLLSLADPGTTVSLSASLVQTIFDGGRLQAAVDIA
RSRQRELLESYRSAIITALKEVEDALGNASRDANQEAAQREILAEAQRALRLAELRYREG
AADLLTVLDAQRTLFSAQDQLAQLRQARLTDAVGLYKALGGGWRAENSMAAGG
>WP_001140999.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLV
NGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMP
LMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILA
FVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMV
IIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSA
LLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYL
IVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFG
AKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF
>WP_000213885.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTD
QSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNNGEEAVAAKNPESEEYKVN
EKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWL
MTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAI
GAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGM
FIIGIIAILVGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIET
MFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQ
NLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNM
DTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAIL
VTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGI
NDAFIVATIFSIIALILCLFLQSNKKAKATAQKLEASSNNNHE
>WP_000128093.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|LmrB|antibiotic efflux|1
MTAYPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQVFLVGISIFFLGT
LLGGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYMGIFGLVIGLAPAI
GPTLSGYLVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPIDFISVIFSVLGFG
GLLYGTSSISEKGFDNPIVLVSMIGGVVLVALFVLRQYRLSTPLLNFAVFKNKQFTVGII
IMGVTMVSMIGSETILPIFVQNLLHRSALDSGLTLLPGAIVMAFMSMTSGALYEKFGPRN
LALVGMAIVVITTAYFVVMDEQTSTIMLATVYAIRMVGIALGLIPVMTHTMNQLKPEMNA
HGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMSDYNGMNKIDMMNQIKVDTMLHGY
HAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>WP_000857095.1|FEATURES|resfam|multidrug|emrB|antibiotic efflux|1
MKTQTPFAELSGGRLLLAAFVIALSNFMVVLDTTIANVSVPHITGNLAVSSTQGTWVVTS
YAVAEAICVPLTGWLAGRFGTVRVFIFGLIGFTVFSFLCGLATSLEMLVFFRIGQGLCGG
PLMPLSQTLLMRIFPQEKHAQAMGLWAMTTVVGPILGPILGGLISDNLSWHWIFFINLPV
GIVCVLAAMRLLRVAETETISLRIDTVGLGLLILWIGALQLMLDLGHERDWFNSTSIVVL
ALTAAIGFVVFLIWELTDKHPVVDVKVFRHRGFAISVLALSLGFGAFFGSIVLIPQWLQM
NLSYTATWAGYLTATMGFGSLTMSPIVAKLSTKHDPRALASFGLILLGIVTLMRAFWTTD
ADFMALAWPQILQGFAVPFFFIPLSNIALGSVLQQEIASAAGLMNFLRTMAGAIGASIAV
TVWDDHAKVARSEMVSNLHTTEVQNTLLQNGFTADSTLGIISNLVDKEAITMSANHVFLL
FAIVFVFAGLVIWLCPKPKQVSGMPSH
>NP_308991.2|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|1
MKKRKTVKKRYVIALVIVIAGLITLWRILNAPVPTYQTLIVRPGDLQQSVLATGKLDALR
KVDVGAQVSGQLKTLSVAIGDKVKKDQLLGVIDPEQAENQIKEVEATLMELRAQRQQAEA
ELKLARVTYSRQQRLAQTQAVSLQDLDTAATEMAVKQAQIGTIDAQIKRNQASLDTAKTN
LDYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLKPG
QKAWFTVLGDPLTRYEGQIKDVLPTPEKVNDAIFYYARFEVPNPNGLLRLDMTAQVHIQL
TDVKNVLTIPLSALGDPVGDNRYKVKLLRNGETREREVTIGARNDTDVEIVKGLEAGDEV
VIGEAKPGAAQ
>CBZ41941.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MLQQFLIMSIISSIMTLLLIMIVRIICIKYFKAQLNHKVWLLVVLSIFLPLIPINNLLQL
NIPGILSSDMISHSSKSINHNLSNENTNLTKDLALDIQHHEMPFILIILLVVWFIGLIFF
SFKFISAIKQIAFIKDLSIRSPILDNQLKKCINDLNIKEKSIAIIHVDEVENPMVFWLGK
YYIVLPTNIMDMMEEEEIDYIISHELIHIKNKDLWGNYIFTIFTSIVWFNPALHLAKKLF
NIDCEISCDNQVLTKLSQSNHTSYGKAILKCWAIQKQSVNNFAAKYLLGTQSNLKSRIVN
VSKFKNTRNRKWKFLPYVVLSVLILLQGLMVSDHSDKNEYTDDIKYTNLKGLGSHFSGFK
GSFVLYDNQKKEYFLYNEKESRKRYTPDSTYKPYLALIGFDKNVMSLNNTEQKWNGNENV
FKEWNQNQNLSSAMRYSVNWYFENIDRSIKNKDLKNYISELQYGNENISGSKNYWNESSL
KISAIEQVKLLMKIDNQQLKFDENYINAVKDSITLKKANQYRYLGKTGTGIINGKETNGW
FIGTIEKNGKSYYFATHLDGKNNASGKKAKDISEKILEEMELMQ
>NP_309628.1|FEATURES|resfam|multidrug|phoQ|antibiotic target alteration|0
MKKLLRLFFPLSLRVRFLLATAAVVLVLSLAYGMVALIGYSVSFDKTTFRLLRGESNLFY
TLAKWENNKLHVELPENIDKQSPTMTLIYDENGQLLWAQRDVPWLMKMIQPDWLKSNGFH
EIEADVNDTSLLLSGDHSIQQQLQEVREDDDDAEMTHSVAVNVYPATSRMPKLTIVVVDT
IPVELKSSYMVWSWFIYVLSANLLLVIPLLWVAAWWSLRPIEALAKEVRELEEHNRELLN
PATTRELTSLVRNLNRLLKSERERYDKYRTTLTDLTHSLKTPLAVLQSTLRSLRSEKMSV
SDAEPVMLEQISRISQQIGYYLHRASMHGGTLLSRELHPVAPLLDNLTSALNKVYQRKGV
NISLDISPEISFVGEQNDFVEVMGNVLDNACKYCLEFVEISARQTDEHLYIVVEDDGPGI
PLSKREVIFDRGQRVDTLRPGQGVGLAVAREITKQYEGKIVAGESMLGGARMEVIFGRQH
STPKDE
>P55922.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
MTISAQVIDTIVEWIDDNLHQPLRIEDIARHAGYSKWHLQRLFLQYKGESLGRYIRERKL
LLAARDLRESDERVYEICLRYGFESQQTFTRIFTRTFHQPPGAYRKENHSRTH
>WP_006809718.1|FEATURES|NCBI|tetracycline|tet37|antibiotic inactivation|0
MKKPLFICVVLVMIIASAASLPFVLNAGFGQPPQGAQLSEVEASPHYRDGQFHNTLPTPG
FTGQQNMLVAWWQFLTRKTENARPAQPLPLVKTDLASLSPDQDTLVWLGHSSWYMQLAGK
RILIDPVLSNYAAPFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIKALLPK
VKRVVTPLGVGSHLRYWGMSQDIIDERDWNQSVHISDALTVHVLPARHFSGRGIKRNQTL
WGSFMFVTPERKVYYSGDSGYGPHFKSIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETA
QASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDSTQ
QFREWWE
>YP_001083264.1|FEATURES|resfam|multidrug|golS|antibiotic efflux|0
MDIGEVAKKAKVTTATLRFYEEKGLIKSIGRQGLRRQYGKQVIDQLALIALGRAAGFSLN
EIATMFGQDGKPDLDRQKLKDKAEQLEQMAKRLHFISQGLEHAAVCPAENHMECPTFQKF
LKAAIAGEYQPTKL
>AAK45103.1|FEATURES|resfam|glycopeptide|vanXA|antibiotic target alteration|1
MSAGRWSESPSATSWPVRPVNTTTPSGPVPPVSEAARAAGLVDVRGVVPDAAIDLRYATA
NNFTGTQLYPPGARCLVHESMAEGLAAAAAVLRPHGQVLVFWDCYRPHDVQVRMFDVVPN
PAWVARPGKYAHSHEAGRSVDVTFASAQRQCPSVRRSGELCLADMGTDFDDFSSRATAFA
TQGVSAEAQANRAHLRAAMQAGGLTVYSGEWWHFDGPGAGVDRPILEVPVD
>CAA25445.1|FEATURES|NCBI|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>CAD56147.1|FEATURES|NCBI|bacitracin|uppP|antibiotic inactivation|1
MFREMRRKRQQLSAEESIAILERMTNGVLALHGDEGYPYAVPVSYVYADGKIYFHSAMKG
HKVDAIMRNERVSFCVVERDDVCPGEFTTYFRSVVLFGKTRILTEEAEKLAALSLLADKY
SPGEPGKDAEIAKGFNLLMVEIAVEHMTGKEA
>ABD22979.1|FEATURES|NCBI|fosfomycin|FosX|antibiotic inactivation|1
MGILGISHLTFVVRDVERTARLVCEGLGAEEVYDSKAKNFSLSREKFFLLGGVWLAFMEG
VPSERSYRHVAFEVTEEEIARYEASLRNLGVEVREPRPRVAGEGLSLYFYDYDNNLFELH
AGTLAQRLERYTQ
>CAP09892.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLSDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLNALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09894.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLAREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRAR
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPPGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>ACI16367.1|FEATURES|NCBI|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALVRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPTLASG
>CAT00035.1|FEATURES|NCBI|trimethoprim|dfrA5|antibiotic target replacement|1
MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYA
VVSRSGSVATNDDMVVFPSIEAAMGKLKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDS
EPEGNVFFPEIPKDFNVVFEQEFHSNINYRYQIWQRG
>ACO54027.1|FEATURES|NCBI|sulfonamide|sul1|antibiotic target replacement|1
MGLCRYGAHNCCLFARPIPIVEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAA
IEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRY
ALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVR
FFEARVSALRRSGVAADRLILDPGLGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSR
KSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDA
RDRGLDHA
>ACR40101.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVVAFGRIRILEDEAERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGK
>ACR40102.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKG
HKVDAIRGCDKASFCVIEQDEVHGEEYTTYFRSVVAFGRIRILEDEAERMAAARLLGDRY
HPHHEEALGRELAKSFSHMLVICLDIEHMTGK
>CAQ53849.2|FEATURES|NCBI|trimethoprim|dfrA5|antibiotic target replacement|1
MKVSLMAARARNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSAWTANNDNVVVFPSIEEAMGGLAKLNGHVIVSGGGEIYRETLPMASTLHVSTIDI
EPEGDVFFPNIPNFFEVVFEQHFSSNINYCYQIWKKG
>BAK53145.1|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MMKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGE
VEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKE
DGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVS
KKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETE
SRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRV
TIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLA
LVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTL
DDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKF
EKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALE
NNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSG
TAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYEN
GNKKYDIDE
>EJY24646.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYMVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>WP_004207704.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MALRKSLSLAALTACLVVTLPLSAAPKKKAPAKKAEEVPTLPTLMPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFG
LEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVSDNSAANLLLPMLGGPEGLT
SFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLMGRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDK
KAEAAIAEAAHSALEFVSKAQKSGLD
>WP_005812825.1|FEATURES|resfinder|nitroimidazole|nimJ|antibiotic inactivation|1
MNEFREMRRKRQQLSEEESIAILQKATAGTLALLGDNDYPYAVPISYVYADGRLYFHSAL
SGHKVDAIRKCDKASFCVIEQDEVHPEKYTTFFRSVIAFGRIHIIEDETEKLETARMLVN
RYNPNQEEALQKELENGLSRMLMIRFDIEHLTGKEAIELVRRHQK
>BAO48025.1|FEATURES|NCBI|fosfomycin|fosX|antibiotic inactivation|1
MEGISHITLIVRDLSRMTTFLCDGLGAREVYDSAGHNYSLSREKFFVLGGVWLAAMEGVP
PSERSYQHVAFRVSESDLAVYQARLGSLGVEIRPPRPRVNGEGLSLYFYDFDNHLFELHT
GTLEQRLARYGAGR
>AHU60294.1|FEATURES|NCBI|multidrug|smeR|antibiotic efflux|0
MRPRRSMLFIPGANAAMLSTSFVYGADAVMFDLEDAVALREKDTARLLVHHALQHPFYQD
VEKVVRINPLNTPFGLADLEAVVRGGADIVRLPKTDSKNDVLELEAQVERIERECGREVG
STRLMAAIESAKGVVNAVDIATSSPRMVAIALAAFDYVMDMGTSRGDGTELFYARCAVLH
AARVAGIAAYDVVWSDINNEEGFLKEVQLAKGLGFNGKSLVNPRQIELLHQAYSPTRKEV
EHAYEVIAAAEEAESRGLGVVSLNGKMIDGPIIDHARKVVALSASGIRD
>AJE61443.1|FEATURES|NCBI|beta_lactam|NDM-4|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGVVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AKI29907.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQAFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNIDIKDIKNIKIREELL
EKYLAIITN
>AKI29913.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>AKO62869.1|FEATURES|NCBI|quinolone|QnrB17|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AKQ05893.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMG
IYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVP
CHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLY
FSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQK
FLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQ
GNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQ
EVAEERSNKIMQEVEIAANMISLPNYE
>AKQ05895.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMG
IYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVP
CHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAY
FSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRR
FLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQ
GSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSK
EVAEERSNKIMQEIKIVSNMISLPNYE
>AKQ05898.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMV
IYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVP
CHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEA
YFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQM
QFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSG
QGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVS
KEVAEERSNRILQKVQIISNAIKLPEYE
>ALA99186.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFAAEG
VKGTIVVLDARTQTYQAYDAARAGKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRQYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI
>ALA99191.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MMMLSRWRRSAVVLRIAAALLSPLAVAIPAHADAIANAANAVAPKIVERADWGKYFDAEG
AKGTIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKP
RSMKRWNAAMNLRDAFRVSCLPCYQVVSRKIARTYAQGKLDAVGYGNHTIGSAADAYWVD
NSLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDI
GWWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI
>ALI92811.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>KPU95363.1|FEATURES|NCBI|bacitracin|uppP|antibiotic efflux|0
MTLSDMWNIGLMQGFAGLSLFAVLLLMGLGLAIIFGQMGVINMAHGEFMTIGAYSVFLAA
QVTEHLAPAFMPYYFPISIALAFVFAFIVGWLVEWALIRHLYKRPLDTLLATWGVSLGLQ
QIFRTFIGPKEVSPTLPEWLMGSWTPHEGLDIPINGMFVLVLTALVTGGVLIALHRSRWG
LRVRATVANRTMANATGIDTKKTDRLTFAIGCGIAGVAGAAFTTIGSTGPTSGSLYIVDA
FLVVTFGGAASLLGTVVSAFGIAQTQSVSEFFMTGSMAKVLTLSLIVLILMMRPQGLFAV
KVRR
>ALM24145.1|FEATURES|NCBI|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGDIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLNYYKEAKPHMNFYI
>AMR98919.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIFLLFGLFCSFALANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKANKRILPASTF
KIFNALIALNEDVVKDTNEIFYHYKGEKVFLPSWKNNANLALAMQRSQLPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWIDDSLQISLKEQATLLFKLANLTLDYPKHIQEEVI
NIIKLKENDHYELFAKTGWGLRQYGQIVGFIKSKKSDKIYAFALNMNISDFNKLYLREEI
VQLYLDQL
>AON96418.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRKVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
PNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>ARO85965.1|FEATURES|NCBI|beta_lactam|B224_5390|antibiotic inactivation|1
MSRILLSSLLAAGLFCSLPASAATGCMLFADGSGKPFSAQGDCASQLPPASTFKIPLALM
GYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSRWMTYSVIWYSQRLTEWLGAARFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGTGYPKLLDGSLDRDQQIGWFVGWASKQDQKLIFVHTVIQKP
GKQFASLRAREEVFAALPEQLKKL
>AEL00452.2|FEATURES|NCBI|quinolone|QnrB34|antibiotic target protection|1
MTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>BBB21811.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMHHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>AUN87920.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
VFVPFSIRYLIKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPI
IVWVTIAGFIPAILLFFVEIEYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGR
NNSNLQREIVPANFVNSTVKYVYNRYLAEPIPFTTLGDDAKRDTNQSKPTLMFLVVGETA
RGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNRARN
SEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKDHPKFCDKNTCYDEVVLQDLD
SEIAQMKGDKLVVFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDEELTNTYDNTI
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYTFAPDDQTRVPMQ
VWMSPGFTKEKGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNV
Q
>ALMZ01000078_optrA_20|FEATURES|resfinder|multidrug|salA|antibiotic target protection|1
LSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>DQ993182_1|FEATURES|resfinder|trimethoprim|dfrB7|antibiotic target replacement|1
MDQSSKEVSSPATDQFALPFRATFGLGDRVRKKSGAAWQGQVVGWYSTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
